Citrus Sinensis ID: 003982
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 782 | 2.2.26 [Sep-21-2011] | |||||||
| P43298 | 942 | Probable receptor protein | no | no | 0.920 | 0.764 | 0.494 | 0.0 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.826 | 0.541 | 0.312 | 1e-67 | |
| Q9LJF3 | 1164 | Receptor-like protein kin | no | no | 0.898 | 0.603 | 0.304 | 5e-67 | |
| Q9FN37 | 1036 | Phytosulfokine receptor 2 | no | no | 0.847 | 0.639 | 0.294 | 4e-66 | |
| Q8GUQ5 | 1207 | Brassinosteroid LRR recep | N/A | no | 0.872 | 0.565 | 0.291 | 6e-64 | |
| Q8LPB4 | 1021 | Phytosulfokine receptor 1 | N/A | no | 0.826 | 0.632 | 0.310 | 8e-64 | |
| Q9ZWC8 | 1166 | Serine/threonine-protein | no | no | 0.910 | 0.610 | 0.296 | 1e-63 | |
| Q8L899 | 1207 | Systemin receptor SR160 O | N/A | no | 0.869 | 0.563 | 0.291 | 4e-63 | |
| Q42371 | 976 | LRR receptor-like serine/ | no | no | 0.890 | 0.713 | 0.256 | 4e-63 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.913 | 0.571 | 0.293 | 1e-62 |
| >sp|P43298|TMK1_ARATH Probable receptor protein kinase TMK1 OS=Arabidopsis thaliana GN=TMK1 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 660 bits (1703), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 371/751 (49%), Positives = 480/751 (63%), Gaps = 31/751 (4%)
Query: 28 DGSVMLKLAQSLQNLPSD--WSSTSSTGYCEWTGINCDNSNRVTTISLAKSGLSGTLSPE 85
D S ML L +SL N PS WS C+WT I C + RVT I + SGL GTLSP+
Sbjct: 28 DLSAMLSLKKSL-NPPSSFGWSDPDP---CKWTHIVCTGTKRVTRIQIGHSGLQGTLSPD 83
Query: 86 ISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145
+ +L++LE L Q NNI+G +PSL+ SLQ + L NNNF S+P+ F GLT+LQ + +
Sbjct: 84 LRNLSELERLELQWNNISGPVPSLSGLASLQVLMLSNNNFDSIPSDVFQGLTSLQSVEID 143
Query: 146 DNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFF--DSFSNLQNLRLSYNNFTGSL 203
+NP W P L +++L ++AN+ G +P F D F L L L++NN G L
Sbjct: 144 NNP-FKSWEIPESLRNASALQNFSANSANVSGSLPGFLGPDEFPGLSILHLAFNNLEGEL 202
Query: 204 PASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDL 263
P S A S +Q+LW+N Q+L +G + VL MT L++VWLH N+F+GP+PD S + L L
Sbjct: 203 PMSLAGSQVQSLWLNGQKL--TGDITVLQNMTGLKEVWLHSNKFSGPLPDFSGLKELESL 260
Query: 264 SLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQ-KVSLDHNNFCKNSSDA 322
SLRDN TG VPAS++SL +L ++L NN LQGP P+F S V + D N+FC +S
Sbjct: 261 SLRDNSFTGPVPASLLSLESLKVVNLTNNHLQGPVPVFKSSVSVDLDKDSNSFCLSSPGE 320
Query: 323 GKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGN 382
CDP+V +LL IA YP L++SW+GN+ C W + CS G I I+L L G
Sbjct: 321 ---CDPRVKSLLLIASSFDYPPRLAESWKGNDPCTNWIGIACSNGNITVISLEKMELTGT 377
Query: 383 ISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKFTV 442
ISP + + SL+ + L NNLTG IP LT L +L+ LDVS+N L GKVP F SNV
Sbjct: 378 ISPEFGAIKSLQRIILGINNLTGMIPQELTTLPNLKTLDVSSNKLFGKVPGFRSNVVVNT 437
Query: 443 SPGNPFIGTNVDTTPGGAGTPGSKPSGPS---GSPAASSKSKLSVGTIVAIVVVVVIFIA 499
+ GNP IG + + + S SG KS +G IV V+ ++ I
Sbjct: 438 N-GNPDIGKDKSSLSSPGSSSPSGGSGSGINGDKDRRGMKSSTFIGIIVGSVLGGLLSIF 496
Query: 500 VVFFVVYKFIARRKHRKFGRVKNPEV---------GNEMNKNGVTGGNGTNGYNGVPSEL 550
++ +V+ + +R+ R G + V NE K V G + + G G+
Sbjct: 497 LIGLLVFCWYKKRQKRFSGSESSNAVVVHPRHSGSDNESVKITVAGSSVSVG--GISDTY 554
Query: 551 HSQSSGDVSDR-HLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIA 609
+ +V D + E GN+ ISI+VLR VT+NFS NILG GGFGVVY GEL DGTKIA
Sbjct: 555 TLPGTSEVGDNIQMVEAGNMLISIQVLRSVTNNFSSDNILGSGGFGVVYKGELHDGTKIA 614
Query: 610 VKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQH 669
VKRME+ + KG +EF++EIAVLTKVRHRHLV LLGYC++G+E+LLVYEYMP+GTL++H
Sbjct: 615 VKRMENGVIAGKGFAEFKSEIAVLTKVRHRHLVTLLGYCLDGNEKLLVYEYMPQGTLSRH 674
Query: 670 LFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVA 729
LFEW + G PL WKQR+T+ALDVARGVEYLH LA QSFIHRDLKPSNIL+GDDMRAKVA
Sbjct: 675 LFEWSEEGLKPLLWKQRLTLALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 734
Query: 730 DFGLVKNAPDGKYSVETRLAGTFGYLAPEYA 760
DFGLV+ AP+GK S+ETR+AGTFGYLAPEYA
Sbjct: 735 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 765
|
Probable receptor. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 258 bits (660), Expect = 1e-67, Method: Compositional matrix adjust.
Identities = 223/713 (31%), Positives = 335/713 (46%), Gaps = 67/713 (9%)
Query: 68 VTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPS-LANATSLQDIYLDNNNFT 126
+ + L + +G + + T L + N + G +P+ + NA SL+ + L +N T
Sbjct: 426 LMALDLDSNNFTGEIPKSLWKSTNLMEFTASYNRLEGYLPAEIGNAASLKRLVLSDNQLT 485
Query: 127 SVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSF 186
LT+L VL+L N N+ P EL TSLTTL + + N+ G IPD +
Sbjct: 486 GEIPREIGKLTSLSVLNL--NANMFQGKIPVELGDCTSLTTLDLGSNNLQGQIPDKITAL 543
Query: 187 SNLQNLRLSYNNFTGSLP----ASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWL 242
+ LQ L LSYNN +GS+P A F + ++ +L G D L
Sbjct: 544 AQLQCLVLSYNNLSGSIPSKPSAYFHQIEMPDLSFLQHH----GIFD------------L 587
Query: 243 HKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLF 301
N+ +GPIP+ L +C L ++SL +N L+G +PAS+ L L + L N L G P
Sbjct: 588 SYNRLSGPIPEELGECLVLVEISLSNNHLSGEIPASLSRLTNLTILDLSGNALTGSIPKE 647
Query: 302 PS---KVQKVSLDHNNFCKNSSDAGKPCDPQVT-TLLQIAGDMGYPAILSDSWE------ 351
K+Q ++L +N + ++ V L + D PA L + E
Sbjct: 648 MGNSLKLQGLNLANNQLNGHIPESFGLLGSLVKLNLTKNKLDGPVPASLGNLKELTHMDL 707
Query: 352 -GNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDG 410
NN + +++ + + G I NLT L+ L + +N L+G IP
Sbjct: 708 SFNNLSGELSSELSTMEKLVGLYIEQNKFTGEIPSELGNLTQLEYLDVSENLLSGEIPTK 767
Query: 411 LTKLASLQNLDVSNNNLSGKVPDFGSNVKFTVSPGNPFIGTNVDTTPGGAGTPGSKP--S 468
+ L +L+ L+++ NNL G+VP G V P A G+K
Sbjct: 768 ICGLPNLEFLNLAKNNLRGEVPSDG-----------------VCQDPSKALLSGNKELCG 810
Query: 469 GPSGSPAASSKSKLSVGTIVAIVVVVVIFIAVVFFVVYKFIARRKHRKFGRVKNPEVGNE 528
GS +KL + I +++ F +VF V+ R+ RVK +
Sbjct: 811 RVVGSDCKIEGTKLR--SAWGIAGLMLGFTIIVFVFVFSL---RRWAMTKRVKQRDDPER 865
Query: 529 MNKNGVTGGNGTNGYNGVPSELHSQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEANI 588
M ++ + G N Y S S +++ +FE + + + + + TD+FS+ NI
Sbjct: 866 MEESRLKGFVDQNLYFLSGSRSREPLSINIA---MFEQPLLKVRLGDIVEATDHFSKKNI 922
Query: 589 LGRGGFGVVYGGELPDGTKIAVKRM-ESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY 647
+G GGFG VY LP +AVK++ E+ T GN+ EF AE+ L KV+H +LV+LLGY
Sbjct: 923 IGDGGFGTVYKACLPGEKTVAVKKLSEAKTQGNR---EFMAEMETLGKVKHPNLVSLLGY 979
Query: 648 CINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS 707
C E+LLVYEYM G+L H L W +R+ IA+ ARG+ +LH
Sbjct: 980 CSFSEEKLLVYEYMVNGSL-DHWLRNQTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPH 1038
Query: 708 FIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYA 760
IHRD+K SNIL+ D KVADFGL + + V T +AGTFGY+ PEY
Sbjct: 1039 IIHRDIKASNILLDGDFEPKVADFGLARLISACESHVSTVIAGTFGYIPPEYG 1091
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LJF3|BRL3_ARATH Receptor-like protein kinase BRI1-like 3 OS=Arabidopsis thaliana GN=BRL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 256 bits (654), Expect = 5e-67, Method: Compositional matrix adjust.
Identities = 242/795 (30%), Positives = 374/795 (47%), Gaps = 92/795 (11%)
Query: 35 LAQSLQNLPSDWSSTSSTGYCEWTGINCDNSNRVTTISLAKSGLSGT-LSPEISSLTQLE 93
L ++L+ L D S S TG + +C + + +++L + LSG LS +S L+++
Sbjct: 300 LCRTLEVL--DLSGNSLTGQLPQSFTSCGS---LQSLNLGNNKLSGDFLSTVVSKLSRIT 354
Query: 94 TLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFT-SVPTGCFDGLTNLQVLS-LSDNPNL 150
L NNI+G++P SL N ++L+ + L +N FT VP+G F L + VL L N
Sbjct: 355 NLYLPFNNISGSVPISLTNCSNLRVLDLSSNEFTGEVPSG-FCSLQSSSVLEKLLIANNY 413
Query: 151 APWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFA-- 208
P EL K SL T+ + + GLIP + L +L + NN TG +P S
Sbjct: 414 LSGTVPVELGKCKSLKTIDLSFNALTGLIPKEIWTLPKLSDLVMWANNLTGGIPESICVD 473
Query: 209 KSDIQNLWMNDQQLGLSGTL-DVLSGMTQLRQVWLHKNQFTGPIP-DLSKCESLFDLSLR 266
+++ L +N+ L +G+L + +S T + + L N TG IP + K E L L L
Sbjct: 474 GGNLETLILNNNLL--TGSLPESISKCTNMLWISLSSNLLTGEIPVGIGKLEKLAILQLG 531
Query: 267 DNQLTGVVPASVISLPALLNISLQNNKLQGPYP-LFPSKVQKV---SLDHNNFCKNSSDA 322
+N LTG +P+ + + L+ + L +N L G P S+ V S+ F ++
Sbjct: 532 NNSLTGNIPSELGNCKNLIWLDLNSNNLTGNLPGELASQAGLVMPGSVSGKQFAFVRNEG 591
Query: 323 GKPCD-------------------PQVTT-------------LLQIAGDMGYPAILSDSW 350
G C P V + + G M Y + ++
Sbjct: 592 GTDCRGAGGLVEFEGIRAERLEHFPMVHSCPKTRIYSGMTMYMFSSNGSMIYLDLSYNAV 651
Query: 351 EGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDG 410
G+ P + G + +NL + LL G I ++ L ++ L L N+L G +P
Sbjct: 652 SGS-----IPLGYGAMGYLQVLNLGHNLLTGTIPDSFGGLKAIGVLDLSHNDLQGFLPGS 706
Query: 411 LTKLASLQNLDVSNNNLSGKVPDFGSNVKFTVSPGNPFIGTNVDTTPGGAGTP---GSKP 467
L L+ L +LDVSNNNL+G +P G F + T G G P S
Sbjct: 707 LGGLSFLSDLDVSNNNLTGPIPFGGQLTTFPL--------TRYANNSGLCGVPLPPCSSG 758
Query: 468 SGPSGSPAASSKSKLSVGTIVAIVVVVVIFIAVVFFVVYKFIARRKHRKFGRVKNPEVGN 527
S P+ S A K ++ G IV F+ +V ++ + AR+ +K
Sbjct: 759 SRPTRSHAHPKKQSIATGMSAGIVFS---FMCIVMLIMALYRARKVQKK----------E 805
Query: 528 EMNKNGVTGGNGTNGYNGVPSELHSQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEAN 587
+ + + + + S +H S +V+ FE ++ L + T+ FS +
Sbjct: 806 KQREKYIESLPTSGSSSWKLSSVHEPLSINVAT---FEKPLRKLTFAHLLEATNGFSADS 862
Query: 588 ILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY 647
++G GGFG VY +L DG+ +A+K++ T +G EF AE+ + K++HR+LV LLGY
Sbjct: 863 MIGSGGFGDVYKAKLADGSVVAIKKLIQVT--GQGDREFMAEMETIGKIKHRNLVPLLGY 920
Query: 648 CINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS 707
C G ERLLVYEYM G+L L E G L W R IA+ ARG+ +LH
Sbjct: 921 CKIGEERLLVYEYMKYGSLETVLHEKTKKGGIFLDWSARKKIAIGAARGLAFLHHSCIPH 980
Query: 708 FIHRDLKPSNILIGDDMRAKVADFGLVK--NAPDGKYSVETRLAGTFGYLAPEYAGKHWM 765
IHRD+K SN+L+ D A+V+DFG+ + +A D SV T LAGT GY+ PEY +
Sbjct: 981 IIHRDMKSSNVLLDQDFVARVSDFGMARLVSALDTHLSVST-LAGTPGYVPPEY---YQS 1036
Query: 766 ILCQMTGLIWLHGSV 780
C G ++ +G +
Sbjct: 1037 FRCTAKGDVYSYGVI 1051
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Binds brassinolide. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. May be involved in cell growth and vascular differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FN37|PSKR2_ARATH Phytosulfokine receptor 2 OS=Arabidopsis thaliana GN=PSKR2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 253 bits (646), Expect = 4e-66, Method: Compositional matrix adjust.
Identities = 224/761 (29%), Positives = 361/761 (47%), Gaps = 98/761 (12%)
Query: 61 NCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAI-PSLANATSLQDIY 119
NC S + + + + L+G L + S+ +LE LS N ++G + +L+N + L+ +
Sbjct: 205 NCSKS--IQQLHIDSNRLTGQLPDYLYSIRELEQLSLSGNYLSGELSKNLSNLSGLKSLL 262
Query: 120 LDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLI 179
+ N F+ V F LT L+ L +S N FP L++ + L L + N ++ G I
Sbjct: 263 ISENRFSDVIPDVFGNLTQLEHLDVSSNK--FSGRFPPSLSQCSKLRVLDLRNNSLSGSI 320
Query: 180 PDFFDSFSNLQNLRLSYNNFTGSLPASFA---KSDIQNLWMNDQQ--------------- 221
F F++L L L+ N+F+G LP S K I +L N+ +
Sbjct: 321 NLNFTGFTDLCVLDLASNHFSGPLPDSLGHCPKMKILSLAKNEFRGKIPDTFKNLQSLLF 380
Query: 222 --------LGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTG 272
+ S T++VL L + L KN IP+ ++ ++L L+L + L G
Sbjct: 381 LSLSNNSFVDFSETMNVLQHCRNLSTLILSKNFIGEEIPNNVTGFDNLAILALGNCGLRG 440
Query: 273 VVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTT 332
+P+ +++ L + L N G P + K++ SL + +F N+ P +T
Sbjct: 441 QIPSWLLNCKKLEVLDLSWNHFYGTIPHWIGKME--SLFYIDFSNNTLTGAIPV--AITE 496
Query: 333 LLQIAGDMGYPAILSDS------WEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPA 386
L + G + ++DS + N + +G P+ S+ +I L N L G I P
Sbjct: 497 LKNLIRLNGTASQMTDSSGIPLYVKRNKSSNGLPYNQVSRFPP-SIYLNNNRLNGTILPE 555
Query: 387 YANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKF------ 440
L L L L +NN TG IPD ++ L +L+ LD+S N+L G +P ++ F
Sbjct: 556 IGRLKELHMLDLSRNNFTGTIPDSISGLDNLEVLDLSYNHLYGSIPLSFQSLTFLSRFSV 615
Query: 441 -------TVSPGNPFIGTNVDTTPGGAG------TPGSKPSGPSGSPAASSKS-----KL 482
+ G F + G G +P +P SS+ K
Sbjct: 616 AYNRLTGAIPSGGQFYSFPHSSFEGNLGLCRAIDSPCDVLMSNMLNPKGSSRRNNNGGKF 675
Query: 483 SVGTIVAIVVVVVIFIAVVFFVVYKFIARRKHRKFGRVKNPEVGNEMNKNGVTGGNGTNG 542
+IV + + + I I ++ V+ I+R+ R+ N++++ ++G + G
Sbjct: 676 GRSSIVVLTISLAIGITLLLSVILLRISRKDVDD--RI------NDVDEETISGVSKALG 727
Query: 543 YNGVPSEL---HSQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYG 599
PS++ HS D +S+E L + T+NFS+ANI+G GGFG+VY
Sbjct: 728 ----PSKIVLFHSCGCKD-------------LSVEELLKSTNNFSQANIIGCGGFGLVYK 770
Query: 600 GELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659
PDG+K AVKR+ + + EFQAE+ L++ H++LV+L GYC +G++RLL+Y
Sbjct: 771 ANFPDGSKAAVKRLSGDC--GQMEREFQAEVEALSRAEHKNLVSLQGYCKHGNDRLLIYS 828
Query: 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNIL 719
+M G+L L E D G L W R+ IA ARG+ YLH + + + IHRD+K SNIL
Sbjct: 829 FMENGSLDYWLHERVD-GNMTLIWDVRLKIAQGAARGLAYLHKVCEPNVIHRDVKSSNIL 887
Query: 720 IGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYA 760
+ + A +ADFGL + V T L GT GY+ PEY+
Sbjct: 888 LDEKFEAHLADFGLARLLRPYDTHVTTDLVGTLGYIPPEYS 928
|
Phytosulfokine receptor with a serine/threonine-protein kinase activity. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 246 bits (627), Expect = 6e-64, Method: Compositional matrix adjust.
Identities = 219/752 (29%), Positives = 347/752 (46%), Gaps = 70/752 (9%)
Query: 71 ISLAKSGLSGTLSPE-ISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSV 128
+ ++ + SG L + +S L+ ++T+ N G +P S +N L+ + + +NN T V
Sbjct: 357 VDISYNNFSGKLPVDTLSKLSNIKTMVLSFNKFVGGLPDSFSNLLKLETLDMSSNNLTGV 416
Query: 129 -PTG-CFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSF 186
P+G C D + NL+VL L +N L P P+ L+ + L +L + + G IP S
Sbjct: 417 IPSGICKDPMNNLKVLYLQNN--LFKGPIPDSLSNCSQLVSLDLSFNYLTGSIPSSLGSL 474
Query: 187 SNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLSGTLDV-LSGMTQLRQVWLHK 244
S L++L L N +G +P ++NL ++ L +G + LS T+L + L
Sbjct: 475 SKLKDLILWLNQLSGEIPQELMYLQALENLILDFNDL--TGPIPASLSNCTKLNWISLSN 532
Query: 245 NQFTGPIP-DLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG--PYPLF 301
NQ +G IP L + +L L L +N ++G +PA + + +L+ + L N L G P PLF
Sbjct: 533 NQLSGEIPASLGRLSNLAILKLGNNSISGNIPAELGNCQSLIWLDLNTNFLNGSIPPPLF 592
Query: 302 PSK--VQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAG---------DMGYPAILSDSW 350
+ L + +D K C LL+ G +P + +
Sbjct: 593 KQSGNIAVALLTGKRYVYIKNDGSKECH-GAGNLLEFGGIRQEQLDRISTRHPCNFTRVY 651
Query: 351 EG-------------------NNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLT 391
G N P + + +NL + L+G I L
Sbjct: 652 RGITQPTFNHNGSMIFLDLSYNKLEGSIPKELGAMYYLSILNLGHNDLSGMIPQQLGGLK 711
Query: 392 SLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKFTVSPGNPFIGT 451
++ L L N G IP+ LT L L +D+SNNNLSG +P+ + F P F
Sbjct: 712 NVAILDLSYNRFNGTIPNSLTSLTLLGEIDLSNNNLSGMIPE---SAPFDTFPDYRFANN 768
Query: 452 NVDTTPGGAGTPGSKPSGPSGSPAASSKSKLSVGTIVAIVVVVVIF-IAVVFFVVYKFIA 510
++ P P SGP KS ++ V + ++F + +F ++ I
Sbjct: 769 SLCGYP----LPIPCSSGPKSDANQHQKSHRRQASLAGSVAMGLLFSLFCIFGLIIVAIE 824
Query: 511 RRKHRKFGRVKNPEVGNEMNKNGVTGGNGTNGYNGVPSELHSQSSGDVSDRHLFEGGNVA 570
+K R+ E E +G + N S + S + FE
Sbjct: 825 TKKRRR-----KKEAALEAYMDGHSHSATANSAWKFTSAREALSINLAA----FEKPLRK 875
Query: 571 ISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEI 630
++ L + T+ F +++G GGFG VY +L DG+ +A+K++ + +G EF AE+
Sbjct: 876 LTFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKLIH--VSGQGDREFTAEM 933
Query: 631 AVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIA 690
+ K++HR+LV LLGYC G ERLLVYEYM G+L L + G L W R IA
Sbjct: 934 ETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDRKKIG-IKLNWPARRKIA 992
Query: 691 LDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK--NAPDGKYSVETRL 748
+ ARG+ +LH IHRD+K SN+L+ +++ A+V+DFG+ + +A D SV T L
Sbjct: 993 IGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLSVST-L 1051
Query: 749 AGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780
AGT GY+ PEY + C G ++ +G V
Sbjct: 1052 AGTPGYVPPEY---YQSFRCSTKGDVYSYGVV 1080
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. Solanum lycopersicum (taxid: 4081) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LPB4|PSKR1_DAUCA Phytosulfokine receptor 1 OS=Daucus carota GN=PSKR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 245 bits (626), Expect = 8e-64, Method: Compositional matrix adjust.
Identities = 237/763 (31%), Positives = 354/763 (46%), Gaps = 117/763 (15%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPS-LANATSLQDIYLDN 122
N + V + LA + LSG++ E+ L+ L L+ Q N ++GA+ S L ++L + + +
Sbjct: 204 NCSSVEYLGLASNNLSGSIPQELFQLSNLSVLALQNNRLSGALSSKLGKLSNLGRLDISS 263
Query: 123 NNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDF 182
N F+ F L L S NL P L+ S S++ L + N + G I
Sbjct: 264 NKFSGKIPDVFLELNKLWYFSAQS--NLFNGEMPRSLSNSRSISLLSLRNNTLSGQIYLN 321
Query: 183 FDSFSNLQNLRLSYNNFTGSLPA-----------SFAK----SDIQNLWMNDQQL----- 222
+ +NL +L L+ N+F+GS+P+ +FAK + I + N Q L
Sbjct: 322 CSAMTNLTSLDLASNSFSGSIPSNLPNCLRLKTINFAKIKFIAQIPESFKNFQSLTSLSF 381
Query: 223 ------GLSGTLDVLSGMTQLRQVWLHKN-------------------------QFTGPI 251
+S L++L L+ + L N Q G +
Sbjct: 382 SNSSIQNISSALEILQHCQNLKTLVLTLNFQKEELPSVPSLQFKNLKVLIIASCQLRGTV 441
Query: 252 PD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKV-- 308
P LS SL L L NQL+G +P + SL +L + L NN G P + +Q +
Sbjct: 442 PQWLSNSPSLQLLDLSWNQLSGTIPPWLGSLNSLFYLDLSNNTFIGEIPHSLTSLQSLVS 501
Query: 309 --------SLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDG-- 358
S D F K +++AG LQ +P ++ S+ N+ +G
Sbjct: 502 KENAVEEPSPDFPFFKKKNTNAGG---------LQYNQPSSFPPMIDLSY---NSLNGSI 549
Query: 359 WP-FVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASL 417
WP F Q + +NL N L+GNI + +TSL+ L L NNL+G IP L KL+ L
Sbjct: 550 WPEFGDLRQLHV--LNLKNNNLSGNIPANLSGMTSLEVLDLSHNNLSGNIPPSLVKLSFL 607
Query: 418 QNLDVSNNNLSGKVPDFGSNVKFTVSPGNPFIGTNVDTTPGGAGTPGSKPSGPSGSPAAS 477
V+ N LSG +P + V+F P + F G G G S SP S
Sbjct: 608 STFSVAYNKLSGPIP---TGVQFQTFPNSSFEGNQ-----GLCGEHASPCHITDQSPHGS 659
Query: 478 S-KSKLSVGTIVAIVVVVVIFIAVVFFVVYKFIARRKHRKFGRVKNPEVGNEMNKNGVTG 536
+ KSK ++ IVA V V + VF + + + G V +PE + ++
Sbjct: 660 AVKSKKNIRKIVA--VAVGTGLGTVFLLTVTLLIILRTTSRGEV-DPEKKADADE----- 711
Query: 537 GNGTNGYNGVPSELHSQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGV 596
EL S+S ++ N +S++ + + T +F++ANI+G GGFG+
Sbjct: 712 -----------IELGSRSVVLFHNKD----SNNELSLDDILKSTSSFNQANIIGCGGFGL 756
Query: 597 VYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656
VY LPDGTK+A+KR+ +T + EFQAE+ L++ +H +LV LLGYC +++LL
Sbjct: 757 VYKATLPDGTKVAIKRLSGDT--GQMDREFQAEVETLSRAQHPNLVHLLGYCNYKNDKLL 814
Query: 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPS 716
+Y YM G+L L E D G L WK R+ IA A G+ YLH + +HRD+K S
Sbjct: 815 IYSYMDNGSLDYWLHEKVD-GPPSLDWKTRLRIARGAAEGLAYLHQSCEPHILHRDIKSS 873
Query: 717 NILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEY 759
NIL+ D A +ADFGL + V T L GT GY+ PEY
Sbjct: 874 NILLSDTFVAHLADFGLARLILPYDTHVTTDLVGTLGYIPPEY 916
|
Phytosulfokine receptor with a serine/threonine-protein kinase activity. Regulates, in response to phytosulfokine binding, a signaling cascade involved in plant cell differentiation, organogenesis and somatic embryogenesis. Daucus carota (taxid: 4039) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZWC8|BRL1_ARATH Serine/threonine-protein kinase BRI1-like 1 OS=Arabidopsis thaliana GN=BRL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 245 bits (625), Expect = 1e-63, Method: Compositional matrix adjust.
Identities = 244/822 (29%), Positives = 383/822 (46%), Gaps = 110/822 (13%)
Query: 6 PQVSICAVVLLLLQLTTTSLGDDGSVMLKLAQSLQNLPSDWSSTSSTGYCEWTGINCDNS 65
P++S+ L++L L+ + + LPS +++ C W
Sbjct: 295 PELSLLCKTLVILDLSGNTFSGE-------------LPSQFTA------CVW-------- 327
Query: 66 NRVTTISLAKSGLSGT-LSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNN 123
+ ++L + LSG L+ +S +T + L NNI+G++P SL N ++L+ + L +N
Sbjct: 328 --LQNLNLGNNYLSGDFLNTVVSKITGITYLYVAYNNISGSVPISLTNCSNLRVLDLSSN 385
Query: 124 NFT-SVPTGCFDGLTNLQVLS--LSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIP 180
FT +VP+G F L + VL L N N P EL K SL T+ + + G IP
Sbjct: 386 GFTGNVPSG-FCSLQSSPVLEKILIAN-NYLSGTVPMELGKCKSLKTIDLSFNELTGPIP 443
Query: 181 DFFDSFSNLQNLRLSYNNFTGSLPASFAKS--DIQNLWMNDQQLGLSGTL-DVLSGMTQL 237
NL +L + NN TG++P +++ L +N+ L +G++ + +S T +
Sbjct: 444 KEIWMLPNLSDLVMWANNLTGTIPEGVCVKGGNLETLILNNNLL--TGSIPESISRCTNM 501
Query: 238 RQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG 296
+ L N+ TG IP + L L L +N L+G VP + + +L+ + L +N L G
Sbjct: 502 IWISLSSNRLTGKIPSGIGNLSKLAILQLGNNSLSGNVPRQLGNCKSLIWLDLNSNNLTG 561
Query: 297 PYP-LFPSKVQKV---SLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEG 352
P S+ V S+ F ++ G C G + + I ++ E
Sbjct: 562 DLPGELASQAGLVMPGSVSGKQFAFVRNEGGTDCRGA-------GGLVEFEGIRAERLER 614
Query: 353 NNACDGWP----------FVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNN 402
P + + G +I +++ ++G I P Y N+ L+ L L N
Sbjct: 615 LPMVHSCPATRIYSGMTMYTFSANGSMIYFDISYNAVSGFIPPGYGNMGYLQVLNLGHNR 674
Query: 403 LTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKF----TVSPGN-----PFIGTNV 453
+TG IPD L ++ LD+S+NNL G +P ++ F VS N PF G +
Sbjct: 675 ITGTIPDSFGGLKAIGVLDLSHNNLQGYLPGSLGSLSFLSDLDVSNNNLTGPIPF-GGQL 733
Query: 454 DTTP--------GGAGTP----GSKPSGPSGSPAASSKSKLSVGTIVAIVVVVVIFIAVV 501
T P G G P GS P P S + K ++ I I + F+ +V
Sbjct: 734 TTFPVSRYANNSGLCGVPLRPCGSAPRRPITSRIHAKKQTVATAVIAGIAFSFMCFVMLV 793
Query: 502 FFVVYKFIARRKHRKFGRVKNPEVGNEMNKNGVTGGNGTNGYNGVPSELHSQSSGDVSDR 561
+ ++K +K R K E + T G+ + + VP L S +V+
Sbjct: 794 MALYRVRKVQKKEQK--REKYIE-------SLPTSGSCSWKLSSVPEPL----SINVAT- 839
Query: 562 HLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNK 621
FE ++ L + T+ FS ++G GGFG VY +L DG+ +A+K++ T +
Sbjct: 840 --FEKPLRKLTFAHLLEATNGFSAETMVGSGGFGEVYKAQLRDGSVVAIKKLIRIT--GQ 895
Query: 622 GLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEW-HDHGYTP 680
G EF AE+ + K++HR+LV LLGYC G ERLLVYEYM G+L L E G
Sbjct: 896 GDREFMAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKWGSLETVLHEKSSKKGGIY 955
Query: 681 LTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK--NAP 738
L W R IA+ ARG+ +LH IHRD+K SN+L+ +D A+V+DFG+ + +A
Sbjct: 956 LNWAARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDEDFEARVSDFGMARLVSAL 1015
Query: 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780
D SV T LAGT GY+ PEY + C G ++ +G +
Sbjct: 1016 DTHLSVST-LAGTPGYVPPEY---YQSFRCTAKGDVYSYGVI 1053
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. Binds brassinolide. May be involved in cell growth and vascular differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1 | Back alignment and function description |
|---|
Score = 243 bits (621), Expect = 4e-63, Method: Compositional matrix adjust.
Identities = 220/754 (29%), Positives = 349/754 (46%), Gaps = 74/754 (9%)
Query: 71 ISLAKSGLSGTLSPE-ISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSV 128
+ ++ + SG L + + L+ ++T+ N G +P S +N L+ + + +NN T +
Sbjct: 357 VDISNNNFSGKLPVDTLLKLSNIKTMVLSFNKFVGGLPDSFSNLPKLETLDMSSNNLTGI 416
Query: 129 -PTG-CFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSF 186
P+G C D + NL+VL L +N L P P+ L+ + L +L + + G IP S
Sbjct: 417 IPSGICKDPMNNLKVLYLQNN--LFKGPIPDSLSNCSQLVSLDLSFNYLTGSIPSSLGSL 474
Query: 187 SNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLSGTLDV-LSGMTQLRQVWLHK 244
S L++L L N +G +P ++NL ++ L +G + LS T+L + L
Sbjct: 475 SKLKDLILWLNQLSGEIPQELMYLQALENLILDFNDL--TGPIPASLSNCTKLNWISLSN 532
Query: 245 NQFTGPIP-DLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG--PYPLF 301
NQ +G IP L + +L L L +N ++G +PA + + +L+ + L N L G P PLF
Sbjct: 533 NQLSGEIPASLGRLSNLAILKLGNNSISGNIPAELGNCQSLIWLDLNTNFLNGSIPPPLF 592
Query: 302 PSK--VQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAG---------DMGYPAILSDSW 350
+ L + +D K C LL+ G +P + +
Sbjct: 593 KQSGNIAVALLTGKRYVYIKNDGSKECH-GAGNLLEFGGIRQEQLDRISTRHPCNFTRVY 651
Query: 351 EG------------------NNACDG-WPFVTCSQGRIITINLANKLLAGNISPAYANLT 391
G N +G P + + +NL + L+G I L
Sbjct: 652 RGITQPTFNHNGSMIFLDLSYNKLEGSIPKELGAMYYLSILNLGHNDLSGMIPQQLGGLK 711
Query: 392 SLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKFTVSPGNPFIGT 451
++ L L N G IP+ LT L L +D+SNNNLSG +P+ + F P F
Sbjct: 712 NVAILDLSYNRFNGTIPNSLTSLTLLGEIDLSNNNLSGMIPE---SAPFDTFPDYRFANN 768
Query: 452 NVDTTPGGAGTPGSKPSGPSGSPAASSKSKLSVGTIVAIVVVVVIF-IAVVFFVVYKFIA 510
++ P P SGP KS ++ V + ++F + +F ++ I
Sbjct: 769 SLCGYP----LPLPCSSGPKSDANQHQKSHRRQASLAGSVAMGLLFSLFCIFGLIIVAIE 824
Query: 511 RRKHRKFGRVKNPEVGNEMNKNGVTGGNGTNGYNGVPSELHSQSSGDVSDRHLFEGGNVA 570
+K R+ E E +G + N S + S + FE
Sbjct: 825 TKKRRR-----KKEAALEAYMDGHSHSATANSAWKFTSAREALSINLAA----FEKPLRK 875
Query: 571 ISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEI 630
++ L + T+ F +++G GGFG VY +L DG+ +A+K++ + +G EF AE+
Sbjct: 876 LTFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKLIH--VSGQGDREFTAEM 933
Query: 631 AVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYT--PLTWKQRVT 688
+ K++HR+LV LLGYC G ERLLVYEYM G+L L HD T L W R
Sbjct: 934 ETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVL---HDRKKTGIKLNWPARRK 990
Query: 689 IALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK--NAPDGKYSVET 746
IA+ ARG+ +LH IHRD+K SN+L+ +++ A+V+DFG+ + +A D SV T
Sbjct: 991 IAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLSVST 1050
Query: 747 RLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780
LAGT GY+ PEY + C G ++ +G V
Sbjct: 1051 -LAGTPGYVPPEY---YQSFRCSTKGDVYSYGVV 1080
|
Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development. Solanum peruvianum (taxid: 4082) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q42371|ERECT_ARATH LRR receptor-like serine/threonine-protein kinase ERECTA OS=Arabidopsis thaliana GN=ERECTA PE=1 SV=1 | Back alignment and function description |
|---|
Score = 243 bits (621), Expect = 4e-63, Method: Compositional matrix adjust.
Identities = 220/859 (25%), Positives = 366/859 (42%), Gaps = 163/859 (18%)
Query: 15 LLLLQLTTTSLGDDGSVMLKLAQSLQ---NLPSDWSSTSSTGYCEWTGINCDN-SNRVTT 70
L L L T ++G+ +L++ +S + N+ DW+++ S+ YC W G++C+N + V
Sbjct: 13 LFCLSLVATVTSEEGATLLEIKKSFKDVNNVLYDWTTSPSSDYCVWRGVSCENVTFNVVA 72
Query: 71 ISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP----------------------- 107
++L+ L G +SP I L L ++ + N ++G IP
Sbjct: 73 LNLSDLNLDGEISPAIGDLKSLLSIDLRGNRLSGQIPDEIGDCSSLQNLDLSFNELSGDI 132
Query: 108 --SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDN------PNLAPWP----- 154
S++ L+ + L NN + NL++L L+ N P L W
Sbjct: 133 PFSISKLKQLEQLILKNNQLIGPIPSTLSQIPNLKILDLAQNKLSGEIPRLIYWNEVLQY 192
Query: 155 -----------FPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSL 203
+L + T L + N ++ G IP+ + + Q L LSYN TG +
Sbjct: 193 LGLRGNNLVGNISPDLCQLTGLWYFDVRNNSLTGSIPETIGNCTAFQVLDLSYNQLTGEI 252
Query: 204 PASFAKSDIQNLWMNDQQLG-----------------LSGTL------DVLSGMTQLRQV 240
P + L + QL LSG L +L +T ++
Sbjct: 253 PFDIGFLQVATLSLQGNQLSGKIPSVIGLMQALAVLDLSGNLLSGSIPPILGNLTFTEKL 312
Query: 241 WLHKNQFTGPIP-DLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYP 299
+LH N+ TG IP +L L L L DN LTG +P + L L ++++ NN L+GP P
Sbjct: 313 YLHSNKLTGSIPPELGNMSKLHYLELNDNHLTGHIPPELGKLTDLFDLNVANNDLEGPIP 372
Query: 300 LFPSKVQKVSLDHNNFCKNSSD---AGKPCDPQVTTLLQIAGDMGYPAILSDSWEG---- 352
DH + C N + G + Q M Y + S++ +G
Sbjct: 373 -----------DHLSSCTNLNSLNVHGNKFSGTIPRAFQKLESMTYLNLSSNNIKGPIPV 421
Query: 353 --------------NNACDGW-PFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLY 397
NN +G P ++ +NL+ + G + + NL S+ +
Sbjct: 422 ELSRIGNLDTLDLSNNKINGIIPSSLGDLEHLLKMNLSRNHITGVVPGDFGNLRSIMEID 481
Query: 398 LQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKFTV------------SPG 445
L N+++GPIP+ L +L ++ L + NNNL+G V + + TV
Sbjct: 482 LSNNDISGPIPEELNQLQNIILLRLENNNLTGNVGSLANCLSLTVLNVSHNNLVGDIPKN 541
Query: 446 NPFIGTNVDTTPGGAGTPGSKPSGPSGSPAASSKSKLSVGTIVAIVVVVVIFIAVVFFVV 505
N F + D+ G G GS + P + + +S I+ I + ++ + +V
Sbjct: 542 NNFSRFSPDSFIGNPGLCGSWLNSPCHDSRRTVRVSISRAAILGIAIGGLVILLMVLIA- 600
Query: 506 YKFIARRKHRKFGRVKNPEVGNEMNKNGVTGGNGTNGYNGVPSELHSQSSGDVSDRHLFE 565
A R H N +G + + S+ + H+
Sbjct: 601 ----ACRPH-----------------------NPPPFLDGSLDKPVTYSTPKLVILHM-- 631
Query: 566 GGNVAISI-EVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLS 624
N+A+ + E + ++T+N SE I+G G VY L + +A+KR+ S+ + +
Sbjct: 632 --NMALHVYEDIMRMTENLSEKYIIGHGASSTVYKCVLKNCKPVAIKRLYSH--NPQSMK 687
Query: 625 EFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTP---L 681
+F+ E+ +L+ ++HR+LV+L Y ++ LL Y+Y+ G+L L HG T L
Sbjct: 688 QFETELEMLSSIKHRNLVSLQAYSLSHLGSLLFYDYLENGSLWDLL-----HGPTKKKTL 742
Query: 682 TWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK 741
W R+ IA A+G+ YLH IHRD+K SNIL+ D+ A++ DFG+ K+ K
Sbjct: 743 DWDTRLKIAYGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDLEARLTDFGIAKSLCVSK 802
Query: 742 YSVETRLAGTFGYLAPEYA 760
T + GT GY+ PEYA
Sbjct: 803 SHTSTYVMGTIGYIDPEYA 821
|
Receptor kinase that, together with ERL1 and ERL2, regulates aerial architecture, including inflorescence (e.g. shoot apical meristem-originating organ shape, elongation of the internode and pedicels, and adaxial-abaxial polarity), and stomatal patterning (e.g. density and clustering), probably by tuning cell division and expansion. Modulates plant transpiration efficiency by controlling stomatal density, leaf photosynthetic capacity, epidermal cell expansion, mesophyll cell proliferation and cell-cell contact. Probable major trait regulating canalization (maintenance of phenotype despite varying environment) in many aspect of the plant physiology (e.g. plant morphology, light-dependent leaves number, branch number, flowering time, phytate and mineral concentrations) by transducing microenvironmental variation into phenotypic differentiation (ecological amplifier). May maintain development integrity in heat stress conditions. Regulates cell wall composition and structure. Confers resistance to the pathogenic bacteria Ralstonia solanacearum and to the necrotrophic fungi Plectosphaerella cucumerina and Pythium irregulare, and required for callose deposition upon infection. Resistance to P.cucumerina seems cell wall-mediated. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 241 bits (615), Expect = 1e-62, Method: Compositional matrix adjust.
Identities = 248/844 (29%), Positives = 364/844 (43%), Gaps = 130/844 (15%)
Query: 9 SICA--VVLLLLQLTTTSLGDDGSVMLKLAQSLQNLPSDWSSTSSTG--------YCEWT 58
SIC+ L L L+ T L + V L QSL+ L D S+ S G E T
Sbjct: 330 SICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQL--DLSNNSLAGSIPEALFELVELT 387
Query: 59 GINCDNSNRVTTIS-------------LAKSGLSGTLSPEISSLTQLETLSFQMNNIAGA 105
+ N+ T+S L + L G L EIS+L +LE L N +G
Sbjct: 388 DLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGE 447
Query: 106 IP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFP-------- 156
IP + N TSL+ I + N+F L L +L L N + P
Sbjct: 448 IPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNELVGGLPASLGNCHQLN 507
Query: 157 ------NELTKS--------TSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGS 202
N+L+ S L L + N ++ G +PD S NL + LS+N G+
Sbjct: 508 ILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGT 567
Query: 203 L-----PASFAKSDIQNLWMNDQ---QLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIP-D 253
+ +S+ D+ N D+ +LG S LD L L KNQ TG IP
Sbjct: 568 IHPLCGSSSYLSFDVTNNGFEDEIPLELGNSQNLDRLR---------LGKNQLTGKIPWT 618
Query: 254 LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKV---SL 310
L K L L + N LTG +P ++ L +I L NN L GP P + K+ ++ L
Sbjct: 619 LGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKL 678
Query: 311 DHNNFCKNSSDAGKPCDPQVTTLL----------QIAGDMGYPAILSDSWEGNNACDGWP 360
N F ++ C + L Q G++G +L+ + N P
Sbjct: 679 SSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLN--LDKNQFSGSLP 736
Query: 361 FVTCSQGRIITINLANKLLAGNISPAYANLTSLKN-LYLQQNNLTGPIPDGLTKLASLQN 419
++ + L+ L G I L L++ L L NN TG IP + L+ L+
Sbjct: 737 QAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLET 796
Query: 420 LDVSNNNLSGKVP----DFGS----NVKFTVSPGN---PFIGTNVDTTPGGAGTPGSKPS 468
LD+S+N L+G+VP D S NV F G F D+ G G GS S
Sbjct: 797 LDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQFSRWPADSFLGNTGLCGSPLS 856
Query: 469 GPSGSPAASSKSKLSVGTIVAIVVVVVIFIAVVFFVVYKFIARRKHRKFGRVKNPEVGNE 528
+ + + + LS ++V I + + + +V +++H F +V
Sbjct: 857 RCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVIALFFKQRHDFFKKV-------- 908
Query: 529 MNKNGVTGGNGTNGYNGVPSELHSQSSGDVSDRHLFEGG--NVAISIEVLRQVTDNFSEA 586
G+G+ Y S + + + LF G I E + + T N SE
Sbjct: 909 --------GHGSTAYTSSSSSSQA------THKPLFRNGASKSDIRWEDIMEATHNLSEE 954
Query: 587 NILGRGGFGVVYGGELPDGTKIAVKRM--ESNTMGNKGLSEFQAEIAVLTKVRHRHLVAL 644
++G GG G VY EL +G +AVK++ + + M NK F E+ L ++RHRHLV L
Sbjct: 955 FMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKS---FSREVKTLGRIRHRHLVKL 1011
Query: 645 LGYCINGSE--RLLVYEYMPRGTLAQHLFEWH---DHGYTPLTWKQRVTIALDVARGVEY 699
+GYC + SE LL+YEYM G++ L E + L W+ R+ IA+ +A+GVEY
Sbjct: 1012 MGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEY 1071
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK---NAPDGKYSVETRLAGTFGYLA 756
LH +HRD+K SN+L+ +M A + DFGL K D T A ++GY+A
Sbjct: 1072 LHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIA 1131
Query: 757 PEYA 760
PEYA
Sbjct: 1132 PEYA 1135
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 782 | ||||||
| 297831152 | 930 | leucine-rich repeat family protein [Arab | 0.927 | 0.779 | 0.622 | 0.0 | |
| 224130728 | 908 | predicted protein [Populus trichocarpa] | 0.914 | 0.787 | 0.650 | 0.0 | |
| 224142687 | 900 | predicted protein [Populus trichocarpa] | 0.918 | 0.797 | 0.635 | 0.0 | |
| 15229508 | 928 | leucine-rich repeat protein kinase-like | 0.924 | 0.779 | 0.618 | 0.0 | |
| 224125576 | 925 | predicted protein [Populus trichocarpa] | 0.936 | 0.791 | 0.637 | 0.0 | |
| 224589575 | 928 | leucine-rich repeat receptor-like protei | 0.924 | 0.779 | 0.617 | 0.0 | |
| 147798019 | 921 | hypothetical protein VITISV_043132 [Viti | 0.946 | 0.803 | 0.632 | 0.0 | |
| 296089594 | 897 | unnamed protein product [Vitis vinifera] | 0.920 | 0.802 | 0.643 | 0.0 | |
| 224087245 | 931 | predicted protein [Populus trichocarpa] | 0.925 | 0.777 | 0.632 | 0.0 | |
| 356568467 | 928 | PREDICTED: probable receptor protein kin | 0.957 | 0.807 | 0.627 | 0.0 |
| >gi|297831152|ref|XP_002883458.1| leucine-rich repeat family protein [Arabidopsis lyrata subsp. lyrata] gi|297329298|gb|EFH59717.1| leucine-rich repeat family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 915 bits (2366), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 467/750 (62%), Positives = 573/750 (76%), Gaps = 25/750 (3%)
Query: 24 SLGDDGSVMLKLAQSLQNLPSDWSSTSSTGYCEWTGINCDNSNRVTTISLAKSGLSGTLS 83
S+ DDG+ ML LA+S PSDWS+T+ST +C+W+G+ C RV ISLA L+G ++
Sbjct: 22 SVADDGTAMLALAKSFNPPPSDWSTTTSTDFCKWSGVRC-TGGRVNIISLADKSLTGFIA 80
Query: 84 PEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLS 143
PEIS+L++L+++S Q N ++G IPS A +SLQ+IY+D+N F V TG F GLT+LQ+LS
Sbjct: 81 PEISTLSELKSVSIQRNKLSGKIPSFAKLSSLQEIYMDDNFFVGVETGAFAGLTSLQILS 140
Query: 144 LSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSL 203
LSDN N+ W FP+EL STSLT +Y+DN NI G++PD FDSF++LQ+LRLSYNN TG L
Sbjct: 141 LSDNKNITAWSFPSELVDSTSLTKIYLDNTNIVGVLPDIFDSFASLQDLRLSYNNITGVL 200
Query: 204 PASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDL 263
P S AKS IQNLW+N+Q+LG+SGT++VLS MT L Q WLHKNQF GPIPDLSK E+LFDL
Sbjct: 201 PPSLAKSSIQNLWINNQELGMSGTIEVLSSMTSLSQAWLHKNQFFGPIPDLSKSENLFDL 260
Query: 264 SLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAG 323
LRDNQLTG+VP +++SL +L NISL NNK QGP PLFPS+V KV++DHN+FC ++ AG
Sbjct: 261 QLRDNQLTGIVPPTLLSLGSLKNISLDNNKFQGPLPLFPSEV-KVTIDHNDFC--TTKAG 317
Query: 324 KPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTC-SQGR-IITINLANKLLAG 381
+ C PQV TLL +AG +GYP++L++SW+G++AC GW +VTC S G+ ++T+NL AG
Sbjct: 318 QTCSPQVMTLLAVAGGLGYPSMLAESWQGDDACSGWAYVTCDSAGKNVVTLNLGKHGFAG 377
Query: 382 NISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKFT 441
ISPA ANLTSLK++YL NNLTG IP LT + SLQ +DVSNNNL G++P F + VKF
Sbjct: 378 FISPAIANLTSLKSIYLNDNNLTGVIPKELTFMTSLQLIDVSNNNLRGEIPKFPAAVKFN 437
Query: 442 VSPGNPFIGTNVDTTPGGAGTPGSKPSGPSGSPAASSKSKLSVGTIVAIVVVVVIFIAVV 501
PGN +GTN G G+ GS +S VG IV ++V V++F+A++
Sbjct: 438 YKPGNALLGTN-----AGDGSTPGTGGASGGSGGSSGGGGSKVGVIVGVIVAVLVFLAIL 492
Query: 502 FFVVYKFIARRKHRKFGRVKNPEVGNEMNKNGVTGGNG----------TNGYNGVPSELH 551
FVVYKF+ +RK+ +F R + G + + V+ G N +N L+
Sbjct: 493 GFVVYKFVMKRKYGRFNRTDPEKAGKILVSDAVSNGGSGGGGYANGHGANNFNA----LN 548
Query: 552 SQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVK 611
S SSGD SDR L EGG+V I +EVLRQVT+NFSE NILGRGGFGVVY GEL DGTK AVK
Sbjct: 549 SPSSGDNSDRFLLEGGSVTIPMEVLRQVTNNFSEDNILGRGGFGVVYAGELHDGTKTAVK 608
Query: 612 RMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLF 671
RME MGNKG+SEFQAEIAVLTKVRHRHLVALLGYC+NG+ERLLVYEYMP+G L QHLF
Sbjct: 609 RMECAAMGNKGMSEFQAEIAVLTKVRHRHLVALLGYCVNGNERLLVYEYMPQGNLGQHLF 668
Query: 672 EWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADF 731
EW + GY+PLTWKQRV+IALDVARGVEYLHSLAQQSFIHRDLKPSNIL+GDDMRAKVADF
Sbjct: 669 EWRELGYSPLTWKQRVSIALDVARGVEYLHSLAQQSFIHRDLKPSNILLGDDMRAKVADF 728
Query: 732 GLVKNAPDGKYSVETRLAGTFGYLAPEYAG 761
GLVKNAPDGKYSVETRLAGTFGYLAPEYA
Sbjct: 729 GLVKNAPDGKYSVETRLAGTFGYLAPEYAA 758
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224130728|ref|XP_002328361.1| predicted protein [Populus trichocarpa] gi|222838076|gb|EEE76441.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 914 bits (2363), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 481/739 (65%), Positives = 564/739 (76%), Gaps = 24/739 (3%)
Query: 26 GDDGSVMLKLAQSLQNLPSDWSSTSSTGYCEWTGINCDNSN-RVTTISLAKSGLSGTLSP 84
DDGS ++KLA S+ LPS WS+ SSTG+C W GI CD+SN RVT+ISL+K +SGTL P
Sbjct: 22 ADDGSAIIKLASSITPLPSGWSTKSSTGFCSWRGIKCDSSNTRVTSISLSKLSISGTLPP 81
Query: 85 EISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144
EIS+L++L++L+FQ N ++GAIPSLAN T+LQ I LD+NNFTS+ G GLT+LQ LS+
Sbjct: 82 EISTLSELQSLTFQDNQLSGAIPSLANLTNLQIILLDSNNFTSISPGFLQGLTSLQTLSV 141
Query: 145 SDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLP 204
DN NL PW P +L + TSLTTL + N+FG IPD F S +LQNLRLSYNNFTG+LP
Sbjct: 142 GDNVNLFPWILPTDLEQCTSLTTLTAKDCNLFGSIPDVFGSLPSLQNLRLSYNNFTGALP 201
Query: 205 ASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLS 264
SFA S IQNLW+N+QQ GL+G+++V+ MTQL QVWLHKN+FTGPIPDL++C+S+FDL
Sbjct: 202 PSFANSGIQNLWLNNQQNGLTGSIEVIGSMTQLAQVWLHKNEFTGPIPDLTECKSIFDLQ 261
Query: 265 LRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGK 324
LRDNQL+G+VPAS++SLP L+N+SL NNK QGP P FP V KV D NN K + G
Sbjct: 262 LRDNQLSGIVPASLVSLPKLVNVSLSNNKFQGPVPQFPPSVTKVDNDGNN--KYCAPPGV 319
Query: 325 PCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCS--QGRIITINLANKLLAGN 382
CD QV TLL IAG GYP+ILSD W+ NNAC GW FVTC + ++T+NLA + G
Sbjct: 320 SCDAQVMTLLGIAGGFGYPSILSDGWDDNNAC-GWAFVTCDVDKKNVVTVNLAKQHFPGR 378
Query: 383 ISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKFTV 442
IS ++ANLTSLKNLYL NNLTG IPD L KL L DVSNNNLSGK+P+F ++VKF
Sbjct: 379 ISSSFANLTSLKNLYLNDNNLTGSIPDSLIKLPELVTFDVSNNNLSGKIPNFPASVKFIT 438
Query: 443 SPGNPFIGTNVDTTPGGAGTPGSKPSGPSGSPAASSKSKLSVGTIVAIVVVVVIFIAVVF 502
PGNPF+GT VDT G GT S G +K S G I +I+V VIFIAV+
Sbjct: 439 KPGNPFLGTKVDT---GGGTTTSSDVG---------TTKKSGGMIASIIVAAVIFIAVLS 486
Query: 503 FVVYKFIARRKHRKFGRVKNPEVGNEMNKNGVTGGNGTNGYNGVPSELHSQSSGDVSDRH 562
V+YK+ R + K + + G + NGV GG GYN V EL SQSS + ++
Sbjct: 487 IVLYKYRKRPRKYK--KKVGWDSGKALFNNGVAGG----GYNEVSIELSSQSSVGENGKN 540
Query: 563 LFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKG 622
+FE GNVA+ IEV+RQ TDNF E NI GRGGFGVVY GEL DGTKIAVKRMES MG KG
Sbjct: 541 IFEDGNVALPIEVIRQATDNFHEINITGRGGFGVVYRGELHDGTKIAVKRMESTVMGTKG 600
Query: 623 LSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLT 682
+SEFQAEIAVLTKVRHRHLVALLGYCING+ERLLVYEYMP+GTL QHLFE HD+GYTPLT
Sbjct: 601 MSEFQAEIAVLTKVRHRHLVALLGYCINGNERLLVYEYMPQGTLGQHLFECHDYGYTPLT 660
Query: 683 WKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742
WKQR+TIALDVARGVEYLHSLAQQSFIHRDLKPSNIL+GD MRAKVADFGLVKNAPDGKY
Sbjct: 661 WKQRITIALDVARGVEYLHSLAQQSFIHRDLKPSNILLGDSMRAKVADFGLVKNAPDGKY 720
Query: 743 SVETRLAGTFGYLAPEYAG 761
SVETRLAGTFGYLAPEYA
Sbjct: 721 SVETRLAGTFGYLAPEYAA 739
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224142687|ref|XP_002324686.1| predicted protein [Populus trichocarpa] gi|222866120|gb|EEF03251.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 904 bits (2337), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 472/743 (63%), Positives = 559/743 (75%), Gaps = 25/743 (3%)
Query: 32 MLKLAQSLQNLPSDWSSTSSTGYCEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQ 91
MLKLA +L P WS+T++ GYC+W G+ CDNSN V +I+LA GLSGTL E+S+L+Q
Sbjct: 1 MLKLASALTPTPKGWSTTNTNGYCKWNGVKCDNSNNVISINLASQGLSGTLPSELSTLSQ 60
Query: 92 LETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLA 151
L++ S Q N + G +PSLAN L+++Y+ NNFTS+P F GLT+LQ LS+ N NL
Sbjct: 61 LQSFSLQDNKLIGPLPSLANLAFLREVYIGTNNFTSIPADFFKGLTSLQTLSMDANINLE 120
Query: 152 PWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSD 211
PW +LT+S+SL T +ANIFG IP+ F SF +LQNLRLSYNN TG LP SFA S
Sbjct: 121 PWVLSTDLTESSSLNTFEASHANIFGAIPNMFASFPSLQNLRLSYNNLTGGLPPSFANSG 180
Query: 212 IQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLT 271
IQNLW+N+Q++GLSGT++VL M QL QVWL KNQFTGPIPD SK +SLFDL LRDNQ T
Sbjct: 181 IQNLWLNNQEMGLSGTIEVLPSMEQLSQVWLQKNQFTGPIPDFSKSKSLFDLQLRDNQFT 240
Query: 272 GVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVT 331
G+ P S+ S LLNIS NNKLQGP P F V+ + NNFC ++ AG C PQVT
Sbjct: 241 GIFPVSLSSQAGLLNISFYNNKLQGPVPQFGKGVKVDNSGLNNFCVDT--AGVACHPQVT 298
Query: 332 TLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGR--IITINLANKLLAGNISPAYAN 389
TLL+IAG GYP +LSDSW+GN+AC+GWPFVTC + +IT++L + G ISPA+ N
Sbjct: 299 TLLEIAGGFGYPVMLSDSWKGNDACNGWPFVTCDSQKKTVITVSLGKQHFGGIISPAFVN 358
Query: 390 LTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKFTVSPGNPFI 449
LT+L L L NNL+GPIPD L KL+ L LDVSNNNL+GK+P F S+VK T++PGNPF+
Sbjct: 359 LTTLTTLKLNDNNLSGPIPDSLIKLSQLSLLDVSNNNLTGKIPAFASSVKLTITPGNPFL 418
Query: 450 GTNVDTTPG---------GAGTPGSKPSGPSGSPAASSKSKLSVGTIVAIVVVVVIFIAV 500
G+ + G TPG P+G + K+S G ++A VV +VI A+
Sbjct: 419 GSGGGSGSGGTPSSGSDSNTTTPGGVPNG-----RGNGGKKVSPG-VIAGVVGIVIVGAI 472
Query: 501 VFFVVYKFIARRKHRKFGRVKNPEVGNEMN---KNGVTGGNGTNGYNGVPSELHSQSSGD 557
FFV++K ++K K GRV + E GN +N KNG + TNGY GV SE+ SQSSG+
Sbjct: 473 GFFVLFKVNRKKKRGKSGRVNDQESGNGINALVKNGSSCC--TNGY-GVLSEIQSQSSGN 529
Query: 558 VSDRHLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNT 617
S RH FEGGNV ISIEVLRQVTDNFSE NILG+GGFGVVY GEL DGTKIAVKRMES
Sbjct: 530 HSGRHFFEGGNVVISIEVLRQVTDNFSENNILGKGGFGVVYKGELHDGTKIAVKRMESGA 589
Query: 618 MGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHG 677
MG KG++EFQAEIAVLTKVRHRHLVALLGYCING+ERLLVYEYMP+GTLAQHLFEW + G
Sbjct: 590 MGTKGMNEFQAEIAVLTKVRHRHLVALLGYCINGNERLLVYEYMPQGTLAQHLFEWQELG 649
Query: 678 YTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737
Y PLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNIL+GDDMRAKVADFGLVKNA
Sbjct: 650 YPPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILLGDDMRAKVADFGLVKNA 709
Query: 738 PDGKYSVETRLAGTFGYLAPEYA 760
PDGKYS+ETRLAGTFGYLAPEYA
Sbjct: 710 PDGKYSMETRLAGTFGYLAPEYA 732
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15229508|ref|NP_189017.1| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] gi|9293948|dbj|BAB01851.1| unnamed protein product [Arabidopsis thaliana] gi|332643288|gb|AEE76809.1| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 902 bits (2331), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 464/750 (61%), Positives = 567/750 (75%), Gaps = 27/750 (3%)
Query: 24 SLGDDGSVMLKLAQSLQNLPSDWSSTSSTGYCEWTGINCDNSNRVTTISLAKSGLSGTLS 83
S+ DD + ML LA+S PSDWSST T +C+W+G+ C RVTTISLA L+G ++
Sbjct: 22 SVADDQTAMLALAKSFNPPPSDWSST--TDFCKWSGVRC-TGGRVTTISLADKSLTGFIA 78
Query: 84 PEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLS 143
PEIS+L++L+++S Q N ++G IPS A +SLQ+IY+D NNF V TG F GLT+LQ+LS
Sbjct: 79 PEISTLSELKSVSIQRNKLSGTIPSFAKLSSLQEIYMDENNFVGVETGAFAGLTSLQILS 138
Query: 144 LSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSL 203
LSDN N+ W FP+EL STSLTT+Y+DN NI G++PD FDS ++LQNLRLSYNN TG L
Sbjct: 139 LSDNNNITTWSFPSELVDSTSLTTIYLDNTNIAGVLPDIFDSLASLQNLRLSYNNITGVL 198
Query: 204 PASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDL 263
P S KS IQNLW+N+Q LG+SGT++VLS MT L Q WLHKN F GPIPDLSK E+LFDL
Sbjct: 199 PPSLGKSSIQNLWINNQDLGMSGTIEVLSSMTSLSQAWLHKNHFFGPIPDLSKSENLFDL 258
Query: 264 SLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAG 323
LRDN LTG+VP ++++L +L NISL NNK QGP PLF +V KV++DHN FC ++ AG
Sbjct: 259 QLRDNDLTGIVPPTLLTLASLKNISLDNNKFQGPLPLFSPEV-KVTIDHNVFC--TTKAG 315
Query: 324 KPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTC-SQGR-IITINLANKLLAG 381
+ C PQV TLL +AG +GYP++L++SW+G++AC GW +V+C S G+ ++T+NL G
Sbjct: 316 QSCSPQVMTLLAVAGGLGYPSMLAESWQGDDACSGWAYVSCDSAGKNVVTLNLGKHGFTG 375
Query: 382 NISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKFT 441
ISPA ANLTSLK+LYL N+LTG IP LT + SLQ +DVSNNNL G++P F + VKF+
Sbjct: 376 FISPAIANLTSLKSLYLNGNDLTGVIPKELTFMTSLQLIDVSNNNLRGEIPKFPATVKFS 435
Query: 442 VSPGNPFIGTNVDTTPGGAGTPGSKPSGPSGSPAASSKSKLSVGTIVAIVVVVVIFIAVV 501
PGN +GTN GG G+ G +S VG IV ++V V++F+A++
Sbjct: 436 YKPGNALLGTN-----GGDGSSPGTGGASGGPGGSSGGGGSKVGVIVGVIVAVLVFLAIL 490
Query: 502 FFVVYKFIARRKHRKFGRVKNPEVGNEMNKNGV----------TGGNGTNGYNGVPSELH 551
FVVYKF+ +RK+ +F R +VG + + V G+G N +N L+
Sbjct: 491 GFVVYKFVMKRKYGRFNRTDPEKVGKILVSDAVSNGGSGNGGYANGHGANNFNA----LN 546
Query: 552 SQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVK 611
S SSGD SDR L EGG+V I +EVLRQVT+NFSE NILGRGGFGVVY GEL DGTK AVK
Sbjct: 547 SPSSGDNSDRFLLEGGSVTIPMEVLRQVTNNFSEDNILGRGGFGVVYAGELHDGTKTAVK 606
Query: 612 RMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLF 671
RME MGNKG+SEFQAEIAVLTKVRHRHLVALLGYC+NG+ERLLVYEYMP+G L QHLF
Sbjct: 607 RMECAAMGNKGMSEFQAEIAVLTKVRHRHLVALLGYCVNGNERLLVYEYMPQGNLGQHLF 666
Query: 672 EWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADF 731
EW + GY+PLTWKQRV+IALDVARGVEYLHSLAQQSFIHRDLKPSNIL+GDDMRAKVADF
Sbjct: 667 EWSELGYSPLTWKQRVSIALDVARGVEYLHSLAQQSFIHRDLKPSNILLGDDMRAKVADF 726
Query: 732 GLVKNAPDGKYSVETRLAGTFGYLAPEYAG 761
GLVKNAPDGKYSVETRLAGTFGYLAPEYA
Sbjct: 727 GLVKNAPDGKYSVETRLAGTFGYLAPEYAA 756
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224125576|ref|XP_002319620.1| predicted protein [Populus trichocarpa] gi|222857996|gb|EEE95543.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 902 bits (2330), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 475/745 (63%), Positives = 578/745 (77%), Gaps = 13/745 (1%)
Query: 23 TSLGDDGSVMLKLAQSLQNLPSDWSSTSSTGYCEWTGINCDNS-NRVTTISLAKSGLSGT 81
T+ DDG+ +LKLA+S+ LPS WS+ SST +C W GINCD+S +RVT+ISL+K LSGT
Sbjct: 18 TATADDGATILKLAKSITPLPSGWSTKSSTTFCSWHGINCDSSKSRVTSISLSKLSLSGT 77
Query: 82 LSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQV 141
L PEIS+L++L++LS Q N ++G +PSLAN T+LQ I+LD+NNFTS+P G F GLT LQ
Sbjct: 78 LPPEISTLSELQSLSVQGNQLSGDLPSLANLTNLQYIFLDSNNFTSIPPGFFQGLTGLQT 137
Query: 142 LSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTG 201
S+ +N NL+PW P +L + TSLTTL ++ +FG IPD F S +LQNLRLSYNN TG
Sbjct: 138 FSIGNNVNLSPWQLPTDLAQCTSLTTLTANDCQLFGSIPDVFGSLPSLQNLRLSYNNLTG 197
Query: 202 SLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLF 261
LP SFA S IQNLW+N+QQ+GL+G+++V+ +TQL QVWLH NQFTGPIPDL++C+SLF
Sbjct: 198 VLPPSFANSGIQNLWVNNQQIGLTGSIEVIGSITQLSQVWLHMNQFTGPIPDLTECKSLF 257
Query: 262 DLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSD 321
DL LRDNQ TG+VPAS++SLP L+N+SL NNK QGP P FP V +++ + K +
Sbjct: 258 DLQLRDNQFTGIVPASLVSLPNLVNVSLSNNKFQGPVPQFPPSV--ITVKNEGINKYCAG 315
Query: 322 AGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGR--IITINLANKLL 379
G PCD V TLL+IAG GYP+ LSD W+GN+AC GWP VTC G+ ++T+NLA +
Sbjct: 316 PGVPCDALVMTLLEIAGGFGYPSTLSDKWDGNDAC-GWPLVTCDVGKKNVVTVNLAKQQF 374
Query: 380 AGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVK 439
G+ISP++A L+SLK+LYL +NNLTG IPD LTKL L+ LDVSNNNLSGK+P+F +VK
Sbjct: 375 TGSISPSFAKLSSLKSLYLNENNLTGSIPDSLTKLPELETLDVSNNNLSGKIPEFPRSVK 434
Query: 440 FTVSPGNPFIGTNVDTTPGGAGTPGSKPSGPSGSPAASSKS---KLSVGTIVAIVVVVVI 496
PGNPF+ T+VDT+ GG S SG+ + S + K+ G I I+V VVI
Sbjct: 435 LITKPGNPFLRTDVDTSSGGTTNGTSNGGTTSGTSSGGSSAGSTKIPGGVIAGIIVAVVI 494
Query: 497 FIAVVFFVVYKFIARRKHRKFGRVKNPEVGNEMNKNGVTGGNGTNGYNGVPSELHSQSSG 556
FI V+ FV+Y++ +++H K G+ + G E KN V GG NG N VP+ LHSQSS
Sbjct: 495 FIVVLSFVLYQY--KKRHPKSGKELKWDGGKEFFKNEVAGGG--NGSNKVPNALHSQSSD 550
Query: 557 DVSDRHLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESN 616
+ +++FEGGNVA+ IE LRQVTDNF E NI+GRGGFGVVY GEL DGTKIAVKRMES
Sbjct: 551 GDNSKNIFEGGNVAVPIEFLRQVTDNFHEINIIGRGGFGVVYRGELHDGTKIAVKRMEST 610
Query: 617 TMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDH 676
MGNKG+SEFQAEIAVLTKVRHRHLVALLGYCING+ERLLVYEYMP+GTL QHLFE HD+
Sbjct: 611 VMGNKGISEFQAEIAVLTKVRHRHLVALLGYCINGNERLLVYEYMPQGTLGQHLFECHDY 670
Query: 677 GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736
YTPLTWKQR+TIALDVARGVEYLH LAQQSFIHRDLK SNIL+GDDMRAKVADFGLVKN
Sbjct: 671 RYTPLTWKQRITIALDVARGVEYLHGLAQQSFIHRDLKTSNILLGDDMRAKVADFGLVKN 730
Query: 737 APDGKYSVETRLAGTFGYLAPEYAG 761
APDGKYSVETRLAGTFGYLAPEYA
Sbjct: 731 APDGKYSVETRLAGTFGYLAPEYAA 755
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224589575|gb|ACN59321.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 898 bits (2321), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 463/750 (61%), Positives = 566/750 (75%), Gaps = 27/750 (3%)
Query: 24 SLGDDGSVMLKLAQSLQNLPSDWSSTSSTGYCEWTGINCDNSNRVTTISLAKSGLSGTLS 83
S+ DD + ML LA+S PSDWSST T +C+W+G+ C RVTTISLA L+G ++
Sbjct: 22 SVADDQTAMLALAKSFNPPPSDWSST--TDFCKWSGVRC-TGGRVTTISLADKSLTGFIA 78
Query: 84 PEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLS 143
PEIS+L++L+++S Q N ++G IPS A +SLQ+IY+D NNF V TG F GLT+LQ+LS
Sbjct: 79 PEISTLSELKSVSIQRNKLSGTIPSFAKLSSLQEIYMDENNFVGVETGAFAGLTSLQILS 138
Query: 144 LSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSL 203
LSDN N+ W FP+EL STSLTT+Y+DN NI G++PD FDS ++LQNLRLSYNN TG L
Sbjct: 139 LSDNNNITTWSFPSELVDSTSLTTIYLDNTNIAGVLPDIFDSLASLQNLRLSYNNITGVL 198
Query: 204 PASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDL 263
P S KS IQNLW+N+Q LG+SGT++VLS MT L Q WLHKN F GPIPDLSK E+LFDL
Sbjct: 199 PPSLGKSSIQNLWINNQDLGMSGTIEVLSSMTSLSQAWLHKNHFFGPIPDLSKSENLFDL 258
Query: 264 SLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAG 323
LRDN LTG+VP ++++L +L NISL NNK QGP PLF +V KV++DHN FC ++ AG
Sbjct: 259 QLRDNDLTGIVPPTLLTLASLKNISLDNNKFQGPLPLFSPEV-KVTIDHNVFC--TTKAG 315
Query: 324 KPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTC-SQGR-IITINLANKLLAG 381
+ C PQV TLL +AG +GYP++L++SW+G++AC GW +V+C S G+ ++T+NL G
Sbjct: 316 QSCSPQVMTLLAVAGGLGYPSMLAESWQGDDACSGWAYVSCDSAGKNVVTLNLGKHGFTG 375
Query: 382 NISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKFT 441
ISPA ANLTSLK+LYL N+LTG IP LT + SLQ +DVSNNNL G++P F + VKF+
Sbjct: 376 FISPAIANLTSLKSLYLNGNDLTGVIPKELTFMTSLQLIDVSNNNLRGEIPKFPATVKFS 435
Query: 442 VSPGNPFIGTNVDTTPGGAGTPGSKPSGPSGSPAASSKSKLSVGTIVAIVVVVVIFIAVV 501
PGN +GTN GG G+ G +S VG IV ++V V++F+A++
Sbjct: 436 YKPGNALLGTN-----GGDGSSPGTGGASGGPGGSSGGGGSKVGVIVGVIVAVLVFLAIL 490
Query: 502 FFVVYKFIARRKHRKFGRVKNPEVGNEMNKNGV----------TGGNGTNGYNGVPSELH 551
FVVYKF+ +RK+ +F R +VG + + V G+G N +N L+
Sbjct: 491 GFVVYKFVMKRKYGRFNRTDPEKVGKILVSDAVSNGGSGNGGYANGHGANNFNA----LN 546
Query: 552 SQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVK 611
S SSGD SDR L EGG+V I +EVLRQVT+NFSE NILGRGGFGVVY GEL DGTK AVK
Sbjct: 547 SPSSGDNSDRFLLEGGSVTIPMEVLRQVTNNFSEDNILGRGGFGVVYAGELHDGTKTAVK 606
Query: 612 RMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLF 671
ME MGNKG+SEFQAEIAVLTKVRHRHLVALLGYC+NG+ERLLVYEYMP+G L QHLF
Sbjct: 607 GMECAAMGNKGMSEFQAEIAVLTKVRHRHLVALLGYCVNGNERLLVYEYMPQGNLGQHLF 666
Query: 672 EWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADF 731
EW + GY+PLTWKQRV+IALDVARGVEYLHSLAQQSFIHRDLKPSNIL+GDDMRAKVADF
Sbjct: 667 EWSELGYSPLTWKQRVSIALDVARGVEYLHSLAQQSFIHRDLKPSNILLGDDMRAKVADF 726
Query: 732 GLVKNAPDGKYSVETRLAGTFGYLAPEYAG 761
GLVKNAPDGKYSVETRLAGTFGYLAPEYA
Sbjct: 727 GLVKNAPDGKYSVETRLAGTFGYLAPEYAA 756
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147798019|emb|CAN69461.1| hypothetical protein VITISV_043132 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 894 bits (2311), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 481/761 (63%), Positives = 572/761 (75%), Gaps = 21/761 (2%)
Query: 8 VSICAVVLLLLQLTTTSLGDDGSVMLKLAQSLQNLPSDWSSTSSTGYCEWTGINC----D 63
VS+C LL L T++L DD +VM L + L PS W+ + +C W GINC D
Sbjct: 5 VSLC----LLFSLLTSALADDAAVMDNLRKGLSXTPSGWTGSD---FCSWEGINCGNTGD 57
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNN 123
++ VT I++A GLSGTL +++ L+QL TLSFQ N++ G++PSLAN LQBIYL++N
Sbjct: 58 SNGXVTAINMASKGLSGTLPSDLNQLSQLVTLSFQSNSLXGSLPSLANLQFLQBIYLNSN 117
Query: 124 NFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFF 183
NF S+ F LT+LQ +SL +NP+LAPW P+ L++S SL Y NANI G IPD+F
Sbjct: 118 NFXSIDKDFFTNLTSLQTVSLGENPDLAPWSIPDGLSQSKSLAIFYASNANIEGSIPDWF 177
Query: 184 DSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLH 243
S +L LRLSYNN GSLP+S + IQ LWMN+QQ GLSGT+DVL+ M L QVWL
Sbjct: 178 GSMPSLNELRLSYNNLNGSLPSSLPGTSIQKLWMNNQQSGLSGTIDVLAAMPDLXQVWLQ 237
Query: 244 KNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPS 303
N FTGPIPDLS C LFDL LRDNQ TG+VP+S+ SLP L+NI+L+NNKLQGP P F +
Sbjct: 238 ANAFTGPIPDLSNCTQLFDLQLRDNQFTGIVPSSLTSLPQLVNITLKNNKLQGPVPEFST 297
Query: 304 KVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVT 363
V V LD+N FC+ S PCD QVTTLL++AG +GYP L+DSWEGN+ACB W F++
Sbjct: 298 GV-NVELDNNKFCRTSV---GPCDSQVTTLLEVAGALGYPTTLADSWEGNDACBQWAFIS 353
Query: 364 C-SQGRIITI-NLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLD 421
C +QG+ +TI N A + G ISPA+ANLTSL+NLYL N LTG IP+ LT L LQ LD
Sbjct: 354 CDTQGKNVTIVNFAKRGFTGTISPAFANLTSLRNLYLNDNKLTGSIPESLTSLTQLQVLD 413
Query: 422 VSNNNLSGKVPDFGSNVKFTVSPGNPFIGTNVDTTPGGAGTPGSKPSGPSGSPAAS-SKS 480
VSNNNL+G +P FG VK T + GN +G D+ G + + G+ + PSG+PA S + S
Sbjct: 414 VSNNNLTGGIPKFGDGVKVTTT-GNLLLGNGTDSGSGDSPSSGTDTTSPSGTPAGSPNGS 472
Query: 481 KLSVGTIVAIVVVVVIFIAVVFFVVYKFIARRKHRKFGRVKNPEVGNEMNKNGVTGGNGT 540
S G I AIVV VVIFI VV FV YK R++H+KFGRV NPE G EM N V G
Sbjct: 473 TPSAGVIAAIVVAVVIFIGVVLFVSYKCYVRKQHKKFGRVDNPENGKEMVVNKVM--GGM 530
Query: 541 NGYNGVPSELHSQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYGG 600
GY GVPSELHSQSSGD SD +FEGGN+AISI+VLRQVT+NFSE NILGRGGFGVVY G
Sbjct: 531 GGYGGVPSELHSQSSGDHSDIPVFEGGNIAISIQVLRQVTNNFSEDNILGRGGFGVVYKG 590
Query: 601 ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660
EL DGTKIAVKRMES +G KG++EFQAEIAVLTKVRHRHLVALLG+C+NG+ERLLVYEY
Sbjct: 591 ELHDGTKIAVKRMESAAVGTKGMNEFQAEIAVLTKVRHRHLVALLGFCVNGNERLLVYEY 650
Query: 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI 720
MP+GTL QHLF+W ++GY PLTWKQRVTIALDV RGVEYLHSLAQQSFIHRDLKPSNIL+
Sbjct: 651 MPQGTLGQHLFDWRENGYPPLTWKQRVTIALDVGRGVEYLHSLAQQSFIHRDLKPSNILL 710
Query: 721 GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAG 761
GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYA
Sbjct: 711 GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAA 751
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296089594|emb|CBI39413.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 885 bits (2288), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 474/737 (64%), Positives = 562/737 (76%), Gaps = 17/737 (2%)
Query: 32 MLKLAQSLQNLPSDWSSTSSTGYCEWTGINC----DNSNRVTTISLAKSGLSGTLSPEIS 87
M L + L + PS W+ + +C W GINC D++ RVT I++A GLSGTL +++
Sbjct: 1 MDNLRKGLSSTPSGWTGSD---FCSWEGINCGNTGDSNGRVTAINMASKGLSGTLPSDLN 57
Query: 88 SLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDN 147
L+QL TLSFQ N+++G++PSLAN LQDIYL++NNFTS+ F LT+LQ +SL +N
Sbjct: 58 QLSQLVTLSFQSNSLSGSLPSLANLQFLQDIYLNSNNFTSIDKDFFTNLTSLQTVSLGEN 117
Query: 148 PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASF 207
P+LAPW P+ L++S SL Y NANI G IPD+F S +L LRLSYNN GSLP+S
Sbjct: 118 PDLAPWSIPDGLSQSKSLAIFYASNANIEGSIPDWFGSMPSLNELRLSYNNLNGSLPSSL 177
Query: 208 AKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRD 267
+ IQ LWMN+QQ GLSGT+DVL+ M LRQVWL N FTGPIPDLS C LFDL LRD
Sbjct: 178 PGTSIQKLWMNNQQSGLSGTIDVLAAMPDLRQVWLQANAFTGPIPDLSNCTQLFDLQLRD 237
Query: 268 NQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCD 327
NQ TG+VP+S+ SLP L+NI+L+NNKLQGP P F + V V LD+N FC+ S PCD
Sbjct: 238 NQFTGIVPSSLTSLPKLVNITLKNNKLQGPVPEFSTGV-NVELDNNKFCRTSV---GPCD 293
Query: 328 PQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTC-SQGRIITI-NLANKLLAGNISP 385
QVTTLL++AG +GYP L+DSWEGN+AC+ W F++C +QG+ +TI N A + G ISP
Sbjct: 294 SQVTTLLEVAGALGYPTTLADSWEGNDACNQWAFISCDTQGKNVTIVNFAKRGFTGTISP 353
Query: 386 AYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKFTVSPG 445
A+ANLTSL+NLYL N LTG IP+ LT L LQ LDVSNNNL+G +P FG VK T + G
Sbjct: 354 AFANLTSLRNLYLNDNKLTGSIPESLTSLTQLQVLDVSNNNLTGGIPKFGDGVKVTTT-G 412
Query: 446 NPFIGTNVDTTPGGAGTPGSKPSGPSGSPAAS-SKSKLSVGTIVAIVVVVVIFIAVVFFV 504
N +G D+ G + + G+ + PSG+PA S + S S G I AIVV VVIFI VV FV
Sbjct: 413 NLLLGNGTDSGSGDSPSSGTDTTSPSGTPAGSPNGSTPSAGVIAAIVVAVVIFIGVVLFV 472
Query: 505 VYKFIARRKHRKFGRVKNPEVGNEMNKNGVTGGNGTNGYNGVPSELHSQSSGDVSDRHLF 564
YK R++H+KFGRV NPE G EM N V G GY GVPSELHSQSSGD SD +F
Sbjct: 473 SYKCYVRKQHKKFGRVDNPENGKEMVVNKVM--GGMGGYGGVPSELHSQSSGDHSDIPVF 530
Query: 565 EGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLS 624
EGGN+AISI+VLRQVT+NFSE NILGRGGFGVVY GEL DGTKIAVKRMES +G KG++
Sbjct: 531 EGGNIAISIQVLRQVTNNFSEDNILGRGGFGVVYKGELHDGTKIAVKRMESAAVGTKGMN 590
Query: 625 EFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWK 684
EFQAEIAVLTKVRHRHLVALLG+C+NG+ERLLVYEYMP+GTL QHLF+W ++GY PLTWK
Sbjct: 591 EFQAEIAVLTKVRHRHLVALLGFCVNGNERLLVYEYMPQGTLGQHLFDWRENGYPPLTWK 650
Query: 685 QRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSV 744
QRVTIALDV RGVEYLHSLAQQSFIHRDLKPSNIL+GDDMRAKVADFGLVKNAPDGKYSV
Sbjct: 651 QRVTIALDVGRGVEYLHSLAQQSFIHRDLKPSNILLGDDMRAKVADFGLVKNAPDGKYSV 710
Query: 745 ETRLAGTFGYLAPEYAG 761
ETRLAGTFGYLAPEYA
Sbjct: 711 ETRLAGTFGYLAPEYAA 727
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224087245|ref|XP_002308106.1| predicted protein [Populus trichocarpa] gi|222854082|gb|EEE91629.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 881 bits (2276), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 467/738 (63%), Positives = 558/738 (75%), Gaps = 14/738 (1%)
Query: 33 LKLAQSLQNLPSDWSSTSSTGYCEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQL 92
LKLA +L P WS+T+S YC W G+ CD+SN V +I+LA LSG L E+S+L+QL
Sbjct: 32 LKLASALTPTPKGWSTTNSDDYCNWNGVKCDSSNNVISINLATQSLSGILPSELSTLSQL 91
Query: 93 ETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAP 152
++LS Q N ++GA+PSLAN SL++IY+ NNFTS+P CF GLT+LQ +S+++N NL
Sbjct: 92 QSLSLQENKLSGALPSLANLASLREIYIGTNNFTSIPQDCFKGLTSLQTMSMNENINLES 151
Query: 153 WPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDI 212
W +LT+S SLTT NA IFG IPD F SF +LQNLRLSYNN TG LP SFA S+I
Sbjct: 152 WVISTDLTESPSLTTFEASNAKIFGTIPDMFASFPSLQNLRLSYNNLTGGLPPSFANSEI 211
Query: 213 QNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTG 272
QNLW+N+Q++GLSG ++VLS M QL QVWL KNQFTGP+PDLSK ++LFDL LRDNQ TG
Sbjct: 212 QNLWLNNQEMGLSGNIEVLSSMEQLSQVWLQKNQFTGPVPDLSKSKNLFDLQLRDNQFTG 271
Query: 273 VVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTT 332
++P S+ SLP LLNISL NNKLQGP P F V + NNFC ++ AG CDPQVTT
Sbjct: 272 ILPVSLHSLPGLLNISLSNNKLQGPVPQFGKDVIVDNSGLNNFCVDT--AGVACDPQVTT 329
Query: 333 LLQIAGDMGYPAILSDSWEGNNACDGWPFVTC--SQGRIITINLANKLLAGNISPAYANL 390
LL+IAG GYP LSDSW+GN+AC GWPFV C S+ + T++L + G ISPA+ANL
Sbjct: 330 LLEIAGGFGYPVTLSDSWKGNDACSGWPFVFCDSSKKTVTTVSLGKQHFGGIISPAFANL 389
Query: 391 TSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKFTVSPGNPFIG 450
T+L L L NNL+GPIPD L KL+ L LDVSNNNL+GK+P F ++VK T +PGNPF+G
Sbjct: 390 TALTTLKLNDNNLSGPIPDSLAKLSQLSLLDVSNNNLTGKIPSFATSVKLTTTPGNPFLG 449
Query: 451 TNVDTTPGGAGTPGSKPS------GPSGSPAASSKSKLSVGTIVAIVVVVVIFIAVVFFV 504
+ GGA +PGS + GP+G K +S G I IVV +VI + F+
Sbjct: 450 SGGVPGSGGAPSPGSDSNTTAPGDGPNGKGIGGKK--VSPGLIAGIVVGLVIVGVIGVFL 507
Query: 505 VYKFIARRKHRKFGRVKNPEVGNEMNKNGVTGGNG-TNGYNGVPSELHSQSSGDVSDRHL 563
++K ++K K GRV + E G+ ++ G +G T GY GV SE+ SQSSG+ S R++
Sbjct: 508 LFKINIKKKRGKSGRVNDQENGDGISALVTNGSSGCTKGY-GVLSEIQSQSSGNHSGRNI 566
Query: 564 FEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGL 623
FEGGN ISIEVLRQVTDNFSE NILG+GGFGVVY GEL DGTKIAVKRME+ MG KG+
Sbjct: 567 FEGGNNVISIEVLRQVTDNFSENNILGKGGFGVVYKGELHDGTKIAVKRMEAGAMGTKGM 626
Query: 624 SEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTW 683
+EFQAEIAVLTKVRHRHLVALLGYCING+ERLLVYEYMP+G LAQHLFEW + GY PLTW
Sbjct: 627 NEFQAEIAVLTKVRHRHLVALLGYCINGNERLLVYEYMPQGNLAQHLFEWQELGYPPLTW 686
Query: 684 KQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743
KQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNIL+GDDMRAKVADFGLVKNAPDG YS
Sbjct: 687 KQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILLGDDMRAKVADFGLVKNAPDGNYS 746
Query: 744 VETRLAGTFGYLAPEYAG 761
+ETRLAGTFGYLAPEYA
Sbjct: 747 METRLAGTFGYLAPEYAA 764
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356568467|ref|XP_003552432.1| PREDICTED: probable receptor protein kinase TMK1-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 870 bits (2247), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 480/765 (62%), Positives = 573/765 (74%), Gaps = 16/765 (2%)
Query: 2 MRKKPQVSICAVVLLLLQLTTTSLGDDGSVMLKLAQSLQNLPSDWSSTSSTGYCEWTGIN 61
+++KP +S+C + LLLL L T++ DDG M KLA++L PS W+ +S +C+WTG+
Sbjct: 6 LKQKPLLSLCKLFLLLLSLACTAIADDGVFMSKLAKALIPSPSGWTGSS---FCQWTGVK 62
Query: 62 CDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLD 121
C ++NRVT I +A L GTL P+++SL+QL +LS Q N ++GA+PSLAN + L+ ++LD
Sbjct: 63 C-SANRVTIIKIASQSLGGTLPPDLNSLSQLTSLSLQNNKLSGALPSLANLSMLESVFLD 121
Query: 122 NNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPD 181
NNFTS+P GCF GLT+LQ LS++D+ NLAPW P ELT S +L L + NAN+ G +PD
Sbjct: 122 GNNFTSIPDGCFQGLTSLQTLSMADSVNLAPWTIPTELTDSNNLVKLDLGNANLIGTLPD 181
Query: 182 FFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQ-LGLSGTLDVLSGMTQLRQV 240
FD F +LQ LRLSYNN TG LP SF S+IQNLW+N+Q G SG+++VL+ MT L QV
Sbjct: 182 VFDKFVSLQELRLSYNNLTGGLPKSFGGSEIQNLWLNNQNGFGFSGSIEVLASMTHLSQV 241
Query: 241 WLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPL 300
WL KNQFTGPIPDLS C +LFDL LRDNQLTGVVP S++SL +L N+SL NN LQGP P
Sbjct: 242 WLQKNQFTGPIPDLSNCTTLFDLQLRDNQLTGVVPPSLMSLSSLQNVSLDNNALQGPVPS 301
Query: 301 FPSKVQKVSLDH-NNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGW 359
F V K +LD N+FC D G PCD +++TLL IA GYP L+ SW GN+ CD W
Sbjct: 302 FEKGV-KFTLDGINSFCLK--DVG-PCDSRISTLLDIAAGFGYPLQLARSWTGNDPCDDW 357
Query: 360 PFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQN 419
FV C+ G+IIT+NLA + L G ISPA+ANLT L+NL+L NNL G IP LT LA L+
Sbjct: 358 SFVVCAGGKIITVNLAKQNLTGTISPAFANLTDLRNLFLNDNNLGGSIPGSLTNLAQLEV 417
Query: 420 LDVSNNNLSGKVPDFGSNVKFTVSPGNPFIGTNVDTTPGGAGTPGSKPSG--PSGSPAAS 477
L+VSNNNLSG VP F + VKFT + GN +G + G TP SK SG PSGSP+
Sbjct: 418 LNVSNNNLSGDVPKFPTKVKFTTA-GNDLLGRSDGGGGGSGTTP-SKGSGDAPSGSPSTG 475
Query: 478 -SKSKLSVGTIVAIVVVVVIFIAVVFFVVYKFIARRKHRKFGRVKNPEVGNEMNKNGVTG 536
S LS I IV++ V F+AVV FV K A+ +H KFGRV NPE G K +
Sbjct: 476 PGGSSLSPAWIAGIVLIAVFFVAVVVFVFCKCHAKNRHGKFGRVNNPENGKGEVKIDMMS 535
Query: 537 GNGTNGYNGVPSELHSQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGV 596
+NGY GVPSEL SQ S + SD H+FEGGN ISI+VLRQVTDNFSE NILGRGGFGV
Sbjct: 536 VTNSNGYGGVPSELQSQGS-ERSDVHVFEGGNATISIQVLRQVTDNFSEKNILGRGGFGV 594
Query: 597 VYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656
VY GEL DGT+IAVKRMES G+KGL+EFQAEIAVL+KVRHRHLVALLGYCING+ERLL
Sbjct: 595 VYKGELHDGTQIAVKRMESVATGSKGLNEFQAEIAVLSKVRHRHLVALLGYCINGNERLL 654
Query: 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPS 716
VYEYMP+GTL QHLF+W ++G PLTWKQRV IALDVARGVEYLHSLAQQSFIHRDLKPS
Sbjct: 655 VYEYMPQGTLTQHLFDWGENGCAPLTWKQRVAIALDVARGVEYLHSLAQQSFIHRDLKPS 714
Query: 717 NILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAG 761
NIL+GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYA
Sbjct: 715 NILLGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAA 759
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 782 | ||||||
| TAIR|locus:2095188 | 928 | AT3G23750 [Arabidopsis thalian | 0.951 | 0.801 | 0.572 | 1.2e-225 | |
| TAIR|locus:2059703 | 943 | AT2G01820 [Arabidopsis thalian | 0.533 | 0.442 | 0.460 | 1.6e-171 | |
| TAIR|locus:2013825 | 942 | TMK1 "transmembrane kinase 1" | 0.529 | 0.439 | 0.462 | 3e-170 | |
| TAIR|locus:2024016 | 886 | AT1G24650 [Arabidopsis thalian | 0.524 | 0.462 | 0.418 | 7.3e-152 | |
| TAIR|locus:2097310 | 1002 | BAM2 "BARELY ANY MERISTEM 2" [ | 0.478 | 0.373 | 0.300 | 6.3e-64 | |
| TAIR|locus:2182870 | 1192 | EMS1 "EXCESS MICROSPOROCYTES1" | 0.507 | 0.333 | 0.286 | 6.1e-63 | |
| TAIR|locus:2170483 | 1173 | FLS2 "FLAGELLIN-SENSITIVE 2" [ | 0.494 | 0.329 | 0.317 | 1.3e-62 | |
| TAIR|locus:2169965 | 1003 | BAM1 "BARELY ANY MERISTEM 1" [ | 0.480 | 0.374 | 0.290 | 7.3e-62 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.496 | 0.345 | 0.297 | 1.6e-61 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.507 | 0.317 | 0.291 | 4.7e-61 |
| TAIR|locus:2095188 AT3G23750 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2178 (771.8 bits), Expect = 1.2e-225, P = 1.2e-225
Identities = 437/763 (57%), Positives = 530/763 (69%)
Query: 6 PQVSICAVVXXXXXXXXXXXGDDGSVMLKLAQSLQNLPSDWSSTSSTGYCEWTGINCDNS 65
P + V+ DD + ML LA+S PSDWSST T +C+W+G+ C
Sbjct: 4 PTPLLLLVLLTTITFFTTSVADDQTAMLALAKSFNPPPSDWSST--TDFCKWSGVRC-TG 60
Query: 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNF 125
RVTTISLA L+G ++PEIS+L++L+++S Q N ++G IPS A +SLQ+IY+D NNF
Sbjct: 61 GRVTTISLADKSLTGFIAPEISTLSELKSVSIQRNKLSGTIPSFAKLSSLQEIYMDENNF 120
Query: 126 TSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDS 185
V TG F GLT+LQ+LSLSDN N+ W FP+EL STSLTT+Y+DN NI G++PD FDS
Sbjct: 121 VGVETGAFAGLTSLQILSLSDNNNITTWSFPSELVDSTSLTTIYLDNTNIAGVLPDIFDS 180
Query: 186 FSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKN 245
++LQNLRLSYNN TG LP S KS IQNLW+N+Q LG+SGT++VLS MT L Q WLHKN
Sbjct: 181 LASLQNLRLSYNNITGVLPPSLGKSSIQNLWINNQDLGMSGTIEVLSSMTSLSQAWLHKN 240
Query: 246 QFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKV 305
F GPIPDLSK E+LFDL LRDN LTG+VP ++++L +L NISL NNK QGP PLF +V
Sbjct: 241 HFFGPIPDLSKSENLFDLQLRDNDLTGIVPPTLLTLASLKNISLDNNKFQGPLPLFSPEV 300
Query: 306 QKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTC- 364
KV++DHN FC ++ AG+ C PQV TLL +AG +GYP++L++SW+G++AC GW +V+C
Sbjct: 301 -KVTIDHNVFC--TTKAGQSCSPQVMTLLAVAGGLGYPSMLAESWQGDDACSGWAYVSCD 357
Query: 365 SQGR-IITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVS 423
S G+ ++T+NL G ISPA ANLTSLK+LYL N+LTG IP LT + SLQ +DVS
Sbjct: 358 SAGKNVVTLNLGKHGFTGFISPAIANLTSLKSLYLNGNDLTGVIPKELTFMTSLQLIDVS 417
Query: 424 NNNLSGKVPDFGSNVKFTVSPGNPFIGTNVDXXXXXXXXXXXXXXXXXXXXXXXXXXXLS 483
NNNL G++P F + VKF+ PGN +GTN
Sbjct: 418 NNNLRGEIPKFPATVKFSYKPGNALLGTNGGDGSSPGTGGASGGPGGSSGGGGS-----K 472
Query: 484 VGTXXXXXXXXXXXXXXXXXXXYKFIARRKHRKFGRVKNPEVGNEM------NKXXXXXX 537
VG YKF+ +RK+ +F R +VG + N
Sbjct: 473 VGVIVGVIVAVLVFLAILGFVVYKFVMKRKYGRFNRTDPEKVGKILVSDAVSNGGSGNGG 532
Query: 538 XXXXXXXXXPSELHSQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEANILXXXXXXXX 597
+ L+S SSGD SDR L EGG+V I +EVLRQVT+NFSE NIL
Sbjct: 533 YANGHGANNFNALNSPSSGDNSDRFLLEGGSVTIPMEVLRQVTNNFSEDNILGRGGFGVV 592
Query: 598 XXXELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657
EL DGTK AVKRME MGNKG+SEFQAEIAVLTKVRHRHLVALLGYC+NG+ERLLV
Sbjct: 593 YAGELHDGTKTAVKRMECAAMGNKGMSEFQAEIAVLTKVRHRHLVALLGYCVNGNERLLV 652
Query: 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSN 717
YEYMP+G L QHLFEW + GY+PLTWKQRV+IALDVARGVEYLHSLAQQSFIHRDLKPSN
Sbjct: 653 YEYMPQGNLGQHLFEWSELGYSPLTWKQRVSIALDVARGVEYLHSLAQQSFIHRDLKPSN 712
Query: 718 ILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYA 760
IL+GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYA
Sbjct: 713 ILLGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYA 755
|
|
| TAIR|locus:2059703 AT2G01820 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 907 (324.3 bits), Expect = 1.6e-171, Sum P(2) = 1.6e-171
Identities = 199/432 (46%), Positives = 270/432 (62%)
Query: 26 GDDGSVMLKLAQSLQNLPSD--WSSTSSTGYCEWTGINCDNSNRVTTISLAKSGLSGTLS 83
G D S M L SL NL SD WS+ + C+W + CD SNRVT I L + G+ GTL
Sbjct: 27 GLDDSTMQSLKSSL-NLTSDVDWSNPNP---CKWQSVQCDGSNRVTKIQLKQKGIRGTLP 82
Query: 84 PEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLS 143
+ SL++L L +N I+G IP L+ + LQ + L +N FTSVP F G+++LQ +
Sbjct: 83 TNLQSLSELVILELFLNRISGPIPDLSGLSRLQTLNLHDNLFTSVPKNLFSGMSSLQEMY 142
Query: 144 LSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFS--NLQNLRLSYNNFTG 201
L +NP PW P+ + ++TSL L + N +I G IPDFF S S +L NL+LS N G
Sbjct: 143 LENNP-FDPWVIPDTVKEATSLQNLTLSNCSIIGKIPDFFGSQSLPSLTNLKLSQNGLEG 201
Query: 202 SLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLF 261
LP SFA + IQ+L++N Q+L +G++ VL MT L +V L NQF+GPIPDLS SL
Sbjct: 202 ELPMSFAGTSIQSLFLNGQKL--NGSISVLGNMTSLVEVSLQGNQFSGPIPDLSGLVSLR 259
Query: 262 DLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDH-NNFCKNSS 320
++R+NQLTGVVP S++SL +L ++L NN LQGP PLF V +++ N+FC N
Sbjct: 260 VFNVRENQLTGVVPQSLVSLSSLTTVNLTNNYLQGPTPLFGKSVGVDIVNNMNSFCTNV- 318
Query: 321 DAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLA 380
AG+ CDP+V TL+ +A GYP L++SW+GNN C W +TCS G I +N+ + L+
Sbjct: 319 -AGEACDPRVDTLVSVAESFGYPVKLAESWKGNNPCVNWVGITCSGGNITVVNMRKQDLS 377
Query: 381 GNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKF 440
G ISP+ A LTSL+ + L N L+G IPD LT L+ L+ LDVSNN+ G P F V
Sbjct: 378 GTISPSLAKLTSLETINLADNKLSGHIPDELTTLSKLRLLDVSNNDFYGIPPKFRDTVTL 437
Query: 441 TVSPGNPFIGTN 452
V+ GN +G N
Sbjct: 438 -VTEGNANMGKN 448
|
|
| TAIR|locus:2013825 TMK1 "transmembrane kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 929 (332.1 bits), Expect = 3.0e-170, Sum P(2) = 3.0e-170
Identities = 197/426 (46%), Positives = 264/426 (61%)
Query: 28 DGSVMLKLAQSLQNLPSDWSSTSSTGYCEWTGINCDNSNRVTTISLAKSGLSGTLSPEIS 87
D S ML L +SL N PS + S C+WT I C + RVT I + SGL GTLSP++
Sbjct: 28 DLSAMLSLKKSL-NPPSSFG-WSDPDPCKWTHIVCTGTKRVTRIQIGHSGLQGTLSPDLR 85
Query: 88 SLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDN 147
+L++LE L Q NNI+G +PSL+ SLQ + L NNNF S+P+ F GLT+LQ + + +N
Sbjct: 86 NLSELERLELQWNNISGPVPSLSGLASLQVLMLSNNNFDSIPSDVFQGLTSLQSVEIDNN 145
Query: 148 PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFF--DSFSNLQNLRLSYNNFTGSLPA 205
P W P L +++L ++AN+ G +P F D F L L L++NN G LP
Sbjct: 146 P-FKSWEIPESLRNASALQNFSANSANVSGSLPGFLGPDEFPGLSILHLAFNNLEGELPM 204
Query: 206 SFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSL 265
S A S +Q+LW+N Q+L +G + VL MT L++VWLH N+F+GP+PD S + L LSL
Sbjct: 205 SLAGSQVQSLWLNGQKL--TGDITVLQNMTGLKEVWLHSNKFSGPLPDFSGLKELESLSL 262
Query: 266 RDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQ-KVSLDHNNFCKNSSDAGK 324
RDN TG VPAS++SL +L ++L NN LQGP P+F S V + D N+FC +S G+
Sbjct: 263 RDNSFTGPVPASLLSLESLKVVNLTNNHLQGPVPVFKSSVSVDLDKDSNSFCLSSP--GE 320
Query: 325 PCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNIS 384
CDP+V +LL IA YP L++SW+GN+ C W + CS G I I+L L G IS
Sbjct: 321 -CDPRVKSLLLIASSFDYPPRLAESWKGNDPCTNWIGIACSNGNITVISLEKMELTGTIS 379
Query: 385 PAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKFTVSP 444
P + + SL+ + L NNLTG IP LT L +L+ LDVS+N L GKVP F SNV +
Sbjct: 380 PEFGAIKSLQRIILGINNLTGMIPQELTTLPNLKTLDVSSNKLFGKVPGFRSNVVVNTN- 438
Query: 445 GNPFIG 450
GNP IG
Sbjct: 439 GNPDIG 444
|
|
| TAIR|locus:2024016 AT1G24650 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 791 (283.5 bits), Expect = 7.3e-152, Sum P(2) = 7.3e-152
Identities = 179/428 (41%), Positives = 249/428 (58%)
Query: 28 DGSVMLKLAQSLQNLPS-DWSSTSSTGYCEWTG-INCDNSNRVTTISLAKSGLSGTLSPE 85
D +VM+ L SL+ + +WS + C+W+ I CD SNRVT I + G+SG L P+
Sbjct: 23 DEAVMIALRDSLKLSGNPNWSGSDP---CKWSMFIKCDASNRVTAIQIGDRGISGKLPPD 79
Query: 86 ISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145
+ LT L N + G IPSLA SL +Y ++N+FTSVP F GL++LQ +SL
Sbjct: 80 LGKLTSLTKFEVMRNRLTGPIPSLAGLKSLVTVYANDNDFTSVPEDFFSGLSSLQHVSLD 139
Query: 146 DNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDF-FDS--FSNLQNLRLSYNNFTGS 202
+NP W P L +TSL N N+ G IPD+ F+ FS+L L+LSYN+
Sbjct: 140 NNP-FDSWVIPPSLENATSLVDFSAVNCNLSGKIPDYLFEGKDFSSLTTLKLSYNSLVCE 198
Query: 203 LPASFAKSDIQNLWMNDQQLG---LSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCES 259
P +F+ S +Q L +N Q+ G L G++ L MT L V L N F+GP+PD S S
Sbjct: 199 FPMNFSDSRVQVLMLNGQK-GREKLHGSISFLQKMTSLTNVTLQGNSFSGPLPDFSGLVS 257
Query: 260 LFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDH-NNFCKN 318
L ++R+NQL+G+VP+S+ L +L +++L NN LQGP P F + K L+ N+FC +
Sbjct: 258 LKSFNVRENQLSGLVPSSLFELQSLSDVALGNNLLQGPTPNFTAPDIKPDLNGLNSFCLD 317
Query: 319 SSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKL 378
+ G CDP+V TLL I GYP ++ W+GN+ C GW +TC+ I IN N
Sbjct: 318 TP--GTSCDPRVNTLLSIVEAFGYPVNFAEKWKGNDPCSGWVGITCTGTDITVINFKNLG 375
Query: 379 LAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNV 438
L G ISP +A+ SL+ + L QNNL G IP L KL++L+ LDVS N L G+VP F + +
Sbjct: 376 LNGTISPRFADFASLRVINLSQNNLNGTIPQELAKLSNLKTLDVSKNRLCGEVPRFNTTI 435
Query: 439 KFTVSPGN 446
T GN
Sbjct: 436 VNTT--GN 441
|
|
| TAIR|locus:2097310 BAM2 "BARELY ANY MERISTEM 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 386 (140.9 bits), Expect = 6.3e-64, Sum P(2) = 6.3e-64
Identities = 119/396 (30%), Positives = 187/396 (47%)
Query: 42 LPSDWSSTSSTGYCEWTGINCDNSNR-VTTISLAKSGLSGTLSPEISSLTQLETLSFQMN 100
L + W+ ST +C WTG+ CD S R VT++ L+ LSGTLS +++ L L+ LS N
Sbjct: 46 LLTSWNL--STTFCSWTGVTCDVSLRHVTSLDLSGLNLSGTLSSDVAHLPLLQNLSLAAN 103
Query: 101 NIAGAIP-SLANATSLQDIYLDNNNFT-SVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNE 158
I+G IP ++N L+ + L NN F S P GL NL+VL L +N NL P
Sbjct: 104 QISGPIPPQISNLYELRHLNLSNNVFNGSFPDELSSGLVNLRVLDLYNN-NLTG-DLPVS 161
Query: 159 LTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWM 217
LT T L L++ G IP + ++ L+ L +S N TG +P + ++ L++
Sbjct: 162 LTNLTQLRHLHLGGNYFSGKIPATYGTWPVLEYLAVSGNELTGKIPPEIGNLTTLRELYI 221
Query: 218 NDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIP-DLSKCESLFDLSLRDNQLTGVVPA 276
+G + +++L + TG IP ++ K + L L L+ N TG +
Sbjct: 222 GYYNAFENGLPPEIGNLSELVRFDAANCGLTGEIPPEIGKLQKLDTLFLQVNAFTGTITQ 281
Query: 277 SVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQI 336
+ + +L ++ L NN G P S+++ ++L N +N P +
Sbjct: 282 ELGLISSLKSMDLSNNMFTGEIPTSFSQLKNLTL--LNLFRNKLYGAIP---------EF 330
Query: 337 AGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNL 396
G+M +L WE NN P GR++ ++L++ L G + P + L L
Sbjct: 331 IGEMPELEVLQ-LWE-NNFTGSIPQKLGENGRLVILDLSSNKLTGTLPPNMCSGNRLMTL 388
Query: 397 YLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVP 432
N L G IPD L K SL + + N L+G +P
Sbjct: 389 ITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIP 424
|
|
| TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 378 (138.1 bits), Expect = 6.1e-63, Sum P(2) = 6.1e-63
Identities = 119/416 (28%), Positives = 191/416 (45%)
Query: 32 MLKLAQSLQN--LPSDWSSTSSTGYCEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSL 89
++ +SL+N L S W+ +SS +C+W G+ C RV ++SL L G + EISSL
Sbjct: 30 LISFKRSLENPSLLSSWNVSSSASHCDWVGVTC-LLGRVNSLSLPSLSLRGQIPKEISSL 88
Query: 90 TQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNP 148
L L N +G IP + N LQ + L N+ T + L L L LSDN
Sbjct: 89 KNLRELCLAGNQFSGKIPPEIWNLKHLQTLDLSGNSLTGLLPRLLSELPQLLYLDLSDNH 148
Query: 149 NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFA 208
P P+ +L++L + N ++ G IP SNL NL + N+F+G +P+
Sbjct: 149 FSGSLP-PSFFISLPALSSLDVSNNSLSGEIPPEIGKLSNLSNLYMGLNSFSGQIPSEIG 207
Query: 209 KSDIQNLWMNDQQLGLSGTLDV-LSGMTQLRQVWLHKNQFTGPIP-DLSKCESLFDLSLR 266
+ + +G L +S + L ++ L N IP + +L L+L
Sbjct: 208 NISLLKNFAAPSCF-FNGPLPKEISKLKHLAKLDLSYNPLKCSIPKSFGELHNLSILNLV 266
Query: 267 DNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKV--SLDHNNFCKN-SSDAG 323
+L G++P + + +L ++ L N L GP PL S++ + S + N + S G
Sbjct: 267 SAELIGLIPPELGNCKSLKSLMLSFNSLSGPLPLELSEIPLLTFSAERNQLSGSLPSWMG 326
Query: 324 K--PCDPQVTTLLQIAGDMGY-----PAILSDSWEGNNACDGWPFVTCSQGRIITINLAN 376
K D + + +G++ + P + S N P C G + I+L+
Sbjct: 327 KWKVLDSLLLANNRFSGEIPHEIEDCPMLKHLSLASNLLSGSIPRELCGSGSLEAIDLSG 386
Query: 377 KLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVP 432
LL+G I + +SL L L N + G IP+ L KL L LD+ +NN +G++P
Sbjct: 387 NLLSGTIEEVFDGCSSLGELLLTNNQINGSIPEDLWKLP-LMALDLDSNNFTGEIP 441
|
|
| TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 452 (164.2 bits), Expect = 1.3e-62, Sum P(2) = 1.3e-62
Identities = 132/416 (31%), Positives = 209/416 (50%)
Query: 44 SDWSSTSSTGYCEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIA 103
SDW+ S +C WTGI CD++ V ++SL + L G LSP I++LT L+ L N+
Sbjct: 50 SDWTIIGSLRHCNWTGITCDSTGHVVSVSLLEKQLEGVLSPAIANLTYLQVLDLTSNSFT 109
Query: 104 GAIPS-LANATSLQDIYLDNNNFT-SVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTK 161
G IP+ + T L + L N F+ S+P+G ++ L N+ L L +N L P E+ K
Sbjct: 110 GKIPAEIGKLTELNQLILYLNYFSGSIPSGIWE-LKNIFYLDLRNN--LLSGDVPEEICK 166
Query: 162 STSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQ 220
++SL + D N+ G IP+ +LQ + N+ TGS+P S +++ +L ++
Sbjct: 167 TSSLVLIGFDYNNLTGKIPECLGDLVHLQMFVAAGNHLTGSIPVSIGTLANLTDLDLSGN 226
Query: 221 QLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIP-DLSKCESLFDLSLRDNQLTGVVPASVI 279
QL D + L+ + L +N G IP ++ C SL L L DNQLTG +PA +
Sbjct: 227 QLTGKIPRD-FGNLLNLQSLVLTENLLEGDIPAEIGNCSSLVQLELYDNQLTGKIPAELG 285
Query: 280 SLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGD 339
+L L + + NKL P S + L H +N G P ++ L +
Sbjct: 286 NLVQLQALRIYKNKLTSSIP--SSLFRLTQLTHLGLSENHL-VG-PISEEIGFLESLE-- 339
Query: 340 MGYPAILSDSWEGNNACDGWP-FVTCSQG-RIITINLANKLLAGNISPAYANLTSLKNLY 397
+L+ NN +P +T + ++T+ N ++G + LT+L+NL
Sbjct: 340 -----VLT--LHSNNFTGEFPQSITNLRNLTVLTVGFNN--ISGELPADLGLLTNLRNLS 390
Query: 398 LQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVP-DFGS-NVKFTVSPG-NPFIG 450
N LTGPIP ++ L+ LD+S+N ++G++P FG N+ F +S G N F G
Sbjct: 391 AHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGFGRMNLTF-ISIGRNHFTG 445
|
|
| TAIR|locus:2169965 BAM1 "BARELY ANY MERISTEM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 367 (134.2 bits), Expect = 7.3e-62, Sum P(2) = 7.3e-62
Identities = 116/399 (29%), Positives = 188/399 (47%)
Query: 40 QNLP-SDWSSTSSTGYCEWTGINCDNSNR-VTTISLAKSGLSGTLSPEISSLTQLETLSF 97
+N P S W ST +C W G+ CD S R VT++ L+ LSGTLSP++S L L+ LS
Sbjct: 43 KNSPLSSWKV--STSFCTWIGVTCDVSRRHVTSLDLSGLNLSGTLSPDVSHLRLLQNLSL 100
Query: 98 QMNNIAGAIP-SLANATSLQDIYLDNNNFT-SVPTGCFDGLTNLQVLSLSDNPNLAPWPF 155
N I+G IP +++ + L+ + L NN F S P GL NL+VL + +N NL
Sbjct: 101 AENLISGPIPPEISSLSGLRHLNLSNNVFNGSFPDEISSGLVNLRVLDVYNN-NLTG-DL 158
Query: 156 PNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQN 214
P +T T L L++ G IP + S+ ++ L +S N G +P + ++
Sbjct: 159 PVSVTNLTQLRHLHLGGNYFAGKIPPSYGSWPVIEYLAVSGNELVGKIPPEIGNLTTLRE 218
Query: 215 LWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIP-DLSKCESLFDLSLRDNQLTGV 273
L++ G + +++L + TG IP ++ K + L L L+ N +G
Sbjct: 219 LYIGYYNAFEDGLPPEIGNLSELVRFDGANCGLTGEIPPEIGKLQKLDTLFLQVNVFSGP 278
Query: 274 VPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTL 333
+ + +L +L ++ L NN G P ++++ ++L N +N P
Sbjct: 279 LTWELGTLSSLKSMDLSNNMFTGEIPASFAELKNLTL--LNLFRNKLHGEIP-------- 328
Query: 334 LQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSL 393
+ GD+ +L WE NN P G++ ++L++ L G + P + L
Sbjct: 329 -EFIGDLPELEVLQ-LWE-NNFTGSIPQKLGENGKLNLVDLSSNKLTGTLPPNMCSGNKL 385
Query: 394 KNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVP 432
+ L N L G IPD L K SL + + N L+G +P
Sbjct: 386 ETLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIP 424
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 387 (141.3 bits), Expect = 1.6e-61, Sum P(2) = 1.6e-61
Identities = 126/424 (29%), Positives = 203/424 (47%)
Query: 28 DGSVMLKLA----QSLQNLPSDWSSTSSTGYCEWTGINCD--------NSNRVTTISLAK 75
DG +L+L Q N +W+ T C W G+NC NS VT++ L+
Sbjct: 36 DGQFLLELKNRGFQDSLNRLHNWNGIDETP-CNWIGVNCSSQGSSSSSNSLVVTSLDLSS 94
Query: 76 SGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFT-SVPTGCF 133
LSG +SP I L L L+ N + G IP + N + L+ ++L+NN F S+P
Sbjct: 95 MNLSGIVSPSIGGLVNLVYLNLAYNALTGDIPREIGNCSKLEVMFLNNNQFGGSIPVE-I 153
Query: 134 DGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLR 193
+ L+ L+ ++ +N L+ P P E+ +L L N+ G +P + + L R
Sbjct: 154 NKLSQLRSFNICNN-KLSG-PLPEEIGDLYNLEELVAYTNNLTGPLPRSLGNLNKLTTFR 211
Query: 194 LSYNNFTGSLPASFAKS-DIQNLWMNDQQLGLSGTLDVLSGM-TQLRQVWLHKNQFTGPI 251
N+F+G++P K +++ L + Q +SG L GM +L++V L +N+F+G I
Sbjct: 212 AGQNDFSGNIPTEIGKCLNLKLLGL--AQNFISGELPKEIGMLVKLQEVILWQNKFSGFI 269
Query: 252 P-DLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSL 310
P D+ SL L+L N L G +P+ + ++ +L + L N+L G P K+ KV
Sbjct: 270 PKDIGNLTSLETLALYGNSLVGPIPSEIGNMKSLKKLYLYQNQLNGTIPKELGKLSKVM- 328
Query: 311 DHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRII 370
+F +N P + + L++ Y + + G P +
Sbjct: 329 -EIDFSENLLSGEIPVELSKISELRLL----Y--LFQNKLTGII-----PNELSKLRNLA 376
Query: 371 TINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGK 430
++L+ L G I P + NLTS++ L L N+L+G IP GL + L +D S N LSGK
Sbjct: 377 KLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVDFSENQLSGK 436
Query: 431 VPDF 434
+P F
Sbjct: 437 IPPF 440
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 388 (141.6 bits), Expect = 4.7e-61, Sum P(2) = 4.7e-61
Identities = 125/429 (29%), Positives = 198/429 (46%)
Query: 46 WSSTSSTGYCEWTGINCDNSN--RVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIA 103
W+S + YC WTG+ CDN+ RV ++L GL+G++SP L L NN+
Sbjct: 50 WNS-DNINYCSWTGVTCDNTGLFRVIALNLTGLGLTGSISPWFGRFDNLIHLDLSSNNLV 108
Query: 104 GAIPS-LANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKS 162
G IP+ L+N TSL+ ++L +N T L N++ L + DN + P L
Sbjct: 109 GPIPTALSNLTSLESLFLFSNQLTGEIPSQLGSLVNIRSLRIGDNELVGD--IPETLGNL 166
Query: 163 TSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQL 222
+L L + + + G IP +Q+L L N G +PA ++ + +
Sbjct: 167 VNLQMLALASCRLTGPIPSQLGRLVRVQSLILQDNYLEGPIPAELGNCSDLTVFTAAENM 226
Query: 223 GLSGTLDV-LSGMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVIS 280
L+GT+ L + L + L N TG IP L + L LSL NQL G++P S+
Sbjct: 227 -LNGTIPAELGRLENLEILNLANNSLTGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLAD 285
Query: 281 LPALLNISLQNNKLQGPYPL-FPSKVQKVSL----DH------NNFCKNSSDAGKPCDPQ 329
L L + L N L G P F + Q + L +H + C N+++ +
Sbjct: 286 LGNLQTLDLSANNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNL----EQL 341
Query: 330 VTTLLQIAGDMGYPAILSDSWE----GNNACDGW-PFVTCSQGRIITINLANKLLAGNIS 384
V + Q++G++ S + NN+ G P + + L N L G +S
Sbjct: 342 VLSGTQLSGEIPVELSKCQSLKQLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLS 401
Query: 385 PAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVP-DFGS--NVKFT 441
P+ +NLT+L+ L L NNL G +P ++ L L+ L + N SG++P + G+ ++K
Sbjct: 402 PSISNLTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMI 461
Query: 442 VSPGNPFIG 450
GN F G
Sbjct: 462 DMFGNHFEG 470
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh2_kg.3__2591__AT3G23750.1 | annotation not avaliable (930 aa) | |||||||||
(Arabidopsis lyrata) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 782 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-44 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-43 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-43 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-43 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-41 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-41 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-39 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-38 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-35 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-34 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-32 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-29 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-26 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-24 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-24 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-24 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-24 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-24 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-24 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-22 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-22 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-22 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-21 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-21 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-21 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-20 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-20 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-20 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-20 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-19 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-19 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-19 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-19 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-19 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-18 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-18 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-18 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-18 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-18 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-18 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-18 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-17 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-17 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-17 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-17 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 8e-17 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 8e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-17 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 9e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 9e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-16 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-16 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-16 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-16 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-16 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-16 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 9e-16 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-15 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-15 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-15 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-15 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-15 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 8e-15 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-15 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 9e-15 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-14 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-14 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 7e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-14 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 9e-14 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-13 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-13 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-13 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-13 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-12 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-12 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-12 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-12 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-12 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-11 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-11 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-11 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 9e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-10 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-10 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-10 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-10 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 8e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-09 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-09 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-09 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 8e-09 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 9e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-08 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-08 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-08 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-07 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-07 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-07 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-07 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-07 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 6e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 9e-07 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-06 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-06 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-06 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 9e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 9e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-05 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-05 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-05 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 6e-05 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-05 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-05 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 2e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-04 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-04 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 6e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 7e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 9e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.001 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 0.001 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 0.001 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.001 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 0.001 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.002 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 0.002 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 0.003 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 0.003 | |
| pfam01636 | 238 | pfam01636, APH, Phosphotransferase enzyme family | 0.003 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 0.003 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 2e-44
Identities = 65/172 (37%), Positives = 89/172 (51%), Gaps = 11/172 (6%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY 647
LG GGFG VY G K+A+K ++ + L E EI +L K+ H ++V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDS-SSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 648 CINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS 707
+ + LV EY G+L L E L+ + + I L + G+EYLHS
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENE----GKLSEDEILRILLQILEGLEYLHS---NG 112
Query: 708 FIHRDLKPSNILIG-DDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
IHRDLKP NIL+ D+ + K+ADFGL K K S+ + GT Y+APE
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK-SLLKTIVGTPAYMAPE 163
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 2e-43
Identities = 61/176 (34%), Positives = 94/176 (53%), Gaps = 12/176 (6%)
Query: 588 ILGRGGFGVVYGGEL---PDGTKI--AVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
LG G FG VY G L DG ++ AVK ++ + + + EF E ++ K+ H ++V
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDAS-EQQIEEFLREARIMRKLDHPNIV 64
Query: 643 ALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHS 702
LLG C ++V EYMP G L +L + L+ ++ AL +ARG+EYL S
Sbjct: 65 KLLGVCTEEEPLMIVMEYMPGGDLLDYL---RKNRPKELSLSDLLSFALQIARGMEYLES 121
Query: 703 LAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
++FIHRDL N L+G+++ K++DFGL ++ D Y ++APE
Sbjct: 122 ---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPE 174
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 156 bits (398), Expect = 3e-43
Identities = 59/176 (33%), Positives = 92/176 (52%), Gaps = 13/176 (7%)
Query: 588 ILGRGGFGVVYGGEL---PDGTKI--AVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
LG G FG VY G+L K+ AVK ++ + + + EF E ++ K+ H ++V
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDAS-EQQIEEFLREARIMRKLDHPNVV 64
Query: 643 ALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHS 702
LLG C +V EYM G L +L + L+ ++ AL +ARG+EYL S
Sbjct: 65 KLLGVCTEEEPLYIVMEYMEGGDLLSYL---RKNRPK-LSLSDLLSFALQIARGMEYLES 120
Query: 703 LAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
++FIHRDL N L+G+++ K++DFGL ++ D Y + ++APE
Sbjct: 121 ---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPE 173
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 6e-43
Identities = 60/174 (34%), Positives = 84/174 (48%), Gaps = 14/174 (8%)
Query: 588 ILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646
LG G FG VY G +AVK ++ + +K + EI +L ++ H ++V L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ 706
+ LV EY G L +L PL+ + IAL + RG+EYLHS
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSR-----GGPLSEDEAKKIALQILRGLEYLHS---N 117
Query: 707 SFIHRDLKPSNILIGDDMRAKVADFGLVK--NAPDGKYSVETRLAGTFGYLAPE 758
IHRDLKP NIL+ ++ K+ADFGL K + GT Y+APE
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT---FVGTPWYMAPE 168
|
Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 3e-41
Identities = 180/707 (25%), Positives = 297/707 (42%), Gaps = 94/707 (13%)
Query: 71 ISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFT-SV 128
I L + LSG + EI LT L L NN+ G IP SL N +LQ ++L N + +
Sbjct: 217 IYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPI 276
Query: 129 PTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSN 188
P F L L L LSDN P + + +L L++ + N G IP S
Sbjct: 277 PPSIF-SLQKLISLDLSDN--SLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPR 333
Query: 189 LQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQL-GLSGTL-DVLSGMTQLRQVWLHKNQ 246
LQ L+L N F+G +P + K + NL + D L+G + + L L ++ L N
Sbjct: 334 LQVLQLWSNKFSGEIPKNLGKHN--NLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNS 391
Query: 247 FTGPIP-DLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPL----F 301
G IP L C SL + L+DN +G +P+ LP + + + NN LQG
Sbjct: 392 LEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDM 451
Query: 302 PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQ--IAGD-----MGYPAILSDSWEGNN 354
PS +Q +SL N F D+ + L + +G ++ N
Sbjct: 452 PS-LQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENK 510
Query: 355 ACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKL 414
P S ++++++L++ L+G I +++ + L L L QN L+G IP L +
Sbjct: 511 LSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNV 570
Query: 415 ASLQNLDVSNNNLSGKVPDFGSNVKFTVSPGNPFIGTNVDTTPGGAGTPGSKPSGPSGSP 474
SL +++S+N+L G +P G+ F+ N G G + SG P
Sbjct: 571 ESLVQVNISHNHLHGSLPSTGA-----------FLAINASAVAGNIDLCGGDTT--SGLP 617
Query: 475 AAS--SKSKLSVGTIVAIVVVVVIFIAVVFFVVYKFIARRKHRKFGRVKNPEVGNEMNKN 532
K+ I + ++ V F V FI R + + RV+N + E+
Sbjct: 618 PCKRVRKTPSWWFYITCTLGAFLVLALVAFGFV--FIRGRNNLELKRVENEDGTWEL--- 672
Query: 533 GVTGGNGTNGYNGVPSELHSQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEANILGRG 592
F V+ SI + + + E N++ RG
Sbjct: 673 ------------------------------QFFDSKVSKSITI-NDILSSLKEENVISRG 701
Query: 593 GFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING 651
G Y G+ + +G + VK + N S +EIA + K++H ++V L+G C +
Sbjct: 702 KKGASYKGKSIKNGMQFVVKEI------NDVNSIPSSEIADMGKLQHPNIVKLIGLCRSE 755
Query: 652 SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHR 711
L++EY+ L++ L L+W++R IA+ +A+ + +LH + +
Sbjct: 756 KGAYLIHEYIEGKNLSEVL--------RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVG 807
Query: 712 DLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
+L P I+I D ++ + G +T+ + Y+APE
Sbjct: 808 NLSPEKIII------DGKDEPHLRLSLPGLLCTDTKCFISSAYVAPE 848
|
Length = 968 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 3e-41
Identities = 56/171 (32%), Positives = 88/171 (51%), Gaps = 12/171 (7%)
Query: 587 NILGRGGFGVVYGGELPDG----TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
LG G FG VY G+L T++AVK ++ + + +F E V+ K+ H ++V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS-EEERKDFLKEARVMKKLGHPNVV 59
Query: 643 ALLGYCINGSERLLVYEYMPRGTLAQHL----FEWHDHGYTPLTWKQRVTIALDVARGVE 698
LLG C LV EYM G L +L + + L+ K ++ A+ +A+G+E
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLA 749
YL S + F+HRDL N L+G+D+ K++DFGL ++ D Y +
Sbjct: 120 YLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGG 167
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 144 bits (367), Expect = 5e-39
Identities = 56/173 (32%), Positives = 81/173 (46%), Gaps = 12/173 (6%)
Query: 587 NILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
LG G FG VY + G +A+K ++ + K EI +L K++H ++V L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI-KKDRERILREIKILKKLKHPNIVRLY 63
Query: 646 GYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQ 705
+ + LV EY G L L G L+ + + +EYLHS
Sbjct: 64 DVFEDEDKLYLVMEYCEGGDLFDLL---KKRG--RLSEDEARFYLRQILSALEYLHS--- 115
Query: 706 QSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
+ +HRDLKP NIL+ +D K+ADFGL + G+ T GT Y+APE
Sbjct: 116 KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL--TTFVGTPEYMAPE 166
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 8e-38
Identities = 63/176 (35%), Positives = 92/176 (52%), Gaps = 14/176 (7%)
Query: 589 LGRGGFGVVYGGEL-----PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVA 643
LG G FG VY G L TK+AVK ++ + EF E +++ K+ H ++V
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGAS-EEEREEFLEEASIMKKLSHPNIVR 65
Query: 644 LLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSL 703
LLG C G +V EYMP G L L HG LT K + +AL +A+G+EYL S
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL---RKHG-EKLTLKDLLQMALQIAKGMEYLES- 120
Query: 704 AQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN-APDGKYSVETRLAGTFGYLAPE 758
++F+HRDL N L+ +++ K++DFGL ++ D Y ++APE
Sbjct: 121 --KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPE 174
|
Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 1e-35
Identities = 123/442 (27%), Positives = 191/442 (43%), Gaps = 96/442 (21%)
Query: 44 SDWSSTSSTGYCEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLET-------LS 96
S+W+S++ C W GI C+NS+RV +I L+ +SG +S I L ++T LS
Sbjct: 49 SNWNSSAD--VCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLS 106
Query: 97 FQM------------------NNIAGAIPS----------LANATSLQDIYLDNNNFTS- 127
+ NN G+IP L+N +I D +F+S
Sbjct: 107 GPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSL 166
Query: 128 -------------VPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNAN 174
+P LT+L+ L+L+ N + P EL + SL +Y+ N
Sbjct: 167 KVLDLGGNVLVGKIP-NSLTNLTSLEFLTLASNQLVGQ--IPRELGQMKSLKWIYLGYNN 223
Query: 175 IFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLSGTL-DVLS 232
+ G IP ++L +L L YNN TG +P+S ++Q L++ Q LSG + +
Sbjct: 224 LSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFL--YQNKLSGPIPPSIF 281
Query: 233 GMTQLRQVWLHKNQFTGPIPDL-SKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQN 291
+ +L + L N +G IP+L + ++L L L N TG +P ++ SLP L + L +
Sbjct: 282 SLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWS 341
Query: 292 NKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWE 351
NK G P K HNN T+L ++
Sbjct: 342 NKFSGEIPKNLGK-------HNNL----------------TVLDLST------------- 365
Query: 352 GNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGL 411
NN P CS G + + L + L G I + SL+ + LQ N+ +G +P
Sbjct: 366 -NNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEF 424
Query: 412 TKLASLQNLDVSNNNLSGKVPD 433
TKL + LD+SNNNL G++
Sbjct: 425 TKLPLVYFLDISNNNLQGRINS 446
|
Length = 968 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 59/202 (29%), Positives = 92/202 (45%), Gaps = 24/202 (11%)
Query: 587 NILGRGGFGVVYGGELPD-GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
+LGRG FG VY D G +AVK +E + + L + EI +L+ ++H ++V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 646 GYCIN--GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSL 703
G + + + EY+ G+L+ L + L + G+ YLHS
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL-----KKFGKLPEPVIRKYTRQILEGLAYLHS- 119
Query: 704 AQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR-LAGTFGYLAPEYAGK 762
+HRD+K +NIL+ D K+ADFG K D + T + GT ++APE
Sbjct: 120 --NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE---- 173
Query: 763 HWMILCQMTGL---IWLHGSVG 781
+I + G IW S+G
Sbjct: 174 --VIRGEEYGRAADIW---SLG 190
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 8e-32
Identities = 54/171 (31%), Positives = 83/171 (48%), Gaps = 12/171 (7%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY 647
+G+GGFG VY G ++A+K ++ + K + EI +L K +H ++V G
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKK--EKIINEIQILKKCKHPNIVKYYGS 65
Query: 648 CINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS 707
+ E +V E+ G+L L LT Q + ++ +G+EYLHS
Sbjct: 66 YLKKDELWIVMEFCSGGSLKDLL----KSTNQTLTESQIAYVCKELLKGLEYLHS---NG 118
Query: 708 FIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
IHRD+K +NIL+ D K+ DFGL D K + GT ++APE
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK--ARNTMVGTPYWMAPE 167
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 59/149 (39%), Positives = 89/149 (59%), Gaps = 10/149 (6%)
Query: 589 LGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYC 648
+G+G FG V G+ G K+AVK ++ ++ F AE +V+T +RH +LV LLG
Sbjct: 14 IGKGEFGDVMLGDY-RGQKVAVKCLKDDS---TAAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 649 INGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSF 708
+ G+ +V EYM +G+L +L G +T Q++ ALDV G+EYL ++F
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALDVCEGMEYLEE---KNF 123
Query: 709 IHRDLKPSNILIGDDMRAKVADFGLVKNA 737
+HRDL N+L+ +D+ AKV+DFGL K A
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAKEA 152
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 55/160 (34%), Positives = 80/160 (50%), Gaps = 19/160 (11%)
Query: 589 LGRGGFGVVYGGEL----PDGTK--IAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
LG G FG V+ GE P+ K +AVK ++ N +F+ E +LT +H ++V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIV 71
Query: 643 ALLGYCINGSERLLVYEYMPRGTLAQHL---------FEWHDHGYTPLTWKQRVTIALDV 693
G C G ++V+EYM G L + L + D LT Q + IA+ +
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 694 ARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733
A G+ Y LA Q F+HRDL N L+G D+ K+ DFG+
Sbjct: 132 ASGMVY---LASQHFVHRDLATRNCLVGYDLVVKIGDFGM 168
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 56/155 (36%), Positives = 80/155 (51%), Gaps = 9/155 (5%)
Query: 589 LGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYC 648
LG G FG V+ G TK+AVK ++ TM F E ++ K+RH LV L C
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVC 70
Query: 649 INGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSF 708
+V EYM +G+L L L Q V +A +A G+ YL S +++
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFL---KSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNY 124
Query: 709 IHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743
IHRDL NIL+G+++ K+ADFGL + D +Y+
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 58/180 (32%), Positives = 87/180 (48%), Gaps = 18/180 (10%)
Query: 583 FSEANILGRGGFGVVYGGEL--PDGT--KIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH 638
ILG G FG V G+L DG+ K+AVK M+ + + EF +E A + H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 639 RHLVALLGYCINGSER------LLVYEYMPRGTLAQHLFEWHDHG---YTPLTWKQRVTI 689
+++ L+G C S +++ +M G L L G PL + +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPL--QTLLKF 118
Query: 690 ALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLA 749
+D+A G+EYL + ++FIHRDL N ++ +DM VADFGL K G Y + R+A
Sbjct: 119 MVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA 175
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 58/174 (33%), Positives = 78/174 (44%), Gaps = 13/174 (7%)
Query: 589 LGRGGFGVVYG-GELPDGTKIAVKRMESNTMGNKGLSEF-QAEIAVLTKVRHRHLVALLG 646
LG+G FG V + G A+K ++ + + E E +L+++ H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 647 YCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQ 705
Y E+L LV EY P G L HL G + A ++ +EYLHS
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFSEERARF--YAAEIVLALEYLHS--- 111
Query: 706 QSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEY 759
I+RDLKP NIL+ D K+ DFGL K T GT YLAPE
Sbjct: 112 LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEV 164
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 65/191 (34%), Positives = 95/191 (49%), Gaps = 23/191 (12%)
Query: 572 SIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIA 631
SI++LR+ LG G FG V+ G + T +AVK ++ TM K +F AE
Sbjct: 7 SIQLLRK----------LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK---DFLAEAQ 53
Query: 632 VLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIAL 691
++ K+RH L+ L C +V E M G+L ++L L Q + +A
Sbjct: 54 IMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYL---QGGAGRALKLPQLIDMAA 110
Query: 692 DVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGT 751
VA G+ YL + Q++IHRDL N+L+G++ KVADFGL + + Y E R
Sbjct: 111 QVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY--EAREGAK 165
Query: 752 F--GYLAPEYA 760
F + APE A
Sbjct: 166 FPIKWTAPEAA 176
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 53/178 (29%), Positives = 85/178 (47%), Gaps = 10/178 (5%)
Query: 582 NFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
N+ +++GRG FGVVY G L G +A+K++ + + L EI +L ++H +
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYL 700
+V +G ++ EY G+L Q + + P V +G+ YL
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQII-----KKFGPFPESLVAVYVYQVLQGLAYL 115
Query: 701 HSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
H +Q IHRD+K +NIL D K+ADFG+ D + + GT ++APE
Sbjct: 116 H---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS-VVGTPYWMAPE 169
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 104 bits (259), Expect = 7e-24
Identities = 61/198 (30%), Positives = 85/198 (42%), Gaps = 15/198 (7%)
Query: 589 LGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSE-FQAEIAVLTKVRH-RHLVALLG 646
LG G FG VY D +A+K + E F EI +L + H ++V L
Sbjct: 8 LGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ 706
+ + LV EY+ G+L L PL+ + + I + +EYLHS +
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLL--KKIGRKGPLSESEALFILAQILSALEYLHS---K 120
Query: 707 SFIHRDLKPSNILIG-DDMRAKVADFGLVKNAPDGKYSVETR-----LAGTFGYLAPEYA 760
IHRD+KP NIL+ D K+ DFGL K PD + GT GY+APE
Sbjct: 121 GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180
Query: 761 GKHWMILCQMTGLIWLHG 778
+ + IW G
Sbjct: 181 LGLSLAYASSSSDIWSLG 198
|
Length = 384 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 58/183 (31%), Positives = 92/183 (50%), Gaps = 17/183 (9%)
Query: 583 FSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
F+ LG G FG V+ G + ++A+K ++S+ + +FQ E+ L ++RH+HL+
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLK--QQDFQKEVQALKRLRHKHLI 65
Query: 643 ALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTP----LTWKQRVTIALDVARGVE 698
+L C G ++ E M +G+L L +P L + +A VA G+
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFL-------RSPEGQVLPVASLIDMACQVAEGMA 118
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
YL Q+ IHRDL NIL+G+D+ KVADFGL + + Y + + + APE
Sbjct: 119 YLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI-PYKWTAPE 174
Query: 759 YAG 761
A
Sbjct: 175 AAS 177
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 2e-22
Identities = 59/182 (32%), Positives = 89/182 (48%), Gaps = 19/182 (10%)
Query: 587 NILGRGGFGVVYGGE---LPDGT--KIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHL 641
LG G FG V L D T ++AVK + + + S+F+ EI +L + H ++
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHS-GEEQHRSDFEREIEILRTLDHENI 68
Query: 642 VALLGYCINGSER--LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
V G C R L+ EY+P G+L +L D + K+ + + + +G++Y
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ----INLKRLLLFSSQICKGMDY 124
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK---YSVETRLAGTFGYLA 756
L S Q +IHRDL NIL+ + K++DFGL K P+ K Y E + F Y A
Sbjct: 125 LGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-A 180
Query: 757 PE 758
PE
Sbjct: 181 PE 182
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 4e-22
Identities = 56/151 (37%), Positives = 85/151 (56%), Gaps = 12/151 (7%)
Query: 588 ILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY 647
+G+G FG V G+ G K+AVK ++++ F AE +V+T++RH +LV LLG
Sbjct: 13 TIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQA----FLAEASVMTQLRHSNLVQLLGV 67
Query: 648 CINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ 706
+ L +V EYM +G+L +L G + L + +LDV +EYL +
Sbjct: 68 IVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEA---N 121
Query: 707 SFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737
+F+HRDL N+L+ +D AKV+DFGL K A
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 152
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 6e-22
Identities = 60/154 (38%), Positives = 83/154 (53%), Gaps = 14/154 (9%)
Query: 588 ILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY 647
I+G G FG V GE G K+AVK ++ + F E AV+TK+ H++LV LLG
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA----FLEETAVMTKLHHKNLVRLLGV 67
Query: 648 CI-NGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ 706
+ NG +V E M +G L L G ++ Q + +LDVA G+EYL S +
Sbjct: 68 ILHNGLY--IVMELMSKGNLVNFL---RTRGRALVSVIQLLQFSLDVAEGMEYLES---K 119
Query: 707 SFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740
+HRDL NIL+ +D AKV+DFGL + G
Sbjct: 120 KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG 153
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 8e-22
Identities = 54/155 (34%), Positives = 75/155 (48%), Gaps = 10/155 (6%)
Query: 589 LGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYC 648
LG G FGVV+ G+ +A+K + M +F E V+ K+ H +LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 649 INGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSF 708
+V EYM G L +L E T + + + DV +EYL S F
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLRERKGKLGT----EWLLDMCSDVCEAMEYLES---NGF 121
Query: 709 IHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743
IHRDL N L+G+D KV+DFGL + D +Y+
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 1e-21
Identities = 57/164 (34%), Positives = 83/164 (50%), Gaps = 21/164 (12%)
Query: 589 LGRGGFGVVYGGE----LPDGTK--IAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
LG G FG V+ E LP+ K +AVK ++ + + +FQ E +LT ++H+H+V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR--QDFQREAELLTVLQHQHIV 70
Query: 643 ALLGYCINGSERLLVYEYMPRGTL----------AQHLFEWHDHGYTPLTWKQRVTIALD 692
G C G L+V+EYM G L A+ L D LT Q + IA
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 693 VARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736
+A G+ YL SL F+HRDL N L+G + K+ DFG+ ++
Sbjct: 131 IASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRD 171
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 55/160 (34%), Positives = 87/160 (54%), Gaps = 8/160 (5%)
Query: 589 LGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYC 648
+G+G FG VY G L T++AVK S T+ +F E +L + H ++V L+G C
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRS-TLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 649 INGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSF 708
+ +V E +P G+L L + + LT K+ + ++LD A G+EYL S ++
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNR----LTVKKLLQMSLDAAAGMEYLES---KNC 114
Query: 709 IHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRL 748
IHRDL N L+G++ K++DFG+ + G Y+V L
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 54/173 (31%), Positives = 85/173 (49%), Gaps = 10/173 (5%)
Query: 587 NILGRGGFGVVYGGELPD-GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
+ LG G +G VY G +AVK ++ +TM + EF E AV+ +++H +LV LL
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLL 68
Query: 646 GYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQ 705
G C ++ E+M G L +L E + + + +A ++ +EYL
Sbjct: 69 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLEK--- 122
Query: 706 QSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
++FIHRDL N L+G++ KVADFGL + Y+ + APE
Sbjct: 123 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 175
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 56/176 (31%), Positives = 84/176 (47%), Gaps = 14/176 (7%)
Query: 589 LGRGGFGVVYGGEL--PDGTKI--AVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVAL 644
LG G FGVV GE G I AVK ++S+ + + + +F E A++ + H +L+ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDI-MDDFLKEAAIMHSLDHENLIRL 61
Query: 645 LGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA 704
G + ++V E P G+L L A+ +A G+ YL
Sbjct: 62 YGVVLTHP-LMMVTELAPLGSLLDRL---RKDALGHFLISTLCDYAVQIANGMRYLE--- 114
Query: 705 QQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK--YSVETRLAGTFGYLAPE 758
+ FIHRDL NIL+ D + K+ DFGL++ P + Y +E L F + APE
Sbjct: 115 SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE 170
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-21
Identities = 52/170 (30%), Positives = 83/170 (48%), Gaps = 10/170 (5%)
Query: 589 LGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYC 648
+G G FG+V+ G + K+A+K + M + +F E V+ K+ H LV L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE---DFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 649 INGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSF 708
S LV+E+M G L+ +L + + + + LDV G+ YL +
Sbjct: 69 TERSPICLVFEFMEHGCLSDYLRAQRGK----FSQETLLGMCLDVCEGMAYLE---SSNV 121
Query: 709 IHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
IHRDL N L+G++ KV+DFG+ + D +Y+ T + +PE
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPE 171
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 1e-20
Identities = 55/177 (31%), Positives = 87/177 (49%), Gaps = 23/177 (12%)
Query: 583 FSEANILGRGGFGVVYGGEL--PDG----TKIAVKRMESNTMGNKGLSEFQAEIAVLTKV 636
F E LG G FG VY GEL P+ T +A+K ++ N K EF+ E +++ +
Sbjct: 9 FLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP-KVQQEFRQEAELMSDL 65
Query: 637 RHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLF-----------EWHDHGYTPLTWKQ 685
+H ++V LLG C +++EY+ G L + L + + L
Sbjct: 66 QHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSD 125
Query: 686 RVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742
+ IA+ +A G+EYL S F+HRDL N L+G+ + K++DFGL ++ Y
Sbjct: 126 FLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADY 179
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 58/173 (33%), Positives = 91/173 (52%), Gaps = 12/173 (6%)
Query: 589 LGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYC 648
LG+G FG V+ G T++A+K ++ TM + F E V+ K+RH LV L Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQL--YA 68
Query: 649 INGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS 707
+ E + +V EYM +G+L L L Q V +A +A G+ Y+ + +
Sbjct: 69 VVSEEPIYIVTEYMSKGSLLDFL---KGEMGKYLRLPQLVDMAAQIASGMAYVERM---N 122
Query: 708 FIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYA 760
++HRDL+ +NIL+G+++ KVADFGL + D +Y+ + APE A
Sbjct: 123 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 175
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-20
Identities = 55/174 (31%), Positives = 84/174 (48%), Gaps = 33/174 (18%)
Query: 589 LGRGGFGVVYGGELP------DGTKIAVKRME---SNTMGNKGLSEFQAEIAVLTKVRHR 639
+G+G FG V+ P T +AVK ++ S M +FQ E A++ + H
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA----DFQREAALMAEFDHP 68
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHL-----------------FEWHDHGYTPLT 682
++V LLG C G L++EYM G L + L PL+
Sbjct: 69 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 683 WKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736
+++ IA VA G+ YL +++ F+HRDL N L+G++M K+ADFGL +N
Sbjct: 129 CTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRN 179
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 3e-20
Identities = 61/173 (35%), Positives = 94/173 (54%), Gaps = 12/173 (6%)
Query: 589 LGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYC 648
LG+G FG V+ G TK+A+K ++ TM + F E ++ K+RH LV L Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA---FLQEAQIMKKLRHDKLVPL--YA 68
Query: 649 INGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS 707
+ E + +V E+M +G+L L E D Y L Q V +A +A G+ Y+ + +
Sbjct: 69 VVSEEPIYIVTEFMGKGSLLDFLKE-GDGKYLKL--PQLVDMAAQIADGMAYIERM---N 122
Query: 708 FIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYA 760
+IHRDL+ +NIL+GD++ K+ADFGL + D +Y+ + APE A
Sbjct: 123 YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 175
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 4e-20
Identities = 50/182 (27%), Positives = 81/182 (44%), Gaps = 16/182 (8%)
Query: 580 TDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH 638
+ + +G G G VY + G ++A+K+M + + EI ++ +H
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM---RLRKQNKELIINEILIMKDCKH 74
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
++V + G E +V EYM G+L + + + Q + +V +G+E
Sbjct: 75 PNIVDYYDSYLVGDELWVVMEYMDGGSLTD-IITQNF---VRMNEPQIAYVCREVLQGLE 130
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR--LAGTFGYLA 756
YLHS IHRD+K NIL+ D K+ADFG A R + GT ++A
Sbjct: 131 YLHSQNV---IHRDIKSDNILLSKDGSVKLADFGF---AAQLTKEKSKRNSVVGTPYWMA 184
Query: 757 PE 758
PE
Sbjct: 185 PE 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (226), Expect = 4e-20
Identities = 67/204 (32%), Positives = 96/204 (47%), Gaps = 33/204 (16%)
Query: 588 ILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQA--EIAVLTKVRHRHLVAL 644
LG G +GVVY + G +A+K++ + +G+ A EI++L +++H ++V L
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLD-NEEEGIPS-TALREISLLKELKHPNIVKL 63
Query: 645 LGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA 704
L + LV+EY L ++L D PL+ +I + RG+ Y HS
Sbjct: 64 LDVIHTERKLYLVFEYCDM-DLKKYL----DKRPGPLSPNLIKSIMYQLLRGLAYCHS-- 116
Query: 705 QQSFIHRDLKPSNILIGDDMRAKVADFGLVK--NAPDGKYSVETRLAGTFGYLAPEYAGK 762
+HRDLKP NILI D K+ADFGL + P Y+ E T Y APE
Sbjct: 117 -HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV---TLWYRAPE---- 168
Query: 763 HWMILCQM----TGL-IWLHGSVG 781
IL T + IW SVG
Sbjct: 169 ---ILLGSKHYSTAVDIW---SVG 186
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 6e-20
Identities = 56/176 (31%), Positives = 88/176 (50%), Gaps = 19/176 (10%)
Query: 589 LGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY 647
+G G G+V+ + G +A+K++ + ++ EI L +H ++V LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 648 CINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS 707
+GS +LV EYMP L++ L + PL Q + + +GV Y+H+
Sbjct: 68 FPHGSGFVLVMEYMPS-DLSEVLRDEER----PLPEAQVKSYMRMLLKGVAYMHAN---G 119
Query: 708 FIHRDLKPSNILIGDDMRAKVADFGL--VKNAPDGK-YS--VETRLAGTFGYLAPE 758
+HRDLKP+N+LI D K+ADFGL + + + + YS V TR Y APE
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRW-----YRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 6e-20
Identities = 51/154 (33%), Positives = 75/154 (48%), Gaps = 10/154 (6%)
Query: 589 LGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYC 648
LG G FGVV+ G+ K+A+K + M + +F E V+ K+ H LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE---DFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 649 INGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSF 708
+V E+M G L +L + L+ +++ DV G+EYL + SF
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQGK----LSKDMLLSMCQDVCEGMEYLE---RNSF 121
Query: 709 IHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742
IHRDL N L+ KV+DFG+ + D +Y
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 7e-20
Identities = 56/155 (36%), Positives = 76/155 (49%), Gaps = 10/155 (6%)
Query: 589 LGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYC 648
LG G FGVV G+ +A+K ++ +M EF E V+ K+ H LV L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 649 INGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSF 708
+V EYM G L +L E H + P Q + + DV G+ YL S + F
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYLRE-HGKRFQP---SQLLEMCKDVCEGMAYLES---KQF 121
Query: 709 IHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743
IHRDL N L+ D KV+DFGL + D +Y+
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 8e-20
Identities = 61/173 (35%), Positives = 89/173 (51%), Gaps = 12/173 (6%)
Query: 589 LGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYC 648
LG G FG V+ G TK+AVK ++ TM + F E ++ K+RH LV L Y
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES---FLEEAQIMKKLRHDKLVQL--YA 68
Query: 649 INGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS 707
+ E + +V EYM +G+L L D L V +A VA G+ Y+ + +
Sbjct: 69 VVSEEPIYIVTEYMSKGSLLDFL---KDGEGRALKLPNLVDMAAQVAAGMAYIERM---N 122
Query: 708 FIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYA 760
+IHRDL+ +NIL+GD + K+ADFGL + D +Y+ + APE A
Sbjct: 123 YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 175
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-19
Identities = 54/169 (31%), Positives = 79/169 (46%), Gaps = 21/169 (12%)
Query: 589 LGRGGFGVVYGGEL----PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVAL 644
LG G FG V+ E P+ KI V + +F E +LT ++H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 645 LGYCINGSERLLVYEYMPRGTLAQHLFEWHDHG-----------YTPLTWKQRVTIALDV 693
G C+ G ++V+EYM G L + L HG LT Q + IA +
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFL---RAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 694 ARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742
A G+ Y LA Q F+HRDL N L+G+++ K+ DFG+ ++ Y
Sbjct: 130 AAGMVY---LASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDY 175
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 2e-19
Identities = 58/171 (33%), Positives = 86/171 (50%), Gaps = 8/171 (4%)
Query: 588 ILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY 647
+LG+G FG V+ G L D T +AVK + + + +F +E +L + H ++V L+G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKI-KFLSEARILKQYDHPNIVKLIGV 60
Query: 648 CINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS 707
C +V E +P G L + D L KQ V ALD A G+ YL S ++
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDE----LKTKQLVKFALDAAAGMAYLES---KN 113
Query: 708 FIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
IHRDL N L+G++ K++DFG+ + DG YS + APE
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPE 164
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 61/184 (33%), Positives = 91/184 (49%), Gaps = 33/184 (17%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESN--TMGNKGLSEFQA--EIAVLTKVRHRHLVA 643
LG G + VVY G +A+K+++ G++ F A EI +L +++H +++
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGIN-FTALREIKLLQELKHPNIIG 66
Query: 644 LL-----GYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
LL IN LV+E+M T + + + TP K L RG+E
Sbjct: 67 LLDVFGHKSNIN-----LVFEFME--TDLEKVIKDKSIVLTPADIKS---YMLMTLRGLE 116
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN--APDGKYS--VETRLAGTFGY 754
YLHS +HRDLKP+N+LI D K+ADFGL ++ +P+ K + V TR Y
Sbjct: 117 YLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRW-----Y 168
Query: 755 LAPE 758
APE
Sbjct: 169 RAPE 172
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 3e-19
Identities = 60/179 (33%), Positives = 95/179 (53%), Gaps = 12/179 (6%)
Query: 583 FSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGN-KGLSEFQAEIAVLTKVRHRH 640
F + +LG+GGFG V ++ G A K++E + KG S E +L KV R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 641 LVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
+V+L Y + L LV M G L H++ + G+ + V A ++ G+E
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEE---GRAVFYAAEICCGLED 117
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
LH Q+ ++RDLKP NIL+ D +++D GL + P+G+ +++ R+ GT GY+APE
Sbjct: 118 LH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TIKGRV-GTVGYMAPE 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 5e-19
Identities = 55/176 (31%), Positives = 81/176 (46%), Gaps = 20/176 (11%)
Query: 589 LGRGGFGVVYGGEL-PDGTKIAVKR--MESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
LG+G GVVY P G A+K+ ++ + K L E+ L ++V
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLL---RELKTLRSCESPYVVKCY 65
Query: 646 G-YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRV--TIALDVARGVEYLHS 702
G + G + V EYM G+LA L + V IA + +G++YLH+
Sbjct: 66 GAFYKEGEISI-VLEYMDGGSLADLL-------KKVGKIPEPVLAYIARQILKGLDYLHT 117
Query: 703 LAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
IHRD+KPSN+LI K+ADFG+ K + T + GT Y++PE
Sbjct: 118 KRHI--IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPE 170
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 6e-19
Identities = 55/172 (31%), Positives = 84/172 (48%), Gaps = 15/172 (8%)
Query: 589 LGRGGFGVVYGGELPDGT---KIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
LG G FG V G+L K+AVK M+ + +F +E + + H +++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 646 GYCINGSER------LLVYEYMPRGTLAQHLFEWHDHGYTP--LTWKQRVTIALDVARGV 697
G C+ E +++ +M G L L + G P L + V D+A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLL-YSRLGDCPQYLPTQMLVKFMTDIASGM 125
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLA 749
EYL S +SFIHRDL N ++ ++M VADFGL K +G Y + R+A
Sbjct: 126 EYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIA 174
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 7e-19
Identities = 49/176 (27%), Positives = 80/176 (45%), Gaps = 16/176 (9%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY 647
+G+G FG VY DG +K ++ + M K + E+ +L K+ H +++
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE- 66
Query: 648 CINGSERLL-VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ 706
+L V EY G L+Q + + P +Q + + + ++YLHS +
Sbjct: 67 SFEEKGKLCIVMEYADGGDLSQKI-KKQKKEGKPFPEEQILDWFVQLCLALKYLHS---R 122
Query: 707 SFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTF-G---YLAPE 758
+HRD+KP NI + + K+ DFG+ K S LA T G YL+PE
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISK-----VLSSTVDLAKTVVGTPYYLSPE 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 53/167 (31%), Positives = 82/167 (49%), Gaps = 22/167 (13%)
Query: 588 ILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRH 640
LG G FG V E + + +AVK ++ + K LS+ +E+ ++ + +H++
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKN 77
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHL--------FEWHDHGYTP---LTWKQRVTI 689
++ LLG C +V EY G L L + D P LT K V+
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 690 ALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736
A VARG+E+L A + IHRDL N+L+ +D K+ADFGL ++
Sbjct: 138 AYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARD 181
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 56/164 (34%), Positives = 80/164 (48%), Gaps = 18/164 (10%)
Query: 587 NILGRGGFGVVYGG----ELPDGT---KIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHR 639
N LG G FG VY G L G+ ++AVK + + EF E +++ H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE-KKEFLKEAHLMSNFNHP 59
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWH-DHGYTP-LTWKQRVTIALDVARGV 697
++V LLG C+ + ++ E M G L +L + + P LT K+ + I LDVA+G
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 698 EYLHSLAQQSFIHRDLKPSNILI----GDDMR-AKVADFGLVKN 736
YL Q FIHRDL N L+ D R K+ DFGL ++
Sbjct: 120 VYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 60/180 (33%), Positives = 94/180 (52%), Gaps = 14/180 (7%)
Query: 583 FSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGN-KGLSEFQAEIAVLTKVRHRH 640
F + +LG+GGFG V ++ G A KR+E + KG S E +L KV +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 641 LVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTI-ALDVARGVE 698
+V L Y + L LV M G L H++ + G+ ++R A ++ G+E
Sbjct: 62 VVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFE----EERALFYAAEILCGLE 116
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
LH +++ ++RDLKP NIL+ D +++D GL P+G+ S+ R+ GT GY+APE
Sbjct: 117 DLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-SIRGRV-GTVGYMAPE 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 57/162 (35%), Positives = 85/162 (52%), Gaps = 15/162 (9%)
Query: 587 NILGRGGFGVVYGGEL--PDGTKI--AVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
++G+G FG VY G L DG KI AVK + T + + +F E ++ H +++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVL 59
Query: 643 ALLGYCI--NGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYL 700
+LLG C+ GS L+V YM G L + + P T K + L VA+G+EYL
Sbjct: 60 SLLGICLPSEGSP-LVVLPYMKHGDLRNFI---RSETHNP-TVKDLIGFGLQVAKGMEYL 114
Query: 701 HSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742
A + F+HRDL N ++ + KVADFGL ++ D +Y
Sbjct: 115 ---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-18
Identities = 57/164 (34%), Positives = 87/164 (53%), Gaps = 19/164 (11%)
Query: 587 NILGRGGFGVVYGGEL-PDGTKI--AVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLV 642
+++G G FG V + DG ++ A+KRM+ + +F E+ VL K+ H +++
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH-RDFAGELEVLCKLGHHPNII 71
Query: 643 ALLGYCINGSERLLVYEYMPRGTLAQHL-----------FEWHDHGYTPLTWKQRVTIAL 691
LLG C + L EY P G L L F + + L+ +Q + A
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 692 DVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735
DVARG++YL +Q+ FIHRDL NIL+G++ AK+ADFGL +
Sbjct: 132 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 56/174 (32%), Positives = 83/174 (47%), Gaps = 28/174 (16%)
Query: 589 LGRGGFGVVYGGE------LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
LG G FG V+ E D +AVK ++ T+ + +FQ E +LT ++H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KDFQREAELLTNLQHEHIV 70
Query: 643 ALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGY--------TPLTWK------QRVT 688
G C +G ++V+EYM G L + L HG P K Q +
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFL---RAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 689 IALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742
IA +A G+ Y LA Q F+HRDL N L+G ++ K+ DFG+ ++ Y
Sbjct: 128 IASQIASGMVY---LASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 178
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 3e-18
Identities = 49/157 (31%), Positives = 82/157 (52%), Gaps = 17/157 (10%)
Query: 589 LGRGGFGVVYGGELPD------GTKIAVKRM-ESNTMGNKGLSEFQAEIAVLTKVRHRHL 641
LG+G FG+VY G T++A+K + E+ +M + EF E +V+ + H+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER--IEFLNEASVMKEFNCHHV 71
Query: 642 VALLGYCINGSERLLVYEYMPRGTLAQHLF-----EWHDHGYTPLTWKQRVTIALDVARG 696
V LLG G L+V E M +G L +L ++ G P T ++ + +A ++A G
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733
+ YL + F+HRDL N ++ +D+ K+ DFG+
Sbjct: 132 MAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGM 165
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 5e-18
Identities = 52/159 (32%), Positives = 77/159 (48%), Gaps = 17/159 (10%)
Query: 589 LGRGGFGVV----YGGELPD-GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVA 643
LG G FG V Y G +AVK ++ G + S ++ EI +L + H ++V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVK 70
Query: 644 LLGYCINGSER--LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLH 701
G C + L+ EY+P G+L +L + L Q + A + G+ YLH
Sbjct: 71 YKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK------HKLNLAQLLLFAQQICEGMAYLH 124
Query: 702 SLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740
S Q +IHRDL N+L+ +D K+ DFGL K P+G
Sbjct: 125 S---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 5e-18
Identities = 63/189 (33%), Positives = 95/189 (50%), Gaps = 26/189 (13%)
Query: 583 FSEANILGRGGFGVVYGG-ELPDGTKIAVKRME-SNTMGNKGLSEFQAEIAVLTKVR--- 637
+ E +G G +G VY +L G +A+K++ + LS + EIA+L ++
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR-EIALLKQLESFE 59
Query: 638 HRHLVALLGYC-INGSER----LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALD 692
H ++V LL C ++R LV+E++ + LA +L + G P T K +
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKD---LMRQ 115
Query: 693 VARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAG-- 750
+ RGV++LHS +HRDLKP NIL+ D + K+ADFGL + YS E L
Sbjct: 116 LLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLAR-----IYSFEMALTSVV 167
Query: 751 -TFGYLAPE 758
T Y APE
Sbjct: 168 VTLWYRAPE 176
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 5e-18
Identities = 51/155 (32%), Positives = 76/155 (49%), Gaps = 18/155 (11%)
Query: 588 ILGRGGFGVVYGGE-LPDGTKI----AVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
+LG G FG VY G +P+G K+ A+K + T K E E V+ V H H+V
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVV 72
Query: 643 ALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDH--GYTPLTWKQRVTIALDVARGVEYL 700
LLG C+ S+ L+ + MP G L ++ D+ L W + +A+G+ YL
Sbjct: 73 RLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYL 125
Query: 701 HSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735
++ +HRDL N+L+ K+ DFGL K
Sbjct: 126 E---EKRLVHRDLAARNVLVKTPQHVKITDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 52/177 (29%), Positives = 80/177 (45%), Gaps = 14/177 (7%)
Query: 587 NILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
N +G G FG VY L G +AVK + K + E E+ VL ++H +LV
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 646 GYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYT-PLTWKQRVTIALDVARGVEYLHSLA 704
G ++ + + EY GTL + L +HG + T+ L G+ YLHS
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELL----EHGRILDEHVIRVYTLQL--LEGLAYLHS-- 117
Query: 705 QQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFG---YLAPE 758
+HRD+KP+NI + + K+ DFG + ++ + G Y+APE
Sbjct: 118 -HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPE 173
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 51/167 (30%), Positives = 76/167 (45%), Gaps = 15/167 (8%)
Query: 581 DNFSEANILGRGGFGVVYGGEL----PDGTKIAVKRMESNTMGNKGLSE--FQAEIAVLT 634
D+ + LG G FG VY G D ++ V +++ E F E +++
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVA-VKTLPESCSEQDESDFLMEALIMS 64
Query: 635 KVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTP--LTWKQRVTIALD 692
K H+++V L+G R ++ E M G L L E P LT K + A D
Sbjct: 65 KFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD 124
Query: 693 VARGVEYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVKN 736
VA+G +YL FIHRD+ N L+ G AK+ADFG+ ++
Sbjct: 125 VAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARD 168
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 51/174 (29%), Positives = 79/174 (45%), Gaps = 18/174 (10%)
Query: 582 NFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTK 635
N E LGRG FG V+ + T + VK ++ T SEF+ E+ + K
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQK-TKDENLQSEFRRELDMFRK 64
Query: 636 VRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLF----EWHDHGYTPLTWKQRVTIAL 691
+ H+++V LLG C ++ EY G L Q L + PL+ KQ+V +
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 692 DVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVE 745
+A G+++ L+ F+HRDL N L+ KV+ L K+ Y+ E
Sbjct: 125 QIALGMDH---LSNARFVHRDLAARNCLVSSQREVKVSLLSLSKD----VYNSE 171
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 62/181 (34%), Positives = 94/181 (51%), Gaps = 22/181 (12%)
Query: 589 LGRGGFGVV----YGGELPDGTK--IAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
LG+G FG V Y L D T +AVK+++ +T + L +F+ EI +L ++H ++V
Sbjct: 12 LGKGNFGSVELCRYD-PLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDNIV 68
Query: 643 ALLGYCINGSER--LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYL 700
G C + R LV EY+P G+L +L + H L ++ + A + +G+EYL
Sbjct: 69 KYKGVCYSAGRRNLRLVMEYLPYGSLRDYL-QKHRE---RLDHRKLLLYASQICKGMEYL 124
Query: 701 HSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAG---TFGYLAP 757
+ ++HRDL NIL+ + R K+ DFGL K P K + R G F Y AP
Sbjct: 125 ---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-AP 180
Query: 758 E 758
E
Sbjct: 181 E 181
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 50/182 (27%), Positives = 82/182 (45%), Gaps = 17/182 (9%)
Query: 587 NILGRGGFGVVYG-GELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
+G+G FG V DG + K ++ M K + +E+ +L +++H ++V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 646 GYCINGSERLL--VYEYMPRGTLAQHLFEWH-DHGYTP--LTWK--QRVTIALDVARGVE 698
I+ S + L V EY G LAQ + + + Y W+ ++ +AL
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY------ 119
Query: 699 YLH--SLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLA 756
H S + +HRDLKP+NI + + K+ DFGL K +T GT Y++
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT-YVGTPYYMS 178
Query: 757 PE 758
PE
Sbjct: 179 PE 180
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 55/175 (31%), Positives = 90/175 (51%), Gaps = 16/175 (9%)
Query: 589 LGRGGFGVVYGG-ELPDGTKIAVKRM---ESNTMGNKGLSEFQAEIAVLTKVRHRHLVAL 644
LG G FG VY G L DG AVK + + G + + + + EIA+L+K++H ++V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 645 LGYCINGSERLLVY-EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSL 703
LG + L ++ E +P G+LA+ L + Y + G+EYLH
Sbjct: 68 LGTEREE-DNLYIFLELVPGGSLAKLLKK-----YGSFPEPVIRLYTRQILLGLEYLHD- 120
Query: 704 AQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
++ +HRD+K +NIL+ + K+ADFG+ K ++S G+ ++APE
Sbjct: 121 --RNTVHRDIKGANILVDTNGVVKLADFGMAKQVV--EFSFAKSFKGSPYWMAPE 171
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 52/171 (30%), Positives = 89/171 (52%), Gaps = 12/171 (7%)
Query: 589 LGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYC 648
LG G FG V+ G TK+A+K ++ +M F AE ++ +++H LV L Y
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRL--YA 68
Query: 649 INGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS 707
+ E + ++ EYM G+L L G LT + + +A +A G+ ++ +++
Sbjct: 69 VVTQEPIYIITEYMENGSLVDFLKT--PEG-IKLTINKLIDMAAQIAEGMAFIE---RKN 122
Query: 708 FIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
+IHRDL+ +NIL+ + + K+ADFGL + D +Y+ + APE
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 173
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 4e-17
Identities = 54/191 (28%), Positives = 88/191 (46%), Gaps = 36/191 (18%)
Query: 590 GRGGFGVVY---GGELPDGTKIAVKRMESNTMGNKGLSEFQA---EIAVLTKVRHRHLVA 643
GRG +G VY DG + A+K+ + + G+S Q+ EIA+L +++H ++V+
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGIS--QSACREIALLRELKHENVVS 66
Query: 644 LLGYCINGSERL--LVYEYMPRGTLAQHLFEW--HDHGYTPLTWKQRVTIA------LDV 693
L+ + +++ L+++Y A+H H + L+
Sbjct: 67 LVEVFLEHADKSVYLLFDY------AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILN- 119
Query: 694 ARGVEYLHSLAQQSFIHRDLKPSNILI-GDDM---RAKVADFGLVK--NAPDGKYSVETR 747
GV YLHS +HRDLKP+NIL+ G+ K+ D GL + NAP +
Sbjct: 120 --GVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP 174
Query: 748 LAGTFGYLAPE 758
+ T Y APE
Sbjct: 175 VVVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 5e-17
Identities = 52/164 (31%), Positives = 80/164 (48%), Gaps = 16/164 (9%)
Query: 589 LGRGGFGVVYGG--ELPDGTKI--AVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVAL 644
LG G FG V G + G ++ AVK ++ + G EF E +V+ ++ H +V L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAA-GKKEFLREASVMAQLDHPCIVRL 61
Query: 645 LGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA 704
+G C G +LV E P G L ++L P+ +A VA G+ YL S
Sbjct: 62 IGVCK-GEPLMLVMELAPLGPLLKYL---KKRREIPV--SDLKELAHQVAMGMAYLES-- 113
Query: 705 QQSFIHRDLKPSNILIGDDMRAKVADFGLVK--NAPDGKYSVET 746
+ F+HRDL N+L+ + +AK++DFG+ + A Y T
Sbjct: 114 -KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 5e-17
Identities = 58/180 (32%), Positives = 85/180 (47%), Gaps = 19/180 (10%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKG-LSEFQAEIAVLTKVRHRHLVALLG 646
+ +G +G V+ + G A+K ++ M K + + E +L++ + ++V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 647 YCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQ 705
Y G + L LV EY+P G LA L + G R+ IA ++ +EYLHS
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLL---ENVGSLDEDVA-RIYIA-EIVLALEYLHSN-- 112
Query: 706 QSFIHRDLKPSNILIGDDMRAKVADFGLVK------NAPDGKYSVET-RLAGTFGYLAPE 758
IHRDLKP NILI + K+ DFGL K E R+ GT Y+APE
Sbjct: 113 -GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 6e-17
Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 29/201 (14%)
Query: 581 DNFSEANILGRGGFGVVYGGEL--------PDGTKIAVKRMESNTMGNKGLSEFQAEIAV 632
D + LG G FG V E + +AVK ++ + K LS+ +E+ +
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT-EKDLSDLVSEMEM 73
Query: 633 LTKV-RHRHLVALLGYCINGSERLLVYEYMPRGTLAQHL-----------FEWHDHGYTP 680
+ + +H++++ LLG C ++ EY +G L ++L ++
Sbjct: 74 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ 133
Query: 681 LTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740
+T+K V+ VARG+EYL A Q IHRDL N+L+ ++ K+ADFGL ++ +
Sbjct: 134 MTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNI 190
Query: 741 KYSVET---RLAGTFGYLAPE 758
Y +T RL ++APE
Sbjct: 191 DYYKKTTNGRLP--VKWMAPE 209
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 7e-17
Identities = 64/201 (31%), Positives = 98/201 (48%), Gaps = 29/201 (14%)
Query: 581 DNFSEANILGRGGFGVV-----YG--GELPDGT-KIAVKRMESNTMGNKGLSEFQAEIAV 632
D LG G FG V YG PD T +AVK ++ N +K L++ +E+ +
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-DKDLADLISEMEL 70
Query: 633 LTKV-RHRHLVALLGYCINGSERLLVYEYMPRGTLAQHL-----------FEWHDHGYTP 680
+ + +H++++ LLG C ++ EY +G L + L F+
Sbjct: 71 MKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQ 130
Query: 681 LTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740
L++K V+ A VARG+EYL S + IHRDL N+L+ +D K+ADFGL + D
Sbjct: 131 LSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDI 187
Query: 741 KYSVET---RLAGTFGYLAPE 758
Y +T RL ++APE
Sbjct: 188 DYYKKTSNGRLP--VKWMAPE 206
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 8e-17
Identities = 54/182 (29%), Positives = 93/182 (51%), Gaps = 23/182 (12%)
Query: 589 LGRGGFGVVYGGEL----PDGTK----IAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
LG G FG V EL P+G +AVK ++ + GN +++ + EI +L + H +
Sbjct: 12 LGEGHFGKV---ELCRYDPEGDNTGEQVAVKSLKPESGGNH-IADLKKEIEILRNLYHEN 67
Query: 641 LVALLGYCINGSER--LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
+V G C L+ E++P G+L ++L + + KQ++ A+ + +G++
Sbjct: 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK----INLKQQLKYAVQICKGMD 123
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK--YSVETRLAGTFGYLA 756
YL S + ++HRDL N+L+ + + K+ DFGL K K Y+V+ L + A
Sbjct: 124 YLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYA 180
Query: 757 PE 758
PE
Sbjct: 181 PE 182
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 8e-17
Identities = 50/167 (29%), Positives = 88/167 (52%), Gaps = 19/167 (11%)
Query: 589 LGRGGFGVVYGG-------ELPDGTKIAVKRM-ESNTMGNKGLSEFQAEIAVLTKVRHRH 640
LG+G FG+VY G + P+ T++A+K + E+ +M + EF E +V+ + H
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPE-TRVAIKTVNEAASMRER--IEFLNEASVMKEFNCHH 70
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLF-----EWHDHGYTPLTWKQRVTIALDVAR 695
+V LLG G L++ E M RG L +L ++ P + K+ + +A ++A
Sbjct: 71 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742
G+ YL++ F+HRDL N ++ +D K+ DFG+ ++ + Y
Sbjct: 131 GMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 174
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 8e-17
Identities = 55/173 (31%), Positives = 84/173 (48%), Gaps = 12/173 (6%)
Query: 589 LGRGGFGVVYGGELPDGTKI-AVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLG 646
LG+GGFG V ++ K+ A K+++ + KG E +L KV R +V+L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 647 YCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQ 705
Y + L LV M G L H++ + G + + A + G+E+LH Q
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIY---NVGEPGFPEARAIFYAAQIICGLEHLH---Q 113
Query: 706 QSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
+ ++RDLKP N+L+ D +++D GL GK AGT GY+APE
Sbjct: 114 RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI--KGRAGTPGYMAPE 164
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 9e-17
Identities = 50/172 (29%), Positives = 82/172 (47%), Gaps = 13/172 (7%)
Query: 588 ILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646
LG G +G VY G +A+K + L E EI++L + ++V G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYG 65
Query: 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ 706
++ +V EY G+++ + + + LT ++ I +G+EYLHS
Sbjct: 66 SYFKNTDLWIVMEYCGAGSVSD-IMKITN---KTLTEEEIAAILYQTLKGLEYLHS---N 118
Query: 707 SFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
IHRD+K NIL+ ++ +AK+ADFG+ D T + GT ++APE
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPE 169
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 9e-17
Identities = 54/163 (33%), Positives = 85/163 (52%), Gaps = 17/163 (10%)
Query: 587 NILGRGGFGVVYGGELP-DGTKI-AVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVA 643
+++G G FG V + DG K+ A +M +F E+ VL K+ H +++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 644 LLGYCINGSERLLVYEYMPRGTLAQHLFEWH----------DHGY-TPLTWKQRVTIALD 692
LLG C N + EY P G L L + +HG + LT +Q + A D
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 693 VARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735
VA G++YL +++ FIHRDL N+L+G+++ +K+ADFGL +
Sbjct: 128 VATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 57/179 (31%), Positives = 88/179 (49%), Gaps = 16/179 (8%)
Query: 587 NILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
++G G VVY LP+ K+A+KR++ + E + E+ +++ H ++V
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC-QTSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 646 GYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIAL---DVARGVEYLHS 702
+ G E LV Y+ G+L + + Y P IA +V +G+EYLHS
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLL-DIMK---SSY-PRGGLDEAIIATVLKEVLKGLEYLHS 120
Query: 703 LAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG---KYSVETRLAGTFGYLAPE 758
Q IHRD+K NIL+G+D K+ADFG+ + DG V GT ++APE
Sbjct: 121 NGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 51/179 (28%), Positives = 83/179 (46%), Gaps = 26/179 (14%)
Query: 589 LGRGGFGVVYGG-ELPDGTKIAVKRM----ESNTMGNKGLSEFQAEIAVLTKVRHRHLVA 643
+G G +GVVY + G +A+K++ ES + L E I +L ++ H +++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALRE----IKLLKELNHPNIIK 62
Query: 644 LLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSL 703
LL + + LV+E+M L++ L + + +G+ + HS
Sbjct: 63 LLDVFRHKGDLYLVFEFM-----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS- 116
Query: 704 AQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA--PDGKYS--VETRLAGTFGYLAPE 758
+HRDLKP N+LI + K+ADFGL ++ P Y+ V TR Y APE
Sbjct: 117 --HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRW-----YRAPE 168
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 53/173 (30%), Positives = 88/173 (50%), Gaps = 18/173 (10%)
Query: 583 FSEANILGRGGFGVVYGGELP--DGT--KIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH 638
F+ +LG+G FG V +L DG+ K+AVK ++++ + + EF E A + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 639 RHLVALLGYCINGSER------LLVYEYMPRGTLAQHLFEWHDH-GYTPLTWKQRVTI-- 689
+++ L+G + + +++ +M G L H F G P T + +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDL--HTFLLMSRIGEEPFTLPLQTLVRF 118
Query: 690 ALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742
+D+A G+EYL S ++FIHRDL N ++ ++M VADFGL K G Y
Sbjct: 119 MIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDY 168
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-16
Identities = 63/193 (32%), Positives = 100/193 (51%), Gaps = 29/193 (15%)
Query: 589 LGRGGFGVVYGGEL-------PDG-TKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHR 639
LG G FG V E P+ TK+AVK ++S+ K LS+ +E+ ++ + +H+
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHK 84
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWH----DHGYTP-------LTWKQRVT 688
+++ LLG C ++ EY +G L ++L ++ Y P L++K V+
Sbjct: 85 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144
Query: 689 IALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVET-- 746
A VARG+EYL A + IHRDL N+L+ +D K+ADFGL ++ Y +T
Sbjct: 145 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201
Query: 747 -RLAGTFGYLAPE 758
RL ++APE
Sbjct: 202 GRLP--VKWMAPE 212
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 59/180 (32%), Positives = 93/180 (51%), Gaps = 14/180 (7%)
Query: 583 FSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGN-KGLSEFQAEIAVLTKVRHRH 640
F +LG+GGFG V ++ G A K++E + KG + E +L KV R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 641 LVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQR-VTIALDVARGVE 698
+V+L Y + L LV M G L H++ + G+ +QR + A ++ G+E
Sbjct: 62 VVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFD----EQRAIFYAAELCCGLE 116
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
L ++ ++RDLKP NIL+ D +++D GL P+G+ +V R+ GT GY+APE
Sbjct: 117 DLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-TVRGRV-GTVGYMAPE 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 49/170 (28%), Positives = 85/170 (50%), Gaps = 9/170 (5%)
Query: 589 LGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYC 648
LG G FG V+ G + TK+AVK ++ TM + F E ++ ++H LV L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS---VQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 649 INGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSF 708
++ EYM +G+L L D G + + + + +A G+ Y+ ++++
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLKS--DEG-GKVLLPKLIDFSAQIAEGMAYIE---RKNY 124
Query: 709 IHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
IHRDL+ +N+L+ + + K+ADFGL + D +Y+ + APE
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 174
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 4e-16
Identities = 53/173 (30%), Positives = 85/173 (49%), Gaps = 25/173 (14%)
Query: 588 ILGRGGFGVVYGG-ELPDGTKIAVK---RMESNTMGNKGLSEFQAEIAVLTKVRHRHLVA 643
+LG G FG VY G +P+G + + ++ + T G K EF E ++ + H HLV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 644 LLGYCINGSERLLVYEYMPRGTLAQHLFEWHDH--GYTPLTWKQRVTIALDVARGVEYLH 701
LLG C++ + +L V + MP G L ++ E D+ L W + +A+G+ YL
Sbjct: 74 LLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLE 126
Query: 702 SLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK---------NAPDGKYSVE 745
++ +HRDL N+L+ K+ DFGL + NA GK ++
Sbjct: 127 ---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK 176
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (196), Expect = 4e-16
Identities = 49/160 (30%), Positives = 70/160 (43%), Gaps = 31/160 (19%)
Query: 587 NILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQA--EIAVLTKVRHRHLVA 643
+G G +G VY G +A+K++ +G A EI +L K+RH ++V
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIR-MENEKEGFP-ITAIREIKLLQKLRHPNIVR 62
Query: 644 LLGYCINGSERL----LVYEYMPRGTLAQHLFEWHD------HGYTPLTWKQRVTIALDV 693
L I S+ +V+EYM HD T Q +
Sbjct: 63 L--KEIVTSKGKGSIYMVFEYMD-----------HDLTGLLDSPEVKFTESQIKCYMKQL 109
Query: 694 ARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733
G++YLHS +HRD+K SNILI +D K+ADFGL
Sbjct: 110 LEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGL 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 5e-16
Identities = 61/193 (31%), Positives = 96/193 (49%), Gaps = 29/193 (15%)
Query: 589 LGRGGFGVVYGGEL--------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHR 639
LG G FG V E +AVK ++ + +K LS+ +E+ ++ + +H+
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDAT-DKDLSDLVSEMEMMKMIGKHK 78
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHG--YT---------PLTWKQRVT 688
+++ LLG C ++ EY +G L ++L G Y+ LT+K V+
Sbjct: 79 NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138
Query: 689 IALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVET-- 746
A VARG+EYL A Q IHRDL N+L+ +D K+ADFGL ++ + Y +T
Sbjct: 139 CAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195
Query: 747 -RLAGTFGYLAPE 758
RL ++APE
Sbjct: 196 GRLP--VKWMAPE 206
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 7e-16
Identities = 48/165 (29%), Positives = 88/165 (53%), Gaps = 12/165 (7%)
Query: 587 NILGRGGFGVVYGG--ELPDGTKI--AVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
++G G FG V G +LP +I A+K +++ +K +F E +++ + H +++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKA-GSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 643 ALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHS 702
L G +++ EYM G+L + L E +D G T Q V + +A G++YL
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRE-ND-GK--FTVGQLVGMLRGIASGMKYL-- 122
Query: 703 LAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR 747
++ +++HRDL NIL+ ++ KV+DFGL + D + + T+
Sbjct: 123 -SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK 166
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 8e-16
Identities = 58/200 (29%), Positives = 83/200 (41%), Gaps = 26/200 (13%)
Query: 589 LGRGGFGVVYGG-ELPDGTKIAVKRM---ESNTMGNKGLSEFQAEIAVLTKVRHRHLVAL 644
+G G +GVV G +A+K+ E + K E+ VL ++RH ++V L
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTA---LREVKVLRQLRHENIVNL 65
Query: 645 LGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA 704
LV+EY+ R L L E G P + + + + + Y HS
Sbjct: 66 KEAFRRKGRLYLVFEYVERTLL--ELLEASPGGLPPDAVR---SYIWQLLQAIAYCHSH- 119
Query: 705 QQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE------ 758
+ IHRD+KP NIL+ + K+ DFG + S T T Y APE
Sbjct: 120 --NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT 177
Query: 759 -YAGKH---WMILCQMTGLI 774
Y GK W I C M L+
Sbjct: 178 NY-GKPVDVWAIGCIMAELL 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 9e-16
Identities = 52/166 (31%), Positives = 85/166 (51%), Gaps = 17/166 (10%)
Query: 589 LGRGGFGVVYGGELPD------GTKIAVKRM-ESNTMGNKGLSEFQAEIAVLTKVRHRHL 641
LG+G FG+VY G D T++AVK + ES ++ + EF E +V+ H+
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER--IEFLNEASVMKGFTCHHV 71
Query: 642 VALLGYCINGSERLLVYEYMPRGTLAQHLFEW-----HDHGYTPLTWKQRVTIALDVARG 696
V LLG G L+V E M G L +L ++ G P T ++ + +A ++A G
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742
+ YL++ + F+HRDL N ++ D K+ DFG+ ++ + Y
Sbjct: 132 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY 174
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 58/179 (32%), Positives = 92/179 (51%), Gaps = 12/179 (6%)
Query: 583 FSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGN-KGLSEFQAEIAVLTKVRHRH 640
F +LG+GGFG V ++ G A K++E + KG + E +L KV R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 641 LVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
+V+L Y + L LV M G L H++ + G+ ++ V A ++ G+E
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDE---ERAVFYAAEITCGLED 117
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
LH + ++RDLKP NIL+ D +++D GL P+G+ ++ R+ GT GY+APE
Sbjct: 118 LHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-TIRGRV-GTVGYMAPE 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 44/149 (29%), Positives = 79/149 (53%), Gaps = 18/149 (12%)
Query: 608 IAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLA 667
+AVK + + N ++F E+ +L++++ +++ LLG C++ ++ EYM G L
Sbjct: 49 VAVKILRPDANKN-ARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107
Query: 668 QHLFEWH--------------DHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDL 713
Q L H H +++ + +AL +A G++YL SL +F+HRDL
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDL 164
Query: 714 KPSNILIGDDMRAKVADFGLVKNAPDGKY 742
N L+G+++ K+ADFG+ +N G Y
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGDY 193
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 16/184 (8%)
Query: 582 NFSEANILGRGGFGVVY-GGELPDGTKIAVKRME---SNTMGNKGLSEFQAEIAVLTKVR 637
N+ +LG+G FG VY ++ G ++AVK++ + K ++ + EI +L ++
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 638 HRHLVALLGYCINGSERLLVY-EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARG 696
H +V G C+ E L ++ EYMP G++ L Y LT + G
Sbjct: 63 HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQL-----KAYGALTETVTRKYTRQILEG 116
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK--NAPDGKYSVETRLAGTFGY 754
VEYLHS +HRD+K +NIL K+ DFG K + + GT +
Sbjct: 117 VEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYW 173
Query: 755 LAPE 758
++PE
Sbjct: 174 MSPE 177
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-15
Identities = 54/205 (26%), Positives = 88/205 (42%), Gaps = 36/205 (17%)
Query: 588 ILGRGGFGVVYGGE------LPDGTKIAVKRMESNTMGNKG---LSEFQAEIAVLTKVRH 638
LG G FG V T +AVK ++ N ++ LSEF +L +V H
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFN----LLKQVNH 62
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFE------------------WHDH-GYT 679
H++ L G C LL+ EY G+L L E + D+
Sbjct: 63 PHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122
Query: 680 PLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA-P 738
LT ++ A ++RG++YL A+ +HRDL N+L+ + + K++DFGL ++
Sbjct: 123 ALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE 179
Query: 739 DGKYSVETRLAGTFGYLAPEYAGKH 763
+ Y ++ ++A E H
Sbjct: 180 EDSYVKRSKGRIPVKWMAIESLFDH 204
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 52/189 (27%), Positives = 87/189 (46%), Gaps = 23/189 (12%)
Query: 580 TDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMES-NTMGNKGLSEFQAEIAVLTKVR 637
NF +G+G F VVY L DG +A+K+++ M K + EI +L ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYT---PLTWKQRVTIALDVA 694
H +++ L I +E +V E G L++ + + WK V +
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC---- 116
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY-SVET----RLA 749
+E++HS + +HRD+KP+N+ I K+ D GL G++ S +T L
Sbjct: 117 SALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGL------GRFFSSKTTAAHSLV 167
Query: 750 GTFGYLAPE 758
GT Y++PE
Sbjct: 168 GTPYYMSPE 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 53/163 (32%), Positives = 82/163 (50%), Gaps = 17/163 (10%)
Query: 587 NILGRGGFGVVYGGELP-DGTKI-AVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVA 643
+++G G FG V + DG ++ A + +F E+ VL K+ H +++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 644 LLGYCINGSERLLVYEYMPRGTLAQHLFE----------WHDHGY-TPLTWKQRVTIALD 692
LLG C + L EY P G L L + + + L+ +Q + A D
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 693 VARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735
VARG++YL +Q+ FIHRDL NIL+G++ AK+ADFGL +
Sbjct: 121 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 54/173 (31%), Positives = 79/173 (45%), Gaps = 15/173 (8%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRM--ESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
LG G GVV P G +AVK + E N K + E+ +L K ++V
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILR---ELDILHKCNSPYIVGFY 65
Query: 646 GYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQ 705
G N + + EYM G+L + L + + IA+ V +G+ YLH +
Sbjct: 66 GAFYNNGDISICMEYMDGGSLDKIL----KEVQGRIPERILGKIAVAVLKGLTYLHE--K 119
Query: 706 QSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
IHRD+KPSNIL+ + K+ DFG+ + S+ GT Y+APE
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN---SLAKTFVGTSSYMAPE 169
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 42/148 (28%), Positives = 70/148 (47%), Gaps = 17/148 (11%)
Query: 589 LGRGGFGVVYGG-ELPDGTKIAVKRM---ESNTMGNKGLSEFQAEIAVLTKVRHRHLVAL 644
+G+G FG VY + +A+K + E+ + + Q EI L++ R ++
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAED----EIEDIQQEIQFLSQCRSPYITKY 64
Query: 645 LGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA 704
G + GS+ ++ EY G+ L + L I +V G+EYLH
Sbjct: 65 YGSFLKGSKLWIIMEYCGGGSCL-DLLK-----PGKLDETYIAFILREVLLGLEYLHE-- 116
Query: 705 QQSFIHRDLKPSNILIGDDMRAKVADFG 732
+ IHRD+K +NIL+ ++ K+ADFG
Sbjct: 117 -EGKIHRDIKAANILLSEEGDVKLADFG 143
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-15
Identities = 53/172 (30%), Positives = 83/172 (48%), Gaps = 20/172 (11%)
Query: 583 FSEANILGRGGFGVVYGG-ELPDGTKI----AVKRMESNTMGNKGLSEFQAEIAVLTKVR 637
F + +LG G FG VY G +P+G K+ A+K + T K E E V+ V
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVD 67
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDH--GYTPLTWKQRVTIALDVAR 695
+ H+ LLG C+ + +L + + MP G L ++ E D+ L W + +A+
Sbjct: 68 NPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 120
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK--NAPDGKYSVE 745
G+ YL ++ +HRDL N+L+ K+ DFGL K A + +Y E
Sbjct: 121 GMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAE 169
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 5e-15
Identities = 55/185 (29%), Positives = 89/185 (48%), Gaps = 18/185 (9%)
Query: 580 TDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRM-ESNTMGNKGLSEFQAEIAVLTKVR 637
D E +LG+G +G+VY +L +IA+K + E ++ + L E EIA+ + ++
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHE---EIALHSYLK 63
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIAL---DVA 694
HR++V LG + E +P G+L+ L + PL ++ TI +
Sbjct: 64 HRNIVQYLGSDSENGFFKIFMEQVPGGSLSALL----RSKWGPLKDNEQ-TIIFYTKQIL 118
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIGD-DMRAKVADFGLVKNAPDGKYSVETRLAGTFG 753
G++YLH +HRD+K N+L+ K++DFG K ET GT
Sbjct: 119 EGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET-FTGTLQ 174
Query: 754 YLAPE 758
Y+APE
Sbjct: 175 YMAPE 179
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 7e-15
Identities = 65/193 (33%), Positives = 91/193 (47%), Gaps = 25/193 (12%)
Query: 575 VLRQVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVK--RMESNTMGNKGLSEFQAEIA 631
R VT F + N +G G +G+VY + G +A+K RM+ N +S + EI
Sbjct: 2 RCRSVT-EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMD-NERDGIPISSLR-EIT 58
Query: 632 VLTKVRHRHLVALLGYCINGSER---LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVT 688
+L +RH ++V L + G LV EY Q L D+ TP + Q
Sbjct: 59 LLLNLRHPNIVELK-EVVVGKHLDSIFLVMEY-----CEQDLASLLDNMPTPFSESQVKC 112
Query: 689 IALDVARGVEYLHSLAQQSFI-HRDLKPSNILIGDDMRAKVADFGLVKN--APDGKYSVE 745
+ L + RG++YLH +FI HRDLK SN+L+ D K+ADFGL + P
Sbjct: 113 LMLQLLRGLQYLHE----NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM--- 165
Query: 746 TRLAGTFGYLAPE 758
T T Y APE
Sbjct: 166 TPKVVTLWYRAPE 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 8e-15
Identities = 55/174 (31%), Positives = 86/174 (49%), Gaps = 14/174 (8%)
Query: 589 LGRGGFGVVYGGELPD-GTKIAVKRMESNTMGNKGLSEFQA--EIAVLTKVRHRHLVALL 645
LG+GGFG V ++ + G A K+++ + K E A E +L KV +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKS-GEKMALLEKEILEKVNSPFIVNL- 58
Query: 646 GYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA 704
Y L LV M G L H++ + G L ++ + + + G+ +LHS+
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERG---LEMERVIHYSAQITCGILHLHSM- 114
Query: 705 QQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
++RD+KP N+L+ D +++D GL DGK T+ AGT GY+APE
Sbjct: 115 --DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI--TQRAGTNGYMAPE 164
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 8e-15
Identities = 47/163 (28%), Positives = 88/163 (53%), Gaps = 15/163 (9%)
Query: 588 ILGRGGFGVVYGGELP-DGTK---IAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVA 643
++G G FG V+ G L G K +A+K ++ K +F +E +++ + H +++
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT-EKQRQDFLSEASIMGQFSHHNIIR 70
Query: 644 LLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSL 703
L G +++ EYM G L ++L + HD ++ Q V + +A G++YL
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRD-HDGEFSSY---QLVGMLRGIAAGMKYL--- 123
Query: 704 AQQSFIHRDLKPSNILIGDDMRAKVADFGL---VKNAPDGKYS 743
+ +++HRDL NIL+ ++ KV+DFGL +++ P+G Y+
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYT 166
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 9e-15
Identities = 53/195 (27%), Positives = 81/195 (41%), Gaps = 44/195 (22%)
Query: 582 NFSEANILGRGGFGVVYGGELPDGTKI-AVKRMESNTMGNKGL--------SEFQAEIAV 632
+F ++G+G FG V + D K+ A+K M NK + E +
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYM------NKQKCVEKGSVRNVLN-ERRI 53
Query: 633 LTKVRHRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIAL 691
L ++ H LV L Y E + LV + + G L HL Q+V +
Sbjct: 54 LQELNHPFLVNLW-YSFQDEENMYLVVDLLLGGDLRYHL-------------SQKVKFSE 99
Query: 692 DVAR--------GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743
+ + +EYLHS + IHRD+KP NIL+ + + DF + +
Sbjct: 100 EQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT 156
Query: 744 VETRLAGTFGYLAPE 758
T +GT GY+APE
Sbjct: 157 TST--SGTPGYMAPE 169
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 9e-15
Identities = 46/182 (25%), Positives = 77/182 (42%), Gaps = 26/182 (14%)
Query: 589 LGRGGFGVVY----------------GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAV 632
LG G FG V+ + D + ++ + +F E+ +
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 633 LTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHD------HGYTPLTWKQR 686
L+++ ++ LLG C ++ EYM G L Q L + L++
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 687 VTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS-VE 745
+ +A +A G+ YL SL +F+HRDL N L+G + K+ADFG+ +N Y V+
Sbjct: 133 LYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189
Query: 746 TR 747
R
Sbjct: 190 GR 191
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 56/190 (29%), Positives = 93/190 (48%), Gaps = 25/190 (13%)
Query: 582 NFSEANILGRGGFGVVYGG-ELPDGTKIAVKRME--SNTMGN--KGLSEFQAEIAVLTKV 636
+ + LG G F Y ++ GT +AVK++ NT + + + EI ++ ++
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 637 RHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIA--LDVA 694
H H++ +LG S L E+M G+++ L +G +K+ V I +
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLL---SKYG----AFKEAVIINYTEQLL 113
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFG-LVKNAPDGKYSVETR--L 748
RG+ YLH + IHRD+K +N+LI G +R +ADFG + A G + E + L
Sbjct: 114 RGLSYLH---ENQIIHRDVKGANLLIDSTGQRLR--IADFGAAARLAAKGTGAGEFQGQL 168
Query: 749 AGTFGYLAPE 758
GT ++APE
Sbjct: 169 LGTIAFMAPE 178
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 41/142 (28%), Positives = 78/142 (54%), Gaps = 11/142 (7%)
Query: 608 IAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLA 667
+AVK + ++ ++F EI +++++++ +++ LLG C++ ++ EYM G L
Sbjct: 47 VAVKMLRADVTKT-ARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 668 QHLFE-------WHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI 720
Q L + H + ++ + +A+ +A G++YL SL +F+HRDL N L+
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCLV 162
Query: 721 GDDMRAKVADFGLVKNAPDGKY 742
G+ K+ADFG+ +N G Y
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDY 184
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 51/159 (32%), Positives = 73/159 (45%), Gaps = 13/159 (8%)
Query: 581 DNFSEANILGRGGFGVVY-GGELPDGTKIAVKRME-SNTMGNKGLSEFQAEIAVLTKV-R 637
D+F I+G G F V E + A+K ++ + K + + E VLT++
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 638 HRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARG 696
H ++ L Y E L V EY P G L Q++ +G + A ++
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTR--FYAAEILLA 114
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735
+EYLHS IHRDLKP NIL+ DM K+ DFG K
Sbjct: 115 LEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAK 150
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (182), Expect = 3e-14
Identities = 56/182 (30%), Positives = 82/182 (45%), Gaps = 32/182 (17%)
Query: 589 LGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQA-----EIAVLTKV-RHRHL 641
LG G FG VY G +A+K+M K ++ E+ L K+ H ++
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM------KKKFYSWEECMNLREVKSLRKLNEHPNI 60
Query: 642 VALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLH 701
V L E V+EYM G L Q L + D P + +I + +G+ ++H
Sbjct: 61 VKLKEVFRENDELYFVFEYM-EGNLYQ-LMK--DRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 702 SLAQQSFIHRDLKPSNILIGDDMRAKVADFGL---VKNAPDGKYS--VETRLAGTFGYLA 756
+ F HRDLKP N+L+ K+ADFGL +++ P Y+ V TR Y A
Sbjct: 117 ---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--YTDYVSTRW-----YRA 166
Query: 757 PE 758
PE
Sbjct: 167 PE 168
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 57/174 (32%), Positives = 82/174 (47%), Gaps = 22/174 (12%)
Query: 591 RGGFGVVY-GGELPDGTKIAVKRM-ESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYC 648
+G FG VY + G A+K + +S+ + ++ +AE A++ VA L Y
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 649 INGSERL-LVYEYMPRG---TLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA 704
+ L LV EY+ G +L + L G P W + +V GVE LH
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLIKTL------GGLPEDWAK--QYIAEVVLGVEDLH--- 114
Query: 705 QQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
Q+ IHRD+KP N+LI K+ DFGL +N + K + GT YLAPE
Sbjct: 115 QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK-----KFVGTPDYLAPE 163
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 5e-14
Identities = 48/185 (25%), Positives = 90/185 (48%), Gaps = 17/185 (9%)
Query: 583 FSEANILGRGGFGVVYGGELPDGTKIAVKRMESNT----MGNKGLSEFQAEIAVLTKVRH 638
+++ +LG+G +G VY G G IAVK++E +T K + Q E+ +L ++H
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
++V LG C++ + + E++P G+++ L + + PL + GV
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSIL-----NRFGPLPEPVFCKYTKQILDGVA 116
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK-----NAPDGKYSVETRLAGTFG 753
YLH +HRD+K +N+++ + K+ DFG + ++ + GT
Sbjct: 117 YLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY 173
Query: 754 YLAPE 758
++APE
Sbjct: 174 WMAPE 178
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 6e-14
Identities = 41/141 (29%), Positives = 72/141 (51%), Gaps = 10/141 (7%)
Query: 608 IAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLA 667
+AVK + + N ++F EI ++++++ +++ LL CI ++ EYM G L
Sbjct: 49 VAVKMLREDANKN-ARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 668 QHLFEWH------DHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIG 721
Q L +++ + +A +A G++YL SL +F+HRDL N L+G
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVG 164
Query: 722 DDMRAKVADFGLVKNAPDGKY 742
+ K+ADFG+ +N G Y
Sbjct: 165 KNYTIKIADFGMSRNLYSGDY 185
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 6e-14
Identities = 41/127 (32%), Positives = 64/127 (50%), Gaps = 12/127 (9%)
Query: 371 TINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGK 430
+INL+ + GNI P+ ++TSL+ L L N+ G IP+ L +L SL+ L+++ N+LSG+
Sbjct: 446 SINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGR 505
Query: 431 VPDFGSNVKFTVSPGNPFIGT--NVDTTPGGAGTPGSKPSGPSGSPAASSKSKLSVGTIV 488
VP G N G G PG + GP S +K ++ G V
Sbjct: 506 VP--------AALGGRLLHRASFNFTDNAGLCGIPGLRACGPHLS--VGAKIGIAFGVSV 555
Query: 489 AIVVVVV 495
A + +V+
Sbjct: 556 AFLFLVI 562
|
Length = 623 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 7e-14
Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 51/204 (25%)
Query: 579 VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRM---ESNTMGNKGLSEFQAEIAVLT 634
V + + +G G +G+V P G K+A+K++ E T + L E I +L
Sbjct: 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLRE----IKILR 58
Query: 635 KVRHRHLVALLGYCINGS-----ERLLVYEYMP----RGTLAQHLFEWHDHG----YTPL 681
+ +H +++ +L S + +V E M + QHL DH Y L
Sbjct: 59 RFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSN--DHIQYFLYQIL 116
Query: 682 TWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA-PDG 740
RG++Y+HS + +HRDLKPSN+L+ + K+ DFGL + A P+
Sbjct: 117 -------------RGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160
Query: 741 KYS------VETRLAGTFGYLAPE 758
++ V TR Y APE
Sbjct: 161 DHTGFLTEYVATRW-----YRAPE 179
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 49/178 (27%), Positives = 87/178 (48%), Gaps = 8/178 (4%)
Query: 582 NFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
+F LG+G +G VY + L D A+K ++ +M K + EI +L V H +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYL 700
+++ ++G++ +V EY P G L++ + + + ++ I + + RG++ L
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKR-KLIPEQEIWRIFIQLLRGLQAL 119
Query: 701 HSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
H Q +HRDLK +NIL+ + K+ D G+ K + GT Y+APE
Sbjct: 120 HE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI---GTPHYMAPE 171
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 7e-14
Identities = 63/184 (34%), Positives = 81/184 (44%), Gaps = 22/184 (11%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKI-AVKRMESN-TMGNKGLSEFQAEIAVLTKVRH 638
D+F LG G FG V K A+K + + K + E +L +RH
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQ----RVTIALDVA 694
LV L G + S LV EY+P G L HL G P + +V +AL
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL---RKSGRFPEPVARFYAAQVVLAL--- 114
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGY 754
EYLHSL ++RDLKP N+L+ D K+ DFG K Y+ L GT Y
Sbjct: 115 ---EYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYT----LCGTPEY 164
Query: 755 LAPE 758
LAPE
Sbjct: 165 LAPE 168
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 7e-14
Identities = 50/170 (29%), Positives = 85/170 (50%), Gaps = 10/170 (5%)
Query: 589 LGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYC 648
LG G FG V+ TK+AVK M+ +M + F AE V+ ++H LV L
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKL-HAV 69
Query: 649 INGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSF 708
+ ++ E+M +G+L L + + PL + + + +A G+ ++ Q+++
Sbjct: 70 VTKEPIYIITEFMAKGSLLDFL-KSDEGSKQPL--PKLIDFSAQIAEGMAFIE---QRNY 123
Query: 709 IHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
IHRDL+ +NIL+ + K+ADFGL + D +Y+ + APE
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 173
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 8e-14
Identities = 54/164 (32%), Positives = 75/164 (45%), Gaps = 12/164 (7%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKI-AVKRMESNTMGNKG-LSEFQAEIAVLTKVRH 638
D+F ++GRG FG V+ D ++ A+K + + M + ++ +AE +L
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 639 RHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697
+V L Y E L LV EYMP G L L P + L +A
Sbjct: 61 PWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLI---RKDVFPEETARFYIAELVLA--- 113
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK 741
L S+ + FIHRD+KP NILI D K+ADFGL K K
Sbjct: 114 --LDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 9e-14
Identities = 55/177 (31%), Positives = 84/177 (47%), Gaps = 17/177 (9%)
Query: 589 LGRGGFGVVYG------GELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
LG+GGFG V G+L K+ KR++ KG E +L KV R +V
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKR----KGYEGAMVEKRILAKVHSRFIV 56
Query: 643 ALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHS 702
+L ++ LV M G L H++ D + + G+E+LH
Sbjct: 57 SLAYAFQTKTDLCLVMTIMNGGDLRYHIYNV-DEENPGFPEPRACFYTAQIISGLEHLH- 114
Query: 703 LAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR-LAGTFGYLAPE 758
Q+ I+RDLKP N+L+ +D +++D GL DG+ +T+ AGT G++APE
Sbjct: 115 --QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTKGYAGTPGFMAPE 167
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 9e-14
Identities = 53/184 (28%), Positives = 92/184 (50%), Gaps = 21/184 (11%)
Query: 588 ILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKG-------LSEFQAEIAVLTKVRHR 639
++G G FG VY G G +AVK++E ++ L EIA+L +++H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
++V LG ++ + EY+P G++A L +++G T + + +G+ Y
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALL---NNYGAFEETLVR--NFVRQILKGLNY 121
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR-----LAGTFGY 754
LH+ + IHRD+K +NIL+ + K++DFG+ K S +T L G+ +
Sbjct: 122 LHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 755 LAPE 758
+APE
Sbjct: 179 MAPE 182
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 50/184 (27%), Positives = 87/184 (47%), Gaps = 24/184 (13%)
Query: 588 ILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQ--------AEIAVLTKVRH 638
++G+G +G VY + G +AVK++E Q +EI L + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 639 RHLVALLGYCINGSERLLVY-EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIAL--DVAR 695
++V LG E L ++ EY+P G++ L T +++++ V
Sbjct: 68 LNIVQYLG-FETTEEYLSIFLEYVPGGSIGSCL-------RTYGRFEEQLVRFFTEQVLE 119
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVE-TRLAGTFGY 754
G+ YLHS + +HRDLK N+L+ D K++DFG+ K + D + + + G+ +
Sbjct: 120 GLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFW 176
Query: 755 LAPE 758
+APE
Sbjct: 177 MAPE 180
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 54/176 (30%), Positives = 81/176 (46%), Gaps = 12/176 (6%)
Query: 589 LGRGGFGVVYGGELPDGTKIA---VKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
+G G FG V GE G A VK + ++ ++ L F E+ ++ H +++ L
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLL-FLQEVQPYRELNHPNVLQCL 61
Query: 646 GYCINGSERLLVYEYMPRGTLAQHLFEWHDH--GYTPLTWKQRVTIALDVARGVEYLHSL 703
G CI LLV E+ P G L +L QR +A +VA G+ +LH
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQR--MACEVASGLLWLH-- 117
Query: 704 AQQSFIHRDLKPSNILIGDDMRAKVADFGL-VKNAPDGKYSVETRLAGTFGYLAPE 758
Q FIH DL N + D+ K+ D+GL ++ P+ Y + A +LAPE
Sbjct: 118 -QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPE 172
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 55/187 (29%), Positives = 89/187 (47%), Gaps = 24/187 (12%)
Query: 577 RQVTDNFSEANILGRGGFGVV-YGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTK 635
R+ D+F + +G G G+V E G ++AVK+M+ + L E+ ++
Sbjct: 21 REYLDSFIK---IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRREL--LFNEVVIMRD 75
Query: 636 VRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR 695
H ++V + + G E +V E++ G L + +T + +Q T+ L V R
Sbjct: 76 YHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIV------THTRMNEEQIATVCLSVLR 129
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV----KNAPDGKYSVETRLAGT 751
+ YLH+ Q IHRD+K +IL+ D R K++DFG K P K L GT
Sbjct: 130 ALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK-----SLVGT 181
Query: 752 FGYLAPE 758
++APE
Sbjct: 182 PYWMAPE 188
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 59/191 (30%), Positives = 91/191 (47%), Gaps = 25/191 (13%)
Query: 581 DNFSEANILGRGGFGVV-----YGGELPDGT-KIAVKRMESNTMGNKGLSEFQA---EIA 631
+N S LG G FG V YG D K+AVK ++ SE +A E+
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH----SSEREALMSELK 90
Query: 632 VLTKV-RHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIA 690
+++ + H ++V LLG C G L++ EY G L L + LT + ++ +
Sbjct: 91 IMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL---RRKRESFLTLEDLLSFS 147
Query: 691 LDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN-APDGKYSVE--TR 747
VA+G+ +L A ++ IHRDL N+L+ K+ DFGL ++ D Y V+ R
Sbjct: 148 YQVAKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNAR 204
Query: 748 LAGTFGYLAPE 758
L ++APE
Sbjct: 205 LP--VKWMAPE 213
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 3e-13
Identities = 51/178 (28%), Positives = 92/178 (51%), Gaps = 14/178 (7%)
Query: 583 FSEANILGRGGFGVVYGGELPDGTK--IAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
F++ +G+G FG VY G + + TK +A+K ++ ++ + + Q EI VL++ +
Sbjct: 6 FTKLERIGKGSFGEVYKG-IDNRTKEVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPY 63
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYL 700
+ G + G++ ++ EY+ G+ L PL TI ++ +G++YL
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP------GPLEETYIATILREILKGLDYL 117
Query: 701 HSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
HS + IHRD+K +N+L+ + K+ADFG+ D + T GT ++APE
Sbjct: 118 HS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPE 171
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 44/153 (28%), Positives = 77/153 (50%), Gaps = 10/153 (6%)
Query: 581 DNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHR 639
+++ +G G +G VY ++ G +A+K + G+ Q EI++L + RH
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIK-VIKLEPGD-DFEIIQQEISMLKECRHP 60
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
++VA G + + +V EY G+L + + PL+ Q + + +G+ Y
Sbjct: 61 NIVAYFGSYLRRDKLWIVMEYCGGGSLQ----DIYQVTRGPLSELQIAYVCRETLKGLAY 116
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732
LH + IHRD+K +NIL+ +D K+ADFG
Sbjct: 117 LH---ETGKIHRDIKGANILLTEDGDVKLADFG 146
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 49/165 (29%), Positives = 79/165 (47%), Gaps = 22/165 (13%)
Query: 588 ILGRGGFGVVYGG-ELPDGTKI----AVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
+LG G FG V+ G +P+G I A+K ++ + G + E + + + H ++V
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLDHAYIV 72
Query: 643 ALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTP---LTWKQRVTIALDVARGVEY 699
LLG C G+ LV + P G+L H+ + H P L W + +A+G+ Y
Sbjct: 73 RLLGIC-PGASLQLVTQLSPLGSLLDHVRQ-HRDSLDPQRLLNW------CVQIAKGMYY 124
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP--DGKY 742
L + +HR+L NIL+ D ++ADFG+ D KY
Sbjct: 125 LE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKY 166
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 49/182 (26%), Positives = 81/182 (44%), Gaps = 16/182 (8%)
Query: 582 NFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
+F N +G+G FGVV+ D A+K+++ + M + E E VL K+ +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLT----WKQRVTIALDVARG 696
++ ++ + +V EY G L + L PL W+ + I L G
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLL---KMQRGRPLPEDQVWRFFIQILL----G 113
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLA 756
+ +LHS + +HRD+K N+ + K+ D G+ K D T + GT YL+
Sbjct: 114 LAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGTPYYLS 169
Query: 757 PE 758
PE
Sbjct: 170 PE 171
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 48/178 (26%), Positives = 92/178 (51%), Gaps = 14/178 (7%)
Query: 583 FSEANILGRGGFGVVYGGELPDGTK--IAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
F++ +G+G FG V+ G + + T+ +A+K ++ ++ + + Q EI VL++ +
Sbjct: 6 FTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPY 63
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYL 700
+ G + G++ ++ EY+ G+ L P Q T+ ++ +G++YL
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA------GPFDEFQIATMLKEILKGLDYL 117
Query: 701 HSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
HS + IHRD+K +N+L+ + K+ADFG+ D + T GT ++APE
Sbjct: 118 HS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPE 171
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 5e-13
Identities = 47/163 (28%), Positives = 85/163 (52%), Gaps = 15/163 (9%)
Query: 588 ILGRGGFGVVYGGELPDGTK----IAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVA 643
++G G FG V G L K +A+K +++ K +F +E +++ + H +++
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIH 69
Query: 644 LLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSL 703
L G ++V EYM G+L L + HD +T + Q V + +A G++YL
Sbjct: 70 LEGVVTKSKPVMIVTEYMENGSLDAFLRK-HDGQFTVI---QLVGMLRGIASGMKYL--- 122
Query: 704 AQQSFIHRDLKPSNILIGDDMRAKVADFGL---VKNAPDGKYS 743
+ ++HRDL NIL+ ++ KV+DFGL +++ P+ Y+
Sbjct: 123 SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT 165
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 5e-13
Identities = 49/155 (31%), Positives = 73/155 (47%), Gaps = 18/155 (11%)
Query: 588 ILGRGGFGVVYGG-ELPDGTKI----AVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
+LG G FG VY G +PDG + A+K + NT K E E V+ V ++
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVC 72
Query: 643 ALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDH--GYTPLTWKQRVTIALDVARGVEYL 700
LLG C+ + +L V + MP G L ++ E D L W + +A+G+ YL
Sbjct: 73 RLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYL 125
Query: 701 HSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735
+ +HRDL N+L+ K+ DFGL +
Sbjct: 126 EEV---RLVHRDLAARNVLVKSPNHVKITDFGLAR 157
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 6e-13
Identities = 49/188 (26%), Positives = 85/188 (45%), Gaps = 22/188 (11%)
Query: 589 LGRGGFGVVYGGEL-----PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVA 643
LG FG +Y G L +A+K ++ + EFQ E +++ ++ H ++V
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQ-WGEFQQEASLMAELHHPNIVC 71
Query: 644 LLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHG------------YTPLTWKQRVTIAL 691
LLG +++EY+ +G L + L H + L + IA+
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 692 DVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK-YSVETRLAG 750
+A G+EYL + F+H+DL NILIG+ + K++D GL + Y V+ +
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 751 TFGYLAPE 758
++ PE
Sbjct: 189 PIRWMPPE 196
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 6e-13
Identities = 48/165 (29%), Positives = 72/165 (43%), Gaps = 19/165 (11%)
Query: 605 GTKIAVKRM-ESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL-VYEYMP 662
G ++A+K + + F+ E A+ ++ H ++VALL L V+EY+P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 663 RGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI-- 720
TL + L G L + + L V + H+ Q +HRDLKP NI++
Sbjct: 63 GRTLREVL---AADG--ALPAGETGRLMLQVLDALACAHN---QGIVHRDLKPQNIMVSQ 114
Query: 721 -GDDMRAKVADFGLVKNAPDGKYSVETRLA------GTFGYLAPE 758
G AKV DFG+ P + + L GT Y APE
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE 159
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 8e-13
Identities = 48/156 (30%), Positives = 74/156 (47%), Gaps = 9/156 (5%)
Query: 589 LGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY 647
+GRG FG V+ G L D T +AVK T+ ++F E +L + H ++V L+G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCR-ETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 648 CINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS 707
C +V E + G L L K+ + + + A G+EYL S +
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFLRTEGPR----LKVKELIQMVENAAAGMEYLES---KH 114
Query: 708 FIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743
IHRDL N L+ + K++DFG+ + DG Y+
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA 150
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 52/179 (29%), Positives = 83/179 (46%), Gaps = 24/179 (13%)
Query: 588 ILGRGGFGVVYGGELPD-GTKIAVKRM---ESNTMGNKGLSEFQAEIAVLTKVRHRHLVA 643
++G G +G+V + + G +A+K+ E + M K EI +L ++RH +LV
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR---EIRMLKQLRHENLVN 64
Query: 644 LLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSL 703
L+ LV+E++ L E + +G ++ + RG+E+ HS
Sbjct: 65 LIEVFRRKKRLYLVFEFVDHTVLDD--LEKYPNGLDESRVRK---YLFQILRGIEFCHS- 118
Query: 704 AQQSFIHRDLKPSNILIGDDMRAKVADFGLVK--NAPDGKYS--VETRLAGTFGYLAPE 758
+ IHRD+KP NIL+ K+ DFG + AP Y+ V TR Y APE
Sbjct: 119 --HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRW-----YRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 1e-12
Identities = 48/176 (27%), Positives = 85/176 (48%), Gaps = 10/176 (5%)
Query: 583 FSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
F++ +G+G FG V+ G K+ ++ + + Q EI VL++ ++
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 643 ALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHS 702
G + ++ ++ EY+ G+ A L E PL Q TI ++ +G++YLHS
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGS-ALDLLE-----PGPLDETQIATILREILKGLDYLHS 119
Query: 703 LAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
+ IHRD+K +N+L+ + K+ADFG+ D + GT ++APE
Sbjct: 120 ---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RNTFVGTPFWMAPE 171
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 50/173 (28%), Positives = 81/173 (46%), Gaps = 15/173 (8%)
Query: 589 LGRGGFGVVYGGELPD-GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY 647
LG G FG VY + + G A K ++ + L +F EI +L++ +H ++V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEE--LEDFMVEIDILSECKHPNIVGLYEA 70
Query: 648 CINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS 707
++ ++ E+ G L + E LT Q + + + +LHS
Sbjct: 71 YFYENKLWILIEFCDGGALDSIMLELE----RGLTEPQIRYVCRQMLEALNFLHS---HK 123
Query: 708 FIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR--LAGTFGYLAPE 758
IHRDLK NIL+ D K+ADFG+ + K +++ R GT ++APE
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGV---SAKNKSTLQKRDTFIGTPYWMAPE 173
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 52/172 (30%), Positives = 84/172 (48%), Gaps = 15/172 (8%)
Query: 589 LGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY 647
+G+G G VY ++ G ++A+K+M K L EI V+ + +H ++V L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKEL--IINEILVMRENKHPNIVNYLDS 84
Query: 648 CINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS 707
+ G E +V EY+ G+L + E T + Q + + + +E+LHS
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHS---NQ 135
Query: 708 FIHRDLKPSNILIGDDMRAKVADFGLVKN-APDGKYSVETRLAGTFGYLAPE 758
IHRD+K NIL+G D K+ DFG P+ S + + GT ++APE
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 47/186 (25%), Positives = 80/186 (43%), Gaps = 24/186 (12%)
Query: 582 NFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
+ + ++GRG FG+V+ D + +K++ M Q E VL + H +
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY- 699
++ + ++V EY P GTLA+++ ++R LD + +
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYI-------------QKRCNSLLDEDTILHFF 107
Query: 700 ------LHSLAQQSFIHRDLKPSNILIGD-DMRAKVADFGLVKNAPDGKYSVETRLAGTF 752
LH + + +HRDLK NIL+ M K+ DFG+ K S + GT
Sbjct: 108 VQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL--SSKSKAYTVVGTP 165
Query: 753 GYLAPE 758
Y++PE
Sbjct: 166 CYISPE 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 62/175 (35%), Positives = 87/175 (49%), Gaps = 14/175 (8%)
Query: 588 ILGRGGFG-VVYGGELPDGTKIAVKRMESNT-MGNKGLSEFQAEIAVLTK-VRHRHLVAL 644
++G+G FG V+ DG+ AVK ++ T + K + AE VL K ++H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 645 LGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSL 703
Y +E+L V +Y+ G L HL L + R A +VA + YLHSL
Sbjct: 62 -HYSFQTAEKLYFVLDYVNGGELFFHL----QRERCFLEPRARF-YAAEVASAIGYLHSL 115
Query: 704 AQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
+ I+RDLKP NIL+ + DFGL K + + + T GT YLAPE
Sbjct: 116 ---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 57/178 (32%), Positives = 87/178 (48%), Gaps = 23/178 (12%)
Query: 589 LGRGGFGVVYGG-ELPDGTKIAVK--RMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
+G G +GVVY + G +A+K R+E+ G S EI++L ++ H ++V LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVP--STAIREISLLKELNHPNIVRLL 64
Query: 646 GYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIA---LDVARGVEYLHS 702
+ ++ LV+E+ L L ++ D +PLT I + +G+ Y HS
Sbjct: 65 DVVHSENKLYLVFEF-----LDLDLKKYMDS--SPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 703 LAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK--NAPDGKYSVETRLAGTFGYLAPE 758
+HRDLKP N+LI + K+ADFGL + P Y+ E T Y APE
Sbjct: 118 ---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV---TLWYRAPE 169
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 57/174 (32%), Positives = 85/174 (48%), Gaps = 17/174 (9%)
Query: 589 LGRGGFGVVYGGELPD-GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY 647
LG G FG VY + + G A K +E T + L ++ EI +L H ++V LLG
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIE--TKSEEELEDYMVEIEILATCNHPYIVKLLGA 77
Query: 648 CINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS 707
+ ++ E+ P G + + E D G LT Q I + ++YLHS+
Sbjct: 78 FYWDGKLWIMIEFCPGGAVDAIMLEL-DRG---LTEPQIQVICRQMLEALQYLHSM---K 130
Query: 708 FIHRDLKPSNILIGDDMRAKVADFGL-VKNAPDGKYSVETR--LAGTFGYLAPE 758
IHRDLK N+L+ D K+ADFG+ KN +++ R GT ++APE
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK----TLQRRDSFIGTPYWMAPE 180
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 56/187 (29%), Positives = 79/187 (42%), Gaps = 28/187 (14%)
Query: 581 DNFSEANILGRGGFGVVY-GGELPDGTKIAVKRME-SNTMGNKGLSEFQAEIAVLTKVRH 638
D+ +G G FG V+ + A+K M + K E VL +V H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 639 RHLVALLGYCINGSERLL--VYEYMPRGTLAQHL-----FEWHDHGYTPLTWKQRVTIAL 691
++ L + +R L + EY+P G L +L F T L + + AL
Sbjct: 61 PFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFS----NSTGLFYASEIVCAL 114
Query: 692 DVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGT 751
EYLHS ++RDLKP NIL+ + K+ DFG K D ++ L GT
Sbjct: 115 ------EYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT----LCGT 161
Query: 752 FGYLAPE 758
YLAPE
Sbjct: 162 PEYLAPE 168
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 53/191 (27%), Positives = 92/191 (48%), Gaps = 24/191 (12%)
Query: 577 RQVTDNFSEANILGRGGFGVV-YGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTK 635
R + +N+ + +G G G+V E G ++AVK M+ + L E+ ++
Sbjct: 20 RSLLENYIK---IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRREL--LFNEVVIMRD 74
Query: 636 VRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR 695
+H+++V + + G E ++ E++ G L + + T L +Q T+ V +
Sbjct: 75 YQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ------TRLNEEQIATVCESVLQ 128
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG----LVKNAPDGKYSVETRLAGT 751
+ YLHS Q IHRD+K +IL+ D R K++DFG + K+ P K L GT
Sbjct: 129 ALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK-----SLVGT 180
Query: 752 FGYLAPEYAGK 762
++APE +
Sbjct: 181 PYWMAPEVISR 191
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 54/192 (28%), Positives = 88/192 (45%), Gaps = 34/192 (17%)
Query: 581 DNFSEANILGRGGFGVVY-GGELPDGTKIAVKR--MESNTMGNKGLSEFQA----EIAVL 633
D + + N + G +GVVY + G +A+K+ ME G F EI +L
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG------FPITSLREINIL 58
Query: 634 TKVRHRHLVAL----LGYCINGSERLLVYEYMPRGTLAQH-LFEWHDHGYTPLTWKQRVT 688
K++H ++V + +G ++ + +V EY+ +H L + P +
Sbjct: 59 LKLQHPNIVTVKEVVVGSNLD--KIYMVMEYV------EHDLKSLMETMKQPFLQSEVKC 110
Query: 689 IALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK--NAPDGKYSVET 746
+ L + GV +LH +HRDLK SN+L+ + K+ DFGL + +P Y T
Sbjct: 111 LMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY---T 164
Query: 747 RLAGTFGYLAPE 758
+L T Y APE
Sbjct: 165 QLVVTLWYRAPE 176
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 53/180 (29%), Positives = 82/180 (45%), Gaps = 28/180 (15%)
Query: 589 LGRGGFGVVYGGELPD-GTKIAVKRM---ESNTMGNK-GLSEFQAEIAVLTKVRHRHLVA 643
+G G +GVV+ + G +A+K+ E + + K L E I +L +++H +LV
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALRE----IRMLKQLKHPNLVN 64
Query: 644 LLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHS 702
L+ +L LV+EY L + E + G K+ I + V + H
Sbjct: 65 LI-EVFRRKRKLHLVFEYCDHTVL--NELEKNPRGVPEHLIKK---IIWQTLQAVNFCH- 117
Query: 703 LAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK--NAPDGKYS--VETRLAGTFGYLAPE 758
+ + IHRD+KP NILI + K+ DFG + P Y+ V TR Y APE
Sbjct: 118 --KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRW-----YRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 47/175 (26%), Positives = 77/175 (44%), Gaps = 13/175 (7%)
Query: 588 ILGRGGFGVVYGG--ELPDGTKI--AVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVA 643
+G G FG VY G P+ KI AVK ++ T + +F E ++ + H H+V
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVR-EKFLQEAYIMRQFDHPHIVK 71
Query: 644 LLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSL 703
L+G + +V E P G L +L L + + ++ + YL S
Sbjct: 72 LIGVITE-NPVWIVMELAPLGELRSYLQVNKYS----LDLASLILYSYQLSTALAYLES- 125
Query: 704 AQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
+ F+HRD+ N+L+ K+ DFGL + D Y ++ ++APE
Sbjct: 126 --KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE 178
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 56/183 (30%), Positives = 86/183 (46%), Gaps = 19/183 (10%)
Query: 582 NFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
NF + +G G +GVVY G +A+K++ +T S EI++L ++ H +
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDH---GYTPLTWKQRVTIALDVARGV 697
+V LL ++ LV+E+ L Q L ++ D PL + L +G+
Sbjct: 61 IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASPLSGIPLPLIKSYLFQL--LQGL 113
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK--NAPDGKYSVETRLAGTFGYL 755
+ HS +HRDLKP N+LI + K+ADFGL + P Y+ E T Y
Sbjct: 114 AFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV---TLWYR 167
Query: 756 APE 758
APE
Sbjct: 168 APE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 4e-12
Identities = 43/150 (28%), Positives = 79/150 (52%), Gaps = 12/150 (8%)
Query: 588 ILGRGGFGVVYGGEL-PDGTK---IAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVA 643
++G G FG V G L G + +A+K ++S K +F +E +++ + H +++
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 644 LLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSL 703
L G +++ E+M G L L +D +T + Q V + +A G++YL
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFL-RQNDGQFTVI---QLVGMLRGIAAGMKYL--- 122
Query: 704 AQQSFIHRDLKPSNILIGDDMRAKVADFGL 733
++ +++HRDL NIL+ ++ KV+DFGL
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGL 152
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 60/175 (34%), Positives = 83/175 (47%), Gaps = 14/175 (8%)
Query: 588 ILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKG-LSEFQAEIAVLTK-VRHRHLVAL 644
++G+G FG V DG AVK ++ + K AE VL K V+H LV L
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 645 LGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSL 703
Y +++L V +Y+ G L HL + P + R A ++A + YLHSL
Sbjct: 62 -HYSFQTADKLYFVLDYVNGGELFFHL-QRERSFPEP---RARF-YAAEIASALGYLHSL 115
Query: 704 AQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
+ I+RDLKP NIL+ + DFGL K + + T GT YLAPE
Sbjct: 116 ---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-FCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 52/187 (27%), Positives = 89/187 (47%), Gaps = 24/187 (12%)
Query: 577 RQVTDNFSEANILGRGGFGVV-YGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTK 635
R DNF + +G G G+V + G ++AVK+M+ + L E+ ++
Sbjct: 18 RSYLDNFVK---IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRREL--LFNEVVIMRD 72
Query: 636 VRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR 695
+H ++V + + G E +V E++ G L + +T + +Q T+ L V +
Sbjct: 73 YQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIV------THTRMNEEQIATVCLAVLK 126
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVET----RLAGT 751
+ +LH+ Q IHRD+K +IL+ D R K++DFG + S E L GT
Sbjct: 127 ALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFC-----AQVSKEVPRRKSLVGT 178
Query: 752 FGYLAPE 758
++APE
Sbjct: 179 PYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 5e-12
Identities = 41/179 (22%), Positives = 77/179 (43%), Gaps = 10/179 (5%)
Query: 582 NFSEANILGRGGFG--VVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHR 639
++ +LG+G FG +Y D + + K + + K + EI +L+ ++H
Sbjct: 1 HYIPIRVLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHP 59
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
+++A + ++ + L+ EY GTL + + + + V Y
Sbjct: 60 NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKG---QLFEEEMVLWYLFQIVSAVSY 116
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
+H + +HRD+K NI + K+ DFG+ K ET + GT Y++PE
Sbjct: 117 IH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPE 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 6e-12
Identities = 58/176 (32%), Positives = 80/176 (45%), Gaps = 22/176 (12%)
Query: 589 LGRGGFGVVYGGELPDGTKI-AVKRMESNTMGNKG-LSEFQAEIAVLTKVRHRHLVALLG 646
+G+GG+G V+ + D +I A+KRM+ + + + E +LT + LV LL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL- 67
Query: 647 YCINGSERL-LVYEYMPRG---TLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHS 702
Y E L L EY+P G TL +L + R +A V+ LH
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSED-------HARFYMAEMFE-AVDALHE 119
Query: 703 LAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
L +IHRDLKP N LI K+ DFGL K SV G+ Y+APE
Sbjct: 120 LG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV----VGSPDYMAPE 168
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 51/160 (31%), Positives = 75/160 (46%), Gaps = 14/160 (8%)
Query: 582 NFSEANILGRGGFGVVYGGELPD-GTKIAVKRME---SNTMGNKGLSEFQAEIAVLTKVR 637
N+ +LGRG FG VY D G ++AVK++ + +K ++ + EI +L +R
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 638 HRHLVALLGYCINGSERLL--VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR 695
H +V G + E+ L EYMP G++ L Y LT + +
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL-----KAYGALTENVTRRYTRQILQ 117
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735
GV YLHS +HRD+K +NIL K+ DFG K
Sbjct: 118 GVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 7e-12
Identities = 59/181 (32%), Positives = 87/181 (48%), Gaps = 23/181 (12%)
Query: 588 ILGRGGFGVVYGGELPDGT---KI-AVKRMESNTM--GNKGLSEFQAEIAVLTKVRHRHL 641
+LG+GG+G V+ G KI A+K ++ T+ K + +AE +L V+H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 642 VALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGY----TPLTWKQRVTIALDVARGV 697
V L+ G + L+ EY+ G L HL G T + +++AL
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHL---EREGIFMEDTACFYLSEISLAL------ 113
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAP 757
E+LH QQ I+RDLKP NIL+ K+ DFGL K + +V GT Y+AP
Sbjct: 114 EHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TVTHTFCGTIEYMAP 169
Query: 758 E 758
E
Sbjct: 170 E 170
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 1e-11
Identities = 52/177 (29%), Positives = 77/177 (43%), Gaps = 22/177 (12%)
Query: 589 LGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSE-FQAEIAVLTKVRHRHLVALLG 646
LG GGFG V ++ A+K ++ + G E +E +L + H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 647 YCINGSERLLVY---EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSL 703
++ +Y EY G L L D G + R IA V EYLH+
Sbjct: 61 TF---KDKKYIYMLMEYCLGGELWTIL---RDRGLFD-EYTARFYIAC-VVLAFEYLHN- 111
Query: 704 AQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK--YSVETRLAGTFGYLAPE 758
+ I+RDLKP N+L+ + K+ DFG K G+ ++ GT Y+APE
Sbjct: 112 --RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT----FCGTPEYVAPE 162
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 54/183 (29%), Positives = 84/183 (45%), Gaps = 25/183 (13%)
Query: 583 FSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQ---AEIAVLTKVRH 638
F++ +G G FG VY ++ +A+K+M + G + ++Q E+ L ++RH
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYS--GKQSNEKWQDIIKEVRFLQQLRH 74
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
+ + G + LV EY G+ A + E H PL + I +G+
Sbjct: 75 PNTIEYKGCYLREHTAWLVMEYC-LGS-ASDILEVHK---KPLQEVEIAAICHGALQGLA 129
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG---LVKNAPDGKYSVETRLAGTFGYL 755
YLHS + IHRD+K NIL+ + K+ADFG LV A GT ++
Sbjct: 130 YLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPA--------NSFVGTPYWM 178
Query: 756 APE 758
APE
Sbjct: 179 APE 181
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 41/160 (25%), Positives = 69/160 (43%), Gaps = 22/160 (13%)
Query: 587 NILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQA------------EIAVL 633
LG G +G V G +A+K+++ + N + Q E+ ++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 634 TKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDV 693
+++H +++ L+ + G LV + M L + + + LT Q I L +
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVD----RKIRLTESQVKCILLQI 128
Query: 694 ARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733
G+ LH F+HRDL P+NI I K+ADFGL
Sbjct: 129 LNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGL 165
|
Length = 335 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 59/200 (29%), Positives = 88/200 (44%), Gaps = 49/200 (24%)
Query: 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHR 639
D+ LGRG +GVV +P GT +AVKR+ + V ++ + R
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRAT---------------VNSQEQKR 45
Query: 640 HLVALLGYCINGSERLLVYEYMPR--GTLAQHLFEW-----------------HDHGYTP 680
L+ L + S R + Y G L + W +D G
Sbjct: 46 LLMDL-----DISMRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKG--- 97
Query: 681 LTWKQRV--TIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738
LT + + IA+ + + +EYLHS + S IHRD+KPSN+LI + + K+ DFG+
Sbjct: 98 LTIPEDILGKIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155
Query: 739 DGKYSVETRLAGTFGYLAPE 758
D +T AG Y+APE
Sbjct: 156 DS--VAKTIDAGCKPYMAPE 173
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-11
Identities = 52/151 (34%), Positives = 74/151 (49%), Gaps = 18/151 (11%)
Query: 591 RGGFGVVYGGELPDGTKI-AVKRMESNTMGNKGL-SEFQAEIAVLTKVRHRHLVALLGYC 648
RG FG VY G + +K+ AVK ++ M NK + + QAE L + +V L
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73
Query: 649 INGSERLLVYEYMPRGTLAQHLFEWHDHGY----TPLTWKQRVTIALDVARGVEYLHSLA 704
+ + LV EY+ G + L H +GY + + V +ALD YLH
Sbjct: 74 QSANNVYLVMEYLIGGDVKSLL---HIYGYFDEEMAVKYISEVALALD------YLH--- 121
Query: 705 QQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735
+ IHRDLKP N+LI ++ K+ DFGL K
Sbjct: 122 RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 49/160 (30%), Positives = 74/160 (46%), Gaps = 14/160 (8%)
Query: 582 NFSEANILGRGGFGVVYGGELPD-GTKIAVKRMESNTMG---NKGLSEFQAEIAVLTKVR 637
N+ +LG+G FG VY D G ++AVK+++ + +K ++ + EI +L +
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 638 HRHLVALLGYCINGSERLL--VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR 695
H +V G + ER L E+MP G++ L Y LT +
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-----KSYGALTENVTRKYTRQILE 117
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735
GV YLHS +HRD+K +NIL K+ DFG K
Sbjct: 118 GVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 56/206 (27%), Positives = 84/206 (40%), Gaps = 43/206 (20%)
Query: 580 TDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGN-KGLSEFQA--EIAVLTK 635
++ LG G FG VY ++ G +A+K++ M N K A EI +L K
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKI---LMHNEKDGFPITALREIKILKK 63
Query: 636 VRHRHLVALLGYCINGSE-----RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVT-- 688
++H ++V L+ + + R VY P + DH + L V
Sbjct: 64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTP----------YMDHDLSGLLENPSVKLT 113
Query: 689 ------IALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK----NAP 738
L + G+ YLH + +HRD+K +NILI + K+ADFGL + P
Sbjct: 114 ESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPP 170
Query: 739 DGKYSVE------TRLAGTFGYLAPE 758
+ K T L T Y PE
Sbjct: 171 NPKGGGGGGTRKYTNLVVTRWYRPPE 196
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 54/181 (29%), Positives = 79/181 (43%), Gaps = 11/181 (6%)
Query: 581 DNFSEANILGRGGFGVVY-GGELPDGTKIAVKRM-ESNTMGNKGLSEFQAEIAVLTKVRH 638
+F +++GRG FG V E G A+K M +S + + +S F+ E +L+
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 639 RHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697
+ L Y + L LV EY P G L L + D + +A V
Sbjct: 61 PWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDM-------AQFYLAELV 112
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAP 757
+HS+ Q ++HRD+KP N+LI K+ADFG K GT Y+AP
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAP 172
Query: 758 E 758
E
Sbjct: 173 E 173
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 55/169 (32%), Positives = 86/169 (50%), Gaps = 14/169 (8%)
Query: 581 DNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHR 639
D++ + LG G + VY G+ +G +A+K + + + E ++L ++H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHA 63
Query: 640 HLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
++V LL I+ E L LV+EY+ L Q++ + H G P K + RG+
Sbjct: 64 NIV-LLHDIIHTKETLTLVFEYV-HTDLCQYM-DKHPGGLHPENVK---LFLFQLLRGLS 117
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL--VKNAPDGKYSVE 745
Y+H Q+ +HRDLKP N+LI D K+ADFGL K+ P YS E
Sbjct: 118 YIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNE 163
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 5e-11
Identities = 54/176 (30%), Positives = 83/176 (47%), Gaps = 12/176 (6%)
Query: 589 LGRGGFGVVYGGELPDG---TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
+G G FG V GE+ G ++ VK + + + +F E ++H +L+ L
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSA-SVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 646 GYCINGSERLLVYEYMPRGTLAQHLFEWHD-HGYTP-LTWKQRVTIALDVARGVEYLHSL 703
G C + LLV E+ P G L +L TP T QR +A ++A G+ +LH
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQR--MACEIALGLLHLH-- 117
Query: 704 AQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVET-RLAGTFGYLAPE 758
+ +FIH DL N L+ D+ K+ D+GL N Y V +L ++APE
Sbjct: 118 -KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPE 172
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 5e-11
Identities = 54/185 (29%), Positives = 86/185 (46%), Gaps = 20/185 (10%)
Query: 578 QVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV 636
++T+ + + +G G FG+V + G +A+K++ E+ +L +
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL 66
Query: 637 RHRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVT-IALDVA 694
RH ++++L I+ E + V E + GT L PL KQ + +
Sbjct: 67 RHENIISLSDIFISPLEDIYFVTELL--GTDLHRLLT-----SRPLE-KQFIQYFLYQIL 118
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK-NAPDGKYSVETRLAGTFG 753
RG++Y+HS +HRDLKPSNILI ++ K+ DFGL + P V TR
Sbjct: 119 RGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY----- 170
Query: 754 YLAPE 758
Y APE
Sbjct: 171 YRAPE 175
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 6e-11
Identities = 47/160 (29%), Positives = 76/160 (47%), Gaps = 14/160 (8%)
Query: 582 NFSEANILGRGGFGVVY-GGELPDGTKIAVKRME---SNTMGNKGLSEFQAEIAVLTKVR 637
N+ +LG+G FG VY ++ G ++A K+++ + +K +S + EI +L ++
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 638 HRHLVALLGYCINGSERLLV--YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR 695
H +V G + +E+ L EYMP G++ L Y LT +
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL-----KAYGALTESVTRKYTRQILE 117
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735
G+ YLHS +HRD+K +NIL K+ DFG K
Sbjct: 118 GMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 7e-11
Identities = 57/184 (30%), Positives = 77/184 (41%), Gaps = 31/184 (16%)
Query: 588 ILGRGGFGVVYGGE------------LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTK 635
+LGRG FG V E L G IA +ES M K + E
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVES-LMCEKRIFE------TANS 58
Query: 636 VRHRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVA 694
RH LV L C + + V EY G L H+ H ++ + V A V
Sbjct: 59 ERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHI---HTDVFSE---PRAVFYAACVV 111
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGY 754
G++YLH + ++RDLK N+L+ + K+ADFGL K G + GT +
Sbjct: 112 LGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM-GFGDRTSTFCGTPEF 167
Query: 755 LAPE 758
LAPE
Sbjct: 168 LAPE 171
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 7e-11
Identities = 55/204 (26%), Positives = 81/204 (39%), Gaps = 39/204 (19%)
Query: 582 NFSE---ANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR 637
+ SE N +G G G VY P G A+K + N + + EI +L V
Sbjct: 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN-HEDTVRRQICREIEILRDVN 130
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697
H ++V + E ++ E+M G+L + +A + G+
Sbjct: 131 HPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHI-ADEQ--------FLADVARQILSGI 181
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG----LVKNAPDGKYSVETRLAGTFG 753
YLH + +HRD+KPSN+LI K+ADFG L + SV GT
Sbjct: 182 AYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-----GTIA 233
Query: 754 YLAPE-------------YAGKHW 764
Y++PE YAG W
Sbjct: 234 YMSPERINTDLNHGAYDGYAGDIW 257
|
Length = 353 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 9e-11
Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 16/201 (7%)
Query: 559 SDRHLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNT 617
SD + E +S+ ++ F + +G+G G VY ++ G ++A+++M
Sbjct: 1 SDEEILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQ 57
Query: 618 MGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHG 677
K L EI V+ + ++ ++V L + G E +V EY+ G+L + E
Sbjct: 58 QPKKEL--IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----- 110
Query: 678 YTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737
T + Q + + + +E+LHS IHRD+K NIL+G D K+ DFG
Sbjct: 111 -TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166
Query: 738 PDGKYSVETRLAGTFGYLAPE 758
+ S + + GT ++APE
Sbjct: 167 TP-EQSKRSTMVGTPYWMAPE 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 9e-11
Identities = 54/195 (27%), Positives = 83/195 (42%), Gaps = 31/195 (15%)
Query: 581 DNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGL-SEFQAEIAVLTKVRH 638
D + + +G G +G VY + G +A+K+ M +G+ EI++L +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLE-MDEEGIPPTALREISLLQMLSE 59
Query: 639 R-HLVALLGYCI------NGSERL-LVYEYMPRGTLAQHLFEWHDHGY----TPLTWKQR 686
++V LL + NG L LV+EY L L ++ D PL K
Sbjct: 60 SIYIVRLL--DVEHVEEKNGKPSLYLVFEY-----LDSDLKKFMDSNGRGPGRPLPAKTI 112
Query: 687 VTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD-MRAKVADFGLVKN--APDGKYS 743
+ + +GV + H +HRDLKP N+L+ K+AD GL + P Y+
Sbjct: 113 KSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYT 169
Query: 744 VETRLAGTFGYLAPE 758
E T Y APE
Sbjct: 170 HEIV---TLWYRAPE 181
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 54/185 (29%), Positives = 88/185 (47%), Gaps = 26/185 (14%)
Query: 588 ILGRGGFGVVYGGELPDGTKI-AVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVAL-- 644
I+GRGGFG VYG D K+ A+K ++ + K Q E L + LV+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-----QGETLALNERIMLSLVSTGD 55
Query: 645 ------LGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697
+ Y + ++L + + M G L HL + HG + K+ A ++ G+
Sbjct: 56 CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ---HGV--FSEKEMRFYATEIILGL 110
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAP 757
E++H+ + ++RDLKP+NIL+ + +++D GL + K GT GY+AP
Sbjct: 111 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAP 164
Query: 758 EYAGK 762
E K
Sbjct: 165 EVLQK 169
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 50/200 (25%), Positives = 88/200 (44%), Gaps = 39/200 (19%)
Query: 578 QVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRM----ESNTMGNKGLSEFQAEIAV 632
V + +G G +GVV + G K+A+K++ + T+ + L E + +
Sbjct: 2 DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRE----LKI 57
Query: 633 LTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHD----------HGYTPLT 682
L +H +++A+ P G + ++ D H PLT
Sbjct: 58 LRHFKHDNIIAIRDI------------LRPPGADFKDVYVVMDLMESDLHHIIHSDQPLT 105
Query: 683 WKQRVTIAL-DVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK---NAP 738
++ + L + RG++Y+HS + IHRDLKPSN+L+ +D ++ DFG+ + ++P
Sbjct: 106 -EEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161
Query: 739 DGKYSVETRLAGTFGYLAPE 758
T T Y APE
Sbjct: 162 TEHKYFMTEYVATRWYRAPE 181
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 56/189 (29%), Positives = 89/189 (47%), Gaps = 34/189 (17%)
Query: 588 ILGRGGFGVVYGGELPDGTKI-AVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVAL-- 644
I+GRGGFG VYG D K+ A+K ++ + K Q E L + LV+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-----QGETLALNERIMLSLVSTGD 55
Query: 645 ------LGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697
+ Y + ++L + + M G L HL + HG + + A ++ G+
Sbjct: 56 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ---HGV--FSEAEMRFYAAEIILGL 110
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV----KNAPDGKYSVETRLAGTFG 753
E++H+ + ++RDLKP+NIL+ + +++D GL K P SV GT G
Sbjct: 111 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA--SV-----GTHG 160
Query: 754 YLAPEYAGK 762
Y+APE K
Sbjct: 161 YMAPEVLQK 169
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 53/191 (27%), Positives = 89/191 (46%), Gaps = 22/191 (11%)
Query: 577 RQVTDNFSEANILGRGGFGVVYG------GELPDGTKIAVKRMESNTMGNKGLSEFQAEI 630
R ++F +G G +G VY GEL I V ++E + + Q EI
Sbjct: 5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGEL---AAIKVIKLEPG----EDFAVVQQEI 57
Query: 631 AVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIA 690
++ +H ++VA G + + + E+ G+L Q ++ H PL+ Q ++
Sbjct: 58 IMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSL-QDIY----HVTGPLSESQIAYVS 112
Query: 691 LDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAG 750
+ +G+ YLHS + +HRD+K +NIL+ D+ K+ADFG V + G
Sbjct: 113 RETLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFG-VSAQITATIAKRKSFIG 168
Query: 751 TFGYLAPEYAG 761
T ++APE A
Sbjct: 169 TPYWMAPEVAA 179
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 49/171 (28%), Positives = 83/171 (48%), Gaps = 13/171 (7%)
Query: 589 LGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY 647
+G+G G VY ++ G ++A+K+M K L EI V+ + ++ ++V L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKEL--IINEILVMRENKNPNIVNYLDS 84
Query: 648 CINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS 707
+ G E +V EY+ G+L + E T + Q + + + +++LHS
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALDFLHS---NQ 135
Query: 708 FIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
IHRD+K NIL+G D K+ DFG + S + + GT ++APE
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTMVGTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 54/196 (27%), Positives = 82/196 (41%), Gaps = 41/196 (20%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRM---ESNTMGNKGLSEFQAEIAVLTKVR 637
+ E + LG G G V L + I + + N K + E+ + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILR---ELEINKSCK 57
Query: 638 HRHLVALLGYCINGSERLL--VYEYMPRGTLAQHLFEWHDHGYTPLTWK-----QRV--T 688
++V G ++ S + EY G+L D Y + + ++V
Sbjct: 58 SPYIVKYYGAFLDESSSSIGIAMEYCEGGSL--------DSIYKKVKKRGGRIGEKVLGK 109
Query: 689 IALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVE--T 746
IA V +G+ YLHS + IHRD+KPSNIL+ + K+ DFG+ S E
Sbjct: 110 IAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGV---------SGELVN 157
Query: 747 RLAGTFG----YLAPE 758
LAGTF Y+APE
Sbjct: 158 SLAGTFTGTSFYMAPE 173
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 61/205 (29%), Positives = 90/205 (43%), Gaps = 37/205 (18%)
Query: 569 VAISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKI-AVKRMESNTMGNKGLSEFQ 627
A I LR ++F ++GRG FG V ++ A+K + M + S F
Sbjct: 31 AAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFF 90
Query: 628 AEIAVLTKVRHRHLVAL--------LGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGY 678
E R ++A L Y + L +V EYMP G L +L +D
Sbjct: 91 WE--------ERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLV-NLMSNYD--- 138
Query: 679 TPLTWKQ----RVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL- 733
P W + V +ALD +HS+ FIHRD+KP N+L+ K+ADFG
Sbjct: 139 IPEKWARFYTAEVVLALDA------IHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC 189
Query: 734 VKNAPDGKYSVETRLAGTFGYLAPE 758
+K +G +T + GT Y++PE
Sbjct: 190 MKMDANGMVRCDTAV-GTPDYISPE 213
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 53/180 (29%), Positives = 87/180 (48%), Gaps = 12/180 (6%)
Query: 582 NFSEANILGRGGFGVVYGGE-LPDGTKIAVK--RMESNTMGNKGLSEFQAEIAVLTKVRH 638
++++ +G G +GVVY G G +A+K R+ES G S EI++L +++H
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVP--STAIREISLLKELQH 58
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
++V L + S L++E++ L ++L Y + + +G+
Sbjct: 59 PNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYL--YQILQGIL 115
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
+ HS + +HRDLKP N+LI + K+ADFGL + A V T T Y APE
Sbjct: 116 FCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLAR-AFGIPVRVYTHEVVTLWYRAPE 171
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 53/178 (29%), Positives = 82/178 (46%), Gaps = 15/178 (8%)
Query: 583 FSEANILGRGGFGVVY-GGELPDGTKIAVKRME-SNTMGNKGLSEFQAEIAVLTKVRHRH 640
F++ +G G FG VY ++ +A+K+M S N+ + E+ L +++H +
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYL 700
+ G + LV EY G+ A L E H PL + I +G+ YL
Sbjct: 87 SIEYKGCYLREHTAWLVMEYC-LGS-ASDLLEVHK---KPLQEVEIAAITHGALQGLAYL 141
Query: 701 HSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
HS + IHRD+K NIL+ + + K+ADFG A S GT ++APE
Sbjct: 142 HS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIA-----SPANSFVGTPYWMAPE 191
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (153), Expect = 2e-10
Identities = 61/196 (31%), Positives = 82/196 (41%), Gaps = 49/196 (25%)
Query: 587 NILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQA---------EIAVLTKV 636
+G G +GVV G K+A+K++ SN F EI +L +
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKI-SNV--------FDDLIDAKRILREIKLLRHL 56
Query: 637 RHRHLVALLG-YCINGSERL----LVYEYMPRGT-LAQHLFEWHDHGYTPLTWKQRVTIA 690
RH +++ LL E +V E M T L + + PLT
Sbjct: 57 RHENIIGLLDILRPPSPEDFNDVYIVTELME--TDLHKVI-----KSPQPLTDDHIQYFL 109
Query: 691 LDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL---VKNAPDGK-----Y 742
+ RG++YLHS + IHRDLKPSNIL+ + K+ DFGL V D K Y
Sbjct: 110 YQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEY 166
Query: 743 SVETRLAGTFGYLAPE 758
V TR Y APE
Sbjct: 167 -VVTRW-----YRAPE 176
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 48/180 (26%), Positives = 88/180 (48%), Gaps = 15/180 (8%)
Query: 583 FSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH--- 638
+ ++GRG +G VY G +P G +A+K + +T + +S+ Q E+A+L+++R
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD-VSDIQREVALLSQLRQSQP 61
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
++ G + G ++ EY G++ + L + P+ K I +V ++
Sbjct: 62 PNITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMK-----AGPIAEKYISVIIREVLVALK 115
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
Y+H IHRD+K +NIL+ + K+ DFG+ S + GT ++APE
Sbjct: 116 YIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS-SKRSTFVGTPYWMAPE 171
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 51/257 (19%), Positives = 102/257 (39%), Gaps = 18/257 (7%)
Query: 58 TGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQD 117
+ + + + L+ + + +L + +L L+ L N+++ L+N ++L +
Sbjct: 132 PPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSDLPKLLSNLSNLNN 190
Query: 118 IYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFG 177
+ L N + +P + L+ L+ L LS+N + + L+ +L+ L + N N
Sbjct: 191 LDLSGNKISDLPPE-IELLSALEELDLSNNSII---ELLSSLSNLKNLSGLELSN-NKLE 245
Query: 178 LIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQL 237
+P+ + SNL+ L LS NN S+ + + ++++ L ++ L + L L L
Sbjct: 246 DLPESIGNLSNLETLDLS-NNQISSISSLGSLTNLRELDLSGNSLSNALPLIAL---LLL 301
Query: 238 RQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGP 297
L T +L L + ++ N T S P L+I N L
Sbjct: 302 LLELLLNLLLTLKALELKLNSILLNNNILSNGET--------SSPEALSILESLNNLWTL 353
Query: 298 YPLFPSKVQKVSLDHNN 314
+ N
Sbjct: 354 DNALDESNLNRYIVKNP 370
|
Length = 394 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 59/185 (31%), Positives = 96/185 (51%), Gaps = 29/185 (15%)
Query: 589 LGRGGFGVVYGG-ELPDGTK-IAVKRMESNTMGNKG--LSEFQAEIAVLTKVR---HRHL 641
+G G +G V+ +L +G + +A+KR+ T G +G LS + E+AVL + H ++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQT-GEEGMPLSTIR-EVAVLRHLETFEHPNV 66
Query: 642 VALLGYC-INGSER----LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARG 696
V L C ++ ++R LV+E++ + L +L + + G T K + + RG
Sbjct: 67 VRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKD---MMFQLLRG 122
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAG---TFG 753
+++LHS +HRDLKP NIL+ + K+ADFGL + YS + L T
Sbjct: 123 LDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR-----IYSFQMALTSVVVTLW 174
Query: 754 YLAPE 758
Y APE
Sbjct: 175 YRAPE 179
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 43/149 (28%), Positives = 75/149 (50%), Gaps = 10/149 (6%)
Query: 589 LGRGGFGVVYGGEL---PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
+G G FG V E+ ++ VK +++N +K +EF + ++H +++ L
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 646 GYCINGSERLLVYEYMPRGTLAQHLFEWHDH-GYTPLTWKQRVTIALDVARGVEYLHSLA 704
G C+ LLV+EY G L +L + H + L QR +A ++A GV ++H
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR--MACEIAAGVTHMH--- 116
Query: 705 QQSFIHRDLKPSNILIGDDMRAKVADFGL 733
+ +F+H DL N + D+ KV D+G+
Sbjct: 117 KHNFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 3e-10
Identities = 46/159 (28%), Positives = 77/159 (48%), Gaps = 14/159 (8%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKI-AVKRMESNTMGNKG-LSEFQAEIAVLTKVRH 638
D+F ++GRG FG V + D I A+K++ + M K ++ +AE +L + +
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 639 RHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQ-RVTIALDVARG 696
+V L Y L L+ EY+P G + L + T ++ R IA +
Sbjct: 61 PWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMK-----KDTFTEEETRFYIA-ETILA 113
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735
++ +H L +IHRD+KP N+L+ K++DFGL
Sbjct: 114 IDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCT 149
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 52/187 (27%), Positives = 86/187 (45%), Gaps = 24/187 (12%)
Query: 577 RQVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTK 635
R DNF + +G G G+V + G +AVK+M+ + L E+ ++
Sbjct: 19 RTYLDNFIK---IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRREL--LFNEVVIMRD 73
Query: 636 VRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR 695
+H ++V + + G E +V E++ G L + +T + +Q + L V +
Sbjct: 74 YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV------THTRMNEEQIAAVCLAVLK 127
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV----KNAPDGKYSVETRLAGT 751
+ LH+ Q IHRD+K +IL+ D R K++DFG K P K L GT
Sbjct: 128 ALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK-----SLVGT 179
Query: 752 FGYLAPE 758
++APE
Sbjct: 180 PYWMAPE 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 43/167 (25%), Positives = 77/167 (46%), Gaps = 13/167 (7%)
Query: 576 LRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQ-----AEI 630
+ D + +++L G FG ++ G L D + + T+ + SE Q E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD-HASEIQVTLLLQES 59
Query: 631 AVLTKVRHRHLVALLGYCINGSERLLV-YEYMPRGTLAQHLFEWHD---HGYTPLTWKQR 686
+L + H++++ +L CI E V Y YM G L L + + L+ +Q
Sbjct: 60 CLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQL 119
Query: 687 VTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733
V +A+ +A G+ YLH IH+D+ N +I ++++ K+ D L
Sbjct: 120 VHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNAL 163
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 34/211 (16%)
Query: 589 LGRGGFGVVYGGELPDGT---KIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
+GRG +G VY + DG + A+K++E + E IA+L +++H +++AL
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACRE----IALLRELKHPNVIALQ 64
Query: 646 GYCINGSER--LLVYEYMPRGTLAQHLFEWH---DHGYTPLTWKQRVTIAL--DVARGVE 698
++ S+R L+++Y H+ ++H P+ + + +L + G+
Sbjct: 65 KVFLSHSDRKVWLLFDYAEHDLW--HIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 699 YLHSLAQQSFIHRDLKPSNILI----GDDMRAKVADFGLVK--NAPDGKYSVETRLAGTF 752
YLH+ +HRDLKP+NIL+ + R K+AD G + N+P + + TF
Sbjct: 123 YLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 753 GYLAPE--YAGKH-------WMILCQMTGLI 774
Y APE +H W I C L+
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 54/179 (30%), Positives = 82/179 (45%), Gaps = 17/179 (9%)
Query: 583 FSEANILGRGGFGVVY-GGELPDGTKIAVKRME-SNTMGNKGLSEFQAEIAVLTKVRHRH 640
FS+ +G G FG VY ++ + +A+K+M S N+ + E+ L K+RH +
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYL 700
+ G + LV EY G+ A L E H PL + + +G+ YL
Sbjct: 77 TIQYRGCYLREHTAWLVMEYC-LGS-ASDLLEVHK---KPLQEVEIAAVTHGALQGLAYL 131
Query: 701 HSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK-NAPDGKYSVETRLAGTFGYLAPE 758
HS + IHRD+K NIL+ + K+ DFG AP + GT ++APE
Sbjct: 132 HS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF------VGTPYWMAPE 181
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 56/196 (28%), Positives = 87/196 (44%), Gaps = 29/196 (14%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGL---------SEFQAEIA 631
D+F + LG G GVV TK+ + R M K + ++ E+
Sbjct: 1 DDFEKLGELGAGNGGVV--------TKV-LHRPSGLIMARKLIHLEIKPAIRNQIIRELK 51
Query: 632 VLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIAL 691
VL + ++V G + E + E+M G+L Q L + G P +++IA
Sbjct: 52 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK---AGRIPENILGKISIA- 107
Query: 692 DVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGT 751
V RG+ YL + +HRD+KPSNIL+ K+ DFG+ D S+ GT
Sbjct: 108 -VLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGT 161
Query: 752 FGYLAPE-YAGKHWMI 766
Y++PE G H+ +
Sbjct: 162 RSYMSPERLQGTHYTV 177
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 55/166 (33%), Positives = 83/166 (50%), Gaps = 24/166 (14%)
Query: 589 LGRGGFGVVYGGELP-DGTKIAVK--RMESNTMGNKGLSEFQA--EIAVLTKVRHRHLVA 643
LG G + VY G G +A+K R+E +G F A E ++L ++H ++V
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHE----EGAP-FTAIREASLLKDLKHANIV- 66
Query: 644 LLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIAL-DVARGVEYLH 701
L I+ + L LV+EY+ L Q++ + G + V + L + RG+ Y H
Sbjct: 67 TLHDIIHTKKTLTLVFEYLDT-DLKQYM-DDCGGGLSM----HNVRLFLFQLLRGLAYCH 120
Query: 702 SLAQQSFIHRDLKPSNILIGDDMRAKVADFGL--VKNAPDGKYSVE 745
Q+ +HRDLKP N+LI + K+ADFGL K+ P YS E
Sbjct: 121 ---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNE 163
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 7e-10
Identities = 55/189 (29%), Positives = 83/189 (43%), Gaps = 13/189 (6%)
Query: 573 IEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKI-AVKRMESNTMGNKGLSEFQAEIA 631
I LR +++ ++GRG FG V K+ A+K + M + S F E
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 632 VLTKVRHRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIA 690
+ + V L Y L +V EYMP G L + + + V +A
Sbjct: 95 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLA 154
Query: 691 LDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL-VKNAPDGKYSVETRLA 749
LD +HS+ FIHRD+KP N+L+ K+ADFG +K +G +T +
Sbjct: 155 LDA------IHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV- 204
Query: 750 GTFGYLAPE 758
GT Y++PE
Sbjct: 205 GTPDYISPE 213
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 57/163 (34%), Positives = 83/163 (50%), Gaps = 18/163 (11%)
Query: 589 LGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQA--EIAVLTKVRHRHLVALL 645
LG G + VY G +G +A+K + T +G+ F A E ++L ++H ++V LL
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKT--EEGVP-FTAIREASLLKGLKHANIV-LL 68
Query: 646 GYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA 704
I+ E L V+EYM LAQ++ + H G P + + RG+ Y+H
Sbjct: 69 HDIIHTKETLTFVFEYM-HTDLAQYMIQ-HPGGLHPYNVR---LFMFQLLRGLAYIH--- 120
Query: 705 QQSFIHRDLKPSNILIGDDMRAKVADFGLV--KNAPDGKYSVE 745
Q +HRDLKP N+LI K+ADFGL K+ P YS E
Sbjct: 121 GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSE 163
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 7e-10
Identities = 51/159 (32%), Positives = 81/159 (50%), Gaps = 18/159 (11%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKI-AVKRMESNTMGNKG-LSEFQAEIAVLTKVRH 638
++F ++G+G FG V + D KI A+K + + M K L+ +AE VL +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 639 RHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVT---IALDVA 694
+V+L Y ++ L L+ E++P G L L ++ T+ + VT +A +
Sbjct: 61 PWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTMLIKYD-------TFSEDVTRFYMA-ECV 111
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733
+E +H L FIHRD+KP NILI K++DFGL
Sbjct: 112 LAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 57/182 (31%), Positives = 81/182 (44%), Gaps = 29/182 (15%)
Query: 588 ILGRGGFG-VVYGGELPDGTKIAVKRMESNTMGNKG-LSEFQAEIAVLTKVRHRHLVALL 645
+LG+G FG V+ E G A+K + + K ++ E VL RH L AL
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL- 60
Query: 646 GYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR--------G 696
Y +RL V EY G L HL ++RV + AR
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLS------------RERV-FTEERARFYGAEIVSA 107
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLA 756
+EYLHS + ++RD+K N+++ D K+ DFGL K +++T GT YLA
Sbjct: 108 LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLA 163
Query: 757 PE 758
PE
Sbjct: 164 PE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 8e-10
Identities = 57/177 (32%), Positives = 77/177 (43%), Gaps = 22/177 (12%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEI-----AVLTKVRHRHLV 642
+G G G VY G +AVK+M GNK E I VL ++V
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRT--GNK---EENKRILMDLDVVLKSHDCPYIV 77
Query: 643 ALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHS 702
GY I S+ + E M T L + P ++T+A+ V+ LH
Sbjct: 78 KCYGYFITDSDVFICMELM--STCLDKLLKRIQGPI-PEDILGKMTVAI-----VKALHY 129
Query: 703 LAQ-QSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
L + IHRD+KPSNIL+ K+ DFG+ D K +TR AG Y+APE
Sbjct: 130 LKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK--AKTRSAGCAAYMAPE 184
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 8e-10
Identities = 54/189 (28%), Positives = 78/189 (41%), Gaps = 34/189 (17%)
Query: 582 NFSEANILGRGGFGVVYGGELPDGTKIAV----KRMESNTMGNKGLSEFQAEIAVLTKVR 637
+F LG G FG V + + K+ E M K + E ++L ++
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKM--KQVQHVAQEKSILMELS 76
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR-- 695
H +V ++ + + + E++ G L HL G P DVA+
Sbjct: 77 HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHL---RKAGRFPN----------DVAKFY 123
Query: 696 ------GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLA 749
EYLHS I+RDLKP N+L+ + KV DFG K PD ++ L
Sbjct: 124 HAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT----LC 176
Query: 750 GTFGYLAPE 758
GT YLAPE
Sbjct: 177 GTPEYLAPE 185
|
Length = 329 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-10
Identities = 53/176 (30%), Positives = 85/176 (48%), Gaps = 16/176 (9%)
Query: 589 LGRGGFGVVYGG-ELPDGTKIAVK--RMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
+G G +G VY L G AVK ++E S Q EI ++ + +H ++VA
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPG----DDFSLIQQEIFMVKECKHCNIVAYF 72
Query: 646 GYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQ 705
G ++ + + EY G+L Q ++ H PL+ Q + + +G+ YLHS +
Sbjct: 73 GSYLSREKLWICMEYCGGGSL-QDIY----HVTGPLSELQIAYVCRETLQGLAYLHSKGK 127
Query: 706 QSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAG 761
+HRD+K +NIL+ D+ K+ADFG V + GT ++APE A
Sbjct: 128 ---MHRDIKGANILLTDNGDVKLADFG-VAAKITATIAKRKSFIGTPYWMAPEVAA 179
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 9e-10
Identities = 48/176 (27%), Positives = 82/176 (46%), Gaps = 20/176 (11%)
Query: 589 LGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQA-EIAVLTKVRHRHLVALLG 646
+G G +G V+ +A+KR+ + ++G+ EI +L +++H+++V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 647 YCINGSERLLVYEYMPRGTLAQHLFEWHD--HGYTPLTWKQRVTIALDVARGVEYLHSLA 704
+ + LV+EY Q L ++ D +G + L +G+ + HS
Sbjct: 67 VLHSDKKLTLVFEYCD-----QDLKKYFDSCNGDIDPEIVKSFMFQL--LKGLAFCHS-- 117
Query: 705 QQSFIHRDLKPSNILIGDDMRAKVADFGLVKN--APDGKYSVETRLAGTFGYLAPE 758
+ +HRDLKP N+LI + K+ADFGL + P YS E T Y P+
Sbjct: 118 -HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV---TLWYRPPD 169
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 42/179 (23%), Positives = 80/179 (44%), Gaps = 9/179 (5%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQ-AEIAVLTKVRHR 639
+ F ++G G +GVV + +I + ++ N+ + E E+ +L ++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
++V L + LV+EY+ + L L E +G P + + + + + +
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNML--ELLEEMPNGVPPEKVRSYI---YQLIKAIHW 115
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
H + +HRD+KP N+LI + K+ DFG +N +G + T T Y +PE
Sbjct: 116 CH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPE 171
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 48/175 (27%), Positives = 80/175 (45%), Gaps = 14/175 (8%)
Query: 589 LGRGGFGVVYGGELPDGTK---IAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
LG G FG V G K +A+K +++ + E E ++ ++ + ++V ++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSV-RDEMMREAEIMHQLDNPYIVRMI 61
Query: 646 GYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQ 705
G C +LV E G L + L D +T V + V+ G++YL
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFLSGKKDE----ITVSNVVELMHQVSMGMKYLE---G 113
Query: 706 QSFIHRDLKPSNILIGDDMRAKVADFGLVK--NAPDGKYSVETRLAGTFGYLAPE 758
++F+HRDL N+L+ + AK++DFGL K A D Y + + APE
Sbjct: 114 KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPE 168
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 50/185 (27%), Positives = 82/185 (44%), Gaps = 28/185 (15%)
Query: 589 LGRGGFGVVYGG---ELPDGTKIAVKRMESNTMGNKGLSEFQA--EIAVLTKVR-HRHLV 642
LG+G +G+V E + +A+K++ +N K L++ +A E+ +L R H+++
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKI-TNVFSKKILAK-RALRELKLLRHFRGHKNIT 65
Query: 643 ALL------GYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARG 696
L N L +YE + L Q + PLT + + G
Sbjct: 66 CLYDMDIVFPGNFNE---LYLYEELMEADLHQII-----RSGQPLTDAHFQSFIYQILCG 117
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVE---TRLAGTFG 753
++Y+HS + +HRDLKP N+L+ D K+ DFGL + + T T
Sbjct: 118 LKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRW 174
Query: 754 YLAPE 758
Y APE
Sbjct: 175 YRAPE 179
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 46/171 (26%), Positives = 84/171 (49%), Gaps = 13/171 (7%)
Query: 589 LGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY 647
+G+G G V+ ++ G ++A+K++ K L EI V+ ++++ ++V L
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL--IINEILVMKELKNPNIVNFLDS 84
Query: 648 CINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS 707
+ G E +V EY+ G+L + E T + Q + + + +E+LH+
Sbjct: 85 FLVGDELFVVMEYLAGGSLTDVVTE------TCMDEAQIAAVCRECLQALEFLHA---NQ 135
Query: 708 FIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
IHRD+K N+L+G D K+ DFG + S + + GT ++APE
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP-EQSKRSTMVGTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-09
Identities = 60/259 (23%), Positives = 101/259 (38%), Gaps = 31/259 (11%)
Query: 79 SGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTN 138
S S + +L L +L +N + I L T+L + LDNNN T +P +N
Sbjct: 82 SLDGSENLLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSN 141
Query: 139 LQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNN 198
L+ L LSDN + P+ L +L L + ++ L + SNL NL LS N
Sbjct: 142 LKELDLSDNKIES---LPSPLRNLPNLKNLDLSFNDLSDLPKLLSNL-SNLNNLDLSGNK 197
Query: 199 FTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCE 258
+ LP + ++ L ++ L N + LS +
Sbjct: 198 IS-DLP------------------------PEIELLSALEELDLSNNSIIELLSSLSNLK 232
Query: 259 SLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFP-SKVQKVSLDHNNFCK 317
+L L L +N+L +P S+ +L L + L NN++ L + ++++ L N+
Sbjct: 233 NLSGLELSNNKLED-LPESIGNLSNLETLDLSNNQISSISSLGSLTNLRELDLSGNSLSN 291
Query: 318 NSSDAGKPCDPQVTTLLQI 336
L +
Sbjct: 292 ALPLIALLLLLLELLLNLL 310
|
Length = 394 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 51/186 (27%), Positives = 84/186 (45%), Gaps = 21/186 (11%)
Query: 589 LGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYC 648
LG G FG VY + + +A ++ +T + L ++ EI +L H ++V LL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKV-IDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 649 INGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSF 708
+ ++ E+ G + + E PLT Q + + YLH +
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELE----RPLTEPQIRVVCKQTLEALNYLH---ENKI 124
Query: 709 IHRDLKPSNILIGDDMRAKVADFGL-VKNAPDGKYSVETR--LAGTFGYLAPEYAGKHWM 765
IHRDLK NIL D K+ADFG+ KN +++ R GT ++APE +
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSAKNT----RTIQRRDSFIGTPYWMAPE------V 174
Query: 766 ILCQMT 771
++C+ +
Sbjct: 175 VMCETS 180
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 2e-09
Identities = 53/199 (26%), Positives = 85/199 (42%), Gaps = 34/199 (17%)
Query: 588 ILGRGGFGVVYGGELPD-GTKIAVKRMESNTMGNKGLSE-FQAEIAVLTKVRHRHLVALL 645
++G+GG G VY P ++A+K++ + N L + F E + + H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 646 GYCINGSERLLVYEYMP--RGTLAQHLFE--WH-DHGYTPLTWKQRV----TIALDVARG 696
C S+ VY MP G + L + W + L K V +I +
Sbjct: 69 SIC---SDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK--------------NAPDGKY 742
+EY+HS + +HRDLKP NIL+G + D+G + + Y
Sbjct: 126 IEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 743 SVET---RLAGTFGYLAPE 758
S T ++ GT Y+APE
Sbjct: 183 SSMTIPGKIVGTPDYMAPE 201
|
Length = 932 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 59/186 (31%), Positives = 86/186 (46%), Gaps = 22/186 (11%)
Query: 581 DNFSEANILGRGGFGVVYGG-ELPDGTKIAVK--RMESNTMGNKGLSEFQAEIAVLTKVR 637
D + + +G G +GVVY + IA+K R+E G S EI++L +++
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVP--STAIREISLLKEMQ 59
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697
H ++V L + LV+EY+ L +H+ D P K T + RG+
Sbjct: 60 HGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIK---TYLYQILRGI 115
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRA---KVADFGLVK--NAPDGKYSVETRLAGTF 752
Y HS +HRDLKP N+LI D R K+ADFGL + P ++ E T
Sbjct: 116 AYCHS---HRVLHRDLKPQNLLI--DRRTNALKLADFGLARAFGIPVRTFTHEVV---TL 167
Query: 753 GYLAPE 758
Y APE
Sbjct: 168 WYRAPE 173
|
Length = 294 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 58/175 (33%), Positives = 83/175 (47%), Gaps = 14/175 (8%)
Query: 588 ILGRGGFG-VVYGGELPDGTKIAVKRMESNTMGN-KGLSEFQAEIAVLTK-VRHRHLVAL 644
++G+G FG V+ DG AVK ++ + N K AE VL K V+H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 645 LGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSL 703
Y +E+L V +++ G L HL + + R A ++A + YLHS+
Sbjct: 62 -HYSFQTTEKLYFVLDFVNGGELFFHL----QRERSFPEPRARFYAA-EIASALGYLHSI 115
Query: 704 AQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
+ ++RDLKP NIL+ + DFGL K + T GT YLAPE
Sbjct: 116 ---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGI-AQSDTTTTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 57/191 (29%), Positives = 88/191 (46%), Gaps = 19/191 (9%)
Query: 581 DNFSEANILGRGGFGVVYG-GELPDGTKIAVKRME---SNTMGNKGLSEFQAEIAVLTKV 636
D+F + + LG G GVV+ P G +A K + + N+ + E Q VL +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQ----VLHEC 60
Query: 637 RHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARG 696
++V G + E + E+M G+L Q L G P +V+IA V +G
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIA--VIKG 115
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLA 756
+ YL + +HRD+KPSNIL+ K+ DFG+ D S+ GT Y++
Sbjct: 116 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMS 170
Query: 757 PE-YAGKHWMI 766
PE G H+ +
Sbjct: 171 PERLQGTHYSV 181
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 59.5 bits (145), Expect = 2e-09
Identities = 30/73 (41%), Positives = 39/73 (53%), Gaps = 17/73 (23%)
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA---------PDGKYSVE 745
+ ++Y+HS + IHRDLKPSNIL+ D R K+ADFGL ++ P V
Sbjct: 118 KALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 746 TRLAGTFGYLAPE 758
TR Y APE
Sbjct: 175 TRW-----YRAPE 182
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 49/182 (26%), Positives = 84/182 (46%), Gaps = 13/182 (7%)
Query: 582 NFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMES-NTMGNKGLSEFQAEIAVLTKVRHR 639
NF +GRG F VY L DG +A+K+++ + M K ++ EI +L ++ H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGY---TPLTWKQRVTIALDVARG 696
+++ I +E +V E G L++ + + WK V +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC----SA 118
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLA 756
+E++HS + +HRD+KP+N+ I K+ D GL + K + L GT Y++
Sbjct: 119 LEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMS 174
Query: 757 PE 758
PE
Sbjct: 175 PE 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 52/172 (30%), Positives = 78/172 (45%), Gaps = 15/172 (8%)
Query: 589 LGRGGFGVVYGGELPDGTKI-AVKRME-SNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646
+G G FG VY ++ AVK+M S N+ + E+ L +++H + + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ 706
+ LV EY G+ A L E H PL + I +G+ YLHS
Sbjct: 89 CYLKEHTAWLVMEYC-LGS-ASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHS---H 140
Query: 707 SFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
+ IHRD+K NIL+ + + K+ADFG + S GT ++APE
Sbjct: 141 NMIHRDIKAGNILLTEPGQVKLADFGSASKS-----SPANSFVGTPYWMAPE 187
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 46/182 (25%), Positives = 79/182 (43%), Gaps = 15/182 (8%)
Query: 582 NFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
+ +G G FG +Y D +K ++ M K + E+ +L K++H +
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTP---LTWKQRVTIALDVARGV 697
+V +V EY G L + + ++ L+W V I+L G+
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW--FVQISL----GL 114
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDD-MRAKVADFGLVKNAPDGKYSVETRLAGTFGYLA 756
+++H + +HRD+K NI + + M AK+ DFG+ + D T GT YL+
Sbjct: 115 KHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT-CVGTPYYLS 170
Query: 757 PE 758
PE
Sbjct: 171 PE 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 52/182 (28%), Positives = 83/182 (45%), Gaps = 13/182 (7%)
Query: 582 NFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMES-NTMGNKGLSEFQAEIAVLTKVRHR 639
NF +GRG F VY L D +A+K+++ M K + EI +L ++ H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHG-YTP--LTWKQRVTIALDVARG 696
+++ L I +E +V E G L+Q + + P WK V +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC----SA 118
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLA 756
VE++HS + +HRD+KP+N+ I K+ D GL + K + L GT Y++
Sbjct: 119 VEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMS 174
Query: 757 PE 758
PE
Sbjct: 175 PE 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 53/186 (28%), Positives = 85/186 (45%), Gaps = 19/186 (10%)
Query: 582 NFSEANILGRGGFGVVY-----GGELPDGTKIAVKRMESNTMGNKG--LSEFQAEIAVLT 634
NF +LG G +G V+ GG G A+K ++ T+ K + E VL
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGH-DAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLE 59
Query: 635 KVRHRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDV 693
VR + L Y +L L+ +Y+ G L HL++ + + + RV IA ++
Sbjct: 60 AVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ---REHFTES-EVRVYIA-EI 114
Query: 694 ARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN-APDGKYSVETRLAGTF 752
+++LH Q I+RD+K NIL+ + + DFGL K + + + GT
Sbjct: 115 VLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTI 170
Query: 753 GYLAPE 758
Y+APE
Sbjct: 171 EYMAPE 176
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 48/185 (25%), Positives = 82/185 (44%), Gaps = 24/185 (12%)
Query: 589 LGRGGFGVVYGGELPDG--TKIAVKR--MESNTMG------NKGLSEFQAEIAVLTK-VR 637
LG G FG VY + +A+K + + G +K + + +E+ ++ + +R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQH---LFEWHDHGYTPLTWKQRVTIALDVA 694
H ++V + +V + + L +H L E W V + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL--- 124
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN-APDGKYSVETRLAGTFG 753
+ YLH ++ +HRDL P+NI++G+D + + DFGL K P+ K T + GT
Sbjct: 125 -ALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL---TSVVGTIL 178
Query: 754 YLAPE 758
Y PE
Sbjct: 179 YSCPE 183
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 56/187 (29%), Positives = 87/187 (46%), Gaps = 37/187 (19%)
Query: 588 ILGRGGFGVVY------GGELPD-GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
+LG+G FG V+ G PD G A+K ++ T+ + + E +L +V H
Sbjct: 3 VLGQGSFGKVFLVRKITG---PDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPF 59
Query: 641 LVALLGYCINGSERL-LVYEYMPRGTLAQHL-----FEWHDHGYTPLTWKQRVTIALDVA 694
+V L Y +L L+ +++ G L L F D + ++A
Sbjct: 60 IVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA----------ELA 108
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK---YSVETRLAGT 751
+++LHSL I+RDLKP NIL+ ++ K+ DFGL K + D + YS GT
Sbjct: 109 LALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS----FCGT 161
Query: 752 FGYLAPE 758
Y+APE
Sbjct: 162 VEYMAPE 168
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 5e-09
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 34/185 (18%)
Query: 588 ILGRGGFGVVYGGELP-DGTKIAVKRMESN----------TMGNKGLSEFQAEIAVLTKV 636
+LG+G FG V EL G AVK ++ + TM K + E LT
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLT-- 59
Query: 637 RHRHLVALLGYCINGSERLL--VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTI-ALDV 693
HL YC ++ L V E++ G L H+ D G L R T A ++
Sbjct: 60 ---HL-----YCTFQTKEHLFFVMEFLNGGDLMFHI---QDKGRFDL---YRATFYAAEI 105
Query: 694 ARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFG 753
G+++LHS + I+RDLK N+++ D K+ADFG+ K G T GT
Sbjct: 106 VCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPD 161
Query: 754 YLAPE 758
Y+APE
Sbjct: 162 YIAPE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 57/184 (30%), Positives = 80/184 (43%), Gaps = 32/184 (17%)
Query: 588 ILGRGGFGVVYGGELP-DGTKIAVKRMESN----------TMGNKGLSEFQAEIAVLTKV 636
+LG+G FG V+ EL A+K ++ + TM K + E LT
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT-- 59
Query: 637 RHRHLVALLGYC-INGSERLL-VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVA 694
HL YC E L V EY+ G L H+ H T+ A ++
Sbjct: 60 ---HL-----YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATF-----YAAEII 106
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGY 754
G+++LHS + ++RDLK NIL+ D K+ADFG+ K G T GT Y
Sbjct: 107 CGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-FCGTPDY 162
Query: 755 LAPE 758
+APE
Sbjct: 163 IAPE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 58/191 (30%), Positives = 87/191 (45%), Gaps = 19/191 (9%)
Query: 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRME---SNTMGNKGLSEFQAEIAVLTKV 636
D+F + LG G GVV + P G +A K + + N+ + E Q VL +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQ----VLHEC 60
Query: 637 RHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARG 696
++V G + E + E+M G+L Q L E P +V+IA V RG
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR---IPEEILGKVSIA--VLRG 115
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLA 756
+ YL + +HRD+KPSNIL+ K+ DFG+ D S+ GT Y++
Sbjct: 116 LAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMS 170
Query: 757 PE-YAGKHWMI 766
PE G H+ +
Sbjct: 171 PERLQGTHYSV 181
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 7e-09
Identities = 63/241 (26%), Positives = 111/241 (46%), Gaps = 29/241 (12%)
Query: 531 KNGVTGGNGTNGYNGVPSELHSQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEANILG 590
KN G+ + +L + ++ E I ++ R ++ NI+G
Sbjct: 16 KNHKANKGGSGKFEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIG 75
Query: 591 RGGFGVVYGGELPDGT-KIAVKR-MESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY- 647
G FGVVY D + K+A+K+ ++ N+ E+ ++ + H +++ L Y
Sbjct: 76 NGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR-------ELLIMKNLNHINIIFLKDYY 128
Query: 648 ---CINGSERLL----VYEYMPRGTLAQHLFEWHDHGYT-PLTWKQRVTIALDVARGVEY 699
C +E+ + V E++P+ T+ +++ + + + PL + + L R + Y
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQL--CRALAY 185
Query: 700 LHSLAQQSFI-HRDLKPSNILIGDDMRA-KVADFGLVKNAPDGKYSVETRLAGTFGYLAP 757
+HS FI HRDLKP N+LI + K+ DFG KN G+ SV + + F Y AP
Sbjct: 186 IHS----KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSV-SYICSRF-YRAP 239
Query: 758 E 758
E
Sbjct: 240 E 240
|
Length = 440 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 7e-09
Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 34/211 (16%)
Query: 589 LGRGGFGVVYGGELPDGTK---IAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
+GRG +G VY + DG A+K++E + E IA+L +++H ++++L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACRE----IALLRELKHPNVISLQ 64
Query: 646 GYCINGSER--LLVYEYMPRGTLAQHLFEWH---DHGYTPLTWKQRVTIAL--DVARGVE 698
++ ++R L+++Y H+ ++H P+ + + +L + G+
Sbjct: 65 KVFLSHADRKVWLLFDYAEHDLW--HIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122
Query: 699 YLHSLAQQSFIHRDLKPSNILI----GDDMRAKVADFGLVK--NAPDGKYSVETRLAGTF 752
YLH+ +HRDLKP+NIL+ + R K+AD G + N+P + + TF
Sbjct: 123 YLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 753 GYLAPE--YAGKH-------WMILCQMTGLI 774
Y APE +H W I C L+
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 8e-09
Identities = 52/181 (28%), Positives = 84/181 (46%), Gaps = 15/181 (8%)
Query: 582 NFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGL-SEFQAEIAVLTKVRHR 639
NF + LG G + VY G G +A+K E + +G S EI+++ +++H
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALK--EIHLDAEEGTPSTAIREISLMKELKHE 58
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
++V L ++ +LV+EYM L +++ G + T L +G+ +
Sbjct: 59 NIVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQL--LKGIAF 115
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK--NAPDGKYSVETRLAGTFGYLAP 757
H + +HRDLKP N+LI K+ADFGL + P +S E T Y AP
Sbjct: 116 CH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV---TLWYRAP 169
Query: 758 E 758
+
Sbjct: 170 D 170
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 8e-09
Identities = 54/207 (26%), Positives = 75/207 (36%), Gaps = 50/207 (24%)
Query: 589 LGRGGFGVVYGGELPD-GTKIAVKRMESNTM--GNKGLSEFQAEIAVLTKVRHRHLVALL 645
LG+G G V+ L G A+K ++ M NK + E +L + H L L
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNK-VKRVLTEQEILATLDHPFLPTL- 66
Query: 646 GYCINGSER--LLVYEYMPRGTLAQHLFEWHDHGYTPLT----WKQRVTIALDVARGVEY 699
Y +E LV +Y P G L L + + V +AL EY
Sbjct: 67 -YASFQTETYLCLVMDYCPGGEL-FRLLQRQPGKCLSEEVARFYAAEVLLAL------EY 118
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG------------------K 741
LH L ++RDLKP NIL+ + ++DF L K +
Sbjct: 119 LHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175
Query: 742 YSVETRLA----------GTFGYLAPE 758
ET GT Y+APE
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPE 202
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 8e-09
Identities = 54/186 (29%), Positives = 80/186 (43%), Gaps = 36/186 (19%)
Query: 588 ILGRGGFGVVYGGELPDGTK--IAVKRMESN----------TMGNKGLSEFQAEIAVLTK 635
+LG+G FG V EL GT AVK ++ + TM K +
Sbjct: 2 VLGKGSFGKVLLAEL-KGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG------- 53
Query: 636 VRHRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVA 694
+H L L C +RL V EY+ G L H+ + A ++
Sbjct: 54 -KHPFLTQLHS-CFQTKDRLFFVMEYVNGGDLMFHI-----QRSGRFDEPRARFYAAEIV 106
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG-KYSVETR-LAGTF 752
G+++LH ++ I+RDLK N+L+ + K+ADFG+ K +G V T GT
Sbjct: 107 LGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILGGVTTSTFCGTP 160
Query: 753 GYLAPE 758
Y+APE
Sbjct: 161 DYIAPE 166
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 9e-09
Identities = 53/175 (30%), Positives = 84/175 (48%), Gaps = 14/175 (8%)
Query: 588 ILGRGGFG-VVYGGELPDGTKIAVKRMESNTMGNKG-LSEFQAEIAVLTKVRHRHLVALL 645
+LG+G FG V+ E G A+K ++ + K ++ E VL RH L AL
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL- 60
Query: 646 GYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTI-ALDVARGVEYLHSL 703
Y +RL V EY G L HL + ++ + R ++ ++YLH
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSR--ERVFS----EDRARFYGAEIVSALDYLH-- 112
Query: 704 AQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
++++ ++RDLK N+++ D K+ DFGL K +++T GT YLAPE
Sbjct: 113 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 53/176 (30%), Positives = 83/176 (47%), Gaps = 39/176 (22%)
Query: 581 DNFSEANILGRGGFGVVYGGELPD-GTKIAVK--RMESNTMGNKGLSEFQA----EIAVL 633
D F +G G +G VY D G +A+K R+++ G F EI +L
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG------FPITAIREIKIL 60
Query: 634 TKVRHRHLVALLGYCINGSERL----------LVYEYMPR---GTLAQHLFEW-HDHGYT 679
++ HR++V L + + L LV+EYM G L L + DH +
Sbjct: 61 RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS 120
Query: 680 PLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735
+ KQ L+ G+ Y H +++F+HRD+K SNIL+ + + K+ADFGL +
Sbjct: 121 FM--KQ----LLE---GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLAR 164
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 57/183 (31%), Positives = 78/183 (42%), Gaps = 31/183 (16%)
Query: 588 ILGRGGFG-VVYGGELPDGTKIAVKRMESNTMGNKG-LSEFQAEIAVLTKVRHRHLVALL 645
+LG+G FG V+ E G A+K ++ + K ++ E VL RH L AL
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL- 60
Query: 646 GYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR--------G 696
Y +RL V EY G L HL ++RV + D AR
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLS------------RERV-FSEDRARFYGAEIVSA 107
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR-LAGTFGYL 755
+ YLHS ++RDLK N+++ D K+ DFGL K + GT YL
Sbjct: 108 LGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYL 162
Query: 756 APE 758
APE
Sbjct: 163 APE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 38/217 (17%)
Query: 578 QVTDNFSEANILGRGGFGVV-YGGELPDGTKIAVKRM----ESNTMGNKGLSEFQAEIAV 632
+V D + + +G G +G V + G K+A+K++ +S + E + +
Sbjct: 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELR----L 67
Query: 633 LTKVRHRHLVALLGYCINGSERL-------LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQ 685
L ++H +++ LL L LV +M GT L + +
Sbjct: 68 LKHMKHENVIGLLD-VFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLS------ED 118
Query: 686 RVT-IALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSV 744
R+ + + +G++Y+H+ IHRDLKP N+ + +D K+ DFGL + S
Sbjct: 119 RIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTD----SE 171
Query: 745 ETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSVG 781
T T Y APE +WM Q T IW SVG
Sbjct: 172 MTGYVVTRWYRAPEVI-LNWMHYTQ-TVDIW---SVG 203
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 49/175 (28%), Positives = 81/175 (46%), Gaps = 14/175 (8%)
Query: 589 LGRGGFGVVYGG--ELPDGTKIAVKRMESNTMGNKGLS-EFQAEIAVLTKVRHRHLVALL 645
LG G FG V G ++ K ++ N + L E E V+ ++ + ++V ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 646 GYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQ 705
G C +LV E G L + L + + H +T K + V+ G++YL +
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFL-QKNKH----VTEKNITELVHQVSMGMKYLE---E 113
Query: 706 QSFIHRDLKPSNILIGDDMRAKVADFGLVK--NAPDGKYSVETRLAGTFGYLAPE 758
+F+HRDL N+L+ AK++DFGL K A + Y +T + APE
Sbjct: 114 TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPE 168
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 2e-08
Identities = 38/93 (40%), Positives = 48/93 (51%), Gaps = 24/93 (25%)
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD--GKYSVETRLAGTF 752
RG++Y+HS IHRDLKPSNI + +D K+ DFGL ++ D Y V TR
Sbjct: 129 RGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGY-VATRW---- 180
Query: 753 GYLAPEYAGKHWMILCQM----TGLIWLHGSVG 781
Y APE ++L M T IW SVG
Sbjct: 181 -YRAPE------IMLNWMHYNQTVDIW---SVG 203
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 56/190 (29%), Positives = 81/190 (42%), Gaps = 33/190 (17%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGT--KIAVKRME-SNTMGNKGLSEFQAEIAVLTKVR 637
++F+ LG G FG V + +A+KR E S + K + +E +L +
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVT------IAL 691
H V L G + S LV E++ G +T L +R A
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEF-----------FTFLRRNKRFPNDVGCFYAA 138
Query: 692 DVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR---L 748
+ EYL SL + ++RDLKP N+L+ D K+ DFG K V+TR L
Sbjct: 139 QIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAK-------VVDTRTYTL 188
Query: 749 AGTFGYLAPE 758
GT Y+APE
Sbjct: 189 CGTPEYIAPE 198
|
Length = 340 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 37/142 (26%), Positives = 75/142 (52%), Gaps = 21/142 (14%)
Query: 589 LGRGGFGVVYGG---ELPDG-----TKIAVKRMESNTMGNKGLSE-FQAEIAVLTKVRHR 639
LG+G F ++ G E+ D T++ +K ++ + ++ SE F ++++++ H+
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHK 59
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
HLV G C+ G E ++V EY+ G+L +L + + ++WK L+VA+ + +
Sbjct: 60 HLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKK--NKNLINISWK------LEVAKQLAW 111
Query: 700 -LHSLAQQSFIHRDLKPSNILI 720
LH L + H ++ N+L+
Sbjct: 112 ALHFLEDKGLTHGNVCAKNVLL 133
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 39/149 (26%), Positives = 70/149 (46%), Gaps = 12/149 (8%)
Query: 588 ILGRGGFGVVYGG--ELPDGTK--IAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVA 643
ILG G FG + G +LP + +A+ + + + F AE L + H ++V
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRG-FLAEALTLGQFDHSNIVR 70
Query: 644 LLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSL 703
L G G+ ++V EYM G L L + H+ L Q + + +A G++Y L
Sbjct: 71 LEGVITRGNTMMIVTEYMSNGALDSFLRK-HE---GQLVAGQLMGMLPGLASGMKY---L 123
Query: 704 AQQSFIHRDLKPSNILIGDDMRAKVADFG 732
++ ++H+ L +L+ D+ K++ F
Sbjct: 124 SEMGYVHKGLAAHKVLVNSDLVCKISGFR 152
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 54/181 (29%), Positives = 81/181 (44%), Gaps = 27/181 (14%)
Query: 588 ILGRGGFG-VVYGGELPDGTKIAVKRMESNTMGNKG-LSEFQAEIAVLTKVRHRHLVALL 645
+LG+G FG V+ E G A+K ++ + K ++ E VL RH L +L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL- 60
Query: 646 GYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVT-------IALDVARGV 697
Y +RL V EY+ G L HL ++RV ++ +
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLS------------RERVFSEDRTRFYGAEIVSAL 108
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAP 757
+YLHS ++RDLK N+++ D K+ DFGL K +++T GT YLAP
Sbjct: 109 DYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAP 164
Query: 758 E 758
E
Sbjct: 165 E 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 57/182 (31%), Positives = 83/182 (45%), Gaps = 18/182 (9%)
Query: 588 ILGRGGFG-VVYGGELPDGTKIAVKRMESNT-MGNKGLSEFQAEIAVLTK-VRHRHLVAL 644
++G+G FG V+ + AVK ++ + K +E VL K V+H LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 645 LGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSL 703
+ +++L V +Y+ G L HL L + R A ++A + YLHSL
Sbjct: 62 -HFSFQTADKLYFVLDYINGGELFYHL----QRERCFLEPRARF-YAAEIASALGYLHSL 115
Query: 704 AQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN--APDGKYSVETRLAGTFGYLAPEYAG 761
+ ++RDLKP NIL+ + DFGL K +G S GT YLAPE
Sbjct: 116 ---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST---FCGTPEYLAPEVLH 169
Query: 762 KH 763
K
Sbjct: 170 KQ 171
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 52/191 (27%), Positives = 84/191 (43%), Gaps = 34/191 (17%)
Query: 587 NILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGN--KGLSEFQA--EIAVLTKVRHRHL 641
+G+G FG V+ +A+K++ M N +G A EI +L ++H ++
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKV---LMENEKEGFP-ITALREIKILQLLKHENV 73
Query: 642 VALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR------ 695
V L+ C + Y +G+ +FE+ +H L + V L +
Sbjct: 74 VNLIEICRTKATPYNRY----KGSFYL-VFEFCEHDLAGLLSNKNVKFTLSEIKKVMKML 128
Query: 696 --GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV------KNAPDGKYSVETR 747
G+ Y+H +HRD+K +NILI D K+ADFGL KN+ +Y+ R
Sbjct: 129 LNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT--NR 183
Query: 748 LAGTFGYLAPE 758
+ T Y PE
Sbjct: 184 VV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 40/121 (33%), Positives = 64/121 (52%), Gaps = 14/121 (11%)
Query: 629 EIAVLTKVRHRHLVALLGYCINGSER--LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQR 686
E+++L ++H ++V L + I +ER LV+EY+ L Q+L D+ ++
Sbjct: 53 EVSLLKNLKHANIVTL--HDIIHTERCLTLVFEYL-DSDLKQYL----DNCGNLMSMHNV 105
Query: 687 VTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL--VKNAPDGKYSV 744
+ RG+ Y H ++ +HRDLKP N+LI + K+ADFGL K+ P YS
Sbjct: 106 KIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSN 162
Query: 745 E 745
E
Sbjct: 163 E 163
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 20/164 (12%)
Query: 605 GTKIAVKRMESNT-MGNK-----GLSEFQA----EIAVLTKVRHRHLVALLGYCINGSER 654
G+ VK + + T M K S + E+ ++ + R ++V+ G +N +
Sbjct: 19 GSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNI 78
Query: 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLK 714
+ E+M G+L + + P+ + IA+ V G+ YL++ +HRD+K
Sbjct: 79 CMCMEFMDCGSLDRIYKK-----GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIK 131
Query: 715 PSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
PSNIL+ + K+ DFG+ + S+ GT Y++PE
Sbjct: 132 PSNILVNSRGQIKLCDFGVSGELIN---SIADTFVGTSTYMSPE 172
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 47/161 (29%), Positives = 75/161 (46%), Gaps = 14/161 (8%)
Query: 589 LGRGGFGVVYGG--ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646
LG G + VY G +L D +A+K + + + E+++L ++H ++V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71
Query: 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ 706
LV+EY+ + L Q+L D + + RG+ Y H ++
Sbjct: 72 IIHTEKSLTLVFEYLDK-DLKQYL----DDCGNSINMHNVKLFLFQLLRGLNYCH---RR 123
Query: 707 SFIHRDLKPSNILIGDDMRAKVADFGL--VKNAPDGKYSVE 745
+HRDLKP N+LI + K+ADFGL K+ P YS E
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNE 164
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 50/186 (26%), Positives = 80/186 (43%), Gaps = 19/186 (10%)
Query: 582 NFSEANILGRGGFGVVY-----GGELPDGTKIAVKRMESNTMGNKGLS--EFQAEIAVLT 634
NF +LG G +G V+ G G A+K ++ T+ K + + E VL
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGH-DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 59
Query: 635 KVRHRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIAL-D 692
+R + L Y +L L+ +Y+ G L HL + +Q V I +
Sbjct: 60 HIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK------EQEVQIYSGE 113
Query: 693 VARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTF 752
+ +E+LH L I+RD+K NIL+ + + DFGL K + + GT
Sbjct: 114 IVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTI 170
Query: 753 GYLAPE 758
Y+AP+
Sbjct: 171 EYMAPD 176
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 6e-08
Identities = 52/215 (24%), Positives = 86/215 (40%), Gaps = 35/215 (16%)
Query: 589 LGRGGFGVVYGGELPDGT------KIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
LG FG VY G L +A+K ++ G EF+ E + ++++H ++V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPL-REEFKHEAMMRSRLQHPNIV 71
Query: 643 ALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQR-----------VTIAL 691
LLG +++ Y L + L H T + V I
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 692 DVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGT 751
+A G+E+L S +H+DL N+L+ D + K++D GL + Y +L G
Sbjct: 132 QIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADY---YKLMGN 185
Query: 752 ----FGYLAPEYA--GKHWMILCQMTGLIWLHGSV 780
+++PE GK + IW +G V
Sbjct: 186 SLLPIRWMSPEAIMYGK-----FSIDSDIWSYGVV 215
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 52/188 (27%), Positives = 89/188 (47%), Gaps = 25/188 (13%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKI-AVKRMESNTMGNKG-LSEFQAEIAVLTKVRH 638
D+F ++GRG FG V ++ + ++ A+K + M + + F+ E VL
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVN-GD 59
Query: 639 RHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR-- 695
R + L Y L LV +Y G L L ++ D + D+AR
Sbjct: 60 RRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR------------LPEDMARFY 107
Query: 696 ---GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG-LVKNAPDGKYSVETRLA-G 750
V + S+ Q ++HRD+KP N+L+ + ++ADFG ++ DG +V++ +A G
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG--TVQSNVAVG 165
Query: 751 TFGYLAPE 758
T Y++PE
Sbjct: 166 TPDYISPE 173
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 8e-08
Identities = 35/132 (26%), Positives = 59/132 (44%), Gaps = 12/132 (9%)
Query: 603 PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMP 662
P T +AVK++ ++ + L Q EI +++H +++ + I SE +V M
Sbjct: 23 PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82
Query: 663 RGTLAQHLFEWHDHGYTPLTWKQRVTIAL---DVARGVEYLHSLAQQSFIHRDLKPSNIL 719
G+ L G L IA DV ++Y+HS FIHR +K S+IL
Sbjct: 83 YGSCEDLLKTHFPEGLPEL------AIAFILKDVLNALDYIHSKG---FIHRSVKASHIL 133
Query: 720 IGDDMRAKVADF 731
+ D + ++
Sbjct: 134 LSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 9e-08
Identities = 51/187 (27%), Positives = 82/187 (43%), Gaps = 26/187 (13%)
Query: 587 NILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQ----AEIAVLTKVRHRHL 641
ILG G G VY L +AVK + + E Q +E+ +L K ++
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-----VELQKQIMSELEILYKCDSPYI 61
Query: 642 VALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLH 701
+ G + + E+M G+L + P R+ +A V +G+ YL
Sbjct: 62 IGFYGAFFVENRISICTEFMDGGSLDVY-------RKIPEHVLGRIAVA--VVKGLTYLW 112
Query: 702 SLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE-YA 760
SL +HRD+KPSN+L+ + K+ DFG+ + S+ GT Y+APE +
Sbjct: 113 SL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN---SIAKTYVGTNAYMAPERIS 166
Query: 761 GKHWMIL 767
G+ + I
Sbjct: 167 GEQYGIH 173
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 14/161 (8%)
Query: 589 LGRGGFGVVYGG--ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646
LG G + V+ G +L + +A+K + + + E+++L ++H ++V L
Sbjct: 14 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71
Query: 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ 706
LV+EY L + L ++ D ++ + RG+ Y H ++
Sbjct: 72 IVHTDKSLTLVFEY-----LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RR 123
Query: 707 SFIHRDLKPSNILIGDDMRAKVADFGL--VKNAPDGKYSVE 745
+HRDLKP N+LI + K+ADFGL K+ P YS E
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNE 164
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 56/215 (26%), Positives = 91/215 (42%), Gaps = 26/215 (12%)
Query: 574 EVLRQVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAV 632
+ + +V + + + +G G +G V + G ++AVK++ E+ +
Sbjct: 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 69
Query: 633 LTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVT---- 688
L ++H +++ LL E L HL + Q++T
Sbjct: 70 LKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLM---GADLNNIVKCQKLTDDHV 122
Query: 689 --IALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVET 746
+ + RG++Y+HS IHRDLKPSN+ + +D K+ DFGL ++ D T
Sbjct: 123 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----T 175
Query: 747 RLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSVG 781
T Y APE +WM Q T IW SVG
Sbjct: 176 GYVATRWYRAPEIM-LNWMHYNQ-TVDIW---SVG 205
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 35/112 (31%), Positives = 52/112 (46%), Gaps = 9/112 (8%)
Query: 651 GSERLLVYEYMP-RGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFI 709
G +L + P E D +PLT + + + VARG+E+L A + I
Sbjct: 140 GQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL---ASRKCI 196
Query: 710 HRDLKPSNILIGDDMRAKVADFGLVKNA---PDGKYSVETRLAGTFGYLAPE 758
HRDL NIL+ ++ K+ DFGL ++ PD RL ++APE
Sbjct: 197 HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP--LKWMAPE 246
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 52/185 (28%), Positives = 81/185 (43%), Gaps = 34/185 (18%)
Query: 588 ILGRGGFGVVYGGELPDGTKI-AVKRMESN----------TMGNKGLSEFQAEIAVLTKV 636
+LG+G FG V EL + A+K ++ + TM + + E LT
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLT-- 59
Query: 637 RHRHLVALLGYCINGSERLL--VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTI-ALDV 693
HL +C ++ L V EY+ G L H+ + R A ++
Sbjct: 60 ---HL-----FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFD------EARARFYAAEI 105
Query: 694 ARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFG 753
G+++LH + I+RDLK N+L+ D K+ADFG+ K +G+ T GT
Sbjct: 106 ICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPD 161
Query: 754 YLAPE 758
Y+APE
Sbjct: 162 YIAPE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 53/204 (25%), Positives = 88/204 (43%), Gaps = 44/204 (21%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDG-TKIAVKRMESNTMGNKG-LSEFQAEIAVLTKVRH 638
++F ++ G +G VY + + A+K++ + + + + E +LT +
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 639 RHLVALLGYCINGSERLL--VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR- 695
+V++ +C ++R L V EY+ G A L K + +D+AR
Sbjct: 61 PFVVSM--FCSFETKRHLCMVMEYVEGGDCATLL-------------KNIGALPVDMARM 105
Query: 696 -------GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK--------NAPDG 740
+EYLH+ +HRDLKP N+LI K+ DFGL K N +G
Sbjct: 106 YFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEG 162
Query: 741 KYSVETR------LAGTFGYLAPE 758
+TR + GT Y+APE
Sbjct: 163 HIEKDTREFLDKQVCGTPEYIAPE 186
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 29/67 (43%), Positives = 36/67 (53%), Gaps = 13/67 (19%)
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG----KYSVETRLAGT 751
G+++LHS IHRDLKPSNI++ D K+ DFGL + A Y V TR
Sbjct: 130 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRY--- 182
Query: 752 FGYLAPE 758
Y APE
Sbjct: 183 --YRAPE 187
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 52/183 (28%), Positives = 87/183 (47%), Gaps = 15/183 (8%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKI-AVKRMESNTMGNKGLSE-FQAEIAVLTKVRH 638
D+F ++GRG FG V ++ +I A+K + M + + F+ E VL
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 639 RHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697
+ + L Y L LV +Y G L L ++ D + +A V
Sbjct: 61 QWITTL-HYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMA-------RFYIAEMV 112
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG-LVKNAPDGKYSVETRLA-GTFGYL 755
+HS+ Q ++HRD+KP N+L+ + ++ADFG +K DG +V++ +A GT Y+
Sbjct: 113 LAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG--TVQSSVAVGTPDYI 170
Query: 756 APE 758
+PE
Sbjct: 171 SPE 173
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-07
Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 57 WTGINC--DNSNR---VTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLA 110
W+G +C D++ + + L GL G + +IS L L++++ N+I G IP SL
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG 463
Query: 111 NATSLQDIYLDNNNFT-SVPTGCFDGLTNLQVLSLSDN 147
+ TSL+ + L N+F S+P LT+L++L+L+ N
Sbjct: 464 SITSLEVLDLSYNSFNGSIPES-LGQLTSLRILNLNGN 500
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 39/140 (27%), Positives = 59/140 (42%), Gaps = 29/140 (20%)
Query: 148 PNLAPWPFPNELTKSTS----LTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSL 203
P PW + ST + L +DN + G IP+ +LQ++ LS N+ G++
Sbjct: 399 PQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNI 458
Query: 204 PASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD-LSKCESLFD 262
P S G+ +T L + L N F G IP+ L + SL
Sbjct: 459 PPSL------------------GS------ITSLEVLDLSYNSFNGSIPESLGQLTSLRI 494
Query: 263 LSLRDNQLTGVVPASVISLP 282
L+L N L+G VPA++
Sbjct: 495 LNLNGNSLSGRVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 50/182 (27%), Positives = 83/182 (45%), Gaps = 17/182 (9%)
Query: 588 ILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646
++G+G +GVV + G K+A+K++ + EI +L +RH +V +
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 647 YCINGSER-----LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLH 701
+ S R +V+E M + + + +D LT + + R ++Y+H
Sbjct: 67 IMLPPSRREFKDIYVVFELM--ESDLHQVIKANDD----LTPEHHQFFLYQLLRALKYIH 120
Query: 702 SLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA-PDGKYSV-ETRLAGTFGYLAPEY 759
+ + HRDLKP NIL D + K+ DFGL + A D ++ T T Y APE
Sbjct: 121 T---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 177
Query: 760 AG 761
G
Sbjct: 178 CG 179
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 55/183 (30%), Positives = 83/183 (45%), Gaps = 18/183 (9%)
Query: 582 NFSEANILGRGGFGVVYGGELPDGTK--IAVKRMESNTM-GNKGLSEFQAEIAVLTKVRH 638
+F+ +LG+G FG V E GT A+K ++ + + + + E VL
Sbjct: 1 DFNFLMVLGKGSFGKVMLAE-RKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK 59
Query: 639 RHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697
+ L C +RL V EY+ G L H+ V A ++A G+
Sbjct: 60 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-----QQVGKFKEPHAVFYAAEIAIGL 114
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK-NAPDGKYSVETR-LAGTFGYL 755
+LHS + I+RDLK N+++ + K+ADFG+ K N GK TR GT Y+
Sbjct: 115 FFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK---TTRTFCGTPDYI 168
Query: 756 APE 758
APE
Sbjct: 169 APE 171
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 49/185 (26%), Positives = 81/185 (43%), Gaps = 14/185 (7%)
Query: 579 VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR 637
++ + +GRG FG V P GT +AVKR+ S K ++ V+ +
Sbjct: 2 TAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTV-DEKEQKRLLMDLDVVMRSS 60
Query: 638 H-RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRV--TIALDVA 694
++V G + + E M ++ F + + + + IA+
Sbjct: 61 DCPYIVKFYGALFREGDCWICMELM---DISLDKFYKYVYEVLKSVIPEEILGKIAVATV 117
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSV-ETRLAGTFG 753
+ + YL + IHRD+KPSNIL+ + K+ DFG+ D S+ +TR AG
Sbjct: 118 KALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD---SIAKTRDAGCRP 172
Query: 754 YLAPE 758
Y+APE
Sbjct: 173 YMAPE 177
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 36/87 (41%), Positives = 46/87 (52%), Gaps = 12/87 (13%)
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGY 754
RG++Y+HS IHRDLKPSN+ + +D ++ DFGL + A D T T Y
Sbjct: 129 RGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEM----TGYVATRWY 181
Query: 755 LAPEYAGKHWMILCQMTGLIWLHGSVG 781
APE +WM Q T IW SVG
Sbjct: 182 RAPEIM-LNWMHYNQ-TVDIW---SVG 203
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 53/184 (28%), Positives = 84/184 (45%), Gaps = 18/184 (9%)
Query: 580 TDNFSEANILGRGGFGVVYGGELPDGTKI-AVKRMESNT-MGNKGLSEFQAEIAVLTKVR 637
NF +LG+G FG V E ++ A+K ++ + + + + E VL
Sbjct: 1 DFNFL--MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD 58
Query: 638 HRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARG 696
+ L C +RL V EY+ G L H+ Q V A +++ G
Sbjct: 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI-----QQVGKFKEPQAVFYAAEISVG 113
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK-NAPDGKYSVETR-LAGTFGY 754
+ +LH ++ I+RDLK N+++ + K+ADFG+ K + DG V TR GT Y
Sbjct: 114 LFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG---VTTRTFCGTPDY 167
Query: 755 LAPE 758
+APE
Sbjct: 168 IAPE 171
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 49/181 (27%), Positives = 82/181 (45%), Gaps = 26/181 (14%)
Query: 588 ILGRGGFGVVYGGELP-DGTKIAVKRMESNT-MGNKGLSEFQAEIAVLTKVRHRHLVALL 645
+LG+G FG V L G AVK ++ + + + + E +L+ R+ + L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 646 GYCINGSERLL-VYEYMPRGTLAQHL-----FEWHDHGYTPLTWKQRVTI-ALDVARGVE 698
C +RL V E++ G L H+ F+ + R A ++ +
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD-----------EARARFYAAEITSALM 110
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA-PDGKYSVETRLAGTFGYLAP 757
+LH + I+RDLK N+L+ + K+ADFG+ K +GK + + GT Y+AP
Sbjct: 111 FLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT--STFCGTPDYIAP 165
Query: 758 E 758
E
Sbjct: 166 E 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 44/175 (25%), Positives = 68/175 (38%), Gaps = 33/175 (18%)
Query: 576 LRQVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLT 634
L T F ++G G +G VY G +A+K M+ + E + E +L
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEE---EIKEEYNILR 57
Query: 635 KV-RHRHLVALLG------YCINGSERLLVYEYMPRGT---LAQHLFEWHDHGYTPLTWK 684
K H ++ G N + LV E G+ L + L
Sbjct: 58 KYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGL----------RKKG 107
Query: 685 QRVT------IALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733
+R+ I + RG+ YLH + IHRD+K NIL+ + K+ DFG+
Sbjct: 108 KRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGV 159
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 49/186 (26%), Positives = 81/186 (43%), Gaps = 19/186 (10%)
Query: 582 NFSEANILGRGGFGVVY-----GGELPDGTKI-AVKRMESNTMGNKG--LSEFQAEIAVL 633
NF +LG G +G V+ G D K+ A+K ++ + K + + E VL
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTG--HDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVL 58
Query: 634 TKVRHRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALD 692
VR + L Y +L L+ +Y+ G + HL++ D+ + R +
Sbjct: 59 EHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ-RDNFSED---EVRFYSG-E 113
Query: 693 VARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTF 752
+ +E+LH L ++RD+K NIL+ + + DFGL K + GT
Sbjct: 114 IILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTI 170
Query: 753 GYLAPE 758
Y+APE
Sbjct: 171 EYMAPE 176
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 55/190 (28%), Positives = 87/190 (45%), Gaps = 15/190 (7%)
Query: 573 IEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKI-AVKRMESNTMGNKGLSEFQAEIA 631
I L+ +++ ++GRG FG V K+ A+K + M + S F E
Sbjct: 35 IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 632 VLTKVRHRHLVALLGYCINGSERLL--VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTI 689
+ + V L +C ++ L V EYMP G L +L +D P W + T
Sbjct: 95 DIMAFANSPWVVQL-FCAFQDDKYLYMVMEYMPGGDLV-NLMSNYD---VPEKWAKFYTA 149
Query: 690 ALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL-VKNAPDGKYSVETRL 748
+V ++ +HS+ IHRD+KP N+L+ K+ADFG +K G +T +
Sbjct: 150 --EVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV 204
Query: 749 AGTFGYLAPE 758
GT Y++PE
Sbjct: 205 -GTPDYISPE 213
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 52/177 (29%), Positives = 86/177 (48%), Gaps = 21/177 (11%)
Query: 589 LGRGGFGVVYGG-ELPDGTKIAVK--RMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
LG+G +G VY P G +A+K R+E + ++ E+ +L K ++V
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLE---LDESKFNQIIMELDILHKAVSPYIVDFY 65
Query: 646 G-YCINGSERLLVY---EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLH 701
G + I G+ VY EYM G+L + P +R+T A V +G+++L
Sbjct: 66 GAFFIEGA----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYA--VVKGLKFLK 119
Query: 702 SLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
+ + IHRD+KP+N+L+ + + K+ DFG+ N S+ G Y+APE
Sbjct: 120 E--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL---VASLAKTNIGCQSYMAPE 171
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 54/191 (28%), Positives = 86/191 (45%), Gaps = 18/191 (9%)
Query: 576 LRQVTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLT 634
LR F ++G G +G VY G + G A+K M+ G++ E + EI +L
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTGDEE-EEIKQEINMLK 57
Query: 635 KV-RHRHLVALLGYCINGS------ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRV 687
K HR++ G I + + LV E+ G++ + + G T L +
Sbjct: 58 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNT-LKEEWIA 114
Query: 688 TIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR 747
I ++ RG+ +LH Q IHRD+K N+L+ ++ K+ DFG V D
Sbjct: 115 YICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFG-VSAQLDRTVGRRNT 170
Query: 748 LAGTFGYLAPE 758
GT ++APE
Sbjct: 171 FIGTPYWMAPE 181
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 52/196 (26%), Positives = 83/196 (42%), Gaps = 18/196 (9%)
Query: 571 ISIEVLRQVTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAE 629
I + LR F ++G G +G VY G + G A+K M+ + E + E
Sbjct: 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTEDEEEEIKLE 62
Query: 630 IAVLTKV-RHRHLVALLGYCINGS------ERLLVYEYMPRGTLAQHLFEWHDHGYTPLT 682
I +L K HR++ G I S + LV E+ G++ + +
Sbjct: 63 INMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE-D 121
Query: 683 WKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742
W I ++ RG+ +LH+ IHRD+K N+L+ ++ K+ DFG V D
Sbjct: 122 WI--AYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFG-VSAQLDRTV 175
Query: 743 SVETRLAGTFGYLAPE 758
GT ++APE
Sbjct: 176 GRRNTFIGTPYWMAPE 191
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 5e-07
Identities = 30/87 (34%), Positives = 47/87 (54%), Gaps = 8/87 (9%)
Query: 675 DHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734
+ PLT + ++ + VARG+E+L A + IHRDL NIL+ ++ K+ DFGL
Sbjct: 164 ELYKEPLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLA 220
Query: 735 KNA---PDGKYSVETRLAGTFGYLAPE 758
++ PD + RL ++APE
Sbjct: 221 RDIYKDPDYVRKGDARLP--LKWMAPE 245
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 6e-07
Identities = 26/86 (30%), Positives = 37/86 (43%), Gaps = 26/86 (30%)
Query: 114 SLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNA 173
+L+ + L NN T +P G F GL NL+VL LS N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGN-------------------------- 34
Query: 174 NIFGLIPDFFDSFSNLQNLRLSYNNF 199
N+ + P+ F +L++L LS NN
Sbjct: 35 NLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 9e-07
Identities = 50/182 (27%), Positives = 80/182 (43%), Gaps = 28/182 (15%)
Query: 589 LGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQA-----EIAVLTKVRHRHLV 642
+GRG +G+V K+A+K++ +N N+ A EI +L + H +++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKI-ANAFDNR----IDAKRTLREIKLLRHLDHENVI 67
Query: 643 ALLGYCINGSER------LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARG 696
A+ + R +VYE M L Q + L+ + RG
Sbjct: 68 AIKD-IMPPPHREAFNDVYIVYELMDT-DLHQII-----RSSQTLSDDHCQYFLYQLLRG 120
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLA 756
++Y+HS + +HRDLKPSN+L+ + K+ DFGL + K T T Y A
Sbjct: 121 LKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTT-SEKGDFMTEYVVTRWYRA 176
Query: 757 PE 758
PE
Sbjct: 177 PE 178
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 56/190 (29%), Positives = 81/190 (42%), Gaps = 44/190 (23%)
Query: 588 ILGRGGFGVVYGGELPDGTKI-AVKRMESN----------TMGNKGLSEFQAEIAVLTKV 636
+LG+G FG V EL ++ A+K ++ + TM K + A
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-------- 53
Query: 637 RHRHLVALLGYCINGSERLL-VYEYMPRGTL------AQHLFEWHDHGYTPLTWKQRVTI 689
+H L AL C +RL V EY+ G L ++ E Y VT+
Sbjct: 54 KHPFLTALHC-CFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYA-----AEVTL 107
Query: 690 ALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK-NAPDGKYSVETRL 748
AL +LH + I+RDLK NIL+ + K+ADFG+ K +G + T
Sbjct: 108 AL------MFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT--TTF 156
Query: 749 AGTFGYLAPE 758
GT Y+APE
Sbjct: 157 CGTPDYIAPE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 40/156 (25%), Positives = 73/156 (46%), Gaps = 12/156 (7%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRM--ESNTMGNKGLSEFQAEIAVLTKVRH 638
D+F ++GRG FG V + D I ++ +++ + + ++ +AE +L +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 639 RHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697
+V + Y L L+ E++P G + L + T + T +A V
Sbjct: 61 AWVVKMF-YSFQDKRNLYLIMEFLPGGDMMTLLMKKD-------TLSEEAT-QFYIAETV 111
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733
+ ++ Q FIHRD+KP N+L+ K++DFGL
Sbjct: 112 LAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 46/167 (27%), Positives = 74/167 (44%), Gaps = 20/167 (11%)
Query: 579 VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR 637
V + + +G G G+V + G +AVK++ E+ +L V
Sbjct: 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVN 78
Query: 638 HRHLVALLGYCI------NGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIAL 691
H+++++LL + LV E M L Q + DH +R++ L
Sbjct: 79 HKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHMELDH--------ERMSYLL 129
Query: 692 -DVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737
+ G+++LHS IHRDLKPSNI++ D K+ DFGL + A
Sbjct: 130 YQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 51/184 (27%), Positives = 90/184 (48%), Gaps = 17/184 (9%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKI-AVKRMESNTMGNKGLSE-FQAEIAVLTKVRH 638
++F ++GRG FG V +L + K+ A+K + M + + F+ E VL +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLT--WKQRVTIALDVARG 696
+ + L + + LV +Y G L L ++ D + + + IA+D
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAID---- 116
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG-LVKNAPDGKYSVETRLA-GTFGY 754
S+ Q ++HRD+KP NIL+ + ++ADFG +K DG +V++ +A GT Y
Sbjct: 117 -----SVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG--TVQSSVAVGTPDY 169
Query: 755 LAPE 758
++PE
Sbjct: 170 ISPE 173
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 28/184 (15%)
Query: 589 LGRGGFGVVYGGELPD-GTKIAVKRMESNTMGNKGLS-EFQAEIAVLTKVR---HRHLVA 643
+G G +G VY P G +A+K + T GL E+A+L ++ H ++V
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQT-NEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 644 LLGYCING-----SERLLVYEYMPRGTLAQHLFEWHDHGYTP-LTWKQRVTIALDVARGV 697
L+ C ++ LV+E++ Q L + D P L + + RG+
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVD-----QDLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAG---TFGY 754
++LH+ +HRDLKP NIL+ + K+ADFGL + YS + L T Y
Sbjct: 122 DFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLAR-----IYSCQMALTPVVVTLWY 173
Query: 755 LAPE 758
APE
Sbjct: 174 RAPE 177
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 44/154 (28%), Positives = 68/154 (44%), Gaps = 12/154 (7%)
Query: 583 FSEANILGRGGFGVVYGGELPDGTKI-AVKRMESNTMGNKG-LSEFQAEIAVLTKVRHRH 640
F + +G G FG V D + A+K + + + + +AE +L + +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 641 LVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
+V L Y + L V +Y+P G + L G R IA ++ +E
Sbjct: 63 VVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRL---GIFEEDLA-RFYIA-ELTCAIES 116
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733
+H + FIHRD+KP NILI D K+ DFGL
Sbjct: 117 VHKMG---FIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 18/41 (43%), Positives = 27/41 (65%), Gaps = 3/41 (7%)
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735
RG++YLHS +HRD+KP N+L+ + K+ DFGL +
Sbjct: 114 RGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 55/190 (28%), Positives = 87/190 (45%), Gaps = 32/190 (16%)
Query: 582 NFSEANILGRGGFGVVYGGELPDGTKI-AVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
+F+ +LG+G FG V E ++ A+K ++ + + Q + T V R
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV-------IQDDDVECTMVEKR- 52
Query: 641 LVALLG---------YCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIA 690
++AL G C +RL V EY+ G L + + V A
Sbjct: 53 VLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQ-----VGRFKEPHAVFYA 107
Query: 691 LDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK-NAPDGKYSVETR-L 748
++A G+ +LHS + I+RDLK N+++ + K+ADFG+ K N DG V T+
Sbjct: 108 AEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG---VTTKTF 161
Query: 749 AGTFGYLAPE 758
GT Y+APE
Sbjct: 162 CGTPDYIAPE 171
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 27/90 (30%), Positives = 51/90 (56%), Gaps = 7/90 (7%)
Query: 631 AVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIA 690
+++++V H HL + G C+ GSE ++V E++ G L L + + G P+ WK +T+A
Sbjct: 68 SLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWK--ITVA 123
Query: 691 LDVARGVEYLHSLAQQSFIHRDLKPSNILI 720
+A + YL ++ +H ++ NIL+
Sbjct: 124 QQLASALSYLED---KNLVHGNVCAKNILL 150
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 28/82 (34%), Positives = 44/82 (53%), Gaps = 8/82 (9%)
Query: 680 PLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA-- 737
LT + + + VA+G+E+L A + IHRDL NIL+ ++ K+ DFGL ++
Sbjct: 175 VLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 231
Query: 738 -PDGKYSVETRLAGTFGYLAPE 758
PD + RL ++APE
Sbjct: 232 DPDYVRKGDARLP--LKWMAPE 251
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 19/42 (45%), Positives = 30/42 (71%), Gaps = 4/42 (9%)
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIG-DDMRAKVADFGLVK 735
RG++Y+HS + +HRDLKP+N+ I +D+ K+ DFGL +
Sbjct: 125 RGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLAR 163
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 40/144 (27%), Positives = 62/144 (43%), Gaps = 18/144 (12%)
Query: 618 MGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHG 677
+G KG + +A +L V H ++ + ++G+ +V +P + L+ +
Sbjct: 98 IGQKGTTLIEA--MLLQNVNHPSVIRMKDTLVSGAITCMV---LPH--YSSDLYTYLTKR 150
Query: 678 YTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK-- 735
PL Q + I + G+ YLH Q IHRD+K NI I D + + D G +
Sbjct: 151 SRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFP 207
Query: 736 -NAPDGKYSVETRLAGTFGYLAPE 758
AP LAGT APE
Sbjct: 208 VVAPA-----FLGLAGTVETNAPE 226
|
Length = 357 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 42/155 (27%), Positives = 70/155 (45%), Gaps = 10/155 (6%)
Query: 581 DNFSEANILGRGGFGVVYGGELPD-GTKIAVKRMESNTMGNK-GLSEFQAEIAVLTKVRH 638
++F ++GRG FG V + D G A+K + M K + +AE +L +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
+V + + L+ E++P G + L + T + T +A V
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKD-------TLTEEET-QFYIAETVL 112
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733
+ S+ Q FIHRD+KP N+L+ K++DFGL
Sbjct: 113 AIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 4e-06
Identities = 49/188 (26%), Positives = 78/188 (41%), Gaps = 42/188 (22%)
Query: 589 LGRGGFGVV---YGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
+G G G+V Y L +A+K++ E+ ++ V H+++++LL
Sbjct: 25 IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 646 GYCINGSERLLVYEYMPRGTLAQH-----LFEWHDHGYTPLTWKQRVTIALDVAR----- 695
+ P+ +L + + E D Q + + LD R
Sbjct: 83 NV------------FTPQKSLEEFQDVYLVMELMDANLC-----QVIQMELDHERMSYLL 125
Query: 696 -----GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAG 750
G+++LHS IHRDLKPSNI++ D K+ DFGL + A G + T
Sbjct: 126 YQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVV 180
Query: 751 TFGYLAPE 758
T Y APE
Sbjct: 181 TRYYRAPE 188
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 5e-06
Identities = 36/89 (40%), Positives = 48/89 (53%), Gaps = 16/89 (17%)
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS--VETRLAGTF 752
G++Y+HS IHRDLKP N+ + +D K+ DFGL ++A D + + V TR
Sbjct: 128 CGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHA-DAEMTGYVVTRW---- 179
Query: 753 GYLAPEYAGKHWMILCQMTGLIWLHGSVG 781
Y APE +WM Q T IW SVG
Sbjct: 180 -YRAPEVI-LNWMHYNQ-TVDIW---SVG 202
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 52/184 (28%), Positives = 76/184 (41%), Gaps = 21/184 (11%)
Query: 589 LGRGGFGVVY---------GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHR 639
LG+G FG VY L +I V + N E +L+K+ H
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ-----EAQLLSKLDHP 62
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
+V + ++ EY L L E G T L+ Q + + GV Y
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKT-LSENQVCEWFIQLLLGVHY 121
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEY 759
+H Q+ +HRDLK NI + +++ K+ DFG V G + T GT Y++PE
Sbjct: 122 MH---QRRILHRDLKAKNIFLKNNL-LKIGDFG-VSRLLMGSCDLATTFTGTPYYMSPE- 175
Query: 760 AGKH 763
A KH
Sbjct: 176 ALKH 179
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 5e-06
Identities = 55/174 (31%), Positives = 80/174 (45%), Gaps = 15/174 (8%)
Query: 589 LGRGGFGVVYGGELPDGTKI-AVKRM-ESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646
+G+G FG V D +I A+K + +++ + ++ AE VL +V +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-K 59
Query: 647 YCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQ 705
+ E+L LV ++ G L HL G L+ + T L A +E LH
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHL---QREGRFDLSRARFYTAELLCA--LENLHKF-- 112
Query: 706 QSFIHRDLKPSNILIGDDMRAKVADFGLVK-NAPDGKYSVETRLAGTFGYLAPE 758
+ I+RDLKP NIL+ + DFGL K N D + GT YLAPE
Sbjct: 113 -NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKT--NTFCGTPEYLAPE 163
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 5e-06
Identities = 50/175 (28%), Positives = 77/175 (44%), Gaps = 14/175 (8%)
Query: 589 LGRGGFGVVYGGELPDGTKI-AVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRH---LVA 643
+G+G FG VY D +I A+K + + K ++ E +L + +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 644 LLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSL 703
L S+ LV +YM G L HL + ++ + + IA ++ +E+LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHL--QKEGRFS--EDRAKFYIA-ELVLALEHLH-- 113
Query: 704 AQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
+ ++RDLKP NIL+ + DFGL K A GT YLAPE
Sbjct: 114 -KYDIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPE 166
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-06
Identities = 28/63 (44%), Positives = 36/63 (57%), Gaps = 5/63 (7%)
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYL 755
G+++LHS IHRDLKPSNI++ D K+ DFGL + A G + T T Y
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYR 192
Query: 756 APE 758
APE
Sbjct: 193 APE 195
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 9e-06
Identities = 17/59 (28%), Positives = 27/59 (45%), Gaps = 1/59 (1%)
Query: 91 QLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNP 148
L++L N + + +L+ + L NN TS+ F GL +L+ L LS N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
|
Length = 60 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 9e-06
Identities = 44/154 (28%), Positives = 69/154 (44%), Gaps = 12/154 (7%)
Query: 583 FSEANILGRGGFG-VVYGGELPDGTKIAVKRMESNTMGNKG-LSEFQAEIAVLTKVRHRH 640
F + LG G FG V ++ A+K + + N+ ++ +AE +L + +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 641 LVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
+V L Y + L V +Y+P G + L P + L +A +E
Sbjct: 63 VVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRM---EVFPEVLARFYIAELTLA--IES 116
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733
+H + FIHRD+KP NILI D K+ DFGL
Sbjct: 117 VHKMG---FIHRDIKPDNILIDLDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 45/154 (29%), Positives = 69/154 (44%), Gaps = 12/154 (7%)
Query: 583 FSEANILGRGGFG-VVYGGELPDGTKIAVKRM-ESNTMGNKGLSEFQAEIAVLTKVRHRH 640
F + LG G FG V ++ A+K + + + + ++ +AE +L + +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 641 LVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
+V L Y + L V +Y+P G + L G P + L A VE
Sbjct: 63 VVRLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRM---GIFPEDLARFYIAELTCA--VES 116
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733
+H + FIHRD+KP NILI D K+ DFGL
Sbjct: 117 VHKM---GFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 1e-05
Identities = 42/171 (24%), Positives = 71/171 (41%), Gaps = 25/171 (14%)
Query: 619 GNKGLSEFQAEIAVLTKVRHRHLVAL--------LGYCINGSERLLVYEYMPRGTLAQHL 670
G++ + + EI L ++ H +++ + Y I +Y +M
Sbjct: 203 GSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEA----- 257
Query: 671 FEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVAD 730
F+W D PL + R I + VEY+H + IHRD+K NI + D + + D
Sbjct: 258 FDWKD---RPLLKQTR-AIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDGKIVLGD 310
Query: 731 FGLVKNAPDGKYSVETRLAGTFGYLAPE-YAGKHWMILCQMTGLIWLHGSV 780
FG + + + GT +PE AG + C++T IW G +
Sbjct: 311 FGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGY---CEITD-IWSCGLI 357
|
Length = 501 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 25/115 (21%), Positives = 45/115 (39%), Gaps = 14/115 (12%)
Query: 626 FQAEIAVLTKVRHRHLVA--LLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTW 683
+ E+A+L + + L +L + L+ E++ TL ++
Sbjct: 38 REREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL------------DEVSE 85
Query: 684 KQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738
+++ IA +A + LH L H DL P NIL+ D + D+ P
Sbjct: 86 EEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 48/180 (26%), Positives = 75/180 (41%), Gaps = 24/180 (13%)
Query: 588 ILGRGGFGVVYGGELPDGTKIAVKRMESNTM--GNKGLSEFQAEIAVLTKVRHRHLVALL 645
++GRG + V L +I ++ + ++ + Q E V + + L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 646 GYCINGSERL-LVYEYMPRGTLAQH------LFEWHDHGYTPLTWKQRVTIALDVARGVE 698
C + RL LV EY+ G L H L E H Y + IAL+
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYA-----AEICIALN------ 110
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
+LH ++ I+RDLK N+L+ D K+ D+G+ K G + GT Y+APE
Sbjct: 111 FLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGL-GPGDTTSTFCGTPNYIAPE 166
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 41/204 (20%), Positives = 82/204 (40%), Gaps = 43/204 (21%)
Query: 588 ILGRGGFG-VVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVA--- 643
++G+G +G V DG + +K++ + + E +L++++H ++VA
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 644 -----------LLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALD 692
++G+C G + E + + EW +
Sbjct: 67 SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWF----------------VQ 110
Query: 693 VARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTF 752
+A ++YLH ++ +HRDLK N+ + KV D G+ + + + + + L GT
Sbjct: 111 IAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIAR-VLENQCDMASTLIGTP 166
Query: 753 GYLAPE--------YAGKHWMILC 768
Y++PE Y W + C
Sbjct: 167 YYMSPELFSNKPYNYKSDVWALGC 190
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 6e-05
Identities = 50/182 (27%), Positives = 78/182 (42%), Gaps = 28/182 (15%)
Query: 588 ILGRGGFGVVYGGELPDGTKIAVKRMESNTMGN--KGLSEFQAEIAVL-TKVRHRHLVAL 644
++GRG + V EL +I ++ + N + + Q E V T H LV L
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 645 LGYCINGSERL-LVYEYMPRGTLAQH------LFEWHDHGYTPLTWKQRVTIALDVARGV 697
C RL V E++ G L H L E H Y+ +++AL+
Sbjct: 62 HS-CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYS-----AEISLALN----- 110
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK-NAPDGKYSVETRLAGTFGYLA 756
+LH + I+RDLK N+L+ + K+ D+G+ K G + + GT Y+A
Sbjct: 111 -FLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT--STFCGTPNYIA 164
Query: 757 PE 758
PE
Sbjct: 165 PE 166
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 6e-05
Identities = 49/194 (25%), Positives = 75/194 (38%), Gaps = 35/194 (18%)
Query: 132 CFDGLTN---LQVLSLSDNP----NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFF- 183
GLT LQ L LSDN L +S+SL L ++N +
Sbjct: 73 LLQGLTKGCGLQELDLSDNALGPDGCGVLE---SLLRSSSLQELKLNNNGLGDRGLRLLA 129
Query: 184 ----DSFSNLQNLRLSYNNFTGSLPASFAK-----SDIQNLWMNDQQLGLSGTLDVLSGM 234
D L+ L L N G+ + AK D++ L + + +G +G + G+
Sbjct: 130 KGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGL 189
Query: 235 ---TQLRQVWLHKNQFT--GPIPDLSKC----ESLFDLSLRDNQLTGV-----VPASVIS 280
L + L+ N T G L++ +SL L+L DN LT A +
Sbjct: 190 KANCNLEVLDLNNNGLTDEGAS-ALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSP 248
Query: 281 LPALLNISLQNNKL 294
+LL +SL N +
Sbjct: 249 NISLLTLSLSCNDI 262
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-05
Identities = 48/182 (26%), Positives = 76/182 (41%), Gaps = 28/182 (15%)
Query: 588 ILGRGGFGVVYGGELPDGTKIAVKRMESNTMGN--KGLSEFQAEIAVLTKVRHRHLVALL 645
++GRG + V L +I ++ + N + + Q E V + + + L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 646 GYCINGSERLL-VYEYMPRGTLAQH------LFEWHDHGYTPLTWKQRVTIALDVARGVE 698
C RL V EY+ G L H L E H Y+ +++AL+
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS-----AEISLALN------ 110
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA--PDGKYSVETRLAGTFGYLA 756
YLH ++ I+RDLK N+L+ + K+ D+G+ K P S GT Y+A
Sbjct: 111 YLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS---TFCGTPNYIA 164
Query: 757 PE 758
PE
Sbjct: 165 PE 166
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 7e-05
Identities = 51/190 (26%), Positives = 73/190 (38%), Gaps = 32/190 (16%)
Query: 588 ILGRGGFG-VVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646
+LG G G V+ + DG AVK ++ M + QAE+ L +V
Sbjct: 39 VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHE 98
Query: 647 YCINGSER--------LLVYEYMPRGTLAQHL---------FEWHDHGYTPLTWKQRVTI 689
R LV +Y G L Q + F H+ G +
Sbjct: 99 DFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGL----------L 148
Query: 690 ALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN-APDGKYSVETRL 748
+ V V ++HS + IHRD+K +NIL+ + K+ DFG K A V
Sbjct: 149 FIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTF 205
Query: 749 AGTFGYLAPE 758
GT Y+APE
Sbjct: 206 CGTPYYVAPE 215
|
Length = 496 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 42/174 (24%), Positives = 76/174 (43%), Gaps = 14/174 (8%)
Query: 589 LGRGGFG-VVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY 647
+G G FG + DG + +K + + M K E + E+AVL+ ++H ++V
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 648 CINGSERLLVYEYMPRGTLAQHLFEWHDHGYTP---LTWKQRVTIALDVARGVEYLHSLA 704
+V +Y G L + + + L W ++ +AL +++H
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLAL------KHVHD-- 119
Query: 705 QQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
+ +HRD+K NI + D K+ DFG+ + + + GT YL+PE
Sbjct: 120 -RKILHRDIKSQNIFLTKDGTIKLGDFGIAR-VLNSTVELARTCIGTPYYLSPE 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 52/210 (24%), Positives = 82/210 (39%), Gaps = 25/210 (11%)
Query: 15 LLLLQLTTTSLGDDGSVMLKLAQ---SLQNLPSDWSSTSSTGYCEWTGINCDNSNRVTTI 71
L L L+ +LG DG +L+ SLQ L + + G D + +
Sbjct: 83 LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKL 142
Query: 72 SLAKSGLSGT----LSPEISSLTQLETLSFQMNNIAGA-IPSLANA----TSLQDIYLDN 122
L ++ L G L+ + + L+ L+ N I A I +LA +L+ + L+N
Sbjct: 143 VLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNN 202
Query: 123 NNFT----SVPTGCFDGLTNLQVLSLSDNPNLAPWPF----PNELTKSTSLTTLYMDNAN 174
N T S L +L+VL+L DN NL L+ + SL TL + +
Sbjct: 203 NGLTDEGASALAETLASLKSLEVLNLGDN-NLTDAGAAALASALLSPNISLLTLSLSCND 261
Query: 175 I----FGLIPDFFDSFSNLQNLRLSYNNFT 200
I + + +L L L N F
Sbjct: 262 ITDDGAKDLAEVLAEKESLLELDLRGNKFG 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 2e-04
Identities = 39/158 (24%), Positives = 72/158 (45%), Gaps = 26/158 (16%)
Query: 624 SEFQAEIAVLTKVRHRHLVALLGYCINGSERLL--VYEYMPRGTLAQHLFEWHDHGYTPL 681
S+ E+ V+ +++H+++V + +N + + L + E+ G L++++ + + + +
Sbjct: 57 SQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKM-FGKI 115
Query: 682 TWKQRVTIALDVARGVEYLHSLAQ----QSFIHRDLKPSNILIGDDMR------------ 725
V I + + Y H+L + +HRDLKP NI + +R
Sbjct: 116 EEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNL 175
Query: 726 -----AKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
AK+ DFGL KN G S+ GT Y +PE
Sbjct: 176 NGRPIAKIGDFGLSKNI--GIESMAHSCVGTPYYWSPE 211
|
Length = 1021 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 4e-04
Identities = 19/39 (48%), Positives = 25/39 (64%)
Query: 389 NLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNL 427
L +LK L L NNLT P+ + L SL++LD+S NNL
Sbjct: 22 GLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 6e-04
Identities = 25/68 (36%), Positives = 36/68 (52%), Gaps = 14/68 (20%)
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA----PDGKYSVETRLAG 750
+ ++++H + HRD+KP NILI DD K+ADFG + P +Y + TR
Sbjct: 111 KSLDHMH---RNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEY-ISTRW-- 163
Query: 751 TFGYLAPE 758
Y APE
Sbjct: 164 ---YRAPE 168
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 6e-04
Identities = 27/85 (31%), Positives = 42/85 (49%), Gaps = 4/85 (4%)
Query: 675 DHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734
D G LT ++ VARG+E+L A ++ +HRDL N+L+ K+ DFGL
Sbjct: 228 DDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLA 284
Query: 735 KN-APDGKYSVETRLAGTFGYLAPE 758
++ D Y + ++APE
Sbjct: 285 RDIMHDSNYVSKGSTFLPVKWMAPE 309
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 37.7 bits (88), Expect = 6e-04
Identities = 17/43 (39%), Positives = 21/43 (48%), Gaps = 5/43 (11%)
Query: 25 LGDDGSVMLKLAQSLQNLP----SDWSSTSSTGYCEWTGINCD 63
L DD +L SL P S W+ SS+ C WTG+ CD
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNP-SSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 7e-04
Identities = 68/304 (22%), Positives = 111/304 (36%), Gaps = 31/304 (10%)
Query: 138 NLQVLSLSDNPNLAPWPFPNELTKSTSLTT--LYMDNANIFGLIPDFF-DSFSNLQNLRL 194
N LS N N ++L + + N+ S S L +L L
Sbjct: 15 NTLREVLSSNTYHTTPQSINLNFPDSNLESVAVNRLALNLSSNTLLLLPSSLSRLLSLDL 74
Query: 195 SYNNFTGSLPASFAKSDIQNLWMNDQQL-GLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD 253
+ SL S ++ L D L L + L +T L + L N T IP
Sbjct: 75 LSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNIT-DIPP 133
Query: 254 LSK--CESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLF--PSKVQKVS 309
L +L +L L DN++ +P+ + +LP L N+ L N L L S + +
Sbjct: 134 LIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLD 192
Query: 310 LDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRI 369
L N + L ++ D+ +I+ +N +
Sbjct: 193 LSGNKISDLPPEIELLSA-----LEEL--DLSNNSIIELLSSLSN-----------LKNL 234
Query: 370 ITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSG 429
+ L+N L NL++L+ L L N ++ L L +L+ LD+S N+LS
Sbjct: 235 SGLELSNNKLEDLPES-IGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSN 291
Query: 430 KVPD 433
+P
Sbjct: 292 ALPL 295
|
Length = 394 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 8e-04
Identities = 26/80 (32%), Positives = 43/80 (53%), Gaps = 4/80 (5%)
Query: 680 PLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN-AP 738
PL + + VA+G+++L A ++ IHRD+ N+L+ D AK+ DFGL ++
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264
Query: 739 DGKYSVETRLAGTFGYLAPE 758
D Y V+ ++APE
Sbjct: 265 DSNYVVKGNARLPVKWMAPE 284
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 9e-04
Identities = 24/67 (35%), Positives = 36/67 (53%), Gaps = 4/67 (5%)
Query: 693 VARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN-APDGKYSVETRLAGT 751
VA+G+ +L A ++ IHRDL NIL+ K+ DFGL ++ D Y V+
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 752 FGYLAPE 758
++APE
Sbjct: 280 VKWMAPE 286
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 40/147 (27%), Positives = 64/147 (43%), Gaps = 21/147 (14%)
Query: 316 CKNSSD------AGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWP---FVTCSQ 366
C NSS +GK ++++ + P I + + N P F T S
Sbjct: 65 CNNSSRVVSIDLSGKNISGKISSAI-----FRLPYIQTINLSNNQLSGPIPDDIFTTSSS 119
Query: 367 GRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNN 426
R + NL+N G+I L+ L L N L+G IP+ + +SL+ LD+ N
Sbjct: 120 LRYL--NLSNNNFTGSIPRGSIPN--LETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNV 175
Query: 427 LSGKVPDFGSNV---KFTVSPGNPFIG 450
L GK+P+ +N+ +F N +G
Sbjct: 176 LVGKIPNSLTNLTSLEFLTLASNQLVG 202
|
Length = 968 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 31/144 (21%), Positives = 72/144 (50%), Gaps = 13/144 (9%)
Query: 597 VYGGELPDGTKIAVKRMESNTMGNKGLSE-FQAEIAVLTKVRHRHLVALLGYCINGSERL 655
+Y G + ++ ++ + G+K L + + EI L ++ +++ + G+ I+ + L
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 656 ----LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHR 711
L+ EY RG L + L + D L++K ++ +A+D +G+ L+ + ++
Sbjct: 95 PRLSLILEYCTRGYLREVLDKEKD-----LSFKTKLDMAIDCCKGLYNLYKYTNKP--YK 147
Query: 712 DLKPSNILIGDDMRAKVADFGLVK 735
+L + L+ ++ + K+ GL K
Sbjct: 148 NLTSVSFLVTENYKLKIICHGLEK 171
|
Length = 283 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 27/209 (12%)
Query: 563 LFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYG-GELPDGTKIAVKRMESNTMGNK 621
LF + + +E L TD + +G+G +G VY DG+ AVK ++ + ++
Sbjct: 4 LFPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE 63
Query: 622 GLSEFQAEIAVLTKV-RHRHLVALLGYC-----INGSERLLVYEYMPRGTLAQHLFEWHD 675
E +AE +L + H ++V G + G + LV E G++ + +
Sbjct: 64 ---EIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV----- 115
Query: 676 HGYTPLTWKQRVT------IALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVA 729
G L QR+ I G+++LH+ IHRD+K +NIL+ + K+
Sbjct: 116 KGL--LICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLV 170
Query: 730 DFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
DFG+ + T + GT ++APE
Sbjct: 171 DFGVSAQLTSTRLRRNTSV-GTPFWMAPE 198
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 25/79 (31%), Positives = 41/79 (51%), Gaps = 4/79 (5%)
Query: 681 LTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN-APD 739
L++ V + VA G+E+L A ++ +HRDL N+LI + K+ DFGL ++ D
Sbjct: 236 LSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRD 292
Query: 740 GKYSVETRLAGTFGYLAPE 758
Y + ++APE
Sbjct: 293 SNYISKGSTFLPLKWMAPE 311
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 39/142 (27%), Positives = 64/142 (45%), Gaps = 20/142 (14%)
Query: 589 LGRGGFGVVYGGEL---PDGTKIAVKRMESNTM------GNKGLSEFQAEIAVLTKVRHR 639
LG+G F +Y G L D + + S + L+ F ++++++ H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLA-FFETASLMSQLSHK 61
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARG-VE 698
HLV L G C+ E ++V EY+ G L L ++ L WK LDVA+
Sbjct: 62 HLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNN--VSLHWK------LDVAKQLAS 112
Query: 699 YLHSLAQQSFIHRDLKPSNILI 720
LH L + +H ++ NIL+
Sbjct: 113 ALHYLEDKKLVHGNVCGKNILV 134
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 31/121 (25%), Positives = 51/121 (42%), Gaps = 6/121 (4%)
Query: 603 PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMP 662
P GT + V+ + + L Q E+ + RH +++ GS ++ +M
Sbjct: 23 PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82
Query: 663 RGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD 722
G+ L + G + I RG+ YLH Q +IHR++K S+ILI
Sbjct: 83 YGSANSLLKTYFPEGMSEALIG---NILFGALRGLNYLH---QNGYIHRNIKASHILISG 136
Query: 723 D 723
D
Sbjct: 137 D 137
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 36.3 bits (85), Expect = 0.002
Identities = 14/38 (36%), Positives = 24/38 (63%), Gaps = 2/38 (5%)
Query: 391 TSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428
T+L+ L L N +T +P L+ L +L+ LD+S N ++
Sbjct: 1 TNLETLDLSNNQITD-LP-PLSNLPNLETLDLSGNKIT 36
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 35.9 bits (84), Expect = 0.003
Identities = 14/36 (38%), Positives = 19/36 (52%), Gaps = 2/36 (5%)
Query: 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNP 148
T+L+ + L NN T +P L NL+ L LS N
Sbjct: 1 TNLETLDLSNNQITDLPP--LSNLPNLETLDLSGNK 34
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 47/189 (24%), Positives = 84/189 (44%), Gaps = 21/189 (11%)
Query: 580 TDNFSEANILGRGGFGVVYG-GELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR- 637
+D + +G+G +G V+ +G+K AVK ++ ++ E +AE +L +
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDE---EIEAEYNILKALSD 73
Query: 638 HRHLVALLGY-----CINGSERLLVYEYMPRGT---LAQHLFEWHDHGYTPLTWKQRVTI 689
H ++V G NG + LV E G+ L + + + P+ I
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPII----AYI 129
Query: 690 ALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLA 749
+ G+++LH IHRD+K +NIL+ + K+ DFG+ + T +
Sbjct: 130 LHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV- 185
Query: 750 GTFGYLAPE 758
GT ++APE
Sbjct: 186 GTPFWMAPE 194
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 27/163 (16%), Positives = 43/163 (26%), Gaps = 49/163 (30%)
Query: 625 EFQAEIAVLTKVRHRHLVA--LLGYCINGSERLLVYEYMPR------------------- 663
E + E+A+L + + +L +G L + M
Sbjct: 36 ELRRELALLRHLAAAGIPVPRVLAGGTDGGGLGLPFLLMEGLPGEVLTRPLDPAERGALL 95
Query: 664 GTLAQHLFEWHDHGYT--PLTWKQRVTIALD---VARGVEYLHS---------------- 702
LA+ L H PL + R + L A + +
Sbjct: 96 EALARLLARLHSVPPEALPLARRLRRRLKLLRQLAAALRRLVAAELLDRLAELWERLLAA 155
Query: 703 ------LAQQSFIHRDLKPSNILIGDDMR-AKVADFGLVKNAP 738
+H DL P N+L+ R V DF
Sbjct: 156 LLALLPALPLVLVHGDLHPGNLLVDPGGRVTGVIDFEDAGLGD 198
|
This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 32/104 (30%), Positives = 49/104 (47%), Gaps = 9/104 (8%)
Query: 629 EIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVT 688
EI +L + HR ++ L+ S +V MP+ LF + D PL +Q +T
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYK--CDLFTYVD-RSGPLPLEQAIT 189
Query: 689 IALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732
I + + YLH + IHRD+K NI + + A + DFG
Sbjct: 190 IQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFG 230
|
Length = 392 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.004
Identities = 38/114 (33%), Positives = 53/114 (46%), Gaps = 23/114 (20%)
Query: 655 LLVYEYMPRGTL--------AQHL-FEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQ 705
LL+ EY G L +HL F+ ++ G L + Q + +ALD +HS
Sbjct: 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG---LLFYQ-IVLALD------EVHS--- 187
Query: 706 QSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG-KYSVETRLAGTFGYLAPE 758
+ +HRDLK +NI + K+ DFG K D V + GT YLAPE
Sbjct: 188 RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE 241
|
Length = 478 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 782 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.98 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.98 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.98 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.98 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.97 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.97 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.97 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.97 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.97 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.97 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.97 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.97 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.97 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.97 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.97 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.97 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.97 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.97 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.97 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.97 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.97 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.97 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.97 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.97 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.97 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.97 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.97 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.96 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.96 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.96 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.96 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.96 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.96 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.96 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.96 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.96 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.96 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.96 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.96 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.96 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.96 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.96 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.96 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.96 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.96 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.96 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.96 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.96 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.96 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.96 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.96 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.96 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.96 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.96 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.96 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.96 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.96 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.96 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.96 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.96 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.96 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.96 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.96 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.95 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.95 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.95 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.95 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.95 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.95 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.95 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.95 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.95 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.95 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.95 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.95 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.95 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.95 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.95 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.95 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.95 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.95 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.95 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.95 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.95 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.95 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.95 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.95 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.95 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.95 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.95 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.95 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.95 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.95 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.95 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.95 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.95 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.95 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.95 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.95 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.95 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.95 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.95 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.95 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.95 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.95 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.95 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.95 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.94 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.94 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.94 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.94 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.94 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.94 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.94 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.94 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.94 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.94 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.94 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.94 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.94 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.94 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.94 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.94 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.94 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.94 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.94 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.94 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.94 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.94 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.94 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.94 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.94 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.94 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.94 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.94 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.94 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.94 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.94 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.94 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.94 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.94 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.94 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.94 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.94 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.94 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.94 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.94 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.94 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.94 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.94 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.94 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.94 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.94 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.94 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.94 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.94 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.94 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.94 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.94 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.94 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.94 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.93 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.93 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.93 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.93 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.93 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.93 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.93 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.93 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.93 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.93 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.93 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.93 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.93 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.93 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.93 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.93 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.93 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.93 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.93 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.93 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.93 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.93 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.93 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.93 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.93 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.93 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.93 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.93 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.93 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.93 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.93 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.93 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.93 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.93 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.93 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.93 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.93 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.92 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.92 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.92 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.92 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.92 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.92 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.92 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.92 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.92 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.92 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.92 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.92 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.92 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.92 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.92 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.92 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.91 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.91 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.91 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.91 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.9 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.9 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.9 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.89 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.89 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.89 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.88 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.88 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.88 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.87 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.86 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.86 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.86 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.84 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.84 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.78 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.77 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.76 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.76 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.75 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.74 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.72 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.72 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.69 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.67 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.64 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.62 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.61 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.61 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.56 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.5 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.49 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.49 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.48 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.48 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.47 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.44 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.37 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.36 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.35 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.34 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.33 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.32 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.29 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.28 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.23 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.22 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.21 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.19 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.19 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.18 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.18 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.12 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.12 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.11 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.11 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.1 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.1 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.08 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.08 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.03 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.0 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.99 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.92 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.9 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.89 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.88 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.84 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.79 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.68 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.66 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.66 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.57 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.57 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.56 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.53 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.48 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.46 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.44 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.42 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.41 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.38 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-75 Score=710.80 Aligned_cols=715 Identities=26% Similarity=0.431 Sum_probs=410.8
Q ss_pred CCCCCChhHHHHHH--HHHHHhhccccchhHHHHHHHHHhcCCCC---CCCCCCCCCCCccccceEeCCCCCEEEEEeCC
Q 003982 1 MMRKKPQVSICAVV--LLLLQLTTTSLGDDGSVMLKLAQSLQNLP---SDWSSTSSTGYCEWTGINCDNSNRVTTISLAK 75 (782)
Q Consensus 1 ~m~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~~~~~~~~~---~~w~~~~~~~~c~w~gv~c~~~~~v~~L~l~~ 75 (782)
|..+.|+..+++++ +.++.......++|+.||++||+++.+.. .+| +...+||.|.||+|++.++|+.|+|++
T Consensus 1 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~w--~~~~~~c~w~gv~c~~~~~v~~L~L~~ 78 (968)
T PLN00113 1 MAKKGPQHCPYLIFMLFFLFLNFSMLHAEELELLLSFKSSINDPLKYLSNW--NSSADVCLWQGITCNNSSRVVSIDLSG 78 (968)
T ss_pred CCCCCCCCCChHHHHHHHHHHHccCCCHHHHHHHHHHHHhCCCCcccCCCC--CCCCCCCcCcceecCCCCcEEEEEecC
Confidence 44555555433333 33334455567789999999999996432 345 356789999999999888999999999
Q ss_pred CCCCcccCccccCCccCceeecccCccCccCC-C-CCCCCCCCEEeCCCCcccCCC----------------------CC
Q 003982 76 SGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-S-LANATSLQDIYLDNNNFTSVP----------------------TG 131 (782)
Q Consensus 76 ~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~-l~~l~~L~~L~Ls~n~l~~~~----------------------~~ 131 (782)
++++|.++..+..+++|++|+|++|++++.+| . +..+++|++|+|++|++++.. +.
T Consensus 79 ~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~ 158 (968)
T PLN00113 79 KNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPN 158 (968)
T ss_pred CCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCCh
Confidence 99999999999999999999999999987666 3 447777777777777776422 22
Q ss_pred CCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccc-c
Q 003982 132 CFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-S 210 (782)
Q Consensus 132 ~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~ 210 (782)
.++++++|++|+|++|.+.. .+|..+.++++|++|+|++|++++.+|..+..+++|++|+|++|++++.+|..+.. .
T Consensus 159 ~~~~l~~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~ 236 (968)
T PLN00113 159 DIGSFSSLKVLDLGGNVLVG--KIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLT 236 (968)
T ss_pred HHhcCCCCCEEECccCcccc--cCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCC
Confidence 23444444444444444433 23444444444444444444444444444444444444444444444444444433 3
Q ss_pred ccchhhcccccCCCccccccccCCCCCcEEEeecccccCCCC-CCCCCCCCCEEEcCCCcCccCcch-------------
Q 003982 211 DIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIP-DLSKCESLFDLSLRDNQLTGVVPA------------- 276 (782)
Q Consensus 211 ~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~------------- 276 (782)
+|+.|++++|.+... ....++++++|++|+|++|++++..| .+..+++|+.|+|++|++++.+|.
T Consensus 237 ~L~~L~L~~n~l~~~-~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l 315 (968)
T PLN00113 237 SLNHLDLVYNNLTGP-IPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHL 315 (968)
T ss_pred CCCEEECcCceeccc-cChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEEC
Confidence 444444444433211 11223344444444444444443332 233344444444444444444444
Q ss_pred -----------hhcCCCCCCEEEccCCcccCCCCCC---CCCccEEEccCCcCCCCCCCCCCCC-C--------------
Q 003982 277 -----------SVISLPALLNISLQNNKLQGPYPLF---PSKVQKVSLDHNNFCKNSSDAGKPC-D-------------- 327 (782)
Q Consensus 277 -----------~~~~l~~L~~L~l~~N~l~~~~~~~---~~~l~~L~l~~N~~~~~~~~~~~~~-~-------------- 327 (782)
.+..+++|+.|++++|++++.+|.. ..+|+.|++++|++++..+...... .
T Consensus 316 ~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~ 395 (968)
T PLN00113 316 FSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGE 395 (968)
T ss_pred CCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEeccc
Confidence 4444444444444444444433322 1234444554444432111000000 0
Q ss_pred --hhhh---hHH--Hh---------hcCCC-------------------------CCc----------------------
Q 003982 328 --PQVT---TLL--QI---------AGDMG-------------------------YPA---------------------- 344 (782)
Q Consensus 328 --~~~~---~~~--~~---------~~~~~-------------------------~~~---------------------- 344 (782)
.... .+. .+ +..+. .+.
T Consensus 396 ~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~ 475 (968)
T PLN00113 396 IPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSK 475 (968)
T ss_pred CCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccc
Confidence 0000 000 00 00000 000
Q ss_pred cc-ccCcCCCCCCCCCCcccccCCceeEEEccCcccccccCccccccccCCeEecccccccccCCccCCCCCCCCeEecC
Q 003982 345 IL-SDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVS 423 (782)
Q Consensus 345 ~~-~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls 423 (782)
.+ ..+..+|...+.+|..+..+++|+.|+|++|.+.+.+|..+.++++|++|+|++|+++|.+|..|..+++|+.|||+
T Consensus 476 ~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 555 (968)
T PLN00113 476 RLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLS 555 (968)
T ss_pred cceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECC
Confidence 00 01111222334566666667777777777777777777777778888888888888888888888888888888888
Q ss_pred CCcCCCCCCCC-C--CCcceecCCCCCCCCCCCCCCCC-------CCCC---CCCCCCCCCCCCCCCCCccceeeeeeeh
Q 003982 424 NNNLSGKVPDF-G--SNVKFTVSPGNPFIGTNVDTTPG-------GAGT---PGSKPSGPSGSPAASSKSKLSVGTIVAI 490 (782)
Q Consensus 424 ~N~l~g~~p~~-~--~~~~~~~~~~n~~~~~~~~~~~~-------~~~~---~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 490 (782)
+|+++|.+|.. . ..+....+++|++.+.-|....- ..+. +...+....+...... .....++++++
T Consensus 556 ~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~-~~~~~~~~~~~ 634 (968)
T PLN00113 556 QNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVR-KTPSWWFYITC 634 (968)
T ss_pred CCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCcccc-ccceeeeehhH
Confidence 88888777732 2 34555666777766532211000 0000 0000000000000111 11122233333
Q ss_pred hHHHHHHHHHHHHHHHHHHHhhhccccCCcCCCccccccccCcccCCCCCCCCCCCCCccccCCCCCCCccccccCC-cc
Q 003982 491 VVVVVIFIAVVFFVVYKFIARRKHRKFGRVKNPEVGNEMNKNGVTGGNGTNGYNGVPSELHSQSSGDVSDRHLFEGG-NV 569 (782)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 569 (782)
++++++++++++++++ +.++|++++..+.. . .. +. .+ ...++.. ..
T Consensus 635 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~-----~--~~----~~----------~~-----------~~~~~~~~~~ 681 (968)
T PLN00113 635 TLGAFLVLALVAFGFV-FIRGRNNLELKRVE-----N--ED----GT----------WE-----------LQFFDSKVSK 681 (968)
T ss_pred HHHHHHHHHHHHHHHH-HHHhhhcccccccc-----c--cc----cc----------cc-----------ccccccccch
Confidence 3222222222222222 22222211111100 0 00 00 00 0000000 01
Q ss_pred cccHHHHHHHhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEE
Q 003982 570 AISIEVLRQVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYC 648 (782)
Q Consensus 570 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~ 648 (782)
.+..+ .....|...++||+|+||.||+|.. .++..||||+++.... ...+|++.+++++||||+++++++
T Consensus 682 ~~~~~---~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~ 752 (968)
T PLN00113 682 SITIN---DILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLC 752 (968)
T ss_pred hhhHH---HHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEE
Confidence 12222 2335677889999999999999965 5789999999865331 123568899999999999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEE
Q 003982 649 INGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKV 728 (782)
Q Consensus 649 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL 728 (782)
.+++..++||||+++|+|.++++. ++|.++..++.|+++|++|||..+..+|+||||||+||+++.++.+++
T Consensus 753 ~~~~~~~lv~Ey~~~g~L~~~l~~--------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~ 824 (968)
T PLN00113 753 RSEKGAYLIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL 824 (968)
T ss_pred EcCCCCEEEEeCCCCCcHHHHHhc--------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEE
Confidence 999999999999999999999853 789999999999999999999644589999999999999999988887
Q ss_pred EeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 729 ADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 729 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
. ||.+...... ....||+.|||||++.+. .++.++||||+||+
T Consensus 825 ~-~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~---~~~~~sDv~S~Gvv 867 (968)
T PLN00113 825 R-LSLPGLLCTD-----TKCFISSAYVAPETRETK---DITEKSDIYGFGLI 867 (968)
T ss_pred E-eccccccccC-----CCccccccccCcccccCC---CCCcccchhhHHHH
Confidence 5 6655433221 123578999999998764 45778999999986
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=401.17 Aligned_cols=368 Identities=27% Similarity=0.413 Sum_probs=268.9
Q ss_pred CCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEec
Q 003982 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144 (782)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 144 (782)
.+++.|+|++|++++.+|..++++++|++|++++|++++..| .|.++++|++|+|++|++++..+..+.++++|++|+|
T Consensus 212 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 291 (968)
T PLN00113 212 KSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDL 291 (968)
T ss_pred CCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEEC
Confidence 368889999999998899899999999999999999988777 7888899999999999888766667888888999999
Q ss_pred cCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccc-cccchhhcccccCC
Q 003982 145 SDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLG 223 (782)
Q Consensus 145 s~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~l~l~~~~~~ 223 (782)
++|++.. .+|..+.++++|+.|++++|.+++..|..+..+++|+.|++++|++++.+|..+.. ..|+.|+++.|.+.
T Consensus 292 s~n~l~~--~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~ 369 (968)
T PLN00113 292 SDNSLSG--EIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLT 369 (968)
T ss_pred cCCeecc--CCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeE
Confidence 8888876 57777888888888888888888888888888888888888888888888876655 46777777777654
Q ss_pred CccccccccCCCCCcEEEeecccccCCCC-------------------------CCCCCCCCCEEEcCCCcCccCcchhh
Q 003982 224 LSGTLDVLSGMTQLRQVWLHKNQFTGPIP-------------------------DLSKCESLFDLSLRDNQLTGVVPASV 278 (782)
Q Consensus 224 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-------------------------~~~~l~~L~~L~L~~N~l~~~~p~~~ 278 (782)
... ...+..+++|+.|++++|++.+..| .+..+++|+.|++++|++++.+|..+
T Consensus 370 ~~~-p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 448 (968)
T PLN00113 370 GEI-PEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRK 448 (968)
T ss_pred eeC-ChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhh
Confidence 211 1223334444444554444444333 24444455555555555554444444
Q ss_pred cCCCCCCEEEccCCcccCCCCCCC--CCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCccc-ccCcCCCCC
Q 003982 279 ISLPALLNISLQNNKLQGPYPLFP--SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAIL-SDSWEGNNA 355 (782)
Q Consensus 279 ~~l~~L~~L~l~~N~l~~~~~~~~--~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 355 (782)
..+++|+.|++++|++.+.+|..+ .+|+.|++++|++++..+.. +.....+ ..+..+|+.
T Consensus 449 ~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~-----------------~~~l~~L~~L~Ls~N~l 511 (968)
T PLN00113 449 WDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRK-----------------LGSLSELMQLKLSENKL 511 (968)
T ss_pred ccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChh-----------------hhhhhccCEEECcCCcc
Confidence 445555555555555554444322 34555555555554332110 1111112 234455666
Q ss_pred CCCCCcccccCCceeEEEccCcccccccCccccccccCCeEecccccccccCCccCCCCCCCCeEecCCCcCCCCCCCCC
Q 003982 356 CDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFG 435 (782)
Q Consensus 356 ~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~ 435 (782)
.+.+|..+..+++|++|+|++|.++|.+|..|.++++|+.|+|++|+++|.+|..+..+++|+.|++++|+++|.+|..+
T Consensus 512 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~ 591 (968)
T PLN00113 512 SGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTG 591 (968)
T ss_pred eeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcc
Confidence 67899999999999999999999999999999999999999999999999999999999999999999999999999765
Q ss_pred C--CcceecCCCCCCCCCCC
Q 003982 436 S--NVKFTVSPGNPFIGTNV 453 (782)
Q Consensus 436 ~--~~~~~~~~~n~~~~~~~ 453 (782)
. .+....+.|||..|+..
T Consensus 592 ~~~~~~~~~~~~n~~lc~~~ 611 (968)
T PLN00113 592 AFLAINASAVAGNIDLCGGD 611 (968)
T ss_pred hhcccChhhhcCCccccCCc
Confidence 3 34455678999999754
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=332.41 Aligned_cols=189 Identities=29% Similarity=0.481 Sum_probs=168.4
Q ss_pred HhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
...+|...+.||+|+||+||+|++ .++..||||.+.+.....+..+.+..|+++++.++|||||++++++.+++..|+|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 346788899999999999999955 4689999999988766667788899999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCC------CcEEEEee
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD------MRAKVADF 731 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~------~~~kL~Df 731 (782)
||||.||+|..+++. .+.+++..++.++.|++.||++||+ ++||||||||+|||++.. -.+||+||
T Consensus 88 MEyC~gGDLs~yi~~-----~~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADF 159 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRR-----RGRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADF 159 (429)
T ss_pred EEeCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEeccc
Confidence 999999999999987 3468999999999999999999999 999999999999999764 46899999
Q ss_pred ccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 732 GLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 732 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|+|+.+..+.. ....+|+|.|||||++... .|+.++|+||+|+|
T Consensus 160 GfAR~L~~~~~--a~tlcGSplYMAPEV~~~~---~YdAKADLWSiG~I 203 (429)
T KOG0595|consen 160 GFARFLQPGSM--AETLCGSPLYMAPEVIMSQ---QYDAKADLWSIGTI 203 (429)
T ss_pred chhhhCCchhH--HHHhhCCccccCHHHHHhc---cccchhhHHHHHHH
Confidence 99999886543 3457999999999998654 57999999999986
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=313.61 Aligned_cols=195 Identities=26% Similarity=0.405 Sum_probs=171.1
Q ss_pred cCCCccceeecccceEEEEE-EeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEe-EEEeCCe-EEEE
Q 003982 581 DNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG-YCINGSE-RLLV 657 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~-~~~~~~~-~~lv 657 (782)
.+|.+.++||+|.||+||++ +..+|..||.|.+.-..++.++.+....|+.++++++|||||++++ .+.++.+ .++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 45778899999999999999 6779999999999877777888899999999999999999999998 4444444 7899
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCeEEcCCCCCCEEECCCCcEEEEeecccee
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQ-QSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~-~~ivHrDikp~NIll~~~~~~kL~DfG~a~~ 736 (782)
||||.+|+|.+.++.++++ .+.+++.++++++.|++.||.++|.... .-|+||||||.||+++.+|.+||+|||+++.
T Consensus 99 mE~c~~GDLsqmIk~~K~q-kr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQ-KRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhc-cccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 9999999999999988766 4678999999999999999999997322 2389999999999999999999999999999
Q ss_pred cCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 737 APDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+.... ......+|||+||+||.+.+. |+.+++||||+|++
T Consensus 178 l~s~~-tfA~S~VGTPyYMSPE~i~~~---~Y~~kSDiWslGCl 217 (375)
T KOG0591|consen 178 LSSKT-TFAHSLVGTPYYMSPERIHES---GYNFKSDIWSLGCL 217 (375)
T ss_pred hcchh-HHHHhhcCCCcccCHHHHhcC---CCCcchhHHHHHHH
Confidence 87644 334557899999999999886 88999999999986
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=318.20 Aligned_cols=192 Identities=30% Similarity=0.461 Sum_probs=164.8
Q ss_pred HhcCCCccceeecccceEEEEE-EeCCCcEEEEEEeccccCChh-----hHHHHHHHHHHHHhcCCCCcceEEeEEEeCC
Q 003982 579 VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNK-----GLSEFQAEIAVLTKVRHRHLVALLGYCINGS 652 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~-----~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~ 652 (782)
+.+.|.+.+.||+|+||.|-+| ...+|+.||||++.+...... .....++|+++|++++|||||++++++..++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 5678899999999999999999 677899999999987654321 2234579999999999999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCC---CcEEEE
Q 003982 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD---MRAKVA 729 (782)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~---~~~kL~ 729 (782)
..|+||||++||+|.+.+.. .+.+.+...+.+++|++.|+.|||+ .||+||||||+|||+..+ ..+||+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~-----nk~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA-----NKYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred ceEEEEEEecCccHHHHHHh-----ccccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEec
Confidence 99999999999999999876 3457788889999999999999999 899999999999999766 789999
Q ss_pred eeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 730 DFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 730 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|||+|+..+... .....||||.|.|||++...-.-.+..+.|+||+|||
T Consensus 322 DFGlAK~~g~~s--fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcv 370 (475)
T KOG0615|consen 322 DFGLAKVSGEGS--FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCV 370 (475)
T ss_pred ccchhhccccce--ehhhhcCCccccChhheecCCeecccchheeeeccce
Confidence 999999887544 3345799999999999876522334457799999997
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=331.53 Aligned_cols=205 Identities=48% Similarity=0.832 Sum_probs=177.4
Q ss_pred CcccccHHHHHHHhcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEe
Q 003982 567 GNVAISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646 (782)
Q Consensus 567 ~~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~ 646 (782)
....|++++++.++++|.....||+|+||.||+|...+|+.||||++....... .++|..|++++.+++|||+++++|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlG 138 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLG 138 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEE
Confidence 445689999999999999999999999999999999899999999887654221 456999999999999999999999
Q ss_pred EEEeCC-eEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCc
Q 003982 647 YCINGS-ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR 725 (782)
Q Consensus 647 ~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~ 725 (782)
||.+.+ +.++|+|||++|+|.+.++.... . +++|..+.+||.++|+||+|||+.+...||||||||+|||+|++++
T Consensus 139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~--~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~ 215 (361)
T KOG1187|consen 139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKG--E-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN 215 (361)
T ss_pred EEecCCceEEEEEEccCCCCHHHHhCCCCC--C-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC
Confidence 999998 59999999999999999976322 1 7899999999999999999999976668999999999999999999
Q ss_pred EEEEeeccceecCC-CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 726 AKVADFGLVKNAPD-GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 726 ~kL~DfG~a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+||+|||+|+..+. ....... ..||.+|+|||+.... ..+.++||||||||
T Consensus 216 aKlsDFGLa~~~~~~~~~~~~~-~~gt~gY~~PEy~~~g---~lt~KsDVySFGVv 267 (361)
T KOG1187|consen 216 AKLSDFGLAKLGPEGDTSVSTT-VMGTFGYLAPEYASTG---KLTEKSDVYSFGVV 267 (361)
T ss_pred EEccCccCcccCCccccceeee-cCCCCccCChhhhccC---CcCcccccccchHH
Confidence 99999999976654 3221111 1799999999998753 24779999999996
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=324.81 Aligned_cols=188 Identities=29% Similarity=0.478 Sum_probs=167.7
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCC-hhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
.+|...+.||+|+|+.+|+++. .+|+.||+|++.+.... ....+...+||++.++++|||||+++++|++..++|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999965 78999999999876542 346678999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
|+|+.++|.+++++ .+++++.++..+++||+.||.|||+ .+|+|||||..|+|++++.++||+|||+|..+.
T Consensus 98 ELC~~~sL~el~Kr-----rk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR-----RKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE 169 (592)
T ss_pred EecCCccHHHHHHh-----cCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeec
Confidence 99999999999975 4679999999999999999999999 899999999999999999999999999999987
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... ++....||||.|.|||++... |-.+.+||||+|||
T Consensus 170 ~~~-Erk~TlCGTPNYIAPEVl~k~---gHsfEvDiWSlGcv 207 (592)
T KOG0575|consen 170 YDG-ERKKTLCGTPNYIAPEVLNKS---GHSFEVDIWSLGCV 207 (592)
T ss_pred Ccc-cccceecCCCcccChhHhccC---CCCCchhhhhhhhH
Confidence 543 234557999999999998854 55677888888876
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=308.62 Aligned_cols=183 Identities=27% Similarity=0.428 Sum_probs=161.1
Q ss_pred CccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCC-eEEEEEEcc
Q 003982 584 SEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS-ERLLVYEYM 661 (782)
Q Consensus 584 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~-~~~lv~e~~ 661 (782)
+..+.||+|..|+||++++ .+++.+|+|++.. ..+....+++.+|++++++.+||+||.+||.|..+. ...++||||
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL-NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 3468899999999999955 5788999999943 334567788999999999999999999999999999 599999999
Q ss_pred CCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCC
Q 003982 662 PRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK 741 (782)
Q Consensus 662 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~ 741 (782)
++|+|.+++.. .+.+++.....|+.++++||.|||+ .++||||||||+|||++..|+|||||||.+..+.+.
T Consensus 161 DgGSLd~~~k~-----~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 161 DGGSLDDILKR-----VGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred CCCCHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 99999999976 2568999999999999999999996 389999999999999999999999999999887664
Q ss_pred ceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 742 YSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 742 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
....++||..|||||.+.+. .++.++||||||+.
T Consensus 233 --~a~tfvGT~~YMsPERi~g~---~Ys~~sDIWSLGLs 266 (364)
T KOG0581|consen 233 --IANTFVGTSAYMSPERISGE---SYSVKSDIWSLGLS 266 (364)
T ss_pred --hcccccccccccChhhhcCC---cCCcccceecccHH
Confidence 33557899999999999886 45667999999974
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=307.50 Aligned_cols=189 Identities=28% Similarity=0.420 Sum_probs=166.3
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCCh-hhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGN-KGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
.++|++.++||+|+||.||.++. .+++.||+|++++..... .+.+....|..++.+++||+||.++..|+++++.|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 35789999999999999999954 568899999998876543 3678889999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
+||+.||+|...+++ .+.+++..+.-++..|+.||.|||+ .||||||+||+|||+|.+|.++|+|||+++..
T Consensus 104 ld~~~GGeLf~hL~~-----eg~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQR-----EGRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EeccCCccHHHHHHh-----cCCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 999999999999976 4568999999999999999999999 99999999999999999999999999999865
Q ss_pred CCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 738 PDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..... ....+|||+.|||||++.+. |++..+|-||+||+
T Consensus 176 ~~~~~-~t~tfcGT~eYmAPEil~~~---gy~~~vDWWsLGil 214 (357)
T KOG0598|consen 176 LKDGD-ATRTFCGTPEYMAPEILLGK---GYDKAVDWWSLGIL 214 (357)
T ss_pred ccCCC-ccccccCCccccChHHHhcC---CCCcccchHhHHHH
Confidence 44332 23347999999999999886 77778888888875
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=313.96 Aligned_cols=192 Identities=27% Similarity=0.367 Sum_probs=167.6
Q ss_pred HhcCCCccceeecccceEEEEE-EeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC--CeEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING--SERL 655 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~--~~~~ 655 (782)
..+.|+.+++||+|+||.||+| +..+|+.||+|++..+........-..+||.+|++++||||+++.+...+. +.+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 3456777899999999999999 567899999999988776667778889999999999999999999988876 7899
Q ss_pred EEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccce
Q 003982 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (782)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~ 735 (782)
+|+|||++ +|..++.. ....+++.+++.++.|++.||+|+|+ +||+|||||.+|||||.+|.+||+|||+|+
T Consensus 195 lVFeYMdh-DL~GLl~~----p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr 266 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSS----PGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLAR 266 (560)
T ss_pred EEEecccc-hhhhhhcC----CCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEecccccee
Confidence 99999966 78887754 23469999999999999999999998 999999999999999999999999999999
Q ss_pred ecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 736 NAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 736 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.+........+..+-|.+|+|||.+.|. -.|+.+.|+||.|+|
T Consensus 267 ~y~~~~~~~~T~rVvTLWYRpPELLLG~--t~Yg~aVDlWS~GCI 309 (560)
T KOG0600|consen 267 FYTPSGSAPYTSRVVTLWYRPPELLLGA--TSYGTAVDLWSVGCI 309 (560)
T ss_pred eccCCCCcccccceEEeeccChHHhcCC--cccccceeehhhhHH
Confidence 8876654444556779999999999987 456778899999986
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=313.39 Aligned_cols=187 Identities=36% Similarity=0.581 Sum_probs=163.1
Q ss_pred cceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCC-eEEEEEEccCCC
Q 003982 586 ANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS-ERLLVYEYMPRG 664 (782)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~-~~~lv~e~~~~g 664 (782)
.+.||+|+||+||+|.+.....||||++.....+....++|.+|+.+|.+++|||||+++|++.++. ..++||||+++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 4559999999999999955555999999887665555789999999999999999999999999887 799999999999
Q ss_pred CHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-eEEcCCCCCCEEECCCC-cEEEEeeccceecCCCCc
Q 003982 665 TLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS-FIHRDLKPSNILIGDDM-RAKVADFGLVKNAPDGKY 742 (782)
Q Consensus 665 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~-ivHrDikp~NIll~~~~-~~kL~DfG~a~~~~~~~~ 742 (782)
+|.++++.. ....+++..++.++.|||+||.|||+ .+ ||||||||+|||++.++ ++||+|||+++......
T Consensus 126 sL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 126 SLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred cHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 999999774 23569999999999999999999998 67 99999999999999997 99999999998766432
Q ss_pred eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 743 SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 743 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
...+...||+.|||||++.+. ...++.++||||||||
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~-~~~~~~K~DvySFgIv 235 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGE-KSPYTEKSDVYSFGIV 235 (362)
T ss_pred ccccCCCCCccccChhhhcCC-CCcCCccchhhhHHHH
Confidence 122335799999999999965 3467899999999996
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=292.12 Aligned_cols=189 Identities=24% Similarity=0.351 Sum_probs=158.7
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
++|+...++|+|+||+||+|+. .+|+.||||++.....+..-.+-..+|++++++++|||+|.++.+|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 4688889999999999999954 579999999998766444555667899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
||+. ++.+.+.++ ...++...+..+.+|++.|+.|+|+ +++|||||||+|||++..+.+||||||+|+.+..
T Consensus 82 ~~dh-TvL~eLe~~----p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 82 YCDH-TVLHELERY----PNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred ecch-HHHHHHHhc----cCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 9976 444445443 2348999999999999999999999 8999999999999999999999999999998874
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.. ...+..+.|++|+|||.+.+. ..++...||||+|+|
T Consensus 154 pg-d~YTDYVATRWYRaPELLvGD--tqYG~pVDiWAiGCv 191 (396)
T KOG0593|consen 154 PG-DNYTDYVATRWYRAPELLVGD--TQYGKPVDIWAIGCV 191 (396)
T ss_pred Cc-chhhhhhhhhhccChhhhccc--CcCCCcccchhhhHH
Confidence 22 233456789999999998875 344556778887775
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=281.57 Aligned_cols=189 Identities=28% Similarity=0.431 Sum_probs=162.6
Q ss_pred cCCCccceeecccceEEEEE-EeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
.+|...+++|+|.||.||+| +..+|+.||||+++.....+.-.....+|++.++.++|+||+.++++|.+.+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46888999999999999999 66789999999998876554455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
||+ .+|+.++++ ....++..+++.++.++++|++|||+ +.|+||||||.|+|++++|.+||+|||+|+.+..
T Consensus 82 fm~-tdLe~vIkd----~~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 82 FMP-TDLEVVIKD----KNIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGS 153 (318)
T ss_pred ecc-ccHHHHhcc----cccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCC
Confidence 995 489888865 34679999999999999999999998 8999999999999999999999999999998876
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... ..+..+-|.+|+|||.+-|.- .++...||||.|||
T Consensus 154 p~~-~~~~~V~TRWYRAPELLfGsr--~Yg~~VDmWavGCI 191 (318)
T KOG0659|consen 154 PNR-IQTHQVVTRWYRAPELLFGSR--QYGTGVDMWAVGCI 191 (318)
T ss_pred CCc-ccccceeeeeccChHHhccch--hcCCcchhhhHHHH
Confidence 443 233346799999999887652 34445777777765
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=295.93 Aligned_cols=194 Identities=26% Similarity=0.410 Sum_probs=170.2
Q ss_pred hcCCCccceeecccceEEEEE-EeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
.++|++.++||.|..++||+| ..+.+..||||++..+..... .+.+++|+..|+.++||||++++..|..+...|+||
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 467999999999999999999 556789999999988775444 789999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
.||.+|++.+.++..... .+.+..+..|.+++++||.|||. +|.||||||+.|||++++|.|||+|||.+..+.
T Consensus 104 pfMa~GS~ldIik~~~~~---Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPD---GLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred hhhcCCcHHHHHHHHccc---cccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 999999999999886654 38999999999999999999998 999999999999999999999999999877654
Q ss_pred CCCcee--e-ecccccccccCccccccchhhhHHHHHHHHHhcccC
Q 003982 739 DGKYSV--E-TRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSVG 781 (782)
Q Consensus 739 ~~~~~~--~-~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv~ 781 (782)
+..... . ..++||++|||||++...- -||++++|||||||.|
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~-~GYdfKaDIwSfGITA 222 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQL-HGYDFKADIWSFGITA 222 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcc-cCccchhhhhhhhHHH
Confidence 433211 1 4468999999999954332 5899999999999964
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=306.47 Aligned_cols=187 Identities=29% Similarity=0.470 Sum_probs=168.6
Q ss_pred cCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
++|.+.+.||+|+||+||||+ ..+.+.||+|.+.+....+++.+.+++|++++++++||||+.++++|+...+.|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 578889999999999999995 4567899999999887777889999999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+.| +|..++.+ .+.++++.+..++.+++.||.|||+ .+|+|||+||+||+++..+.+|++|||+|+....
T Consensus 82 ~a~g-~L~~il~~-----d~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~ 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ-----DGKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMST 152 (808)
T ss_pred hhhh-hHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhccc
Confidence 9976 99999976 3569999999999999999999999 9999999999999999999999999999998776
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.. ...+.+.|||.|||||...+. .++..+|+||+|+|
T Consensus 153 ~t-~vltsikGtPlYmAPElv~e~---pyd~~sDlWslGci 189 (808)
T KOG0597|consen 153 NT-SVLTSIKGTPLYMAPELVEEQ---PYDHTSDLWSLGCI 189 (808)
T ss_pred Cc-eeeeeccCcccccCHHHHcCC---CccchhhHHHHHHH
Confidence 43 455677899999999988865 56777888888876
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=280.74 Aligned_cols=185 Identities=31% Similarity=0.427 Sum_probs=165.4
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
++|+..+.||.|+||+|..++. .+|..||+|++++... ..+..+....|..+++.+.||+++++++.+.+.+..|+||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 5678899999999999999955 4688999999987653 3345567789999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||++||.|..++++ .+++++..++.+|.||+.|++|||+ .+|++||+||+|||+|++|.+||+|||+|+...
T Consensus 124 eyv~GGElFS~Lrk-----~~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 124 EYVPGGELFSYLRK-----SGRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred eccCCccHHHHHHh-----cCCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 99999999999987 4569999999999999999999999 899999999999999999999999999999887
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... -..||||.|+|||+++.. |+..++|-|||||+
T Consensus 196 ~rT----~TlCGTPeYLAPEii~sk---~ynkavDWWalGVL 230 (355)
T KOG0616|consen 196 GRT----WTLCGTPEYLAPEIIQSK---GYNKAVDWWALGVL 230 (355)
T ss_pred CcE----EEecCCccccChHHhhcC---CCCcchhHHHHHHH
Confidence 643 346899999999998876 77888999999985
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=303.85 Aligned_cols=193 Identities=26% Similarity=0.414 Sum_probs=165.5
Q ss_pred HHhcCCCccceeecccceEEEEE-EeCCCcEEEEEEeccccCC---hhhHHHHHHHHHHHHhcC-CCCcceEEeEEEeCC
Q 003982 578 QVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMG---NKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGS 652 (782)
Q Consensus 578 ~~~~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~ 652 (782)
...++|.+.+.||+|+||.|+.| ...++..||+|++.+.... ....+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34578999999999999999999 5567899999988765221 123556779999999999 999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCC-CcEEEEee
Q 003982 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD-MRAKVADF 731 (782)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~-~~~kL~Df 731 (782)
..|+||||+.+|+|.+++.+ .+++.+.++..+++|++.|++|+|+ +||+||||||+||+++.+ +++||+||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-----~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DF 165 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-----KGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDF 165 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-----cCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEecc
Confidence 99999999999999999976 3468899999999999999999998 899999999999999999 99999999
Q ss_pred ccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 732 GLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 732 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|++..... ........+||+.|+|||++.+.+. -...++||||+|||
T Consensus 166 G~s~~~~~-~~~~l~t~cGsp~Y~aPEvl~~~~~-Y~g~~aDvWS~GVi 212 (370)
T KOG0583|consen 166 GLSAISPG-EDGLLKTFCGSPAYAAPEVLSGKGT-YSGKAADVWSLGVI 212 (370)
T ss_pred ccccccCC-CCCcccCCCCCcccCCHHHhCCCCC-cCCchhhhhhhHHH
Confidence 99998741 1122345689999999999998752 12578999999996
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=286.51 Aligned_cols=185 Identities=30% Similarity=0.490 Sum_probs=155.4
Q ss_pred CccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHh--cCCCCcceEEeEEEeCC----eEEEE
Q 003982 584 SEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTK--VRHRHLVALLGYCINGS----ERLLV 657 (782)
Q Consensus 584 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~nI~~~~~~~~~~~----~~~lv 657 (782)
...++||+|+||.||||.. +++.||||++.. +..+.|+.|-+|++. ++|+||++++++-.... ++++|
T Consensus 213 ~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred hhHHHhhcCccceeehhhc-cCceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 3467899999999999988 669999999964 446788999888885 57999999999876555 78999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc------CCCCeEEcCCCCCCEEECCCCcEEEEee
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSL------AQQSFIHRDLKPSNILIGDDMRAKVADF 731 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~------~~~~ivHrDikp~NIll~~~~~~kL~Df 731 (782)
+||.+.|+|.++|.. ..++|.+..+++..+++||+|||+. .+.+|+|||||++||||..|+++.|+||
T Consensus 287 t~fh~kGsL~dyL~~------ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKA------NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred eeeccCCcHHHHHHh------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 999999999999976 3589999999999999999999973 3568999999999999999999999999
Q ss_pred ccceecCCCCcee-eecccccccccCccccccchhhh---HHHHHHHHHhccc
Q 003982 732 GLVKNAPDGKYSV-ETRLAGTFGYLAPEYAGKHWMIL---CQMTGLIWLHGSV 780 (782)
Q Consensus 732 G~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~---~~~~~dvws~Gvv 780 (782)
|+|..+..+.... .-..+||.+|||||++.+.-.+. .-...||||+|.|
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLV 413 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLV 413 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHH
Confidence 9999887544322 22368999999999987653322 3456899999976
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=298.81 Aligned_cols=193 Identities=27% Similarity=0.439 Sum_probs=166.3
Q ss_pred HHHhcCCCccceeecccceEEEEE-EeCCCcEEEEEEeccccCC-hhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCCe
Q 003982 577 RQVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSE 653 (782)
Q Consensus 577 ~~~~~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~ 653 (782)
.+...+|...+.||+|+|++||+| +..+++.||||++.+...- +...+-..+|-..|.+| .||.|++++..|+++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 445578999999999999999999 5567899999999775432 23445677888999999 79999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecc
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~ 733 (782)
.|+|+||+++|+|.+++.+. +.+++.....++.+|+.||+|||+ +|||||||||+|||+|+|+++||+|||.
T Consensus 149 LYFvLe~A~nGdll~~i~K~-----Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGs 220 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKY-----GSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGS 220 (604)
T ss_pred eEEEEEecCCCcHHHHHHHh-----CcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccc
Confidence 99999999999999999873 568999999999999999999999 9999999999999999999999999999
Q ss_pred ceecCCCCce----------e--eecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 734 VKNAPDGKYS----------V--ETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 734 a~~~~~~~~~----------~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|+.+.+.... . ...++||..|.+||++.+. .++..+|+|+||||
T Consensus 221 AK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~---~~~~~sDiWAlGCi 276 (604)
T KOG0592|consen 221 AKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDS---PAGPSSDLWALGCI 276 (604)
T ss_pred cccCChhhccccCccCcccccCcccceeeeecccCHHHhcCC---CCCcccchHHHHHH
Confidence 9877542211 1 1447999999999999987 45788999999986
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=304.08 Aligned_cols=383 Identities=22% Similarity=0.308 Sum_probs=306.0
Q ss_pred CCCCCCCCccccceEeCC---------------CCCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCCCCCC
Q 003982 47 SSTSSTGYCEWTGINCDN---------------SNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLAN 111 (782)
Q Consensus 47 ~~~~~~~~c~w~gv~c~~---------------~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~l~~ 111 (782)
+.++.++.|.-.-..|+. ...+..|++++|.|+..-+..|.++++|+.+++.+|.++.+ |.|+.
T Consensus 44 ~~cpa~c~c~~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~I-P~f~~ 122 (873)
T KOG4194|consen 44 SECPATCPCNTRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTRI-PRFGH 122 (873)
T ss_pred ccCCCcCCCCceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhhhc-ccccc
Confidence 445666667666666753 23678899999999988888899999999999999999954 55555
Q ss_pred C-CCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCc
Q 003982 112 A-TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQ 190 (782)
Q Consensus 112 l-~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 190 (782)
. .+|+.|+|.+|.|+++....+..++.|+.||||.|.|+. .--+.|..-.++++|+|++|+|+.+..+.|.++.+|.
T Consensus 123 ~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~--i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~ 200 (873)
T KOG4194|consen 123 ESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISE--IPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLL 200 (873)
T ss_pred cccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhc--ccCCCCCCCCCceEEeeccccccccccccccccchhe
Confidence 4 559999999999999999999999999999999999999 3445677778999999999999999999999999999
Q ss_pred EEEcccCcCCCCCCc-cccc-cccchhhcccccCCCccccccccCCCCCcEEEeecccccCCCC-CCCCCCCCCEEEcCC
Q 003982 191 NLRLSYNNFTGSLPA-SFAK-SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIP-DLSKCESLFDLSLRD 267 (782)
Q Consensus 191 ~L~Ls~N~l~~~~p~-~~~~-~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~ 267 (782)
.|.|+.|+++ .+|. .|.+ ..|+.|+++.|.+...... .|.++++|+.|.|.+|.+...-. .|..+.++++|+|+.
T Consensus 201 tlkLsrNrit-tLp~r~Fk~L~~L~~LdLnrN~irive~l-tFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~ 278 (873)
T KOG4194|consen 201 TLKLSRNRIT-TLPQRSFKRLPKLESLDLNRNRIRIVEGL-TFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLET 278 (873)
T ss_pred eeecccCccc-ccCHHHhhhcchhhhhhccccceeeehhh-hhcCchhhhhhhhhhcCcccccCcceeeecccceeeccc
Confidence 9999999999 6655 5553 6899999999998765332 48889999999999999987554 488899999999999
Q ss_pred CcCccCcchhhcCCCCCCEEEccCCcccCCCCC---CCCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCc
Q 003982 268 NQLTGVVPASVISLPALLNISLQNNKLQGPYPL---FPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPA 344 (782)
Q Consensus 268 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~---~~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (782)
|++..+-..++.+++.|+.|+||.|.|...-+. +..+|++|+|++|++++++..... -+.++.
T Consensus 279 N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~-------~L~~Le------- 344 (873)
T KOG4194|consen 279 NRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFR-------VLSQLE------- 344 (873)
T ss_pred chhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHH-------HHHHhh-------
Confidence 999988888899999999999999999876664 346899999999999887733221 111111
Q ss_pred ccccCcCCCCCCCCCC-cccccCCceeEEEccCcccccccCc---cccccccCCeEecccccccccCCccCCCCCCCCeE
Q 003982 345 ILSDSWEGNNACDGWP-FVTCSQGRIITINLANKLLAGNISP---AYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNL 420 (782)
Q Consensus 345 ~~~~~~~~~~~~~~~p-~~~~~~~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L 420 (782)
....+.|.++.+. ..+..+.+|+.|||++|.|++.|.. .|.+|++|+.|+|.+|+|...--.+|..++.|+.|
T Consensus 345 ---~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~L 421 (873)
T KOG4194|consen 345 ---ELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHL 421 (873)
T ss_pred ---hhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCccccee
Confidence 1222334444443 3466678999999999999988754 57889999999999999986666789999999999
Q ss_pred ecCCCcCCCCCCCCC--CCcceecCCCCCCCCC
Q 003982 421 DVSNNNLSGKVPDFG--SNVKFTVSPGNPFIGT 451 (782)
Q Consensus 421 ~ls~N~l~g~~p~~~--~~~~~~~~~~n~~~~~ 451 (782)
||.+|.|-..-|+-. -.++...+..-.++|.
T Consensus 422 dL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCD 454 (873)
T KOG4194|consen 422 DLGDNAIASIQPNAFEPMELKELVMNSSSFLCD 454 (873)
T ss_pred cCCCCcceeecccccccchhhhhhhcccceEEe
Confidence 999999987767422 2445556666667774
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=299.34 Aligned_cols=190 Identities=26% Similarity=0.372 Sum_probs=162.6
Q ss_pred HhcCCCccceeecccceEEEEE-EeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC-CCCcceEEeEEEeCC-eEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGS-ERL 655 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~-~~~ 655 (782)
+.++|.+.++||.|+||.||+| ...++..||||++++....-+ .-.=.||++.+++++ ||||+++.+++.+.+ ..|
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~e-e~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHH-HHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 4578999999999999999999 556899999999987654322 122358999999998 999999999999988 899
Q ss_pred EEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccce
Q 003982 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (782)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~ 735 (782)
+||||| .-+|++++++. .+.+++.++..|+.||++||+|+|+ +|+.|||+||+|||+.....+||+|||+|+
T Consensus 87 fVfE~M-d~NLYqLmK~R----~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLAR 158 (538)
T KOG0661|consen 87 FVFEFM-DCNLYQLMKDR----NRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAR 158 (538)
T ss_pred eeHHhh-hhhHHHHHhhc----CCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEeccccccc
Confidence 999999 56899999763 4679999999999999999999998 999999999999999988899999999999
Q ss_pred ecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhcccC
Q 003982 736 NAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSVG 781 (782)
Q Consensus 736 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv~ 781 (782)
....... .+..+.|++|+|||++... .-+....|||++|+|.
T Consensus 159 ev~SkpP--YTeYVSTRWYRAPEvLLrs--~~Ys~pvD~wA~GcI~ 200 (538)
T KOG0661|consen 159 EVRSKPP--YTEYVSTRWYRAPEVLLRS--GYYSSPVDMWAVGCIM 200 (538)
T ss_pred ccccCCC--cchhhhcccccchHHhhhc--cccCCchHHHHHHHHH
Confidence 8876442 2456789999999998765 2356778899999874
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=280.27 Aligned_cols=190 Identities=27% Similarity=0.378 Sum_probs=161.2
Q ss_pred hcCCCccceeecccceEEEEE-EeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC--CeEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING--SERLL 656 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~--~~~~l 656 (782)
.+.|+.++.|++|+||.||+| +.++++.||+|+++.+.......-.-.+||.++.+++|||||.+..+.... +.+|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 345777899999999999999 556889999999987664444445568999999999999999998876643 57999
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecccee
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~ 736 (782)
|||||+. +|..++.... +++...+++.++.|+++|++|||+ +.|+|||+|++|+|+++.|.+||+|||+|+.
T Consensus 155 VMe~~Eh-DLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ 226 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLARE 226 (419)
T ss_pred eHHHHHh-hHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhh
Confidence 9999976 8888886632 468999999999999999999998 8999999999999999999999999999999
Q ss_pred cCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 737 APDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+.... ...++.+-|.+|+|||.+.+. -.++...||||+|+|
T Consensus 227 ygsp~-k~~T~lVVTLWYRaPELLLG~--~tyst~iDMWSvGCI 267 (419)
T KOG0663|consen 227 YGSPL-KPYTPLVVTLWYRAPELLLGA--KTYSTAVDMWSVGCI 267 (419)
T ss_pred hcCCc-ccCcceEEEeeecCHHHhcCC--cccCcchhhhhHHHH
Confidence 88753 233556789999999998875 446777888888886
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=311.49 Aligned_cols=191 Identities=31% Similarity=0.521 Sum_probs=164.2
Q ss_pred CCccceeecccceEEEEEEeC------CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEE
Q 003982 583 FSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656 (782)
Q Consensus 583 y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 656 (782)
....+.||+|+||+||+|+.. +...||||.++... +.+.+++|++|+++++.++|||||+++|+|.+++..++
T Consensus 488 i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M 566 (774)
T KOG1026|consen 488 IVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM 566 (774)
T ss_pred eeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence 345788999999999999542 35579999998654 34478999999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEE
Q 003982 657 VYEYMPRGTLAQHLFEWHDHG---------YTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAK 727 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~---------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~k 727 (782)
|+|||..|||.++|+....+. ..+++..+.+.||.|||.|++||-+ +.+|||||..+|+||.++..||
T Consensus 567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~VK 643 (774)
T KOG1026|consen 567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLVVK 643 (774)
T ss_pred EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceEEE
Confidence 999999999999998754432 2238899999999999999999998 8999999999999999999999
Q ss_pred EEeeccceecCCCCceeee-cccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 728 VADFGLVKNAPDGKYSVET-RLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 728 L~DfG~a~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|+|||+++.....+|.... ...-.++|||||-+... .++..+||||+|||
T Consensus 644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~---kFTteSDVWs~GVv 694 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYG---KFTTESDVWSFGVV 694 (774)
T ss_pred ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcC---cccchhhhhhhhhh
Confidence 9999999988777765432 34457899999977654 46889999999997
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=299.33 Aligned_cols=194 Identities=32% Similarity=0.505 Sum_probs=166.9
Q ss_pred cccccHHHHHHHhcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeE
Q 003982 568 NVAISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY 647 (782)
Q Consensus 568 ~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~ 647 (782)
...++.+.+. ..+.||+|-||.||.|.+.....||+|.++... ...+.|.+|+++|++++|++||+++++
T Consensus 200 ~wei~r~~l~-------l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~---m~~~~f~~Ea~iMk~L~H~~lV~l~gV 269 (468)
T KOG0197|consen 200 PWEIPREELK-------LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS---MSPEAFLREAQIMKKLRHEKLVKLYGV 269 (468)
T ss_pred CeeecHHHHH-------HHHHhcCCccceEEEEEEcCCCcccceEEeccc---cChhHHHHHHHHHHhCcccCeEEEEEE
Confidence 3345555554 367899999999999999777799999998754 344788899999999999999999999
Q ss_pred EEeCCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEE
Q 003982 648 CINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAK 727 (782)
Q Consensus 648 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~k 727 (782)
|..++..|||||||+.|+|.++|+. .+...+...+.+.++.|||+|++||++ +++|||||.++||||+++..+|
T Consensus 270 ~~~~~piyIVtE~m~~GsLl~yLr~---~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vK 343 (468)
T KOG0197|consen 270 CTKQEPIYIVTEYMPKGSLLDYLRT---REGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVK 343 (468)
T ss_pred EecCCceEEEEEecccCcHHHHhhh---cCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEE
Confidence 9998899999999999999999986 224568889999999999999999998 8999999999999999999999
Q ss_pred EEeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 728 VADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 728 L~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|+|||+|+...++.+.......-...|.|||.+... ....++|||||||+
T Consensus 344 IsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~---~FS~kSDVWSFGVl 393 (468)
T KOG0197|consen 344 ISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYG---KFSSKSDVWSFGVL 393 (468)
T ss_pred EcccccccccCCCceeecCCCCCCceecCHHHHhhC---Ccccccceeehhhh
Confidence 999999997776666554443446789999988765 56889999999996
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=294.60 Aligned_cols=191 Identities=26% Similarity=0.377 Sum_probs=162.5
Q ss_pred HhcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCCh-hhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGN-KGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 656 (782)
..++|+++++||+|+||.||.|+ ..+|..||+|++++..+-. ...+..+.|-.+|...++|.||+++..|++.++.|+
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 56789999999999999999994 4579999999999877533 356778999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecccee
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~ 736 (782)
||||++||++..+|.. .+.+++..+..++.+++.|++.+|. .|+|||||||+|+|||..|++||+|||++.-
T Consensus 219 iMEylPGGD~mTLL~~-----~~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMR-----KDTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEecCCccHHHHHHh-----cCcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccch
Confidence 9999999999999976 4679999999999999999999998 8999999999999999999999999999743
Q ss_pred cCC----------------------CCce-----ee-------------------ecccccccccCccccccchhhhHHH
Q 003982 737 APD----------------------GKYS-----VE-------------------TRLAGTFGYLAPEYAGKHWMILCQM 770 (782)
Q Consensus 737 ~~~----------------------~~~~-----~~-------------------~~~~gt~~y~aPE~~~~~~~~~~~~ 770 (782)
+.. ..+. .. ..++|||.|||||++.+. |++.
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k---gY~~ 367 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK---GYGK 367 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC---CCCc
Confidence 211 0000 00 124799999999999876 5666
Q ss_pred HHHHHHhccc
Q 003982 771 TGLIWLHGSV 780 (782)
Q Consensus 771 ~~dvws~Gvv 780 (782)
.+|.||+|+|
T Consensus 368 ~cDwWSLG~I 377 (550)
T KOG0605|consen 368 ECDWWSLGCI 377 (550)
T ss_pred cccHHHHHHH
Confidence 6777777765
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=283.56 Aligned_cols=202 Identities=25% Similarity=0.394 Sum_probs=165.4
Q ss_pred CcccccHHHHHHHhcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHh--cCCCCcceE
Q 003982 567 GNVAISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTK--VRHRHLVAL 644 (782)
Q Consensus 567 ~~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~nI~~~ 644 (782)
+....+.-..+.+.++..+.+.||+|.||+||+|++ .|+.||||++...+ .+.+.+|.++++. ++|+||+.+
T Consensus 197 SGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srd-----E~SWfrEtEIYqTvmLRHENILgF 270 (513)
T KOG2052|consen 197 SGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRD-----ERSWFRETEIYQTVMLRHENILGF 270 (513)
T ss_pred CCCCchhHhHHhhhheeEEEEEecCccccceeeccc-cCCceEEEEecccc-----hhhhhhHHHHHHHHHhccchhhhh
Confidence 334456667778888899999999999999999999 68999999997533 3567788888875 599999999
Q ss_pred EeEEEeC----CeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-----cCCCCeEEcCCCC
Q 003982 645 LGYCING----SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHS-----LAQQSFIHRDLKP 715 (782)
Q Consensus 645 ~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-----~~~~~ivHrDikp 715 (782)
++.-..+ .+.|+|++|.+.|||+++|.+ ..++.+..++++..+|.||+|||. +.+..|+|||||+
T Consensus 271 IaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKS 344 (513)
T KOG2052|consen 271 IAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKS 344 (513)
T ss_pred hhccccCCCceEEEEEeeecccCCcHHHHHhh------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccccc
Confidence 9876543 357999999999999999976 468999999999999999999995 3467899999999
Q ss_pred CCEEECCCCcEEEEeeccceecCCCCce---eeecccccccccCccccccchhhh---HHHHHHHHHhccc
Q 003982 716 SNILIGDDMRAKVADFGLVKNAPDGKYS---VETRLAGTFGYLAPEYAGKHWMIL---CQMTGLIWLHGSV 780 (782)
Q Consensus 716 ~NIll~~~~~~kL~DfG~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~---~~~~~dvws~Gvv 780 (782)
+||||.+++.+.|+|+|+|......... .....+||.+|||||++.+.-... .-..+||||||+|
T Consensus 345 KNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLV 415 (513)
T KOG2052|consen 345 KNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLV 415 (513)
T ss_pred ccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHH
Confidence 9999999999999999999887654322 224568999999999986542211 2334899999986
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=299.39 Aligned_cols=187 Identities=27% Similarity=0.473 Sum_probs=166.1
Q ss_pred hcCCCccceeecccceEEEEE-EeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
...|...+.||+|+.|.||.| +..+++.||||++.... ....+-+.+|+.+|+..+|+|||.+++.|...++.|+||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~--Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK--QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEecc--CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 456888899999999999999 56678999999998765 233456789999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
|||+||+|.+.+.. ..+++.++..|+++++.||+|||. +||+|||||.+|||++.+|.+||+|||++..+.
T Consensus 350 Eym~ggsLTDvVt~------~~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~ 420 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTK------TRMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQIS 420 (550)
T ss_pred eecCCCchhhhhhc------ccccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccc
Confidence 99999999999865 348999999999999999999998 999999999999999999999999999999887
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhcccC
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSVG 781 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv~ 781 (782)
.... .....+|||+|||||+.... .++.+.|||||||++
T Consensus 421 ~~~~-KR~TmVGTPYWMAPEVvtrk---~YG~KVDIWSLGIMa 459 (550)
T KOG0578|consen 421 EEQS-KRSTMVGTPYWMAPEVVTRK---PYGPKVDIWSLGIMA 459 (550)
T ss_pred cccC-ccccccCCCCccchhhhhhc---ccCccccchhhhhHH
Confidence 6543 33557899999999998875 568899999999985
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=281.64 Aligned_cols=189 Identities=31% Similarity=0.499 Sum_probs=157.7
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCC--eEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS--ERLLV 657 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~--~~~lv 657 (782)
.+|...+.||+|+||.||.+.. .+|..+|||.+.... ....+.+++|+++|.+++|||||+++|...... .++++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~--~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED--SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeeccc--chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 4567789999999999999954 458999999997653 222677999999999999999999999755444 68999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECC-CCcEEEEeecccee
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD-DMRAKVADFGLVKN 736 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~-~~~~kL~DfG~a~~ 736 (782)
|||+++|+|.+++.... . .+++..++.+.+|+++||+|||+ +|||||||||+|||++. ++.+||+|||+++.
T Consensus 95 mEy~~~GsL~~~~~~~g---~-~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~ 167 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYG---G-KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKK 167 (313)
T ss_pred eeccCCCcHHHHHHHcC---C-CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCccccc
Confidence 99999999999997632 2 59999999999999999999998 99999999999999999 69999999999987
Q ss_pred cCC--CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 737 APD--GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 737 ~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... ..........||+.|||||+..+. ......+||||+|++
T Consensus 168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g--~~~~~~sDiWSlGCt 211 (313)
T KOG0198|consen 168 LESKGTKSDSELSVQGTPNYMAPEVIRNG--EVARRESDIWSLGCT 211 (313)
T ss_pred cccccccccccccccCCccccCchhhcCC--CcCCccchhhhcCCE
Confidence 763 111223456899999999999852 112258999999985
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=283.42 Aligned_cols=203 Identities=28% Similarity=0.420 Sum_probs=161.8
Q ss_pred cccHHHHHHHhcCCCccceeecccceEEEEE-EeCCCcEEEEEEeccccCCh------------hhHHHHHHHHHHHHhc
Q 003982 570 AISIEVLRQVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGN------------KGLSEFQAEIAVLTKV 636 (782)
Q Consensus 570 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l 636 (782)
.+...+-++..++|++.+.||+|.||.|-+| ...+++.||||++.+..... ...++.++||.+|+++
T Consensus 86 ~~~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl 165 (576)
T KOG0585|consen 86 RYDDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL 165 (576)
T ss_pred eecCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc
Confidence 3444445566789999999999999999999 45678999999997654321 1345789999999999
Q ss_pred CCCCcceEEeEEEeC--CeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCC
Q 003982 637 RHRHLVALLGYCING--SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLK 714 (782)
Q Consensus 637 ~h~nI~~~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik 714 (782)
+|||||+++.+..++ +..|||+|||..|.+...- .....+++.+++.++++++.||+|||. +||||||||
T Consensus 166 ~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p-----~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIK 237 (576)
T KOG0585|consen 166 HHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP-----PDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIK 237 (576)
T ss_pred CCcCeeEEEEeecCcccCceEEEEEeccCCccccCC-----CCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccc
Confidence 999999999998765 5789999999988764322 112238999999999999999999998 899999999
Q ss_pred CCCEEECCCCcEEEEeeccceecCCCCce----eeecccccccccCccccccch-hhhHHHHHHHHHhccc
Q 003982 715 PSNILIGDDMRAKVADFGLVKNAPDGKYS----VETRLAGTFGYLAPEYAGKHW-MILCQMTGLIWLHGSV 780 (782)
Q Consensus 715 p~NIll~~~~~~kL~DfG~a~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~dvws~Gvv 780 (782)
|+|+|++++|++||+|||.+.....+... .-...+|||.|+|||...+.- ...+..+.||||+||.
T Consensus 238 PsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVT 308 (576)
T KOG0585|consen 238 PSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVT 308 (576)
T ss_pred hhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhh
Confidence 99999999999999999999876332111 112368999999999876621 2346778899999873
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-33 Score=277.96 Aligned_cols=189 Identities=25% Similarity=0.421 Sum_probs=163.3
Q ss_pred HhcCCCccceeecccceEEEEE-EeCCCcEEEEEEeccccCCh-hhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGN-KGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 656 (782)
...+|++.+.||+|+||.|-+| ....|+.||||.++++...+ ...-.+++|++||..++||||+++|.+|+..+...+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 3467889999999999999999 55789999999999877533 355678999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecccee
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~ 736 (782)
||||..+|.|++++.+ .+.+++.++..+++||+.|+.|+|. ++++|||+|.+|||+|.++++||+|||++..
T Consensus 131 vMEYaS~GeLYDYiSe-----r~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNl 202 (668)
T KOG0611|consen 131 VMEYASGGELYDYISE-----RGSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNL 202 (668)
T ss_pred EEEecCCccHHHHHHH-----hccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhh
Confidence 9999999999999987 3569999999999999999999998 9999999999999999999999999999988
Q ss_pred cCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhcc
Q 003982 737 APDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGS 779 (782)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gv 779 (782)
+.+..+- ..+||+|-|.+||+..|.-. -....|.||+||
T Consensus 203 y~~~kfL--qTFCGSPLYASPEIvNG~PY--~GPEVDsWsLGv 241 (668)
T KOG0611|consen 203 YADKKFL--QTFCGSPLYASPEIVNGTPY--KGPEVDSWSLGV 241 (668)
T ss_pred hccccHH--HHhcCCcccCCccccCCCCC--CCCccchhhHHH
Confidence 8776542 45799999999999876521 122344555554
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9e-33 Score=277.26 Aligned_cols=192 Identities=27% Similarity=0.367 Sum_probs=155.8
Q ss_pred cCCCccceeecccceEEEEE-EeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCC-cceEEeEEEeCC------
Q 003982 581 DNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH-LVALLGYCINGS------ 652 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-I~~~~~~~~~~~------ 652 (782)
..|..+++||+|+||+||+| ...+|+.||+|++......+.......+|+.++++++|+| |+++++++.+..
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 44666788999999999999 4568899999999876543335567789999999999999 999999998877
Q ss_pred eEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeec
Q 003982 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (782)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG 732 (782)
..++|+||+ .-+|.+++....... ..++...++.+++|+++||+|||+ ++|+||||||+||+++++|.+||+|||
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccc
Confidence 789999999 569999998754322 357778999999999999999999 999999999999999999999999999
Q ss_pred cceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 733 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+|+...-+.. ..+..++|..|+|||++.+. --+....||||+|+|
T Consensus 166 lAra~~ip~~-~yt~evvTlWYRaPEvLlGs--~~Ys~~vDiWs~GcI 210 (323)
T KOG0594|consen 166 LARAFSIPMR-TYTPEVVTLWYRAPEVLLGS--TSYSTSVDIWSLGCI 210 (323)
T ss_pred hHHHhcCCcc-cccccEEEeeccCHHHhcCC--CcCCCCcchHhHHHH
Confidence 9997653221 23445789999999987765 113334555655554
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-32 Score=281.59 Aligned_cols=192 Identities=29% Similarity=0.468 Sum_probs=164.7
Q ss_pred HhcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
..+...+.++||+|-||+|..|....+..||||.++.... .....+|.+|+++|.+++||||++++|+|..++..++|+
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~-~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDAT-KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccc-hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 4456678899999999999999987789999999987652 345789999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
|||++|+|.+++.+.... ....+....|+.||+.|++||.+ .++||||+.++|+|++.++++||+|||+++.+.
T Consensus 615 EYmEnGDLnqFl~aheap---t~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELP---TAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHhcCcHHHHHHhccCc---ccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccc
Confidence 999999999999875332 13445567799999999999999 899999999999999999999999999999877
Q ss_pred CCCc-eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKY-SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.+.+ +.+.+.+-..+|||||.+.-. ..+.++|+|+|||.
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillg---kFttaSDvWafgvT 728 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLG---KFTTASDVWAFGVT 728 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhc---cccchhhhhhhHHH
Confidence 6664 455666778899999965432 34789999999973
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=291.55 Aligned_cols=189 Identities=26% Similarity=0.396 Sum_probs=167.6
Q ss_pred hcCCCccceeecccceEEEEE-EeCCCcEEEEEEeccc-cCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESN-TMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
.+.|+..+.||.|+.|.|..| +..+|+.+|||++.+. ...+.....+++|+-+|+-+.||||+++|++|+...+.|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 356888999999999999999 5678999999999876 33444567899999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
.||+++|.|.+++.+ .+++++.++.++++||+.|+.|+|. .+|+|||+||+|+|+|..+++||+|||+|...
T Consensus 91 lEyv~gGELFdylv~-----kG~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe 162 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVR-----KGPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLE 162 (786)
T ss_pred EEecCCchhHHHHHh-----hCCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecc
Confidence 999999999999976 4679999999999999999999998 89999999999999999999999999999876
Q ss_pred CCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 738 PDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..+.-- ..-||+|.|.|||+++|.-.-|| ++||||.|||
T Consensus 163 ~~gklL--eTSCGSPHYA~PEIV~G~pYdG~--~sDVWSCGVI 201 (786)
T KOG0588|consen 163 VPGKLL--ETSCGSPHYAAPEIVSGRPYDGR--PSDVWSCGVI 201 (786)
T ss_pred cCCccc--cccCCCcccCCchhhcCCCCCCC--ccccchhHHH
Confidence 554422 23589999999999999854454 7999999997
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-33 Score=278.35 Aligned_cols=184 Identities=28% Similarity=0.450 Sum_probs=149.8
Q ss_pred CCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCC-----eEE
Q 003982 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS-----ERL 655 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~-----~~~ 655 (782)
.|...+++|.|+||.||+|.. ++++.||||++-.+. +--.+|.++|+.++|||||++..+|.... ...
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK------RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 466789999999999999954 457999999986654 22347999999999999999998887543 235
Q ss_pred EEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCC-CcEEEEeeccc
Q 003982 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD-MRAKVADFGLV 734 (782)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~-~~~kL~DfG~a 734 (782)
+|||||+. +|+++++.+... ...++.-+++-+.+||++||.|||+ .||+||||||.|+|+|.+ |.+||+|||.|
T Consensus 99 lVleymP~-tL~~~~r~~~~~-~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRA-NQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhc-CCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 89999965 899999875443 3568888999999999999999998 899999999999999977 89999999999
Q ss_pred eecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 735 KNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 735 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+....+... .....|++|+|||.+.|. .-++.+.||||.|+|
T Consensus 174 K~L~~~epn--iSYicSRyYRaPELifga--~~Yt~~IDiWSaGCV 215 (364)
T KOG0658|consen 174 KVLVKGEPN--ISYICSRYYRAPELIFGA--TEYTTSIDIWSAGCV 215 (364)
T ss_pred eeeccCCCc--eeEEEeccccCHHHHcCc--cccCceeEEhhhhHH
Confidence 998766543 223459999999988765 335556777777776
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-33 Score=284.62 Aligned_cols=188 Identities=26% Similarity=0.439 Sum_probs=167.3
Q ss_pred cCCCccceeecccceEEEEE-EeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
..|+..+.||+|+||.||+| +..+++.||+|++.... ...+.+++++|+.++.+++++||.++|+.+..+...+++||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~-~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE-AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhh-cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 34677789999999999999 55688999999998754 34578899999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
||.||++.+.++. ...+++.++..++++++.|+.|||+ .+.+|||||+.||++..+|.+|++|||.+.....
T Consensus 92 y~~gGsv~~lL~~-----~~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 92 YCGGGSVLDLLKS-----GNILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTN 163 (467)
T ss_pred HhcCcchhhhhcc-----CCCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeec
Confidence 9999999999864 3445888889999999999999998 8999999999999999999999999999998876
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhcccC
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSVG 781 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv~ 781 (782)
..... ..++|||.|||||++... +++.++|||||||.+
T Consensus 164 ~~~rr-~tfvGTPfwMAPEVI~~~---~Y~~KADIWSLGITa 201 (467)
T KOG0201|consen 164 TVKRR-KTFVGTPFWMAPEVIKQS---GYDTKADIWSLGITA 201 (467)
T ss_pred hhhcc-ccccccccccchhhhccc---cccchhhhhhhhHHH
Confidence 55443 567999999999999964 789999999999864
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=258.58 Aligned_cols=190 Identities=30% Similarity=0.477 Sum_probs=165.7
Q ss_pred hcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCCh-hhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGN-KGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
.++|++.+.||+|.||.||.|+ .+++..||+|++.+..... ...+.+++|+++-..++||||+++|++|.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 3578899999999999999995 4567899999998765322 2456789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
+||.++|+++..|++.+ ...+++.....+.+|+|.|+.|+|. ++||||||||+|+|++..+..||+|||-+...
T Consensus 101 lEya~~gel~k~L~~~~---~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGR---MKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEecCCchHHHHHHhcc---cccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 99999999999998532 3458888999999999999999998 99999999999999999999999999998766
Q ss_pred CCCCceeeecccccccccCccccccchhhhHHHHHHHHHhcccC
Q 003982 738 PDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSVG 781 (782)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv~ 781 (782)
+.+. ....|||..|.|||+..+. +.+...|+|++||+.
T Consensus 175 p~~k---R~tlcgt~dyl~pEmv~~~---~hd~~Vd~w~lgvl~ 212 (281)
T KOG0580|consen 175 PSNK---RKTLCGTLDYLPPEMVEGR---GHDKFVDLWSLGVLC 212 (281)
T ss_pred CCCC---ceeeecccccCCHhhcCCC---CccchhhHHHHHHHH
Confidence 5332 2446899999999999885 678899999999864
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-34 Score=266.29 Aligned_cols=189 Identities=28% Similarity=0.459 Sum_probs=166.0
Q ss_pred HhcCCCccceeecccceEEEEE-EeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
+.+.|++.+.||+|.|+.||++ +.++|+.+|+|++..........+++.+|++|.+.++||||+++.+.+.+.+..|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 4567888899999999999999 677899999999988877777889999999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCC---CcEEEEeeccc
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD---MRAKVADFGLV 734 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~---~~~kL~DfG~a 734 (782)
+|+|.|++|..-+-+. --+++..+..+++||++||.|+|. +||||||+||+|+++.+. .-+||+|||+|
T Consensus 89 Fe~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvA 160 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLA 160 (355)
T ss_pred EecccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceE
Confidence 9999999998766542 236888999999999999999998 999999999999999643 46999999999
Q ss_pred eecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 735 KNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 735 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
....++ .....++|||+|||||++... .+..-+|||+.|||
T Consensus 161 i~l~~g--~~~~G~~GtP~fmaPEvvrkd---py~kpvDiW~cGVi 201 (355)
T KOG0033|consen 161 IEVNDG--EAWHGFAGTPGYLSPEVLKKD---PYSKPVDIWACGVI 201 (355)
T ss_pred EEeCCc--cccccccCCCcccCHHHhhcC---CCCCcchhhhhhHH
Confidence 998743 355667899999999998876 34556899999986
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-33 Score=286.98 Aligned_cols=184 Identities=32% Similarity=0.513 Sum_probs=163.7
Q ss_pred CcccccHHHHHHHhcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEe
Q 003982 567 GNVAISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646 (782)
Q Consensus 567 ~~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~ 646 (782)
+...++++++.. ++.||.|+.|.||.|+. .++.||||+++.-+ +.+|+-|++++||||+.+.|
T Consensus 117 e~WeiPFe~IsE-------LeWlGSGaQGAVF~Grl-~netVAVKKV~elk---------ETdIKHLRkLkH~NII~FkG 179 (904)
T KOG4721|consen 117 ELWEIPFEEISE-------LEWLGSGAQGAVFLGRL-HNETVAVKKVRELK---------ETDIKHLRKLKHPNIITFKG 179 (904)
T ss_pred hhccCCHHHhhh-------hhhhccCcccceeeeec-cCceehhHHHhhhh---------hhhHHHHHhccCcceeeEee
Confidence 345677777653 67899999999999998 67899999886433 45788999999999999999
Q ss_pred EEEeCCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcE
Q 003982 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRA 726 (782)
Q Consensus 647 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~ 726 (782)
+|.....+|||||||+.|.|+++|+. ..+++....+.+..+||.|+.|||. +.|||||||.-||||..+..|
T Consensus 180 VCtqsPcyCIiMEfCa~GqL~~VLka-----~~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~V 251 (904)
T KOG4721|consen 180 VCTQSPCYCIIMEFCAQGQLYEVLKA-----GRPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVV 251 (904)
T ss_pred eecCCceeEEeeeccccccHHHHHhc-----cCccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceE
Confidence 99999999999999999999999976 4678999999999999999999998 899999999999999999999
Q ss_pred EEEeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 727 KVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 727 kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
||+|||.++...+.. ....++||..|||||++..+ .|..+.||||||||
T Consensus 252 KIsDFGTS~e~~~~S--TkMSFaGTVaWMAPEvIrne---PcsEKVDIwSfGVV 300 (904)
T KOG4721|consen 252 KISDFGTSKELSDKS--TKMSFAGTVAWMAPEVIRNE---PCSEKVDIWSFGVV 300 (904)
T ss_pred EeccccchHhhhhhh--hhhhhhhhHhhhCHHHhhcC---CcccccceehhHHH
Confidence 999999998876643 33457899999999999997 89999999999997
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-32 Score=291.91 Aligned_cols=188 Identities=27% Similarity=0.468 Sum_probs=160.9
Q ss_pred CCCccceeecccceEEEEEEeC----CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 582 NFSEANILGRGGFGVVYGGELP----DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
...+.++||.|.||+||+|+++ ....||||.++... .++.+.+|..|+.||.+++||||+++.|+.......+||
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 3457899999999999999764 24579999997653 466788999999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
+|||++|+|..+|++.. +.+++-+...+.+.|+.|++||-+ .++|||||.++||||+.+..+|++|||+++.+
T Consensus 709 TEyMENGsLDsFLR~~D----GqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQND----GQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred hhhhhCCcHHHHHhhcC----CceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccceeec
Confidence 99999999999998732 458999999999999999999998 89999999999999999999999999999988
Q ss_pred CCCCceeeecccc--cccccCccccccchhhhHHHHHHHHHhccc
Q 003982 738 PDGKYSVETRLAG--TFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 738 ~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+++.....+...| ..+|.|||.+.-. +.+.++||||+|||
T Consensus 782 edd~~~~ytt~GGKIPiRWTAPEAIa~R---KFTsASDVWSyGIV 823 (996)
T KOG0196|consen 782 EDDPEAAYTTLGGKIPIRWTAPEAIAYR---KFTSASDVWSYGIV 823 (996)
T ss_pred ccCCCccccccCCccceeecChhHhhhc---ccCchhhccccceE
Confidence 7654222222223 5689999976543 45889999999997
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-33 Score=270.31 Aligned_cols=184 Identities=28% Similarity=0.445 Sum_probs=164.8
Q ss_pred CCccceeecccceEEEEE-EeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEcc
Q 003982 583 FSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYM 661 (782)
Q Consensus 583 y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~ 661 (782)
|.++++||+|+||.||+| +...|+.+|+|.+..+ ...+++.+|+.+|++++.|++|++||.|......|+|||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 556888999999999999 5668999999998753 46788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCC
Q 003982 662 PRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK 741 (782)
Q Consensus 662 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~ 741 (782)
..|++.+.++.. .+++++.++..+++..++||+|||. ..-||||||+.|||++-+|.+||+|||.|-.+.+..
T Consensus 111 GAGSiSDI~R~R----~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 111 GAGSISDIMRAR----RKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM 183 (502)
T ss_pred CCCcHHHHHHHh----cCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence 999999988753 4579999999999999999999998 678999999999999999999999999998887654
Q ss_pred ceeeecccccccccCccccccchhhhHHHHHHHHHhcccC
Q 003982 742 YSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSVG 781 (782)
Q Consensus 742 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv~ 781 (782)
..+ ...+|||.|||||++... |++..+||||+||.+
T Consensus 184 AKR-NTVIGTPFWMAPEVI~EI---GY~~~ADIWSLGITa 219 (502)
T KOG0574|consen 184 AKR-NTVIGTPFWMAPEVIEEI---GYDTKADIWSLGITA 219 (502)
T ss_pred Hhh-CccccCcccccHHHHHHh---ccchhhhHhhhcchh
Confidence 333 446899999999999885 889999999999865
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-32 Score=286.33 Aligned_cols=194 Identities=27% Similarity=0.476 Sum_probs=165.1
Q ss_pred HHHhcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEE
Q 003982 577 RQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656 (782)
Q Consensus 577 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 656 (782)
....+...+.+.||+|+||+||+|+|- ..||||+++......+..+.|+.|+.++++-+|.||+-+.||+..+.. .|
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AI 464 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AI 464 (678)
T ss_pred ccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-ee
Confidence 333444567899999999999999883 369999999887777788999999999999999999999999998877 99
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecccee
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~ 736 (782)
|+.+|+|-+|+.+++..+ ..++..+...||+|+++|+.|||. ++|||||||..|||+.++++|||+|||++..
T Consensus 465 iTqwCeGsSLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 465 ITQWCEGSSLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred eehhccCchhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceee
Confidence 999999999999998643 348889999999999999999999 9999999999999999999999999999865
Q ss_pred cCCCC-ceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 737 APDGK-YSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 737 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
...-. ........|...|||||+++..-...+.+++||||||+|
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV 582 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIV 582 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHH
Confidence 33211 011122347889999999886667788999999999997
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-33 Score=289.83 Aligned_cols=321 Identities=23% Similarity=0.276 Sum_probs=198.5
Q ss_pred CCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEec
Q 003982 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144 (782)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 144 (782)
++++.|+|.+|-|+..-.+++..++.|+.||||.|.|+.++. .|..-.++++|+|++|+|+.+..+.|.++.+|.+|.|
T Consensus 125 ghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkL 204 (873)
T KOG4194|consen 125 GHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKL 204 (873)
T ss_pred cceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeec
Confidence 355556666666555555555566666666666666655443 4555555666666666666666666666666666666
Q ss_pred cCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccc-cccchhhcccccCC
Q 003982 145 SDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLG 223 (782)
Q Consensus 145 s~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~l~l~~~~~~ 223 (782)
+.|+++. ..+..|.+|++|+.|+|..|+|.-..--.|..+++|+.|.|..|++...-...|.. .+++.|++..|++.
T Consensus 205 srNritt--Lp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~ 282 (873)
T KOG4194|consen 205 SRNRITT--LPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQ 282 (873)
T ss_pred ccCcccc--cCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhh
Confidence 6666655 23345555666666666666655444445556666666666666665222222222 35556666655543
Q ss_pred CccccccccCCCCCcEEEeecccccCCCCC-CCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCC--
Q 003982 224 LSGTLDVLSGMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPL-- 300 (782)
Q Consensus 224 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-- 300 (782)
.. ....+-+++.|+.|+||.|.|..+.++ +..+.+|+.|+|++|+|+...+.+|..+..|+.|+|++|+++-....
T Consensus 283 ~v-n~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af 361 (873)
T KOG4194|consen 283 AV-NEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAF 361 (873)
T ss_pred hh-hcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHH
Confidence 21 122344566666666666666654443 55556666666666666666666666666666666666666533222
Q ss_pred -CCCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCccc
Q 003982 301 -FPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLL 379 (782)
Q Consensus 301 -~~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l 379 (782)
.+++|++|||++|.++....+.. ..+..++.|+.|+|-+|+|
T Consensus 362 ~~lssL~~LdLr~N~ls~~IEDaa-------------------------------------~~f~gl~~LrkL~l~gNql 404 (873)
T KOG4194|consen 362 VGLSSLHKLDLRSNELSWCIEDAA-------------------------------------VAFNGLPSLRKLRLTGNQL 404 (873)
T ss_pred HHhhhhhhhcCcCCeEEEEEecch-------------------------------------hhhccchhhhheeecCcee
Confidence 34566666666666654432211 2244578999999999999
Q ss_pred ccccCccccccccCCeEecccccccccCCccCCCCCCCCeEecCCCcC
Q 003982 380 AGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNL 427 (782)
Q Consensus 380 ~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l 427 (782)
+.+.-..|.++..|++|||.+|.|....|++|..+ .|+.|-+..-++
T Consensus 405 k~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssf 451 (873)
T KOG4194|consen 405 KSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSF 451 (873)
T ss_pred eecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccce
Confidence 97666799999999999999999999999999999 899988865554
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=288.98 Aligned_cols=189 Identities=24% Similarity=0.387 Sum_probs=159.8
Q ss_pred cCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCC-hhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
++|++.+.||+|+||+||+|. ..+++.||+|++.+.... ......+++|++++.+++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 478999999999999999995 456899999999764322 234467889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++|+|.+++.+ ...+++.++..++.|++.||+|||+ .||+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLMK-----KDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 99999999999865 2458999999999999999999998 899999999999999999999999999987543
Q ss_pred CCCc----------------------------------eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKY----------------------------------SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.... ......+||+.|+|||++.+. +++.++|+||+||+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~---~~~~~~DvwSlGvi 225 (363)
T cd05628 153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT---GYNKLCDWWSLGVI 225 (363)
T ss_pred ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC---CCCCchhhhhhHHH
Confidence 2110 001234799999999998764 46778999999986
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=283.06 Aligned_cols=190 Identities=26% Similarity=0.375 Sum_probs=170.4
Q ss_pred cCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCe-EEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE-RLLVY 658 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~-~~lv~ 658 (782)
++|..++++|+|+||.++.++ ..+++.||+|.+..........+...+|+.++++++||||+.+.+.|++++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 578999999999999999984 4567899999999887777778889999999999999999999999999888 89999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
+||+||++.+.+.+.+ ..-++++.+..++.|++.|+.|||+ +.|+|||||+.|||+++++.|||.|||+|+...
T Consensus 84 ~Y~eGg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred eecCCCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 9999999999998754 2458999999999999999999998 999999999999999999999999999999887
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... ......+||+.||.||++.|. .+..++||||+|++
T Consensus 158 ~~~-~~a~tvvGTp~YmcPEil~d~---pYn~KSDiWsLGC~ 195 (426)
T KOG0589|consen 158 PED-SLASTVVGTPYYMCPEILSDI---PYNEKSDIWSLGCC 195 (426)
T ss_pred Cch-hhhheecCCCcccCHHHhCCC---CCCccCcchhhcch
Confidence 654 233456899999999999996 67888999999975
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=267.84 Aligned_cols=190 Identities=28% Similarity=0.405 Sum_probs=160.2
Q ss_pred hcCCCccceeecccceEEEEE-EeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEe-----CCe
Q 003982 580 TDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN-----GSE 653 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~-----~~~ 653 (782)
...|...+.||+|++|.|.+| +..+|+.||||++..........++..+|+++++.++|+||+.+.+++.. -..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 455666889999999999999 56789999999997555445577889999999999999999999998865 246
Q ss_pred EEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecc
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~ 733 (782)
.|+|+|+| +-+|.+.++. .+.++..++..+++|+++||.|+|+ .+|+|||+||.|++++.+..+||+|||+
T Consensus 101 vYiV~elM-etDL~~iik~-----~~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKS-----QQDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred eEEehhHH-hhHHHHHHHc-----CccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccc
Confidence 79999999 6789999876 3459999999999999999999999 8999999999999999999999999999
Q ss_pred ceecCCCCc-eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 734 VKNAPDGKY-SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 734 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|+....... ..-+..+.|.+|+|||++... ..++.+.||||+|+|
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~--~~Yt~aiDiWSvGCI 217 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNS--SEYTKAIDIWSVGCI 217 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhcc--ccccchhhhhhhhHH
Confidence 998864311 112455779999999987543 367788888888886
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-32 Score=256.46 Aligned_cols=195 Identities=31% Similarity=0.447 Sum_probs=167.3
Q ss_pred HHHHhcCCCccceeecccceEEEEE-EeCCCcEEEEEEeccccCCh------hhHHHHHHHHHHHHhcC-CCCcceEEeE
Q 003982 576 LRQVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGN------KGLSEFQAEIAVLTKVR-HRHLVALLGY 647 (782)
Q Consensus 576 l~~~~~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~-h~nI~~~~~~ 647 (782)
-..+..+|...+.+|+|..++|.++ ...+|+.+|+|++....... .-.+.-.+|+.+++++. ||+|+++.++
T Consensus 12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ 91 (411)
T KOG0599|consen 12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV 91 (411)
T ss_pred HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence 3456678899999999999999998 55688999999997543221 12344568999999985 9999999999
Q ss_pred EEeCCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEE
Q 003982 648 CINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAK 727 (782)
Q Consensus 648 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~k 727 (782)
|+++...++|+|.|+.|.|.+++.+ ...+++++...|++|+.+|++|||. +.|||||+||+|||++++.++|
T Consensus 92 yes~sF~FlVFdl~prGELFDyLts-----~VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~ 163 (411)
T KOG0599|consen 92 YESDAFVFLVFDLMPRGELFDYLTS-----KVTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIK 163 (411)
T ss_pred ccCcchhhhhhhhcccchHHHHhhh-----heeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceE
Confidence 9999999999999999999999976 3568999999999999999999998 8999999999999999999999
Q ss_pred EEeeccceecCCCCceeeecccccccccCccccccc---hhhhHHHHHHHHHhccc
Q 003982 728 VADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKH---WMILCQMTGLIWLHGSV 780 (782)
Q Consensus 728 L~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~~dvws~Gvv 780 (782)
|+|||+|+.++.+. .-...||||+|.|||.+.-. -..|+....|+|++|||
T Consensus 164 isDFGFa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVI 217 (411)
T KOG0599|consen 164 ISDFGFACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVI 217 (411)
T ss_pred EeccceeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHH
Confidence 99999999988765 23457999999999976533 24678889999999996
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=285.39 Aligned_cols=189 Identities=27% Similarity=0.413 Sum_probs=164.7
Q ss_pred HhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcC-CCCcceEEeEEEeCCeEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSERL 655 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~~~ 655 (782)
..++|...++||+|.||.|+.+.. .+++.||||++++... .+++.+..+.|.+|+.... ||.++.++..|++.++.|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 457899999999999999999954 4678999999998764 4567888899999988775 999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccce
Q 003982 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (782)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~ 735 (782)
.||||+.||++..+.+ .+.+++..+.-+++.++.||+|||+ +||||||||.+|||+|.+|.+||+|||+++
T Consensus 446 fvmey~~Ggdm~~~~~------~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIH------TDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEecCCCcEEEEEe------cccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEeccccccc
Confidence 9999999999443332 2468999999999999999999998 999999999999999999999999999998
Q ss_pred ecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 736 NAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 736 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
....... ....+||||.|||||++.+. .|+.+.|=|||||+
T Consensus 517 e~m~~g~-~TsTfCGTpey~aPEil~e~---~Yt~aVDWW~lGVL 557 (694)
T KOG0694|consen 517 EGMGQGD-RTSTFCGTPEFLAPEVLTEQ---SYTRAVDWWGLGVL 557 (694)
T ss_pred ccCCCCC-ccccccCChhhcChhhhccC---cccchhhHHHHHHH
Confidence 7653332 34568999999999999986 67889999999985
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=279.12 Aligned_cols=185 Identities=28% Similarity=0.351 Sum_probs=159.8
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCC-hhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
++|++.+.||+|+||.||+|.. .+++.||+|++...... .+..+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 4688999999999999999955 47899999999754321 234567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ +||+||||||+||++++++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~ 152 (291)
T cd05612 81 EYVPGGELFSYLRN-----SGRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR 152 (291)
T ss_pred eCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence 99999999999865 2458899999999999999999998 899999999999999999999999999998765
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... ....||+.|+|||++.+. +.+.++||||+||+
T Consensus 153 ~~~----~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~i 187 (291)
T cd05612 153 DRT----WTLCGTPEYLAPEVIQSK---GHNKAVDWWALGIL 187 (291)
T ss_pred CCc----ccccCChhhcCHHHHcCC---CCCchhhHHHHHHH
Confidence 432 234689999999998765 45778999999986
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=287.62 Aligned_cols=189 Identities=24% Similarity=0.407 Sum_probs=158.5
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
++|++.+.||+|+||.||+|+. .+++.||||++..... .......+.+|+++++.++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4789999999999999999955 4689999999976432 2234566889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++|+|.+++.. ...+++.++..++.|++.||+|||+ .||+||||||+|||++.++.+||+|||++....
T Consensus 81 E~~~~g~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 81 EYLPGGDMMTLLMK-----KDTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred CCCCCcHHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 99999999999865 2458999999999999999999998 899999999999999999999999999987543
Q ss_pred CCCce-------------------------------------eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYS-------------------------------------VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..... .....+||+.|+|||++.+. +++.++||||+||+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~i 228 (364)
T cd05599 153 KSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT---GYNKECDWWSLGVI 228 (364)
T ss_pred ccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC---CCCCeeeeecchhH
Confidence 21100 00124699999999988664 45677888888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=287.31 Aligned_cols=196 Identities=23% Similarity=0.301 Sum_probs=161.1
Q ss_pred HHHHhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCe
Q 003982 576 LRQVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE 653 (782)
Q Consensus 576 l~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~ 653 (782)
+....++|++.+.||+|+||.||+|.. .+++.||+|++.+... .....+.+.+|+++++.++||||+++++++.++..
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 334457899999999999999999965 4688999999975432 22344568899999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecc
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~ 733 (782)
.|+||||+++|+|.+++.. ..+++..+..++.|++.||+|||+ .||+||||||+|||+++++.+||+|||+
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~------~~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~ 188 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSN------YDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGT 188 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEeccc
Confidence 9999999999999998854 247889999999999999999998 8999999999999999999999999999
Q ss_pred ceecCCCCceeeecccccccccCccccccch-hhhHHHHHHHHHhccc
Q 003982 734 VKNAPDGKYSVETRLAGTFGYLAPEYAGKHW-MILCQMTGLIWLHGSV 780 (782)
Q Consensus 734 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~dvws~Gvv 780 (782)
|..............+||+.|+|||++.+.- ...+..++|+||+||+
T Consensus 189 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~i 236 (370)
T cd05621 189 CMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 236 (370)
T ss_pred ceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHH
Confidence 9876543332233457999999999875431 0113456788888875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=287.01 Aligned_cols=189 Identities=24% Similarity=0.341 Sum_probs=158.2
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
.+|++.+.||+|+||.||+|+. .+++.||||++.+... .......+.+|++++++++||||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3689999999999999999954 5689999999975432 1234567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+|..+.
T Consensus 81 E~~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~ 152 (376)
T cd05598 81 DYIPGGDMMSLLIR-----LGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 152 (376)
T ss_pred eCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCcccc
Confidence 99999999999865 2457889999999999999999998 899999999999999999999999999975321
Q ss_pred CCC------------------------------------------ceeeecccccccccCccccccchhhhHHHHHHHHH
Q 003982 739 DGK------------------------------------------YSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWL 776 (782)
Q Consensus 739 ~~~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws 776 (782)
... .......+||+.|||||++.+. +++.++||||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwS 229 (376)
T cd05598 153 WTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT---GYTQLCDWWS 229 (376)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC---CCCcceeeee
Confidence 000 0001124699999999998764 4577899999
Q ss_pred hccc
Q 003982 777 HGSV 780 (782)
Q Consensus 777 ~Gvv 780 (782)
+||+
T Consensus 230 lGvi 233 (376)
T cd05598 230 VGVI 233 (376)
T ss_pred ccce
Confidence 9987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=287.61 Aligned_cols=189 Identities=26% Similarity=0.399 Sum_probs=158.0
Q ss_pred cCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
++|++.+.||+|+||.||+|. ..+++.||||++.+... .....+.+++|++++++++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 478999999999999999994 45789999999875432 2334567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++...
T Consensus 81 E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~ 152 (377)
T cd05629 81 EFLPGGDLMTMLIK-----YDTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFH 152 (377)
T ss_pred eCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeecccccccc
Confidence 99999999999865 2458899999999999999999998 899999999999999999999999999986432
Q ss_pred CCCc-------------e---------------------------------eeecccccccccCccccccchhhhHHHHH
Q 003982 739 DGKY-------------S---------------------------------VETRLAGTFGYLAPEYAGKHWMILCQMTG 772 (782)
Q Consensus 739 ~~~~-------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 772 (782)
.... . .....+||+.|+|||++.+. .++.++
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~ 229 (377)
T cd05629 153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ---GYGQEC 229 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC---CCCCce
Confidence 1000 0 00124699999999998764 456788
Q ss_pred HHHHhccc
Q 003982 773 LIWLHGSV 780 (782)
Q Consensus 773 dvws~Gvv 780 (782)
|+||+||+
T Consensus 230 DiwSlGvi 237 (377)
T cd05629 230 DWWSLGAI 237 (377)
T ss_pred eeEecchh
Confidence 99999986
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=287.18 Aligned_cols=188 Identities=25% Similarity=0.358 Sum_probs=157.1
Q ss_pred CCCccceeecccceEEEEEE-eCCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 582 NFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
.|+..+.||+|+||+||+|. ..+++.||+|++..... .......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 58889999999999999994 45788999999976542 23345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++|+|.+++.+ ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~ 153 (381)
T cd05626 82 YIPGGDMMSLLIR-----MEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRW 153 (381)
T ss_pred cCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCccccc
Confidence 9999999999865 2458899999999999999999998 8999999999999999999999999999754311
Q ss_pred CCc----------------------------------------------eeeecccccccccCccccccchhhhHHHHHH
Q 003982 740 GKY----------------------------------------------SVETRLAGTFGYLAPEYAGKHWMILCQMTGL 773 (782)
Q Consensus 740 ~~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d 773 (782)
... ......+||+.|+|||++.+. +++.++|
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~---~~~~~~D 230 (381)
T cd05626 154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK---GYTQLCD 230 (381)
T ss_pred ccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC---CCCCccc
Confidence 000 001124699999999998654 4567788
Q ss_pred HHHhccc
Q 003982 774 IWLHGSV 780 (782)
Q Consensus 774 vws~Gvv 780 (782)
|||+||+
T Consensus 231 iwSlG~i 237 (381)
T cd05626 231 WWSVGVI 237 (381)
T ss_pred eeehhhH
Confidence 8888876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=283.81 Aligned_cols=184 Identities=27% Similarity=0.384 Sum_probs=161.2
Q ss_pred CCCccceeecccceEEEEE-EeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC-C-----CCcceEEeEEEeCCeE
Q 003982 582 NFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-H-----RHLVALLGYCINGSER 654 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~nI~~~~~~~~~~~~~ 654 (782)
+|.+.++||+|+||+|.+| +..+++.||||+++... ....+...|+++|..++ | -|+|+++++|...++.
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k---~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK---RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh---HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 8999999999999999999 67789999999998654 56677888999999997 4 4899999999999999
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCC--CcEEEEeec
Q 003982 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD--MRAKVADFG 732 (782)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~--~~~kL~DfG 732 (782)
|||+|.+ .-+|+++++..+ ..+++...+..|+.||+.||.+||+ .||||+||||+|||+.+- ..+||+|||
T Consensus 264 ciVfELL-~~NLYellK~n~---f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 264 CIVFELL-STNLYELLKNNK---FRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred eeeehhh-hhhHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecc
Confidence 9999999 569999998744 4569999999999999999999998 999999999999999754 479999999
Q ss_pred cceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhcccCC
Q 003982 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSVGS 782 (782)
Q Consensus 733 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv~~ 782 (782)
.|+......+ ..+.++.|+|||++.|. .++.+.||||||+|.+
T Consensus 337 SSc~~~q~vy----tYiQSRfYRAPEVILGl---pY~~~IDmWSLGCIlA 379 (586)
T KOG0667|consen 337 SSCFESQRVY----TYIQSRFYRAPEVILGL---PYDTAIDMWSLGCILA 379 (586)
T ss_pred cccccCCcce----eeeeccccccchhhccC---CCCCccceeehhhhHH
Confidence 9988766443 24568899999999995 7788899999998853
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-33 Score=290.86 Aligned_cols=339 Identities=24% Similarity=0.326 Sum_probs=282.8
Q ss_pred CCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCCCCCCCCCCCEEeCCCCccc--CCCCCCCCCCCCCCEEe
Q 003982 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFT--SVPTGCFDGLTNLQVLS 143 (782)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~--~~~~~~~~~l~~L~~L~ 143 (782)
.+++-|.|...+|. .+|++++.+.+|++|.+++|++..+.-.++.|+.|+.+++.+|++. +||++.| .+..|+.||
T Consensus 32 t~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF-~l~dLt~lD 109 (1255)
T KOG0444|consen 32 TQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLISVHGELSDLPRLRSVIVRDNNLKNSGIPTDIF-RLKDLTILD 109 (1255)
T ss_pred hheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhHhhhhhhccchhhHHHhhhccccccCCCCchhc-ccccceeee
Confidence 37899999999998 8999999999999999999999988888999999999999999987 6888854 699999999
Q ss_pred ccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccc-cccchhhcccccC
Q 003982 144 LSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQL 222 (782)
Q Consensus 144 Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~l~l~~~~~ 222 (782)
||+|++.+ .|..+.+-+++-.|+|++|+|..+....|-+++.|-+||||+|++. .+|+.+.. ..|+.|.+++|.+
T Consensus 110 LShNqL~E---vP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL 185 (1255)
T KOG0444|consen 110 LSHNQLRE---VPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPL 185 (1255)
T ss_pred cchhhhhh---cchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChh
Confidence 99999999 8999999999999999999999998888999999999999999998 88887766 6899999999987
Q ss_pred CCccccccccCCCCCcEEEeeccccc--CCCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCC-
Q 003982 223 GLSGTLDVLSGMTQLRQVWLHKNQFT--GPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYP- 299 (782)
Q Consensus 223 ~~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~- 299 (782)
...... .+-.|++|++|++++.+-+ ..|+.+..+.+|..+|||.|++. .+|+.+.++++|..|+||+|+|+..--
T Consensus 186 ~hfQLr-QLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~ 263 (1255)
T KOG0444|consen 186 NHFQLR-QLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMT 263 (1255)
T ss_pred hHHHHh-cCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeecc
Confidence 654332 3456889999999998754 46668999999999999999999 899999999999999999999995322
Q ss_pred -CCCCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCC--CCCCCcccccCCceeEEEccC
Q 003982 300 -LFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNA--CDGWPFVTCSQGRIITINLAN 376 (782)
Q Consensus 300 -~~~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~~L~~L~Ls~ 376 (782)
....+|++|.+|+|+++.++... +....+...+..+|. .+.||..++.+.+|+.+..++
T Consensus 264 ~~~W~~lEtLNlSrNQLt~LP~av------------------cKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aan 325 (1255)
T KOG0444|consen 264 EGEWENLETLNLSRNQLTVLPDAV------------------CKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAAN 325 (1255)
T ss_pred HHHHhhhhhhccccchhccchHHH------------------hhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhc
Confidence 23468999999999998766222 122222223333332 457888888888888888888
Q ss_pred cccccccCccccccccCCeEecccccccccCCccCCCCCCCCeEecCCCcCCCCCC
Q 003982 377 KLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVP 432 (782)
Q Consensus 377 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p 432 (782)
|.+. ..|..++.+..|+.|.|++|++- .+|+++.-|+.|+.||+.+|+=--.+|
T Consensus 326 N~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPP 379 (1255)
T KOG0444|consen 326 NKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPP 379 (1255)
T ss_pred cccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCC
Confidence 8887 77888888888888888888887 788888888888888888887555555
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=282.05 Aligned_cols=185 Identities=28% Similarity=0.432 Sum_probs=159.2
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
++|++.+.||+|+||.||+|+. .+++.||+|++..... .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 5788999999999999999965 4688999999976432 1234567899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++...
T Consensus 98 e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 98 EFVVGGELFTHLRK-----AGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred cCCCCChHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 99999999999865 2457889999999999999999998 899999999999999999999999999998765
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.... ...||+.|+|||++.+. +.+.++|+||+||+
T Consensus 170 ~~~~----~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~i 204 (329)
T PTZ00263 170 DRTF----TLCGTPEYLAPEVIQSK---GHGKAVDWWTMGVL 204 (329)
T ss_pred CCcc----eecCChhhcCHHHHcCC---CCCCcceeechHHH
Confidence 4332 24689999999988764 34567888888875
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=281.09 Aligned_cols=186 Identities=27% Similarity=0.357 Sum_probs=159.3
Q ss_pred hcCCCccceeecccceEEEEEEeC-C-CcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGELP-D-GTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 656 (782)
.++|.+.+.||+|+||.||+|... + +..||+|++..... .....+.+.+|+++++.++||||+++++++.+++..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 356899999999999999999543 3 36899999975432 23345678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecccee
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~ 736 (782)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+ .||+||||||+|||++.++.+||+|||+++.
T Consensus 109 v~Ey~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR-----NKRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 9999999999999865 2458999999999999999999998 8999999999999999999999999999987
Q ss_pred cCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 737 APDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..... ....||+.|+|||++.+. +++.++|+||+||+
T Consensus 181 ~~~~~----~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlGvi 217 (340)
T PTZ00426 181 VDTRT----YTLCGTPEYIAPEILLNV---GHGKAADWWTLGIF 217 (340)
T ss_pred cCCCc----ceecCChhhcCHHHHhCC---CCCccccccchhhH
Confidence 65422 234689999999998764 45678899999986
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=280.70 Aligned_cols=186 Identities=29% Similarity=0.512 Sum_probs=157.8
Q ss_pred CCccceeecccceEEEEEEeC--CC---cEEEEEEeccc-cCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEE
Q 003982 583 FSEANILGRGGFGVVYGGELP--DG---TKIAVKRMESN-TMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656 (782)
Q Consensus 583 y~~~~~lg~G~~g~Vy~~~~~--~~---~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 656 (782)
-...++||+|+||.||+|... ++ ..||||..+.. .......++|.+|+++|+.++||||+++||++......++
T Consensus 159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~i 238 (474)
T KOG0194|consen 159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLML 238 (474)
T ss_pred ccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEE
Confidence 344689999999999999553 22 23899998863 3456788999999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecccee
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~ 736 (782)
|||+|+||+|.++|+...+ .++..+...++.+.|+||+|||+ +++|||||.++|+|++.++.+||+|||+++.
T Consensus 239 vmEl~~gGsL~~~L~k~~~----~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 239 VMELCNGGSLDDYLKKNKK----SLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred EEEecCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccC
Confidence 9999999999999987432 48999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCCceeeecc-cccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 737 APDGKYSVETRL-AGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 737 ~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.. .+...... .-...|+|||.+... -++.++|||||||+
T Consensus 312 ~~--~~~~~~~~~klPirWLAPEtl~~~---~~s~kTDV~sfGV~ 351 (474)
T KOG0194|consen 312 GS--QYVMKKFLKKLPIRWLAPETLNTG---IFSFKTDVWSFGVL 351 (474)
T ss_pred Cc--ceeeccccccCcceecChhhhccC---ccccccchhheeee
Confidence 54 22222211 235789999998875 57889999999997
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=278.39 Aligned_cols=182 Identities=27% Similarity=0.350 Sum_probs=154.6
Q ss_pred ceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEccCCC
Q 003982 587 NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRG 664 (782)
Q Consensus 587 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~g 664 (782)
+.||+|+||.||+|.. .+++.||+|++++... .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999954 5789999999976432 2334567889999999999999999999999999999999999999
Q ss_pred CHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCcee
Q 003982 665 TLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSV 744 (782)
Q Consensus 665 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~~ 744 (782)
+|.+++.. ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~ 151 (323)
T cd05571 81 ELFFHLSR-----ERVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-T 151 (323)
T ss_pred cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-c
Confidence 99998865 2458999999999999999999998 8999999999999999999999999999875432221 1
Q ss_pred eecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 745 ETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 745 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
....+||+.|+|||++.+. .++.++||||+||+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~i 184 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDN---DYGRAVDWWGLGVV 184 (323)
T ss_pred ccceecCccccChhhhcCC---CCCccccCcccchh
Confidence 2335799999999998764 45678999999987
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=280.31 Aligned_cols=185 Identities=28% Similarity=0.417 Sum_probs=160.5
Q ss_pred cCCCccceeecccceEEEEEEeC-CCcEEEEEEeccccCC-hhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
++|++.+.||+|+||.||+|... +++.||||+++..... ....+.+.+|+++++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47899999999999999999654 6889999999765322 234567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++....
T Consensus 81 e~~~g~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~ 152 (333)
T cd05600 81 EYVPGGDFRTLLNN-----LGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV 152 (333)
T ss_pred eCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence 99999999999865 2458899999999999999999998 899999999999999999999999999997654
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
. ......||+.|+|||++.+. .++.++||||+||+
T Consensus 153 ~----~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~i 187 (333)
T cd05600 153 T----YANSVVGSPDYMAPEVLRGK---GYDFTVDYWSLGCM 187 (333)
T ss_pred c----ccCCcccCccccChhHhcCC---CCCCccceecchHH
Confidence 4 12335689999999998765 56778999999986
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=276.91 Aligned_cols=188 Identities=28% Similarity=0.442 Sum_probs=165.4
Q ss_pred HhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCCh-hhHHHHHHHHHHHHhcC-CCCcceEEeEEEeCCeEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGN-KGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSERL 655 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~~~ 655 (782)
....|.+.+.||+|.||.||++.. .+|+.+|+|.+.+..... .....+.+|+.+|+++. ||||+.++++|++....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 456788899999999999999955 459999999998776432 35678999999999998 999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCC----CcEEEEee
Q 003982 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD----MRAKVADF 731 (782)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~----~~~kL~Df 731 (782)
+|||++.||.|.+.+... .+++.++..++.|++.|++|||+ .||+|||+||+|+|+... +.+|++||
T Consensus 113 lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred EEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 999999999999999763 28999999999999999999998 899999999999999643 47999999
Q ss_pred ccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 732 GLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 732 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|+|..... .......+||++|+|||++.+. +++...||||+||+
T Consensus 184 Gla~~~~~--~~~~~~~~Gtp~y~APEvl~~~---~y~~~~DiWS~Gvi 227 (382)
T KOG0032|consen 184 GLAKFIKP--GERLHTIVGTPEYVAPEVLGGR---PYGDEVDVWSIGVI 227 (382)
T ss_pred CCceEccC--CceEeeecCCccccCchhhcCC---CCCcccchhHHHHH
Confidence 99998876 2234567899999999998864 67888999999987
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=283.83 Aligned_cols=198 Identities=24% Similarity=0.298 Sum_probs=162.7
Q ss_pred HHHHHHhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC
Q 003982 574 EVLRQVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCING 651 (782)
Q Consensus 574 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~ 651 (782)
..+....++|++.+.||+|+||.||+|+. .+++.||+|++.+... .....+.+.+|+.+++.++||||+++++++.++
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 34445568999999999999999999955 4688999999875332 223445678999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEee
Q 003982 652 SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADF 731 (782)
Q Consensus 652 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~Df 731 (782)
...++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+||
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeC
Confidence 999999999999999998864 247888999999999999999998 89999999999999999999999999
Q ss_pred ccceecCCCCceeeecccccccccCccccccchh-hhHHHHHHHHHhccc
Q 003982 732 GLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWM-ILCQMTGLIWLHGSV 780 (782)
Q Consensus 732 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~dvws~Gvv 780 (782)
|+++.............+||+.|+|||++...-. ..++.++|+||+||+
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvi 236 (371)
T cd05622 187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 236 (371)
T ss_pred CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHH
Confidence 9998765433222334579999999998764310 114567888888876
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=270.63 Aligned_cols=188 Identities=29% Similarity=0.458 Sum_probs=157.9
Q ss_pred CCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCCh-hhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 582 NFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGN-KGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
.|+..+.||+|+||.||+|. ..+++.||+|.+....... .....+.+|++++++++|++|+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 37788999999999999995 4678999999987654322 234567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++|+|.+++.... ...+++..+..++.|++.||+|||+ .||+||||||+||++++++.+||+|||++.....
T Consensus 81 ~~~~g~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 81 IMNGGDLKFHIYNMG---NPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred ecCCCcHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 999999988876422 2358999999999999999999998 8999999999999999999999999999987644
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... .....||+.|+|||++.+. .++.++||||+||+
T Consensus 155 ~~~--~~~~~g~~~y~aPE~~~~~---~~~~~~DvwslGvi 190 (285)
T cd05631 155 GET--VRGRVGTVGYMAPEVINNE---KYTFSPDWWGLGCL 190 (285)
T ss_pred CCe--ecCCCCCCCccCHhhhcCC---CCCcccCchhHHHH
Confidence 321 2334689999999998754 34667888888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=285.49 Aligned_cols=188 Identities=26% Similarity=0.354 Sum_probs=155.2
Q ss_pred CCCccceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
.|+..+.||+|+||+||+|.. .+++.||+|++.+... .......+.+|++++++++||||+++++++.+++..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588999999999999999954 5788999999976432 22345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++|+|.+++.+ ...+++..+..++.|++.||+|||+ .||+||||||+|||++.++.+||+|||+|.....
T Consensus 82 ~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~ 153 (382)
T cd05625 82 YIPGGDMMSLLIR-----MGIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (382)
T ss_pred CCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCccccc
Confidence 9999999999865 2357889999999999999999998 8999999999999999999999999999753210
Q ss_pred CC----------------------------------------------ceeeecccccccccCccccccchhhhHHHHHH
Q 003982 740 GK----------------------------------------------YSVETRLAGTFGYLAPEYAGKHWMILCQMTGL 773 (782)
Q Consensus 740 ~~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d 773 (782)
.. .......+||+.|+|||++.+. +++.++|
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~---~~~~~~D 230 (382)
T cd05625 154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT---GYTQLCD 230 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC---CCCCeee
Confidence 00 0001124699999999987654 4456777
Q ss_pred HHHhccc
Q 003982 774 IWLHGSV 780 (782)
Q Consensus 774 vws~Gvv 780 (782)
|||+||+
T Consensus 231 iwSlGvi 237 (382)
T cd05625 231 WWSVGVI 237 (382)
T ss_pred EEechHH
Confidence 8877775
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=277.80 Aligned_cols=193 Identities=24% Similarity=0.330 Sum_probs=163.1
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
++|.+.+.||+|+||.||+|.. .+++.||+|+++.... .....+.+.+|+++++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4789999999999999999954 5789999999986543 2234567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++|+|.+++.+. ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++....
T Consensus 81 e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 153 (330)
T cd05601 81 EYQPGGDLLSLLNRY----EDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLT 153 (330)
T ss_pred CCCCCCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECC
Confidence 999999999998763 2358999999999999999999998 899999999999999999999999999998775
Q ss_pred CCCceeeecccccccccCccccccch---hhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHW---MILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~dvws~Gvv 780 (782)
...........||+.|+|||++.+.. ...++.++||||+||+
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~i 198 (330)
T cd05601 154 ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVI 198 (330)
T ss_pred CCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccce
Confidence 54433333457899999999876421 1134678999999987
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=278.13 Aligned_cols=189 Identities=24% Similarity=0.339 Sum_probs=158.6
Q ss_pred CCCccceeecccceEEEEEEe----CCCcEEEEEEeccccCC--hhhHHHHHHHHHHHHhcC-CCCcceEEeEEEeCCeE
Q 003982 582 NFSEANILGRGGFGVVYGGEL----PDGTKIAVKRMESNTMG--NKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSER 654 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~~ 654 (782)
+|++.+.||+|+||.||+++. .+++.||+|++.+.... ....+.+.+|+++++.++ ||+|+++++++.+.+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 488899999999999999854 36789999999754321 234567889999999995 99999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccc
Q 003982 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734 (782)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a 734 (782)
++||||+++|+|.+++.+ ...+++.++..++.|++.||+|||+ .||+||||||+|||++.++.+||+|||++
T Consensus 81 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~ 152 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ-----RDNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLS 152 (332)
T ss_pred EEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCC
Confidence 999999999999999865 2458999999999999999999998 89999999999999999999999999999
Q ss_pred eecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 735 KNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 735 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+..............||+.|+|||++.+.. ....++||||+||+
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~i 196 (332)
T cd05614 153 KEFLSEEKERTYSFCGTIEYMAPEIIRGKG--GHGKAVDWWSLGIL 196 (332)
T ss_pred ccccccCCCccccccCCccccCHHHhcCCC--CCCCccccccchhh
Confidence 865433322223457999999999987642 24567899999987
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=281.27 Aligned_cols=189 Identities=24% Similarity=0.395 Sum_probs=159.9
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
++|+..+.||+|+||.||+|.. .+++.||+|++..... .......+++|++++.+++||+|+++++++.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4688999999999999999954 5689999999975432 2334567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++|+|.+++.+ ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++....
T Consensus 81 E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 81 EFLPGGDMMTLLMK-----KDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred eCCCCccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 99999999999865 2458999999999999999999998 899999999999999999999999999987543
Q ss_pred CCCc----------------------------------eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKY----------------------------------SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.... ......+||+.|+|||++.+. +++.++|+||+||+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~---~~~~~~DiwSlGvi 225 (360)
T cd05627 153 KAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT---GYNKLCDWWSLGVI 225 (360)
T ss_pred cccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC---CCCCcceeccccce
Confidence 2100 001134799999999998764 56778999999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=268.13 Aligned_cols=183 Identities=26% Similarity=0.459 Sum_probs=162.6
Q ss_pred cceeecccceEEEEE-EeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEccCCC
Q 003982 586 ANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRG 664 (782)
Q Consensus 586 ~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~g 664 (782)
.++||.|-||+||-| +.++|+.||||++.+.....+....++.|+.|++.++||.||.+.--|++++..++|||-+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 588999999999999 5568999999999988877777788999999999999999999999999999999999999 66
Q ss_pred CHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCC---CcEEEEeeccceecCCCC
Q 003982 665 TLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD---MRAKVADFGLVKNAPDGK 741 (782)
Q Consensus 665 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~---~~~kL~DfG~a~~~~~~~ 741 (782)
+..+.+-... .+.+++...+.+..||+.||+|||. ++|+|+|+||+|||+.+. .++||+|||+|+.++...
T Consensus 648 DMLEMILSsE---kgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks 721 (888)
T KOG4236|consen 648 DMLEMILSSE---KGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS 721 (888)
T ss_pred hHHHHHHHhh---cccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence 7777765432 3568999999999999999999998 999999999999999643 589999999999998766
Q ss_pred ceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 742 YSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 742 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+. ...+|||.|.|||++... |+...-||||+|||
T Consensus 722 FR--rsVVGTPAYLaPEVLrnk---GyNrSLDMWSVGVI 755 (888)
T KOG4236|consen 722 FR--RSVVGTPAYLAPEVLRNK---GYNRSLDMWSVGVI 755 (888)
T ss_pred hh--hhhcCCccccCHHHHhhc---cccccccceeeeEE
Confidence 54 346899999999999986 88889999999997
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=278.76 Aligned_cols=185 Identities=28% Similarity=0.410 Sum_probs=157.8
Q ss_pred CCccceeecccceEEEEE-EeCCCcEEEEEEecccc-CChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEc
Q 003982 583 FSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNT-MGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (782)
Q Consensus 583 y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 660 (782)
|.-++.||-|+||.||-| +..+.+.||||++.-.. ...+.++++.+|++++++++|||++.+.|+|..+...|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 445677999999999999 45678899999986432 2345678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~ 740 (782)
| -|+-.+.+.-.+ +++.+-++..|..+.+.||+|||+ .+.||||||+.|||+++.|.|||+|||.|....+.
T Consensus 108 C-lGSAsDlleVhk----KplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA 179 (948)
T KOG0577|consen 108 C-LGSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA 179 (948)
T ss_pred H-hccHHHHHHHHh----ccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCch
Confidence 9 568878776543 468999999999999999999999 89999999999999999999999999998766442
Q ss_pred CceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 741 KYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..++|||+|||||++..+-.--|+-+.||||+||.
T Consensus 180 -----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGIT 214 (948)
T KOG0577|consen 180 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 214 (948)
T ss_pred -----hcccCCccccchhHheeccccccCCccceeeccch
Confidence 34689999999998765433346888999999984
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-33 Score=278.31 Aligned_cols=371 Identities=22% Similarity=0.369 Sum_probs=301.7
Q ss_pred CEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccC
Q 003982 67 RVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSD 146 (782)
Q Consensus 67 ~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~ 146 (782)
-.+.+++.+|+++ ++|++++.+..++.|+.++|+++..++++..+.+|..|+++.|.+..++++ ++.+..|+.|+..+
T Consensus 69 ~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls~lp~~i~s~~~l~~l~~s~n~~~el~~~-i~~~~~l~dl~~~~ 146 (565)
T KOG0472|consen 69 CLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLSELPEQIGSLISLVKLDCSSNELKELPDS-IGRLLDLEDLDATN 146 (565)
T ss_pred ceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHhhccHHHhhhhhhhhhhccccceeecCch-HHHHhhhhhhhccc
Confidence 4788999999998 899999999999999999999998888999999999999999999999988 77888999999999
Q ss_pred CCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccc-cccchhhcccccCCCc
Q 003982 147 NPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLS 225 (782)
Q Consensus 147 N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~l~l~~~~~~~~ 225 (782)
|++.. .|+++.++.+|..|++.+|++....|+.+. ++.|++||+..|.+. ++|+.++. ..+..|++..|.+..-
T Consensus 147 N~i~s---lp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~l 221 (565)
T KOG0472|consen 147 NQISS---LPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIRFL 221 (565)
T ss_pred ccccc---CchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccccC
Confidence 99999 899999999999999999999998777776 999999999999998 99998877 5788999999987643
Q ss_pred cccccccCCCCCcEEEeecccccCCCCC-CCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCCCCC-
Q 003982 226 GTLDVLSGMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPS- 303 (782)
Q Consensus 226 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~- 303 (782)
+.|.++..|++|+++.|+++..+.+ ..++++|.+|||++|+++ ..|+.++-+.+|+.||+|+|.+++.++..-.
T Consensus 222 ---Pef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sLgnl 297 (565)
T KOG0472|consen 222 ---PEFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSLGNL 297 (565)
T ss_pred ---CCCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccCCcccccc
Confidence 3678899999999999999987776 568999999999999999 8999999999999999999999987665321
Q ss_pred CccEEEccCCcCCCCCCCC---------------------CCCCC------------------hhhhhHHHhhcC-CCC-
Q 003982 304 KVQKVSLDHNNFCKNSSDA---------------------GKPCD------------------PQVTTLLQIAGD-MGY- 342 (782)
Q Consensus 304 ~l~~L~l~~N~~~~~~~~~---------------------~~~~~------------------~~~~~~~~~~~~-~~~- 342 (782)
.|+.|.+-+|.++.+..++ ..+.. ...+...++... ...
T Consensus 298 hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~V 377 (565)
T KOG0472|consen 298 HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLV 377 (565)
T ss_pred eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccC
Confidence 6788888888885321000 00000 000111111110 000
Q ss_pred Cc----------ccccCc-----------------------CCCCCCCCCCcccccCCceeEEEccCcccccccCccccc
Q 003982 343 PA----------ILSDSW-----------------------EGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYAN 389 (782)
Q Consensus 343 ~~----------~~~~~~-----------------------~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~ 389 (782)
|. +...++ .+++..+.+|..++.+++|+.|+|++|.+. .+|..++.
T Consensus 378 PdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~ 456 (565)
T KOG0472|consen 378 PDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGS 456 (565)
T ss_pred CHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhh
Confidence 00 000111 234556778888999999999999999998 69999999
Q ss_pred cccCCeEeccccccc----------------------ccCCc-cCCCCCCCCeEecCCCcCCCCCCCCC--CCcceecCC
Q 003982 390 LTSLKNLYLQQNNLT----------------------GPIPD-GLTKLASLQNLDVSNNNLSGKVPDFG--SNVKFTVSP 444 (782)
Q Consensus 390 l~~L~~L~Ls~N~l~----------------------g~~p~-~~~~l~~L~~L~ls~N~l~g~~p~~~--~~~~~~~~~ 444 (782)
+..|+.||+|+|+|. |.++. .+.+|.+|..|||.+|.|...||.++ .++....++
T Consensus 457 lv~Lq~LnlS~NrFr~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~ 536 (565)
T KOG0472|consen 457 LVRLQTLNLSFNRFRMLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELD 536 (565)
T ss_pred hhhhheecccccccccchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEec
Confidence 999999999999876 23333 48889999999999999999999877 677888899
Q ss_pred CCCCC
Q 003982 445 GNPFI 449 (782)
Q Consensus 445 ~n~~~ 449 (782)
|||+.
T Consensus 537 gNpfr 541 (565)
T KOG0472|consen 537 GNPFR 541 (565)
T ss_pred CCccC
Confidence 99985
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=276.55 Aligned_cols=193 Identities=23% Similarity=0.300 Sum_probs=159.5
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
++|++.+.||+|+||+||++.. .+++.||+|++.+... .....+.+.+|+.+++.++|+||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4789999999999999999954 5689999999975332 2334567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++|+|.+++.+. ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++....
T Consensus 81 e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 153 (331)
T cd05597 81 DYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLL 153 (331)
T ss_pred ecCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecC
Confidence 999999999998653 2348899999999999999999998 899999999999999999999999999997765
Q ss_pred CCCceeeecccccccccCccccccch--hhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHW--MILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~dvws~Gvv 780 (782)
...........||+.|+|||++...- ...++.++|+||+||+
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~ 197 (331)
T cd05597 154 ADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVC 197 (331)
T ss_pred CCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhH
Confidence 43322223346899999999875310 0124557888888876
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=274.41 Aligned_cols=182 Identities=28% Similarity=0.364 Sum_probs=153.9
Q ss_pred ceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEccCCC
Q 003982 587 NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRG 664 (782)
Q Consensus 587 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~g 664 (782)
+.||+|+||.||++.. .+|+.||+|+++.... .......+.+|++++++++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4689999999999954 5789999999976532 2334567788999999999999999999999999999999999999
Q ss_pred CHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCcee
Q 003982 665 TLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSV 744 (782)
Q Consensus 665 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~~ 744 (782)
+|..++.. ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~ 151 (323)
T cd05595 81 ELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-T 151 (323)
T ss_pred cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-c
Confidence 99888865 2458999999999999999999998 8999999999999999999999999999875432221 1
Q ss_pred eecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 745 ETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 745 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.....||+.|+|||++.+. .++.++|+||+||+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlGvi 184 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDN---DYGRAVDWWGLGVV 184 (323)
T ss_pred cccccCCcCcCCcccccCC---CCCchhchhhhHHH
Confidence 1235689999999998764 45678999999986
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=276.74 Aligned_cols=193 Identities=22% Similarity=0.276 Sum_probs=160.1
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
++|++.+.||+|+||.||+++. .+++.||+|++.+... .......+.+|..++..++|++|+++++++.+++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4789999999999999999965 4678999999975322 2234556888999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++|+|.+++.+.. ..+++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||++....
T Consensus 81 Ey~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 153 (331)
T cd05624 81 DYYVGGDLLTLLSKFE----DRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMN 153 (331)
T ss_pred eCCCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999997532 358899999999999999999998 899999999999999999999999999998765
Q ss_pred CCCceeeecccccccccCccccccchh--hhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWM--ILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~dvws~Gvv 780 (782)
...........||+.|+|||++.+.-. -.++.++|+||+||+
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvi 197 (331)
T cd05624 154 QDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVC 197 (331)
T ss_pred CCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehh
Confidence 433322233569999999998764200 124567899999986
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=271.43 Aligned_cols=189 Identities=21% Similarity=0.345 Sum_probs=159.0
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
++|++.+.||+|+||.||+|+. .+++.||+|+++.........+.+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 4689999999999999999965 467899999998655444456778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|++++.+..+... ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 81 YVEKNMLELLEEM-----PNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred cCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 9988766544321 2358999999999999999999998 8999999999999999999999999999987654
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..........||+.|+|||++.+. .++.++|+||+||+
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslGvi 190 (287)
T cd07848 153 GSNANYTEYVATRWYRSPELLLGA---PYGKAVDMWSVGCI 190 (287)
T ss_pred cccccccccccccccCCcHHHcCC---CCCCchhHHhHHHH
Confidence 332222335689999999998764 35678999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=281.84 Aligned_cols=193 Identities=24% Similarity=0.301 Sum_probs=158.6
Q ss_pred HhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCC-hhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 656 (782)
..++|++.+.||+|+||.||+|.. .+++.||+|++.+.... ......+.+|+++++.++||||+++++++.++...++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 356799999999999999999954 56889999999754322 2234567899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecccee
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~ 736 (782)
||||+++|+|.+++.. ..+++..+..++.|++.||+|||+ .||+||||||+|||++.++.+||+|||++..
T Consensus 121 v~Ey~~gg~L~~~l~~------~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 121 VMEYMPGGDLVNLMSN------YDIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 9999999999998854 247888899999999999999998 8999999999999999999999999999987
Q ss_pred cCCCCceeeecccccccccCccccccch-hhhHHHHHHHHHhccc
Q 003982 737 APDGKYSVETRLAGTFGYLAPEYAGKHW-MILCQMTGLIWLHGSV 780 (782)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~dvws~Gvv 780 (782)
............+||+.|+|||++.+.- ...++.++|+||+||+
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvi 236 (370)
T cd05596 192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 236 (370)
T ss_pred ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHH
Confidence 6543322223457999999999875421 0123556778887775
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=274.88 Aligned_cols=182 Identities=27% Similarity=0.366 Sum_probs=153.8
Q ss_pred ceeecccceEEEEEE-eCCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEccCCC
Q 003982 587 NILGRGGFGVVYGGE-LPDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRG 664 (782)
Q Consensus 587 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~g 664 (782)
+.||+|+||.||++. ..+++.||+|++.+... .......+.+|+++++.++||||+++++++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 468999999999995 45789999999976532 2335567889999999999999999999999999999999999999
Q ss_pred CHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCcee
Q 003982 665 TLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSV 744 (782)
Q Consensus 665 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~~ 744 (782)
+|..++.. ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~ 151 (328)
T cd05593 81 ELFFHLSR-----ERVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-T 151 (328)
T ss_pred CHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-c
Confidence 99888854 2458999999999999999999998 8999999999999999999999999999876432221 1
Q ss_pred eecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 745 ETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 745 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
....+||+.|+|||++.+. .++.++||||+||+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslGvi 184 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDN---DYGRAVDWWGLGVV 184 (328)
T ss_pred cccccCCcCccChhhhcCC---CCCccCCccccchH
Confidence 2335799999999998754 34677889999886
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=281.57 Aligned_cols=189 Identities=29% Similarity=0.422 Sum_probs=162.2
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCCh-hhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGN-KGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
++|.+.+.||+|+||+||+|.. .+++.||||+++...... .....+.+|+++++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 4789999999999999999955 478999999997654322 45567899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++++|.+++... ..+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++....
T Consensus 81 e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 152 (350)
T cd05573 81 EYMPGGDLMNLLIRK-----DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMN 152 (350)
T ss_pred cCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence 999999999998762 458999999999999999999998 899999999999999999999999999997654
Q ss_pred CCC----------------------------ceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGK----------------------------YSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... ........||+.|+|||++.+. .++.++||||+||+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~i 219 (350)
T cd05573 153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT---PYGLECDWWSLGVI 219 (350)
T ss_pred ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC---CCCCceeeEecchh
Confidence 432 0112234689999999998775 45778999999987
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=277.57 Aligned_cols=194 Identities=26% Similarity=0.455 Sum_probs=155.7
Q ss_pred hcCCCccceeecccceEEEEEEe------CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCC
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGS 652 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~ 652 (782)
.++|++.+.||+|+||.||+|.. .+++.||||+++... .....+.+.+|+++++.+ +||||+++++++...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 46799999999999999999953 235689999987543 234456789999999999 8999999999887654
Q ss_pred -eEEEEEEccCCCCHHHHHHhhccC-------------------------------------------------------
Q 003982 653 -ERLLVYEYMPRGTLAQHLFEWHDH------------------------------------------------------- 676 (782)
Q Consensus 653 -~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------- 676 (782)
..+++|||+++|+|.+++......
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 578999999999999998753210
Q ss_pred --CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCc-eeeeccccccc
Q 003982 677 --GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY-SVETRLAGTFG 753 (782)
Q Consensus 677 --~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~ 753 (782)
...++++.++..++.|+++||+|||+ .||+||||||+||+++.++.+||+|||+++....... .......+++.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 01347888999999999999999998 8999999999999999999999999999986543221 12222345788
Q ss_pred ccCccccccchhhhHHHHHHHHHhccc
Q 003982 754 YLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 754 y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|+|||++.+. .++.++||||+||+
T Consensus 242 y~aPE~~~~~---~~~~~sDiwslG~i 265 (338)
T cd05102 242 WMAPESIFDK---VYTTQSDVWSFGVL 265 (338)
T ss_pred ccCcHHhhcC---CCCcccCHHHHHHH
Confidence 9999988654 35678899999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-30 Score=278.75 Aligned_cols=181 Identities=23% Similarity=0.268 Sum_probs=154.2
Q ss_pred hcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
..+|.+.+.||+|+||.||+|. ..+++.||+|.... +.+.+|++++++++||||+++++++......++|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 4679999999999999999994 46789999996532 35688999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
|++ +++|.+++.. ...+++.+++.++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+|+...
T Consensus 163 e~~-~~~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 163 PRY-KTDLYCYLAA-----KRNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPV 233 (391)
T ss_pred ecC-CCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence 999 4788888755 2357899999999999999999998 899999999999999999999999999997543
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
...........||+.|+|||++.+. .++.++||||+||+
T Consensus 234 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlGvi 272 (391)
T PHA03212 234 DINANKYYGWAGTIATNAPELLARD---PYGPAVDIWSAGIV 272 (391)
T ss_pred cccccccccccCccCCCChhhhcCC---CCCcHHHHHHHHHH
Confidence 3222222345799999999998764 45778999999986
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=269.43 Aligned_cols=194 Identities=27% Similarity=0.502 Sum_probs=158.9
Q ss_pred hcCCCccceeecccceEEEEEEeCC-----------------CcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcc
Q 003982 580 TDNFSEANILGRGGFGVVYGGELPD-----------------GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~ 642 (782)
.++|++.+.||+|+||.||+|...+ +..||+|++.... ......++.+|++++++++||||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCee
Confidence 3578999999999999999996432 3369999987543 234567899999999999999999
Q ss_pred eEEeEEEeCCeEEEEEEccCCCCHHHHHHhhccC--------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 003982 643 ALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDH--------------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSF 708 (782)
Q Consensus 643 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~i 708 (782)
++++++.+.+..++||||+++|+|.+++...... ....+++.++..++.|++.||+|||+ .||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i 159 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNF 159 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCc
Confidence 9999999999999999999999999998653211 11346888999999999999999998 899
Q ss_pred EEcCCCCCCEEECCCCcEEEEeeccceecCCCCce-eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 709 IHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS-VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 709 vHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+||||||+||++++++.+||+|||+++........ ......++..|+|||++... .++.++|+||+|++
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~~ 229 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG---KFTTASDVWAFGVT 229 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC---CCCchhhhHHHHHH
Confidence 99999999999999999999999999876543322 22234567899999987654 35678999999976
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=272.24 Aligned_cols=183 Identities=27% Similarity=0.357 Sum_probs=153.9
Q ss_pred ceeecccceEEEEEE-eCCCcEEEEEEeccccCC-hhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEccCCC
Q 003982 587 NILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRG 664 (782)
Q Consensus 587 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~g 664 (782)
+.||+|+||.||++. ..+++.||+|+++..... ......+.+|+++++.++||||+++++++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 468999999999995 457899999999765322 234567788999999999999999999999999999999999999
Q ss_pred CHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCcee
Q 003982 665 TLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSV 744 (782)
Q Consensus 665 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~~ 744 (782)
+|..++.. ...+++.++..++.|++.||+|||+ ..||+||||||+||+++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (325)
T cd05594 81 ELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-T 152 (325)
T ss_pred cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-c
Confidence 99988764 2458999999999999999999996 26999999999999999999999999999875432221 1
Q ss_pred eecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 745 ETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 745 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.....||+.|+|||++.+. .++.++||||+||+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~i 185 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDN---DYGRAVDWWGLGVV 185 (325)
T ss_pred cccccCCcccCCHHHHccC---CCCCccccccccce
Confidence 1234689999999998764 45678999999987
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-30 Score=285.71 Aligned_cols=195 Identities=29% Similarity=0.396 Sum_probs=158.9
Q ss_pred hcCCCccceeecccceEEEEEEeCCC-cEEEEEEeccccCChhhHHHHHHHHHHHHhcC-CCCcceEEeE-EEe------
Q 003982 580 TDNFSEANILGRGGFGVVYGGELPDG-TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGY-CIN------ 650 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~-~~~------ 650 (782)
..++++.++|.+|||+.||.|+...+ ..||+|++-.. ++...+..++|+++|+.|+ |+|||.+++. ...
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 34567899999999999999977665 99999998765 3667888999999999998 9999999993 221
Q ss_pred CCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEe
Q 003982 651 GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVAD 730 (782)
Q Consensus 651 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~D 730 (782)
..++++.||||+||.|-+++...... .+++.++++|++|+++|+.+||.+ +..|||||||-+|||++.++..||||
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~---~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQT---RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhc---cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCc
Confidence 24678999999999999999864432 399999999999999999999973 46799999999999999999999999
Q ss_pred eccceecCCCCcee--------eecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 731 FGLVKNAPDGKYSV--------ETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 731 fG~a~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
||.|...-...... .....-|+.|+|||++.=.-.++.+.++|||++||+
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGcl 247 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCL 247 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHH
Confidence 99986543221100 011246999999998754434678999999999986
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=268.99 Aligned_cols=189 Identities=25% Similarity=0.361 Sum_probs=156.8
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
.++|++.+.||+|+||.||+|.. .+++.||||++..... ......+.+|+++++.++||||+++++++.++...++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 36799999999999999999965 4789999999975432 223456788999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||++ +++.+++... ...+++.++..++.|++.||+|||+ .||+||||||+||++++++.+||+|||++....
T Consensus 83 e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 83 EYVH-TDLCQYMDKH----PGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred ECCC-cCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 9995 6888877542 2458899999999999999999998 899999999999999999999999999987654
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.... ......||+.|+|||++.+. ..+..++|+||+||+
T Consensus 155 ~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~i 193 (303)
T cd07869 155 VPSH-TYSNEVVTLWYRPPDVLLGS--TEYSTCLDMWGVGCI 193 (303)
T ss_pred CCCc-cCCCCcccCCCCChHHHcCC--CCCCcHHHHHHHHHH
Confidence 3221 12234689999999987653 234667899999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-30 Score=272.77 Aligned_cols=180 Identities=26% Similarity=0.322 Sum_probs=152.4
Q ss_pred eecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEccCCCCH
Q 003982 589 LGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTL 666 (782)
Q Consensus 589 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~gsL 666 (782)
||+|+||.||+|.. .+++.||+|++++... .......+.+|++++++++||||+++++++.+++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999955 4688999999975432 234556788999999999999999999999999999999999999999
Q ss_pred HHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCceeee
Q 003982 667 AQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVET 746 (782)
Q Consensus 667 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~ 746 (782)
.+++.. ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 ~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~ 151 (312)
T cd05585 81 FHHLQR-----EGRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTN 151 (312)
T ss_pred HHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-ccc
Confidence 999865 2458999999999999999999998 8999999999999999999999999999876433221 223
Q ss_pred cccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 747 RLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 747 ~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..+||+.|+|||++.+. .++.++||||+||+
T Consensus 152 ~~~gt~~y~aPE~~~~~---~~~~~~DvwslGvi 182 (312)
T cd05585 152 TFCGTPEYLAPELLLGH---GYTKAVDWWTLGVL 182 (312)
T ss_pred cccCCcccCCHHHHcCC---CCCCccceechhHH
Confidence 45799999999988764 45667888888876
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=267.04 Aligned_cols=188 Identities=23% Similarity=0.361 Sum_probs=156.5
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
++|.+.+.||+|+||.||+|.. .+++.||+|+++.... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 5799999999999999999954 5789999999975432 2234567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|++ ++|.+++... ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~ 155 (288)
T cd07871 84 YLD-SDLKQYLDNC----GNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSV 155 (288)
T ss_pred CCC-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence 996 5898888642 2347889999999999999999998 8999999999999999999999999999976543
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... ......|++.|+|||++.+. ..+..++|+||+||+
T Consensus 156 ~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~~ 193 (288)
T cd07871 156 PTK-TYSNEVVTLWYRPPDVLLGS--TEYSTPIDMWGVGCI 193 (288)
T ss_pred CCc-cccCceecccccChHHhcCC--cccCcHHHHHHHHHH
Confidence 221 11234679999999987653 235678999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=283.28 Aligned_cols=190 Identities=22% Similarity=0.321 Sum_probs=160.6
Q ss_pred CCCccceeecccceEEEEEEe-CC-CcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 582 NFSEANILGRGGFGVVYGGEL-PD-GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
.|.+.+.||+|++|.||+|.. .+ ++.||+|.+.... ......+++|+++++.++||||+++++++.+.+..|+|||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND--ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 488999999999999999943 44 6788888775433 3445678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++|+|.+++.+.... ..++++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++....
T Consensus 146 ~~~gg~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKE-HLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred CCCCCCHHHHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 99999999988754322 3568999999999999999999998 8999999999999999999999999999987654
Q ss_pred CCc-eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKY-SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... ......+||+.|+|||++.+. .++.++||||+||+
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~~ 260 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWERK---RYSKKADMWSLGVI 260 (478)
T ss_pred ccccccccccCCCccccCHhHhCCC---CCCcHHhHHHHHHH
Confidence 321 123345799999999998765 45778999999986
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=271.76 Aligned_cols=182 Identities=27% Similarity=0.395 Sum_probs=155.7
Q ss_pred ceeecccceEEEEEEe----CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEccC
Q 003982 587 NILGRGGFGVVYGGEL----PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMP 662 (782)
Q Consensus 587 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~ 662 (782)
+.||+|+||.||++.. .+++.||+|+++...........+.+|++++++++||||+++++++.+++..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999854 367899999998654333455677889999999999999999999999999999999999
Q ss_pred CCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCc
Q 003982 663 RGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742 (782)
Q Consensus 663 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~ 742 (782)
+|+|.+++.+ ...+++.++..++.|++.||+|||+ .||+||||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 153 (318)
T cd05582 82 GGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 153 (318)
T ss_pred CCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC
Confidence 9999998865 2458999999999999999999998 8999999999999999999999999999876544321
Q ss_pred eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 743 SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 743 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
......||+.|+|||++.+. +.+.++||||+|++
T Consensus 154 -~~~~~~g~~~y~aPE~~~~~---~~~~~~DiwslG~i 187 (318)
T cd05582 154 -KAYSFCGTVEYMAPEVVNRR---GHTQSADWWSFGVL 187 (318)
T ss_pred -ceecccCChhhcCHHHHcCC---CCCCccceeccceE
Confidence 22345789999999998764 44678999999986
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-30 Score=231.22 Aligned_cols=189 Identities=24% Similarity=0.357 Sum_probs=159.1
Q ss_pred cCCCccceeecccceEEEEE-EeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
.+|...++||+|++|+||+| .+.+++.||+|+++.+..++.......+|+.+++.++|.|||+++++...++..-+|+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 35677889999999999999 55678999999998876555567788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|| ..+|.++.... .+.++.+.+..++.|+++|+.|+|+ +++.|||+||+|.+++.+|++|++|||+|+.++-
T Consensus 82 ~c-dqdlkkyfdsl----ng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgi 153 (292)
T KOG0662|consen 82 FC-DQDLKKYFDSL----NGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGI 153 (292)
T ss_pred Hh-hHHHHHHHHhc----CCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence 99 45676666443 4568999999999999999999999 8999999999999999999999999999998765
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.. ...+..+-|.+|++|.++-+. --+....|+||.|+|
T Consensus 154 pv-rcysaevvtlwyrppdvlfga--kly~tsidmwsagci 191 (292)
T KOG0662|consen 154 PV-RCYSAEVVTLWYRPPDVLFGA--KLYSTSIDMWSAGCI 191 (292)
T ss_pred ce-EeeeceeeeeeccCcceeeee--ehhccchHhhhcchH
Confidence 33 122334569999999988765 235566778888775
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-30 Score=278.30 Aligned_cols=188 Identities=29% Similarity=0.428 Sum_probs=158.6
Q ss_pred CCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCC------eEE
Q 003982 583 FSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS------ERL 655 (782)
Q Consensus 583 y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~------~~~ 655 (782)
|...+.||+|+||.||+|+ ..+|+.||||.++... ..+..+...+|+++|++++|||||+++++-++.. ...
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 4456789999999999996 6789999999998754 3456788899999999999999999999865543 568
Q ss_pred EEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEC--CCC--cEEEEee
Q 003982 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIG--DDM--RAKVADF 731 (782)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~--~~~--~~kL~Df 731 (782)
+|||||.+|||...+.+- .+...+++.+.+.+..+++.||.|||+ +||+||||||.||++- .+| ..||+||
T Consensus 94 lvmEyC~gGsL~~~L~~P--EN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSP--ENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred EEEeecCCCcHHHHhcCc--ccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeecc
Confidence 999999999999999763 335679999999999999999999998 9999999999999984 223 4799999
Q ss_pred ccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 732 GLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 732 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|.|+..+++. ....++||+.|.+||..... ..++.-.|.|||||.
T Consensus 169 G~Arel~d~s--~~~S~vGT~~YLhPel~E~q--~~y~~tVDLWS~Gvt 213 (732)
T KOG4250|consen 169 GAARELDDNS--LFTSLVGTEEYLHPELYERQ--KKYTATVDLWSFGVT 213 (732)
T ss_pred cccccCCCCC--eeeeecCchhhcChHHHhhc--cCcCceeehhhhhhH
Confidence 9999998766 44567899999999998852 234666889999985
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=271.22 Aligned_cols=183 Identities=30% Similarity=0.442 Sum_probs=152.4
Q ss_pred cceeecccceEEEEEEe----CCCcEEEEEEeccccC--ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 586 ANILGRGGFGVVYGGEL----PDGTKIAVKRMESNTM--GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
.+.||+|+||.||++.. .+++.||+|+++.... .......+.+|++++++++||||+++++++.+++..|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 36799999999999954 3578999999976432 12334567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++++|.+++.. ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (323)
T cd05584 81 YLSGGELFMHLER-----EGIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH 152 (323)
T ss_pred CCCCchHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc
Confidence 9999999998865 2457888999999999999999998 8999999999999999999999999999875433
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... ......||+.|+|||++.+. ..+.++||||+||+
T Consensus 153 ~~~-~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~i 189 (323)
T cd05584 153 EGT-VTHTFCGTIEYMAPEILMRS---GHGKAVDWWSLGAL 189 (323)
T ss_pred CCC-cccccCCCccccChhhccCC---CCCCcceecccHHH
Confidence 221 12235689999999998764 34667888888876
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=256.53 Aligned_cols=149 Identities=30% Similarity=0.378 Sum_probs=133.6
Q ss_pred cCCCccceeecccceEEEEEEeCC-CcEEEEEEeccccCC-hhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGELPD-GTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
++|+.++.||.|.-|+||.++..+ +..+|+|++.+.... .....+.+.|-+||+.++||.++.+|+.++.++..|++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 346678899999999999997654 589999999887654 446678889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccce
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~ 735 (782)
|||+||+|...+++. ..+.+++..+..++..++.||+|||. .|||.|||||+||||.++|++-|+||.++.
T Consensus 157 eyCpGGdL~~LrqkQ---p~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~ 227 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQ---PGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSL 227 (459)
T ss_pred ecCCCccHHHHHhhC---CCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccc
Confidence 999999999988763 34569999999999999999999998 899999999999999999999999999864
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=269.84 Aligned_cols=187 Identities=26% Similarity=0.365 Sum_probs=155.7
Q ss_pred CCCccceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCCC-CcceEEeEEEeCCeEEEEE
Q 003982 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHR-HLVALLGYCINGSERLLVY 658 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~-nI~~~~~~~~~~~~~~lv~ 658 (782)
+|++.+.||+|+||.||+|.. .+++.||||++.+... .....+.+..|.+++..++|+ +|+++++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 588899999999999999955 4678999999976532 233556788899999999764 6888999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ .||+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05587 81 EYVNGGDLMYHIQQ-----VGKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENI 152 (324)
T ss_pred cCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecC
Confidence 99999999988865 2457899999999999999999998 899999999999999999999999999987543
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.... .....+||+.|+|||++.+. .++.++|+||+||+
T Consensus 153 ~~~~-~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslGvi 190 (324)
T cd05587 153 FGGK-TTRTFCGTPDYIAPEIIAYQ---PYGKSVDWWAFGVL 190 (324)
T ss_pred CCCC-ceeeecCCccccChhhhcCC---CCCcccchhhhHHH
Confidence 2221 12335799999999998764 34678899999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=273.01 Aligned_cols=193 Identities=22% Similarity=0.289 Sum_probs=157.7
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
++|++.+.||+|+||.||++.. .+++.||+|++.+... .......+.+|+.++..++|++|+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 4789999999999999999965 4578899999865332 2234456888999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++|+|.+++.+. ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++....
T Consensus 81 ey~~~g~L~~~l~~~----~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~ 153 (332)
T cd05623 81 DYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 153 (332)
T ss_pred eccCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecc
Confidence 999999999999753 2358899999999999999999998 899999999999999999999999999997654
Q ss_pred CCCceeeecccccccccCccccccch--hhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHW--MILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~dvws~Gvv 780 (782)
..........+||+.|+|||++...- .-.++.++|+||+||+
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvi 197 (332)
T cd05623 154 EDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVC 197 (332)
T ss_pred cCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHH
Confidence 43322223457999999999875210 0123556788888875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-30 Score=292.66 Aligned_cols=192 Identities=31% Similarity=0.569 Sum_probs=164.0
Q ss_pred CCCccceeecccceEEEEEEeC--CCc----EEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEE
Q 003982 582 NFSEANILGRGGFGVVYGGELP--DGT----KIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL 655 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~ 655 (782)
..+..+.||+|.||.||+|... ++. .||||.+++.. +..+..+|.+|..+|+.++||||++++|++.+....+
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 3456789999999999999543 343 48999887653 3567889999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhhccCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecc
Q 003982 656 LVYEYMPRGTLAQHLFEWHDHG--YTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (782)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~ 733 (782)
+++|||++|+|..++++.+... ...++..+...++.|+|+|+.||++ +++|||||.++|+|++....|||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccch
Confidence 9999999999999998864332 3458899999999999999999998 8999999999999999999999999999
Q ss_pred ceecCCCCceeeecc-cccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 734 VKNAPDGKYSVETRL-AGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 734 a~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|+.+.+..+...... .-...|||||.+.+. ..+.++|||||||+
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~---iFtskSDvWsFGVl 893 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDG---IFTSKSDVWSFGVL 893 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhc---ccccccchhhhHHH
Confidence 997776665543322 234689999999985 56899999999996
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=272.09 Aligned_cols=189 Identities=27% Similarity=0.423 Sum_probs=155.0
Q ss_pred CCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC-----CeEE
Q 003982 582 NFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING-----SERL 655 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~-----~~~~ 655 (782)
+|++.+.||+|+||.||+|. ..+++.||||++...........++.+|++++++++||||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 58899999999999999995 45789999999875433334456788999999999999999999987643 2479
Q ss_pred EEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccce
Q 003982 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (782)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~ 735 (782)
+||||++ ++|.+++.. ...+++..+..++.|+++||.|||+ .||+||||||+||+++.++.+||+|||+++
T Consensus 81 lv~e~~~-~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~ 151 (338)
T cd07859 81 VVFELME-SDLHQVIKA-----NDDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLAR 151 (338)
T ss_pred EEEecCC-CCHHHHHHh-----cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCcccc
Confidence 9999994 689888864 2458999999999999999999998 899999999999999999999999999997
Q ss_pred ecCCCCc--eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 736 NAPDGKY--SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 736 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
....... .......||+.|+|||++.+.. ..++.++||||+||+
T Consensus 152 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~~DvwSlGvv 197 (338)
T cd07859 152 VAFNDTPTAIFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCI 197 (338)
T ss_pred ccccccCccccccCCCCCCCcCCHHHHhccc-cccCchhHHHHHHHH
Confidence 6532211 1123357899999999876521 245778999999986
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=267.84 Aligned_cols=187 Identities=28% Similarity=0.398 Sum_probs=160.6
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
.++|++.+.||+|+||.||+++. .++..||+|++.... .....+++.+|++++++++||||+++++++.+++..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 46899999999999999999955 468899999987543 2345678999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++++|.+++.. ...+++..+..++.|++.||.|||+ ..+|+||||||+||+++.++.+||+|||++....
T Consensus 83 e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 83 EHMDGGSLDQVLKE-----AKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred ecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 99999999999865 2358899999999999999999997 2479999999999999999999999999987664
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... .....||+.|+|||++.+. .++.++|+||+||+
T Consensus 156 ~~~---~~~~~g~~~y~aPE~~~~~---~~~~~~DiwslG~i 191 (331)
T cd06649 156 DSM---ANSFVGTRSYMSPERLQGT---HYSVQSDIWSMGLS 191 (331)
T ss_pred ccc---cccCCCCcCcCCHhHhcCC---CCCchHhHHHHHHH
Confidence 322 1234689999999998765 35778999999986
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=270.96 Aligned_cols=185 Identities=28% Similarity=0.404 Sum_probs=152.9
Q ss_pred CCccceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHH---HhcCCCCcceEEeEEEeCCeEEEE
Q 003982 583 FSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVL---TKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 583 y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l---~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
|++.+.||+|+||.||+|.. .+++.||||++++... .....+.+.+|++++ +.++||||+++++++.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 67889999999999999954 5789999999976532 223445677776665 466799999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
|||+++++|...+.. ..+++.++..++.|++.||+|||+ .||+||||||+||++++++.+||+|||+++..
T Consensus 81 ~E~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 81 MEYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred EcCCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 999999999887743 358999999999999999999998 89999999999999999999999999998754
Q ss_pred CCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 738 PDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..... .....+|++.|+|||++.+. .++.++|+||+||+
T Consensus 152 ~~~~~-~~~~~~g~~~y~aPE~~~~~---~~~~~~DiwslG~i 190 (324)
T cd05589 152 MGFGD-RTSTFCGTPEFLAPEVLTET---SYTRAVDWWGLGVL 190 (324)
T ss_pred CCCCC-cccccccCccccCHhHhcCC---CCCcccchhhHHHH
Confidence 32221 22345789999999988764 34667899999976
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=268.97 Aligned_cols=190 Identities=26% Similarity=0.395 Sum_probs=168.8
Q ss_pred HhcCCCccceeecccceEEEEE-EeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
....|.+.+.||+|.|+.|..| +..++..||+|.+++........+.+.+|+++|+.++||||++++.+.+.+...|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3467899999999999999999 445799999999998877666667799999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
|||+.+|.+++++... +.+.+.++..++.|+++|++|||+ ++|||||||++||+++.+.++||+|||++..+
T Consensus 134 ~eya~~ge~~~yl~~~-----gr~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~ 205 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKH-----GRMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFF 205 (596)
T ss_pred EEeccCchhHHHHHhc-----ccchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceee
Confidence 9999999999999763 346668899999999999999998 89999999999999999999999999999988
Q ss_pred CCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 738 PDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.... .....+|++.|.|||++.+.- --+...|+||+|||
T Consensus 206 ~~~~--~lqt~cgsppyAaPEl~~g~~--y~gpe~D~Wslgvv 244 (596)
T KOG0586|consen 206 DYGL--MLQTFCGSPPYAAPELFNGKK--YDGPEVDIWSLGVV 244 (596)
T ss_pred cccc--cccccCCCCCccChHhhcCcc--cCCcceehhhhhhh
Confidence 7543 223468999999999998873 34678999999997
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=269.06 Aligned_cols=182 Identities=27% Similarity=0.419 Sum_probs=149.9
Q ss_pred ceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHh-cCCCCcceEEeEEEeCCeEEEEEEccCC
Q 003982 587 NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTK-VRHRHLVALLGYCINGSERLLVYEYMPR 663 (782)
Q Consensus 587 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~-l~h~nI~~~~~~~~~~~~~~lv~e~~~~ 663 (782)
+.||+|+||.||+|.. .+++.||+|+++.... .....+.+..|.+++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999955 4678999999976432 12334556667777765 4799999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCce
Q 003982 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743 (782)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~ 743 (782)
|+|..++.. ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 g~L~~~~~~-----~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~ 151 (316)
T cd05592 81 GDLMFHIQS-----SGRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-G 151 (316)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-C
Confidence 999988865 2358999999999999999999998 899999999999999999999999999998654322 2
Q ss_pred eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 744 VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 744 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.....+||+.|+|||++.+. .++.++|+||+||+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~i 185 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQ---KYNESVDWWSFGVL 185 (316)
T ss_pred ccccccCCccccCHHHHcCC---CCCCcccchhHHHH
Confidence 22345799999999998764 34667888988876
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=270.47 Aligned_cols=182 Identities=24% Similarity=0.368 Sum_probs=152.2
Q ss_pred ceeecccceEEEEEEe-CCCcEEEEEEeccccCC-hhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCCeEEEEEEccCC
Q 003982 587 NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLLVYEYMPR 663 (782)
Q Consensus 587 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~lv~e~~~~ 663 (782)
++||+|+||.||+|.. .+++.||+|++++.... ....+.+++|..+++++ +||||+++++++.+....|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4689999999999954 56889999999865432 23456788999999988 699999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCce
Q 003982 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743 (782)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~ 743 (782)
|+|.+++.. ...+++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||+++.......
T Consensus 81 g~L~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~- 151 (329)
T cd05588 81 GDLMFHMQR-----QRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD- 151 (329)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCCC-
Confidence 999888754 2458999999999999999999998 8999999999999999999999999999875322111
Q ss_pred eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 744 VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 744 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.....+||+.|+|||++.+. .++.++|+||+||+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~~ 185 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGE---DYGFSVDWWALGVL 185 (329)
T ss_pred ccccccCCccccCHHHHcCC---CCCCccceechHHH
Confidence 12335789999999998764 34567888888875
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=269.21 Aligned_cols=187 Identities=25% Similarity=0.351 Sum_probs=155.6
Q ss_pred CCCccceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCCeEEEEE
Q 003982 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
+|++.+.||+|+||.||+|.. .+++.||+|++.+... .....+.+..|.+++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 588899999999999999954 4678999999976532 123345667788888877 4899999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++|+|.+++.. ...+++.++..++.|++.||+|||+ .||+||||||+||++++++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 81 EYVNGGDLMYQIQQ-----VGRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred cCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 99999999988865 2458899999999999999999998 899999999999999999999999999997643
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.... ......||+.|+|||++.+. .++.++|+||+||+
T Consensus 153 ~~~~-~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlGvi 190 (323)
T cd05616 153 WDGV-TTKTFCGTPDYIAPEIIAYQ---PYGKSVDWWAFGVL 190 (323)
T ss_pred CCCC-ccccCCCChhhcCHHHhcCC---CCCCccchhchhHH
Confidence 2221 22345789999999998764 45678899999986
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=251.99 Aligned_cols=195 Identities=26% Similarity=0.362 Sum_probs=162.8
Q ss_pred hcCCCccceeecccceEEEEEEeC---C--CcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEe-CCe
Q 003982 580 TDNFSEANILGRGGFGVVYGGELP---D--GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN-GSE 653 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~-~~~ 653 (782)
...|+....||+|++|.||+|... + .+.+|+|.++.++..........+|+..++.++||||+.+..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 346889999999999999999332 2 3379999998765444445678899999999999999999999887 788
Q ss_pred EEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCC----CcEEEE
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD----MRAKVA 729 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~----~~~kL~ 729 (782)
.++++||.+. +|...++-++......++...++.|++||+.|+.|||+ +=|+|||+||.|||+..+ |.|||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEee
Confidence 9999999976 89998877665555679999999999999999999998 789999999999999887 899999
Q ss_pred eeccceecCCCCc--eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 730 DFGLVKNAPDGKY--SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 730 DfG~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|||+|+.+.+.-. ....+++-|.+|+|||.+.|. --++.+.|||+.|||
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa--~hYT~AiDvWAiGCI 229 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGA--RHYTKAIDVWAIGCI 229 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhccc--ccccchhhhHHHHHH
Confidence 9999998766432 223456779999999998875 346778888888876
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=282.17 Aligned_cols=196 Identities=24% Similarity=0.315 Sum_probs=164.3
Q ss_pred HHhcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCC----
Q 003982 578 QVTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS---- 652 (782)
Q Consensus 578 ~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~---- 652 (782)
...++|++.+.||+|+||+||+|. ..+++.||||++............+.+|+.++..++|+||++++..+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 345789999999999999999994 557899999999876655566778899999999999999999988765432
Q ss_pred ----eEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEE
Q 003982 653 ----ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKV 728 (782)
Q Consensus 653 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL 728 (782)
..++||||+++|+|.+++...... ...+++.++..++.|++.||.|||+ .||+||||||+||+++.++.+||
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~-~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKT-NRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEE
Confidence 368999999999999998764332 3568999999999999999999998 89999999999999999999999
Q ss_pred EeeccceecCCCCc-eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 729 ADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 729 ~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+|||+++....... ......+||+.|+|||++.+. .++.++||||+||+
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~---~~s~k~DVwSlGvi 234 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK---PYSKKADMFSLGVL 234 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCC---CCCcHHHHHHHHHH
Confidence 99999987653221 122345799999999998764 35788999999986
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-31 Score=274.33 Aligned_cols=190 Identities=27% Similarity=0.387 Sum_probs=160.3
Q ss_pred cCCCccceeecccceEEEEEEeCC-CcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGELPD-GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
+.|.++..||.|+||.||+|..++ +-..|.|++.... ..+.+++.-||+|+..++||+|+++++.|...+..|+..|
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks--eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS--EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc--hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 345667789999999999995444 4456778887654 5678899999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
||.||.....+-+. ..++++.++..+++|++.||.|||+ .+|||||+|+.|||++-+|.++|+|||.+.....
T Consensus 110 FC~GGAVDaimlEL----~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~ 182 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLEL----GRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS 182 (1187)
T ss_pred ecCCchHhHHHHHh----ccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchh
Confidence 99999998887664 3569999999999999999999999 8999999999999999999999999999876543
Q ss_pred CCceeeecccccccccCccccccc--hhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKH--WMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~dvws~Gvv 780 (782)
.. .....++|||+|||||+..-. -...|++++|||||||.
T Consensus 183 t~-qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGIT 224 (1187)
T KOG0579|consen 183 TR-QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGIT 224 (1187)
T ss_pred HH-hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhH
Confidence 22 234557899999999975421 22368999999999984
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=268.90 Aligned_cols=182 Identities=24% Similarity=0.373 Sum_probs=151.4
Q ss_pred ceeecccceEEEEEEe-CCCcEEEEEEeccccCC-hhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCCeEEEEEEccCC
Q 003982 587 NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLLVYEYMPR 663 (782)
Q Consensus 587 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~lv~e~~~~ 663 (782)
+.||+|+||.||+|.. .+++.||+|++++.... ....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999954 56889999999865432 23456688899988876 799999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCce
Q 003982 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743 (782)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~ 743 (782)
|+|..++.. ...+++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~-----~~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~- 151 (329)
T cd05618 81 GDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD- 151 (329)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-
Confidence 999888754 2458999999999999999999998 8999999999999999999999999999875432211
Q ss_pred eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 744 VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 744 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
......||+.|+|||++.+. .++.++|+||+||+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~i 185 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGE---DYGFSVDWWALGVL 185 (329)
T ss_pred ccccccCCccccCHHHHcCC---CCCCccceecccHH
Confidence 12335789999999988754 34567888888875
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-29 Score=266.16 Aligned_cols=187 Identities=27% Similarity=0.400 Sum_probs=159.6
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
.++|++.+.||+|+||.||+|.. .++..+|+|++.... .......+.+|++++++++||||+++++++.+.+..++||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 36899999999999999999955 468889999887643 2345577999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++++|.+++.. ...+++..+..++.|++.|+.|||+ ..+|+||||||+||++++++.+||+|||++....
T Consensus 83 e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 83 EHMDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred ecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 99999999999865 2357889999999999999999997 2479999999999999999999999999987654
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... .....|+..|+|||++.+. .++.++|+||+||+
T Consensus 156 ~~~---~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~i 191 (333)
T cd06650 156 DSM---ANSFVGTRSYMSPERLQGT---HYSVQSDIWSMGLS 191 (333)
T ss_pred hhc---cccCCCCccccCHHHhcCC---CCCcHHHHHHHHHH
Confidence 322 1234689999999998764 35678999999986
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=267.85 Aligned_cols=182 Identities=31% Similarity=0.442 Sum_probs=149.9
Q ss_pred ceeecccceEEEEEEe-CCCcEEEEEEeccccCC-hhhHHHHHHHHH-HHHhcCCCCcceEEeEEEeCCeEEEEEEccCC
Q 003982 587 NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIA-VLTKVRHRHLVALLGYCINGSERLLVYEYMPR 663 (782)
Q Consensus 587 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~-~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~ 663 (782)
+.||+|+||+||+|.. .+++.||+|++.+.... ....+++.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999955 57899999999764321 223345555554 56789999999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCce
Q 003982 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743 (782)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~ 743 (782)
|+|.+++.. ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~ 151 (323)
T cd05575 81 GELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-K 151 (323)
T ss_pred CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-C
Confidence 999998865 2458899999999999999999998 899999999999999999999999999987543222 1
Q ss_pred eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 744 VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 744 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
......||+.|+|||++.+. .++.++|+||+||+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~i 185 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQ---PYDRTVDWWCLGAV 185 (323)
T ss_pred ccccccCChhhcChhhhcCC---CCCccccccccchh
Confidence 22345789999999998764 45778999999986
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=267.84 Aligned_cols=182 Identities=25% Similarity=0.391 Sum_probs=151.4
Q ss_pred ceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCCeEEEEEEccCC
Q 003982 587 NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLLVYEYMPR 663 (782)
Q Consensus 587 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~lv~e~~~~ 663 (782)
+.||+|+||.||+|.. .+++.||||++++... .....+.+..|.+++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4689999999999955 4688999999976432 223456677888888876 699999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCce
Q 003982 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743 (782)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~ 743 (782)
|+|.+++.. ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++.......
T Consensus 81 g~L~~~i~~-----~~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~- 151 (320)
T cd05590 81 GDLMFHIQK-----SRRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK- 151 (320)
T ss_pred chHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-
Confidence 999988865 2458999999999999999999998 8999999999999999999999999999876432221
Q ss_pred eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 744 VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 744 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
......||+.|+|||++.+. ..+.++|+||+||+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~i 185 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEM---LYGPSVDWWAMGVL 185 (320)
T ss_pred cccccccCccccCHHHHcCC---CCCCccchhhhHHH
Confidence 22335789999999988764 34567888888876
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-29 Score=285.48 Aligned_cols=194 Identities=22% Similarity=0.323 Sum_probs=160.4
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCC-hhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
++|++.++||+|+||.||+|.. .+++.||+|++...... ....+++.+|++++++++||||+++++++.+.+..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 5799999999999999999954 46899999999764322 234567999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccC------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeec
Q 003982 659 EYMPRGTLAQHLFEWHDH------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG 732 (782)
||++||+|.+++...... .....++..+..++.|+++||+|||+ .||+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999998753211 12345677889999999999999998 899999999999999999999999999
Q ss_pred cceecCCCC-----------------ceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 733 LVKNAPDGK-----------------YSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 733 ~a~~~~~~~-----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+++...... .......+||+.|||||++.+. ..+.++||||+||+
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~---~~S~kSDIWSLGVI 220 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV---PASESTDIYALGVI 220 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC---CCCcHhHHHHHHHH
Confidence 998662110 0011234699999999998765 45778999999986
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=272.97 Aligned_cols=188 Identities=26% Similarity=0.382 Sum_probs=156.7
Q ss_pred CCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCC-----eEE
Q 003982 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS-----ERL 655 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~-----~~~ 655 (782)
+|++.+.||+|+||.||+|.. .+++.||||++..........+++.+|+++++.++||||+++++++.... ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999954 57899999998754333345678899999999999999999999998776 789
Q ss_pred EEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccce
Q 003982 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (782)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~ 735 (782)
+||||+. ++|.+.+.. ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++
T Consensus 81 lv~e~~~-~~l~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~ 151 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS-----PQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLAR 151 (372)
T ss_pred EEeeccc-cCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEecccccee
Confidence 9999995 578777743 3458999999999999999999998 899999999999999999999999999998
Q ss_pred ecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 736 NAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 736 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..............+++.|+|||++.+. ..+..++||||+||+
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~i 194 (372)
T cd07853 152 VEEPDESKHMTQEVVTQYYRAPEILMGS--RHYTSAVDIWSVGCI 194 (372)
T ss_pred ecccCccccCCCCCcCCCcCCHHHHcCC--CCCCcHHHHHhHHHH
Confidence 7654332222334679999999988764 124668999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-32 Score=283.98 Aligned_cols=336 Identities=21% Similarity=0.274 Sum_probs=223.1
Q ss_pred CEEEEEeCCCCCC-cccCccccCCccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEecc
Q 003982 67 RVTTISLAKSGLS-GTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145 (782)
Q Consensus 67 ~v~~L~l~~~~l~-~~~~~~l~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls 145 (782)
=|..+|+++|.++ +..|..+..++++++|.|...++..+|..++.+.+|++|.+++|++.++... ++.|+.|+.+++.
T Consensus 8 FVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~~vPeEL~~lqkLEHLs~~HN~L~~vhGE-Ls~Lp~LRsv~~R 86 (1255)
T KOG0444|consen 8 FVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLEQVPEELSRLQKLEHLSMAHNQLISVHGE-LSDLPRLRSVIVR 86 (1255)
T ss_pred eeecccccCCcCCCCcCchhHHHhhheeEEEechhhhhhChHHHHHHhhhhhhhhhhhhhHhhhhh-hccchhhHHHhhh
Confidence 3778999999999 5889999999999999999999998877999999999999999999988755 8889999999999
Q ss_pred CCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCc
Q 003982 146 DNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLS 225 (782)
Q Consensus 146 ~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~ 225 (782)
+|++...+ +|..+.++..|+.|||++|+++.. |..+....++-.|+||+|+|. +||..++
T Consensus 87 ~N~LKnsG-iP~diF~l~dLt~lDLShNqL~Ev-P~~LE~AKn~iVLNLS~N~Ie-tIPn~lf----------------- 146 (1255)
T KOG0444|consen 87 DNNLKNSG-IPTDIFRLKDLTILDLSHNQLREV-PTNLEYAKNSIVLNLSYNNIE-TIPNSLF----------------- 146 (1255)
T ss_pred ccccccCC-CCchhcccccceeeecchhhhhhc-chhhhhhcCcEEEEcccCccc-cCCchHH-----------------
Confidence 99998864 688999999999999999999776 888999999999999999998 9998764
Q ss_pred cccccccCCCCCcEEEeecccccCCCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCccc-CCCCCC---
Q 003982 226 GTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQ-GPYPLF--- 301 (782)
Q Consensus 226 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~-~~~~~~--- 301 (782)
.+++.|-.||||+|++...||....+..|++|+|++|.+.-.--..+..+++|+.|.+++-+=+ .-+|..
T Consensus 147 ------inLtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~ 220 (1255)
T KOG0444|consen 147 ------INLTDLLFLDLSNNRLEMLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDD 220 (1255)
T ss_pred ------HhhHhHhhhccccchhhhcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhh
Confidence 3566677777777777777777777777777777777665333334445555666666655433 223332
Q ss_pred CCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCccccc
Q 003982 302 PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAG 381 (782)
Q Consensus 302 ~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~ 381 (782)
+.+|..+|+|+|++..++ +.++.+ ..+.....+.|.+..+........+|++|+||.|+++
T Consensus 221 l~NL~dvDlS~N~Lp~vP-----------ecly~l-------~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt- 281 (1255)
T KOG0444|consen 221 LHNLRDVDLSENNLPIVP-----------ECLYKL-------RNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT- 281 (1255)
T ss_pred hhhhhhccccccCCCcch-----------HHHhhh-------hhhheeccCcCceeeeeccHHHHhhhhhhccccchhc-
Confidence 345566666666553222 000000 0000000011111111122223345555555555555
Q ss_pred ccCccccccccCCeEecccccccc-cCCccCCCCCCCCeEecCCCcCCCCCCCCC--CCcceecCCCCCC
Q 003982 382 NISPAYANLTSLKNLYLQQNNLTG-PIPDGLTKLASLQNLDVSNNNLSGKVPDFG--SNVKFTVSPGNPF 448 (782)
Q Consensus 382 ~~p~~~~~l~~L~~L~Ls~N~l~g-~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~--~~~~~~~~~~n~~ 448 (782)
.+|..+..|++|+.|.+.+|+++- -||..+++|.+|+++..++|.|.=.+..++ ..++.+.++.|.+
T Consensus 282 ~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LElVPEglcRC~kL~kL~L~~NrL 351 (1255)
T KOG0444|consen 282 VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLELVPEGLCRCVKLQKLKLDHNRL 351 (1255)
T ss_pred cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccccCchhhhhhHHHHHhcccccce
Confidence 455555555555555555555542 255555555556655555555543222332 2334444455544
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=268.43 Aligned_cols=182 Identities=26% Similarity=0.368 Sum_probs=151.8
Q ss_pred ceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCCeEEEEEEccCC
Q 003982 587 NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLLVYEYMPR 663 (782)
Q Consensus 587 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~lv~e~~~~ 663 (782)
++||+|+||.||+|.. .+++.||+|++++... .....+.+..|.+++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4689999999999955 4678999999976532 233456678899998866 799999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCce
Q 003982 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743 (782)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~ 743 (782)
|+|...+.. ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~- 151 (321)
T cd05591 81 GDLMFQIQR-----SRKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV- 151 (321)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCc-
Confidence 999988865 2458899999999999999999998 8999999999999999999999999999876433221
Q ss_pred eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 744 VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 744 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
......||+.|+|||++.+. .++.++|+||+||+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~i 185 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQEL---EYGPSVDWWALGVL 185 (321)
T ss_pred cccccccCccccCHHHHcCC---CCCCccceechhHH
Confidence 22335689999999988764 34667899999986
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=247.52 Aligned_cols=184 Identities=23% Similarity=0.410 Sum_probs=154.3
Q ss_pred cceeecccceEEEEE-EeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC-CCCcceEEeEEEeCCeEEEEEEccCC
Q 003982 586 ANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSERLLVYEYMPR 663 (782)
Q Consensus 586 ~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~~~lv~e~~~~ 663 (782)
.+.||+|+++.|--+ ...+|..||||++++.. ...+.+..+|++++...+ |+||++++++|+++...|+|||-|.|
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 467999999999988 67789999999998764 456788899999999986 99999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCC---CcEEEEeeccceecCCC
Q 003982 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD---MRAKVADFGLVKNAPDG 740 (782)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~---~~~kL~DfG~a~~~~~~ 740 (782)
|+|...+++ ...+++.++.++..+|+.||.|||. +||.|||+||+|||-.+- .-+||+||.++.-..-.
T Consensus 161 GplLshI~~-----~~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~ 232 (463)
T KOG0607|consen 161 GPLLSHIQK-----RKHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLN 232 (463)
T ss_pred chHHHHHHH-----hhhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeeccccccccccC
Confidence 999999977 3458999999999999999999998 999999999999998654 35899999987543211
Q ss_pred --C----ceeeecccccccccCcccc---ccchhhhHHHHHHHHHhccc
Q 003982 741 --K----YSVETRLAGTFGYLAPEYA---GKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 741 --~----~~~~~~~~gt~~y~aPE~~---~~~~~~~~~~~~dvws~Gvv 780 (782)
. ...-...+|+..|||||+. .+. +..++..+|.||+|||
T Consensus 233 ~~~spastP~L~tPvGSAEfMAPEVVd~fv~q-A~~YDKrCDlwSLGvI 280 (463)
T KOG0607|consen 233 NDCSPASTPELLTPVGSAEFMAPEVVDVFVDQ-ATFYDKRCDLWSLGVI 280 (463)
T ss_pred CCCCCCCCccccCcccchhhcchhHHhhhccc-cccccccccHHHHHHH
Confidence 1 1111234789999999963 344 4567888999999997
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=261.56 Aligned_cols=184 Identities=28% Similarity=0.447 Sum_probs=153.8
Q ss_pred eecccceEEEEEEe-CCCcEEEEEEeccccCCh-hhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEccCCCCH
Q 003982 589 LGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGN-KGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTL 666 (782)
Q Consensus 589 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~gsL 666 (782)
||+|+||+||++.. .+++.||+|.+....... ...+.+..|++++++++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999954 578999999987643222 2346678899999999999999999999999999999999999999
Q ss_pred HHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCceeee
Q 003982 667 AQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVET 746 (782)
Q Consensus 667 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~ 746 (782)
...+...... ...+++..+..++.|++.||+|||+ .||+||||||+||++++++.+||+|||++......... ..
T Consensus 81 ~~~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~ 155 (280)
T cd05608 81 RYHIYNVDEE-NPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TK 155 (280)
T ss_pred HHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-cc
Confidence 9887653322 3468999999999999999999998 89999999999999999999999999999876543321 22
Q ss_pred cccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 747 RLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 747 ~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
...||+.|+|||++.+. .++.++|+||+|++
T Consensus 156 ~~~g~~~y~aPE~~~~~---~~~~~~DvwslG~i 186 (280)
T cd05608 156 GYAGTPGFMAPELLQGE---EYDFSVDYFALGVT 186 (280)
T ss_pred ccCCCcCccCHHHhcCC---CCCccccHHHHHHH
Confidence 34689999999998765 34678899999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=267.24 Aligned_cols=187 Identities=25% Similarity=0.350 Sum_probs=155.6
Q ss_pred CCCccceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcC-CCCcceEEeEEEeCCeEEEEE
Q 003982 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~~~lv~ 658 (782)
+|+..+.||+|+||+||+|.. .+++.||+|++.+... .....+.+..|.++++.+. |++|+++++++.+.+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 477889999999999999954 5789999999976432 2234566788999998886 577888999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++|+|.+++.. ...+++.++..++.|++.||+|||+ .||+||||||+||++++++.+||+|||+++...
T Consensus 81 Ey~~~g~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 81 EYVNGGDLMYHIQQ-----VGKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred cCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 99999999998865 2458999999999999999999998 899999999999999999999999999987643
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.... ......||+.|+|||++.+. .++.++|+||+||+
T Consensus 153 ~~~~-~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslGvi 190 (323)
T cd05615 153 VDGV-TTRTFCGTPDYIAPEIIAYQ---PYGKSVDWWAYGVL 190 (323)
T ss_pred CCCc-cccCccCCccccCHHHHcCC---CCCCccchhhhHHH
Confidence 3221 12335689999999988764 35678899999986
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=267.93 Aligned_cols=182 Identities=31% Similarity=0.429 Sum_probs=149.7
Q ss_pred ceeecccceEEEEEE-eCCCcEEEEEEeccccC-ChhhHHHHHHHHH-HHHhcCCCCcceEEeEEEeCCeEEEEEEccCC
Q 003982 587 NILGRGGFGVVYGGE-LPDGTKIAVKRMESNTM-GNKGLSEFQAEIA-VLTKVRHRHLVALLGYCINGSERLLVYEYMPR 663 (782)
Q Consensus 587 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~ 663 (782)
+.||+|+||+||+|. ..+|+.||+|++.+... .......+.+|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 468999999999995 45789999999976432 1233455555655 46778999999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCce
Q 003982 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743 (782)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~ 743 (782)
|+|..++.. ...+++.++..++.|++.||+|||+ .||+||||||+||++++++.+||+|||+++...... .
T Consensus 81 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~ 151 (325)
T cd05604 81 GELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-D 151 (325)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-C
Confidence 999888754 3458999999999999999999998 899999999999999999999999999987543221 1
Q ss_pred eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 744 VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 744 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.....+||+.|+|||++.+. .++.++|+||+||+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~i 185 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQ---PYDNTVDWWCLGAV 185 (325)
T ss_pred CcccccCChhhCCHHHHcCC---CCCCcCccccccce
Confidence 22345789999999998764 34668999999987
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=260.52 Aligned_cols=189 Identities=24% Similarity=0.359 Sum_probs=166.2
Q ss_pred hcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
.+-|...+.||+|-|++|-.|+ .-+|..||||++.+.+.+......+.+|++.|+-++|||||++|.+.......|+|+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 4568888999999999999994 348999999999999888778888999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE-CCCCcEEEEeeccceec
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI-GDDMRAKVADFGLVKNA 737 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll-~~~~~~kL~DfG~a~~~ 737 (782)
|+=.+|+|++|+.++. ..+.+..+.++++||+.|+.|+|. ..+||||+||+||.+ .+-|-|||+|||++..+
T Consensus 97 ELGD~GDl~DyImKHe----~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHE----EGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF 169 (864)
T ss_pred EecCCchHHHHHHhhh----ccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccC
Confidence 9999999999998753 348999999999999999999998 899999999999876 45689999999999888
Q ss_pred CCCCceeeecccccccccCccccccc-hhhhHHHHHHHHHhccc
Q 003982 738 PDGKYSVETRLAGTFGYLAPEYAGKH-WMILCQMTGLIWLHGSV 780 (782)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~dvws~Gvv 780 (782)
.++.. -...||+..|-|||++.|. |. -.+.||||+|||
T Consensus 170 ~PG~k--L~TsCGSLAYSAPEILLGDsYD---APAVDiWSLGVI 208 (864)
T KOG4717|consen 170 QPGKK--LTTSCGSLAYSAPEILLGDSYD---APAVDIWSLGVI 208 (864)
T ss_pred CCcch--hhcccchhhccCchhhhcCccC---CcchhhhHHHHH
Confidence 76542 2446899999999998765 33 467899999996
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=267.47 Aligned_cols=182 Identities=25% Similarity=0.370 Sum_probs=153.1
Q ss_pred ceeecccceEEEEEEe-CCCcEEEEEEeccccCC-hhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCCeEEEEEEccCC
Q 003982 587 NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLLVYEYMPR 663 (782)
Q Consensus 587 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~lv~e~~~~ 663 (782)
+.||+|+||.||+|.. .+++.||+|++++.... ....+.+.+|+.++.++ +||+|+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999954 56789999999865432 23456788999999888 599999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCce
Q 003982 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743 (782)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~ 743 (782)
|+|..++.. ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 151 (327)
T cd05617 81 GDLMFHMQR-----QRKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD- 151 (327)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-
Confidence 999988764 2458999999999999999999998 8999999999999999999999999999875332221
Q ss_pred eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 744 VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 744 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.....+||+.|+|||++.+. .++.++|+||+||+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslGvi 185 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGE---EYGFSVDWWALGVL 185 (327)
T ss_pred ceecccCCcccCCHHHHCCC---CCCchheeehhHHH
Confidence 22345799999999998764 45678899999986
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=267.48 Aligned_cols=182 Identities=32% Similarity=0.442 Sum_probs=148.9
Q ss_pred ceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHH-HHHhcCCCCcceEEeEEEeCCeEEEEEEccCC
Q 003982 587 NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIA-VLTKVRHRHLVALLGYCINGSERLLVYEYMPR 663 (782)
Q Consensus 587 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~ 663 (782)
++||+|+||.||+|+. .+++.||+|++.+... ......++.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999955 5688999999976432 1223445555554 67889999999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCce
Q 003982 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743 (782)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~ 743 (782)
++|...+.. ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~- 151 (321)
T cd05603 81 GELFFHLQR-----ERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE- 151 (321)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-
Confidence 999888754 2457889999999999999999998 8999999999999999999999999999875432221
Q ss_pred eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 744 VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 744 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.....+||+.|+|||++.+. .++.++|+||+||+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~i 185 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKE---PYDRTVDWWCLGAV 185 (321)
T ss_pred ccccccCCcccCCHHHhcCC---CCCCcCcccccchh
Confidence 22345789999999988664 35667899999986
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-29 Score=257.99 Aligned_cols=189 Identities=24% Similarity=0.384 Sum_probs=156.8
Q ss_pred cCCCccceeecccceEEEEEEe----CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL----PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 656 (782)
++|++.+.||+|+||.||+|.. ..+..||+|.++... .......+.+|+.++++++||||+++++++..++..++
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 5688999999999999999954 245689999987643 23445678999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecccee
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~ 736 (782)
||||+++|+|.+++... ...+++.+++.++.|++.||+|||+ .|++||||||+||+++.++.+|++|||.+..
T Consensus 84 v~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 84 VTEYMSNGALDSFLRKH----EGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred EEEeCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCccccc
Confidence 99999999999998652 2358999999999999999999998 8999999999999999999999999998765
Q ss_pred cCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 737 APDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.............++..|+|||.+.+. .++.++||||+|++
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~ 197 (266)
T cd05064 157 DKSEAIYTTMSGKSPVLWAAPEAIQYH---HFSSASDVWSFGIV 197 (266)
T ss_pred ccccchhcccCCCCceeecCHHHHhhC---CccchhHHHHHHHH
Confidence 433221111122356789999987654 45778999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-29 Score=263.92 Aligned_cols=182 Identities=27% Similarity=0.415 Sum_probs=151.1
Q ss_pred ceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHh-cCCCCcceEEeEEEeCCeEEEEEEccCC
Q 003982 587 NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTK-VRHRHLVALLGYCINGSERLLVYEYMPR 663 (782)
Q Consensus 587 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~-l~h~nI~~~~~~~~~~~~~~lv~e~~~~ 663 (782)
+.||+|+||.||+|.. .+++.||||+++.... .......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4689999999999965 4578999999976532 12334556778888876 4899999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCce
Q 003982 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743 (782)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~ 743 (782)
|+|.+++.. ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 151 (316)
T cd05619 81 GDLMFHIQS-----CHKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA- 151 (316)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-
Confidence 999999865 2357899999999999999999998 8999999999999999999999999999876432221
Q ss_pred eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 744 VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 744 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
......||+.|+|||++.+. .++.++|+||+||+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~i 185 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQ---KYNTSVDWWSFGVL 185 (316)
T ss_pred ceeeecCCccccCHHHHcCC---CCCchhhhhhHHHH
Confidence 12335689999999998765 45678999999986
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-29 Score=260.92 Aligned_cols=188 Identities=27% Similarity=0.381 Sum_probs=151.4
Q ss_pred cCCCccceeecccceEEEEEEe--CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhc---CCCCcceEEeEEEe-----
Q 003982 581 DNFSEANILGRGGFGVVYGGEL--PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV---RHRHLVALLGYCIN----- 650 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~nI~~~~~~~~~----- 650 (782)
++|++.+.||+|+||.||+|.. .+++.||+|+++...........+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 4799999999999999999965 3468899999876543333445666777777765 69999999998852
Q ss_pred CCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEe
Q 003982 651 GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVAD 730 (782)
Q Consensus 651 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~D 730 (782)
....++||||++ ++|.+++.... ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~D 153 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLAD 153 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEcc
Confidence 456899999995 68988886532 2358999999999999999999998 8999999999999999999999999
Q ss_pred eccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 731 FGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 731 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
||+++...... ......||+.|+|||++.+. .+..++||||+||+
T Consensus 154 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~i 198 (290)
T cd07862 154 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQS---SYATPVDLWSVGCI 198 (290)
T ss_pred ccceEeccCCc--ccccccccccccChHHHhCC---CCCCccchHHHHHH
Confidence 99998765432 22334689999999987654 34567889999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=267.01 Aligned_cols=182 Identities=29% Similarity=0.400 Sum_probs=147.2
Q ss_pred ceeecccceEEEEEEe-CCCcEEEEEEeccccCC-hhhHHHHHHHH-HHHHhcCCCCcceEEeEEEeCCeEEEEEEccCC
Q 003982 587 NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEI-AVLTKVRHRHLVALLGYCINGSERLLVYEYMPR 663 (782)
Q Consensus 587 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~-~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~ 663 (782)
+.||+|+||+||+|.. .+++.||+|++.+.... ......+.+|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4699999999999955 46788999999764321 12233444444 456788999999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCce
Q 003982 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743 (782)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~ 743 (782)
++|.+++.. ...+++..+..++.|+++||+|||+ .||+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~- 151 (325)
T cd05602 81 GELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG- 151 (325)
T ss_pred CcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-
Confidence 999998865 2457888999999999999999998 8999999999999999999999999999875432221
Q ss_pred eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 744 VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 744 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.....+||+.|+|||++.+. .++.++||||+||+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~i 185 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQ---PYDRTVDWWCLGAV 185 (325)
T ss_pred CcccccCCccccCHHHHcCC---CCCCccccccccHH
Confidence 12345799999999988764 34567889998876
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=255.23 Aligned_cols=187 Identities=29% Similarity=0.453 Sum_probs=159.1
Q ss_pred cCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEc
Q 003982 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 660 (782)
++|++.+.||+|+||.||+++..++..+|+|.+.... ....++.+|++++++++||||+++++++.+....++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA---MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC---ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 4578889999999999999988888899999887543 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~ 740 (782)
+++|+|.+++... ...+++..+..++.|++.||+|||+ .||+||||||+||++++++.+||+|||.++.....
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05114 81 MENGCLLNYLRQR----QGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD 153 (256)
T ss_pred CCCCcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence 9999999988652 1347899999999999999999998 89999999999999999999999999998876543
Q ss_pred CceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 741 KYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.........++..|+|||+.... .+..++|+||+|++
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~s~G~~ 190 (256)
T cd05114 154 EYTSSSGAKFPVKWSPPEVFNFS---KYSSKSDVWSFGVL 190 (256)
T ss_pred ceeccCCCCCchhhCChhhcccC---ccchhhhhHHHHHH
Confidence 33222233456789999998754 45778999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-29 Score=264.61 Aligned_cols=182 Identities=27% Similarity=0.417 Sum_probs=150.5
Q ss_pred ceeecccceEEEEEEe-CCCcEEEEEEeccccCC-hhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCCeEEEEEEccCC
Q 003982 587 NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLLVYEYMPR 663 (782)
Q Consensus 587 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~lv~e~~~~ 663 (782)
+.||+|+||.||+|.. .+++.||+|++++.... ......+..|.+++... +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999955 46889999999764321 23445667788888754 899999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCce
Q 003982 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743 (782)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~ 743 (782)
|+|.+++.. ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 g~L~~~i~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 151 (316)
T cd05620 81 GDLMFHIQD-----KGRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-N 151 (316)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-C
Confidence 999988865 2458899999999999999999998 899999999999999999999999999987543222 1
Q ss_pred eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 744 VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 744 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.....+||+.|+|||++.+. .++.++|+||+||+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslGvi 185 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGL---KYTFSVDWWSFGVL 185 (316)
T ss_pred ceeccCCCcCccCHHHHcCC---CCCcccchhhhHHH
Confidence 22345789999999998764 34677899999876
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=270.07 Aligned_cols=186 Identities=27% Similarity=0.403 Sum_probs=151.8
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
++|+..+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|+++++.++|+||+++++++.+.+..++|||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 3455678899999999999954 578999999986543 23445778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++++|.+. ...++..+..++.|++.||+|||+ .||+||||||+||++++++.+||+|||+++....
T Consensus 153 ~~~~~~L~~~---------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 153 FMDGGSLEGT---------HIADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred cCCCCccccc---------ccCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 9999998543 235677888999999999999998 8999999999999999999999999999987653
Q ss_pred CCceeeecccccccccCccccccchh--hhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWM--ILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~dvws~Gvv 780 (782)
... ......||..|+|||++..... .....++|||||||+
T Consensus 221 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvi 262 (353)
T PLN00034 221 TMD-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVS 262 (353)
T ss_pred ccc-cccccccCccccCccccccccccCcCCCcchhHHHHHHH
Confidence 221 1223478999999998753211 112457899999986
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=259.25 Aligned_cols=188 Identities=29% Similarity=0.471 Sum_probs=157.1
Q ss_pred CCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChh-hHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNK-GLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
.|++.+.||+|+||.||++.. .+++.||+|++........ ....+.+|++++++++||||+++++++.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 478899999999999999954 5789999999976443222 33557789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++|+|.+++.... ...+++.++..++.|++.|++|||+ .||+||||||+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 81 LMNGGDLKFHIYNMG---NPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154 (285)
T ss_pred ccCCCcHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 999999998876421 2458999999999999999999998 8999999999999999999999999999987644
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... .....|++.|+|||++.+. ..+.++|+||+||+
T Consensus 155 ~~~--~~~~~~~~~y~aPE~~~~~---~~~~~~Diws~G~~ 190 (285)
T cd05605 155 GET--IRGRVGTVGYMAPEVVKNE---RYTFSPDWWGLGCL 190 (285)
T ss_pred CCc--cccccCCCCccCcHHhcCC---CCCccccchhHHHH
Confidence 322 1234689999999998654 34567888888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=272.83 Aligned_cols=187 Identities=25% Similarity=0.396 Sum_probs=150.8
Q ss_pred HhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC------
Q 003982 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING------ 651 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~------ 651 (782)
..++|++.+.||+|+||.||+|.. .+++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 356799999999999999999955 568899999886432 2345799999999999999999887542
Q ss_pred --CeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCC-cEEE
Q 003982 652 --SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM-RAKV 728 (782)
Q Consensus 652 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~-~~kL 728 (782)
...++||||++ +++.+++...... ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .+||
T Consensus 138 ~~~~l~lvmE~~~-~~l~~~~~~~~~~-~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL 212 (440)
T PTZ00036 138 KNIFLNVVMEFIP-QTVHKYMKHYARN-NHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKL 212 (440)
T ss_pred CceEEEEEEecCC-ccHHHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceee
Confidence 24678999996 5787777654332 3568999999999999999999998 8999999999999999664 7999
Q ss_pred EeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 729 ADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 729 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+|||+|+....... .....||+.|+|||++.+. ..++.++||||+||+
T Consensus 213 ~DFGla~~~~~~~~--~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlGvi 260 (440)
T PTZ00036 213 CDFGSAKNLLAGQR--SVSYICSRFYRAPELMLGA--TNYTTHIDLWSLGCI 260 (440)
T ss_pred eccccchhccCCCC--cccCCCCcCccCHHHhcCC--CCCCcHHHHHHHHHH
Confidence 99999987654321 1234689999999987653 235678999999986
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-29 Score=270.43 Aligned_cols=194 Identities=27% Similarity=0.467 Sum_probs=157.2
Q ss_pred hcCCCccceeecccceEEEEEEe------CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCC
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGS 652 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~ 652 (782)
.++|++.+.||+|+||.||+|.. .++..||+|+++.... ......+.+|+++++.+ +||||+++++++.+.+
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 35788999999999999999853 2345799999976432 33456788999999999 8999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHHhhcc---------------------------------------------------------
Q 003982 653 ERLLVYEYMPRGTLAQHLFEWHD--------------------------------------------------------- 675 (782)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 675 (782)
..++||||+++|+|.++++....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 99999999999999999865321
Q ss_pred --------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCce-eee
Q 003982 676 --------HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS-VET 746 (782)
Q Consensus 676 --------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~-~~~ 746 (782)
....++++.++..++.|++.||+|||+ +||+||||||+||++++++.+||+|||+++........ ...
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 011347889999999999999999998 89999999999999999999999999999876443321 112
Q ss_pred cccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 747 RLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 747 ~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
...+++.|||||++.+. .++.++||||+||+
T Consensus 273 ~~~~~~~y~aPE~~~~~---~~~~~~DvwSlGvi 303 (374)
T cd05106 273 NARLPVKWMAPESIFDC---VYTVQSDVWSYGIL 303 (374)
T ss_pred CCCCccceeCHHHhcCC---CCCccccHHHHHHH
Confidence 22356789999988654 35778899999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-29 Score=270.79 Aligned_cols=194 Identities=27% Similarity=0.426 Sum_probs=157.1
Q ss_pred hcCCCccceeecccceEEEEEEe------CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCC
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGS 652 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~ 652 (782)
.++|++.+.||+|+||.||+|.+ .++..||||+++... .....+.+.+|+++++.+ +||||+++++++.+.+
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 34688899999999999999953 245689999997543 233456788999999999 8999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHHhhcc---------------------------------------------------------
Q 003982 653 ERLLVYEYMPRGTLAQHLFEWHD--------------------------------------------------------- 675 (782)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 675 (782)
..++||||+++|+|.+++.+...
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 99999999999999999875321
Q ss_pred -------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCc
Q 003982 676 -------------HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742 (782)
Q Consensus 676 -------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~ 742 (782)
.....+++.++..++.|++.||+|||+ .||+||||||+||++++++.+||+|||+++.......
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 011247889999999999999999998 8999999999999999999999999999987654332
Q ss_pred e-eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 743 S-VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 743 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
. ......++..|+|||++.+. .++.++|+|||||+
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~---~~~~~sDi~slG~~ 305 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNC---VYTFESDVWSYGIL 305 (375)
T ss_pred ccccCCCCCCcceeChhHhcCC---CCCCCCCHHHHHHH
Confidence 1 11223356789999988664 34667888988875
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=262.69 Aligned_cols=182 Identities=27% Similarity=0.404 Sum_probs=152.5
Q ss_pred ceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCCeEEEEEEccCC
Q 003982 587 NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLLVYEYMPR 663 (782)
Q Consensus 587 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~lv~e~~~~ 663 (782)
+.||+|+||.||+|.. .+++.||||++++... .......+.+|.++++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999955 4678999999986532 223456678899999887 699999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCce
Q 003982 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743 (782)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~ 743 (782)
|+|..++.. ...+++.++..++.|++.||+|||+ .||+||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 151 (318)
T cd05570 81 GDLMFHIQR-----SGRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV- 151 (318)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-
Confidence 999988865 2358999999999999999999998 8999999999999999999999999999875332221
Q ss_pred eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 744 VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 744 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.....+||+.|+|||++.+. .++.++|+||+||+
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~---~~~~~~DiwslGvi 185 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQ---PYGPAVDWWALGVL 185 (318)
T ss_pred cccceecCccccCHHHhcCC---CCCcchhhhhHHHH
Confidence 12234689999999998764 45678999999986
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=267.28 Aligned_cols=186 Identities=28% Similarity=0.373 Sum_probs=154.5
Q ss_pred HhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCC-----
Q 003982 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS----- 652 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~----- 652 (782)
..++|++.+.||+|+||.||+|.. .+++.||||++...........++.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 457899999999999999999954 56899999999765444445677889999999999999999999986543
Q ss_pred -eEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEee
Q 003982 653 -ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADF 731 (782)
Q Consensus 653 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~Df 731 (782)
..|+||||+++ ++.+.+.. .+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Df 167 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF 167 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecC
Confidence 46999999964 66666532 37889999999999999999998 89999999999999999999999999
Q ss_pred ccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 732 GLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 732 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|+++...... ......||+.|+|||++.+. .++.++||||+||+
T Consensus 168 g~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~---~~~~~~DiwSlG~i 211 (359)
T cd07876 168 GLARTACTNF--MMTPYVVTRYYRAPEVILGM---GYKENVDIWSVGCI 211 (359)
T ss_pred CCccccccCc--cCCCCcccCCCCCchhccCC---CCCcchhhHHHHHH
Confidence 9997654322 12334689999999998764 45678899999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=265.05 Aligned_cols=181 Identities=26% Similarity=0.343 Sum_probs=148.7
Q ss_pred eecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhc---CCCCcceEEeEEEeCCeEEEEEEccCC
Q 003982 589 LGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKV---RHRHLVALLGYCINGSERLLVYEYMPR 663 (782)
Q Consensus 589 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l---~h~nI~~~~~~~~~~~~~~lv~e~~~~ 663 (782)
||+|+||+||+|+. .+++.||||++.+... .......+..|..++.+. +||||+++++++.+....|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999954 5689999999975432 122344556677777665 699999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCce
Q 003982 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743 (782)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~ 743 (782)
|+|.+++.. ...+++..+..++.|+++||+|||+ .||+||||||+||+++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~-----~~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~- 151 (330)
T cd05586 81 GELFWHLQK-----EGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK- 151 (330)
T ss_pred ChHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-
Confidence 999988865 2458999999999999999999998 8999999999999999999999999999875433221
Q ss_pred eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 744 VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 744 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.....+||+.|+|||++.+. .+.+.++||||+||+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslGvi 186 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDE--KGYTKHVDFWSLGVL 186 (330)
T ss_pred CccCccCCccccCHHHHcCC--CCCCCccceeccccE
Confidence 12345799999999998754 234678999999987
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=253.49 Aligned_cols=189 Identities=25% Similarity=0.469 Sum_probs=160.4
Q ss_pred hcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
.++|++.+.||+|++|.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++++.+....+++||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 35788999999999999999988788899999986543 345788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++++|.+++.... ...+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||.+.....
T Consensus 82 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 82 YMAKGSLLDFLKSDE---GGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred cCCCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCC
Confidence 999999999986532 2357888999999999999999998 8999999999999999999999999999987765
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..........++..|+|||+.... ..+.++|+||+|++
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~ 193 (261)
T cd05072 156 NEYTAREGAKFPIKWTAPEAINFG---SFTIKSDVWSFGIL 193 (261)
T ss_pred CceeccCCCccceecCCHHHhccC---CCChhhhhhhhHHH
Confidence 433222233456789999987654 34667899999986
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=266.80 Aligned_cols=194 Identities=28% Similarity=0.443 Sum_probs=158.2
Q ss_pred hcCCCccceeecccceEEEEEEeC------CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC-CCCcceEEeEEEeCC
Q 003982 580 TDNFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGS 652 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~ 652 (782)
.++|.+.+.||+|+||.||+|... .+..||||+++... .....+.+.+|+++++++. ||||+++++++.+.+
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 467889999999999999999642 23479999997543 2344577999999999996 999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHHhhccC--------------------------------------------------------
Q 003982 653 ERLLVYEYMPRGTLAQHLFEWHDH-------------------------------------------------------- 676 (782)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------------- 676 (782)
..|+||||+++|+|.+++.+....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 999999999999999998753210
Q ss_pred -----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEC
Q 003982 677 -----------------------------------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIG 721 (782)
Q Consensus 677 -----------------------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~ 721 (782)
....+++.++..++.|+++||+|||+ .+|+||||||+||+++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEe
Confidence 11347888899999999999999998 8999999999999999
Q ss_pred CCCcEEEEeeccceecCCCCc-eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 722 DDMRAKVADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 722 ~~~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+++.+||+|||+++....... .......+++.|+|||++.+. .++.++||||+||+
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwSlGvi 328 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN---LYTTLSDVWSYGIL 328 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC---CCCchhhHHHHHHH
Confidence 999999999999987643322 112223567889999988664 34678999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=256.11 Aligned_cols=182 Identities=18% Similarity=0.316 Sum_probs=153.6
Q ss_pred cceeecccceEEEEEEeCCCcEEEEEEeccccCChh-hHHHHHHHHHHHHhcCCCCcceEEeEEEe----CCeEEEEEEc
Q 003982 586 ANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNK-GLSEFQAEIAVLTKVRHRHLVALLGYCIN----GSERLLVYEY 660 (782)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~nI~~~~~~~~~----~~~~~lv~e~ 660 (782)
...||+|+++.||+|.. +|+.||||+++....... ..+.+.+|++++++++||||+++++++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36799999999999988 789999999976543222 35778899999999999999999999877 3567999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~ 740 (782)
+++|+|.+++.. ...+++.....++.|++.|+.|||+ ..+++||||||+||++++++.+||+|||+++.....
T Consensus 104 ~~~g~L~~~l~~-----~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~ 176 (283)
T PHA02988 104 CTRGYLREVLDK-----EKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP 176 (283)
T ss_pred CCCCcHHHHHhh-----CCCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc
Confidence 999999999865 2458899999999999999999997 248899999999999999999999999999865443
Q ss_pred CceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 741 KYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.. ...|+..|+|||++.+... .++.++|||||||+
T Consensus 177 ~~----~~~~~~~y~aPE~~~~~~~-~~~~k~Di~SlGvi 211 (283)
T PHA02988 177 PF----KNVNFMVYFSYKMLNDIFS-EYTIKDDIYSLGVV 211 (283)
T ss_pred cc----cccCcccccCHHHhhhccc-cccchhhhhHHHHH
Confidence 22 2367899999999876321 46789999999986
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=229.50 Aligned_cols=191 Identities=27% Similarity=0.373 Sum_probs=159.0
Q ss_pred CCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCCeEEEEEEc
Q 003982 583 FSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLLVYEY 660 (782)
Q Consensus 583 y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~lv~e~ 660 (782)
....+.||+|++|+|-+-++ .+|+..|+|+++... ..++.++..+|+.+..+. .+|++|.++|.+......++.||.
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~ 126 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL 126 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence 33467799999999988744 579999999997654 456778888999886654 699999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~ 740 (782)
| ..||..+.++.-.+ .+.+++..+-+|+..+++||.|||+ +..+||||+||+|||++.+|++|+||||.+-.+.++
T Consensus 127 M-~tSldkfy~~v~~~-g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 127 M-DTSLDKFYRKVLKK-GGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS 202 (282)
T ss_pred h-hhhHHHHHHHHHhc-CCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence 9 56888877665554 4568999999999999999999998 589999999999999999999999999999887664
Q ss_pred CceeeecccccccccCccccccchh-hhHHHHHHHHHhccc
Q 003982 741 KYSVETRLAGTFGYLAPEYAGKHWM-ILCQMTGLIWLHGSV 780 (782)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~dvws~Gvv 780 (782)
-.. +-..|...|||||.+..+-+ .|++.++||||+||.
T Consensus 203 iAk--t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGIt 241 (282)
T KOG0984|consen 203 IAK--TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGIT 241 (282)
T ss_pred hHH--HHhcCCCccCChhhcCcccCcccceeehhhhhhhhh
Confidence 432 22358889999998875533 388999999999973
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=254.31 Aligned_cols=186 Identities=31% Similarity=0.529 Sum_probs=158.5
Q ss_pred CCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEcc
Q 003982 583 FSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYM 661 (782)
Q Consensus 583 y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~ 661 (782)
|++.+.||+|+||+||+++. .+++.||+|++..............+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 67889999999999999955 45678999999876543334444566999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCC
Q 003982 662 PRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK 741 (782)
Q Consensus 662 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~ 741 (782)
++++|.+++.. ...+++.++..++.|+++||++||+ .||+||||||+||+++.++.++|+|||.+..... .
T Consensus 81 ~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~ 151 (260)
T PF00069_consen 81 PGGSLQDYLQK-----NKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-N 151 (260)
T ss_dssp TTEBHHHHHHH-----HSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTS-T
T ss_pred ccccccccccc-----ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc-c
Confidence 99999999973 2458999999999999999999999 8999999999999999999999999999986522 1
Q ss_pred ceeeecccccccccCccccc-cchhhhHHHHHHHHHhccc
Q 003982 742 YSVETRLAGTFGYLAPEYAG-KHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 742 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~~~dvws~Gvv 780 (782)
........++..|+|||+.. +. ..+.++|+||+|++
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~Di~slG~i 188 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGK---KYTRKSDIWSLGII 188 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTS---SBSTHHHHHHHHHH
T ss_pred ccccccccccccccccccccccc---cccccccccccccc
Confidence 22334457899999999987 32 45788999999986
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=265.35 Aligned_cols=189 Identities=27% Similarity=0.409 Sum_probs=156.6
Q ss_pred HHHHhcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC---
Q 003982 576 LRQVTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING--- 651 (782)
Q Consensus 576 l~~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~--- 651 (782)
...+.++|.+.+.||+|+||.||+|. ..+++.||||++..........+.+.+|++++++++||||+++++++...
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 34566889999999999999999995 45788999999976543334456788999999999999999999887543
Q ss_pred ---CeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEE
Q 003982 652 ---SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKV 728 (782)
Q Consensus 652 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL 728 (782)
...|+++|++ +++|.+++.. ..+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl 159 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRI 159 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEE
Confidence 3468999988 7899887643 358999999999999999999998 89999999999999999999999
Q ss_pred EeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 729 ADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 729 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+|||+++...... ....||+.|+|||++.+. .....++||||+||+
T Consensus 160 ~Dfg~~~~~~~~~----~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~i 205 (343)
T cd07878 160 LDFGLARQADDEM----TGYVATRWYRAPEIMLNW--MHYNQTVDIWSVGCI 205 (343)
T ss_pred cCCccceecCCCc----CCccccccccCchHhcCC--ccCCchhhhHhHHHH
Confidence 9999998765422 234689999999988653 134567899999986
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=266.13 Aligned_cols=187 Identities=26% Similarity=0.362 Sum_probs=155.7
Q ss_pred HHhcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC-----
Q 003982 578 QVTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING----- 651 (782)
Q Consensus 578 ~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~----- 651 (782)
...++|++.+.||+|+||.||+|. ...++.||||++..........+.+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 345789999999999999999995 45688999999976544445567788999999999999999999988643
Q ss_pred -CeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEe
Q 003982 652 -SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVAD 730 (782)
Q Consensus 652 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~D 730 (782)
...++||||+++ ++.+.+.. .+++..+..++.|+++||+|||+ .||+||||||+||++++++.+||+|
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~D 162 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILD 162 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEee
Confidence 356999999964 67666632 37889999999999999999998 8999999999999999999999999
Q ss_pred eccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 731 FGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 731 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
||+++...... ......||+.|+|||++.+. ++..++|+||+||+
T Consensus 163 fg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~---~~~~~~DiwslG~i 207 (355)
T cd07874 163 FGLARTAGTSF--MMTPYVVTRYYRAPEVILGM---GYKENVDIWSVGCI 207 (355)
T ss_pred CcccccCCCcc--ccCCccccCCccCHHHHcCC---CCCchhhHHHHHHH
Confidence 99998654432 12334689999999998764 45678999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=252.63 Aligned_cols=190 Identities=27% Similarity=0.384 Sum_probs=159.5
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... ......+++|+.++++++||||+++++++...+..++||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc--cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 35799999999999999999964 578899999987543 233456889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++++|.+++.. ..++++..+..++.|++.|++|||+ .||+|||+||+||++++++.+||+|||++....
T Consensus 86 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 86 EYCGGGSLQDIYHV-----TGPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKIT 157 (267)
T ss_pred eCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeec
Confidence 99999999998864 2458899999999999999999998 899999999999999999999999999998664
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.... ......|++.|+|||++......+++.++|+||+||+
T Consensus 158 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~i 198 (267)
T cd06646 158 ATIA-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGIT 198 (267)
T ss_pred cccc-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHH
Confidence 3221 1223468899999998753322345678999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-28 Score=254.70 Aligned_cols=193 Identities=31% Similarity=0.569 Sum_probs=159.5
Q ss_pred cCCCccceeecccceEEEEEEeCC------CcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeE
Q 003982 581 DNFSEANILGRGGFGVVYGGELPD------GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSER 654 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~ 654 (782)
++|++.+.||+|+||.||+|.... ...||+|.+.... .......+.+|++++++++||||+++++++...+..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 468889999999999999996532 2579999987543 234456789999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhhccCCC-----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCC
Q 003982 655 LLVYEYMPRGTLAQHLFEWHDHGY-----------TPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD 723 (782)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~ 723 (782)
+++|||+++++|.+++........ ..+++.++..++.|++.||.|||+ .|++||||||+||+++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCC
Confidence 999999999999999976432211 457889999999999999999998 899999999999999999
Q ss_pred CcEEEEeeccceecCCCCc-eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 724 MRAKVADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 724 ~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+.+||+|||+++....... .......+++.|+|||++.+. .++.++|+||+||+
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~sDv~slG~i 215 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG---KFTTESDIWSFGVV 215 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccC---cCchhhhHHHHHHH
Confidence 9999999999986543322 222334568899999987654 45778999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-28 Score=251.36 Aligned_cols=187 Identities=30% Similarity=0.451 Sum_probs=158.6
Q ss_pred cCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEc
Q 003982 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 660 (782)
++|++.+.||+|++|.||.|+..++..+|+|.++... ...+.+.+|+.++++++||||+++++++.+....+++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS---MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc---ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 4688899999999999999988777789999987543 2346789999999999999999999999998899999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~ 740 (782)
+++++|.+++... ...+++..++.++.|++.||+|||+ .|++|+||||+||++++++.+||+|||.++.....
T Consensus 81 ~~~~~l~~~i~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 81 MSNGCLLNYLREH----GKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred CCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 9999999988652 2258999999999999999999998 89999999999999999999999999999876554
Q ss_pred CceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 741 KYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.........++..|+|||+..+. ..+.++|+||+|++
T Consensus 154 ~~~~~~~~~~~~~y~~pe~~~~~---~~~~~~Di~slG~~ 190 (256)
T cd05113 154 EYTSSVGSKFPVRWSPPEVLLYS---KFSSKSDVWAFGVL 190 (256)
T ss_pred ceeecCCCccChhhCCHHHHhcC---cccchhHHHHHHHH
Confidence 43222223456789999998754 34678999999986
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-28 Score=251.74 Aligned_cols=187 Identities=31% Similarity=0.477 Sum_probs=156.8
Q ss_pred cCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEc
Q 003982 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 660 (782)
.+|++.+.||+|++|.||+|...++..+|+|++..... ...++.+|++++++++||||+++++++.+.+..++||||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 35788999999999999999877778899999865432 335788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~ 740 (782)
+++++|.+++... ...+++..+..++.|++.|++|||+ .|++||||||+||++++++.+||+|||.++...+.
T Consensus 81 ~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~ 153 (256)
T cd05059 81 MANGCLLNYLRER----KGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD 153 (256)
T ss_pred CCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccc
Confidence 9999999998652 1357999999999999999999998 89999999999999999999999999999866543
Q ss_pred CceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 741 KYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.........++..|+|||+..+. .++.++|+||+|++
T Consensus 154 ~~~~~~~~~~~~~y~~Pe~~~~~---~~~~~~Di~slG~i 190 (256)
T cd05059 154 QYTSSQGTKFPVKWAPPEVFDYS---RFSSKSDVWSFGVL 190 (256)
T ss_pred cccccCCCCCCccccCHHHhccC---CCCchhhHHHHHHH
Confidence 32222222345679999988754 35678999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=258.31 Aligned_cols=188 Identities=22% Similarity=0.362 Sum_probs=155.8
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
++|.+.+.||+|+||.||+|.. .+++.||+|+++.... ......+.+|++++++++||||+++++++..++..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 5789999999999999999954 4678899999975432 2334567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++ ++.+++... ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~~~~-~l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 156 (309)
T cd07872 85 YLDK-DLKQYMDDC----GNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSV 156 (309)
T ss_pred CCCC-CHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCC
Confidence 9964 888887552 2347889999999999999999998 8999999999999999999999999999976543
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... ......+|+.|+|||++.+. ..+..++|+||+|++
T Consensus 157 ~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~i 194 (309)
T cd07872 157 PTK-TYSNEVVTLWYRPPDVLLGS--SEYSTQIDMWGVGCI 194 (309)
T ss_pred Ccc-ccccccccccccCCHHHhCC--CCCCcHHHHHHHHHH
Confidence 221 11234578999999987653 234678999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-28 Score=274.58 Aligned_cols=197 Identities=19% Similarity=0.271 Sum_probs=152.0
Q ss_pred HHHhcCCCccceeecccceEEEEEEeC--CCcEEEEEE--------------eccc-cCChhhHHHHHHHHHHHHhcCCC
Q 003982 577 RQVTDNFSEANILGRGGFGVVYGGELP--DGTKIAVKR--------------MESN-TMGNKGLSEFQAEIAVLTKVRHR 639 (782)
Q Consensus 577 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~--------------~~~~-~~~~~~~~~~~~E~~~l~~l~h~ 639 (782)
..+.++|++.+.||+|+||+||+|..+ .+..+++|. +.+. .........+++|++++++++||
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 345678999999999999999998542 222222221 1111 11123456688999999999999
Q ss_pred CcceEEeEEEeCCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEE
Q 003982 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNIL 719 (782)
Q Consensus 640 nI~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIl 719 (782)
||+++++++.+.+..|+|+|++ ++++.+++..............++..++.|++.||+|||+ +||+||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEE
Confidence 9999999999999999999999 5678887754322212223466788899999999999998 89999999999999
Q ss_pred ECCCCcEEEEeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 720 IGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 720 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
++.++.+||+|||+++.+............||+.|+|||++.+. +++.++||||+||+
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlGvi 357 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD---GYCEITDIWSCGLI 357 (501)
T ss_pred ECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCC---CCCcHHHHHHHHHH
Confidence 99999999999999987765433333345799999999998765 45778999999986
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=282.24 Aligned_cols=199 Identities=22% Similarity=0.361 Sum_probs=160.4
Q ss_pred HHhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC--CeE
Q 003982 578 QVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING--SER 654 (782)
Q Consensus 578 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~--~~~ 654 (782)
...++|.+.+.||+|+||.||+|.. .++..||+|++............+..|+.++++++||||++++++|.+. ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 3457899999999999999999954 5678899999986655556677899999999999999999999988653 568
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC----CCCeEEcCCCCCCEEECCC-------
Q 003982 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA----QQSFIHRDLKPSNILIGDD------- 723 (782)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~----~~~ivHrDikp~NIll~~~------- 723 (782)
|+||||+++|+|.+++...... ...+++..++.|+.||+.||.|||+.. ..+||||||||+|||++.+
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~-~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKM-FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 9999999999999999764332 346899999999999999999999721 1359999999999999642
Q ss_pred ----------CcEEEEeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 724 ----------MRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 724 ----------~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+.+||+|||++........ .....||+.|+|||++.+.- ..++.++||||||||
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~-~~~s~KSDVWSLG~I 232 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHET-KSYDDKSDMWALGCI 232 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhccC-CCCCchhHHHHHHHH
Confidence 3589999999987643321 23346899999999875431 124678999999986
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-28 Score=250.64 Aligned_cols=189 Identities=31% Similarity=0.468 Sum_probs=159.5
Q ss_pred hcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
.++|++.+.||+|++|.||+|...+++.||+|.++... ...+.+.+|++++++++||||+++++++...+..+++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 45688999999999999999987778899999987643 235678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++++|.+++.... ...+++.++..++.|++.|+.|||+ .||+||||||+||++++++.+||+|||++.....
T Consensus 82 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 82 LMKYGSLLEYLQGGA---GRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred cccCCcHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 999999999986532 2358999999999999999999998 8999999999999999999999999999987764
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
...........+..|+|||+..+. ..+.++|+||+|++
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~ 193 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALYN---RFSIKSDVWSFGIL 193 (261)
T ss_pred CcccccCCCcCceeccCccccccC---CCCchhhHHHHHHH
Confidence 332222222234579999987764 35678999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.7e-29 Score=233.74 Aligned_cols=196 Identities=25% Similarity=0.371 Sum_probs=161.6
Q ss_pred HhcCCCccceeecccceEEEEE-EeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCC-----
Q 003982 579 VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS----- 652 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~----- 652 (782)
-.++|++.+.+|+|+|+-||.+ ...++..||+|++.... .++.+..++|++..++++|||+++++++...+.
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 4578999999999999999999 46788999999998765 567788999999999999999999998875443
Q ss_pred eEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeec
Q 003982 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (782)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG 732 (782)
..|++++|...|+|.+.+.....+ ...+++.+++.|+.++++||++||+. ...++||||||.||++.+++.++|.|||
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~k-g~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIK-GNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEecc
Confidence 489999999999999999876554 34689999999999999999999982 1349999999999999999999999999
Q ss_pred cceecCCC---Cc-----eeeecccccccccCcccc-----------ccchhhhHHHHHHHHHhc
Q 003982 733 LVKNAPDG---KY-----SVETRLAGTFGYLAPEYA-----------GKHWMILCQMTGLIWLHG 778 (782)
Q Consensus 733 ~a~~~~~~---~~-----~~~~~~~gt~~y~aPE~~-----------~~~~~~~~~~~~dvws~G 778 (782)
.+....-. .. +.......|..|+|||.+ .|.|++||+.|+.+|.-+
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~s 239 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGES 239 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCC
Confidence 98654321 10 011112358899999964 366888998888888654
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-28 Score=252.72 Aligned_cols=181 Identities=28% Similarity=0.421 Sum_probs=151.3
Q ss_pred eecccceEEEEEEe-CCCcEEEEEEeccccCCh-hhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEccCCCCH
Q 003982 589 LGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGN-KGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTL 666 (782)
Q Consensus 589 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~gsL 666 (782)
||+|+||.||+++. .+|+.||+|++....... ...+.+..|++++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999954 568999999997543222 2234566799999999999999999999999999999999999999
Q ss_pred HHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCceeee
Q 003982 667 AQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVET 746 (782)
Q Consensus 667 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~ 746 (782)
.+++.... ...+++..+..++.|++.||+|||+ .||+||||||+||++++++.++|+|||++....... ...
T Consensus 81 ~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~ 152 (277)
T cd05607 81 KYHIYNVG---ERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TIT 152 (277)
T ss_pred HHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eee
Confidence 98876532 2358899999999999999999998 899999999999999999999999999998765432 223
Q ss_pred cccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 747 RLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 747 ~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
...|++.|+|||++.+. .++.++|+||+||+
T Consensus 153 ~~~~~~~y~aPE~~~~~---~~~~~~DvwslGv~ 183 (277)
T cd05607 153 QRAGTNGYMAPEILKEE---PYSYPVDWFAMGCS 183 (277)
T ss_pred ccCCCCCccCHHHHccC---CCCCchhHHHHHHH
Confidence 34689999999998765 35678899999976
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-29 Score=287.11 Aligned_cols=196 Identities=28% Similarity=0.384 Sum_probs=169.7
Q ss_pred HHHhcCCCccceeecccceEEEEE-EeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEE
Q 003982 577 RQVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL 655 (782)
Q Consensus 577 ~~~~~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~ 655 (782)
+.+.-+|.....||.|.||.||-| ...+|...|+|.++......+..+...+|+.++..++|||+|+++|+-.+.+..+
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 445567778889999999999999 6778999999999877655666778899999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccce
Q 003982 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (782)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~ 735 (782)
|.||||++|+|.+.+.. .+..++.....+..|++.|+.|||+ .|||||||||+||+++.+|.+|++|||.|.
T Consensus 1311 IFMEyC~~GsLa~ll~~-----gri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEH-----GRIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAV 1382 (1509)
T ss_pred HHHHHhccCcHHHHHHh-----cchhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeeccccee
Confidence 99999999999999865 3346777778889999999999998 899999999999999999999999999998
Q ss_pred ecCCCCceee---ecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 736 NAPDGKYSVE---TRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 736 ~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.+........ ....||+.|||||++.+--.-|-.-+.||||+|||
T Consensus 1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCV 1430 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCV 1430 (1509)
T ss_pred EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccce
Confidence 8765431221 23579999999999987655677788999999997
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-28 Score=264.44 Aligned_cols=186 Identities=26% Similarity=0.356 Sum_probs=155.1
Q ss_pred HhcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC------
Q 003982 579 VTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING------ 651 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~------ 651 (782)
..++|.+.+.||+|+||.||+|. ...++.||||++..........+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 45789999999999999999995 45688999999976544445567788999999999999999999987543
Q ss_pred CeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEee
Q 003982 652 SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADF 731 (782)
Q Consensus 652 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~Df 731 (782)
...|+||||++ +++.+.+.. .+++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+||
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Df 170 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF 170 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeC
Confidence 35799999996 477776642 37888999999999999999998 89999999999999999999999999
Q ss_pred ccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 732 GLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 732 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|+++....... .....||+.|+|||++.+. .++.++||||+||+
T Consensus 171 G~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~---~~~~~~DiwSlG~i 214 (364)
T cd07875 171 GLARTAGTSFM--MTPYVVTRYYRAPEVILGM---GYKENVDIWSVGCI 214 (364)
T ss_pred CCccccCCCCc--ccCCcccCCcCCHHHHhCC---CCCchhhHHhHHHH
Confidence 99986644221 2334689999999998764 45678999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=249.20 Aligned_cols=189 Identities=29% Similarity=0.444 Sum_probs=160.0
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCC---hhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG---NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 656 (782)
++|.+.+.||+|++|.||+|.. .+++.||+|.+...... ....+.+.+|++++++++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5789999999999999999954 57899999998754322 1234678999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecccee
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~ 736 (782)
|+||+++++|.+.+.. ...+++..+..++.|++.|+.|||+ .||+||||||+||++++++.++|+|||+++.
T Consensus 82 v~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~ 153 (263)
T cd06625 82 FMEYMPGGSVKDQLKA-----YGALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKR 153 (263)
T ss_pred EEEECCCCcHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 9999999999998865 2457889999999999999999998 8999999999999999999999999999976
Q ss_pred cCCCCceee--ecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 737 APDGKYSVE--TRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 737 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
......... ....|+..|+|||++.+.. ++.++|+||+|++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~i 196 (263)
T cd06625 154 LQTICSSGTGMKSVTGTPYWMSPEVISGEG---YGRKADVWSVGCT 196 (263)
T ss_pred ccccccccccccCCCcCccccCcceeccCC---CCchhhhHHHHHH
Confidence 543221111 2345788999999988763 6788999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=261.73 Aligned_cols=183 Identities=26% Similarity=0.450 Sum_probs=157.5
Q ss_pred ceeecccceEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEccCCCC
Q 003982 587 NILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGT 665 (782)
Q Consensus 587 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~gs 665 (782)
-+||+|+||+||.|+.. +...+|||.+.... .++.+.+.+||..-++++|.|||+++|.+.+.+..-+.||-++||+
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd--sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD--SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccccc--chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 46999999999999654 45578999987544 5667889999999999999999999999999999999999999999
Q ss_pred HHHHHHhhccCCCCCC--CHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEC-CCCcEEEEeeccceecCCCCc
Q 003982 666 LAQHLFEWHDHGYTPL--TWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIG-DDMRAKVADFGLVKNAPDGKY 742 (782)
Q Consensus 666 L~~~l~~~~~~~~~~l--~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~-~~~~~kL~DfG~a~~~~~~~~ 742 (782)
|.++++. ..+++ .+.++-.+.+||++||.|||+ +.|||||||-+|||++ -.|.+||+|||.++.+..-.
T Consensus 659 LSsLLrs----kWGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin- 730 (1226)
T KOG4279|consen 659 LSSLLRS----KWGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN- 730 (1226)
T ss_pred HHHHHHh----ccCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccCC-
Confidence 9999975 35677 778888999999999999998 8999999999999996 57999999999998875432
Q ss_pred eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 743 SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 743 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.....+.||..|||||++...- -|++.++||||||+.
T Consensus 731 P~TETFTGTLQYMAPEvIDqG~-RGYG~aADIWS~GCT 767 (1226)
T KOG4279|consen 731 PCTETFTGTLQYMAPEVIDQGP-RGYGKAADIWSFGCT 767 (1226)
T ss_pred ccccccccchhhhChHhhccCC-cCCCchhhhhhccce
Confidence 2233467999999999987653 488999999999984
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-28 Score=267.89 Aligned_cols=182 Identities=25% Similarity=0.304 Sum_probs=153.6
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
..+|.+.+.||+|+||.||+|.. ..++.||||.... ..+.+|++++++++|+||+++++++...+..++||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 45799999999999999999955 4578899995422 34578999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
|++ .++|.+++... ...+++.+++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+++...
T Consensus 240 e~~-~~~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~ 311 (461)
T PHA03211 240 PKY-RSDLYTYLGAR----LRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFAR 311 (461)
T ss_pred Ecc-CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecc
Confidence 999 57888887542 2358999999999999999999998 899999999999999999999999999998764
Q ss_pred CCCce-eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYS-VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..... ......||+.|+|||++.+. .++.++|||||||+
T Consensus 312 ~~~~~~~~~~~~GT~~Y~APE~~~~~---~~~~~sDvwSlGvi 351 (461)
T PHA03211 312 GSWSTPFHYGIAGTVDTNAPEVLAGD---PYTPSVDIWSAGLV 351 (461)
T ss_pred cccccccccccCCCcCCcCHHHHcCC---CCCchHHHHHHHHH
Confidence 33211 12235699999999998765 35778999999986
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.2e-28 Score=260.62 Aligned_cols=181 Identities=24% Similarity=0.319 Sum_probs=151.9
Q ss_pred HhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
...+|++.+.||+|+||.||+|.. .+++.||+|+.... ....|+.++++++||||+++++++.+....++|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 345799999999999999999965 45678999975432 235689999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
|||+ .++|.+++... ...+++.++..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||+++..
T Consensus 136 ~e~~-~~~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 136 LPHY-SSDLYTYLTKR----SRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFP 207 (357)
T ss_pred EEcc-CCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCcccccc
Confidence 9999 56888887642 3458999999999999999999998 89999999999999999999999999998754
Q ss_pred CCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 738 PDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.... ......||+.|+|||++.+. .++.++||||+||+
T Consensus 208 ~~~~--~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlGvv 245 (357)
T PHA03209 208 VVAP--AFLGLAGTVETNAPEVLARD---KYNSKADIWSAGIV 245 (357)
T ss_pred ccCc--ccccccccccccCCeecCCC---CCCchhhHHHHHHH
Confidence 3222 11234689999999998764 34678999999986
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-28 Score=252.07 Aligned_cols=189 Identities=26% Similarity=0.415 Sum_probs=158.5
Q ss_pred cCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
++|.+.+.||+|+||.||+|. ..+++.||+|.++... ......+++|+.+++.++||||+++++++...+..+++||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 467888999999999999995 4568899999987543 2344668899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++++|.+++.. .+.+++.++..++.|++.|++|||+ .|++||||||+||+++.++.+||+|||++.....
T Consensus 87 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06645 87 FCGGGSLQDIYHV-----TGPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITA 158 (267)
T ss_pred ccCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence 9999999998865 2458999999999999999999998 8999999999999999999999999999876643
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.. .......|++.|+|||++...-.-.++.++|+||+||+
T Consensus 159 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~i 198 (267)
T cd06645 159 TI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGIT 198 (267)
T ss_pred cc-cccccccCcccccChhhhccccCCCCCchhhhHHHHHH
Confidence 22 12233468999999998742111235678999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-29 Score=243.73 Aligned_cols=189 Identities=28% Similarity=0.364 Sum_probs=159.9
Q ss_pred hcCCCccceeecccceEEEEE-EeCCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
.++|+.+++||+|+||.|..+ ...+++.||+|++++... ..++...-..|-++++..+||.+..+...|+..+..|.|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 457888999999999999999 456899999999988754 344556677899999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
|||..||.|.-.+.+ .+.+++.....+...|+.||.|||+ ++||.||+|.+|.|+|+||.+||+|||+++.-
T Consensus 247 MeyanGGeLf~HLsr-----er~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 247 MEYANGGELFFHLSR-----ERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEccCceEeeehhh-----hhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhc
Confidence 999999999888865 3568888899999999999999998 89999999999999999999999999999864
Q ss_pred CCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 738 PDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
-.... ....+||||.|.|||++.|. -++.+.|-|++|||
T Consensus 319 I~~g~-t~kTFCGTPEYLAPEVleDn---DYgraVDWWG~GVV 357 (516)
T KOG0690|consen 319 IKYGD-TTKTFCGTPEYLAPEVLEDN---DYGRAVDWWGVGVV 357 (516)
T ss_pred ccccc-eeccccCChhhcCchhhccc---cccceeehhhhhHH
Confidence 33222 33458999999999999876 33455566666654
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.3e-28 Score=250.06 Aligned_cols=192 Identities=26% Similarity=0.390 Sum_probs=161.7
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
++|++.+.||+|+||.||+|.. .+++.||||.+..... .......+.+|++++++++||||+++++++.+.+..+++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5789999999999999999954 5789999998865332 2344567899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++++|.+++...... ...+++..+..++.|++.||+|||+ .|++||||||+||+++.++.++|+|||.+....
T Consensus 82 e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQ-KRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCcHHHHHHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 999999999988654332 3457899999999999999999998 899999999999999999999999999988765
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.... ......|++.|+|||++.+. +++.++|+||+|++
T Consensus 158 ~~~~-~~~~~~~~~~~~aPE~~~~~---~~~~~~Di~slG~~ 195 (267)
T cd08228 158 SKTT-AAHSLVGTPYYMSPERIHEN---GYNFKSDIWSLGCL 195 (267)
T ss_pred chhH-HHhcCCCCccccChhhhccC---CCCchhhHHHHHHH
Confidence 4322 11234588899999988654 45778999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-29 Score=263.55 Aligned_cols=181 Identities=23% Similarity=0.404 Sum_probs=154.0
Q ss_pred cceeecccceEEEEE-EeCCCcEEEEEEeccccCC--hhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCe--EEEEEEc
Q 003982 586 ANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMG--NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE--RLLVYEY 660 (782)
Q Consensus 586 ~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~--~~lv~e~ 660 (782)
.++||+|+|-+||+| +..+|..||--.++..... ....++|..|+.+|+.|+||||++++++|.+... ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 567999999999999 5557888875544443332 3456899999999999999999999999998765 7799999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCC-CcEEEEeeccceecCC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD-MRAKVADFGLVKNAPD 739 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~-~~~kL~DfG~a~~~~~ 739 (782)
+..|+|..|+++++ .++.+.++.|++||++||.|||++ ...|||||||-+||||+.. |.|||+|+|+|.....
T Consensus 125 ~TSGtLr~Y~kk~~-----~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 125 FTSGTLREYRKKHR-----RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ccCCcHHHHHHHhc-----cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 99999999998853 478899999999999999999984 5899999999999999865 8999999999988765
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhcc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGS 779 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gv 779 (782)
..+ ...+|||.|||||+.... |....||||||+
T Consensus 199 s~a---ksvIGTPEFMAPEmYEE~----YnE~VDVYaFGM 231 (632)
T KOG0584|consen 199 SHA---KSVIGTPEFMAPEMYEEN----YNELVDVYAFGM 231 (632)
T ss_pred ccc---ceeccCccccChHHHhhh----cchhhhhhhhhH
Confidence 432 336899999999998875 578899999996
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=250.99 Aligned_cols=190 Identities=29% Similarity=0.473 Sum_probs=161.0
Q ss_pred HhcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCCh-hhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGN-KGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 656 (782)
..+.|+.-++||+|+||.||.++ ..+|+.||.|.+.+..... ........|-.|+++++.+.||.+-..|++.+..++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 34568888999999999999994 4579999999887654322 234556789999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecccee
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~ 736 (782)
|+..|.||+|.-.+.. .+...+++..+..++.+|+.||++||. .+||.||+||+|||+|+.|+++|+|+|+|..
T Consensus 263 VLtlMNGGDLkfHiyn---~g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYN---HGNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVE 336 (591)
T ss_pred EEEeecCCceeEEeec---cCCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEe
Confidence 9999999999887765 334579999999999999999999998 8999999999999999999999999999999
Q ss_pred cCCCCceeeecccccccccCccccccc--------hhhhHHHHHHHHH
Q 003982 737 APDGKYSVETRLAGTFGYLAPEYAGKH--------WMILCQMTGLIWL 776 (782)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~~~~dvws 776 (782)
+..+... ...+||.+|||||++.+. |++||..|++|=+
T Consensus 337 i~~g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G 382 (591)
T KOG0986|consen 337 IPEGKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAG 382 (591)
T ss_pred cCCCCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcc
Confidence 8876543 334899999999987754 6777777766643
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.6e-28 Score=252.42 Aligned_cols=188 Identities=30% Similarity=0.466 Sum_probs=157.2
Q ss_pred CCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCCh-hhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGN-KGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
.|+..+.||+|+||+||+|.. .+++.||+|.+....... .....+.+|++++++++|++|+++++++.+++..+++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 367788999999999999954 578999999997654322 234567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++++|.+++.... ...+++..+..++.|++.||.|||+ .||+||||||+||++++++.+||+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05632 81 IMNGGDLKFHIYNMG---NPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE 154 (285)
T ss_pred eccCccHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCC
Confidence 999999998886532 2358999999999999999999998 8999999999999999999999999999876543
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... .....|+..|+|||++.+. .++.++|+||+|++
T Consensus 155 ~~~--~~~~~g~~~~~aPE~~~~~---~~~~~~Di~slG~~ 190 (285)
T cd05632 155 GES--IRGRVGTVGYMAPEVLNNQ---RYTLSPDYWGLGCL 190 (285)
T ss_pred CCc--ccCCCCCcCccChHHhcCC---CCCcccchHHHHHH
Confidence 221 1234689999999998654 35667899999976
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.9e-28 Score=252.63 Aligned_cols=188 Identities=30% Similarity=0.476 Sum_probs=156.7
Q ss_pred CCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChh-hHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 582 NFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNK-GLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
.|+..+.||+|+||.||+|. ..+++.||||.+........ ....+.+|+.++++++|++|+.+++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 36778999999999999994 45789999999876543222 34567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++++|.+++.... ...+++.++..++.|++.||.|||+ .||+||||||+||++++++.++|+|||++.....
T Consensus 81 ~~~g~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05630 81 LMNGGDLKFHIYHMG---EAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 154 (285)
T ss_pred ecCCCcHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence 999999999886532 2358999999999999999999998 8999999999999999999999999999876543
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... .....|++.|+|||++.+. ..+.++|+||+|++
T Consensus 155 ~~~--~~~~~g~~~y~aPE~~~~~---~~~~~~DiwslG~~ 190 (285)
T cd05630 155 GQT--IKGRVGTVGYMAPEVVKNE---RYTFSPDWWALGCL 190 (285)
T ss_pred Ccc--ccCCCCCccccChHHHcCC---CCCCccccHHHHHH
Confidence 321 1234689999999998654 34567888888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.8e-28 Score=251.72 Aligned_cols=195 Identities=27% Similarity=0.492 Sum_probs=159.5
Q ss_pred HhcCCCccceeecccceEEEEEEeC------CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCC
Q 003982 579 VTDNFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS 652 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~ 652 (782)
..++|++.+.||+|++|.||+|... ++..||+|++.... ......++.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 4567999999999999999998642 35679999986433 2234567899999999999999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHHhhccCC-----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEE
Q 003982 653 ERLLVYEYMPRGTLAQHLFEWHDHG-----YTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAK 727 (782)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~k 727 (782)
..++||||+++++|.+++.+..... ...+++..+..++.|++.||+|||+ .|++||||||+||++++++.+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEE
Confidence 9999999999999999987643211 1346788899999999999999998 8999999999999999999999
Q ss_pred EEeeccceecCCCCcee-eecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 728 VADFGLVKNAPDGKYSV-ETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 728 L~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|+|||+++......... .....+++.|+|||++.+. .++.++|+||+||+
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~ 210 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG---VFTTYSDVWSFGVV 210 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcC---CcCchhHHHHHHHH
Confidence 99999998665433222 1223457789999998764 45788999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-28 Score=254.03 Aligned_cols=187 Identities=26% Similarity=0.386 Sum_probs=150.6
Q ss_pred CCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhc---CCCCcceEEeEEEe-----CC
Q 003982 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV---RHRHLVALLGYCIN-----GS 652 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~nI~~~~~~~~~-----~~ 652 (782)
+|++.+.||+|+||+||+|.. .+++.||+|.++...........+.+|+++++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 588899999999999999954 5789999999876543333334566777777665 69999999998864 24
Q ss_pred eEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeec
Q 003982 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (782)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG 732 (782)
..+++|||++ +++.+++.... ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg 153 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVP---PPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFG 153 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccC
Confidence 5799999996 58888876532 2348999999999999999999998 899999999999999999999999999
Q ss_pred cceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 733 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+++...... ......||..|+|||++.+. ++..++|+||+||+
T Consensus 154 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~~ 196 (288)
T cd07863 154 LARIYSCQM--ALTPVVVTLWYRAPEVLLQS---TYATPVDMWSVGCI 196 (288)
T ss_pred ccccccCcc--cCCCccccccccCchHhhCC---CCCCcchhhhHHHH
Confidence 998664322 12234689999999988654 45778899999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-28 Score=252.03 Aligned_cols=193 Identities=32% Similarity=0.536 Sum_probs=160.1
Q ss_pred cCCCccceeecccceEEEEEEeC------CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeE
Q 003982 581 DNFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSER 654 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~ 654 (782)
++|.+.+.||+|+||.||+|... +++.||||+++.... .+..+.+.+|++++++++||||+++++++......
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 56888999999999999999653 347899999875432 33467899999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhhcc---------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCc
Q 003982 655 LLVYEYMPRGTLAQHLFEWHD---------HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR 725 (782)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~---------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~ 725 (782)
++||||+++++|.+++..... .....+++.++..++.|++.|++|||+ .|++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCe
Confidence 999999999999999976421 122457899999999999999999998 89999999999999999999
Q ss_pred EEEEeeccceecCCCCc-eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 726 AKVADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 726 ~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+||+|||+++....... .......+++.|+|||++.+. ..+.++|+||+|++
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 213 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR---KFTTESDVWSFGVV 213 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccC---CcchhhhHHHHHHH
Confidence 99999999986543322 222333467889999988764 35778999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=252.01 Aligned_cols=190 Identities=26% Similarity=0.382 Sum_probs=158.7
Q ss_pred CCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEc
Q 003982 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 660 (782)
+|++.+.||+|++|.||+|.. .+++.||+|++..........+.+.+|+.++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 588899999999999999955 4789999999876543344557788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~ 740 (782)
++ +++.+++..... ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 81 LS-MDLKKYLDSLPK--GQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred CC-CCHHHHHhcCCC--CCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence 97 688888765332 2468999999999999999999998 89999999999999999999999999998765432
Q ss_pred CceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 741 KYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
. .......+++.|+|||++.+. ...+.++|+||+|++
T Consensus 155 ~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~i 191 (285)
T cd07861 155 V-RVYTHEVVTLWYRAPEVLLGS--PRYSTPVDIWSIGTI 191 (285)
T ss_pred c-ccccCCcccccccChHHhcCC--CCcCcHHHHHHHHHH
Confidence 2 112233578899999987654 234678999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=248.91 Aligned_cols=188 Identities=30% Similarity=0.483 Sum_probs=156.4
Q ss_pred hcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
.++|++.+.||+|++|.||+|...+...||+|+++... ...+++.+|++++++++||||+++++++. ....++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTE 80 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc---cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEE
Confidence 35699999999999999999977677789999997543 23467899999999999999999999874 456799999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++|+|.+++.+.. ...+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||.+.....
T Consensus 81 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 81 YMSKGSLLDFLKGEM---GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED 154 (262)
T ss_pred cCCCCcHHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence 999999999996522 2357899999999999999999998 8999999999999999999999999999987654
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..........++..|+|||+..+. .++.++|+||+|++
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~---~~~~~~DvwslG~~ 192 (262)
T cd05071 155 NEYTARQGAKFPIKWTAPEAALYG---RFTIKSDVWSFGIL 192 (262)
T ss_pred cccccccCCcccceecCHhHhccC---CCCchhhHHHHHHH
Confidence 433222233467789999987653 35778999999986
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=249.10 Aligned_cols=188 Identities=29% Similarity=0.497 Sum_probs=157.5
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
.+|.+.+.||+|++|.||+|.. ..++.||+|+++... ...+++.+|++++++++||||+++++++..++..+++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 4577889999999999999954 468899999987543 345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++++|.+++.... ...+++..+..++.|++.||+|||+ .|++||||||+||++++++.+||+|||.+.....
T Consensus 83 ~~~~~~L~~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 83 FMTYGNLLDYLRECN---RQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred eCCCCcHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 999999999986532 2357899999999999999999998 8999999999999999999999999999987655
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..........++..|+|||++.+. ..+.++||||+|++
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~i 194 (263)
T cd05052 157 DTYTAHAGAKFPIKWTAPESLAYN---KFSIKSDVWAFGVL 194 (263)
T ss_pred ceeeccCCCCCccccCCHHHhccC---CCCchhHHHHHHHH
Confidence 433222222346689999987654 34567899999986
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=256.28 Aligned_cols=188 Identities=26% Similarity=0.447 Sum_probs=153.6
Q ss_pred cCCCccceeecccceEEEEEEeC-CCc----EEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEE
Q 003982 581 DNFSEANILGRGGFGVVYGGELP-DGT----KIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL 655 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~ 655 (782)
.+|++.+.||+|+||.||+|.+. +++ .||+|+++... .....+++.+|+.+++.++||||+++++++... ..+
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 56899999999999999999643 333 48999986432 234567899999999999999999999998764 568
Q ss_pred EEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccce
Q 003982 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (782)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~ 735 (782)
+++||+++|+|.+++.+. ...+++..+..++.|++.||+|||+ .||+||||||+||++++++.+||+|||+++
T Consensus 85 ~v~e~~~~g~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 85 LITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred eeeecCCCCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccc
Confidence 999999999999998753 2347889999999999999999998 899999999999999999999999999998
Q ss_pred ecCCCCcee-eecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 736 NAPDGKYSV-ETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 736 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
......... .....++..|+|||++.+. ..+.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~---~~~~~~Di~slGv~ 200 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILHR---IYTHQSDVWSYGVT 200 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhccC---CCCchhhhHHHHHH
Confidence 765432211 1122346789999988654 45678899999975
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=256.23 Aligned_cols=185 Identities=25% Similarity=0.361 Sum_probs=147.2
Q ss_pred cceeecccceEEEEEEeC---CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEe--CCeEEEEEEc
Q 003982 586 ANILGRGGFGVVYGGELP---DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN--GSERLLVYEY 660 (782)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~--~~~~~lv~e~ 660 (782)
.++||+|+||+||+|... +++.||+|.++... ....+.+|++++++++||||+++++++.. +...+++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC----CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 467999999999999653 56789999987543 23457889999999999999999998864 4567899999
Q ss_pred cCCCCHHHHHHhhccC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE----CCCCcEEEEeec
Q 003982 661 MPRGTLAQHLFEWHDH----GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI----GDDMRAKVADFG 732 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll----~~~~~~kL~DfG 732 (782)
+. +++.+++...... ....+++..+..++.|++.||+|||+ .||+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 82 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred cC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 95 5888887543211 12358999999999999999999998 899999999999999 456789999999
Q ss_pred cceecCCCCc--eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 733 LVKNAPDGKY--SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 733 ~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+|+....... .......||+.|+|||++.+. ..++.++|+||+||+
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~i 205 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGA--RHYTKAIDIWAIGCI 205 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCC--CCcCchhhHHHHHHH
Confidence 9987654321 122345789999999988663 134678999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=251.43 Aligned_cols=193 Identities=31% Similarity=0.537 Sum_probs=159.5
Q ss_pred hcCCCccceeecccceEEEEEEe------CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCe
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE 653 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~ 653 (782)
.++|.+.+.||+|+||.||++.. .++..+|+|.+.... ....+.+.+|++++++++||||+++++++...+.
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 35788999999999999999963 234568999886543 3456789999999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhhcc--------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCc
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHD--------HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR 725 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~--------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~ 725 (782)
.++||||+++++|.+++..... .....+++..+..++.|++.||+|||+ .|++||||||+||++++++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLL 158 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCc
Confidence 9999999999999999875321 112348999999999999999999998 89999999999999999999
Q ss_pred EEEEeeccceecCCCCc-eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 726 AKVADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 726 ~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+||+|||+++....... .......++..|+|||++.+. ..+.++|+||+|++
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~sDiwslG~i 211 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR---KFTTESDVWSLGVV 211 (288)
T ss_pred EEeccCCccccccCCceeecCCCCCccccccCHHHhccC---CCCchhhHHHHHHH
Confidence 99999999986643322 112233457789999988764 45778999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=247.27 Aligned_cols=189 Identities=26% Similarity=0.387 Sum_probs=162.8
Q ss_pred CCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEc
Q 003982 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 660 (782)
+|.+.+.||+|++|.||+|.. .+++.|++|.+..........+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 477889999999999999954 5789999999976655566778899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~ 740 (782)
+++++|.+++.... ...+++..+..++.|++.||.|||+ .|++||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~l~~~~---~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 81 AENGDLHKLLKMQR---GRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred CCCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 99999999987632 2458899999999999999999998 89999999999999999999999999999876543
Q ss_pred CceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 741 KYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... .....|++.|+|||+..+. .++.++|+||+|++
T Consensus 155 ~~~-~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 190 (256)
T cd08529 155 TNF-ANTIVGTPYYLSPELCEDK---PYNEKSDVWALGVV 190 (256)
T ss_pred cch-hhccccCccccCHHHhcCC---CCCCccchHHHHHH
Confidence 321 2234688999999988765 34678999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=267.78 Aligned_cols=187 Identities=24% Similarity=0.346 Sum_probs=149.8
Q ss_pred HHHHhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCC------CCcceEEeEE
Q 003982 576 LRQVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH------RHLVALLGYC 648 (782)
Q Consensus 576 l~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h------~nI~~~~~~~ 648 (782)
+....++|++.+.||+|+||+||+|.. ..++.||||+++... .....+..|+++++.++| ++++.+++++
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 344568899999999999999999954 567899999996432 233456678888777754 4588888888
Q ss_pred EeC-CeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCC---
Q 003982 649 ING-SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM--- 724 (782)
Q Consensus 649 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~--- 724 (782)
... ...++|||++ +++|.+++.+ ...+++.++..++.|++.||+|||+ +.|||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~-----~~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMK-----HGPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVV 272 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCccc
Confidence 764 5788999988 7889888865 2458999999999999999999996 25999999999999998765
Q ss_pred -------------cEEEEeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 725 -------------RAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 725 -------------~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.+||+|||.+...... ....+||+.|+|||++.+. .++.++||||+||+
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~~~----~~~~~gt~~Y~APE~~~~~---~~~~~~DiwSlGvi 334 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDERHS----RTAIVSTRHYRSPEVVLGL---GWMYSTDMWSMGCI 334 (467)
T ss_pred ccccccccCCCCceEEECCCCccccCccc----cccccCCccccCcHHhhcC---CCCcHHHHHHHHHH
Confidence 4999999987643321 2345799999999998765 45778999999986
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=252.02 Aligned_cols=185 Identities=32% Similarity=0.421 Sum_probs=159.8
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCC-hhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
++|++.+.||+|++|.||++.. .+++.||+|++...... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 4688999999999999999954 46899999998764322 234577899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++++|.+++... ..+++..+..++.|++.||+|||+ .|++||||+|+||+++.++.+||+|||++....
T Consensus 81 e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 152 (290)
T cd05580 81 EYVPGGELFSHLRKS-----GRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK 152 (290)
T ss_pred ecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccC
Confidence 999999999998652 458999999999999999999998 899999999999999999999999999998765
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... ....|++.|+|||++.+. ..+.++|+||+|++
T Consensus 153 ~~~----~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 187 (290)
T cd05580 153 GRT----YTLCGTPEYLAPEIILSK---GYGKAVDWWALGIL 187 (290)
T ss_pred CCC----CCCCCCccccChhhhcCC---CCCccccHHHHHHH
Confidence 432 234689999999988654 45677899999976
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=248.01 Aligned_cols=186 Identities=33% Similarity=0.554 Sum_probs=153.3
Q ss_pred ccceeecccceEEEEEEeC-----CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 585 EANILGRGGFGVVYGGELP-----DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 585 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
+.+.||.|+||.||+|.+. .+..|+||.++.. ......+.+.+|++.+++++||||++++|++...+..++|||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeeccccccccccccccccccccccccccccccc
Confidence 4678999999999999665 3568999999553 234457899999999999999999999999998888999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++|+|.+++... ....+++.++..++.|+++||.|||+ .+++|+||+++||++++++.+||+|||++.....
T Consensus 82 ~~~~g~L~~~L~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 82 YCPGGSLDDYLKSK---NKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp --TTEBHHHHHHHT---CTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred cccccccccccccc---cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 99999999999874 12458999999999999999999999 8999999999999999999999999999988733
Q ss_pred CCc-eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKY-SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... .......+...|+|||.+.+.. ++.++||||||++
T Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~---~~~ksDVysfG~~ 194 (259)
T PF07714_consen 156 KSKYKNDSSQQLPLRYLAPEVLKDGE---YTKKSDVYSFGML 194 (259)
T ss_dssp SSSEEESTTSESGGGGS-HHHHHHSE---ESHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccc---ccccccccccccc
Confidence 222 2222334678899999987763 6999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=247.06 Aligned_cols=192 Identities=25% Similarity=0.400 Sum_probs=162.4
Q ss_pred cCCCccceeecccceEEEEEEeC-CCcEEEEEEeccccCC-hhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
++|++.+.||+|++|.||+|... +++.||+|.++..... ....+.+.+|++++++++|++|+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999554 8899999998754332 334678999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++++|.+++...... ...+++..+..++.|++.|+.|||+ .||+||||||+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQ-KRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred ecCCCCCHHHHHHHhccc-CCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 999999999998764332 3458999999999999999999998 899999999999999999999999999987664
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..... .....+++.|+|||++.+. ++..++|+||+||+
T Consensus 158 ~~~~~-~~~~~~~~~y~apE~~~~~---~~~~~~Di~slG~i 195 (267)
T cd08224 158 SKTTA-AHSLVGTPYYMSPERIHEN---GYNFKSDIWSLGCL 195 (267)
T ss_pred CCCcc-cceecCCccccCHHHhccC---CCCchhcHHHHHHH
Confidence 43211 1224578899999987654 45678999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=244.07 Aligned_cols=183 Identities=32% Similarity=0.511 Sum_probs=153.4
Q ss_pred ceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEccCCCCH
Q 003982 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTL 666 (782)
Q Consensus 587 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~gsL 666 (782)
++||+|+||.||+|...+++.||+|++.... .......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 4689999999999988788999999987543 233455788999999999999999999999999999999999999999
Q ss_pred HHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCceeee
Q 003982 667 AQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVET 746 (782)
Q Consensus 667 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~ 746 (782)
.+++... ...+++..+..++.|++.||.|+|+ .|++||||||+||++++++.+||+|||++............
T Consensus 80 ~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (250)
T cd05085 80 LSFLRKK----KDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSG 152 (250)
T ss_pred HHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccccCC
Confidence 9988642 2347899999999999999999998 89999999999999999999999999999765443332222
Q ss_pred cccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 747 RLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 747 ~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
...++..|+|||+.... ....++|+||+|++
T Consensus 153 ~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~l 183 (250)
T cd05085 153 LKQIPIKWTAPEALNYG---RYSSESDVWSYGIL 183 (250)
T ss_pred CCCCcccccCHHHhccC---CCCchhHHHHHHHH
Confidence 22346789999987654 35678999999976
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=248.60 Aligned_cols=190 Identities=26% Similarity=0.367 Sum_probs=150.9
Q ss_pred ceeecccceEEEEEEeCC---CcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEccCC
Q 003982 587 NILGRGGFGVVYGGELPD---GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPR 663 (782)
Q Consensus 587 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~ 663 (782)
+.||+|+||.||+|.... ...+|+|.+.... .......+.+|+++++.++||||+++++++.+....++||||+++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 358999999999995433 3568888876433 234456788999999999999999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCce
Q 003982 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743 (782)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~ 743 (782)
|+|.+++...........++..+..++.|++.|++|||+ .||+||||||+||+++.++.+||+|||++.........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 999999977543323345678889999999999999998 89999999999999999999999999998764433221
Q ss_pred -eeecccccccccCccccccc----hhhhHHHHHHHHHhccc
Q 003982 744 -VETRLAGTFGYLAPEYAGKH----WMILCQMTGLIWLHGSV 780 (782)
Q Consensus 744 -~~~~~~gt~~y~aPE~~~~~----~~~~~~~~~dvws~Gvv 780 (782)
......+++.|+|||+.... .....+.++|+||+|++
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~ 198 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVT 198 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHH
Confidence 12233457789999986431 12345678999999976
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.7e-28 Score=249.00 Aligned_cols=189 Identities=31% Similarity=0.522 Sum_probs=161.2
Q ss_pred hcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
..+|++.+.||+|++|.||+|...+++.+|+|++.... ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 45688899999999999999988779999999987654 3345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++++|.+++.... ...+++..+..++.|++.|++|||+ .||+||||||+||++++++.+||+|||.+.....
T Consensus 83 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 83 LMEKGSLLAFLRSPE---GQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred ecccCCHHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 999999999997532 2457999999999999999999998 8999999999999999999999999999987654
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..... ....++..|+|||+..+. ....++|+||+|++
T Consensus 157 ~~~~~-~~~~~~~~~~~PE~~~~~---~~~~~~DiwslG~~ 193 (261)
T cd05148 157 DVYLS-SDKKIPYKWTAPEAASHG---TFSTKSDVWSFGIL 193 (261)
T ss_pred ccccc-cCCCCceEecCHHHHccC---CCCchhhHHHHHHH
Confidence 33222 223457789999987654 34668999999976
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=246.87 Aligned_cols=188 Identities=32% Similarity=0.515 Sum_probs=156.5
Q ss_pred hcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
.++|++.+.||+|++|.||+|...++..+|+|.+..... ..+.+.+|+.++++++|++|+++++++. ....+++||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE 80 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence 357889999999999999999887888999999976542 3467899999999999999999999875 456899999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++++|.+++.+.. ...+++.++..++.|++.||+|||+ .||+||||||+||++++++.++|+|||.+.....
T Consensus 81 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 81 YMSKGSLLDFLKDGE---GRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred ecCCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 999999999986521 2357999999999999999999998 8999999999999999999999999999987654
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..........++..|+|||+..+. ..+.++|+||+|++
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~ 192 (260)
T cd05070 155 NEYTARQGAKFPIKWTAPEAALYG---RFTIKSDVWSFGIL 192 (260)
T ss_pred cccccccCCCCCccccChHHHhcC---CCcchhhhHHHHHH
Confidence 332222223356689999987653 34678899999976
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=246.98 Aligned_cols=189 Identities=26% Similarity=0.445 Sum_probs=157.3
Q ss_pred cCCCccceeecccceEEEEEEeC----CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGELP----DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 656 (782)
++|++.+.||+|+||.||+|.+. +...||||+++... ......++.+|+.++++++||||+++++++.+.+..++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 56889999999999999999663 24579999886543 23456778999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecccee
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~ 736 (782)
+|||+++++|.+++... ...+++.++..++.|++.|++|||+ .+|+||||||+||++++++.+||+|||+++.
T Consensus 83 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~ 155 (266)
T cd05033 83 ITEYMENGSLDKFLREN----DGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRR 155 (266)
T ss_pred EEEcCCCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhc
Confidence 99999999999998652 2358999999999999999999998 8999999999999999999999999999987
Q ss_pred cCCCCc-eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 737 APDGKY-SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 737 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
...... .......+++.|+|||+..+. .++.++|+||+|++
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~---~~~~~~Dv~slG~~ 197 (266)
T cd05033 156 LEDSEATYTTKGGKIPIRWTAPEAIAYR---KFTSASDVWSFGIV 197 (266)
T ss_pred ccccccceeccCCCCCccccChhhhccC---CCccccchHHHHHH
Confidence 752221 111122346789999988754 45678899999976
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=276.46 Aligned_cols=201 Identities=23% Similarity=0.298 Sum_probs=170.0
Q ss_pred cHHHHHHHhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCC-hhhHHHHHHHHHHHHhcCCCCcceEEeEEE
Q 003982 572 SIEVLRQVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCI 649 (782)
Q Consensus 572 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~ 649 (782)
....++...++|.++++||+|+||.|..++. .+++.||+|++.+..+- ......|..|-.+|..-+.+=|+.++..|.
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 3556777789999999999999999999955 57889999999886543 345667899999999989999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEE
Q 003982 650 NGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVA 729 (782)
Q Consensus 650 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~ 729 (782)
++.+.|+|||||+||+|..++..+ .++++..+..++..|+-||.-+|+ .|+|||||||+|||+|..|++||+
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~-----~~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLA 217 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKF-----DRLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLA 217 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhc-----CCChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeec
Confidence 999999999999999999999774 358999999999999999999998 899999999999999999999999
Q ss_pred eeccceecCCCCceeeecccccccccCccccccc--hhhhHHHHHHHHHhccc
Q 003982 730 DFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKH--WMILCQMTGLIWLHGSV 780 (782)
Q Consensus 730 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~dvws~Gvv 780 (782)
|||.+-.+...+.-.....+|||.|++||++..+ ..-.++..+|-||+||+
T Consensus 218 DFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~ 270 (1317)
T KOG0612|consen 218 DFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVF 270 (1317)
T ss_pred cchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHH
Confidence 9999888775554444556899999999987532 11124455677777775
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-27 Score=243.23 Aligned_cols=188 Identities=21% Similarity=0.327 Sum_probs=160.3
Q ss_pred CCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEc
Q 003982 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 660 (782)
+|++.+.||+|+||.||++.. .+++.||+|.++... .....+.+.+|+.++++++||||+++++++.+++..+++|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 578899999999999999954 478999999986543 234567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~ 740 (782)
++++++.+++.... ...+++..+..++.|++.||.|||+ .||+|+||||+||++++++.++++|||.+......
T Consensus 80 ~~~~~l~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 153 (255)
T cd08219 80 CDGGDLMQKIKLQR---GKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP 153 (255)
T ss_pred CCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence 99999999886522 2357899999999999999999998 89999999999999999999999999999766543
Q ss_pred CceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 741 KYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.. ......|++.|+|||++.+. .++.++|+||+|++
T Consensus 154 ~~-~~~~~~~~~~~~aPE~~~~~---~~~~~~Dv~slG~i 189 (255)
T cd08219 154 GA-YACTYVGTPYYVPPEIWENM---PYNNKSDIWSLGCI 189 (255)
T ss_pred cc-ccccccCCccccCHHHHccC---CcCchhhhhhhchh
Confidence 21 12234688999999998764 46788999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=246.66 Aligned_cols=192 Identities=28% Similarity=0.482 Sum_probs=154.3
Q ss_pred CCccceeecccceEEEEEEeCC-Cc--EEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC------Ce
Q 003982 583 FSEANILGRGGFGVVYGGELPD-GT--KIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING------SE 653 (782)
Q Consensus 583 y~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~------~~ 653 (782)
|.+.+.||+|+||.||+|.... +. .||+|.++.........+.+.+|++++++++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999996644 33 689999876544455678899999999999999999999987532 24
Q ss_pred EEEEEEccCCCCHHHHHHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeec
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHD-HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG 732 (782)
.+++|||+++|+|.+++...+. .....+++..+..++.|++.||+|||+ +||+||||||+||++++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCC
Confidence 6899999999999998754321 123458999999999999999999998 899999999999999999999999999
Q ss_pred cceecCCCCceee-ecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 733 LVKNAPDGKYSVE-TRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 733 ~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+++.......... ....+++.|+|||+..+. .++.++|+||+|++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~---~~~~~~Di~slG~i 203 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADR---VYTTKSDVWSFGVT 203 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCC---CcChHHHHHHHHHH
Confidence 9987654332221 222456789999988764 45778999999986
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=246.95 Aligned_cols=189 Identities=26% Similarity=0.464 Sum_probs=158.7
Q ss_pred HhcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
..++|++.++||+|+||.||+|...+++.||+|.+.... ....++.+|+.++++++||||+++++++. .+..+++|
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS---MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC---CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 346789999999999999999988889999999987654 23467899999999999999999999864 56789999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++++|.+++.... ...+++.++..++.|++.||+|||+ .|++||||||+||++++++.++|+|||.+....
T Consensus 80 e~~~~~~L~~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 80 EYMENGSLVDFLKTPE---GIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIE 153 (260)
T ss_pred EcCCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecC
Confidence 9999999999886522 3458899999999999999999998 899999999999999999999999999998776
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
...........++..|+|||++... .+..++|+||+|++
T Consensus 154 ~~~~~~~~~~~~~~~y~~pe~~~~~---~~~~~~Di~slG~~ 192 (260)
T cd05067 154 DNEYTAREGAKFPIKWTAPEAINYG---TFTIKSDVWSFGIL 192 (260)
T ss_pred CCCcccccCCcccccccCHHHhccC---CcCcccchHHHHHH
Confidence 4333222333467789999987654 35678899999976
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=257.68 Aligned_cols=193 Identities=27% Similarity=0.462 Sum_probs=155.2
Q ss_pred cCCCccceeecccceEEEEEEe------CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeC-C
Q 003982 581 DNFSEANILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCING-S 652 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~-~ 652 (782)
++|++.+.||+|+||.||+|.. .+++.||+|+++... .....+.+.+|+.+++++ +|+||+++++++... .
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 5789999999999999999943 235789999987543 234456788999999999 799999999988654 5
Q ss_pred eEEEEEEccCCCCHHHHHHhhccC--------------------------------------------------------
Q 003982 653 ERLLVYEYMPRGTLAQHLFEWHDH-------------------------------------------------------- 676 (782)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------------- 676 (782)
..+++|||+++++|.+++......
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 678999999999999998643210
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCcee-eeccccccccc
Q 003982 677 GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSV-ETRLAGTFGYL 755 (782)
Q Consensus 677 ~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~~-~~~~~gt~~y~ 755 (782)
...++++..+..++.|++.||+|||+ .||+||||||+||++++++.+||+|||+++......... .....++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 01258999999999999999999998 899999999999999999999999999998764332211 22234567899
Q ss_pred CccccccchhhhHHHHHHHHHhccc
Q 003982 756 APEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 756 aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|||++.+. .++.++||||+||+
T Consensus 243 aPE~~~~~---~~~~~~Di~SlGv~ 264 (337)
T cd05054 243 APESIFDK---VYTTQSDVWSFGVL 264 (337)
T ss_pred CcHHhcCC---CCCccccHHHHHHH
Confidence 99987664 46778899999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=247.78 Aligned_cols=181 Identities=25% Similarity=0.386 Sum_probs=154.3
Q ss_pred cCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
++|++.+.||+|+||.||+|. ..+++.||+|++.... .....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 367889999999999999995 4678999999987543 23445678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|++++++..+. .+++..+..++.|++.|++|||+ .||+|+||||+||+++.++.+||+|||++.....
T Consensus 80 ~~~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 80 FMDGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred cCCCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence 99999986542 36788899999999999999998 8999999999999999999999999999986644
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.. .....||..|+|||++.+. ....++|+||+|++
T Consensus 148 ~~---~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~~ 182 (279)
T cd06619 148 SI---AKTYVGTNAYMAPERISGE---QYGIHSDVWSLGIS 182 (279)
T ss_pred cc---ccCCCCChhhcCceeecCC---CCCCcchHHHHHHH
Confidence 32 1234689999999998764 34678889998875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-28 Score=274.57 Aligned_cols=196 Identities=26% Similarity=0.386 Sum_probs=159.3
Q ss_pred HHHhcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEe-----
Q 003982 577 RQVTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN----- 650 (782)
Q Consensus 577 ~~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~----- 650 (782)
.+...+|+..+.||+|+||.||+++ .-||+.||||+|.... +......+.+|++.+++++|||||+++..|.+
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 3556778889999999999999994 4599999999998776 56677889999999999999999999864432
Q ss_pred --------------------------------------------------C-----------------------------
Q 003982 651 --------------------------------------------------G----------------------------- 651 (782)
Q Consensus 651 --------------------------------------------------~----------------------------- 651 (782)
.
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence 0
Q ss_pred -----------------------------------CeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 003982 652 -----------------------------------SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARG 696 (782)
Q Consensus 652 -----------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~a 696 (782)
...||-||||+.-.+.+++.+.+-. -.....++++++|++|
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~----~~~d~~wrLFreIlEG 709 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN----SQRDEAWRLFREILEG 709 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc----hhhHHHHHHHHHHHHH
Confidence 1237899999887777777653211 1467889999999999
Q ss_pred HHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC----C-------------CCceeeecccccccccCccc
Q 003982 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP----D-------------GKYSVETRLAGTFGYLAPEY 759 (782)
Q Consensus 697 L~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~----~-------------~~~~~~~~~~gt~~y~aPE~ 759 (782)
|.|+|+ .|||||||||.|||++++..|||+|||+|.... . ......+..+||.-|+|||+
T Consensus 710 LaYIH~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl 786 (1351)
T KOG1035|consen 710 LAYIHD---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL 786 (1351)
T ss_pred HHHHHh---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence 999998 899999999999999999999999999998721 0 01112345689999999999
Q ss_pred cccchhhhHHHHHHHHHhccc
Q 003982 760 AGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 760 ~~~~~~~~~~~~~dvws~Gvv 780 (782)
+.+.-+..++.+.||||+|||
T Consensus 787 l~~~~~~~Yn~KiDmYSLGIV 807 (1351)
T KOG1035|consen 787 LSDTSSNKYNSKIDMYSLGIV 807 (1351)
T ss_pred hcccccccccchhhhHHHHHH
Confidence 998744468999999999997
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-29 Score=239.13 Aligned_cols=188 Identities=26% Similarity=0.346 Sum_probs=156.3
Q ss_pred cceeecccceEEEEE-EeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCCeEEEEEEccCC
Q 003982 586 ANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLLVYEYMPR 663 (782)
Q Consensus 586 ~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~lv~e~~~~ 663 (782)
...||.|+||+|+|- +.+.|+..|||++..... +.+.+++..|.+...+- +.||||+++|.+..++..|+-||.| .
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d 146 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-D 146 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-h
Confidence 567999999999998 556799999999987653 56788899998875554 6999999999999999999999999 5
Q ss_pred CCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCce
Q 003982 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743 (782)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~ 743 (782)
.|+..+.+.........+++.-.-.|...++.||.||-+ ...|||||+||+|||++..|.+||+|||.+-.+.++-.
T Consensus 147 ~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA- 223 (361)
T KOG1006|consen 147 ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA- 223 (361)
T ss_pred hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHHHH-
Confidence 677666544333334568888888999999999999997 48999999999999999999999999999877655332
Q ss_pred eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 744 VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 744 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.+.-+|...|||||.+...-. |++..+|+||+||.
T Consensus 224 -kT~daGCrpYmAPERi~p~~~-gyDiRSDvWSLGIT 258 (361)
T KOG1006|consen 224 -KTVDAGCRPYMAPERIDPSDK-GYDIRSDVWSLGIT 258 (361)
T ss_pred -hhhccCCccccChhccCCccC-Ccchhhhhhhhcce
Confidence 233478999999998876644 89999999999984
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=263.41 Aligned_cols=183 Identities=24% Similarity=0.291 Sum_probs=153.7
Q ss_pred HhcCCCccceeecccceEEEEEEe---CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGGEL---PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL 655 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~ 655 (782)
...+|.+.+.||+|+||.||+|.. ..+..||+|.+... +...+|++++++++||||+++++++......+
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 346799999999999999999954 24578999988643 23568999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccce
Q 003982 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (782)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~ 735 (782)
++||++. +++.+++.. ...+++.+++.++.|++.||+|||+ .||+||||||+|||++.++.+||+|||+++
T Consensus 163 lv~e~~~-~~l~~~l~~-----~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~ 233 (392)
T PHA03207 163 MVMPKYK-CDLFTYVDR-----SGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAAC 233 (392)
T ss_pred EEehhcC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCcccc
Confidence 9999995 688888843 3468999999999999999999998 899999999999999999999999999998
Q ss_pred ecCCCCcee-eecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 736 NAPDGKYSV-ETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 736 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
......... .....||+.|+|||++.+. .+..++||||+||+
T Consensus 234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslGvi 276 (392)
T PHA03207 234 KLDAHPDTPQCYGWSGTLETNSPELLALD---PYCAKTDIWSAGLV 276 (392)
T ss_pred ccCcccccccccccccccCccCHhHhcCC---CCCchhhHHHHHHH
Confidence 765433221 2245799999999998764 34667899999986
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=249.62 Aligned_cols=193 Identities=28% Similarity=0.501 Sum_probs=158.0
Q ss_pred cCCCccceeecccceEEEEEEe-----CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-----PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL 655 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~ 655 (782)
++|++.+.||+|+||.||+|.. .++..||+|.+.... .......+.+|++++++++||||+++++++..+...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 4678889999999999999963 356789999997543 2344578899999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCC
Q 003982 656 LVYEYMPRGTLAQHLFEWHDH------------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD 723 (782)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~ 723 (782)
++|||+++++|.+++...... ....+++.++..++.|++.||+|||+ +|++||||||+||+++++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCC
Confidence 999999999999998542210 01347889999999999999999998 899999999999999999
Q ss_pred CcEEEEeeccceecCCCCc-eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 724 MRAKVADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 724 ~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+.+||+|||+++....... .......++..|+|||++.+. .++.++|+||+|++
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~i 215 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG---KFSSDSDIWSFGVV 215 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccC---CCCchhhhHHHHHH
Confidence 9999999999987644322 122233457789999988754 35778999999976
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=251.17 Aligned_cols=186 Identities=28% Similarity=0.382 Sum_probs=157.7
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
++|++.+.||+|+||.||++.. .++..+|+|.+.... ......++.+|++++++++||||+++++++.+++..++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 3689999999999999999954 467889999886542 23445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++++|.+++... ..+++..+..++.|+++||.|||+ ..+++||||||+||++++++.+||+|||++.....
T Consensus 80 y~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (308)
T cd06615 80 HMDGGSLDQVLKKA-----GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 152 (308)
T ss_pred ccCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence 99999999998652 458899999999999999999996 25899999999999999999999999999876543
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.. .....|++.|+|||++.+. ..+.++|+||+|++
T Consensus 153 ~~---~~~~~~~~~~~aPE~~~~~---~~~~~~DiwslG~~ 187 (308)
T cd06615 153 SM---ANSFVGTRSYMSPERLQGT---HYTVQSDIWSLGLS 187 (308)
T ss_pred cc---cccCCCCcCccChhHhcCC---CCCccchHHHHHHH
Confidence 22 1234689999999987654 24567899999976
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=245.81 Aligned_cols=189 Identities=32% Similarity=0.529 Sum_probs=160.5
Q ss_pred hcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
.++|++.+.||+|++|.||+|...+++.||||.+.... ...+++.+|+.++++++||||+++++++.+....+++||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc---cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 46789999999999999999987778899999987644 234678999999999999999999999998899999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++++|.+++.+.. ...+++.++..++.|++.|+.|||+ .|++|+||||+||++++++.+||+|||.+.....
T Consensus 82 ~~~~~~L~~~i~~~~---~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 82 YMSKGSLLDFLKSGE---GKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred ccCCCCHHHHHhccc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 999999999986522 2358999999999999999999998 8999999999999999999999999999987654
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..........++..|+|||.+.+. ..+.++|+||+|++
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~---~~~~~~Di~slG~i 193 (261)
T cd05034 156 DEYTAREGAKFPIKWTAPEAANYG---RFTIKSDVWSFGIL 193 (261)
T ss_pred hhhhhhhccCCCccccCHHHhccC---CcCchhHHHHHHHH
Confidence 322222222346689999988764 45778999999986
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=247.02 Aligned_cols=190 Identities=26% Similarity=0.402 Sum_probs=152.2
Q ss_pred ceeecccceEEEEEEeC---CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEccCC
Q 003982 587 NILGRGGFGVVYGGELP---DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPR 663 (782)
Q Consensus 587 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~ 663 (782)
+.||+|+||.||+|... ++..+|+|.++.... ......+.+|+.++++++||||+++++++.+....++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 35899999999999653 345799998876542 23445788999999999999999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCce
Q 003982 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743 (782)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~ 743 (782)
|+|.+++...........++..+..++.|++.|++|||+ .|++||||||+||+++.++.+||+|||.++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 999999976443323346778888999999999999998 89999999999999999999999999998765443322
Q ss_pred e-eecccccccccCccccccch----hhhHHHHHHHHHhccc
Q 003982 744 V-ETRLAGTFGYLAPEYAGKHW----MILCQMTGLIWLHGSV 780 (782)
Q Consensus 744 ~-~~~~~gt~~y~aPE~~~~~~----~~~~~~~~dvws~Gvv 780 (782)
. .....++..|+|||++.+.. ..+.+.++|+||+|++
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~ 198 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVT 198 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHH
Confidence 2 22345788899999876421 1124568899999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=248.52 Aligned_cols=189 Identities=28% Similarity=0.400 Sum_probs=161.1
Q ss_pred CCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEc
Q 003982 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 660 (782)
+|++.+.||+|++|.||+|.. .+++.||+|++..........+.+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 588899999999999999965 5789999999987654445567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~ 740 (782)
+ +++|.+++.... .++++.++..++.|+++||+|||+ .|++|+||||+||++++++.++|+|||.+......
T Consensus 81 ~-~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 81 M-PSDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred c-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 9 999999986532 458999999999999999999998 89999999999999999999999999999876543
Q ss_pred CceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 741 KYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.........|+..|+|||++.+. .....++|+||+|++
T Consensus 153 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~~ 190 (286)
T cd07832 153 EPRLYSHQVATRWYRAPELLYGA--RKYDPGVDLWAVGCI 190 (286)
T ss_pred CCCccccccCcccccCceeeecc--ccCCchhHHHHHHHH
Confidence 32222334689999999987543 124678999999976
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=253.88 Aligned_cols=189 Identities=19% Similarity=0.266 Sum_probs=154.2
Q ss_pred ccceeecc--cceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEcc
Q 003982 585 EANILGRG--GFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYM 661 (782)
Q Consensus 585 ~~~~lg~G--~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~ 661 (782)
+.++||+| +|++||++. ..+|+.||+|+++.........+.+++|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 678999994 467899999999766544455667888999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCC
Q 003982 662 PRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK 741 (782)
Q Consensus 662 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~ 741 (782)
++|+|.+++.... ...+++..++.++.|++.||+|||+ .||+||||||+||+++.++.++++||+.+.......
T Consensus 82 ~~~~l~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 82 AYGSAKDLICTHF---MDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred CCCcHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 9999999986532 2348999999999999999999998 899999999999999999999999998754432211
Q ss_pred ce------eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 742 YS------VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 742 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.. ......++..|+|||++.+.. .+++.++||||+||+
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~~DiwslG~i 199 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNL-QGYDAKSDIYSVGIT 199 (327)
T ss_pred ccccccccccccccceecccChHHhhccc-CCCCchhhHHHHHHH
Confidence 10 011234677899999987531 145778999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=250.60 Aligned_cols=193 Identities=26% Similarity=0.470 Sum_probs=156.7
Q ss_pred cCCCccceeecccceEEEEEEeCC---------------CcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEE
Q 003982 581 DNFSEANILGRGGFGVVYGGELPD---------------GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~ 645 (782)
++|++.+.||+|+||.||+|.... ...||+|.+.... .......+.+|++++++++||||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 579999999999999999985432 2358999987542 234556799999999999999999999
Q ss_pred eEEEeCCeEEEEEEccCCCCHHHHHHhhccC-------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCE
Q 003982 646 GYCINGSERLLVYEYMPRGTLAQHLFEWHDH-------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNI 718 (782)
Q Consensus 646 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NI 718 (782)
+++......++||||+++++|.+++...... ....+++..+..++.|++.|++|||+ .|++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhE
Confidence 9999999999999999999999998653210 11246888999999999999999998 8999999999999
Q ss_pred EECCCCcEEEEeeccceecCCCCc-eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 719 LIGDDMRAKVADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 719 ll~~~~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
++++++.+||+|||++........ .......++..|+|||+.... ..+.++|+|||||+
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwSlG~~ 220 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG---KFTTASDVWAFGVT 220 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccC---CcCchhhHHHHHHH
Confidence 999999999999999976543322 112223457789999987654 35778999999976
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=248.82 Aligned_cols=195 Identities=28% Similarity=0.507 Sum_probs=157.9
Q ss_pred HhcCCCccceeecccceEEEEEEeC------CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCC
Q 003982 579 VTDNFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS 652 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~ 652 (782)
..++|++.+.||+|+||.||+|... .+..||+|.+.... .......+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 3568999999999999999998532 24579999886543 2234456889999999999999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHHhhccC-----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEE
Q 003982 653 ERLLVYEYMPRGTLAQHLFEWHDH-----GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAK 727 (782)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~k 727 (782)
..++||||+++|+|.+++...... +....++..+..++.|++.||+|||+ ++|+||||||+||++++++.+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEE
Confidence 999999999999999999764321 12345778889999999999999998 8999999999999999999999
Q ss_pred EEeeccceecCCCCcee-eecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 728 VADFGLVKNAPDGKYSV-ETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 728 L~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|+|||+++......... .....++..|+|||++.+. .++.++|+||+||+
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~---~~~~~~DvwslG~~ 210 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG---VFTTSSDMWSFGVV 210 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccC---CCChHhHHHHHHHH
Confidence 99999988654433211 1222456789999988764 35778999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=243.58 Aligned_cols=183 Identities=28% Similarity=0.452 Sum_probs=151.0
Q ss_pred ceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEccCCCC
Q 003982 587 NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGT 665 (782)
Q Consensus 587 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~gs 665 (782)
+.||+|+||.||+|.. .+++.||+|.+.... .......+.+|++++++++||||+++++++......++||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 4689999999999955 578999999886432 23455779999999999999999999999999999999999999999
Q ss_pred HHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCceee
Q 003982 666 LAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVE 745 (782)
Q Consensus 666 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~ 745 (782)
|.+++... ...+++.++..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||.+...........
T Consensus 80 L~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 80 FLTFLRTE----GPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred HHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence 99998642 2357899999999999999999998 8999999999999999999999999999876543322111
Q ss_pred -ecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 746 -TRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 746 -~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
....++..|+|||++.+. ..+.++|+||+|++
T Consensus 153 ~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~i 185 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYG---RYSSESDVWSFGIL 185 (252)
T ss_pred CCCCCCceeecCchhhcCC---CCChHHHHHHHHHH
Confidence 111234579999988664 34678999999976
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=243.86 Aligned_cols=189 Identities=22% Similarity=0.361 Sum_probs=161.6
Q ss_pred CCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEc
Q 003982 582 NFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 660 (782)
+|+..+.||+|+||.||.++ ..+++.+++|.+..........+++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 58899999999999999984 45688999999876655556677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~ 740 (782)
+++++|.+++.+.. ...+++.++..++.|++.|+.|||+ .|++||||+|+||++++++.+||+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 81 ANGGTLYDKIVRQK---GQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred cCCCcHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 99999999987532 2357899999999999999999998 89999999999999999999999999999876543
Q ss_pred CceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 741 KYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.. ......|++.|+|||+..+. ..+.++|+||+|++
T Consensus 155 ~~-~~~~~~~~~~y~ape~~~~~---~~~~~~Dv~slG~i 190 (256)
T cd08221 155 YS-MAETVVGTPYYMSPELCQGV---KYNFKSDIWALGCV 190 (256)
T ss_pred cc-cccccCCCccccCHhhcCCC---CCCCcchhHHHHHH
Confidence 32 22334689999999987664 23567899999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=250.86 Aligned_cols=194 Identities=27% Similarity=0.449 Sum_probs=159.8
Q ss_pred hcCCCccceeecccceEEEEEEeCC-----------------CcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcc
Q 003982 580 TDNFSEANILGRGGFGVVYGGELPD-----------------GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~ 642 (782)
.++|++.+.||+|+||.||+|.... +..||+|++.... .....+.+.+|++++++++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 3578999999999999999985432 2468999987543 234567899999999999999999
Q ss_pred eEEeEEEeCCeEEEEEEccCCCCHHHHHHhhccC------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCC
Q 003982 643 ALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDH------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPS 716 (782)
Q Consensus 643 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~ 716 (782)
++++++..++..+++|||+++++|.+++.+.... ....+++..+..++.|++.||+|||+ .||+||||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~ 159 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATR 159 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchh
Confidence 9999999999999999999999999999765421 12368999999999999999999998 89999999999
Q ss_pred CEEECCCCcEEEEeeccceecCCCCc-eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 717 NILIGDDMRAKVADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 717 NIll~~~~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
||+++.++.++|+|||.++....... .......+++.|+|||++.+. .++.++||||+|++
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~~ 221 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG---KFTTKSDVWAFGVT 221 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC---CCCccchhhhhHHH
Confidence 99999999999999999986544332 222334567889999987654 35678899999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=250.59 Aligned_cols=194 Identities=29% Similarity=0.504 Sum_probs=159.1
Q ss_pred hcCCCccceeecccceEEEEEEe--------CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEe
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL--------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCIN 650 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~ 650 (782)
.++|.+.+.||+|+||.||+|+. .++..||+|.+.... .....+++.+|+.+++.+ +||||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 46788899999999999999953 134579999886532 234567899999999999 79999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHHhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEE
Q 003982 651 GSERLLVYEYMPRGTLAQHLFEWHDH-----------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNIL 719 (782)
Q Consensus 651 ~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIl 719 (782)
....+++|||+++|+|.+++...... ....+++.++..++.|+++||+|||+ .||+||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEE
Confidence 99999999999999999999764321 12347888999999999999999998 89999999999999
Q ss_pred ECCCCcEEEEeeccceecCCCCcee-eecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 720 IGDDMRAKVADFGLVKNAPDGKYSV-ETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 720 l~~~~~~kL~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+++++.+||+|||.++......... .....+++.|+|||++.+. .++.++||||+|++
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~ 228 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR---VYTHQSDVWSFGVL 228 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC---CCCchhhHHHHHHH
Confidence 9999999999999998765433221 1223456789999988664 45778999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-27 Score=243.74 Aligned_cols=187 Identities=31% Similarity=0.488 Sum_probs=155.4
Q ss_pred cCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEc
Q 003982 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 660 (782)
++|++.+.||+|++|.||+|....+..+|+|++.... ...+.+.+|++++++++||||+++++++. .+..+++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 5688899999999999999987777789999886543 23467889999999999999999998875 4568999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~ 740 (782)
+++++|.+++.... ...+++..+..++.|++.||+|||+ .|++||||||+||++++++.++|+|||.+......
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 82 MGKGSLLDFLKEGD---GKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred CCCCCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 99999999986522 2347899999999999999999998 89999999999999999999999999999876543
Q ss_pred CceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 741 KYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.........++..|+|||+..+. .++.++|+||+||+
T Consensus 156 ~~~~~~~~~~~~~y~~Pe~~~~~---~~~~~~Di~slG~~ 192 (260)
T cd05069 156 EYTARQGAKFPIKWTAPEAALYG---RFTIKSDVWSFGIL 192 (260)
T ss_pred cccccCCCccchhhCCHHHhccC---CcChHHHHHHHHHH
Confidence 32222223456789999987653 35678999999986
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=238.57 Aligned_cols=184 Identities=27% Similarity=0.393 Sum_probs=150.8
Q ss_pred HhcCCCcc-ceeecccceEEEEE-EeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEe----C
Q 003982 579 VTDNFSEA-NILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCIN----G 651 (782)
Q Consensus 579 ~~~~y~~~-~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~----~ 651 (782)
++++|.+. ++||-|-.|.|..+ +.++++.+|+|++... ...++|++.--+. .|||||+++++|+. .
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 45666664 67899999999999 6678999999988643 4678888876665 49999999998763 4
Q ss_pred CeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECC---CCcEEE
Q 003982 652 SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD---DMRAKV 728 (782)
Q Consensus 652 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~---~~~~kL 728 (782)
....+|||+|+||+|...+++. +.+.++++++..|++||+.|++|||+ .+|.||||||+|+|... +..+||
T Consensus 132 kcLLiVmE~meGGeLfsriq~~---g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKL 205 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDR---GDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKL 205 (400)
T ss_pred eeeEeeeecccchHHHHHHHHc---ccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEe
Confidence 5678999999999999999773 34679999999999999999999999 89999999999999964 457999
Q ss_pred EeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 729 ADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 729 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+|||+|+....... . ...+-||+|.|||++..+ .++..+|+||+||+
T Consensus 206 tDfGFAK~t~~~~~-L-~TPc~TPyYvaPevlg~e---KydkscdmwSlgVi 252 (400)
T KOG0604|consen 206 TDFGFAKETQEPGD-L-MTPCFTPYYVAPEVLGPE---KYDKSCDMWSLGVI 252 (400)
T ss_pred cccccccccCCCcc-c-cCCcccccccCHHHhCch---hcCCCCCccchhHH
Confidence 99999987654221 2 224679999999998876 45777788888886
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=258.78 Aligned_cols=193 Identities=27% Similarity=0.451 Sum_probs=156.7
Q ss_pred cCCCccceeecccceEEEEEEeC------CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC-CCCcceEEeEEEeCCe
Q 003982 581 DNFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSE 653 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~ 653 (782)
++|.+.+.||+|+||.||+|.+. .++.||+|+++... .....+.+.+|++++.++. ||||+++++++.+.+.
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 45777899999999999999643 34689999997643 2334457889999999997 9999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhhcc----------------------------------------------------------
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHD---------------------------------------------------------- 675 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 675 (782)
.++||||+++|+|.+++++...
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 9999999999999999975421
Q ss_pred -----------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE
Q 003982 676 -----------------------------------HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI 720 (782)
Q Consensus 676 -----------------------------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll 720 (782)
.....+++..+..++.|++.||+|||+ .+|+||||||+||++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEEE
Confidence 011246778889999999999999998 899999999999999
Q ss_pred CCCCcEEEEeeccceecCCCCc-eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 721 GDDMRAKVADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 721 ~~~~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
++++.+||+|||+++....... .......+++.|+|||++.+. ....++|+||+||+
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslGvi 330 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN---LYTTLSDVWSFGIL 330 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC---CCCcHhHHHHHHHH
Confidence 9999999999999986543221 112234568899999988654 34678999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-27 Score=246.76 Aligned_cols=188 Identities=31% Similarity=0.524 Sum_probs=154.9
Q ss_pred cCCCccceeecccceEEEEEEe-----CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC--Ce
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-----PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING--SE 653 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~--~~ 653 (782)
++|++.+.||+|+||.||+|.. .++..||+|++.... ....+.+.+|++++++++||||+++++++... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 5788999999999999999863 357899999987543 44567899999999999999999999987543 46
Q ss_pred EEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecc
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~ 733 (782)
.++||||+++++|.+++... ...+++..+..++.|++.||+|||+ .||+||||||+||++++++.+||+|||+
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~ 154 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKH----RERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGL 154 (284)
T ss_pred eEEEEEecCCCCHHHHHHhc----CcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcc
Confidence 78999999999999998652 2348899999999999999999998 8999999999999999999999999999
Q ss_pred ceecCCCCce--eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 734 VKNAPDGKYS--VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 734 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+......... ......++..|+|||+..+. .+..++|+||+||+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~ 200 (284)
T cd05081 155 TKVLPQDKEYYKVREPGESPIFWYAPESLTES---KFSVASDVWSFGVV 200 (284)
T ss_pred cccccCCCcceeecCCCCCceEeeCHHHhccC---CcChHHHHHHHHHH
Confidence 9876543221 11122234569999998764 35778999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=250.39 Aligned_cols=188 Identities=23% Similarity=0.367 Sum_probs=155.9
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
++|.+.+.||+|+||.||+|.. .+++.||+|.++.... ......+.+|++++++++||||+++++++..+...++|||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 5789999999999999999954 4688999999875432 2334567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|++ ++|.+++... ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++.....
T Consensus 85 ~~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 156 (301)
T cd07873 85 YLD-KDLKQYLDDC----GNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSI 156 (301)
T ss_pred ccc-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence 996 5898888652 2347899999999999999999998 8999999999999999999999999999876543
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... ......+++.|+|||++.+. .....++||||+||+
T Consensus 157 ~~~-~~~~~~~~~~y~~PE~~~~~--~~~~~~~Dv~slG~~ 194 (301)
T cd07873 157 PTK-TYSNEVVTLWYRPPDILLGS--TDYSTQIDMWGVGCI 194 (301)
T ss_pred CCC-cccccceeecccCcHHHhCC--CCCccHHHHHHHHHH
Confidence 221 11223568899999987653 234668999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=249.96 Aligned_cols=186 Identities=26% Similarity=0.445 Sum_probs=158.6
Q ss_pred hcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
..+|++.+.||+|++|.||+|. ..+++.||+|.+..... ...+.+.+|+++++.++||||+++++.+..+...++||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc--chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 3578999999999999999995 45789999999876542 33567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++++|.+++.+ ..+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||.+....
T Consensus 97 e~~~~~~L~~~~~~------~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~ 167 (296)
T cd06654 97 EYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (296)
T ss_pred cccCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence 99999999998854 347889999999999999999998 899999999999999999999999999987654
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.... ......|++.|+|||++.+. .+..++|+||+||+
T Consensus 168 ~~~~-~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~s~Gvi 205 (296)
T cd06654 168 PEQS-KRSTMVGTPYWMAPEVVTRK---AYGPKVDIWSLGIM 205 (296)
T ss_pred cccc-ccCcccCCccccCHHHHcCC---CCCccchHHHHHHH
Confidence 3221 11234688999999987764 35678999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-27 Score=249.02 Aligned_cols=186 Identities=26% Similarity=0.436 Sum_probs=159.6
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
.++|++.+.||+|++|.||+|.. .+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 46899999999999999999954 5789999999975442 33467889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++++|.+++.+ ..+++.++..++.|++.||.|||+ .|++||||||+||+++.++.+||+|||.+....
T Consensus 96 e~~~~~~L~~~~~~------~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~ 166 (297)
T cd06656 96 EYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (297)
T ss_pred cccCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence 99999999998854 347889999999999999999998 899999999999999999999999999987764
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..... .....+++.|+|||+..+. ..+.++|+||+||+
T Consensus 167 ~~~~~-~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slGvi 204 (297)
T cd06656 167 PEQSK-RSTMVGTPYWMAPEVVTRK---AYGPKVDIWSLGIM 204 (297)
T ss_pred CCccC-cCcccCCccccCHHHHcCC---CCCcHHHHHHHHHH
Confidence 43221 1234678999999988764 34678999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=246.18 Aligned_cols=192 Identities=25% Similarity=0.408 Sum_probs=161.5
Q ss_pred cCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
++|++.+.||+|++|.||+|. ..+++.||||.+..... .....+++.+|+++++.++||||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 468889999999999999995 45889999998875432 2335568899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++++|.+++...... ...+++..+..++.|++.|+.|||+ .|++|+||||+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQ-KRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCHHHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 999999999988754322 3468999999999999999999998 899999999999999999999999999987665
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..... .....|+..|+|||+..+. +.+.++|+||+|++
T Consensus 158 ~~~~~-~~~~~~~~~~~ape~~~~~---~~~~~~Dv~slG~i 195 (267)
T cd08229 158 SKTTA-AHSLVGTPYYMSPERIHEN---GYNFKSDIWSLGCL 195 (267)
T ss_pred cCCcc-cccccCCcCccCHHHhcCC---CccchhhHHHHHHH
Confidence 43221 1234688999999988654 45678999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-27 Score=244.32 Aligned_cols=189 Identities=27% Similarity=0.402 Sum_probs=155.5
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCC---hhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC--CeE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG---NKGLSEFQAEIAVLTKVRHRHLVALLGYCING--SER 654 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~--~~~ 654 (782)
.+|++.+.||+|+||.||+|.. .+++.||+|.+...... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4788999999999999999954 56899999988643211 23456789999999999999999999988764 467
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccc
Q 003982 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734 (782)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a 734 (782)
+++|||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||.+
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~ 153 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-----GALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGAS 153 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccc
Confidence 8999999999999988652 347888999999999999999998 89999999999999999999999999998
Q ss_pred eecCCCCc--eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 735 KNAPDGKY--SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 735 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
........ .......|+..|+|||++.+. ..+.++|+||+|++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~i 198 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGE---GYGRKADIWSVGCT 198 (265)
T ss_pred cccccccccccccccCCCCccccChhhhcCC---CCCcchhHHHHHHH
Confidence 76543211 111234588999999988764 34678999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=258.67 Aligned_cols=199 Identities=25% Similarity=0.385 Sum_probs=167.8
Q ss_pred HHHHHHHhcCCCccceeecccceEEEEE-EeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC-CCCcceEEeEEEe
Q 003982 573 IEVLRQVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCIN 650 (782)
Q Consensus 573 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~ 650 (782)
++.+..-++.|++.++||.|.+|.||++ ...+++..|+|+..... ...++++.|.++++... |||++.++++|..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 3444445677889999999999999999 45678999999887654 44567888999999874 9999999999874
Q ss_pred -----CCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCc
Q 003982 651 -----GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR 725 (782)
Q Consensus 651 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~ 725 (782)
+++.|+|||||.+||..++++... ...+.|..+..|++.++.|+.+||. ..++|||||-.|||++.++.
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~ 161 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAE 161 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCc
Confidence 468899999999999999998865 3568999999999999999999998 89999999999999999999
Q ss_pred EEEEeeccceecCCCCceeeecccccccccCccccccc--hhhhHHHHHHHHHhcccC
Q 003982 726 AKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKH--WMILCQMTGLIWLHGSVG 781 (782)
Q Consensus 726 ~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~dvws~Gvv~ 781 (782)
|||+|||.+...+.... .....+|||+|||||++.-. ....++..+|+||+||.|
T Consensus 162 VKLvDFGvSaQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITa 218 (953)
T KOG0587|consen 162 VKLVDFGVSAQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITA 218 (953)
T ss_pred EEEeeeeeeeeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhcccee
Confidence 99999999998876443 33446899999999987533 334578889999999976
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=250.01 Aligned_cols=194 Identities=30% Similarity=0.501 Sum_probs=158.7
Q ss_pred hcCCCccceeecccceEEEEEEeC------CCcEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCC
Q 003982 580 TDNFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGS 652 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~ 652 (782)
.++|++.+.||+|+||.||++... ....+|+|++.... ......++.+|+++++++ +|+||+++++++..++
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 456888999999999999999653 23679999987543 234556789999999999 7999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHHhhcc-----------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEC
Q 003982 653 ERLLVYEYMPRGTLAQHLFEWHD-----------HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIG 721 (782)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~ 721 (782)
..+++|||+++|+|.+++..... .....+++..++.++.|++.||+|||+ .||+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEc
Confidence 99999999999999999875321 123468999999999999999999998 8999999999999999
Q ss_pred CCCcEEEEeeccceecCCCCcee-eecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 722 DDMRAKVADFGLVKNAPDGKYSV-ETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 722 ~~~~~kL~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+++.+||+|||.++......... .....++..|+|||+..+. .++.++|+||+||+
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 223 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR---VYTHQSDVWSFGVL 223 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccC---CcCcccceeehhhH
Confidence 99999999999998765433221 1222346789999987654 45677899999976
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-27 Score=245.41 Aligned_cols=192 Identities=30% Similarity=0.496 Sum_probs=155.6
Q ss_pred CCccceeecccceEEEEEEeC-C---CcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCe-----
Q 003982 583 FSEANILGRGGFGVVYGGELP-D---GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE----- 653 (782)
Q Consensus 583 y~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~----- 653 (782)
|.+.+.||+|+||.||+|... + +..||+|+++...........+.+|++.++.++||||+++++++.+...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567899999999999999643 2 3679999998655445566789999999999999999999998876554
Q ss_pred -EEEEEEccCCCCHHHHHHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEee
Q 003982 654 -RLLVYEYMPRGTLAQHLFEWHDH-GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADF 731 (782)
Q Consensus 654 -~~lv~e~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~Df 731 (782)
.+++|||+++++|.+++...... ....+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence 79999999999999998654322 22358999999999999999999998 89999999999999999999999999
Q ss_pred ccceecCCCCceee-ecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 732 GLVKNAPDGKYSVE-TRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 732 G~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|+++.......... ....++..|+|||++.+. ..+.++|+||+|++
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~---~~~~~~Dv~SlG~i 204 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR---VYTSKSDVWAFGVT 204 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccC---CCCcccchHHHHHH
Confidence 99987654432211 122346789999987654 34667888888876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-27 Score=247.99 Aligned_cols=192 Identities=30% Similarity=0.512 Sum_probs=158.5
Q ss_pred cCCCccceeecccceEEEEEEe------CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSER 654 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~ 654 (782)
++|.+.+.||+|+||.||+|.. .++..+++|.+.... ....+.+.+|++++++++||||+++++++...+..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 4678889999999999999953 234568999886543 34457799999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhhcc-----------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCC
Q 003982 655 LLVYEYMPRGTLAQHLFEWHD-----------HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD 723 (782)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~ 723 (782)
++||||+++++|.+++..... .....+++..++.++.|++.|++|||+ +||+||||||+||+++++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGAN 159 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccC
Confidence 999999999999999975321 112347899999999999999999998 899999999999999999
Q ss_pred CcEEEEeeccceecCCCCc-eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 724 MRAKVADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 724 ~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+.+||+|||++........ .......++..|+|||++.+. .+..++|+||+|++
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 214 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR---KFTTESDVWSFGVI 214 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccC---CCCchhhHHHHHHH
Confidence 9999999999976544332 122334568899999987764 45678999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-27 Score=247.45 Aligned_cols=188 Identities=27% Similarity=0.511 Sum_probs=155.9
Q ss_pred CCCccceeecccceEEEEEEe-----CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC--CeE
Q 003982 582 NFSEANILGRGGFGVVYGGEL-----PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING--SER 654 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~--~~~ 654 (782)
.|.+.+.||+|+||.||.|.. .++..||+|.++... .......+.+|++++++++||||+++++++.+. ...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 468899999999999999963 357889999987543 234457899999999999999999999998875 568
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccc
Q 003982 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734 (782)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a 734 (782)
++||||+++++|.+++.+. ...+++.++..++.|++.||+|||+ .|++||||||+||+++.++.+||+|||++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN----KNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred EEEEEccCCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCccc
Confidence 9999999999999998652 2357999999999999999999998 89999999999999999999999999999
Q ss_pred eecCCCCc--eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 735 KNAPDGKY--SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 735 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+....... .......++..|+|||+..+. .++.++|+||+|++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~---~~~~~~Di~slG~i 201 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQS---KFYIASDVWSFGVT 201 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccC---CCCccccchhhhhh
Confidence 87654321 112234567789999987664 35678999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-27 Score=247.21 Aligned_cols=189 Identities=24% Similarity=0.321 Sum_probs=157.5
Q ss_pred cCCCccceeecccceEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
++|+..+.||+|++|.||+|... +++.||+|++..........+.+.+|++++++++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46889999999999999999654 68999999987554333345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|++++.+..+... ...+++..+..++.|++.||+|||+ .|++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07847 81 YCDHTVLNELEKN-----PRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTG 152 (286)
T ss_pred ccCccHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCC
Confidence 9998888776543 2358999999999999999999998 8999999999999999999999999999987654
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... ......++..|+|||++.+. .....++|+||+||+
T Consensus 153 ~~~-~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~i 190 (286)
T cd07847 153 PGD-DYTDYVATRWYRAPELLVGD--TQYGPPVDVWAIGCV 190 (286)
T ss_pred Ccc-cccCcccccccCCHHHHhCC--CCcCchhhhHHHHHH
Confidence 331 11223578899999987653 124568999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-27 Score=244.24 Aligned_cols=189 Identities=26% Similarity=0.421 Sum_probs=156.5
Q ss_pred cCCCccceeecccceEEEEEEeC-C---CcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGELP-D---GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 656 (782)
.+|++.+.||+|+||.||+|... + +..+|+|.++... .....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 56888999999999999999643 2 3479999987543 23456789999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecccee
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~ 736 (782)
||||+++++|.+++... ...+++.++..++.|++.|++|||+ .|++||||||+||+++.++.+||+|||.+..
T Consensus 83 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 83 VTEYMENGSLDAFLRKH----DGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred EEEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 99999999999998652 2357999999999999999999998 8999999999999999999999999999987
Q ss_pred cCCCCceee--ecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 737 APDGKYSVE--TRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 737 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
......... ....++..|+|||++.+. ..+.++|+||+|++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~---~~~~~~Dv~slG~~ 198 (267)
T cd05066 156 LEDDPEAAYTTRGGKIPIRWTAPEAIAYR---KFTSASDVWSYGIV 198 (267)
T ss_pred cccccceeeecCCCccceeecCHhHhccC---ccCchhhhHHHHHH
Confidence 654322111 112235689999998764 45778999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-27 Score=241.65 Aligned_cols=189 Identities=22% Similarity=0.361 Sum_probs=158.5
Q ss_pred CCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEe-CCeEEEEEE
Q 003982 582 NFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN-GSERLLVYE 659 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~-~~~~~lv~e 659 (782)
+|++.+.||+|++|.||++. ..+++.||+|++..........+.+.+|++++++++|+|++++++.+.. ....+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 58899999999999999995 4467899999997655445566788999999999999999999988764 446789999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++++|.+++.... ...+++.++..++.|++.|++|||+ .|++||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~l~~~~---~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 81 FCEGGDLYHKLKEQK---GKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred ccCCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 999999999987532 2358999999999999999999998 8999999999999999999999999999987643
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... ......|++.|+|||+..+. .+..++|+||+|++
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~i 191 (257)
T cd08223 155 QCD-MASTLIGTPYYMSPELFSNK---PYNYKSDVWALGCC 191 (257)
T ss_pred cCC-ccccccCCcCccChhHhcCC---CCCchhhhHHHHHH
Confidence 221 22234688999999987764 34678999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-27 Score=247.35 Aligned_cols=192 Identities=27% Similarity=0.460 Sum_probs=156.6
Q ss_pred CCCccceeecccceEEEEEEeC------CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEE
Q 003982 582 NFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL 655 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~ 655 (782)
+|++.+.||+|+||.||+|... ....+|+|.+.... ......++.+|+.++++++||||+++++.+...+..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 4788899999999999999542 23578888886543 2344578999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhhcc-------------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCC
Q 003982 656 LVYEYMPRGTLAQHLFEWHD-------------------HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPS 716 (782)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~ 716 (782)
++|||+++++|.+++...+. .....+++..+..++.|++.||+|||+ .|++||||||+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~ 156 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAAR 156 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhh
Confidence 99999999999999875321 112457899999999999999999998 89999999999
Q ss_pred CEEECCCCcEEEEeeccceecCCCCc-eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 717 NILIGDDMRAKVADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 717 NIll~~~~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
||++++++.+||+|||+++....... .......++..|+|||+..+. .++.++||||+|++
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~---~~~~~~Di~slG~~ 218 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH---IYTTQSDVWSFGVL 218 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC---CcchHhHHHHHHHH
Confidence 99999999999999999976543221 111223456789999987654 46788999999986
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-27 Score=243.67 Aligned_cols=189 Identities=25% Similarity=0.449 Sum_probs=158.0
Q ss_pred HhcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
..++|++.+.||+|+||.||+|...++..+|+|.+.... ...+.+.+|++++++++|+||+++++++.+ ...+++|
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 356899999999999999999987778889999887542 345678999999999999999999999887 7789999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++++|.+++.... ...+++.++..++.|++.||+|||+ .|++||||||+||+++.++.+||+|||.+....
T Consensus 80 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 80 EFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIE 153 (260)
T ss_pred EeCCCCcHHHHHHhCC---ccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeecc
Confidence 9999999999986521 2357888999999999999999998 899999999999999999999999999998765
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
...........++..|+|||++... .++.++|+||+||+
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~---~~~~~~Di~slG~~ 192 (260)
T cd05073 154 DNEYTAREGAKFPIKWTAPEAINFG---SFTIKSDVWSFGIL 192 (260)
T ss_pred CCCcccccCCcccccccCHhHhccC---CcCccccchHHHHH
Confidence 4333222223456789999988654 34667889998875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-27 Score=242.26 Aligned_cols=187 Identities=29% Similarity=0.497 Sum_probs=158.0
Q ss_pred cCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEc
Q 003982 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 660 (782)
.+|++.+.||+|++|.||+|.+.++..+|+|++..... ....+.+|++++++++||||+++++++......+++|||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM---SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC---CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 46788899999999999999877788999999875442 345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~ 740 (782)
+++++|.+++... ...+++..+..++.|++.|++|||+ .+++||||||+||+++.++.+||+|||.+......
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 81 MEHGCLSDYLRAQ----RGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153 (256)
T ss_pred CCCCcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccC
Confidence 9999999988642 2357899999999999999999998 89999999999999999999999999999866543
Q ss_pred CceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 741 KYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.........++..|+|||+..+. .+..++|+||+|++
T Consensus 154 ~~~~~~~~~~~~~~~aPe~~~~~---~~~~~~Dv~slG~~ 190 (256)
T cd05112 154 QYTSSTGTKFPVKWSSPEVFSFS---KYSSKSDVWSFGVL 190 (256)
T ss_pred cccccCCCccchhhcCHhHhccC---CcChHHHHHHHHHH
Confidence 33222223456789999988754 35678999999975
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-27 Score=243.00 Aligned_cols=188 Identities=27% Similarity=0.493 Sum_probs=158.6
Q ss_pred CCCccceeecccceEEEEEEeCCCcEEEEEEeccccCC----hhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 582 NFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMG----NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
+|++.+.||+|+||.||+|...+++.+|+|.++..... ....+.+.+|++++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 47889999999999999998778999999998754321 22346688999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
|||+++++|.+++.+. .++++..+..++.|++.|++|||+ .+|+|+||+|+||++++++.+||+|||++...
T Consensus 81 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 81 MEFVPGGSISSILNRF-----GPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 9999999999998652 357889999999999999999998 89999999999999999999999999998764
Q ss_pred CCCC-----ceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 738 PDGK-----YSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 738 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.... ........|+..|+|||+..+. .+..++|+||+|++
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~---~~~~~~Dv~slG~~ 197 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINES---GYGRKSDIWSIGCT 197 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCC---CCcchhhHHHHHHH
Confidence 3211 1111234688999999998765 45678999999986
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-27 Score=250.24 Aligned_cols=193 Identities=32% Similarity=0.501 Sum_probs=157.3
Q ss_pred cCCCccceeecccceEEEEEEeC--------CCcEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeC
Q 003982 581 DNFSEANILGRGGFGVVYGGELP--------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCING 651 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~ 651 (782)
++|.+.+.||+|+||.||+|... +...+|+|.++... ......++.+|+++++++ +||||+++++++...
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 57899999999999999999542 23579999997543 234556788999999999 799999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHHhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE
Q 003982 652 SERLLVYEYMPRGTLAQHLFEWHDH-----------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI 720 (782)
Q Consensus 652 ~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll 720 (782)
+..++||||+++|+|.+++...... ....+++.++..++.|++.||+|||+ .|++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEE
Confidence 9999999999999999999764321 12348899999999999999999998 899999999999999
Q ss_pred CCCCcEEEEeeccceecCCCCcee-eecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 721 GDDMRAKVADFGLVKNAPDGKYSV-ETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 721 ~~~~~~kL~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+.++.+||+|||.++......... .....+++.|+|||++.+. .++.++|+||+||+
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~~ 231 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR---IYTHQSDVWSFGVL 231 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccC---CCCcHHHHHHHHHH
Confidence 999999999999987664322111 1112345689999988764 35678999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=248.34 Aligned_cols=200 Identities=23% Similarity=0.331 Sum_probs=161.4
Q ss_pred HHHHHHHhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEE-
Q 003982 573 IEVLRQVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCI- 649 (782)
Q Consensus 573 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~- 649 (782)
.+.+....++|++.+.||+|+||.||+|.. .+++.+|+|++.... .....+.+|+.+++++ +||||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 344555678999999999999999999954 568899999886532 2335688899999999 6999999999874
Q ss_pred ----eCCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCc
Q 003982 650 ----NGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR 725 (782)
Q Consensus 650 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~ 725 (782)
.+...++||||+++++|.+++...... ...+++..+..++.|++.|+.|||+ .+++||||||+||++++++.
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~ 162 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKR-GERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGG 162 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhcc-CccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCC
Confidence 345689999999999999988654322 3457899999999999999999998 89999999999999999999
Q ss_pred EEEEeeccceecCCCCceeeecccccccccCccccccch--hhhHHHHHHHHHhccc
Q 003982 726 AKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHW--MILCQMTGLIWLHGSV 780 (782)
Q Consensus 726 ~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~dvws~Gvv 780 (782)
+||+|||++......... .....|++.|+|||++.... ...++.++|+||+||+
T Consensus 163 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi 218 (286)
T cd06638 163 VKLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGIT 218 (286)
T ss_pred EEEccCCceeecccCCCc-cccccCCCcccChhhhchhhhccccccchhhhhhHHHH
Confidence 999999999876543221 22346899999999875421 1235778999999986
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=249.99 Aligned_cols=188 Identities=23% Similarity=0.353 Sum_probs=156.2
Q ss_pred CCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEc
Q 003982 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 660 (782)
+|++.+.||+|++|.||+|.. .+|+.||+|+++...........+.+|++++++++||||+++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 488899999999999999955 5789999999976543334446788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~ 740 (782)
++ +++.+++... ...+++..+..++.|+++||.|||+ .||+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 152 (284)
T cd07839 81 CD-QDLKKYFDSC----NGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 152 (284)
T ss_pred CC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence 96 5888877542 2458999999999999999999998 89999999999999999999999999999865432
Q ss_pred CceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 741 KYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.. ......+++.|+|||++.+. ...+.++|+||+||+
T Consensus 153 ~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~i 189 (284)
T cd07839 153 VR-CYSAEVVTLWYRPPDVLFGA--KLYSTSIDMWSAGCI 189 (284)
T ss_pred CC-CcCCCccccCCcChHHHhCC--cccCcHHHHHHHHHH
Confidence 21 11233578899999987653 124668999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.4e-27 Score=245.09 Aligned_cols=192 Identities=32% Similarity=0.512 Sum_probs=158.6
Q ss_pred cCCCccceeecccceEEEEEEe------CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSER 654 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~ 654 (782)
.+|...+.||+|+||.||++.. .++..+|+|.+.... ....+.+.+|++++++++|+||+++++++.+....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC--HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 5677889999999999999953 245689999886543 45567899999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhhccC----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCC
Q 003982 655 LLVYEYMPRGTLAQHLFEWHDH----------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM 724 (782)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~ 724 (782)
+++|||+++++|.+++...... ....+++..+..++.|++.|++|||+ .|++||||||+||++++++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCC
Confidence 9999999999999998753210 11347899999999999999999998 8999999999999999999
Q ss_pred cEEEEeeccceecCCCCce-eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 725 RAKVADFGLVKNAPDGKYS-VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 725 ~~kL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.+||+|||++......... ......+++.|+|||++.+. .++.++|+|||||+
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 213 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR---KFTTESDIWSFGVV 213 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccC---CcCchhhHHHHHHH
Confidence 9999999999765433321 12223457889999988765 46788999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-27 Score=247.81 Aligned_cols=190 Identities=25% Similarity=0.351 Sum_probs=159.7
Q ss_pred cCCCccceeecccceEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
++|++.+.||+|++|.||+|... +++.||+|+++.........+.+.+|++++++++|+||+++++++.+++..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999654 68899999987654444456789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|++++.+..+... ...+++.++..++.|++.|++|||+ .|++||||+|+||++++++.+||+|||.+.....
T Consensus 81 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 81 YVERTLLELLEAS-----PGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRA 152 (288)
T ss_pred cCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence 9988666554432 2348999999999999999999998 8999999999999999999999999999887655
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..........++..|+|||++.+. ..++.++|+||+|++
T Consensus 153 ~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~~Dv~slG~~ 191 (288)
T cd07833 153 RPASPLTDYVATRWYRAPELLVGD--TNYGKPVDVWAIGCI 191 (288)
T ss_pred CccccccCcccccCCcCCchhcCC--CCcCchhhHHHHHHH
Confidence 432122335678999999998764 246788999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-27 Score=246.80 Aligned_cols=194 Identities=28% Similarity=0.520 Sum_probs=159.0
Q ss_pred hcCCCccceeecccceEEEEEEeC------CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCe
Q 003982 580 TDNFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE 653 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~ 653 (782)
.++|.+.+.||+|+||.||+|... ++..||+|.+.... .......+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 357889999999999999999543 34689999986543 23345678899999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhhccC-----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEE
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHDH-----GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKV 728 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL 728 (782)
.++||||+++++|.+++...... ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEE
Confidence 99999999999999999764321 12347888999999999999999998 89999999999999999999999
Q ss_pred EeeccceecCCCCc-eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 729 ADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 729 ~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+|||+++....... .......++..|+|||++.+. ..+.++|+||+|++
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 210 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG---VFTTKSDVWSFGVV 210 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcC---CCCcccchHHHHHH
Confidence 99999876544332 122234567899999987654 35678899999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-27 Score=248.92 Aligned_cols=189 Identities=25% Similarity=0.377 Sum_probs=158.4
Q ss_pred cCCCccceeecccceEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
++|++.+.||+|++|.||+|... +++.||+|++..........+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46889999999999999999664 58999999987654333345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|++++++.++... ...+++.++..++.|++.||+|||+ .|++||||+|+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 81 FVDHTVLDDLEKY-----PNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred cCCccHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 9999888776543 2348999999999999999999998 8999999999999999999999999999887644
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... ......++..|+|||+..+. .....++|+||+|++
T Consensus 153 ~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~~ 190 (286)
T cd07846 153 PGE-VYTDYVATRWYRAPELLVGD--TKYGRAVDIWAVGCL 190 (286)
T ss_pred Ccc-ccCcccceeeccCcHHhccc--cccCchHhHHHHHHH
Confidence 321 22234578899999987653 234568999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=240.69 Aligned_cols=181 Identities=27% Similarity=0.401 Sum_probs=149.4
Q ss_pred eeecccceEEEEEEe---CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEccCCC
Q 003982 588 ILGRGGFGVVYGGEL---PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRG 664 (782)
Q Consensus 588 ~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~g 664 (782)
.||+|+||.||+|.+ .++..+|+|+++.........+++.+|+.++++++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999954 35788999998765444445678999999999999999999999875 45678999999999
Q ss_pred CHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCcee
Q 003982 665 TLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSV 744 (782)
Q Consensus 665 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~~ 744 (782)
+|.+++.. ...+++..+..++.|++.|++|||+ +||+||||||+||++++++.+||+|||++..........
T Consensus 81 ~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~ 152 (257)
T cd05116 81 PLNKFLQK-----NKHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY 152 (257)
T ss_pred cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence 99999864 2358899999999999999999998 899999999999999999999999999998765433211
Q ss_pred --eecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 745 --ETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 745 --~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.....++..|+|||++... ....++|+||+|++
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~ 187 (257)
T cd05116 153 KAKTHGKWPVKWYAPECMNYY---KFSSKSDVWSFGVL 187 (257)
T ss_pred eecCCCCCCccccCHhHhccC---CcCchhHHHHHHHH
Confidence 1222346789999987653 45678999999976
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.3e-27 Score=248.93 Aligned_cols=191 Identities=26% Similarity=0.345 Sum_probs=160.2
Q ss_pred cCCCccceeecccceEEEEEEeC-CCcEEEEEEeccccCCh-hhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGN-KGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
++|+..+.||+|++|.||+|... +++.||+|.+....... ...+.+.+|++++++++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 46889999999999999999654 58999999998765432 35677899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++++|.+++.... ...+++..+..++.|++.||+|||+ .|++||||||+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 81 DYCPGGELFRLLQRQP---GKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EecCCCCHHHHHHhCC---CCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 9999999999886422 2458999999999999999999998 899999999999999999999999999987543
Q ss_pred CCCce----------------------------eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYS----------------------------VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..... ......||..|+|||++.+. ..+.++|+||+|++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~Di~slG~l 221 (316)
T cd05574 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD---GHGSAVDWWTLGIL 221 (316)
T ss_pred ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC---CCCchHHHHHHHHH
Confidence 22110 01123688999999998765 35778999999986
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-27 Score=249.81 Aligned_cols=191 Identities=31% Similarity=0.513 Sum_probs=153.6
Q ss_pred cCCCccceeecccceEEEEEEeC-CCc--EEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCCeEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGELP-DGT--KIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLL 656 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~l 656 (782)
++|++.+.||+|+||.||+|... ++. .+|+|.++... .....+.+.+|++++.++ +||||+++++++.+.+..++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC-CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 57888999999999999999653 454 45777765432 234557789999999999 89999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCc
Q 003982 657 VYEYMPRGTLAQHLFEWHDH-----------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR 725 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~ 725 (782)
||||+++++|.+++...... ....+++.+++.++.|++.|++|||+ .|++||||||+||++++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCc
Confidence 99999999999999764311 12357899999999999999999998 89999999999999999999
Q ss_pred EEEEeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 726 AKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 726 ~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+||+|||++....... ......++..|+|||+..+. ..+.++||||+||+
T Consensus 163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 212 (303)
T cd05088 163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYS---VYTTNSDVWSYGVL 212 (303)
T ss_pred EEeCccccCcccchhh--hcccCCCcccccCHHHHhcc---CCcccccchhhhhH
Confidence 9999999986432211 11112346679999987664 34678999999986
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.7e-27 Score=244.78 Aligned_cols=188 Identities=24% Similarity=0.415 Sum_probs=151.9
Q ss_pred cCCCccceeecccceEEEEEEeC-CCc----EEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEE
Q 003982 581 DNFSEANILGRGGFGVVYGGELP-DGT----KIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL 655 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~ 655 (782)
++|++.+.||+|+||+||+|.+. +++ .+++|.+.... ......++..|+..+++++||||+++++++. ....+
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~ 84 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQ 84 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc-chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccE
Confidence 46788999999999999999653 444 47778775322 2334567888999999999999999999875 45578
Q ss_pred EEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccce
Q 003982 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (782)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~ 735 (782)
+++||+++|+|.+++... ...+++..+..++.|++.||+|||+ .|++||||||+||++++++.+||+|||.++
T Consensus 85 ~i~e~~~~gsL~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~ 157 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQH----RDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVAD 157 (279)
T ss_pred EEEEeCCCCcHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccce
Confidence 999999999999999653 2358999999999999999999998 899999999999999999999999999998
Q ss_pred ecCCCCce-eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 736 NAPDGKYS-VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 736 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
........ ......++..|+|||++.+. ..+.++|+||||++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~---~~~~~~Dv~slG~i 200 (279)
T cd05111 158 LLYPDDKKYFYSEHKTPIKWMALESILFG---RYTHQSDVWSYGVT 200 (279)
T ss_pred eccCCCcccccCCCCCcccccCHHHhccC---CcCchhhHHHHHHH
Confidence 76433221 11233567789999988654 34678999999986
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=245.42 Aligned_cols=191 Identities=28% Similarity=0.403 Sum_probs=158.5
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
.+.|++.+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+++++.++||||+++++++..++..++||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 36788999999999999999965 458899999987543 445678899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||++++++..++.+. ...+++..+..++.|++.|++|||+ .|++||||||+||+++.++.+||+|||++....
T Consensus 89 e~~~~~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 161 (292)
T cd06644 89 EFCPGGAVDAIMLEL----DRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNV 161 (292)
T ss_pred ecCCCCcHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceecc
Confidence 999999998877542 2358999999999999999999998 899999999999999999999999999987643
Q ss_pred CCCceeeecccccccccCccccccc--hhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKH--WMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~dvws~Gvv 780 (782)
.... ......+++.|+|||++.+. -...++.++|+||+||+
T Consensus 162 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~i 204 (292)
T cd06644 162 KTLQ-RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGIT 204 (292)
T ss_pred cccc-ccceecCCccccCceeeccccccCCCCCchhhhHhHHHH
Confidence 3221 11234578999999987531 01234667899999986
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.4e-27 Score=247.00 Aligned_cols=185 Identities=25% Similarity=0.459 Sum_probs=158.7
Q ss_pred cCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
++|++.+.||.|++|.||+|. ..+++.||+|.+.... ....+.+.+|+++++.++||||+++++++...+..++|+|
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK--QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc--CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 468999999999999999995 4678999999987543 2345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++++|.+++.. ..+++.++..++.|++.|++|||+ .|++||||||+||+++.++.+||+|||++.....
T Consensus 97 ~~~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 97 YLAGGSLTDVVTE------TCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred ecCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 9999999998854 347999999999999999999998 8999999999999999999999999999876544
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.... .....|++.|+|||++.+. +...++|+||+||+
T Consensus 168 ~~~~-~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slGvi 204 (296)
T cd06655 168 EQSK-RSTMVGTPYWMAPEVVTRK---AYGPKVDIWSLGIM 204 (296)
T ss_pred cccc-CCCcCCCccccCcchhcCC---CCCchhhHHHHHHH
Confidence 3221 1234688999999987754 34678999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-27 Score=246.32 Aligned_cols=192 Identities=28% Similarity=0.402 Sum_probs=154.0
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHH-HHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAV-LTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
++|++.+.||+|+||.||+|.. .+|+.||+|+++...... ...++..|+.. ++..+||||+++++++..++..+++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH-HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 4688999999999999999955 478999999997654322 33455556665 56678999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ-SFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~-~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
||++ ++|.+++...... ...+++..+..++.|++.|++|||+ + +++||||||+||+++.++.+||+|||.+...
T Consensus 80 e~~~-~~l~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDK-GLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL 154 (283)
T ss_pred hhhc-ccHHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 9996 6898888764433 2568999999999999999999998 5 9999999999999999999999999998866
Q ss_pred CCCCceeeecccccccccCccccccchh-hhHHHHHHHHHhccc
Q 003982 738 PDGKYSVETRLAGTFGYLAPEYAGKHWM-ILCQMTGLIWLHGSV 780 (782)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~dvws~Gvv 780 (782)
..... .....|+..|+|||++.+... .+++.++|+||+|++
T Consensus 155 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~ 196 (283)
T cd06617 155 VDSVA--KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGIT 196 (283)
T ss_pred ccccc--cccccCCccccChhhcCCcccccccCccccchhhHHH
Confidence 43221 122467889999998764211 245667899999976
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.5e-27 Score=244.15 Aligned_cols=189 Identities=27% Similarity=0.425 Sum_probs=153.6
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCc----EEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGT----KIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSER 654 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~ 654 (782)
.++|++.+.||+|+||+||+|.+ .+++ .||+|+++... .....+++.+|+.+++.++||||+++++++.. ...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~ 83 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STV 83 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCc
Confidence 35688899999999999999964 3444 48999986543 23456778999999999999999999999875 457
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccc
Q 003982 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734 (782)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a 734 (782)
++++||+++|+|.+++.+. ...+++.++..++.|++.||+|||+ .||+||||||+||++++++.+||+|||++
T Consensus 84 ~l~~~~~~~g~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~ 156 (279)
T cd05109 84 QLVTQLMPYGCLLDYVREN----KDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLA 156 (279)
T ss_pred EEEEEcCCCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCce
Confidence 8999999999999998652 2358999999999999999999998 89999999999999999999999999999
Q ss_pred eecCCCCcee-eecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 735 KNAPDGKYSV-ETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 735 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+......... .....+++.|+|||+..+. ..+.++||||+|++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~---~~~~~~Di~slG~~ 200 (279)
T cd05109 157 RLLDIDETEYHADGGKVPIKWMALESILHR---RFTHQSDVWSYGVT 200 (279)
T ss_pred eecccccceeecCCCccchhhCCHHHhccC---CCCchhHHHHHHHH
Confidence 8765432211 1122346789999987654 45678899999875
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6e-27 Score=253.03 Aligned_cols=194 Identities=25% Similarity=0.432 Sum_probs=154.3
Q ss_pred hcCCCccceeecccceEEEEEEe------CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeC-
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCING- 651 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~- 651 (782)
.++|++.+.||+|+||.||+|.. .+++.||||+++... .......+.+|++++.++ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 35799999999999999999953 357789999997543 234456788999999999 689999999988654
Q ss_pred CeEEEEEEccCCCCHHHHHHhhccC-------------------------------------------------------
Q 003982 652 SERLLVYEYMPRGTLAQHLFEWHDH------------------------------------------------------- 676 (782)
Q Consensus 652 ~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------- 676 (782)
...+++|||+++|+|.+++......
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 4678999999999999998653210
Q ss_pred -------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCc-eeeecc
Q 003982 677 -------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY-SVETRL 748 (782)
Q Consensus 677 -------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~-~~~~~~ 748 (782)
....+++..+..++.|+++||+|||+ .||+||||||+||+++.++.+||+|||++........ ......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 01236788889999999999999998 8999999999999999999999999999876543221 111222
Q ss_pred cccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 749 AGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 749 ~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.+++.|+|||++.+. .++.++|+||+|++
T Consensus 242 ~~~~~y~aPE~~~~~---~~~~~~Di~slG~~ 270 (343)
T cd05103 242 RLPLKWMAPETIFDR---VYTIQSDVWSFGVL 270 (343)
T ss_pred CCCcceECcHHhcCC---CCCchhhHHHHHHH
Confidence 356789999987654 45678999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-27 Score=246.90 Aligned_cols=190 Identities=27% Similarity=0.389 Sum_probs=158.8
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
++|++.+.||+|++|.||+|.. .++..||+|++.... ....+.+.+|++++++++||||+++++++.++...++|||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES--EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC--HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 5688899999999999999965 468899999987543 4456789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++++|.+++... ...+++.++..++.|++.|+.|||+ .||+||||||+||+++.++.++|+|||.+.....
T Consensus 83 ~~~~~~L~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~ 155 (280)
T cd06611 83 FCDGGALDSIMLEL----ERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS 155 (280)
T ss_pred ccCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence 99999999988653 2358999999999999999999998 8999999999999999999999999999876543
Q ss_pred CCceeeecccccccccCccccccch--hhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHW--MILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~dvws~Gvv 780 (782)
... ......|++.|+|||++...- ...++.++|+||+|++
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~i 197 (280)
T cd06611 156 TLQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGIT 197 (280)
T ss_pred ccc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHH
Confidence 221 122346899999999864221 1234667899999976
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.6e-27 Score=248.95 Aligned_cols=185 Identities=26% Similarity=0.364 Sum_probs=146.6
Q ss_pred cceeecccceEEEEEEeC---CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEe--CCeEEEEEEc
Q 003982 586 ANILGRGGFGVVYGGELP---DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN--GSERLLVYEY 660 (782)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~--~~~~~lv~e~ 660 (782)
..+||+|+||.||+|... ++..||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 467999999999999754 45789999987543 23467889999999999999999998854 4677999999
Q ss_pred cCCCCHHHHHHhhcc----CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE----CCCCcEEEEeec
Q 003982 661 MPRGTLAQHLFEWHD----HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI----GDDMRAKVADFG 732 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll----~~~~~~kL~DfG 732 (782)
++ +++.+++..... .....+++..+..++.|++.||+|||+ .||+||||||+||++ +.++.+||+|||
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 95 578887754221 112358899999999999999999998 899999999999999 456789999999
Q ss_pred cceecCCCCce--eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 733 LVKNAPDGKYS--VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 733 ~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+++........ ......||+.|+|||++.+. ..++.++||||+||+
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlG~i 205 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGA--RHYTKAIDIWAIGCI 205 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCC--CccCcHHHHHhHHHH
Confidence 99876543221 12334689999999988653 234678999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=241.82 Aligned_cols=188 Identities=29% Similarity=0.523 Sum_probs=156.8
Q ss_pred CCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCCh-------hhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCe
Q 003982 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGN-------KGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE 653 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~ 653 (782)
+|.+.+.||+|++|.||+|.. .+++.||+|.+....... ...+.+++|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 477889999999999999954 568899999887543221 133568899999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecc
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~ 733 (782)
.+++|||+++++|.+++.. ...+++..+..++.|++.|++|||+ .|++||||+|+||++++++.+||+|||.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~ 152 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN-----YGAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGI 152 (267)
T ss_pred cEEEEEecCCCCHHHHHHh-----ccCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCC
Confidence 9999999999999999965 2457889999999999999999998 8999999999999999999999999999
Q ss_pred ceecCCCCce-----eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 734 VKNAPDGKYS-----VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 734 a~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
++........ ......|+..|+|||++.+. ..+.++|+||+|++
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~---~~~~~~Dv~slG~i 201 (267)
T cd06628 153 SKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT---SYTRKADIWSLGCL 201 (267)
T ss_pred CcccccccccCCccccccccCCCcCccChhHhccC---CCCchhhhHHHHHH
Confidence 8876532111 11124578899999988764 34677899999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.1e-27 Score=244.00 Aligned_cols=194 Identities=29% Similarity=0.456 Sum_probs=157.0
Q ss_pred hcCCCccceeecccceEEEEEEeC------CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCe
Q 003982 580 TDNFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE 653 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~ 653 (782)
.++|.+.+.||+|++|.||+|... .+..||+|.+.... .......+.+|+.++++++|+||+++++++.+...
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 456889999999999999999654 35679999886433 23345678999999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhhccC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCC---cEEE
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHDH--GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM---RAKV 728 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~---~~kL 728 (782)
.++||||+++++|.+++...... ....+++..+..++.|++.|++|||+ .+++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEe
Confidence 99999999999999999765321 12358999999999999999999998 8999999999999998654 5999
Q ss_pred EeeccceecCCCCceee-ecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 729 ADFGLVKNAPDGKYSVE-TRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 729 ~DfG~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+|||+++.......... .....+..|+|||++.+. .++.++||||+||+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~i 210 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDG---IFTSKTDVWSFGVL 210 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcC---CcCchhHHHHHHHH
Confidence 99999987644332211 122335689999998654 46788999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-27 Score=249.08 Aligned_cols=193 Identities=30% Similarity=0.506 Sum_probs=156.6
Q ss_pred cCCCccceeecccceEEEEEEeC--------CCcEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeC
Q 003982 581 DNFSEANILGRGGFGVVYGGELP--------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCING 651 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~ 651 (782)
++|.+.+.||+|+||.||+|... ....||+|.++... ......++.+|+++++++ +||||+++++++.+.
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 56788999999999999999531 24579999987543 234567788999999999 599999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHHhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE
Q 003982 652 SERLLVYEYMPRGTLAQHLFEWHDH-----------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI 720 (782)
Q Consensus 652 ~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll 720 (782)
+..+++|||+++|+|.+++...... ....+++.++..++.|++.||+|||+ .|++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEE
Confidence 9999999999999999999764321 12358899999999999999999998 899999999999999
Q ss_pred CCCCcEEEEeeccceecCCCCcee-eecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 721 GDDMRAKVADFGLVKNAPDGKYSV-ETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 721 ~~~~~~kL~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
++++.+||+|||.++......... .....++..|+|||++.+. .++.++|+||+||+
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~~ 225 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR---VYTHQSDVWSFGIL 225 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccC---CcCccchhhHHHHH
Confidence 999999999999998665432211 1112345679999987664 35678999999976
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.4e-27 Score=246.39 Aligned_cols=193 Identities=26% Similarity=0.470 Sum_probs=155.6
Q ss_pred cCCCccceeecccceEEEEEEeC-----------------CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcce
Q 003982 581 DNFSEANILGRGGFGVVYGGELP-----------------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVA 643 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~ 643 (782)
++|++.+.||+|+||.||++... +...||+|++.... ......++.+|+++++.++|+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcce
Confidence 56899999999999999998432 23468999987543 2345578999999999999999999
Q ss_pred EEeEEEeCCeEEEEEEccCCCCHHHHHHhhccCC------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCC
Q 003982 644 LLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHG------YTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSN 717 (782)
Q Consensus 644 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~N 717 (782)
+++++...+..+++|||+++++|.+++....... ...+++.++..++.|++.|++|||+ .|++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhe
Confidence 9999999999999999999999999987643211 1247788999999999999999998 899999999999
Q ss_pred EEECCCCcEEEEeeccceecCCCCce-eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 718 ILIGDDMRAKVADFGLVKNAPDGKYS-VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 718 Ill~~~~~~kL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|++++++.++|+|||+++........ ......+++.|+|||+..+. ..+.++|+||+||+
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~---~~~~~~DiwSlG~~ 221 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG---KFTTASDVWAFGVT 221 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC---CccchhhhhHHHHH
Confidence 99999999999999999866443321 12223446789999976543 24568899999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-27 Score=244.33 Aligned_cols=192 Identities=25% Similarity=0.392 Sum_probs=157.0
Q ss_pred HhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeC-----
Q 003982 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCING----- 651 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~----- 651 (782)
..+.|++.+.||+|+||+||+|.. .+++.||+|++.... .....+.+|+.+++++ +||||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 456788899999999999999954 568899999986543 3346788999999998 699999999998753
Q ss_pred -CeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEe
Q 003982 652 -SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVAD 730 (782)
Q Consensus 652 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~D 730 (782)
...+++|||+++++|.+++.... ...+++..+..++.|++.|++|||+ .+|+||||||+||++++++.+||+|
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~D 154 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVD 154 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEcc
Confidence 45799999999999999987522 2458899999999999999999998 8999999999999999999999999
Q ss_pred eccceecCCCCceeeecccccccccCccccccc--hhhhHHHHHHHHHhccc
Q 003982 731 FGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKH--WMILCQMTGLIWLHGSV 780 (782)
Q Consensus 731 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~dvws~Gvv 780 (782)
||++....... .......|++.|+|||++... -..++..++|+||+||+
T Consensus 155 fg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~ 205 (272)
T cd06637 155 FGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGIT 205 (272)
T ss_pred CCCceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHH
Confidence 99998654322 122335689999999987532 11245678999999986
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=243.90 Aligned_cols=188 Identities=27% Similarity=0.398 Sum_probs=155.7
Q ss_pred CCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEcc
Q 003982 583 FSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYM 661 (782)
Q Consensus 583 y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~ 661 (782)
|++.+.||+|+||.||+|.. .++..+|+|.+.... ....+.+.+|+++++.++||||+++++++..+...++||||+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 67788899999999999955 457788999886543 345677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCC
Q 003982 662 PRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK 741 (782)
Q Consensus 662 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~ 741 (782)
+++++..++... ..++++..+..++.|++.||.|||+ .|++||||||+||+++.++.+||+|||++.......
T Consensus 85 ~~~~l~~~~~~~----~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 85 AGGAVDAVMLEL----ERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 157 (282)
T ss_pred CCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEccccccccccccc
Confidence 999998887542 2458999999999999999999998 899999999999999999999999999987654322
Q ss_pred ceeeecccccccccCccccccch--hhhHHHHHHHHHhccc
Q 003982 742 YSVETRLAGTFGYLAPEYAGKHW--MILCQMTGLIWLHGSV 780 (782)
Q Consensus 742 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~dvws~Gvv 780 (782)
.......+++.|+|||++...- ...++.++|+||+||+
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi 197 (282)
T cd06643 158 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGIT 197 (282)
T ss_pred -cccccccccccccCHhhccccCCCCCCCCccchhhhHHHH
Confidence 1223346899999999874210 1134568999999986
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-27 Score=246.90 Aligned_cols=192 Identities=24% Similarity=0.392 Sum_probs=154.9
Q ss_pred CCCccceeecccceEEEEEEeC------CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEE
Q 003982 582 NFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL 655 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~ 655 (782)
+|++.+.||+|+||.||+|... +++.||+|++.... .......+.+|+.++..++||||+++++++.+....+
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 4677889999999999999642 35789999997543 2334567899999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhhcc-----------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCC
Q 003982 656 LVYEYMPRGTLAQHLFEWHD-----------HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM 724 (782)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~ 724 (782)
+++||+++++|.+++..... .....+++..+..++.|++.||+|||+ .||+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCC
Confidence 99999999999999853211 112347888999999999999999998 8999999999999999999
Q ss_pred cEEEEeeccceecCCCCce-eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 725 RAKVADFGLVKNAPDGKYS-VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 725 ~~kL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.+||+|||+++........ ......+++.|+|||++... .++.++|+||+|++
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~~ 215 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG---KFSIDSDIWSYGVV 215 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcC---CCCcchhHHHHHHH
Confidence 9999999998876443321 12233467899999987543 34667889998875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=227.96 Aligned_cols=185 Identities=26% Similarity=0.401 Sum_probs=154.2
Q ss_pred cceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC-CCCcceEEeEEEeCCeEEEEEEccCC
Q 003982 586 ANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSERLLVYEYMPR 663 (782)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~~~lv~e~~~~ 663 (782)
+..||.|+.|+|++++. .+|...|||.+.+.. ..++.+++...++++-.-+ +|+||+.+|||..+...++.||.| .
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s 174 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-S 174 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-H
Confidence 56689999999999955 468999999998764 3456778888888776554 899999999999999999999998 4
Q ss_pred CCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCce
Q 003982 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743 (782)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~ 743 (782)
..+.+++++. .+++++.-+-++...+++||.||.+ ++||+|||+||+|||+|+.|++|++|||++-.+.+...+
T Consensus 175 ~C~ekLlkri----k~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh 248 (391)
T KOG0983|consen 175 TCAEKLLKRI----KGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH 248 (391)
T ss_pred HHHHHHHHHh----cCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccccc
Confidence 4555666543 2468888888999999999999998 589999999999999999999999999999887765543
Q ss_pred eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 744 VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 744 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+...|.+.|||||.+.-.-...++..+|||||||.
T Consensus 249 --trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGIT 283 (391)
T KOG0983|consen 249 --TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGIT 283 (391)
T ss_pred --ccccCCccccCccccCCCCCCccchhhhhhhhccc
Confidence 34579999999998764434578999999999984
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.1e-27 Score=244.11 Aligned_cols=193 Identities=28% Similarity=0.469 Sum_probs=157.8
Q ss_pred cCCCccceeecccceEEEEEEeC------CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeE
Q 003982 581 DNFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSER 654 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~ 654 (782)
++|++.+.||+|+||.||+|... +.+.||+|.+.... .....+++.+|++++++++||||+++++++.+....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 57888999999999999999653 34679999886543 122467899999999999999999999999998999
Q ss_pred EEEEEccCCCCHHHHHHhhccCC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEe
Q 003982 655 LLVYEYMPRGTLAQHLFEWHDHG----YTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVAD 730 (782)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~D 730 (782)
++||||+++++|.+++....... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++++|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEcc
Confidence 99999999999999997643211 1258999999999999999999998 8999999999999999999999999
Q ss_pred eccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 731 FGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 731 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
||++...............++..|+|||.+.+. ....++|+||+|++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~---~~~~~~Di~slG~~ 207 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQED---DFSTKSDVWSFGVL 207 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccC---CCCchhhHHHHHHH
Confidence 999875543332222334567789999987653 23567899999976
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=240.21 Aligned_cols=190 Identities=27% Similarity=0.410 Sum_probs=160.9
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
++|++.+.||+|++|.||+|.. .+++.+|+|.+.... ....+.+.+|++++++++||||+++++++.+....+++||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP--GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc--hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 5789999999999999999965 467889999997654 2356789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++++|.+++... ...+++.++..++.|++.|++|||+ .||+|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~~~~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 81 YCGGGSLQDIYQVT----RGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA 153 (262)
T ss_pred CCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhh
Confidence 99999999988652 2358899999999999999999998 8999999999999999999999999999876543
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.. .......++..|+|||+....-...++.++|+||+|++
T Consensus 154 ~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~ 193 (262)
T cd06613 154 TI-AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGIT 193 (262)
T ss_pred hh-hccccccCCccccCchhhcccccCCcCchhhhHHHHHH
Confidence 22 12233468889999998765311245778999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=240.78 Aligned_cols=187 Identities=33% Similarity=0.574 Sum_probs=157.6
Q ss_pred ceeecccceEEEEEEeCC----CcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEccC
Q 003982 587 NILGRGGFGVVYGGELPD----GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMP 662 (782)
Q Consensus 587 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~ 662 (782)
+.||+|+||.||+|.... +..||+|++....... ..+.+.+|+++++.++|+||+++++++.+....+++|||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 468999999999996543 7899999997654322 46789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhhccC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 663 RGTLAQHLFEWHDH----GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 663 ~gsL~~~l~~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
+++|.+++...... ....+++.++..++.|++.|++|||+ .|++||||||+||++++++.+||+|||.+....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEcccccccccc
Confidence 99999999764211 02568999999999999999999998 899999999999999999999999999998775
Q ss_pred CCC-ceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGK-YSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... ........++..|+|||++... .++.++|+||+|++
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 196 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDG---IFTSKSDVWSFGVL 196 (262)
T ss_pred cccccccccCCCcCccccCHHHhccC---CcchhhccHHHHHH
Confidence 532 1222334578899999988764 56788999999986
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=240.52 Aligned_cols=194 Identities=24% Similarity=0.374 Sum_probs=161.6
Q ss_pred CCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEe--CCeEEEEE
Q 003982 582 NFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN--GSERLLVY 658 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~--~~~~~lv~ 658 (782)
+|++.+.||.|++|.||+|. ..+++.||+|++..........+++..|++++++++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 57889999999999999994 4578899999997665555667789999999999999999999998764 35679999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeEEcCCCCCCEEECCCCcEEEEeecccee
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA--QQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~ 736 (782)
||+++++|.+++...... ..++++..++.++.|++.||+|||..+ ..+++|+||||+||+++.++.+||+|||++..
T Consensus 81 e~~~~~~L~~~l~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKE-RKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred hhccCCCHHHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999999765432 356899999999999999999999211 28999999999999999999999999999987
Q ss_pred cCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 737 APDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
....... .....|++.|+|||++.+. .++.++|+||+|++
T Consensus 160 ~~~~~~~-~~~~~~~~~~~~pE~~~~~---~~~~~~Dv~slG~i 199 (265)
T cd08217 160 LGHDSSF-AKTYVGTPYYMSPEQLNHM---SYDEKSDIWSLGCL 199 (265)
T ss_pred ccCCccc-ccccccCCCccChhhhcCC---CCCchhHHHHHHHH
Confidence 7653321 2234689999999998765 35678999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=239.90 Aligned_cols=188 Identities=25% Similarity=0.414 Sum_probs=160.4
Q ss_pred CCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEc
Q 003982 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 660 (782)
+|+..+.||+|++|.||+|.. .+++.+|+|++..........+.+.+|++++++++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 588899999999999999944 5788999999987655556678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCC-CcEEEEeeccceecCC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD-MRAKVADFGLVKNAPD 739 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~-~~~kL~DfG~a~~~~~ 739 (782)
+++++|.+++.+.. ...+++..+..++.|++.|++|||+ +|++||||||+||+++++ +.+||+|||.+.....
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 81 APGGTLAEYIQKRC---NSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred CCCCCHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 99999999997632 2347899999999999999999998 899999999999999855 4689999999987654
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... .....|+..|+|||+..+. ..+.++|+||+|++
T Consensus 155 ~~~--~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~~ 190 (256)
T cd08220 155 KSK--AYTVVGTPCYISPELCEGK---PYNQKSDIWALGCV 190 (256)
T ss_pred Ccc--ccccccCCcccCchhccCC---CCCcccchHHHHHH
Confidence 321 1224678899999998764 45678999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=246.50 Aligned_cols=188 Identities=29% Similarity=0.381 Sum_probs=157.2
Q ss_pred CCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCC---hhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG---NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
+|++.+.||+|++|.||+|.. .+++.||||+++..... ......+..|++++++++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 478889999999999999964 56899999999765533 22345678899999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
|||+ +++|.+++... ...+++.++..++.|+++||+|||+ .||+||||||+||+++.++.+||+|||++...
T Consensus 81 ~e~~-~~~L~~~i~~~----~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 152 (298)
T cd07841 81 FEFM-ETDLEKVIKDK----SIVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSF 152 (298)
T ss_pred Eccc-CCCHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeec
Confidence 9999 89999998652 1358999999999999999999998 89999999999999999999999999999876
Q ss_pred CCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 738 PDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..... ......+++.|+|||++.+. ..+..++|+||+|++
T Consensus 153 ~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~i 192 (298)
T cd07841 153 GSPNR-KMTHQVVTRWYRAPELLFGA--RHYGVGVDMWSVGCI 192 (298)
T ss_pred cCCCc-cccccccceeeeCHHHHhCC--CCCCcHHHHHHHHHH
Confidence 54321 11223467889999987542 235678999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-27 Score=247.47 Aligned_cols=175 Identities=23% Similarity=0.307 Sum_probs=149.6
Q ss_pred HhcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC-CCCcceEEeEEEeCCeEEEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~~~lv 657 (782)
....|++.++||+|+.+.||++...+.+.||+|++.....+.....-|..|+..|.+++ |.+|+++++|-..++..|+|
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 34568899999999999999999888899999988777767778889999999999997 99999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
|||= .-+|..+|.+.. ...+...++.+..||+.|+.++|. .||||.||||.|+|+- .|.+||+|||+|..+
T Consensus 439 mE~G-d~DL~kiL~k~~----~~~~~~~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKK----SIDPDWFLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLV-KGRLKLIDFGIANAI 509 (677)
T ss_pred eecc-cccHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEE-eeeEEeeeechhccc
Confidence 9976 669999997632 223333788999999999999998 8999999999999884 568999999999988
Q ss_pred CCCCcee-eecccccccccCcccccc
Q 003982 738 PDGKYSV-ETRLAGTFGYLAPEYAGK 762 (782)
Q Consensus 738 ~~~~~~~-~~~~~gt~~y~aPE~~~~ 762 (782)
....... ....+||+.||+||.+.+
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~ 535 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTD 535 (677)
T ss_pred CccccceeeccccCcccccCHHHHhh
Confidence 7665433 345789999999997543
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=244.73 Aligned_cols=189 Identities=26% Similarity=0.336 Sum_probs=154.6
Q ss_pred hcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
.++|.+.+.||+|+||.||+|. ..+++.||+|++..... ......+.+|+++++.++|+||+++++++.+++..++||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4689999999999999999995 45789999999875432 233456788999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||++ +++.+++... ...+++..+..++.|++.||.|||+ .||+||||||+||+++.++++||+|||+++...
T Consensus 83 e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 83 EYMH-TDLAQYMIQH----PGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKS 154 (291)
T ss_pred eccc-CCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence 9995 6787776442 2347888899999999999999998 899999999999999999999999999987643
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.... ......+++.|+|||++.+. .+...++|+||+||+
T Consensus 155 ~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~~ 193 (291)
T cd07870 155 IPSQ-TYSSEVVTLWYRPPDVLLGA--TDYSSALDIWGAGCI 193 (291)
T ss_pred CCCC-CCCCccccccccCCceeecC--CCCCcHHHHHHHHHH
Confidence 3221 11223578899999987653 234567899999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.9e-27 Score=245.62 Aligned_cols=188 Identities=24% Similarity=0.370 Sum_probs=154.9
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
++|++.+.||+|++|.||+|.. .+++.||+|.+..... ......+.+|++++++++||||+++++++.+....++|||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE-EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc-cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 6789999999999999999955 4789999999875432 2233456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|++ ++|.+++... ...+++..+..++.|++.||.|||+ .||+||||||+||++++++.+||+|||.++....
T Consensus 84 ~~~-~~L~~~~~~~----~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 155 (291)
T cd07844 84 YLD-TDLKQYMDDC----GGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSV 155 (291)
T ss_pred cCC-CCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCC
Confidence 997 4898888653 2357899999999999999999998 8999999999999999999999999999875432
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... ......++..|+|||+..+. .....++|+||+|++
T Consensus 156 ~~~-~~~~~~~~~~~~aPE~~~~~--~~~~~~~Dv~slG~i 193 (291)
T cd07844 156 PSK-TYSNEVVTLWYRPPDVLLGS--TEYSTSLDMWGVGCI 193 (291)
T ss_pred CCc-cccccccccccCCcHHhhcC--cccCcHHHHHHHHHH
Confidence 211 11223468899999987653 234678999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=240.34 Aligned_cols=189 Identities=27% Similarity=0.426 Sum_probs=155.1
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCC---hhhHHHHHHHHHHHHhcCCCCcceEEeEEEe--CCeE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG---NKGLSEFQAEIAVLTKVRHRHLVALLGYCIN--GSER 654 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~--~~~~ 654 (782)
.+|+..+.||+|+||.||+|.. .+++.||+|++...... .+..+.+.+|+.++++++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3688999999999999999954 56899999998654322 2345678999999999999999999998875 3567
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccc
Q 003982 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734 (782)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a 734 (782)
+++|||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 82 ~l~~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~ 153 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA-----YGALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGAS 153 (266)
T ss_pred EEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCc
Confidence 899999999999999865 2347899999999999999999998 89999999999999999999999999998
Q ss_pred eecCCCCc--eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 735 KNAPDGKY--SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 735 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+....... .......++..|+|||++.+. ..+.++|+||+|++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~i 198 (266)
T cd06651 154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGE---GYGRKADVWSLGCT 198 (266)
T ss_pred cccccccccCCccccCCccccccCHHHhCCC---CCCchhhhHHHHHH
Confidence 76533111 111224578899999988654 34668899999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.7e-27 Score=245.30 Aligned_cols=194 Identities=31% Similarity=0.524 Sum_probs=158.6
Q ss_pred hcCCCccceeecccceEEEEEEeC------CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCe
Q 003982 580 TDNFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE 653 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~ 653 (782)
.++|++.+.||+|+||.||+|... ++..||+|++.... .....+++.+|+.++++++||||+++++++.++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 357889999999999999999653 46789999987543 23445779999999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhhcc-----------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCC
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHD-----------------HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPS 716 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~-----------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~ 716 (782)
.+++|||+++++|.+++..... .....+++.+++.++.|++.||+|||+ .+++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHh
Confidence 9999999999999999975321 112347888999999999999999998 89999999999
Q ss_pred CEEECCCCcEEEEeeccceecCCCCce-eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 717 NILIGDDMRAKVADFGLVKNAPDGKYS-VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 717 NIll~~~~~~kL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
||++++++.+||+|||.+......... .......+..|+|||...+. .++.++|+||+||+
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~i 221 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN---RYTTESDVWAYGVV 221 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC---CCCchhHHHHHHHH
Confidence 999999999999999998765433221 11222346679999987654 46778999999986
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=245.61 Aligned_cols=191 Identities=29% Similarity=0.490 Sum_probs=153.4
Q ss_pred cCCCccceeecccceEEEEEEeC-CCc--EEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCCeEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGELP-DGT--KIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLL 656 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~l 656 (782)
++|++.+.||+|+||.||+|... ++. .+++|.++... .....+.+.+|++++.++ +||||+++++++.+....++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC-CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 57889999999999999999654 333 47888876422 234457789999999999 69999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCc
Q 003982 657 VYEYMPRGTLAQHLFEWHDH-----------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR 725 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~ 725 (782)
+|||+++++|.+++...... ....+++..+..++.|++.|++|||+ .||+||||||+||++++++.
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCe
Confidence 99999999999999753211 11348899999999999999999998 89999999999999999999
Q ss_pred EEEEeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 726 AKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 726 ~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+||+|||++....... .......+..|+|||+..+. .++.++||||+||+
T Consensus 158 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwSlG~i 207 (297)
T cd05089 158 SKIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYS---VYTTKSDVWSFGVL 207 (297)
T ss_pred EEECCcCCCcccccee--ccCCCCcCccccCchhhccC---CCCchhhHHHHHHH
Confidence 9999999986432211 11111235579999987654 35678999999986
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.3e-27 Score=244.76 Aligned_cols=187 Identities=30% Similarity=0.499 Sum_probs=152.1
Q ss_pred cCC-CccceeecccceEEEEEE-----eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC--C
Q 003982 581 DNF-SEANILGRGGFGVVYGGE-----LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING--S 652 (782)
Q Consensus 581 ~~y-~~~~~lg~G~~g~Vy~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~--~ 652 (782)
++| ...+.||+|+||+||.+. ..+++.||+|.++... .......+.+|++++++++||||+++++++... .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK 81 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence 344 889999999999998753 2467889999987543 223456788999999999999999999987654 4
Q ss_pred eEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeec
Q 003982 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (782)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG 732 (782)
..+++|||+++++|.+++.. ..+++.++..++.|++.|++|||+ .||+||||||+||++++++.+||+|||
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~------~~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg 152 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPK------HKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFG 152 (283)
T ss_pred eEEEEecCCCCCCHHHHHHH------cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecc
Confidence 57899999999999999864 248999999999999999999998 899999999999999999999999999
Q ss_pred cceecCCCCce--eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 733 LVKNAPDGKYS--VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 733 ~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+++........ ......++..|+|||+..+. .++.++|+||+|++
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~---~~~~~~Di~slG~~ 199 (283)
T cd05080 153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLKEN---KFSYASDVWSFGVT 199 (283)
T ss_pred cccccCCcchhhccCCCCCCCceeeCHhHhccc---CCCcccccHHHHHH
Confidence 99876543211 11222456679999987654 34678899999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=240.87 Aligned_cols=191 Identities=29% Similarity=0.430 Sum_probs=162.3
Q ss_pred CCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEc
Q 003982 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 660 (782)
+|.+.+.||+|++|.||+|.. .+++.||+|.++.........+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 588899999999999999954 4789999999987654445678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~ 740 (782)
+++++|.+++.. ...+++..+..++.|++.|++|||+ .|++|+||+|+||++++++.+||+|||.+......
T Consensus 81 ~~~~~L~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 81 CSGGTLEELLEH-----GRILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred CCCCcHHHHHhh-----cCCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence 999999999865 2347889999999999999999998 89999999999999999999999999998876543
Q ss_pred Cceee---ecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 741 KYSVE---TRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 741 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..... ....+++.|+|||++.+.-......++|+||+|++
T Consensus 153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~i 195 (264)
T cd06626 153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCV 195 (264)
T ss_pred CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHH
Confidence 32211 12457889999999876421236778999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=239.38 Aligned_cols=181 Identities=25% Similarity=0.398 Sum_probs=146.7
Q ss_pred eeecccceEEEEEEeC---CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEccCCC
Q 003982 588 ILGRGGFGVVYGGELP---DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRG 664 (782)
Q Consensus 588 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~g 664 (782)
.||+|+||.||+|.+. ++..||+|++.... .....+.+.+|++++++++||||+++++++. ....++||||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence 3899999999999553 35579999987543 2344577999999999999999999999875 45789999999999
Q ss_pred CHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCcee
Q 003982 665 TLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSV 744 (782)
Q Consensus 665 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~~ 744 (782)
+|.+++... ...+++.++..++.|++.|++|||+ .|++||||||+||+++.++.+||+|||++..........
T Consensus 80 ~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 80 PLNKFLSGK----KDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred CHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence 999988642 2358999999999999999999998 899999999999999999999999999997654332111
Q ss_pred --eecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 745 --ETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 745 --~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.....++..|+|||++... ..+.++|+||||++
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~ 187 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFR---KFSSRSDVWSYGIT 187 (257)
T ss_pred eccCCCCCCcccCCHHHHccC---CCCchhhHHHHHHH
Confidence 1112235789999987654 34668999999975
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=240.88 Aligned_cols=178 Identities=22% Similarity=0.380 Sum_probs=145.0
Q ss_pred ceeecccceEEEEEEeCC-------------CcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCe
Q 003982 587 NILGRGGFGVVYGGELPD-------------GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE 653 (782)
Q Consensus 587 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~ 653 (782)
+.||+|+||.||+|...+ ...||+|.+.... ......+.+|+.+++.++||||+++++++.++..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 468999999999996422 2358889876543 3345678899999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCc-------E
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR-------A 726 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~-------~ 726 (782)
.+++|||+++++|..++... ...+++..+..++.|+++|++|||+ .||+||||||+||+++.++. +
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~ 151 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRK----SDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFI 151 (262)
T ss_pred CEEEEecccCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCcee
Confidence 99999999999998887542 2458999999999999999999998 89999999999999987654 8
Q ss_pred EEEeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 727 KVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 727 kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|++|||.+...... ....++..|+|||++.+. ..++.++||||+||+
T Consensus 152 ~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~~ 198 (262)
T cd05077 152 KLSDPGIPITVLSR-----QECVERIPWIAPECVEDS--KNLSIAADKWSFGTT 198 (262)
T ss_pred EeCCCCCCccccCc-----ccccccccccChhhhcCC--CCCCchhHHHHHHHH
Confidence 99999998755322 123578899999987643 234667899999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=245.07 Aligned_cols=190 Identities=27% Similarity=0.443 Sum_probs=156.9
Q ss_pred cCCCccceeecccceEEEEEEe------CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCCe
Q 003982 581 DNFSEANILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSE 653 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~ 653 (782)
++|.+.+.||+|+||.||+|.. ..+..||||.++... .....+.+.+|+++++++ +||||+++++++...+.
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 5688999999999999999953 234579999987543 234457789999999999 79999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecc
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~ 733 (782)
.+++|||+++|+|.+++.+.. ...+++.++..++.|++.|++|||+ .+|+|+||||+||+++.++.+|++|||+
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKR---ESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCcc
Confidence 999999999999999986522 1237999999999999999999998 8999999999999999999999999999
Q ss_pred ceecCCCCc-eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 734 VKNAPDGKY-SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 734 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
++....... .......++..|+|||++.+. ..+.++|+||+||+
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslGvi 232 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNC---VYTFESDVWSYGIL 232 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccC---CCCcHhHHHHHHHH
Confidence 986644321 111223457789999987654 35678999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=239.85 Aligned_cols=189 Identities=23% Similarity=0.360 Sum_probs=160.2
Q ss_pred CCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEc
Q 003982 582 NFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 660 (782)
+|++.+.||+|+||.||++. ..+++.||+|++..........+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 58899999999999999994 45789999999976544445667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~ 740 (782)
+++++|.+++.... ...+++.++..++.|++.|+.|||+ .|++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~ 154 (256)
T cd08218 81 CEGGDLYKKINAQR---GVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154 (256)
T ss_pred CCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence 99999999886522 2347889999999999999999998 89999999999999999999999999999876543
Q ss_pred CceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 741 KYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... .....|++.|+|||+..+. ..+.++|+||+||+
T Consensus 155 ~~~-~~~~~~~~~~~~pe~~~~~---~~~~~~Dv~slG~i 190 (256)
T cd08218 155 VEL-ARTCIGTPYYLSPEICENR---PYNNKSDIWALGCV 190 (256)
T ss_pred hhh-hhhccCCccccCHHHhCCC---CCCCccchhHHHHH
Confidence 221 1234578899999987664 24567899999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=238.34 Aligned_cols=184 Identities=35% Similarity=0.589 Sum_probs=157.0
Q ss_pred hcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
.++|++.+.||+|++|.||+|.. .++.||+|.++... ...+++.+|+.++++++|+||+++++++.+....++|||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 80 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDS---TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE 80 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccch---hHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence 35788899999999999999976 48899999997654 246789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++++|.+++.... ...+++..+..++.|++.|+.|||+ .|++||||||+||+++.++.+||+|||.++....
T Consensus 81 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~ 154 (256)
T cd05039 81 YMAKGSLVDYLRSRG---RAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ 154 (256)
T ss_pred ecCCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEccccccccccc
Confidence 999999999986532 2358999999999999999999998 8999999999999999999999999999987643
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... ...++..|+|||++.+. .+..++|+||+|++
T Consensus 155 ~~~----~~~~~~~~~ape~~~~~---~~~~~~Di~slG~i 188 (256)
T cd05039 155 GQD----SGKLPVKWTAPEALREK---KFSTKSDVWSFGIL 188 (256)
T ss_pred ccc----cCCCcccccCchhhcCC---cCCcHHHHHHHHHH
Confidence 221 12346689999987654 34568999999976
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=242.35 Aligned_cols=188 Identities=27% Similarity=0.422 Sum_probs=147.5
Q ss_pred eeecccceEEEEEEeCCCc---EEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEccCCC
Q 003982 588 ILGRGGFGVVYGGELPDGT---KIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRG 664 (782)
Q Consensus 588 ~lg~G~~g~Vy~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~g 664 (782)
.||+|+||.||+|...++. .+++|.+.... .....+.+.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 5899999999999654433 45667665432 2345678999999999999999999999999999999999999999
Q ss_pred CHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCc-e
Q 003982 665 TLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY-S 743 (782)
Q Consensus 665 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~-~ 743 (782)
+|.+++.+.... ....++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++........ .
T Consensus 81 ~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 81 DLKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred cHHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 999999764322 2346777888999999999999998 8999999999999999999999999999864332221 1
Q ss_pred eeecccccccccCccccccch----hhhHHHHHHHHHhccc
Q 003982 744 VETRLAGTFGYLAPEYAGKHW----MILCQMTGLIWLHGSV 780 (782)
Q Consensus 744 ~~~~~~gt~~y~aPE~~~~~~----~~~~~~~~dvws~Gvv 780 (782)
......++..|+|||+..... ....+.++|+||+||+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~ 197 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVT 197 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHH
Confidence 122346788999999875421 1123567899999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=239.14 Aligned_cols=182 Identities=32% Similarity=0.520 Sum_probs=152.3
Q ss_pred cCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEE-eCCeEEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCI-NGSERLLVYE 659 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~-~~~~~~lv~e 659 (782)
++|.+.+.||+|+||.||++.. .+..||+|.++.. ...+.+.+|+.++++++|+|++++++++. +....+++||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 4788899999999999999976 4788999988643 23567899999999999999999999765 4567899999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++++|.+++.+.. ...+++..+..++.|++.||+|||+ .|++||||||+||++++++.+||+|||+++....
T Consensus 81 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 81 YMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred CCCCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccc
Confidence 999999999986522 2347899999999999999999998 8999999999999999999999999999876543
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.. ....++..|+|||+..+. ..+.++|+||+|++
T Consensus 155 ~~----~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~i 188 (256)
T cd05082 155 TQ----DTGKLPVKWTAPEALREK---KFSTKSDVWSFGIL 188 (256)
T ss_pred cC----CCCccceeecCHHHHccC---CCCchhhhHHHHHH
Confidence 22 122346689999988664 35678999999976
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=241.57 Aligned_cols=189 Identities=26% Similarity=0.438 Sum_probs=154.8
Q ss_pred cCCCccceeecccceEEEEEEeC-CC---cEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGELP-DG---TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 656 (782)
.+|++.+.||+|+||.||+|... ++ ..||||.+.... .....++|..|+.++++++||||+++++++.++...++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 45788999999999999999653 33 369999987542 34456789999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecccee
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~ 736 (782)
||||+++++|.+++... ...+++.++..++.|++.|++|||+ .|++||||||+||+++.++.+||+|||++..
T Consensus 83 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~ 155 (269)
T cd05065 83 ITEFMENGALDSFLRQN----DGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRF 155 (269)
T ss_pred EEecCCCCcHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccc
Confidence 99999999999988652 2357899999999999999999998 8999999999999999999999999999876
Q ss_pred cCCCCcee--eeccc--ccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 737 APDGKYSV--ETRLA--GTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 737 ~~~~~~~~--~~~~~--gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
........ ..... .+..|+|||++.+. .++.++|+||+|++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~---~~~~~~DvwslG~~ 200 (269)
T cd05065 156 LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR---KFTSASDVWSYGIV 200 (269)
T ss_pred cccCccccccccccCCCcceeecCHhHhccC---cccchhhhhhhHHH
Confidence 54322111 11111 24579999988754 45678999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=244.39 Aligned_cols=193 Identities=25% Similarity=0.296 Sum_probs=156.6
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC-CCCcceEEeEEEeCCe-----
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSE----- 653 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~----- 653 (782)
++|++.+.||+|+||.||+|.. .+++.||+|+++...........+.+|+.++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4688999999999999999954 57899999998765433334567889999999995 6999999999887665
Q ss_pred EEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECC-CCcEEEEeec
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD-DMRAKVADFG 732 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~-~~~~kL~DfG 732 (782)
.|+||||+++ ++.+++..........+++..+..++.|++.||+|||+ .||+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999975 89888866433323468999999999999999999998 89999999999999998 8899999999
Q ss_pred cceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 733 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.++....... ......+++.|+|||++.+. ...+.++|+||+|++
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~~ 201 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGS--THYSTPVDIWSVGCI 201 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCC--CCCCchHHHHHHHHH
Confidence 9886543221 11223568899999987653 235678999999986
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=247.33 Aligned_cols=193 Identities=25% Similarity=0.346 Sum_probs=157.2
Q ss_pred CCCccceeecccceEEEEEEeC---CCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC--CeEE
Q 003982 582 NFSEANILGRGGFGVVYGGELP---DGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCING--SERL 655 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~--~~~~ 655 (782)
+|++.+.||+|++|.||+|... +++.||+|.+..... .....+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788999999999999999654 578999999987431 122346678899999999999999999999988 8899
Q ss_pred EEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECC----CCcEEEEee
Q 003982 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD----DMRAKVADF 731 (782)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~----~~~~kL~Df 731 (782)
+||||++ +++.+.+..........+++..+..++.|++.|++|||+ .+|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 9999996 478777765444433468999999999999999999998 89999999999999999 899999999
Q ss_pred ccceecCCCCc--eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 732 GLVKNAPDGKY--SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 732 G~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|++........ .......+++.|+|||++.+. ..++.++|+||+|++
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~~ 205 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGA--RHYTKAIDIWAIGCI 205 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCC--CCCCcHHHHHHHHHH
Confidence 99987644322 112334678999999987553 234678999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=244.16 Aligned_cols=190 Identities=24% Similarity=0.325 Sum_probs=157.2
Q ss_pred CCCccceeecccceEEEEEEe----CCCcEEEEEEeccccCC--hhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCCeE
Q 003982 582 NFSEANILGRGGFGVVYGGEL----PDGTKIAVKRMESNTMG--NKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSER 654 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~ 654 (782)
+|++.+.||+|+||.||+|.. .+|+.||+|++...... ....+.+.+|+++++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478899999999999999964 36889999999754321 22346788999999999 599999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccc
Q 003982 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734 (782)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a 734 (782)
++||||+++++|.+++.. ...+++.++..++.|++.||.|||+ .|++||||||+||+++.++.+||+|||++
T Consensus 81 ~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 152 (290)
T cd05613 81 HLILDYINGGELFTHLSQ-----RERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLS 152 (290)
T ss_pred EEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccc
Confidence 999999999999999865 2357889999999999999999998 89999999999999999999999999999
Q ss_pred eecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 735 KNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 735 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
...............|+..|+|||+..... .+....+|+||+|++
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~~Dv~slG~~ 197 (290)
T cd05613 153 KEFHEDEVERAYSFCGTIEYMAPDIVRGGD-GGHDKAVDWWSMGVL 197 (290)
T ss_pred eecccccccccccccCCcccCChhhccCCC-CCCCccccHHHHHHH
Confidence 876543322223356899999999876431 134567899999976
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=245.01 Aligned_cols=189 Identities=24% Similarity=0.355 Sum_probs=156.6
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCC-hhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
++|++.+.||+|+||.||++.. .+++.||+|.+...... ....+.+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 3688999999999999999954 46789999998765422 234567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++++|.+++.. ...+++..+..++.|++.|++|||+ .|++||||||+||+++.++.+||+|||.++...
T Consensus 81 e~~~g~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~ 152 (305)
T cd05609 81 EYVEGGDCATLLKN-----IGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGL 152 (305)
T ss_pred ecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccC
Confidence 99999999999865 2458999999999999999999998 899999999999999999999999999886421
Q ss_pred CCC--------------ceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGK--------------YSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... ........|+..|+|||++.+. +.+.++|+||+|++
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~v 205 (305)
T cd05609 153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ---GYGKPVDWWAMGII 205 (305)
T ss_pred cCccccccccccccchhhccccCCccCccccCchhccCC---CCCchhhHHHHHHH
Confidence 100 0011123578899999987654 45678899999976
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=241.89 Aligned_cols=194 Identities=23% Similarity=0.422 Sum_probs=159.8
Q ss_pred hcCCCccceeecccceEEEEEEeCC-----CcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEe-CCe
Q 003982 580 TDNFSEANILGRGGFGVVYGGELPD-----GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN-GSE 653 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~-~~~ 653 (782)
.++|++.+.||+|+||.||+|.... +..||+|++.... .....+.+.+|+.++++++||||+++++++.. +..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 4678999999999999999996654 6889999886432 34456778999999999999999999998776 467
Q ss_pred EEEEEEccCCCCHHHHHHhhccC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEe
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHDH---GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVAD 730 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~D 730 (782)
.++++||+++++|.+++...... ....+++.++..++.|++.||+|||+ .+++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998764321 12458999999999999999999998 8999999999999999999999999
Q ss_pred eccceecCCCCcee-eecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 731 FGLVKNAPDGKYSV-ETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 731 fG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
||+++.+....... .....++..|+|||++.+. .++.++||||+|++
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~---~~~~~~Di~slG~~ 208 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNK---EYSSASDVWSFGVL 208 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcC---CCCchhhHHHhHHH
Confidence 99998664433222 1223457789999988664 45778999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-27 Score=247.84 Aligned_cols=188 Identities=22% Similarity=0.352 Sum_probs=159.1
Q ss_pred hcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCC------hhhHHHHHHHHHHHHhcC---CCCcceEEeEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMG------NKGLSEFQAEIAVLTKVR---HRHLVALLGYCI 649 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~---h~nI~~~~~~~~ 649 (782)
..+|...+.+|+|+||.|+.|. .++...|+||.+.++..- ++..-..-.|+.||..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 3568999999999999999994 456678999998775421 112223457999999997 999999999999
Q ss_pred eCCeEEEEEEcc-CCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEE
Q 003982 650 NGSERLLVYEYM-PRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKV 728 (782)
Q Consensus 650 ~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL 728 (782)
+++++|++||-. ++.+|.+++.. ...+++.++..|++|++.|+++||+ .||||||||-+||.++.+|-+||
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~-----kp~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~kl 711 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEF-----KPRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKL 711 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhc-----cCccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEE
Confidence 999999999976 45688888865 3458999999999999999999998 89999999999999999999999
Q ss_pred EeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 729 ADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 729 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+|||.|.....+.+. .++||..|.|||++.|.-.+| .--|||++||+
T Consensus 712 idfgsaa~~ksgpfd---~f~gtv~~aapevl~g~~y~g--k~qdiwalgil 758 (772)
T KOG1152|consen 712 IDFGSAAYTKSGPFD---VFVGTVDYAAPEVLGGEKYLG--KPQDIWALGIL 758 (772)
T ss_pred eeccchhhhcCCCcc---eeeeeccccchhhhCCCccCC--Ccchhhhhhhe
Confidence 999999888776653 357999999999999884443 35899999986
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=241.73 Aligned_cols=186 Identities=27% Similarity=0.413 Sum_probs=160.6
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
++|++.+.||.|++|.||+|.. .+++.||+|++.... .......+.+|+++++.++|+||+++++++.++...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 3688899999999999999954 468899999987543 23445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++++|.+++.. .++++..+..++.|++.|+.|||+ .+++||||+|+||++++++.++|+|||+++....
T Consensus 80 ~~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 150 (274)
T cd06609 80 YCGGGSCLDLLKP------GKLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTS 150 (274)
T ss_pred eeCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence 9999999999864 268999999999999999999998 8999999999999999999999999999987764
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... ......+++.|+|||++.+. .++.++|+||+|++
T Consensus 151 ~~~-~~~~~~~~~~y~~PE~~~~~---~~~~~sDv~slG~i 187 (274)
T cd06609 151 TMS-KRNTFVGTPFWMAPEVIKQS---GYDEKADIWSLGIT 187 (274)
T ss_pred ccc-ccccccCCccccChhhhccC---CCCchhhHHHHHHH
Confidence 321 22334688899999998775 36788999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=244.47 Aligned_cols=189 Identities=25% Similarity=0.363 Sum_probs=157.0
Q ss_pred cCCCccceeecccceEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC--CeEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING--SERLLV 657 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~--~~~~lv 657 (782)
++|++.+.||+|++|.||+|... +++.+|+|.++...........+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57888999999999999999654 688999999976554434445678899999999999999999998877 889999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
|||++ ++|.+++.... ..+++.++..++.|++.||+|||+ .|++||||||+||+++.++.+||+|||.+...
T Consensus 85 ~e~~~-~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~ 156 (293)
T cd07843 85 MEYVE-HDLKSLMETMK----QPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREY 156 (293)
T ss_pred ehhcC-cCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence 99996 58988886522 258999999999999999999998 89999999999999999999999999999876
Q ss_pred CCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 738 PDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..... ......+++.|+|||++.+. .....++|+||+|++
T Consensus 157 ~~~~~-~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~~ 196 (293)
T cd07843 157 GSPLK-PYTQLVVTLWYRAPELLLGA--KEYSTAIDMWSVGCI 196 (293)
T ss_pred cCCcc-ccccccccccccCchhhcCC--ccccchhhHHHHHHH
Confidence 54321 11233578899999987653 124678999999976
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=239.86 Aligned_cols=183 Identities=31% Similarity=0.542 Sum_probs=152.6
Q ss_pred ceeecccceEEEEEEeCC--C--cEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEccC
Q 003982 587 NILGRGGFGVVYGGELPD--G--TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMP 662 (782)
Q Consensus 587 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~ 662 (782)
+.||+|++|.||+|.+.+ + ..||+|.+...... ...+++.+|++++++++||||+++++++.+ ...+++|||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 468999999999996533 3 36999999876533 566789999999999999999999999988 88999999999
Q ss_pred CCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCc
Q 003982 663 RGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742 (782)
Q Consensus 663 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~ 742 (782)
+++|.+++.+... ..+++..+..++.|++.||+|||+ .|++||||||+||+++.++.+||+|||+++.......
T Consensus 79 ~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 79 LGSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred CCcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEecccccccccccccc
Confidence 9999999876321 358999999999999999999998 8999999999999999999999999999987654221
Q ss_pred --eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 743 --SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 743 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.......++..|+|||++.+. .++.++|+||+|++
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~---~~~~~~Di~slG~~ 189 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRTR---TFSHASDVWMFGVT 189 (257)
T ss_pred ceecccCCCCCceecCHHHhccc---CcCchhhhHHHHHH
Confidence 111223567889999987764 45778899999976
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=240.68 Aligned_cols=188 Identities=24% Similarity=0.407 Sum_probs=153.9
Q ss_pred cCCCccceeecccceEEEEEEeCC----CcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGELPD----GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 656 (782)
++|.+.+.||+|+||.||+|...+ ...||+|...... .....+.+.+|+.++++++||||+++++++.+ ...++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 468889999999999999996533 2468999886543 23456789999999999999999999998875 55789
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecccee
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~ 736 (782)
||||+++++|.+++... ...+++..+..++.|++.|++|||+ .|++||||||+||+++.++.+||+|||+++.
T Consensus 84 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 84 VMELAPLGELRSYLQVN----KYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred EEEcCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeee
Confidence 99999999999998652 2347999999999999999999998 8999999999999999999999999999987
Q ss_pred cCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 737 APDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.............++..|+|||++... +.+.++|+||+|++
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 197 (270)
T cd05056 157 LEDESYYKASKGKLPIKWMAPESINFR---RFTSASDVWMFGVC 197 (270)
T ss_pred cccccceecCCCCccccccChhhhccC---CCCchhhhHHHHHH
Confidence 655433222233345689999987654 34678899999976
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=248.30 Aligned_cols=193 Identities=31% Similarity=0.496 Sum_probs=156.5
Q ss_pred cCCCccceeecccceEEEEEEeC--------CCcEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeC
Q 003982 581 DNFSEANILGRGGFGVVYGGELP--------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCING 651 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~ 651 (782)
.+|.+.+.||+|+||.||+|... ++..||+|.++... .....+++.+|+++++++ +||||+++++++.+.
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 46889999999999999999532 12368999887532 234567899999999999 799999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHHhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE
Q 003982 652 SERLLVYEYMPRGTLAQHLFEWHDH-----------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI 720 (782)
Q Consensus 652 ~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll 720 (782)
+..+++|||+++|+|.+++.+.... ....+++.++..++.|++.||.|||+ +||+||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEE
Confidence 9999999999999999999764321 12357889999999999999999998 899999999999999
Q ss_pred CCCCcEEEEeeccceecCCCCcee-eecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 721 GDDMRAKVADFGLVKNAPDGKYSV-ETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 721 ~~~~~~kL~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+.++.+||+|||+++......... .....++..|+|||++.+. .++.++|+||+|++
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 225 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR---VYTHQSDVWSFGVL 225 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccC---CcCchhhhHHHHHH
Confidence 999999999999998765432211 1122345679999988664 34678999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=238.53 Aligned_cols=185 Identities=29% Similarity=0.436 Sum_probs=160.3
Q ss_pred cCCCccceeecccceEEEEEEeCC-CcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGELPD-GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
++|+..+.||+|++|.||+|...+ ++.||+|.+.... ..+.+.+|++++++++||||+++++++.+....++++|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 578999999999999999997654 7899999986542 26789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++++|.+++... ...+++..+..++.|++.|+.|||+ .+++||||+|+||++++++.+||+|||++.....
T Consensus 79 ~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 79 YCGAGSVSDIMKIT----NKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151 (256)
T ss_pred cCCCCcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence 99999999998642 2458999999999999999999998 8999999999999999999999999999887654
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... ......|+..|+|||++.+. +++.++|+||+||+
T Consensus 152 ~~~-~~~~~~~~~~y~~PE~~~~~---~~~~~~Di~s~G~i 188 (256)
T cd06612 152 TMA-KRNTVIGTPFWMAPEVIQEI---GYNNKADIWSLGIT 188 (256)
T ss_pred Ccc-ccccccCCccccCHHHHhcC---CCCchhhHHHHHHH
Confidence 321 22234578899999998765 56788999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=243.98 Aligned_cols=192 Identities=23% Similarity=0.366 Sum_probs=157.9
Q ss_pred cCCCccceeecccceEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
++|++.+.||+|+||.||+|... +++.||+|.+.... .......+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 36888999999999999999654 78999999986542 23445788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++++|.+++.... ....+++..+..++.|++.|+.|||+ ..||+||||||+||+++.++.+||+|||.+.....
T Consensus 80 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 80 YMDAGSLDKLYAGGV--ATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA 155 (286)
T ss_pred ecCCCCHHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence 999999988886521 12368999999999999999999996 25999999999999999999999999999876643
Q ss_pred CCceeeecccccccccCccccccch---hhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHW---MILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~dvws~Gvv 780 (782)
... ....+++.|+|||++.+.- ...++.++|+||+||+
T Consensus 156 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~i 196 (286)
T cd06622 156 SLA---KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLS 196 (286)
T ss_pred Ccc---ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHH
Confidence 221 2235788999999875421 1124667889999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-26 Score=237.26 Aligned_cols=187 Identities=29% Similarity=0.481 Sum_probs=158.7
Q ss_pred CCCccceeecccceEEEEEEeC-CCcEEEEEEeccccCC---hhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 582 NFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMG---NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
+|+..+.||+|++|.||+|... +++.||+|.+...... .+..+.+.+|++++++++|+||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4778899999999999999654 7899999998654321 23557789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
+||+++++|.+++... ..+++..+..++.|++.|++|||+ .|++|+||+|+||+++.++.+||+|||.+...
T Consensus 81 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~ 152 (258)
T cd06632 81 LELVPGGSLAKLLKKY-----GSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQV 152 (258)
T ss_pred EEecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceec
Confidence 9999999999998652 357899999999999999999998 89999999999999999999999999998776
Q ss_pred CCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 738 PDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.... ......|+..|+|||.+...- ....++|+||+|++
T Consensus 153 ~~~~--~~~~~~~~~~y~~pe~~~~~~--~~~~~~D~~slG~~ 191 (258)
T cd06632 153 VEFS--FAKSFKGSPYWMAPEVIAQQG--GYGLAADIWSLGCT 191 (258)
T ss_pred cccc--cccccCCCcceeCHHHhcCCC--CCCchhhhHHHHHH
Confidence 4433 123346889999999876541 35678999999986
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=241.79 Aligned_cols=177 Identities=23% Similarity=0.360 Sum_probs=144.0
Q ss_pred eeecccceEEEEEEeCC-------------------------CcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcc
Q 003982 588 ILGRGGFGVVYGGELPD-------------------------GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642 (782)
Q Consensus 588 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~ 642 (782)
.||+|+||.||+|.... ...||+|++.... ......+.+|+.++++++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 58999999999985311 1358999886543 23456788899999999999999
Q ss_pred eEEeEEEeCCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECC
Q 003982 643 ALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD 722 (782)
Q Consensus 643 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~ 722 (782)
++++++.+....++||||+++|+|..++... ...+++..+..++.|+++||+|||+ .||+||||||+||++++
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~ 152 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKE----KGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLAR 152 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEec
Confidence 9999999999999999999999998888642 2357899999999999999999998 89999999999999976
Q ss_pred CC-------cEEEEeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 723 DM-------RAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 723 ~~-------~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
++ .+|++|||.+....... ...++..|+|||++.+. ...+.++|+||||++
T Consensus 153 ~~~~~~~~~~~kl~d~g~~~~~~~~~-----~~~~~~~~~aPe~~~~~--~~~~~~~Dv~slG~~ 210 (274)
T cd05076 153 LGLAEGTSPFIKLSDPGVSFTALSRE-----ERVERIPWIAPECVPGG--NSLSTAADKWSFGTT 210 (274)
T ss_pred cCcccCccceeeecCCcccccccccc-----ccccCCcccCchhhcCC--CCCCcHHHHHHHHHH
Confidence 43 48999999886543221 23467889999988653 234678999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=239.32 Aligned_cols=192 Identities=30% Similarity=0.493 Sum_probs=162.3
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
++|++.+.||.|++|+||+|.. .++..+|+|++....... ..+.+.+|+++++.++|+||+++++.+..+...+++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 4789999999999999999964 467899999987654333 66789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++++|.+++..... ...+++..+..++.|++.|++|||+ .|++||||||+||++++++.+||+|||++.....
T Consensus 80 ~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 80 YLSGGSLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred ccCCCcHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 9999999999876322 2358999999999999999999998 8999999999999999999999999999876654
Q ss_pred CCce---eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYS---VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.... ......|+..|+|||++... ...+.++|+||+||+
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~--~~~~~~~Dv~slG~i 196 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQV--HGYDFKADIWSFGIT 196 (267)
T ss_pred CccccccccccccCChhhcChHHHccc--cCcCcccchHhHhHH
Confidence 3321 12334689999999987654 245778999999976
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=236.79 Aligned_cols=183 Identities=32% Similarity=0.510 Sum_probs=153.2
Q ss_pred ceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEccCCCCH
Q 003982 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTL 666 (782)
Q Consensus 587 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~gsL 666 (782)
++||+|++|.||+|...+++.||+|++...... .....+.+|++++++++||||+++++++.+....++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 468999999999997766999999998765432 4567899999999999999999999999999999999999999999
Q ss_pred HHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCceee-
Q 003982 667 AQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVE- 745 (782)
Q Consensus 667 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~- 745 (782)
.+++... ...+++..+..++.+++.|++|||+ .+++||||||+||+++.++.+||+|||.+.......+...
T Consensus 80 ~~~l~~~----~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (251)
T cd05041 80 LTFLRKK----KNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD 152 (251)
T ss_pred HHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence 9998652 2357889999999999999999998 8999999999999999999999999999986654332221
Q ss_pred ecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 746 TRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 746 ~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
....++..|+|||++.+. .++.++|+||+||+
T Consensus 153 ~~~~~~~~y~~PE~~~~~---~~~~~~Di~slG~i 184 (251)
T cd05041 153 GLKQIPIKWTAPEALNYG---RYTSESDVWSYGIL 184 (251)
T ss_pred ccCcceeccCChHhhccC---CCCcchhHHHHHHH
Confidence 112235679999987654 35678999999975
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.8e-27 Score=246.28 Aligned_cols=183 Identities=27% Similarity=0.437 Sum_probs=153.6
Q ss_pred CCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEcc
Q 003982 583 FSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYM 661 (782)
Q Consensus 583 y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~ 661 (782)
|.....||+|+||.||++.. .++..||||.+.... ....+.+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 34456799999999999954 568899999986543 344567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCC
Q 003982 662 PRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK 741 (782)
Q Consensus 662 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~ 741 (782)
++++|.+++.. ..+++.++..++.|++.|++|||+ .||+||||||+||++++++.+||+|||++.......
T Consensus 102 ~~~~L~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~ 172 (292)
T cd06658 102 EGGALTDIVTH------TRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV 172 (292)
T ss_pred CCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc
Confidence 99999988743 347899999999999999999998 899999999999999999999999999987654322
Q ss_pred ceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 742 YSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 742 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
. ......|+..|+|||+..+. .++.++|+||+||+
T Consensus 173 ~-~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slGvi 207 (292)
T cd06658 173 P-KRKSLVGTPYWMAPEVISRL---PYGTEVDIWSLGIM 207 (292)
T ss_pred c-cCceeecCccccCHHHHccC---CCCchhhHHHHHHH
Confidence 1 12234688999999987653 45678999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=238.49 Aligned_cols=189 Identities=28% Similarity=0.428 Sum_probs=155.2
Q ss_pred cCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccC---ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC--CeE
Q 003982 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTM---GNKGLSEFQAEIAVLTKVRHRHLVALLGYCING--SER 654 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~--~~~ 654 (782)
.+|++.+.||+|++|.||+|. ..+++.||+|++..... .....+.+++|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 478999999999999999995 45689999998754321 233556889999999999999999999998764 457
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccc
Q 003982 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734 (782)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a 734 (782)
+++|||+++++|.+++.. ...+++..+..++.|++.|+.|||+ .|++||||||+||+++.++.++|+|||++
T Consensus 82 ~~v~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~ 153 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA-----YGALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGAS 153 (264)
T ss_pred EEEEEeCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccc
Confidence 899999999999998865 2347889999999999999999998 89999999999999999999999999999
Q ss_pred eecCCCCc--eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 735 KNAPDGKY--SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 735 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+....... .......|+..|+|||++.+. +.+.++|+||+|++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 198 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGE---GYGRKADVWSVACT 198 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcCC---CCCccccHHHHHHH
Confidence 76532111 111234588999999988764 34567899999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=240.52 Aligned_cols=190 Identities=26% Similarity=0.432 Sum_probs=156.9
Q ss_pred CCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCC--------hhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCC
Q 003982 582 NFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMG--------NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS 652 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--------~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~ 652 (782)
+|.+.+.||+|++|.||+|. ..+++.||+|.++..... ....+.+.+|+.++++++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 57788999999999999995 457899999988643211 112356788999999999999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeec
Q 003982 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (782)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG 732 (782)
..++||||+++++|.+++.+. ..+++..+..++.|++.|+.|||+ .+++||||+|+||+++.++.++++|||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~ 153 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFG 153 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeecc
Confidence 999999999999999998653 458899999999999999999998 899999999999999999999999999
Q ss_pred cceecCCCCce-eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 733 LVKNAPDGKYS-VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 733 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+++........ ......|+..|+|||.+.... .+.+.++|+||+|++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~~~Dv~slG~~ 201 (272)
T cd06629 154 ISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYS-QGYSAKVDIWSLGCV 201 (272)
T ss_pred ccccccccccccccccccCCccccCHHHhcccc-CCCCccchhHHHHHH
Confidence 98765432111 122345789999999876542 235678999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=237.37 Aligned_cols=188 Identities=32% Similarity=0.570 Sum_probs=157.0
Q ss_pred CCccceeecccceEEEEEEeCC-----CcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 583 FSEANILGRGGFGVVYGGELPD-----GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 583 y~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
+++.+.||+|+||.||++...+ +..||+|++..... ....+.+.+|+++++.++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 3567889999999999996543 47899999965432 22567899999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
|||+++++|.+++..... ..+++.++..++.|++.|++|||+ .|++||||||+||++++++.++|+|||.+...
T Consensus 80 ~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~ 153 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDL 153 (258)
T ss_pred EeccCCCCHHHHHHhhhh---ccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceec
Confidence 999999999999876321 128999999999999999999998 89999999999999999999999999999877
Q ss_pred CCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 738 PDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
............+++.|+|||...+. .++.++|+||+|++
T Consensus 154 ~~~~~~~~~~~~~~~~y~~Pe~~~~~---~~~~~~Di~slG~i 193 (258)
T smart00219 154 YDDDYYKKKGGKLPIRWMAPESLKDG---KFTSKSDVWSFGVL 193 (258)
T ss_pred ccccccccccCCCcccccChHHhccC---CCCcchhHHHHHHH
Confidence 65433222223367899999987543 46788999999976
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-29 Score=237.01 Aligned_cols=185 Identities=26% Similarity=0.389 Sum_probs=151.5
Q ss_pred ccceeecccceEEEEE-EeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCC-----eEEEEE
Q 003982 585 EANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS-----ERLLVY 658 (782)
Q Consensus 585 ~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~-----~~~lv~ 658 (782)
..+.||.|+||+||.+ +-++|+.||+|++..-...-...+++-+|++++..++|.|++..++...-.. +.|+++
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 3577999999999999 6678999999998654433346688999999999999999999988765432 457888
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
|.|. .+|.+.+-. .+.++...++-+.+||++||.|||+ .+|.||||||.|.+++++..+||+|||+|+.-+
T Consensus 137 ELmQ-SDLHKIIVS-----PQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 137 ELMQ-SDLHKIIVS-----PQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHH-hhhhheecc-----CCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccc
Confidence 9884 477776643 4678999999999999999999999 899999999999999999999999999999766
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.......+..+-|.+|+|||++.|. -.+.-+.||||+|+|
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGa--RhYs~AvDiWSVGCI 247 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGA--RRYTGAVDIWSVGCI 247 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcc--hhhcCccceehhhHH
Confidence 5443333445679999999998875 345667788888875
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=241.15 Aligned_cols=188 Identities=27% Similarity=0.468 Sum_probs=156.5
Q ss_pred CCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCC----hhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEE
Q 003982 582 NFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMG----NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~----~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 656 (782)
+|+..+.||+|++|.||+|. ..+++.||+|++...... ....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 47888999999999999995 467899999998754321 1245778999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCC-cEEEEeeccce
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM-RAKVADFGLVK 735 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~-~~kL~DfG~a~ 735 (782)
||||+++++|.+++.+ ..++++..+..++.|++.||.|||+ .|++||||||+||+++.++ .+||+|||.+.
T Consensus 81 v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~ 152 (268)
T cd06630 81 FVEWMAGGSVSHLLSK-----YGAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAA 152 (268)
T ss_pred EEeccCCCcHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccccccc
Confidence 9999999999999865 2458899999999999999999998 8999999999999998775 69999999987
Q ss_pred ecCCCCce---eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 736 NAPDGKYS---VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 736 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
........ ......|+..|+|||++.+. ..+.++|+||+|++
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~---~~~~~~Dv~slG~~ 197 (268)
T cd06630 153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE---QYGRSCDVWSVGCV 197 (268)
T ss_pred ccccccccCCccccccccccceeCHhHhccC---CCCcccchHHHHHH
Confidence 76543211 11234678899999987654 34677899999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=238.51 Aligned_cols=190 Identities=27% Similarity=0.449 Sum_probs=155.0
Q ss_pred hcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
.+.+.....||+|+||.||+|. ..++..||+|.+.... ....+.+.+|++++++++|+||+++++++.+++..++++
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 3445556789999999999995 4467889999887543 345578999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCC--CHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECC-CCcEEEEeeccce
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPL--TWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD-DMRAKVADFGLVK 735 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l--~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~-~~~~kL~DfG~a~ 735 (782)
||+++++|.+++.... ..+ ++..+..++.|++.|++|||+ .||+||||||+||+++. ++.+||+|||.+.
T Consensus 85 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 85 EQVPGGSLSALLRSKW----GPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred ecCCCCCHHHHHHHhc----ccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 9999999999987521 234 778889999999999999998 89999999999999976 6799999999987
Q ss_pred ecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 736 NAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 736 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
....... ......|++.|+|||++.... .++..++|+||+||+
T Consensus 158 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~-~~~~~~~Dv~slGvv 200 (268)
T cd06624 158 RLAGINP-CTETFTGTLQYMAPEVIDKGP-RGYGAPADIWSLGCT 200 (268)
T ss_pred ecccCCC-ccccCCCCccccChhhhcccc-ccCCchhhhHHHHHH
Confidence 6543221 112235789999999875531 135678999999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.5e-27 Score=241.90 Aligned_cols=186 Identities=26% Similarity=0.392 Sum_probs=159.6
Q ss_pred CCCccceeecccceEEEEEEeC-CCcEEEEEEeccccCCh-hhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 582 NFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGN-KGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
+|++.+.||+|+||.||+|... +++.||+|++....... ...+.+.+|++++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5888999999999999999654 68999999997654322 456789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++++|.+++... .++++.++..++.|+++||.|||+ .|++|+||+|+||++++++.++|+|||.+.....
T Consensus 81 ~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 152 (258)
T cd05578 81 LLLGGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP 152 (258)
T ss_pred CCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence 99999999998652 468899999999999999999998 8999999999999999999999999999887654
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.. ......|+..|+|||++.+. ..+.++|+||+|++
T Consensus 153 ~~--~~~~~~~~~~y~~PE~~~~~---~~~~~~Di~slG~~ 188 (258)
T cd05578 153 DT--LTTSTSGTPGYMAPEVLCRQ---GYSVAVDWWSLGVT 188 (258)
T ss_pred Cc--cccccCCChhhcCHHHHccc---CCCCcccchhhHHH
Confidence 32 11234578899999987764 25677889999876
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=245.55 Aligned_cols=183 Identities=27% Similarity=0.408 Sum_probs=154.1
Q ss_pred CCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEcc
Q 003982 583 FSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYM 661 (782)
Q Consensus 583 y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~ 661 (782)
|+....||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..+++|||+
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc--cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 33455799999999999954 578999999986543 234567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCC
Q 003982 662 PRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK 741 (782)
Q Consensus 662 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~ 741 (782)
++++|.+++.. ..+++..+..++.|++.||+|||+ .|++||||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~ 171 (297)
T cd06659 101 QGGALTDIVSQ------TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 171 (297)
T ss_pred CCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccc
Confidence 99999987743 347899999999999999999998 899999999999999999999999999987654322
Q ss_pred ceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 742 YSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 742 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
. ......|+..|+|||++.+. .++.++|+||+|++
T Consensus 172 ~-~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~i 206 (297)
T cd06659 172 P-KRKSLVGTPYWMAPEVISRT---PYGTEVDIWSLGIM 206 (297)
T ss_pred c-cccceecCccccCHHHHccC---CCCchhhHHHHHHH
Confidence 1 12234689999999998764 45778999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-26 Score=239.36 Aligned_cols=188 Identities=27% Similarity=0.450 Sum_probs=154.0
Q ss_pred cCCCccceeecccceEEEEEEeC-CCc----EEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEE
Q 003982 581 DNFSEANILGRGGFGVVYGGELP-DGT----KIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL 655 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~ 655 (782)
.+|++.+.||+|+||.||+|... ++. .||+|.+..... .....++.+|+.++++++||||+++++++.. ...+
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 56888999999999999999643 333 589998865542 3455778999999999999999999999887 7889
Q ss_pred EEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccce
Q 003982 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (782)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~ 735 (782)
+||||+++|+|.+++... ...+++..+..++.|++.|++|||+ .|++||||||+||++++++.+||+|||.++
T Consensus 85 ~v~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 85 LITQLMPLGCLLDYVRNH----KDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred EEEecCCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccc
Confidence 999999999999998652 2348999999999999999999998 899999999999999999999999999998
Q ss_pred ecCCCCceee-ecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 736 NAPDGKYSVE-TRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 736 ~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.......... ....++..|+|||..... ....++|+||+|++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~---~~~~~~Di~slG~~ 200 (279)
T cd05057 158 LLDVDEKEYHAEGGKVPIKWMALESILHR---IYTHKSDVWSYGVT 200 (279)
T ss_pred cccCcccceecCCCcccccccCHHHhhcC---CcCchhhHHHHHHH
Confidence 7654322111 112235689999987543 45678999999975
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=243.42 Aligned_cols=186 Identities=27% Similarity=0.485 Sum_probs=157.6
Q ss_pred cCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
+.|+..+.||+|+||.||+|. ..+++.||+|.+..... ....+.+.+|++++++++||||+++++++..+...++|||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 346677889999999999995 45678999999875432 3455789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++++|.+++.. ..+++..+..++.|+++|+.|||+ .|++|+||+|+||++++++.++|+|||++.....
T Consensus 83 ~~~~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 83 YLGGGSALDLLKP------GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred ccCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccC
Confidence 9999999988743 357899999999999999999998 8999999999999999999999999999876654
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... ......|+..|+|||++.+. ....++|+||+|++
T Consensus 154 ~~~-~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~i 190 (277)
T cd06642 154 TQI-KRNTFVGTPFWMAPEVIKQS---AYDFKADIWSLGIT 190 (277)
T ss_pred cch-hhhcccCcccccCHHHhCcC---CCchhhhHHHHHHH
Confidence 321 11234578899999998765 45678999999986
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=242.37 Aligned_cols=189 Identities=27% Similarity=0.391 Sum_probs=156.7
Q ss_pred CCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEc
Q 003982 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 660 (782)
+|+..+.||+|++|.||+|.. .+++.||||++............+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 488899999999999999955 4789999999876543334456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~ 740 (782)
+. ++|.+++.... ...+++..+..++.|++.||+|||+ .|++||||+|+||++++++.+||+|||++......
T Consensus 81 ~~-~~l~~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 81 LH-QDLKKFMDASP---LSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 153 (284)
T ss_pred cc-cCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 95 68888876522 2458999999999999999999998 89999999999999999999999999998765432
Q ss_pred CceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 741 KYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.. ......+++.|+|||+..+. ..+..++|+||+|++
T Consensus 154 ~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~i 190 (284)
T cd07860 154 VR-TYTHEVVTLWYRAPEILLGC--KYYSTAVDIWSLGCI 190 (284)
T ss_pred cc-ccccccccccccCCeEEecC--CCCCcHHHHHHHHHH
Confidence 21 11223568899999987653 124667999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=240.21 Aligned_cols=186 Identities=26% Similarity=0.488 Sum_probs=157.9
Q ss_pred CCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC---CCCcceEEeEEEeCCeEEEE
Q 003982 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR---HRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~nI~~~~~~~~~~~~~~lv 657 (782)
.|+..+.||+|+||.||+|.. .+++.||+|++.... .....+++.+|++++++++ |||++++++++.+....++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 477889999999999999964 578999999987543 2345677889999999997 99999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
|||+++++|.+++.. ..+++..+..++.|++.|+.|||+ .||+||||+|+||++++++.++|+|||.+...
T Consensus 81 ~e~~~~~~L~~~~~~------~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06917 81 MEYAEGGSVRTLMKA------GPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALL 151 (277)
T ss_pred EecCCCCcHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence 999999999988754 258899999999999999999998 89999999999999999999999999999877
Q ss_pred CCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 738 PDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..... ......|+..|+|||++.+. .....++|+||+||+
T Consensus 152 ~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~~ 191 (277)
T cd06917 152 NQNSS-KRSTFVGTPYWMAPEVITEG--KYYDTKADIWSLGIT 191 (277)
T ss_pred CCCcc-ccccccCCcceeCHHHhccC--CccccchhHHHHHHH
Confidence 65432 22334689999999987643 234568999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=242.62 Aligned_cols=186 Identities=25% Similarity=0.390 Sum_probs=157.3
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
++|++.+.||+|++|+||++.. .+++.||+|++.... .....+.+.+|+++++.++||||+++++++......++|||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 5688899999999999999954 468899999886543 23456789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++++|.+++.. .+.+++..+..++.+++.|+.|||+ ..+++||||||+||++++++.++|+|||++.....
T Consensus 84 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 84 FMDCGSLDRIYKK-----GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred cCCCCCHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 9999999988765 2458999999999999999999996 25899999999999999999999999999865433
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.. .....|+..|+|||++.+. ..+.++|+||+||+
T Consensus 157 ~~---~~~~~~~~~~~aPE~~~~~---~~~~~~Di~slG~~ 191 (284)
T cd06620 157 SI---ADTFVGTSTYMSPERIQGG---KYTVKSDVWSLGIS 191 (284)
T ss_pred hc---cCccccCcccCCHHHHccC---CCCccchHHHHHHH
Confidence 21 1234689999999987653 44668899999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=243.15 Aligned_cols=199 Identities=25% Similarity=0.336 Sum_probs=160.4
Q ss_pred HHHHHHhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeC
Q 003982 574 EVLRQVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCING 651 (782)
Q Consensus 574 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~ 651 (782)
+.+....++|.+.+.||+|+||.||+|.. .+++.+|+|++.... .....+.+|+.+++++ +||||+++++++...
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 44445678899999999999999999954 578899999986532 2345678899999998 799999999998754
Q ss_pred -----CeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcE
Q 003982 652 -----SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRA 726 (782)
Q Consensus 652 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~ 726 (782)
+..++||||+++++|.+++...... ...+++..+..++.|++.||+|||+ .|++||||||+||++++++.+
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLIC-GQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCE
Confidence 3579999999999999988654322 3458999999999999999999998 899999999999999999999
Q ss_pred EEEeeccceecCCCCceeeecccccccccCccccccc--hhhhHHHHHHHHHhccc
Q 003982 727 KVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKH--WMILCQMTGLIWLHGSV 780 (782)
Q Consensus 727 kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~dvws~Gvv 780 (782)
||+|||++......... .....|+..|+|||++... .....+.++|+||+||+
T Consensus 168 kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi 222 (291)
T cd06639 168 KLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGIT 222 (291)
T ss_pred EEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHH
Confidence 99999998866543221 1234688999999987542 11234678999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=237.60 Aligned_cols=177 Identities=23% Similarity=0.406 Sum_probs=146.2
Q ss_pred ceeecccceEEEEEEeCCCc-----------EEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEE
Q 003982 587 NILGRGGFGVVYGGELPDGT-----------KIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL 655 (782)
Q Consensus 587 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~ 655 (782)
+.||+|+||.||+|...+.. .+++|++.... .....+.+|+.++++++||||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 46899999999999664332 57888776543 126788999999999999999999999988 7789
Q ss_pred EEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCC-------cEEE
Q 003982 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM-------RAKV 728 (782)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~-------~~kL 728 (782)
+||||+++|+|.+++.... ..+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .+||
T Consensus 77 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl 149 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREK----NNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKL 149 (259)
T ss_pred EEEEcCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEe
Confidence 9999999999999987632 258899999999999999999998 8999999999999999887 7999
Q ss_pred EeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 729 ADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 729 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+|||++...... ....++..|+|||++.+.- .....++|+||+|++
T Consensus 150 ~Dfg~a~~~~~~-----~~~~~~~~y~aPE~~~~~~-~~~~~~~Di~slG~~ 195 (259)
T cd05037 150 SDPGIPITVLSR-----EERVERIPWIAPECIRNGQ-ASLTIAADKWSFGTT 195 (259)
T ss_pred CCCCcccccccc-----cccccCCCccChhhhcCCC-CCcchhhHHHHHHHH
Confidence 999999865441 1234677899999976541 235678999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-26 Score=237.53 Aligned_cols=189 Identities=26% Similarity=0.455 Sum_probs=155.3
Q ss_pred cCCCccceeecccceEEEEEEeC-CC---cEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGELP-DG---TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 656 (782)
.+|+..+.||+|++|.||+|... ++ ..+|+|.++... .....+++..|++++++++||||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 46788899999999999999653 33 379999886543 23446778999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecccee
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~ 736 (782)
||||+++++|.+++... ...+++.++..++.|++.|++|||+ .|++||||||+||++++++.+||+|||++..
T Consensus 84 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 84 ITEYMENGALDKYLRDH----DGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred EEEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCcccee
Confidence 99999999999998652 2458999999999999999999998 8999999999999999999999999999886
Q ss_pred cCCCCceeee--cccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 737 APDGKYSVET--RLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 737 ~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.......... ....++.|+|||++... ..+.++|+||+||+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~---~~~~~~Dv~slG~i 199 (268)
T cd05063 157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYR---KFTSASDVWSFGIV 199 (268)
T ss_pred cccccccceeccCCCcCceecCHHHhhcC---CcChHhHHHHHHHH
Confidence 6543221111 11234579999987653 35678999999976
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-26 Score=243.93 Aligned_cols=190 Identities=30% Similarity=0.407 Sum_probs=155.2
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC--CeEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING--SERLL 656 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~--~~~~l 656 (782)
.++|++.+.||+|+||.||+|.. .+|+.||+|+++...........+.+|++++++++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 46799999999999999999954 5689999999976543333344567899999999999999999998765 56899
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecccee
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~ 736 (782)
||||++ ++|.+++.... ..+++.++..++.|++.|++|||+ .|++||||||+||++++++.+||+|||.+..
T Consensus 86 v~e~~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~ 157 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLART 157 (309)
T ss_pred EEecCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeee
Confidence 999996 58888876532 458999999999999999999998 8999999999999999999999999999987
Q ss_pred cCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 737 APDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
...... ......+++.|+|||++.+. ...+.++|+||+|++
T Consensus 158 ~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslG~i 198 (309)
T cd07845 158 YGLPAK-PMTPKVVTLWYRAPELLLGC--TTYTTAIDMWAVGCI 198 (309)
T ss_pred cCCccC-CCCcccccccccChhhhcCC--CCcCchHHHHHHHHH
Confidence 654321 11223457889999987653 124668999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-26 Score=238.38 Aligned_cols=186 Identities=26% Similarity=0.472 Sum_probs=158.6
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
..|+..+.||+|+||.||+|.. .+++.||+|+++... .....+.+.+|++++++++||||+++++++.++...++|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 4577788999999999999965 468899999987543 23456789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++++|.+++.. .++++.++..++.|++.|++|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 83 ~~~~~~L~~~i~~------~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 83 YLGGGSALDLLRA------GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred cCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 9999999998853 357889999999999999999998 8999999999999999999999999999977654
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... ......++..|+|||++.+. ..+.++|+||+|++
T Consensus 154 ~~~-~~~~~~~~~~y~apE~~~~~---~~~~~~Dv~slG~i 190 (277)
T cd06640 154 TQI-KRNTFVGTPFWMAPEVIQQS---AYDSKADIWSLGIT 190 (277)
T ss_pred Ccc-ccccccCcccccCHhHhccC---CCccHHHHHHHHHH
Confidence 332 12234578899999998765 35778999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-26 Score=237.81 Aligned_cols=192 Identities=28% Similarity=0.484 Sum_probs=154.6
Q ss_pred CCccceeecccceEEEEEEeC----CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCC------
Q 003982 583 FSEANILGRGGFGVVYGGELP----DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS------ 652 (782)
Q Consensus 583 y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~------ 652 (782)
|++.+.||+|+||.||+|... +++.||||++..........+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567889999999999999542 4688999999776555556778999999999999999999999886542
Q ss_pred eEEEEEEccCCCCHHHHHHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEee
Q 003982 653 ERLLVYEYMPRGTLAQHLFEWHD-HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADF 731 (782)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~Df 731 (782)
..++++||+++|+|.+++..... .....+++..+..++.|++.|++|||+ .||+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence 24789999999999988754321 122357889999999999999999998 89999999999999999999999999
Q ss_pred ccceecCCCCce-eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 732 GLVKNAPDGKYS-VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 732 G~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|+++........ ......+++.|++||.+.+. ..+.++|+||+|++
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~---~~~~~sDi~slG~i 204 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADN---VYTTHSDVWAFGVT 204 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcC---ccchhhhhHHHHHH
Confidence 999876443321 11223456789999987664 45678999999976
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-26 Score=248.56 Aligned_cols=187 Identities=27% Similarity=0.374 Sum_probs=155.0
Q ss_pred HHhcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC-----
Q 003982 578 QVTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING----- 651 (782)
Q Consensus 578 ~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~----- 651 (782)
...++|++.+.||+|+||.||+|. ..+++.||+|++..........+++.+|++++++++||||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 356789999999999999999995 45789999999875443344556788899999999999999999988644
Q ss_pred -CeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEe
Q 003982 652 -SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVAD 730 (782)
Q Consensus 652 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~D 730 (782)
...|+||||+. +++.+.+.. .+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~D 161 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILD 161 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEcc
Confidence 35699999995 588887743 27888999999999999999998 8999999999999999999999999
Q ss_pred eccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 731 FGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 731 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
||+++....... .....+++.|+|||++.+. +++.++|+||+||+
T Consensus 162 fg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~~ 206 (353)
T cd07850 162 FGLARTAGTSFM--MTPYVVTRYYRAPEVILGM---GYKENVDIWSVGCI 206 (353)
T ss_pred CccceeCCCCCC--CCCCcccccccCHHHHhCC---CCCCchhhHhHHHH
Confidence 999987654321 2234578999999988664 45678899999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-26 Score=239.16 Aligned_cols=180 Identities=27% Similarity=0.389 Sum_probs=145.0
Q ss_pred eeecccceEEEEEEe-CCCcEEEEEEeccccCChh-hHHHHHHHHHHHHh---cCCCCcceEEeEEEeCCeEEEEEEccC
Q 003982 588 ILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNK-GLSEFQAEIAVLTK---VRHRHLVALLGYCINGSERLLVYEYMP 662 (782)
Q Consensus 588 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~---l~h~nI~~~~~~~~~~~~~~lv~e~~~ 662 (782)
.||+|+||.||++.. .+++.||+|.+.+...... ....+.+|..+++. .+||+|+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999955 5688999999876543222 22334445444433 469999999999999999999999999
Q ss_pred CCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCc
Q 003982 663 RGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742 (782)
Q Consensus 663 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~ 742 (782)
+++|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||++........
T Consensus 81 ~~~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~ 152 (279)
T cd05633 81 GGDLHYHLSQ-----HGVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 152 (279)
T ss_pred CCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc
Confidence 9999988865 2458999999999999999999998 8999999999999999999999999999876543221
Q ss_pred eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 743 SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 743 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
....|++.|+|||+..+. ..++.++|+||+||+
T Consensus 153 ---~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~~ 185 (279)
T cd05633 153 ---HASVGTHGYMAPEVLQKG--TAYDSSADWFSLGCM 185 (279)
T ss_pred ---cCcCCCcCccCHHHhcCC--CCCCchhhhHHHHHH
Confidence 224689999999987642 235678999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-26 Score=237.35 Aligned_cols=185 Identities=32% Similarity=0.527 Sum_probs=147.9
Q ss_pred ceeecccceEEEEEEeC-CCc--EEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCCeEEEEEEccC
Q 003982 587 NILGRGGFGVVYGGELP-DGT--KIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLLVYEYMP 662 (782)
Q Consensus 587 ~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~lv~e~~~ 662 (782)
+.||+|+||.||+|... ++. .+|+|.++... .....+.+.+|+++++++ +||||+++++++...+..+++|||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 36899999999999654 343 46888876432 234556889999999999 79999999999999999999999999
Q ss_pred CCCHHHHHHhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEee
Q 003982 663 RGTLAQHLFEWHDH-----------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADF 731 (782)
Q Consensus 663 ~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~Df 731 (782)
+++|.+++...+.. ....+++.++..++.|++.|++|||+ .|++||||||+||++++++.+||+||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCC
Confidence 99999998764311 12347899999999999999999998 89999999999999999999999999
Q ss_pred ccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 732 GLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 732 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|++....... .......+..|+|||++.+. ..+.++|+||||++
T Consensus 157 gl~~~~~~~~--~~~~~~~~~~y~apE~~~~~---~~~~~~Di~slG~i 200 (270)
T cd05047 157 GLSRGQEVYV--KKTMGRLPVRWMAIESLNYS---VYTTNSDVWSYGVL 200 (270)
T ss_pred CCccccchhh--hccCCCCccccCChHHHccC---CCCchhhHHHHHHH
Confidence 9986432111 11112235679999987654 45778999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-26 Score=241.20 Aligned_cols=186 Identities=27% Similarity=0.460 Sum_probs=158.1
Q ss_pred hcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
.++|.+.+.||+|+||.||++. ..+++.||+|.+.... ....+.+.+|+.++++++||||+++++++......++|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 3678999999999999999995 4578899999986543 234567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++++|.+++.+ ..+++.++..++.|++.|+.|||+ .|++||||||+||+++.++.+||+|||++....
T Consensus 96 e~~~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~ 166 (293)
T cd06647 96 EYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (293)
T ss_pred ecCCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccc
Confidence 99999999998864 247889999999999999999998 899999999999999999999999999987665
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..... .....|++.|+|||++.+. ..+.++|+||+|++
T Consensus 167 ~~~~~-~~~~~~~~~y~~PE~~~~~---~~~~~~Dv~slG~l 204 (293)
T cd06647 167 PEQSK-RSTMVGTPYWMAPEVVTRK---AYGPKVDIWSLGIM 204 (293)
T ss_pred ccccc-cccccCChhhcCchhhccC---CCCchhhHHHHHHH
Confidence 43321 1234688899999987653 34668999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.2e-26 Score=235.50 Aligned_cols=181 Identities=30% Similarity=0.482 Sum_probs=147.8
Q ss_pred ceeecccceEEEEEEeC-C---CcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEccC
Q 003982 587 NILGRGGFGVVYGGELP-D---GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMP 662 (782)
Q Consensus 587 ~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~ 662 (782)
+.||+|+||.||+|... . +..||+|.+...... ...+++.+|++++++++||||+++++++. ....++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 46899999999999542 2 268999999765532 45577899999999999999999999876 456899999999
Q ss_pred CCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCc
Q 003982 663 RGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742 (782)
Q Consensus 663 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~ 742 (782)
+++|.+++... ..+++..+..++.|++.|++|||+ .+++||||||+||+++.++.+||+|||.++.......
T Consensus 79 ~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 79 LGPLLKYLKKR-----REIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred CCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 99999999752 258999999999999999999998 8999999999999999999999999999986644332
Q ss_pred eee--ecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 743 SVE--TRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 743 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... ....++..|+|||+..+. .++.++|+||+|++
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~ 187 (257)
T cd05060 151 YYRATTAGRWPLKWYAPECINYG---KFSSKSDVWSYGVT 187 (257)
T ss_pred ccccccCccccccccCHHHhcCC---CCCccchHHHHHHH
Confidence 111 111235679999987654 45678999999976
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-26 Score=235.48 Aligned_cols=181 Identities=34% Similarity=0.545 Sum_probs=151.9
Q ss_pred cCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEc
Q 003982 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 660 (782)
++|++.+.||+|+||.||++.. +++.||+|.+.... ..+.+.+|+.++++++||||+++++++... ..+++|||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence 5688999999999999999975 67889999986532 346789999999999999999999998654 57999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~ 740 (782)
+++++|.+++.... ...+++..+..++.|++.|+.|||+ .|++||||||+||+++.++.+||+|||++......
T Consensus 80 ~~~~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 80 MSKGNLVNFLRTRG---RALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred CCCCCHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence 99999999987532 2357899999999999999999998 89999999999999999999999999998765432
Q ss_pred CceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 741 KYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
. .....+..|+|||++.+. .++.++|+||+|++
T Consensus 154 ~----~~~~~~~~y~~pe~~~~~---~~~~~~Dv~slG~~ 186 (254)
T cd05083 154 V----DNSKLPVKWTAPEALKHK---KFSSKSDVWSYGVL 186 (254)
T ss_pred C----CCCCCCceecCHHHhccC---CcCchhhHHHHHHH
Confidence 1 112345689999988654 35678999999976
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=242.93 Aligned_cols=193 Identities=25% Similarity=0.354 Sum_probs=157.1
Q ss_pred HHhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCC----
Q 003982 578 QVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS---- 652 (782)
Q Consensus 578 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~---- 652 (782)
...++|++.+.||+|++|.||+|.. .+++.||+|+++...........+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 4567899999999999999999965 46889999999765433444567889999999999999999999987654
Q ss_pred ------eEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcE
Q 003982 653 ------ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRA 726 (782)
Q Consensus 653 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~ 726 (782)
..++|+||+++ ++...+... ...+++..+..++.|++.||+|||+ .||+||||||+||++++++.+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~ 155 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG----LVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQI 155 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcE
Confidence 78999999975 777776542 2358999999999999999999998 899999999999999999999
Q ss_pred EEEeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 727 KVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 727 kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
||+|||.+...............++..|+|||++.+. ...+.++|+||+||+
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~~Di~slG~~ 207 (302)
T cd07864 156 KLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGE--ERYGPAIDVWSCGCI 207 (302)
T ss_pred EeCcccccccccCCcccccccceeccCccChHHhcCC--CCCCchhHHHHHHHH
Confidence 9999999987654332111223467889999987543 134668999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-26 Score=241.75 Aligned_cols=189 Identities=28% Similarity=0.484 Sum_probs=152.7
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCc----EEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGT----KIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSER 654 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~ 654 (782)
.++|+..+.||+|+||.||+|.. .++. .||+|.+.... ......++.+|+.++++++||||+++++++... ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 35678899999999999999954 3444 47888886543 233445788999999999999999999998754 46
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccc
Q 003982 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734 (782)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a 734 (782)
++++||+++|+|.+++... ...+++..+..++.|++.||+|||+ .||+||||||+||++++++.+||+|||++
T Consensus 84 ~~v~e~~~~g~l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~ 156 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEH----KDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLA 156 (303)
T ss_pred eeeehhcCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEcccccc
Confidence 7999999999999998652 2347899999999999999999998 89999999999999999999999999999
Q ss_pred eecCCCCce-eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 735 KNAPDGKYS-VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 735 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+........ ......++..|+|||++.+. .++.++||||+|++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~---~~~~~~DiwslG~~ 200 (303)
T cd05110 157 RLLEGDEKEYNADGGKMPIKWMALECIHYR---KFTHQSDVWSYGVT 200 (303)
T ss_pred ccccCcccccccCCCccccccCCHHHhccC---CCChHHHHHHHHHH
Confidence 876533221 11223456789999987654 45788999999975
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-26 Score=235.37 Aligned_cols=183 Identities=30% Similarity=0.518 Sum_probs=146.5
Q ss_pred ceeecccceEEEEEEeC----CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEE-eCCeEEEEEEcc
Q 003982 587 NILGRGGFGVVYGGELP----DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCI-NGSERLLVYEYM 661 (782)
Q Consensus 587 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~-~~~~~~lv~e~~ 661 (782)
+.||+|+||.||+|... +...||+|++.... .....+.+.+|+.+++.++||||+++++++. .++..+++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 46899999999999642 24579999885432 2345678889999999999999999999776 455679999999
Q ss_pred CCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCC
Q 003982 662 PRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK 741 (782)
Q Consensus 662 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~ 741 (782)
++++|.+++.... ...++..+..++.|++.|+.|||+ .+++||||||+||++++++.+||+|||+++......
T Consensus 80 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~ 152 (262)
T cd05058 80 KHGDLRNFIRSET----HNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE 152 (262)
T ss_pred CCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence 9999999986521 235778889999999999999998 899999999999999999999999999997654322
Q ss_pred cee---eecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 742 YSV---ETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 742 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... .....++..|+|||+.... +...++||||+|++
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~ 191 (262)
T cd05058 153 YYSVHNHTGAKLPVKWMALESLQTQ---KFTTKSDVWSFGVL 191 (262)
T ss_pred ceeecccccCcCCccccChhHhccC---ccchHHHHHHHHHH
Confidence 111 1123457789999987653 45778999999986
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-29 Score=250.55 Aligned_cols=301 Identities=24% Similarity=0.325 Sum_probs=178.8
Q ss_pred ccCccccCCccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccC
Q 003982 81 TLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELT 160 (782)
Q Consensus 81 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~ 160 (782)
++|++++.+.+|+.|+|..|.|...| +|.++..|.+|+++.|.|+.+|.....++++|.+|||.+|++.+ .|..+.
T Consensus 197 tlP~~lg~l~~L~~LyL~~Nki~~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklke---~Pde~c 272 (565)
T KOG0472|consen 197 TLPPELGGLESLELLYLRRNKIRFLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLKE---VPDEIC 272 (565)
T ss_pred cCChhhcchhhhHHHHhhhcccccCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeecccccccc---CchHHH
Confidence 44555555555555555555554332 45555555555555555555555555555555566666665555 555555
Q ss_pred CCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCcccccc----ccchhhc--ccccCC-------Ccc-
Q 003982 161 KSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKS----DIQNLWM--NDQQLG-------LSG- 226 (782)
Q Consensus 161 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~----~l~~l~l--~~~~~~-------~~~- 226 (782)
-+++|+.||+++|.|++. |..++++ +|+.|-+.+|.+. ++..++-.. -+++|.- -+-++. ..+
T Consensus 273 lLrsL~rLDlSNN~is~L-p~sLgnl-hL~~L~leGNPlr-TiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t 349 (565)
T KOG0472|consen 273 LLRSLERLDLSNNDISSL-PYSLGNL-HLKFLALEGNPLR-TIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMT 349 (565)
T ss_pred HhhhhhhhcccCCccccC-Ccccccc-eeeehhhcCCchH-HHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCC
Confidence 555566666666655554 4455555 5555556555544 222221110 0111110 000000 000
Q ss_pred ----ccccccCCCC--------------------------CcEEEeecccccCCCCCCCCCCCCCE-EEcCCCcCccCcc
Q 003982 227 ----TLDVLSGMTQ--------------------------LRQVWLHKNQFTGPIPDLSKCESLFD-LSLRDNQLTGVVP 275 (782)
Q Consensus 227 ----~~~~~~~l~~--------------------------L~~L~L~~N~l~~~~~~~~~l~~L~~-L~L~~N~l~~~~p 275 (782)
.......+.+ ....+++.|++...|..+..++.+.+ +++++|.++ .+|
T Consensus 350 ~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~is-fv~ 428 (565)
T KOG0472|consen 350 LPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKIS-FVP 428 (565)
T ss_pred CCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccc-cch
Confidence 0011111223 44555555555555545554544444 344444444 777
Q ss_pred hhhcCCCCCCEEEccCCcccCCCCCC--CCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCC
Q 003982 276 ASVISLPALLNISLQNNKLQGPYPLF--PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGN 353 (782)
Q Consensus 276 ~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (782)
..++.+++|+.|+|++|.+...+..+ +..|+.|++++|+|.
T Consensus 429 ~~l~~l~kLt~L~L~NN~Ln~LP~e~~~lv~Lq~LnlS~NrFr------------------------------------- 471 (565)
T KOG0472|consen 429 LELSQLQKLTFLDLSNNLLNDLPEEMGSLVRLQTLNLSFNRFR------------------------------------- 471 (565)
T ss_pred HHHHhhhcceeeecccchhhhcchhhhhhhhhheecccccccc-------------------------------------
Confidence 88888888888888888887544443 235888888888774
Q ss_pred CCCCCCCcccccCCceeEEEccCcccccccCccccccccCCeEecccccccccCCccCCCCCCCCeEecCCCcCCCCCC
Q 003982 354 NACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVP 432 (782)
Q Consensus 354 ~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p 432 (782)
.+|.+......++++-.++|+++..-|..+.+|.+|..|||.+|.+. .||..++++++|+.|+|++|++. .|+
T Consensus 472 ----~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr-~Pr 544 (565)
T KOG0472|consen 472 ----MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR-QPR 544 (565)
T ss_pred ----cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC-CCH
Confidence 44555555566777777889998766667999999999999999999 89999999999999999999998 444
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.1e-26 Score=236.42 Aligned_cols=185 Identities=27% Similarity=0.467 Sum_probs=156.9
Q ss_pred CCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEc
Q 003982 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 660 (782)
-|+..+.||+|+||.||+|.. .+++.||+|++..... ....+.+.+|++++++++||||+++++++.++...++||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 467788999999999999954 5788999999865432 34457789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~ 740 (782)
+++++|.+++.. ..+++..+..++.|++.|+.|||+ .|++|+||||+||+++.++.++|+|||++......
T Consensus 84 ~~~~~l~~~i~~------~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06641 84 LGGGSALDLLEP------GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 154 (277)
T ss_pred CCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccc
Confidence 999999998853 357899999999999999999998 89999999999999999999999999998766543
Q ss_pred CceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 741 KYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.. ......++..|+|||++.+. ....++|+||+||+
T Consensus 155 ~~-~~~~~~~~~~y~~PE~~~~~---~~~~~~Dv~slG~~ 190 (277)
T cd06641 155 QI-KRNTFVGTPFWMAPEVIKQS---AYDSKADIWSLGIT 190 (277)
T ss_pred hh-hhccccCCccccChhhhccC---CCCchhhHHHHHHH
Confidence 21 12234678899999988654 34668999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=239.57 Aligned_cols=178 Identities=20% Similarity=0.363 Sum_probs=146.3
Q ss_pred ceeecccceEEEEEEeC-C-------CcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 587 NILGRGGFGVVYGGELP-D-------GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 587 ~~lg~G~~g~Vy~~~~~-~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
+.||+|+||.||+|... . ...||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 46899999999999542 2 2348888876433 344567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCc--------EEEEe
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR--------AKVAD 730 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~--------~kL~D 730 (782)
||+++|+|.+++... ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++. ++++|
T Consensus 79 e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 79 EYVKFGSLDTYLKKN----KNLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD 151 (258)
T ss_pred ecCCCCcHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecc
Confidence 999999999998652 2257899999999999999999998 89999999999999987765 69999
Q ss_pred eccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 731 FGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 731 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
||.+....... ...+++.|+|||++.+.. ..+.++|+||+|++
T Consensus 152 ~g~~~~~~~~~-----~~~~~~~y~aPE~~~~~~--~~~~~~DiwslG~~ 194 (258)
T cd05078 152 PGISITVLPKE-----ILLERIPWVPPECIENPQ--NLSLAADKWSFGTT 194 (258)
T ss_pred cccccccCCch-----hccccCCccCchhccCCC--CCCchhhHHHHHHH
Confidence 99886554322 235788999999987631 24668999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-27 Score=245.98 Aligned_cols=188 Identities=29% Similarity=0.501 Sum_probs=160.9
Q ss_pred cCCCccceeecccceEEEEEEeCC-CcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGELPD-GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
.+.....+||-|-||.||.|.|+. .-.||||.++.+. .+.++|..|+.+|+.++|||+|+++|+|..+..+|||+|
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt---MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE 343 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE 343 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc---hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence 344557889999999999998854 5679999997654 577999999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
||..|+|.++|+++.+. .++.-..++++.||..|++||.. +++|||||.++|+||.++..||++|||+++.+..
T Consensus 344 fM~yGNLLdYLRecnr~---ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg 417 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNRS---EVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG 417 (1157)
T ss_pred cccCccHHHHHHHhchh---hcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence 99999999999987543 46667788999999999999998 8999999999999999999999999999999877
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+.|.......-.+.|.|||-+.-. ....++|||+|||+
T Consensus 418 DTYTAHAGAKFPIKWTAPEsLAyN---tFSiKSDVWAFGVL 455 (1157)
T KOG4278|consen 418 DTYTAHAGAKFPIKWTAPESLAYN---TFSIKSDVWAFGVL 455 (1157)
T ss_pred CceecccCccCcccccCccccccc---ccccchhhHHHHHH
Confidence 665443222336789999976543 44678999999985
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-26 Score=245.47 Aligned_cols=189 Identities=25% Similarity=0.417 Sum_probs=156.7
Q ss_pred HHHHhcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCC--
Q 003982 576 LRQVTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS-- 652 (782)
Q Consensus 576 l~~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~-- 652 (782)
+..+.++|++.+.||+|++|.||+|. ..+++.||||++..........+.+.+|++++++++||||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 34467889999999999999999994 557899999998654433345567889999999999999999999987653
Q ss_pred ----eEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEE
Q 003982 653 ----ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKV 728 (782)
Q Consensus 653 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL 728 (782)
..++||||+ +++|.+++.. ..+++..+..++.|+++|++|||+ .||+||||||+||+++.++.+||
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl 159 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKI 159 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEE
Confidence 458999999 7788887743 358999999999999999999998 89999999999999999999999
Q ss_pred EeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 729 ADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 729 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+|||++....... ....+++.|+|||++.+. .....++|+||+|++
T Consensus 160 ~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~l 205 (343)
T cd07880 160 LDFGLARQTDSEM----TGYVVTRWYRAPEVILNW--MHYTQTVDIWSVGCI 205 (343)
T ss_pred eecccccccccCc----cccccCCcccCHHHHhCC--CCCCcHHHHHHHHHH
Confidence 9999998654322 233578899999987653 134678999999986
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=7e-26 Score=239.50 Aligned_cols=190 Identities=28% Similarity=0.366 Sum_probs=154.6
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
++|++.+.||+|++|.||+|.. .+++.||+|++..........+.+.+|++++++++||||+++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 5789999999999999999955 478999999987654333445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECC-CCcEEEEeeccceecC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD-DMRAKVADFGLVKNAP 738 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~-~~~~kL~DfG~a~~~~ 738 (782)
|++ +++.+.+.... ....++..+..++.|++.||+|||+ +|++||||+|+||+++. ++.+||+|||++....
T Consensus 82 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 82 YLD-LDLKKHMDSSP---DFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred ccc-ccHHHHHHhCC---CCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 995 58888775421 2336788889999999999999998 89999999999999985 5679999999997654
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... .......+++.|+|||++.+. ..+..++|+||+||+
T Consensus 155 ~~~-~~~~~~~~~~~y~~PE~~~~~--~~~~~~~Dv~slG~i 193 (294)
T PLN00009 155 IPV-RTFTHEVVTLWYRAPEILLGS--RHYSTPVDIWSVGCI 193 (294)
T ss_pred CCc-cccccCceeecccCHHHHhCC--CCCCcHHHHHHHHHH
Confidence 321 111233578899999987653 235678999999986
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=242.48 Aligned_cols=185 Identities=26% Similarity=0.503 Sum_probs=153.9
Q ss_pred CCccceeecccceEEEEEEeC---CCc--EEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 583 FSEANILGRGGFGVVYGGELP---DGT--KIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 583 y~~~~~lg~G~~g~Vy~~~~~---~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
....+.||+|-||.||+|... .|+ .||||.-+.+. ..+..+.|..|+-+|+.++||||++++|+|.+ ...|+|
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wiv 468 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIV 468 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEE
Confidence 345688999999999999542 333 58899887643 34457889999999999999999999999975 578999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
||.++.|.|..+++... ..++......++.||+.||.|||+ ..+|||||.++|||+.+..-|||+|||+++..
T Consensus 469 mEL~~~GELr~yLq~nk----~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNK----DSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred EecccchhHHHHHHhcc----ccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhc
Confidence 99999999999998743 348888999999999999999999 89999999999999999999999999999999
Q ss_pred CCCCceeeecccccccccCccccccchhhhHHHHHHHHHhcc
Q 003982 738 PDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGS 779 (782)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gv 779 (782)
++..+...+...-.+.|||||-+.=. ..+.++|||=|||
T Consensus 542 ed~~yYkaS~~kLPIKWmaPESINfR---rFTtASDVWMFgV 580 (974)
T KOG4257|consen 542 EDDAYYKASRGKLPIKWMAPESINFR---RFTTASDVWMFGV 580 (974)
T ss_pred cccchhhccccccceeecCccccchh---cccchhhHHHHHH
Confidence 98887665554557789999964322 3466777776665
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.8e-26 Score=238.29 Aligned_cols=189 Identities=25% Similarity=0.381 Sum_probs=156.6
Q ss_pred CCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEc
Q 003982 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 660 (782)
+|++.+.||+|++|.||+|.. .+++.||||+++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 588899999999999999965 4688999999976542 23346678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~ 740 (782)
+++ ++.+++..... ...+++..+..++.|++.||+|||+ .|++||||||+||++++++.+||+|||.+......
T Consensus 80 ~~~-~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~ 153 (284)
T cd07836 80 MDK-DLKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP 153 (284)
T ss_pred CCc-cHHHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC
Confidence 974 88888765322 2458999999999999999999998 89999999999999999999999999998765432
Q ss_pred CceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 741 KYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.. ......+++.|+|||++.+. ..+..++|+||+||+
T Consensus 154 ~~-~~~~~~~~~~y~~PE~~~~~--~~~~~~~Dv~slG~~ 190 (284)
T cd07836 154 VN-TFSNEVVTLWYRAPDVLLGS--RTYSTSIDIWSVGCI 190 (284)
T ss_pred cc-ccccccccccccChHHhcCC--CCCCcHHHHHHHHHH
Confidence 21 11223578899999987653 234678999999986
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-26 Score=246.16 Aligned_cols=188 Identities=26% Similarity=0.409 Sum_probs=153.4
Q ss_pred hcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC-----Ce
Q 003982 580 TDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING-----SE 653 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~-----~~ 653 (782)
.++|++.+.||+|++|.||+|. ..+++.||+|++.... ......++.+|+.++++++||||+++++++... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 4789999999999999999995 4578999999986432 233456788999999999999999999987654 35
Q ss_pred EEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecc
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~ 733 (782)
.++++||++ +++.+.+.. ..+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+
T Consensus 83 ~~lv~e~~~-~~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~ 152 (336)
T cd07849 83 VYIVQELME-TDLYKLIKT------QHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGL 152 (336)
T ss_pred EEEEehhcc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccc
Confidence 799999996 578777643 358999999999999999999998 8999999999999999999999999999
Q ss_pred ceecCCCCce--eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 734 VKNAPDGKYS--VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 734 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+......... ......|++.|+|||.+.+. .+++.++|+||+||+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslGvi 199 (336)
T cd07849 153 ARIADPEHDHTGFLTEYVATRWYRAPEIMLNS--KGYTKAIDIWSVGCI 199 (336)
T ss_pred eeeccccccccCCcCCcCcCCCccChHHhhCC--CCCCcHHHHHHHHHH
Confidence 9865432211 11234689999999986542 235678999999986
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.9e-26 Score=242.02 Aligned_cols=191 Identities=25% Similarity=0.331 Sum_probs=153.9
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCC------
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS------ 652 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~------ 652 (782)
.++|++.+.||+|+||.||+|.. .+++.||||++............+.+|++++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 45799999999999999999954 47899999998755433334456778999999999999999999987654
Q ss_pred --eEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEe
Q 003982 653 --ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVAD 730 (782)
Q Consensus 653 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~D 730 (782)
..++||||+. +++.+.+... ...+++.++..++.|++.||+|||+ .|++||||||+||+++.++.+||+|
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~d 162 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNK----NVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLAD 162 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECc
Confidence 3499999995 5788777541 2358999999999999999999998 8999999999999999999999999
Q ss_pred eccceecCCCCce---eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 731 FGLVKNAPDGKYS---VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 731 fG~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
||.+......... ......++..|+|||++.+. ..++.++|+||+|++
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~~ 213 (310)
T cd07865 163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE--RDYGPPIDMWGAGCI 213 (310)
T ss_pred CCCcccccCCcccCCCCccCcccCccccCcHHhcCC--cccCchhhhHHHHHH
Confidence 9999765432211 11223578899999987654 224568999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.4e-26 Score=233.32 Aligned_cols=191 Identities=26% Similarity=0.441 Sum_probs=163.9
Q ss_pred CCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEc
Q 003982 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 660 (782)
+|++.+.||+|++|.||++.. .+++.||+|++..........+.+.+|++++++++|||++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 588899999999999999955 4689999999987665556677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~ 740 (782)
+++++|.+++...... ...+++.++..++.+++.|+.|||+ .|++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKKE-GKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhcc-CCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 9999999999774322 3568999999999999999999998 89999999999999999999999999999876554
Q ss_pred CceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 741 KYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
. .......|++.|+|||+..+. ....++|+||+|++
T Consensus 157 ~-~~~~~~~~~~~y~~pe~~~~~---~~~~~~Dv~slG~~ 192 (258)
T cd08215 157 V-DLAKTVVGTPYYLSPELCQNK---PYNYKSDIWSLGCV 192 (258)
T ss_pred c-ceecceeeeecccChhHhccC---CCCccccHHHHHHH
Confidence 3 122334688999999987665 35678999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.9e-26 Score=237.36 Aligned_cols=194 Identities=25% Similarity=0.356 Sum_probs=159.2
Q ss_pred HhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCC----
Q 003982 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGS---- 652 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~---- 652 (782)
..++|++.+.||+|++|.||+|.. .+++.|++|++.... ...+.+.+|+++++++ +|+||+++++++.+..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 357899999999999999999965 467899999987643 3456799999999999 6999999999997654
Q ss_pred --eEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEe
Q 003982 653 --ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVAD 730 (782)
Q Consensus 653 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~D 730 (782)
..++||||+++++|.+++...... ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d 156 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKK-GKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVD 156 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECC
Confidence 489999999999999988764322 2468999999999999999999998 8999999999999999999999999
Q ss_pred eccceecCCCCceeeecccccccccCccccccc--hhhhHHHHHHHHHhccc
Q 003982 731 FGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKH--WMILCQMTGLIWLHGSV 780 (782)
Q Consensus 731 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~dvws~Gvv 780 (782)
||++........ ......|+..|+|||++... ....++.++|+||+||+
T Consensus 157 ~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~i 207 (275)
T cd06608 157 FGVSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGIT 207 (275)
T ss_pred Cccceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHH
Confidence 999876644322 22234689999999987532 12245678899999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.1e-26 Score=244.82 Aligned_cols=192 Identities=27% Similarity=0.417 Sum_probs=157.5
Q ss_pred HHHHHHHhcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC
Q 003982 573 IEVLRQVTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING 651 (782)
Q Consensus 573 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~ 651 (782)
...+..+.++|.+.+.||+|+||.||+|. ..+++.||+|+++.........+.+.+|++++++++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 34566778999999999999999999994 46789999999976543333456788999999999999999999988643
Q ss_pred ------CeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCc
Q 003982 652 ------SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR 725 (782)
Q Consensus 652 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~ 725 (782)
...+++++++ +++|.+++.. ..+++..+..++.|+++|++|||+ .||+||||||+||++++++.
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~ 158 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCE 158 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCC
Confidence 3467888887 7899887743 348999999999999999999998 89999999999999999999
Q ss_pred EEEEeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 726 AKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 726 ~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+||+|||+++...... ....+++.|+|||+..+. ...+.++|+||+|++
T Consensus 159 ~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslG~i 207 (345)
T cd07877 159 LKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNW--MHYNQTVDIWSVGCI 207 (345)
T ss_pred EEEecccccccccccc----cccccCCCccCHHHHhCc--cCCCchhhHHHHHHH
Confidence 9999999987654321 234578899999987552 234567899999986
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-26 Score=250.64 Aligned_cols=184 Identities=27% Similarity=0.448 Sum_probs=152.4
Q ss_pred ccceeecccceEEEEEEe-CCCc----EEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 585 EANILGRGGFGVVYGGEL-PDGT----KIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 585 ~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
..++||+|+||+||+|.+ ++|+ +||+|++.... ..+..+++.+|+-+|.+++|||++++++++.... ..+|++
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 468899999999999954 3443 68999886543 3456788999999999999999999999998776 889999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
||+.|+|.++++..+ ..+..++.+.|..||++||.|||+ +++|||||.++||||..-..+||.|||+|+....
T Consensus 778 ~mP~G~LlDyvr~hr----~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHR----DNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred hcccchHHHHHHHhh----ccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 999999999998754 347889999999999999999998 8999999999999999999999999999998765
Q ss_pred CCceee-ecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVE-TRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
...+.. ....-.+.|||=|.+... .++-++||||+||.
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~---~~thqSDVWsfGVt 889 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIR---KYTHQSDVWSFGVT 889 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhcc---CCCchhhhhhhhhh
Confidence 432221 112235678888876654 46788999999984
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.8e-26 Score=237.39 Aligned_cols=189 Identities=29% Similarity=0.490 Sum_probs=156.5
Q ss_pred cCCCccceeecccceEEEEEEeC-----CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEe--CCe
Q 003982 581 DNFSEANILGRGGFGVVYGGELP-----DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN--GSE 653 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~--~~~ 653 (782)
++|+..+.||+|+||.||+|... +++.||||++...... ...+.+.+|++++++++||||+++++++.. ...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 46778899999999999999643 3678999999765432 356789999999999999999999999887 557
Q ss_pred EEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecc
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~ 733 (782)
.+++|||+++++|.+++.... ..+++..+..++.|++.||+|||+ .|++||||||+||+++.++.+||+|||.
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~ 155 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGL 155 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCc----cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEccccc
Confidence 899999999999999986532 248999999999999999999998 8999999999999999999999999999
Q ss_pred ceecCCCCc--eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 734 VKNAPDGKY--SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 734 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+........ .......++..|+|||+..+. ....++|+||+|++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~---~~~~~~Di~slG~~ 201 (284)
T cd05038 156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTS---KFSSASDVWSFGVT 201 (284)
T ss_pred ccccccCCcceeccCCCCCcccccCcHHHccC---CCCcccchHHHhhh
Confidence 987753221 111122345679999987654 45678999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.6e-26 Score=238.73 Aligned_cols=199 Identities=26% Similarity=0.393 Sum_probs=158.8
Q ss_pred cHHHHHHHhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEE
Q 003982 572 SIEVLRQVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCI 649 (782)
Q Consensus 572 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~ 649 (782)
+...+....+.|++.+.||+|+||.||+|.. .+++.||+|++.... ....++..|+.+++++ +||||+++++++.
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 83 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFI 83 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence 3444445667899999999999999999954 568899999986542 3446788999999998 6999999999985
Q ss_pred e------CCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCC
Q 003982 650 N------GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD 723 (782)
Q Consensus 650 ~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~ 723 (782)
. ....+++|||+++|+|.+++.... ...+++..+..++.|++.|++|||+ .||+||||||+||+++++
T Consensus 84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~ 157 (282)
T cd06636 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK---GNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTEN 157 (282)
T ss_pred cccccCCCCEEEEEEEeCCCCcHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCC
Confidence 3 457899999999999999886533 2347888899999999999999998 899999999999999999
Q ss_pred CcEEEEeeccceecCCCCceeeecccccccccCccccccc--hhhhHHHHHHHHHhccc
Q 003982 724 MRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKH--WMILCQMTGLIWLHGSV 780 (782)
Q Consensus 724 ~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~dvws~Gvv 780 (782)
+.++|+|||++........ ......|++.|+|||++... -...++.++|+||+||+
T Consensus 158 ~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~ 215 (282)
T cd06636 158 AEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGIT 215 (282)
T ss_pred CCEEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHH
Confidence 9999999999876543211 11234689999999987521 01234667899999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.2e-26 Score=234.71 Aligned_cols=179 Identities=26% Similarity=0.335 Sum_probs=152.9
Q ss_pred eecccceEEEEEEe-CCCcEEEEEEeccccCC-hhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEccCCCCH
Q 003982 589 LGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTL 666 (782)
Q Consensus 589 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~gsL 666 (782)
||+|++|.||+|.. .+++.||+|++.+.... ....+.+.+|++++++++||||+++++++.++...+++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 68999999999965 35899999999765432 23557799999999999999999999999999999999999999999
Q ss_pred HHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCceeee
Q 003982 667 AQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVET 746 (782)
Q Consensus 667 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~ 746 (782)
.+++.+ ...+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++.+||+|||.+....... ...
T Consensus 81 ~~~l~~-----~~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~ 150 (262)
T cd05572 81 WTILRD-----RGLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTW 150 (262)
T ss_pred HHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccc
Confidence 999865 2348899999999999999999998 899999999999999999999999999998775432 112
Q ss_pred cccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 747 RLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 747 ~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
...|++.|+|||++.+. +++.++|+||+|++
T Consensus 151 ~~~~~~~~~~PE~~~~~---~~~~~~Di~slG~i 181 (262)
T cd05572 151 TFCGTPEYVAPEIILNK---GYDFSVDYWSLGIL 181 (262)
T ss_pred cccCCcCccChhHhcCC---CCCChhhhhhhHHH
Confidence 34688999999987653 45678899999976
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.9e-26 Score=237.35 Aligned_cols=181 Identities=29% Similarity=0.426 Sum_probs=151.3
Q ss_pred eecccceEEEEEE-eCCCcEEEEEEeccccCC-hhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEccCCCCH
Q 003982 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTL 666 (782)
Q Consensus 589 lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~gsL 666 (782)
||+|+||+||+|. ..+++.||+|.+...... ......+.+|++++++++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 6899999999994 457899999999764322 22345677899999999999999999999999999999999999999
Q ss_pred HHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCceeee
Q 003982 667 AQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVET 746 (782)
Q Consensus 667 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~ 746 (782)
.+++.... ...+++.++..++.|++.|+.|||+ .|++||||+|+||++++++.+||+|||.+....... ...
T Consensus 81 ~~~l~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~ 152 (277)
T cd05577 81 KYHIYNVG---EPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIK 152 (277)
T ss_pred HHHHHHcC---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--ccc
Confidence 99886532 2358999999999999999999998 899999999999999999999999999987654321 112
Q ss_pred cccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 747 RLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 747 ~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
...++..|+|||+..+. .+..++|+||+||+
T Consensus 153 ~~~~~~~y~~PE~~~~~---~~~~~~Di~slG~i 183 (277)
T cd05577 153 GRAGTPGYMAPEVLQGE---VYDFSVDWFALGCT 183 (277)
T ss_pred cccCCCCcCCHHHhcCC---CCCchhhhHHHHHH
Confidence 23578899999997764 25678999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=231.05 Aligned_cols=187 Identities=29% Similarity=0.512 Sum_probs=161.8
Q ss_pred CCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEc
Q 003982 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 660 (782)
+|++.+.||+|++|.||++.. .+++.||+|.+..........+.+.+|++++++++|||++++++++.+....+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 578899999999999999954 4678999999987765445678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~ 740 (782)
+++++|.+++... ..+++..+..++.|++.|+.|||+ .||+||||||+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 81 AENGSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred CCCCcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 9999999998652 458999999999999999999998 89999999999999999999999999999877653
Q ss_pred CceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 741 KYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... .....++..|+|||+..+. ....++|+|++|++
T Consensus 153 ~~~-~~~~~~~~~y~~pe~~~~~---~~~~~~Dv~~lG~~ 188 (254)
T cd06627 153 SKD-DASVVGTPYWMAPEVIEMS---GASTASDIWSLGCT 188 (254)
T ss_pred ccc-ccccccchhhcCHhhhcCC---CCCcchhHHHHHHH
Confidence 321 1234678899999987664 25678999999976
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-26 Score=237.59 Aligned_cols=187 Identities=29% Similarity=0.424 Sum_probs=159.6
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
++|+..+.||+|++|.||+|.. .+++.||+|++..... ....+++.+|++++++++||||+++++++......++++|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 3678889999999999999955 4689999999876542 3456778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++++|.+++.... ..+++..+..++.|++.|++|||+ ..|++||||||+||++++++.+||+|||.+.....
T Consensus 80 ~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~ 153 (265)
T cd06605 80 YMDGGSLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN 153 (265)
T ss_pred ecCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence 999999999987532 468899999999999999999996 37999999999999999999999999999876543
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.... ...++..|+|||+..+. .++.++|+||+|++
T Consensus 154 ~~~~---~~~~~~~y~~PE~~~~~---~~~~~~Dv~slG~~ 188 (265)
T cd06605 154 SLAK---TFVGTSSYMAPERIQGN---DYSVKSDIWSLGLS 188 (265)
T ss_pred HHhh---cccCChhccCHHHHcCC---CCCchhhHHHHHHH
Confidence 2211 15688899999998765 56788999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=237.24 Aligned_cols=188 Identities=28% Similarity=0.352 Sum_probs=156.6
Q ss_pred CCccceeecccceEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC--CeEEEEEE
Q 003982 583 FSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING--SERLLVYE 659 (782)
Q Consensus 583 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~--~~~~lv~e 659 (782)
|++.+.||+|++|.||+|... +++.||+|++..........+.+.+|++++++++|||++++++++.+. +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 677899999999999999654 588999999987643334556788999999999999999999999988 88999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|++ ++|.+++... ...+++..+..++.|++.|++|||+ .|++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~~-~~l~~~~~~~----~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~ 152 (287)
T cd07840 81 YMD-HDLTGLLDSP----EVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTK 152 (287)
T ss_pred ccc-ccHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence 997 4888887542 1358999999999999999999998 8999999999999999999999999999987755
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..........++..|+|||.+.+. .....++||||+|++
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~~Dv~slG~~ 191 (287)
T cd07840 153 RNSADYTNRVITLWYRPPELLLGA--TRYGPEVDMWSVGCI 191 (287)
T ss_pred CCcccccccccccccCCceeeEcc--ccCChHHHHHHHHHH
Confidence 432222334568899999977653 234678999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6e-26 Score=239.28 Aligned_cols=193 Identities=26% Similarity=0.350 Sum_probs=153.3
Q ss_pred CCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC-CCCcceEEeEEEeCCeEEEEEE
Q 003982 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~~~lv~e 659 (782)
+|...+.||+|+||.||++.. .+++.||+|.+..... ......+.+|+.++.++. ||||+++++++..+...+++||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD-EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC-hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 456678899999999999954 5689999999876542 245667899999999996 9999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+. +++.++...........+++..+..++.|++.||+|||+ ..+++||||||+||+++.++.+||+|||++.....
T Consensus 84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 985 466554432222223568999999999999999999997 25999999999999999999999999999976543
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... .....|++.|+|||++.+.-...++.++|+||+||+
T Consensus 161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~i 199 (288)
T cd06616 161 SIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGIT 199 (288)
T ss_pred CCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHH
Confidence 221 122357899999998765311245678999999986
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.2e-26 Score=234.77 Aligned_cols=189 Identities=23% Similarity=0.412 Sum_probs=159.2
Q ss_pred CCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEc
Q 003982 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 660 (782)
+|++.+.||+|++|.||+|.. .++..||+|.+..........+.+.+|++++++++|+||+++++.+.+....++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 578899999999999999955 4688999999976544444567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCC-cEEEEeeccceecCC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM-RAKVADFGLVKNAPD 739 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~-~~kL~DfG~a~~~~~ 739 (782)
+++++|.+++.+.. ...+++..+..++.|++.|+.|||+ .+++|+||||+||++++++ .+||+|||.+.....
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 81 CDGGDLMKRINRQR---GVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred CCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 99999999986532 2357899999999999999999998 8999999999999999885 569999999877654
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... ......|++.|+|||+..+. .++.++|+||+|++
T Consensus 155 ~~~-~~~~~~~~~~~~ape~~~~~---~~~~~~Dv~slG~i 191 (257)
T cd08225 155 SME-LAYTCVGTPYYLSPEICQNR---PYNNKTDIWSLGCV 191 (257)
T ss_pred Ccc-cccccCCCccccCHHHHcCC---CCCchhhHHHHHHH
Confidence 321 11224588999999987764 45778999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=236.80 Aligned_cols=188 Identities=28% Similarity=0.369 Sum_probs=155.9
Q ss_pred CCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEcc
Q 003982 583 FSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYM 661 (782)
Q Consensus 583 y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~ 661 (782)
|++.+.||+|++|.||+|.. .+|+.||+|++............+.+|++++++++||||+++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 67789999999999999954 57999999999765443444567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCC
Q 003982 662 PRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK 741 (782)
Q Consensus 662 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~ 741 (782)
+ ++|.+++.... ...+++..+..++.|+++||+|||+ .+++||||+|+||++++++.++|+|||.+.......
T Consensus 81 ~-~~l~~~~~~~~---~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 81 D-LDLKKYMDSSP---LTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV 153 (283)
T ss_pred C-cCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence 5 68998886532 1358999999999999999999998 899999999999999999999999999997654322
Q ss_pred ceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 742 YSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 742 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
. ......++..|+|||++.+. ..+..++|+||+|++
T Consensus 154 ~-~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~~ 189 (283)
T cd07835 154 R-TYTHEVVTLWYRAPEILLGS--RQYSTPVDIWSIGCI 189 (283)
T ss_pred c-ccCccccccCCCCCceeecC--cccCcHHHHHHHHHH
Confidence 1 11223568899999987653 124668999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=233.40 Aligned_cols=191 Identities=23% Similarity=0.468 Sum_probs=157.5
Q ss_pred CCCccceeecccceEEEEEEeCC--CcEEEEEEecccc--------CChhhHHHHHHHHHHHHh-cCCCCcceEEeEEEe
Q 003982 582 NFSEANILGRGGFGVVYGGELPD--GTKIAVKRMESNT--------MGNKGLSEFQAEIAVLTK-VRHRHLVALLGYCIN 650 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~--------~~~~~~~~~~~E~~~l~~-l~h~nI~~~~~~~~~ 650 (782)
+|++.+.||+|+||.||+|.... ++.+|+|.+.... .......++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999997654 6889999886432 122345667788888875 789999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEe
Q 003982 651 GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVAD 730 (782)
Q Consensus 651 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~D 730 (782)
.+..+++|||+++++|.+++...... ...+++..++.++.|++.|+.|||+ ..|++||||||+||++++++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEK-KQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999988654332 3458999999999999999999995 26899999999999999999999999
Q ss_pred eccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 731 FGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 731 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
||.+....... ......|+..|+|||++.+. .+..++|+||+|++
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~---~~~~~~Dv~slG~l 202 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNE---PYGEKADVWAFGCI 202 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCC---CCchHHHHHHHHHH
Confidence 99998765433 22334688999999998764 35778999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.1e-27 Score=236.42 Aligned_cols=195 Identities=28% Similarity=0.392 Sum_probs=159.0
Q ss_pred hcCCCccceeecccceEEEEE-EeCCCcEEEEEEeccccCCh-----hhHHHHHHHHHHHHhcCCCCcceEEeEEE-eCC
Q 003982 580 TDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGN-----KGLSEFQAEIAVLTKVRHRHLVALLGYCI-NGS 652 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~nI~~~~~~~~-~~~ 652 (782)
.++|-.+..||+|+|+.||+| +....+.||||+-....-.. ...+...+|.+|-+.++||.||++|+|+. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 456888999999999999999 77778899999765433211 13455789999999999999999999986 556
Q ss_pred eEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEC---CCCcEEEE
Q 003982 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIG---DDMRAKVA 729 (782)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~---~~~~~kL~ 729 (782)
.+|-|+|||+|-+|.-++++. +.++++++..|+.||+.||.||.+. ...|||=|+||.|||+- ..|.+||+
T Consensus 542 sFCTVLEYceGNDLDFYLKQh-----klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQH-----KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred cceeeeeecCCCchhHHHHhh-----hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEee
Confidence 788999999999999999773 4589999999999999999999974 57999999999999995 34789999
Q ss_pred eeccceecCCCCce------eeecccccccccCccccc-cchhhhHHHHHHHHHhccc
Q 003982 730 DFGLVKNAPDGKYS------VETRLAGTFGYLAPEYAG-KHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 730 DfG~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~-~~~~~~~~~~~dvws~Gvv 780 (782)
|||+++..++..+. ......||.+|.+||.+. +.--....-+.||||+|||
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVI 673 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVI 673 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehh
Confidence 99999988765543 234567999999999754 3222345668899999986
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=256.27 Aligned_cols=261 Identities=26% Similarity=0.373 Sum_probs=207.9
Q ss_pred EEEEEeCCCCCCcccCccccCCccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCC
Q 003982 68 VTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDN 147 (782)
Q Consensus 68 v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 147 (782)
-..|+|++++|+ .+|+.+. ++|+.|++++|+|+.++. .+++|++|+|++|+|+.+|.. .++|+.|+|++|
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~LP~---lp~~Lk~LdLs~N~LtsLP~l----p~sL~~L~Ls~N 272 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLPA---LPPELRTLEVSGNQLTSLPVL----PPGLLELSIFSN 272 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCCCCC---CCCCCcEEEecCCccCcccCc----ccccceeeccCC
Confidence 457899999998 7888776 489999999999997654 258899999999999998753 578999999999
Q ss_pred CCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccc
Q 003982 148 PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGT 227 (782)
Q Consensus 148 ~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~ 227 (782)
++.. +|..+ ++|+.|+|++|+++.+ |. .+++|++|+|++|+|+ .+|..
T Consensus 273 ~L~~---Lp~lp---~~L~~L~Ls~N~Lt~L-P~---~p~~L~~LdLS~N~L~-~Lp~l--------------------- 320 (788)
T PRK15387 273 PLTH---LPALP---SGLCKLWIFGNQLTSL-PV---LPPGLQELSVSDNQLA-SLPAL--------------------- 320 (788)
T ss_pred chhh---hhhch---hhcCEEECcCCccccc-cc---cccccceeECCCCccc-cCCCC---------------------
Confidence 9887 44432 5688999999999876 44 2478999999999998 56642
Q ss_pred cccccCCCCCcEEEeecccccCCCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCCCCCCccE
Q 003982 228 LDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQK 307 (782)
Q Consensus 228 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~ 307 (782)
..+|+.|++++|+|++.+. + ..+|+.|+|++|+|++ +|.. .++|+.|++++|+|++ +|..+++|+.
T Consensus 321 ------p~~L~~L~Ls~N~L~~LP~-l--p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP~l~~~L~~ 386 (788)
T PRK15387 321 ------PSELCKLWAYNNQLTSLPT-L--PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPALPSGLKE 386 (788)
T ss_pred ------cccccccccccCccccccc-c--ccccceEecCCCccCC-CCCC---Ccccceehhhcccccc-Ccccccccce
Confidence 2457778888888886443 2 2578899999999884 5543 3567888899999885 6667778999
Q ss_pred EEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccccCccc
Q 003982 308 VSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAY 387 (782)
Q Consensus 308 L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~ 387 (782)
|++++|+|++++. ..++|+.|++++|.|++ +|..+
T Consensus 387 LdLs~N~Lt~LP~--------------------------------------------l~s~L~~LdLS~N~Lss-IP~l~ 421 (788)
T PRK15387 387 LIVSGNRLTSLPV--------------------------------------------LPSELKELMVSGNRLTS-LPMLP 421 (788)
T ss_pred EEecCCcccCCCC--------------------------------------------cccCCCEEEccCCcCCC-CCcch
Confidence 9999998865441 01468899999999985 66543
Q ss_pred cccccCCeEecccccccccCCccCCCCCCCCeEecCCCcCCCCCCC
Q 003982 388 ANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPD 433 (782)
Q Consensus 388 ~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~ 433 (782)
.+|+.|+|++|+|+ .+|+.+.+++.|+.|+|++|+|+|.+|.
T Consensus 422 ---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 422 ---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred ---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence 46788999999998 7899999999999999999999998874
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=238.71 Aligned_cols=187 Identities=27% Similarity=0.377 Sum_probs=154.4
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
+.|...+.||+|++|.||+|.. .+++.||+|++..... .....+++.+|+++++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 5588899999999999999954 4689999999865432 2334567899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||++ |++.+.+... ...+++..+..++.|++.||.|||+ .||+||||+|+||++++++.+||+|||++....
T Consensus 95 e~~~-g~l~~~~~~~----~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 95 EYCL-GSASDILEVH----KKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HhhC-CCHHHHHHHc----ccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 9996 5777776542 2358999999999999999999998 899999999999999999999999999987654
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... ...+++.|+|||++.+.-.-.+..++||||+|++
T Consensus 167 ~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~i 203 (307)
T cd06607 167 PAN-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 203 (307)
T ss_pred CCC-----CccCCccccCceeeeccCCCCCCcccchHHHHHH
Confidence 322 2357889999998742211235678999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=235.65 Aligned_cols=180 Identities=26% Similarity=0.387 Sum_probs=144.1
Q ss_pred eeecccceEEEEEEe-CCCcEEEEEEeccccCChh-hHHHHHHHHH---HHHhcCCCCcceEEeEEEeCCeEEEEEEccC
Q 003982 588 ILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNK-GLSEFQAEIA---VLTKVRHRHLVALLGYCINGSERLLVYEYMP 662 (782)
Q Consensus 588 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~~E~~---~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~ 662 (782)
.||+|+||.||+|.. .+++.||+|.+.+...... ....+..|.. .++...||+|+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 479999999999954 5688999999876543222 1222334433 4444579999999999999999999999999
Q ss_pred CCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCc
Q 003982 663 RGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742 (782)
Q Consensus 663 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~ 742 (782)
+++|.+++.. ...+++.++..++.|++.|++|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 81 g~~L~~~l~~-----~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~ 152 (278)
T cd05606 81 GGDLHYHLSQ-----HGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 152 (278)
T ss_pred CCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC
Confidence 9999988754 2458999999999999999999998 8999999999999999999999999999876543221
Q ss_pred eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 743 SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 743 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
....|+..|+|||++.+. ...+.++|+||+||+
T Consensus 153 ---~~~~~~~~y~aPE~~~~~--~~~~~~~Di~s~G~~ 185 (278)
T cd05606 153 ---HASVGTHGYMAPEVLQKG--VAYDSSADWFSLGCM 185 (278)
T ss_pred ---cCcCCCcCCcCcHHhcCC--CCCCcccchHhHHHH
Confidence 234689999999997643 124567899999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.2e-26 Score=234.09 Aligned_cols=189 Identities=28% Similarity=0.447 Sum_probs=161.4
Q ss_pred CCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEc
Q 003982 582 NFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 660 (782)
+|++.+.||+|++|.||++. ..+++.+|+|.+...........++.+|++++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 57889999999999999994 45788999999987654455667888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~ 740 (782)
+++++|.+++.+.... ...+++..+..++.|++.|++|||+ .|++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRKKK-RKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 9999999998764322 3468999999999999999999998 89999999999999999999999999999876554
Q ss_pred CceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 741 KYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
. .....+++.|+|||+..+. ..+.++|+||+|++
T Consensus 157 ~---~~~~~~~~~~~~Pe~~~~~---~~~~~~D~~slG~~ 190 (256)
T cd08530 157 M---AKTQIGTPHYMAPEVWKGR---PYSYKSDIWSLGCL 190 (256)
T ss_pred C---cccccCCccccCHHHHCCC---CCCchhhHHHHHHH
Confidence 2 1224578899999987664 34667899999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=235.73 Aligned_cols=189 Identities=26% Similarity=0.359 Sum_probs=156.8
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC--CeEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING--SERLLV 657 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~--~~~~lv 657 (782)
++|+..+.||.|++|.||+|.. .+++.||+|.+..... .....++.+|++++++++||||+++++++.+. +..++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 3688899999999999999965 4688999999875432 24557789999999999999999999988654 468999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
|||+++++|.+++...... ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++...
T Consensus 80 ~e~~~~~~L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~ 155 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKR-GGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL 155 (287)
T ss_pred EEecCCCCHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccc
Confidence 9999999999987654332 3458899999999999999999998 89999999999999999999999999998765
Q ss_pred CCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 738 PDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..... ....++..|+|||.+.+. ..+.++|+||+|++
T Consensus 156 ~~~~~---~~~~~~~~y~~pE~~~~~---~~~~~~Dv~slG~i 192 (287)
T cd06621 156 VNSLA---GTFTGTSFYMAPERIQGK---PYSITSDVWSLGLT 192 (287)
T ss_pred ccccc---ccccCCccccCHHHhcCC---CCCchhhHHHHHHH
Confidence 43221 234578899999987654 35678899999976
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.7e-26 Score=244.52 Aligned_cols=190 Identities=28% Similarity=0.401 Sum_probs=154.9
Q ss_pred HhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeC--CeE
Q 003982 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCING--SER 654 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~--~~~ 654 (782)
+.++|++.+.||+|+||.||+|.. .+++.||+|++............+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 467899999999999999999965 4688999999865433334456778899999999 999999999988654 367
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccc
Q 003982 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734 (782)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a 734 (782)
++||||++ ++|.+++.. ..+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||.+
T Consensus 85 ~lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~ 154 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA------NILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLA 154 (337)
T ss_pred EEEecccc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccch
Confidence 99999996 588888754 257888999999999999999998 89999999999999999999999999999
Q ss_pred eecCCCCce----eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 735 KNAPDGKYS----VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 735 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
......... ......|++.|+|||++.+. ...+.++|+||+|++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~sDi~slG~~ 202 (337)
T cd07852 155 RSLSELEENPENPVLTDYVATRWYRAPEILLGS--TRYTKGVDMWSVGCI 202 (337)
T ss_pred hccccccccccCcchhcccccccccCceeeecc--ccccccchHHHHHHH
Confidence 866443211 22234689999999987543 234567999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=236.04 Aligned_cols=184 Identities=26% Similarity=0.428 Sum_probs=154.8
Q ss_pred CCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEc
Q 003982 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 660 (782)
.|...+.||+|++|.||++.. .+++.+|+|++.... ....+.+.+|+.++++++||||+++++++...+..++++||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 345567899999999999954 578899999886433 23456688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~ 740 (782)
+++++|.+++.. ..+++.++..++.|++.|++|||+ .|++||||+|+||+++.++.++|+|||.+......
T Consensus 98 ~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~ 168 (285)
T cd06648 98 LEGGALTDIVTH------TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE 168 (285)
T ss_pred cCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccC
Confidence 999999998865 347889999999999999999998 89999999999999999999999999988755432
Q ss_pred CceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 741 KYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.. ......|++.|+|||+..+. .++.++|+||+||+
T Consensus 169 ~~-~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slGv~ 204 (285)
T cd06648 169 VP-RRKSLVGTPYWMAPEVISRL---PYGTEVDIWSLGIM 204 (285)
T ss_pred Cc-ccccccCCccccCHHHhcCC---CCCCcccHHHHHHH
Confidence 21 12234689999999988764 35678999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=232.04 Aligned_cols=188 Identities=28% Similarity=0.434 Sum_probs=161.3
Q ss_pred cCCCccceeecccceEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
.+|++.+.||+|++|.||+|... +++.||+|++...... ...+.+.+|++++.+++|+||+++++++......++|||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 36888999999999999999654 5899999998765422 456789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++++|.+++... ..+++..+..++.|+++|++|||+ ..|++||||+|+||+++.++.++|+|||.+.....
T Consensus 80 ~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~--~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~ 152 (264)
T cd06623 80 YMDGGSLADLLKKV-----GKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLEN 152 (264)
T ss_pred ecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhc--cCCCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 99999999999752 468999999999999999999996 27999999999999999999999999999987654
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..... ....++..|+|||+..+. .++.++|+||+|++
T Consensus 153 ~~~~~-~~~~~~~~y~~pE~~~~~---~~~~~~Dv~slG~i 189 (264)
T cd06623 153 TLDQC-NTFVGTVTYMSPERIQGE---SYSYAADIWSLGLT 189 (264)
T ss_pred CCCcc-cceeecccccCHhhhCCC---CCCchhhHHHHHHH
Confidence 33221 234578899999988765 56778999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=241.25 Aligned_cols=187 Identities=21% Similarity=0.311 Sum_probs=151.0
Q ss_pred ceeecc--cceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEccCC
Q 003982 587 NILGRG--GFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPR 663 (782)
Q Consensus 587 ~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~ 663 (782)
+.||+| +||+||+|.. .+++.||+|++..........+.+++|+.+++.++||||+++++++..++..++||||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 8999999954 5799999999976654455567899999999999999999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCce
Q 003982 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743 (782)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~ 743 (782)
+++.+++.+... ..+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+|++||+.+.........
T Consensus 84 ~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 84 GSANSLLKTYFP---EGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred CCHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 999999876432 348899999999999999999998 89999999999999999999999999865433221100
Q ss_pred e------eecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 744 V------ETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 744 ~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
. .....++..|+|||++.+.+. +.+.++|+||+|++
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~DiwslG~~ 199 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLY-GYNVKSDIYSVGIT 199 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCC-CCCchhhHHHHHHH
Confidence 0 011234667999999876421 35678999999976
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.9e-26 Score=245.16 Aligned_cols=190 Identities=24% Similarity=0.385 Sum_probs=154.9
Q ss_pred hcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEe----CCeE
Q 003982 580 TDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN----GSER 654 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~----~~~~ 654 (782)
.++|++.+.||+|++|.||+|. ..+++.||+|++..........+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 4789999999999999999995 4578999999997654333456778889999999999999999988763 3467
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccc
Q 003982 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734 (782)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a 734 (782)
++||||+. ++|.+++.. ...+++.++..++.|++.||.|||+ .||+||||||+||++++++.+||+|||++
T Consensus 84 ~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~ 154 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS-----DQPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMA 154 (334)
T ss_pred EEEEehhh-hhHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccc
Confidence 99999995 688888754 2448999999999999999999998 89999999999999999999999999999
Q ss_pred eecCCCCce---eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 735 KNAPDGKYS---VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 735 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
......... ......|+..|+|||++.+. ...+.++|+||+|++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~~Di~slG~~ 201 (334)
T cd07855 155 RGLSSSPTEHKYFMTEYVATRWYRAPELLLSL--PEYTTAIDMWSVGCI 201 (334)
T ss_pred eeecccCcCCCcccccccccccccChHHhcCC--cccccccchHHHHHH
Confidence 765432211 11234688999999987543 134677889999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-27 Score=243.48 Aligned_cols=187 Identities=24% Similarity=0.311 Sum_probs=163.1
Q ss_pred cCCCccceeecccceEEEEEEeCCCc-EEEEEEeccccC-ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGELPDGT-KIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
.++..+..||-|+||+|-.+...... .+|+|++++... +.+..+....|-.+|...+.|.||++|..|.+.++.|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34455678999999999988664333 489999987653 4456677889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
|-|-||.++..+++ .+.++..+...++..+++|++|||+ +|||.||+||+|.+++.+|-+||.|||+|+.+.
T Consensus 500 EaClGGElWTiLrd-----Rg~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 500 EACLGGELWTILRD-----RGSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred HhhcCchhhhhhhh-----cCCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 99999999999976 4568899999999999999999998 999999999999999999999999999999987
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.+. ..-.+||||.|.|||++.+. |-+.+.|.||+||+
T Consensus 572 ~g~--KTwTFcGTpEYVAPEIILnK---GHD~avDyWaLGIl 608 (732)
T KOG0614|consen 572 SGR--KTWTFCGTPEYVAPEIILNK---GHDRAVDYWALGIL 608 (732)
T ss_pred cCC--ceeeecCCcccccchhhhcc---CcchhhHHHHHHHH
Confidence 654 22347999999999999876 77999999999985
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-25 Score=229.99 Aligned_cols=185 Identities=22% Similarity=0.284 Sum_probs=150.4
Q ss_pred HHHHHHHhcCCCcccee--ecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEE
Q 003982 573 IEVLRQVTDNFSEANIL--GRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYC 648 (782)
Q Consensus 573 ~~~l~~~~~~y~~~~~l--g~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~ 648 (782)
..+.....++|++.+.+ |+|+||.||++. ..++..+|+|.+....... . |+.....+ +||||+++++++
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~--e~~~~~~~~~h~~iv~~~~~~ 78 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----I--EPMVHQLMKDNPNFIKLYYSV 78 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----h--hHHHHHHhhcCCCEEEEEEEE
Confidence 34445566788888777 999999999995 4578899999987543211 1 22222222 699999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCC-cEE
Q 003982 649 INGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM-RAK 727 (782)
Q Consensus 649 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~-~~k 727 (782)
...+..++||||+++++|.+++... ..+++.++..++.|+++|++|||+ .|++||||||+||+++.++ .++
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~ 150 (267)
T PHA03390 79 TTLKGHVLIMDYIKDGDLFDLLKKE-----GKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIY 150 (267)
T ss_pred ecCCeeEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEE
Confidence 9999999999999999999998652 368999999999999999999998 8999999999999999998 999
Q ss_pred EEeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 728 VADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 728 L~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|+|||.+....... ...|+..|+|||++.+. .+..++|+||+|++
T Consensus 151 l~dfg~~~~~~~~~-----~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~i 195 (267)
T PHA03390 151 LCDYGLCKIIGTPS-----CYDGTLDYFSPEKIKGH---NYDVSFDWWAVGVL 195 (267)
T ss_pred EecCccceecCCCc-----cCCCCCcccChhhhcCC---CCCchhhHHHHHHH
Confidence 99999987665322 23578999999998764 45678999999986
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=235.03 Aligned_cols=187 Identities=32% Similarity=0.513 Sum_probs=151.3
Q ss_pred ceeecccceEEEEEEeCC-------CcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 587 NILGRGGFGVVYGGELPD-------GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 587 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
+.||+|+||.||+|...+ ++.+|+|.+.... .......+.+|+.++++++||||+++++++...+..++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 368999999999996532 2579999886543 22446778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCC-----cEEEEeec
Q 003982 660 YMPRGTLAQHLFEWHDH--GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM-----RAKVADFG 732 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~-----~~kL~DfG 732 (782)
|+++++|.+++...... ....+++.++..++.|++.|++|||+ .+++|+||||+||+++.++ .+|++|||
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 99999999999764322 12347889999999999999999998 8999999999999999877 89999999
Q ss_pred cceecCCCCce-eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 733 LVKNAPDGKYS-VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 733 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+++........ ......++..|+|||++.+. .++.++|||||||+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~i 202 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDG---KFTTQSDVWSFGVL 202 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccC---CcccchhHHHHHHH
Confidence 99765433221 11223457789999988764 45778999999976
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.3e-26 Score=243.65 Aligned_cols=189 Identities=25% Similarity=0.402 Sum_probs=154.3
Q ss_pred hcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC-----Ce
Q 003982 580 TDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING-----SE 653 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~-----~~ 653 (782)
..+|.+.+.||+|+||+||+|. ..+++.||||.+............+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 4679999999999999999995 45789999999876433334456778899999999999999999987654 34
Q ss_pred EEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecc
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~ 733 (782)
.++++||+. ++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+
T Consensus 84 ~~lv~e~~~-~~L~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~ 154 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS-----SQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGL 154 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCcc
Confidence 799999995 688888754 2458999999999999999999998 8999999999999999999999999999
Q ss_pred ceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 734 VKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 734 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
++...... .......++..|+|||++... .....++|+||+||+
T Consensus 155 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~i 198 (337)
T cd07858 155 ARTTSEKG-DFMTEYVVTRWYRAPELLLNC--SEYTTAIDVWSVGCI 198 (337)
T ss_pred ccccCCCc-ccccccccccCccChHHHhcC--CCCCCcccHHHHHHH
Confidence 98765432 112234578899999987542 124567899999975
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=235.71 Aligned_cols=189 Identities=30% Similarity=0.471 Sum_probs=160.1
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcC-CCCcceEEeEEEeCCeEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~~~lv 657 (782)
++|.+.+.||+|++|.||+|.. .+++.||+|++..... .....+.+.+|++++++++ ||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4688999999999999999954 4789999999976432 2334567889999999998 99999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
|||+++++|.+++.+ ...+++.++..++.|++.||.|||+ .|++|+||||+||+++.++.++++|||++...
T Consensus 81 ~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~ 152 (280)
T cd05581 81 LEYAPNGELLQYIRK-----YGSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVL 152 (280)
T ss_pred EcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCcccccc
Confidence 999999999999865 2368999999999999999999998 89999999999999999999999999998765
Q ss_pred CCCCc-------------------eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 738 PDGKY-------------------SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 738 ~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..... .......++..|+|||+..+. ....++|+||+|++
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~---~~~~~~Di~slG~~ 211 (280)
T cd05581 153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK---PAGKSSDLWALGCI 211 (280)
T ss_pred CCccccccCCCCCccccccccccccccccccCCccccCHHHhCCC---CCChhhhHHHHHHH
Confidence 44221 112234578999999987664 35778999999976
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=238.98 Aligned_cols=187 Identities=27% Similarity=0.422 Sum_probs=155.4
Q ss_pred HHhcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEe-CCeEE
Q 003982 578 QVTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN-GSERL 655 (782)
Q Consensus 578 ~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~-~~~~~ 655 (782)
.+.++|++.+.||+|+||.||+|. ..+++.||+|++.+........+.+.+|++++++++||||+++++++.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 367889999999999999999995 5588999999987544333455778899999999999999999999876 45789
Q ss_pred EEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccce
Q 003982 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (782)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~ 735 (782)
++|||+ +++|.+++.. .++++..+..++.|+++||+|||+ .||+||||+|+||++++++.+||+|||.+.
T Consensus 87 lv~e~~-~~~L~~~~~~------~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 87 FVTELL-GTDLHRLLTS------RPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEeehh-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 999999 6688887753 347888889999999999999998 899999999999999999999999999987
Q ss_pred ecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 736 NAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 736 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
...... ....++..|+|||++.+. ..+..++|+||+|++
T Consensus 157 ~~~~~~----~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~i 195 (328)
T cd07856 157 IQDPQM----TGYVSTRYYRAPEIMLTW--QKYDVEVDIWSAGCI 195 (328)
T ss_pred ccCCCc----CCCcccccccCceeeecc--CCcCcHHHHHHHHHH
Confidence 553321 223578899999987552 245778999999986
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=239.51 Aligned_cols=188 Identities=26% Similarity=0.369 Sum_probs=151.1
Q ss_pred CCCccceeecccceEEEEEEeC-C--CcEEEEEEeccccCChhhHHHHHHHHHHHHhcC-CCCcceEEeEEEeC----Ce
Q 003982 582 NFSEANILGRGGFGVVYGGELP-D--GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCING----SE 653 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~----~~ 653 (782)
+|++.+.||+|+||.||+++.. . +..||+|++..........+.+.+|++++++++ ||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788999999999999999653 4 778999998754323334567889999999994 99999999875432 45
Q ss_pred EEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecc
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~ 733 (782)
.++++||+. ++|.+++.. ...+++.++..++.|++.||+|||+ .||+||||||+||++++++.+||+|||.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~ 151 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS-----GQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGL 151 (332)
T ss_pred EEEEEeccc-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence 788999985 688888754 3458999999999999999999998 8999999999999999999999999999
Q ss_pred ceecCCCCce---eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 734 VKNAPDGKYS---VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 734 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
++........ ......||+.|+|||+..+. .+++.++|+||+||+
T Consensus 152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~~Di~slGv~ 199 (332)
T cd07857 152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSF--QSYTKAIDVWSVGCI 199 (332)
T ss_pred ceecccccccccccccCcccCccccCcHHHhCC--CCCCcHHHHHHHHHH
Confidence 9866532211 11234689999999987543 245678999999986
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-25 Score=228.20 Aligned_cols=188 Identities=29% Similarity=0.432 Sum_probs=162.1
Q ss_pred CCCccceeecccceEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC--CeEEEEE
Q 003982 582 NFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING--SERLLVY 658 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~--~~~~lv~ 658 (782)
+|+..+.||+|++|.||+|... +++.|++|++..........+.+.+|++++++++||||+++++.+.+. ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999654 789999999977654445678899999999999999999999999988 8899999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++++|.+++... ..+++.++..++.|++.|++|||+ .|++|+||+|+||+++.++.++|+|||.+....
T Consensus 81 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 152 (260)
T cd06606 81 EYVSGGSLSSLLKKF-----GKLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLG 152 (260)
T ss_pred EecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence 999999999998762 268999999999999999999998 899999999999999999999999999998776
Q ss_pred CCCce-eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYS-VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..... ......++..|+|||+..+. ....++|+||+|++
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pE~~~~~---~~~~~~Dv~slG~i 192 (260)
T cd06606 153 DIETGEGTGSVRGTPYWMAPEVIRGE---EYGRAADIWSLGCT 192 (260)
T ss_pred cccccccccCCCCCccccCHhhhcCC---CCCchhhHHHHHHH
Confidence 54321 12234688899999988765 25778999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=235.06 Aligned_cols=190 Identities=26% Similarity=0.331 Sum_probs=156.7
Q ss_pred CCCccceeecccceEEEEEEe----CCCcEEEEEEeccccCC--hhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCCeE
Q 003982 582 NFSEANILGRGGFGVVYGGEL----PDGTKIAVKRMESNTMG--NKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSER 654 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~ 654 (782)
+|++.+.||+|++|.||++.. .+++.||||++++.... ....+.+.+|++++.++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 478889999999999999853 35788999998754321 22456788999999999 599999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccc
Q 003982 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734 (782)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a 734 (782)
++||||+++++|.+++.. ...+++.++..++.|+++||+|||+ .|++||||||+||+++.++.++|+|||++
T Consensus 81 ~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~ 152 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ-----REHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLS 152 (288)
T ss_pred EEEEecCCCCcHHHHHhh-----cCCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECccc
Confidence 999999999999998864 2358899999999999999999998 89999999999999999999999999998
Q ss_pred eecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 735 KNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 735 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+..............|+..|+|||+..+.. .+....+|+||+|++
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~~Dv~slG~i 197 (288)
T cd05583 153 KEFLAEEEERAYSFCGTIEYMAPEVIRGGS-GGHDKAVDWWSLGVL 197 (288)
T ss_pred cccccccccccccccCCccccCHHHhcCCC-CCCcchhhhHHHHHH
Confidence 765443322223346889999999876541 135678899999976
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-25 Score=227.63 Aligned_cols=185 Identities=31% Similarity=0.501 Sum_probs=160.0
Q ss_pred CCCccceeecccceEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEc
Q 003982 582 NFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 660 (782)
+|+..+.||+|++|.||++... +++.+++|++..... ...+.+.+|++++++++||+|+++++++......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 4788899999999999999654 788999999976542 4567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~ 740 (782)
+++++|.+++.... ..+++.++..++.|++.|+.|||+ .|++||||+|+||++++++.++|+|||.+......
T Consensus 79 ~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 79 CSGGSLKDLLKSTN----QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred CCCCcHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence 99999999886521 458999999999999999999998 89999999999999999999999999998876553
Q ss_pred CceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 741 KYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.. .....++..|+|||++.+. .++.++|+||+|++
T Consensus 152 ~~--~~~~~~~~~~~~PE~~~~~---~~~~~~Dv~slG~i 186 (253)
T cd05122 152 KA--RNTMVGTPYWMAPEVINGK---PYDYKADIWSLGIT 186 (253)
T ss_pred cc--ccceecCCcccCHHHHcCC---CCCccccHHHHHHH
Confidence 32 2234688999999988765 25778999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=234.63 Aligned_cols=180 Identities=26% Similarity=0.422 Sum_probs=151.9
Q ss_pred cceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEccCCC
Q 003982 586 ANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRG 664 (782)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~g 664 (782)
...||+|+||.||++.. .+++.||+|++.... ......+.+|+.+++.++|+||+++++++...+..+++|||++++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 46789999999999955 578999999886433 334567899999999999999999999999999999999999999
Q ss_pred CHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCcee
Q 003982 665 TLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSV 744 (782)
Q Consensus 665 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~~ 744 (782)
+|.+++.. ..+++..+..++.|++.|++|||+ .|++||||+|+||+++.++.++|+|||.+........ .
T Consensus 103 ~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~ 172 (292)
T cd06657 103 ALTDIVTH------TRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R 172 (292)
T ss_pred cHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceecccccc-c
Confidence 99987743 347899999999999999999998 8999999999999999999999999999876543221 1
Q ss_pred eecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 745 ETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 745 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.....|++.|+|||+..+. ....++|+||+||+
T Consensus 173 ~~~~~~~~~y~~pE~~~~~---~~~~~~Dv~slGvi 205 (292)
T cd06657 173 RKSLVGTPYWMAPELISRL---PYGPEVDIWSLGIM 205 (292)
T ss_pred ccccccCccccCHHHhcCC---CCCchhhHHHHHHH
Confidence 2234688999999987653 34568999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=240.38 Aligned_cols=186 Identities=26% Similarity=0.433 Sum_probs=152.4
Q ss_pred HHhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC-----
Q 003982 578 QVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING----- 651 (782)
Q Consensus 578 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~----- 651 (782)
...++|.+.+.||+|++|.||+|.. .+++.||||++............+.+|++++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence 3457899999999999999999964 5789999999876443334456788999999999999999999998754
Q ss_pred -CeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEe
Q 003982 652 -SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVAD 730 (782)
Q Consensus 652 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~D 730 (782)
...++|+||+. .++.+... ..+++.++..++.|++.||+|||+ .|++||||||+||+++.++.+||+|
T Consensus 92 ~~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~d 160 (342)
T cd07879 92 FQDFYLVMPYMQ-TDLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILD 160 (342)
T ss_pred CceEEEEecccc-cCHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEee
Confidence 34689999995 46655541 248899999999999999999998 8999999999999999999999999
Q ss_pred eccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 731 FGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 731 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
||+++...... ....+++.|+|||++.+. ..++.++|+||+||+
T Consensus 161 fg~~~~~~~~~----~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slGvi 204 (342)
T cd07879 161 FGLARHADAEM----TGYVVTRWYRAPEVILNW--MHYNQTVDIWSVGCI 204 (342)
T ss_pred CCCCcCCCCCC----CCceeeecccChhhhcCc--cccCchHHHHHHHHH
Confidence 99987653321 223578899999987652 135678999999986
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-25 Score=232.55 Aligned_cols=184 Identities=26% Similarity=0.318 Sum_probs=148.8
Q ss_pred CCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC-CCCcceEEeEEEeC--CeEEEEE
Q 003982 583 FSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCING--SERLLVY 658 (782)
Q Consensus 583 y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~--~~~~lv~ 658 (782)
|++.+.||+|+||.||+|. ..+++.||+|+++..... .......+|+.++.++. |+||+++++++.+. +..++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS-LEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCC-chhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 6778999999999999995 457899999998764322 22334457888999885 99999999999987 8899999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||++ +++.+.+... ...+++.++..++.|++.||+|||+ .|++||||||+||++++ +.+||+|||.++...
T Consensus 80 e~~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~ 150 (282)
T cd07831 80 ELMD-MNLYELIKGR----KRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIY 150 (282)
T ss_pred ecCC-ccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccc
Confidence 9996 5888877542 2358999999999999999999998 89999999999999999 999999999998764
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..... ....+++.|+|||+.... ...+.++|+||+||+
T Consensus 151 ~~~~~--~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slGv~ 188 (282)
T cd07831 151 SKPPY--TEYISTRWYRAPECLLTD--GYYGPKMDIWAVGCV 188 (282)
T ss_pred cCCCc--CCCCCCcccCChhHhhcC--CCCCcchhHHHHHHH
Confidence 43211 224578899999975432 123568999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-25 Score=233.78 Aligned_cols=188 Identities=28% Similarity=0.438 Sum_probs=159.7
Q ss_pred HhcCCCccceeecccceEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
..+.|+..+.||+|++|.||+|... +++.||+|++..... ..+.+.+|++++++++|+||+++++++......+++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 3456888899999999999999654 688999999976542 457788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
+||+++++|.+++.... ..+++.++..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+...
T Consensus 94 ~e~~~~~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 166 (286)
T cd06614 94 MEYMDGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQL 166 (286)
T ss_pred EeccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence 99999999999997632 368999999999999999999998 89999999999999999999999999988765
Q ss_pred CCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 738 PDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..... ......+++.|+|||++.+. .++.++|+||+||+
T Consensus 167 ~~~~~-~~~~~~~~~~y~~PE~~~~~---~~~~~~Dv~slGvi 205 (286)
T cd06614 167 TKEKS-KRNSVVGTPYWMAPEVIKRK---DYGPKVDIWSLGIM 205 (286)
T ss_pred ccchh-hhccccCCcccCCHhHhcCC---CCCCccccHHHHHH
Confidence 43321 11234578899999987764 34678999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=237.75 Aligned_cols=188 Identities=20% Similarity=0.218 Sum_probs=151.6
Q ss_pred ccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEccCCC
Q 003982 585 EANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRG 664 (782)
Q Consensus 585 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~g 664 (782)
+.+.+|.|+++.||++.. +++.||||++..........+.+++|++++++++||||+++++++.+.+..+++|||++++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 344455556666666554 7899999999876444566788999999999999999999999999999999999999999
Q ss_pred CHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCce-
Q 003982 665 TLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS- 743 (782)
Q Consensus 665 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~- 743 (782)
++.+++..... ..+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||.+.........
T Consensus 85 ~l~~~l~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~ 158 (314)
T cd08216 85 SCEDLLKTHFP---EGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ 158 (314)
T ss_pred CHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence 99999876322 347889999999999999999998 89999999999999999999999999988755432210
Q ss_pred -----eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 744 -----VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 744 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
......++..|+|||++.... .+++.++|+||+||+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~~Diws~G~i 199 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNL-QGYNEKSDIYSVGIT 199 (314)
T ss_pred cccccccccccccccccCHHHhcCCC-CCCCcchhHHHHHHH
Confidence 112234678899999886542 245678999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=239.23 Aligned_cols=191 Identities=28% Similarity=0.358 Sum_probs=153.2
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCC------
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS------ 652 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~------ 652 (782)
.++|++.+.||+|++|.||+|.. .+++.||+|++............+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 47899999999999999999954 56899999998765433334456789999999999999999999875433
Q ss_pred --eEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEe
Q 003982 653 --ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVAD 730 (782)
Q Consensus 653 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~D 730 (782)
..++||||+. +++.+.+... ...+++.++..++.|+++||+|||+ .||+||||||+||++++++.+||+|
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~----~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~d 158 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENP----SVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIAD 158 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECc
Confidence 4699999995 4677766531 2358999999999999999999998 8999999999999999999999999
Q ss_pred eccceecCCCCce----------eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 731 FGLVKNAPDGKYS----------VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 731 fG~a~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
||++......... ......+++.|+|||++.+. ...+.++|+||+|++
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~i 216 (311)
T cd07866 159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE--RRYTTAVDIWGIGCV 216 (311)
T ss_pred CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCC--CccCchhHhHHHHHH
Confidence 9998765432211 11223568889999987653 235678999999986
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=232.05 Aligned_cols=181 Identities=29% Similarity=0.419 Sum_probs=152.2
Q ss_pred eecccceEEEEEEeC-CCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEccCCCCH
Q 003982 589 LGRGGFGVVYGGELP-DGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTL 666 (782)
Q Consensus 589 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~gsL 666 (782)
||+|+||.||++... +++.||+|++..... .....+.+.+|++++++++||||+++++.+.+....|++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 589999999999665 589999999976543 224567789999999999999999999999999999999999999999
Q ss_pred HHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCc----
Q 003982 667 AQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY---- 742 (782)
Q Consensus 667 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~---- 742 (782)
.+++.+. ..+++..+..++.|++.||+|||+ .|++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 152 (265)
T cd05579 81 ASLLENV-----GSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN 152 (265)
T ss_pred HHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence 9998752 358999999999999999999998 8999999999999999999999999999876543211
Q ss_pred ---eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 743 ---SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 743 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.......++..|+|||+..+. ....++|+||+|++
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~---~~~~~~Dv~slG~~ 190 (265)
T cd05579 153 DDEKEDKRIVGTPDYIAPEVILGQ---GHSKTVDWWSLGCI 190 (265)
T ss_pred cccccccCcccCccccCHHHhcCC---CCCcchhhHHHHHH
Confidence 122334578899999987664 35678999999976
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-25 Score=228.88 Aligned_cols=178 Identities=29% Similarity=0.388 Sum_probs=146.8
Q ss_pred ceeecccceEEEEEEe-CCCcEEEEEEeccccCC-hhhHHHHHHHHHHH-HhcCCCCcceEEeEEEeCCeEEEEEEccCC
Q 003982 587 NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVL-TKVRHRHLVALLGYCINGSERLLVYEYMPR 663 (782)
Q Consensus 587 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l-~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~ 663 (782)
+.||+|++|.||+|.. .+++.||+|++.+.... ......+..|..++ ...+|+||+++++++...+..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5689999999999954 56889999998764322 12233445555544 455899999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCce
Q 003982 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743 (782)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~ 743 (782)
++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||++......
T Consensus 82 ~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 150 (260)
T cd05611 82 GDCASLIKT-----LGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN--- 150 (260)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceecccc---
Confidence 999999865 2458899999999999999999998 89999999999999999999999999998765431
Q ss_pred eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 744 VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 744 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
....|++.|+|||+..+. .+..++|+||+|++
T Consensus 151 --~~~~~~~~y~~pe~~~~~---~~~~~~Dv~slG~i 182 (260)
T cd05611 151 --KKFVGTPDYLAPETILGV---GDDKMSDWWSLGCV 182 (260)
T ss_pred --ccCCCCcCccChhhhcCC---CCcchhhhHHHHHH
Confidence 224578899999998775 25778999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.3e-26 Score=239.31 Aligned_cols=188 Identities=25% Similarity=0.372 Sum_probs=153.9
Q ss_pred CCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCC-hhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
-|..++.||-|+||+|..++. .+...||+|.+++.+.- .......+.|-.||...+.+=||++|..|.+.+..|+||+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 466788999999999999954 34667999999876532 2244567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC-
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP- 738 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~- 738 (782)
|++||++..+|.+ .+.+.+..+..++..+.+|+++.|+ .|+|||||||+|||||.+|.+||+|||++.-+.
T Consensus 710 YIPGGDmMSLLIr-----mgIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIR-----MGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred ccCCccHHHHHHH-----hccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeecccccccee
Confidence 9999999999976 3568888899999999999999998 899999999999999999999999999974321
Q ss_pred --------CCCcee--------------------------------eecccccccccCccccccchhhhHHHHHHHHHhc
Q 003982 739 --------DGKYSV--------------------------------ETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHG 778 (782)
Q Consensus 739 --------~~~~~~--------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~G 778 (782)
.+...+ ....+||+.|+|||++... |++-.+|-||.|
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~---g~~q~cdwws~g 858 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART---GYTQLCDWWSVG 858 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc---CccccchhhHhh
Confidence 110000 0113699999999998764 666677788888
Q ss_pred cc
Q 003982 779 SV 780 (782)
Q Consensus 779 vv 780 (782)
||
T Consensus 859 vi 860 (1034)
T KOG0608|consen 859 VI 860 (1034)
T ss_pred HH
Confidence 75
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.4e-25 Score=234.65 Aligned_cols=186 Identities=27% Similarity=0.395 Sum_probs=152.7
Q ss_pred CCCccceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
.|...+.||+|+||.||+|.. .++..||+|++..... ..+....+.+|++++++++|||++++++++.++...++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 366788999999999999964 5688999999875432 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|++ |++.+.+... ..++++.++..++.|++.|+.|||+ .||+||||+|+||+++.++.+||+|||++.....
T Consensus 106 ~~~-g~l~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 106 YCL-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred CCC-CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 996 5787776542 2458999999999999999999998 8999999999999999999999999999875543
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
. ....|++.|+|||++...-.-..+.++|+||+||+
T Consensus 178 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvi 213 (317)
T cd06635 178 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 213 (317)
T ss_pred c-----ccccCCccccChhhhhcCCCCCCCccccHHHHHHH
Confidence 2 22357889999998742111124668899999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-26 Score=231.90 Aligned_cols=189 Identities=26% Similarity=0.357 Sum_probs=157.8
Q ss_pred hcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCCeEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLL 656 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~l 656 (782)
..+|..+.+||+|+||.|..|. ..+.+.||||+++++.. .++..+.-..|-++++-. +-|.+++++.+|++-+..|.
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 4578889999999999999994 44567899999988754 233445556677777765 47899999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecccee
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~ 736 (782)
||||+.||+|.-.+++. +.+.+..+..+|..|+-||-|||+ +|||.||+|.+|||+|.+|.+||+|||+++.
T Consensus 428 VMEyvnGGDLMyhiQQ~-----GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQV-----GKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred EEEEecCchhhhHHHHh-----cccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeecccccc
Confidence 99999999999888773 457778899999999999999998 9999999999999999999999999999986
Q ss_pred cCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 737 APDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
---+.. ....++|||.|+|||++.-+ .+....|-||+||+
T Consensus 500 ni~~~~-TTkTFCGTPdYiAPEIi~Yq---PYgksvDWWa~GVL 539 (683)
T KOG0696|consen 500 NIFDGV-TTKTFCGTPDYIAPEIIAYQ---PYGKSVDWWAFGVL 539 (683)
T ss_pred cccCCc-ceeeecCCCcccccceEEec---ccccchhHHHHHHH
Confidence 543332 33457999999999998765 55677888888875
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.4e-26 Score=227.98 Aligned_cols=188 Identities=24% Similarity=0.335 Sum_probs=156.1
Q ss_pred HHHHhcCCCccceeecccceEEEEE-EeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCC--C----CcceEEeEE
Q 003982 576 LRQVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH--R----HLVALLGYC 648 (782)
Q Consensus 576 l~~~~~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~----nI~~~~~~~ 648 (782)
......+|.+...+|+|+||.|-++ +...+..||||+++.- .+..+..+-|+++++++.+ | -++++.+||
T Consensus 84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF 160 (415)
T KOG0671|consen 84 GDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF 160 (415)
T ss_pred ccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence 3345789999999999999999999 5556889999999753 3566777889999999942 2 378888999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECC------
Q 003982 649 INGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD------ 722 (782)
Q Consensus 649 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~------ 722 (782)
.-.++.++|+|.+ |.|+++++.. .+..+++..++..+++|++++++|||+ .+++|-|+||+|||+.+
T Consensus 161 dyrghiCivfell-G~S~~dFlk~---N~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~ 233 (415)
T KOG0671|consen 161 DYRGHICIVFELL-GLSTFDFLKE---NNYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKT 233 (415)
T ss_pred hccCceEEEEecc-ChhHHHHhcc---CCccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEE
Confidence 9999999999999 7799999965 346789999999999999999999999 89999999999999932
Q ss_pred --------------CCcEEEEeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 723 --------------DMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 723 --------------~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+..+|++|||.|....... ...+.|..|+|||++.+. |....+||||+|+|
T Consensus 234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgL---GwS~pCDvWSiGCI 298 (415)
T KOG0671|consen 234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGL---GWSQPCDVWSIGCI 298 (415)
T ss_pred eccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheecc---CcCCccCceeeeeE
Confidence 2358999999998765433 345679999999999885 44445579999987
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-27 Score=250.62 Aligned_cols=192 Identities=29% Similarity=0.416 Sum_probs=167.0
Q ss_pred HhcCCCccceeecccceEEEEE-EeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
-.++|+....+|.|++|.|||+ +...++..|+|+++... ....+-.++|+-+++..+||||+.+++.|...+..|+.
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep--~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP--GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccC--CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 3467889999999999999999 55689999999998765 45567789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
||||.+|+|.+..+- .+++++.++..+.+..++|++|||+ .|-+|||||-.||++++.|.+|++|||.+..+
T Consensus 91 MEycgggslQdiy~~-----TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqi 162 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHV-----TGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQI 162 (829)
T ss_pred EEecCCCcccceeee-----cccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhh
Confidence 999999999887643 5789999999999999999999999 89999999999999999999999999998877
Q ss_pred CCCCceeeecccccccccCccccccchhhhHHHHHHHHHhcccC
Q 003982 738 PDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSVG 781 (782)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv~ 781 (782)
...-. ....+.||++|||||+..=.-.-|+...+|+|++|+-|
T Consensus 163 tati~-KrksfiGtpywmapEvaaverkggynqlcdiwa~gitA 205 (829)
T KOG0576|consen 163 TATIA-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITA 205 (829)
T ss_pred hhhhh-hhhcccCCccccchhHHHHHhcccccccccccccccch
Confidence 65333 23457899999999986533345778889999999865
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-25 Score=240.36 Aligned_cols=188 Identities=29% Similarity=0.409 Sum_probs=158.0
Q ss_pred CCCccceeecccceEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCC-----eEE
Q 003982 582 NFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS-----ERL 655 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~-----~~~ 655 (782)
+|++.+.||+|++|.||+|... +++.||+|++..........+.+.+|+++++.++||||+++++++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888999999999999999654 5899999999765433445678999999999999999999999988775 789
Q ss_pred EEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccce
Q 003982 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (782)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~ 735 (782)
++|||++ ++|.+++.. ..++++..+..++.|++.||+|||+ .||+||||||+||+++.++.++|+|||.+.
T Consensus 81 lv~e~~~-~~l~~~l~~-----~~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~ 151 (330)
T cd07834 81 IVTELME-TDLHKVIKS-----PQPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLAR 151 (330)
T ss_pred EEecchh-hhHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceE
Confidence 9999997 578887754 2368999999999999999999998 899999999999999999999999999998
Q ss_pred ecCCCCc--eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 736 NAPDGKY--SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 736 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
....... .......+++.|+|||++.+. ..+..++|+||+|++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~sDi~slG~i 196 (330)
T cd07834 152 GVDPDEDEKGFLTEYVVTRWYRAPELLLSS--SRYTKAIDIWSVGCI 196 (330)
T ss_pred eecccccccccccccccccCcCCceeeecc--cCCCcchhHHHHHHH
Confidence 7655331 112234578899999998764 256778999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.8e-28 Score=227.10 Aligned_cols=190 Identities=25% Similarity=0.368 Sum_probs=148.7
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEe--------C
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN--------G 651 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~--------~ 651 (782)
..|....+||+|.||+||+|+. .+|+.||+|++--+...........+|+++++.++|+|++.++..|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 3466678899999999999954 467889998775544334455678899999999999999998877653 2
Q ss_pred CeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEee
Q 003982 652 SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADF 731 (782)
Q Consensus 652 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~Df 731 (782)
...|+||.+|+. +|...+... ...++..++.+++.++..||.|+|+ ..|+|||+||+|+|++.++.+||+||
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~----~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNR----KVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCc----cccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeecc
Confidence 347999999975 788887542 2468999999999999999999998 89999999999999999999999999
Q ss_pred ccceecCCCCce---eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 732 GLVKNAPDGKYS---VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 732 G~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|+|+.+...... ..+..+.|.+|++||.+.|.- -++...|+|+.|+|
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r--~yg~~iDiWgAgCi 218 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDR--EYGPPIDIWGAGCI 218 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhccc--ccCCcchhHhHHHH
Confidence 999766443211 123345699999999887652 23445666666654
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=5e-25 Score=231.50 Aligned_cols=187 Identities=26% Similarity=0.364 Sum_probs=157.7
Q ss_pred CCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEcc
Q 003982 583 FSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYM 661 (782)
Q Consensus 583 y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~ 661 (782)
|++.+.||+|++|.||+|.. .+++.+|+|++............+.+|++++++++|+||+++++++.++...++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 66788999999999999955 47889999998765543345678889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCC
Q 003982 662 PRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK 741 (782)
Q Consensus 662 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~ 741 (782)
++ ++.+++... ...+++.++..++.|++.||.|||+ .+|+|+||||+||++++++.+||+|||.+.......
T Consensus 81 ~~-~l~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~ 152 (283)
T cd05118 81 DT-DLYKLIKDR----QRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152 (283)
T ss_pred CC-CHHHHHHhh----cccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence 65 888887652 2468999999999999999999998 899999999999999999999999999998775533
Q ss_pred ceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 742 YSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 742 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.......++..|+|||++.+. ...+.++|+||+|++
T Consensus 153 -~~~~~~~~~~~~~~PE~~~~~--~~~~~~~Di~slG~~ 188 (283)
T cd05118 153 -RPYTHYVVTRWYRAPELLLGD--KGYSTPVDIWSVGCI 188 (283)
T ss_pred -ccccCccCcccccCcHHHhcC--CCCCchhHHHHHHHH
Confidence 122234578899999987653 246788999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.6e-26 Score=213.01 Aligned_cols=178 Identities=22% Similarity=0.455 Sum_probs=146.8
Q ss_pred hcCCCccceeecccceEEEEE-EeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC-CCCcceEEeEEEeCC--eEE
Q 003982 580 TDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGS--ERL 655 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~--~~~ 655 (782)
.++|++.+++|+|.+++||.| ...+.+.++||++++- ..+.+.+|+++++.++ ||||++++++..++. ...
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 467899999999999999999 5667889999999763 3578999999999998 999999999987764 457
Q ss_pred EEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCC-cEEEEeeccc
Q 003982 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM-RAKVADFGLV 734 (782)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~-~~kL~DfG~a 734 (782)
+|+||+.+.+..... ..++..++..++.++++||.|+|+ .||+|||+||.|+++|... .++|+|+|+|
T Consensus 112 LiFE~v~n~Dfk~ly--------~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLA 180 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLY--------PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLA 180 (338)
T ss_pred hHhhhhccccHHHHh--------hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchH
Confidence 999999988776654 347888999999999999999999 8999999999999999764 6999999999
Q ss_pred eecCCCCceeeecccccccccCcccccc---------chhhhHHHHHHHH
Q 003982 735 KNAPDGKYSVETRLAGTFGYLAPEYAGK---------HWMILCQMTGLIW 775 (782)
Q Consensus 735 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~~~~dvw 775 (782)
.++..+... .-.+.+.+|.-||.+.+ .|++||+++++||
T Consensus 181 EFYHp~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miF 228 (338)
T KOG0668|consen 181 EFYHPGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 228 (338)
T ss_pred hhcCCCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHh
Confidence 988765421 22356889999997654 4555555555554
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.8e-25 Score=230.88 Aligned_cols=189 Identities=17% Similarity=0.200 Sum_probs=138.1
Q ss_pred hcCCCccceeecccceEEEEEEeCC----CcEEEEEEeccccCChh-h--------HHHHHHHHHHHHhcCCCCcceEEe
Q 003982 580 TDNFSEANILGRGGFGVVYGGELPD----GTKIAVKRMESNTMGNK-G--------LSEFQAEIAVLTKVRHRHLVALLG 646 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~-~--------~~~~~~E~~~l~~l~h~nI~~~~~ 646 (782)
.++|.+.+.||+|+||.||+|...+ +..+|+|+......... + ......+...+..+.|++|+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4689999999999999999996544 34566665433221100 0 011223344556678999999998
Q ss_pred EEEeCC----eEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECC
Q 003982 647 YCINGS----ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD 722 (782)
Q Consensus 647 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~ 722 (782)
++.... ..++++|++. .++.+.+... ...++..+..++.|++.||+|||+ .+|+||||||+||+++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~ 161 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRI-----KCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDG 161 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHhh-----ccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcC
Confidence 766543 3478888773 4666655431 235778899999999999999998 89999999999999999
Q ss_pred CCcEEEEeeccceecCCCCce------eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 723 DMRAKVADFGLVKNAPDGKYS------VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 723 ~~~~kL~DfG~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
++.+||+|||+|+........ ......||+.|+|||+..+. .++.++||||+||+
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~---~~~~~~DiwSlG~~ 222 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA---CVTRRGDLESLGYC 222 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC---CCCcHHHHHHHHHH
Confidence 999999999999876432111 11224699999999988765 45788999999986
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.6e-25 Score=236.61 Aligned_cols=190 Identities=26% Similarity=0.374 Sum_probs=152.5
Q ss_pred hcCCCc-cceeecccceEEEEEE-eCCCcEEEEEEeccccCChh------------hHHHHHHHHHHHHhcCCCCcceEE
Q 003982 580 TDNFSE-ANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNK------------GLSEFQAEIAVLTKVRHRHLVALL 645 (782)
Q Consensus 580 ~~~y~~-~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~------------~~~~~~~E~~~l~~l~h~nI~~~~ 645 (782)
.++|.. .+.||+|+||+||+|. ..+++.||||++........ ....+.+|++++++++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 456654 5779999999999995 45789999999875432210 112577899999999999999999
Q ss_pred eEEEeCCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCc
Q 003982 646 GYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR 725 (782)
Q Consensus 646 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~ 725 (782)
+++...+..++||||++ ++|.+++.. ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++.
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~ 157 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDR-----KIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGI 157 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCC
Confidence 99999999999999996 689888854 2458999999999999999999998 89999999999999999999
Q ss_pred EEEEeeccceecCCCCc-------------eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 726 AKVADFGLVKNAPDGKY-------------SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 726 ~kL~DfG~a~~~~~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+||+|||.+........ .......+++.|+|||++.+. .....++|+||+|++
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~~ 223 (335)
T PTZ00024 158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA--EKYHFAVDMWSVGCI 223 (335)
T ss_pred EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccC--CCCCcHHHHHHHHHH
Confidence 99999999976652110 011123468899999988653 124678999999986
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.1e-27 Score=234.34 Aligned_cols=369 Identities=21% Similarity=0.242 Sum_probs=269.6
Q ss_pred CCCCCCccc---cceEeCCC----------CCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCC
Q 003982 49 TSSTGYCEW---TGINCDNS----------NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATS 114 (782)
Q Consensus 49 ~~~~~~c~w---~gv~c~~~----------~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~ 114 (782)
++..+-|+- .-|.|+.. ...++|+|..|+|+..-+.+|+.+++|+.|||++|+|+.+.| +|.++.+
T Consensus 37 CP~pC~Cs~~~g~~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~ 116 (498)
T KOG4237|consen 37 CPAPCTCSDVEGGIVDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLAS 116 (498)
T ss_pred CCCCcccCCCCCceEEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHh
Confidence 455556665 45788753 478999999999997777889999999999999999999988 8999999
Q ss_pred CCEEeCCC-CcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEE
Q 003982 115 LQDIYLDN-NNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLR 193 (782)
Q Consensus 115 L~~L~Ls~-n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 193 (782)
|.+|-+.+ |+|+.+|.+.|.+|..|+.|.+.-|++.- .....|..+++|..|.|..|.+..+-...|..+..++.+.
T Consensus 117 l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~C--ir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlh 194 (498)
T KOG4237|consen 117 LLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINC--IRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLH 194 (498)
T ss_pred hhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcc--hhHHHHHHhhhcchhcccchhhhhhccccccchhccchHh
Confidence 98887755 99999999999999999999999999988 5667899999999999999999888667999999999999
Q ss_pred cccCcCC------------CCCCccccc-----------------------cccchh---hcccccCCCccccccccCCC
Q 003982 194 LSYNNFT------------GSLPASFAK-----------------------SDIQNL---WMNDQQLGLSGTLDVLSGMT 235 (782)
Q Consensus 194 Ls~N~l~------------~~~p~~~~~-----------------------~~l~~l---~l~~~~~~~~~~~~~~~~l~ 235 (782)
+..|.+- -..|.++.. ..++.+ ...............|..++
T Consensus 195 lA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~ 274 (498)
T KOG4237|consen 195 LAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLP 274 (498)
T ss_pred hhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcc
Confidence 9999832 111221111 012222 11222223333345799999
Q ss_pred CCcEEEeecccccCCCC-CCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCCCCC---CccEEEcc
Q 003982 236 QLRQVWLHKNQFTGPIP-DLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPS---KVQKVSLD 311 (782)
Q Consensus 236 ~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~---~l~~L~l~ 311 (782)
+|+.|+|++|+++++.+ +|.....++.|.|..|+|..+--..|.++..|+.|+|.+|+|+...|..+. .|.+|.|-
T Consensus 275 ~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~ 354 (498)
T KOG4237|consen 275 NLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLL 354 (498)
T ss_pred cceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehc
Confidence 99999999999999776 599999999999999999988888999999999999999999988887665 57788888
Q ss_pred CCcCCCCC------------CCCCCCCChhhhhHHHhhcC---CCCCccccc---CcC------------------CCCC
Q 003982 312 HNNFCKNS------------SDAGKPCDPQVTTLLQIAGD---MGYPAILSD---SWE------------------GNNA 355 (782)
Q Consensus 312 ~N~~~~~~------------~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~---~~~------------------~~~~ 355 (782)
.|.|.=.. ...+.|.........+++.. ++...--.. .-. +|..
T Consensus 355 ~Np~~CnC~l~wl~~Wlr~~~~~~~~~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~ 434 (498)
T KOG4237|consen 355 SNPFNCNCRLAWLGEWLRKKSVVGNPRCQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKL 434 (498)
T ss_pred cCcccCccchHHHHHHHhhCCCCCCCCCCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccc
Confidence 88874211 12223322222222222111 000000000 000 0111
Q ss_pred CCCCCcccccCCceeEEEccCcccccccCccccccccCCeEecccccccccCCccCCCCCCCCeEecCCC
Q 003982 356 CDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNN 425 (782)
Q Consensus 356 ~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N 425 (782)
+..+|..+. ...+.|++.+|.++ .+|.. .+.+| .+||++|+++-.--..|.++++|.+|-||+|
T Consensus 435 lk~lp~~iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 435 LKLLPRGIP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred hhhcCCCCC--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 112222211 13457889999988 56666 66778 8999999988777788889999999988887
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-24 Score=229.77 Aligned_cols=185 Identities=27% Similarity=0.394 Sum_probs=151.7
Q ss_pred CCccceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEc
Q 003982 583 FSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (782)
Q Consensus 583 y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 660 (782)
|...+.||+|++|+||+|.. .+++.||+|++..... .....+.+.+|++++++++|||++++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 56678899999999999954 5688999999875432 223456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~ 740 (782)
+. +++.+++... ..++++.++..++.|++.|+.|||+ .|++||||+|+||++++++.+||+|||++......
T Consensus 103 ~~-~~l~~~l~~~----~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~ 174 (313)
T cd06633 103 CL-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA 174 (313)
T ss_pred CC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCCC
Confidence 95 5777776542 2458999999999999999999998 89999999999999999999999999988643321
Q ss_pred CceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 741 KYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
....|+..|+|||++...-.-..+.++|+||+||+
T Consensus 175 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvi 209 (313)
T cd06633 175 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 209 (313)
T ss_pred -----CCccccccccChhhccccCCCCCCchhhHHHHHHH
Confidence 23468899999998743211134668899999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=6e-25 Score=242.74 Aligned_cols=180 Identities=23% Similarity=0.317 Sum_probs=133.4
Q ss_pred HhcCCCccceeecccceEEEEEEe-----------------CCCcEEEEEEeccccCCh------------hhHHHHHHH
Q 003982 579 VTDNFSEANILGRGGFGVVYGGEL-----------------PDGTKIAVKRMESNTMGN------------KGLSEFQAE 629 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~------------~~~~~~~~E 629 (782)
..++|++.++||+|+||+||+|.. ..++.||||++....... ...+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 356899999999999999999843 235679999986533110 011233457
Q ss_pred HHHHHhcCCCCc-----ceEEeEEEe--------CCeEEEEEEccCCCCHHHHHHhhccC-------------------C
Q 003982 630 IAVLTKVRHRHL-----VALLGYCIN--------GSERLLVYEYMPRGTLAQHLFEWHDH-------------------G 677 (782)
Q Consensus 630 ~~~l~~l~h~nI-----~~~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~ 677 (782)
+.++.+++|.++ ++++++|.. .+..++||||+++++|.++++..... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777888876554 667777653 35679999999999999998642110 0
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCceeeecccccccccCc
Q 003982 678 YTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAP 757 (782)
Q Consensus 678 ~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aP 757 (782)
...+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++..............+|+.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 1234677889999999999999998 8999999999999999999999999999976543322111222358899999
Q ss_pred cccc
Q 003982 758 EYAG 761 (782)
Q Consensus 758 E~~~ 761 (782)
|.+.
T Consensus 380 E~l~ 383 (507)
T PLN03224 380 EELV 383 (507)
T ss_pred hhhc
Confidence 9864
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-25 Score=238.86 Aligned_cols=185 Identities=27% Similarity=0.523 Sum_probs=153.9
Q ss_pred ccceeecccceEEEEEEeC--CCc--EEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEc
Q 003982 585 EANILGRGGFGVVYGGELP--DGT--KIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (782)
Q Consensus 585 ~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 660 (782)
..+.||+|.||+|++|.|. .|+ .||||.++..... ....+|.+|+.+|.+++|||++++||+..+ ....+|||+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~-~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN-AIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc-hhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 4678999999999999664 344 5899999877643 367899999999999999999999999887 778899999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~ 740 (782)
++.|+|.+.|++.. ...+.......++.|||.|+.||.. +++||||+.++|+++...-.|||+|||+.+.+...
T Consensus 192 aplGSLldrLrka~---~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 192 APLGSLLDRLRKAK---KAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred cccchHHHHHhhcc---ccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 99999999998722 3467888899999999999999998 89999999999999999999999999999988654
Q ss_pred C--ceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 741 K--YSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 741 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
. |.......-...|+|||.+.-. ...-++|+|++||.
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~---kFShaSDvWmyGVT 304 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHR---KFSHASDVWMYGVT 304 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccc---cccccchhhhhhhh
Confidence 4 3233333446789999987643 34667888888873
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=227.78 Aligned_cols=186 Identities=30% Similarity=0.405 Sum_probs=151.0
Q ss_pred CCccceeecccceEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHHhc---CCCCcceEEeEEEeCCe-----
Q 003982 583 FSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV---RHRHLVALLGYCINGSE----- 653 (782)
Q Consensus 583 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~nI~~~~~~~~~~~~----- 653 (782)
|++.+.||+|++|.||+|... +++.||+|+++...........+.+|+.+++++ +||||+++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 677899999999999999765 589999999976543333345667788877766 59999999999988776
Q ss_pred EEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecc
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~ 733 (782)
.+++|||+. +++.+++.... ...+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~---~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~ 153 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP---KPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGL 153 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCc
Confidence 899999996 58888876532 1358999999999999999999998 8999999999999999999999999999
Q ss_pred ceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 734 VKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 734 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+......... ....++..|+|||++.+. ....++|+||+|++
T Consensus 154 ~~~~~~~~~~--~~~~~~~~~~~PE~~~~~---~~~~~~Di~s~G~~ 195 (287)
T cd07838 154 ARIYSFEMAL--TSVVVTLWYRAPEVLLQS---SYATPVDMWSVGCI 195 (287)
T ss_pred ceeccCCccc--ccccccccccChHHhccC---CCCCcchhhhHHHH
Confidence 9876543211 223578899999987654 34567889998875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-25 Score=239.11 Aligned_cols=186 Identities=28% Similarity=0.427 Sum_probs=155.5
Q ss_pred HhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCe----
Q 003982 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE---- 653 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~---- 653 (782)
+.++|++.+.||+|++|.||+|.. .+++.||+|++..........+.+.+|+.++++++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 467899999999999999999965 467899999987643333445677889999999999999999988776554
Q ss_pred --EEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEee
Q 003982 654 --RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADF 731 (782)
Q Consensus 654 --~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~Df 731 (782)
.++|+||+ +++|.+++.. ..+++.++..++.|++.|++|||+ .||+||||||+||++++++.+||+||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~df 162 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDF 162 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEccc
Confidence 89999999 6799888754 358999999999999999999998 89999999999999999999999999
Q ss_pred ccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 732 GLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 732 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|++....... ....++..|+|||...+. .+...++|+||+||+
T Consensus 163 g~~~~~~~~~----~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslGv~ 205 (343)
T cd07851 163 GLARHTDDEM----TGYVATRWYRAPEIMLNW--MHYNQTVDIWSVGCI 205 (343)
T ss_pred cccccccccc----cCCcccccccCHHHHhCC--CCCCchHhHHHHHHH
Confidence 9998664321 233578899999987653 145678999999986
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=252.71 Aligned_cols=189 Identities=28% Similarity=0.346 Sum_probs=157.9
Q ss_pred hcCCCccceeecccceEEEEEEeC-CCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
.++|.+.+.||+|+||.||+|... +++.||||+++.... .......+.+|+.+++.++||||+++++++......|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 367999999999999999999654 789999999976543 233457789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
|||+++++|.+++... ..+++..++.++.||+.||+|||. .||+||||||+|||++.++.+||+|||+++..
T Consensus 83 mEy~~g~~L~~li~~~-----~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~ 154 (669)
T cd05610 83 MEYLIGGDVKSLLHIY-----GYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154 (669)
T ss_pred EeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCccc
Confidence 9999999999998652 347889999999999999999998 89999999999999999999999999999876
Q ss_pred CCCCceeeecccccccccCccccccchhhhHHHHHHHHHhcc
Q 003982 738 PDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGS 779 (782)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gv 779 (782)
..... ......+|+.|+|||... +..+....+++|++|.
T Consensus 155 ~~~~~-~~~~~~~t~~~~~pe~~~--~~~~~~~~s~~~s~g~ 193 (669)
T cd05610 155 LNREL-NMMDILTTPSMAKPKNDY--SRTPGQVLSLISSLGF 193 (669)
T ss_pred cCCcc-cccccccCccccCccccc--cCCCCceeeeeeecCc
Confidence 54332 223457899999999532 2344455677777774
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8e-25 Score=236.41 Aligned_cols=187 Identities=24% Similarity=0.367 Sum_probs=149.9
Q ss_pred hcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC-------
Q 003982 580 TDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING------- 651 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~------- 651 (782)
..+|.+.+.||+|+||.||+|. ..+++.||+|.+.... ....+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~--~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC--CchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 4689999999999999999995 4578999999987654 24457788999999999999999999776543
Q ss_pred -------CeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECC-C
Q 003982 652 -------SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD-D 723 (782)
Q Consensus 652 -------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~-~ 723 (782)
...++||||++ ++|.+++.+ ..+++..+..++.|++.||+|||+ .||+||||||+||+++. +
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~ 151 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ------GPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTED 151 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCC
Confidence 35789999996 588877743 358899999999999999999998 89999999999999984 5
Q ss_pred CcEEEEeeccceecCCCCce--eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 724 MRAKVADFGLVKNAPDGKYS--VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 724 ~~~kL~DfG~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+.+||+|||.+......... ......++..|+|||++.+. .....++|+||+||+
T Consensus 152 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwSlGvi 208 (342)
T cd07854 152 LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP--NNYTKAIDMWAAGCI 208 (342)
T ss_pred ceEEECCcccceecCCccccccccccccccccccCHHHHhCc--cccCchhhHHHHHHH
Confidence 57899999999765432111 11223578899999976542 234668999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=249.37 Aligned_cols=190 Identities=29% Similarity=0.468 Sum_probs=159.4
Q ss_pred CccceeecccceEEEEEEeC----C----CcEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCCeE
Q 003982 584 SEANILGRGGFGVVYGGELP----D----GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSER 654 (782)
Q Consensus 584 ~~~~~lg~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~ 654 (782)
.+.+.+|+|.||.|++|... . ...||||.++.... ..+.+.+..|+++|+.+ +|+||+.++|++...+..
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~-~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~ 377 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS-SSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPL 377 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccC-cHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCce
Confidence 44568999999999999531 1 45799999986653 36788999999999998 599999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhhc---------cCCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCC
Q 003982 655 LLVYEYMPRGTLAQHLFEWH---------DHGY--TPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD 723 (782)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~---------~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~ 723 (782)
++|+||++.|+|.++++..+ .... ..++..+.+.++.|||.|++||++ .++||||+.++|||+.++
T Consensus 378 ~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi~~~ 454 (609)
T KOG0200|consen 378 YVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLITKN 454 (609)
T ss_pred EEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEecCC
Confidence 99999999999999998866 1111 138899999999999999999998 899999999999999999
Q ss_pred CcEEEEeeccceecCCCCceeeecccc--cccccCccccccchhhhHHHHHHHHHhccc
Q 003982 724 MRAKVADFGLVKNAPDGKYSVETRLAG--TFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 724 ~~~kL~DfG~a~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..+||+|||+|+......+.......| ...|||||.+.+. .++.++||||+||+
T Consensus 455 ~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~---~ft~kSDVWSfGI~ 510 (609)
T KOG0200|consen 455 KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDR---VFTSKSDVWSFGIL 510 (609)
T ss_pred CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccC---cccccchhhHHHHH
Confidence 999999999999877666554332233 3469999988884 56889999999985
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=230.34 Aligned_cols=186 Identities=27% Similarity=0.386 Sum_probs=151.6
Q ss_pred CCCccceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
.|...+.||+|++|.||+|.. .+++.+|+|.+..... .....+++.+|+++++.++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 366678899999999999965 4678999999865322 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+. |++.+.+... ..++++.++..++.|++.|+.|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 96 ~~~-~~l~~~~~~~----~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 96 YCL-GSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred ccC-CCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 996 6887776542 2357899999999999999999998 8999999999999999999999999999876543
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
. ....|++.|+|||++.+.-.-....++||||+||+
T Consensus 168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~i 203 (308)
T cd06634 168 A-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 203 (308)
T ss_pred c-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHH
Confidence 2 22357889999998642111124567899999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-25 Score=218.45 Aligned_cols=189 Identities=23% Similarity=0.363 Sum_probs=161.5
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCC-hhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCCeEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLL 656 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~l 656 (782)
..+|+.+++||+|+|+.|..+++ ++.+.||+|++++.-.. ++..+..+.|-.+..+. +||.+|-++.+|+++...++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 46789999999999999999955 56789999999887554 34667788888888876 59999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecccee
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~ 736 (782)
|.||++||+|.-.+++ .+.++++.+..+...|.-||.|||+ +|||.||+|..|||+|.+|.+||+|+|+++.
T Consensus 329 vieyv~ggdlmfhmqr-----qrklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEecCcceeeehhh-----hhcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhc
Confidence 9999999999877765 3458999999999999999999999 8999999999999999999999999999986
Q ss_pred cCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 737 APDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
--... ...+.++|||.|.|||++.+. -+.+..|-|++||+
T Consensus 401 ~l~~g-d~tstfcgtpnyiapeilrge---eygfsvdwwalgvl 440 (593)
T KOG0695|consen 401 GLGPG-DTTSTFCGTPNYIAPEILRGE---EYGFSVDWWALGVL 440 (593)
T ss_pred CCCCC-cccccccCCCcccchhhhccc---ccCceehHHHHHHH
Confidence 43322 133557999999999999987 34667888888875
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=228.64 Aligned_cols=186 Identities=28% Similarity=0.414 Sum_probs=153.5
Q ss_pred CCccceeecccceEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC-CCCcceEEeEEEeCCeEEEEEEc
Q 003982 583 FSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSERLLVYEY 660 (782)
Q Consensus 583 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~~~lv~e~ 660 (782)
|++.+.||+|++|.||+|... +++.||+|++...... .......+|+..+++++ ||||+++++++.+++..++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 677899999999999999764 5788999998754321 22334567999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~ 740 (782)
+ +|++.+.+.... ...+++.++..++.|++.||.|||+ +|++|+||+|+||++++++.++|+|||.+......
T Consensus 80 ~-~~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (283)
T cd07830 80 M-EGNLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR 152 (283)
T ss_pred C-CCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence 9 889998886532 2357999999999999999999998 89999999999999999999999999999876543
Q ss_pred CceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 741 KYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.. .....++..|+|||++.+. ...+.++|+||+|++
T Consensus 153 ~~--~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~s~G~~ 188 (283)
T cd07830 153 PP--YTDYVSTRWYRAPEILLRS--TSYSSPVDIWALGCI 188 (283)
T ss_pred CC--cCCCCCcccccCceeeecC--cCcCCccchhhHHHH
Confidence 22 1234578899999987543 234567999999986
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=228.40 Aligned_cols=187 Identities=31% Similarity=0.408 Sum_probs=156.4
Q ss_pred CCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEcc
Q 003982 583 FSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYM 661 (782)
Q Consensus 583 y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~ 661 (782)
|+..+.||+|++|.||+|.. .+++.||+|++..........+.+..|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 56778899999999999955 45899999999876533445677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCC
Q 003982 662 PRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK 741 (782)
Q Consensus 662 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~ 741 (782)
+ ++|.+++.+.. ..+++..+..++.|++.||+|||+ .||+||||+|+||++++++.+||+|||.+.......
T Consensus 81 ~-~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 152 (282)
T cd07829 81 D-MDLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL 152 (282)
T ss_pred C-cCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence 7 58999987632 358999999999999999999998 899999999999999999999999999988765432
Q ss_pred ceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 742 YSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 742 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
. ......++..|+|||++.+. ..++.++|+||+|++
T Consensus 153 ~-~~~~~~~~~~~~aPE~~~~~--~~~~~~~Dv~slG~~ 188 (282)
T cd07829 153 R-TYTHEVVTLWYRAPEILLGS--KHYSTAVDIWSVGCI 188 (282)
T ss_pred c-ccCccccCcCcCChHHhcCC--cCCCccccHHHHHHH
Confidence 1 11223457789999987653 245678999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.9e-24 Score=221.25 Aligned_cols=180 Identities=31% Similarity=0.400 Sum_probs=152.9
Q ss_pred eecccceEEEEEEeC-CCcEEEEEEeccccCCh-hhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEccCCCCH
Q 003982 589 LGRGGFGVVYGGELP-DGTKIAVKRMESNTMGN-KGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTL 666 (782)
Q Consensus 589 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~gsL 666 (782)
||+|++|.||++... +++.||+|++....... .....+..|++++++++||||+++++.+..+...+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999654 58999999987654322 2566889999999999999999999999999999999999999999
Q ss_pred HHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCceeee
Q 003982 667 AQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVET 746 (782)
Q Consensus 667 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~ 746 (782)
.+++... ..+++..+..++.|++.|+.|||+ .+++|+||+|+||+++.++.++|+|||.+........ ...
T Consensus 81 ~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~ 151 (250)
T cd05123 81 FSHLSKE-----GRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTN 151 (250)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC-ccc
Confidence 9998652 358999999999999999999998 8999999999999999999999999999887654321 123
Q ss_pred cccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 747 RLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 747 ~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
...++..|+|||...+. ..+..+|+||+|++
T Consensus 152 ~~~~~~~~~~Pe~~~~~---~~~~~~D~~slG~~ 182 (250)
T cd05123 152 TFCGTPEYLAPEVLLGK---GYGKAVDWWSLGVL 182 (250)
T ss_pred CCcCCccccChHHhCCC---CCCchhhHHHHHHH
Confidence 34678899999988764 35678999999976
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=225.56 Aligned_cols=190 Identities=23% Similarity=0.337 Sum_probs=152.6
Q ss_pred CCCccceeecccceEEEEEEeC-CCcEEEEEEecccc---CChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 582 NFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNT---MGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
+|.+.+.||+|+||.||++... .+..+++|+++... .......++.+|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5888999999999999999553 34556666655422 2223345677899999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
|||+++++|.+++.+.... ...+++.+++.++.|++.|+.|||+ .|++|+||||+||++++ +.+||+|||.+...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHT-GKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EEeCCCCCHHHHHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeec
Confidence 9999999999988764333 3468999999999999999999998 89999999999999975 56999999998776
Q ss_pred CCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 738 PDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..... ......|++.|+|||+..+. +.+.++|+||+|++
T Consensus 156 ~~~~~-~~~~~~~~~~~~~pe~~~~~---~~~~~~Dv~slG~~ 194 (260)
T cd08222 156 MGSCD-LATTFTGTPYYMSPEALKHQ---GYDSKSDIWSLGCI 194 (260)
T ss_pred CCCcc-cccCCCCCcCccCHHHHccC---CCCchhhHHHHHHH
Confidence 44322 12234578899999987653 34667999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-24 Score=219.74 Aligned_cols=167 Identities=20% Similarity=0.254 Sum_probs=138.4
Q ss_pred ccceEEEEE-EeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEccCCCCHHHHH
Q 003982 592 GGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHL 670 (782)
Q Consensus 592 G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~gsL~~~l 670 (782)
|.+|.||++ +..+++.||+|++.... .+.+|...+....||||+++++++.+....+++|||+++|+|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 899999999 45678999999997643 2334555555567999999999999999999999999999999998
Q ss_pred HhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCceeeecccc
Q 003982 671 FEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAG 750 (782)
Q Consensus 671 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~g 750 (782)
.+. ..+++..+..++.|++.||+|||+ .||+||||||+||+++.++.++++|||.+....... ....+
T Consensus 77 ~~~-----~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~ 144 (237)
T cd05576 77 SKF-----LNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAV 144 (237)
T ss_pred HHh-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCc
Confidence 652 348999999999999999999998 899999999999999999999999999886654322 12345
Q ss_pred cccccCccccccchhhhHHHHHHHHHhccc
Q 003982 751 TFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 751 t~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+..|+|||+..+. ..+.++|+||+|++
T Consensus 145 ~~~y~aPE~~~~~---~~~~~~DvwslG~i 171 (237)
T cd05576 145 ENMYCAPEVGGIS---EETEACDWWSLGAI 171 (237)
T ss_pred CccccCCcccCCC---CCCchhhHHHHHHH
Confidence 7789999987654 34668899999976
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-24 Score=226.72 Aligned_cols=190 Identities=26% Similarity=0.406 Sum_probs=151.7
Q ss_pred cCCCccceeecccceEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC-CCCcceEEeEEEeCCeEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~~~lv~ 658 (782)
++|++.+.||+|++|.||+|... +++.||||+++.... .....++.+|++++.+.. ||||+++++++.+....+++|
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 56888999999999999999765 489999999976542 233456667777776665 999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||++ +++.++.... ...+++..+..++.|++.|++|||+ ..||+||||+|+||++++++.+||+|||.+....
T Consensus 94 e~~~-~~l~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 94 ELMS-TCLDKLLKRI----QGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eccC-cCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 9984 5777766542 2368999999999999999999996 2599999999999999999999999999987664
Q ss_pred CCCceeeecccccccccCccccccch-hhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHW-MILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~dvws~Gvv 780 (782)
..... ....++..|+|||++.+.- ....+.++|+||+|++
T Consensus 167 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~i 207 (296)
T cd06618 167 DSKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGIS 207 (296)
T ss_pred CCCcc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHH
Confidence 43221 2235788999999876431 1235678899999975
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-24 Score=245.84 Aligned_cols=173 Identities=24% Similarity=0.281 Sum_probs=120.8
Q ss_pred HhcCCCccceeecccceEEEEEEeC-C----CcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeE------
Q 003982 579 VTDNFSEANILGRGGFGVVYGGELP-D----GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY------ 647 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~------ 647 (782)
..++|.+.+.||+|+||.||+|... + +..||||++..... .+.+..| .+....+.++..++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 3568999999999999999999654 4 68999998864321 1111111 1111122222222211
Q ss_pred EEeCCeEEEEEEccCCCCHHHHHHhhccC---------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcC
Q 003982 648 CINGSERLLVYEYMPRGTLAQHLFEWHDH---------------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRD 712 (782)
Q Consensus 648 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~---------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrD 712 (782)
.......++||||+++++|.+++...... .........+..++.|++.||+|||+ .+|+|||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRD 280 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRD 280 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCc
Confidence 24566789999999999999988642100 00011234567899999999999998 8999999
Q ss_pred CCCCCEEECC-CCcEEEEeeccceecCCCCceeeecccccccccCcccc
Q 003982 713 LKPSNILIGD-DMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYA 760 (782)
Q Consensus 713 ikp~NIll~~-~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~ 760 (782)
|||+|||++. ++.+||+|||+|+..............+++.|||||++
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~ 329 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQY 329 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHh
Confidence 9999999986 57999999999987654433333456789999999954
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.9e-24 Score=225.04 Aligned_cols=169 Identities=26% Similarity=0.233 Sum_probs=131.2
Q ss_pred HHHHhcCCCccceeecccceEEEEEEeC--CCcEEEEEEeccccC---ChhhHHHHHHHHHHHHhcCCCCcce-EEeEEE
Q 003982 576 LRQVTDNFSEANILGRGGFGVVYGGELP--DGTKIAVKRMESNTM---GNKGLSEFQAEIAVLTKVRHRHLVA-LLGYCI 649 (782)
Q Consensus 576 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~nI~~-~~~~~~ 649 (782)
.....++|.+.+.||+|+||+||+|... +++.||||++..... .....+.+.+|++++++++|+||++ +++
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~--- 89 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA--- 89 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---
Confidence 4456678999999999999999999653 577889998764311 1234567999999999999999985 443
Q ss_pred eCCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCC-CCCCEEECCCCcEEE
Q 003982 650 NGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDL-KPSNILIGDDMRAKV 728 (782)
Q Consensus 650 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDi-kp~NIll~~~~~~kL 728 (782)
.+..|+||||++|++|.. .. . .. ...++.|+++||+|||+ .||+|||| ||+||+++.++.+||
T Consensus 90 -~~~~~LVmE~~~G~~L~~-~~---~-----~~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikL 153 (365)
T PRK09188 90 -TGKDGLVRGWTEGVPLHL-AR---P-----HG---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAV 153 (365)
T ss_pred -cCCcEEEEEccCCCCHHH-hC---c-----cc---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEE
Confidence 246799999999999962 21 1 11 14678999999999998 89999999 999999999999999
Q ss_pred EeeccceecCCCCcee-------eecccccccccCccccccc
Q 003982 729 ADFGLVKNAPDGKYSV-------ETRLAGTFGYLAPEYAGKH 763 (782)
Q Consensus 729 ~DfG~a~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~ 763 (782)
+|||+|+......... -....+++.|+|||++...
T Consensus 154 iDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 154 IDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred EECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9999999775533111 1345688899999987544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-24 Score=231.33 Aligned_cols=180 Identities=28% Similarity=0.378 Sum_probs=151.4
Q ss_pred HhcCCCccceeecccceEEEEE-EeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCCeEEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLL 656 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~l 656 (782)
+.+.|.....+|.|+|+.|-.+ ...+++.++||++.+.. .+-.+|+.++... +||||+++++.+.+..+.|+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc------cccccccchhhhhcCCCcceeecceecCCceeee
Confidence 5678888999999999999988 55678999999997753 3345677666665 59999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE-CCCCcEEEEeeccce
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI-GDDMRAKVADFGLVK 735 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll-~~~~~~kL~DfG~a~ 735 (782)
|||++.|+.+.+.+... +....++..|+++|+.|+.|||+ +||||||+||+|||+ ++.++++|+|||.++
T Consensus 394 v~e~l~g~ell~ri~~~------~~~~~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~ 464 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSK------PEFCSEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWS 464 (612)
T ss_pred eehhccccHHHHHHHhc------chhHHHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhh
Confidence 99999999888877542 22337788899999999999998 899999999999999 588999999999998
Q ss_pred ecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 736 NAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 736 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
...... ...+-|..|.|||++.. .+++.++|+||+||+
T Consensus 465 ~~~~~~----~tp~~t~~y~APEvl~~---~~yt~acD~WSLGvl 502 (612)
T KOG0603|consen 465 ELERSC----DTPALTLQYVAPEVLAI---QEYTEACDWWSLGVL 502 (612)
T ss_pred hCchhh----cccchhhcccChhhhcc---CCCCcchhhHHHHHH
Confidence 876641 12245889999999884 378999999999986
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-24 Score=211.52 Aligned_cols=184 Identities=27% Similarity=0.377 Sum_probs=154.0
Q ss_pred hcCCCccceeecccceEEEEE-EeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC------C
Q 003982 580 TDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING------S 652 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~------~ 652 (782)
..+|.-++.+|.|.. .|..| +...+++||+|++..........++..+|...+..+.|+||++++.++.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 346777888999998 56556 556789999998876654455678899999999999999999999988643 3
Q ss_pred eEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeec
Q 003982 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (782)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG 732 (782)
+.|+||||| ..+|.+++.- .++-+++..+..|++.|++|||+ .||+||||||+||++..++.+||.|||
T Consensus 95 e~y~v~e~m-~~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg 163 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVILM-------ELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFG 163 (369)
T ss_pred hHHHHHHhh-hhHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccch
Confidence 569999999 6689888863 36778899999999999999999 899999999999999999999999999
Q ss_pred cceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 733 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+|+..... ..-++.+.|++|+|||++.+. ++-...||||+||+
T Consensus 164 ~ar~e~~~--~~mtpyVvtRyyrapevil~~---~~ke~vdiwSvGci 206 (369)
T KOG0665|consen 164 LARTEDTD--FMMTPYVVTRYYRAPEVILGM---GYKENVDIWSVGCI 206 (369)
T ss_pred hhcccCcc--cccCchhheeeccCchheecc---CCcccchhhhhhhH
Confidence 99876543 234567889999999999886 56777899999986
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.3e-25 Score=243.18 Aligned_cols=370 Identities=24% Similarity=0.303 Sum_probs=233.9
Q ss_pred EEEEEeCCCCCCcccCccccCCccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCC
Q 003982 68 VTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDN 147 (782)
Q Consensus 68 v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 147 (782)
+..|||++|.+. ..|..+..+.+|+.|+++.|.|...+.+..++.+|++|.|.+|.+..+|.+ +..+++|++||+|+|
T Consensus 47 L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~~vp~s~~~~~~l~~lnL~~n~l~~lP~~-~~~lknl~~LdlS~N 124 (1081)
T KOG0618|consen 47 LKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIRSVPSSCSNMRNLQYLNLKNNRLQSLPAS-ISELKNLQYLDLSFN 124 (1081)
T ss_pred eEEeeccccccc-cCCchhhhHHHHhhcccchhhHhhCchhhhhhhcchhheeccchhhcCchh-HHhhhcccccccchh
Confidence 788999998887 889999999999999999999997777888999999999999999998877 888999999999999
Q ss_pred CCCCCCCCCcccCCCcccCeeecc-------------------ccccCCCCcccccCCCCCcEEEcccCcCCCCCCcccc
Q 003982 148 PNLAPWPFPNELTKSTSLTTLYMD-------------------NANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFA 208 (782)
Q Consensus 148 ~l~~~~~~p~~~~~l~~L~~L~L~-------------------~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 208 (782)
++.. +|..+..++.++.+..+ .|.+.+.++..+..+.+ .|+|++|++....-..+.
T Consensus 125 ~f~~---~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~~~dls~~~ 199 (1081)
T KOG0618|consen 125 HFGP---IPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEMEVLDLSNLA 199 (1081)
T ss_pred ccCC---CchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchhhhhe--eeecccchhhhhhhhhcc
Confidence 9877 55555555444444444 44444444444444444 466666666511111111
Q ss_pred c------------------cccchhhcccccCCCccccccccCCCCCcEEEeecccccCCCCCCCCCCCCCEEEcCCCcC
Q 003982 209 K------------------SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQL 270 (782)
Q Consensus 209 ~------------------~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l 270 (782)
. ..++.|+...|.+. ..+.-.--.+|+.++++.|++++.+..+..+.+|+.|+..+|+|
T Consensus 200 ~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~---~~~~~p~p~nl~~~dis~n~l~~lp~wi~~~~nle~l~~n~N~l 276 (1081)
T KOG0618|consen 200 NLEVLHCERNQLSELEISGPSLTALYADHNPLT---TLDVHPVPLNLQYLDISHNNLSNLPEWIGACANLEALNANHNRL 276 (1081)
T ss_pred chhhhhhhhcccceEEecCcchheeeeccCcce---eeccccccccceeeecchhhhhcchHHHHhcccceEecccchhH
Confidence 0 12223333333222 00111112457777777777777665567777777777777777
Q ss_pred ccCcchhhcCCCCCCEEEccCCcccCCCCCC--CCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCC-Cc---
Q 003982 271 TGVVPASVISLPALLNISLQNNKLQGPYPLF--PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGY-PA--- 344 (782)
Q Consensus 271 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--- 344 (782)
+ .+|..+...++|+.|.+..|.+.-.+|.. ...|++|+|..|++..++.....-......++-.....+.. +.
T Consensus 277 ~-~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e 355 (1081)
T KOG0618|consen 277 V-ALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEE 355 (1081)
T ss_pred H-hhHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccc
Confidence 5 66777777777777777777777544432 46799999999999877632211111111111111111111 00
Q ss_pred ----ccccCcCCCCCC-CCCCcccccCCceeEEEccCcccccccCccccccccCCeEecccccccc--------------
Q 003982 345 ----ILSDSWEGNNAC-DGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTG-------------- 405 (782)
Q Consensus 345 ----~~~~~~~~~~~~-~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g-------------- 405 (782)
.+...+..||.+ +..=..+....+|+.|+|++|+|.......+.++..|+.|+||+|+++.
T Consensus 356 ~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL 435 (1081)
T KOG0618|consen 356 NNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLTTLPDTVANLGRLHTL 435 (1081)
T ss_pred hhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhHHH
Confidence 111122223322 2222234445677777777777764333456667777777777776652
Q ss_pred --------cCCccCCCCCCCCeEecCCCcCCCC-CC-CCC-CCcceecCCCCCCC
Q 003982 406 --------PIPDGLTKLASLQNLDVSNNNLSGK-VP-DFG-SNVKFTVSPGNPFI 449 (782)
Q Consensus 406 --------~~p~~~~~l~~L~~L~ls~N~l~g~-~p-~~~-~~~~~~~~~~n~~~ 449 (782)
..| ++.+++.|+.+|+|.|+|+.. +| ... ..++.++++||.+.
T Consensus 436 ~ahsN~l~~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 436 RAHSNQLLSFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred hhcCCceeech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence 455 778899999999999999754 33 233 68888999999963
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.5e-23 Score=234.00 Aligned_cols=258 Identities=23% Similarity=0.272 Sum_probs=195.1
Q ss_pred ccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeee
Q 003982 90 TQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLY 169 (782)
Q Consensus 90 ~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~ 169 (782)
..-..|+|++|.|+.+|+.+. ++|+.|+|++|+|+.+|.. +++|++|+|++|+++. +|.. .++|+.|+
T Consensus 201 ~~~~~LdLs~~~LtsLP~~l~--~~L~~L~L~~N~Lt~LP~l----p~~Lk~LdLs~N~Lts---LP~l---p~sL~~L~ 268 (788)
T PRK15387 201 NGNAVLNVGESGLTTLPDCLP--AHITTLVIPDNNLTSLPAL----PPELRTLEVSGNQLTS---LPVL---PPGLLELS 268 (788)
T ss_pred CCCcEEEcCCCCCCcCCcchh--cCCCEEEccCCcCCCCCCC----CCCCcEEEecCCccCc---ccCc---ccccceee
Confidence 445678888888887666664 4788899999998888753 5788889998888887 4432 35788888
Q ss_pred ccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeecccccC
Q 003982 170 MDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTG 249 (782)
Q Consensus 170 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~ 249 (782)
|++|.++.+ |.. ..+|+.|+|++|+++ .+|.. .++|+.|+|++|+|++
T Consensus 269 Ls~N~L~~L-p~l---p~~L~~L~Ls~N~Lt-~LP~~---------------------------p~~L~~LdLS~N~L~~ 316 (788)
T PRK15387 269 IFSNPLTHL-PAL---PSGLCKLWIFGNQLT-SLPVL---------------------------PPGLQELSVSDNQLAS 316 (788)
T ss_pred ccCCchhhh-hhc---hhhcCEEECcCCccc-ccccc---------------------------ccccceeECCCCcccc
Confidence 888888764 432 256888888888887 56642 4689999999999997
Q ss_pred CCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCCCCCCccEEEccCCcCCCCCCCCCCCCChh
Q 003982 250 PIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQ 329 (782)
Q Consensus 250 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~~~ 329 (782)
.+.. ..+|+.|++++|+|++ +|.. ..+|+.|+|++|+|++ +|..+++|+.|++++|++..++
T Consensus 317 Lp~l---p~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~lp~~L~~L~Ls~N~L~~LP---------- 378 (788)
T PRK15387 317 LPAL---PSELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS-LPTLPSELYKLWAYNNRLTSLP---------- 378 (788)
T ss_pred CCCC---cccccccccccCcccc-cccc---ccccceEecCCCccCC-CCCCCcccceehhhccccccCc----------
Confidence 6442 2468889999999984 5542 2478999999999995 5567788999999999886544
Q ss_pred hhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccccCccccccccCCeEecccccccccCCc
Q 003982 330 VTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPD 409 (782)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~ 409 (782)
.. ..+|+.|+|++|.|++ +|... ++|+.|++++|+|+ .+|.
T Consensus 379 -------------------------------~l---~~~L~~LdLs~N~Lt~-LP~l~---s~L~~LdLS~N~Ls-sIP~ 419 (788)
T PRK15387 379 -------------------------------AL---PSGLKELIVSGNRLTS-LPVLP---SELKELMVSGNRLT-SLPM 419 (788)
T ss_pred -------------------------------cc---ccccceEEecCCcccC-CCCcc---cCCCEEEccCCcCC-CCCc
Confidence 11 1368999999999995 66543 68999999999999 4776
Q ss_pred cCCCCCCCCeEecCCCcCCCCCCCCC--CCcceecCCCCCCCCC
Q 003982 410 GLTKLASLQNLDVSNNNLSGKVPDFG--SNVKFTVSPGNPFIGT 451 (782)
Q Consensus 410 ~~~~l~~L~~L~ls~N~l~g~~p~~~--~~~~~~~~~~n~~~~~ 451 (782)
.+ .+|+.|++++|+|+..+..++ ..+....+.+||+.+.
T Consensus 420 l~---~~L~~L~Ls~NqLt~LP~sl~~L~~L~~LdLs~N~Ls~~ 460 (788)
T PRK15387 420 LP---SGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLSER 460 (788)
T ss_pred ch---hhhhhhhhccCcccccChHHhhccCCCeEECCCCCCCch
Confidence 43 468899999999995433444 4667788999999764
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.4e-23 Score=206.52 Aligned_cols=203 Identities=21% Similarity=0.307 Sum_probs=164.7
Q ss_pred ccHHHHHHHhcCCCccceeecccceEEEEEEeCC------CcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceE
Q 003982 571 ISIEVLRQVTDNFSEANILGRGGFGVVYGGELPD------GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVAL 644 (782)
Q Consensus 571 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~ 644 (782)
-...++.....+++....+.+|+||+||+|.+++ .+.|-||.++... ++-....+..|.-.+..+.|||+.++
T Consensus 274 ~r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A-S~iQv~~~L~es~lly~~sH~nll~V 352 (563)
T KOG1024|consen 274 RRLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA-SQIQVNLLLQESMLLYGASHPNLLSV 352 (563)
T ss_pred hhHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc-cHHHHHHHHHHHHHHhcCcCCCccce
Confidence 3456677777889999999999999999995543 4457788776543 34456778899999999999999999
Q ss_pred EeEEEeC-CeEEEEEEccCCCCHHHHHHhhccC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE
Q 003982 645 LGYCING-SERLLVYEYMPRGTLAQHLFEWHDH---GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI 720 (782)
Q Consensus 645 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll 720 (782)
.+++.++ ...++++.++.-|+|..++..++.. ..+.++..+.+.++.|++.|++|||+ .||||.||.++|.++
T Consensus 353 ~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvI 429 (563)
T KOG1024|consen 353 LGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVI 429 (563)
T ss_pred eEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhccee
Confidence 9988654 5678999999999999999976533 23457777889999999999999998 899999999999999
Q ss_pred CCCCcEEEEeeccceecCCCCceeee-cccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 721 GDDMRAKVADFGLVKNAPDGKYSVET-RLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 721 ~~~~~~kL~DfG~a~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|+..++||+|=.+++..-+.++.--+ .......||+||.+... -+..++|+|||||+
T Consensus 430 dd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~---~yssasDvWsfGVl 487 (563)
T KOG1024|consen 430 DDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNS---HYSSASDVWSFGVL 487 (563)
T ss_pred hhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhh---hhcchhhhHHHHHH
Confidence 99999999999999987766654322 12346689999988775 45778999999985
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-23 Score=228.09 Aligned_cols=184 Identities=32% Similarity=0.399 Sum_probs=147.0
Q ss_pred CCccceeecccce-EEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC-CCCcceEEeEEEeCCeEEEEEEc
Q 003982 583 FSEANILGRGGFG-VVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSERLLVYEY 660 (782)
Q Consensus 583 y~~~~~lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~~~lv~e~ 660 (782)
|.-.+++|.|+.| .||+|.. +|+.||||++-.+ .....++|+..++.-+ ||||+++++.-.++...|+..|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e-----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE-----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH-----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence 3445678999987 7899988 7899999998643 3456789999999875 99999999998899999999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECC---C--CcEEEEeeccce
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD---D--MRAKVADFGLVK 735 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~---~--~~~kL~DfG~a~ 735 (782)
| .-+|.+++...... .........+.+..|+++||++||+ .+||||||||.||||+. + ..++|+|||+++
T Consensus 585 C-~~sL~dlie~~~~d-~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 585 C-ACSLQDLIESSGLD-VEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred h-hhhHHHHHhccccc-hhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 9 56999999763111 1111114457789999999999999 89999999999999975 3 478999999999
Q ss_pred ecCCCCc--eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 736 NAPDGKY--SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 736 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
....+.. .......||-+|+|||++...- -..+.||||+|+|
T Consensus 660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~---~~~avDiFslGCv 703 (903)
T KOG1027|consen 660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDR---KTQAVDIFSLGCV 703 (903)
T ss_pred ccCCCcchhhcccCCCCcccccCHHHHhccc---cCcccchhhcCce
Confidence 8876543 3334567999999999998762 2458899999987
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.5e-22 Score=203.03 Aligned_cols=188 Identities=33% Similarity=0.429 Sum_probs=155.9
Q ss_pred CCccceeecccceEEEEEEeCC-CcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEcc
Q 003982 583 FSEANILGRGGFGVVYGGELPD-GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYM 661 (782)
Q Consensus 583 y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~ 661 (782)
|++.+.||+|++|.||++...+ ++.+|+|.+...... ...+.+.+|++.+++++|+|++++++++......++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 5678899999999999996654 889999999865422 25678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCC
Q 003982 662 PRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK 741 (782)
Q Consensus 662 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~ 741 (782)
++++|.+++..... .+++..+..++.+++.++.+||+ .+++|+|++|.||+++.++.++|+|||.+.......
T Consensus 80 ~~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~ 152 (225)
T smart00221 80 EGGDLFDYLRKKGG----KLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL 152 (225)
T ss_pred CCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence 99999999876321 17889999999999999999998 899999999999999999999999999998775542
Q ss_pred ceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 742 YSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 742 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
........++..|++||+..+. .....++|+|++|++
T Consensus 153 ~~~~~~~~~~~~~~~pe~~~~~--~~~~~~~Dv~~lG~~ 189 (225)
T smart00221 153 AALLKTVKGTPFYLAPEVLLGG--KGYGEAVDIWSLGVI 189 (225)
T ss_pred cccccceeccCCcCCHhHhcCC--CCCCchhhHHHHHHH
Confidence 1111234578899999987311 234558899998875
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=231.83 Aligned_cols=247 Identities=21% Similarity=0.328 Sum_probs=154.1
Q ss_pred ccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeee
Q 003982 90 TQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLY 169 (782)
Q Consensus 90 ~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~ 169 (782)
.+...|+++++.++.++..+. ++|+.|+|++|+|+.+|...+ ++|++|+|++|+++. +|..+. .+|+.|+
T Consensus 178 ~~~~~L~L~~~~LtsLP~~Ip--~~L~~L~Ls~N~LtsLP~~l~---~nL~~L~Ls~N~Lts---LP~~l~--~~L~~L~ 247 (754)
T PRK15370 178 NNKTELRLKILGLTTIPACIP--EQITTLILDNNELKSLPENLQ---GNIKTLYANSNQLTS---IPATLP--DTIQEME 247 (754)
T ss_pred cCceEEEeCCCCcCcCCcccc--cCCcEEEecCCCCCcCChhhc---cCCCEEECCCCcccc---CChhhh--ccccEEE
Confidence 345666676666665444332 456677777777776665533 366677777776665 444332 3566677
Q ss_pred ccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeecccccC
Q 003982 170 MDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTG 249 (782)
Q Consensus 170 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~ 249 (782)
|++|++..+ |..+. ++|++|+|++|+|+ .+|..+ .++|+.|+|++|+|+.
T Consensus 248 Ls~N~L~~L-P~~l~--s~L~~L~Ls~N~L~-~LP~~l--------------------------~~sL~~L~Ls~N~Lt~ 297 (754)
T PRK15370 248 LSINRITEL-PERLP--SALQSLDLFHNKIS-CLPENL--------------------------PEELRYLSVYDNSIRT 297 (754)
T ss_pred CcCCccCcC-ChhHh--CCCCEEECcCCccC-cccccc--------------------------CCCCcEEECCCCcccc
Confidence 777766643 44432 35666777777666 455433 2467777777777776
Q ss_pred CCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCCCCCCccEEEccCCcCCCCCCCCCCCCChh
Q 003982 250 PIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQ 329 (782)
Q Consensus 250 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~~~ 329 (782)
.+..+. ++|+.|++++|+|+. +|..+. ++|+.|++++|.+++.+...+++|+.|++++|+|+.++
T Consensus 298 LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~LP~~l~~sL~~L~Ls~N~L~~LP---------- 362 (754)
T PRK15370 298 LPAHLP--SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTSLPASLPPELQVLDVSKNQITVLP---------- 362 (754)
T ss_pred Ccccch--hhHHHHHhcCCcccc-CCcccc--ccceeccccCCccccCChhhcCcccEEECCCCCCCcCC----------
Confidence 554432 467777777777773 454432 56777777777777644445567777777777765433
Q ss_pred hhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccccCccccccccCCeEecccccccccCCc
Q 003982 330 VTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPD 409 (782)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~ 409 (782)
..+ .++|+.|+|++|+|+ .+|..+. ..|+.|++++|+|+ .+|.
T Consensus 363 -------------------------------~~l--p~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~ 405 (754)
T PRK15370 363 -------------------------------ETL--PPTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPE 405 (754)
T ss_pred -------------------------------hhh--cCCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCch
Confidence 111 136778888888887 4565554 36778888888877 4454
Q ss_pred cC----CCCCCCCeEecCCCcCC
Q 003982 410 GL----TKLASLQNLDVSNNNLS 428 (782)
Q Consensus 410 ~~----~~l~~L~~L~ls~N~l~ 428 (782)
.+ ..++.+..|+|.+|+|+
T Consensus 406 sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 406 SLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred hHHHHhhcCCCccEEEeeCCCcc
Confidence 33 34577778888888876
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-22 Score=233.04 Aligned_cols=202 Identities=24% Similarity=0.372 Sum_probs=139.4
Q ss_pred CEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccC
Q 003982 67 RVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSD 146 (782)
Q Consensus 67 ~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~ 146 (782)
+.+.|++++++++ .+|..+. ++|+.|+|++|+|+.+++.+. ++|++|+|++|+|+.+|.... ++|+.|+|++
T Consensus 179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~LtsLP~~l~--~nL~~L~Ls~N~LtsLP~~l~---~~L~~L~Ls~ 250 (754)
T PRK15370 179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELKSLPENLQ--GNIKTLYANSNQLTSIPATLP---DTIQEMELSI 250 (754)
T ss_pred CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCCcCChhhc--cCCCEEECCCCccccCChhhh---ccccEEECcC
Confidence 4789999999998 5777664 589999999999998766553 589999999999999987533 4799999999
Q ss_pred CCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCcc
Q 003982 147 NPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSG 226 (782)
Q Consensus 147 N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~ 226 (782)
|++.. +|..+. ++|+.|+|++|+|+.+ |..+. ++|++|+|++|+|+ .+|..+.
T Consensus 251 N~L~~---LP~~l~--s~L~~L~Ls~N~L~~L-P~~l~--~sL~~L~Ls~N~Lt-~LP~~lp------------------ 303 (754)
T PRK15370 251 NRITE---LPERLP--SALQSLDLFHNKISCL-PENLP--EELRYLSVYDNSIR-TLPAHLP------------------ 303 (754)
T ss_pred CccCc---CChhHh--CCCCEEECcCCccCcc-ccccC--CCCcEEECCCCccc-cCcccch------------------
Confidence 99987 676664 5899999999999864 66553 58999999999999 6776543
Q ss_pred ccccccCCCCCcEEEeecccccCCCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCCCCCCcc
Q 003982 227 TLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQ 306 (782)
Q Consensus 227 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~ 306 (782)
++|+.|++++|+++..+..+. ++|+.|++++|.|++ +|..+. ++|+.|++++|+|+..+...+.+|+
T Consensus 304 --------~sL~~L~Ls~N~Lt~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~~LP~~lp~~L~ 370 (754)
T PRK15370 304 --------SGITHLNVQSNSLTALPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQITVLPETLPPTIT 370 (754)
T ss_pred --------hhHHHHHhcCCccccCCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCCcCChhhcCCcC
Confidence 234445555555554332221 345555555555552 344332 4555555555555532222334555
Q ss_pred EEEccCCcCC
Q 003982 307 KVSLDHNNFC 316 (782)
Q Consensus 307 ~L~l~~N~~~ 316 (782)
.|+|++|+++
T Consensus 371 ~LdLs~N~Lt 380 (754)
T PRK15370 371 TLDVSRNALT 380 (754)
T ss_pred EEECCCCcCC
Confidence 5555555554
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.9e-23 Score=209.26 Aligned_cols=191 Identities=23% Similarity=0.350 Sum_probs=157.5
Q ss_pred HHHHHHHhcCCCccceeecccceEEEEEEe-C---CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC-CCCcceEEeE
Q 003982 573 IEVLRQVTDNFSEANILGRGGFGVVYGGEL-P---DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGY 647 (782)
Q Consensus 573 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~-~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~ 647 (782)
.+.+....+.|..+++||+|+|++||++.. . ..+.||+|.+.... ...+...|+++|..+. +.||+.+.++
T Consensus 28 ~q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts----~p~ri~~El~~L~~~gG~~ni~~~~~~ 103 (418)
T KOG1167|consen 28 RQDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS----SPSRILNELEMLYRLGGSDNIIKLNGC 103 (418)
T ss_pred HhhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc----CchHHHHHHHHHHHhccchhhhcchhh
Confidence 344556778899999999999999999933 2 46789999987643 3467899999999996 9999999999
Q ss_pred EEeCCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCC-CcE
Q 003982 648 CINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD-MRA 726 (782)
Q Consensus 648 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~-~~~ 726 (782)
+...+...+|+||++..+..++... ++..++..+++.++.||.++|. .|||||||||.|++.+.. +.-
T Consensus 104 ~rnnd~v~ivlp~~~H~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg 172 (418)
T KOG1167|consen 104 FRNNDQVAIVLPYFEHDRFRDLYRS--------LSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRG 172 (418)
T ss_pred hccCCeeEEEecccCccCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCc
Confidence 9999999999999999988888754 7789999999999999999998 999999999999999854 678
Q ss_pred EEEeeccceecCC----------------------------------CCcee---------eecccccccccCccccccc
Q 003982 727 KVADFGLVKNAPD----------------------------------GKYSV---------ETRLAGTFGYLAPEYAGKH 763 (782)
Q Consensus 727 kL~DfG~a~~~~~----------------------------------~~~~~---------~~~~~gt~~y~aPE~~~~~ 763 (782)
.|+|||+|...+. ..+.. .-...||++|+|||++..-
T Consensus 173 ~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~ 252 (418)
T KOG1167|consen 173 VLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC 252 (418)
T ss_pred eEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc
Confidence 9999999862110 00000 0123699999999998775
Q ss_pred hhhhHHHHHHHHHhccc
Q 003982 764 WMILCQMTGLIWLHGSV 780 (782)
Q Consensus 764 ~~~~~~~~~dvws~Gvv 780 (782)
..++.+.||||.|||
T Consensus 253 --~~QttaiDiws~GVI 267 (418)
T KOG1167|consen 253 --PRQTTAIDIWSAGVI 267 (418)
T ss_pred --cCcCCccceeeccce
Confidence 457889999999997
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-23 Score=198.64 Aligned_cols=187 Identities=25% Similarity=0.401 Sum_probs=148.8
Q ss_pred HHhcCCCccceeecccceEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeE-EEeCCeE
Q 003982 578 QVTDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGY-CINGSER 654 (782)
Q Consensus 578 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~-~~~~~~~ 654 (782)
...+.|.+.+.+|+|.||.+-.++++ ..+.+|+|.+.... ...++|.+|..---.+ .|.||+.-|++ |+..+.+
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence 45677999999999999999999654 56789999887643 4568899998765555 48999988764 5667788
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEC--CCCcEEEEeec
Q 003982 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIG--DDMRAKVADFG 732 (782)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~--~~~~~kL~DfG 732 (782)
+.++||++.|+|.+-+.. ..+-+...+.++.|+++|++|||+ +++||||||.+|||+- +...+||+|||
T Consensus 98 vF~qE~aP~gdL~snv~~------~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG 168 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEA------AGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFG 168 (378)
T ss_pred EEeeccCccchhhhhcCc------ccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecc
Confidence 899999999999887743 347788889999999999999999 9999999999999993 44589999999
Q ss_pred cceecCCCCceeeecccccccccCccccc--cchhhhHHHHHHHHHhccc
Q 003982 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAG--KHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 733 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~~~dvws~Gvv 780 (782)
.++..+..- ...--+..|.|||... ..-.+.|....|+|.||||
T Consensus 169 ~t~k~g~tV----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi 214 (378)
T KOG1345|consen 169 LTRKVGTTV----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGII 214 (378)
T ss_pred cccccCcee----hhhhhhcccCCcHHHhhccccceEecccccchheeee
Confidence 987665422 1122366799999643 1234678999999999997
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=199.75 Aligned_cols=174 Identities=32% Similarity=0.464 Sum_probs=147.8
Q ss_pred cceEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEccCCCCHHHHHH
Q 003982 593 GFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLF 671 (782)
Q Consensus 593 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~ 671 (782)
+||.||+|... +++.+|+|++....... ..+.+.+|++.+++++|+||+++++++......++++||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKK-KRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEeccccccc-HHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 57999999665 58999999997654322 16889999999999999999999999999999999999999999999986
Q ss_pred hhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCceeeeccccc
Q 003982 672 EWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGT 751 (782)
Q Consensus 672 ~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt 751 (782)
.. ..+++..+..++.+++.++.|||+ .+++|+||+|+||++++++.++|+|||.+....... ......++
T Consensus 80 ~~-----~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~ 149 (244)
T smart00220 80 KR-----GRLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGT 149 (244)
T ss_pred hc-----cCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCC
Confidence 52 227899999999999999999998 899999999999999999999999999998765532 12334678
Q ss_pred ccccCccccccchhhhHHHHHHHHHhccc
Q 003982 752 FGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 752 ~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..|+|||+..+. ..+.++|+|++|++
T Consensus 150 ~~~~~pE~~~~~---~~~~~~Di~slG~~ 175 (244)
T smart00220 150 PEYMAPEVLLGK---GYGKAVDVWSLGVI 175 (244)
T ss_pred cCCCCHHHHccC---CCCchhhHHHHHHH
Confidence 899999987643 34668999999976
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.6e-21 Score=191.17 Aligned_cols=181 Identities=36% Similarity=0.549 Sum_probs=152.0
Q ss_pred eecccceEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEccCCCCHH
Q 003982 589 LGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLA 667 (782)
Q Consensus 589 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~gsL~ 667 (782)
||+|.+|.||++... +++.+++|++....... ..+.+.+|++.++.++|++|+++++++......+++|||+++++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 689999999999764 48999999997654221 3578999999999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECC-CCcEEEEeeccceecCCCCceeee
Q 003982 668 QHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD-DMRAKVADFGLVKNAPDGKYSVET 746 (782)
Q Consensus 668 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~-~~~~kL~DfG~a~~~~~~~~~~~~ 746 (782)
+++.... ..+++..+..++.++++++++||+ .|++|+||+|.||+++. ++.++|+|||.+........ ...
T Consensus 80 ~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~ 151 (215)
T cd00180 80 DLLKENE----GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLK 151 (215)
T ss_pred HHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhh
Confidence 9986532 357899999999999999999998 89999999999999999 89999999999987755321 112
Q ss_pred cccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 747 RLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 747 ~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
...+...|++||..... .....+.|+|++|++
T Consensus 152 ~~~~~~~~~~pe~~~~~--~~~~~~~D~~~lg~~ 183 (215)
T cd00180 152 TIVGTPAYMAPEVLLGK--GYYSEKSDIWSLGVI 183 (215)
T ss_pred cccCCCCccChhHhccc--CCCCchhhhHHHHHH
Confidence 23568899999987663 234678999999976
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-21 Score=190.03 Aligned_cols=143 Identities=17% Similarity=0.207 Sum_probs=110.8
Q ss_pred cceeecccceEEEEEEeCCCcEEEEEEeccccCChhh------------------------HHHHHHHHHHHHhcCCCCc
Q 003982 586 ANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKG------------------------LSEFQAEIAVLTKVRHRHL 641 (782)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~------------------------~~~~~~E~~~l~~l~h~nI 641 (782)
.+.||+|++|.||+|...+|+.||||+++........ .....+|++++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999997778999999999765321111 1123459999999988887
Q ss_pred ceEEeEEEeCCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCeEEcCCCCCCEEE
Q 003982 642 VALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYL-HSLAQQSFIHRDLKPSNILI 720 (782)
Q Consensus 642 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L-H~~~~~~ivHrDikp~NIll 720 (782)
.....+.. ...++||||++++++...... ..+++..++..++.|++.+|+|+ |+ .||+||||||+||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli 151 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK-----DAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLY 151 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEE
Confidence 55443322 234899999988776544322 23588999999999999999999 66 899999999999999
Q ss_pred CCCCcEEEEeeccceecCC
Q 003982 721 GDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 721 ~~~~~~kL~DfG~a~~~~~ 739 (782)
+ ++.++|+|||+|.....
T Consensus 152 ~-~~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 152 H-DGKLYIIDVSQSVEHDH 169 (190)
T ss_pred E-CCcEEEEEccccccCCC
Confidence 8 47899999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.5e-22 Score=207.74 Aligned_cols=195 Identities=21% Similarity=0.257 Sum_probs=161.4
Q ss_pred cccHHHHHHHhcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC------CCCcc
Q 003982 570 AISIEVLRQVTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR------HRHLV 642 (782)
Q Consensus 570 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~nI~ 642 (782)
.+.+...+....+|.+....|+|-|++|.+|. ...|..||||+|.... .-.+.=.+|+++|++|. -.+++
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE---~M~KtGl~EleiLkKL~~AD~Edk~Hcl 497 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE---VMHKTGLKELEILKKLNDADPEDKFHCL 497 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch---HHhhhhhHHHHHHHHhhccCchhhhHHH
Confidence 34555666778899999999999999999994 4567899999998754 23355578999999995 24789
Q ss_pred eEEeEEEeCCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECC
Q 003982 643 ALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD 722 (782)
Q Consensus 643 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~ 722 (782)
+++..|....+.|+|+|-+ ..+|.++|+.+... ..+....+..++.|+.-||..|-. .||+|.||||.||||++
T Consensus 498 rl~r~F~hknHLClVFE~L-slNLRevLKKyG~n--vGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE 571 (752)
T KOG0670|consen 498 RLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRN--VGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNE 571 (752)
T ss_pred HHHHHhhhcceeEEEehhh-hchHHHHHHHhCcc--cceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEecc
Confidence 9999999999999999988 66899999887553 458889999999999999999998 89999999999999987
Q ss_pred C-CcEEEEeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhcc
Q 003982 723 D-MRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGS 779 (782)
Q Consensus 723 ~-~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gv 779 (782)
. ..+||||||.|........ ++...+..|.|||++.|. .++...|+||+||
T Consensus 572 ~k~iLKLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~---~yd~~iD~WSvgc 623 (752)
T KOG0670|consen 572 SKNILKLCDFGSASFASENEI---TPYLVSRFYRAPEIILGL---PYDYPIDTWSVGC 623 (752)
T ss_pred CcceeeeccCccccccccccc---cHHHHHHhccCcceeecC---cccCCccceeece
Confidence 6 4679999999987765432 344557889999999885 5666778888886
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.4e-20 Score=229.68 Aligned_cols=306 Identities=17% Similarity=0.206 Sum_probs=196.2
Q ss_pred CEEEEEeCCC------CCCcccCccccCC-ccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCC
Q 003982 67 RVTTISLAKS------GLSGTLSPEISSL-TQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNL 139 (782)
Q Consensus 67 ~v~~L~l~~~------~l~~~~~~~l~~l-~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L 139 (782)
++..|.+..+ ++...+|..+..+ .+|+.|++.++.+...+..| .+.+|++|+|++|++..++.+ +..+++|
T Consensus 559 ~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~~lP~~f-~~~~L~~L~L~~s~l~~L~~~-~~~l~~L 636 (1153)
T PLN03210 559 NLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLRCMPSNF-RPENLVKLQMQGSKLEKLWDG-VHSLTGL 636 (1153)
T ss_pred cccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCCCCCCcC-CccCCcEEECcCccccccccc-cccCCCC
Confidence 5666766544 2344567777766 45888888888887666665 467888888888888887765 5678888
Q ss_pred CEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhccc
Q 003982 140 QVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMND 219 (782)
Q Consensus 140 ~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~ 219 (782)
++|+|++|.... .+| .+..+++|+.|+|++|.....+|..+..+++|+.|++++|..-+.+|..+....|+.|.+++
T Consensus 637 k~L~Ls~~~~l~--~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~Lsg 713 (1153)
T PLN03210 637 RNIDLRGSKNLK--EIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLNLSG 713 (1153)
T ss_pred CEEECCCCCCcC--cCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCCCCCEEeCCC
Confidence 888888775443 244 47778888888888887767778888888888888888875555777766556777777777
Q ss_pred ccCCCccccccccCCCCCcEEEeecccccCCCCCCCCCC-------------------------------CCCEEEcCCC
Q 003982 220 QQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCE-------------------------------SLFDLSLRDN 268 (782)
Q Consensus 220 ~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~-------------------------------~L~~L~L~~N 268 (782)
|.... .. + ...++|++|++++|.++..+..+ .++ +|+.|+|++|
T Consensus 714 c~~L~-~~-p--~~~~nL~~L~L~~n~i~~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n 788 (1153)
T PLN03210 714 CSRLK-SF-P--DISTNISWLDLDETAIEEFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDI 788 (1153)
T ss_pred CCCcc-cc-c--cccCCcCeeecCCCccccccccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCC
Confidence 64211 11 1 12457788888888776544332 233 4555555555
Q ss_pred cCccCcchhhcCCCCCCEEEccCCcccCCCCCC--CCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCccc
Q 003982 269 QLTGVVPASVISLPALLNISLQNNKLQGPYPLF--PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAIL 346 (782)
Q Consensus 269 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (782)
...+.+|.+++++++|+.|++++|...+.+|.. +.+|+.|++++|..
T Consensus 789 ~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~~L~sL~~L~Ls~c~~------------------------------- 837 (1153)
T PLN03210 789 PSLVELPSSIQNLHKLEHLEIENCINLETLPTGINLESLESLDLSGCSR------------------------------- 837 (1153)
T ss_pred CCccccChhhhCCCCCCEEECCCCCCcCeeCCCCCccccCEEECCCCCc-------------------------------
Confidence 544455555555555555555554433333332 34455555554421
Q ss_pred ccCcCCCCCCCCCCcccccCCceeEEEccCcccccccCccccccccCCeEecccccccccCCccCCCCCCCCeEecCCCc
Q 003982 347 SDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNN 426 (782)
Q Consensus 347 ~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~ 426 (782)
+..+|.. .++|+.|+|++|.|+ .+|.++..+++|++|+|++|+-...+|..+..++.|+.|+++++.
T Consensus 838 ---------L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 838 ---------LRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred ---------ccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCc
Confidence 1222221 246777777777776 467777777777777777644333566667777777777777664
|
syringae 6; Provisional |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.7e-23 Score=204.81 Aligned_cols=141 Identities=19% Similarity=0.283 Sum_probs=108.0
Q ss_pred cceEeCCCCCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCcccCCCCCCCCCC
Q 003982 58 TGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGL 136 (782)
Q Consensus 58 ~gv~c~~~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l 136 (782)
.+.+|++.+ =..++-++.+|+ .+|..+. .....++|..|+|+.++| +|+.+++|+.||||+|+|+.|.+++|.++
T Consensus 39 ~pC~Cs~~~-g~~VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL 114 (498)
T KOG4237|consen 39 APCTCSDVE-GGIVDCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGL 114 (498)
T ss_pred CCcccCCCC-CceEEccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhh
Confidence 456666543 356788888888 6665543 345678888888888887 78888888888888888888888888888
Q ss_pred CCCCEEeccC-CCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCc
Q 003982 137 TNLQVLSLSD-NPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPA 205 (782)
Q Consensus 137 ~~L~~L~Ls~-N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 205 (782)
++|..|-+.+ |+|+. ..-..|.+|..|+.|.+.-|++.-+..+.|..+++|..|.+-.|.+. .++.
T Consensus 115 ~~l~~Lvlyg~NkI~~--l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~ 181 (498)
T KOG4237|consen 115 ASLLSLVLYGNNKITD--LPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICK 181 (498)
T ss_pred HhhhHHHhhcCCchhh--hhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhcc
Confidence 8877776655 88877 33446788888888888888888888888888888888888888887 5554
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-20 Score=194.46 Aligned_cols=135 Identities=27% Similarity=0.400 Sum_probs=115.9
Q ss_pred HHHh-cCCCccceeecccceEEEEE-EeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC-----C---CCcceEEe
Q 003982 577 RQVT-DNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-----H---RHLVALLG 646 (782)
Q Consensus 577 ~~~~-~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~nI~~~~~ 646 (782)
..+. .+|.+.++||.|-|++||.| +..+.+.||+|+.+.. ....+....||+++++++ | ..||++++
T Consensus 73 D~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD 149 (590)
T KOG1290|consen 73 DVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLD 149 (590)
T ss_pred ccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeec
Confidence 3445 78999999999999999999 6677889999999764 345677889999999984 3 36999999
Q ss_pred EEEe----CCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE
Q 003982 647 YCIN----GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI 720 (782)
Q Consensus 647 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll 720 (782)
.|.. +.+++||+|++ |-+|..++... ..+.++...++.|++|++.||.|||+ +.||||.||||+|||+
T Consensus 150 ~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s---~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 150 HFKHSGPNGQHVCMVFEVL-GDNLLKLIKYS---NYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLL 221 (590)
T ss_pred cceecCCCCcEEEEEehhh-hhHHHHHHHHh---CCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence 9975 35789999999 88999998764 34568999999999999999999998 5899999999999998
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.7e-20 Score=181.47 Aligned_cols=144 Identities=19% Similarity=0.224 Sum_probs=113.5
Q ss_pred cceeecccceEEEEEEeCCCcEEEEEEeccccCChh------------------------hHHHHHHHHHHHHhcCCCCc
Q 003982 586 ANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNK------------------------GLSEFQAEIAVLTKVRHRHL 641 (782)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------------------------~~~~~~~E~~~l~~l~h~nI 641 (782)
.+.||+|++|+||+|...+|+.||||+++....... ....+++|.+.+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 578999999999999776899999999986532100 02234689999999999988
Q ss_pred ceEEeEEEeCCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEC
Q 003982 642 VALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIG 721 (782)
Q Consensus 642 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~ 721 (782)
.....+... ..++||||++++++...... ..+++..++..++.|++.++.++|+ ..||+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE
Confidence 665554433 24899999988755443221 1347788999999999999999996 37999999999999998
Q ss_pred CCCcEEEEeeccceecCC
Q 003982 722 DDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 722 ~~~~~kL~DfG~a~~~~~ 739 (782)
++.++|+|||+|.....
T Consensus 153 -~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 -DGKPYIIDVSQAVELDH 169 (190)
T ss_pred -CCCEEEEEcccceecCC
Confidence 88999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-22 Score=224.05 Aligned_cols=216 Identities=23% Similarity=0.347 Sum_probs=161.4
Q ss_pred cCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeec
Q 003982 91 QLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYM 170 (782)
Q Consensus 91 ~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L 170 (782)
+|+.|+.++|.++...+. .--.+|+++++++|+++.+| +++..+.+|+.|+..+|++.. +|..+...++|+.|.+
T Consensus 220 ~l~~L~a~~n~l~~~~~~-p~p~nl~~~dis~n~l~~lp-~wi~~~~nle~l~~n~N~l~~---lp~ri~~~~~L~~l~~ 294 (1081)
T KOG0618|consen 220 SLTALYADHNPLTTLDVH-PVPLNLQYLDISHNNLSNLP-EWIGACANLEALNANHNRLVA---LPLRISRITSLVSLSA 294 (1081)
T ss_pred chheeeeccCcceeeccc-cccccceeeecchhhhhcch-HHHHhcccceEecccchhHHh---hHHHHhhhhhHHHHHh
Confidence 334444444444422221 22367999999999999999 889999999999999999977 8899999999999999
Q ss_pred cccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccc---cccchhhcccccCCCccccccccCCCCCcEEEeecccc
Q 003982 171 DNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK---SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQF 247 (782)
Q Consensus 171 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~---~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l 247 (782)
.+|.+..+ |.....+++|++|+|..|+|. .+|+.+.. ..+..+..+.|.+........ ..++.|+.|++.+|+|
T Consensus 295 ~~nel~yi-p~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e-~~~~~Lq~LylanN~L 371 (1081)
T KOG0618|consen 295 AYNELEYI-PPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEE-NNHAALQELYLANNHL 371 (1081)
T ss_pred hhhhhhhC-CCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccc-hhhHHHHHHHHhcCcc
Confidence 99999876 677788999999999999998 88876544 234455555555543332221 2367799999999999
Q ss_pred cC-CCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCCC---CCCccEEEccCCcC
Q 003982 248 TG-PIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLF---PSKVQKVSLDHNNF 315 (782)
Q Consensus 248 ~~-~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~---~~~l~~L~l~~N~~ 315 (782)
+. ..|.+.+++.|+.|+|++|+|.......+.++..|++|+||+|+|+.. |.. ...|++|...+|++
T Consensus 372 td~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~~L-p~tva~~~~L~tL~ahsN~l 442 (1081)
T KOG0618|consen 372 TDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLTTL-PDTVANLGRLHTLRAHSNQL 442 (1081)
T ss_pred cccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhhhh-hHHHHhhhhhHHHhhcCCce
Confidence 98 566788999999999999999944445678899999999999999842 221 23445555555444
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.3e-19 Score=223.11 Aligned_cols=285 Identities=16% Similarity=0.225 Sum_probs=188.3
Q ss_pred CEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCCCCCCCCCCCEEeCCCCc-ccCCCCCCCCCCCCCCEEecc
Q 003982 67 RVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNN-FTSVPTGCFDGLTNLQVLSLS 145 (782)
Q Consensus 67 ~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~-l~~~~~~~~~~l~~L~~L~Ls 145 (782)
.++.|.+.++.+. .+|..+ ...+|+.|+|++|++......+..+++|++|+|+++. ++.+|. +..+++|++|+|+
T Consensus 590 ~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~--ls~l~~Le~L~L~ 665 (1153)
T PLN03210 590 KLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLEKLWDGVHSLTGLRNIDLRGSKNLKEIPD--LSMATNLETLKLS 665 (1153)
T ss_pred ccEEEEecCCCCC-CCCCcC-CccCCcEEECcCccccccccccccCCCCCEEECCCCCCcCcCCc--cccCCcccEEEec
Confidence 4566666666554 555554 3566666666666666554455666666666666543 444442 5556666666666
Q ss_pred CCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCc
Q 003982 146 DNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLS 225 (782)
Q Consensus 146 ~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~ 225 (782)
+|.... .+|..+.++++|+.|++++|...+.+|..+ ++++|++|++++|...+.+|... .+++.|+++.|.+...
T Consensus 666 ~c~~L~--~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~~--~nL~~L~L~~n~i~~l 740 (1153)
T PLN03210 666 DCSSLV--ELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDIS--TNISWLDLDETAIEEF 740 (1153)
T ss_pred CCCCcc--ccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCcccccccc--CCcCeeecCCCccccc
Confidence 654433 356666666666666666654434444433 45556666665554433444321 2344444444432210
Q ss_pred cc----------------------------cccccCCCCCcEEEeecccccCCCC-CCCCCCCCCEEEcCCCcCccCcch
Q 003982 226 GT----------------------------LDVLSGMTQLRQVWLHKNQFTGPIP-DLSKCESLFDLSLRDNQLTGVVPA 276 (782)
Q Consensus 226 ~~----------------------------~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~ 276 (782)
.. .......++|+.|+|++|...+.+| .++++++|+.|+|++|..-+.+|.
T Consensus 741 P~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~ 820 (1153)
T PLN03210 741 PSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPT 820 (1153)
T ss_pred cccccccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCC
Confidence 00 0011224689999999997666555 699999999999999865557787
Q ss_pred hhcCCCCCCEEEccCCcccCCCCCCCCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCC
Q 003982 277 SVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNAC 356 (782)
Q Consensus 277 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (782)
.+ ++++|+.|++++|.....+|..+.+|+.|+|++|.++.
T Consensus 821 ~~-~L~sL~~L~Ls~c~~L~~~p~~~~nL~~L~Ls~n~i~~--------------------------------------- 860 (1153)
T PLN03210 821 GI-NLESLESLDLSGCSRLRTFPDISTNISDLNLSRTGIEE--------------------------------------- 860 (1153)
T ss_pred CC-CccccCEEECCCCCccccccccccccCEeECCCCCCcc---------------------------------------
Confidence 76 79999999999998777888888899999999998753
Q ss_pred CCCCcccccCCceeEEEccCcccccccCccccccccCCeEeccccc
Q 003982 357 DGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNN 402 (782)
Q Consensus 357 ~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 402 (782)
+|..+..+++|++|+|++|+--..+|..+..+++|+.|++++|.
T Consensus 861 --iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 861 --VPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred --ChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCc
Confidence 45566778899999999954444688899999999999999885
|
syringae 6; Provisional |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.5e-20 Score=182.23 Aligned_cols=169 Identities=14% Similarity=0.143 Sum_probs=129.3
Q ss_pred HHhcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChh-hHHH------HHHHHHHHHhcCCCCcceEEeEEEe
Q 003982 578 QVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNK-GLSE------FQAEIAVLTKVRHRHLVALLGYCIN 650 (782)
Q Consensus 578 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~~------~~~E~~~l~~l~h~nI~~~~~~~~~ 650 (782)
...++|+..+++|.|+||.||.++. ++..+|+|++.......+ .... +++|++.+.++.||+|..+.+++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 4578999999999999999999866 677899999976543222 2223 6899999999999999999998764
Q ss_pred C--------CeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECC
Q 003982 651 G--------SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD 722 (782)
Q Consensus 651 ~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~ 722 (782)
. ...+++|||++|.+|.++.. .++ ....+++.++..+|+ .|++|||+||+||++++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~ 170 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSK 170 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeC
Confidence 3 35789999999999977631 222 246699999999998 89999999999999999
Q ss_pred CCcEEEEeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 723 DMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 723 ~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
++ ++|+|||........... . .+.... .+..+.|+|++|+.
T Consensus 171 ~g-i~liDfg~~~~~~e~~a~-d------------~~vler---~y~~~~di~~lg~~ 211 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKAK-D------------RIDLER---HYGIKNEIKDLGYY 211 (232)
T ss_pred CC-EEEEECCCcccccchhhH-H------------HHHHHh---HhcccccccceeEe
Confidence 88 999999988655322110 0 022222 12357899999974
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5e-20 Score=173.63 Aligned_cols=186 Identities=24% Similarity=0.339 Sum_probs=147.6
Q ss_pred HhcCCCccceeecccceEEEEE-EeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCC-CCcceEEeEEEeCCeEEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH-RHLVALLGYCINGSERLL 656 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~nI~~~~~~~~~~~~~~l 656 (782)
...+|.+++.||.|+||.+|.| ...+|..||||+-.... ....+..|.++++.+++ ..|+.+..|..+..+-.+
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl 88 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL 88 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC----CCcchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence 4578999999999999999999 66789999999754322 23567889999999974 788888888888889999
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEC---CCCcEEEEeecc
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIG---DDMRAKVADFGL 733 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~---~~~~~kL~DfG~ 733 (782)
||+.+ |.+|.++..-+. +.++.++++.++-|++.-++|+|. +++|||||||+|+|.. ....+.++|||+
T Consensus 89 VMdLL-GPsLEdLfnfC~----R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGL 160 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFNFCS----RRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGL 160 (341)
T ss_pred eeecc-CccHHHHHHHHh----hhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccc
Confidence 99999 999988775443 358999999999999999999998 8999999999999995 335789999999
Q ss_pred ceecCCCC------ceeeecccccccccCccccccchhhhHHHHHHHHHhcc
Q 003982 734 VKNAPDGK------YSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGS 779 (782)
Q Consensus 734 a~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gv 779 (782)
|+.+.+.. +.......||.+|.+=-...+. --....|+=|+|-
T Consensus 161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~---eqSRRDDmeSvgY 209 (341)
T KOG1163|consen 161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGI---EQSRRDDMESVGY 209 (341)
T ss_pred hhhhccccccccCccccCCccceeeeehhhhhhhhh---hhhhhhhhhhhcc
Confidence 99876643 2333445799999886654433 1234455555553
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.8e-19 Score=176.25 Aligned_cols=185 Identities=22% Similarity=0.329 Sum_probs=149.2
Q ss_pred hcCCCccceeecccceEEEEE-EeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC-CCCcceEEeEEEeCCeEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~~~lv 657 (782)
.-+|++.++||+|+||+++.| ..-+++.||||.=... .+...++.|.+.++.+. .++|+..+.+..++.+-.+|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV 102 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV 102 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEecccc----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence 357899999999999999999 6778999999954332 23467888999998885 79999999888888888999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCC-----CcEEEEeec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD-----MRAKVADFG 732 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~-----~~~kL~DfG 732 (782)
+|.+ |.+|.++..-+ .+.++.+++..+|.|++.-++|+|+ +.+|.|||||+|+||..- ..+.++|||
T Consensus 103 idLL-GPSLEDLFD~C----gR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFG 174 (449)
T KOG1165|consen 103 IDLL-GPSLEDLFDLC----GRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFG 174 (449)
T ss_pred hhhh-CcCHHHHHHHh----cCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEecc
Confidence 9999 89998876543 2459999999999999999999999 899999999999999643 468999999
Q ss_pred cceecCCCC------ceeeecccccccccCccccccchhhhHHHHHHHHHhcc
Q 003982 733 LVKNAPDGK------YSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGS 779 (782)
Q Consensus 733 ~a~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gv 779 (782)
+|+.+.+.. +.......||.+||+=-...+.-. ....|+=|+|-
T Consensus 175 mAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQ---SRRDDLEaLGH 224 (449)
T KOG1165|consen 175 MAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQ---SRRDDLEALGH 224 (449)
T ss_pred chhhhcCccccccCccccccccccceeeeEeeccccchh---hhhhhHHHhhh
Confidence 999887654 333445679999999776554422 44455655554
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.8e-18 Score=169.97 Aligned_cols=139 Identities=19% Similarity=0.275 Sum_probs=107.3
Q ss_pred CCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhc-----CCCCcceEEeEEEeCC---eE
Q 003982 583 FSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-----RHRHLVALLGYCINGS---ER 654 (782)
Q Consensus 583 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~nI~~~~~~~~~~~---~~ 654 (782)
+...+.||+|++|.||. +..++.. +||++.... ....+.+.+|+++++.+ .||||++++++++++. ..
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~--~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRG--DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccc--cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 34567899999999996 3334444 799887643 23456799999999999 5799999999998873 43
Q ss_pred E-EEEEc--cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHH-HHHhhcCCCCeEEcCCCCCCEEECC----CCcE
Q 003982 655 L-LVYEY--MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV-EYLHSLAQQSFIHRDLKPSNILIGD----DMRA 726 (782)
Q Consensus 655 ~-lv~e~--~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL-~~LH~~~~~~ivHrDikp~NIll~~----~~~~ 726 (782)
+ +|+|| +++++|.+++.+ ..+++. ..++.|++.++ +|||+ .+|+||||||+||+++. +..+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~------~~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~ 148 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQ------CRYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIP 148 (210)
T ss_pred EEEEecCCCCcchhHHHHHHc------ccccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcE
Confidence 4 78999 557999999965 124444 35678888887 99998 89999999999999974 3479
Q ss_pred EEEe-ecccee
Q 003982 727 KVAD-FGLVKN 736 (782)
Q Consensus 727 kL~D-fG~a~~ 736 (782)
+|+| ||.+..
T Consensus 149 ~LiDg~G~~~~ 159 (210)
T PRK10345 149 VVCDNIGESTF 159 (210)
T ss_pred EEEECCCCcce
Confidence 9999 554443
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-18 Score=185.94 Aligned_cols=185 Identities=24% Similarity=0.263 Sum_probs=142.9
Q ss_pred CCCccceeecccceEEEEEEeCCC--cEEEEEEeccccCChhhHHHHHHHHHHHHhcCC----CCcceEEeEE-EeCCeE
Q 003982 582 NFSEANILGRGGFGVVYGGELPDG--TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH----RHLVALLGYC-INGSER 654 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h----~nI~~~~~~~-~~~~~~ 654 (782)
+|.+.+.||+|+||.||.|..... ..+|+|........ .. ..+..|..++..+.. +++..+++.. ..+...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~-~~-~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGS-KP-SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccC-CC-ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 799999999999999999965443 47888877654311 11 268889999888863 6899999998 477888
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCC-----CcEEEE
Q 003982 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD-----MRAKVA 729 (782)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~-----~~~kL~ 729 (782)
|+||+.+ |.+|.++..... .+.++..++..++.|++.+|+++|+ .|++||||||.|+++... ..+.|.
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~ll 169 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLL 169 (322)
T ss_pred EEEEecc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEE
Confidence 9999988 899999775533 3569999999999999999999998 899999999999999754 469999
Q ss_pred eeccce--ecCCCCc-----ee--eecccccccccCccccccchhhhHHHHHHHHHhc
Q 003982 730 DFGLVK--NAPDGKY-----SV--ETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHG 778 (782)
Q Consensus 730 DfG~a~--~~~~~~~-----~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~G 778 (782)
|||+|+ .+..... .+ ...+.||..|+++....+. .-....|+||++
T Consensus 170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~---e~~r~DDles~~ 224 (322)
T KOG1164|consen 170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI---EQGRRDDLESLF 224 (322)
T ss_pred ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCC---ccCCchhhhhHH
Confidence 999998 3221111 11 1234599999999977654 224556666654
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=7.7e-21 Score=169.88 Aligned_cols=163 Identities=35% Similarity=0.499 Sum_probs=135.8
Q ss_pred CCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCC
Q 003982 108 SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFS 187 (782)
Q Consensus 108 ~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 187 (782)
.+.++...+.|.||+|+++.+|++ +..+.+|+.|++++|+++. +|..++.+++|+.|+++-|++.- .|..|+.++
T Consensus 28 gLf~~s~ITrLtLSHNKl~~vppn-ia~l~nlevln~~nnqie~---lp~~issl~klr~lnvgmnrl~~-lprgfgs~p 102 (264)
T KOG0617|consen 28 GLFNMSNITRLTLSHNKLTVVPPN-IAELKNLEVLNLSNNQIEE---LPTSISSLPKLRILNVGMNRLNI-LPRGFGSFP 102 (264)
T ss_pred cccchhhhhhhhcccCceeecCCc-HHHhhhhhhhhcccchhhh---cChhhhhchhhhheecchhhhhc-CccccCCCc
Confidence 444556666666777777766666 6667777777777777776 77788888888888888888754 489999999
Q ss_pred CCcEEEcccCcCCC-CCCccccccccchhhcccccCCCccccccccCCCCCcEEEeecccccCCCCCCCCCCCCCEEEcC
Q 003982 188 NLQNLRLSYNNFTG-SLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLR 266 (782)
Q Consensus 188 ~L~~L~Ls~N~l~~-~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~ 266 (782)
.|+.|||++|++.. .+|..|+. |+.|+.|+|++|.|.-.+++++.+++|+.|.+.
T Consensus 103 ~levldltynnl~e~~lpgnff~------------------------m~tlralyl~dndfe~lp~dvg~lt~lqil~lr 158 (264)
T KOG0617|consen 103 ALEVLDLTYNNLNENSLPGNFFY------------------------MTTLRALYLGDNDFEILPPDVGKLTNLQILSLR 158 (264)
T ss_pred hhhhhhccccccccccCCcchhH------------------------HHHHHHHHhcCCCcccCChhhhhhcceeEEeec
Confidence 99999999999973 56877654 889999999999999999999999999999999
Q ss_pred CCcCccCcchhhcCCCCCCEEEccCCcccCCCCC
Q 003982 267 DNQLTGVVPASVISLPALLNISLQNNKLQGPYPL 300 (782)
Q Consensus 267 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~ 300 (782)
+|.+- ..|..++.++.|++|++.+|+++-.+|.
T Consensus 159 dndll-~lpkeig~lt~lrelhiqgnrl~vlppe 191 (264)
T KOG0617|consen 159 DNDLL-SLPKEIGDLTRLRELHIQGNRLTVLPPE 191 (264)
T ss_pred cCchh-hCcHHHHHHHHHHHHhcccceeeecChh
Confidence 99998 7999999999999999999999966554
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.76 E-value=9.4e-18 Score=180.07 Aligned_cols=191 Identities=31% Similarity=0.482 Sum_probs=156.1
Q ss_pred CCccceeecccceEEEEEEeCCCcEEEEEEeccccCChh-hHHHHHHHHHHHHhcCCC-CcceEEeEEEeCCeEEEEEEc
Q 003982 583 FSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNK-GLSEFQAEIAVLTKVRHR-HLVALLGYCINGSERLLVYEY 660 (782)
Q Consensus 583 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~-nI~~~~~~~~~~~~~~lv~e~ 660 (782)
|.+.+.||.|+||.||++... ..+++|.+........ ....+.+|+.+++.+.|+ +|+++.+.+......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677889999999999999765 8899999987654333 577899999999999988 799999999877778999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCC-cEEEEeeccceecCC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM-RAKVADFGLVKNAPD 739 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~-~~kL~DfG~a~~~~~ 739 (782)
+.++++.+++...... ..++......++.|++.+++|+|+ .+++|||+||+||+++... .++++|||.++....
T Consensus 80 ~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 80 VDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred CCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 9999999666542111 258899999999999999999998 8999999999999999988 799999999986654
Q ss_pred CCce-----eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYS-----VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.... ......||..|+|||...+.-........|+|++|++
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~ 200 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGIT 200 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHH
Confidence 3321 2345679999999998876200134678999999954
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=7.7e-21 Score=169.86 Aligned_cols=177 Identities=26% Similarity=0.382 Sum_probs=144.0
Q ss_pred CCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeecccccCCCCCCCCCCCCCEEE
Q 003982 185 SFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLS 264 (782)
Q Consensus 185 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~ 264 (782)
++.+++.|.||+|+++ .+|..++ .+.+|+.|++.+|+++..++.++.+++|+.|+
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia------------------------~l~nlevln~~nnqie~lp~~issl~klr~ln 85 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIA------------------------ELKNLEVLNLSNNQIEELPTSISSLPKLRILN 85 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHH------------------------HhhhhhhhhcccchhhhcChhhhhchhhhhee
Confidence 5677788888888888 6666554 37888888888888888888888888888888
Q ss_pred cCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCCCCCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCc
Q 003982 265 LRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPA 344 (782)
Q Consensus 265 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (782)
+.-|++. ..|..|+.++.|+.|||+.|++..
T Consensus 86 vgmnrl~-~lprgfgs~p~levldltynnl~e------------------------------------------------ 116 (264)
T KOG0617|consen 86 VGMNRLN-ILPRGFGSFPALEVLDLTYNNLNE------------------------------------------------ 116 (264)
T ss_pred cchhhhh-cCccccCCCchhhhhhcccccccc------------------------------------------------
Confidence 8888888 888888888888888888888763
Q ss_pred ccccCcCCCCCCCCCCcccccCCceeEEEccCcccccccCccccccccCCeEecccccccccCCccCCCCCCCCeEecCC
Q 003982 345 ILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSN 424 (782)
Q Consensus 345 ~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~ 424 (782)
..+|..|..++-|+.|+|+.|.+. .+|+.+++|++|+.|.+.+|.+- .+|.+++.++.|++|.+.+
T Consensus 117 ------------~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqg 182 (264)
T KOG0617|consen 117 ------------NSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQG 182 (264)
T ss_pred ------------ccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccc
Confidence 133445556667788888888887 78999999999999999999998 8899999999999999999
Q ss_pred CcCCCCCCCCC-----CCcceecCCCCCCC
Q 003982 425 NNLSGKVPDFG-----SNVKFTVSPGNPFI 449 (782)
Q Consensus 425 N~l~g~~p~~~-----~~~~~~~~~~n~~~ 449 (782)
|+|+-.+|+++ ...+......|||.
T Consensus 183 nrl~vlppel~~l~l~~~k~v~r~E~NPwv 212 (264)
T KOG0617|consen 183 NRLTVLPPELANLDLVGNKQVMRMEENPWV 212 (264)
T ss_pred ceeeecChhhhhhhhhhhHHHHhhhhCCCC
Confidence 99999999765 33344556788873
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.7e-17 Score=159.47 Aligned_cols=156 Identities=18% Similarity=0.139 Sum_probs=119.1
Q ss_pred CccceeecccceEEEEEEeCCCcEEEEEEeccccCC--hhhHHHHHHHHHHHHhcC-CCCcceEEeEEEeCCeEEEEEEc
Q 003982 584 SEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMG--NKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSERLLVYEY 660 (782)
Q Consensus 584 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~~~lv~e~ 660 (782)
.+...|++|+||+||.+.. .+.+++.+.+.....- ......+++|+++|+++. |++|++++++ ...+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4567899999999998866 7788888877654421 112346899999999996 5889999886 346999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCC-CCCCEEECCCCcEEEEeeccceecCC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDL-KPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDi-kp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
++|.+|.+.... ....++.|++.+++++|+ .||+|||| ||+||+++.++.++|+|||+|.....
T Consensus 80 I~G~~L~~~~~~------------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 80 LAGAAMYQRPPR------------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred ecCccHHhhhhh------------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 999888654311 113578899999999998 89999999 79999999999999999999986554
Q ss_pred CCc-----e-e------eecccccccccCccc
Q 003982 740 GKY-----S-V------ETRLAGTFGYLAPEY 759 (782)
Q Consensus 740 ~~~-----~-~------~~~~~gt~~y~aPE~ 759 (782)
... . . ......++.|++|+.
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~ 176 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVE 176 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHH
Confidence 331 0 0 001126788999984
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.2e-17 Score=168.59 Aligned_cols=149 Identities=16% Similarity=0.131 Sum_probs=115.2
Q ss_pred HhcCCCccceeecccceEEEEEE--eCCCcEEEEEEeccccCCh----------------------hhHHHHHHHHHHHH
Q 003982 579 VTDNFSEANILGRGGFGVVYGGE--LPDGTKIAVKRMESNTMGN----------------------KGLSEFQAEIAVLT 634 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~~----------------------~~~~~~~~E~~~l~ 634 (782)
....|.+.+.||+|++|.||+|. ..+|+.||+|+++...... .....+++|+++++
T Consensus 26 ~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~ 105 (237)
T smart00090 26 RGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQ 105 (237)
T ss_pred cCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHH
Confidence 33358899999999999999997 5689999999987543110 01134678999999
Q ss_pred hcCCC--CcceEEeEEEeCCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-eEEc
Q 003982 635 KVRHR--HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS-FIHR 711 (782)
Q Consensus 635 ~l~h~--nI~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~-ivHr 711 (782)
++.+. .+++++++ ...++||||++++++...... .......++..++.|++.++++||+ .| |+||
T Consensus 106 ~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~ 173 (237)
T smart00090 106 RLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-----DVEPEEEEEFELYDDILEEMRKLYK---EGELVHG 173 (237)
T ss_pred HHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc-----cCCcchHHHHHHHHHHHHHHHHHHh---cCCEEeC
Confidence 99753 34455543 235899999999887665422 1235666778999999999999998 88 9999
Q ss_pred CCCCCCEEECCCCcEEEEeeccceecCCC
Q 003982 712 DLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (782)
Q Consensus 712 Dikp~NIll~~~~~~kL~DfG~a~~~~~~ 740 (782)
||||+||+++ ++.++|+|||.|......
T Consensus 174 Dikp~NIli~-~~~i~LiDFg~a~~~~~~ 201 (237)
T smart00090 174 DLSEYNILVH-DGKVVIIDVSQSVELDHP 201 (237)
T ss_pred CCChhhEEEE-CCCEEEEEChhhhccCCc
Confidence 9999999999 889999999998866543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.5e-17 Score=164.98 Aligned_cols=138 Identities=21% Similarity=0.346 Sum_probs=116.4
Q ss_pred ceeecccceEEEEEEeCCCcEEEEEEeccccCChh------hHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEc
Q 003982 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNK------GLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (782)
Q Consensus 587 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 660 (782)
+.||+|++|.||+|.. .+..+++|+......... ...++.+|++++..++|++|+....++.+....+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5789999999999987 778899998764432211 234678899999999999998888888788888999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
++|++|.+.+.. ..+ ++..++.+++.++.++|. .|++|||++|+||+++ ++.++++|||.+....
T Consensus 81 ~~G~~L~~~~~~--------~~~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~~ 145 (211)
T PRK14879 81 IEGEPLKDLINS--------NGM-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEFSK 145 (211)
T ss_pred eCCcCHHHHHHh--------ccH-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccCCC
Confidence 999999998854 122 788999999999999998 8999999999999999 7889999999987643
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.74 E-value=5e-20 Score=197.20 Aligned_cols=279 Identities=22% Similarity=0.254 Sum_probs=142.5
Q ss_pred EEeCCCCCC-cccCccccCCccCceeecccCccCcc----CC-CCCCCCCCCEEeCCCCcccCCCC------CCCCCCCC
Q 003982 71 ISLAKSGLS-GTLSPEISSLTQLETLSFQMNNIAGA----IP-SLANATSLQDIYLDNNNFTSVPT------GCFDGLTN 138 (782)
Q Consensus 71 L~l~~~~l~-~~~~~~l~~l~~L~~L~L~~N~l~~~----~~-~l~~l~~L~~L~Ls~n~l~~~~~------~~~~~l~~ 138 (782)
|+|..++++ ......+..+.+|+.|+++++.++.. ++ .+...++|++|+++.+.+...+. ..+..+++
T Consensus 3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~ 82 (319)
T cd00116 3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG 82 (319)
T ss_pred cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCc
Confidence 566666666 34444456667777777777777432 12 35566667777777776653221 12444556
Q ss_pred CCEEeccCCCCCCCCCCCcccCCCcc---cCeeeccccccCC----CCcccccCC-CCCcEEEcccCcCCCCCCcccccc
Q 003982 139 LQVLSLSDNPNLAPWPFPNELTKSTS---LTTLYMDNANIFG----LIPDFFDSF-SNLQNLRLSYNNFTGSLPASFAKS 210 (782)
Q Consensus 139 L~~L~Ls~N~l~~~~~~p~~~~~l~~---L~~L~L~~N~l~~----~~~~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~~ 210 (782)
|+.|++++|.+.. ..+..+..+.+ |++|++++|+++. .+...+..+ ++|+.|++++|++++.....+.
T Consensus 83 L~~L~l~~~~~~~--~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~-- 158 (319)
T cd00116 83 LQELDLSDNALGP--DGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALA-- 158 (319)
T ss_pred eeEEEccCCCCCh--hHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHH--
Confidence 6666666665543 12223333322 5555555555542 122233344 5555555555555532211111
Q ss_pred ccchhhcccccCCCccccccccCCCCCcEEEeecccccCCC-----CCCCCCCCCCEEEcCCCcCccC----cchhhcCC
Q 003982 211 DIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPI-----PDLSKCESLFDLSLRDNQLTGV----VPASVISL 281 (782)
Q Consensus 211 ~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~-----~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l 281 (782)
..+..+++|++|++++|.+++.. ..+..+++|+.|+|++|.+++. ++..+..+
T Consensus 159 ------------------~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~ 220 (319)
T cd00116 159 ------------------KALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASL 220 (319)
T ss_pred ------------------HHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhccc
Confidence 01223445555555555555311 1123334555555555555432 22233344
Q ss_pred CCCCEEEccCCcccCCCCCCCCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCc
Q 003982 282 PALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPF 361 (782)
Q Consensus 282 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 361 (782)
++|++|++++|++++... ..+... ++
T Consensus 221 ~~L~~L~ls~n~l~~~~~----------------------------------~~l~~~-------------------~~- 246 (319)
T cd00116 221 KSLEVLNLGDNNLTDAGA----------------------------------AALASA-------------------LL- 246 (319)
T ss_pred CCCCEEecCCCcCchHHH----------------------------------HHHHHH-------------------Hh-
Confidence 455555555555442100 000000 00
Q ss_pred ccccCCceeEEEccCcccc----cccCccccccccCCeEeccccccccc----CCccCCCC-CCCCeEecCCCcC
Q 003982 362 VTCSQGRIITINLANKLLA----GNISPAYANLTSLKNLYLQQNNLTGP----IPDGLTKL-ASLQNLDVSNNNL 427 (782)
Q Consensus 362 ~~~~~~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L~Ls~N~l~g~----~p~~~~~l-~~L~~L~ls~N~l 427 (782)
.....|+.|++++|.++ ..+...+..+++|++|++++|+++.. +...+... +.|+.||+.+|++
T Consensus 247 --~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 247 --SPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred --ccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 01246777777777775 22444556667788888888888743 44445445 6778888877764
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.9e-17 Score=161.85 Aligned_cols=134 Identities=23% Similarity=0.371 Sum_probs=110.0
Q ss_pred eeecccceEEEEEEeCCCcEEEEEEeccccCChh------hHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEcc
Q 003982 588 ILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNK------GLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYM 661 (782)
Q Consensus 588 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~ 661 (782)
.||+|++|.||+|.. ++..+++|+......... ...++.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 379999999999985 678899998654332211 2356789999999999887766666666777789999999
Q ss_pred CCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 662 PRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 662 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
+|++|.+.+... . . .++.+++.+|.++|+ .|++|||++|+||+++ ++.++++|||++....
T Consensus 80 ~g~~l~~~~~~~-----~---~----~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 80 EGKPLKDVIEEG-----N---D----ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred CCccHHHHHhhc-----H---H----HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 999998887431 0 0 789999999999998 8999999999999999 8899999999987653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.1e-18 Score=206.35 Aligned_cols=135 Identities=15% Similarity=0.120 Sum_probs=99.1
Q ss_pred hcCC-CCcceEEeEE-------EeCCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 003982 635 KVRH-RHLVALLGYC-------INGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ 706 (782)
Q Consensus 635 ~l~h-~nI~~~~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~ 706 (782)
.++| +||.++++++ .+....+.++||+ +++|.+++... ...+++.+++.++.||++||+|||+ +
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~---~ 99 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP----DRSVDAFECFHVFRQIVEIVNAAHS---Q 99 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc----cccccHHHHHHHHHHHHHHHHHHHh---C
Confidence 3445 5777888876 2334567888988 66999999641 3458999999999999999999998 8
Q ss_pred CeEEcCCCCCCEEECCC-------------------CcEEEEeeccceecCCCCc---------------eeeecccccc
Q 003982 707 SFIHRDLKPSNILIGDD-------------------MRAKVADFGLVKNAPDGKY---------------SVETRLAGTF 752 (782)
Q Consensus 707 ~ivHrDikp~NIll~~~-------------------~~~kL~DfG~a~~~~~~~~---------------~~~~~~~gt~ 752 (782)
||+||||||+|||++.. +.+|++|||+++....... ......+||+
T Consensus 100 gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 179 (793)
T PLN00181 100 GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS 179 (793)
T ss_pred CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence 99999999999999654 4456666666553211000 0011135899
Q ss_pred cccCccccccchhhhHHHHHHHHHhccc
Q 003982 753 GYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 753 ~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+|||||++.+. .++.++|||||||+
T Consensus 180 ~Y~APE~~~~~---~~~~~sDVwSlGvi 204 (793)
T PLN00181 180 WYTSPEEDNGS---SSNCASDVYRLGVL 204 (793)
T ss_pred ceEChhhhccC---CCCchhhhhhHHHH
Confidence 99999998765 35778999999986
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.3e-17 Score=160.57 Aligned_cols=141 Identities=21% Similarity=0.182 Sum_probs=111.3
Q ss_pred cCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCCh--------------------hhHHHHHHHHHHHHhcCCC-
Q 003982 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGN--------------------KGLSEFQAEIAVLTKVRHR- 639 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------~~~~~~~~E~~~l~~l~h~- 639 (782)
..|.+.+.||+|+||.||++...+|+.||||++....... .....+.+|+.++..+.|+
T Consensus 15 ~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 15 VVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred chhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3488899999999999999988789999999876532110 0112367899999999887
Q ss_pred -CcceEEeEEEeCCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCE
Q 003982 640 -HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNI 718 (782)
Q Consensus 640 -nI~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NI 718 (782)
.++..++ ....++||||++++++.+.... .....++.+++.++.++|+ .||+||||||+||
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Ni 156 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNI 156 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccE
Confidence 4455544 2456899999999988765320 2345788999999999998 8999999999999
Q ss_pred EECCCCcEEEEeeccceecCC
Q 003982 719 LIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 719 ll~~~~~~kL~DfG~a~~~~~ 739 (782)
++++++.++|+|||.+.....
T Consensus 157 ll~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 157 LVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred EEcCCCcEEEEECCccccCCC
Confidence 999999999999999976554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.6e-19 Score=191.68 Aligned_cols=278 Identities=21% Similarity=0.210 Sum_probs=159.0
Q ss_pred eeecccCccCccC-C-CCCCCCCCCEEeCCCCcccCC----CCCCCCCCCCCCEEeccCCCCCC--C--CCCCcccCCCc
Q 003982 94 TLSFQMNNIAGAI-P-SLANATSLQDIYLDNNNFTSV----PTGCFDGLTNLQVLSLSDNPNLA--P--WPFPNELTKST 163 (782)
Q Consensus 94 ~L~L~~N~l~~~~-~-~l~~l~~L~~L~Ls~n~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~--~--~~~p~~~~~l~ 163 (782)
.|+|+.+.+++.. . .+..+.+|++|+++++.++.. ....+...++|++|++++|.+.. . ..++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 4777788876422 2 456667788888888887532 12224556677888887776652 0 01223444555
Q ss_pred ccCeeeccccccCCCCcccccCCCC---CcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCC-CCCcE
Q 003982 164 SLTTLYMDNANIFGLIPDFFDSFSN---LQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGM-TQLRQ 239 (782)
Q Consensus 164 ~L~~L~L~~N~l~~~~~~~~~~l~~---L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l-~~L~~ 239 (782)
+|+.|++++|.+.+..+..+..+.+ |++|++++|++++.....+. ..+..+ ++|++
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~--------------------~~l~~~~~~L~~ 141 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLA--------------------KGLKDLPPALEK 141 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHH--------------------HHHHhCCCCceE
Confidence 6666666666665544444444443 66666666665521111110 012223 55666
Q ss_pred EEeecccccCCCC-----CCCCCCCCCEEEcCCCcCccC----cchhhcCCCCCCEEEccCCcccCCCCCCCCCccEEEc
Q 003982 240 VWLHKNQFTGPIP-----DLSKCESLFDLSLRDNQLTGV----VPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSL 310 (782)
Q Consensus 240 L~L~~N~l~~~~~-----~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~l 310 (782)
|++++|.+++... .+..+++|++|+|++|.+++. ++..+..+++|++|++++|.+++...
T Consensus 142 L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~----------- 210 (319)
T cd00116 142 LVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGA----------- 210 (319)
T ss_pred EEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHH-----------
Confidence 6666666553211 134445555666665555531 22333344455555555555442100
Q ss_pred cCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccccCccccc-
Q 003982 311 DHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYAN- 389 (782)
Q Consensus 311 ~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~- 389 (782)
..++..+..+++|+.|++++|.+++.....+..
T Consensus 211 ----------------------------------------------~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~ 244 (319)
T cd00116 211 ----------------------------------------------SALAETLASLKSLEVLNLGDNNLTDAGAAALASA 244 (319)
T ss_pred ----------------------------------------------HHHHHHhcccCCCCEEecCCCcCchHHHHHHHHH
Confidence 111223445678999999999998744433332
Q ss_pred ----cccCCeEeccccccc----ccCCccCCCCCCCCeEecCCCcCCCCCC--------CCCCCcceecCCCCCC
Q 003982 390 ----LTSLKNLYLQQNNLT----GPIPDGLTKLASLQNLDVSNNNLSGKVP--------DFGSNVKFTVSPGNPF 448 (782)
Q Consensus 390 ----l~~L~~L~Ls~N~l~----g~~p~~~~~l~~L~~L~ls~N~l~g~~p--------~~~~~~~~~~~~~n~~ 448 (782)
.+.|++|++++|+++ ..+...+..+++|+.+|+++|+++..-. ..+..+......+|||
T Consensus 245 ~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 245 LLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred HhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 379999999999997 2455667778999999999999986522 2334555555555554
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.7e-16 Score=180.75 Aligned_cols=142 Identities=23% Similarity=0.290 Sum_probs=114.2
Q ss_pred hcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCCh------hhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCe
Q 003982 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGN------KGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE 653 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~ 653 (782)
...|...+.||+|+||.||+|..... .+++|+........ ...+++.+|++++++++|++|+..+.++.++..
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 34456788999999999999977444 44444332211111 124568899999999999999998888888788
Q ss_pred EEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecc
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~ 733 (782)
.++||||+++++|.+++. ....++.|+++++.|||+ .|++|||+||+||++ +++.++|+|||+
T Consensus 411 ~~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGl 473 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGL 473 (535)
T ss_pred CEEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCcc
Confidence 899999999999998874 346789999999999998 899999999999999 678999999999
Q ss_pred ceecCC
Q 003982 734 VKNAPD 739 (782)
Q Consensus 734 a~~~~~ 739 (782)
++....
T Consensus 474 a~~~~~ 479 (535)
T PRK09605 474 GKYSDL 479 (535)
T ss_pred cccCCc
Confidence 987543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.7e-17 Score=187.84 Aligned_cols=185 Identities=24% Similarity=0.308 Sum_probs=143.4
Q ss_pred CccceeecccceEEEEE-EeCCCcEEEEEEec----cccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 584 SEANILGRGGFGVVYGG-ELPDGTKIAVKRME----SNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 584 ~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~----~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
...+++|.|++|.|+.+ +....+.++.|.+. ...........+..|+.+-..++|||++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45678999999987777 44445555555443 22211223334777888888999999988877777766666669
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
|||++ +|..++.. ...+...++..++.|++.|++|+|+ .||.|||+|++|++++.++.+||+|||.+..+.
T Consensus 401 E~~~~-Dlf~~~~~-----~~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS-----NGKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred hcccH-HHHHHHhc-----ccccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeec
Confidence 99999 99999865 2358889999999999999999999 899999999999999999999999999987654
Q ss_pred CCC-c--eeeecccccccccCccccccc-hhhhHHHHHHHHHhccc
Q 003982 739 DGK-Y--SVETRLAGTFGYLAPEYAGKH-WMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~-~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~dvws~Gvv 780 (782)
... . .....++|+..|+|||...+. |. -...||||.|||
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~yd---pr~vDiwS~~ii 514 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYD---PRAVDVWSCGII 514 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccccccC---cchhhhhhccce
Confidence 322 1 344567899999999987765 33 456899999986
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.1e-17 Score=160.21 Aligned_cols=181 Identities=24% Similarity=0.398 Sum_probs=145.2
Q ss_pred cceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEccCCCC
Q 003982 586 ANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGT 665 (782)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~gs 665 (782)
..+|.+...|+.|+|++ .|..+++|++.......+..++|.+|.-.++.+.||||+.+++.|..+....++.+||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 45688889999999999 56677789888776666667889999999999999999999999999999999999999999
Q ss_pred HHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEc-CCCCCCEEECCCCcEEEE--eeccceecCCCCc
Q 003982 666 LAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHR-DLKPSNILIGDDMRAKVA--DFGLVKNAPDGKY 742 (782)
Q Consensus 666 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHr-Dikp~NIll~~~~~~kL~--DfG~a~~~~~~~~ 742 (782)
|+.++++.. ...++..++++++.++++|++|||+. ..++-| .+.+..|++|++.+++|. |--++.
T Consensus 274 lynvlhe~t---~vvvd~sqav~faldiargmaflhsl--ep~ipr~~lns~hvmidedltarismad~kfsf------- 341 (448)
T KOG0195|consen 274 LYNVLHEQT---SVVVDHSQAVRFALDIARGMAFLHSL--EPMIPRFYLNSKHVMIDEDLTARISMADTKFSF------- 341 (448)
T ss_pred HHHHHhcCc---cEEEecchHHHHHHHHHhhHHHHhhc--chhhhhhhcccceEEecchhhhheecccceeee-------
Confidence 999997632 34568889999999999999999995 445544 799999999999988774 221111
Q ss_pred eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 743 SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 743 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+.. ...-.|.||+||.++..-.-....++|+|||+|+
T Consensus 342 qe~-gr~y~pawmspealqrkped~n~raadmwsfail 378 (448)
T KOG0195|consen 342 QEV-GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAIL 378 (448)
T ss_pred ecc-ccccCcccCCHHHHhcCchhcchhhhhHHHHHHH
Confidence 111 1234788999998876644445678999999875
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.2e-17 Score=179.36 Aligned_cols=176 Identities=25% Similarity=0.337 Sum_probs=147.6
Q ss_pred eeecccceEEEEEE----eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC-CCCcceEEeEEEeCCeEEEEEEccC
Q 003982 588 ILGRGGFGVVYGGE----LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSERLLVYEYMP 662 (782)
Q Consensus 588 ~lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~~~lv~e~~~ 662 (782)
++|+|++|.|+.++ ...|..||+|+.++.............|..++...+ ||.++++...++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 36899999999763 335778999998876654444446677888899887 9999999999999999999999999
Q ss_pred CCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCc
Q 003982 663 RGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742 (782)
Q Consensus 663 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~ 742 (782)
+|++...+.+ ...+++.....+...++-|++++|+ .+|+|||+|++||+++.+|.+++.|||+++..-....
T Consensus 81 gg~lft~l~~-----~~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~ 152 (612)
T KOG0603|consen 81 GGDLFTRLSK-----EVMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI 152 (612)
T ss_pred cchhhhcccc-----CCchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence 9999888754 3446777888889999999999998 8999999999999999999999999999987654332
Q ss_pred eeeecccccccccCccccccchhhhHHHHHHHHHhcccC
Q 003982 743 SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSVG 781 (782)
Q Consensus 743 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv~ 781 (782)
.|||..|||||+..++ ..+.|.||+||+.
T Consensus 153 -----~cgt~eymApEI~~gh-----~~a~D~ws~gvl~ 181 (612)
T KOG0603|consen 153 -----ACGTYEYRAPEIINGH-----LSAADWWSFGVLA 181 (612)
T ss_pred -----cccchhhhhhHhhhcc-----CCcccchhhhhhH
Confidence 2899999999998855 6678999999863
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.5e-15 Score=147.34 Aligned_cols=140 Identities=19% Similarity=0.214 Sum_probs=102.0
Q ss_pred cceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHH----------------------HHHHHHHHHhcCCC--Cc
Q 003982 586 ANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSE----------------------FQAEIAVLTKVRHR--HL 641 (782)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~----------------------~~~E~~~l~~l~h~--nI 641 (782)
.+.||+|+||+||+|...+++.||||++............ ...|.+.+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999998778999999998764322111111 14567777776544 35
Q ss_pred ceEEeEEEeCCeEEEEEEccCCCCHHHH-HHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE
Q 003982 642 VALLGYCINGSERLLVYEYMPRGTLAQH-LFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI 720 (782)
Q Consensus 642 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll 720 (782)
++.+++ ...++||||++++.+... +.... .. .++..++.+++.++.++|. ..||+||||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~------~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR------LL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh------hc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEE
Confidence 555543 245899999998554321 21110 11 5678899999999999996 3799999999999999
Q ss_pred CCCCcEEEEeeccceecCC
Q 003982 721 GDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 721 ~~~~~~kL~DfG~a~~~~~ 739 (782)
+ ++.++++|||.+.....
T Consensus 149 ~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 149 D-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred E-CCcEEEEECcccccccC
Confidence 9 89999999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.61 E-value=9.2e-16 Score=176.66 Aligned_cols=185 Identities=19% Similarity=0.192 Sum_probs=140.0
Q ss_pred HHhcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC---CCCcceEEeEEEeCCeE
Q 003982 578 QVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR---HRHLVALLGYCINGSER 654 (782)
Q Consensus 578 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~nI~~~~~~~~~~~~~ 654 (782)
.-.+.|.+.+.||+|+||.||+|...+|+.||+|+=++...-+ |.-=.+++.||+ -+-|..+...+.-.+..
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE-----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE-----FYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee-----eeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 3456789999999999999999987789999999876554222 111122333343 24555666666667788
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECC-------CCcEE
Q 003982 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD-------DMRAK 727 (782)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~-------~~~~k 727 (782)
++|+||.+.|+|.+++. ..+.+++.-++.+..|+++.+++||. .+|||+||||+|+++.. ..-++
T Consensus 770 ~lv~ey~~~Gtlld~~N-----~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLIN-----TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred eeeeeccccccHHHhhc-----cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceE
Confidence 99999999999999986 24668999999999999999999998 89999999999999942 24589
Q ss_pred EEeeccceecCCCC-ceeeecccccccccCccccccchhhhHHHHHHHHHhc
Q 003982 728 VADFGLVKNAPDGK-YSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHG 778 (782)
Q Consensus 728 L~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~G 778 (782)
|+|||.+..+.--. .......++|-.+--+|+..|. ..++..|.|+++
T Consensus 842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~gr---pWtYq~DyfGlA 890 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGR---PWTYQIDYFGLA 890 (974)
T ss_pred EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCC---CCchhhhhHHHH
Confidence 99999987543211 1233456789999999999887 234566777664
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=6e-15 Score=138.99 Aligned_cols=136 Identities=21% Similarity=0.222 Sum_probs=114.0
Q ss_pred ccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCC--CCcceEEeEEEeCCeEEEEEEccC
Q 003982 585 EANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH--RHLVALLGYCINGSERLLVYEYMP 662 (782)
Q Consensus 585 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~nI~~~~~~~~~~~~~~lv~e~~~ 662 (782)
+.+.||+|.++.||++... +..+++|.+..... ...+.+|+..++.++| ..+++++++....+..+++|||++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~ 76 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-DEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE 76 (155)
T ss_pred cceecccccccceEEEEec-CCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence 4578999999999999874 47899999865431 4678999999999986 599999998888888999999998
Q ss_pred CCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 663 RGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 663 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
++.+..+ +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.+...
T Consensus 77 g~~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 77 GETLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred CeecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 8766433 44566778999999999999854458999999999999999899999999988653
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.61 E-value=9e-15 Score=147.99 Aligned_cols=139 Identities=18% Similarity=0.209 Sum_probs=106.8
Q ss_pred cceee-cccceEEEEEEeCCCcEEEEEEeccccC-----------ChhhHHHHHHHHHHHHhcCCCCc--ceEEeEEEeC
Q 003982 586 ANILG-RGGFGVVYGGELPDGTKIAVKRMESNTM-----------GNKGLSEFQAEIAVLTKVRHRHL--VALLGYCING 651 (782)
Q Consensus 586 ~~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~nI--~~~~~~~~~~ 651 (782)
...|| .|+.|+||.+.. .+..++||++..... ......++.+|++++.+++|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35677 788889998877 478899998864221 11234578899999999998875 6777764432
Q ss_pred C----eEEEEEEccCC-CCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcE
Q 003982 652 S----ERLLVYEYMPR-GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRA 726 (782)
Q Consensus 652 ~----~~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~ 726 (782)
. ..++||||++| .+|.+++.+ .+++.. .+.+++.++.+||+ .||+||||||+|||++.++.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~------~~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v 181 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE------APLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKF 181 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc------CCCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCE
Confidence 2 23599999997 688888743 234443 36789999999998 899999999999999998999
Q ss_pred EEEeeccceecC
Q 003982 727 KVADFGLVKNAP 738 (782)
Q Consensus 727 kL~DfG~a~~~~ 738 (782)
+|+|||.+....
T Consensus 182 ~LIDfg~~~~~~ 193 (239)
T PRK01723 182 WLIDFDRGELRT 193 (239)
T ss_pred EEEECCCcccCC
Confidence 999999987654
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.8e-14 Score=165.92 Aligned_cols=158 Identities=25% Similarity=0.396 Sum_probs=111.8
Q ss_pred ccccchhHHHHHHHHHhcCCCC-CCCCCCCC-CCCccccceEeCCC-----CCEEEEEeCCCCCCcccCccccCCccCce
Q 003982 22 TTSLGDDGSVMLKLAQSLQNLP-SDWSSTSS-TGYCEWTGINCDNS-----NRVTTISLAKSGLSGTLSPEISSLTQLET 94 (782)
Q Consensus 22 ~~~~~~~~~~l~~~~~~~~~~~-~~w~~~~~-~~~c~w~gv~c~~~-----~~v~~L~l~~~~l~~~~~~~l~~l~~L~~ 94 (782)
+.....|..||+.+|+++.... .+|...+. ...|.|.||.|+.. ..|+.|+|++|++.|.+|..+..+++|+.
T Consensus 367 ~~t~~~~~~aL~~~k~~~~~~~~~~W~g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~ 446 (623)
T PLN03150 367 SKTLLEEVSALQTLKSSLGLPLRFGWNGDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQS 446 (623)
T ss_pred cccCchHHHHHHHHHHhcCCcccCCCCCCCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCCE
Confidence 3455679999999999996543 26643211 01137999999631 24889999999999999999999999999
Q ss_pred eecccCccCccCC-CCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeecccc
Q 003982 95 LSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNA 173 (782)
Q Consensus 95 L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N 173 (782)
|+|++|.+.|.+| .+..+++|+.|+|++|++++..+ ..+.++++|+.|+|++|
T Consensus 447 L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP--------------------------~~l~~L~~L~~L~Ls~N 500 (623)
T PLN03150 447 INLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIP--------------------------ESLGQLTSLRILNLNGN 500 (623)
T ss_pred EECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCc--------------------------hHHhcCCCCCEEECcCC
Confidence 9999999988777 68888888888888888776444 44445555555555555
Q ss_pred ccCCCCcccccCC-CCCcEEEcccCcCCCCCCc
Q 003982 174 NIFGLIPDFFDSF-SNLQNLRLSYNNFTGSLPA 205 (782)
Q Consensus 174 ~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~p~ 205 (782)
++++.+|..+..+ .++..+++.+|...+..|.
T Consensus 501 ~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~ 533 (623)
T PLN03150 501 SLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG 533 (623)
T ss_pred cccccCChHHhhccccCceEEecCCccccCCCC
Confidence 5556666666543 4567788888876655553
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.50 E-value=4.8e-14 Score=143.20 Aligned_cols=190 Identities=22% Similarity=0.326 Sum_probs=118.7
Q ss_pred CCccceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCC----------CCcceEEeEEE-
Q 003982 583 FSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRH----------RHLVALLGYCI- 649 (782)
Q Consensus 583 y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h----------~nI~~~~~~~~- 649 (782)
+...+.||.|+++.||.+.+ .+++.+|||++..... .....+.+++|.-....+.+ -.++..++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 34578899999999999954 5689999999865442 23367778877765555322 22333333222
Q ss_pred --------eC---C-----eEEEEEEccCCCCHHHHHHhhccCCCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEc
Q 003982 650 --------NG---S-----ERLLVYEYMPRGTLAQHLFEWHDHGYT--PLTWKQRVTIALDVARGVEYLHSLAQQSFIHR 711 (782)
Q Consensus 650 --------~~---~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHr 711 (782)
.. . ..+++|+-+ -++|.+++......... .+....+..+..|+++.+++||+ .|++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEec
Confidence 11 1 236788877 56888876543222111 23334456677899999999999 899999
Q ss_pred CCCCCCEEECCCCcEEEEeeccceecCCCCceeeecccccccccCccccccc-----hhhhHHHHHHHHHhccc
Q 003982 712 DLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKH-----WMILCQMTGLIWLHGSV 780 (782)
Q Consensus 712 Dikp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~~dvws~Gvv 780 (782)
||||+|++++.+|.++|+||+.....+... . . ...+..|.+||..... -....+.+.|.|++|++
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~--~-~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ 239 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRY--R-C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGIT 239 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEE--E-G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCcee--e-c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHH
Confidence 999999999999999999999877665421 1 1 2345789999965331 12345778888888875
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=4.7e-15 Score=167.19 Aligned_cols=185 Identities=20% Similarity=0.212 Sum_probs=137.5
Q ss_pred CCCccceeecccceEEEEEEeCCCcEEEEEEecccc--CChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 582 NFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNT--MGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
+|...+.+|++.|=.|.+|++++|. |+||++-+.. ..-+..++..+|++ ...++|||.+.+.-+....+..|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 4666889999999999999887777 8899986654 22223344445555 556789999999888888888899999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC-
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP- 738 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~- 738 (782)
|.. -+|++.+.- +.-+..-+.+.|+.|++.|+..+|+ .||+|+|||.+|||++.-..+.|+||..-+...
T Consensus 102 yvk-hnLyDRlST-----RPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYL 172 (1431)
T KOG1240|consen 102 YVK-HNLYDRLST-----RPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYL 172 (1431)
T ss_pred HHh-hhhhhhhcc-----chHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccC
Confidence 994 489988853 2336777889999999999999998 899999999999999999999999998665321
Q ss_pred --CC--Cc--eeeecccccccccCcccccc----------chhhhHHHHHHHHHhccc
Q 003982 739 --DG--KY--SVETRLAGTFGYLAPEYAGK----------HWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 --~~--~~--~~~~~~~gt~~y~aPE~~~~----------~~~~~~~~~~dvws~Gvv 780 (782)
+. ++ ...+. ..-.+|.|||.+-. .|- -..+=||||+|+|
T Consensus 173 PeDNPadf~fFFDTS-rRRtCYiAPERFv~~~~~~~~~q~~~~--L~paMDIFS~GCV 227 (1431)
T KOG1240|consen 173 PEDNPADFTFFFDTS-RRRTCYIAPERFVSALGKTSVGQDAPL--LTPAMDIFSAGCV 227 (1431)
T ss_pred CCCCcccceEEEecC-CceeeecChHhhhccccccccCCcccc--cChhhhhhhhhHH
Confidence 11 11 11111 12337999996432 221 3556678888876
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.49 E-value=5e-14 Score=136.58 Aligned_cols=93 Identities=25% Similarity=0.174 Sum_probs=78.3
Q ss_pred CCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCce
Q 003982 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743 (782)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~ 743 (782)
|+|.+++... ..++++.++..++.|++.||+|||+ .+ ||+||+++.++.+|+ ||.++......
T Consensus 1 GsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-- 63 (176)
T smart00750 1 VSLADILEVR----GRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-- 63 (176)
T ss_pred CcHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc--
Confidence 6888888652 2458999999999999999999998 55 999999999999999 99988765422
Q ss_pred eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 744 VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 744 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..||+.|||||++.+. .++.++||||+||+
T Consensus 64 ----~~g~~~y~aPE~~~~~---~~~~~~DiwSlG~i 93 (176)
T smart00750 64 ----SRVDPYFMAPEVIQGQ---SYTEKADIYSLGIT 93 (176)
T ss_pred ----CCCcccccChHHhcCC---CCcchhhHHHHHHH
Confidence 2589999999998775 45778999999986
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.48 E-value=1e-13 Score=159.70 Aligned_cols=104 Identities=29% Similarity=0.367 Sum_probs=90.2
Q ss_pred CCCCCCcccccCCceeEEEccCcccccccCccccccccCCeEecccccccccCCccCCCCCCCCeEecCCCcCCCCCCC-
Q 003982 355 ACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPD- 433 (782)
Q Consensus 355 ~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~- 433 (782)
..+.+|..++.+++|+.|+|++|.|.|.+|..++++++|+.|+|++|+++|.+|+.++++++|+.|+|++|+++|.+|.
T Consensus 430 L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~ 509 (623)
T PLN03150 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAA 509 (623)
T ss_pred ccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChH
Confidence 3456788899999999999999999999999999999999999999999999999999999999999999999999994
Q ss_pred CC---CCcceecCCCCCCCCCCCCCCCC
Q 003982 434 FG---SNVKFTVSPGNPFIGTNVDTTPG 458 (782)
Q Consensus 434 ~~---~~~~~~~~~~n~~~~~~~~~~~~ 458 (782)
++ .......+.+|+.+|+.+....|
T Consensus 510 l~~~~~~~~~l~~~~N~~lc~~p~l~~C 537 (623)
T PLN03150 510 LGGRLLHRASFNFTDNAGLCGIPGLRAC 537 (623)
T ss_pred HhhccccCceEEecCCccccCCCCCCCC
Confidence 33 23345678899999976543333
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=2e-14 Score=145.28 Aligned_cols=135 Identities=27% Similarity=0.381 Sum_probs=98.0
Q ss_pred CCCCcceEEeEEEe---------------------------CCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHH
Q 003982 637 RHRHLVALLGYCIN---------------------------GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTI 689 (782)
Q Consensus 637 ~h~nI~~~~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i 689 (782)
+||||+++.++|.+ +...|+||..++ -+|.+++.. ...+.....-+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~------~~~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT------RHRSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc------CCCchHHHHHH
Confidence 59999999887764 234589999884 488888854 33567788889
Q ss_pred HHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE--CCCC--cEEEEeeccceecCCCCcee-----eecccccccccCcccc
Q 003982 690 ALDVARGVEYLHSLAQQSFIHRDLKPSNILI--GDDM--RAKVADFGLVKNAPDGKYSV-----ETRLAGTFGYLAPEYA 760 (782)
Q Consensus 690 ~~qi~~aL~~LH~~~~~~ivHrDikp~NIll--~~~~--~~kL~DfG~a~~~~~~~~~~-----~~~~~gt~~y~aPE~~ 760 (782)
..|+++|+.|||+ +||.|||+|++|||+ |+|+ .+.++|||++-.-+....+. .....|...-||||+.
T Consensus 347 laQlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ 423 (598)
T KOG4158|consen 347 LAQLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA 423 (598)
T ss_pred HHHHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence 9999999999998 899999999999999 3443 67899999875433321111 1123477789999986
Q ss_pred ccc---hhhhHHHHHHHHHhcccC
Q 003982 761 GKH---WMILCQMTGLIWLHGSVG 781 (782)
Q Consensus 761 ~~~---~~~~~~~~~dvws~Gvv~ 781 (782)
... ...---.++|.|+.|-++
T Consensus 424 ta~PGp~avvny~kAD~WA~Gala 447 (598)
T KOG4158|consen 424 TAVPGPNAVVNYEKADTWAAGALA 447 (598)
T ss_pred hcCCCCceeeccchhhhhhhhhhH
Confidence 543 222223468899888654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.6e-13 Score=149.35 Aligned_cols=144 Identities=24% Similarity=0.280 Sum_probs=103.3
Q ss_pred cceeecccceEEEEEEeCCCcEEEEEEeccccCChh--------------------------------------hHHHHH
Q 003982 586 ANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNK--------------------------------------GLSEFQ 627 (782)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~--------------------------------------~~~~~~ 627 (782)
.+.||.|++|+||+|+..+|+.||||+.++.....- ..-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 467999999999999999999999999865421100 001355
Q ss_pred HHHHHHHhcC-----CCCcceEEeEEEeCCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHH-HHHHHh
Q 003982 628 AEIAVLTKVR-----HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR-GVEYLH 701 (782)
Q Consensus 628 ~E~~~l~~l~-----h~nI~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~-aL~~LH 701 (782)
+|++.+.+++ +++|.-..-+.......++||||++|+++.+....... .. ....++.+++. .+..+|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~----~~---~~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA----GL---DRKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc----CC---CHHHHHHHHHHHHHHHHH
Confidence 6777777663 34433222233334567999999999999887643111 12 23456666666 467888
Q ss_pred hcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 702 SLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 702 ~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
. .|++|+|+||.||+++++++++++|||++.....
T Consensus 275 ~---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 275 R---DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred h---CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 7 8999999999999999999999999999987764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.44 E-value=6.4e-15 Score=155.40 Aligned_cols=214 Identities=20% Similarity=0.337 Sum_probs=161.5
Q ss_pred EEeCCCCcccCCCCCCCC-CCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcc
Q 003982 117 DIYLDNNNFTSVPTGCFD-GLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLS 195 (782)
Q Consensus 117 ~L~Ls~n~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 195 (782)
.|.|++-++...|.+.+. .+..-...||+.|++.. +|..+..+-.|+.+.|+.|.+..+ |..+.++..|++|||+
T Consensus 54 ~l~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~e---lp~~~~~f~~Le~liLy~n~~r~i-p~~i~~L~~lt~l~ls 129 (722)
T KOG0532|consen 54 RLLLSGRRLKEFPRGAASYDLTDTVFADLSRNRFSE---LPEEACAFVSLESLILYHNCIRTI-PEAICNLEALTFLDLS 129 (722)
T ss_pred ccccccchhhcCCCccccccccchhhhhcccccccc---CchHHHHHHHHHHHHHHhccceec-chhhhhhhHHHHhhhc
Confidence 345555556655554443 24445567888888877 778888888889999999988654 8888999999999999
Q ss_pred cCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeecccccCCCCCCCCCCCCCEEEcCCCcCccCcc
Q 003982 196 YNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVP 275 (782)
Q Consensus 196 ~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p 275 (782)
.|+++ .+|..++. --|+.|-+++|+++..++.++.+..|..||.+.|.|. .+|
T Consensus 130 ~NqlS-~lp~~lC~-------------------------lpLkvli~sNNkl~~lp~~ig~~~tl~~ld~s~nei~-slp 182 (722)
T KOG0532|consen 130 SNQLS-HLPDGLCD-------------------------LPLKVLIVSNNKLTSLPEEIGLLPTLAHLDVSKNEIQ-SLP 182 (722)
T ss_pred cchhh-cCChhhhc-------------------------CcceeEEEecCccccCCcccccchhHHHhhhhhhhhh-hch
Confidence 99998 88877653 3488888888888888888888888889999999888 788
Q ss_pred hhhcCCCCCCEEEccCCcccCCCCCCCCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCC
Q 003982 276 ASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNA 355 (782)
Q Consensus 276 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (782)
..++.+.+|+.|.+..|.+...
T Consensus 183 sql~~l~slr~l~vrRn~l~~l---------------------------------------------------------- 204 (722)
T KOG0532|consen 183 SQLGYLTSLRDLNVRRNHLEDL---------------------------------------------------------- 204 (722)
T ss_pred HHhhhHHHHHHHHHhhhhhhhC----------------------------------------------------------
Confidence 8888888888888888887632
Q ss_pred CCCCCcccccCCceeEEEccCcccccccCccccccccCCeEecccccccccCCccCCC---CCCCCeEecCCCc
Q 003982 356 CDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTK---LASLQNLDVSNNN 426 (782)
Q Consensus 356 ~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~---l~~L~~L~ls~N~ 426 (782)
|.+++ .-.|..||+|.|+++ .||.+|.+|+.|++|-|.+|.|. ..|..++. ..=.++|+..-.+
T Consensus 205 ----p~El~-~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 205 ----PEELC-SLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred ----CHHHh-CCceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhcc
Confidence 33344 225777888888887 68888888888888888888888 55655533 3445677776664
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.37 E-value=6.7e-13 Score=146.34 Aligned_cols=62 Identities=32% Similarity=0.558 Sum_probs=38.9
Q ss_pred ceeEEEccCcccccccCccccccccCCeEecccccccccCCccCCCCCCCCeEecCCCcCCCCCC
Q 003982 368 RIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVP 432 (782)
Q Consensus 368 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p 432 (782)
++..|.+.+|++.. ++..+++++.|++|++++|+++ .++. ++.+.+|+.|++++|.++..+|
T Consensus 233 ~l~~l~l~~n~~~~-~~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~ 294 (394)
T COG4886 233 NLSGLELSNNKLED-LPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALP 294 (394)
T ss_pred cccccccCCceeee-ccchhccccccceecccccccc-cccc-ccccCccCEEeccCccccccch
Confidence 33444444444442 2455666677777777777777 4444 7777777777777777777666
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.36 E-value=7.1e-13 Score=147.20 Aligned_cols=149 Identities=21% Similarity=0.245 Sum_probs=97.4
Q ss_pred HhcCCCccceeecccceEEEEEEeCC-CcEEEEEEeccccCCh--------------------------------hhH--
Q 003982 579 VTDNFSEANILGRGGFGVVYGGELPD-GTKIAVKRMESNTMGN--------------------------------KGL-- 623 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~--------------------------------~~~-- 623 (782)
....|+. +.||+|++|+||+|...+ |+.||||+.++..... +..
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 3456776 889999999999998877 9999999997542100 001
Q ss_pred ----HHHHHHHHHHHhcC----CCCcceEEeEE-EeCCeEEEEEEccCCCCHHHHHHhhccCC--CCCCCHHHHHHHHHH
Q 003982 624 ----SEFQAEIAVLTKVR----HRHLVALLGYC-INGSERLLVYEYMPRGTLAQHLFEWHDHG--YTPLTWKQRVTIALD 692 (782)
Q Consensus 624 ----~~~~~E~~~l~~l~----h~nI~~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--~~~l~~~~~~~i~~q 692 (782)
-++.+|+..+.+++ +...+.+-.++ .-....++||||++|+.+.+.-.- ...+ ...+....+..++.|
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l-~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAAL-RAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHH-HhcCCCHHHHHHHHHHHHHHH
Confidence 12455666666653 33222222222 224567899999999999774221 1111 011222333333333
Q ss_pred HHHHHHHHhhcCCCCeEEcCCCCCCEEECCCC----cEEEEeeccceecCC
Q 003982 693 VARGVEYLHSLAQQSFIHRDLKPSNILIGDDM----RAKVADFGLVKNAPD 739 (782)
Q Consensus 693 i~~aL~~LH~~~~~~ivHrDikp~NIll~~~~----~~kL~DfG~a~~~~~ 739 (782)
+ +. .|++|+|+||.||+++.++ +++++|||++.....
T Consensus 276 i-------f~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 V-------FR---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred H-------Hh---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3 33 7999999999999999888 999999999987754
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.35 E-value=8.2e-13 Score=145.64 Aligned_cols=106 Identities=35% Similarity=0.525 Sum_probs=50.9
Q ss_pred eeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCC-CCCEEeccCCCCCCCCCCCcccCCCcccCeeeccc
Q 003982 94 TLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLT-NLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172 (782)
Q Consensus 94 ~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~ 172 (782)
.|+++.|.+...+..+..++.++.|++.+|.++.+++. ...++ +|+.|++++|++.. +|..+..+++|+.|++++
T Consensus 97 ~l~~~~~~~~~~~~~~~~~~~l~~L~l~~n~i~~i~~~-~~~~~~nL~~L~l~~N~i~~---l~~~~~~l~~L~~L~l~~ 172 (394)
T COG4886 97 SLDLNLNRLRSNISELLELTNLTSLDLDNNNITDIPPL-IGLLKSNLKELDLSDNKIES---LPSPLRNLPNLKNLDLSF 172 (394)
T ss_pred eeeccccccccCchhhhcccceeEEecCCcccccCccc-cccchhhcccccccccchhh---hhhhhhccccccccccCC
Confidence 35555555544444444445555555555555555543 22232 55555555555554 334444445555555555
Q ss_pred cccCCCCcccccCCCCCcEEEcccCcCCCCCCc
Q 003982 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPA 205 (782)
Q Consensus 173 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 205 (782)
|+++.. |.....++.|+.|++++|+++ .+|.
T Consensus 173 N~l~~l-~~~~~~~~~L~~L~ls~N~i~-~l~~ 203 (394)
T COG4886 173 NDLSDL-PKLLSNLSNLNNLDLSGNKIS-DLPP 203 (394)
T ss_pred chhhhh-hhhhhhhhhhhheeccCCccc-cCch
Confidence 554443 222224444555555555544 4443
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.4e-11 Score=118.84 Aligned_cols=140 Identities=15% Similarity=0.166 Sum_probs=101.6
Q ss_pred cceeecccceEEEEEEeCC-------CcEEEEEEeccccCC----------h----------hhHHHH----HHHHHHHH
Q 003982 586 ANILGRGGFGVVYGGELPD-------GTKIAVKRMESNTMG----------N----------KGLSEF----QAEIAVLT 634 (782)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~----------~----------~~~~~~----~~E~~~l~ 634 (782)
...||.|.-+.||.|...+ +..+|||+++..... + ...+.+ ++|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3568999999999996543 479999988532210 0 011223 48999999
Q ss_pred hcCC--CCcceEEeEEEeCCeEEEEEEccCCCCHHH-HHHhhccCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCeEE
Q 003982 635 KVRH--RHLVALLGYCINGSERLLVYEYMPRGTLAQ-HLFEWHDHGYTPLTWKQRVTIALDVARGVEYL-HSLAQQSFIH 710 (782)
Q Consensus 635 ~l~h--~nI~~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L-H~~~~~~ivH 710 (782)
++.. -++++++++ ...++||||+.+..+.. .+++ ..++..+...+..+++.++..+ |+ .|+||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H~---~glVH 148 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYKE---CNLVH 148 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHHh---CCeec
Confidence 9964 567777764 45689999997654422 2322 1345566778889999999999 77 89999
Q ss_pred cCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 711 RDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 711 rDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
+|+++.||+++ ++.++++|||.|.....
T Consensus 149 GDLs~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 149 ADLSEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CCCCHHHEEEE-CCcEEEEECCCceeCCC
Confidence 99999999996 46799999998876643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.4e-14 Score=151.16 Aligned_cols=178 Identities=25% Similarity=0.358 Sum_probs=113.2
Q ss_pred CccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCee
Q 003982 89 LTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTL 168 (782)
Q Consensus 89 l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L 168 (782)
++.-...||+.|++..++..+..+-.|..|.|.+|.|..+|.. +.++..|++|||+.|+++. +|..+..|+ |+.|
T Consensus 74 ltdt~~aDlsrNR~~elp~~~~~f~~Le~liLy~n~~r~ip~~-i~~L~~lt~l~ls~NqlS~---lp~~lC~lp-Lkvl 148 (722)
T KOG0532|consen 74 LTDTVFADLSRNRFSELPEEACAFVSLESLILYHNCIRTIPEA-ICNLEALTFLDLSSNQLSH---LPDGLCDLP-LKVL 148 (722)
T ss_pred ccchhhhhccccccccCchHHHHHHHHHHHHHHhccceecchh-hhhhhHHHHhhhccchhhc---CChhhhcCc-ceeE
Confidence 3344445555555554444444445555555555555555543 4555555555555555555 444444433 6667
Q ss_pred eccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeeccccc
Q 003982 169 YMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFT 248 (782)
Q Consensus 169 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 248 (782)
-+++|+++.. |+.++.+..|..||.+.|++. .+|..+. ++.+|+.|.+.+|++.
T Consensus 149 i~sNNkl~~l-p~~ig~~~tl~~ld~s~nei~-slpsql~------------------------~l~slr~l~vrRn~l~ 202 (722)
T KOG0532|consen 149 IVSNNKLTSL-PEEIGLLPTLAHLDVSKNEIQ-SLPSQLG------------------------YLTSLRDLNVRRNHLE 202 (722)
T ss_pred EEecCccccC-CcccccchhHHHhhhhhhhhh-hchHHhh------------------------hHHHHHHHHHhhhhhh
Confidence 7777776544 566667777777777777777 6665543 4777777777777777
Q ss_pred CCCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCC
Q 003982 249 GPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYP 299 (782)
Q Consensus 249 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~ 299 (782)
..++++. .-.|..||++.|+++ .+|-.|.+|+.|++|.|.+|.|+.++.
T Consensus 203 ~lp~El~-~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqSPPA 251 (722)
T KOG0532|consen 203 DLPEELC-SLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQSPPA 251 (722)
T ss_pred hCCHHHh-CCceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCCChH
Confidence 7777766 344777888888887 778888888888888888888875443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.5e-13 Score=155.77 Aligned_cols=192 Identities=22% Similarity=0.301 Sum_probs=150.5
Q ss_pred cCCCccceeecccceEEEEEEeC--CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC-CCCcceEEeEEEeCCeEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGELP--DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~~~lv 657 (782)
..|...+.||+|+++.|-.+... ....+|+|.+..........+....|..+-+.+. |+|++.+++...+....+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 34666777999999999887442 3445677766554322334555666887777776 99999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCCCeEEcCCCCCCEEECCCC-cEEEEeeccce
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLH-SLAQQSFIHRDLKPSNILIGDDM-RAKVADFGLVK 735 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~~~~ivHrDikp~NIll~~~~-~~kL~DfG~a~ 735 (782)
++|..++++.+.+.. .+....+......++.|+..++.|+| . .++.|||+||+|.+++..+ ..+++|||+|.
T Consensus 100 ~~~s~g~~~f~~i~~---~~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISH---PDSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred cCccccccccccccc---CCccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhc
Confidence 999999999887731 11224666778889999999999999 6 8999999999999999999 99999999998
Q ss_pred ecCC--CCceeeecccc-cccccCccccccc-hhhhHHHHHHHHHhcccC
Q 003982 736 NAPD--GKYSVETRLAG-TFGYLAPEYAGKH-WMILCQMTGLIWLHGSVG 781 (782)
Q Consensus 736 ~~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~~~~dvws~Gvv~ 781 (782)
.+.. +........+| ++.|+|||...+. +. ....|+||.|++.
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~---~~~~d~~S~g~~l 220 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYR---GPSVDVWSLGIVL 220 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhc---CCCcccccccccc
Confidence 7766 23333445678 9999999988874 32 4458999999975
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.29 E-value=4.6e-13 Score=141.67 Aligned_cols=118 Identities=29% Similarity=0.376 Sum_probs=98.6
Q ss_pred eEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeec
Q 003982 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (782)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG 732 (782)
+.|+.|++|...+|.+++...+. ....++...+.++.|++.|++| + |.+|||+||.||++..+..+||.|||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~--~e~~s~s~~~~~~~q~~~~~~y--k----~~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT--GEERSLSLMLDIFKQIAPAVEY--K----GLIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc--ccccchhHHHHHHHhhccchhh--c----cchhhhccccccccccchhhhhhhhh
Confidence 57899999999999999965332 2345778889999999999999 3 89999999999999999999999999
Q ss_pred cceecCCCC-----ceeeecccccccccCccccccchhhhHHHHHHHHHhcccC
Q 003982 733 LVKNAPDGK-----YSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSVG 781 (782)
Q Consensus 733 ~a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv~ 781 (782)
+........ ....+..+||..||+||++.+. -++.++|||++|+|.
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~---~y~~kvdIyaLGlil 452 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ---QYSEKVDIYALGLIL 452 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhh---hhhhhcchhhHHHHH
Confidence 987765544 3334556899999999999976 468899999999874
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.3e-11 Score=118.79 Aligned_cols=132 Identities=20% Similarity=0.177 Sum_probs=96.6
Q ss_pred cceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCc-ceEEeEEEeCCeEEEEEEccCCC
Q 003982 586 ANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHL-VALLGYCINGSERLLVYEYMPRG 664 (782)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-~~~~~~~~~~~~~~lv~e~~~~g 664 (782)
.+.++.|.++.||+++. .+..|++|+..... .....+++|+++++.+.+.++ ++++.+. ....++||||++|.
T Consensus 3 ~~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~ 76 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV-ANKKYVVRIPGNGT---ELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGS 76 (170)
T ss_pred eeecCCcccCceEEEEE-CCeEEEEEeCCCCc---ccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCC
Confidence 46789999999999986 47889999876543 122356889999998865554 4555443 33458999999998
Q ss_pred CHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 665 TLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA--QQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 665 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
++... . . ....++.+++++++.||+.. ..+++|+|++|.||+++ ++.++++|||.+...
T Consensus 77 ~l~~~--~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 77 ELLTE--D--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred ccccc--c--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 77542 0 0 11245778999999999821 12369999999999999 668999999998653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.23 E-value=2.5e-12 Score=125.62 Aligned_cols=136 Identities=25% Similarity=0.260 Sum_probs=101.7
Q ss_pred ccCCCCCcEEEeecccccCCCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCCCCCCccEEEc
Q 003982 231 LSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSL 310 (782)
Q Consensus 231 ~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~l 310 (782)
......|++||||+|.++.+.....-.|+++.|++++|.|.. +. .+..+++|+.||||+|.++...
T Consensus 280 ~dTWq~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~~-v~-nLa~L~~L~~LDLS~N~Ls~~~------------ 345 (490)
T KOG1259|consen 280 ADTWQELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIRT-VQ-NLAELPQLQLLDLSGNLLAECV------------ 345 (490)
T ss_pred cchHhhhhhccccccchhhhhhhhhhccceeEEeccccceee-eh-hhhhcccceEeecccchhHhhh------------
Confidence 334567888888888888777777777888888888888873 22 3777888888888888877311
Q ss_pred cCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccccCcccccc
Q 003982 311 DHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANL 390 (782)
Q Consensus 311 ~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l 390 (782)
.+-..+.++.+|.|+.|.|.. -..+..|
T Consensus 346 --------------------------------------------------Gwh~KLGNIKtL~La~N~iE~--LSGL~KL 373 (490)
T KOG1259|consen 346 --------------------------------------------------GWHLKLGNIKTLKLAQNKIET--LSGLRKL 373 (490)
T ss_pred --------------------------------------------------hhHhhhcCEeeeehhhhhHhh--hhhhHhh
Confidence 122345677888888887752 2357778
Q ss_pred ccCCeEeccccccccc-CCccCCCCCCCCeEecCCCcCCCCCC
Q 003982 391 TSLKNLYLQQNNLTGP-IPDGLTKLASLQNLDVSNNNLSGKVP 432 (782)
Q Consensus 391 ~~L~~L~Ls~N~l~g~-~p~~~~~l~~L~~L~ls~N~l~g~~p 432 (782)
-+|.+||+++|+|... --..++++|-|+.|.|.+|+|.+.+.
T Consensus 374 YSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 374 YSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred hhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence 8999999999999742 23568999999999999999998665
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.7e-10 Score=106.87 Aligned_cols=135 Identities=24% Similarity=0.340 Sum_probs=103.4
Q ss_pred ceeecccceEEEEEEeCCCcEEEEEEeccccCChh------hHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEc
Q 003982 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNK------GLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (782)
Q Consensus 587 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 660 (782)
..+++|+-+.+|.+.+ -|..+++|.=.+..+... ...+-.+|++++.+++--.|...+-+..+++...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 4578999999999977 444566664333332222 234567899999999877887777788889999999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
++|..|.+.+... ...++..+-.-+.-||. .||+|+|+.++||++..+. +.++|||++..-.
T Consensus 81 I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~ 142 (204)
T COG3642 81 IEGELLKDALEEA------------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEFSD 142 (204)
T ss_pred eCChhHHHHHHhc------------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccccc
Confidence 9998888788541 13456666666778998 9999999999999997765 9999999997543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.21 E-value=3.6e-12 Score=144.26 Aligned_cols=151 Identities=30% Similarity=0.483 Sum_probs=102.2
Q ss_pred hcCCCccceeecccceEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
..+|..++.|..|++|.||.++++ +.+.+|+| +.+... -.++ ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l------ilRn---ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL------ILRN---ILTFAGNPFVV---------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccch------hhhc---cccccCCccee----------------
Confidence 467888999999999999999664 46778885 333220 0111 22222333333
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
|+-...++. .++++. +++.+++|+|+ .||+|||+||+|.+|+.-|.+|++|||+++..-
T Consensus 136 -----gDc~tllk~-----~g~lPv--------dmvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GL 194 (1205)
T KOG0606|consen 136 -----GDCATLLKN-----IGPLPV--------DMVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGL 194 (1205)
T ss_pred -----chhhhhccc-----CCCCcc--------hhhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhh
Confidence 444444432 223332 23889999998 899999999999999999999999999876421
Q ss_pred C--------C-----Cce-eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 D--------G-----KYS-VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~--------~-----~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
. + ..+ .....+|||.|+|||++... ||..-.|-|++|+|
T Consensus 195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrq---gygkpvdwwamGiI 247 (1205)
T KOG0606|consen 195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQ---GYGKPVDWWAMGII 247 (1205)
T ss_pred hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhh---ccCCCccHHHHHHH
Confidence 1 0 011 12345899999999998775 56666777777765
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=3.6e-10 Score=103.98 Aligned_cols=146 Identities=21% Similarity=0.241 Sum_probs=111.4
Q ss_pred ccceeecccceEEEEEEeCCCcEEEEEEeccccCChh------hHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 585 EANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNK------GLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 585 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
....+.+|+-+.|+++.+ .|+.+.||.=....+... ..++..+|++.+.+++--.|....-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 467899999999999988 677777774332222211 3456789999999998767777777788888889999
Q ss_pred EccCC-CCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCC---cEEEEeeccc
Q 003982 659 EYMPR-GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM---RAKVADFGLV 734 (782)
Q Consensus 659 e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~---~~kL~DfG~a 734 (782)
||++| .++.+++...... +........+++++-+.+.-||. .+|||+|+..+||++.+++ .+.++|||++
T Consensus 90 E~~~g~~~vk~~i~~~~~~---~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMED---ESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred EeccchhHHHHHHHHHccC---cccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecch
Confidence 99976 4788888765432 22223336889999999999998 9999999999999997665 4689999998
Q ss_pred eec
Q 003982 735 KNA 737 (782)
Q Consensus 735 ~~~ 737 (782)
...
T Consensus 164 ~~s 166 (229)
T KOG3087|consen 164 SVS 166 (229)
T ss_pred hcc
Confidence 643
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.6e-12 Score=132.16 Aligned_cols=208 Identities=19% Similarity=0.138 Sum_probs=114.7
Q ss_pred cCCccCceeecccCccCccCC--CCCCCCCCCEEeCCCCcccCCCC--CCCCCCCCCCEEeccCCCCCCCCCCCcccCCC
Q 003982 87 SSLTQLETLSFQMNNIAGAIP--SLANATSLQDIYLDNNNFTSVPT--GCFDGLTNLQVLSLSDNPNLAPWPFPNELTKS 162 (782)
Q Consensus 87 ~~l~~L~~L~L~~N~l~~~~~--~l~~l~~L~~L~Ls~n~l~~~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l 162 (782)
+++.+|+.+.|.+..+..... ....+++++.||||+|-|....+ .....|++|+.|+|+.|++...+.- ..-..+
T Consensus 118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s-~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISS-NTTLLL 196 (505)
T ss_pred hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccc-cchhhh
Confidence 577778888888777664432 46677888888888888775322 2345688888888888887763211 112356
Q ss_pred cccCeeeccccccCCC-CcccccCCCCCcEEEcccCcCCCCCCccccc-cccchhhcccccCCCccccccccCCCCCcEE
Q 003982 163 TSLTTLYMDNANIFGL-IPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQV 240 (782)
Q Consensus 163 ~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L 240 (782)
++|+.|.|+.|.++.. +...+..+|+|+.|+|+.|...........- ..|+.|++++|++.........+.++.|+.|
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~L 276 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQL 276 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhh
Confidence 7788888888888732 2344556788888888888522111111110 3445555555555444444444455555555
Q ss_pred EeecccccCC-CCC------CCCCCCCCEEEcCCCcCccC-cchhhcCCCCCCEEEccCCccc
Q 003982 241 WLHKNQFTGP-IPD------LSKCESLFDLSLRDNQLTGV-VPASVISLPALLNISLQNNKLQ 295 (782)
Q Consensus 241 ~L~~N~l~~~-~~~------~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~ 295 (782)
.++.+.+... .|+ ...+++|++|+++.|+|... .-..+..+++|+.|.+..|.|+
T Consensus 277 nls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 277 NLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLN 339 (505)
T ss_pred hccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccc
Confidence 5555555441 111 13344555555555554311 1122233344444444444444
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.1e-11 Score=133.99 Aligned_cols=143 Identities=24% Similarity=0.373 Sum_probs=113.2
Q ss_pred HHhcCCCCcceEEeEEEeCCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcC
Q 003982 633 LTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRD 712 (782)
Q Consensus 633 l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrD 712 (782)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+.. ....+++.-...+.++++.||+|+|.. ..-.|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~----~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN----EDIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc----cccCccHHHHHHHHHHHHHHHHHHhcC--cceeeee
Confidence 3567899999999999999999999999999999999976 235689999999999999999999982 3339999
Q ss_pred CCCCCEEECCCCcEEEEeeccceecCCC-CceeeecccccccccCccccccchhhh----HHHHHHHHHhcccC
Q 003982 713 LKPSNILIGDDMRAKVADFGLVKNAPDG-KYSVETRLAGTFGYLAPEYAGKHWMIL----CQMTGLIWLHGSVG 781 (782)
Q Consensus 713 ikp~NIll~~~~~~kL~DfG~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~----~~~~~dvws~Gvv~ 781 (782)
+++.|.++|....+||+|||+....... .........-..-|.|||.+.+.-... -..+.|+||+||+-
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~ 148 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIM 148 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHH
Confidence 9999999999999999999998766431 111111112345699999887642222 25678999999873
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.18 E-value=9.8e-12 Score=117.53 Aligned_cols=86 Identities=28% Similarity=0.400 Sum_probs=16.5
Q ss_pred CCCCCCCCEEeCCCCcccCCCCCCCC-CCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCC
Q 003982 109 LANATSLQDIYLDNNNFTSVPTGCFD-GLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFS 187 (782)
Q Consensus 109 l~~l~~L~~L~Ls~n~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 187 (782)
+.+..++++|+|.+|.|+.+.. ++ .+.+|+.|||++|+|.. + ..+..++.|+.|++++|+|+.+.+.....++
T Consensus 15 ~~n~~~~~~L~L~~n~I~~Ie~--L~~~l~~L~~L~Ls~N~I~~---l-~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp 88 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQISTIEN--LGATLDKLEVLDLSNNQITK---L-EGLPGLPRLKTLDLSNNRISSISEGLDKNLP 88 (175)
T ss_dssp ---------------------S----TT-TT--EEE-TTS--S------TT----TT--EEE--SS---S-CHHHHHH-T
T ss_pred cccccccccccccccccccccc--hhhhhcCCCEEECCCCCCcc---c-cCccChhhhhhcccCCCCCCccccchHHhCC
Confidence 3344445555555555554421 22 34455555555555544 1 1344445555555555555544222223455
Q ss_pred CCcEEEcccCcCC
Q 003982 188 NLQNLRLSYNNFT 200 (782)
Q Consensus 188 ~L~~L~Ls~N~l~ 200 (782)
+|++|+|++|+|.
T Consensus 89 ~L~~L~L~~N~I~ 101 (175)
T PF14580_consen 89 NLQELYLSNNKIS 101 (175)
T ss_dssp T--EEE-TTS---
T ss_pred cCCEEECcCCcCC
Confidence 5555666555554
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.12 E-value=4.3e-10 Score=113.42 Aligned_cols=144 Identities=20% Similarity=0.278 Sum_probs=109.8
Q ss_pred cceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCC--CCcceEEeEEEeCC---eEEEEEEc
Q 003982 586 ANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH--RHLVALLGYCINGS---ERLLVYEY 660 (782)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~nI~~~~~~~~~~~---~~~lv~e~ 660 (782)
.+.|+.|..+.||++...+|+.+++|+....... .....+.+|+++++.+++ ..+++++.+..... ..++||||
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 3668999999999998766789999987654321 234678999999999975 45677887766532 56899999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC------------------------------------
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA------------------------------------ 704 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~------------------------------------ 704 (782)
++|.++.+.+.. ..++..+...++.++++++.+||+..
T Consensus 82 i~G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (223)
T cd05154 82 VDGRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP 155 (223)
T ss_pred eCCEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence 999887665421 23566777778888888888888521
Q ss_pred -----------------CCCeEEcCCCCCCEEECC--CCcEEEEeecccee
Q 003982 705 -----------------QQSFIHRDLKPSNILIGD--DMRAKVADFGLVKN 736 (782)
Q Consensus 705 -----------------~~~ivHrDikp~NIll~~--~~~~kL~DfG~a~~ 736 (782)
...++|+|++|.||+++. ++.+.++||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 256899999999999998 66789999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.12 E-value=2.5e-11 Score=114.79 Aligned_cols=122 Identities=23% Similarity=0.277 Sum_probs=34.3
Q ss_pred EEEEEeCCCCCCcccCcccc-CCccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccC
Q 003982 68 VTTISLAKSGLSGTLSPEIS-SLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSD 146 (782)
Q Consensus 68 v~~L~l~~~~l~~~~~~~l~-~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~ 146 (782)
.++|+|.+|+|+. + +.++ .+.+|+.|+|++|.|+.+ +.+..+++|++|++++|+|+++.+.....+++|++|+|++
T Consensus 21 ~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~l-~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L~~ 97 (175)
T PF14580_consen 21 LRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITKL-EGLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYLSN 97 (175)
T ss_dssp -----------------S--TT-TT--EEE-TTS--S---TT----TT--EEE--SS---S-CHHHHHH-TT--EEE-TT
T ss_pred ccccccccccccc-c-cchhhhhcCCCEEECCCCCCccc-cCccChhhhhhcccCCCCCCccccchHHhCCcCCEEECcC
Confidence 4556666666552 2 2343 355566666666666543 2455556666666666666655433223455666666666
Q ss_pred CCCCCCCCCCcccCCCcccCeeeccccccCCCC---cccccCCCCCcEEE
Q 003982 147 NPNLAPWPFPNELTKSTSLTTLYMDNANIFGLI---PDFFDSFSNLQNLR 193 (782)
Q Consensus 147 N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~l~~L~~L~ 193 (782)
|+|..... -..+..+++|+.|+|.+|.++... .-.+..+|+|+.||
T Consensus 98 N~I~~l~~-l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 98 NKISDLNE-LEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp S---SCCC-CGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEET
T ss_pred CcCCChHH-hHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeC
Confidence 66555221 133444555555555555554321 12234455555555
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.11 E-value=5.2e-11 Score=128.91 Aligned_cols=188 Identities=24% Similarity=0.243 Sum_probs=146.6
Q ss_pred cCCCccceeec--ccceEEEEEEe---CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC-CCCcceEEeEEEeCCeE
Q 003982 581 DNFSEANILGR--GGFGVVYGGEL---PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSER 654 (782)
Q Consensus 581 ~~y~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~~ 654 (782)
..+.+.+.+|. |.+|.||.+.. .++..+|+|+-+..........+=.+|+..-+.++ |++.++.+..+++.+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34556788899 99999999844 57889999985433322223344456777767775 99999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHH----HHHHHhhcCCCCeEEcCCCCCCEEECCC-CcEEEE
Q 003982 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR----GVEYLHSLAQQSFIHRDLKPSNILIGDD-MRAKVA 729 (782)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~----aL~~LH~~~~~~ivHrDikp~NIll~~~-~~~kL~ 729 (782)
++-+|++ +.++.++.+... .-++....+....+... |+.++|+ .+++|-|+||.||+...+ ..++++
T Consensus 194 fiqtE~~-~~sl~~~~~~~~----~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~ 265 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHTPC----NFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLT 265 (524)
T ss_pred eeeeccc-cchhHHhhhccc----ccCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecC
Confidence 9999999 567777765532 23677788888888888 9999998 899999999999999999 889999
Q ss_pred eeccceecCCCCcee----eecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 730 DFGLVKNAPDGKYSV----ETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 730 DfG~a~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|||+...+.+..... ....-|...|++||...+. +...+|+|++|.|
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l----~~~~~di~sl~ev 316 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL----ATFASDIFSLGEV 316 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhccc----cchHhhhcchhhh
Confidence 999998887655321 2222467789999999886 6788999999865
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.11 E-value=8.7e-12 Score=121.89 Aligned_cols=183 Identities=23% Similarity=0.284 Sum_probs=105.8
Q ss_pred CccccCCccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCC----CC-------------------CCCCCCC
Q 003982 83 SPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPT----GC-------------------FDGLTNL 139 (782)
Q Consensus 83 ~~~l~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~----~~-------------------~~~l~~L 139 (782)
|=.+.-+++|+.+.++.+.-..+..-...-+.|+++...+..++..|. .. ...-..|
T Consensus 207 ~f~l~~f~~l~~~~~s~~~~~~i~~~~~~kptl~t~~v~~s~~~~~~~l~pe~~~~D~~~~E~~t~~G~~~~~~dTWq~L 286 (490)
T KOG1259|consen 207 SFNLNAFRNLKTLKFSALSTENIVDIELLKPTLQTICVHNTTIQDVPSLLPETILADPSGSEPSTSNGSALVSADTWQEL 286 (490)
T ss_pred ccchHHhhhhheeeeeccchhheeceeecCchhheeeeecccccccccccchhhhcCccCCCCCccCCceEEecchHhhh
Confidence 334455666777766665433222211123567777777666654221 10 0112356
Q ss_pred CEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhccc
Q 003982 140 QVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMND 219 (782)
Q Consensus 140 ~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~ 219 (782)
++||||+|.|+. +..+..-+++++.|++++|.|+.+. .+..+++|+.||||+|.++ .+-.+-
T Consensus 287 telDLS~N~I~~---iDESvKL~Pkir~L~lS~N~i~~v~--nLa~L~~L~~LDLS~N~Ls-~~~Gwh------------ 348 (490)
T KOG1259|consen 287 TELDLSGNLITQ---IDESVKLAPKLRRLILSQNRIRTVQ--NLAELPQLQLLDLSGNLLA-ECVGWH------------ 348 (490)
T ss_pred hhccccccchhh---hhhhhhhccceeEEeccccceeeeh--hhhhcccceEeecccchhH-hhhhhH------------
Confidence 677777776666 5556666667777777777776552 2666677777777777766 333221
Q ss_pred ccCCCccccccccCCCCCcEEEeecccccCCCCCCCCCCCCCEEEcCCCcCccC-cchhhcCCCCCCEEEccCCcccC
Q 003982 220 QQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGV-VPASVISLPALLNISLQNNKLQG 296 (782)
Q Consensus 220 ~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~ 296 (782)
..+-+++.|.|+.|.+.. ...+..+-+|..||+++|+|... --..++++|.|+++.|.+|.+.+
T Consensus 349 ------------~KLGNIKtL~La~N~iE~-LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 349 ------------LKLGNIKTLKLAQNKIET-LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred ------------hhhcCEeeeehhhhhHhh-hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 125566677777776652 23455666677777777777642 23456677777777777777664
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1e-11 Score=137.15 Aligned_cols=177 Identities=28% Similarity=0.331 Sum_probs=112.9
Q ss_pred cCCccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccC
Q 003982 87 SSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLT 166 (782)
Q Consensus 87 ~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~ 166 (782)
..+..++.++++.|.|......+..+++|+.|++.+|+|..+... +..+++|++|+|++|+|+.. ..+..++.|+
T Consensus 69 ~~l~~l~~l~l~~n~i~~~~~~l~~~~~l~~l~l~~n~i~~i~~~-l~~~~~L~~L~ls~N~I~~i----~~l~~l~~L~ 143 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIAKILNHLSKLKSLEALDLYDNKIEKIENL-LSSLVNLQVLDLSFNKITKL----EGLSTLTLLK 143 (414)
T ss_pred HHhHhHHhhccchhhhhhhhcccccccceeeeeccccchhhcccc-hhhhhcchheeccccccccc----cchhhccchh
Confidence 456677777788888876444577778888888888888876653 56678888888888888772 3456666688
Q ss_pred eeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeeccc
Q 003982 167 TLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQ 246 (782)
Q Consensus 167 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~ 246 (782)
.|++++|.|+.+ ..+..++.|+.+++++|++. .+.... ...+.+++.+++.+|.
T Consensus 144 ~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~-~ie~~~-----------------------~~~~~~l~~l~l~~n~ 197 (414)
T KOG0531|consen 144 ELNLSGNLISDI--SGLESLKSLKLLDLSYNRIV-DIENDE-----------------------LSELISLEELDLGGNS 197 (414)
T ss_pred hheeccCcchhc--cCCccchhhhcccCCcchhh-hhhhhh-----------------------hhhccchHHHhccCCc
Confidence 888888888775 34556888888888888887 333210 1235666666666666
Q ss_pred ccCCCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCccc
Q 003982 247 FTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQ 295 (782)
Q Consensus 247 l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 295 (782)
+.. +..+..+..+..+++..|.++..-+.....+..|+.+++++|.+.
T Consensus 198 i~~-i~~~~~~~~l~~~~l~~n~i~~~~~l~~~~~~~L~~l~l~~n~i~ 245 (414)
T KOG0531|consen 198 IRE-IEGLDLLKKLVLLSLLDNKISKLEGLNELVMLHLRELYLSGNRIS 245 (414)
T ss_pred hhc-ccchHHHHHHHHhhcccccceeccCcccchhHHHHHHhcccCccc
Confidence 663 223334444445566677666322211111112555555555555
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=5.4e-10 Score=122.00 Aligned_cols=155 Identities=16% Similarity=0.210 Sum_probs=117.3
Q ss_pred EeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEccCCCCHHHHHHhhccCCCCC
Q 003982 601 ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTP 680 (782)
Q Consensus 601 ~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~ 680 (782)
+..++.+|.|..++.... .......+-++.++.+|||||+++++.++.++..|+|+|.+. .|..++.+
T Consensus 33 ~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------- 100 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------- 100 (690)
T ss_pred eeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH--------
Confidence 556788888888876542 334557788899999999999999999999999999999984 57777765
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCceeeecccccccccCccc-
Q 003982 681 LTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEY- 759 (782)
Q Consensus 681 l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~- 759 (782)
+....+..-+.||+.||.|||. +.+++|++|.-.-|+|+..|+.||++|..+.......... ....--..|..|+.
T Consensus 101 l~~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~-~~~~~~~s~~~P~~~ 177 (690)
T KOG1243|consen 101 LGKEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPA-KSLYLIESFDDPEEI 177 (690)
T ss_pred hHHHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccc-ccchhhhcccChhhc
Confidence 3467788889999999999996 4899999999999999999999999999886554322100 00111224666664
Q ss_pred -----cccchhhhHHH
Q 003982 760 -----AGKHWMILCQM 770 (782)
Q Consensus 760 -----~~~~~~~~~~~ 770 (782)
.-|.|.+||..
T Consensus 178 ~~s~~s~D~~~Lg~li 193 (690)
T KOG1243|consen 178 DPSEWSIDSWGLGCLI 193 (690)
T ss_pred CccccchhhhhHHHHH
Confidence 23556666653
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1e-11 Score=127.78 Aligned_cols=207 Identities=16% Similarity=0.163 Sum_probs=150.6
Q ss_pred CCCCCCCEEeCCCCcccCCCC-CCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCccc-ccCCC
Q 003982 110 ANATSLQDIYLDNNNFTSVPT-GCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDF-FDSFS 187 (782)
Q Consensus 110 ~~l~~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~ 187 (782)
+++.+|+...|.+..+...+. .....+++++.||||+|-+....++......+++|+.|+|+.|++.-..... -..++
T Consensus 118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 578899999999999887664 5677899999999999988775555566788999999999999986543322 23678
Q ss_pred CCcEEEcccCcCCCCCCccc--cccccchhhcccccCCCccccccccCCCCCcEEEeecccccCCC--CCCCCCCCCCEE
Q 003982 188 NLQNLRLSYNNFTGSLPASF--AKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPI--PDLSKCESLFDL 263 (782)
Q Consensus 188 ~L~~L~Ls~N~l~~~~p~~~--~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~l~~L~~L 263 (782)
+|+.|.|+.|.|+..--.++ ..++++.|++..|... .........+..|++|+|++|++-... +....++.|..|
T Consensus 198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~-~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~L 276 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEII-LIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQL 276 (505)
T ss_pred hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhccccc-ceecchhhhhhHHhhccccCCcccccccccccccccchhhh
Confidence 99999999999983211111 1267888999888522 111223345778999999999988755 568889999999
Q ss_pred EcCCCcCccC-cchh-----hcCCCCCCEEEccCCcccCCCC----CCCCCccEEEccCCcCCC
Q 003982 264 SLRDNQLTGV-VPAS-----VISLPALLNISLQNNKLQGPYP----LFPSKVQKVSLDHNNFCK 317 (782)
Q Consensus 264 ~L~~N~l~~~-~p~~-----~~~l~~L~~L~l~~N~l~~~~~----~~~~~l~~L~l~~N~~~~ 317 (782)
+++.+.+..+ +|+. -..+++|++|+++.|++..-.. ....+|+.|.+..|.++-
T Consensus 277 nls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 277 NLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred hccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence 9999998864 4444 3567899999999999863211 123466666666666643
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=5.2e-12 Score=126.66 Aligned_cols=188 Identities=22% Similarity=0.278 Sum_probs=106.0
Q ss_pred CCEEEEEeCCCCCCc----ccCccccCCccCceeecccCccC---ccCC-C-------CCCCCCCCEEeCCCCcccCCCC
Q 003982 66 NRVTTISLAKSGLSG----TLSPEISSLTQLETLSFQMNNIA---GAIP-S-------LANATSLQDIYLDNNNFTSVPT 130 (782)
Q Consensus 66 ~~v~~L~l~~~~l~~----~~~~~l~~l~~L~~L~L~~N~l~---~~~~-~-------l~~l~~L~~L~Ls~n~l~~~~~ 130 (782)
..++.|+|++|.+.. .+...+.+.++|+..++++---. ..+| . +...++|++||||.|.|..--.
T Consensus 30 ~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~ 109 (382)
T KOG1909|consen 30 DSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGI 109 (382)
T ss_pred CceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccch
Confidence 356777777776642 23344566666776666653221 1122 1 2334455555555555442110
Q ss_pred CCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCC-------------cccccCCCCCcEEEcccC
Q 003982 131 GCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLI-------------PDFFDSFSNLQNLRLSYN 197 (782)
Q Consensus 131 ~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~-------------~~~~~~l~~L~~L~Ls~N 197 (782)
. .+-..+.++..|++|+|.||.+.-.- ..-..+-+.|+++...+|
T Consensus 110 ~----------------------~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rN 167 (382)
T KOG1909|consen 110 R----------------------GLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRN 167 (382)
T ss_pred H----------------------HHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeecc
Confidence 0 01123444556666666666653211 122344567888888888
Q ss_pred cCCCCCCc-cccccccchhhcccccCCCccccccccCCCCCcEEEeecccccCCCC-----CCCCCCCCCEEEcCCCcCc
Q 003982 198 NFTGSLPA-SFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIP-----DLSKCESLFDLSLRDNQLT 271 (782)
Q Consensus 198 ~l~~~~p~-~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-----~~~~l~~L~~L~L~~N~l~ 271 (782)
++. ..+. .+. ..|...+.|+++.+..|.+..... .|..+++|+.|||++|-|+
T Consensus 168 rle-n~ga~~~A--------------------~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft 226 (382)
T KOG1909|consen 168 RLE-NGGATALA--------------------EAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFT 226 (382)
T ss_pred ccc-cccHHHHH--------------------HHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhh
Confidence 876 3322 111 134456778888888887764222 2677888888888888876
Q ss_pred cC----cchhhcCCCCCCEEEccCCcccC
Q 003982 272 GV----VPASVISLPALLNISLQNNKLQG 296 (782)
Q Consensus 272 ~~----~p~~~~~l~~L~~L~l~~N~l~~ 296 (782)
.. +...+..++.|+.|+++++.+..
T Consensus 227 ~egs~~LakaL~s~~~L~El~l~dcll~~ 255 (382)
T KOG1909|consen 227 LEGSVALAKALSSWPHLRELNLGDCLLEN 255 (382)
T ss_pred hHHHHHHHHHhcccchheeeccccccccc
Confidence 42 44556677778888888887764
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.2e-09 Score=103.32 Aligned_cols=129 Identities=21% Similarity=0.295 Sum_probs=85.5
Q ss_pred EEEEEEeCCCcEEEEEEeccccCC------------------------hhhHHHHHHHHHHHHhcCCC--CcceEEeEEE
Q 003982 596 VVYGGELPDGTKIAVKRMESNTMG------------------------NKGLSEFQAEIAVLTKVRHR--HLVALLGYCI 649 (782)
Q Consensus 596 ~Vy~~~~~~~~~vavK~~~~~~~~------------------------~~~~~~~~~E~~~l~~l~h~--nI~~~~~~~~ 649 (782)
.||.|...+|..+|||+.+..... .......++|++.|.++... ++++++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 389998889999999988542110 01234567899999999865 567776552
Q ss_pred eCCeEEEEEEccC--CCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCeEEcCCCCCCEEECCCCcE
Q 003982 650 NGSERLLVYEYMP--RGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYL-HSLAQQSFIHRDLKPSNILIGDDMRA 726 (782)
Q Consensus 650 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L-H~~~~~~ivHrDikp~NIll~~~~~~ 726 (782)
..++||||++ |..+..+. .. .++..+...++.+++..+..+ |. .||+|+|+.+.||+++++ .+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~-~~------~~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLK-DV------DLSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHH-HC------GGGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CE
T ss_pred ---CCEEEEEecCCCccchhhHH-hc------cccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eE
Confidence 3479999998 55554433 21 112344566788888866664 66 899999999999999887 99
Q ss_pred EEEeeccceecCC
Q 003982 727 KVADFGLVKNAPD 739 (782)
Q Consensus 727 kL~DfG~a~~~~~ 739 (782)
.++|||.|.....
T Consensus 146 ~iIDf~qav~~~~ 158 (188)
T PF01163_consen 146 YIIDFGQAVDSSH 158 (188)
T ss_dssp EE--GTTEEETTS
T ss_pred EEEecCcceecCC
Confidence 9999998876653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.00 E-value=7.4e-09 Score=105.97 Aligned_cols=143 Identities=15% Similarity=0.166 Sum_probs=103.5
Q ss_pred ceeecccceEEEEEEeCCCcEEEEEEeccccCCh---------hhHHHHHHHHHHHHhcCCCCc--ceEEeEEEe-----
Q 003982 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGN---------KGLSEFQAEIAVLTKVRHRHL--VALLGYCIN----- 650 (782)
Q Consensus 587 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~~E~~~l~~l~h~nI--~~~~~~~~~----- 650 (782)
+.+-+-....|++... +|+.|.||+........ .....+.+|.+.+.++...+| ++++++.+.
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4444444455777766 67899999874432111 011247899999998864444 445666653
Q ss_pred CCeEEEEEEccCCC-CHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECC-------
Q 003982 651 GSERLLVYEYMPRG-TLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD------- 722 (782)
Q Consensus 651 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~------- 722 (782)
....++|||++++. +|.+++.++.. .+.+......++.+++..+.-||. .||+|+|+++.|||++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~---~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~ 180 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWAT---NPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREE 180 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCC
Confidence 23578999999875 78888764322 234567778999999999999998 99999999999999975
Q ss_pred CCcEEEEeecccee
Q 003982 723 DMRAKVADFGLVKN 736 (782)
Q Consensus 723 ~~~~kL~DfG~a~~ 736 (782)
+..+.++||+.+..
T Consensus 181 ~~~~~LIDl~r~~~ 194 (268)
T PRK15123 181 DLKLSVIDLHRAQI 194 (268)
T ss_pred CceEEEEECCcccc
Confidence 46899999998864
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=4e-11 Score=132.37 Aligned_cols=128 Identities=30% Similarity=0.332 Sum_probs=72.5
Q ss_pred CCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhh
Q 003982 137 TNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLW 216 (782)
Q Consensus 137 ~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~ 216 (782)
..++.+++..|.+.. +-..+..+++|+.|++.+|+|..+.. .+..+++|++|++++|.|+...+
T Consensus 72 ~~l~~l~l~~n~i~~---~~~~l~~~~~l~~l~l~~n~i~~i~~-~l~~~~~L~~L~ls~N~I~~i~~------------ 135 (414)
T KOG0531|consen 72 TSLKELNLRQNLIAK---ILNHLSKLKSLEALDLYDNKIEKIEN-LLSSLVNLQVLDLSFNKITKLEG------------ 135 (414)
T ss_pred HhHHhhccchhhhhh---hhcccccccceeeeeccccchhhccc-chhhhhcchheeccccccccccc------------
Confidence 334444444444443 22234455555555555555555421 25566677777777777762222
Q ss_pred cccccCCCccccccccCCCCCcEEEeecccccCCCCCCCCCCCCCEEEcCCCcCccCcc-hhhcCCCCCCEEEccCCccc
Q 003982 217 MNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVP-ASVISLPALLNISLQNNKLQ 295 (782)
Q Consensus 217 l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~ 295 (782)
+..++.|+.|++++|.++. +..+..++.|+.+++++|+++..-+ . ...+.+++.+++.+|.+.
T Consensus 136 --------------l~~l~~L~~L~l~~N~i~~-~~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~ 199 (414)
T KOG0531|consen 136 --------------LSTLTLLKELNLSGNLISD-ISGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIR 199 (414)
T ss_pred --------------hhhccchhhheeccCcchh-ccCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchh
Confidence 2345567777777777763 3445557777777777777774333 1 456667777777777766
Q ss_pred C
Q 003982 296 G 296 (782)
Q Consensus 296 ~ 296 (782)
.
T Consensus 200 ~ 200 (414)
T KOG0531|consen 200 E 200 (414)
T ss_pred c
Confidence 3
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=4.2e-11 Score=120.25 Aligned_cols=191 Identities=21% Similarity=0.248 Sum_probs=140.7
Q ss_pred cccCCccCceeecccCccCccCC-C----CCCCCCCCEEeCCCCcccCCCCCC-------------CCCCCCCCEEeccC
Q 003982 85 EISSLTQLETLSFQMNNIAGAIP-S----LANATSLQDIYLDNNNFTSVPTGC-------------FDGLTNLQVLSLSD 146 (782)
Q Consensus 85 ~l~~l~~L~~L~L~~N~l~~~~~-~----l~~l~~L~~L~Ls~n~l~~~~~~~-------------~~~l~~L~~L~Ls~ 146 (782)
++-.-++|++||||+|.|....+ . +.++..|++|+|.||.+...-... ...-+.|+++..++
T Consensus 87 aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~r 166 (382)
T KOG1909|consen 87 ALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGR 166 (382)
T ss_pred HHhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeec
Confidence 34455689999999999864332 2 677889999999999988433222 34457899999999
Q ss_pred CCCCCCCC--CCcccCCCcccCeeeccccccCCC----CcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccc
Q 003982 147 NPNLAPWP--FPNELTKSTSLTTLYMDNANIFGL----IPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQ 220 (782)
Q Consensus 147 N~l~~~~~--~p~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~ 220 (782)
|++...+- +...|...+.|+.+.++.|.|... +...|..+++|+.|||..|-++..-...++
T Consensus 167 Nrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~La------------ 234 (382)
T KOG1909|consen 167 NRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALA------------ 234 (382)
T ss_pred cccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHH------------
Confidence 99877321 223567778999999999998632 345678899999999999998733222222
Q ss_pred cCCCccccccccCCCCCcEEEeecccccCCCCC-----C-CCCCCCCEEEcCCCcCccC----cchhhcCCCCCCEEEcc
Q 003982 221 QLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD-----L-SKCESLFDLSLRDNQLTGV----VPASVISLPALLNISLQ 290 (782)
Q Consensus 221 ~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-----~-~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~ 290 (782)
..+..+++|++|++++|.++..... + ...++|++|.|.+|.|+.. +...+...+.|..|+|+
T Consensus 235 --------kaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLn 306 (382)
T KOG1909|consen 235 --------KALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLN 306 (382)
T ss_pred --------HHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCC
Confidence 2455688999999999999865442 2 3478999999999999742 44556678899999999
Q ss_pred CCccc
Q 003982 291 NNKLQ 295 (782)
Q Consensus 291 ~N~l~ 295 (782)
+|++.
T Consensus 307 gN~l~ 311 (382)
T KOG1909|consen 307 GNRLG 311 (382)
T ss_pred ccccc
Confidence 99984
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.90 E-value=9e-09 Score=101.35 Aligned_cols=140 Identities=20% Similarity=0.197 Sum_probs=101.7
Q ss_pred CCccceeecccceEEEEEEeCCCcEEEEEEeccccCC--------------------hhhHHHHHHHHHHHHhcCCC--C
Q 003982 583 FSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMG--------------------NKGLSEFQAEIAVLTKVRHR--H 640 (782)
Q Consensus 583 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------~~~~~~~~~E~~~l~~l~h~--n 640 (782)
+.+...||.|.-+.||.|..+.|.++|||.=+....+ .......++|.++|+++.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 5567899999999999999889999999943211100 11234568999999999754 7
Q ss_pred cceEEeEEEeCCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE
Q 003982 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI 720 (782)
Q Consensus 641 I~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll 720 (782)
+++.+++ +...+||||++|-.|...- ++.+....++..|++-+..+-. .||||+|+++-||++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV 235 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILV 235 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEE
Confidence 8888766 4568999999987665432 1223333445555555444445 799999999999999
Q ss_pred CCCCcEEEEeeccceecCC
Q 003982 721 GDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 721 ~~~~~~kL~DfG~a~~~~~ 739 (782)
++||.+.++||=-+.....
T Consensus 236 ~~dg~~~vIDwPQ~v~~~h 254 (304)
T COG0478 236 TEDGDIVVIDWPQAVPISH 254 (304)
T ss_pred ecCCCEEEEeCcccccCCC
Confidence 9999999999976655433
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.89 E-value=1e-09 Score=85.34 Aligned_cols=60 Identities=38% Similarity=0.597 Sum_probs=43.5
Q ss_pred ccCceeecccCccCccCC-CCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCC
Q 003982 90 TQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPN 149 (782)
Q Consensus 90 ~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 149 (782)
++|++|++++|+|+.+++ .|.++++|++|++++|+++.+++..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 356777777777776666 677777777777777777777777777777777777777753
|
... |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.88 E-value=7.6e-10 Score=119.96 Aligned_cols=189 Identities=17% Similarity=0.163 Sum_probs=140.8
Q ss_pred HHHhcCCCccceeecccceEEEEEE--eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC-CCCcceEEeEEEeCCe
Q 003982 577 RQVTDNFSEANILGRGGFGVVYGGE--LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSE 653 (782)
Q Consensus 577 ~~~~~~y~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~ 653 (782)
.....+|..+..||.|.|+.|+++. ..++..|++|..............-..|+-+...+. |.+++.++..|..-..
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 3455678899999999999999984 357889999988766544333333456666666664 8999998888888888
Q ss_pred EEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCC-CcEEEEeec
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD-MRAKVADFG 732 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~-~~~kL~DfG 732 (782)
.|+--|||++++......- ...+++..++.+..|++.++.++|+ ..++|+|+||+||++..+ +..++.|||
T Consensus 341 ~~ip~e~~~~~s~~l~~~~-----~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~ 412 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVT-----SQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFG 412 (524)
T ss_pred ccCchhhhcCcchhhhhHH-----HHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhccccc
Confidence 8899999999988766522 2347788899999999999999998 899999999999999886 788999999
Q ss_pred cceecCCCCceeeeccccccccc-CccccccchhhhHHHHHHHHHhcc
Q 003982 733 LVKNAPDGKYSVETRLAGTFGYL-APEYAGKHWMILCQMTGLIWLHGS 779 (782)
Q Consensus 733 ~a~~~~~~~~~~~~~~~gt~~y~-aPE~~~~~~~~~~~~~~dvws~Gv 779 (782)
++....-.. ....+.-+++ .+|++...+ ....+.|++++|+
T Consensus 413 ~~t~~~~~~----~~~~~~~r~~p~~~~~~e~~--~~~~~~~~~sl~~ 454 (524)
T KOG0601|consen 413 CWTRLAFSS----GVFHHIDRLYPIAEILLEDY--PHLSKADIFSLGL 454 (524)
T ss_pred cccccceec----ccccccccccccchhhcccc--ccccccccccccc
Confidence 986532111 1112334455 366555543 3455788888873
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.84 E-value=2.8e-09 Score=82.88 Aligned_cols=61 Identities=38% Similarity=0.562 Sum_probs=57.4
Q ss_pred CceeEEEccCcccccccCccccccccCCeEecccccccccCCccCCCCCCCCeEecCCCcC
Q 003982 367 GRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNL 427 (782)
Q Consensus 367 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l 427 (782)
++|++|++++|+|+...+..|.++++|++|++++|+++...|..|..+++|+.|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4799999999999987778999999999999999999988889999999999999999986
|
... |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.79 E-value=5.1e-09 Score=123.49 Aligned_cols=111 Identities=23% Similarity=0.354 Sum_probs=61.7
Q ss_pred ccCceeecccCccCccCCCCCCCCCCCEEeCCCCc--ccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCe
Q 003982 90 TQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNN--FTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTT 167 (782)
Q Consensus 90 ~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~--l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~ 167 (782)
...+...+-+|.+....... ..++|++|-+..|. +..++...|..++.|++|||++|.-.. .+|..++.|-+|++
T Consensus 523 ~~~rr~s~~~~~~~~~~~~~-~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~--~LP~~I~~Li~Lry 599 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIEHIAGSS-ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLS--KLPSSIGELVHLRY 599 (889)
T ss_pred hheeEEEEeccchhhccCCC-CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccC--cCChHHhhhhhhhc
Confidence 44555555555554333222 22356666666664 555555556666666666666554322 35666666666666
Q ss_pred eeccccccCCCCcccccCCCCCcEEEcccCcCCCCCC
Q 003982 168 LYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLP 204 (782)
Q Consensus 168 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 204 (782)
|+|++..++. +|..+.++..|.+|++..+.-...+|
T Consensus 600 L~L~~t~I~~-LP~~l~~Lk~L~~Lnl~~~~~l~~~~ 635 (889)
T KOG4658|consen 600 LDLSDTGISH-LPSGLGNLKKLIYLNLEVTGRLESIP 635 (889)
T ss_pred ccccCCCccc-cchHHHHHHhhheecccccccccccc
Confidence 6666666653 36666666666666666555443333
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.68 E-value=2.2e-07 Score=92.03 Aligned_cols=127 Identities=26% Similarity=0.329 Sum_probs=93.7
Q ss_pred CCcEEEEEEeccccCCh-----hhHHHHHHHHHHHHhcCCC--CcceEEeEEEeCC----eEEEEEEccCCC-CHHHHHH
Q 003982 604 DGTKIAVKRMESNTMGN-----KGLSEFQAEIAVLTKVRHR--HLVALLGYCINGS----ERLLVYEYMPRG-TLAQHLF 671 (782)
Q Consensus 604 ~~~~vavK~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~--nI~~~~~~~~~~~----~~~lv~e~~~~g-sL~~~l~ 671 (782)
.++.|.+|......... ....+..+|.+.+.++... .+++.+++.+... ..++|+|++++. +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 45566666543221111 2345678899988888643 4566777766532 458999999874 7888886
Q ss_pred hhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCC---cEEEEeeccceecC
Q 003982 672 EWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM---RAKVADFGLVKNAP 738 (782)
Q Consensus 672 ~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~---~~kL~DfG~a~~~~ 738 (782)
... ..+......++.+++..+.-||. .||+|+|+++.|||++.+. .+.++||+-++...
T Consensus 111 ~~~-----~~~~~~~~~ll~~l~~~i~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 111 QWE-----QLDPSQRRELLRALARLIAKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred hhc-----ccchhhHHHHHHHHHHHHHHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 522 15566778899999999999998 9999999999999999887 89999999887654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.66 E-value=9.1e-08 Score=105.99 Aligned_cols=143 Identities=21% Similarity=0.275 Sum_probs=99.3
Q ss_pred ceeecccceEEEEEEeCCCcEEEEEEeccccCC--------------------------------hh------hHHHHHH
Q 003982 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMG--------------------------------NK------GLSEFQA 628 (782)
Q Consensus 587 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------------~~------~~~~~~~ 628 (782)
+.|+.++-|+||+|+..+|+.||||+.++.... ++ ..-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 778999999999999999999999987543211 00 0112456
Q ss_pred HHHHHHhcC-----CCCcceEEeEEEeCCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH-HHHHhh
Q 003982 629 EIAVLTKVR-----HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARG-VEYLHS 702 (782)
Q Consensus 629 E~~~l~~l~-----h~nI~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~a-L~~LH~ 702 (782)
|+..+.+++ .++|.-..-|+.-.....++|||++|-.+.+...-.. ...+.+. ++..++++ +..+-.
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~----~g~d~k~---ia~~~~~~f~~q~~~ 283 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS----AGIDRKE---LAELLVRAFLRQLLR 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh----cCCCHHH---HHHHHHHHHHHHHHh
Confidence 777777763 4555444445555677899999999988888743211 1244333 33333333 222322
Q ss_pred cCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 703 LAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 703 ~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
.|+.|.|.+|.||+++.++.+.+.|||+...+.+
T Consensus 284 ---dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 ---DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 6999999999999999999999999999877654
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=2.1e-08 Score=100.05 Aligned_cols=145 Identities=21% Similarity=0.287 Sum_probs=105.1
Q ss_pred HHHHHhcCCCCcceEEeEEEeCC-----eEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 003982 630 IAVLTKVRHRHLVALLGYCINGS-----ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA 704 (782)
Q Consensus 630 ~~~l~~l~h~nI~~~~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 704 (782)
...+-++.|.||++++.|+.+.+ +..+++|||+-|++.++|++.++. ...+......+|+.||+.||.|||+ +
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~-~~a~~~~~wkkw~tqIlsal~yLhs-~ 195 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKN-QKALFQKAWKKWCTQILSALSYLHS-C 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHh-hhhhhHHHHHHHHHHHHhhhhhhhc-c
Confidence 33455567999999999987654 467899999999999999886554 4557788888999999999999998 5
Q ss_pred CCCeEEcCCCCCCEEECCCCcEEEEeeccceecC--C-CCceeeecccccccccCccccccchhhhHHHHHHHHHhcc
Q 003982 705 QQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP--D-GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGS 779 (782)
Q Consensus 705 ~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~--~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gv 779 (782)
...|+|+++.-+-|++..++-+|+.----..... . ..........+-++|.|||+-.-. .....+|||+||.
T Consensus 196 ~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~t---n~~~a~dIy~fgm 270 (458)
T KOG1266|consen 196 DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTT---NTTGASDIYKFGM 270 (458)
T ss_pred CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccc---ccccchhhhhhhH
Confidence 6899999999999999999988874211110000 0 000011122367899999974332 3356788999884
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.57 E-value=7.5e-07 Score=87.21 Aligned_cols=157 Identities=22% Similarity=0.263 Sum_probs=110.6
Q ss_pred ccHHHHHHHhcCCCccceee---cccceEEEEEEeCCCcEEEEEEeccccCChh----------------------hHHH
Q 003982 571 ISIEVLRQVTDNFSEANILG---RGGFGVVYGGELPDGTKIAVKRMESNTMGNK----------------------GLSE 625 (782)
Q Consensus 571 ~~~~~l~~~~~~y~~~~~lg---~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------------------~~~~ 625 (782)
...+.+.....+..+.+..| .|.-+.||+|...++..+|||+++.....-+ ....
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 45667777777777766655 5666799999887899999999865432110 0112
Q ss_pred HHHHHHHHHhcC--CCCcceEEeEEEeCCeEEEEEEccCCC-CHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 003982 626 FQAEIAVLTKVR--HRHLVALLGYCINGSERLLVYEYMPRG-TLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHS 702 (782)
Q Consensus 626 ~~~E~~~l~~l~--h~nI~~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 702 (782)
.++|++.|+++. +-.+++.+++. .-.+||||+... .-.-.|.+ .++...+...+..++++.+.-|-.
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD------v~~e~~e~~~~~~~~v~~~~~l~~ 184 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD------VPLELEEAEGLYEDVVEYMRRLYK 184 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc------CCcCchhHHHHHHHHHHHHHHHHH
Confidence 357888888885 55667776653 347999999543 11222221 223344677788888888888875
Q ss_pred cCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCC
Q 003982 703 LAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (782)
Q Consensus 703 ~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~ 740 (782)
..++||+|++.=|||+. ++.+.++|||-|.....+
T Consensus 185 --~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 185 --EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred --hcCcccccchhhheEEE-CCeEEEEECccccccCCC
Confidence 37999999999999998 889999999998776543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.57 E-value=1e-06 Score=85.27 Aligned_cols=141 Identities=21% Similarity=0.187 Sum_probs=102.7
Q ss_pred ecccceEEEEEEeCCCcEEEEEEeccccCC----hhhHHHHHHHHHHHHhcCCCC--cceEEeEEEe----CCeEEEEEE
Q 003982 590 GRGGFGVVYGGELPDGTKIAVKRMESNTMG----NKGLSEFQAEIAVLTKVRHRH--LVALLGYCIN----GSERLLVYE 659 (782)
Q Consensus 590 g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~E~~~l~~l~h~n--I~~~~~~~~~----~~~~~lv~e 659 (782)
|+|+.+.|++... +|+.|-+|+-...... .-....|.+|+..+.++...+ +++++..... ....++|+|
T Consensus 27 ~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe 105 (216)
T PRK09902 27 RRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE 105 (216)
T ss_pred CCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence 6788889998876 4557889977521111 224578999999999986333 5555522211 123589999
Q ss_pred ccCC-CCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCc--EEEEeecccee
Q 003982 660 YMPR-GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR--AKVADFGLVKN 736 (782)
Q Consensus 660 ~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~--~kL~DfG~a~~ 736 (782)
-+++ -+|.+++.+. ...+.+......+..+++..++-||. .|+.|+|+.+.||+++.++. ++++||.-++.
T Consensus 106 ~L~g~~~L~~~l~~~---~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 106 DMAGFISIADWYAQH---AVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred eCCCCccHHHHHhcC---CcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 8854 5788877542 12346777888999999999999998 89999999999999986666 99999987654
Q ss_pred c
Q 003982 737 A 737 (782)
Q Consensus 737 ~ 737 (782)
.
T Consensus 180 ~ 180 (216)
T PRK09902 180 R 180 (216)
T ss_pred h
Confidence 3
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.3e-09 Score=118.71 Aligned_cols=129 Identities=29% Similarity=0.226 Sum_probs=87.1
Q ss_pred CCCcEEEeecccccCCCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCCCC--CCccEEEccC
Q 003982 235 TQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFP--SKVQKVSLDH 312 (782)
Q Consensus 235 ~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~--~~l~~L~l~~ 312 (782)
-.|...+.+.|.|......+.-++.|+.|+|++|+++.+. .+..+++|++|||+.|.|.-..-..+ .+|+.
T Consensus 164 n~L~~a~fsyN~L~~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~L~~----- 236 (1096)
T KOG1859|consen 164 NKLATASFSYNRLVLMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCKLQL----- 236 (1096)
T ss_pred hhHhhhhcchhhHHhHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhhhee-----
Confidence 4677788888888876667777888888888888888543 77788888888888888874322221 23444
Q ss_pred CcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccccCcccccccc
Q 003982 313 NNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTS 392 (782)
Q Consensus 313 N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~ 392 (782)
|+|.||-++. -..+.+|.+
T Consensus 237 -----------------------------------------------------------L~lrnN~l~t--L~gie~Lks 255 (1096)
T KOG1859|consen 237 -----------------------------------------------------------LNLRNNALTT--LRGIENLKS 255 (1096)
T ss_pred -----------------------------------------------------------eeecccHHHh--hhhHHhhhh
Confidence 4444444442 124667778
Q ss_pred CCeEecccccccccC-CccCCCCCCCCeEecCCCcCCCCC
Q 003982 393 LKNLYLQQNNLTGPI-PDGLTKLASLQNLDVSNNNLSGKV 431 (782)
Q Consensus 393 L~~L~Ls~N~l~g~~-p~~~~~l~~L~~L~ls~N~l~g~~ 431 (782)
|+.|||++|-|.+-- -.-++.|..|+.|+|.+|+|..-+
T Consensus 256 L~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 256 LYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred hhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 888888888776531 122455677788888888876543
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.7e-08 Score=99.28 Aligned_cols=81 Identities=25% Similarity=0.374 Sum_probs=37.3
Q ss_pred CEEEEEeCCCCCCc--ccCccccCCccCceeecccCccCccCCCC-CCCCCCCEEeCCCCcccC-CCCCCCCCCCCCCEE
Q 003982 67 RVTTISLAKSGLSG--TLSPEISSLTQLETLSFQMNNIAGAIPSL-ANATSLQDIYLDNNNFTS-VPTGCFDGLTNLQVL 142 (782)
Q Consensus 67 ~v~~L~l~~~~l~~--~~~~~l~~l~~L~~L~L~~N~l~~~~~~l-~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L 142 (782)
+|.++||.+|.|+. .+-.-+.+|+.|++|+|+.|++...+..+ ..+++|++|-|.+..+.- -....+..+|.++.|
T Consensus 72 ~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vtel 151 (418)
T KOG2982|consen 72 DVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTEL 151 (418)
T ss_pred hhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhhhh
Confidence 45555555555542 22223445555555555555555444333 234455555555544431 111223444555555
Q ss_pred eccCC
Q 003982 143 SLSDN 147 (782)
Q Consensus 143 ~Ls~N 147 (782)
.+|.|
T Consensus 152 HmS~N 156 (418)
T KOG2982|consen 152 HMSDN 156 (418)
T ss_pred hhccc
Confidence 55555
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.48 E-value=9.7e-07 Score=93.91 Aligned_cols=140 Identities=17% Similarity=0.254 Sum_probs=108.4
Q ss_pred ceEEEEE-EeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEe----CCeEEEEEEccCC-CCHH
Q 003982 594 FGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN----GSERLLVYEYMPR-GTLA 667 (782)
Q Consensus 594 ~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~----~~~~~lv~e~~~~-gsL~ 667 (782)
..+.|++ ...+|..|++|++.... .........-+++++++.|+|||++..++.. +...++|++|+++ ++|.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r--~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDR--DQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred cceeEeeeeccCCceeeeeeecccc--ccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 3578999 55689999999994432 1122233455778899999999999998763 4567899999986 6777
Q ss_pred HHHHhhccC----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 668 QHLFEWHDH----------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 668 ~~l~~~~~~----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
+........ .....++..++.++.|+..||.++|+ .|..-+-+.+.+|+++.+.+++|...|.....
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeee
Confidence 765432221 12346789999999999999999999 89999999999999999999999888876554
Q ss_pred C
Q 003982 738 P 738 (782)
Q Consensus 738 ~ 738 (782)
.
T Consensus 444 ~ 444 (655)
T KOG3741|consen 444 Q 444 (655)
T ss_pred c
Confidence 3
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.46 E-value=2.6e-06 Score=85.47 Aligned_cols=142 Identities=15% Similarity=0.173 Sum_probs=87.4
Q ss_pred ceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCC--cceEEeEEEeCCeEEEEEEccCCC
Q 003982 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH--LVALLGYCINGSERLLVYEYMPRG 664 (782)
Q Consensus 587 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--I~~~~~~~~~~~~~~lv~e~~~~g 664 (782)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +++.+++....+...+|||+++|.
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 56899999999984 35567889876432 2345788999999986433 577788877777888999999886
Q ss_pred C-HH--------------H----HHHhhccCCCCCCCHHHHH-HHHHH----------HHH-HHHHHhhc-CCCCeEEcC
Q 003982 665 T-LA--------------Q----HLFEWHDHGYTPLTWKQRV-TIALD----------VAR-GVEYLHSL-AQQSFIHRD 712 (782)
Q Consensus 665 s-L~--------------~----~l~~~~~~~~~~l~~~~~~-~i~~q----------i~~-aL~~LH~~-~~~~ivHrD 712 (782)
+ +. . .+.+.+.-........... .+-.+ +.. ..++|... ....++|+|
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 3 11 1 1111221100111111100 11000 001 11222211 134678999
Q ss_pred CCCCCEEECCCCcEEEEeecccee
Q 003982 713 LKPSNILIGDDMRAKVADFGLVKN 736 (782)
Q Consensus 713 ikp~NIll~~~~~~kL~DfG~a~~ 736 (782)
+.|.||++++++ +.++||+.+..
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999888 99999998754
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.2e-07 Score=111.94 Aligned_cols=293 Identities=20% Similarity=0.197 Sum_probs=173.1
Q ss_pred CEEEEEeCCCCCCcccCccccCCccCceeecccCc--cCccCC-CCCCCCCCCEEeCCCCc-ccCCCCCCCCCCCCCCEE
Q 003982 67 RVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNN--IAGAIP-SLANATSLQDIYLDNNN-FTSVPTGCFDGLTNLQVL 142 (782)
Q Consensus 67 ~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~--l~~~~~-~l~~l~~L~~L~Ls~n~-l~~~~~~~~~~l~~L~~L 142 (782)
.+..+.+-++++. .++....+ +.|++|-+..|. +..... .|..++.|++|||++|. ++.+|.. +++|-+|++|
T Consensus 524 ~~rr~s~~~~~~~-~~~~~~~~-~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~-I~~Li~LryL 600 (889)
T KOG4658|consen 524 SVRRMSLMNNKIE-HIAGSSEN-PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSS-IGELVHLRYL 600 (889)
T ss_pred heeEEEEeccchh-hccCCCCC-CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChH-Hhhhhhhhcc
Confidence 5667777777765 33433333 368888888886 443333 48889999999999765 4455544 8889999999
Q ss_pred eccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccC
Q 003982 143 SLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQL 222 (782)
Q Consensus 143 ~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~ 222 (782)
+|++..+.. +|..+.+++.|.+|++..+.-...+|.....+++|++|.+..-..... . ..+
T Consensus 601 ~L~~t~I~~---LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~-~-----~~l---------- 661 (889)
T KOG4658|consen 601 DLSDTGISH---LPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSND-K-----LLL---------- 661 (889)
T ss_pred cccCCCccc---cchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccc-h-----hhH----------
Confidence 999999887 899999999999999998887666678788899999998876552200 0 000
Q ss_pred CCccccccccCCCCCcEEEeecccccCCCCCCCCCCCCC----EEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCC
Q 003982 223 GLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLF----DLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPY 298 (782)
Q Consensus 223 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~----~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 298 (782)
..+.++.+|+.+....... .....+..+..|. .+.+..+... ..+.++..+.+|+.|.+.++.+....
T Consensus 662 ------~el~~Le~L~~ls~~~~s~-~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~ 733 (889)
T KOG4658|consen 662 ------KELENLEHLENLSITISSV-LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIV 733 (889)
T ss_pred ------Hhhhcccchhhheeecchh-HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchhh
Confidence 1123466666666644443 1122222222222 3333333333 45667778888888888888876433
Q ss_pred CCCCCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcc
Q 003982 299 PLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKL 378 (782)
Q Consensus 299 ~~~~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~ 378 (782)
.......+.++ ....+..+... +-.....+.+.-..++|+.|++..+.
T Consensus 734 ~~~~~~~~~~~-------------------~f~~l~~~~~~-------------~~~~~r~l~~~~f~~~L~~l~l~~~~ 781 (889)
T KOG4658|consen 734 IEWEESLIVLL-------------------CFPNLSKVSIL-------------NCHMLRDLTWLLFAPHLTSLSLVSCR 781 (889)
T ss_pred cccccccchhh-------------------hHHHHHHHHhh-------------ccccccccchhhccCcccEEEEeccc
Confidence 32222221111 00001100000 00001122223334677788887777
Q ss_pred cccccCccccccccCCeEeccccccccc-CCccCCCCCCCCeEe
Q 003982 379 LAGNISPAYANLTSLKNLYLQQNNLTGP-IPDGLTKLASLQNLD 421 (782)
Q Consensus 379 l~~~~p~~~~~l~~L~~L~Ls~N~l~g~-~p~~~~~l~~L~~L~ 421 (782)
....+.+....+..+..+-+..+.+.+. .-...+.++++..+.
T Consensus 782 ~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~~l~~i~~~~ 825 (889)
T KOG4658|consen 782 LLEDIIPKLKALLELKELILPFNKLEGLRMLCSLGGLPQLYWLP 825 (889)
T ss_pred ccccCCCHHHHhhhcccEEecccccccceeeecCCCCceeEecc
Confidence 7666666666666666666666666655 233344444444333
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.7e-08 Score=99.20 Aligned_cols=45 Identities=33% Similarity=0.355 Sum_probs=28.2
Q ss_pred ccccccCCeEeccccccccc-CCccCCCCCCCCeEecCCCcCCCCC
Q 003982 387 YANLTSLKNLYLQQNNLTGP-IPDGLTKLASLQNLDVSNNNLSGKV 431 (782)
Q Consensus 387 ~~~l~~L~~L~Ls~N~l~g~-~p~~~~~l~~L~~L~ls~N~l~g~~ 431 (782)
+..++.+.-|+|+.|+|... --+++..+++|..|-+++|+|...+
T Consensus 220 se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~l 265 (418)
T KOG2982|consen 220 SEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSDPL 265 (418)
T ss_pred CCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccccc
Confidence 33444555666777766542 2355677788888888888876433
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.5e-06 Score=95.97 Aligned_cols=143 Identities=17% Similarity=0.197 Sum_probs=93.8
Q ss_pred cceeecccceEEEEEEeCCCcEEEEEEeccccCCh-----------------------------hhH------HHHHHHH
Q 003982 586 ANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGN-----------------------------KGL------SEFQAEI 630 (782)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------------------~~~------~~~~~E~ 630 (782)
.+.||..+.|+||+|+.++|+.||||+-++.-... +.. -+|.+|+
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 46799999999999999999999999765432110 000 1245566
Q ss_pred HHHHhc----CCCC------cceEEeEEEeCCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHH
Q 003982 631 AVLTKV----RHRH------LVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYL 700 (782)
Q Consensus 631 ~~l~~l----~h~n------I~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 700 (782)
+...++ +|-+ |++++ +.-.....++||||+|..+.+.-.- .+ ..++...+..-+ .++. +
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i-~~---~gi~~~~i~~~l---~~~~--~ 314 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAI-DK---RGISPHDILNKL---VEAY--L 314 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHH-HH---cCCCHHHHHHHH---HHHH--H
Confidence 655554 3444 44443 2334567999999999887765322 11 235555444333 3331 1
Q ss_pred hhcCCCCeEEcCCCCCCEEECC----CCcEEEEeeccceecCC
Q 003982 701 HSLAQQSFIHRDLKPSNILIGD----DMRAKVADFGLVKNAPD 739 (782)
Q Consensus 701 H~~~~~~ivHrDikp~NIll~~----~~~~kL~DfG~a~~~~~ 739 (782)
+.....|++|+|-+|.||+++. ++++.+.|||+......
T Consensus 315 ~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 315 EQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 1111269999999999999984 67899999999876654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.38 E-value=3.8e-06 Score=81.64 Aligned_cols=140 Identities=18% Similarity=0.211 Sum_probs=92.5
Q ss_pred HHhcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHH---------HHHHHHHHHhcCCC---CcceEE
Q 003982 578 QVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSE---------FQAEIAVLTKVRHR---HLVALL 645 (782)
Q Consensus 578 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~---------~~~E~~~l~~l~h~---nI~~~~ 645 (782)
....+|.+.+++......-|.+-+. +|+.+++|....... ...+. ..+++..+.+++.. ....++
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~--r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~y 104 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENR--RPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPY 104 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhh--hHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccce
Confidence 3456788888888777666666665 789999998765431 11122 23445545555322 223322
Q ss_pred eEEE-----eCCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE
Q 003982 646 GYCI-----NGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI 720 (782)
Q Consensus 646 ~~~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll 720 (782)
.+.+ -....+++|||++|..+.+... +++ .++..+++++..+|+ .|+.|+|.+|.|+++
T Consensus 105 l~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~---------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv 168 (229)
T PF06176_consen 105 LAAEKKIFRYTSSYVLLMEYIEGVELNDIED---------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLV 168 (229)
T ss_pred eeeeeeeccceeEEEEEEEEecCeecccchh---------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEE
Confidence 2222 1234568999999988766531 222 245667788999998 899999999999999
Q ss_pred CCCCcEEEEeeccceec
Q 003982 721 GDDMRAKVADFGLVKNA 737 (782)
Q Consensus 721 ~~~~~~kL~DfG~a~~~ 737 (782)
++++ ++++||+..+..
T Consensus 169 ~~~~-i~iID~~~k~~~ 184 (229)
T PF06176_consen 169 SNNG-IRIIDTQGKRMS 184 (229)
T ss_pred ECCc-EEEEECcccccc
Confidence 8654 999999876543
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 782 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-30 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-29 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-25 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-24 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-22 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-21 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-21 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-20 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-15 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 5e-05 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-15 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 3e-15 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 7e-05 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-15 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-14 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 9e-14 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 9e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-13 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-13 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-13 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-13 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-13 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-13 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-12 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-12 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-12 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-12 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-12 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 4e-12 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-10 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-08 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-12 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-12 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-12 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-12 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-12 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-12 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-11 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-11 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-11 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-11 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-11 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-11 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-11 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-11 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-11 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-11 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-11 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-11 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-11 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-11 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-10 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-10 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-10 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-10 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-10 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-10 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-10 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 7e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 9e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 9e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-09 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-09 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-09 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-09 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-09 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-09 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-09 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-09 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-09 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-09 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 4e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-09 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 9e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 9e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-08 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-08 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-08 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-08 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-08 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-08 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-08 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-08 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-08 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-08 | ||
| 3rfs_A | 272 | Design Of A Binding Scaffold Based On Variable Lymp | 6e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 7e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-08 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-08 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 8e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 8e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 9e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 9e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-08 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-07 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-07 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-07 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-07 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-07 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-07 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-07 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-07 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-07 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-07 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-07 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-07 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-07 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-07 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-07 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-07 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-07 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-07 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-07 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-07 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-07 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-07 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-07 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-07 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-07 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-07 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-07 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-07 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-07 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-07 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-07 | ||
| 3rfj_A | 279 | Design Of A Binding Scaffold Based On Variable Lymp | 4e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-07 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-07 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-07 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 8e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 8e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 8e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 8e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 8e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 8e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 8e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 8e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 8e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 9e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 9e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 9e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 9e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 9e-07 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 9e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 9e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 9e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-06 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-06 | ||
| 3m18_A | 251 | Crystal Structure Of Variable Lymphocyte Receptor V | 2e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-06 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-06 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-06 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-06 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-06 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-06 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-06 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-06 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-06 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-06 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-06 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-06 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-06 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-06 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-06 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-06 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-06 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-06 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-06 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-06 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-06 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-06 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-06 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-06 | ||
| 4g8a_A | 635 | Crystal Structure Of Human Tlr4 Polymorphic Variant | 3e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-06 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-06 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-06 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-06 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-06 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-06 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-06 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-06 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-06 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-06 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-06 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-06 | ||
| 3m19_A | 251 | Crystal Structure Of Variable Lymphocyte Receptor V | 4e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-06 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-06 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-06 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-06 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 6e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-06 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-06 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-06 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-06 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 7e-06 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 7e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 7e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 8e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 8e-06 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 8e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 8e-06 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 8e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 8e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 8e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 8e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-06 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 8e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 8e-06 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 8e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 8e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 9e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 9e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 9e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-06 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-06 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 9e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 9e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 9e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 9e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 9e-06 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 9e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 9e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 9e-06 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-05 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-05 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-05 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-05 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-05 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-05 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-05 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-05 | ||
| 2z66_A | 306 | Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 A | 1e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-05 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-05 | ||
| 3fxi_A | 605 | Crystal Structure Of The Human Tlr4-Human Md-2-E.Co | 1e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-05 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-05 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-05 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-05 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-05 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-05 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-05 | ||
| 2o6r_A | 177 | Structural Diversity Of The Hagfish Variable Lympho | 2e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-05 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-05 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-05 | ||
| 2o6s_A | 208 | Structural Diversity Of The Hagfish Variable Lympho | 5e-05 | ||
| 3v44_A | 407 | Crystal Structure Of The N-Terminal Fragment Of Zeb | 6e-05 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 7e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-05 | ||
| 3kj4_A | 286 | Structure Of Rat Nogo Receptor Bound To 1d9 Antagon | 8e-05 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-05 | ||
| 2z63_A | 570 | Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 A | 8e-05 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 8e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 8e-05 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-05 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 9e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-04 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-04 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-04 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-04 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-04 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-04 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-04 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-04 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-04 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-04 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 3e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-04 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 3e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-04 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-04 | ||
| 2ft3_A | 332 | Crystal Structure Of The Biglycan Dimer Core Protei | 3e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 3e-04 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 3e-04 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-04 | ||
| 3a79_B | 562 | Crystal Structure Of Tlr2-Tlr6-Pam2csk4 Complex Len | 3e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-04 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 4e-04 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 4e-04 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-04 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 4e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-04 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-04 | ||
| 3j0a_A | 844 | Homology Model Of Human Toll-Like Receptor 5 Fitted | 4e-04 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-04 | ||
| 3oja_B | 597 | Crystal Structure Of Lrim1APL1C COMPLEX Length = 59 | 5e-04 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-04 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-04 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 5e-04 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 6e-04 | ||
| 1p8t_A | 285 | Crystal Structure Of Nogo-66 Receptor Length = 285 | 6e-04 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-04 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-04 | ||
| 1ozn_A | 285 | 1.5a Crystal Structure Of The Nogo Receptor Ligand | 6e-04 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 7e-04 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 7e-04 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-04 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-04 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 8e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-04 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 8e-04 | ||
| 3o6n_A | 390 | Crystal Structure Of Apl1 Leucine-Rich Repeat Domai | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3RFJ|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 279 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3M18|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R2.1 In Complex With Hen Egg Lysozyme Length = 251 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4G8A|A Chain A, Crystal Structure Of Human Tlr4 Polymorphic Variant D299g And T399i In Complex With Md-2 And Lps Length = 635 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3M19|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R5.1 Length = 251 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2Z66|A Chain A, Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 306 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3FXI|A Chain A, Crystal Structure Of The Human Tlr4-Human Md-2-E.Coli Lps Ra Complex Length = 605 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2O6R|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors B61 Length = 177 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2O6S|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors B59 Length = 208 | Back alignment and structure |
|
| >pdb|3V44|A Chain A, Crystal Structure Of The N-Terminal Fragment Of Zebrafish Tlr5 Length = 407 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2Z63|A Chain A, Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 570 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2FT3|A Chain A, Crystal Structure Of The Biglycan Dimer Core Protein Length = 332 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3A79|B Chain B, Crystal Structure Of Tlr2-Tlr6-Pam2csk4 Complex Length = 562 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3J0A|A Chain A, Homology Model Of Human Toll-Like Receptor 5 Fitted Into An Electron Microscopy Single Particle Reconstruction Length = 844 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3OJA|B Chain B, Crystal Structure Of Lrim1APL1C COMPLEX Length = 597 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3O6N|A Chain A, Crystal Structure Of Apl1 Leucine-Rich Repeat Domain Length = 390 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 289 bits (742), Expect = 9e-92
Identities = 76/214 (35%), Positives = 124/214 (57%), Gaps = 7/214 (3%)
Query: 548 SELHSQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTK 607
S+ + + +S +L + + + L + T+NF ++G G FG VY G L DG K
Sbjct: 6 SKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAK 65
Query: 608 IAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLA 667
+A+KR ++G+ EF+ EI L+ RH HLV+L+G+C +E +L+Y+YM G L
Sbjct: 66 VALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123
Query: 668 QHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAK 727
+HL+ D ++W+QR+ I + ARG+ YLH+ ++ IHRD+K NIL+ ++ K
Sbjct: 124 RHLYG-SDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPK 179
Query: 728 VADFGLVKNAPDGKYS-VETRLAGTFGYLAPEYA 760
+ DFG+ K + + + T + GT GY+ PEY
Sbjct: 180 ITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYF 213
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 285 bits (732), Expect = 4e-90
Identities = 90/208 (43%), Positives = 120/208 (57%), Gaps = 7/208 (3%)
Query: 557 DVSDRHLFEG--GNVAI-SIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRM 613
DV E G + S+ L+ +DNFS NILGRGGFG VY G L DGT +AVKR+
Sbjct: 3 DVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL 62
Query: 614 ESN-TMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFE 672
+ T G + +FQ E+ +++ HR+L+ L G+C+ +ERLLVY YM G++A L E
Sbjct: 63 KEERTQGGE--LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 120
Query: 673 WHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732
PL W +R IAL ARG+ YLH IHRD+K +NIL+ ++ A V DFG
Sbjct: 121 -RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 179
Query: 733 LVKNAPDGKYSVETRLAGTFGYLAPEYA 760
L K V T + GT G++APEY
Sbjct: 180 LAKLMDYKDTHVTTAVRGTIGHIAPEYL 207
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 279 bits (716), Expect = 4e-88
Identities = 75/210 (35%), Positives = 112/210 (53%), Gaps = 25/210 (11%)
Query: 572 SIEVLRQVTDNFSE------ANILGRGGFGVVYGGELPDGTKIAVKRMES--NTMGNKGL 623
S L+ VT+NF E N +G GGFGVVY G + + T +AVK++ + + +
Sbjct: 16 SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELK 74
Query: 624 SEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTW 683
+F EI V+ K +H +LV LLG+ +G + LVY YMP G+L L G PL+W
Sbjct: 75 QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL--DGTPPLSW 132
Query: 684 KQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743
R IA A G+ +LH + IHRD+K +NIL+ + AK++DFGL + + +
Sbjct: 133 HMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 744 -VETRLAGTFGYLAPEYAGKHWMILCQMTG 772
+ +R+ GT Y+APE + G
Sbjct: 190 VMTSRIVGTTAYMAPEA----------LRG 209
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 5e-66
Identities = 97/429 (22%), Positives = 171/429 (39%), Gaps = 81/429 (18%)
Query: 21 TTTSLGDDGSVMLKLAQSL--QNLPSDWSSTSSTGYCEWTGINCDNSNRVTTISLAKSGL 78
+ SL + ++ L +NL DWSS + C + G+ C + +VT+I L+ L
Sbjct: 6 PSQSLYREIHQLISFKDVLPDKNLLPDWSSNKN--PCTFDGVTCRDD-KVTSIDLSSKPL 62
Query: 79 S---GTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSV--PTGCF 133
+ +S + SLT LE+L ++I G++ + SL + L N+ +
Sbjct: 63 NVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSL 122
Query: 134 DGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPD---FFDSFSNLQ 190
+ L+ L++S N P K SL L + +I G D L+
Sbjct: 123 GSCSGLKFLNVSSNTLDFPGKVS-GGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELK 181
Query: 191 NLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGP 250
+L +S N +G + +S L + + N F+
Sbjct: 182 HLAISGNKISGDVD--------------------------VSRCVNLEFLDVSSNNFSTG 215
Query: 251 IPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFP-SKVQKVS 309
IP L C +L L + N+L+G ++ + L +++ +N+ GP P P +Q +S
Sbjct: 216 IPFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLS 275
Query: 310 LDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRI 369
L N F G+ + D G C +
Sbjct: 276 LAENKF------TGE---------------------IPDFLSGA----------CDT--L 296
Query: 370 ITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIP-DGLTKLASLQNLDVSNNNLS 428
++L+ G + P + + + L++L L NN +G +P D L K+ L+ LD+S N S
Sbjct: 297 TGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFS 356
Query: 429 GKVPDFGSN 437
G++P+ +N
Sbjct: 357 GELPESLTN 365
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 3e-59
Identities = 105/385 (27%), Positives = 156/385 (40%), Gaps = 66/385 (17%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNN 123
+ + + + ++ + LSG S IS+ T+L+ L+ N G IP SLQ + L N
Sbjct: 221 DCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP-LPLKSLQYLSLAEN 279
Query: 124 NFT-SVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIP-D 181
FT +P L L LS N + P + L +L + + N G +P D
Sbjct: 280 KFTGEIPDFLSGACDTLTGLDLSGN-HFYG-AVPPFFGSCSLLESLALSSNNFSGELPMD 337
Query: 182 FFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSG-------- 233
L+ L LS+N F+G LP S NL + L LS SG
Sbjct: 338 TLLKMRGLKVLDLSFNEFSGELPESLT-----NLSASLLTLDLSSNN--FSGPILPNLCQ 390
Query: 234 --MTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQ 290
L++++L N FTG IP LS C L L L N L+G +P+S+ SL L ++ L
Sbjct: 391 NPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLW 450
Query: 291 NNKLQGPYPLF---PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILS 347
N L+G P ++ + LD N+ G+ +
Sbjct: 451 LNMLEGEIPQELMYVKTLETLILDFNDL------TGE---------------------IP 483
Query: 348 DSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPI 407
N C+ + I+L+N L G I L +L L L N+ +G I
Sbjct: 484 SGL-SN----------CTN--LNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNI 530
Query: 408 PDGLTKLASLQNLDVSNNNLSGKVP 432
P L SL LD++ N +G +P
Sbjct: 531 PAELGDCRSLIWLDLNTNLFNGTIP 555
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 8e-55
Identities = 87/373 (23%), Positives = 153/373 (41%), Gaps = 27/373 (7%)
Query: 69 TTISLAKSGLSGTLSPE-ISSLTQLETLSFQMNNIAGAIP-SLANAT-SLQDIYLDNNNF 125
+++L+ + SG L + + + L+ L N +G +P SL N + SL + L +NNF
Sbjct: 321 ESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNF 380
Query: 126 T-SVPTG-CFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFF 183
+ + C + LQ L L +N P L+ + L +L++ + G IP
Sbjct: 381 SGPILPNLCQNPKNTLQELYLQNN-GFT-GKIPPTLSNCSELVSLHLSFNYLSGTIPSSL 438
Query: 184 DSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLSGTL-DVLSGMTQLRQVW 241
S S L++L+L N G +P ++ L ++ L +G + LS T L +
Sbjct: 439 GSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDL--TGEIPSGLSNCTNLNWIS 496
Query: 242 LHKNQFTGPIP-DLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPL 300
L N+ TG IP + + E+L L L +N +G +PA + +L+ + L N G P
Sbjct: 497 LSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIP- 555
Query: 301 FPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWP 360
K S + + G +
Sbjct: 556 ------------AAMFKQSGKIAA--NFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRS 601
Query: 361 FVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNL 420
N+ +++ G+ SP + N S+ L + N L+G IP + + L L
Sbjct: 602 EQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFIL 661
Query: 421 DVSNNNLSGKVPD 433
++ +N++SG +PD
Sbjct: 662 NLGHNDISGSIPD 674
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 9e-55
Identities = 82/381 (21%), Positives = 150/381 (39%), Gaps = 56/381 (14%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEI---SSLTQLETLSFQMNNIAGAIPSLANATSLQDIYL 120
N + + L+ + +SG +L+ L+ N I+G + ++ +L+ + +
Sbjct: 149 KLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD-VSRCVNLEFLDV 207
Query: 121 DNNNFT-SVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLI 179
+NNF+ +P + LQ L +S N L+ F ++ T L L + + G I
Sbjct: 208 SSNNFSTGIPF--LGDCSALQHLDISGN-KLS-GDFSRAISTCTELKLLNISSNQFVGPI 263
Query: 180 PDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQ 239
P +LQ L L+ N FTG +P + + L
Sbjct: 264 PPL--PLKSLQYLSLAENKFTGEIPDFLSGA-----------------------CDTLTG 298
Query: 240 VWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVIS-LPALLNISLQNNKLQGP 297
+ L N F G +P C L L+L N +G +P + + L + L N+ G
Sbjct: 299 LDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGE 358
Query: 298 YPLF----PSKVQKVSLDHNNFCKN-SSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEG 352
P + + + L NNF + + + L L +
Sbjct: 359 LPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELY-----------LQN---- 403
Query: 353 NNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLT 412
N P + +++++L+ L+G I + +L+ L++L L N L G IP L
Sbjct: 404 NGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELM 463
Query: 413 KLASLQNLDVSNNNLSGKVPD 433
+ +L+ L + N+L+G++P
Sbjct: 464 YVKTLETLILDFNDLTGEIPS 484
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 7e-54
Identities = 101/410 (24%), Positives = 170/410 (41%), Gaps = 63/410 (15%)
Query: 37 QSLQNLPSDWSSTSSTGYCEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLS 96
SL+ L D S+ S +G + D + ++++ + +SG + +S LE L
Sbjct: 151 NSLEVL--DLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLD 206
Query: 97 FQMNNIAGAIPSLANATSLQDIYLDNNNFT-SVPTGCFDGLTNLQVLSLSDNPNLAPWPF 155
NN + IP L + ++LQ + + N + T L++L++S N P
Sbjct: 207 VSSNNFSTGIPFLGDCSALQHLDISGNKLSGDFSRAIS-TCTELKLLNISSN-QFV-GPI 263
Query: 156 PNELTKSTSLTTLYMDNANIFGLIPD-FFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQ 213
P SL L + G IPD + L L LS N+F G++P F S ++
Sbjct: 264 PPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLE 321
Query: 214 NLWMNDQQLGLSGTL--DVLSGMTQLRQVWLHKNQFTGPIPD-LSKC-ESLFDLSLRDNQ 269
+L ++ SG L D L M L+ + L N+F+G +P+ L+ SL L L N
Sbjct: 322 SLALSSNNF--SGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNN 379
Query: 270 LTGVVPASV--ISLPALLNISLQNNKLQGPYPLFP---SKVQKVSLDHNNFCKNSSDAGK 324
+G + ++ L + LQNN G P S++ + L N
Sbjct: 380 FSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFN----------- 428
Query: 325 PCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNIS 384
++G + P+ L ++ + L +L G I
Sbjct: 429 ----------YLSGTI--PSSLGSL-----------------SKLRDLKLWLNMLEGEIP 459
Query: 385 PAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDF 434
+ +L+ L L N+LTG IP GL+ +L + +SNN L+G++P +
Sbjct: 460 QELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKW 509
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 2e-53
Identities = 85/385 (22%), Positives = 155/385 (40%), Gaps = 28/385 (7%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLT-QLETLSFQMNNIAGAIPS---LANATSLQDIY 119
+ + L+ + SG L +++L+ L TL NN +G I +LQ++Y
Sbjct: 341 KMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELY 400
Query: 120 LDNNNFT-SVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGL 178
L NN FT +P + L L LS N L+ P+ L + L L + + G
Sbjct: 401 LQNNGFTGKIPPT-LSNCSELVSLHLSFN-YLS-GTIPSSLGSLSKLRDLKLWLNMLEGE 457
Query: 179 IPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLSGTL-DVLSGMTQ 236
IP L+ L L +N+ TG +P+ + +++ + +++ +L +G + + +
Sbjct: 458 IPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRL--TGEIPKWIGRLEN 515
Query: 237 LRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQ 295
L + L N F+G IP L C SL L L N G +PA++ + N +
Sbjct: 516 LAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKI----AANFIA 571
Query: 296 GPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNA 355
G ++ H + + + +
Sbjct: 572 GKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNP---------CNIT--SRVY 620
Query: 356 CDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLA 415
+ G ++ ++++ +L+G I ++ L L L N+++G IPD + L
Sbjct: 621 GGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLR 680
Query: 416 SLQNLDVSNNNLSGKVPDFGSNVKF 440
L LD+S+N L G++P S +
Sbjct: 681 GLNILDLSSNKLDGRIPQAMSALTM 705
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 4e-53
Identities = 82/380 (21%), Positives = 140/380 (36%), Gaps = 61/380 (16%)
Query: 69 TTISLAKSGLSGTLS-PEISSLTQLETLSFQMNNIAGAIPS----LANATSLQDIYLDNN 123
++++ + L L LE L N+I+GA L+ + + N
Sbjct: 129 KFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGN 188
Query: 124 NFT-SVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDF 182
+ V NL+ L +S N N + P L ++L L + + G
Sbjct: 189 KISGDVDVS---RCVNLEFLDVSSN-NFST-GIP-FLGDCSALQHLDISGNKLSGDFSRA 242
Query: 183 FDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTL--DVLSGMTQLRQV 240
+ + L+ L +S N F G +P KS +Q L + + + +G + + L +
Sbjct: 243 ISTCTELKLLNISSNQFVGPIPPLPLKS-LQYLSLAENKF--TGEIPDFLSGACDTLTGL 299
Query: 241 WLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVIS-LPALLNISLQNNKLQGPY 298
L N F G +P C L L+L N +G +P + + L + L N+ G
Sbjct: 300 DLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGEL 359
Query: 299 PLF----PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNN 354
P + + + L NNF G IL + +
Sbjct: 360 PESLTNLSASLLTLDLSSNNFS------GP--------------------ILPNLCQ--- 390
Query: 355 ACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKL 414
+ + + L N G I P +N + L +L+L N L+G IP L L
Sbjct: 391 ---------NPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSL 441
Query: 415 ASLQNLDVSNNNLSGKVPDF 434
+ L++L + N L G++P
Sbjct: 442 SKLRDLKLWLNMLEGEIPQE 461
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 9e-51
Identities = 93/382 (24%), Positives = 155/382 (40%), Gaps = 59/382 (15%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDN 122
+ + ++ + S + P + + L+ L N ++G +++ T L+ + + +
Sbjct: 198 RCVNLEFLDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISS 256
Query: 123 NNFT-SVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELT-KSTSLTTLYMDNANIFGLIP 180
N F +P L +LQ LSL++N P+ L+ +LT L + + +G +P
Sbjct: 257 NQFVGPIPPL---PLKSLQYLSLAEN-KFT-GEIPDFLSGACDTLTGLDLSGNHFYGAVP 311
Query: 181 DFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQV 240
FF S S L++L LS NNF+G LP L M L+ +
Sbjct: 312 PFFGSCSLLESLALSSNNFSGELPMDT-----------------------LLKMRGLKVL 348
Query: 241 WLHKNQFTGPIPD-LSKC-ESLFDLSLRDNQLTGVVPASV--ISLPALLNISLQNNKLQG 296
L N+F+G +P+ L+ SL L L N +G + ++ L + LQNN G
Sbjct: 349 DLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTG 408
Query: 297 PYPLFP---SKVQKVSLDHNNFCKNSSDAGK--PCDPQVTTLLQIAGDMGYPAILSDSWE 351
P S++ + L N +G ++ L + L
Sbjct: 409 KIPPTLSNCSELVSLHLSFNYL------SGTIPSSLGSLSKLRDL--------KLW---- 450
Query: 352 GNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGL 411
N P + T+ L L G I +N T+L + L N LTG IP +
Sbjct: 451 LNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWI 510
Query: 412 TKLASLQNLDVSNNNLSGKVPD 433
+L +L L +SNN+ SG +P
Sbjct: 511 GRLENLAILKLSNNSFSGNIPA 532
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 1e-46
Identities = 88/392 (22%), Positives = 144/392 (36%), Gaps = 68/392 (17%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPS--LANATSLQDIYLD 121
+ ++++ + G + P L L+ LS N G IP +L + L
Sbjct: 245 TCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLS 302
Query: 122 NNNFT-SVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNE-LTKSTSLTTLYMDNANIFGLI 179
N+F +VP F + L+ L+LS N N + P + L K L L + G +
Sbjct: 303 GNHFYGAVPP-FFGSCSLLESLALSSN-NFSG-ELPMDTLLKMRGLKVLDLSFNEFSGEL 359
Query: 180 PD-FFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWM-----NDQQLGLSGTL-DVLS 232
P+ + ++L L LS NNF+G + + ++ L N G +G + LS
Sbjct: 360 PESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNN----GFTGKIPPTLS 415
Query: 233 GMTQLRQVWLHKNQFTGPIP-DLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQN 291
++L + L N +G IP L L DL L N L G +P ++ + L + L
Sbjct: 416 NCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDF 475
Query: 292 NKLQGPYPLF---PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSD 348
N L G P + + +SL +N L+
Sbjct: 476 NDLTGEIPSGLSNCTNLNWISLSNNR-------------------------------LTG 504
Query: 349 SWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIP 408
P + + L+N +GNI + SL L L N G IP
Sbjct: 505 EI---------PKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIP 555
Query: 409 DGLTKLASLQNLDVSNNNLSGKVPDFGSNVKF 440
+ K + ++ N ++GK + N
Sbjct: 556 AAMFKQS----GKIAANFIAGKRYVYIKNDGM 583
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 1e-46
Identities = 81/394 (20%), Positives = 139/394 (35%), Gaps = 81/394 (20%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDN 122
N + + ++ L+ + LSGT+ + SL++L L +N + G IP L +L+ + LD
Sbjct: 416 NCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDF 475
Query: 123 NNFT-SVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPD 181
N+ T +P+ TNL +SLS+N L P + + +L L + N + G IP
Sbjct: 476 NDLTGEIPS-GLSNCTNLNWISLSNN-RLTG-EIPKWIGRLENLAILKLSNNSFSGNIPA 532
Query: 182 FFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVW 241
+L L L+ N F G++PA+
Sbjct: 533 ELGDCRSLIWLDLNTNLFNGTIPAAMF-----KQSGK----------------------- 564
Query: 242 LHKNQFTGPIP-DLSKCESLFDLSLRDN--QLTGVVPASVISLPALLNISLQNNKLQGPY 298
+ N G + + N + G+ + L ++ + G
Sbjct: 565 IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHT 624
Query: 299 PLFPSKVQKVS---LDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNA 355
+ + +N G + P +
Sbjct: 625 SPTFDNNGSMMFLDMSYNMLS---------------------GYI--PKEIGS------- 654
Query: 356 CDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLA 415
+ +NL + ++G+I +L L L L N L G IP ++ L
Sbjct: 655 --------MPY--LFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALT 704
Query: 416 SLQNLDVSNNNLSGKVPDFGSNVKFTVS--PGNP 447
L +D+SNNNLSG +P+ G F + NP
Sbjct: 705 MLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNP 738
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 4e-59
Identities = 55/225 (24%), Positives = 96/225 (42%), Gaps = 34/225 (15%)
Query: 548 SELHSQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTK 607
H SSG V + E L + + RG FG V+ +
Sbjct: 3 HHHHHHSSG------------VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEY 49
Query: 608 IAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS----ERLLVYEYMPR 663
+AVK +K + + E+ L ++H +++ +G G+ + L+ + +
Sbjct: 50 VAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEK 106
Query: 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHS-------LAQQSFIHRDLKPS 716
G+L+ L + ++W + IA +ARG+ YLH + + HRD+K
Sbjct: 107 GSLSDFL---KAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSK 160
Query: 717 NILIGDDMRAKVADFGLVKNAPDGKYSVET-RLAGTFGYLAPEYA 760
N+L+ +++ A +ADFGL GK + +T GT Y+APE
Sbjct: 161 NVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVL 205
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 2e-56
Identities = 72/302 (23%), Positives = 132/302 (43%), Gaps = 19/302 (6%)
Query: 27 DDGSVMLKLAQSLQNLP--SDWSSTSSTGYCEWTGINCD---NSNRVTTISLAKSGLSGT 81
D +L++ + L N S W T+ W G+ CD + RV + L+ L
Sbjct: 6 QDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKP 65
Query: 82 --LSPEISSLTQLETLSFQ-MNNIAGAIP-SLANATSLQDIYLDNNNFT-SVPTGCFDGL 136
+ +++L L L +NN+ G IP ++A T L +Y+ + N + ++P +
Sbjct: 66 YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDF-LSQI 124
Query: 137 TNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNL-QNLRLS 195
L L S N L+ P ++ +L + D I G IPD + SFS L ++ +S
Sbjct: 125 KTLVTLDFSYN-ALSG-TLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTIS 182
Query: 196 YNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTL-DVLSGMTQLRQVWLHKNQFTGPIPDL 254
N TG +P +FA ++ + ++ L G + +++ L KN + +
Sbjct: 183 RNRLTGKIPPTFANLNLAFVDLSRNML--EGDASVLFGSDKNTQKIHLAKNSLAFDLGKV 240
Query: 255 SKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFP--SKVQKVSLDH 312
++L L LR+N++ G +P + L L ++++ N L G P + + +
Sbjct: 241 GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYAN 300
Query: 313 NN 314
N
Sbjct: 301 NK 302
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 4e-45
Identities = 76/343 (22%), Positives = 128/343 (37%), Gaps = 70/343 (20%)
Query: 108 SLANATSLQD----IYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKST 163
L N T+L N + V + L LS P+P P+ L
Sbjct: 17 DLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLP 76
Query: 164 SLTTLYMDNAN-IFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQL 222
L LY+ N + G IP + L L +++ N +G++P
Sbjct: 77 YLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDF---------------- 120
Query: 223 GLSGTLDVLSGMTQLRQVWLHKNQFTGPIP-DLSKCESLFDLSLRDNQLTGVVPASVISL 281
LS + L + N +G +P +S +L ++ N+++G +P S S
Sbjct: 121 --------LSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSF 172
Query: 282 PALLN-ISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDM 340
L +++ N+L G P ++L + +N + GD
Sbjct: 173 SKLFTSMTISRNRLTGK---IPPTFANLNLAFVDLSRN----------------MLEGDA 213
Query: 341 GYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQ 400
+ G++ I+LA LA ++ +L L L+
Sbjct: 214 --SVLF-----GSDK------------NTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRN 253
Query: 401 NNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKFTVS 443
N + G +P GLT+L L +L+VS NNL G++P G+ +F VS
Sbjct: 254 NRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVS 296
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 4e-19
Identities = 44/121 (36%), Positives = 60/121 (49%), Gaps = 9/121 (7%)
Query: 326 CDPQ-VTTLLQIAGDMGYPAILSDSWEGNNACDG-WPFVTCSQ----GRIITINLANKLL 379
C+PQ LLQI D+G P LS + C+ W V C R+ ++L+ L
Sbjct: 3 CNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL 62
Query: 380 AG--NISPAYANLTSLKNLYLQ-QNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGS 436
I + ANL L LY+ NNL GPIP + KL L L +++ N+SG +PDF S
Sbjct: 63 PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS 122
Query: 437 N 437
Sbjct: 123 Q 123
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 7e-15
Identities = 29/142 (20%), Positives = 55/142 (38%), Gaps = 8/142 (5%)
Query: 65 SNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNN 123
S T+++++++ L+G + P ++L L + N + G + + Q I+L N
Sbjct: 173 SKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKN 231
Query: 124 NFT-SVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDF 182
+ + NL L L +N + P LT+ L +L + N+ G IP
Sbjct: 232 SLAFDLGK--VGLSKNLNGLDLRNN-RIYG-TLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287
Query: 183 FDSFSNLQNLRLSYNNFTGSLP 204
+ + N P
Sbjct: 288 G-NLQRFDVSAYANNKCLCGSP 308
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 3e-53
Identities = 56/173 (32%), Positives = 91/173 (52%), Gaps = 7/173 (4%)
Query: 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646
+G G FG V+ E G+ +AVK + + ++EF E+A++ ++RH ++V +G
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGY-TPLTWKQRVTIALDVARGVEYLHSLAQ 705
+V EY+ RG+L + L H G L ++R+++A DVA+G+ YLH+
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLL---HKSGAREQLDERRRLSMAYDVAKGMNYLHNRN- 157
Query: 706 QSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
+HR+LK N+L+ KV DFGL + S AGT ++APE
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS-KSAAGTPEWMAPE 209
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 4e-51
Identities = 39/174 (22%), Positives = 70/174 (40%), Gaps = 13/174 (7%)
Query: 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646
L G ++ G G I VK ++ + +F E L H +++ +LG
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 647 YCINGSERLL--VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA 704
C + + +MP G+L L H+ + Q V ALD+ARG+ +LH+L
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVL---HEGTNFVVDQSQAVKFALDMARGMAFLHTL- 130
Query: 705 QQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
+ L +++I +DM A+++ + ++APE
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADV------KFSFQSPGRMYAPAWVAPE 178
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 3e-50
Identities = 57/187 (30%), Positives = 90/187 (48%), Gaps = 17/187 (9%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
++GRG FGVV + +A+K++ES + F E+ L++V H +
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE----RKAFIVELRQLSRVNHPN 62
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTP-LTWKQRVTIALDVARGVEY 699
+V L G C+N LV EY G+L L H P T ++ L ++GV Y
Sbjct: 63 IVKLYGACLN--PVCLVMEYAEGGSLYNVL---HGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMR-AKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
LHS+ ++ IHRDLKP N+L+ K+ DFG + + T G+ ++APE
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTHMTNNKGSAAWMAPE 173
Query: 759 -YAGKHW 764
+ G ++
Sbjct: 174 VFEGSNY 180
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 1e-49
Identities = 53/200 (26%), Positives = 80/200 (40%), Gaps = 32/200 (16%)
Query: 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAV--LTKVR 637
DN ++GRG +G VY G L D +AVK F E + + +
Sbjct: 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR-----QNFINEKNIYRVPLME 65
Query: 638 HRHLVALLGYCINGS-----ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALD 692
H ++ + + E LLV EY P G+L ++L W +A
Sbjct: 66 HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL------HTSDWVSSCRLAHS 119
Query: 693 VARGVEYLHS------LAQQSFIHRDLKPSNILIGDDMRAKVADFGL-------VKNAPD 739
V RG+ YLH+ + + HRDL N+L+ +D ++DFGL P
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179
Query: 740 GKYSVETRLAGTFGYLAPEY 759
+ + GT Y+APE
Sbjct: 180 EEDNAAISEVGTIRYMAPEV 199
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 2e-48
Identities = 56/195 (28%), Positives = 95/195 (48%), Gaps = 23/195 (11%)
Query: 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRM-----ESNTMGNKGLSEFQAEIAVLT 634
+ +G+GGFG+V+ G + D + +A+K + E T + EFQ E+ +++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 635 KVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVA 694
+ H ++V L G N +V E++P G L L D P+ W ++ + LD+A
Sbjct: 79 NLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRL---LDKA-HPIKWSVKLRLMLDIA 132
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILI-----GDDMRAKVADFGLVKNAPDGKYSVETRLA 749
G+EY+ + +HRDL+ NI + + AKVADFGL + + + L
Sbjct: 133 LGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV----SGLL 187
Query: 750 GTFGYLAPE-YAGKH 763
G F ++APE +
Sbjct: 188 GNFQWMAPETIGAEE 202
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 6e-48
Identities = 54/182 (29%), Positives = 82/182 (45%), Gaps = 20/182 (10%)
Query: 587 NILGRGGFGVVYGGELPDGTKIAVKRM--ESNTMGNKGLSEFQAEIAVLTKVRHRHLVAL 644
I+G GGFG VY G ++AVK + + ++ + + E + ++H +++AL
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 645 LGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA 704
G C+ LV E+ G L + L + V A+ +ARG+ YLH A
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVL---SGK---RIPPDILVNWAVQIARGMNYLHDEA 125
Query: 705 QQSFIHRDLKPSNILIGDDMR--------AKVADFGLVKNAPDGKYSVETRLAGTFGYLA 756
IHRDLK SNILI + K+ DFGL + AG + ++A
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK---MSAAGAYAWMA 182
Query: 757 PE 758
PE
Sbjct: 183 PE 184
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-47
Identities = 42/176 (23%), Positives = 76/176 (43%), Gaps = 14/176 (7%)
Query: 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646
++G+G FG VY G G +A++ ++ L F+ E+ + RH ++V +G
Sbjct: 39 ELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ 706
C++ ++ TL + D L + IA ++ +G+ YLH+ +
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVV---RDAK-IVLDVNKTRQIAQEIVKGMGYLHA---K 149
Query: 707 SFIHRDLKPSNILIGDDMRAKVADFGLVK----NAPDGKYSVETRLAGTFGYLAPE 758
+H+DLK N+ D+ + + DFGL + G +LAPE
Sbjct: 150 GILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPE 204
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 3e-46
Identities = 57/172 (33%), Positives = 89/172 (51%), Gaps = 13/172 (7%)
Query: 589 LGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYC 648
+G G FG VY G+ G +AVK + + L F+ E+ VL K RH +++ +GY
Sbjct: 32 IGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 649 INGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS 707
+L +V ++ +L HL H T K+ + IA ARG++YLH+ +S
Sbjct: 90 TA--PQLAIVTQWCEGSSLYHHL---HASE-TKFEMKKLIDIARQTARGMDYLHA---KS 140
Query: 708 FIHRDLKPSNILIGDDMRAKVADFGLVK-NAPDGKYSVETRLAGTFGYLAPE 758
IHRDLK +NI + +D K+ DFGL + +L+G+ ++APE
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 192
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-45
Identities = 49/186 (26%), Positives = 77/186 (41%), Gaps = 23/186 (12%)
Query: 587 NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
+LG+G FG G + +K + + F E+ V+ + H +++ +
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 646 GYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQ 705
G + EY+ GTL + + W QRV+ A D+A G+ YLHS
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGII---KSMD-SQYPWSQRVSFAKDIASGMAYLHS--- 126
Query: 706 QSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR-------------LAGTF 752
+ IHRDL N L+ ++ VADFGL + D K E + G
Sbjct: 127 MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186
Query: 753 GYLAPE 758
++APE
Sbjct: 187 YWMAPE 192
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 2e-43
Identities = 73/410 (17%), Positives = 132/410 (32%), Gaps = 83/410 (20%)
Query: 67 RVTTISLAKSGLSGTLSPEISSLTQLETL---------SFQMNNIAGAIP-SLANATSLQ 116
++ L + + S + L + L S + ++ S L+
Sbjct: 273 QLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLE 332
Query: 117 DIYLDNNNFTSVPTGCFDGLTNLQVLSLSDN----PNLAPWPFPNELTKSTSLTTLYMDN 172
+ +++N+ + + F GL NL+ LSLS++ L F + + L L +
Sbjct: 333 HLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVS--LAHSPLHILNLTK 390
Query: 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLS 232
I + D F +L+ L L N L
Sbjct: 391 NKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQ-----------------------EWR 427
Query: 233 GMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGV--VPASVISLPALLNISL 289
G+ + +++L N++ + + SL L LR L V P+ L L + L
Sbjct: 428 GLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDL 487
Query: 290 QNNKLQG-PYPLFPS--KVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAIL 346
NN + + K++ + L HNN L
Sbjct: 488 SNNNIANINDDMLEGLEKLEILDLQHNN-------------------------------L 516
Query: 347 SDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGP 406
+ W+ N F+ + +NL + + +L LK + L NNL
Sbjct: 517 ARLWKHANPGGPIYFLK-GLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTL 575
Query: 407 IPDGLTKLASLQNLDVSNNNLSGKVPD-FGSNVK----FTVSPGNPFIGT 451
SL++L++ N ++ FG + + NPF T
Sbjct: 576 PASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMR-FNPFDCT 624
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-40
Identities = 65/389 (16%), Positives = 125/389 (32%), Gaps = 83/389 (21%)
Query: 68 VTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFT 126
+T ++L + L + + +QL +L N I+ P L+ + L +N +
Sbjct: 27 ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86
Query: 127 SVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSF 186
+ F TNL L L N ++ N K +L TL + + +
Sbjct: 87 QLSDKTFAFCTNLTELHLMSN-SIQ-KIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQL 144
Query: 187 SNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQ 246
NLQ L LS N + + L+++ L NQ
Sbjct: 145 ENLQELLLSNNKIQALKSEELD----------------------IFANSSLKKLELSSNQ 182
Query: 247 FTGPIPD-LSKCESLFDLSLRDNQLTGVVPASV---ISLPALLNISLQNNKLQGPYP--- 299
P LF L L + QL + + ++ ++ N+SL N++L
Sbjct: 183 IKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTF 242
Query: 300 --LFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACD 357
L + + + L +NN +D+
Sbjct: 243 LGLKWTNLTMLDLSYNNLNVVGNDS----------------------------------- 267
Query: 358 GWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQN---------NLTGPIP 408
F Q + L + S + L +++ L L+++ +L
Sbjct: 268 ---FAWLPQ--LEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDD 322
Query: 409 DGLTKLASLQNLDVSNNNLSGKVPDFGSN 437
L L++L++ +N++ G + +
Sbjct: 323 FSFQWLKCLEHLNMEDNDIPGIKSNMFTG 351
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 3e-39
Identities = 54/353 (15%), Positives = 114/353 (32%), Gaps = 78/353 (22%)
Query: 89 LTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDN 147
T + L+ N + + + L + + N + + L L+VL+L N
Sbjct: 24 PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83
Query: 148 P--NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPA 205
L+ T+LT L++ + +I + + F NL L LS+N + +
Sbjct: 84 ELSQLS----DKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLG 139
Query: 206 SFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD---LSKCESLFD 262
+ + L+++ L N+ + + SL
Sbjct: 140 TQ------------------------VQLENLQELLLSNNKIQALKSEELDIFANSSLKK 175
Query: 263 LSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYP------LFPSKVQKVSLDHNNFC 316
L L NQ+ P ++ L + L N +L L + ++ +SL ++
Sbjct: 176 LELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLS 235
Query: 317 KNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLAN 376
S+ F+ + ++L+
Sbjct: 236 TTSNTT--------------------------------------FLGLKWTNLTMLDLSY 257
Query: 377 KLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSG 429
L + ++A L L+ +L+ NN+ L L +++ L++ +
Sbjct: 258 NNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQ 310
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 5e-39
Identities = 69/399 (17%), Positives = 125/399 (31%), Gaps = 72/399 (18%)
Query: 63 DNSNRVTTISLAKSGLSGTLSPEIS---SLTQLETLSFQMNNIAGAIPSL---ANATSLQ 116
R+ + L L +L+ ++ + T + LS + ++ + T+L
Sbjct: 192 HAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLT 251
Query: 117 DIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN---- 172
+ L NN V F L L+ L N N+ F + L ++ L +
Sbjct: 252 MLDLSYNNLNVVGNDSFAWLPQLEYFFLEYN-NIQ-HLFSHSLHGLFNVRYLNLKRSFTK 309
Query: 173 -----ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLSG 226
A++ + F L++L + N+ G F +++ L +++ L
Sbjct: 310 QSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRT 369
Query: 227 -TLDVLSGM--TQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVIS-L 281
T + + + L + L KN+ + D S L L L N++ + L
Sbjct: 370 LTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGL 429
Query: 282 PALLNISLQNNKLQGPYP-LFP--SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAG 338
+ I L NK F +Q++ L
Sbjct: 430 ENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVAL----------------------- 466
Query: 339 DMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYL 398
D P + ++L+N +A L L+ L L
Sbjct: 467 ---------------KNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDL 511
Query: 399 QQNNLT--------GPIPDGLTKLASLQNLDVSNNNLSG 429
Q NNL G L L+ L L++ +N
Sbjct: 512 QHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDE 550
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 8e-39
Identities = 78/394 (19%), Positives = 129/394 (32%), Gaps = 56/394 (14%)
Query: 62 CDNSNRVTTISLAKSGLSGTLSPEISSL--TQLETLSFQMNNIAGAIP-SLANATSLQDI 118
+ + L+ + + S E+ + L+ L N I P L +
Sbjct: 141 QVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGL 200
Query: 119 YLDNNNFTSVPT---GCFDGLTNLQVLSLSDN--PNLAPWPFPNELTKSTSLTTLYMDNA 173
+L+N T T+++ LSLS++ + F K T+LT L +
Sbjct: 201 FLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLG--LKWTNLTMLDLSYN 258
Query: 174 NIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSG 233
N+ + D F L+ L YNN S + N+ + L L + S
Sbjct: 259 NLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSL--HGLFNV----RYLNLKRSFTKQS- 311
Query: 234 MTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNN 292
+ + L L++ DN + G+ L L +SL N+
Sbjct: 312 --------ISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNS 363
Query: 293 KLQGPYP-------LFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAI 345
L S + ++L N K SDA + L D+G
Sbjct: 364 FTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWL-GHLEVL-----DLG---- 413
Query: 346 LSDSWEGNN---ACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNN 402
N G + I I L+ ++A + SL+ L L++
Sbjct: 414 ------LNEIGQELTGQEWRGLEN--IFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVA 465
Query: 403 LTG--PIPDGLTKLASLQNLDVSNNNLSGKVPDF 434
L P L +L LD+SNNN++ D
Sbjct: 466 LKNVDSSPSPFQPLRNLTILDLSNNNIANINDDM 499
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-38
Identities = 65/374 (17%), Positives = 113/374 (30%), Gaps = 81/374 (21%)
Query: 69 TTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTS 127
++L + LS + T L L N+I +L + L +N +S
Sbjct: 76 KVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSS 135
Query: 128 VPTGCFDGLTNLQVLSLSDNP--NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDS 185
G L NLQ L LS+N L ++ ++SL L + + I P F +
Sbjct: 136 TKLGTQVQLENLQELLLSNNKIQALKSEEL--DIFANSSLKKLELSSNQIKEFSPGCFHA 193
Query: 186 FSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKN 245
L L L+ SL T +R + L +
Sbjct: 194 IGRLFGLFLNNVQLGPSLTEKLCLEL---------------------ANTSIRNLSLSNS 232
Query: 246 QFTGPIPDL---SKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFP 302
Q + K +L L L N L V S LP L L+ N +Q
Sbjct: 233 QLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQ------- 285
Query: 303 SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFV 362
L ++ + + +
Sbjct: 286 ------HLFSHSLHGLFN-------------------------VRYLNLKRS-------- 306
Query: 363 TCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDV 422
+++ L ++ L L++L ++ N++ G + T L +L+ L +
Sbjct: 307 ------FTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSL 360
Query: 423 SNNNLSGKVPDFGS 436
SN+ S + +
Sbjct: 361 SNSFTSLRTLTNET 374
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 4e-37
Identities = 58/293 (19%), Positives = 104/293 (35%), Gaps = 30/293 (10%)
Query: 36 AQSLQNLPS------DWSSTSSTGYCEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSL 89
+ L + S TS T ++ +S + ++L K+ +S S S L
Sbjct: 346 SNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSP-LHILNLTKNKISKIESDAFSWL 404
Query: 90 TQLETLSFQMNNIAGAIP--SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDN 147
LE L +N I + ++ +IYL N + + F + +LQ L L
Sbjct: 405 GHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRV 464
Query: 148 PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASF 207
P+ +LT L + N NI + D + L+ L L +NN
Sbjct: 465 ALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNN--------- 515
Query: 208 AKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLR 266
+ LW + G + L G++ L + L N F + L + L
Sbjct: 516 ----LARLWKHANPGGP---IYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLG 568
Query: 267 DNQLTGVVPASVISLPALLNISLQNNKLQGPYP----LFPSKVQKVSLDHNNF 315
N L + + + +L +++LQ N + + ++ + N F
Sbjct: 569 LNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPF 621
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-29
Identities = 57/382 (14%), Positives = 107/382 (28%), Gaps = 83/382 (21%)
Query: 69 TTISLAKSGLSGTLSPEISSLTQLETLSFQMNNI------AGAIPSLANATSLQDIYLDN 122
+++ + + G S + L L+ LS + SLA+ + L + L
Sbjct: 332 EHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAH-SPLHILNLTK 390
Query: 123 NNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDF 182
N + + + F L +L+VL L N + E ++ +Y+ L +
Sbjct: 391 NKISKIESDAFSWLGHLEVLDLGLN-EIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNS 449
Query: 183 FDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWL 242
F +LQ L L + + + L + L
Sbjct: 450 FALVPSLQRLMLRRVALKN----------------------VDSSPSPFQPLRNLTILDL 487
Query: 243 HKNQFTGPIPD-LSKCESLFDLSLRDNQLT--------GVVPASVISLPALLNISLQNNK 293
N D L E L L L+ N L G + L L ++L++N
Sbjct: 488 SNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNG 547
Query: 294 LQG-PYPLFP--SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSW 350
P +F +++ + L NN +
Sbjct: 548 FDEIPVEVFKDLFELKIIDLGLNNLNTLPASV---------------------------- 579
Query: 351 EGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYA-NLTSLKNLYLQQNNLTGPIPD 409
F + ++NL L+ + +L L ++ N
Sbjct: 580 ----------FNNQV--SLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627
Query: 410 GLTKLASLQNLDVSNNNLSGKV 431
+ + + LS
Sbjct: 628 IAWFVNWINETHTNIPELSSHY 649
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 7e-28
Identities = 48/336 (14%), Positives = 95/336 (28%), Gaps = 98/336 (29%)
Query: 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172
S + + T VP TN+ VL+L+ N
Sbjct: 4 VSHEVADCSHLKLTQVPDDLP---TNITVLNLTHN------------------------- 35
Query: 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLS 232
+ L F +S L +L + +N + P
Sbjct: 36 -QLRRLPAANFTRYSQLTSLDVGFNTISKLEPELC------------------------Q 70
Query: 233 GMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQN 291
+ L+ + L N+ + + C +L +L L N + + + L+ + L +
Sbjct: 71 KLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSH 130
Query: 292 NKLQG-PYPLFP--SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSD 348
N L +Q++ L +N S+
Sbjct: 131 NGLSSTKLGTQVQLENLQELLLSNNKIQALKSEE-------------------------- 164
Query: 349 SWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIP 408
+ + + L++ + + + L L+L L +
Sbjct: 165 ------------LDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLT 212
Query: 409 DGLT---KLASLQNLDVSNNNLSGKVPDFGSNVKFT 441
+ L S++NL +SN+ LS +K+T
Sbjct: 213 EKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWT 248
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-18
Identities = 43/275 (15%), Positives = 86/275 (31%), Gaps = 91/275 (33%)
Query: 162 STSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQ 221
+ S + + +PD D +N+ L L++N A+F
Sbjct: 3 TVSHEVADCSHLKLTQ-VPD--DLPTNITVLNLTHNQLRRLPAANF-------------- 45
Query: 222 LGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVIS 280
+ +QL + + N + P+ K L L+L+ N+L+ + +
Sbjct: 46 ----------TRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAF 95
Query: 281 LPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDM 340
L + L +N +Q + +N F K +
Sbjct: 96 CTNLTELHLMSNSIQ-------------KIKNNPFVKQKN-------------------- 122
Query: 341 GYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQ 400
+IT++L++ L+ L +L+ L L
Sbjct: 123 ----------------------------LITLDLSHNGLSSTKLGTQVQLENLQELLLSN 154
Query: 401 NNLTGPIPDGLT--KLASLQNLDVSNNNLSGKVPD 433
N + + L +SL+ L++S+N + P
Sbjct: 155 NKIQALKSEELDIFANSSLKKLELSSNQIKEFSPG 189
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 2e-43
Identities = 57/392 (14%), Positives = 115/392 (29%), Gaps = 60/392 (15%)
Query: 58 TGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQD 117
++ + + + ++ + + NNI ++ T L+
Sbjct: 151 DYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQ 210
Query: 118 IYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFG 177
Y+ N+ F + N + + LT + + N
Sbjct: 211 FYMGNSPFVAENICEAWENENSEYAQQYKT-------EDLKWDNLKDLTDVEVYNCPNLT 263
Query: 178 LIPDFFDSFSNLQNLRLSYNNFTG---------SLPASFAKSDIQNLWMNDQQLGLSGTL 228
+P F + +Q + ++ N +L + IQ +++ L
Sbjct: 264 KLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVE 323
Query: 229 DVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNIS 288
L M +L + NQ G +P L L+L NQ+T + + N+S
Sbjct: 324 TSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLS 383
Query: 289 LQNNKLQG-PYPLFPSKV---QKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPA 344
+NKL+ P V + +N P DP + +
Sbjct: 384 FAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINV-------- 435
Query: 345 ILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLT 404
+INL+N ++ ++ + L ++ L N LT
Sbjct: 436 -------------------------SSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT 470
Query: 405 G-------PIPDGLTKLASLQNLDVSNNNLSG 429
+ L ++D+ N L+
Sbjct: 471 EIPKNSLKDENENFKNTYLLTSIDLRFNKLTK 502
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-39
Identities = 52/427 (12%), Positives = 117/427 (27%), Gaps = 79/427 (18%)
Query: 22 TTSLGDDGSVMLKLAQSLQNLPSDWSSTSSTGYCEWT------------GINCDNSNRVT 69
T D + ++ +L + W G++ +++ RVT
Sbjct: 25 TAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVT 84
Query: 70 TISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAI-----PSLANATSLQDIYLDNNN 124
+SL G SG + I LT+LE L+ + ++ S + +
Sbjct: 85 GLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMH 144
Query: 125 FTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFD 184
+ ++ N + + T + + NI +
Sbjct: 145 YQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVM 203
Query: 185 SFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDV-LSGMTQLRQVWLH 243
+ L+ + + F ++ N + T D+ + L V ++
Sbjct: 204 RLTKLRQFYMGNSPFVAENICEAWEN------ENSEYAQQYKTEDLKWDNLKDLTDVEVY 257
Query: 244 KNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFP 302
+P L + +++ N+ AL + +
Sbjct: 258 NCPNLTKLPTFLKALPEMQLINVACNRGISG-EQLKDDWQALADAPVGEK---------- 306
Query: 303 SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFV 362
+Q + + +NN + +
Sbjct: 307 --IQIIYIGYNNL----------------KTFPVETSLQ--------------------- 327
Query: 363 TCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDV 422
+ + + L G + PA+ + L +L L N +T + ++NL
Sbjct: 328 KMKK--LGMLECLYNQLEGKL-PAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSF 384
Query: 423 SNNNLSG 429
++N L
Sbjct: 385 AHNKLKY 391
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-36
Identities = 45/371 (12%), Positives = 93/371 (25%), Gaps = 98/371 (26%)
Query: 79 SGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTN 138
+ + + + +L L N + G +P+ + L + L N T +P
Sbjct: 319 TFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQ 378
Query: 139 LQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN-------ANIFGLIPDFFDSFSNLQN 191
++ LS + N L P + + ++ + F + N+ +
Sbjct: 379 VENLSFAHN-KLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSS 437
Query: 192 LRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTG-- 249
+ LS N + F S + L + L N T
Sbjct: 438 INLSNNQISKFPKELF------------------------STGSPLSSINLMGNMLTEIP 473
Query: 250 ------PIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPS 303
+ L + LR N+LT L + L
Sbjct: 474 KNSLKDENENFKNTYLLTSIDLRFNKLT--------KLSD----DFRATTLP-------- 513
Query: 304 KVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVT 363
+ + L +N+F + + N
Sbjct: 514 YLVGIDLSYNSF---------------SKFPTQPLNSSTLKGFGIR---NQ--------- 546
Query: 364 CSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVS 423
+ SL L + N++ + + + ++ LD+
Sbjct: 547 --------RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIK 595
Query: 424 NNNLSGKVPDF 434
+N +
Sbjct: 596 DNPNISIDLSY 606
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-32
Identities = 39/233 (16%), Positives = 80/233 (34%), Gaps = 23/233 (9%)
Query: 83 SPEISSLTQLETLSFQMNNIAGAI--------PSLANATSLQDIYLDNNNFTSVPTGCFD 134
+ S++ + + F N I P+ ++ I L NN + P F
Sbjct: 395 IFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFS 454
Query: 135 GLTNLQVLSLSDN-----PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDF-FDSFSN 188
+ L ++L N P + + LT++ + + L DF +
Sbjct: 455 TGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPY 514
Query: 189 LQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLG----LSGTL-DVLSGMTQLRQVWL 242
L + LSYN+F+ P S ++ + +Q+ + ++ L Q+ +
Sbjct: 515 LVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQI 573
Query: 243 HKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQ 295
N + + ++ L ++DN + + V L +K Q
Sbjct: 574 GSNDIRK-VNE-KITPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-14
Identities = 39/306 (12%), Positives = 79/306 (25%), Gaps = 73/306 (23%)
Query: 155 FPNELTKSTSLTTLYMDNANIFGLIPDF---FDSFSNLQNLRLSYNNFTGSLPASFAKSD 211
N LT + A I D+ + + L S F A++ +
Sbjct: 8 KDNALTDDAIVPIKLSRTA---EYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNK 64
Query: 212 IQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQL 270
++W Q G+S L+ ++ + L +G +PD + + L L+L +
Sbjct: 65 ELDMWGA--QPGVS-----LNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGE 117
Query: 271 TG----VVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPC 326
P + + + Q + + + L + +
Sbjct: 118 KVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK 177
Query: 327 DPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPA 386
++T I + + +S A
Sbjct: 178 SSRITLKDT-----------------------------------QIGQLSNNITF-VSKA 201
Query: 387 YANLTSLKNLYLQQNNLTGP-------------------IPDGLTKLASLQNLDVSNNNL 427
LT L+ Y+ + L L +++V N
Sbjct: 202 VMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPN 261
Query: 428 SGKVPD 433
K+P
Sbjct: 262 LTKLPT 267
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 7e-12
Identities = 22/101 (21%), Positives = 37/101 (36%), Gaps = 8/101 (7%)
Query: 349 SWEGNNACDGW---PFVTC-SQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLT 404
+W N D W P V+ S GR+ ++L +G + A LT L+ L L +
Sbjct: 59 NWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEK 118
Query: 405 GP----IPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKFT 441
P G++ S + + D+ F+
Sbjct: 119 VNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFS 159
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 8/56 (14%), Positives = 23/56 (41%), Gaps = 7/56 (12%)
Query: 389 NLTSLKNLYLQQNNLTG-------PIPDGLTKLASLQNLDVSNNNLSGKVPDFGSN 437
+++ + + N + P+ K ++ ++++SNN +S + S
Sbjct: 400 SVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFST 455
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 2e-05
Identities = 8/50 (16%), Positives = 15/50 (30%), Gaps = 1/50 (2%)
Query: 389 NLTSLKNLYLQQNNLTG-PIPDGLTKLASLQNLDVSNNNLSGKVPDFGSN 437
++NL N L P ++ + +D S N +
Sbjct: 375 FTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDP 424
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 4e-43
Identities = 50/218 (22%), Positives = 87/218 (39%), Gaps = 22/218 (10%)
Query: 553 QSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKR 612
+S D+ ++ G + + V R + +G+G +G V+ G+ G K+AVK
Sbjct: 9 ESLRDLIEQSQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKV 67
Query: 613 MESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSER----LLVYEYMPRGTLAQ 668
+ + + EI +RH +++ + I G+ L+ +Y G+L
Sbjct: 68 FFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYD 124
Query: 669 HLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSF-----IHRDLKPSNILIGDD 723
+L L K + +A G+ +LH+ + HRDLK NIL+ +
Sbjct: 125 YL---KST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN 178
Query: 724 MRAKVADFGLVKNAPDGKYSVE---TRLAGTFGYLAPE 758
+AD GL V+ GT Y+ PE
Sbjct: 179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-42
Identities = 45/198 (22%), Positives = 77/198 (38%), Gaps = 26/198 (13%)
Query: 575 VLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAE--IAV 632
+ R V + + +G+G +G V+ G G +AVK S + E +
Sbjct: 2 MQRTVARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD-----EKSWFRETELYN 55
Query: 633 LTKVRHRHLVALLGYCINGS----ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVT 688
+RH +++ + + + L+ Y G+L +L L +
Sbjct: 56 TVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLT---TLDTVSCLR 109
Query: 689 IALDVARGVEYLHSLAQQSF-----IHRDLKPSNILIGDDMRAKVADFGL---VKNAPDG 740
I L +A G+ +LH + HRDLK NIL+ + + +AD GL + +
Sbjct: 110 IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQ 169
Query: 741 KYSVETRLAGTFGYLAPE 758
GT Y+APE
Sbjct: 170 LDVGNNPRVGTKRYMAPE 187
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-41
Identities = 69/381 (18%), Positives = 127/381 (33%), Gaps = 39/381 (10%)
Query: 69 TTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTS 127
+ L++ + SL+ L TL N I + + +SLQ + N S
Sbjct: 55 QVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS 114
Query: 128 VPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFS 187
+ L L+ L+++ N + + P + T+L L + + I +
Sbjct: 115 LENFPIGHLKTLKELNVAHN-LIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLH 173
Query: 188 NLQN----LRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLH 243
+ L LS N P +F + + L + + L+ + G+ L L
Sbjct: 174 QMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLV 233
Query: 244 KNQFTG----PIPDLSKCESLFDLSLRDNQLT------GVVPASVISLPALLNISLQNNK 293
+F D S E L +L++ + +L + L + + SL +
Sbjct: 234 LGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVT 293
Query: 294 LQGPYPL-FPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEG 352
++ + Q + L + F K + T +G
Sbjct: 294 IERVKDFSYNFGWQHLELVNCKF--GQFPTLKLKSLKRLTFTSN--------------KG 337
Query: 353 NNACDGWPFVTCSQGRIITINLANKL-LAGNISPAYANLTSLKNLYLQQNNLTGPIPDGL 411
NA + V + ++ N L G S + TSLK L L N + +
Sbjct: 338 GNA---FSEVDLPSLEFLDLSR-NGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNF 392
Query: 412 TKLASLQNLDVSNNNLSGKVP 432
L L++LD ++NL
Sbjct: 393 LGLEQLEHLDFQHSNLKQMSE 413
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-37
Identities = 60/384 (15%), Positives = 118/384 (30%), Gaps = 44/384 (11%)
Query: 69 TTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP--SLANATSLQDIYLDNNNFT 126
+ ++ L+ + I L L+ L+ N I +N T+L+ + L +N
Sbjct: 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162
Query: 127 SVPTGCFDGLTNLQV----LSLSDNP--NLAPWPFPNELTKSTSLTTLYMDNANIFG-LI 179
S+ L + + L LS NP + P F K L L + N ++
Sbjct: 163 SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-----KEIRLHKLTLRNNFDSLNVM 217
Query: 180 PDFFDSFSNLQNLRLSYNNFTG---------SLPASFAKSDIQNLWMNDQQLGLSGTLDV 230
+ L+ RL F S I+ + L +D+
Sbjct: 218 KTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDL 277
Query: 231 LSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQ 290
+ +T + L + D S L L + + + L +L ++
Sbjct: 278 FNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVNCKFGQFPT---LKLKSLKRLTFT 333
Query: 291 NNKLQGPYPLFP-SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDS 349
+NK + ++ + L N + D T+L + LS
Sbjct: 334 SNKGGNAFSEVDLPSLEFLDLSRNGL--SFKGCCSQSDFGTTSLKYL--------DLS-- 381
Query: 350 WEGNNACDGWPFVTCSQGRIITINLANKLLAGNISP-AYANLTSLKNLYLQQNNLTGPIP 408
N ++ ++ + L + +L +L L + +
Sbjct: 382 ---FNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 438
Query: 409 DGLTKLASLQNLDVSNNNLSGKVP 432
L+SL+ L ++ N+
Sbjct: 439 GIFNGLSSLEVLKMAGNSFQENFL 462
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-34
Identities = 69/406 (16%), Positives = 122/406 (30%), Gaps = 69/406 (16%)
Query: 67 RVTTISLAKSGLSGTLSPE-ISSLTQLETLSFQMNNIAG-------AIPSLANATSLQDI 118
R+ ++L + S + I L LE + +L +L
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260
Query: 119 YLD---NNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANI 175
+ + F+ LTN+ SL F + L + N
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY----NFGWQHLELVN-CK 315
Query: 176 FGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTL-DVLSGM 234
FG P +L+ L + N + S ++ L ++ L G G
Sbjct: 316 FGQFP--TLKLKSLKRLTFTSNKGGNAFSEVDLPS-LEFLDLSRNGLSFKGCCSQSDFGT 372
Query: 235 TQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVI-SLPALLNISLQNNK 293
T L+ + L N + E L L + + L + SV SL L+ + + +
Sbjct: 373 TSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 432
Query: 294 LQGPYP-LFP--SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSW 350
+ + +F S ++ + + N+F + P L
Sbjct: 433 TRVAFNGIFNGLSSLEVLKMAGNSF----QENFLPDIFTELRNLT--------------- 473
Query: 351 EGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDG 410
++L+ L A+ +L+SL+ L + NN
Sbjct: 474 --------------------FLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFP 513
Query: 411 LTKLASLQNLDVSNNNLSGKVPD-----FGSNVKFTVSPGNPFIGT 451
L SLQ LD S N++ S ++ N F T
Sbjct: 514 YKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLT-QNDFACT 558
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-33
Identities = 67/387 (17%), Positives = 125/387 (32%), Gaps = 62/387 (16%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLE----TLSFQMNNIAGAIPSLANATSLQDIY 119
N + + L+ + + ++ L Q+ +L +N + P L +
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLT 206
Query: 120 LDNNNFT-SVPTGCFDGLTNLQVLSLSDN----PNLAPWPFPNELTKSTSLTTLYMD--- 171
L NN + +V C GL L+V L + L +LT
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 172 NANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVL 231
I D F+ +N+ + L S+ Q+L + + + G TL +
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYN-FGWQHLELVNCKFGQFPTLKLK 325
Query: 232 SGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLT--GVVPASVISLPALLNISL 289
S L+++ N+ SL L L N L+ G S +L + L
Sbjct: 326 S----LKRLTFTSNKGGNAFS-EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380
Query: 290 QNNKLQGPYPLF--PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILS 347
N + F +++ + H+N L
Sbjct: 381 SFNGVITMSSNFLGLEQLEHLDFQHSN-------------------------------LK 409
Query: 348 DSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPI 407
+ F++ +I +++++ + + L+SL+ L + N+
Sbjct: 410 QMS------EFSVFLSLRN--LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENF 461
Query: 408 -PDGLTKLASLQNLDVSNNNLSGKVPD 433
PD T+L +L LD+S L P
Sbjct: 462 LPDIFTELRNLTFLDLSQCQLEQLSPT 488
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-31
Identities = 60/377 (15%), Positives = 113/377 (29%), Gaps = 77/377 (20%)
Query: 65 SNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNN 123
+ L+ + L S S +L+ L I + + + L + L N
Sbjct: 27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86
Query: 124 NFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYM-DNANIFGLIPDF 182
S+ G F GL++LQ L + NLA + +L L + N +P++
Sbjct: 87 PIQSLALGAFSGLSSLQKLVAVET-NLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144
Query: 183 FDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWL 242
F + +NL++L LS N + + + + L LS
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDL--RVLHQMPLLNLSLDLSL---------------- 186
Query: 243 HKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFP 302
N P K L L+LR+N + V + I L ++
Sbjct: 187 --NPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQ-------GLAGLEVH------- 230
Query: 303 SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFV 362
L F + +A +G +
Sbjct: 231 ------RLVLGEFR------------------------NEGNLEKFD---KSALEGLCNL 257
Query: 363 TCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDV 422
T + R+ ++ +I + LT++ + L + + Q+L++
Sbjct: 258 TIEEFRLAYLDY----YLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLEL 311
Query: 423 SNNNLSGKVPDFGSNVK 439
N ++K
Sbjct: 312 VNCKFGQFPTLKLKSLK 328
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-31
Identities = 55/393 (13%), Positives = 101/393 (25%), Gaps = 93/393 (23%)
Query: 68 VTTISLAKSGLSGTLSPEI-SSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFT 126
+ LA ++ + LT + + S I + + Q + L N F
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVNCKFG 317
Query: 127 SVPTGC-------------------FDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTT 167
PT L +L+ L LS N +TSL
Sbjct: 318 QFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKY 377
Query: 168 LYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGT 227
L + + + +F L++L ++N S
Sbjct: 378 LDLSFNGVITMSSNFL-GLEQLEHLDFQHSNLKQMSEFSV-------------------- 416
Query: 228 LDVLSGMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVIS-LPALL 285
+ L + + + SL L + N + + L L
Sbjct: 417 ---FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT 473
Query: 286 NISLQNNKLQG-PYPLFP--SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGY 342
+ L +L+ F S +Q +++ HNNF + K + L
Sbjct: 474 FLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCL-NSLQVL--------- 523
Query: 343 PAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANL-TSLKNLYLQQN 401
+ + + + + +SL L L QN
Sbjct: 524 ------------------------------DYSLNHIMTSKKQELQHFPSSLAFLNLTQN 553
Query: 402 NLTG--PIPDGLTKLASLQNLDVSNNNLSGKVP 432
+ L + + L V + P
Sbjct: 554 DFACTCEHQSFLQWIKDQRQLLVEVERMECATP 586
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-30
Identities = 55/374 (14%), Positives = 110/374 (29%), Gaps = 65/374 (17%)
Query: 81 TLSPEISSLTQLETLSFQMNNIAGAIP--SLANATSLQDIYLDNNNFTS------VPTGC 132
+ P +L L+ + N + + + L+ L F +
Sbjct: 191 FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
Query: 133 FDGLTNLQVLSLSDN-PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQN 191
+GL NL + + + T++++ + + I + + Q+
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQH 308
Query: 192 LRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQ--FTG 249
L L F ++ L + G + + + L + L +N F G
Sbjct: 309 LELVNCKFGQFPTLKL--KSLKRLTFTSNKGGNAFSE---VDLPSLEFLDLSRNGLSFKG 363
Query: 250 PIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG--PYPLF--PSK 304
SL L L N + + ++ + L L ++ Q++ L+ + +F
Sbjct: 364 CCSQSDFGTTSLKYLDLSFNGVITM-SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 422
Query: 305 VQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTC 364
+ + + H + + F
Sbjct: 423 LIYLDISHTHTRVAFNGI--------------------------------------FNGL 444
Query: 365 SQGRIITINLANKLLAGNISPAY-ANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVS 423
S + + +A N P L +L L L Q L P L+SLQ L++S
Sbjct: 445 SS--LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMS 502
Query: 424 NNNLSGKVPDFGSN 437
+NN
Sbjct: 503 HNNFFSLDTFPYKC 516
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-25
Identities = 42/213 (19%), Positives = 71/213 (33%), Gaps = 12/213 (5%)
Query: 61 NCDNSNRVTTISLAKSGLSGTLSPEI-SSLTQLETLSFQMNNIAGAIPS-LANATSLQDI 118
N ++ + S L + SL L L + A +SL+ +
Sbjct: 391 NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 450
Query: 119 YLDNNNFT-SVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFG 177
+ N+F + F L NL L LS L P +SL L M + N F
Sbjct: 451 KMAGNSFQENFLPDIFTELRNLTFLDLSQC-QLE-QLSPTAFNSLSSLQVLNMSHNNFFS 508
Query: 178 LIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK--SDIQNLWMNDQQLGLSGTLDV---LS 232
L + ++LQ L S N+ S S + L + + T + L
Sbjct: 509 LDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQND--FACTCEHQSFLQ 566
Query: 233 GMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSL 265
+ RQ+ + + P + + L++
Sbjct: 567 WIKDQRQLLVEVERMECATPSDKQGMPVLSLNI 599
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-23
Identities = 53/315 (16%), Positives = 103/315 (32%), Gaps = 38/315 (12%)
Query: 132 CFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQN 191
C + + N+ + N P P S L + + L F SF LQ
Sbjct: 3 CVEVVPNITYQCMELNFYKIPDNLP------FSTKNLDLSFNPLRHLGSYSFFSFPELQV 56
Query: 192 LRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGP 250
L LS ++ S + L + + S L SG++ L+++ +
Sbjct: 57 LDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI-QSLALGAFSGLSSLQKLVAVETNLASL 115
Query: 251 IPD-LSKCESLFDLSLRDNQLTGVVPASVIS-LPALLNISLQNNKLQGPYP-----LFPS 303
+ ++L +L++ N + S L L ++ L +NK+Q Y L
Sbjct: 116 ENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQM 175
Query: 304 KVQKVSLD--HNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPF 361
+ +SLD N A K + ++ L + + +
Sbjct: 176 PLLNLSLDLSLNPMNFIQPGAFK--EIRLHKL-----TLRNNFDSLNVMKTC-------I 221
Query: 362 VTCSQGRIITINLANKLLAGNIS-PAYANLTSLKNLYLQQNNLT------GPIPDGLTKL 414
+ + + L GN+ + L L NL +++ L I D L
Sbjct: 222 QGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCL 281
Query: 415 ASLQNLDVSNNNLSG 429
++ + + + +
Sbjct: 282 TNVSSFSLVSVTIER 296
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 5e-15
Identities = 36/263 (13%), Positives = 72/263 (27%), Gaps = 74/263 (28%)
Query: 179 IPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLR 238
IPD + + +NL LS+N SF +L+
Sbjct: 22 IPD--NLPFSTKNLDLSFNPLRHLGSYSF------------------------FSFPELQ 55
Query: 239 QVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG- 296
+ L + + L L L N + + + L +L + L
Sbjct: 56 VLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASL 115
Query: 297 -PYPLFP-SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNN 354
+P+ ++++++ HN ++ P S+
Sbjct: 116 ENFPIGHLKTLKELNVAHNLI----------------QSFKL------PEYFSNL----- 148
Query: 355 ACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKN----LYLQQNNLTGPIPDG 410
+ ++L++ + L + L L N + P
Sbjct: 149 ------------TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGA 196
Query: 411 LTKLASLQNLDVSNNNLSGKVPD 433
++ L L + NN S V
Sbjct: 197 FKEI-RLHKLTLRNNFDSLNVMK 218
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 4e-14
Identities = 32/218 (14%), Positives = 61/218 (27%), Gaps = 49/218 (22%)
Query: 234 MTQLRQVWLHKNQFTGPIP-DLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNN 292
+ + L N L L L ++ + + SL L + L N
Sbjct: 27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86
Query: 293 KLQGPYPL---FPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDS 349
+Q S +QK+ N +
Sbjct: 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFP--------------------------- 119
Query: 350 WEGNNACDGWPFVTCSQGRIITINLA-NKLLAGNISPAYANLTSLKNLYLQQNNLTGPIP 408
+ +N+A N + + + ++NLT+L++L L N +
Sbjct: 120 -----------IGHLK--TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 166
Query: 409 DGLTKLASLQN----LDVSNNNLSGKVPDFGSNVKFTV 442
L L + LD+S N ++ P ++
Sbjct: 167 TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHK 204
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 8e-40
Identities = 48/186 (25%), Positives = 79/186 (42%), Gaps = 26/186 (13%)
Query: 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAE--IAVLTKVRHRHLVAL 644
+G+G FG V+ G+ G ++AVK S + E I +RH +++
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-----RSWFREAEIYQTVMLRHENILGF 101
Query: 645 LGYCINGS----ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYL 700
+ + + LV +Y G+L +L + + +T + + +AL A G+ +L
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRY---TVTVEGMIKLALSTASGLAHL 155
Query: 701 HSLAQQS-----FIHRDLKPSNILIGDDMRAKVADFGL---VKNAPDGKYSVETRLAGTF 752
H + HRDLK NIL+ + +AD GL +A D GT
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215
Query: 753 GYLAPE 758
Y+APE
Sbjct: 216 RYMAPE 221
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 8e-38
Identities = 57/412 (13%), Positives = 110/412 (26%), Gaps = 94/412 (22%)
Query: 69 TTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAI----------PSLANATSLQDI 118
T + L L + L +L++L+ N A +Q
Sbjct: 494 TDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIF 553
Query: 119 YLDNNNFTSVPT-GCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFG 177
Y+ NN P + L +L N + + LT L +D I
Sbjct: 554 YMGYNNLEEFPASASLQKMVKLGLLDCVHN-KVR---HLEAFGTNVKLTDLKLDYNQIEE 609
Query: 178 LIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLS-----------G 226
+ DF ++ L S+N +P F + + + S
Sbjct: 610 IPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVM----GSVDFSYNKIGSEGRNIS 664
Query: 227 TLDVLSGMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLT-------GVVPASV 278
V L N+ + + + + L +N +T +
Sbjct: 665 CSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNY 724
Query: 279 ISLPALLNISLQNNKLQG-PYPLFPSK---VQKVSLDHNNFCKNSSDAGKPCDPQVTTLL 334
+ L I L+ NKL + + + + +N F ++
Sbjct: 725 KNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCF---------------SSF- 768
Query: 335 QIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLA-NKLLAGN-----ISPAYA 388
P + ++ + + GN
Sbjct: 769 -------------------------PTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGIT 803
Query: 389 NLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNL-SGKVPDFGSNVK 439
SL L + N++ + + L L LD+++N S V ++
Sbjct: 804 TCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNISIDVTSVCPYIE 852
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 5e-37
Identities = 78/444 (17%), Positives = 138/444 (31%), Gaps = 79/444 (17%)
Query: 15 LLLLQLTTTSLGDDGSVMLKLAQSLQNLPSDWSSTSSTGYCEWTGINCDNSNRVTTISLA 74
+ + + L Q L D + E I +R++
Sbjct: 374 DMSEERKHRIRMHYKKMFLDYDQRLNLS--DLLQDAINRNPEMKPI--KKDSRISLKDTQ 429
Query: 75 KSGLS---GTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTG 131
L+ +S I LT+L+ + F + ++ +D D
Sbjct: 430 IGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAV----DWEDANSDYAKQYENEEL 485
Query: 132 CFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGL---------IPDF 182
+ L +L + L + PN+ P+ L L +L + + D
Sbjct: 486 SWSNLKDLTDVELYNCPNM--TQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADD 543
Query: 183 FDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSG----TLDVLSGMTQLR 238
D+ +Q + YNN PAS + + L L L+ +L
Sbjct: 544 EDTGPKIQIFYMGYNNLE-EFPASASLQKMVKL----GLLDCVHNKVRHLEAFGTNVKLT 598
Query: 239 QVWLHKNQFTGPIPD--LSKCESLFDLSLRDNQLTGVVPA-SVISLPALLNISLQNNKLQ 295
+ L NQ IP+ + + + L N+L + + S+ + ++ NK+
Sbjct: 599 DLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIG 657
Query: 296 G-PYPLFPS-------KVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILS 347
+ S V+L +N K ++ ++T+ ILS
Sbjct: 658 SEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATG-SPISTI-----------ILS 705
Query: 348 DSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPI 407
NN + +I + Y N L + L+ N LT +
Sbjct: 706 -----NN-------------LMTSIP---ENSLKPKDGNYKNTYLLTTIDLRFNKLTS-L 743
Query: 408 PDGL--TKLASLQNLDVSNNNLSG 429
D T L L N+DVS N S
Sbjct: 744 SDDFRATTLPYLSNMDVSYNCFSS 767
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-35
Identities = 66/425 (15%), Positives = 120/425 (28%), Gaps = 81/425 (19%)
Query: 40 QNLPSDWSSTSSTGYCEW---TGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLS 96
+W+ + W G++ DN+ RVT +SLA G G + I LT+L+ LS
Sbjct: 296 TIHSLNWNF--NKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLS 353
Query: 97 FQMNNIAGAIPSLANATSLQDIY--LDNNNFTSVPTGCFDGLTNLQVLSLSDN-----PN 149
F ++ + + D+ + D L + L + P
Sbjct: 354 FGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPE 413
Query: 150 LAPWPFPNELTKSTSLTTLYMDNA-NIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFA 208
+ P + + SL + N N I + LQ + + + FT A
Sbjct: 414 MKPIKKDSRI----SLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIA--- 466
Query: 209 KSDIQNLWMNDQQLGLSGTL-DVLSGMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLR 266
+ N S + L V L+ +PD L L L++
Sbjct: 467 ---VDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIA 523
Query: 267 DNQLTGV---------VPASVISLPALLNISLQNNKLQG--PYPLFP--SKVQKVSLDHN 313
N+ + + P + + N L+ K+ + HN
Sbjct: 524 CNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHN 583
Query: 314 NFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITIN 373
L A G N ++ +
Sbjct: 584 KV---------------RHL---------EAF------GTNV------------KLTDLK 601
Query: 374 LANKLLAGNISPAYANLTSLKNLYLQQNNLTG-PIPDGLTKLASLQNLDVSNNNLSGKVP 432
L + A ++ L N L P + + ++D S N + +
Sbjct: 602 LDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGR 661
Query: 433 DFGSN 437
+ +
Sbjct: 662 NISCS 666
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-29
Identities = 42/229 (18%), Positives = 78/229 (34%), Gaps = 21/229 (9%)
Query: 85 EISSLTQLETLSFQMNNIAGAIPSL------ANATSLQDIYLDNNNFTSVPTGCFDGLTN 138
S+ + ++ F N I ++ + + L N PT F +
Sbjct: 639 NAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSP 698
Query: 139 LQVLSLSDN-----PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDF-FDSFSNLQNL 192
+ + LS+N P + P + LTT+ + + L DF + L N+
Sbjct: 699 ISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNM 758
Query: 193 RLSYNNFTGSLPASFAK-SDIQNLWMNDQQLG----LSGTL-DVLSGMTQLRQVWLHKNQ 246
+SYN F+ S P S ++ + Q+ + ++ L Q+ + N
Sbjct: 759 DVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSND 817
Query: 247 FTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQ 295
+ + L+ L + DN + SV L +K Q
Sbjct: 818 IRK-VDE-KLTPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 2e-20
Identities = 37/319 (11%), Positives = 87/319 (27%), Gaps = 59/319 (18%)
Query: 127 SVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSF 186
+G + + + + ++ +L + +T L + G +PD
Sbjct: 287 RYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQL 346
Query: 187 SNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQL------GLSGTLDVLSGMTQLRQV 240
+ L+ L ++ T S + ++ + + D ++ L Q
Sbjct: 347 TELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQD 406
Query: 241 WLHKNQFTGPIPDLSKCE-SLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYP 299
+++N PI S+ + N++T + ++ L L I N+
Sbjct: 407 AINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNI 465
Query: 300 LFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGW 359
+ + D+ +N +
Sbjct: 466 --AVDWEDANSDYAKQYENEELS------------------------------------- 486
Query: 360 PFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGP---------IPDG 410
+ + + L N + +L L++L + N + D
Sbjct: 487 -WSNLKD--LTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADD 543
Query: 411 LTKLASLQNLDVSNNNLSG 429
+Q + NNL
Sbjct: 544 EDTGPKIQIFYMGYNNLEE 562
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 6e-19
Identities = 31/218 (14%), Positives = 71/218 (32%), Gaps = 25/218 (11%)
Query: 58 TGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNI--------AGAIPSL 109
++ +T++L+ + + + ++ + + T+ N + +
Sbjct: 665 CSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNY 724
Query: 110 ANATSLQDIYLDNNNFTSVPTG-CFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTL 168
N L I L N TS+ L L + +S N + FP + S+ L
Sbjct: 725 KNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYN-CFSS--FPTQPLNSSQLKAF 781
Query: 169 Y------MDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQL 222
+ I P + +L L++ N+ + + L + D
Sbjct: 782 GIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKLTPQ-LYILDIADNPN 839
Query: 223 GLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESL 260
+S + + + L ++ D+ C++L
Sbjct: 840 -ISIDVTSVCPYIEAGMYVLLYDK----TQDIRGCDAL 872
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 8e-38
Identities = 67/409 (16%), Positives = 142/409 (34%), Gaps = 61/409 (14%)
Query: 61 NCDNSNRVTTISLAKSGLSGTLSPEIS--SLTQLETLSFQMNNI----AGAIPSLANATS 114
+S +++ + + + ++ L +F+ + L S
Sbjct: 197 GAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCE-MS 255
Query: 115 LQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNAN 174
++ I L + F ++ + F + LQ L L+ +L+ P+ L ++L L +
Sbjct: 256 VESINLQKHYFFNISSNTFHCFSGLQELDLTAT-HLSE--LPSGLVGLSTLKKLVLSANK 312
Query: 175 IFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK--SDIQNLWMNDQQLGLSG-TLDVL 231
L +F +L +L + N L + +++ L ++ + S L
Sbjct: 313 FENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQL 372
Query: 232 SGMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVIS-LPALLNISL 289
++ L+ + L N+ + +C L L L +L S L L ++L
Sbjct: 373 RNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNL 432
Query: 290 QNNKLQG-PYPLFP--SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAIL 346
++ L LF +Q ++L N+F K + L
Sbjct: 433 SHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQK--------------------TNSL 472
Query: 347 SDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGP 406
GR+ + L+ L+ A+ +L + ++ L N LT
Sbjct: 473 QTL-----------------GRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSS 515
Query: 407 IPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVK----FTVSPGNPFIGT 451
+ L+ L + L++++N++S +P + + NP T
Sbjct: 516 SIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLR-QNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-36
Identities = 66/383 (17%), Positives = 129/383 (33%), Gaps = 52/383 (13%)
Query: 62 CDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYL 120
+ +R+ T+ L + L +S L+ L F I+ L N +L+ +YL
Sbjct: 77 FQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYL 136
Query: 121 DNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMD-NANIFGLI 179
+N+ +S+ L+VL +N + +++ T L ++ N N I
Sbjct: 137 GSNHISSIKLPKGFPTEKLKVLDFQNN-AIHYLS-KEDMSSLQQATNLSLNLNGNDIAGI 194
Query: 180 PDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMND----QQLGLSGTLDVLSGMT 235
+ Q+L + S IQ+LW+ +S +
Sbjct: 195 EPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEM 254
Query: 236 QLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKL 294
+ + L K+ F + L +L L L+ + P+ ++ L L + L NK
Sbjct: 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSEL-PSGLVGLSTLKKLVLSANKF 313
Query: 295 QGPYPLFPS---KVQKVSLDHNNF-CKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSW 350
+ + S + +S+ N + + + + L D+ +
Sbjct: 314 ENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENL-ENLREL-----DLSH-------- 359
Query: 351 EGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDG 410
++ I T + N L NL+ L++L L N +
Sbjct: 360 --DD--------------IETSDCCNLQLR--------NLSHLQSLNLSYNEPLSLKTEA 395
Query: 411 LTKLASLQNLDVSNNNLSGKVPD 433
+ L+ LD++ L K
Sbjct: 396 FKECPQLELLDLAFTRLKVKDAQ 418
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-35
Identities = 68/380 (17%), Positives = 133/380 (35%), Gaps = 57/380 (15%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLD- 121
N + ++ L + +S P+ +L+ L FQ N I +++ ++ L+
Sbjct: 127 NQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNL 186
Query: 122 -NNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIP 180
N+ + G FD Q L+ NL + + SL ++ + + P
Sbjct: 187 NGNDIAGIEPGAFDSA-VFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISP 245
Query: 181 DFFDSFS--NLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLSGTLDVLSGMTQL 237
F+ +++++ L + F +F S +Q L + L S L G++ L
Sbjct: 246 AVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL--SELPSGLVGLSTL 303
Query: 238 RQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVIS-LPALLNISLQNNKLQ 295
+++ L N+F S SL LS++ N + + L L + L ++ ++
Sbjct: 304 KKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIE 363
Query: 296 GPYPLFPS-----KVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSW 350
+Q ++L +N ++A
Sbjct: 364 TSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEA---------------------------- 395
Query: 351 EGNNACDGWPFVTCSQGRIITINLANKLLAGNISP-AYANLTSLKNLYLQQNNLTGPIPD 409
F C Q + ++LA L + + NL LK L L + L
Sbjct: 396 ----------FKECPQ--LELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQ 443
Query: 410 GLTKLASLQNLDVSNNNLSG 429
L +LQ+L++ N+
Sbjct: 444 LFDGLPALQHLNLQGNHFPK 463
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-34
Identities = 61/409 (14%), Positives = 122/409 (29%), Gaps = 46/409 (11%)
Query: 47 SSTSSTGYCEWTGINCDNSNR------------VTTISLAKSGLSGTLSPEISSLTQLET 94
+S+ + + N + + + L + S L L
Sbjct: 2 TSSDQKCIEKEVNKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTF 61
Query: 95 LSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPW 153
L I + + L + L N + G L+ L ++
Sbjct: 62 LDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQT-GISSI 120
Query: 154 PFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDI 212
L +L +LY+ + +I + L+ L N +
Sbjct: 121 D-FIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQA 179
Query: 213 QNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIP---DLSKCESLFDLSLRDNQ 269
NL +N ++G + + Q I S +SL+ + D
Sbjct: 180 TNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMD 239
Query: 270 LTGVVPASVISLPA--LLNISLQNNKLQGPYP-LFP--SKVQKVSLDHNNFCKNSSDAGK 324
+ PA L + +I+LQ + F S +Q++ L + + +G
Sbjct: 240 DEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL--SELPSGL 297
Query: 325 PCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQ-GRIITINLA-NKLLAGN 382
+ L +LS N + ++ S + +++ N
Sbjct: 298 VGLSTLKKL-----------VLS-----ANKFENLCQISASNFPSLTHLSIKGNTKRLEL 341
Query: 383 ISPAYANLTSLKNLYLQQNNLT--GPIPDGLTKLASLQNLDVSNNNLSG 429
+ NL +L+ L L +++ L L+ LQ+L++S N
Sbjct: 342 GTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLS 390
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-33
Identities = 66/400 (16%), Positives = 128/400 (32%), Gaps = 71/400 (17%)
Query: 53 GYCEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLT-------QLETLSFQMNNIAGA 105
G + + T SL +IS +E+++ Q +
Sbjct: 210 GGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNI 269
Query: 106 IP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTS 164
+ + LQ++ L + + +P+G GL+ L+ L LS N + S
Sbjct: 270 SSNTFHCFSGLQELDLTATHLSELPSG-LVGLSTLKKLVLSAN-KFENLC-QISASNFPS 326
Query: 165 LTTLYM-DNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLG 223
LT L + N L ++ NL+ L LS+++ S + ++ +L Q L
Sbjct: 327 LTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHL----QSLN 382
Query: 224 LSG------TLDVLSGMTQLRQVWLHKNQFTGPIPD--LSKCESLFDLSLRDNQLTGVVP 275
LS + QL + L + L L+L + L
Sbjct: 383 LSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSE 442
Query: 276 ASVISLPALLNISLQNNKLQGPYPLFP------SKVQKVSLDHNNFCKNSSDAGKPCDPQ 329
LPAL +++LQ N +++ + L + A
Sbjct: 443 QLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHA------- 495
Query: 330 VTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYAN 389
F + + ++L++ L + A ++
Sbjct: 496 -------------------------------FTSLKM--MNHVDLSHNRLTSSSIEALSH 522
Query: 390 LTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSG 429
L + L L N+++ +P L L+ + +++ N L
Sbjct: 523 LKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 7e-33
Identities = 48/386 (12%), Positives = 104/386 (26%), Gaps = 66/386 (17%)
Query: 62 CDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYL 120
N+ T + GL+ + + + E L F N + + + +L + L
Sbjct: 10 EKEVNK--TYNCENLGLN-EIPGTLPNS--TECLEFSFNVLPTIQNTTFSRLINLTFLDL 64
Query: 121 DNNNFTSVPTGCFDGLTNLQVLSLSDNP--NLAPWPFPNELTKSTSLTTLYMDNANIFGL 178
+ F L L L+ NP +A +L L+ I +
Sbjct: 65 TRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSG----PKALKHLFFIQTGISSI 120
Query: 179 IPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLR 238
+ L++L L N+ + +L+
Sbjct: 121 DFIPLHNQKTLESLYLGSNHISSIKLPKG------------------------FPTEKLK 156
Query: 239 QVWLHKNQFTGPIPD----LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKL 294
+ N + L + +L L+L N + G+ +++ +
Sbjct: 157 VLDFQNNAIHYLSKEDMSSLQQATNL-SLNLNGNDIAGI-EPGAFDSAVFQSLNFGGTQN 214
Query: 295 QGPYP-----LFPSKVQKVSLDHNNFCKNSSDA-GKPCDPQVTTLLQIAGDMGYPAILSD 348
+ + + + S C+ V ++ ++ +
Sbjct: 215 LLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESI-----NLQKHYFFNI 269
Query: 349 SWEGNNACDGWPFVTCSQGRIITINLA-NKLLAGNISPAYANLTSLKNLYLQQNNLTGPI 407
S + ++L L + L++LK L L N
Sbjct: 270 S----------SNTFHCFSGLQELDLTATHL--SELPSGLVGLSTLKKLVLSANKFENLC 317
Query: 408 PDGLTKLASLQNLDVSNNNLSGKVPD 433
+ SL +L + N ++
Sbjct: 318 QISASNFPSLTHLSIKGNTKRLELGT 343
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-32
Identities = 61/382 (15%), Positives = 126/382 (32%), Gaps = 58/382 (15%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLE--TLSFQMNNIAGAIPSLANATSLQDIYLD 121
+ ++ + + + ++SSL Q +L+ N+IAG P ++ Q +
Sbjct: 151 PTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFG 210
Query: 122 NNNFT--SVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLI 179
+ +L + + D + P E S+ ++ + F +
Sbjct: 211 GTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNIS 270
Query: 180 PDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQL-GLSGTLDVLSGMTQL 237
+ F FS LQ L L+ + + LP+ S ++ L ++ + L S L
Sbjct: 271 SNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQ--ISASNFPSL 327
Query: 238 RQVWLHKNQFTGPIPD--LSKCESLFDLSLRDNQLT--GVVPASVISLPALLNISLQNNK 293
+ + N + L E+L +L L + + + +L L +++L N+
Sbjct: 328 THLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNE 387
Query: 294 LQGPYPLFPSKV---QKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSW 350
+ + + L + S
Sbjct: 388 PLSLKTEAFKECPQLELLDLAFTRLKV---------------------------KDAQSP 420
Query: 351 EGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPI--- 407
N + +NL++ LL + + L +L++L LQ N+
Sbjct: 421 FQNLH------------LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQK 468
Query: 408 PDGLTKLASLQNLDVSNNNLSG 429
+ L L L+ L +S +LS
Sbjct: 469 TNSLQTLGRLEILVLSFCDLSS 490
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-31
Identities = 62/393 (15%), Positives = 118/393 (30%), Gaps = 72/393 (18%)
Query: 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNF 125
V +I+L K S + L+ L +++ L ++L+ + L N F
Sbjct: 254 MSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKF 313
Query: 126 TSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANI--FGLIPDFF 183
++ +L LS+ N L +L L + + +I
Sbjct: 314 ENLCQISASNFPSLTHLSIKGN-TKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQL 372
Query: 184 DSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWL 242
+ S+LQ+L LSYN +F + ++ L + +L + + L+ + L
Sbjct: 373 RNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNL 432
Query: 243 HKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVV---PASVISLPALLNISLQNNKLQG-P 297
+ +L L+L+ N S+ +L L + L L
Sbjct: 433 SHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSID 492
Query: 298 YPLFP--SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNA 355
F + V L HN +S +A
Sbjct: 493 QHAFTSLKMMNHVDLSHNRLTSSSIEA--------------------------------- 519
Query: 356 CDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTG---------- 405
I +NLA+ ++ + L+ + + L+QN L
Sbjct: 520 -----LSHLKG---IYLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNIYFLEW 571
Query: 406 --------PIPDGLT--KLASLQNLDVSNNNLS 428
+ L+ + +S+ LS
Sbjct: 572 YKENMQKLEDTEDTLCENPPLLRGVRLSDVTLS 604
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-13
Identities = 36/327 (11%), Positives = 68/327 (20%), Gaps = 118/327 (36%)
Query: 118 IYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFG 177
+N +P + + L S N +
Sbjct: 17 YNCENLGLNEIPGTLP---NSTECLEFSFN--------------------------VLPT 47
Query: 178 LIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQL 237
+ F NL L L+ +F +L
Sbjct: 48 IQNTTFSRLINLTFLDLTRCQIYWIHEDTF------------------------QSQHRL 83
Query: 238 RQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG 296
+ L N LS ++L L ++ + + + L
Sbjct: 84 DTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTL------------ 131
Query: 297 PYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNAC 356
+ + L N+ G P
Sbjct: 132 ---------ESLYLGSNHISSIKLPKGFPT------------------------------ 152
Query: 357 DGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYL--QQNNLTGPIPDGLTKL 414
++ ++ N + ++L NL L N++ G I G
Sbjct: 153 ----------EKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDS 201
Query: 415 ASLQNLDVSNNNLSGKVPDFGSNVKFT 441
A Q+L+ + N
Sbjct: 202 AVFQSLNFGGTQNLLVIFKGLKNSTIQ 228
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 8e-07
Identities = 18/142 (12%), Positives = 45/142 (31%), Gaps = 16/142 (11%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNN 123
R+ + L+ LS +SL + + N + + + + L +N
Sbjct: 474 TLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASN 533
Query: 124 NFTSVPTGCFDGLTNLQVLSLSDNP-----NLAPWPFPNELTKSTSLTTLYMDNANIFGL 178
+ + + L+ + ++L NP + + L + +
Sbjct: 534 HISIILPSLLPILSQQRTINLRQNPLDCTCSNIYF-----------LEWYKENMQKLEDT 582
Query: 179 IPDFFDSFSNLQNLRLSYNNFT 200
++ L+ +RLS +
Sbjct: 583 EDTLCENPPLLRGVRLSDVTLS 604
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-37
Identities = 49/155 (31%), Positives = 71/155 (45%), Gaps = 9/155 (5%)
Query: 589 LGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY 647
+GRG FG V+ G L D T +AVK ++F E +L + H ++V L+G
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLP-PDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 648 CINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS 707
C +V E + G L G L K + + D A G+EYL S +
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFL---RTEG-ARLRVKTLLQMVGDAAAGMEYLES---KC 233
Query: 708 FIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742
IHRDL N L+ + K++DFG+ + DG Y
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 139 bits (354), Expect = 2e-36
Identities = 67/364 (18%), Positives = 139/364 (38%), Gaps = 64/364 (17%)
Query: 68 VTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTS 127
L K+ ++ L + L +A I + T+L+ + L+ N T
Sbjct: 24 GIRAVLQKASVTDV--VTQEELESITKLVVAGEKVAS-IQGIEYLTNLEYLNLNGNQITD 80
Query: 128 VPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFS 187
+ L L L + N + + L T+L LY++ NI + P + +
Sbjct: 81 ISP--LSNLVKLTNLYIGTN-KITD---ISALQNLTNLRELYLNEDNISDISP--LANLT 132
Query: 188 NLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQF 247
+ +L L N+ L + + L + + ++ + ++ +T L + L+ NQ
Sbjct: 133 KMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKV---KDVTPIANLTDLYSLSLNYNQI 189
Query: 248 TGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFP-SKVQ 306
I L+ SL + NQ+T + P V ++ L ++ + NNK+ PL S++
Sbjct: 190 ED-ISPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSPLANLSQLT 246
Query: 307 KVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQ 366
+ + N Q++ + ++ +
Sbjct: 247 WLEIGTN---------------QISDI--------------NAVKDLT------------ 265
Query: 367 GRIITINLA-NKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNN 425
++ +N+ N++ +IS NL+ L +L+L N L + + L +L L +S N
Sbjct: 266 -KLKMLNVGSNQI--SDISVL-NNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQN 321
Query: 426 NLSG 429
+++
Sbjct: 322 HITD 325
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-35
Identities = 68/361 (18%), Positives = 140/361 (38%), Gaps = 84/361 (23%)
Query: 69 TTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSV 128
++L + ++ +S+L +L L N I I +L N T+L+++YL+ +N + +
Sbjct: 69 EYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKITD-ISALQNLTNLRELYLNEDNISDI 125
Query: 129 PTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSN 188
LT + L+L N NL+ + L+ T L L + + + + P + ++
Sbjct: 126 S--PLANLTKMYSLNLGANHNLS---DLSPLSNMTGLNYLTVTESKVKDVTP--IANLTD 178
Query: 189 LQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFT 248
L +L L+YN + L+ +T L + NQ T
Sbjct: 179 LYSLSLNYNQIED--------------------------ISPLASLTSLHYFTAYVNQIT 212
Query: 249 GPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFP-SKVQK 307
I ++ L L + +N++T + P + +L L + + N++ + +K++
Sbjct: 213 D-ITPVANMTRLNSLKIGNNKITDLSPLA--NLSQLTWLEIGTNQISDINAVKDLTKLKM 269
Query: 308 VSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQG 367
+++ N Q++ + + LS
Sbjct: 270 LNVGSN---------------QISDISVLNN-------LS-------------------- 287
Query: 368 RIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNL 427
++ ++ L N L LT+L L+L QN++T P L L+ + + D +N +
Sbjct: 288 QLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVI 345
Query: 428 S 428
Sbjct: 346 K 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-29
Identities = 60/341 (17%), Positives = 125/341 (36%), Gaps = 66/341 (19%)
Query: 92 LETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNP--N 149
TL+ I I A+ L + T V T + L ++ L ++ +
Sbjct: 2 AATLATLPAPI-NQIFPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS 58
Query: 150 LAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK 209
+ + T+L L ++ I + P + L NL + N T + A
Sbjct: 59 IQG------IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT-DISALQNL 109
Query: 210 SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQ 269
++++ L++N+ + + L+ +T++ + L N + LS L L++ +++
Sbjct: 110 TNLRELYLNEDNI---SDISPLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESK 166
Query: 270 LTGVVPASVISLPALLNISLQNNKLQGPYPLFP-SKVQKVSLDHNNFCKNSSDAGKPCDP 328
+ V P + +L L ++SL N+++ PL + + + N
Sbjct: 167 VKDVTPIA--NLTDLYSLSLNYNQIEDISPLASLTSLHYFTAYVN--------------- 209
Query: 329 QVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYA 388
Q+T + P ++ + I NK+ A
Sbjct: 210 QITDIT-------------------------PVANMTRLNSLKIG-NNKI---TDLSPLA 240
Query: 389 NLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSG 429
NL+ L L + N ++ + + L L+ L+V +N +S
Sbjct: 241 NLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD 279
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 46/210 (21%), Positives = 84/210 (40%), Gaps = 28/210 (13%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNN 123
++V + I++LT L +LS N I I LA+ TSL N
Sbjct: 163 TESKVKDV------------TPIANLTDLYSLSLNYNQIED-ISPLASLTSLHYFTAYVN 209
Query: 124 NFTSVPTGCFDGLTNLQVLSLSDNP--NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPD 181
T + +T L L + +N +L+P L + LT L + I +
Sbjct: 210 QITDITP--VANMTRLNSLKIGNNKITDLSP------LANLSQLTWLEIGTNQISDINA- 260
Query: 182 FFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVW 241
+ L+ L + N + + S + +L++N+ QLG + ++V+ G+T L ++
Sbjct: 261 -VKDLTKLKMLNVGSNQIS-DISVLNNLSQLNSLFLNNNQLG-NEDMEVIGGLTNLTTLF 317
Query: 242 LHKNQFTGPIPDLSKCESLFDLSLRDNQLT 271
L +N T I L+ + + +
Sbjct: 318 LSQNHITD-IRPLASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 3e-07
Identities = 26/190 (13%), Positives = 62/190 (32%), Gaps = 49/190 (25%)
Query: 251 IPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPL-FPSKVQKVS 309
I + L+ +T VV L ++ + + K+ + + + ++ ++
Sbjct: 15 IFPDADLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEKVASIQGIEYLTNLEYLN 72
Query: 310 LDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRI 369
L+ N Q+T + P + +
Sbjct: 73 LNGN---------------QITDIS-------------------------PLSNLVK--L 90
Query: 370 ITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSG 429
+ + + A NLT+L+ LYL ++N++ P L L + +L++ N+
Sbjct: 91 TNLYIGTNKI--TDISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLS 146
Query: 430 KVPDFGSNVK 439
+ +
Sbjct: 147 DLSPLSNMTG 156
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 45.6 bits (109), Expect = 4e-05
Identities = 15/52 (28%), Positives = 24/52 (46%), Gaps = 3/52 (5%)
Query: 388 ANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVK 439
AN+T L +L + N +T P L L+ L L++ N +S + K
Sbjct: 218 ANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQIS-DINAVKDLTK 266
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 42.5 bits (101), Expect = 3e-04
Identities = 14/49 (28%), Positives = 24/49 (48%), Gaps = 2/49 (4%)
Query: 385 PAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPD 433
A +LT LK L + N ++ L L+ L +L ++NN L + +
Sbjct: 259 NAVKDLTKLKMLNVGSNQISDISV--LNNLSQLNSLFLNNNQLGNEDME 305
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 3e-36
Identities = 48/156 (30%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646
+G G FG+V+ G + K+A+K + M + +F E V+ K+ H LV L G
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYG 70
Query: 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ 706
C+ + LV E+M G L+ +L + + + LDV G+ YL +
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYL---RTQRGL-FAAETLLGMCLDVCEGMAYL---EEA 123
Query: 707 SFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742
IHRDL N L+G++ KV+DFG+ + D +Y
Sbjct: 124 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 159
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-36
Identities = 52/173 (30%), Positives = 85/173 (49%), Gaps = 10/173 (5%)
Query: 587 NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
+ LG G +G VY G +AVK ++ +TM + EF E AV+ +++H +LV LL
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLL 282
Query: 646 GYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQ 705
G C ++ E+M G L +L + ++ + +A ++ +EYL
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEK--- 336
Query: 706 QSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
++FIHR+L N L+G++ KVADFGL + Y+ + APE
Sbjct: 337 KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 389
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 6e-36
Identities = 54/148 (36%), Positives = 82/148 (55%), Gaps = 12/148 (8%)
Query: 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646
+G+G FG V G+ G K+AVK ++++ F AE +V+T++RH +LV LLG
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT----AQAFLAEASVMTQLRHSNLVQLLG 81
Query: 647 YCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQ 705
+ L +V EYM +G+L +L G + L + +LDV +EYL
Sbjct: 82 VIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYL---EG 135
Query: 706 QSFIHRDLKPSNILIGDDMRAKVADFGL 733
+F+HRDL N+L+ +D AKV+DFGL
Sbjct: 136 NNFVHRDLAARNVLVSEDNVAKVSDFGL 163
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 7e-36
Identities = 50/161 (31%), Positives = 82/161 (50%), Gaps = 10/161 (6%)
Query: 587 NILGRGGFGVVYGGELPDG-TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
+ LG G +G VY G +AVK ++ +TM + EF E AV+ +++H +LV LL
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLL 75
Query: 646 GYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQ 705
G C ++ E+M G L +L + ++ + +A ++ +EYL +
Sbjct: 76 GVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYL---EK 129
Query: 706 QSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVET 746
++FIHRDL N L+G++ KVADFGL + Y+
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 170
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 51/155 (32%), Positives = 71/155 (45%), Gaps = 10/155 (6%)
Query: 588 ILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY 647
LG G FGVV G+ +AVK ++ +M EF E + K+ H LV G
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMKLSHPKLVKFYGV 71
Query: 648 CINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS 707
C +V EY+ G L +L HG L Q + + DV G+ +L
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYL---RSHGKG-LEPSQLLEMCYDVCEGMAFL---ESHQ 124
Query: 708 FIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742
FIHRDL N L+ D+ KV+DFG+ + D +Y
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-35
Identities = 67/384 (17%), Positives = 121/384 (31%), Gaps = 37/384 (9%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDN 122
N NR + S L L+ S ++ L N ++ LA T L+ + L +
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 123 NNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDF 182
N + L+ L+ L L++N + EL S+ TL+ N N +
Sbjct: 68 NVLYETLD--LESLSTLRTLDLNNN-YV------QELLVGPSIETLHAAN-NNISRVS-- 115
Query: 183 FDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVW 241
+N+ L+ N T S +Q L + ++ ++ + L +
Sbjct: 116 CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 242 LHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG-PYPL 300
L N + L L L N+L + S + ISL+NNKL L
Sbjct: 176 LQYNFIYD-VKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKAL 233
Query: 301 FP-SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTL---------LQIAGDMGYPAILSDSW 350
++ L N F + + +V T+ Q + P +
Sbjct: 234 RFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGH--- 290
Query: 351 EGNNACDGWPFVTCSQGRIITINLANKLLA------GNISPAYANLTSLKNLYLQQNNLT 404
G C+ P + + + LL+ + N + + +
Sbjct: 291 YGAYCCEDLPAPFADRLIALK-RKEHALLSGQGSETERLECERENQARQREIDALKEQYR 349
Query: 405 GPIPDGLTKLASLQNLDVSNNNLS 428
I + + L+ L
Sbjct: 350 TVIDQVTLRKQAKITLEQKKKALD 373
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-32
Identities = 55/377 (14%), Positives = 119/377 (31%), Gaps = 35/377 (9%)
Query: 69 TTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSV 128
+ L+ + LS + +++ T+LE L+ N + L + ++L+ + L+NN +
Sbjct: 37 KELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE-TLDLESLSTLRTLDLNNNYVQEL 95
Query: 129 PTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSN 188
+++ L ++N N++ +Y+ N I L S
Sbjct: 96 LV-----GPSIETLHAANN-NISRVSCSR----GQGKKNIYLANNKITMLRDLDEGCRSR 145
Query: 189 LQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSG----TLDVLSGMTQLRQVWLHK 244
+Q L L N ++ + + L + L L + +L+ + L
Sbjct: 146 VQYLDLKLNEID-TVNFAELAASSDTL----EHLNLQYNFIYDVKGQVVFAKLKTLDLSS 200
Query: 245 NQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG--PYPLFP 302
N+ P+ + +SLR+N+L ++ ++ L + L+ N F
Sbjct: 201 NKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFS 259
Query: 303 SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWE----------- 351
+ ++ K + + C PA +D
Sbjct: 260 KNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLS 319
Query: 352 -GNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDG 410
+ + +Q R I+ + I + L ++ L + +G
Sbjct: 320 GQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNG 379
Query: 411 LTKLASLQNLDVSNNNL 427
A L
Sbjct: 380 RRAHAELDGTLQQAVGQ 396
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 4e-19
Identities = 31/228 (13%), Positives = 64/228 (28%), Gaps = 12/228 (5%)
Query: 84 PEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLS 143
+L+TL N +A P +A + I L NN + NL+
Sbjct: 185 KGQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVLIEKA-LRFSQNLEHFD 243
Query: 144 LSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYN---NFT 200
L N + +K+ + T+ + L + + +
Sbjct: 244 LRGNG-FHCGTLRDFFSKNQRVQTV--AKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLP 300
Query: 201 GSLPASFAKSDIQNLWMNDQQLGLSGTLDVLS-GMTQLRQVWLHKNQFTGPIPDL-SKCE 258
+ + Q + L+ + R++ K Q+ I + + +
Sbjct: 301 APFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQ 360
Query: 259 SLFDLSLRDNQLTGVVP---ASVISLPALLNISLQNNKLQGPYPLFPS 303
+ L + L V + L L ++ +LQ
Sbjct: 361 AKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSP 408
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 3e-16
Identities = 43/262 (16%), Positives = 96/262 (36%), Gaps = 55/262 (20%)
Query: 179 IPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQL-GLSGTLDVLSGMTQ 236
I + + + + +++ ++ +L + +++ L ++ L +S L+ T+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISA--ADLAPFTK 59
Query: 237 LRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG 296
L + L N DL +L L L +N + ++ P++ + NN +
Sbjct: 60 LELLNLSSNVLYE-TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR 113
Query: 297 -PYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNA 355
+ + L +N ++T L
Sbjct: 114 VSCSRGQG-KKNIYLANN---------------KITMLR--------------------- 136
Query: 356 CDGWPFVTCSQGRIITINLA-NKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKL 414
+ R+ ++L N++ N + A+ +L++L LQ N + + +
Sbjct: 137 ----DLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQVV-F 190
Query: 415 ASLQNLDVSNNNLSGKVPDFGS 436
A L+ LD+S+N L+ P+F S
Sbjct: 191 AKLKTLDLSSNKLAFMGPEFQS 212
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 18/154 (11%), Positives = 34/154 (22%), Gaps = 3/154 (1%)
Query: 88 SLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDN 147
+ LS Q + N ++I + +V L
Sbjct: 311 KRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKK 370
Query: 148 PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASF 207
L N L L + S LQ LR +
Sbjct: 371 -ALDE-QVSNGRRAHAELDGTLQQAVGQIEL-QHATEEQSPLQLLRAIVKRYEEMYVEQQ 427
Query: 208 AKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVW 241
+ + + Q + + + + +L
Sbjct: 428 SVQNNAIRDWDMYQHKETQLAEENARLKKLNGEA 461
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 49/156 (31%), Positives = 72/156 (46%), Gaps = 10/156 (6%)
Query: 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646
LG G FGVV G+ +A+K ++ +M EF E V+ + H LV L G
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYG 86
Query: 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ 706
C ++ EYM G L +L + + +Q + + DV +EYL +
Sbjct: 87 VCTKQRPIFIITEYMANGCLLNYL---REMRHR-FQTQQLLEMCKDVCEAMEYL---ESK 139
Query: 707 SFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742
F+HRDL N L+ D KV+DFGL + D +Y
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 46/158 (29%), Positives = 77/158 (48%), Gaps = 14/158 (8%)
Query: 587 NILGRGGFGVVYGGELPDG----TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
+LG+G FG V +L K+AVK ++++ + + + EF E A + + H H+
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 643 ALLGYCINGSER------LLVYEYMPRGTLAQHL-FEWHDHGYTPLTWKQRVTIALDVAR 695
L+G + + +++ +M G L L L + V +D+A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733
G+EYL + ++FIHRDL N ++ +DM VADFGL
Sbjct: 149 GMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGL 183
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-35
Identities = 54/148 (36%), Positives = 82/148 (55%), Gaps = 12/148 (8%)
Query: 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646
+G+G FG V G+ G K+AVK ++++ F AE +V+T++RH +LV LLG
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT----AQAFLAEASVMTQLRHSNLVQLLG 253
Query: 647 YCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQ 705
+ L +V EYM +G+L +L G + L + +LDV +EYL
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEG--- 307
Query: 706 QSFIHRDLKPSNILIGDDMRAKVADFGL 733
+F+HRDL N+L+ +D AKV+DFGL
Sbjct: 308 NNFVHRDLAARNVLVSEDNVAKVSDFGL 335
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 48/158 (30%), Positives = 82/158 (51%), Gaps = 14/158 (8%)
Query: 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646
LG G FG V+ G TK+AVK ++ +M F AE ++ +++H+ LV L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRLYA 75
Query: 647 YCINGSER--LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA 704
++ ++ EYM G+L L LT + + +A +A G+ ++
Sbjct: 76 VV---TQEPIYIITEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFI---E 126
Query: 705 QQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742
++++IHRDL+ +NIL+ D + K+ADFGL + D +Y
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 6e-35
Identities = 62/224 (27%), Positives = 94/224 (41%), Gaps = 26/224 (11%)
Query: 548 SELHSQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYGGE-LPDGT 606
S H + F+G V I + ++ LG GGF V E L DG
Sbjct: 3 SSHHHHHHSSGRENLYFQGHMVIIDNK-------HYLFIQKLGEGGFSYVDLVEGLHDGH 55
Query: 607 KIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN----GSERLLVYEYMP 662
A+KR+ + + E Q E + H +++ L+ YC+ E L+ +
Sbjct: 56 FYALKRILCHEQ--QDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFK 113
Query: 663 RGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD 722
RGTL + D G LT Q + + L + RG+E +H+ + + HRDLKP+NIL+GD
Sbjct: 114 RGTLWNEIERLKDKG-NFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGD 169
Query: 723 DMRAKVADFGLVKNAPDGKYSVETRLA--------GTFGYLAPE 758
+ + + D G + A L T Y APE
Sbjct: 170 EGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE 213
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 6e-35
Identities = 54/170 (31%), Positives = 86/170 (50%), Gaps = 18/170 (10%)
Query: 587 NILGRGGFGVVYGGE---LPDGTKI--AVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHL 641
LG+G FG V L D T AVK+++ +T + L +F+ EI +L ++H ++
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE--EHLRDFEREIEILKSLQHDNI 104
Query: 642 VALLGYCINGSER--LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
V G C + R L+ EY+P G+L +L H + + + + +G+EY
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKER-IDHIKLLQYTSQICKGMEY 160
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK--YSVETR 747
L + + +IHRDL NIL+ ++ R K+ DFGL K P K Y V+
Sbjct: 161 LGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEP 207
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 49/157 (31%), Positives = 78/157 (49%), Gaps = 13/157 (8%)
Query: 587 NILGRGGFGVVYGGELPDG----TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
ILG G FG V G L K+AVK M+ + + + EF +E A + H +++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 643 ALLGYC-----INGSERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWKQRVTIALDVARG 696
LLG C + +++ +M G L +L + G + + + +D+A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733
+EYL + ++F+HRDL N ++ DDM VADFGL
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGL 193
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 7e-35
Identities = 53/169 (31%), Positives = 86/169 (50%), Gaps = 18/169 (10%)
Query: 587 NILGRGGFGVVYGGE---LPDGTKI--AVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHL 641
LG+G FG V L D T AVK+++ +T + L +F+ EI +L ++H ++
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE--EHLRDFEREIEILKSLQHDNI 73
Query: 642 VALLGYCINGSER--LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
V G C + R L+ EY+P G+L +L H + + + + +G+EY
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKER-IDHIKLLQYTSQICKGMEY 129
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK--YSVET 746
L + + +IHRDL NIL+ ++ R K+ DFGL K P K + V+
Sbjct: 130 LGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKE 175
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 9e-35
Identities = 55/172 (31%), Positives = 86/172 (50%), Gaps = 10/172 (5%)
Query: 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646
LG+G FG V+ G T++A+K ++ TM + F E V+ K+RH LV L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLVQLYA 246
Query: 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ 706
+ +V EYM +G+L L L Q V +A +A G+ Y+
Sbjct: 247 VV-SEEPIYIVTEYMSKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYVER---M 299
Query: 707 SFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
+++HRDL+ +NIL+G+++ KVADFGL + D +Y+ + APE
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 351
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 55/162 (33%), Positives = 81/162 (50%), Gaps = 19/162 (11%)
Query: 587 NILGRGGFGVVYGGELPDG---TKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLV 642
+++G G FG V + A+KRM+ +F E+ VL K+ H +++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNII 89
Query: 643 ALLGYCINGSERLLVYEYMPRGTLAQHL-----------FEWHDHGYTPLTWKQRVTIAL 691
LLG C + L EY P G L L F + + L+ +Q + A
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 692 DVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733
DVARG++YL +Q+ FIHRDL NIL+G++ AK+ADFGL
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGL 188
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-34
Identities = 46/167 (27%), Positives = 78/167 (46%), Gaps = 15/167 (8%)
Query: 587 NILGRGGFGVVYGGELPDG------TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
LG+G FG+VY G T++A+K + + EF E +V+ + H
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEFNCHH 89
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHL-----FEWHDHGYTPLTWKQRVTIALDVAR 695
+V LLG G L++ E M RG L +L ++ P + + + +A ++A
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742
G+ YL F+HRDL N ++ +D K+ DFG+ ++ + Y
Sbjct: 150 GMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 193
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-34
Identities = 61/385 (15%), Positives = 116/385 (30%), Gaps = 45/385 (11%)
Query: 69 TTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP--SLANATSLQDIYLDNNNFT 126
+ ++ L+ S I L L+ L+ N I +N T+L + L N
Sbjct: 107 ENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQ 166
Query: 127 SVPTGCFDGLTNL----QVLSLSDNP--NLAPWPFPNELTKSTSLTTLYM-DNANIFGLI 179
++ L L +S NP + F + L L + N N ++
Sbjct: 167 TITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAF-----QGIKLHELTLRGNFNSSNIM 221
Query: 180 PDFFDSFSNLQNLRLSYNNFTGSLP-ASFAKSDIQNL-WMNDQQLGLSG------TLDVL 231
+ + L RL F F S ++ L + + L+ +
Sbjct: 222 KTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKF 281
Query: 232 SGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQN 291
+ + + L + D+ K LS+ QL LP L +++L
Sbjct: 282 HCLANVSAMSLAGVSIKY-LEDVPKHFKWQSLSIIRCQLKQFPTLD---LPFLKSLTLTM 337
Query: 292 NKLQGPYPL-FPSKVQKVSLDHNNFCKNSSDAGKP-CDPQVTTLLQIAGDMGYPAILSDS 349
NK + + + L N + + + L D+ + + S
Sbjct: 338 NKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHL-----DLSFNGAIIMS 392
Query: 350 WEGNNACDGWPFVTCSQGRIITINLANKLLAGNISP-AYANLTSLKNLYLQQNNLTGPIP 408
F+ + + ++ + L A+ +L L L + N
Sbjct: 393 AN---------FMGLEE--LQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFD 441
Query: 409 DGLTKLASLQNLDVSNNNLSGKVPD 433
L SL L ++ N+
Sbjct: 442 GIFLGLTSLNTLKMAGNSFKDNTLS 466
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-34
Identities = 60/378 (15%), Positives = 121/378 (32%), Gaps = 40/378 (10%)
Query: 69 TTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTS 127
+ L++ + L L L N I P S + TSL+++ S
Sbjct: 59 QWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLAS 118
Query: 128 VPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFS 187
+ + L L+ L+++ N + P + T+L + + I + +
Sbjct: 119 LESFPIGQLITLKKLNVAHN-FIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177
Query: 188 NLQN----LRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLH 243
L +S N +F + L + + L + L L
Sbjct: 178 ENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLI 237
Query: 244 KNQFTG----PIPDLSKCESLFDLSLRD-----NQLTGVVPASVISLPALLNISLQNNKL 294
+F I + S E L D+++ + L + +SL +
Sbjct: 238 LGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI 297
Query: 295 QGPYPL-FPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGN 353
+ + K Q +S+ + + P + +L L+ N
Sbjct: 298 KYLEDVPKHFKWQSLSIIRCQLKQFPTLD----LPFLKSL-----------TLT----MN 338
Query: 354 NACDGWPFVTCSQGRIITINLANKLLAGNISPAYANL--TSLKNLYLQQNNLTGPIPDGL 411
+ V + ++L+ L+ + +Y++L SL++L L N +
Sbjct: 339 KGSISFKKVALPS--LSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANF 395
Query: 412 TKLASLQNLDVSNNNLSG 429
L LQ+LD ++ L
Sbjct: 396 MGLEELQHLDFQHSTLKR 413
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-33
Identities = 63/386 (16%), Positives = 117/386 (30%), Gaps = 45/386 (11%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNN 123
+ N + TI+ L + +L +N I L ++ L N
Sbjct: 161 SYNYIQTIT------VNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGN 214
Query: 124 NF-TSVPTGCFDGLTNLQVLSLSDN--PNLAPWPFPNELT----KSTSLTTLYMDNANIF 176
+++ C L L V L + ++ + N F
Sbjct: 215 FNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDF 274
Query: 177 GLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQ 236
F +N+ + L+ + L Q+L + QL +
Sbjct: 275 SDDIVKFHCLANVSAMSLAGVSIK-YLEDVPKHFKWQSLSIIRCQL----KQFPTLDLPF 329
Query: 237 LRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASV--ISLPALLNISLQNNKL 294
L+ + L N+ + SL L L N L+ S + +L ++ L N
Sbjct: 330 LKSLTLTMNKGSI-SFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGA 388
Query: 295 QGPYPLFP--SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEG 352
F ++Q + H+ + + + ++ L +S
Sbjct: 389 IIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYL-----------DIS----- 432
Query: 353 NNACDGWP---FVTCSQGRIITINLA-NKLLAGNISPAYANLTSLKNLYLQQNNLTGPIP 408
F+ + + T+ +A N +S +AN T+L L L + L
Sbjct: 433 YTNTKIDFDGIFLGLTS--LNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISW 490
Query: 409 DGLTKLASLQNLDVSNNNLSGKVPDF 434
L LQ L++S+NNL
Sbjct: 491 GVFDTLHRLQLLNMSHNNLLFLDSSH 516
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-31
Identities = 62/407 (15%), Positives = 118/407 (28%), Gaps = 67/407 (16%)
Query: 61 NCDNSNRVTTISLAKSGLSGTLSPE-ISSLTQLETLSFQMNNIAG--AIPSLANAT---- 113
++ ++L + S + + +L L + + +
Sbjct: 199 QAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGL 258
Query: 114 ---SLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYM 170
++ + L N S F L N+ +SL+ ++ + ++ K +L +
Sbjct: 259 CDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGV-SIK---YLEDVPKHFKWQSLSI 314
Query: 171 DNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQL-GLSGTLD 229
+ L++L L+ N + S S + L ++ L
Sbjct: 315 IRCQLKQFP---TLDLPFLKSLTLTMNKGSISFKKVALPS-LSYLDLSRNALSFSGCCSY 370
Query: 230 VLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVI-SLPALLNIS 288
G LR + L N + E L L + + L V S SL LL +
Sbjct: 371 SDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLD 430
Query: 289 LQNNKLQGPYP-LFP--SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAI 345
+ + + +F + + + + N+F D TT L
Sbjct: 431 ISYTNTKIDFDGIFLGLTSLNTLKMAGNSF----KDNTLSNVFANTTNLT---------- 476
Query: 346 LSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTG 405
++L+ L + L L+ L + NNL
Sbjct: 477 -------------------------FLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLF 511
Query: 406 PIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVK----FTVSPGNPF 448
+L SL LD S N + K F ++ N
Sbjct: 512 LDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLT-NNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-30
Identities = 46/372 (12%), Positives = 99/372 (26%), Gaps = 81/372 (21%)
Query: 65 SNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNN 124
+ L + + L + +S +I + + Q + +
Sbjct: 260 DVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY-LEDVPKHFKWQSLSIIRCQ 318
Query: 125 FTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFD 184
P L L+ L+L+ N + SL+ L + + +
Sbjct: 319 LKQFP---TLDLPFLKSLTLTMNKGSISFKK----VALPSLSYLDLSRNALSFSGCCSYS 371
Query: 185 SF--SNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWL 242
++L++L LS+N + A+F G+ +L+ +
Sbjct: 372 DLGTNSLRHLDLSFNGAI-IMSANF------------------------MGLEELQHLDF 406
Query: 243 HKNQFTGPIP--DLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG--PY 298
+ E L L + + L +L + + N +
Sbjct: 407 QHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLS 466
Query: 299 PLF--PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNAC 356
+F + + + L + S ++ L
Sbjct: 467 NVFANTTNLTFLDLSKCQLEQISWGVFDTL-HRLQLL----------------------- 502
Query: 357 DGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLAS 416
N+++ L S Y L SL L N + S
Sbjct: 503 ----------------NMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKS 546
Query: 417 LQNLDVSNNNLS 428
L +++NN+++
Sbjct: 547 LAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-29
Identities = 65/384 (16%), Positives = 115/384 (29%), Gaps = 64/384 (16%)
Query: 61 NCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIY 119
C T LS + +I S + + N + S +N + LQ +
Sbjct: 6 PCIEVVPNITYQCMDQKLS-KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSELQWLD 62
Query: 120 LDNNNFTSVPTGCFDGLTNLQVLSLSDNP--NLAPWPFPNELTKSTSLTTLYMDNANIFG 177
L ++ + GL +L L L+ NP + +P F TSL L +
Sbjct: 63 LSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSG----LTSLENLVAVETKLAS 118
Query: 178 LIPDFFDSFSNLQNLRLSYNNFTG-SLPASFAKSDIQNLWMNDQQLGLSG---------T 227
L L+ L +++N LPA F S++ NL + LS
Sbjct: 119 LESFPIGQLITLKKLNVAHNFIHSCKLPAYF--SNLTNL----VHVDLSYNYIQTITVND 172
Query: 228 LDVLSGMTQLRQV-WLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVIS-LPALL 285
L L Q+ + N + L +L+LR N + + + + L L
Sbjct: 173 LQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLH 232
Query: 286 NISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAI 345
L + + L + + CD + + Y
Sbjct: 233 VHRLILGEFKDERNL-------EIFEPSIM-------EGLCDVTIDEF-----RLTYTND 273
Query: 346 LSDSWEGNNACDGWPFVTCSQGRIITINLA-NKLLAGNISPAYANLTSLKNLYLQQNNLT 404
SD + ++LA + ++L + + L
Sbjct: 274 FSDD----------IVKFHCLANVSAMSLAGVSI---KYLEDVPKHFKWQSLSIIRCQLK 320
Query: 405 GPIPDGLTKLASLQNLDVSNNNLS 428
L L++L ++ N S
Sbjct: 321 QFPTLDLP---FLKSLTLTMNKGS 341
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-29
Identities = 68/390 (17%), Positives = 123/390 (31%), Gaps = 63/390 (16%)
Query: 68 VTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFT 126
I L+ + L S S+ ++L+ L I + L ++ L N
Sbjct: 34 TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93
Query: 127 SVPTGCFDGLTNLQVLSLSDNP--NLAPWPFPNELTKSTSLTTLYMDNANIFGL-IPDFF 183
S G F GLT+L+ L + +L +P +L L + + I +P +F
Sbjct: 94 SFSPGSFSGLTSLENLVAVETKLASLESFPIGQ----LITLKKLNVAHNFIHSCKLPAYF 149
Query: 184 DSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLH 243
+ +NL ++ LSYN ++ + L +S
Sbjct: 150 SNLTNLVHVDLSYNYIQTITVNDL--QFLRENPQVNLSLDMSL----------------- 190
Query: 244 KNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVIS-LPALLNISLQNNKLQGPYP--- 299
N + L +L+LR N + + + + L L L + +
Sbjct: 191 -NPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEI 249
Query: 300 --------LFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWE 351
L + + L + N + V+ + L+
Sbjct: 250 FEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCL-ANVSAM-----------SLA---- 293
Query: 352 GNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGL 411
G + + + ++I +L +L LK+L L N + I
Sbjct: 294 GVSIKYLEDVPKHFKWQSLSII-RCQL--KQFPTL--DLPFLKSLTLTMNKGS--ISFKK 346
Query: 412 TKLASLQNLDVSNNNLSGKVPDFGSNVKFT 441
L SL LD+S N LS S++
Sbjct: 347 VALPSLSYLDLSRNALSFSGCCSYSDLGTN 376
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-24
Identities = 53/342 (15%), Positives = 107/342 (31%), Gaps = 38/342 (11%)
Query: 104 GAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNP--NLAPWPFPNELTK 161
G++ + + VP ++ + + LS NP L + F N
Sbjct: 2 GSLNPCIEVVPNITYQCMDQKLSKVPDDIP---SSTKNIDLSFNPLKILKSYSFSN---- 54
Query: 162 STSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQ 221
+ L L + I + + +L NL L+ N P SF S + +L +
Sbjct: 55 FSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSF--SGLTSL----EN 108
Query: 222 LGLSGTL------DVLSGMTQLRQVWLHKNQFTG-PIPD-LSKCESLFDLSLRDNQLTGV 273
L T + + L+++ + N +P S +L + L N + +
Sbjct: 109 LVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTI 168
Query: 274 VPASVISL----PALLNISLQNNKLQG--PYPLFPSKVQKVSLDHNNFCKNSSDAGKPCD 327
+ L L++ + N + K+ +++L N NSS+ K C
Sbjct: 169 TVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNF---NSSNIMKTCL 225
Query: 328 PQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAY 387
+ L +G + + I L + +
Sbjct: 226 QNLAGLHVHRLILGEFKDERNLEIFEPS----IMEGLCDVTIDEFRLTYTNDFSDDIVKF 281
Query: 388 ANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSG 429
L ++ + L ++ + + K Q+L + L
Sbjct: 282 HCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQ 321
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 37/269 (13%), Positives = 70/269 (26%), Gaps = 91/269 (33%)
Query: 179 IPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLR 238
+PD D S+ +N+ LS+N SF S ++L+
Sbjct: 26 VPD--DIPSSTKNIDLSFNPLKILKSYSF------------------------SNFSELQ 59
Query: 239 QVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGP 297
+ L + + L +L L N + P S L +L
Sbjct: 60 WLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSL------------- 106
Query: 298 YPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACD 357
+ + S + L ++
Sbjct: 107 --------ENLVAVETKLASLESFPIGQL-ITLKKL-----------NVAH--------- 137
Query: 358 GWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKL--- 414
N + + + ++NLT+L ++ L N + + L L
Sbjct: 138 ------------------NFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLREN 179
Query: 415 -ASLQNLDVSNNNLSGKVPDFGSNVKFTV 442
+LD+S N + +K
Sbjct: 180 PQVNLSLDMSLNPIDFIQDQAFQGIKLHE 208
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-34
Identities = 84/375 (22%), Positives = 145/375 (38%), Gaps = 49/375 (13%)
Query: 68 VTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTS 127
L K+ ++ T+S + L Q+ TL I I + +L I NN T
Sbjct: 26 KMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNNQLTD 82
Query: 128 VPTGCFDGLTNLQVLSLSDNP--NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDS 185
+ LT L + +++N ++ P L T+LT L + N I + P +
Sbjct: 83 ITP--LKNLTKLVDILMNNNQIADITP------LANLTNLTGLTLFNNQITDIDP--LKN 132
Query: 186 FSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKN 245
+NL L LS N + + A + +Q L +Q L L+ +T L ++ + N
Sbjct: 133 LTNLNRLELSSNTIS-DISALSGLTSLQQLSFGNQVTDLKP----LANLTTLERLDISSN 187
Query: 246 QFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFP-SK 304
+ + I L+K +L L +NQ++ + P L L +SL N+L+ L +
Sbjct: 188 KVSD-ISVLAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKDIGTLASLTN 244
Query: 305 VQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTC 364
+ + L +N + +G ++T L L N + P
Sbjct: 245 LTDLDLANNQISNLAPLSGL---TKLTEL-----------KLG----ANQISNISPLAGL 286
Query: 365 SQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSN 424
+ + + L L +NL +L L L NN++ P ++ L LQ L N
Sbjct: 287 TA--LTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYN 340
Query: 425 NNLSGKVPDFGSNVK 439
N +S V +
Sbjct: 341 NKVSD-VSSLANLTN 354
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-34
Identities = 82/373 (21%), Positives = 147/373 (39%), Gaps = 48/373 (12%)
Query: 60 INCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIY 119
++ + ++VTT+ + G+ + L L ++F N + I L N T L DI
Sbjct: 40 VSQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTD-ITPLKNLTKLVDIL 96
Query: 120 LDNNNFTSVPTGCFDGLTNLQVLSLSDNP--NLAPWPFPNELTKSTSLTTLYMDNANIFG 177
++NN + LTNL L+L +N ++ P L T+L L + + I
Sbjct: 97 MNNNQIADITP--LANLTNLTGLTLFNNQITDIDP------LKNLTNLNRLELSSNTISD 148
Query: 178 LIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQL 237
+ ++LQ L N T P + + ++ L ++ ++ + VL+ +T L
Sbjct: 149 ISA--LSGLTSLQQLSFG-NQVTDLKPLANLTT-LERLDISSNKV---SDISVLAKLTNL 201
Query: 238 RQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGP 297
+ NQ + I L +L +LSL NQL + + SL L ++ L NN++
Sbjct: 202 ESLIATNNQISD-ITPLGILTNLDELSLNGNQLKDIGTLA--SLTNLTDLDLANNQISNL 258
Query: 298 YPLFP-SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNAC 356
PL +K+ ++ L N S AG +T L N
Sbjct: 259 APLSGLTKLTELKLGANQISNISPLAGL---TALTNL---------------ELNENQLE 300
Query: 357 DGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLAS 416
D P + + L ++ ++LT L+ L+ N ++ L L +
Sbjct: 301 DISPISNLKN--LTYLTLYFNNISD--ISPVSSLTKLQRLFFYNNKVSD--VSSLANLTN 354
Query: 417 LQNLDVSNNNLSG 429
+ L +N +S
Sbjct: 355 INWLSAGHNQISD 367
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-33
Identities = 72/357 (20%), Positives = 137/357 (38%), Gaps = 64/357 (17%)
Query: 84 PEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLS 143
+++LT L L+ N I I L N T+L + L +N + + GLT+LQ LS
Sbjct: 106 TPLANLTNLTGLTLFNNQITD-IDPLKNLTNLNRLELSSNTISDISA--LSGLTSLQQLS 162
Query: 144 LSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSL 203
+ L T+L L + + + + +NL++L + N +
Sbjct: 163 FGNQVT-----DLKPLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDIT 215
Query: 204 PASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDL 263
P + + L +N QL + L+ +T L + L NQ + + LS L +L
Sbjct: 216 PLGILTN-LDELSLNGNQLK---DIGTLASLTNLTDLDLANNQISN-LAPLSGLTKLTEL 270
Query: 264 SLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPL-FPSKVQKVSLDHNNFCKNSSDA 322
L NQ++ + P + L AL N+ L N+L+ P+ + ++L N
Sbjct: 271 KLGANQISNISPLA--GLTALTNLELNENQLEDISPISNLKNLTYLTLYFN--------- 319
Query: 323 GKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGN 382
++ + P + ++ + + NK+ +
Sbjct: 320 ------NISDIS-------------------------PVSSLTKLQRLFFY-NNKV---S 344
Query: 383 ISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVK 439
+ ANLT++ L N ++ P L L + L +++ + ++ +NV
Sbjct: 345 DVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVS 399
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 7e-32
Identities = 75/353 (21%), Positives = 135/353 (38%), Gaps = 45/353 (12%)
Query: 84 PEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLS 143
+S LT L+ LSF N + + LAN T+L+ + + +N + + LTNL+ L
Sbjct: 150 SALSGLTSLQQLSFG-NQVTD-LKPLANLTTLERLDISSNKVSDISV--LAKLTNLESLI 205
Query: 144 LSDNP--NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTG 201
++N ++ P L T+L L ++ + + S +NL +L L+ N +
Sbjct: 206 ATNNQISDITP------LGILTNLDELSLNGNQLKDIGT--LASLTNLTDLDLANNQISN 257
Query: 202 SLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLF 261
P S + L + Q+ + L+G+T L + L++NQ I +S ++L
Sbjct: 258 LAPLSGLTK-LTELKLGANQIS---NISPLAGLTALTNLELNENQLED-ISPISNLKNLT 312
Query: 262 DLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPL-FPSKVQKVSLDHNNFCKNSS 320
L+L N ++ + P S SL L + NNK+ L + + +S HN +
Sbjct: 313 YLTLYFNNISDISPVS--SLTKLQRLFFYNNKVSDVSSLANLTNINWLSAGHNQISDLTP 370
Query: 321 DAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLA 380
A ++T L + A P + I N +
Sbjct: 371 LANLT---RITQL----------------GLNDQAWTNAPVNYKANVSIP--NTVKNVTG 409
Query: 381 GNISPAY-ANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVP 432
I+PA ++ S + N + + + + SG V
Sbjct: 410 ALIAPATISDGGSYTEPDITWNLPSY-TNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-23
Identities = 50/257 (19%), Positives = 97/257 (37%), Gaps = 34/257 (13%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNN 123
N N++ I ++SLT L L N I+ + L+ T L ++ L N
Sbjct: 229 NGNQLKDI------------GTLASLTNLTDLDLANNQISN-LAPLSGLTKLTELKLGAN 275
Query: 124 NFTSVPTGCFDGLTNLQVLSLSDNP--NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPD 181
+++ GLT L L L++N +++P ++ +LT L + NI + P
Sbjct: 276 QISNISP--LAGLTALTNLELNENQLEDISP------ISNLKNLTYLTLYFNNISDISP- 326
Query: 182 FFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVW 241
S + LQ L N + + + ++I L Q+ L L+ +T++ Q+
Sbjct: 327 -VSSLTKLQRLFFYNNKVS-DVSSLANLTNINWLSAGHNQIS---DLTPLANLTRITQLG 381
Query: 242 LHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPL- 300
L+ +T + S+ + + PA++ + + N +
Sbjct: 382 LNDQAWTNAPVNYKANVSIPNTVKNVTGAL-IAPATISDGGSYTEPDITWNLPSYTNEVS 440
Query: 301 --FPSKVQKVSLDHNNF 315
F S+ + F
Sbjct: 441 YTF-SQPVTIGKGTTTF 456
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-18
Identities = 58/313 (18%), Positives = 99/313 (31%), Gaps = 85/313 (27%)
Query: 118 IYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFG 177
+ + T L L T +TTL D I
Sbjct: 7 TITQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVS----QTDLDQVTTLQADRLGIKS 60
Query: 178 LIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQL 237
+ D + +NL + S N T + L +T+L
Sbjct: 61 I--DGVEYLNNLTQINFSNNQLTD--------------------------ITPLKNLTKL 92
Query: 238 RQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGP 297
+ ++ NQ I L+ +L L+L +NQ+T + P +L L + L +N +
Sbjct: 93 VDILMNNNQIAD-ITPLANLTNLTGLTLFNNQITDIDPLK--NLTNLNRLELSSNTISDI 149
Query: 298 YPLFP-SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNAC 356
L + +Q++S GN
Sbjct: 150 SALSGLTSLQQLSF-----------------------------------------GNQVT 168
Query: 357 DGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLAS 416
D P + + I+ +NK+ +IS A LT+L++L N ++ P L L +
Sbjct: 169 DLKPLANLTTLERLDIS-SNKV--SDISV-LAKLTNLESLIATNNQISDITP--LGILTN 222
Query: 417 LQNLDVSNNNLSG 429
L L ++ N L
Sbjct: 223 LDELSLNGNQLKD 235
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 6e-16
Identities = 56/297 (18%), Positives = 101/297 (34%), Gaps = 52/297 (17%)
Query: 163 TSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQL 222
+ + I + D + + L N T ++ + + L + +
Sbjct: 2 PLGSATITQDTPINQIFTD--TALAEKMKTVLGKTNVTDTVSQTDLDQ-VTTLQADRLGI 58
Query: 223 GLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLP 282
++D + + L Q+ NQ T I L L D+ + +NQ+ + P + +L
Sbjct: 59 K---SIDGVEYLNNLTQINFSNNQLTD-ITPLKNLTKLVDILMNNNQIADITPLA--NLT 112
Query: 283 ALLNISLQNNKLQGPYPLFP-SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMG 341
L ++L NN++ PL + + ++ L N ++ L
Sbjct: 113 NLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISD---------ISALSGLTS------ 157
Query: 342 YPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKL----------------LAGN-IS 384
L GN D P + + I+ +NK+ N IS
Sbjct: 158 ----LQQLSFGNQVTDLKPLANLTTLERLDIS-SNKVSDISVLAKLTNLESLIATNNQIS 212
Query: 385 --PAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVK 439
LT+L L L N L L L +L +LD++NN +S + K
Sbjct: 213 DITPLGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISN-LAPLSGLTK 266
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 48/167 (28%), Positives = 81/167 (48%), Gaps = 24/167 (14%)
Query: 587 NILGRGGFGVVYGGELPD--------GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-R 637
LG G FG V E +AVK ++ + K LS+ +E+ ++ + +
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGK 99
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHL-----------FEWHDHGYTPLTWKQR 686
H++++ LLG C ++ EY +G L ++L ++ + +T+K
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 687 VTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733
V+ +ARG+EY LA Q IHRDL N+L+ ++ K+ADFGL
Sbjct: 160 VSCTYQLARGMEY---LASQKCIHRDLAARNVLVTENNVMKIADFGL 203
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 5e-34
Identities = 53/165 (32%), Positives = 83/165 (50%), Gaps = 24/165 (14%)
Query: 589 LGRGGFGVVYGGELPD--------GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHR 639
LG G FG V E TK+AVK ++S+ K LS+ +E+ ++ + +H+
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHK 135
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHL-----------FEWHDHGYTPLTWKQRVT 688
+++ LLG C ++ EY +G L ++L + + L+ K V+
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195
Query: 689 IALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733
A VARG+EYL A + IHRDL N+L+ +D K+ADFGL
Sbjct: 196 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGL 237
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-34
Identities = 47/172 (27%), Positives = 71/172 (41%), Gaps = 29/172 (16%)
Query: 587 NILGRGGFGVVYGGELPDG------TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
LG G FG V T +AVK ++ N L + +E VL +V H H
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS-PSELRDLLSEFNVLKQVNHPH 87
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHL-------------------FEWHDHGYTPL 681
++ L G C LL+ EY G+L L L
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 682 TWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733
T ++ A +++G++Y LA+ +HRDL NIL+ + + K++DFGL
Sbjct: 148 TMGDLISFAWQISQGMQY---LAEMKLVHRDLAARNILVAEGRKMKISDFGL 196
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 6e-34
Identities = 48/167 (28%), Positives = 82/167 (49%), Gaps = 24/167 (14%)
Query: 587 NILGRGGFGVVYGGEL--------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-R 637
LG G FG V E + +AVK ++ + K LS+ +E+ ++ + +
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGK 145
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHL-----------FEWHDHGYTPLTWKQR 686
H++++ LLG C ++ EY +G L ++L ++ + +T+K
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 687 VTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733
V+ +ARG+EY LA Q IHRDL N+L+ ++ K+ADFGL
Sbjct: 206 VSCTYQLARGMEY---LASQKCIHRDLAARNVLVTENNVMKIADFGL 249
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-34
Identities = 45/160 (28%), Positives = 77/160 (48%), Gaps = 10/160 (6%)
Query: 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646
LG G FG V+ TK+AVK M+ +M + F AE V+ ++H LV L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHA 250
Query: 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ 706
++ E+M +G+L L + + + + +A G+ ++ Q+
Sbjct: 251 VVT-KEPIYIITEFMAKGSLLDFL---KSDEGSKQPLPKLIDFSAQIAEGMAFI---EQR 303
Query: 707 SFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVET 746
++IHRDL+ +NIL+ + K+ADFGL + D +Y+
Sbjct: 304 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE 343
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 8e-34
Identities = 53/172 (30%), Positives = 78/172 (45%), Gaps = 21/172 (12%)
Query: 587 NILGRGGFGVVYGGELPDG------TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
LG G FG V+ E + +AVK ++ + +FQ E +LT ++H+H
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE--SARQDFQREAELLTMLQHQH 104
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHL----------FEWHDHGYTPLTWKQRVTIA 690
+V G C G L+V+EYM G L + L D PL Q + +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 691 LDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742
VA G+ YL A F+HRDL N L+G + K+ DFG+ ++ Y
Sbjct: 165 SQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY 213
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-33
Identities = 55/172 (31%), Positives = 86/172 (50%), Gaps = 10/172 (5%)
Query: 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646
LG+G FG V+ G T++A+K ++ TM + F E V+ K+RH LV L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLVQLYA 329
Query: 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ 706
+ +V EYM +G+L L L Q V +A +A G+ Y+
Sbjct: 330 VV-SEEPIYIVTEYMSKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYVER---M 382
Query: 707 SFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
+++HRDL+ +NIL+G+++ KVADFGL + D +Y+ + APE
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 434
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 51/162 (31%), Positives = 76/162 (46%), Gaps = 22/162 (13%)
Query: 589 LGRGGFGVVYGGELPDG------TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
LG G FG V+ E + +AVK ++ T+ +FQ E +LT ++H H+V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL--AARKDFQREAELLTNLQHEHIV 80
Query: 643 ALLGYCINGSERLLVYEYMPRGTLAQHL-----------FEWHDHGYTPLTWKQRVTIAL 691
G C +G ++V+EYM G L + L L Q + IA
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 692 DVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733
+A G+ YL A Q F+HRDL N L+G ++ K+ DFG+
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGM 179
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 45/170 (26%), Positives = 76/170 (44%), Gaps = 12/170 (7%)
Query: 587 NILGRGGFGVVYGGELPDG----TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
I+G G G V G L +A+K +++ + +F +E +++ + H +++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT-ERQRRDFLSEASIMGQFDHPNII 113
Query: 643 ALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHS 702
L G G ++V EYM G+L L H T Q V + V G+ YL
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFL---RTHDGQ-FTIMQLVGMLRGVGAGMRYL-- 167
Query: 703 LAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTF 752
+ ++HRDL N+L+ ++ KV+DFGL + D + T G
Sbjct: 168 -SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI 216
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 46/169 (27%), Positives = 84/169 (49%), Gaps = 17/169 (10%)
Query: 587 NILGRGGFGVVYGGELP-----DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHL 641
LG G FG V G ++AVK ++ + G +++ + EI +L + H ++
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENI 85
Query: 642 VALLGYCINGSER--LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
V G C L+ E++P G+L ++L + + KQ++ A+ + +G++Y
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKNK-INLKQQLKYAVQICKGMDY 141
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK--YSVET 746
L S + ++HRDL N+L+ + + K+ DFGL K K Y+V+
Sbjct: 142 LGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD 187
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-33
Identities = 42/163 (25%), Positives = 72/163 (44%), Gaps = 20/163 (12%)
Query: 587 NILGRGGFGVVYGGELPD------GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHR 639
LG G FG V K+AVK ++S +E+ +++ + +H
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH-ADEKEALMSELKIMSHLGQHE 110
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHL---------FEWHDHGYTPLTWKQRVTIA 690
++V LLG C +G L++ EY G L L + + + + +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 691 LDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733
VA+G+ +L A ++ IHRD+ N+L+ + AK+ DFGL
Sbjct: 171 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGL 210
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 55/170 (32%), Positives = 81/170 (47%), Gaps = 19/170 (11%)
Query: 587 NILGRGGFGVVYGGEL---PDGTKI--AVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHL 641
LG G FG V DGT AVK ++++ G + S ++ EI +L + H H+
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLYHEHI 95
Query: 642 VALLGYCINGSER--LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
+ G C + LV EY+P G+L +L H + Q + A + G+ Y
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL---PRH---SIGLAQLLLFAQQICEGMAY 149
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK--YSVETR 747
LH+ Q +IHRDL N+L+ +D K+ DFGL K P+G Y V
Sbjct: 150 LHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED 196
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 45/166 (27%), Positives = 72/166 (43%), Gaps = 23/166 (13%)
Query: 587 NILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHR 639
LGRG FG V + +AVK ++ + +E+ +L + H
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHL 91
Query: 640 HLVALLGYC-INGSERLLVYEYMPRGTLAQHL-----------FEWHDHGYTPLTWKQRV 687
++V LLG C G +++ E+ G L+ +L D LT + +
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 688 TIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733
+ VA+G+E+L A + IHRDL NIL+ + K+ DFGL
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGL 194
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 44/167 (26%), Positives = 68/167 (40%), Gaps = 24/167 (14%)
Query: 587 NILGRGGFGVVYGGELPD------GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHR 639
LG G FG V +AVK ++ + +E+ VL+ + H
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHM 87
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHL-------------FEWHDHGYTPLTWKQR 686
++V LLG C G L++ EY G L L + L +
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 687 VTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733
++ + VA+G+ +L A ++ IHRDL NIL+ K+ DFGL
Sbjct: 148 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGL 191
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-33
Identities = 43/172 (25%), Positives = 72/172 (41%), Gaps = 29/172 (16%)
Query: 587 NILGRGGFGVVYGGELPDG------TKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHR 639
+LG G FG V ++AVK ++ + +E+ ++T++ H
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHE 109
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHL------------------FEWHDHGYTPL 681
++V LLG C L++EY G L +L + L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 682 TWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733
T++ + A VA+G+E+L +S +HRDL N+L+ K+ DFGL
Sbjct: 170 TFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGL 218
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-33
Identities = 45/170 (26%), Positives = 78/170 (45%), Gaps = 13/170 (7%)
Query: 588 ILGRGGFGVVYGGEL-----PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
++G G FG VY G L +A+K +++ K +F E ++ + H +++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT-EKQRVDFLGEAGIMGQFSHHNII 109
Query: 643 ALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHS 702
L G +++ EYM G L + L + + Q V + +A G++YL
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFL---REKDGE-FSVLQLVGMLRGIAAGMKYL-- 163
Query: 703 LAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTF 752
A +++HRDL NIL+ ++ KV+DFGL + D + T G
Sbjct: 164 -ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 212
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-33
Identities = 50/178 (28%), Positives = 81/178 (45%), Gaps = 14/178 (7%)
Query: 587 NILGRGGFGVVYGGELPDGTK----IAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
++G G FG V G L +K +A+K ++ K +F E +++ + H +++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT-EKQRRDFLGEASIMGQFDHPNII 109
Query: 643 ALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHS 702
L G ++V EYM G+L L H T Q V + +A G++YL
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQ-FTVIQLVGMLRGIASGMKYL-- 163
Query: 703 LAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYL--APE 758
+ ++HRDL NILI ++ KV+DFGL + D + T G +PE
Sbjct: 164 -SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPE 220
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-33
Identities = 52/172 (30%), Positives = 81/172 (47%), Gaps = 29/172 (16%)
Query: 587 NILGRGGFGVVYGGELPDG------TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
+G G FG V+ P T +AVK ++ ++FQ E A++ + + +
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDNPN 111
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHL-------------------FEWHDHGYTPL 681
+V LLG C G L++EYM G L + L G PL
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 682 TWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733
+ +++ IA VA G+ Y L+++ F+HRDL N L+G++M K+ADFGL
Sbjct: 172 SCAEQLCIARQVAAGMAY---LSERKFVHRDLATRNCLVGENMVVKIADFGL 220
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 39/164 (23%), Positives = 67/164 (40%), Gaps = 21/164 (12%)
Query: 587 NILGRGGFGVVYGGELPDG------TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
LG FG VY G L +A+K ++ EF+ E + +++H +
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE-GPLREEFRHEAMLRARLQHPN 73
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHL-----------FEWHDHGYTPLTWKQRVTI 689
+V LLG +++ Y G L + L + + L V +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 690 ALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733
+A G+EYL + +H+DL N+L+ D + K++D GL
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGL 174
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 46/167 (27%), Positives = 75/167 (44%), Gaps = 15/167 (8%)
Query: 587 NILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
LG G FG VY G++ P ++AVK + + +F E +++K H++
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS-EQDELDFLMEALIISKFNHQN 94
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHG--YTPLTWKQRVTIALDVARGVE 698
+V +G + R ++ E M G L L E + L + +A D+A G +
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 699 YLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGKY 742
Y L + FIHRD+ N L+ G AK+ DFG+ ++ Y
Sbjct: 155 Y---LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 198
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 49/152 (32%), Positives = 75/152 (49%), Gaps = 13/152 (8%)
Query: 587 NILGRGGFGVVYGGELPDG----TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
++G+G FGVVY GE D + A+K + T + + F E ++ + H +++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVL 85
Query: 643 ALLGYCINGSERLL-VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLH 701
AL+G + + YM G L Q + T K ++ L VARG+EYL
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFI---RSPQRN-PTVKDLISFGLQVARGMEYL- 140
Query: 702 SLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733
A+Q F+HRDL N ++ + KVADFGL
Sbjct: 141 --AEQKFVHRDLAARNCMLDESFTVKVADFGL 170
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-32
Identities = 61/366 (16%), Positives = 127/366 (34%), Gaps = 68/366 (18%)
Query: 71 ISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPS--LANATSLQDIYLDNNNFTSV 128
+ + E +L + ++F+ + + +P+ L + ++ + L++ +
Sbjct: 26 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEI 84
Query: 129 PTGCFDGLTNLQVLSLSDN--PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSF 186
T F +Q L + N L P F N LT L ++ ++ L F +
Sbjct: 85 DTYAFAYAHTIQKLYMGFNAIRYLPPHVFQN----VPLLTVLVLERNDLSSLPRGIFHNT 140
Query: 187 SNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQ 246
L L +S NN + D T L+ + L N+
Sbjct: 141 PKLTTLSMSNNNLE-RIED-----------------------DTFQATTSLQNLQLSSNR 176
Query: 247 FTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQ 306
T + LS SLF ++ N L+ ++ A+ + +N + ++
Sbjct: 177 LTH-VD-LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVELT 229
Query: 307 KVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGY---PAILSDSWEGNNACDGWPFVT 363
+ L HNN + P + + D+ Y I+ +
Sbjct: 230 ILKLQHNNL--TDTAWLLNY-PGLVEV-----DLSYNELEKIMYHPFVKMQ--------- 272
Query: 364 CSQGRIITINLA-NKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDV 422
R+ + ++ N+L ++ + +LK L L N+L + + L+NL +
Sbjct: 273 ----RLERLYISNNRL--VALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYL 325
Query: 423 SNNNLS 428
+N++
Sbjct: 326 DHNSIV 331
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-32
Identities = 78/371 (21%), Positives = 139/371 (37%), Gaps = 71/371 (19%)
Query: 66 NRVTTISLAKSGLSGTLSPEI-SSLTQLETLSFQMNNIAGAIP--SLANATSLQDIYLDN 122
N ++ S + L + S Q+E L+ I I + A A ++Q +Y+
Sbjct: 45 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGF 102
Query: 123 NNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDF 182
N +P F + L VL L N +L+ P + LTTL M N N+ + D
Sbjct: 103 NAIRYLPPHVFQNVPLLTVLVLERN-DLSSLP-RGIFHNTPKLTTLSMSNNNLERIEDDT 160
Query: 183 FDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSG-TLDVLSGMTQLRQVW 241
F + ++LQNL+LS N T S I +L +S L L+ + ++
Sbjct: 161 FQATTSLQNLQLSSNRLT-----HVDLSLIPSL----FHANVSYNLLSTLAIPIAVEELD 211
Query: 242 LHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG-PYPL 300
N + L L L+ N LT A +++ P L+ + L N+L+ Y
Sbjct: 212 ASHNSINV-VRGPV-NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHP 267
Query: 301 FP--SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDG 358
F +++++ + +N ++ L
Sbjct: 268 FVKMQRLERLYISNN---------------RLVAL------------------------- 287
Query: 359 WPFVTCSQGRIITINLA-NKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASL 417
+ ++L+ N LL ++ L+NLYL N++ + +L
Sbjct: 288 -NLYGQPIPTLKVLDLSHNHLL--HVERNQPQFDRLENLYLDHNSIV-TLKLST--HHTL 341
Query: 418 QNLDVSNNNLS 428
+NL +S+N+
Sbjct: 342 KNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 4e-22
Identities = 53/325 (16%), Positives = 102/325 (31%), Gaps = 59/325 (18%)
Query: 108 SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTT 167
+L D+++D L N ++++ ++ + P L +
Sbjct: 16 NLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNS-TMRKLP-AALLDSFRQVEL 73
Query: 168 LYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGT 227
L +++ I + F +Q L + +N LP
Sbjct: 74 LNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPP---------------------- 110
Query: 228 LDVLSGMTQLRQVWLHKNQFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASVISLPALL 285
V + L + L +N + +P L LS+ +N L + + + +L
Sbjct: 111 -HVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQ 168
Query: 286 NISLQNNKLQG-PYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPA 344
N+ L +N+L L PS + ++ +N V L
Sbjct: 169 NLQLSSNRLTHVDLSLIPS-LFHANVSYNLLST------LAIPIAVEEL----------- 210
Query: 345 ILSDSWEGNNACDGWPFVTCSQGRIITINLA-NKLLAGNISPAYANLTSLKNLYLQQNNL 403
S +N+ + + + + L N L + N L + L N L
Sbjct: 211 DAS-----HNSINVVRGPVNVE--LTILKLQHNNLTD---TAWLLNYPGLVEVDLSYNEL 260
Query: 404 TGPIPDGLTKLASLQNLDVSNNNLS 428
+ K+ L+ L +SNN L
Sbjct: 261 EKIMYHPFVKMQRLERLYISNNRLV 285
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-21
Identities = 39/252 (15%), Positives = 81/252 (32%), Gaps = 53/252 (21%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNN 123
+SNR+T + L S + L + N ++ +LA +++++ +N
Sbjct: 173 SSNRLTHVDL-------------SLIPSLFHANVSYNLLS----TLAIPIAVEELDASHN 215
Query: 124 NFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFF 183
+ V L +L L N NL + L + + + ++ F
Sbjct: 216 SINVVRGPVN---VELTILKLQHN-NLTDTAWLLNYP---GLVEVDLSYNELEKIMYHPF 268
Query: 184 DSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLH 243
L+ L +S N +L + L+ + L
Sbjct: 269 VKMQRLERLYISNNRLV-ALNLYG------------------------QPIPTLKVLDLS 303
Query: 244 KNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG-PYPLFP 302
N + + + L +L L N + + S + L N++L +N
Sbjct: 304 HNHLLHVERNQPQFDRLENLYLDHNSIV-TLKLS--THHTLKNLTLSHNDWDCNSLRALF 360
Query: 303 SKVQKVSLDHNN 314
V + ++D +
Sbjct: 361 RNVARPAVDDAD 372
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 8e-13
Identities = 37/324 (11%), Positives = 87/324 (26%), Gaps = 91/324 (28%)
Query: 121 DNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIP 180
+ + + + + + F E + + N+ + L
Sbjct: 6 RQPEYKCIDSNLQYDCV-FYDVHIDMQTQDVYFGF--EDITLNNQKIVTFKNSTMRKLPA 62
Query: 181 DFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQV 240
DSF ++ L L+ + + ++++
Sbjct: 63 ALLDSFRQVELLNLNDLQIE-EIDT-----------------------YAFAYAHTIQKL 98
Query: 241 WLHKNQFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPY 298
++ N +P L L L N L+ + + P L
Sbjct: 99 YMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKL-------------- 143
Query: 299 PLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDG 358
+S+ +NN + D + + L LS +N
Sbjct: 144 -------TTLSMSNNNLERIEDDTFQAT-TSLQNL-----------QLS-----SN---- 175
Query: 359 WPFVTCSQGRIITI------NLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLT 412
R+ + +L + ++ N+ A +++ L N++ + +
Sbjct: 176 ---------RLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINV-VRGPV- 224
Query: 413 KLASLQNLDVSNNNLSGKVPDFGS 436
L L + +NNL+ +
Sbjct: 225 -NVELTILKLQHNNLT-DTAWLLN 246
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 51/152 (33%), Positives = 74/152 (48%), Gaps = 13/152 (8%)
Query: 587 NILGRGGFGVVYGGELPDG----TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
++GRG FG VY G L D AVK + T +S+F E ++ H +++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMKDFSHPNVL 89
Query: 643 ALLGYCINGSE-RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLH 701
+LLG C+ L+V YM G L + H T K + L VA+G++YL
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETH---NPTVKDLIGFGLQVAKGMKYL- 144
Query: 702 SLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733
A + F+HRDL N ++ + KVADFGL
Sbjct: 145 --ASKKFVHRDLAARNCMLDEKFTVKVADFGL 174
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-32
Identities = 63/361 (17%), Positives = 114/361 (31%), Gaps = 41/361 (11%)
Query: 86 ISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144
SL+ L TL N I + + +SLQ + N S+ L L+ L++
Sbjct: 72 YQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131
Query: 145 SDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQN----LRLSYNNFT 200
+ N + + P + T+L L + + I + + L LS N
Sbjct: 132 AHN-LIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190
Query: 201 GSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTG-------PIPD 253
P +F + + L + + L+ + G+ L L +F
Sbjct: 191 FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
Query: 254 LSKCESLFDLSLRDNQLTGV---VPASVISLPALLNISLQNNKLQG-PYPLFPSKVQKVS 309
L +L R L + L + + SL + ++ + Q +
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLE 310
Query: 310 LDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRI 369
L + F + + + L + V
Sbjct: 311 LVNCKFGQFPTLK----LKSLKRL-----TFTSNKGGNAF----------SEVDLPSLE- 350
Query: 370 ITINLA-NKL-LAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNL 427
++L+ N L G S + TSLK L L N + + L L++LD ++NL
Sbjct: 351 -FLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNL 408
Query: 428 S 428
Sbjct: 409 K 409
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-31
Identities = 61/386 (15%), Positives = 121/386 (31%), Gaps = 48/386 (12%)
Query: 69 TTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIA--GAIPSLANATSLQDIYLDNNNFT 126
+ ++ L+ + I L L+ L+ N I +N T+L+ + L +N
Sbjct: 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162
Query: 127 SVPTGCFDGLTNLQV----LSLSDNP--NLAPWPFPNELTKSTSLTTLYM-DNANIFGLI 179
S+ L + + L LS NP + P F K L L + +N + ++
Sbjct: 163 SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-----KEIRLHKLTLRNNFDSLNVM 217
Query: 180 PDFFDSFSNLQNLRLSYNNFTG---------SLPASFAKSDIQNLWMNDQQLGLSGTLDV 230
+ L+ RL F S I+ + L +D+
Sbjct: 218 KTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDL 277
Query: 231 LSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQ 290
+ +T + L + D S L L + + + L +L ++
Sbjct: 278 FNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVNCKFGQF---PTLKLKSLKRLTFT 333
Query: 291 NNKLQGPYPLFP-SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDS 349
+NK + ++ + L N + D T+L + LS
Sbjct: 334 SNKGGNAFSEVDLPSLEFLDLSRNGL--SFKGCCSQSDFGTTSLKYL--------DLS-- 381
Query: 350 WEGNNACDGWPFVTCSQGRIITINLA-NKLLAGNISPAYA--NLTSLKNLYLQQNNLTGP 406
N ++ ++ + L +S +L +L L + +
Sbjct: 382 ---FNGVITMSSNFLGLEQLEHLDFQHSNL--KQMSEFSVFLSLRNLIYLDISHTHTRVA 436
Query: 407 IPDGLTKLASLQNLDVSNNNLSGKVP 432
L+SL+ L ++ N+
Sbjct: 437 FNGIFNGLSSLEVLKMAGNSFQENFL 462
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-28
Identities = 68/371 (18%), Positives = 124/371 (33%), Gaps = 44/371 (11%)
Query: 90 TQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNP 148
+ L N + S + LQ + L ++ G + L++L L L+ NP
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 149 --NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFT-GSLPA 205
+LA + +SL L N+ L L+ L +++N LP
Sbjct: 88 IQSLA----LGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPE 143
Query: 206 SFAK-SDIQNLWMNDQQLG--LSGTLDVLSGMTQLRQVW-LHKNQFTGPIPDLSKCESLF 261
F+ +++++L ++ ++ L VL M L L N P K L
Sbjct: 144 YFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLH 203
Query: 262 DLSLRDNQLTGVVPASVIS-LPAL------LNISLQNNKLQGPYPLFPSKVQKVSLDHNN 314
L+LR+N + V + I L L L L+ + ++++
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263
Query: 315 FCKNSSDAGKPCDP---------------QVTTLLQIAGDMGYPAILSDSWEGNNACDGW 359
D + + + + G N +
Sbjct: 264 LAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFG----WQHLELVNCKFGQF 319
Query: 360 PFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLT--GPIPDGLTKLASL 417
P + + +T +NK + + +L SL+ L L +N L+ G SL
Sbjct: 320 PTLKLKSLKRLTFT-SNKG---GNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSL 375
Query: 418 QNLDVSNNNLS 428
+ LD+S N +
Sbjct: 376 KYLDLSFNGVI 386
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-26
Identities = 73/385 (18%), Positives = 131/385 (34%), Gaps = 42/385 (10%)
Query: 63 DNSNRVTTISLAKSGLSGTLSPEISSLTQLE----TLSFQMNNIAGAIPSLANATSLQDI 118
N + + L+ + + ++ L Q+ +L +N + P L +
Sbjct: 146 SNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKL 205
Query: 119 YLDNNNFT-SVPTGCFDGLTNLQVLSLS-----DNPNLAPWPFPNELTKSTSLTTLYMDN 172
L NN + +V C GL L+V L + NL + + L +LT
Sbjct: 206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD-KSALEGLCNLTIEEFRL 264
Query: 173 ANIFGLIPDFFDSFSNLQNLR---LSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLD 229
A + + D D F+ L N+ L S+ Q+L + + + G TL
Sbjct: 265 AYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFG-WQHLELVNCKFGQFPTL- 322
Query: 230 VLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLT--GVVPASVISLPALLNI 287
+ L+++ N+ SL L L N L+ G S +L +
Sbjct: 323 ---KLKSLKRLTFTSNKGGN-AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYL 378
Query: 288 SLQNNKLQGPYPLFP--SKVQKVSLDHNNFCKNSSDAGKPCD-PQVTTLLQIAGDMGYPA 344
L N + F +++ + H+N K S+ + L D+ +
Sbjct: 379 DLSFNGVITMSSNFLGLEQLEHLDFQHSNL-KQMSEFSVFLSLRNLIYL-----DISHTH 432
Query: 345 ILSDSWEGNNACDGWPFVTCSQGRIITINLA-NKLLAGNISPAYANLTSLKNLYLQQNNL 403
+G + + +A N + + L +L L L Q L
Sbjct: 433 TRVAFNG---IFNGLS-------SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 482
Query: 404 TGPIPDGLTKLASLQNLDVSNNNLS 428
P L+SLQ L++++N L
Sbjct: 483 EQLSPTAFNSLSSLQVLNMASNQLK 507
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-26
Identities = 48/251 (19%), Positives = 94/251 (37%), Gaps = 21/251 (8%)
Query: 76 SGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDG 135
++ + S + L P+L SL+ + +N + +
Sbjct: 290 VSVTIERVKDFSYNFGWQHLELVNCKFGQ-FPTL-KLKSLKRLTFTSNKGGNAFS--EVD 345
Query: 136 LTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLS 195
L +L+ L LS N +TSL L + N + F L++L
Sbjct: 346 LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSF-NGVITMSSNFLGLEQLEHLDFQ 404
Query: 196 YNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTL------DVLSGMTQLRQVWLHKNQFTG 249
++N + ++NL L +S T + +G++ L + + N F
Sbjct: 405 HSNLK-QMSEFSVFLSLRNL----IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 459
Query: 250 PIPD--LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG-PYPLFP--SK 304
++ +L L L QL + P + SL +L +++ +N+L+ P +F +
Sbjct: 460 NFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTS 519
Query: 305 VQKVSLDHNNF 315
+QK+ L N +
Sbjct: 520 LQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-23
Identities = 48/213 (22%), Positives = 87/213 (40%), Gaps = 36/213 (16%)
Query: 63 DNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPS--LANATSLQDIYL 120
+ + + L+ +G+ T+S L QLE L FQ +N+ + +L + +
Sbjct: 370 FGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDI 428
Query: 121 DNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIP 180
+ + G F+GL++L+VL ++ N + P+ T+ +LT L + + L P
Sbjct: 429 SHTHTRVAFNGIFNGLSSLEVLKMAGN-SFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 487
Query: 181 DFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQV 240
F+S S+LQ L ++ N S+P + +T L+++
Sbjct: 488 TAFNSLSSLQVLNMASNQLK-SVPD-----------------------GIFDRLTSLQKI 523
Query: 241 WLHKNQFTGPIPDLSKCESLFDLS--LRDNQLT 271
WLH N + C + LS L N
Sbjct: 524 WLHTNPWDCS------CPRIDYLSRWLNKNSQK 550
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 2e-08
Identities = 34/256 (13%), Positives = 63/256 (24%), Gaps = 72/256 (28%)
Query: 186 FSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKN 245
+ +NL LS+N SF +L+ + L +
Sbjct: 27 PFSTKNLDLSFNPLRHLGSYSF------------------------FSFPELQVLDLSRC 62
Query: 246 QFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG-PYPLFP- 302
+ L L L N + + + L +L + L
Sbjct: 63 EIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGH 122
Query: 303 -SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPF 361
++++++ HN P S+
Sbjct: 123 LKTLKELNVAHNLI----------------------QSFKLPEYFSNL------------ 148
Query: 362 VTCSQGRIITINLANKLLAGNISPAYANLTSLKN----LYLQQNNLTGPIPDGLTKLASL 417
+ ++L++ + L + L L N + I G K L
Sbjct: 149 -----TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRL 202
Query: 418 QNLDVSNNNLSGKVPD 433
L + NN S V
Sbjct: 203 HKLTLRNNFDSLNVMK 218
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 3e-32
Identities = 46/161 (28%), Positives = 73/161 (45%), Gaps = 14/161 (8%)
Query: 587 NILGRGGFGVVYGGEL-PDG----TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHL 641
+LG G FG VY G P+G +A+K + T K E E V+ V + H+
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVDNPHV 79
Query: 642 VALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLH 701
LLG C+ S L+ + MP G L ++ +H + + + + +A+G+ YL
Sbjct: 80 CRLLGICL-TSTVQLITQLMPFGCLLDYV---REHKDN-IGSQYLLNWCVQIAKGMNYL- 133
Query: 702 SLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742
+ +HRDL N+L+ K+ DFGL K +
Sbjct: 134 --EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-32
Identities = 47/176 (26%), Positives = 82/176 (46%), Gaps = 14/176 (7%)
Query: 588 ILGRGGFGVVYGGELPDG---TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVAL 644
LG G FG V G +AVK +++ E AE V+ ++ + ++V +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 645 LGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA 704
+G C +LV E G L ++L + + H + K + + V+ G++YL
Sbjct: 84 IGIC-EAESWMLVMEMAELGPLNKYLQQ-NRH----VKDKNIIELVHQVSMGMKYL---E 134
Query: 705 QQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTF--GYLAPE 758
+ +F+HRDL N+L+ AK++DFGL K + + + G + + APE
Sbjct: 135 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 190
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-32
Identities = 53/170 (31%), Positives = 75/170 (44%), Gaps = 20/170 (11%)
Query: 587 NILGRGGFGVVYGGE---LPDGTKI--AVKRM-ESNTMGNKGLSEFQAEIAVLTKVRHRH 640
+ LG+G FG V L D T AVK++ S + +FQ EI +L +
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR---DFQREIQILKALHSDF 85
Query: 641 LVALLGYCINGSER--LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
+V G + LV EY+P G L L H L + + + + +G+E
Sbjct: 86 IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL---QRHRAR-LDASRLLLYSSQICKGME 141
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK--YSVET 746
YL S + +HRDL NIL+ + K+ADFGL K P K Y V
Sbjct: 142 YLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVRE 188
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 8e-32
Identities = 45/167 (26%), Positives = 74/167 (44%), Gaps = 15/167 (8%)
Query: 587 NILGRGGFGVVYGGELPDG------TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
LG G FG VY G++ ++AVK + + +F E +++K H++
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS-EQDELDFLMEALIISKFNHQN 135
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFE--WHDHGYTPLTWKQRVTIALDVARGVE 698
+V +G + R ++ E M G L L E + L + +A D+A G +
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 699 YLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGKY 742
Y L + FIHRD+ N L+ G AK+ DFG+ ++ Y
Sbjct: 196 Y---LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY 239
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 9e-32
Identities = 48/153 (31%), Positives = 72/153 (47%), Gaps = 13/153 (8%)
Query: 588 ILGRGGFGVVYGGEL--PDG--TKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLV 642
LG G FGVV GE P G +AVK ++ + + + + +F E+ + + HR+L+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 643 ALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHS 702
L G + +V E P G+L L H A+ VA G+ YL S
Sbjct: 85 RLYGVVL-TPPMKMVTELAPLGSLLDRL---RKHQGH-FLLGTLSRYAVQVAEGMGYLES 139
Query: 703 LAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735
+ FIHRDL N+L+ K+ DFGL++
Sbjct: 140 ---KRFIHRDLAARNLLLATRDLVKIGDFGLMR 169
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 37/159 (23%), Positives = 65/159 (40%), Gaps = 13/159 (8%)
Query: 588 ILGRGGFGVVYGGELPDG----TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVA 643
+G G FG V+ G +A+K ++ T + +F E + + H H+V
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-DSVREKFLQEALTMRQFDHPHIVK 80
Query: 644 LLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSL 703
L+G + ++ E G L L + L + A ++ + YL
Sbjct: 81 LIGVIT-ENPVWIIMELCTLGELRSFLQV-RKY---SLDLASLILYAYQLSTALAYL--- 132
Query: 704 AQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742
+ F+HRD+ N+L+ + K+ DFGL + D Y
Sbjct: 133 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 171
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 5e-31
Identities = 49/152 (32%), Positives = 75/152 (49%), Gaps = 13/152 (8%)
Query: 587 NILGRGGFGVVYGGELPDG----TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
++GRG FG VY G L D AVK + T +S+F E ++ H +++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMKDFSHPNVL 153
Query: 643 ALLGYCINGSE-RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLH 701
+LLG C+ L+V YM G L + + + T K + L VA+G+++L
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHN-PTVKDLIGFGLQVAKGMKFL- 208
Query: 702 SLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733
A + F+HRDL N ++ + KVADFGL
Sbjct: 209 --ASKKFVHRDLAARNCMLDEKFTVKVADFGL 238
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 6e-31
Identities = 78/371 (21%), Positives = 139/371 (37%), Gaps = 71/371 (19%)
Query: 66 NRVTTISLAKSGLSGTLSPEI-SSLTQLETLSFQMNNIAGAIP--SLANATSLQDIYLDN 122
N ++ S + L + S Q+E L+ I I + A A ++Q +Y+
Sbjct: 51 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGF 108
Query: 123 NNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDF 182
N +P F + L VL L N +L+ P + LTTL M N N+ + D
Sbjct: 109 NAIRYLPPHVFQNVPLLTVLVLERN-DLSSLP-RGIFHNTPKLTTLSMSNNNLERIEDDT 166
Query: 183 FDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSG-TLDVLSGMTQLRQVW 241
F + ++LQNL+LS N T S I +L +S L L+ + ++
Sbjct: 167 FQATTSLQNLQLSSNRLT-----HVDLSLIPSL----FHANVSYNLLSTLAIPIAVEELD 217
Query: 242 LHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG-PYPL 300
N + L L L+ N LT A +++ P L+ + L N+L+ Y
Sbjct: 218 ASHNSINV-VRGPV-NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHP 273
Query: 301 FP--SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDG 358
F +++++ + +N ++ L
Sbjct: 274 FVKMQRLERLYISNN---------------RLVAL------------------------- 293
Query: 359 WPFVTCSQGRIITINLA-NKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASL 417
+ ++L+ N LL ++ L+NLYL N++ + +L
Sbjct: 294 -NLYGQPIPTLKVLDLSHNHLL--HVERNQPQFDRLENLYLDHNSIV-TLKLST--HHTL 347
Query: 418 QNLDVSNNNLS 428
+NL +S+N+
Sbjct: 348 KNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 1e-24
Identities = 58/338 (17%), Positives = 105/338 (31%), Gaps = 84/338 (24%)
Query: 95 LSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNP--NLAP 152
+ Q ++ + + + + N+ +P D +++L+L+D +
Sbjct: 34 IDMQTQDVYFGFEDI-TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDT 92
Query: 153 WPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDI 212
+ F + ++ LYM I L P F + L L L N+ + SLP
Sbjct: 93 YAFAY----AHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPR------- 140
Query: 213 QNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD--LSKCESLFDLSLRDNQL 270
+ +L + + N I D SL +L L N+L
Sbjct: 141 ----------------GIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRL 183
Query: 271 TGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQV 330
T V S+ +P+L + ++ N L V+++ HN+ ++
Sbjct: 184 T-HVDLSL--IPSLFHANVSYNLLSTLAIP--IAVEELDASHNSINVVRGPVN----VEL 234
Query: 331 TTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANL 390
T L L +N + N
Sbjct: 235 TIL-----------KLQ-----HN-------------NLTDT------------AWLLNY 253
Query: 391 TSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428
L + L N L + K+ L+ L +SNN L
Sbjct: 254 PGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 291
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-22
Identities = 52/370 (14%), Positives = 106/370 (28%), Gaps = 57/370 (15%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNN 123
+SNR+T + L S + L + N ++ +LA +++++ +N
Sbjct: 179 SSNRLTHVDL-------------SLIPSLFHANVSYNLLS----TLAIPIAVEELDASHN 221
Query: 124 NFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFF 183
+ V L +L L N NL L L + + + ++ F
Sbjct: 222 SINVVRGPVN---VELTILKLQHN-NLTD---TAWLLNYPGLVEVDLSYNELEKIMYHPF 274
Query: 184 DSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLH 243
L+ L +S N +L + L+ + L
Sbjct: 275 VKMQRLERLYISNNRLV-ALNLYG------------------------QPIPTLKVLDLS 309
Query: 244 KNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG-PYPLFP 302
N + + + L +L L N + + + + L N++L +N
Sbjct: 310 HNHLLHVERNQPQFDRLENLYLDHNSIVTLKLS---THHTLKNLTLSHNDWDCNSLRALF 366
Query: 303 SKVQKVSLDHNNF---CKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWE-GNNACDG 358
V + ++D + + G C L + + + C
Sbjct: 367 RNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSA 426
Query: 359 WPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQ 418
+ Q I + A + L+ Q N L L +
Sbjct: 427 TDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEI 486
Query: 419 NLDVSNNNLS 428
+ ++ L
Sbjct: 487 DTNLRRYRLP 496
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 4e-08
Identities = 40/248 (16%), Positives = 84/248 (33%), Gaps = 58/248 (23%)
Query: 193 RLSYNNFTGSLPASFAKSDIQ------NLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQ 246
+ YN S++Q ++ ++ Q + + ++ + + V +
Sbjct: 4 QQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDIT-LNNQKIVTFKNST 62
Query: 247 FTGPIPD--LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG-PYPLFP- 302
+P L + L+L D Q+ + + + + + N ++ P +F
Sbjct: 63 MRK-LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQN 121
Query: 303 -SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPF 361
+ + L+ N+ + L I +
Sbjct: 122 VPLLTVLVLERNDL----------------SSLP-------RGIFHN------------- 145
Query: 362 VTCSQGRIITINLANKLLAGNISP-AYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNL 420
++ T++++N L I + TSL+NL L N LT + L + SL +
Sbjct: 146 ----TPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH-VDLSL--IPSLFHA 197
Query: 421 DVSNNNLS 428
+VS N LS
Sbjct: 198 NVSYNLLS 205
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 8e-31
Identities = 45/159 (28%), Positives = 69/159 (43%), Gaps = 13/159 (8%)
Query: 588 ILGRGGFGVVYGGEL--PDGTKI--AVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVA 643
ILG G FG VY G G KI AVK + + +F +E ++ + H H+V
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT-LDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 644 LLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSL 703
L+G ++ E P G L +L + + L V +L + + + YL
Sbjct: 78 LIGIIEEEP-TWIIMELYPYGELGHYL---ERNKNS-LKVLTLVLYSLQICKAMAYL--- 129
Query: 704 AQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742
+ +HRD+ NIL+ K+ DFGL + D Y
Sbjct: 130 ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY 168
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 46/161 (28%), Positives = 73/161 (45%), Gaps = 14/161 (8%)
Query: 587 NILGRGGFGVVYGGEL-PDG----TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHL 641
+LG G FG VY G P+G +A+K + T K E E V+ V + H+
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVDNPHV 79
Query: 642 VALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLH 701
LLG C+ S L+ + MP G L ++ +H + + + + +A+G+ YL
Sbjct: 80 CRLLGICL-TSTVQLITQLMPFGCLLDYV---REHKDN-IGSQYLLNWCVQIAKGMNYL- 133
Query: 702 SLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742
+ +HRDL N+L+ K+ DFGL K +
Sbjct: 134 --EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 46/175 (26%), Positives = 76/175 (43%), Gaps = 14/175 (8%)
Query: 589 LGRGGFGVVYGGELPDG---TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
LG G FG V G +A+K ++ T E E ++ ++ + ++V L+
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 646 GYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQ 705
G C +LV E G L + L + + V+ G++YL +
Sbjct: 77 GVC-QAEALMLVMEMAGGGPLHKFL---VGKREE-IPVSNVAELLHQVSMGMKYL---EE 128
Query: 706 QSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTF--GYLAPE 758
++F+HRDL N+L+ + AK++DFGL K R AG + + APE
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 183
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-30
Identities = 66/377 (17%), Positives = 128/377 (33%), Gaps = 58/377 (15%)
Query: 61 NCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP--SLANATSLQDI 118
C+ S + + + + I + T+ L N I + A+ L+++
Sbjct: 6 RCECSAQDRAVLCHRKRFV-AVPEGIPTETR--LLDLGKNRIK-TLNQDEFASFPHLEEL 61
Query: 119 YLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGL 178
L+ N ++V G F+ L NL+ L L N L P T ++LT L + I L
Sbjct: 62 ELNENIVSAVEPGAFNNLFNLRTLGLRSN-RLKLIP-LGVFTGLSNLTKLDISENKIVIL 119
Query: 179 IPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLSGTLDVLSGMTQL 237
+ F NL++L + N+ +F+ + ++ L + L T + LS + L
Sbjct: 120 LDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPT-EALSHLHGL 178
Query: 238 RQVWLHKNQFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQ 295
+ L I D + L L + + + + L ++S+ + L
Sbjct: 179 IVLRLRHLNINA-IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT 237
Query: 296 G-PYPLFP--SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEG 352
PY ++ ++L +N ++ + L
Sbjct: 238 AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHEL-LRLQEI-----------QLVG---- 281
Query: 353 NNACDGWPFVTCSQGRIITINLANKLLAGNISP-AYANLTSLKNLYLQQNNLTGPIPDGL 411
+L + P A+ L L+ L + N LT
Sbjct: 282 -----------------------GQL--AVVEPYAFRGLNYLRVLNVSGNQLTTLEESVF 316
Query: 412 TKLASLQNLDVSNNNLS 428
+ +L+ L + +N L+
Sbjct: 317 HSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 4e-09
Identities = 35/255 (13%), Positives = 73/255 (28%), Gaps = 74/255 (29%)
Query: 186 FSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKN 245
+ + L L N +L D + L ++ L++N
Sbjct: 31 PTETRLLDLGKNRIK-TLNQ-----------------------DEFASFPHLEELELNEN 66
Query: 246 QFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG-PYPLFP 302
+ + + +L L LR N+L + L L + + NK+ +F
Sbjct: 67 IVSA-VEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQ 125
Query: 303 --SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWP 360
++ + + N + + + A G
Sbjct: 126 DLYNLKSLEVGDN---------------DLVYI------------------SHRAFSGLN 152
Query: 361 FVTCSQGRIITINLA-NKLLAGNISP-AYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQ 418
+ + L L +I A ++L L L L+ N+ +L L+
Sbjct: 153 -------SLEQLTLEKCNL--TSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLK 203
Query: 419 NLDVSNNNLSGKVPD 433
L++S+ +
Sbjct: 204 VLEISHWPYLDTMTP 218
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 35/162 (21%), Positives = 72/162 (44%), Gaps = 25/162 (15%)
Query: 588 ILGRGGFGVVYGGEL--------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHR 639
LG+G F ++ G T++ +K ++ F ++++K+ H+
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS--ESFFEAASMMSKLSHK 72
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
HLV G C+ G E +LV E++ G+L +L + + ++ +A +A + +
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYL---KKNK-NCINILWKLEVAKQLAAAMHF 128
Query: 700 LHSLAQQSFIHRDLKPSNILI--------GDDMRAKVADFGL 733
L + + IH ++ NIL+ G+ K++D G+
Sbjct: 129 ---LEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI 167
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 43/161 (26%), Positives = 72/161 (44%), Gaps = 14/161 (8%)
Query: 587 NILGRGGFGVVYGGELPDG-----TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHL 641
+LG G FG V+ G + +K +E + G + + + + H H+
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHI 77
Query: 642 VALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLH 701
V LLG C GS LV +Y+P G+L H+ H L + + + +A+G+ YL
Sbjct: 78 VRLLGLCP-GSSLQLVTQYLPLGSLLDHV---RQHRGA-LGPQLLLNWGVQIAKGMYYL- 131
Query: 702 SLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742
+ +HR+L N+L+ + +VADFG+ P
Sbjct: 132 --EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 56/274 (20%), Positives = 96/274 (35%), Gaps = 18/274 (6%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDN 122
N NR + S L L+ S ++ L N ++ LA T L+ + L +
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 123 NNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDF 182
N + L+ L+ L L++N + EL S+ TL+ N N +
Sbjct: 68 NVLYETLD--LESLSTLRTLDLNNN-YV------QELLVGPSIETLHAAN-NNISRVS-- 115
Query: 183 FDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVW 241
+N+ L+ N T S +Q L + ++ ++ + L +
Sbjct: 116 CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 242 LHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG-PYPL 300
L N + L L L N+L + S + ISL+NNKL L
Sbjct: 176 LQYNFIYD-VKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKAL 233
Query: 301 FP-SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTL 333
++ L N F + + +V T+
Sbjct: 234 RFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTV 267
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 40/248 (16%), Positives = 89/248 (35%), Gaps = 23/248 (9%)
Query: 85 EISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144
+++ T+LE L+ N + L + ++L+ + L+NN + +++ L
Sbjct: 53 DLAPFTKLELLNLSSNVLYE-TLDLESLSTLRTLDLNNNYVQELLV-----GPSIETLHA 106
Query: 145 SDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLP 204
++N N++ +Y+ N I L S +Q L L N ++
Sbjct: 107 ANN-NISRVSCSR----GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVN 160
Query: 205 ASFAKSDIQNLWMNDQQLGLSG----TLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESL 260
+ + L + L L + +L+ + L N+ P+ +
Sbjct: 161 FAELAASSDTL----EHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLAFMGPEFQSAAGV 216
Query: 261 FDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG--PYPLFPSKVQKVSLDHNNFCKN 318
+SLR+N+L ++ ++ L + L+ N F + ++ K
Sbjct: 217 TWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKL 275
Query: 319 SSDAGKPC 326
+ + C
Sbjct: 276 TGQNEEEC 283
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 44/330 (13%), Positives = 103/330 (31%), Gaps = 86/330 (26%)
Query: 105 AIPSL-ANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKST 163
AI + N + + +++ N++ L LS N L+ +L T
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGN-PLSQIS-AADLAPFT 58
Query: 164 SLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLG 223
L L + + ++ + +S S L+ L L+ N
Sbjct: 59 KLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ----------------------- 93
Query: 224 LSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPA 283
L + + N + + S+ + ++ L +N++T +
Sbjct: 94 ------ELLVGPSIETLHAANNNISR-VS-CSRGQGKKNIYLANNKITMLRDLDEGCRSR 145
Query: 284 LLNISLQNNKLQG-PYPLFPS---KVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGD 339
+ + L+ N++ + + ++ ++L +N + +
Sbjct: 146 VQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN---------------FIYDV------ 184
Query: 340 MGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLA-NKLLAGNISPAYANLTSLKNLYL 398
G ++ T++L+ NKL + P + + + + L
Sbjct: 185 -----------------KGQVVFA----KLKTLDLSSNKLA--FMGPEFQSAAGVTWISL 221
Query: 399 QQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428
+ N L I L +L++ D+ N
Sbjct: 222 RNNKLVL-IEKALRFSQNLEHFDLRGNGFH 250
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 42/213 (19%), Positives = 72/213 (33%), Gaps = 19/213 (8%)
Query: 85 EISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144
E+ +ETL NNI+ + ++IYL NN T + + +Q L L
Sbjct: 94 ELLVGPSIETLHAANNNIS-RVSCSRG-QGKKNIYLANNKITMLRDLDEGCRSRVQYLDL 151
Query: 145 SDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLP 204
N + F S +L L + I+ + F+ L+ L LS N +
Sbjct: 152 KLN-EIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVV--FAKLKTLDLSSNKLA-FMG 207
Query: 205 ASFAK-SDIQNLWMNDQQL-GLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFD 262
F + + + + + +L + L L L N F C +L D
Sbjct: 208 PEFQSAAGVTWISLRNNKLVLIEKAL---RFSQNLEHFDLRGNGFH--------CGTLRD 256
Query: 263 LSLRDNQLTGVVPASVISLPALLNISLQNNKLQ 295
++ ++ V +V L L
Sbjct: 257 FFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLG 289
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 43/262 (16%), Positives = 95/262 (36%), Gaps = 55/262 (20%)
Query: 179 IPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQL-GLSGTLDVLSGMTQ 236
I + + + + +++ ++ +L + +++ L ++ L +S L+ T+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISA--ADLAPFTK 59
Query: 237 LRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG 296
L + L N DL +L L L +N + ++ P++ + NN +
Sbjct: 60 LELLNLSSNVLYE-TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR 113
Query: 297 -PYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNA 355
+ + L +N ++T L +
Sbjct: 114 VSCSRGQG-KKNIYLANN---------------KITML------------------RDLD 139
Query: 356 CDGWPFVTCSQGRIITINLA-NKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKL 414
R+ ++L N++ N + A+ +L++L LQ N + +
Sbjct: 140 EGCRS-------RVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQ-VVF 190
Query: 415 ASLQNLDVSNNNLSGKVPDFGS 436
A L+ LD+S+N L+ P+F S
Sbjct: 191 AKLKTLDLSSNKLAFMGPEFQS 212
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 22/124 (17%), Positives = 37/124 (29%), Gaps = 5/124 (4%)
Query: 84 PEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLS 143
+L+TL N +A P +A + I L NN + NL+
Sbjct: 185 KGQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVLIEKA-LRFSQNLEHFD 243
Query: 144 LSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSL 203
L N + +K+ + T+ + + + L L
Sbjct: 244 LRGNG-FHCGTLRDFFSKNQRVQTVAK---QTVKKLTGQNEEECTVPTLGHYGAYCCEDL 299
Query: 204 PASF 207
PA F
Sbjct: 300 PAPF 303
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 8e-06
Identities = 14/69 (20%), Positives = 27/69 (39%), Gaps = 1/69 (1%)
Query: 371 TINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGK 430
+ + L ++ + ++K L L N L+ L L+ L++S+N L +
Sbjct: 14 IEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-E 72
Query: 431 VPDFGSNVK 439
D S
Sbjct: 73 TLDLESLST 81
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 9e-30
Identities = 55/202 (27%), Positives = 78/202 (38%), Gaps = 30/202 (14%)
Query: 581 DNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHR 639
+F LGRGGFGVV+ D A+KR+ + E+ L K+ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR-ELAREKVMREVKALAKLEHP 63
Query: 640 HLVALLGYCI---------NGSERLLVY---EYMPRGTLAQHLFEWHDHGYTPLTWKQRV 687
+V + S ++ +Y + + L + +
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNG--RCTIEERERSVCL 121
Query: 688 TIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK-----------N 736
I L +A VE+LHS + +HRDLKPSNI D KV DFGLV
Sbjct: 122 HIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 737 APDGKYSVETRLAGTFGYLAPE 758
P Y+ T GT Y++PE
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPE 200
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 62/242 (25%), Positives = 95/242 (39%), Gaps = 25/242 (10%)
Query: 62 CDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP--SLANATSLQDIY 119
C N + T S + GL + I + +Q + N I+ +P S +L ++
Sbjct: 8 CYNEPK-VTTSCPQQGLQ-AVPVGIPAASQ--RIFLHGNRIS-HVPAASFRACRNLTILW 62
Query: 120 LDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLI 179
L +N + F GL L+ L LSDN L P L TL++D + L
Sbjct: 63 LHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVD-PATFHGLGRLHTLHLDRCGLQELG 121
Query: 180 PDFFDSFSNLQNLRLSYNNFTGSLPA-SFAKSDIQNLWMNDQQLGLSG------TLDVLS 232
P F + LQ L L N +LP +F D+ NL L L G
Sbjct: 122 PGLFRGLAALQYLYLQDNALQ-ALPDDTF--RDLGNL----THLFLHGNRISSVPERAFR 174
Query: 233 GMTQLRQVWLHKNQFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQ 290
G+ L ++ LH+N+ + L L L N L+ + ++ L AL + L
Sbjct: 175 GLHSLDRLLLHQNRVAH-VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLN 233
Query: 291 NN 292
+N
Sbjct: 234 DN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 9e-16
Identities = 59/324 (18%), Positives = 91/324 (28%), Gaps = 127/324 (39%)
Query: 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172
+ Q I+L N + VP F NL +L L N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSN------------------------- 66
Query: 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLS 232
+ + F + L+ L LS N S+
Sbjct: 67 -VLARIDAAAFTGLALLEQLDLSDNAQLRSVDP-----------------------ATFH 102
Query: 233 GMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNN 292
G+ +L + L + L G L AL + LQ+N
Sbjct: 103 GLGRLHTLHLDRCGLQ---------------ELGPGLFRG--------LAALQYLYLQDN 139
Query: 293 KLQG-PYPLFP--SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDS 349
LQ P F + + L N +++++
Sbjct: 140 ALQALPDDTFRDLGNLTHLFLHGN---------------RISSV---------------- 168
Query: 350 WEGNNACDGWPFVTCSQGRIITINLANKLLAGN----ISP-AYANLTSLKNLYLQQNNLT 404
A G +L LL N + P A+ +L L LYL NNL+
Sbjct: 169 --PERAFRGLH------------SLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS 214
Query: 405 GPIPDG-LTKLASLQNLDVSNNNL 427
+P L L +LQ L +++N
Sbjct: 215 A-LPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 15/44 (34%), Positives = 23/44 (52%), Gaps = 2/44 (4%)
Query: 386 AYANLTSLKNLYLQQNNLTGPIPDG-LTKLASLQNLDVSNNNLS 428
+ L +L+ LYLQ N L +PD L +L +L + N +S
Sbjct: 124 LFRGLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHGNRIS 166
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 18/56 (32%), Positives = 23/56 (41%), Gaps = 7/56 (12%)
Query: 379 LAGN----ISP-AYANLTSLKNLYLQQNNLTGPIPDG-LTKLASLQNLDVSNNNLS 428
L GN + A+ L SL L L QN + + L L L + NNLS
Sbjct: 160 LHGNRISSVPERAFRGLHSLDRLLLHQNRVAH-VHPHAFRDLGRLMTLYLFANNLS 214
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 21/91 (23%), Positives = 32/91 (35%), Gaps = 13/91 (14%)
Query: 356 CDGWP--FVTCSQGRIITI------NLANKLLAGN----ISP-AYANLTSLKNLYLQQNN 402
C P +C Q + + L GN + ++ +L L+L N
Sbjct: 8 CYNEPKVTTSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNV 67
Query: 403 LTGPIPDGLTKLASLQNLDVSNNNLSGKVPD 433
L T LA L+ LD+S+N V
Sbjct: 68 LARIDAAAFTGLALLEQLDLSDNAQLRSVDP 98
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-29
Identities = 65/333 (19%), Positives = 112/333 (33%), Gaps = 29/333 (8%)
Query: 105 AIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTS 164
+P L + + L N+ + F L +LQ L + N +S
Sbjct: 24 QVPELP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQ-TPGLVIRNNTFRGLSS 80
Query: 165 LTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGS-LPA-SFAK-SDIQNLWMNDQQ 221
L L +D L F+ +NL+ L L+ N G+ L F + ++ L + D
Sbjct: 81 LIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNN 140
Query: 222 LGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISL 281
+ M + + L N+ S CE + + T ++ L
Sbjct: 141 IKKIQPASFFLNMRRFHVLDLTFNKVK------SICEEDLL-NFQGKHFT------LLRL 187
Query: 282 PALLNISLQNNKLQGPYPLFPSK---VQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAG 338
++ + L P K + + L N F S A + D T +Q
Sbjct: 188 SSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGF--KESMAKRFFDAIAGTKIQSLI 245
Query: 339 DMGYPAILSDSWEGNNAC-DGWPFVTCSQGRIITINLANKLLAGNISP-AYANLTSLKNL 396
+ S N D + F + T +L+ + + +++ T L+ L
Sbjct: 246 LSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQL 304
Query: 397 YLQQNNLTGPIPDG-LTKLASLQNLDVSNNNLS 428
L QN + I D L L L++S N L
Sbjct: 305 TLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG 336
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 1e-28
Identities = 78/364 (21%), Positives = 113/364 (31%), Gaps = 76/364 (20%)
Query: 87 SSLTQLETLSFQMNNIAGAIPS--LANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144
S L L+ L + I + +SL + LD N F + TG F+GL NL+VL+L
Sbjct: 51 SRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTL 110
Query: 145 SDNPNLAPWPFPNEL-TKSTSLTTLYMDNANIFGLIPD-FFDSFSNLQNLRLSYNNFTGS 202
+ NL TSL L + + NI + P FF + L L++N
Sbjct: 111 TQC-NLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSI 169
Query: 203 LPASFAK-----------SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFT--- 248
S I MN+ LG T + + L N F
Sbjct: 170 CEEDLLNFQGKHFTLLRLSSITLQDMNEYWLG-WEKCGNPFKNTSITTLDLSGNGFKESM 228
Query: 249 -GPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQK 307
D + L L ++ G S N +G L S V+
Sbjct: 229 AKRFFDAIAGTKIQSLILSNSYNMGS------SFGHTNFKDPDNFTFKG---LEASGVKT 279
Query: 308 VSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQG 367
L + T L+
Sbjct: 280 CDLSKSKIFALLKSV-----FSHFTDLE-------------------------------- 302
Query: 368 RIITINLA-NKLLAGNISP-AYANLTSLKNLYLQQNNLTGPIPDGL-TKLASLQNLDVSN 424
+ LA N++ I A+ LT L L L QN L I + L L+ LD+S
Sbjct: 303 ---QLTLAQNEI--NKIDDNAFWGLTHLLKLNLSQNFLGS-IDSRMFENLDKLEVLDLSY 356
Query: 425 NNLS 428
N++
Sbjct: 357 NHIR 360
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 6e-21
Identities = 43/226 (19%), Positives = 78/226 (34%), Gaps = 21/226 (9%)
Query: 88 SLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTN---LQVLS 143
L+ + + + TS+ + L N F F +Q L
Sbjct: 186 RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLI 245
Query: 144 LSDNPNLAPWPFPNELTK----------STSLTTLYMDNANIFGLIPDFFDSFSNLQNLR 193
LS++ N+ ++ + T + + IF L+ F F++L+ L
Sbjct: 246 LSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLT 305
Query: 194 LSYNNFTGSLPA-SFAK-SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPI 251
L+ N + +F + + L ++ LG S + + +L + L N +
Sbjct: 306 LAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRA-L 362
Query: 252 PD--LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQ 295
D +L +L+L NQL V L +L I L N
Sbjct: 363 GDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 5e-12
Identities = 29/140 (20%), Positives = 54/140 (38%), Gaps = 31/140 (22%)
Query: 63 DNSNRVTTISLAKSGLSGTLSPEI-SSLTQLETLSFQMNNIAGAIPS--LANATSLQDIY 119
+ + ++LA++ ++ + LT L L+ N + G+I S N L+ +
Sbjct: 296 SHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLD 353
Query: 120 LDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLI 179
L N+ ++ F GL NL+ L+L N L ++
Sbjct: 354 LSYNHIRALGDQSFLGLPNLKELALDTN----------------QLKSVP---------- 387
Query: 180 PDFFDSFSNLQNLRLSYNNF 199
FD ++LQ + L N +
Sbjct: 388 DGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 6e-04
Identities = 16/63 (25%), Positives = 26/63 (41%), Gaps = 3/63 (4%)
Query: 371 TINLANKLLAGNISP-AYANLTSLKNLYLQQNNLTGPIPDG-LTKLASLQNLDVSNNNLS 428
+ + + I + L+SL L L N + G LA+L+ L ++ NL
Sbjct: 58 FLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQ-LETGAFNGLANLEVLTLTQCNLD 116
Query: 429 GKV 431
G V
Sbjct: 117 GAV 119
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-29
Identities = 63/400 (15%), Positives = 125/400 (31%), Gaps = 52/400 (13%)
Query: 55 CEWTGINCDNSNR-----------VTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIA 103
C + G + L+ + + + L QL+ L
Sbjct: 2 CSFDGRIAFYRFCNLTQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTP 61
Query: 104 GAIP--SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTK 161
I + N +L+ + L ++ + F GL +L L L
Sbjct: 62 LTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRN 121
Query: 162 STSLTTLYMDNANIFGL-IPDFFDSFSNLQNLRLSYNNFTGSLPASFA---KSDIQNLWM 217
+LT L + I L + F ++L+++ S N + +
Sbjct: 122 LKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSL 181
Query: 218 NDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCE-SLFDLSLRDNQLTGVVPA 276
L ++D M R + L D+S ++ N ++
Sbjct: 182 AANSLYSRVSVDWGKCMNPFRNMVLEIL-------DVSGNGWTVDITGNFSNAISKSQAF 234
Query: 277 SVISLPALLNISLQNNKLQGP-----YPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVT 331
S+I ++ + ++ P L S V+ + L H +S + +
Sbjct: 235 SLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETL-KDLK 293
Query: 332 TLLQIAGDMGY---PAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYA 388
L ++ Y I +++ G + + +NL+ LL S +
Sbjct: 294 VL-----NLAYNKINKIADEAFYGLD-------------NLQVLNLSYNLLGELYSSNFY 335
Query: 389 NLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428
L + + LQ+N++ L LQ LD+ +N L+
Sbjct: 336 GLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-27
Identities = 63/376 (16%), Positives = 117/376 (31%), Gaps = 81/376 (21%)
Query: 63 DNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNI----AGAIPSLANATSLQDI 118
N V + +S + + + + F +NI LA +S++ +
Sbjct: 213 GNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLAR-SSVRHL 271
Query: 119 YLDNNNFTSVPTGCFDGLTNLQVLSLSDN--PNLAPWPFPNELTKSTSLTTLYMDNANIF 176
L + S+ + F+ L +L+VL+L+ N +A +L L + +
Sbjct: 272 DLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIAD----EAFYGLDNLQVLNLSYNLLG 327
Query: 177 GLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQ 236
L F + + L N+ + + +
Sbjct: 328 ELYSSNFYGLPKVAYIDLQKNHIA-IIQD-----------------------QTFKFLEK 363
Query: 237 LRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG 296
L+ + L N T + S+ D+ L N+L + + I L N+L+
Sbjct: 364 LQTLDLRDNALT----TIHFIPSIPDIFLSGNKLVTLPKIN----LTANLIHLSENRLEN 415
Query: 297 -PYPLFP---SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEG 352
F +Q + L+ N F S D +P + L L
Sbjct: 416 LDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQL-----------FLG----- 459
Query: 353 NNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLT 412
N L + L+ L+ LYL N L P +
Sbjct: 460 EN------------------MLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFS 501
Query: 413 KLASLQNLDVSNNNLS 428
L +L+ L +++N L+
Sbjct: 502 HLTALRGLSLNSNRLT 517
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 8e-25
Identities = 46/259 (17%), Positives = 82/259 (31%), Gaps = 21/259 (8%)
Query: 67 RVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNF 125
+ ++LA + ++ L L+ L+ N + + + I L N+
Sbjct: 291 DLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHI 350
Query: 126 TSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDS 185
+ F L LQ L L DN + S+ +++ + L
Sbjct: 351 AIIQDQTFKFLEKLQTLDLRDNAL-------TTIHFIPSIPDIFLSGNKLVTLPKINL-- 401
Query: 186 FSNLQNLRLSYNNFTGSLPASFAK--SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLH 243
+ LS N F +Q L +N + S L Q++L
Sbjct: 402 --TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLG 459
Query: 244 KNQFTGPIPD------LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG- 296
+N L L L N L + P L AL +SL +N+L
Sbjct: 460 ENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVL 519
Query: 297 PYPLFPSKVQKVSLDHNNF 315
+ P+ ++ + + N
Sbjct: 520 SHNDLPANLEILDISRNQL 538
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 9e-25
Identities = 58/292 (19%), Positives = 98/292 (33%), Gaps = 43/292 (14%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPS--LANATSLQDIYLD 121
+ + T + S + L + ++ S L+ + L
Sbjct: 248 GFHNIKDPD------QNTFAGLARS--SVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLA 298
Query: 122 NNNFTSVPTGCFDGLTNLQVLSLSDNP--NLAPWPFPNELTKSTSLTTLYMDNANIFGLI 179
N + F GL NLQVL+LS N L F + + + +I +
Sbjct: 299 YNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYG----LPKVAYIDLQKNHIAIIQ 354
Query: 180 PDFFDSFSNLQNLRLSYNNFT-----GSLPASFAK----SDIQNLWMNDQQLGLSGT--- 227
F LQ L L N T S+P F + + + + LS
Sbjct: 355 DQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLE 414
Query: 228 ----LDVLSGMTQLRQVWLHKNQFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASV--- 278
L L + L+ + L++N+F+ D S+ SL L L +N L +
Sbjct: 415 NLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWD 474
Query: 279 --ISLPALLNISLQNNKLQG-PYPLFP--SKVQKVSLDHNNFCKNSSDAGKP 325
L L + L +N L P +F + ++ +SL+ N S +
Sbjct: 475 VFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPA 526
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 7e-19
Identities = 47/233 (20%), Positives = 82/233 (35%), Gaps = 36/233 (15%)
Query: 87 SSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSD 146
L +L+TL + N + ++ S+ DI+L N ++P ++ LS+
Sbjct: 359 KFLEKLQTLDLRDNALT----TIHFIPSIPDIFLSGNKLVTLPKINL----TANLIHLSE 410
Query: 147 NP--NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPD-FFDSFSNLQNLRLSYNNFTGSL 203
N NL F + L L ++ D +L+ L L N +
Sbjct: 411 NRLENLDILYFLLRVP---HLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAW 467
Query: 204 PASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTG-PIPDLSKCESLFD 262
DV G++ L+ ++L+ N P S +L
Sbjct: 468 ETEL-------------------CWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRG 508
Query: 263 LSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNF 315
LSL N+LT + + L + + N+L P P + + + HN F
Sbjct: 509 LSLNSNRLTVLSHNDL--PANLEILDISRNQLLAPNPDVFVSLSVLDITHNKF 559
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 5e-14
Identities = 46/213 (21%), Positives = 81/213 (38%), Gaps = 15/213 (7%)
Query: 86 ISSLTQLETLSFQMNNIAGAIPS--LANATSLQDIYLDNNNF-----TSVPTGCFDGLTN 138
+ + L+ L N + + SL+ ++L N T + F+GL++
Sbjct: 422 LLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSH 481
Query: 139 LQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNN 198
LQVL L+ N L P P + T+L L +++ + L + +NL+ L +S N
Sbjct: 482 LQVLYLNHN-YLNSLP-PGVFSHLTALRGLSLNSNRLTVLSHNDL--PANLEILDISRNQ 537
Query: 199 FTGSLPASFAKSDIQNLWMN--DQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSK 256
P F + ++ N + LS ++ L+ PD
Sbjct: 538 LLAPNPDVFVSLSVLDITHNKFICECELSTFINWLNHTNVTIAGPP--ADIYCVYPDSFS 595
Query: 257 CESLFDLSLRDNQLTGVVPASVISLPALLNISL 289
SLF LS V+ + SL + ++L
Sbjct: 596 GVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTL 628
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 7e-08
Identities = 31/211 (14%), Positives = 64/211 (30%), Gaps = 46/211 (21%)
Query: 230 VLSGMTQLRQVWLHKNQFTG-PIPDLSKCESLFDLSLRDNQLTGVVPASVI-SLPALLNI 287
V + ++ L N E L L L + +LP L +
Sbjct: 19 VPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRIL 78
Query: 288 SLQNNKLQGPYP---LFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPA 344
L ++K+ +P + ++ L
Sbjct: 79 DLGSSKIYFLHPDAFQGLFHLFELRLYFCG------------------------------ 108
Query: 345 ILSDSWEGNNACDGWPFVTCSQGRIITINLA-NKLLAGNISPAYANLTSLKNLYLQQNNL 403
LSD+ + + ++L+ N++ + + P++ L SLK++ N +
Sbjct: 109 -LSDAVLKDGYFRNLK-------ALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQI 160
Query: 404 TGPIPDGLTKLA--SLQNLDVSNNNLSGKVP 432
L L +L ++ N+L +V
Sbjct: 161 FLVCEHELEPLQGKTLSFFSLAANSLYSRVS 191
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 7e-04
Identities = 8/45 (17%), Positives = 15/45 (33%)
Query: 389 NLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPD 433
L + + L L N + L LQ L++ + +
Sbjct: 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDK 66
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 45/175 (25%), Positives = 69/175 (39%), Gaps = 13/175 (7%)
Query: 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH--RHLVAL 644
+G GG V+ A+K + N+ L ++ EIA L K++ ++ L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 645 LGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA 704
Y I +V E L L + +R + ++ V +H
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWL---KKKK--SIDPWERKSYWKNMLEAVHTIH--- 144
Query: 705 QQSFIHRDLKPSNILIGDDMRAKVADFGLVKN-APDGKYSVETRLAGTFGYLAPE 758
Q +H DLKP+N LI D K+ DFG+ PD V+ GT Y+ PE
Sbjct: 145 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 198
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 2e-29
Identities = 51/185 (27%), Positives = 85/185 (45%), Gaps = 21/185 (11%)
Query: 582 NFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRH 640
+F ++LG G G + + D +AVKR+ + S E+ +L + H +
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP-----ECFSFADREVQLLRESDEHPN 79
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYL 700
++ + + + E TL Q E D + + +T+ G+ +L
Sbjct: 80 VIRYFCTEKDRQFQYIAIELCA-ATL-QEYVEQKDFAHLG---LEPITLLQQTTSGLAHL 134
Query: 701 HSLAQQSFIHRDLKPSNILIGD-----DMRAKVADFGLVKNAPDGKYSVETR--LAGTFG 753
HSL + +HRDLKP NILI ++A ++DFGL K G++S R + GT G
Sbjct: 135 HSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 754 YLAPE 758
++APE
Sbjct: 192 WIAPE 196
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-29
Identities = 45/175 (25%), Positives = 76/175 (43%), Gaps = 14/175 (8%)
Query: 589 LGRGGFGVVYGGELPDG---TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
LG G FG V G +A+K ++ T E E ++ ++ + ++V L+
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 646 GYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQ 705
G C +LV E G L + L + + + V+ G++YL +
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMGMKYL---EE 454
Query: 706 QSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGY--LAPE 758
++F+HR+L N+L+ + AK++DFGL K R AG + APE
Sbjct: 455 KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 509
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 56/230 (24%), Positives = 87/230 (37%), Gaps = 38/230 (16%)
Query: 552 SQSSGDVSDRHLFEGGNVAI---SIEVLRQVTDNFSEANILGRGGFGVVYGGE-LPDGTK 607
S D+ F G V + + V R L GGF VY + + G +
Sbjct: 6 SLGGASGRDQSDFVGQTVELGELRLRVRRV----------LAEGGFAFVYEAQDVGSGRE 55
Query: 608 IAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSER-------LLVYE 659
A+KR+ SN + E+ + K+ H ++V G E L+
Sbjct: 56 YALKRLLSNEE--EKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLT 113
Query: 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNIL 719
+ +G L + L + G PL+ + I R V+++H + IHRDLK N+L
Sbjct: 114 ELCKGQLVEFLKKMESRG--PLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLL 170
Query: 720 IGDDMRAKVADFGLVKNA---PDGKYSVETRLA--------GTFGYLAPE 758
+ + K+ DFG PD +S + R T Y PE
Sbjct: 171 LSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPE 220
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-29
Identities = 58/352 (16%), Positives = 120/352 (34%), Gaps = 41/352 (11%)
Query: 89 LTQLETLSFQMNNIAGAIP--SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSD 146
+++L N I I L +LQ + L ++ ++ F L +L+ L LSD
Sbjct: 25 TAAMKSLDLSFNKIT-YIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSD 83
Query: 147 NP--NLAPWPFPNELTKSTSLTTLYMDNANIFGL-IPDFFDSFSNLQNLRLSYNNFTGSL 203
N +L+ F +SL L + L + F + +NLQ LR+ +
Sbjct: 84 NHLSSLSSSWFGP----LSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEI 139
Query: 204 PASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTG-PIPDLSKCESLFD 262
+G+T L ++ + L +
Sbjct: 140 RR-----------------------IDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHH 176
Query: 263 LSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDA 322
L+L ++ ++ L ++ + L++ L + P V +VS S
Sbjct: 177 LTLHLSESAFLLEIFADILSSVRYLELRDTNLAR-FQFSPLPVDEVSSPMKKLAFRGSVL 235
Query: 323 GKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIIT------INLAN 376
++ LL+ ++ + G + S+ + +++
Sbjct: 236 TDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQ 295
Query: 377 KLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428
L ++S Y+ L +K + ++ + + L SL+ LD+S N +
Sbjct: 296 FYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMV 347
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-28
Identities = 59/369 (15%), Positives = 130/369 (35%), Gaps = 31/369 (8%)
Query: 69 TTISLAKSGLSGTLSPE-ISSLTQLETLSFQMNNIA--GAIPSLANATSLQDIYLDNNN- 124
+ L+ + LS +LS L+ L+ L+ N G N T+LQ + + N
Sbjct: 77 EHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVET 135
Query: 125 FTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFD 184
F+ + F GLT+L L + +L + L + L + + L+ F D
Sbjct: 136 FSEIRRIDFAGLTSLNELEIKAL-SLRNYQ-SQSLKSIRDIHHLTLHLSESAFLLEIFAD 193
Query: 185 SFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHK 244
S+++ L L N + ++ + G T + + + +L + L
Sbjct: 194 ILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILEL 253
Query: 245 NQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPS- 303
++ C ++ V + + + + L S
Sbjct: 254 SEVE-----FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSL 308
Query: 304 --KVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPF 361
KV++++++++ + + L D+ ++ + + + WP
Sbjct: 309 LEKVKRITVENSKVFLVPCSFSQHL-KSLEFL-----DLSENLMVEEYLKNSACKGAWPS 362
Query: 362 VTCSQGRIITINLA-NKLLA-GNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQN 419
+ T+ L+ N L + L +L +L + +N P+PD ++
Sbjct: 363 LQ-------TLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRF 414
Query: 420 LDVSNNNLS 428
L++S+ +
Sbjct: 415 LNLSSTGIR 423
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-27
Identities = 53/359 (14%), Positives = 122/359 (33%), Gaps = 39/359 (10%)
Query: 81 TLSPEISSLTQLETLSFQMNNIAGAIP--SLANATSLQDIYLDNNNFTSVPTGCFDGLTN 138
++ +LT L+TL I A TSL ++ + + + + + +
Sbjct: 114 GVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRD 173
Query: 139 LQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNN 198
+ L+L + + + +S+ L + + N+ ++
Sbjct: 174 IHHLTLHLSES--AFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFR 231
Query: 199 FTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSK-- 256
+ SF +++ L +L + T + ++ + +L K
Sbjct: 232 GSVLTDESF--NELLKLLRYILEL----SEVEFDDCTLNGLGDFNPSESDV-VSELGKVE 284
Query: 257 CESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG-PYPLF--PSKVQKVSLDHN 313
++ L + L + L + I+++N+K+ P ++ + L N
Sbjct: 285 TVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSEN 344
Query: 314 NF----CKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRI 369
KNS+ G P + TL +LS + + G +T +
Sbjct: 345 LMVEEYLKNSACKGAW--PSLQTL-----------VLSQNHLRSMQKTGEILLTLKN--L 389
Query: 370 ITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428
+++++ + + ++ L L + + + +L+ LDVSNNNL
Sbjct: 390 TSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIRV-VKTCI--PQTLEVLDVSNNNLD 444
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-25
Identities = 45/237 (18%), Positives = 92/237 (38%), Gaps = 15/237 (6%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLA--NATSLQDIYLD 121
+ + + + + L LS S L +++ ++ + + + +P + SL+ + L
Sbjct: 284 ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKV-FLVPCSFSQHLKSLEFLDLS 342
Query: 122 NNNFTSVP---TGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGL 178
N + C +LQ L LS N + L +LT+L + N F
Sbjct: 343 ENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISR-NTFHP 401
Query: 179 IPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLR 238
+PD ++ L LS + ++ ++ L +++ L + +L+
Sbjct: 402 MPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQT-LEVLDVSNNNLD-----SFSLFLPRLQ 454
Query: 239 QVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQ 295
++++ +N+ +PD S L + + NQL V L +L I L N
Sbjct: 455 ELYISRNKLKT-LPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-23
Identities = 62/396 (15%), Positives = 122/396 (30%), Gaps = 59/396 (14%)
Query: 63 DNSNRVTTISLAKSGLSGTLSPE-ISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYL 120
N + T+ + + + LT L L + ++ SL + + + L
Sbjct: 120 PNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTL 179
Query: 121 DNNNFTSVPTGCFDGLTNLQVLSLSDNP--NLAPWPFPNELTKSTSLTTLYMDNANI--- 175
+ + D L++++ L L D P P S+ + L + +
Sbjct: 180 HLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPV-DEVSSPMKKLAFRGSVLTDE 238
Query: 176 -FGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSD------------IQNLWMNDQQL 222
F + L + G + ++SD I+ L + L
Sbjct: 239 SFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYL 298
Query: 223 GLSGTLDVLSGMTQLRQVWLHKNQFTG-PIPDLSKCESLFDLSLRDNQLTGVV---PASV 278
+ V S + +++++ + ++ P +SL L L +N + A
Sbjct: 299 FYDLS-TVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACK 357
Query: 279 ISLPALLNISLQNNKLQ----GPYPLFP-SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTL 333
+ P+L + L N L+ L + + + N F P ++ L
Sbjct: 358 GAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWP--EKMRFL 415
Query: 334 LQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGN-ISPAYANLTS 392
LS I L ++ N + L
Sbjct: 416 -----------NLS----STG------IRVVKTC--IPQTLEVLDVSNNNLDSFSLFLPR 452
Query: 393 LKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428
L+ LY+ +N L +PD + L + +S N L
Sbjct: 453 LQELYISRNKLKT-LPDA-SLFPVLLVMKISRNQLK 486
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-22
Identities = 39/343 (11%), Positives = 97/343 (28%), Gaps = 98/343 (28%)
Query: 88 SLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDN 147
+L L + +++ + + +++ +++ + + L ++ +++ ++
Sbjct: 262 TLNGLGDFNPSESDVVSELGKV-ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENS 320
Query: 148 PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASF 207
+F + F +L+ L LS N +
Sbjct: 321 --------------------------KVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNS 354
Query: 208 AKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFT---GPIPDLSKCESLFDLS 264
A L+ + L +N L ++L L
Sbjct: 355 A---------------------CKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLD 393
Query: 265 LRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGK 324
+ N +P S + ++L + ++ P ++ + + +NN S
Sbjct: 394 ISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFL-- 450
Query: 325 PCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNIS 384
P++ L +S N ++ T+
Sbjct: 451 ---PRLQEL-----------YIS-----RN-------------KLKTL------------ 466
Query: 385 PAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNL 427
P + L + + +N L +L SLQ + + N
Sbjct: 467 PDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 44/314 (14%), Positives = 86/314 (27%), Gaps = 119/314 (37%)
Query: 120 LDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLI 179
+ +FTS+P+G ++ L LS N I +
Sbjct: 12 GRSRSFTSIPSGLT---AAMKSLDLSFN--------------------------KITYIG 42
Query: 180 PDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQ 239
+ +NLQ L L + ++ D + L
Sbjct: 43 HGDLRACANLQVLILKSSRIN-TIEG-----------------------DAFYSLGSLE- 77
Query: 240 VWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQ--GP 297
L L DN L+ + + L +L ++L N Q G
Sbjct: 78 ----------------------HLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGV 115
Query: 298 YPLFP--SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNA 355
LFP + +Q + + + + + D T L
Sbjct: 116 TSLFPNLTNLQTLRIGNV----ETFSEIRRIDFAGLTSLN-------------------- 151
Query: 356 CDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLA 415
+ + L S + ++ + +L L + + L+
Sbjct: 152 ---------------ELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILS 196
Query: 416 SLQNLDVSNNNLSG 429
S++ L++ + NL+
Sbjct: 197 SVRYLELRDTNLAR 210
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 16/66 (24%), Positives = 28/66 (42%), Gaps = 5/66 (7%)
Query: 371 TINLA-NKLLAGNISP-AYANLTSLKNLYLQQNNLTG-PIPDGLTKLASLQNLDVSNNNL 427
++L+ N L ++S + L+SLK L L N + L +LQ L + N
Sbjct: 78 HLDLSDNHL--SSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVET 135
Query: 428 SGKVPD 433
++
Sbjct: 136 FSEIRR 141
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 6e-29
Identities = 43/188 (22%), Positives = 84/188 (44%), Gaps = 24/188 (12%)
Query: 589 LGRGGFGVVYGGELPDGTKIAVK--------------RMESNTMGNKGLSE-FQAEIAVL 633
L +G F + E D A+K + ++ + K + F+ E+ ++
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 634 TKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHL---FEWHDHGYTPLTWKQRVTIA 690
T +++ + + G N E ++YEYM ++ + F + + + I
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 691 LDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAG 750
V Y+H+ +++ HRD+KPSNIL+ + R K++DFG + D K ++ G
Sbjct: 158 KSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK--IKG-SRG 212
Query: 751 TFGYLAPE 758
T+ ++ PE
Sbjct: 213 TYEFMPPE 220
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-29
Identities = 45/175 (25%), Positives = 69/175 (39%), Gaps = 13/175 (7%)
Query: 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH--RHLVAL 644
+G GG V+ A+K + N+ L ++ EIA L K++ ++ L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 645 LGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA 704
Y I +V E L L + +R + ++ V +H
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKK--SIDPWERKSYWKNMLEAVHTIH--- 125
Query: 705 QQSFIHRDLKPSNILIGDDMRAKVADFGLVKN-APDGKYSVETRLAGTFGYLAPE 758
Q +H DLKP+N LI D K+ DFG+ PD V+ GT Y+ PE
Sbjct: 126 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 9e-29
Identities = 44/175 (25%), Positives = 68/175 (38%), Gaps = 13/175 (7%)
Query: 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH--RHLVAL 644
+G GG V+ A+K + N+ L ++ EIA L K++ ++ L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 645 LGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA 704
Y I +V E L L + +R + ++ V +H
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKK--SIDPWERKSYWKNMLEAVHTIH--- 172
Query: 705 QQSFIHRDLKPSNILIGDDMRAKVADFGLVKN-APDGKYSVETRLAGTFGYLAPE 758
Q +H DLKP+N LI D K+ DFG+ PD V+ G Y+ PE
Sbjct: 173 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 55/182 (30%), Positives = 72/182 (39%), Gaps = 16/182 (8%)
Query: 581 DNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RH 638
+F + LG G +G V+ DG AVKR S G K + AE+ KV +H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
V L G L E +L QH W L Q D +
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWG----ASLPEAQVWGYLRDTLLALA 171
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK--NAPDGKYSVETRLAGTFGYLA 756
+LHS Q +H D+KP+NI +G R K+ DFGL+ E G Y+A
Sbjct: 172 HLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE----GDPRYMA 224
Query: 757 PE 758
PE
Sbjct: 225 PE 226
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 54/181 (29%), Positives = 90/181 (49%), Gaps = 15/181 (8%)
Query: 581 DNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSE-FQAEIAVLTKVRH 638
++F LG+G FG VY E +A+K + + G+ + E+ + + +RH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 639 RHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697
+++ L GY + + R+ L+ EY P GT+ + L + + ++ T ++A +
Sbjct: 69 PNILRLYGY-FHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANAL 122
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAP 757
Y HS + IHRD+KP N+L+G K+ADFG +AP + L GT YL P
Sbjct: 123 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--TD-LCGTLDYLPP 176
Query: 758 E 758
E
Sbjct: 177 E 177
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 43/178 (24%), Positives = 75/178 (42%), Gaps = 15/178 (8%)
Query: 588 ILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646
+GRG F VY G + ++A ++ + F+ E +L ++H ++V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 647 YCINGSE---RLLVY-EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHS 702
+ + +++ E M GTL +L + + K + + +G+++LH+
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLHT 147
Query: 703 LAQQSFIHRDLKPSNILI-GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEY 759
IHRDLK NI I G K+ D GL S + GT ++APE
Sbjct: 148 -RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA---SFAKAVIGTPEFMAPEM 201
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-28
Identities = 38/159 (23%), Positives = 65/159 (40%), Gaps = 13/159 (8%)
Query: 588 ILGRGGFGVVYGGELPDG----TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVA 643
+G G FG V+ G +A+K ++ T + +F E + + H H+V
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS-DSVREKFLQEALTMRQFDHPHIVK 455
Query: 644 LLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSL 703
L+G + ++ E G L L L + A ++ + YL S
Sbjct: 456 LIGVIT-ENPVWIIMELCTLGELRSFLQV-RKF---SLDLASLILYAYQLSTALAYLES- 509
Query: 704 AQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742
+ F+HRD+ N+L+ + K+ DFGL + D Y
Sbjct: 510 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 546
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-28
Identities = 53/201 (26%), Positives = 79/201 (39%), Gaps = 28/201 (13%)
Query: 577 RQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV 636
+ + + ILG G G V G +AVKRM + EI +LT+
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC-----DIALMEIKLLTES 65
Query: 637 -RHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFE--WHDHGYTPLTWKQRVTIALDV 693
H +++ + E L + D +++ +
Sbjct: 66 DDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 694 ARGVEYLHSLAQQSFIHRDLKPSNILI-------------GDDMRAKVADFGLVKNAPDG 740
A GV +LHSL IHRDLKP NIL+ +++R ++DFGL K G
Sbjct: 125 ASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 741 KYSVETRL---AGTFGYLAPE 758
+ S T L +GT G+ APE
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPE 202
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 49/185 (26%), Positives = 77/185 (41%), Gaps = 37/185 (20%)
Query: 589 LGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSE-FQAEIAVLTKVRHRHLVALLG 646
LG+GGF + + A K + + + E EI++ + H+H+V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 647 YCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR--------GV 697
+ ++ + +V E R +L + K+R + AR G
Sbjct: 83 F-FEDNDFVFVVLELCRRRSLLELH-------------KRRKALTEPEARYYLRQIVLGC 128
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL-VKNAPDGKYSVETRLA---GTFG 753
+YLH IHRDLK N+ + +D+ K+ DFGL K DG+ R GT
Sbjct: 129 QYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-----RKKVLCGTPN 180
Query: 754 YLAPE 758
Y+APE
Sbjct: 181 YIAPE 185
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-28
Identities = 58/262 (22%), Positives = 109/262 (41%), Gaps = 17/262 (6%)
Query: 62 CDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPS--LANATSLQDIY 119
C SN+ + + + GLS + I S T+ L+ NNI I + + L+ +
Sbjct: 50 CSCSNQFSKVVCTRRGLS-EVPQGIPSNTR--YLNLMENNIQ-MIQADTFRHLHHLEVLQ 105
Query: 120 LDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLI 179
L N+ + G F+GL +L L L DN L P + L L++ N I +
Sbjct: 106 LGRNSIRQIEVGAFNGLASLNTLELFDN-WLTVIP-SGAFEYLSKLRELWLRNNPIESIP 163
Query: 180 PDFFDSFSNLQNLRLSYNNFTGSLPA-SFAK-SDIQNLWMNDQQLGLSGTLDVLSGMTQL 237
F+ +L L L + +F +++ L + + + L+ + L
Sbjct: 164 SYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNI---KDMPNLTPLVGL 220
Query: 238 RQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG 296
++ + N F P SL L + ++Q++ + + L +L+ ++L +N L
Sbjct: 221 EELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSS 280
Query: 297 -PYPLFPS--KVQKVSLDHNNF 315
P+ LF + ++ L HN +
Sbjct: 281 LPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 1e-20
Identities = 54/324 (16%), Positives = 100/324 (30%), Gaps = 86/324 (26%)
Query: 114 SLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNA 173
+ + VP G +N + L+L +N N+ + L L +
Sbjct: 55 QFSKVVCTRRGLSEVPQGIP---SNTRYLNLMEN-NIQMIQ-ADTFRHLHHLEVLQLGRN 109
Query: 174 NIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSG 233
+I + F+ ++L L L N T +P+
Sbjct: 110 SIRQIEVGAFNGLASLNTLELFDNWLT-VIPS-----------------------GAFEY 145
Query: 234 MTQLRQVWLHKNQFTGPIPD--LSKCESLFDLSLRD-NQLTGVVPASVISLPALLNISLQ 290
+++LR++WL N IP ++ SL L L + +L + + L L ++L
Sbjct: 146 LSKLRELWLRNNPIES-IPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLG 204
Query: 291 NNKLQGPYPLFP--SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSD 348
++ P ++++ + N+F +
Sbjct: 205 MCNIKDM-PNLTPLVGLEELEMSGNHF---------------PEI--------------- 233
Query: 349 SWEGNNACDGWPFVTCSQGRIITINLANKLLAGN----ISP-AYANLTSLKNLYLQQNNL 403
+ G +L + + I A+ L SL L L NNL
Sbjct: 234 ---RPGSFHGLS------------SLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNL 278
Query: 404 TGPIPDGLTKLASLQNLDVSNNNL 427
+ D T L L L + +N
Sbjct: 279 SSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 46/248 (18%), Positives = 77/248 (31%), Gaps = 71/248 (28%)
Query: 186 FSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKN 245
SN + L L NN + A D + L + L +N
Sbjct: 74 PSNTRYLNLMENNIQ-MIQA-----------------------DTFRHLHHLEVLQLGRN 109
Query: 246 QFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG-PYPLFP 302
I + SL L L DN LT + + L L + L+NN ++ P F
Sbjct: 110 SIRQ-IEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFN 168
Query: 303 --SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWP 360
+ ++ L ++ I ++EG
Sbjct: 169 RVPSLMRLDLGELK--------------------KLE------YISEGAFEG-------- 194
Query: 361 FVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNL 420
+ +NL + ++ P L L+ L + N+ P L+SL+ L
Sbjct: 195 -----LFNLKYLNLGMCNIK-DM-PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKL 247
Query: 421 DVSNNNLS 428
V N+ +S
Sbjct: 248 WVMNSQVS 255
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 43/209 (20%), Positives = 77/209 (36%), Gaps = 19/209 (9%)
Query: 235 TQLRQVWLHKNQFTG-PIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNK 293
+ R + L +N L L L N + + + L +L + L +N
Sbjct: 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134
Query: 294 LQG-PYPLFP--SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLL--------QIAGDM-- 340
L P F SK++++ L +N S A P + L I+
Sbjct: 135 LTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRV-PSLMRLDLGELKKLEYISEGAFE 193
Query: 341 GYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISP-AYANLTSLKNLYLQ 399
G + + N D + ++ N I P ++ L+SLK L++
Sbjct: 194 GLFNLKYLNLGMCNIKDMPNLTPLVGLEELEMS-GNHF--PEIRPGSFHGLSSLKKLWVM 250
Query: 400 QNNLTGPIPDGLTKLASLQNLDVSNNNLS 428
+ ++ + LASL L++++NNLS
Sbjct: 251 NSQVSLIERNAFDGLASLVELNLAHNNLS 279
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 21/86 (24%), Positives = 35/86 (40%), Gaps = 14/86 (16%)
Query: 356 CDGWPF-VTCSQGRIITI------NLANKLLAGN----ISP-AYANLTSLKNLYLQQNNL 403
C V C++ + + N L N I + +L L+ L L +N++
Sbjct: 52 CSNQFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 404 TGPIPDG-LTKLASLQNLDVSNNNLS 428
I G LASL L++ +N L+
Sbjct: 112 RQ-IEVGAFNGLASLNTLELFDNWLT 136
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-28
Identities = 38/179 (21%), Positives = 75/179 (41%), Gaps = 8/179 (4%)
Query: 581 DNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHR 639
+ + +G G FG DG + +K + + M +K E + E+AVL ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
++V +V +Y G L + + + Q + + + +++
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRI---NAQKGVLFQEDQILDWFVQICLALKH 140
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
+H + +HRD+K NI + D ++ DFG+ + + + GT YL+PE
Sbjct: 141 VHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELARACIGTPYYLSPE 195
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 56/196 (28%), Positives = 87/196 (44%), Gaps = 33/196 (16%)
Query: 581 DNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHR 639
+F E ++G GGFG V+ DG +KR++ N + + E+ L K+ H
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE------KAEREVKALAKLDHV 64
Query: 640 HLVALLGYCINGSERL----------------LVYEYMPRGTLAQHLFEWHDHGYTPLTW 683
++V G + E+ +GTL Q + L
Sbjct: 65 NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI---EKRRGEKLDK 121
Query: 684 KQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN-APDGKY 742
+ + + +GV+Y+HS + I+RDLKPSNI + D + K+ DFGLV + DGK
Sbjct: 122 VLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR 178
Query: 743 SVETRLAGTFGYLAPE 758
TR GT Y++PE
Sbjct: 179 ---TRSKGTLRYMSPE 191
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 52/212 (24%), Positives = 77/212 (36%), Gaps = 32/212 (15%)
Query: 87 SSLTQLETLSFQMNNIAGAIPSLA--NATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144
S +L+ L I I A + + L + L N S+ G F GL++LQ L
Sbjct: 49 FSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107
Query: 145 SDNP--NLAPWPFPNELTKSTSLTTLYMDNANIFGLI-PDFFDSFSNLQNLRLSYNNFTG 201
+ +L +P +L L + + I P++F + +NL++L LS N
Sbjct: 108 VETNLASLENFPI----GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ- 162
Query: 202 SLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLR-QVWLHKNQFTGPIPDLSKCESL 260
S+ L VL M L + L N P K L
Sbjct: 163 SIYC--------------------TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRL 202
Query: 261 FDLSLRDNQLTGVVPASVISLPALLNISLQNN 292
+L+L NQL V L +L I L N
Sbjct: 203 KELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 44/211 (20%), Positives = 74/211 (35%), Gaps = 14/211 (6%)
Query: 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172
S +++ L N + + F LQVL LS + + L+TL +
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRC-EIQTIE-DGAYQSLSHLSTLILTG 85
Query: 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPA-SFAK-SDIQNLWMNDQQLGLSGTLDV 230
I L F S+LQ L N SL ++ L + + +
Sbjct: 86 NPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144
Query: 231 LSGMTQLRQVWLHKNQFT----GPIPDLSKCESL-FDLSLRDNQLTGVVPASVISLPALL 285
S +T L + L N+ + L + L L L N + + L
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLK 203
Query: 286 NISLQNNKLQG-PYPLF--PSKVQKVSLDHN 313
++L N+L+ P +F + +QK+ L N
Sbjct: 204 ELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 7e-09
Identities = 26/90 (28%), Positives = 33/90 (36%), Gaps = 28/90 (31%)
Query: 87 SSLTQLETLSFQMNNI----AGAIPSLANAT------------------------SLQDI 118
S+LT LE L N I + L L+++
Sbjct: 146 SNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKEL 205
Query: 119 YLDNNNFTSVPTGCFDGLTNLQVLSLSDNP 148
LD N SVP G FD LT+LQ + L NP
Sbjct: 206 ALDTNQLKSVPDGIFDRLTSLQKIWLHTNP 235
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 34/254 (13%), Positives = 68/254 (26%), Gaps = 78/254 (30%)
Query: 186 FSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKN 245
+ +NL LS+N L + +L+ + L +
Sbjct: 27 PFSTKNLDLSFNPLR-HLGS-----------------------YSFFSFPELQVLDLSRC 62
Query: 246 QFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG-PYPLF- 301
+ I D L L L N + + + L +L + L
Sbjct: 63 EIQT-IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIG 121
Query: 302 -PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWP 360
++++++ HN + + +
Sbjct: 122 HLKTLKELNVAHN---------------LIQSF-----------------KLPEYFSNLT 149
Query: 361 FVTCSQGRIITINLA-NKLLAGNISP-AYANLTSLK----NLYLQQNNLTGPIPDGLTKL 414
+ ++L+ NK+ +I L + +L L N + I G K
Sbjct: 150 NLE-------HLDLSSNKI--QSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKE 199
Query: 415 ASLQNLDVSNNNLS 428
L+ L + N L
Sbjct: 200 IRLKELALDTNQLK 213
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 51/175 (29%), Positives = 83/175 (47%), Gaps = 16/175 (9%)
Query: 589 LGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSE-FQAEIAVLTKVRHRHLVALLG 646
LG+G F VY + G ++A+K ++ M G+ + Q E+ + +++H ++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 647 YCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQ 705
Y S + LV E G + ++L + P + + + G+ YLHS
Sbjct: 79 Y-FEDSNYVYLVLEMCHNGEMNRYL---KNRV-KPFSENEARHFMHQIITGMLYLHS--- 130
Query: 706 QSFIHRDLKPSNILIGDDMRAKVADFGL--VKNAPDGKYSVETRLAGTFGYLAPE 758
+HRDL SN+L+ +M K+ADFGL P K T L GT Y++PE
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK--HYT-LCGTPNYISPE 182
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-28
Identities = 52/245 (21%), Positives = 94/245 (38%), Gaps = 20/245 (8%)
Query: 87 SSLTQLETLSFQMNNIAGAIPS--LANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144
L+ L N I I ++ SL+ + L N +++ + F L++L L+L
Sbjct: 73 QRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNL 131
Query: 145 SDNP--NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGS 202
NP L + LTK L + F + L+ L + ++
Sbjct: 132 LGNPYKTLGETSLFSHLTKLQILRVGN--MDTFTKIQRKDFAGLTFLEELEIDASDLQSY 189
Query: 203 LPASFAK-SDIQNLWMNDQQLGL--SGTLDVLSGMT--QLRQVWLHKNQFT----GPIPD 253
P S ++ +L ++ +Q L +DV S + +LR L F+ G
Sbjct: 190 EPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNS 249
Query: 254 LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG-PYPLFPS--KVQKVSL 310
L K + ++ + D L V + + LL + N+L+ P +F +QK+ L
Sbjct: 250 LIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWL 308
Query: 311 DHNNF 315
N +
Sbjct: 309 HTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 52/321 (16%), Positives = 100/321 (31%), Gaps = 65/321 (20%)
Query: 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172
+++ + L NN T + NLQ L L+ N + + + SL L +
Sbjct: 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSN-GINTIE-EDSFSSLGSLEHLDLSY 109
Query: 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLS 232
+ L +F S+L L L N + +L + + S
Sbjct: 110 NYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGET----------------------SLFS 146
Query: 233 GMTQLRQVWLHKNQFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQ 290
+T+L+ + + I + L +L + + L P S+ S+ + ++ L
Sbjct: 147 HLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILH 206
Query: 291 NNKLQG-PYPLFP--SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILS 347
+ S V+ + L + + L +
Sbjct: 207 MKQHILLLEIFVDVTSSVECLELRDTDLDTF----------HFSEL---------STGET 247
Query: 348 DSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPI 407
+S + R + I L + ++ L L +N L +
Sbjct: 248 NS-----------LIKKFTFRNVKITD-ESLFQ--VMKLLNQISGLLELEFSRNQLKS-V 292
Query: 408 PDG-LTKLASLQNLDVSNNNL 427
PDG +L SLQ + + N
Sbjct: 293 PDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-25
Identities = 49/242 (20%), Positives = 87/242 (35%), Gaps = 22/242 (9%)
Query: 90 TQLETLSFQMNNIAGAIPS--LANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDN 147
+++L N I I + L +LQ + L +N ++ F L +L+ L LS N
Sbjct: 52 EAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYN 110
Query: 148 PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPD-FFDSFSNLQNLRLSYNNFTGSLPA- 205
L+ + +SLT L + L F + LQ LR+ + +
Sbjct: 111 -YLSNLS-SSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRK 168
Query: 206 SFAK-SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD--LSKCESLFD 262
FA + ++ L ++ L S L + + + LH Q + + + S+
Sbjct: 169 DFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHIL-LLEIFVDVTSSVEC 226
Query: 263 LSLRDNQLTG--------VVPASVISLPALLNISLQNNKLQGPYPLF--PSKVQKVSLDH 312
L LRD L S+I N+ + + L L S + ++
Sbjct: 227 LELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSR 286
Query: 313 NN 314
N
Sbjct: 287 NQ 288
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 1e-21
Identities = 36/211 (17%), Positives = 62/211 (29%), Gaps = 44/211 (20%)
Query: 87 SSLTQLETLSFQMNNIAGAIPS--LANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144
S LT+L+ L + I A T L+++ +D ++ S + N+ L L
Sbjct: 146 SHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLIL 205
Query: 145 SDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLP 204
L+ F D S+++ L L +
Sbjct: 206 HMKQ--------------------------HILLLEIFVDVTSSVECLELRDTDLDTFHF 239
Query: 205 ASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLS 264
+ + +G + L R V + + L++ L +L
Sbjct: 240 SELS----------------TGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELE 283
Query: 265 LRDNQLTGVVPASVISLPALLNISLQNNKLQ 295
NQL V L +L I L N
Sbjct: 284 FSRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 9e-09
Identities = 37/250 (14%), Positives = 74/250 (29%), Gaps = 70/250 (28%)
Query: 186 FSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKN 245
+++L LS N T + L L+ + L N
Sbjct: 51 TEAVKSLDLSNNRIT-YISN-----------------------SDLQRCVNLQALVLTSN 86
Query: 246 QFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQ--GPYPLF 301
I + S SL L L N L+ + + L +L ++L N + G LF
Sbjct: 87 GINT-IEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLF 145
Query: 302 PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPF 361
+ L N T + + F
Sbjct: 146 SHLTKLQILRVGNM------------DTFTKIQRKD-----------------------F 170
Query: 362 VTCSQGRIITINLANKLLAGNISP-AYANLTSLKNLYLQQNNLTGPIPDGL-TKLASLQN 419
+ + I+ A+ L + P + ++ ++ +L L + + +S++
Sbjct: 171 AGLTFLEELEID-ASDL--QSYEPKSLKSIQNVSHLILHMKQHIL-LLEIFVDVTSSVEC 226
Query: 420 LDVSNNNLSG 429
L++ + +L
Sbjct: 227 LELRDTDLDT 236
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-28
Identities = 51/206 (24%), Positives = 79/206 (38%), Gaps = 37/206 (17%)
Query: 580 TDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH 638
+F E +LG+G FG V D A+K++ + LS +E+ +L + H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR---HTEEKLSTILSEVMLLASLNH 61
Query: 639 RHLVALLG-YCINGSERL------------LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQ 685
+++V + + + EY GTL + + + W+
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR- 120
Query: 686 RVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN--------- 736
+ + + Y+HS Q IHRDLKP NI I + K+ DFGL KN
Sbjct: 121 ---LFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 737 ----APDGKYSVETRLAGTFGYLAPE 758
G T GT Y+A E
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATE 200
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 49/185 (26%), Positives = 77/185 (41%), Gaps = 37/185 (20%)
Query: 589 LGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSE-FQAEIAVLTKVRHRHLVALLG 646
LG+GGF + + A K + + + E EI++ + H+H+V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 647 YCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR--------GV 697
+ ++ + +V E R +L + K+R + AR G
Sbjct: 109 F-FEDNDFVFVVLELCRRRSLLELH-------------KRRKALTEPEARYYLRQIVLGC 154
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL-VKNAPDGKYSVETRLA---GTFG 753
+YLH IHRDLK N+ + +D+ K+ DFGL K DG+ R GT
Sbjct: 155 QYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-----RKKVLCGTPN 206
Query: 754 YLAPE 758
Y+APE
Sbjct: 207 YIAPE 211
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 46/189 (24%), Positives = 78/189 (41%), Gaps = 17/189 (8%)
Query: 578 QVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV 636
+ ++ILG+G V+ G G A+K + + + + E VL K+
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKL 64
Query: 637 RHRHLVALLGYCINGSERL--LVYEYMPRGTLAQHLFEWHDHGYT-PLTWKQRVTIALDV 693
H+++V L + R L+ E+ P G+L L + L + + + DV
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVL---EEPSNAYGLPESEFLIVLRDV 121
Query: 694 ARGVEYLHSLAQQSFIHRDLKPSNILIG----DDMRAKVADFGLVKNAPDGKYSVETRLA 749
G+ +L +HR++KP NI+ K+ DFG + D + V L
Sbjct: 122 VGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LY 176
Query: 750 GTFGYLAPE 758
GT YL P+
Sbjct: 177 GTEEYLHPD 185
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 39/183 (21%), Positives = 76/183 (41%), Gaps = 7/183 (3%)
Query: 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHR 639
+++ +G G +G DG + K ++ +M +E+ +L +++H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 640 HLVALLGYCINGSERLL--VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697
++V I+ + L V EY G LA + + L + + + + +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER-QYLDEEFVLRVMTQLTLAL 124
Query: 698 EYLHSLAQQSF--IHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYL 755
+ H + +HRDLKP+N+ + K+ DFGL + +T GT Y+
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT-FVGTPYYM 183
Query: 756 APE 758
+PE
Sbjct: 184 SPE 186
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 55/260 (21%), Positives = 95/260 (36%), Gaps = 43/260 (16%)
Query: 90 TQLETLSFQMNNIAGAIP--SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDN 147
L Q N+I+ + L + L NN + + F L LQ L +S N
Sbjct: 54 PDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112
Query: 148 PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSL--PA 205
+L P L +SL L + + I + F N+ + + N S P
Sbjct: 113 -HLV--EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPG 167
Query: 206 SFAKSDIQNLWMND--------------QQLGLSG------TLDVLSGMTQLRQVWLHKN 245
+F + L +++ +L L L+ L ++L ++ L N
Sbjct: 168 AFDGLKLNYLRISEAKLTGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHN 227
Query: 246 QFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQ-------- 295
Q I + LS +L +L L +N+L+ VPA + L L + L N +
Sbjct: 228 QIRM-IENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFC 285
Query: 296 -GPYPLFPSKVQKVSLDHNN 314
+ + + +SL +N
Sbjct: 286 PVGFGVKRAYYNGISLFNNP 305
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 53/222 (23%), Positives = 81/222 (36%), Gaps = 26/222 (11%)
Query: 87 SSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSD 146
S L +L+ L N++ IP +SL ++ + +N VP G F GL N+ + +
Sbjct: 99 SPLRKLQKLYISKNHLV-EIPPNL-PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGG 156
Query: 147 NPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPA- 205
NP L F L L + A + G IP D L L L +N ++
Sbjct: 157 NP-LENSGFEPGAFDGLKLNYLRISEAKLTG-IPK--DLPETLNELHLDHNKIQ-AIELE 211
Query: 206 SFAKSDIQNLWMNDQQLGLSG------TLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCES 259
L +LGL LS + LR++ L N+ + L +
Sbjct: 212 DL--LRYSKL----YRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKL 265
Query: 260 LFDLSLRDNQLTGVVPAS------VISLPALLNISLQNNKLQ 295
L + L N +T V + ISL NN +
Sbjct: 266 LQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVP 307
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 41/243 (16%), Positives = 68/243 (27%), Gaps = 55/243 (22%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIA-GAIPSLA-NATSLQDIYLD 121
+ NR+ + G S L + + N + A + L + +
Sbjct: 131 HDNRIRKVP------KGVFS----GLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRIS 180
Query: 122 NNNFTSVPTGCFDGLTNLQVLSLSDNP--NLAPWPFPNELTKSTSLTTLYMDNANIFGLI 179
T +P L L L N + + L L + + I +
Sbjct: 181 EAKLTGIPKDLP---ETLNELHLDHNKIQAIELEDLLR----YSKLYRLGLGHNQIRMIE 233
Query: 180 PDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQ 239
L+ L L N + +PA + L+
Sbjct: 234 NGSLSFLPTLRELHLDNNKLS-RVPAGL------------------------PDLKLLQV 268
Query: 240 VWLHKNQFT-------GPIPDLSKCESLFDLSLRDNQLT--GVVPASVISLPALLNISLQ 290
V+LH N T P+ K +SL +N + V PA+ + L I
Sbjct: 269 VYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFG 328
Query: 291 NNK 293
N K
Sbjct: 329 NYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 8e-11
Identities = 51/318 (16%), Positives = 99/318 (31%), Gaps = 82/318 (25%)
Query: 131 GCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQ 190
G+ +L L + + P L + + + +P + +
Sbjct: 8 ETTSGIPDLDSLPPTYSAMC-----PFGC--HCHLRVVQCSDLGLKA-VPK--EISPDTT 57
Query: 191 NLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGP 250
L L N+ + L D G+ L + L N+ +
Sbjct: 58 LLDLQNNDIS-ELRK-----------------------DDFKGLQHLYALVLVNNKISK- 92
Query: 251 IPD--LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG-PYPLFP--SKV 305
I + S L L + N L +P ++ +L+ + + +N+++ P +F +
Sbjct: 93 IHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNM 149
Query: 306 QKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCS 365
+ + N + + G ++ L + +
Sbjct: 150 NCIEMGGNPLENSGFEPGAFDGLKLNYL-----RISEAKL-------------------- 184
Query: 366 QGRIITINLANKL----LAGN----ISPAY-ANLTSLKNLYLQQNNLTGPIPDG-LTKLA 415
I +L L L N I + L L L N + I +G L+ L
Sbjct: 185 --TGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRM-IENGSLSFLP 241
Query: 416 SLQNLDVSNNNLSGKVPD 433
+L+ L + NN LS +VP
Sbjct: 242 TLRELHLDNNKLS-RVPA 258
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 4e-27
Identities = 53/219 (24%), Positives = 90/219 (41%), Gaps = 27/219 (12%)
Query: 87 SSLTQLETLSFQMNNIAGAIP--SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144
L LE L N+I I + +L + L +N T++P G F L+ L+ L L
Sbjct: 85 KHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWL 143
Query: 145 SDNP--NLAPWPFPNELTKSTSLTTLYMDNAN-IFGLIPDFFDSFSNLQNLRLSYNNFTG 201
+NP ++ + F + SL L + + + F+ SNL+ L L+ N
Sbjct: 144 RNNPIESIPSYAF----NRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR- 198
Query: 202 SLPASFAKSDIQNLWMNDQQLGLSGTL------DVLSGMTQLRQVWLHKNQFTGPIPD-- 253
+P + + L +L LSG G+ L+++W+ ++Q I
Sbjct: 199 EIPN-L--TPLIKL----DELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQV-IERNA 250
Query: 254 LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNN 292
+SL +++L N LT + L L I L +N
Sbjct: 251 FDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-25
Identities = 46/212 (21%), Positives = 84/212 (39%), Gaps = 19/212 (8%)
Query: 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172
T+ + + L N + F L +L++L LS N ++ +L TL + +
Sbjct: 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRN-HIRTIE-IGAFNGLANLNTLELFD 121
Query: 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSG------ 226
+ + F S L+ L L N +F + I +L ++L L
Sbjct: 122 NRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAF--NRIPSL----RRLDLGELKRLSY 175
Query: 227 -TLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALL 285
+ G++ LR + L IP+L+ L +L L N L+ + P S L L
Sbjct: 176 ISEGAFEGLSNLRYLNLAMCNLRE-IPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQ 234
Query: 286 NISLQNNKLQG-PYPLFP--SKVQKVSLDHNN 314
+ + +++Q F + +++L HNN
Sbjct: 235 KLWMIQSQIQVIERNAFDNLQSLVEINLAHNN 266
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 4e-19
Identities = 33/139 (23%), Positives = 58/139 (41%), Gaps = 17/139 (12%)
Query: 63 DNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDN 122
R++ IS G L+ L L+ M N+ IP+L L ++ L
Sbjct: 168 GELKRLSYIS------EGAFE----GLSNLRYLNLAMCNLR-EIPNLTPLIKLDELDLSG 216
Query: 123 NNFTSVPTGCFDGLTNLQVLSLSDNP--NLAPWPFPNELTKSTSLTTLYMDNANIFGLIP 180
N+ +++ G F GL +LQ L + + + F N SL + + + N+ L
Sbjct: 217 NHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDN----LQSLVEINLAHNNLTLLPH 272
Query: 181 DFFDSFSNLQNLRLSYNNF 199
D F +L+ + L +N +
Sbjct: 273 DLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 9e-17
Identities = 57/325 (17%), Positives = 107/325 (32%), Gaps = 88/325 (27%)
Query: 114 SLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNA 173
+ N VP G TN ++L+L +N
Sbjct: 44 QFSKVICVRKNLREVPDGIS---TNTRLLNLHEN-------------------------- 74
Query: 174 NIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQL-GLSGTLDVL 231
I + + F +L+ L+LS N+ +F +++ L + D +L +
Sbjct: 75 QIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPN--GAF 132
Query: 232 SGMTQLRQVWLHKNQFTGPIPD--LSKCESLFDLSLRD-NQLTGVVPASVISLPALLNIS 288
+++L+++WL N IP ++ SL L L + +L+ + + L L ++
Sbjct: 133 VYLSKLKELWLRNNPIES-IPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLN 191
Query: 289 LQNNKLQG-PYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILS 347
L L+ P K+ ++ L N+ + +
Sbjct: 192 LAMCNLREIPNLTPLIKLDELDLSGNHL---------------SAI-------------- 222
Query: 348 DSWEGNNACDGWPFVTCSQGRIITINLANKLLAGN----ISP-AYANLTSLKNLYLQQNN 402
+ G +L + + I A+ NL SL + L NN
Sbjct: 223 ----RPGSFQGLM------------HLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNN 266
Query: 403 LTGPIPDGLTKLASLQNLDVSNNNL 427
LT D T L L+ + + +N
Sbjct: 267 LTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 44/210 (20%), Positives = 67/210 (31%), Gaps = 45/210 (21%)
Query: 235 TQLRQVWLHKNQFTG-PIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNK 293
T R + LH+NQ + L L L N + + + L L + L +N+
Sbjct: 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123
Query: 294 LQG-PYPLF--PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSW 350
L P F SK++++ L +N S A P + L L +
Sbjct: 124 LTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRI-PSLRRLD-----------LGE-- 169
Query: 351 EGNNACDGWPFVTCSQGRIITI---------NLANKLLAGN-IS--PAYANLTSLKNLYL 398
R+ I NL LA + P L L L L
Sbjct: 170 --LK-------------RLSYISEGAFEGLSNLRYLNLAMCNLREIPNLTPLIKLDELDL 214
Query: 399 QQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428
N+L+ P L LQ L + + +
Sbjct: 215 SGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ 244
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 18/85 (21%), Positives = 34/85 (40%), Gaps = 12/85 (14%)
Query: 356 CDG-WPFVTCSQGRIITI------NLANKLLAGN----ISP-AYANLTSLKNLYLQQNNL 403
C + V C + + + N L N I ++ +L L+ L L +N++
Sbjct: 41 CSNQFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100
Query: 404 TGPIPDGLTKLASLQNLDVSNNNLS 428
LA+L L++ +N L+
Sbjct: 101 RTIEIGAFNGLANLNTLELFDNRLT 125
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 6e-04
Identities = 10/43 (23%), Positives = 24/43 (55%)
Query: 386 AYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428
++ L L+ L++ Q+ + + L SL +++++NNL+
Sbjct: 226 SFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT 268
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 7e-04
Identities = 15/61 (24%), Positives = 31/61 (50%), Gaps = 5/61 (8%)
Query: 376 NKLLAGNISP-AYANLTSLKNLYLQQNNLTGPIPDG-LTKLASLQNLDVSNNNLSGKVPD 433
N + +I A+ + SL+ L L + I +G L++L+ L+++ NL ++P+
Sbjct: 146 NPI--ESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN 202
Query: 434 F 434
Sbjct: 203 L 203
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-27
Identities = 52/197 (26%), Positives = 79/197 (40%), Gaps = 21/197 (10%)
Query: 578 QVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV 636
Q + LG GGFG V G ++A+K+ + K + EI ++ K+
Sbjct: 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKL 69
Query: 637 RHRHLVALL------GYCINGSERLLVYEYMPRGTLAQHLFEWHDHG-YTPLTWKQRVTI 689
H ++V+ LL EY G L ++L + L T+
Sbjct: 70 NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL---NQFENCCGLKEGPIRTL 126
Query: 690 ALDVARGVEYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGKYSVET 746
D++ + YLH + IHRDLKP NI++ + K+ D G K G+
Sbjct: 127 LSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL-CTE 182
Query: 747 RLAGTFGYLAPE-YAGK 762
+ GT YLAPE K
Sbjct: 183 FV-GTLQYLAPELLEQK 198
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 112 bits (280), Expect = 9e-27
Identities = 28/270 (10%), Positives = 60/270 (22%), Gaps = 38/270 (14%)
Query: 524 EVGNEMNKNGVTGGNGTNGYNGVPSELHSQSSGDVSDRHLFEGGNVAISIEVLRQVTDNF 583
E G+ ++ + GY + + + ++ +L Q
Sbjct: 5 EAGDSFMRDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKL 64
Query: 584 SEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSE-FQAEIAVLTKVRHRHL 641
L G VV+ ++ A+K ++ E ++
Sbjct: 65 KLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESP 124
Query: 642 VALLGYC--------------------------INGSERLLVYEYMPRGTLAQ--HLFEW 673
+ LL+ L ++
Sbjct: 125 EEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDF 183
Query: 674 HDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733
+ + R L S + +H P N+ I D R + D
Sbjct: 184 VYVFRGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSA 240
Query: 734 VKNAPDGKYSVETRLAGTFGYLAPEYAGKH 763
+ + + Y E+
Sbjct: 241 LWKVGTRGPAS----SVPVTYAPREFLNAS 266
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 9e-27
Identities = 55/181 (30%), Positives = 93/181 (51%), Gaps = 15/181 (8%)
Query: 581 DNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSE-FQAEIAVLTKVRH 638
D+F LG+G FG VY E + +A+K + + + +G+ + EI + + +RH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 639 RHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697
+++ + Y + +R+ L+ E+ PRG L + L + HG ++ T ++A +
Sbjct: 74 PNILRMYNY-FHDRKRIYLMLEFAPRGELYKELQK---HG--RFDEQRSATFMEELADAL 127
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAP 757
Y H + IHRD+KP N+L+G K+ADFG +AP + T + GT YL P
Sbjct: 128 HYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR--RRT-MCGTLDYLPP 181
Query: 758 E 758
E
Sbjct: 182 E 182
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 50/215 (23%), Positives = 94/215 (43%), Gaps = 15/215 (6%)
Query: 550 LHSQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYGGE-LPDGTKI 608
+ QS G A+ ++ NF +GRG F VY L DG +
Sbjct: 1 MDEQSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPV 60
Query: 609 AVKRME-SNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLA 667
A+K+++ + M K ++ EI +L ++ H +++ I +E +V E G L+
Sbjct: 61 ALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLS 120
Query: 668 QHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAK 727
+ + + + + + + +E++HS + +HRD+KP+N+ I K
Sbjct: 121 RMIKHFKKQK-RLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVK 176
Query: 728 VADFGLVKNAPDGKYSVETRLAGTF-G---YLAPE 758
+ D GL + +S +T A + G Y++PE
Sbjct: 177 LGDLGLGR-----FFSSKTTAAHSLVGTPYYMSPE 206
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-26
Identities = 46/186 (24%), Positives = 78/186 (41%), Gaps = 17/186 (9%)
Query: 581 DNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHR 639
+ ++ILG+G V+ G G A+K + + + + E VL K+ H+
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHK 67
Query: 640 HLVALLGYCINGSERL--LVYEYMPRGTLAQHLFEWHDHGYT-PLTWKQRVTIALDVARG 696
++V L + R L+ E+ P G+L L + L + + + DV G
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVL---EEPSNAYGLPESEFLIVLRDVVGG 124
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIG----DDMRAKVADFGLVKNAPDGKYSVETRLAGTF 752
+ +L +HR++KP NI+ K+ DFG + D + V L GT
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTE 179
Query: 753 GYLAPE 758
YL P+
Sbjct: 180 EYLHPD 185
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 52/260 (20%), Positives = 100/260 (38%), Gaps = 24/260 (9%)
Query: 69 TTISLAKSGLSGTLSPEI-SSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTS 127
T+ L + +S +SP + L +LE L N + +P +LQ++ + N T
Sbjct: 79 HTLILINNKIS-KISPGAFAPLVKLERLYLSKNQLK-ELPEKM-PKTLQELRVHENEITK 135
Query: 128 VPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFS 187
V F+GL + V+ L NP + L+ + + + NI IP
Sbjct: 136 VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQ--GLPP 192
Query: 188 NLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQL-GLSGTLDVLSGMTQLRQVWLHKN 245
+L L L N T AS +++ L ++ + + L+ LR++ L+ N
Sbjct: 193 SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDN--GSLANTPHLRELHLNNN 250
Query: 246 QFTGPIPDLSKCESLFDLSLRDNQLTGV------VPASVISLPALLNISLQNNKLQGPYP 299
+ L+ + + + L +N ++ + P + +SL +N +Q +
Sbjct: 251 KLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ-YWE 309
Query: 300 LFP------SKVQKVSLDHN 313
+ P V L +
Sbjct: 310 IQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 67/383 (17%), Positives = 116/383 (30%), Gaps = 119/383 (31%)
Query: 61 NCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP--SLANATSLQDI 118
C R + + GL + ++ T L Q N I I N +L +
Sbjct: 28 RCQCHLR--VVQCSDLGLE-KVPKDLPPDTA--LLDLQNNKIT-EIKDGDFKNLKNLHTL 81
Query: 119 YLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGL 178
L NN + + G F L L+ L LS N L
Sbjct: 82 ILINNKISKISPGAFAPLVKLERLYLSKN----------------QLKE----------- 114
Query: 179 IPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLR 238
+P+ LQ LR+ N T + V +G+ Q+
Sbjct: 115 LPE--KMPKTLQELRVHENEIT-KVRK-----------------------SVFNGLNQMI 148
Query: 239 QVWLHKNQFT-GPIPD--LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQ 295
V L N I + + L + + D +T +P + P+L + L NK+
Sbjct: 149 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT 205
Query: 296 G-PYPLFP--SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEG 352
+ + K+ L N ++ +
Sbjct: 206 KVDAASLKGLNNLAKLGLSFN---------------SISAV------------------D 232
Query: 353 NNACDGWPFVTCSQGRIITINLA-NKLLAGNISPAYANLTSLKNLYLQQNNLTG------ 405
N + P + ++L NKL+ + A+ ++ +YL NN++
Sbjct: 233 NGSLANTP-------HLRELHLNNNKLVK--VPGGLADHKYIQVVYLHNNNISAIGSNDF 283
Query: 406 PIPDGLTKLASLQNLDVSNNNLS 428
P TK AS + + +N +
Sbjct: 284 CPPGYNTKKASYSGVSLFSNPVQ 306
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 45/228 (19%), Positives = 80/228 (35%), Gaps = 40/228 (17%)
Query: 89 LTQLETLSFQMNNIAGAIP--SLANATSLQDIYLDNNNFTS--VPTGCFDGLTNLQVLSL 144
L+ L N I + + + L N S + G F G+ L + +
Sbjct: 120 PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRI 178
Query: 145 SDN-----PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNF 199
+D P P SLT L++D I + +NL L LS+N+
Sbjct: 179 ADTNITTIPQGLP----------PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSI 228
Query: 200 TGSLPASFAKSDIQNLWMNDQQLGLSGTL-----DVLSGMTQLRQVWLHKNQFT------ 248
+ S ++ +L ++L L+ L+ ++ V+LH N +
Sbjct: 229 SAVDNGSL--ANTPHL----RELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSND 282
Query: 249 -GPIPDLSKCESLFDLSLRDNQL--TGVVPASVISLPALLNISLQNNK 293
P +K S +SL N + + P++ + + L N K
Sbjct: 283 FCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 6e-04
Identities = 9/48 (18%), Positives = 20/48 (41%), Gaps = 3/48 (6%)
Query: 388 ANLTSLKNLYLQQNNLT-GPIPDG-LTKLASLQNLDVSNNNLSGKVPD 433
L + + L N L I +G + L + +++ N++ +P
Sbjct: 142 NGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ 188
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 46/213 (21%), Positives = 83/213 (38%), Gaps = 17/213 (7%)
Query: 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172
+S + L++N S+P G FD LT L LSLS N +TSL L +
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87
Query: 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTL---- 228
N + F L++L ++N + ++NL L +S T
Sbjct: 88 -NGVITMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNL----IYLDISHTHTRVA 141
Query: 229 --DVLSGMTQLRQVWLHKNQFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASVISLPAL 284
+ +G++ L + + N F ++ +L L L QL + P + SL +L
Sbjct: 142 FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSL 201
Query: 285 LNISLQNNKLQG-PYPLFP--SKVQKVSLDHNN 314
+++ +N + + +Q + N+
Sbjct: 202 QVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 234
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 53/280 (18%), Positives = 98/280 (35%), Gaps = 45/280 (16%)
Query: 55 CEWTGINCDNSN----------RVTTISLAKSGLSGTLSPEI-SSLTQLETLSFQMNNIA 103
C T I C++ T + L + L +L + LTQL LS N ++
Sbjct: 7 CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLS 65
Query: 104 -GAIPSLANA--TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELT 160
S ++ TSL+ + L N ++ + F GL L+ L + NL +
Sbjct: 66 FKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHS-NLKQMSEFSVFL 123
Query: 161 KSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQ 220
+L L + + + F+ S+L+ L+++ N+F +
Sbjct: 124 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP--------------- 168
Query: 221 QLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKC-ESLFDLSLRDNQLTGVVPASVI 279
D+ + + L + L + Q P SL L++ N +
Sbjct: 169 --------DIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYK 220
Query: 280 SLPALLNISLQNNKLQG-PYPLF---PSKVQKVSLDHNNF 315
L +L + N + PS + ++L N+F
Sbjct: 221 CLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 57/323 (17%), Positives = 103/323 (31%), Gaps = 77/323 (23%)
Query: 114 SLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNA 173
S +I ++ TSVPTG ++ L L N
Sbjct: 8 SGTEIRCNSKGLTSVPTGIP---SSATRLELESN-------------------------- 38
Query: 174 NIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSG 233
+ L FD + L L LS N + S + G
Sbjct: 39 KLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQS----------------------DFG 76
Query: 234 MTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVIS-LPALLNISLQNN 292
T L+ + L N + E L L + + L + SV L L+ + + +
Sbjct: 77 TTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 136
Query: 293 KLQG-PYPLFP--SKVQKVSLDHNNFCKN-SSDAGKPCDPQVTTLLQIAGDMGYPAILSD 348
+ +F S ++ + + N+F +N D +T L D+ +
Sbjct: 137 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTEL-RNLTFL-----DLSQCQLEQL 190
Query: 349 SWEGNNACDGWPFVTCSQGRIITINLA-NKLLAGNISP-AYANLTSLKNLYLQQNNLTGP 406
S A + + +N++ N ++ Y L SL+ L N++
Sbjct: 191 S---PTAFNSLS-------SLQVLNMSHNNFF--SLDTFPYKCLNSLQVLDYSLNHIMTS 238
Query: 407 IPDGLTKL-ASLQNLDVSNNNLS 428
L +SL L+++ N+ +
Sbjct: 239 KKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 16/61 (26%), Positives = 26/61 (42%), Gaps = 3/61 (4%)
Query: 376 NKLLAGNISP-AYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDF 434
N L + TSLK L L N + + L L++LD ++NL ++ +F
Sbjct: 62 NGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLK-QMSEF 119
Query: 435 G 435
Sbjct: 120 S 120
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-26
Identities = 64/360 (17%), Positives = 116/360 (32%), Gaps = 51/360 (14%)
Query: 70 TISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVP 129
+ A + T + L L +L ++I + + T L + +NN T++
Sbjct: 22 SEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTGIEKLTGLTKLICTSNNITTLD 80
Query: 130 TGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNL 189
TNL L+ N L T T LT L D + L L
Sbjct: 81 ---LSQNTNLTYLACDSN-KLTNLDV----TPLTKLTYLNCDTNKLTKLD---VSQNPLL 129
Query: 190 QNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTG 249
L + N T + S + L + + T ++ TQL + N+ T
Sbjct: 130 TYLNCARNTLT-EIDVSHNTQ-LTELDCHLNKK---ITKLDVTPQTQLTTLDCSFNKITE 184
Query: 250 PIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFP-SKVQKV 308
D+S+ + L L+ N +T + + L + +NKL + P +++
Sbjct: 185 --LDVSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-IDVTPLTQLTYF 238
Query: 309 SLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGR 368
N T L D+ + L+ +Q
Sbjct: 239 DCSVNPL---------------TEL-----DVSTLSKLTTLHCIQTDLLEIDLTHNTQLI 278
Query: 369 IITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428
K+ +++ + T L L Q +T + L++ L L ++N L+
Sbjct: 279 YFQAEGCRKIKELDVT----HNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT 331
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-24
Identities = 58/369 (15%), Positives = 113/369 (30%), Gaps = 51/369 (13%)
Query: 85 EISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144
++S T L L+ N + + + T L + D N T + L L+
Sbjct: 80 DLSQNTNLTYLACDSNKLT-NLD-VTPLTKLTYLNCDTNKLTKLD---VSQNPLLTYLNC 134
Query: 145 SDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLP 204
+ N L ++ +T LT L + + L L S+N T L
Sbjct: 135 ARN-TLTEID----VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT-ELD 186
Query: 205 ASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLS 264
S K + L + + LD L+ QL + N+ T D++ L
Sbjct: 187 VSQNKL-LNRLNCDTNNIT---KLD-LNQNIQLTFLDCSSNKLTEI--DVTPLTQLTYFD 239
Query: 265 LRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGK 324
N LT + V +L L + L +++ +
Sbjct: 240 CSVNPLTEL---DVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCR---------- 286
Query: 325 PCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLA-NKLLAGNI 383
++ L D+ + L + ++ + L +L ++
Sbjct: 287 ----KIKEL-----DVTHNTQLYLLDCQAAGITELDLSQNPK--LVYLYLNNTELTELDV 335
Query: 384 SPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKFTVS 443
S + T LK+L ++ + K+ +L N + + +N T++
Sbjct: 336 S----HNTKLKSLSCVNAHIQD-FSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIA 389
Query: 444 PGNPFIGTN 452
+
Sbjct: 390 VSPDLLDQF 398
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-18
Identities = 42/260 (16%), Positives = 82/260 (31%), Gaps = 28/260 (10%)
Query: 64 NSNRVTTISLAKSGLSGTL--------SPEISSLTQLETLSFQMNNIAGAIPSLANATSL 115
+ N++T + ++++ L L +++ QL L N + I + T L
Sbjct: 178 SFNKITELDVSQNKLLNRLNCDTNNITKLDLNQNIQLTFLDCSSNKLT-EID-VTPLTQL 235
Query: 116 QDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANI 175
N T + L+ L L +L LT +T L +
Sbjct: 236 TYFDCSVNPLTELDVS---TLSKLTTLHCIQT-DLLEID----LTHNTQLIYFQAEGCRK 287
Query: 176 FGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMT 235
+ + L L T L S + L++N+ +L LD +S T
Sbjct: 288 IKELD--VTHNTQLYLLDCQAAGIT-ELDLSQNPK-LVYLYLNNTEL---TELD-VSHNT 339
Query: 236 QLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQ 295
+L+ + + K +L + + Q + ++ + + +S
Sbjct: 340 KLKSLSCVNAHIQD-FSSVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQF 398
Query: 296 G-PYPLFPSKVQKVSLDHNN 314
G P + P N
Sbjct: 399 GNPMNIEPGDGGVYDQATNT 418
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-15
Identities = 57/333 (17%), Positives = 100/333 (30%), Gaps = 74/333 (22%)
Query: 98 QMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNP--NLAPWPF 155
Q + P N S + ++ + L L L ++ ++
Sbjct: 7 QTQSFNDWFPD-DNFASEVAAAFEMQATDTIS---EEQLATLTSLDCHNSSITDM----- 57
Query: 156 PNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNL 215
+ K T LT L + NI L +NL L N T +L + + L
Sbjct: 58 -TGIEKLTGLTKLICTSNNITTLD---LSQNTNLTYLACDSNKLT-NLDVTPLTK-LTYL 111
Query: 216 WMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVP 275
+ +L T +S L + +N T D+S L +L N+ +
Sbjct: 112 NCDTNKL----TKLDVSQNPLLTYLNCARNTLT--EIDVSHNTQLTELDCHLNKKITKLD 165
Query: 276 ASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQ 335
V L + NK+ + +++ D N +T L
Sbjct: 166 --VTPQTQLTTLDCSFNKITELDVSQNKLLNRLNCDTN---------------NITKL-- 206
Query: 336 IAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKN 395
D+ L+ F+ CS ++ I++ LT L
Sbjct: 207 ---DLNQNIQLT-------------FLDCSSNKLTEIDV-------------TPLTQLTY 237
Query: 396 LYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428
N LT + ++ L+ L L +L
Sbjct: 238 FDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL 267
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-13
Identities = 43/261 (16%), Positives = 86/261 (32%), Gaps = 43/261 (16%)
Query: 170 MDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLSGTL 228
+ PD N + + + S + + + +L ++ + +
Sbjct: 6 GQTQSFNDWFPD-----DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT---DM 57
Query: 229 DVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNIS 288
+ +T L ++ N T DLS+ +L L+ N+LT + V L L ++
Sbjct: 58 TGIEKLTGLTKLICTSNNITTL--DLSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLN 112
Query: 289 LQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSD 348
NKL + ++ N T + ++ +
Sbjct: 113 CDTNKLTKLDVSQNPLLTYLNCARNTL----------------TEIDVSH---NTQLTEL 153
Query: 349 SWEGNNACDGWPFVTCSQGRIITINLA-NKLLAGNISPAYANLTSLKNLYLQQNNLTGPI 407
N +Q + T++ + NK+ ++S L L NN+T +
Sbjct: 154 DCHLNKKITKLDVTPQTQ--LTTLDCSFNKITELDVS----QNKLLNRLNCDTNNITK-L 206
Query: 408 PDGLTKLASLQNLDVSNNNLS 428
L + L LD S+N L+
Sbjct: 207 D--LNQNIQLTFLDCSSNKLT 225
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 47/176 (26%), Positives = 83/176 (47%), Gaps = 14/176 (7%)
Query: 589 LGRGGFGVVYGGELPD---GTKIAVKRMESNTMGNKGLSE-FQAEIAVLTKVRHRHLVAL 644
LG GG VY E D K+A+K + + + F+ E+ +++ H+++V++
Sbjct: 19 LGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 645 LGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA 704
+ LV EY+ TL++++ HG PL+ + + G+++ H
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYI---ESHG--PLSVDTAINFTNQILDGIKHAH--- 128
Query: 705 QQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYA 760
+HRD+KP NILI + K+ DFG+ K + + + GT Y +PE A
Sbjct: 129 DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQA 184
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 53/185 (28%), Positives = 83/185 (44%), Gaps = 19/185 (10%)
Query: 579 VTDNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR 637
+ F +LG G F V+ + G A+K ++ + S + EIAVL K++
Sbjct: 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD--SSLENEIAVLKKIK 64
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWKQRVTIALDVARG 696
H ++V L + + LV + + G LF+ + G T K + V
Sbjct: 65 HENIVTLEDIYESTTHYYLVMQLVSGG----ELFDRILERGV--YTEKDASLVIQQVLSA 118
Query: 697 VEYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFG 753
V+YLH +HRDLKP N+L ++ + + DFGL K +G + GT G
Sbjct: 119 VKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM---STACGTPG 172
Query: 754 YLAPE 758
Y+APE
Sbjct: 173 YVAPE 177
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 28/203 (13%)
Query: 588 ILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646
+LG+G +G+VY G +L + +IA+K + ++ EIA+ ++H+++V LG
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVT--IALDVARGVEYLHSLA 704
+ E +P G+L+ L + PL ++ + G++YLH
Sbjct: 87 SFSENGFIKIFMEQVPGGSLSALL----RSKWGPLKDNEQTIGFYTKQILEGLKYLHD-- 140
Query: 705 QQSFIHRDLKPSNILIGDDM-RAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKH 763
+HRD+K N+LI K++DFG K ET GT Y+APE
Sbjct: 141 -NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPE----- 193
Query: 764 WMILCQMTGL-----IWLHGSVG 781
+I G IW S+G
Sbjct: 194 -IIDKGPRGYGKAADIW---SLG 212
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 49/185 (26%), Positives = 75/185 (40%), Gaps = 16/185 (8%)
Query: 579 VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR 637
+ ++ +LG+G FG V + + AVK + + NK S E+ +L K+
Sbjct: 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD 79
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWKQRVTIALDVARG 696
H +++ L + S +V E G LF+ + I V G
Sbjct: 80 HPNIMKLFEILEDSSSFYIVGELYTGG----ELFDEIIKRKR--FSEHDAARIIKQVFSG 133
Query: 697 VEYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFG 753
+ Y+H + +HRDLKP NIL+ D K+ DFGL GT
Sbjct: 134 ITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAY 188
Query: 754 YLAPE 758
Y+APE
Sbjct: 189 YIAPE 193
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-25
Identities = 60/272 (22%), Positives = 100/272 (36%), Gaps = 42/272 (15%)
Query: 81 TLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQ 140
+L L +L S + ++ P+L + L +++ N TS+P LQ
Sbjct: 95 SLPVLPPGLLELSIFSNPLTHL----PALP--SGLCKLWIFGNQLTSLP----VLPPGLQ 144
Query: 141 VLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFT 200
LS+SDN + P + L L+ N N +P S LQ L +S N
Sbjct: 145 ELSVSDNQLAS---LPALPS---ELCKLWAYN-NQLTSLPM---LPSGLQELSVSDNQLA 194
Query: 201 GSLPASFAKSDIQNLWMNDQQL----GLSGTLDVL-----------SGMTQLRQVWLHKN 245
SLP ++ + LW + +L L L L ++L+++ + N
Sbjct: 195 -SLPTLPSE--LYKLWAYNNRLTSLPALPSGLKELIVSGNRLTSLPVLPSELKELMVSGN 251
Query: 246 QFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKV 305
+ T +P L L LS+ NQLT +P S+I L + ++L+ N L ++
Sbjct: 252 RLTS-LPML--PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI 307
Query: 306 QKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIA 337
+ L A
Sbjct: 308 TSAPGYSGPIIRFDMAGASAPRETRALHLAAA 339
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 71/377 (18%), Positives = 141/377 (37%), Gaps = 84/377 (22%)
Query: 61 NCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYL 120
C N+ +++ +SGL+ TL + + TL NN+ ++P+ L+ + +
Sbjct: 36 ACLNNG-NAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPA--LPPELRTLEV 88
Query: 121 DNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIP 180
N TS+P GL L + S +L P + L L++ N +P
Sbjct: 89 SGNQLTSLPVL-PPGLLELSIFSNPLT-HLPALP--------SGLCKLWIFG-NQLTSLP 137
Query: 181 DFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQV 240
LQ L +S N SLPA ++ + LW + QL + + L+++
Sbjct: 138 V---LPPGLQELSVSDNQLA-SLPALPSE--LCKLWAYNNQLT-----SLPMLPSGLQEL 186
Query: 241 WLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPL 300
+ NQ +P L L+ L +N+LT +PA L + + N+L P+
Sbjct: 187 SVSDNQLAS-LPTLP--SELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LPV 238
Query: 301 FPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWP 360
PS+++++ + N ++T+L P +
Sbjct: 239 LPSELKELMVSGN---------------RLTSL---------PMLP-------------- 260
Query: 361 FVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNL 420
++++++ L + + +L+S + L+ N L+ L ++ S
Sbjct: 261 ------SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGY 313
Query: 421 DVSNNNLSGKVPDFGSN 437
S + + +
Sbjct: 314 --SGPIIRFDMAGASAP 328
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 4e-16
Identities = 68/340 (20%), Positives = 117/340 (34%), Gaps = 97/340 (28%)
Query: 98 QMNNIAGAIPSLANA--TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPF 155
+ A + + + + + T++P ++ L + DN
Sbjct: 23 ESRGRAAVVQKMRACLNNGNAVLNVGESGLTTLPDC---LPAHITTLVIPDN-------- 71
Query: 156 PNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNL 215
+LT+L P L+ L +S N T SLP + L
Sbjct: 72 --------NLTSL-----------PA---LPPELRTLEVSGNQLT-SLPVLP--PGLLEL 106
Query: 216 WMNDQQLGLSGT-LDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVV 274
T L L + L ++W+ NQ T +P L L +LS+ DNQL +
Sbjct: 107 ----SIFSNPLTHLPAL--PSGLCKLWIFGNQLTS-LPVL--PPGLQELSVSDNQLA-SL 156
Query: 275 PASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLL 334
PA L + NN+L P+ PS +Q++S+ N Q+ +L
Sbjct: 157 PA---LPSELCKLWAYNNQLTS-LPMLPSGLQELSVSDN---------------QLASL- 196
Query: 335 QIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITI-----NLANKLLAGN-ISPAYA 388
P + S + R+ ++ L +++GN ++
Sbjct: 197 --------PTLPS----------ELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTSLPV 238
Query: 389 NLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428
+ LK L + N LT +P + L +L V N L+
Sbjct: 239 LPSELKELMVSGNRLTS-LPMLPS---GLLSLSVYRNQLT 274
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 34/191 (17%), Positives = 58/191 (30%), Gaps = 15/191 (7%)
Query: 87 SSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145
+ L +LS N + +P SL + +S + L+ N + +T+ S
Sbjct: 258 MLPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGP 316
Query: 146 DN-PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIP-DFFDSFSNLQNLRLSYNNFTGSL 203
++A P E ++ A P D + F N +++ F L
Sbjct: 317 IIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNAD-AFSLFLDRL 375
Query: 204 PASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDL 263
+ +S L L+ LR N F S CE
Sbjct: 376 SETENFIKDAGFKAQ-----ISSWLAQLAEDEALRA-----NTFAMATEATSSCEDRVTF 425
Query: 264 SLRDNQLTGVV 274
L + +V
Sbjct: 426 FLHQMKNVQLV 436
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 54/191 (28%), Positives = 79/191 (41%), Gaps = 21/191 (10%)
Query: 578 QVTDNFSEANILGRGGFGVVY-GGELPDGTKIAVK-------RMESNTMGNKGLSEFQAE 629
+N+ ILGRG VV P + AVK S + E
Sbjct: 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKE 73
Query: 630 IAVLTKV-RHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWKQRV 687
+ +L KV H +++ L + LV++ M +G LF++ + L+ K+
Sbjct: 74 VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKG----ELFDYLTEKVT--LSEKETR 127
Query: 688 TIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR 747
I + + LH + +HRDLKP NIL+ DDM K+ DFG G
Sbjct: 128 KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLRE 182
Query: 748 LAGTFGYLAPE 758
+ GT YLAPE
Sbjct: 183 VCGTPSYLAPE 193
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 4e-25
Identities = 48/186 (25%), Positives = 78/186 (41%), Gaps = 16/186 (8%)
Query: 578 QVTDNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV 636
+ +DN+ LG+G F VV G + A K + + + + + + E + K+
Sbjct: 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 637 RHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWKQRVTIALDVAR 695
+H ++V L S LV++ + G LFE + + +
Sbjct: 63 QHPNIVRLHDSIQEESFHYLVFDLVTGG----ELFEDIVAREF--YSEADASHCIQQILE 116
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGKYSVETRLAGTF 752
+ Y HS +HR+LKP N+L+ K+ADFGL D + AGT
Sbjct: 117 SIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--AWHGFAGTP 171
Query: 753 GYLAPE 758
GYL+PE
Sbjct: 172 GYLSPE 177
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-25
Identities = 60/186 (32%), Positives = 95/186 (51%), Gaps = 13/186 (6%)
Query: 577 RQVT-DNFSEANILGRGGFGVVYGGELPDGTKI-AVKRME-SNTMGNKGLSEFQAEIAVL 633
+ VT + F + +LG+GGFG V ++ K+ A K++E KG + E +L
Sbjct: 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL 238
Query: 634 TKVRHRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALD 692
KV R +V+L Y + L LV M G L H+ + G + V A +
Sbjct: 239 EKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHI---YHMGQAGFPEARAVFYAAE 294
Query: 693 VARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTF 752
+ G+E LH + ++RDLKP NIL+ D +++D GL + P+G+ +++ R GT
Sbjct: 295 ICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TIKGR-VGTV 349
Query: 753 GYLAPE 758
GY+APE
Sbjct: 350 GYMAPE 355
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 107 bits (267), Expect = 5e-25
Identities = 30/244 (12%), Positives = 63/244 (25%), Gaps = 38/244 (15%)
Query: 546 VPSELHSQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYGG-ELPD 604
SE ++ + L+ G L + +LG+ +
Sbjct: 38 TTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQET 97
Query: 605 GTKIAVKRMESNTMGNKGLSE--------------------------FQAEIAVLTKVRH 638
G V + F ++ +
Sbjct: 98 GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 157
Query: 639 RHLVALLGYCINGSERLLVYEYM-PRGTLAQHLFEWHDHG--YTPLTWKQRVTIALDVAR 695
+ ++ + + + Y + L H + L R+ + L V R
Sbjct: 158 KKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIR 217
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYL 755
+ LH +H L+P +I++ + F + DG + + G+
Sbjct: 218 LLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLV--RDGAR---VVSSVSRGFE 269
Query: 756 APEY 759
PE
Sbjct: 270 PPEL 273
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 51/193 (26%), Positives = 78/193 (40%), Gaps = 23/193 (11%)
Query: 577 RQVTDNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSE------FQAE 629
+ + D + + LG G G V E K+A+K + E + E
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 630 IAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWKQRVT 688
I +L K+ H ++ + + + + +V E M G LF+ + L
Sbjct: 66 IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGG----ELFDKVVGNKR--LKEATCKL 118
Query: 689 IALDVARGVEYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGKYSVE 745
+ V+YLH IHRDLKP N+L+ +D K+ DFG K + S+
Sbjct: 119 YFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLM 173
Query: 746 TRLAGTFGYLAPE 758
L GT YLAPE
Sbjct: 174 RTLCGTPTYLAPE 186
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-25
Identities = 67/376 (17%), Positives = 116/376 (30%), Gaps = 115/376 (30%)
Query: 69 TTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAG----------------AIPSLANA 112
++ + + L+ L SL L + + ++ +P L N+
Sbjct: 94 ESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNS 152
Query: 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172
+ L+ I +DNN+ +P D +L+ ++ +N L P EL LT +Y DN
Sbjct: 153 SFLKIIDVDNNSLKKLP----DLPPSLEFIAAGNN-QLEELP---ELQNLPFLTAIYADN 204
Query: 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLS 232
N + D +L+++ N L L
Sbjct: 205 -N---SLKKLPDLPLSLESIVAGNNILE--------------------------ELPELQ 234
Query: 233 GMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNN 292
+ L ++ N +PDL SL L++RDN LT +P SL L +
Sbjct: 235 NLPFLTTIYADNNLLKT-LPDL--PPSLEALNVRDNYLTD-LPELPQSLTFLDVSENIFS 290
Query: 293 KLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEG 352
L P + ++ N L D
Sbjct: 291 GL----SELPPNLYYLNASSNEIRS----------------------------LCDLP-- 316
Query: 353 NNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLT 412
+ +N++N L + L+ L N+L +P+
Sbjct: 317 --------------PSLEELNVSNNKLI-ELPA---LPPRLERLIASFNHLAE-VPELPQ 357
Query: 413 KLASLQNLDVSNNNLS 428
+L+ L V N L
Sbjct: 358 ---NLKQLHVEYNPLR 370
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-21
Identities = 63/378 (16%), Positives = 120/378 (31%), Gaps = 82/378 (21%)
Query: 81 TLSPEISSLTQLETLSFQMNNIAGAIP--------------SLANATSLQDIYLDNNNFT 126
+ E ++ + P ++ L+N +
Sbjct: 25 EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS 84
Query: 127 SVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGL-------- 178
S+P + +L+ L S N +L P SL + + L
Sbjct: 85 SLP----ELPPHLESLVASCN-SLT--ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLG 137
Query: 179 --------IPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDV 230
+P+ + S L+ + + N+ LP ++ + + QL L
Sbjct: 138 VSNNQLEKLPELQN-SSFLKIIDVDNNSLK-KLPDLPPS--LEFIAAGNNQL---EELPE 190
Query: 231 LSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQ 290
L + L ++ N +PDL SL + +N L + +LP L I
Sbjct: 191 LQNLPFLTAIYADNNSLKK-LPDL--PLSLESIVAGNNILE--ELPELQNLPFLTTIYAD 245
Query: 291 NNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSW 350
NN L+ P P ++ +++ N P PQ T L +
Sbjct: 246 NNLLKT-LPDLPPSLEALNVRDNYLTDL------PELPQSLTFLDV-------------- 284
Query: 351 EGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDG 410
N G + + + +N ++ + ++ SL+ L + N L +P
Sbjct: 285 -SENIFSGLSELPPN---LYYLNASSNEIR-SLCD---LPPSLEELNVSNNKLIE-LPAL 335
Query: 411 LTKLASLQNLDVSNNNLS 428
+ L+ L S N+L+
Sbjct: 336 PPR---LERLIASFNHLA 350
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-20
Identities = 63/350 (18%), Positives = 113/350 (32%), Gaps = 85/350 (24%)
Query: 82 LSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQ 140
++P S T L+ +N+ +P N S + Y + + +
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 141 VLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFT 200
V L D + L ++N + +P+ +L++L S N+ T
Sbjct: 62 VSRLRDCLD-------------RQAHELELNNLGL-SSLPE---LPPHLESLVASCNSLT 104
Query: 201 GSLPASFAKSDIQNLWMNDQQLGLSGT-LDVLSGMTQLRQVWLHKNQFTGPIPDLSKCES 259
LP +++L + L L L + + NQ +P+L
Sbjct: 105 -ELPELPQS--LKSL----LVDNNNLKALSDL--PPLLEYLGVSNNQLEK-LPELQNSSF 154
Query: 260 LFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFP-SKVQKVSLDHNNFCKN 318
L + + +N L +P P+L I+ NN+L+ L + + D+N
Sbjct: 155 LKIIDVDNNSLK-KLPDL---PPSLEFIAAGNNQLEELPELQNLPFLTAIYADNN----- 205
Query: 319 SSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKL 378
+ L P + + +I N +
Sbjct: 206 ----------SLKKL---------PDLP--------------------LSLESIVAGNNI 226
Query: 379 LAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428
L P NL L +Y N L +PD SL+ L+V +N L+
Sbjct: 227 L--EELPELQNLPFLTTIYADNNLLKT-LPDLPP---SLEALNVRDNYLT 270
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-20
Identities = 50/264 (18%), Positives = 84/264 (31%), Gaps = 51/264 (19%)
Query: 86 ISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145
LE++ N + +P L N L IY DNN ++P D +L+ L++
Sbjct: 211 PDLPLSLESIVAGNNILE-ELPELQNLPFLTTIYADNNLLKTLP----DLPPSLEALNVR 265
Query: 146 DNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIP-------------DFFDSFSNLQNL 192
DN P T L + + L P D +L+ L
Sbjct: 266 DNYLTD---LPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEEL 322
Query: 193 RLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIP 252
+S N LPA + ++ L + L +V L+Q+ + N P
Sbjct: 323 NVSNNKLI-ELPALPPR--LERLIASFNHLA-----EVPELPQNLKQLHVEYNPLRE-FP 373
Query: 253 DL-----------------SKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQ 295
D+ ++L L + N L P S+ L + + ++
Sbjct: 374 DIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPESVEDL---RMNSERVV 429
Query: 296 GPYPLFPSKVQKVSLDHNNFCKNS 319
PY K+ D +
Sbjct: 430 DPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 5e-18
Identities = 39/214 (18%), Positives = 74/214 (34%), Gaps = 32/214 (14%)
Query: 81 TLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQ 140
L SLT L+ + + L +L + +N S+ D +L+
Sbjct: 271 DLPELPQSLTFLDVSENIFSGL----SELP--PNLYYLNASSNEIRSLC----DLPPSLE 320
Query: 141 VLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFT 200
L++S+N L P + L L N +P+ NL+ L + YN
Sbjct: 321 ELNVSNN-KLIE--LPALPPR---LERLIASF-NHLAEVPE---LPQNLKQLHVEYNPLR 370
Query: 201 GSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESL 260
P +++L MN + L+Q+ + N PD+ ES+
Sbjct: 371 -EFPDIP--ESVEDLRMNSHLAEVPELP------QNLKQLHVETNPLRE-FPDIP--ESV 418
Query: 261 FDLSLRDNQLTGVVPASVISLPALLNISLQNNKL 294
DL + ++ + + L + +++
Sbjct: 419 EDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-12
Identities = 67/358 (18%), Positives = 114/358 (31%), Gaps = 100/358 (27%)
Query: 135 GLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFF----------- 183
T LQ + NL P E S T Y + P
Sbjct: 9 SNTFLQEPLRHSS-NLTE--MPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRL 65
Query: 184 ----------------------DSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMND-- 219
+ +L++L S N+ T LP +++L +++
Sbjct: 66 RDCLDRQAHELELNNLGLSSLPELPPHLESLVASCNSLT-ELPELPQS--LKSLLVDNNN 122
Query: 220 -----------QQLGLSG----TLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLS 264
+ LG+S L L + L+ + + N +PDL SL ++
Sbjct: 123 LKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKK-LPDLPP--SLEFIA 179
Query: 265 LRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGK 324
+NQL +P + +LP L I NN L+ P P ++ + +N
Sbjct: 180 AGNNQLE-ELP-ELQNLPFLTAIYADNNSLKK-LPDLPLSLESIVAGNNIL--------- 227
Query: 325 PCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNIS 384
L ++ L+ + NN P + +N+ + L ++
Sbjct: 228 ------EELPEL----QNLPFLTTIYADNNLLKTLP---DLPPSLEALNVRDNYLT-DLP 273
Query: 385 PAYANLTSLKNLYLQQNNLTGPIPDGLTKL--------------ASLQNLDVSNNNLS 428
+LT L + L+ +P L L SL+ L+VSNN L
Sbjct: 274 ELPQSLTFLDVSENIFSGLS-ELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI 330
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 45/275 (16%), Positives = 92/275 (33%), Gaps = 51/275 (18%)
Query: 163 TSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQL 222
T L ++N+ +P ++ + +++ + + P +Q
Sbjct: 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNG-----------EQR 58
Query: 223 GLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLP 282
++ + Q ++ L+ + +P+L L L N LT +P SL
Sbjct: 59 EMAVSRLRDCLDRQAHELELNNLGLS-SLPEL--PPHLESLVASCNSLT-ELPELPQSLK 114
Query: 283 ALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGY 342
+LL + L P ++ + + NN + + + +
Sbjct: 115 SLLVDNNNLKAL----SDLPPLLEYLGV-SNNQLEKLPELQNS--SFLKII--------- 158
Query: 343 PAILSDSWEGNNACDGWPFVTCSQGRIITINLA-NKLLAGNISPAYANLTSLKNLYLQQN 401
+ NN+ P + I N+L P NL L +Y N
Sbjct: 159 --DVD-----NNSLKKLP---DLPPSLEFIAAGNNQL---EELPELQNLPFLTAIYADNN 205
Query: 402 NLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGS 436
+L +PD SL+++ NN L ++P+ +
Sbjct: 206 SLKK-LPDLPL---SLESIVAGNNILE-ELPELQN 235
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 26/204 (12%), Positives = 56/204 (27%), Gaps = 63/204 (30%)
Query: 233 GMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQN 291
T L++ H + T +P +S + ++ P + L++
Sbjct: 9 SNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRD 67
Query: 292 NKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWE 351
+ + ++ L++ ++L P +
Sbjct: 68 CLDR--------QAHELELNNLGL---------------SSL---------PELP----- 90
Query: 352 GNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGL 411
+ ++ + L + +L SL L+ P
Sbjct: 91 ---------------PHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPP--- 131
Query: 412 TKLASLQNLDVSNNNLSGKVPDFG 435
L+ L VSNN L K+P+
Sbjct: 132 ----LLEYLGVSNNQLE-KLPELQ 150
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 46/176 (26%), Positives = 69/176 (39%), Gaps = 14/176 (7%)
Query: 589 LGRGGFGVVYGGELPD---GTKIAVKRMESNTMGNKGLSE-FQAEIAVLTKVRHRHLVAL 644
+GRGG G VY E D +A+K M + Q E +++ H+V +
Sbjct: 42 VGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 645 LGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA 704
+ + + + LA L G PL + V I + ++ H
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAML---RRQG--PLAPPRAVAIVRQIGSALDAAH--- 151
Query: 705 QQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYA 760
HRD+KP NIL+ D A + DFG+ D K + GT Y+APE
Sbjct: 152 AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERF 207
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-25
Identities = 50/203 (24%), Positives = 81/203 (39%), Gaps = 20/203 (9%)
Query: 565 EGGNVAISIEVLRQVTDNFSEA----NILGRGGFGVVY-GGELPDGTKIAVKRMESNTMG 619
G + E + + FS+ LG+G F VV G + A K + + +
Sbjct: 9 GGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS 68
Query: 620 NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEW-HDHGY 678
+ + + E + K++H ++V L S LV++ + G LFE +
Sbjct: 69 ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG----ELFEDIVAREF 124
Query: 679 TPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVK 735
+ + + Y HS +HR+LKP N+L+ K+ADFGL
Sbjct: 125 --YSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179
Query: 736 NAPDGKYSVETRLAGTFGYLAPE 758
D + AGT GYL+PE
Sbjct: 180 EVNDSE--AWHGFAGTPGYLSPE 200
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-25
Identities = 55/194 (28%), Positives = 86/194 (44%), Gaps = 26/194 (13%)
Query: 577 RQVT-DNFSEANILGRGGFGVVYGGELPDGTKI-AVKRME-SNTMGNKGLSEFQAEIAVL 633
+ + D F + +LGRGGFG V+ ++ K+ A K++ KG E +L
Sbjct: 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKIL 239
Query: 634 TKVRHRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALD 692
KV R +V+L Y L LV M G + H++ +
Sbjct: 240 AKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVD---------EDNPGFQEP 289
Query: 693 VAR--------GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSV 744
A G+E+LH ++ I+RDLKP N+L+ DD +++D GL G+
Sbjct: 290 RAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT 346
Query: 745 ETRLAGTFGYLAPE 758
+ AGT G++APE
Sbjct: 347 KGY-AGTPGFMAPE 359
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 51/186 (27%), Positives = 83/186 (44%), Gaps = 12/186 (6%)
Query: 581 DNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHR 639
D++ ++G G VV P K+A+KR+ + E EI +++ H
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRIN-LEKCQTSMDELLKEIQAMSQCHHP 73
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLA---QHLFEWHDHGYTPLTWKQRVTIALDVARG 696
++V+ + E LV + + G++ +H+ +H L TI +V G
Sbjct: 74 NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG----LVKNAPDGKYSVETRLAGTF 752
+EYLH IHRD+K NIL+G+D ++ADFG L + V GT
Sbjct: 134 LEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 753 GYLAPE 758
++APE
Sbjct: 191 CWMAPE 196
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 105 bits (262), Expect = 2e-24
Identities = 38/209 (18%), Positives = 68/209 (32%), Gaps = 34/209 (16%)
Query: 580 TDNFSEANILGRGGFGVVY------GGELPDGTKIAVKRMESNTMGNKGLSEFQA---EI 630
+ ++LG G F VY + + K +K + EF +
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP-----WEFYIGTQLM 118
Query: 631 AVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIA 690
L + + + +LV E GTL + + + + ++ A
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178
Query: 691 LDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRA-----------KVADFGL---VKN 736
+ + +E +H IH D+KP N ++G+ + D G +K
Sbjct: 179 MRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235
Query: 737 APDGKYSVETRLAGTFGYLAPE-YAGKHW 764
P G T T G+ E + K W
Sbjct: 236 FPKGTIF--TAKCETSGFQCVEMLSNKPW 262
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 58/274 (21%), Positives = 111/274 (40%), Gaps = 27/274 (9%)
Query: 68 VTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTS 127
I+ KS ++ T + L + TLS + I + +L + L +N T
Sbjct: 21 AIKIAAGKSNVTDT--VTQADLDGITTLSAFGTGVT-TIEGVQYLNNLIGLELKDNQITD 77
Query: 128 VPTGCFDGLTNLQVLSLSDNP--NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDS 185
+ LT + L LS NP N++ + S+ TL + + I + P
Sbjct: 78 LA--PLKNLTKITELELSGNPLKNVSA------IAGLQSIKTLDLTSTQITDVTP--LAG 127
Query: 186 FSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKN 245
SNLQ L L N T ++ +++Q L + + Q+ L L+ +++L + N
Sbjct: 128 LSNLQVLYLDLNQIT-NISPLAGLTNLQYLSIGNAQV---SDLTPLANLSKLTTLKADDN 183
Query: 246 QFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKV 305
+ + I L+ +L ++ L++NQ++ V P + + L ++L N + + + +
Sbjct: 184 KISD-ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNL 240
Query: 306 QKVSLDHNNF-----CKNSSDAGKPCDPQVTTLL 334
++ SD G P +T L
Sbjct: 241 VVPNVVKGPSGAPIAPATISDNGTYASPNLTWNL 274
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 48/232 (20%), Positives = 97/232 (41%), Gaps = 21/232 (9%)
Query: 86 ISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145
+L ++ +N+ + A+ + + T++ L NL L L
Sbjct: 15 DPALANAIKIAAGKSNVTD-TVTQADLDGITTLSAFGTGVTTIEG--VQYLNNLIGLELK 71
Query: 146 DNP--NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSL 203
DN +LAP L T +T L + + + +++ L L+ T +
Sbjct: 72 DNQITDLAP------LKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQIT-DV 122
Query: 204 PASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDL 263
S++Q L+++ Q+ + L+G+T L+ + + Q + + L+ L L
Sbjct: 123 TPLAGLSNLQVLYLDLNQI---TNISPLAGLTNLQYLSIGNAQVSD-LTPLANLSKLTTL 178
Query: 264 SLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFP-SKVQKVSLDHNN 314
DN+++ + P + SLP L+ + L+NN++ PL S + V+L +
Sbjct: 179 KADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQT 228
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 48/232 (20%), Positives = 92/232 (39%), Gaps = 16/232 (6%)
Query: 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNF 125
+ +TT+S +G++ T+ + L L L + N I + L N T + ++ L N
Sbjct: 41 DGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQITD-LAPLKNLTKITELELSGNPL 97
Query: 126 TSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDS 185
+V GL +++ L L+ P ++L LY+D I + P
Sbjct: 98 KNVSA--IAGLQSIKTLDLTSTQITDVTPLAG----LSNLQVLYLDLNQITNISP--LAG 149
Query: 186 FSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKN 245
+NLQ L + + L S + L +D ++ + L+ + L +V L N
Sbjct: 150 LTNLQYLSIGNAQVS-DLTPLANLSKLTTLKADDNKIS---DISPLASLPNLIEVHLKNN 205
Query: 246 QFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGP 297
Q + + L+ +LF ++L + +T +L + + P
Sbjct: 206 QISD-VSPLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAP 256
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 57/345 (16%), Positives = 111/345 (32%), Gaps = 106/345 (30%)
Query: 106 IPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSL 165
I + I +N T T L + LS +
Sbjct: 12 IFPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGT----------------GV 53
Query: 166 TTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLS 225
TT+ + +NL L L N T
Sbjct: 54 TTI------------EGVQYLNNLIGLELKDNQIT------------------------- 76
Query: 226 GTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALL 285
L L +T++ ++ L N + ++ +S+ L L Q+T V P + L L
Sbjct: 77 -DLAPLKNLTKITELELSGNPLKN-VSAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQ 132
Query: 286 NISLQNNKLQGPYPLFP-SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPA 344
+ L N++ PL + +Q +S+ + QV+ L +A
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNA---------------QVSDLTPLAN------ 171
Query: 345 ILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLT 404
LS ++ T+ + ++ +ISP A+L +L ++L+ N ++
Sbjct: 172 -LS--------------------KLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQIS 208
Query: 405 GPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKFTVSPGNPFI 449
P L ++L + ++N ++ + + +N+ P
Sbjct: 209 DVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSG 251
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 48/259 (18%), Positives = 94/259 (36%), Gaps = 58/259 (22%)
Query: 172 NANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVL 231
I + PD + +N + +N T ++ + I L + T++ +
Sbjct: 6 PTAINVIFPD--PALANAIKIAAGKSNVTDTVTQADLDG-ITTLSAFGTGVT---TIEGV 59
Query: 232 SGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQN 291
+ L + L NQ T + L + +L L N L V + L ++ + L +
Sbjct: 60 QYLNNLIGLELKDNQITD-LAPLKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTS 116
Query: 292 NKLQGPYPL-FPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSW 350
++ PL S +Q + LD N Q+T + +AG L+
Sbjct: 117 TQITDVTPLAGLSNLQVLYLDLN---------------QITNISPLAG-------LT--- 151
Query: 351 EGNNACDGWPFVTCSQGRIITINLA-NKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPD 409
+ +++ ++ +++P ANL+ L L N ++ I
Sbjct: 152 -----------------NLQYLSIGNAQV--SDLTP-LANLSKLTTLKADDNKISD-IS- 189
Query: 410 GLTKLASLQNLDVSNNNLS 428
L L +L + + NN +S
Sbjct: 190 PLASLPNLIEVHLKNNQIS 208
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 26/141 (18%), Positives = 51/141 (36%), Gaps = 24/141 (17%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNN 123
+ N+++ IS ++SL L + + N I+ + LAN ++L + L N
Sbjct: 181 DDNKISDIS------------PLASLPNLIEVHLKNNQISD-VSPLANTSNLFIVTLTNQ 227
Query: 124 NFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFF 183
T+ P + L V+ +AP + T Y + L
Sbjct: 228 TITNQPVFYNNNLVVPNVVKGPSGAPIAPATISDNGT--------YASPNLTWNLTSFIN 279
Query: 184 D---SFSNLQNLRLSYNNFTG 201
+ +F+ + + F+G
Sbjct: 280 NVSYTFNQSVTFKNTTVPFSG 300
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 49/200 (24%), Positives = 74/200 (37%), Gaps = 30/200 (15%)
Query: 580 TDNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-R 637
T F E +G G FG V+ + DG A+KR + G+ E+ + +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697
H H+V L+ EY G+LA + E + + + + L V RG+
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISE-NYRIMSYFKEAELKDLLLQVGRGL 128
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDD-------------------MRAKVADFGLVKNAP 738
Y+HS S +H D+KPSNI I + K+ D G V
Sbjct: 129 RYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 739 DGKYSVETRLAGTFGYLAPE 758
+ G +LA E
Sbjct: 186 SPQVEE-----GDSRFLANE 200
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 50/193 (25%), Positives = 78/193 (40%), Gaps = 23/193 (11%)
Query: 577 RQVTDNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSE------FQAE 629
+ + D + + LG G G V E K+A++ + E + E
Sbjct: 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 190
Query: 630 IAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWKQRVT 688
I +L K+ H ++ + + + + +V E M G L F+ + L
Sbjct: 191 IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKR--LKEATCKL 243
Query: 689 IALDVARGVEYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGKYSVE 745
+ V+YLH IHRDLKP N+L+ +D K+ DFG K + S+
Sbjct: 244 YFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLM 298
Query: 746 TRLAGTFGYLAPE 758
L GT YLAPE
Sbjct: 299 RTLCGTPTYLAPE 311
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 43/251 (17%), Positives = 89/251 (35%), Gaps = 28/251 (11%)
Query: 60 INCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDI 118
+ + L L + L+ L+ ++ + +P ++ L+ +
Sbjct: 75 LEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETL 132
Query: 119 YLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNL-------APWPFPNELTKSTSLTTLYMD 171
L N ++P L L+ LS+ P L A E +L +L ++
Sbjct: 133 TLARNPLRALPAS-IASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLE 191
Query: 172 NANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSG----- 226
I L P + NL++L++ + + +L + + L ++L L G
Sbjct: 192 WTGIRSL-PASIANLQNLKSLKIRNSPLS-ALGPAIHH--LPKL----EELDLRGCTALR 243
Query: 227 TL-DVLSGMTQLRQVWL-HKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPA 283
+ G L+++ L + +P + + L L LR +P+ + LPA
Sbjct: 244 NYPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPA 302
Query: 284 LLNISLQNNKL 294
I + +
Sbjct: 303 NCIILVPPHLQ 313
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 44/226 (19%), Positives = 83/226 (36%), Gaps = 19/226 (8%)
Query: 82 LSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDG-LTNLQ 140
L P L+Q + N + AN+ + Q + D
Sbjct: 25 LRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRV 84
Query: 141 VLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFT 200
L L L FP++ + + L + +D A + L PD F+ L+ L L+ N
Sbjct: 85 ALELRSV-PLPQ--FPDQAFRLSHLQHMTIDAAGLMEL-PDTMQQFAGLETLTLARNPLR 140
Query: 201 GSLPASFAK-SDIQNLWMNDQ--------QLGLSGTLDVLSGMTQLRQVWLHKNQFTGPI 251
+LPAS A + ++ L + L + G+ L+ + L
Sbjct: 141 -ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLP 199
Query: 252 PDLSKCESLFDLSLRDNQLTGVVPASVISLPAL--LNISLQNNKLQ 295
++ ++L L +R++ L+ + ++ LP L L++ L+
Sbjct: 200 ASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLR-GCTALR 243
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 36/226 (15%), Positives = 73/226 (32%), Gaps = 16/226 (7%)
Query: 81 TLSPEISSLTQLETLSFQMNNIAGAIPSLANATS--LQDIYLDNNNFTSVPTGCFDGLTN 138
+ ++ + + + L +AT + L + P F L++
Sbjct: 47 HSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLPQFPDQAFR-LSH 105
Query: 139 LQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNN 198
LQ +++ L P+ + + L TL + N +P S + L+ L +
Sbjct: 106 LQHMTIDAA-GLME--LPDTMQQFAGLETLTLAR-NPLRALPASIASLNRLRELSIRACP 161
Query: 199 FTGSLPASFAKSDIQNLWMNDQQL---GLSGTL-----DVLSGMTQLRQVWLHKNQFTGP 250
LP A +D L L T ++ + L+ + + + +
Sbjct: 162 ELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSAL 221
Query: 251 IPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQN-NKLQ 295
P + L +L LR P L + L++ + L
Sbjct: 222 GPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL 267
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 3e-09
Identities = 29/168 (17%), Positives = 56/168 (33%), Gaps = 22/168 (13%)
Query: 136 LTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLS 195
+ + L + L P+ + L++ Y + N + +S +N Q +
Sbjct: 11 SSGRENLYFQGSTALR--PYHDVLSQ---WQRHYNADRNRWHSAWRQANS-NNPQIETRT 64
Query: 196 YNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTL-----DVLSGMTQLRQVWLHKNQFTGP 250
+ + L L D ++ L+ + +
Sbjct: 65 GRALK-ATADLLEDATQPGR----VALELRSVPLPQFPDQAFRLSHLQHMTIDAAGLME- 118
Query: 251 IPD-LSKCESLFDLSLRDNQLTGVVPASVISLPAL--LNISLQNNKLQ 295
+PD + + L L+L N L +PAS+ SL L L+I +L
Sbjct: 119 LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIR-ACPELT 164
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 9e-06
Identities = 11/45 (24%), Positives = 21/45 (46%), Gaps = 1/45 (2%)
Query: 389 NLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPD 433
NL +LK+L ++ + L+ + + L L+ LD+ P
Sbjct: 204 NLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPP 247
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 10/58 (17%), Positives = 22/58 (37%), Gaps = 1/58 (1%)
Query: 389 NLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKFTVSPGN 446
L+ L L +N L +P + L L+ L + ++P+ ++ +
Sbjct: 125 QFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQG 181
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 5e-05
Identities = 13/65 (20%), Positives = 28/65 (43%), Gaps = 2/65 (3%)
Query: 364 CSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVS 423
+Q + + L + L L+ L+++ + L +PD + + A L+ L ++
Sbjct: 78 ATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLA 135
Query: 424 NNNLS 428
N L
Sbjct: 136 RNPLR 140
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 9/45 (20%), Positives = 17/45 (37%)
Query: 389 NLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPD 433
+L L+ L L+ P A L+ L + + + +P
Sbjct: 227 HLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPL 271
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 2e-04
Identities = 12/47 (25%), Positives = 26/47 (55%), Gaps = 1/47 (2%)
Query: 382 NISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428
+ S + L +L++L L+ + +P + L +L++L + N+ LS
Sbjct: 174 DASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLS 219
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 10/45 (22%), Positives = 19/45 (42%)
Query: 389 NLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPD 433
LK L L+ + +P + +L L+ LD+ ++P
Sbjct: 251 GRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPS 295
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-24
Identities = 47/187 (25%), Positives = 78/187 (41%), Gaps = 22/187 (11%)
Query: 579 VTDNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR 637
V D + LG G FGVV+ E G K + + +K + EI+++ ++
Sbjct: 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK--YTVKNEISIMNQLH 106
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEW---HDHGYTPLTWKQRVTIALDVA 694
H L+ L + E +L+ E++ G LF+ D+ + + +
Sbjct: 107 HPKLINLHDAFEDKYEMVLILEFLSGG----ELFDRIAAEDYKMSE---AEVINYMRQAC 159
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIG--DDMRAKVADFGL-VKNAPDGKYSVETRLAGT 751
G++++H S +H D+KP NI+ K+ DFGL K PD V T
Sbjct: 160 EGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV---TTAT 213
Query: 752 FGYLAPE 758
+ APE
Sbjct: 214 AEFAAPE 220
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-24
Identities = 39/183 (21%), Positives = 73/183 (39%), Gaps = 32/183 (17%)
Query: 589 LGRGGFGVVYGGE---LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
+ GG G +Y + +G + +K + ++ + + AE L +V H +V +
Sbjct: 88 IAHGGLGWIYLALDRNV-NGRPVVLKGL-VHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 646 GYCINGSERL--------LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697
+ +V EY+ +L + + L + + L++ +
Sbjct: 146 NF---VEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPAL 195
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAP 757
YLHS ++ DLKP NI++ ++ + K+ D G V L GT G+ AP
Sbjct: 196 SYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS-----FGYLYGTPGFQAP 246
Query: 758 EYA 760
E
Sbjct: 247 EIV 249
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 49/199 (24%), Positives = 86/199 (43%), Gaps = 25/199 (12%)
Query: 573 IEVLRQ--VTDNFSEANILGRGGFGVVY-GGELPDGTKIAVK----RMESNTMGNKGLSE 625
+E +Q V D + LG G F +V E G + A K R + E
Sbjct: 2 METFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREE 61
Query: 626 FQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWK 684
+ E+++L +V H +++ L N ++ +L+ E + G LF++ L+ +
Sbjct: 62 IEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGG----ELFDFLAQKES--LSEE 115
Query: 685 QRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI----GDDMRAKVADFGL-VKNAPD 739
+ + + GV YLH+ + H DLKP NI++ K+ DFGL +
Sbjct: 116 EATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 740 GKYSVETRLAGTFGYLAPE 758
++ + GT ++APE
Sbjct: 173 VEFKN---IFGTPEFVAPE 188
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 58/209 (27%), Positives = 85/209 (40%), Gaps = 36/209 (17%)
Query: 90 TQLETLSFQMNNI----AGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145
+ L Q N + + A L T L+ +YL++N ++P G F L NL+ L ++
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRL---TKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT 93
Query: 146 DNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPA 205
DN L P + +L L +D + L P FDS + L L L YN SLP
Sbjct: 94 DN-KLQALP-IGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPK 150
Query: 206 SFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD--LSKCESLFDL 263
V +T L+++ L+ NQ +P+ K L L
Sbjct: 151 -----------------------GVFDKLTSLKELRLYNNQLKR-VPEGAFDKLTELKTL 186
Query: 264 SLRDNQLTGVVPASVISLPALLNISLQNN 292
L +NQL V + SL L + LQ N
Sbjct: 187 KLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 44/157 (28%), Positives = 64/157 (40%), Gaps = 12/157 (7%)
Query: 69 TTISLAKSGLSGTLSPEI-SSLTQLETLSFQMNNIAGAIPS--LANATSLQDIYLDNNNF 125
+ L + L TL I L LETL N + A+P +L ++ LD N
Sbjct: 64 RLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQL 121
Query: 126 TSVPTGCFDGLTNLQVLSLSDN--PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFF 183
S+P FD LT L LSL N +L F K TSL L + N + + F
Sbjct: 122 KSLPPRVFDSLTKLTYLSLGYNELQSLPKGVF----DKLTSLKELRLYNNQLKRVPEGAF 177
Query: 184 DSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMND 219
D + L+ L+L N +F ++ L + +
Sbjct: 178 DKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQE 214
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 5e-18
Identities = 49/211 (23%), Positives = 80/211 (37%), Gaps = 64/211 (30%)
Query: 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172
+ + L +N +S+P+ F LT L++L L+DN L TL
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDN----------------KLQTLP--- 77
Query: 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLS 232
F NL+ L ++ N +LP V
Sbjct: 78 -------AGIFKELKNLETLWVTDNKLQ-ALPI-----------------------GVFD 106
Query: 233 GMTQLRQVWLHKNQFTGPIPD-----LSKCESLFDLSLRDNQLTGVVPASVI-SLPALLN 286
+ L ++ L +NQ +P L+K L LSL N+L +P V L +L
Sbjct: 107 QLVNLAELRLDRNQLKS-LPPRVFDSLTK---LTYLSLGYNELQ-SLPKGVFDKLTSLKE 161
Query: 287 ISLQNNKLQG-PYPLFP--SKVQKVSLDHNN 314
+ L NN+L+ P F ++++ + LD+N
Sbjct: 162 LRLYNNQLKRVPEGAFDKLTELKTLKLDNNQ 192
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 24/63 (38%), Positives = 32/63 (50%), Gaps = 3/63 (4%)
Query: 88 SLTQLETLSFQMNNIAGAIPSLA--NATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145
LT L+ L N + +P A T L+ + LDNN VP G FD L L++L L
Sbjct: 155 KLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQ 213
Query: 146 DNP 148
+NP
Sbjct: 214 ENP 216
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 6e-08
Identities = 52/247 (21%), Positives = 87/247 (35%), Gaps = 74/247 (29%)
Query: 186 FSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKN 245
++ + L L N + SLP+ +T+LR ++L+ N
Sbjct: 36 PADTKKLDLQSNKLS-SLPSK-----------------------AFHRLTKLRLLYLNDN 71
Query: 246 QFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASVI-SLPALLNISLQNNKLQG-PYPLF 301
+ +P + ++L L + DN+L +P V L L + L N+L+ P +F
Sbjct: 72 KLQT-LPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVF 129
Query: 302 PS--KVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGW 359
S K+ +SL +N ++ +L P D
Sbjct: 130 DSLTKLTYLSLGYN---------------ELQSL---------PK---------GVFDK- 155
Query: 360 PFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGL-TKLASLQ 418
+ + L N L A+ LT LK L L N L +P+G L L+
Sbjct: 156 ------LTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKR-VPEGAFDSLEKLK 208
Query: 419 NLDVSNN 425
L + N
Sbjct: 209 MLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 36/171 (21%), Positives = 60/171 (35%), Gaps = 47/171 (27%)
Query: 263 LSLRDNQLTGVVPASVISLPALLNISLQNNKLQG-PYPLFP--SKVQKVSLDHNNFCKNS 319
L L+ N+L+ + + L L + L +NKLQ P +F ++ + + N +
Sbjct: 42 LDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKL--QA 99
Query: 320 SDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLL 379
G L++ N+L
Sbjct: 100 LPIGVFDQLVNLAELRLDR-------------------------------------NQLK 122
Query: 380 AGNISP-AYANLTSLKNLYLQQNNLTGPIPDGL-TKLASLQNLDVSNNNLS 428
+ + P + +LT L L L N L +P G+ KL SL+ L + NN L
Sbjct: 123 S--LPPRVFDSLTKLTYLSLGYNELQS-LPKGVFDKLTSLKELRLYNNQLK 170
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 48/191 (25%), Positives = 86/191 (45%), Gaps = 23/191 (12%)
Query: 579 VTDNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLS----EFQAEIAVL 633
V D++ LG G F +V + G + A K ++ + + E + E+ +L
Sbjct: 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62
Query: 634 TKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWKQRVTIALD 692
++RH +++ L N ++ +L+ E + G LF++ + LT +
Sbjct: 63 REIRHPNIITLHDIFENKTDVVLILELVSGGE----LFDFLAEKES--LTEDEATQFLKQ 116
Query: 693 VARGVEYLHSLAQQSFIHRDLKPSNILI----GDDMRAKVADFGL-VKNAPDGKYSVETR 747
+ GV YLHS + H DLKP NI++ + R K+ DFG+ K ++
Sbjct: 117 ILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN--- 170
Query: 748 LAGTFGYLAPE 758
+ GT ++APE
Sbjct: 171 IFGTPEFVAPE 181
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-24
Identities = 47/184 (25%), Positives = 74/184 (40%), Gaps = 14/184 (7%)
Query: 579 VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR 637
+++ + LG G +G V + + A+K + ++ S+ E+AVL +
Sbjct: 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD 94
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697
H +++ L + + LV E G L + I V GV
Sbjct: 95 HPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH---RMK--FNEVDAAVIIKQVLSGV 149
Query: 698 EYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGY 754
YLH + +HRDLKP N+L+ D K+ DFGL + K GT Y
Sbjct: 150 TYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK--KMKERLGTAYY 204
Query: 755 LAPE 758
+APE
Sbjct: 205 IAPE 208
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 7e-24
Identities = 55/191 (28%), Positives = 92/191 (48%), Gaps = 20/191 (10%)
Query: 577 RQVTDNFSEANILGRGGFGVVY-GGELPDGTKIAVKRME------SNTMGNKGLSEFQAE 629
++ + +++GRG VV G + AVK ME S + + E
Sbjct: 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRE 149
Query: 630 IAVLTKVR-HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWKQRV 687
+L +V H H++ L+ + S LV++ M +G L F++ + L+ K+
Sbjct: 150 THILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL----FDYLTEKVA--LSEKETR 203
Query: 688 TIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR 747
+I + V +LH+ + +HRDLKP NIL+ D+M+ +++DFG + G+
Sbjct: 204 SIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE--KLRE 258
Query: 748 LAGTFGYLAPE 758
L GT GYLAPE
Sbjct: 259 LCGTPGYLAPE 269
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 8e-24
Identities = 53/183 (28%), Positives = 80/183 (43%), Gaps = 22/183 (12%)
Query: 589 LGRGGFGVVYGGELPD---GTKIAVKRMESNTMGNKG-LSEFQAEIAVLTKVRHRHLVAL 644
LG GG V+ D +AVK + ++ + F+ E + H +VA+
Sbjct: 20 LGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 645 LGY-CINGSERLLVY---EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYL 700
L Y EY+ TL + H G P+T K+ + + D + + +
Sbjct: 78 YDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEG--PMTPKRAIEVIADACQALNFS 132
Query: 701 HSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR---LAGTFGYLAP 757
H Q IHRD+KP+NI+I KV DFG+ + D SV T+ + GT YL+P
Sbjct: 133 H---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV-TQTAAVIGTAQYLSP 188
Query: 758 EYA 760
E A
Sbjct: 189 EQA 191
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 9e-24
Identities = 42/186 (22%), Positives = 75/186 (40%), Gaps = 15/186 (8%)
Query: 578 QVTDNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV 636
+ T+ + LG+G F VV ++ G + A + + + + + + E + +
Sbjct: 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL 67
Query: 637 RHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWKQRVTIALDVAR 695
+H ++V L L+++ + G LFE Y + +
Sbjct: 68 KHPNIVRLHDSISEEGHHYLIFDLVTGG----ELFEDIVAREY--YSEADASHCIQQILE 121
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGKYSVETRLAGTF 752
V + H +HR+LKP N+L+ K+ADFGL + + AGT
Sbjct: 122 AVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF-AGTP 177
Query: 753 GYLAPE 758
GYL+PE
Sbjct: 178 GYLSPE 183
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-23
Identities = 28/202 (13%), Positives = 53/202 (26%), Gaps = 35/202 (17%)
Query: 588 ILGRGGFGVVY-GGELPDGTKIAVK--------------RMESNTMGNKGLSEFQAEIAV 632
+LG+ + G V +M+ + + L + +
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 633 LTKVRHRHLVALL--------------GYCINGSERLLVYEYMPRGTLAQHLFEWHDHG- 677
+R L+ + R +Y M + L H
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSS 203
Query: 678 -YTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736
+ L R+ + L V R + LH +H L+P +I++ + F +
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 737 APDGKYSVETRLAGTFGYLAPE 758
S R A
Sbjct: 261 DGASAVSPIGRGFAPPETTAER 282
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 41/186 (22%), Positives = 67/186 (36%), Gaps = 17/186 (9%)
Query: 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172
++L N + T L L+L L TL + +
Sbjct: 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD----GTLPVLGTLDLSH 86
Query: 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPAS-FAK-SDIQNLWMNDQQLGLSGTL-- 228
N +P + L L +S+N T SLP ++Q L++ +L TL
Sbjct: 87 -NQLQSLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNEL---KTLPP 141
Query: 229 DVLSGMTQLRQVWLHKNQFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASVISLPALLN 286
+L+ +L ++ L N T +P L+ E+L L L++N L +P L
Sbjct: 142 GLLTPTPKLEKLSLANNNLTE-LPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPF 199
Query: 287 ISLQNN 292
L N
Sbjct: 200 AFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 2e-22
Identities = 57/213 (26%), Positives = 90/213 (42%), Gaps = 19/213 (8%)
Query: 108 SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTT 167
++ S ++ D N T++P + +L LS+N L + L T LT
Sbjct: 5 EVSKVASHLEVNCDKRNLTALPPDLP---KDTTILHLSEN-LLYTFS-LATLMPYTRLTQ 59
Query: 168 LYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQL-GLS 225
L +D A + L + L L LS+N SLP + L ++ +L L
Sbjct: 60 LNLDRAELTKL--QVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLP 116
Query: 226 GTLDVLSGMTQLRQVWLHKNQFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASVI-SLP 282
L L G+ +L++++L N+ +P L+ L LSL +N LT +PA ++ L
Sbjct: 117 --LGALRGLGELQELYLKGNELKT-LPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLE 172
Query: 283 ALLNISLQNNKLQG-PYPLFPS-KVQKVSLDHN 313
L + LQ N L P F S + L N
Sbjct: 173 NLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 37/138 (26%), Positives = 56/138 (40%), Gaps = 6/138 (4%)
Query: 84 PEISSLTQLETLSFQMNNIAGAIPSL-ANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVL 142
+L L TL N + ++P L +L + + N TS+P G GL LQ L
Sbjct: 71 QVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQEL 129
Query: 143 SLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGS 202
L N L P P LT + L L + N N+ L + NL L L N+ +
Sbjct: 130 YLKGN-ELKTLP-PGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-T 186
Query: 203 LPAS-FAKSDIQNLWMND 219
+P F + +++
Sbjct: 187 IPKGFFGSHLLPFAFLHG 204
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 18/64 (28%), Positives = 28/64 (43%), Gaps = 4/64 (6%)
Query: 87 SSLTQLETLSFQMNNIAGAIPS--LANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144
+ +LE LS NN+ +P+ L +L + L N+ ++P G F L L
Sbjct: 145 TPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYTIPKGFFG-SHLLPFAFL 202
Query: 145 SDNP 148
NP
Sbjct: 203 HGNP 206
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 42/203 (20%), Positives = 64/203 (31%), Gaps = 57/203 (28%)
Query: 235 TQLRQVWLHKNQFTG-PIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNK 293
+ L +N + L L L+L +LT + +LP L + L +N+
Sbjct: 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVDG-TLPVLGTLDLSHNQ 88
Query: 294 LQGPYPLFP--SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWE 351
LQ L + + + N ++T+L P
Sbjct: 89 LQSLPLLGQTLPALTVLDVSFN---------------RLTSL---------PL------- 117
Query: 352 GNNACDGWPFVTCSQGRIITINLANKLLAGN----ISP-AYANLTSLKNLYLQQNNLTGP 406
A G L L GN + P L+ L L NNLT
Sbjct: 118 --GALRGLG------------ELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE- 162
Query: 407 IPDGL-TKLASLQNLDVSNNNLS 428
+P GL L +L L + N+L
Sbjct: 163 LPAGLLNGLENLDTLLLQENSLY 185
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 46/191 (24%), Positives = 82/191 (42%), Gaps = 23/191 (12%)
Query: 579 VTDNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLS----EFQAEIAVL 633
V D + LG G F +V E G + A K ++ E + E+++L
Sbjct: 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 634 TKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWKQRVTIALD 692
+V H +++ L N ++ +L+ E + G LF++ L+ ++ +
Sbjct: 70 RQVLHHNVITLHDVYENRTDVVLILELVSGG----ELFDFLAQKES--LSEEEATSFIKQ 123
Query: 693 VARGVEYLHSLAQQSFIHRDLKPSNILI----GDDMRAKVADFGL-VKNAPDGKYSVETR 747
+ GV YLH+ + H DLKP NI++ K+ DFGL + ++
Sbjct: 124 ILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--- 177
Query: 748 LAGTFGYLAPE 758
+ GT ++APE
Sbjct: 178 IFGTPEFVAPE 188
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 37/178 (20%), Positives = 69/178 (38%), Gaps = 12/178 (6%)
Query: 588 ILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQA---EIAVLTKVRHRHLVA 643
++G+G F VV G + AVK ++ + + E ++ ++H H+V
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 644 LLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSL 703
LL + +V+E+M L + + + + + Y H
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVK-RADAGFVYSEAVASHYMRQILEALRYCHD- 148
Query: 704 AQQSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
+ IHRD+KP +L+ + K+ FG+ + R GT ++APE
Sbjct: 149 --NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR-VGTPHFMAPE 203
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 36/210 (17%), Positives = 75/210 (35%), Gaps = 18/210 (8%)
Query: 561 RHLFEGGNVAISIEVLRQVTDN---FSEANILGRG--GFGVVYGG-ELPDGTKIAVKRME 614
H + + + + ++G+G V P G + V+R+
Sbjct: 2 AHHHHHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN 61
Query: 615 SNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWH 674
N+ ++ Q E+ V H ++V I +E +V +M G+ + L H
Sbjct: 62 LEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSA-KDLICTH 120
Query: 675 DHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG-- 732
+ I V + ++Y+H ++HR +K S+ILI D + ++
Sbjct: 121 FMD--GMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSN 175
Query: 733 --LVKNAP--DGKYSVETRLAGTFGYLAPE 758
++ + + +L+PE
Sbjct: 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPE 205
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-23
Identities = 49/185 (26%), Positives = 75/185 (40%), Gaps = 16/185 (8%)
Query: 579 VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR 637
+ ++ +LG+G FG V + + AVK + + NK S E+ +L K+
Sbjct: 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD 79
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWKQRVTIALDVARG 696
H +++ L + S +V E G LF+ + I V G
Sbjct: 80 HPNIMKLFEILEDSSSFYIVGELYTGGE----LFDEIIKRKR--FSEHDAARIIKQVFSG 133
Query: 697 VEYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFG 753
+ Y+H + +HRDLKP NIL+ D K+ DFGL GT
Sbjct: 134 ITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAY 188
Query: 754 YLAPE 758
Y+APE
Sbjct: 189 YIAPE 193
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 41/154 (26%), Positives = 68/154 (44%), Gaps = 10/154 (6%)
Query: 580 TDNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH 638
+ + LG G FG VY G A K +E+ + L ++ EI +L H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE--LEDYIVEIEILATCDH 75
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
++V LLG + + ++ E+ P G + + LT Q + + +
Sbjct: 76 PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM----LELDRGLTEPQIQVVCRQMLEALN 131
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732
+LHS + IHRDLK N+L+ + ++ADFG
Sbjct: 132 FLHS---KRIIHRDLKAGNVLMTLEGDIRLADFG 162
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 53/197 (26%), Positives = 92/197 (46%), Gaps = 24/197 (12%)
Query: 571 ISIEVLRQVTDNFSEANILGRGGFGVVY-GGELPDGTKIAVK--RMESNTMGNKGLSEFQ 627
++++V + + + + LG G F VY + +A+K ++ + G++
Sbjct: 1 MALDVKSRA-KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGIN-RT 58
Query: 628 A--EIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQ 685
A EI +L ++ H +++ LL + S LV+++M L + LT
Sbjct: 59 ALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVII----KDNSLVLTPSH 113
Query: 686 RVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL--VKNAPDGKYS 743
L +G+EYLH +HRDLKP+N+L+ ++ K+ADFGL +P+ Y+
Sbjct: 114 IKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT 170
Query: 744 --VETRLAGTFGYLAPE 758
V TR Y APE
Sbjct: 171 HQVVTRW-----YRAPE 182
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 51/200 (25%), Positives = 82/200 (41%), Gaps = 19/200 (9%)
Query: 567 GNVAISIEVLRQVT-DNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLS 624
G + IS E T ++ + +GRG +G V P G +AVKR+ S K
Sbjct: 7 GKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQK 65
Query: 625 EFQAEIAVLTK-VRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTW 683
+ ++ V+ + ++V G + + E M + + + +
Sbjct: 66 QLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPE 124
Query: 684 KQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG----LVKNAPD 739
+ I L + + +L IHRD+KPSNIL+ K+ DFG LV
Sbjct: 125 EILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD---- 178
Query: 740 GKYSV-ETRLAGTFGYLAPE 758
S+ +TR AG Y+APE
Sbjct: 179 ---SIAKTRDAGCRPYMAPE 195
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 44/154 (28%), Positives = 70/154 (45%), Gaps = 12/154 (7%)
Query: 580 TDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH 638
+ F LG G +G VY G +A+K++ L E EI+++ +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE----SDLQEIIKEISIMQQCDS 83
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
H+V G ++ +V EY G+++ + + LT + TI +G+E
Sbjct: 84 PHVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRN---KTLTEDEIATILQSTLKGLE 139
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732
YLH IHRD+K NIL+ + AK+ADFG
Sbjct: 140 YLHF---MRKIHRDIKAGNILLNTEGHAKLADFG 170
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 3e-23
Identities = 48/246 (19%), Positives = 77/246 (31%), Gaps = 39/246 (15%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLT--QLETLSFQMNNIAGAIPSLAN-----ATSLQ 116
+ + ++L ++GT P + T L L+ + + A LA L+
Sbjct: 93 GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLK 152
Query: 117 DIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKS--TSLTTLYMDNAN 174
+ + + + L L LSDNP L + L +L L + NA
Sbjct: 153 VLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAG 212
Query: 175 ---IFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVL 231
G+ + LQ L LS+N+ + A
Sbjct: 213 METPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS-----------------------C 249
Query: 232 SGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQN 291
+QL + L L L L L N+L S LP + N+SL+
Sbjct: 250 DWPSQLNSLNLSFTGLKQVPKGLPA--KLSVLDLSYNRLDRNP--SPDELPQVGNLSLKG 305
Query: 292 NKLQGP 297
N
Sbjct: 306 NPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 53/302 (17%), Positives = 86/302 (28%), Gaps = 49/302 (16%)
Query: 55 CEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATS 114
C ++ D S+ + A L G L +++T + + + S
Sbjct: 15 CNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQ-----FTDIIKSLS 69
Query: 115 LQDIYLDNNNFTSVPTGC---FDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTT---- 167
L+ + + S G++ LQ L+L + P P L
Sbjct: 70 LKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLR 129
Query: 168 ------------------------LYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSL 203
L + A+ + F L L LS N G
Sbjct: 130 NVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGER 189
Query: 204 PASFAK-----SDIQNLWMNDQQL-GLSGTL-DVLSGMTQLRQVWLHKNQFTGPIPDL-- 254
A +Q L + + + SG + + QL+ + L N
Sbjct: 190 GLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSC 249
Query: 255 SKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG-PYPLFPSKVQKVSLDHN 313
L L+L L V L + L N+L P P +V +SL N
Sbjct: 250 DWPSQLNSLNLSFTGLKQVPKG---LPAKLSVLDLSYNRLDRNPSPDELPQVGNLSLKGN 306
Query: 314 NF 315
F
Sbjct: 307 PF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 6e-14
Identities = 56/320 (17%), Positives = 94/320 (29%), Gaps = 60/320 (18%)
Query: 123 NNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPD- 181
N + + G +L+ L + F ++ KS SL L + A I I
Sbjct: 29 NCLGAADVELYGGGRSLEYLLKRVDTEADLGQFT-DIIKSLSLKRLTVRAARIPSRILFG 87
Query: 182 --FFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQ 239
S LQ L L TG+ P ++ +L + + L ++
Sbjct: 88 ALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILN-----------LRNVS---- 132
Query: 240 VWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYP 299
W ++ + + K L LS+ V PAL + L +N G
Sbjct: 133 -WATRDAWLAELQQWLK-PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190
Query: 300 LFPSKVQKV--SLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACD 357
L + +L + +
Sbjct: 191 LISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARV---------------------- 228
Query: 358 GWPFVTCSQGRIITINLA-NKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLAS 416
++ ++L+ N L +P+ + L +L L L +P GL A
Sbjct: 229 ----------QLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGL--PAK 275
Query: 417 LQNLDVSNNNLSGKVPDFGS 436
L LD+S N L P
Sbjct: 276 LSVLDLSYNRLDR-NPSPDE 294
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 44/272 (16%), Positives = 89/272 (32%), Gaps = 38/272 (13%)
Query: 174 NIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSG 233
N PD+ +F+ L + SL + D + + LS
Sbjct: 16 NFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVD-----TEADLGQFTDIIKSLS- 69
Query: 234 MTQLRQVWLHKNQFTGPIPD----LSKCESLFDLSLRDNQLTGVVPASVISL--PALLNI 287
L+++ + + I + L +L+L + ++TG P ++ P L +
Sbjct: 70 ---LKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNIL 126
Query: 288 SLQNNKLQGPYPLFPS-------KVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDM 340
+L+N ++ +S+ + S + + P ++TL D+
Sbjct: 127 NLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVF-PALSTL-----DL 180
Query: 341 GYPAILSDSWEGNNACDGWPFVTCSQGRIITINLAN---KLLAGNISPAYANLTSLKNLY 397
L + + C + + L N + +G S A L+ L
Sbjct: 181 SDNPELGERGLISALCPLKF------PTLQVLALRNAGMETPSGVCSALAAARVQLQGLD 234
Query: 398 LQQNNLTG-PIPDGLTKLASLQNLDVSNNNLS 428
L N+L + L +L++S L
Sbjct: 235 LSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK 266
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-23
Identities = 42/154 (27%), Positives = 80/154 (51%), Gaps = 11/154 (7%)
Query: 580 TDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH 638
+ F++ +G+G FG V+ G + +A+K ++ ++ + + Q EI VL++
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDS 79
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
++ G + ++ ++ EY+ G+ L E PL Q TI ++ +G++
Sbjct: 80 PYVTKYYGSYLKDTKLWIIMEYLGGGSA-LDLLE-----PGPLDETQIATILREILKGLD 133
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732
YLHS + IHRD+K +N+L+ + K+ADFG
Sbjct: 134 YLHS---EKKIHRDIKAANVLLSEHGEVKLADFG 164
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 57/231 (24%), Positives = 91/231 (39%), Gaps = 24/231 (10%)
Query: 537 GNGTNGYNGVPSELHSQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEA----NILGRG 592
+ ++G + L+ QS V+ ++ + D S+ + LGRG
Sbjct: 5 HHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRG 64
Query: 593 GFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING 651
+VY + A+K ++ + EI VL ++ H +++ L
Sbjct: 65 ATSIVYRCKQKGTQKPYALKVLKKT----VDKKIVRTEIGVLLRLSHPNIIKLKEIFETP 120
Query: 652 SERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIH 710
+E LV E + G LF+ + GY + + + V YLH +H
Sbjct: 121 TEISLVLELVTGG----ELFDRIVEKGY--YSERDAADAVKQILEAVAYLHE---NGIVH 171
Query: 711 RDLKPSNILI---GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
RDLKP N+L D K+ADFGL K + + GT GY APE
Sbjct: 172 RDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--LMKTVCGTPGYCAPE 220
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 4e-23
Identities = 46/185 (24%), Positives = 74/185 (40%), Gaps = 18/185 (9%)
Query: 579 VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR 637
+ ++ N +GRG +G V + + A K++ + + + F+ EI ++ +
Sbjct: 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLD 64
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWKQRVTIALDVARG 696
H +++ L + ++ LV E G LFE I DV
Sbjct: 65 HPNIIRLYETFEDNTDIYLVMELCTGG----ELFERVVHKRV--FRESDAARIMKDVLSA 118
Query: 697 VEYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFG 753
V Y H + HRDLKP N L D K+ DFGL GK + GT
Sbjct: 119 VAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--MMRTKVGTPY 173
Query: 754 YLAPE 758
Y++P+
Sbjct: 174 YVSPQ 178
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 54/197 (27%), Positives = 80/197 (40%), Gaps = 22/197 (11%)
Query: 574 EVLRQVTDNFSE-----ANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQ 627
+ Q +NF+ + LGRG F VV G + A K ++ G +E
Sbjct: 17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEIL 76
Query: 628 AEIAVLTKVRHR-HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWKQ 685
EIAVL + ++ L N SE +L+ EY G + F ++
Sbjct: 77 HEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEI----FSLCLPELAEMVSEND 132
Query: 686 RVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGL-VKNAPDGK 741
+ + + GV YLH + +H DLKP NIL+ K+ DFG+ K +
Sbjct: 133 VIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE 189
Query: 742 YSVETRLAGTFGYLAPE 758
+ GT YLAPE
Sbjct: 190 LRE---IMGTPEYLAPE 203
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 53/197 (26%), Positives = 88/197 (44%), Gaps = 25/197 (12%)
Query: 575 VLRQ--VTDNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLS----EFQ 627
V RQ V D + LG G F VV E G + A K ++ + + +
Sbjct: 3 VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 628 AEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWKQR 686
E+++L +++H +++ L N ++ +L+ E + G LF++ + LT ++
Sbjct: 63 REVSILKEIQHPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKES--LTEEEA 116
Query: 687 VTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI----GDDMRAKVADFGL-VKNAPDGK 741
+ GV YLHSL H DLKP NI++ R K+ DFGL K +
Sbjct: 117 TEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173
Query: 742 YSVETRLAGTFGYLAPE 758
+ + GT ++APE
Sbjct: 174 FKN---IFGTPEFVAPE 187
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 5e-23
Identities = 41/187 (21%), Positives = 81/187 (43%), Gaps = 19/187 (10%)
Query: 577 RQVTDNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTK 635
+++ + + A LGRG FG+V+ E K ++ + EI++L
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV---LVKKEISILNI 57
Query: 636 VRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWKQRVTIALDVA 694
RHR+++ L + E ++++E++ + FE + + L ++ V+ V
Sbjct: 58 ARHRNILHLHESFESMEELVMIFEFISGLDI----FERINTSAFE-LNEREIVSYVHQVC 112
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIG--DDMRAKVADFGL-VKNAPDGKYSVETRLAGT 751
+++LHS + H D++P NI+ K+ +FG + P + + L
Sbjct: 113 EALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTA 166
Query: 752 FGYLAPE 758
Y APE
Sbjct: 167 PEYYAPE 173
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 6e-23
Identities = 42/154 (27%), Positives = 73/154 (47%), Gaps = 12/154 (7%)
Query: 580 TDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH 638
++ +G+G G VY ++ G ++A+++M K EI V+ + ++
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK--ELIINEILVMRENKN 76
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
++V L + G E +V EY+ G+L + E T + Q + + + +E
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALE 130
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732
+LHS IHRD+K NIL+G D K+ DFG
Sbjct: 131 FLHS---NQVIHRDIKSDNILLGMDGSVKLTDFG 161
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 6e-23
Identities = 39/154 (25%), Positives = 69/154 (44%), Gaps = 12/154 (7%)
Query: 580 TDNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH 638
+G G G+V E G ++AVK M+ + E+ ++ +H
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR--ELLFNEVVIMRDYQH 101
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
++V + + G E ++ E++ G L + + L +Q T+ V + +
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ------VRLNEEQIATVCEAVLQALA 155
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732
YLH+ Q IHRD+K +IL+ D R K++DFG
Sbjct: 156 YLHA---QGVIHRDIKSDSILLTLDGRVKLSDFG 186
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 6e-23
Identities = 55/211 (26%), Positives = 88/211 (41%), Gaps = 49/211 (23%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQA------------------- 628
+G+G +GVV D T A+K + + + +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 629 -----EIAVLTKVRHRHLVALLGYCI----NGSERLLVYEYMPRGTLAQHLFEWHDHGYT 679
EIA+L K+ H ++V L + N +V+E + +G + E
Sbjct: 81 EQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPV----MEVPTLK-- 132
Query: 680 PLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739
PL+ Q D+ +G+EYLH Q IHRD+KPSN+L+G+D K+ADFG+
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189
Query: 740 GKYSVETRLAGTFGYLAPE--------YAGK 762
+ GT ++APE ++GK
Sbjct: 190 SDALLSNT-VGTPAFMAPESLSETRKIFSGK 219
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-23
Identities = 59/182 (32%), Positives = 86/182 (47%), Gaps = 18/182 (9%)
Query: 582 NFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
S+ ILG G FG V+ E G K+A K + T G K E + EI+V+ ++ H +
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKII--KTRGMKDKEEVKNEISVMNQLDHAN 147
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWKQRVTIALDVARGVEY 699
L+ L + ++ +LV EY+ G LF+ D Y LT + + G+ +
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGG----ELFDRIIDESYN-LTELDTILFMKQICEGIRH 202
Query: 700 LHSLAQQSFIHRDLKPSNILIG--DDMRAKVADFGL-VKNAPDGKYSVETRLAGTFGYLA 756
+H +H DLKP NIL D + K+ DFGL + P K V GT +LA
Sbjct: 203 MHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV---NFGTPEFLA 256
Query: 757 PE 758
PE
Sbjct: 257 PE 258
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 9e-23
Identities = 52/189 (27%), Positives = 79/189 (41%), Gaps = 26/189 (13%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQA----EIAVLTKVRHR--HL 641
LG GGFG VY G + D +A+K +E + + + G E+ +L KV +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 642 VALLGYCINGSERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWKQRVTIALDVARGVEYL 700
+ LL + +L+ E P Q LF++ + G L + + V V +
Sbjct: 111 IRLLDWFERPDSFVLILER-PEP--VQDLFDFITERG--ALQEELARSFFWQVLEAVRHC 165
Query: 701 HSLAQQSFIHRDLKPSNILI-GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE- 758
H+ +HRD+K NILI + K+ DFG D Y+ GT Y PE
Sbjct: 166 HN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD---FDGTRVYSPPEW 219
Query: 759 -----YAGK 762
Y G+
Sbjct: 220 IRYHRYHGR 228
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 9e-23
Identities = 44/189 (23%), Positives = 73/189 (38%), Gaps = 23/189 (12%)
Query: 577 RQVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEF-QAEIAVLT 634
R+ + +GRG FG V+ + G + AVK++ L F E+
Sbjct: 54 REEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR--------LEVFRVEELVACA 105
Query: 635 KVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVA 694
+ +V L G G + E + G+L Q + + L + +
Sbjct: 106 GLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQ-----MGCLPEDRALYYLGQAL 160
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIGDD-MRAKVADFGLVKNAPDGKYSVETR----LA 749
G+EYLH+ + +H D+K N+L+ D RA + DFG +
Sbjct: 161 EGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217
Query: 750 GTFGYLAPE 758
GT ++APE
Sbjct: 218 GTETHMAPE 226
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 51/184 (27%), Positives = 84/184 (45%), Gaps = 16/184 (8%)
Query: 579 VTDNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR 637
V D++ LG G FGVV+ E G A K + + +K + EI ++ +R
Sbjct: 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK--ETVRKEIQTMSVLR 212
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697
H LV L + +E +++YE+M G L + + + H+ ++ + V V +G+
Sbjct: 213 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK----MSEDEAVEYMRQVCKGL 268
Query: 698 EYLHSLAQQSFIHRDLKPSNILIG--DDMRAKVADFGL-VKNAPDGKYSVETRLAGTFGY 754
++H +++H DLKP NI+ K+ DFGL P V GT +
Sbjct: 269 CHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEF 322
Query: 755 LAPE 758
APE
Sbjct: 323 AAPE 326
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-22
Identities = 50/194 (25%), Positives = 79/194 (40%), Gaps = 21/194 (10%)
Query: 575 VLRQVTDNFSEA----NILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSE-FQA 628
++ T FS+ +LG+G FG V + G + AVK + + K E
Sbjct: 16 FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR 75
Query: 629 EIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWKQRV 687
E+ +L ++ H +++ L + + LV E G L F+ +
Sbjct: 76 EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKR--FSEVDAA 129
Query: 688 TIALDVARGVEYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGKYSV 744
I V G+ Y+H +HRDLKP N+L+ D ++ DFGL + K
Sbjct: 130 RIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--K 184
Query: 745 ETRLAGTFGYLAPE 758
GT Y+APE
Sbjct: 185 MKDKIGTAYYIAPE 198
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 46/181 (25%), Positives = 77/181 (42%), Gaps = 17/181 (9%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY 647
+G+G F V + G ++A+K ++ + L + E+ ++ + H ++V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 648 CINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS 707
L+ EY G + +L HG + K+ + + V+Y H Q+
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVA---HGR--MKEKEARSKFRQIVSAVQYCH---QKR 134
Query: 708 FIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE------YAG 761
+HRDLK N+L+ DM K+ADFG G ++ G Y APE Y G
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK-LDA-FCGAPPYAAPELFQGKKYDG 192
Query: 762 K 762
Sbjct: 193 P 193
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 2e-22
Identities = 57/187 (30%), Positives = 88/187 (47%), Gaps = 27/187 (14%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVK--RMESNTMGNKGLSEFQA--EIAVLTKV 636
+ + + +G G +GVVY + G +A+K R+++ G A EI++L ++
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEG----IPSTAIREISLLKEL 76
Query: 637 RHRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR 695
H ++V+L+ I+ L LV+E+M + L + L D T L Q + R
Sbjct: 77 HHPNIVSLID-VIHSERCLTLVFEFMEKD-LKKVL----DENKTGLQDSQIKIYLYQLLR 130
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL--VKNAPDGKYS--VETRLAGT 751
GV + H +HRDLKP N+LI D K+ADFGL P Y+ V T
Sbjct: 131 GVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLW--- 184
Query: 752 FGYLAPE 758
Y AP+
Sbjct: 185 --YRAPD 189
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 2e-22
Identities = 52/187 (27%), Positives = 88/187 (47%), Gaps = 25/187 (13%)
Query: 581 DNFSEANILGRGGFGVVY-GGELPDGTKIAVK--RMESNTMGNKGLSEFQA--EIAVLTK 635
+NF + +G G +GVVY G +A+K R+++ +G+ A EI++L +
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE---TEGVP-STAIREISLLKE 58
Query: 636 VRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR 695
+ H ++V LL ++ LV+E++ + L + + T + + + +
Sbjct: 59 LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQ 114
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL--VKNAPDGKYS--VETRLAGT 751
G+ + HS +HRDLKP N+LI + K+ADFGL P Y+ V T
Sbjct: 115 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW--- 168
Query: 752 FGYLAPE 758
Y APE
Sbjct: 169 --YRAPE 173
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-22
Identities = 47/188 (25%), Positives = 78/188 (41%), Gaps = 23/188 (12%)
Query: 578 QVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTK- 635
Q TD + +G G + V + AVK + +K + EI +L +
Sbjct: 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII------DKSKRDPTEEIEILLRY 72
Query: 636 VRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWKQRVTIALDVA 694
+H +++ L +G +V E M G L + + + ++ + +
Sbjct: 73 GQHPNIITLKDVYDDGKYVYVVTELMKGG----ELLDKILRQKF--FSEREASAVLFTIT 126
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILI----GDDMRAKVADFGLVKNAPDGKYSVETRLAG 750
+ VEYLH+ Q +HRDLKPSNIL G+ ++ DFG K + T
Sbjct: 127 KTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT-PCY 182
Query: 751 TFGYLAPE 758
T ++APE
Sbjct: 183 TANFVAPE 190
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 3e-22
Identities = 46/155 (29%), Positives = 72/155 (46%), Gaps = 10/155 (6%)
Query: 580 TDNFSEANILGRGGFGVVY-GGELPDGTKIAVKRME-SNTMGNKGLSEFQAEIAVLTKVR 637
FS+ +G G FG VY ++ + +A+K+M S N+ + E+ L K+R
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697
H + + G + LV EY G+ + L E H PL + + +G+
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASD-LLEVHK---KPLQEVEIAAVTHGALQGL 167
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732
YLHS + IHRD+K NIL+ + K+ DFG
Sbjct: 168 AYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFG 199
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 3e-22
Identities = 50/213 (23%), Positives = 85/213 (39%), Gaps = 23/213 (10%)
Query: 549 ELHSQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVY-GGELPDGTK 607
EL Q + + + + ++ + LG G GVV+ P G
Sbjct: 8 ELDEQQRKRLEAFLTQKQKVGELKDDDFEKI-------SELGAGNGGVVFKVSHKPSGLV 60
Query: 608 IAVK--RMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGT 665
+A K +E + E+ VL + ++V G + E + E+M G+
Sbjct: 61 MARKLIHLEIKPAIRNQI---IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 117
Query: 666 LAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR 725
L Q L + + +++ V +G+ YL + +HRD+KPSNIL+
Sbjct: 118 LDQVL-----KKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGE 170
Query: 726 AKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
K+ DFG+ D S+ GT Y++PE
Sbjct: 171 IKLCDFGVSGQLID---SMANSFVGTRSYMSPE 200
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-22
Identities = 60/245 (24%), Positives = 103/245 (42%), Gaps = 23/245 (9%)
Query: 523 PEVGNEMNKNGVTGGNGTNGYNGVPSELHSQSSGDVSDRHLFEGGNVAISIEVLRQVT-D 581
V + K V + L + F ++E+ +T +
Sbjct: 130 EHVQGHLVKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMN 189
Query: 582 NFSEANILGRGGFGVVYGGELPDGTKI-AVKRME-SNTMGNKGLSEFQAEIAVLTKV--- 636
+FS I+GRGGFG VYG D K+ A+K ++ +G + E +L+ V
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 249
Query: 637 RHRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTI-ALDVA 694
+V + Y + ++L + + M G L HL HG + + A ++
Sbjct: 250 DCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFS---EADMRFYAAEII 302
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR-LAGTFG 753
G+E++H+ ++RDLKP+NIL+ + +++D GL + K GT G
Sbjct: 303 LGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHG 355
Query: 754 YLAPE 758
Y+APE
Sbjct: 356 YMAPE 360
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 5e-22
Identities = 45/187 (24%), Positives = 85/187 (45%), Gaps = 26/187 (13%)
Query: 581 DNFSEANILGRGGFGVVY-GGELPDGTKIAVK--RMESNTMGNKGLSEFQA--EIAVLTK 635
+ + +G G +G V+ +A+K R++ + +G+ A EI +L +
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD---EGVP-SSALREICLLKE 57
Query: 636 VRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR 695
++H+++V L + + LV+E+ + L ++ D L + + + +
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYF----DSCNGDLDPEIVKSFLFQLLK 112
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL--VKNAPDGKYS--VETRLAGT 751
G+ + HS ++ +HRDLKP N+LI + K+A+FGL P YS V T
Sbjct: 113 GLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLW--- 166
Query: 752 FGYLAPE 758
Y P+
Sbjct: 167 --YRPPD 171
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 5e-22
Identities = 53/198 (26%), Positives = 79/198 (39%), Gaps = 42/198 (21%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQA----EIAVLTKVR----HR 639
LG+GGFG V+ G L D ++A+K + N + E+A+L KV H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR---- 695
++ LL + +LV E Q LF++ +T K + +R
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPA---QDLFDY-------ITEKGPLG--EGPSRCFFG 146
Query: 696 ----GVEYLHSLAQQSFIHRDLKPSNILI-GDDMRAKVADFGLVKNAPDGKYSVETRLAG 750
+++ HS + +HRD+K NILI AK+ DFG D Y+ G
Sbjct: 147 QVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD---FDG 200
Query: 751 TFGYLAPE------YAGK 762
T Y PE Y
Sbjct: 201 TRVYSPPEWISRHQYHAL 218
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 6e-22
Identities = 52/184 (28%), Positives = 84/184 (45%), Gaps = 17/184 (9%)
Query: 581 DNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTK-VRH 638
D+ LGRG +GVV +P G +AVKR+ + T+ ++ ++ + + V
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRA-TVNSQEQKRLLMDLDISMRTVDC 65
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
V G + + E M +L + + D G + IA+ + + +E
Sbjct: 66 PFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKG-QTIPEDILGKIAVSIVKALE 123
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG----LVKNAPDGKYSVETRLAGTFGY 754
+LHS + S IHRD+KPSN+LI + K+ DFG LV + + AG Y
Sbjct: 124 HLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD------VAKDIDAGCKPY 175
Query: 755 LAPE 758
+APE
Sbjct: 176 MAPE 179
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 8e-22
Identities = 45/182 (24%), Positives = 73/182 (40%), Gaps = 21/182 (11%)
Query: 588 ILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALL 645
+LG G V L + AVK +E + S E+ +L + + HR+++ L+
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR--SRVFREVEMLYQCQGHRNVLELI 77
Query: 646 GYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQ 705
+ LV+E M G++ H+ H + + + DVA +++LH+
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSILSHI---HKRRH--FNELEASVVVQDVASALDFLHN--- 129
Query: 706 QSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGKYSVETR------LAGTFGYLA 756
+ HRDLKP NIL K+ DF L G+ Y+A
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 757 PE 758
PE
Sbjct: 190 PE 191
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 9e-22
Identities = 38/212 (17%), Positives = 84/212 (39%), Gaps = 20/212 (9%)
Query: 86 ISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145
+ + + + ++ + S+ I +N++ SV L N+ L L+
Sbjct: 20 DDAFAETIKDNLKKKSVTD-AVTQNELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLN 76
Query: 146 DNP--NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSL 203
N ++ P L +L L++D + L L++L L +N + +
Sbjct: 77 GNKLTDIKP------LANLKNLGWLFLDENKVKDL--SSLKDLKKLKSLSLEHNGIS-DI 127
Query: 204 PASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDL 263
+++L++ + ++ + VLS +T+L + L NQ + I L+ L +L
Sbjct: 128 NGLVHLPQLESLYLGNNKI---TDITVLSRLTKLDTLSLEDNQISD-IVPLAGLTKLQNL 183
Query: 264 SLRDNQLTGVVPASVISLPALLNISLQNNKLQ 295
L N ++ + + L L + L + +
Sbjct: 184 YLSKNHISDLRA--LAGLKNLDVLELFSQECL 213
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 5e-20
Identities = 45/240 (18%), Positives = 82/240 (34%), Gaps = 42/240 (17%)
Query: 60 INCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIY 119
+ + N + I S + ++ I L + L N + I LAN +L ++
Sbjct: 40 VTQNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLT-DIKPLANLKNLGWLF 96
Query: 120 LDNNNFTSVPTGCFDGLTNLQVLSLSDNP--NLAPWPFPNELTKSTSLTTLYMDNANIFG 177
LD N + + L L+ LSL N ++ L L +LY+ N I
Sbjct: 97 LDENKVKDLSS--LKDLKKLKSLSLEHNGISDING------LVHLPQLESLYLGNNKITD 148
Query: 178 LIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQL 237
+ + L L L N + + L+G+T+L
Sbjct: 149 I--TVLSRLTKLDTLSLEDNQIS--------------------------DIVPLAGLTKL 180
Query: 238 RQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGP 297
+ ++L KN + + L+ ++L L L + +L + + L P
Sbjct: 181 QNLYLSKNHISD-LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTP 239
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 46/312 (14%), Positives = 98/312 (31%), Gaps = 82/312 (26%)
Query: 117 DIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIF 176
+ + + D +L ++ NEL + + +N++I
Sbjct: 6 ETITVPTPIKQIFS--DDAFAETIKDNLKKK-SVTDAVTQNELNS---IDQIIANNSDIK 59
Query: 177 GLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQ 236
+ N+ L L+ N T DI+ L + +
Sbjct: 60 SV--QGIQYLPNVTKLFLNGNKLT----------DIKPL----------------ANLKN 91
Query: 237 LRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG 296
L ++L +N+ + L + L LSL N ++ + LP L ++ L NNK+
Sbjct: 92 LGWLFLDENKVKD-LSSLKDLKKLKSLSLEHNGISDINGLV--HLPQLESLYLGNNKITD 148
Query: 297 PYPLFP-SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNA 355
L +K+ +SL+ N Q++ +
Sbjct: 149 ITVLSRLTKLDTLSLEDN---------------QISDI---------------------- 171
Query: 356 CDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLA 415
P ++ + + L+ ++ ++ A L +L L L + + L
Sbjct: 172 ---VPLAGLTK--LQNLYLSKNHIS-DLRAL-AGLKNLDVLELFSQECLNKPINHQSNLV 224
Query: 416 SLQNLDVSNNNL 427
+ ++ +L
Sbjct: 225 VPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 44/264 (16%), Positives = 86/264 (32%), Gaps = 78/264 (29%)
Query: 166 TTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLS 225
+ I + D D+F+ L + T
Sbjct: 5 SETITVPTPIKQIFSD--DAFAETIKDNLKKKSVT------------------------- 37
Query: 226 GTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALL 285
+ + + Q+ + + + + ++ L L N+LT + P + +L L
Sbjct: 38 -DAVTQNELNSIDQIIANNSDIKS-VQGIQYLPNVTKLFLNGNKLTDIKPLA--NLKNLG 93
Query: 286 NISLQNNKLQGPYPLFP-SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPA 344
+ L NK++ L K++ +SL+HN ++ +
Sbjct: 94 WLFLDENKVKDLSSLKDLKKLKSLSLEHN---------------GISDI----------- 127
Query: 345 ILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLT 404
V Q + ++ L N + +I+ + LT L L L+ N ++
Sbjct: 128 --------------NGLVHLPQ--LESLYLGNNKIT-DITVL-SRLTKLDTLSLEDNQIS 169
Query: 405 GPIPDGLTKLASLQNLDVSNNNLS 428
L L LQNL +S N++S
Sbjct: 170 DI--VPLAGLTKLQNLYLSKNHIS 191
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 16/97 (16%), Positives = 36/97 (37%), Gaps = 13/97 (13%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNN 123
N+++ I ++ LT+L+ L N+I+ + +LA +L + L +
Sbjct: 164 EDNQISDIV------------PLAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELFSQ 210
Query: 124 NFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELT 160
+ P L + +D + P ++
Sbjct: 211 ECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGD 247
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 1e-21
Identities = 37/209 (17%), Positives = 68/209 (32%), Gaps = 30/209 (14%)
Query: 87 SSLTQLETLSFQMNNI-AGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145
+ + +F ++ + + + + NN T LT L+ L L
Sbjct: 297 EIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQ 356
Query: 146 DNPNLAPWPFPNELTKS-TSLTTLYMDNANI-FGLIPDFFDSFSNLQNLRLSYNNFTGSL 203
N L E+T SL L + ++ + +L +L +S N T ++
Sbjct: 357 MN-QLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTI 415
Query: 204 PASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDL 263
+++ + LH N+ + K E+L +L
Sbjct: 416 FRCL--------------------------PPRIKVLDLHSNKIKSIPKQVVKLEALQEL 449
Query: 264 SLRDNQLTGVVPASVISLPALLNISLQNN 292
++ NQL V L +L I L N
Sbjct: 450 NVASNQLKSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 6e-20
Identities = 55/360 (15%), Positives = 107/360 (29%), Gaps = 56/360 (15%)
Query: 86 ISSLTQLETLSFQMNNIAGAIPSLA--NATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLS 143
I SL++L L N I + L+ + L +N + NL+ L
Sbjct: 41 ILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHNKLVKIS---CHPTVNLKHLD 96
Query: 144 LSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQN-LRLSYNNFTGS 202
LS N P E + L L + ++ + + L L
Sbjct: 97 LSFNA-FDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKE 155
Query: 203 LPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLR------QVWLHKNQFTGPIPDLSK 256
P + ++L + + +S T + L N+ + + L+K
Sbjct: 156 DPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAK 215
Query: 257 CE--------SLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKV 308
+ +L ++ N ++ ++ + S+ N KLQG
Sbjct: 216 LQTNPKLSNLTLNNIETTWNSFIRIL--QLVWHTTVWYFSISNVKLQGQLDFRDFDYSGT 273
Query: 309 SLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGR 368
SL + + SD + Y + + + T S R
Sbjct: 274 SLKALSIHQVVSD-----------VFGFPQSYIYEIFSNMNIKN---------FTVSGTR 313
Query: 369 IITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428
++ + + ++ +L N LT + + L L+ L + N L
Sbjct: 314 MVHM------------LCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK 361
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 6e-20
Identities = 57/373 (15%), Positives = 116/373 (31%), Gaps = 49/373 (13%)
Query: 88 SLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVP-TGCFDGLTNLQVLSLSD 146
+LE L N + I +L+ + L N F ++P F ++ L+ L LS
Sbjct: 67 FNQELEYLDLSHNKLV-KISC-HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLST 124
Query: 147 NPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPAS 206
+L + L + + + L T
Sbjct: 125 T-HLEKSSV-LPIAHLNISKVLLVLGETYGEKED--PEGLQDFNTESLHIVFPTNKEFHF 180
Query: 207 FAK-----------SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGP----I 251
S+I+ + +++ L L +L + L+ + T I
Sbjct: 181 ILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRI 240
Query: 252 PDLSKCESLFDLSLRDNQLTGVVPASVI-----SLPALLNISLQNNKLQGPYP---LFPS 303
L +++ S+ + +L G + SL AL + ++ P S
Sbjct: 241 LQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFS 300
Query: 304 KVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVT 363
+ + + C +++ L + D + C +
Sbjct: 301 NMNIKNFTVSGTRMVHM----LCPSKISPFLHL--DFSNNLLTDTV---FENCGHLTELE 351
Query: 364 CSQGRIITINLANKLLA--GNISPAYANLTSLKNLYLQQNNLTGPIPDGL-TKLASLQNL 420
T+ L L I+ + SL+ L + QN+++ G + SL +L
Sbjct: 352 -------TLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSL 404
Query: 421 DVSNNNLSGKVPD 433
++S+N L+ +
Sbjct: 405 NMSSNILTDTIFR 417
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 1e-19
Identities = 47/325 (14%), Positives = 112/325 (34%), Gaps = 17/325 (5%)
Query: 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172
+ + N + + T L+ L++L +S N + + + L L + +
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHN-RIQYLD-ISVFKFNQELEYLDLSH 78
Query: 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLP--ASFAK-SDIQNLWMNDQQLGLSGTLD 229
N I NL++L LS+N F +LP F S ++ L ++ L ++
Sbjct: 79 -NKLVKIS--CHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHL-EKSSVL 133
Query: 230 VLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISL 289
++ + +V L + G D + SL T ++ + +L
Sbjct: 134 PIAHLNIS-KVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANL 192
Query: 290 QNNKLQG-PYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAI--- 345
+ + ++ S + K S+ + + ++I + + +
Sbjct: 193 ELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYF 252
Query: 346 -LSDSWEGNNACDGWPFVTCSQGRIITI-NLANKLLAGNISPAYANLTSLKNLYLQQNNL 403
+S+ + + + ++I + + + S Y +++ +
Sbjct: 253 SISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGT 312
Query: 404 TGPIPDGLTKLASLQNLDVSNNNLS 428
+K++ +LD SNN L+
Sbjct: 313 RMVHMLCPSKISPFLHLDFSNNLLT 337
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 2e-16
Identities = 55/396 (13%), Positives = 117/396 (29%), Gaps = 58/396 (14%)
Query: 63 DNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP--SLAN--ATSLQDI 118
N +++ + L+ + L + I+ L + L L + SL +
Sbjct: 112 GNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIV 171
Query: 119 YLDNNNFTSVPTGCFDGLTNLQVLSLSDNP---------NLAPWPFPNELTKSTSLTTLY 169
+ N F + + NL++ ++ ++ N + +L +
Sbjct: 172 FPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIE 231
Query: 170 MDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKS--------DIQNLWMNDQQ 221
+ ++ + + +S G L I + +
Sbjct: 232 TTWNSFIRILQ--LVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFG 289
Query: 222 LGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISL 281
S ++ S M + + + SK L +N LT V + L
Sbjct: 290 FPQSYIYEIFSNMNIKN-FTVSGTRMV-HMLCPSKISPFLHLDFSNNLLTDTVFENCGHL 347
Query: 282 PALLNISLQNNKLQGPYPLF-----PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQI 336
L + LQ N+L+ + +Q++ + N+ + + +L
Sbjct: 348 TELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSL--- 404
Query: 337 AGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGN----ISPAYANLTS 392
+M + + + + L N I L +
Sbjct: 405 --NMSSNILTDTIFRC-----------------LPPRIKVLDLHSNKIKSIPKQVVKLEA 445
Query: 393 LKNLYLQQNNLTGPIPDG-LTKLASLQNLDVSNNNL 427
L+ L + N L +PDG +L SLQ + + N
Sbjct: 446 LQELNVASNQLKS-VPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 2e-14
Identities = 31/162 (19%), Positives = 59/162 (36%), Gaps = 25/162 (15%)
Query: 62 CDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANA----TSLQD 117
+ + + + L+ T+ LT+LETL QMN + + +A SLQ
Sbjct: 320 PSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQ 378
Query: 118 IYLDNNNFTSV-PTGCFDGLTNLQVLSLSDN--PNLAPWPFPNELT-------------- 160
+ + N+ + G +L L++S N + P +
Sbjct: 379 LDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIKSIPK 438
Query: 161 ---KSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNF 199
K +L L + + + + FD ++LQ + L N +
Sbjct: 439 QVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 7e-08
Identities = 22/88 (25%), Positives = 45/88 (51%), Gaps = 2/88 (2%)
Query: 61 NCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYL 120
+C + + +++++ + L+ T+ + +++ L N I + +LQ++ +
Sbjct: 394 DCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIKSIPKQVVKLEALQELNV 451
Query: 121 DNNNFTSVPTGCFDGLTNLQVLSLSDNP 148
+N SVP G FD LT+LQ + L NP
Sbjct: 452 ASNQLKSVPDGIFDRLTSLQKIWLHTNP 479
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 50/209 (23%), Positives = 83/209 (39%), Gaps = 19/209 (9%)
Query: 552 SQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVY-GGELPDGTKIAV 610
S SSG + G I ++ +G G G V+ G IAV
Sbjct: 3 SGSSGKQTGYLTIGGQRYQAEI-------NDLENLGEMGSGTCGQVWKMRFRKTGHVIAV 55
Query: 611 KRMESNTMGNKGLSEFQAEIAVLTK-VRHRHLVALLGYCINGSERLLVYEYMPRGTLAQH 669
K+M + + ++ V+ K ++V G I ++ + E M
Sbjct: 56 KQMRRSG-NKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAE--- 111
Query: 670 LFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVA 729
+ G P+ + + + + + + YL + IHRD+KPSNIL+ + + K+
Sbjct: 112 KLKKRMQG--PIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLC 167
Query: 730 DFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
DFG+ D K + R AG Y+APE
Sbjct: 168 DFGISGRLVDDK--AKDRSAGCAAYMAPE 194
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 46/190 (24%), Positives = 74/190 (38%), Gaps = 29/190 (15%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKI-AVKRME-SNTMGNKGLSEFQAEIAVLTKVRH 638
++F ILG G F V ++ A+K +E + + + E V++++ H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 639 RHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR-- 695
V L + E+L Y G L +++ ++ + R
Sbjct: 90 PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-------------RKIGSFDETCTRFY 135
Query: 696 ------GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR-L 748
+EYLH IHRDLKP NIL+ +DM ++ DFG K
Sbjct: 136 TAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 192
Query: 749 AGTFGYLAPE 758
GT Y++PE
Sbjct: 193 VGTAQYVSPE 202
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 98.5 bits (245), Expect = 2e-21
Identities = 45/237 (18%), Positives = 81/237 (34%), Gaps = 33/237 (13%)
Query: 84 PEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLS 143
+ + Q L N++ ++P + + + N S+P + +L+ L
Sbjct: 53 LKECLINQFSELQLNRLNLS-SLPD-NLPPQITVLEITQNALISLP----ELPASLEYLD 106
Query: 144 LSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSL 203
DN L+ P SL L +DN N ++P+ + L+ + N T L
Sbjct: 107 ACDN-RLST--LPELPA---SLKHLDVDN-NQLTMLPE---LPALLEYINADNNQLT-ML 155
Query: 204 PASFAKSDIQNLWMNDQQLGLSG-TLDVL-SGMTQLRQVWLHKNQFTG-P--IPDLSKCE 258
P +L + L + L L L + + N P E
Sbjct: 156 PEL-----PTSL----EVLSVRNNQLTFLPELPESLEALDVSTNLLESLPAVPVRNHHSE 206
Query: 259 SL-FDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNN 314
R+N++T +P +++SL I L++N L S+ H
Sbjct: 207 ETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGP 262
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 84.3 bits (208), Expect = 5e-17
Identities = 57/344 (16%), Positives = 108/344 (31%), Gaps = 88/344 (25%)
Query: 85 EISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144
+S + T+S + A + N S+ C + L L
Sbjct: 12 SLSQNSFYNTISGTYADYFSAWDKW---EKQALPGENRNEAVSLLKECL--INQFSELQL 66
Query: 145 SDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLP 204
+ NL+ P+ L +T L + N +P+ ++L+ L N + +LP
Sbjct: 67 NRL-NLSS--LPDNLPPQ--ITVLEITQ-NALISLPE---LPASLEYLDACDNRLS-TLP 116
Query: 205 ASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLS 264
L+ + + NQ T +P+L L ++
Sbjct: 117 ELP---------------------------ASLKHLDVDNNQLTM-LPEL--PALLEYIN 146
Query: 265 LRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGK 324
+NQLT ++P SL L S++NN+L P P ++ + + N
Sbjct: 147 ADNNQLT-MLPELPTSLEVL---SVRNNQLTFL-PELPESLEALDVSTN----------- 190
Query: 325 PCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNIS 384
+ +L PA+ S+ I + +I
Sbjct: 191 ----LLESL---------PAVPVR-------------NHHSEETEIFFRCRENRIT-HIP 223
Query: 385 PAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428
+L + L+ N L+ I + L++ + + S
Sbjct: 224 ENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFS 267
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 80.4 bits (198), Expect = 7e-16
Identities = 45/239 (18%), Positives = 89/239 (37%), Gaps = 41/239 (17%)
Query: 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNF 125
N+ + + L + LS +L + Q+ L N + ++P L SL+ + +N
Sbjct: 59 NQFSELQLNRLNLS-SLPDNL--PPQITVLEITQNAL-ISLPELP--ASLEYLDACDNRL 112
Query: 126 TSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDS 185
+++P + +L+ L + +N L P L + DN N ++P+
Sbjct: 113 STLP----ELPASLKHLDVDNN-QLTM--LPELPA---LLEYINADN-NQLTMLPE---L 158
Query: 186 FSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTL-----DVLSGMTQLRQV 240
++L+ L + N T LP ++L + L +S L V +
Sbjct: 159 PTSLEVLSVRNNQLT-FLPEL-----PESL----EALDVSTNLLESLPAVPVRNHHSEET 208
Query: 241 ----WLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKL 294
+N+ T IP+ + + + L DN L+ + S+ A +
Sbjct: 209 EIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF 266
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 78.5 bits (193), Expect = 3e-15
Identities = 47/297 (15%), Positives = 98/297 (32%), Gaps = 67/297 (22%)
Query: 136 LTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLS 195
+L S + + + + K + L+ + + L+L+
Sbjct: 10 NFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQLN 67
Query: 196 YNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLS 255
N + SLP + I L + L + L + N+ + +P+L
Sbjct: 68 RLNLS-SLPDNLPPQ-ITVLEITQNALI-----SLPELPASLEYLDACDNRLST-LPEL- 118
Query: 256 KCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNF 315
SL L + +NQLT ++P L + + NN+L P P+ ++ +S+ +N
Sbjct: 119 -PASLKHLDVDNNQLT-MLPELPALLEYI---NADNNQLTM-LPELPTSLEVLSVRNN-- 170
Query: 316 CKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLA 375
Q+T L P + + ++++
Sbjct: 171 -------------QLTFL---------PELP--------------------ESLEALDVS 188
Query: 376 NKLLAGNISPAYANLTSLKN----LYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428
LL ++ + ++N +T IP+ + L + + +N LS
Sbjct: 189 TNLLE-SLPAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLS 243
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 2e-21
Identities = 52/188 (27%), Positives = 79/188 (42%), Gaps = 28/188 (14%)
Query: 581 DNFSEANILGRGGFGVVY-GGELPDGTKIAVK--RMESNTMGNKGLSEFQA--EIAVLTK 635
+ + + +G G +GVV+ G +A+K + + A EI +L +
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPV----IKKIALREIRMLKQ 58
Query: 636 VRHRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVA 694
++H +LV LL RL LV+EY T+ L + + G K +I
Sbjct: 59 LKHPNLVNLLE-VFRRKRRLHLVFEYCDH-TVLHEL-DRYQRGVPEHLVK---SITWQTL 112
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL--VKNAPDGKYS--VETRLAG 750
+ V + H + IHRD+KP NILI K+ DFG + P Y V TR
Sbjct: 113 QAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRW-- 167
Query: 751 TFGYLAPE 758
Y +PE
Sbjct: 168 ---YRSPE 172
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 48/184 (26%), Positives = 76/184 (41%), Gaps = 11/184 (5%)
Query: 579 VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR 637
+ D F LG G FG V+ E G + +K + + + + +AEI VL +
Sbjct: 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP-MEQIEAEIEVLKSLD 78
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697
H +++ + + +V E G L + + G L+ + + +
Sbjct: 79 HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKA-LSEGYVAELMKQMMNAL 137
Query: 698 EYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGY 754
Y HS Q +H+DLKP NIL K+ DFGL + + T AGT Y
Sbjct: 138 AYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE--HSTNAAGTALY 192
Query: 755 LAPE 758
+APE
Sbjct: 193 MAPE 196
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 3e-21
Identities = 48/235 (20%), Positives = 79/235 (33%), Gaps = 47/235 (20%)
Query: 568 NVAISIEVLRQVTDNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEF 626
N+ L ++ + +G+G +GVV E A+K M N + +
Sbjct: 13 NLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDV 72
Query: 627 QA---EIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTL----------------- 666
+ E+ ++ K+ H ++ L + LV E G L
Sbjct: 73 ERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAM 132
Query: 667 ------------------AQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSF 708
+ + + K I + + YLH+ Q
Sbjct: 133 DVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGI 189
Query: 709 IHRDLKPSNILIGDDMRA--KVADFGL---VKNAPDGKYSVETRLAGTFGYLAPE 758
HRD+KP N L + K+ DFGL +G+Y T AGT ++APE
Sbjct: 190 CHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE 244
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 3e-21
Identities = 52/187 (27%), Positives = 78/187 (41%), Gaps = 26/187 (13%)
Query: 581 DNFSEANILGRGGFGVVY-GGELPDGTKIAVK--RMESNTMGNKGLSEFQA--EIAVLTK 635
+ + ++G G +G+V G +A+K + K A EI +L +
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVK----KIAMREIKLLKQ 80
Query: 636 VRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR 695
+RH +LV LL C LV+E++ T+ L E +G + +
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDL-ELFPNGLDYQVVQ---KYLFQIIN 135
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL--VKNAPDGKYS--VETRLAGT 751
G+ + HS + IHRD+KP NIL+ K+ DFG AP Y V TR
Sbjct: 136 GIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRW--- 189
Query: 752 FGYLAPE 758
Y APE
Sbjct: 190 --YRAPE 194
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 4e-21
Identities = 47/203 (23%), Positives = 74/203 (36%), Gaps = 29/203 (14%)
Query: 575 VLRQVTDNFSEA----NILGRGGFGVVYGG-ELPDGTKIAVK-----------RMESNTM 618
+R+ E+ LG G +G V E ++ A+K + N
Sbjct: 26 YVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKN 85
Query: 619 GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGY 678
K E EI++L + H +++ L + LV E+ G L + +
Sbjct: 86 IEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN---RHK 142
Query: 679 TPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVK 735
I + G+ YLH + +HRD+KP NIL+ + K+ DFGL
Sbjct: 143 --FDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSS 197
Query: 736 NAPDGKYSVETRLAGTFGYLAPE 758
GT Y+APE
Sbjct: 198 FFSKDY--KLRDRLGTAYYIAPE 218
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 4e-21
Identities = 42/176 (23%), Positives = 67/176 (38%), Gaps = 19/176 (10%)
Query: 588 ILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALL 645
LG G F + AVK + + + Q EI L H ++V L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVK-----IISKRMEANTQKEITALKLCEGHPNIVKLH 72
Query: 646 GYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQ 705
+ LV E + G L + + + + + + I + V ++H
Sbjct: 73 EVFHDQLHTFLVMELLNGGELFERIKK---KKH--FSETEASYIMRKLVSAVSHMHD--- 124
Query: 706 QSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
+HRDLKP N+L D++ K+ DFG + P ++T T Y APE
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP-CFTLHYAAPE 179
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 5e-21
Identities = 54/187 (28%), Positives = 88/187 (47%), Gaps = 27/187 (14%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVK--RMESNTMGNKGLSEFQA--EIAVLTKV 636
+ + +G G +GVVY + G A+K R+E +G+ EI++L ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED---EGIP-STTIREISILKEL 57
Query: 637 RHRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR 695
+H ++V L I+ +RL LV+E++ + L + L D L + L +
Sbjct: 58 KHSNIVKLYD-VIHTKKRLVLVFEHLDQD-LKKLL----DVCEGGLESVTAKSFLLQLLN 111
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL--VKNAPDGKYS--VETRLAGT 751
G+ Y H + +HRDLKP N+LI + K+ADFGL P KY+ + T
Sbjct: 112 GIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLW--- 165
Query: 752 FGYLAPE 758
Y AP+
Sbjct: 166 --YRAPD 170
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 6e-21
Identities = 49/191 (25%), Positives = 81/191 (42%), Gaps = 30/191 (15%)
Query: 581 DNFSEANILGRGGFGVVY-GGELPDGTKIAVK--RMESNTMGNKGLSEFQA--EIAVLTK 635
F + LG G + VY G G +A+K +++S +G A EI+++ +
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE----EGTP-STAIREISLMKE 59
Query: 636 VRHRHLVALLGYCINGSERL-LVYEYMP---RGTLAQHLFEWHDHGYTPLTWKQRVTIAL 691
++H ++V L I+ +L LV+E+M + + G K
Sbjct: 60 LKHENIVRLYD-VIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVK---YFQW 115
Query: 692 DVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL--VKNAPDGKYS--VETR 747
+ +G+ + H +HRDLKP N+LI + K+ DFGL P +S V T
Sbjct: 116 QLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTL 172
Query: 748 LAGTFGYLAPE 758
Y AP+
Sbjct: 173 W-----YRAPD 178
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 6e-21
Identities = 45/170 (26%), Positives = 73/170 (42%), Gaps = 17/170 (10%)
Query: 571 ISIEVLRQVTDNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQAE 629
I + LR F ++G G +G VY G + G A+K M+ + E + E
Sbjct: 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQE 70
Query: 630 IAVLTKV-RHRHLVALLGYCINGSERL------LVYEYMPRGTLAQHLFEWHDHGYTPLT 682
I +L K HR++ G I + LV E+ G++ L + L
Sbjct: 71 INMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGN--TLK 127
Query: 683 WKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732
+ I ++ RG+ +LH IHRD+K N+L+ ++ K+ DFG
Sbjct: 128 EEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFG 174
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 6e-21
Identities = 43/196 (21%), Positives = 78/196 (39%), Gaps = 40/196 (20%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQA--EIAVLTKVRHRHLVALL 645
LG G +G V + AVK ++ + E EI +L ++RH++++ L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 646 GYCINGSER--LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR-------- 695
N ++ +V EY G Q + + R + A
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGM--QEMLDSVPEK--------RFPV--CQAHGYFCQLID 120
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLA---GTF 752
G+EYLHS Q +H+D+KP N+L+ K++ G+ A ++ + G+
Sbjct: 121 GLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVA-EALH-PFAADDTCRTSQGSP 175
Query: 753 GYLAPE-------YAG 761
+ PE ++G
Sbjct: 176 AFQPPEIANGLDTFSG 191
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 7e-21
Identities = 52/187 (27%), Positives = 82/187 (43%), Gaps = 27/187 (14%)
Query: 581 DNFSEANILGRGGFGVVYGGELPD-GTKIAVK--RMESNTMGNKGLSEFQA--EIAVLTK 635
+ + + + LG G + VY G+ +A+K R+E +G A E+++L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE----EGAP-CTAIREVSLLKD 56
Query: 636 VRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR 695
++H ++V L LV+EY+ + L Q+L D + + R
Sbjct: 57 LKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYL----DDCGNIINMHNVKLFLFQLLR 111
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL--VKNAPDGKYS--VETRLAGT 751
G+ Y H Q +HRDLKP N+LI + K+ADFGL K+ P Y V T
Sbjct: 112 GLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLW--- 165
Query: 752 FGYLAPE 758
Y P+
Sbjct: 166 --YRPPD 170
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 1e-20
Identities = 47/189 (24%), Positives = 72/189 (38%), Gaps = 29/189 (15%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKI-AVKRMESNTMGNKGLSE-FQAEIAVLTKVRH 638
+++ ++GRG FG V K+ A+K + M + S F E ++
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 639 RHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR-- 695
+V L Y L +V EYMP G L + + AR
Sbjct: 129 PWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM--------------SNYDVPEKWARFY 173
Query: 696 ------GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLA 749
++ +HS+ FIHRD+KP N+L+ K+ADFG
Sbjct: 174 TAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 230
Query: 750 GTFGYLAPE 758
GT Y++PE
Sbjct: 231 GTPDYISPE 239
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 1e-20
Identities = 63/360 (17%), Positives = 118/360 (32%), Gaps = 42/360 (11%)
Query: 90 TQLETLSFQMNNI----AGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145
+ + LS N+I I L + L+ + L +N S+ F +L+ L +S
Sbjct: 52 PRTKALSLSQNSISELRMPDISFL---SELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVS 108
Query: 146 DNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPD--FFDSFSNLQNLRLSYNNFTGSL 203
N L SL L + N F ++P F + + L L LS F
Sbjct: 109 HN-RLQNISC----CPMASLRHLDLSF-NDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLD 162
Query: 204 PASFAKSDIQNLWMNDQQLGLS-GTLDVLSGM-TQLRQVWLHKNQFTGPIPDLSKCESLF 261
A + + ++ + G + L T + + H N ++S +L
Sbjct: 163 LLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVN-ALG 221
Query: 262 DLSLRDNQLTGVVPASVISL-------PALLNISLQNNKLQGPY------PLFPSKVQKV 308
L L + +L +++ P LLN++LQ+ + +P V+ +
Sbjct: 222 HLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYL 281
Query: 309 SLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGR 368
++ + + L I + L + +
Sbjct: 282 NIYNLTITERIDREEFTYSETALKSLMIE-HVKNQVFLFSK---EALYSVFAEMNIKM-- 335
Query: 369 IITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428
++I+ + + +S L QN T + G + L LQ L + N L
Sbjct: 336 -LSISDTPFIHMVCPP----SPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK 390
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 7e-20
Identities = 61/396 (15%), Positives = 119/396 (30%), Gaps = 64/396 (16%)
Query: 88 SLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVP-TGCFDGLTNLQVLSLSD 146
LE L N + I SL+ + L N+F +P F LT L L LS
Sbjct: 98 FNQDLEYLDVSHNRLQ-NISC-CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSA 155
Query: 147 N------------------------PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDF 182
++ + +T++ L ++F +
Sbjct: 156 AKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQ--V 213
Query: 183 FDSFSNLQNLRLSYNN--------FTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGM 234
S + L +L+LS L + N+ + + ++ +
Sbjct: 214 NMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFF 273
Query: 235 --TQLRQVWLHKNQFTGPIP------DLSKCESLFDLSLRDNQLTGVVPASVISLPALLN 286
+ + ++ T I + +SL +++ A +
Sbjct: 274 WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNI 333
Query: 287 ISLQNNKLQG---PYPLFPSKVQKVSLDHNNFCKNSSDAGKPCD--PQVTTL------LQ 335
L + P PS ++ N F + C ++ TL L+
Sbjct: 334 KMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQG---CSTLKRLQTLILQRNGLK 390
Query: 336 -IAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNI--SPAYANLT- 391
+S + + + + ++ L+ N+ + L
Sbjct: 391 NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPP 450
Query: 392 SLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNL 427
+K L L N + IP +T L +LQ L+V++N L
Sbjct: 451 KVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQL 485
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 1e-15
Identities = 34/213 (15%), Positives = 65/213 (30%), Gaps = 38/213 (17%)
Query: 87 SSLTQLETLSFQMNNIAGAIPSLA--NATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144
S ++ +++ I + + +S + N FT L LQ L L
Sbjct: 326 SVFAEMNIKMLSISDT-PFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLIL 384
Query: 145 SDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLP 204
N L N+ +L +
Sbjct: 385 QRN----------------GLKNF-----------FKVALMTKNMSSLETLDVSLNSLNS 417
Query: 205 ASFAK-----SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCES 259
++ + I L ++ L L +++ + LH N+ D++ ++
Sbjct: 418 HAYDRTCAWAESILVLNLSSNML-TGSVFRCLP--PKVKVLDLHNNRIMSIPKDVTHLQA 474
Query: 260 LFDLSLRDNQLTGVVPASVISLPALLNISLQNN 292
L +L++ NQL V L +L I L +N
Sbjct: 475 LQELNVASNQLKSVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 22/60 (36%), Positives = 35/60 (58%), Gaps = 2/60 (3%)
Query: 90 TQLETLSFQMNNIAGAIPS-LANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNP 148
+++ L N I +IP + + +LQ++ + +N SVP G FD LT+LQ + L DNP
Sbjct: 450 PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNP 508
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 95.6 bits (237), Expect = 1e-20
Identities = 55/272 (20%), Positives = 95/272 (34%), Gaps = 44/272 (16%)
Query: 86 ISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145
+ + + + ++ + S+ I +N++ SV L N+ L L+
Sbjct: 17 DDAFAETIKDNLKKKSVTD-AVTQNELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLN 73
Query: 146 DNP--NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSL 203
N ++ P LT +L L++D I L L++L L +N +
Sbjct: 74 GNKLTDIKP------LTNLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGIS--- 122
Query: 204 PASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDL 263
DI L + QL ++L N+ T I LS+ L L
Sbjct: 123 -------DINGL----------------VHLPQLESLYLGNNKITD-ITVLSRLTKLDTL 158
Query: 264 SLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFP-SKVQKVSLDHNNFCKNSSDA 322
SL DNQ++ +VP + L L N+ L N + L + + L +
Sbjct: 159 SLEDNQISDIVP--LAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFSQECLNKPINH 216
Query: 323 GKPCDPQVTTLLQIAGDMGYPAILSDSWEGNN 354
T+ G + P I+SD +
Sbjct: 217 QSNL-VVPNTVKNTDGSLVTPEIISDDGDYEK 247
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 73.6 bits (180), Expect = 1e-13
Identities = 47/314 (14%), Positives = 103/314 (32%), Gaps = 82/314 (26%)
Query: 115 LQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNAN 174
+ + + + D +L ++ NEL + + +N++
Sbjct: 1 MGETITVSTPIKQIFP--DDAFAETIKDNLKKK-SVTDAVTQNELNS---IDQIIANNSD 54
Query: 175 IFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGM 234
I + N+ L L+ N T DI+ L + +
Sbjct: 55 IKSV--QGIQYLPNVTKLFLNGNKLT----------DIKPL----------------TNL 86
Query: 235 TQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKL 294
L ++L +N+ + L + L LSL N ++ + ++ LP L ++ L NNK+
Sbjct: 87 KNLGWLFLDENKIKD-LSSLKDLKKLKSLSLEHNGISDING--LVHLPQLESLYLGNNKI 143
Query: 295 QGPYPLFP-SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGN 353
L +K+ +SL+ N Q++ ++ +AG
Sbjct: 144 TDITVLSRLTKLDTLSLEDN---------------QISDIVPLAG--------------- 173
Query: 354 NACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTK 413
++ + L+ ++ ++ A L +L L L + +
Sbjct: 174 ------------LTKLQNLYLSKNHIS-DLRAL-AGLKNLDVLELFSQECLNKPINHQSN 219
Query: 414 LASLQNLDVSNNNL 427
L + ++ +L
Sbjct: 220 LVVPNTVKNTDGSL 233
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 65.1 bits (158), Expect = 5e-11
Identities = 28/138 (20%), Positives = 49/138 (35%), Gaps = 23/138 (16%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNN 123
N ++ I+ + L QLE+L N I I L+ T L + L++N
Sbjct: 117 EHNGISDIN------------GLVHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDN 163
Query: 124 NFTSVPTGCFDGLTNLQVLSLSDNP--NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPD 181
+ + GLT LQ L LS N +L L +L L + + +
Sbjct: 164 QISDIV--PLAGLTKLQNLYLSKNHISDLRA------LAGLKNLDVLELFSQECLNKPIN 215
Query: 182 FFDSFSNLQNLRLSYNNF 199
+ ++ + +
Sbjct: 216 HQSNLVVPNTVKNTDGSL 233
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 60.1 bits (145), Expect = 2e-09
Identities = 45/265 (16%), Positives = 86/265 (32%), Gaps = 78/265 (29%)
Query: 165 LTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGL 224
+ + I + PD D+F+ L + T
Sbjct: 1 MGETITVSTPIKQIFPD--DAFAETIKDNLKKKSVT------------------------ 34
Query: 225 SGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPAL 284
+ + + Q+ + + + + ++ L L N+LT + P + +L L
Sbjct: 35 --DAVTQNELNSIDQIIANNSDIKS-VQGIQYLPNVTKLFLNGNKLTDIKPLT--NLKNL 89
Query: 285 LNISLQNNKLQGPYPLFP-SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYP 343
+ L NK++ L K++ +SL+HN +
Sbjct: 90 GWLFLDENKIKDLSSLKDLKKLKSLSLEHNGISDIN------------------------ 125
Query: 344 AILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNL 403
V Q + ++ L N + +I+ + LT L L L+ N +
Sbjct: 126 ----------------GLVHLPQ--LESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQI 165
Query: 404 TGPIPDGLTKLASLQNLDVSNNNLS 428
+ L L LQNL +S N++S
Sbjct: 166 SD--IVPLAGLTKLQNLYLSKNHIS 188
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 20/139 (14%), Positives = 48/139 (34%), Gaps = 22/139 (15%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNN 123
N+++ I ++ LT+L+ L N+I+ + +LA +L + L +
Sbjct: 161 EDNQISDIV------------PLAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFSQ 207
Query: 124 NFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFF 183
+ P L + +D + P ++ + N+ +P+F
Sbjct: 208 ECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGD---------YEKPNVKWHLPEFT 258
Query: 184 DSFSNLQNLRLSYNNFTGS 202
+ S + ++
Sbjct: 259 NEVSFIFYQPVTIGKAKAR 277
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 1e-20
Identities = 59/189 (31%), Positives = 83/189 (43%), Gaps = 34/189 (17%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSE-FQAEIAVLTKVRHRHLVALLG 646
LG G FG V GE G K+AVK + + + + + EI L RH H++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR--------GVE 698
++ +V EY+ G L ++ + RV AR V+
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICK-----------HGRVEE--MEARRLFQQILSAVD 125
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
Y H +HRDLKP N+L+ M AK+ADFGL DG++ + T G+ Y APE
Sbjct: 126 YCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRTS-CGSPNYAAPE 180
Query: 759 ------YAG 761
YAG
Sbjct: 181 VISGRLYAG 189
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-20
Identities = 50/189 (26%), Positives = 74/189 (39%), Gaps = 27/189 (14%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKI-AVKRMESNTMGNKGLSE-FQAEIAVLTKVRH 638
D+F ++GRG F V ++ ++ A+K M M +G F+ E VL
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 639 RHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR-- 695
R + L + L LV EY G L L K I ++AR
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLS------------KFGERIPAEMARFY 167
Query: 696 ------GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLA 749
++ +H L ++HRD+KP NIL+ ++ADFG
Sbjct: 168 LAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV 224
Query: 750 GTFGYLAPE 758
GT YL+PE
Sbjct: 225 GTPDYLSPE 233
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 2e-20
Identities = 46/184 (25%), Positives = 84/184 (45%), Gaps = 21/184 (11%)
Query: 589 LGRGGFGVVYGG---ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
+GRG +G VY + D A+K++E + E IA+L +++H ++++L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE----IALLRELKHPNVISLQ 84
Query: 646 GYCINGSERL--LVYEYMP---RGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYL 700
++ ++R L+++Y + H + L ++ + G+ YL
Sbjct: 85 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 701 HSLAQQSFIHRDLKPSNILIGDDMRA----KVADFGL--VKNAPDGKYSVETRLAGTFGY 754
H+ +HRDLKP+NIL+ + K+AD G + N+P + + TF Y
Sbjct: 145 HA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 201
Query: 755 LAPE 758
APE
Sbjct: 202 RAPE 205
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 3e-20
Identities = 54/210 (25%), Positives = 85/210 (40%), Gaps = 36/210 (17%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKI-AVKRMESNTMGNKGLSE-FQAEIAVLTKVRH 638
++F ++GRG FG V +L + K+ A+K + M + + F+ E VL
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 639 RHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR-- 695
+ + L Y L LV +Y G L L K + ++AR
Sbjct: 134 KWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLS------------KFEDRLPEEMARFY 180
Query: 696 ------GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK-NAPDGKYSVETRL 748
++ +H L ++HRD+KP NIL+ + ++ADFG DG
Sbjct: 181 LAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV-A 236
Query: 749 AGTFGYLAPEYAGKHWMILCQMTGLIWLHG 778
GT Y++PE IL M G +G
Sbjct: 237 VGTPDYISPE-------ILQAMEGGKGRYG 259
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 3e-20
Identities = 30/189 (15%), Positives = 69/189 (36%), Gaps = 9/189 (4%)
Query: 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172
+ ++ + G F G +L+ + +S N L + + L + ++
Sbjct: 30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIE-ADVFSNLPKLHEIRIEK 88
Query: 173 AN-IFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTL--D 229
AN + + P+ F + NLQ L +S LP +Q + ++ Q T+ +
Sbjct: 89 ANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERN 147
Query: 230 VLSGMT-QLRQVWLHKNQFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASVISLPALLN 286
G++ + +WL+KN I + + + +N L + +
Sbjct: 148 SFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVI 206
Query: 287 ISLQNNKLQ 295
+ + ++
Sbjct: 207 LDISRTRIH 215
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 8e-20
Identities = 53/313 (16%), Positives = 102/313 (32%), Gaps = 30/313 (9%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLA--NATSLQDIYLD 121
++ I G S LE + N++ I + N L +I ++
Sbjct: 38 VLTKLRVIQ------KGAFS----GFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87
Query: 122 N-NNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYM-DNANIFGLI 179
NN + F L NLQ L +S+ + P S L + DN NI +
Sbjct: 88 KANNLLYINPEAFQNLPNLQYLLISNT-GIKHLP-DVHKIHSLQKVLLDIQDNINIHTIE 145
Query: 180 PDFFDSFS-NLQNLRLSYNNFTGSLPASFAKSDIQNL-WMNDQQL-GLSGTLDVLSGMTQ 236
+ F S L L+ N ++F + + L ++ L L DV G +
Sbjct: 146 RNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPN--DVFHGASG 203
Query: 237 LRQVWLHKNQFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKL 294
+ + + + +P L + L S L + L AL+ SL
Sbjct: 204 PVILDISRTRIH-SLPSYGLENLKKLRARST--YNLKKLPTLE--KLVALMEASLTYPSH 258
Query: 295 QGPYPLFPSKVQKVSL--DHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEG 352
+ + ++ ++ + + + + + + ++ +
Sbjct: 259 CCAFANWRRQISELHPICNKSILRQEVDYMTQARGQRSSLAEDNESSYSRGFDMTYTEFD 318
Query: 353 NNACDGWPFVTCS 365
+ C+ VTCS
Sbjct: 319 YDLCNEVVDVTCS 331
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 52/195 (26%), Positives = 74/195 (37%), Gaps = 38/195 (19%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQA------EIAVLTKVRHRHL 641
LG G FG V+ ++ VK ++ + E EIA+L++V H ++
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 642 VALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR------ 695
+ +L N LV E G LF + + R+ +A
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSG---LDLFAF-------IDRHPRLDE--PLASYIFRQL 139
Query: 696 --GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFG 753
V YL + IHRD+K NI+I +D K+ DFG GK T GT
Sbjct: 140 VSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL-FYT-FCGTIE 194
Query: 754 YLAPE------YAGK 762
Y APE Y G
Sbjct: 195 YCAPEVLMGNPYRGP 209
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 4e-20
Identities = 53/224 (23%), Positives = 90/224 (40%), Gaps = 29/224 (12%)
Query: 547 PSELHSQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYGGEL-PDG 605
PS S D R ++++ ++G G FGVVY +L G
Sbjct: 20 PSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSG 79
Query: 606 TKIAVKRMESNTMGNKGLSEFQA-EIAVLTKVRHRHLVALLGYCINGSERL------LVY 658
+A+K++ + F+ E+ ++ K+ H ++V L + + E+ LV
Sbjct: 80 ELVAIKKVLQD-------KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 132
Query: 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNI 718
+Y+P T+ + + L + R + Y+HS HRD+KP N+
Sbjct: 133 DYVPE-TVYRVA-RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNL 187
Query: 719 LIGDDMRA-KVADFGLVKNAPDGKYSVE---TRLAGTFGYLAPE 758
L+ D K+ DFG K G+ +V +R Y APE
Sbjct: 188 LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPE 226
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 5e-20
Identities = 45/180 (25%), Positives = 69/180 (38%), Gaps = 25/180 (13%)
Query: 588 ILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALL 645
+LG G G V G K A+K + + + E+ + H+V +L
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-------ARQEVDHHWQASGGPHIVCIL 88
Query: 646 GYCINGSER----LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLH 701
N L++ E M G L + E D +T ++ I D+ +++LH
Sbjct: 89 DVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTE---REAAEIMRDIGTAIQFLH 145
Query: 702 SLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
S + HRD+KP N+L D K+ DFG K T Y+APE
Sbjct: 146 S---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL---QTPCYTPYYVAPE 199
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 5e-20
Identities = 49/209 (23%), Positives = 92/209 (44%), Gaps = 44/209 (21%)
Query: 569 VAISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQA 628
+A + Q ++ ++G G FGVV+ +L + ++A+K++ + F+
Sbjct: 28 LASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-------KRFKN 80
Query: 629 -EIAVLTKVRHRHLVALLGYCINGSERL------LVYEYMPRGTLAQHLFEWHDHGYTPL 681
E+ ++ V+H ++V L + + ++ LV EY+P T+ + H
Sbjct: 81 RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRAS----RH----- 130
Query: 682 TWKQRVTIALD--------VARGVEYLHSLAQQSFIHRDLKPSNILI-GDDMRAKVADFG 732
K + T+ + + R + Y+HS+ HRD+KP N+L+ K+ DFG
Sbjct: 131 YAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFG 187
Query: 733 LVKNAPDGKYSVE---TRLAGTFGYLAPE 758
K G+ +V +R Y APE
Sbjct: 188 SAKILIAGEPNVSYICSRY-----YRAPE 211
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 6e-20
Identities = 58/189 (30%), Positives = 84/189 (44%), Gaps = 34/189 (17%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSE-FQAEIAVLTKVRHRHLVALLG 646
LG G FG V G+ G K+AVK + + + + + EI L RH H++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR--------GVE 698
S+ +V EY+ G L ++ + R+ +R GV+
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICK-----------NGRLDE--KESRRLFQQILSGVD 130
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
Y H +HRDLKP N+L+ M AK+ADFGL DG++ + T G+ Y APE
Sbjct: 131 YCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRTS-CGSPNYAAPE 185
Query: 759 ------YAG 761
YAG
Sbjct: 186 VISGRLYAG 194
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 63/218 (28%), Positives = 91/218 (41%), Gaps = 19/218 (8%)
Query: 38 SLQNLPSDWSSTSSTGYCEWTGI----NCDNSNRVTTISLAKSGLSGTLSPEISSLTQLE 93
Q P D + + + + + N + I S + I L +
Sbjct: 9 IKQIFPDDAFAETIKANLKKKSVTDAVTQNELNSIDQIIANNSDI--KSVQGIQYLPNVR 66
Query: 94 TLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPW 153
L+ N + I +L T+L + L N S+P G FD LTNL+ L L +N L
Sbjct: 67 YLALGGNKLH-DISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVEN-QLQSL 124
Query: 154 PFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPAS-FAK-SD 211
P K T+LT L + + + L FD +NL L LSYN SLP F K +
Sbjct: 125 P-DGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQ 182
Query: 212 IQNLWMNDQQLGLS---GTLDVLSGMTQLRQVWLHKNQ 246
+++L + QL S G D L T L+ +WLH N
Sbjct: 183 LKDLRLYQNQLK-SVPDGVFDRL---TSLQYIWLHDNP 216
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 35/185 (18%), Positives = 61/185 (32%), Gaps = 35/185 (18%)
Query: 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172
L + T T + L ++ + +++ + ++ L +
Sbjct: 19 AETIKANLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQ----YLPNVRYLALGG 72
Query: 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLS 232
+ + +NL L L+ N SLP V
Sbjct: 73 NKLHDI--SALKELTNLTYLILTGNQLQ-SLPN-----------------------GVFD 106
Query: 233 GMTQLRQVWLHKNQFTG-PIPDLSKCESLFDLSLRDNQLTGVVPASVI-SLPALLNISLQ 290
+T L+++ L +NQ P K +L L+L NQL +P V L L + L
Sbjct: 107 KLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLS 165
Query: 291 NNKLQ 295
N+LQ
Sbjct: 166 YNQLQ 170
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 8e-09
Identities = 39/199 (19%), Positives = 67/199 (33%), Gaps = 43/199 (21%)
Query: 121 DNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIP 180
P F L ++ NEL S+ + +N++I +
Sbjct: 6 STPIKQIFPDDAFAETIKAN---LKKK-SVTDAVTQNELN---SIDQIIANNSDIKSVQG 58
Query: 181 DFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQV 240
N++ L L N + L +T L +
Sbjct: 59 --IQYLPNVRYLALGGNKLH--------------------------DISALKELTNLTYL 90
Query: 241 WLHKNQFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASVI-SLPALLNISLQNNKLQG- 296
L NQ +P+ K +L +L L +NQL +P V L L ++L +N+LQ
Sbjct: 91 ILTGNQLQS-LPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQSL 148
Query: 297 PYPLFPS--KVQKVSLDHN 313
P +F + ++ L +N
Sbjct: 149 PKGVFDKLTNLTELDLSYN 167
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 2e-19
Identities = 43/190 (22%), Positives = 67/190 (35%), Gaps = 33/190 (17%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY 647
LG G +G V +AVK ++ + EI + + H ++V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 648 CINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR--------GVEY 699
G+ + L EY G L + + A+ GV Y
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEP-----------DIGMPE--PDAQRFFHQLMAGVVY 120
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLA-GTFGYLAPE 758
LH HRD+KP N+L+ + K++DFGL GT Y+APE
Sbjct: 121 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 759 ------YAGK 762
+ +
Sbjct: 178 LLKRREFHAE 187
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 3e-19
Identities = 49/189 (25%), Positives = 78/189 (41%), Gaps = 30/189 (15%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKI-AVKRME-SNTMGNKGLSEFQAEIAVLTKVRH 638
D+F +G+G FG V + D K+ A+K M + + E+ ++ + H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 639 RHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR-- 695
LV L Y E + +V + + G L HL +Q V + +
Sbjct: 75 PFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL-------------QQNVHFKEETVKLF 120
Query: 696 ------GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLA 749
++YL + Q IHRD+KP NIL+ + + DF + P T +A
Sbjct: 121 ICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI--TTMA 175
Query: 750 GTFGYLAPE 758
GT Y+APE
Sbjct: 176 GTKPYMAPE 184
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 3e-19
Identities = 43/214 (20%), Positives = 71/214 (33%), Gaps = 58/214 (27%)
Query: 90 TQLETLSFQMNNIAGAIP--SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDN 147
+ L NN++ + T+L + L +N+ + + F + NL+ L LS N
Sbjct: 39 SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98
Query: 148 PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASF 207
L TL F L+ L L N+ +
Sbjct: 99 H----------------LHTLD----------EFLFSDLQALEVLLLYNNHIV-VVDR-- 129
Query: 208 AKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFT----GPIPDLSKCESLFDL 263
+ M QL++++L +NQ + I D +K L L
Sbjct: 130 ---------------------NAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLL 168
Query: 264 SLRDNQLTGVVPASVISLPAL--LNISLQNNKLQ 295
L N+L + + LPA + L NN L+
Sbjct: 169 DLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 1e-16
Identities = 29/143 (20%), Positives = 52/143 (36%), Gaps = 15/143 (10%)
Query: 87 SSLTQLETLSFQMNNIAGAIPSLA--NATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144
+ LT L +L N++ I S A +L+ + L +N+ ++ F L L+VL L
Sbjct: 61 TRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLL 119
Query: 145 SDNP--NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLR---LSYNNF 199
+N + F + + L LY+ I + + L L LS N
Sbjct: 120 YNNHIVVVDRNAFED-M---AQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKL 175
Query: 200 TGSLPASFA---KSDIQNLWMND 219
L++++
Sbjct: 176 KKLPLTDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 29/176 (16%), Positives = 51/176 (28%), Gaps = 55/176 (31%)
Query: 122 NNNFTSVPTGCFDGLTNLQVLSLSDN--PNLAPWPFPNELTKSTSLTTLYMDNANIFGLI 179
+VP + +L LS N L P LT L +L + + ++ +
Sbjct: 27 KQQLPNVPQSLP---SYTALLDLSHNNLSRLRAEWTPTRLTN---LHSLLLSHNHLNFIS 80
Query: 180 PDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQ 239
+ F NL+ L LS N+ +L + S + L
Sbjct: 81 SEAFVPVPNLRYLDLSSNHLH-TLDE-----------------------FLFSDLQALEV 116
Query: 240 VWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQ 295
L L +N + V + + L + L N++
Sbjct: 117 -----------------------LLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS 149
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 29/134 (21%), Positives = 43/134 (32%), Gaps = 29/134 (21%)
Query: 186 FSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKN 245
S L LS+NN + L A + + +T L + L N
Sbjct: 38 PSYTALLDLSHNNLS-RLRAEWT----------------------PTRLTNLHSLLLSHN 74
Query: 246 QFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG-PYPLFP 302
I +L L L N L + L AL + L NN + F
Sbjct: 75 HLNF-ISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFE 133
Query: 303 --SKVQKVSLDHNN 314
+++QK+ L N
Sbjct: 134 DMAQLQKLYLSQNQ 147
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 15/68 (22%), Positives = 21/68 (30%), Gaps = 6/68 (8%)
Query: 87 SSLTQLETLSFQMNNI----AGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQV- 141
+ QL+ L N I I L + L +N +P L
Sbjct: 133 EDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKN 192
Query: 142 -LSLSDNP 148
L L +NP
Sbjct: 193 GLYLHNNP 200
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 11/44 (25%), Positives = 24/44 (54%), Gaps = 2/44 (4%)
Query: 386 AYANLTSLKNLYLQQNNLTGPIPDG-LTKLASLQNLDVSNNNLS 428
A+ + +L+ L L N+L + + + L +L+ L + NN++
Sbjct: 83 AFVPVPNLRYLDLSSNHLHT-LDEFLFSDLQALEVLLLYNNHIV 125
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 12/42 (28%), Positives = 22/42 (52%), Gaps = 2/42 (4%)
Query: 388 ANLTSLKNLYLQQNNLTGPIPDG-LTKLASLQNLDVSNNNLS 428
++L +L+ L L N++ + +A LQ L +S N +S
Sbjct: 109 SDLQALEVLLLYNNHIVV-VDRNAFEDMAQLQKLYLSQNQIS 149
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 16/47 (34%), Positives = 24/47 (51%), Gaps = 5/47 (10%)
Query: 386 AYANLTSLKNLYLQQNNLTGPIPDG----LTKLASLQNLDVSNNNLS 428
A+ ++ L+ LYL QN ++ P KL L LD+S+N L
Sbjct: 131 AFEDMAQLQKLYLSQNQISR-FPVELIKDGNKLPKLMLLDLSSNKLK 176
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 8e-04
Identities = 16/54 (29%), Positives = 25/54 (46%), Gaps = 2/54 (3%)
Query: 376 NKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDG-LTKLASLQNLDVSNNNLS 428
N L LT+L +L L N+L I + +L+ LD+S+N+L
Sbjct: 49 NNLSRLRAEWTPTRLTNLHSLLLSHNHLNF-ISSEAFVPVPNLRYLDLSSNHLH 101
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 3e-19
Identities = 45/250 (18%), Positives = 83/250 (33%), Gaps = 37/250 (14%)
Query: 56 EWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPS--LANAT 113
+ + I P + TQ TL ++ IPS +N
Sbjct: 12 QEEDFRVTC-KDIQRI------------PSLPPSTQ--TLKLIETHLR-TIPSHAFSNLP 55
Query: 114 SLQDIYLDNNN-FTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172
++ IY+ + + + F L+ + + + + NL P+ L + L L + N
Sbjct: 56 NISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYID-PDALKELPLLKFLGIFN 114
Query: 173 ANIFGLIPD--FFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTL-- 228
+ PD S L ++ N + S+P + Q L L L
Sbjct: 115 -TGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVN----AFQGLCNETLTLKLYNNGFT 169
Query: 229 ----DVLSGMTQLRQVWLHKNQFTGPIPD--LSKCES-LFDLSLRDNQLTGVVPASVISL 281
+G T+L V+L+KN++ I S L + +T + + L
Sbjct: 170 SVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHL 228
Query: 282 PALLNISLQN 291
L+ +
Sbjct: 229 KELIARNTWT 238
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 34/219 (15%), Positives = 70/219 (31%), Gaps = 24/219 (10%)
Query: 90 TQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPN 149
Q E +I IPSL S Q + L + ++P+ F L N+ + +S +
Sbjct: 11 HQEEDFRVTCKDIQ-RIPSLP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVT 67
Query: 150 LAPWPFPNELTKSTSLTTLYMDNANIFGLIP-DFFDSFSNLQNLRLSYNNFTGSLPASFA 208
L + + +T + + N I D L+ L + P
Sbjct: 68 LQQLE-SHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTK 125
Query: 209 KSDIQNLWM-----NDQQLGLSGTLDVLSGMT-QLRQVWLHKNQFTGPIPD----LSKCE 258
++ N + + G+ + + L+ N FT + +K
Sbjct: 126 VYSTDIFFILEITDNPYMTSIPV--NAFQGLCNETLTLKLYNNGFTS-VQGYAFNGTK-- 180
Query: 259 SLFDLSLRDNQLTGVVPASVIS-LPALLNI-SLQNNKLQ 295
L + L N+ V+ + + ++ + +
Sbjct: 181 -LDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 43/332 (12%), Positives = 83/332 (25%), Gaps = 122/332 (36%)
Query: 104 GAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKST 163
G +D + + +P+ + Q L L +
Sbjct: 2 GCSSPPCECHQEEDFRVTCKDIQRIPSL----PPSTQTLKLIETH--------------- 42
Query: 164 SLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLG 223
L T+ F + N+ + +S + L +
Sbjct: 43 -LRTIP----------SHAFSNLPNISRIYVSIDVTLQQLES------------------ 73
Query: 224 LSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPA 283
++++ + + LT + P ++ LP
Sbjct: 74 -----HSFYNLSKVTHIEIRNT----------------------RNLTYIDPDALKELPL 106
Query: 284 LLNISLQNNKLQ--GPYPLFPSKVQKVSLD--HNNFCKNSSDAGKPCDPQVTTLLQIAGD 339
L + + N L+ S L+ N +T++
Sbjct: 107 LKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNP--------------YMTSI------ 146
Query: 340 MGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLA-NKLLAGNISPAYANLTSLKNLYL 398
NA G T +T+ L N ++ N T L +YL
Sbjct: 147 ------------PVNAFQGLCNET------LTLKLYNNGF--TSVQGYAFNGTKLDAVYL 186
Query: 399 QQNNLTGPIPDG-LTKLAS-LQNLDVSNNNLS 428
+N I + S LDVS +++
Sbjct: 187 NKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 6e-06
Identities = 14/89 (15%), Positives = 32/89 (35%), Gaps = 7/89 (7%)
Query: 65 SNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANA---TSLQDIYLD 121
N T+ L +G + ++ + T+L+ + N I A + + +
Sbjct: 155 CNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVS 213
Query: 122 NNNFTSVPTGCFDGLTNLQVLSLSDNPNL 150
+ T++P+ + L L + L
Sbjct: 214 QTSVTALPSKGLEHLKELIARN---TWTL 239
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 5e-19
Identities = 51/199 (25%), Positives = 83/199 (41%), Gaps = 38/199 (19%)
Query: 581 DNFSEANILGRGGFGVVY-GGELPDGTKIAVK--RMESNTMGNKGLSEFQA--EIAVLTK 635
+ + +G+G FG V+ G K+A+K ME+ G A EI +L
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP----ITALREIKILQL 72
Query: 636 VRHRHLVALLGYCINGSERL--------LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRV 687
++H ++V L+ C + LV+++ LA L + T +
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL----SNVLVKFTLSEIK 127
Query: 688 TIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL------VKNAPDGK 741
+ + G+ Y+H +HRD+K +N+LI D K+ADFGL KN+ +
Sbjct: 128 RVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 742 YS--VETRLAGTFGYLAPE 758
Y+ V T Y PE
Sbjct: 185 YTNRVVTLW-----YRPPE 198
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 6e-19
Identities = 45/192 (23%), Positives = 70/192 (36%), Gaps = 37/192 (19%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY 647
LG G +G V +AVK ++ + EI + + H ++V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 648 CINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR--------GVEY 699
G+ + L EY G L + + A+ GV Y
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEP-----------DIGMPE--PDAQRFFHQLMAGVVY 120
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLA---GTFGYLA 756
LH HRD+KP N+L+ + K++DFGL + E L GT Y+A
Sbjct: 121 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN--NRERLLNKMCGTLPYVA 175
Query: 757 PE------YAGK 762
PE + +
Sbjct: 176 PELLKRREFHAE 187
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 6e-19
Identities = 43/166 (25%), Positives = 73/166 (43%), Gaps = 21/166 (12%)
Query: 581 DNFSEANILGRGGFGVVY-GGELPDGTKIAVK--RMESNTMGNKGLSEFQA--EIAVL-- 633
+ +G G +G VY + G +A+K R+ + G GL E+A+L
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLP-ISTVREVALLRR 67
Query: 634 -TKVRHRHLVALL----GYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRV 687
H ++V L+ + ++ LV+E++ + L +L L +
Sbjct: 68 LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL---DKAPPPGLPAETIK 123
Query: 688 TIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733
+ RG+++LH+ +HRDLKP NIL+ K+ADFGL
Sbjct: 124 DLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGL 166
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 6e-19
Identities = 36/182 (19%), Positives = 61/182 (33%), Gaps = 53/182 (29%)
Query: 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172
++ +I L+ N +P G F L+ + LS+N ++ L
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNN----------------QISELA--- 72
Query: 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLS 232
PD F +L +L L N T LP +
Sbjct: 73 -------PDAFQGLRSLNSLVLYGNKIT-ELPK-----------------------SLFE 101
Query: 233 GMTQLRQVWLHKNQFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQ 290
G+ L+ + L+ N+ + +L LSL DN+L + + L A+ + L
Sbjct: 102 GLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLA 160
Query: 291 NN 292
N
Sbjct: 161 QN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 29/139 (20%), Positives = 46/139 (33%), Gaps = 32/139 (23%)
Query: 63 DNSNRVTTISLAKSGLSGTLSPEI-SSLTQLETLSFQMNNIAGAIPS--LANATSLQDIY 119
++ I L+ + +S L+P+ L L +L N I +P SLQ +
Sbjct: 53 SPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLL 110
Query: 120 LDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLI 179
L+ N + F L NL +LSL DN + +
Sbjct: 111 LNANKINCLRVDAFQDLHNLNLLSLYDN--------------------------KLQTIA 144
Query: 180 PDFFDSFSNLQNLRLSYNN 198
F +Q + L N
Sbjct: 145 KGTFSPLRAIQTMHL-AQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 4e-10
Identities = 16/63 (25%), Positives = 27/63 (42%), Gaps = 3/63 (4%)
Query: 88 SLTQLETLSFQMNNIAGAIPSLA--NATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145
L L+ L N I + A + +L + L +N ++ G F L +Q + L+
Sbjct: 102 GLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLA 160
Query: 146 DNP 148
NP
Sbjct: 161 QNP 163
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 11/41 (26%), Positives = 17/41 (41%), Gaps = 2/41 (4%)
Query: 389 NLTSLKNLYLQQNNLTGPIPDGL-TKLASLQNLDVSNNNLS 428
L SL+ L L N + + L +L L + +N L
Sbjct: 102 GLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKLQ 141
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 8e-04
Identities = 16/44 (36%), Positives = 24/44 (54%), Gaps = 2/44 (4%)
Query: 386 AYANLTSLKNLYLQQNNLTGPIPDGL-TKLASLQNLDVSNNNLS 428
A+ L SL +L L N +T +P L L SLQ L ++ N ++
Sbjct: 75 AFQGLRSLNSLVLYGNKITE-LPKSLFEGLFSLQLLLLNANKIN 117
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 7e-19
Identities = 51/198 (25%), Positives = 78/198 (39%), Gaps = 25/198 (12%)
Query: 574 EVLRQVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTM-GNKGLSEFQAEIA 631
E R+ D F + G+G FG V G E G +A+K++ + N+ L +
Sbjct: 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQI----MQ 71
Query: 632 VLTKVRHRHLVALLGYCINGSER-------LLVYEYMPRGTLAQHLFEWHDHGYTPLTWK 684
L + H ++V L Y ER +V EY+P TL + +
Sbjct: 72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCC-RNYYRRQVAPPPI 129
Query: 685 QRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI-GDDMRAKVADFGLVKNAPDGKYS 743
+ R + LH + HRD+KP N+L+ D K+ DFG K + +
Sbjct: 130 LIKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN 188
Query: 744 VE---TRLAGTFGYLAPE 758
V +R Y APE
Sbjct: 189 VAYICSRY-----YRAPE 201
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 9e-19
Identities = 48/225 (21%), Positives = 90/225 (40%), Gaps = 33/225 (14%)
Query: 548 SELHSQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVY-GGELPDGT 606
+ H G + + G + + D + LG G +G VY +
Sbjct: 2 AHHHHHHMGTLEAQTQGPGSMSVSAAPSATSI-DRYRRITKLGEGTYGEVYKAIDTVTNE 60
Query: 607 KIAVK--RMESNTMGNKGLSEFQA--EIAVLTKVRHRHLVALLGYCINGSERLLVYEYMP 662
+A+K R+E G A E+++L +++HR+++ L + L++EY
Sbjct: 61 TVAIKRIRLEHEEEG----VPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE 116
Query: 663 RGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI-- 720
L +++ D ++ + + + GV + HS + +HRDLKP N+L+
Sbjct: 117 N-DLKKYM----DKN-PDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSV 167
Query: 721 ---GDDMRAKVADFGL--VKNAPDGKYS--VETRLAGTFGYLAPE 758
+ K+ DFGL P +++ + T Y PE
Sbjct: 168 SDASETPVLKIGDFGLARAFGIPIRQFTHEIITLW-----YRPPE 207
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 56/189 (29%), Positives = 85/189 (44%), Gaps = 35/189 (18%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSE-FQAEIAVLTKVRHRHLVALLG 646
LG G FG V K+A+K + + + + EI+ L +RH H++ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR--------GVE 698
++ ++V EY LF D+ + K+R+T D R +E
Sbjct: 77 VITTPTDIVMVIEYA-----GGELF---DY----IVEKKRMTE--DEGRRFFQQIICAIE 122
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
Y H +HRDLKP N+L+ D++ K+ADFGL DG + ++T G+ Y APE
Sbjct: 123 YCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF-LKT-SCGSPNYAAPE 177
Query: 759 ------YAG 761
YAG
Sbjct: 178 VINGKLYAG 186
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 2e-18
Identities = 66/267 (24%), Positives = 102/267 (38%), Gaps = 32/267 (11%)
Query: 506 YKFIARRKH--RKFGRVKNPEVGNEMNKNGVTGGNGTNGYNGVPSELHSQSSGDVSDRHL 563
FI R R + E E + +G + SG SD
Sbjct: 71 NTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSG 130
Query: 564 FEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKI-AVKRME-SNTMGNK 621
E V+++ R + F +LG+G FG V + + A+K ++ +
Sbjct: 131 AEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKD 190
Query: 622 GLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTP 680
++ E VL RH L AL Y +RL V EY G L HL
Sbjct: 191 EVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHL---------- 239
Query: 681 LTWKQRVTI---------ALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADF 731
R + ++ ++YLHS +++ ++RDLK N+++ D K+ DF
Sbjct: 240 ----SRERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDF 293
Query: 732 GLVKNAPDGKYSVETRLAGTFGYLAPE 758
GL K +++T GT YLAPE
Sbjct: 294 GLCKEGIKDGATMKT-FCGTPEYLAPE 319
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 2e-18
Identities = 36/159 (22%), Positives = 56/159 (35%), Gaps = 16/159 (10%)
Query: 611 KRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHL 670
+ + + +I + ++ V L + + + L +
Sbjct: 93 ESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWM 152
Query: 671 FEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVAD 730
+ I + +A VE+LHS + +HRDLKPSNI D KV D
Sbjct: 153 NR--RCSLEDREHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGD 207
Query: 731 FGLVK-----------NAPDGKYSVETRLAGTFGYLAPE 758
FGLV P Y+ T GT Y++PE
Sbjct: 208 FGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE 246
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-18
Identities = 32/212 (15%), Positives = 71/212 (33%), Gaps = 38/212 (17%)
Query: 87 SSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSD 146
S+ ++ A + A SL I L N N T + TG + N++ L++++
Sbjct: 20 STFKAYLNGLLGQSSTA--NITEAQMNSLTYITLANINVTDL-TG-IEYAHNIKDLTINN 75
Query: 147 NP--NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLP 204
N P ++ ++L L + ++ ++L L +S++ S
Sbjct: 76 IHATNYNP------ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDS-- 127
Query: 205 ASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLS 264
L ++ + ++ + L N I L L L+
Sbjct: 128 ----------------------ILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLN 165
Query: 265 LRDNQLTGVVPASVISLPALLNISLQNNKLQG 296
++ + + + P L + + + G
Sbjct: 166 IQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 7e-16
Identities = 29/208 (13%), Positives = 64/208 (30%), Gaps = 55/208 (26%)
Query: 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNF 125
N +T I+LA ++ L+ I ++ L+ + ++ ++L+ + + +
Sbjct: 44 NSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHATN-YNPISGLSNLERLRIMGKDV 100
Query: 126 TSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDS 185
TS GLT+L +L +S + I ++
Sbjct: 101 TSDKIPNLSGLTSLTLLDISHS--------------------------AHDDSILTKINT 134
Query: 186 FSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKN 245
+ ++ LSYN +DI L + +L+ + + +
Sbjct: 135 LPKVNSIDLSYNGAI---------TDIMP----------------LKTLPELKSLNIQFD 169
Query: 246 QFTGPIPDLSKCESLFDLSLRDNQLTGV 273
+ L L + G
Sbjct: 170 GVHD-YRGIEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 32/214 (14%), Positives = 64/214 (29%), Gaps = 50/214 (23%)
Query: 220 QQLGLSGTLDV-LSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASV 278
LG S T ++ + M L + L T + + ++ DL++ + T P S
Sbjct: 28 GLLGQSSTANITEAQMNSLTYITLANINVTD-LTGIEYAHNIKDLTINNIHATNYNPIS- 85
Query: 279 ISLPALLNISLQNNKLQ--GPYPLFP-SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQ 335
L L + + + L + + + + H+
Sbjct: 86 -GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSA--------------------- 123
Query: 336 IAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKN 395
DS T + + +I+L+ +I P L LK+
Sbjct: 124 ----------HDDS-------ILTKINTLPK--VNSIDLSYNGAITDIMP-LKTLPELKS 163
Query: 396 LYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSG 429
L +Q + + + L L + + G
Sbjct: 164 LNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 6e-06
Identities = 13/56 (23%), Positives = 27/56 (48%), Gaps = 1/56 (1%)
Query: 382 NISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSN 437
N +P + L++L+ L + ++T L+ L SL LD+S++ + +
Sbjct: 80 NYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 7e-05
Identities = 12/72 (16%), Positives = 27/72 (37%)
Query: 371 TINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGK 430
+ + K + + P + LTSL L + + I + L + ++D+S N
Sbjct: 92 RLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD 151
Query: 431 VPDFGSNVKFTV 442
+ + +
Sbjct: 152 IMPLKTLPELKS 163
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 3e-18
Identities = 53/192 (27%), Positives = 72/192 (37%), Gaps = 34/192 (17%)
Query: 105 AIPS--LANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKS 162
++PS A+ L L + ++ F GLT L L+L N L
Sbjct: 28 SVPSGIPADTEKL---DLQSTGLATLSDATFRGLTKLTWLNLDYN-QLQTLS-AGVFDDL 82
Query: 163 TSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQL 222
T L TL + N + L FD + L L L N SLP+
Sbjct: 83 TELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLK-SLPS----------------- 124
Query: 223 GLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASVIS 280
G D L T+L+++ L+ NQ IP K +L LSL NQL V +
Sbjct: 125 ---GVFDRL---TKLKELRLNTNQLQS-IPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDR 177
Query: 281 LPALLNISLQNN 292
L L I+L N
Sbjct: 178 LGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 48/166 (28%), Positives = 67/166 (40%), Gaps = 37/166 (22%)
Query: 88 SLTQLETLSFQMNNI----AGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLS 143
LT+L L+ N + AG L T L + L NN S+P G FD LT L L
Sbjct: 57 GLTKLTWLNLDYNQLQTLSAGVFDDL---TELGTLGLANNQLASLPLGVFDHLTQLDKLY 113
Query: 144 LSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSL 203
L N+L L FD + L+ LRL+ N S+
Sbjct: 114 LGG----------NQLKS----------------LPSGVFDRLTKLKELRLNTNQLQ-SI 146
Query: 204 PAS-FAK-SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQF 247
PA F K +++Q L ++ QL S + +L+ + L NQF
Sbjct: 147 PAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGNQF 191
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 30/112 (26%), Positives = 51/112 (45%), Gaps = 13/112 (11%)
Query: 210 SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFT----GPIPDLSKCESLFDLSL 265
+D + L + L + + G+T+L + L NQ G DL++ L L L
Sbjct: 35 ADTEKLDLQSTGLA-TLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTE---LGTLGL 90
Query: 266 RDNQLTGVVPASV-ISLPALLNISLQNNKLQG-PYPLFPS--KVQKVSLDHN 313
+NQL +P V L L + L N+L+ P +F K++++ L+ N
Sbjct: 91 ANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTN 141
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 4e-18
Identities = 51/191 (26%), Positives = 75/191 (39%), Gaps = 38/191 (19%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY 647
+G G FGV +AVK +E ++ + Q EI +RH ++V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENV---QREIINHRSLRHPNIVRFKEV 84
Query: 648 CINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR--------GVEY 699
+ + ++ EY G L+E + R + D AR GV Y
Sbjct: 85 ILTPTHLAIIMEYASGG----ELYER-------ICNAGRFSE--DEARFFFQQLLSGVSY 131
Query: 700 LHSLAQQSFIHRDLKPSNILI--GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAP 757
HS HRDLK N L+ R K+ DFG K++ ++ + GT Y+AP
Sbjct: 132 CHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTV-GTPAYIAP 186
Query: 758 E------YAGK 762
E Y GK
Sbjct: 187 EVLLRQEYDGK 197
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 43/180 (23%), Positives = 73/180 (40%), Gaps = 24/180 (13%)
Query: 588 ILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALL 645
+LG G G V K A+K ++ + + E+ + + + H+V ++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIV 121
Query: 646 GYCINGSER----LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLH 701
N L+V E + G L + + D +T ++ I + ++YLH
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE---REASEIMKSIGEAIQYLH 178
Query: 702 SLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
S + HRD+KP N+L + K+ DFG K S+ T T Y+APE
Sbjct: 179 S---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTP-CYTPYYVAPE 233
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 20/148 (13%), Positives = 47/148 (31%), Gaps = 16/148 (10%)
Query: 589 LGRGGFGVVYGGELPD---GTKIAVKRMESNTMGNKG-LSEFQAEIAVLTKVRHRHLVAL 644
G + D ++A+ ++ + L E + L+++ + +
Sbjct: 39 HGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 645 LGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA 704
L + L+V E++ G+L + D +P + +A + H
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSP---VGAIRAMQSLAAAADAAH--- 146
Query: 705 QQSFIHRDLKPSNILIGDDMRAKVADFG 732
+ PS + + D +A
Sbjct: 147 RAGVALSIDHPSRVRVSIDGDVVLAYPA 174
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 49/190 (25%), Positives = 80/190 (42%), Gaps = 34/190 (17%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKI-AVKRME-SNTMGNKGLSEFQAEIAVLTKVRH 638
+F LG G FG V+ + A+K ++ + K + E +L+ V H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 639 RHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTI-ALDVAR- 695
++ + ++++ ++ +Y+ G L L ++ VA+
Sbjct: 66 PFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLL--------------RKSQRFPNPVAKF 110
Query: 696 -------GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRL 748
+EYLHS I+RDLKP NIL+ + K+ DFG K PD Y+ L
Sbjct: 111 YAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT----L 163
Query: 749 AGTFGYLAPE 758
GT Y+APE
Sbjct: 164 CGTPDYIAPE 173
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 53/189 (28%), Positives = 74/189 (39%), Gaps = 32/189 (16%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKI-AVKRME-SNTMGNKGLSEFQAEIAVLTKVRH 638
D F LG G FG V + + A+K ++ + K + E +L V
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 639 RHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR-- 695
LV L + + L +V EY+ G + HL ++ + AR
Sbjct: 101 PFLVKLE-FSFKDNSNLYMVMEYVAGGEMFSHL-------------RRIGRFSEPHARFY 146
Query: 696 ------GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLA 749
EYLHSL I+RDLKP N+LI +V DFG K ++ L
Sbjct: 147 AAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT----LC 199
Query: 750 GTFGYLAPE 758
GT LAPE
Sbjct: 200 GTPEALAPE 208
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 43/199 (21%), Positives = 73/199 (36%), Gaps = 32/199 (16%)
Query: 578 QVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQA--------- 628
+ ++ + G +G V G +G +A+KR+ + + ++
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78
Query: 629 EIAVLTKVRHRHLVALLGYCINGSERL-----LVYEYMPRGT-LAQHLFEWHDHGYTPLT 682
EI +L H +++ L ++ E LV E M T LAQ + ++
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM--RTDLAQVI----HDQRIVIS 132
Query: 683 WKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742
+ + G+ LH +HRDL P NIL+ D+ + DF L +
Sbjct: 133 PQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN 189
Query: 743 S---VETRLAGTFGYLAPE 758
V R Y APE
Sbjct: 190 KTHYVTHRW-----YRAPE 203
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 40/211 (18%), Positives = 64/211 (30%), Gaps = 43/211 (20%)
Query: 86 ISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145
L + ++ + S + +Q+ DN+N S+ TNL+ L LS
Sbjct: 15 DPGLANAVKQNLGKQSVT-DLVSQKELSGVQNFNGDNSNIQSLAG--MQFFTNLKELHLS 71
Query: 146 DNP--NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSL 203
N +L+P L T L L ++ + L + L L L N
Sbjct: 72 HNQISDLSP------LKDLTKLEELSVNRNRLKNLNG---IPSACLSRLFLDNNELR--- 119
Query: 204 PASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDL 263
D L + L + + N+ I L L L
Sbjct: 120 -----------------------DTDSLIHLKNLEILSIRNNKLKS-IVMLGFLSKLEVL 155
Query: 264 SLRDNQLTGVVPASVISLPALLNISLQNNKL 294
L N++T + L + I L K
Sbjct: 156 DLHGNEITNTGG--LTRLKKVNWIDLTGQKC 184
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 5e-16
Identities = 37/239 (15%), Positives = 81/239 (33%), Gaps = 53/239 (22%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNN 123
VT + L+ ++ + +NI ++ + T+L++++L +N
Sbjct: 27 GKQSVTDLV------------SQKELSGVQNFNGDNSNIQ-SLAGMQFFTNLKELHLSHN 73
Query: 124 NFTSVPTGCFDGLTNLQVLSLSDNP--NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPD 181
+ + LT L+ LS++ N NL S L+ L++DN +
Sbjct: 74 QISDLSP--LKDLTKLEELSVNRNRLKNLNG-------IPSACLSRLFLDNNELRDTDS- 123
Query: 182 FFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVW 241
NL+ L + N ++ +L +++L +
Sbjct: 124 -LIHLKNLEILSIRNNKLK--------------------------SIVMLGFLSKLEVLD 156
Query: 242 LHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPL 300
LH N+ T L++ + + + L + L + + + PY +
Sbjct: 157 LHGNEITN-TGGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYI 214
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 33/266 (12%), Positives = 76/266 (28%), Gaps = 77/266 (28%)
Query: 163 TSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQL 222
+ + ++ L+ S +QN +N
Sbjct: 19 ANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ---------------------- 54
Query: 223 GLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLP 282
+L + T L+++ L NQ + + L L +LS+ N+L + + I
Sbjct: 55 ----SLAGMQFFTNLKELHLSHNQISD-LSPLKDLTKLEELSVNRNRLKNL---NGIPSA 106
Query: 283 ALLNISLQNNKLQGPYPLFP-SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMG 341
L + L NN+L+ L ++ +S+ +N ++ +++ +
Sbjct: 107 CLSRLFLDNNELRDTDSLIHLKNLEILSIRNN---------------KLKSIVMLGF--- 148
Query: 342 YPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQN 401
LS ++ ++L + N L + + L
Sbjct: 149 ----LS--------------------KLEVLDLHGNEIT-NTGG-LTRLKKVNWIDLTGQ 182
Query: 402 NLTGPIPDGLTKLASLQNLDVSNNNL 427
+L + +
Sbjct: 183 KCVNEPVKYQPELYITNTVKDPDGRW 208
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 37/195 (18%), Positives = 62/195 (31%), Gaps = 42/195 (21%)
Query: 55 CEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPS--LANA 112
CE T ++C ++ ++ I + L N +
Sbjct: 11 CEGTTVDC-SNQKLNKI---PEHIP----------QYTAELRLNNNEFTVLEATGIFKKL 56
Query: 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172
L+ I NN T + G F+G + + + L+ N L SL TL + +
Sbjct: 57 PQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN-RLENVQ-HKMFKGLESLKTLMLRS 114
Query: 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLS 232
I + D F S+++ L L N T ++ G D L
Sbjct: 115 NRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAP--------------------GAFDTLH 153
Query: 233 GMTQLRQVWLHKNQF 247
++ L L N F
Sbjct: 154 SLSTL---NLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-16
Identities = 32/173 (18%), Positives = 57/173 (32%), Gaps = 31/173 (17%)
Query: 122 NNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPD 181
N +P L L++N K L + N I +
Sbjct: 20 NQKLNKIPEHIP---QYTAELRLNNN-EFTVLEATGIFKKLPQLRKINFSNNKITDIEEG 75
Query: 182 FFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVW 241
F+ S + + L+ N ++ + G+ L+ +
Sbjct: 76 AFEGASGVNEILLTSNRLE-NVQHK-----------------------MFKGLESLKTLM 111
Query: 242 LHKNQFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNN 292
L N+ T + + S+ LSL DNQ+T V P + +L +L ++L N
Sbjct: 112 LRSNRITC-VGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 7e-04
Identities = 13/46 (28%), Positives = 24/46 (52%), Gaps = 3/46 (6%)
Query: 389 NLTSLKNLYLQQNNLTGPIPDGL-TKLASLQNLDVSNNNLSGKVPD 433
L SLK L L+ N +T + + L+S++ L + +N ++ V
Sbjct: 103 GLESLKTLMLRSNRITC-VGNDSFIGLSSVRLLSLYDNQIT-TVAP 146
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 52/190 (27%), Positives = 74/190 (38%), Gaps = 31/190 (16%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKI-AVKRME-SNTMGNKGLSEFQAEIAVLTKVRH 638
++F +LG+G FG V + A+K + + ++ E VL RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 639 RHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR-- 695
L AL Y +RL V EY G L HL + + AR
Sbjct: 65 PFLTALK-YAFQTHDRLCFVMEYANGGELFFHL-------------SRERVFTEERARFY 110
Query: 696 ------GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR-L 748
+EYLHS ++RD+K N+++ D K+ DFGL K +
Sbjct: 111 GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTF 165
Query: 749 AGTFGYLAPE 758
GT YLAPE
Sbjct: 166 CGTPEYLAPE 175
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 42/167 (25%), Positives = 72/167 (43%), Gaps = 25/167 (14%)
Query: 581 DNFSEANILGRGGFGVVYGG--ELPDGTKIAVK--RMESNTMGNKGLSEFQA--EIAVL- 633
+ +G G +G V+ G +A+K R+++ G E+AVL
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG----MPLSTIREVAVLR 66
Query: 634 --TKVRHRHLVALL----GYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQR 686
H ++V L + +L LV+E++ + L +L + +
Sbjct: 67 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL---DKVPEPGVPTETI 122
Query: 687 VTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733
+ + RG+++LHS +HRDLKP NIL+ + K+ADFGL
Sbjct: 123 KDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL 166
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 5e-16
Identities = 50/191 (26%), Positives = 84/191 (43%), Gaps = 31/191 (16%)
Query: 581 DNFSEANILGRGGFGVVY---GGELPDGTKI-AVKRMESNTMGNKGLSEFQAEIAVLTKV 636
F +LG+G FG V+ D ++ A+K ++ T+ + + E +L +V
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 637 RHRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR 695
H +V L Y +L L+ +++ G L L + V + +
Sbjct: 84 NHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRL-------------SKEVMFTEEDVK 129
Query: 696 --------GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR 747
+++LHSL I+RDLKP NIL+ ++ K+ DFGL K + D + +
Sbjct: 130 FYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS- 185
Query: 748 LAGTFGYLAPE 758
GT Y+APE
Sbjct: 186 FCGTVEYMAPE 196
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 38/167 (22%), Positives = 65/167 (38%), Gaps = 22/167 (13%)
Query: 588 ILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALL 645
+LG G G V K A+K ++ + + E+ + + + H+V ++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIV 77
Query: 646 GYCINGSER----LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLH 701
N L+V E + G L + + G T ++ I + ++YLH
Sbjct: 78 DVYENLYAGRKCLLIVMECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLH 134
Query: 702 SLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGKYSVE 745
S + HRD+KP N+L + K+ DFG K KY
Sbjct: 135 S---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEKYDKS 178
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 4e-15
Identities = 47/232 (20%), Positives = 85/232 (36%), Gaps = 77/232 (33%)
Query: 579 VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQA---EIAVLT 634
+ +S LG G FG+V ++ G + A+K++ L + + E+ ++
Sbjct: 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV---------LQDPRYKNRELDIMK 55
Query: 635 KVRHRHLVALLGYCINGSERL--------------------------------------L 656
+ H +++ L+ Y + +
Sbjct: 56 VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115
Query: 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIAL------DVARGVEYLHSLAQQSFIH 710
+ EY+P TL + L + + + + + L + R V ++HSL H
Sbjct: 116 IMEYVP-DTLHKVL-------KSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICH 164
Query: 711 RDLKPSNILI-GDDMRAKVADFGLVKNAPDGKYSVE---TRLAGTFGYLAPE 758
RD+KP N+L+ D K+ DFG K + SV +R Y APE
Sbjct: 165 RDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPE 211
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 6e-15
Identities = 42/168 (25%), Positives = 71/168 (42%), Gaps = 27/168 (16%)
Query: 578 QVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQA-----EIA 631
Q+ D + +++G G +G V + + +A+K++ + EIA
Sbjct: 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI-LRVFEDLID----CKRILREIA 104
Query: 632 VLTKVRHRHLVALLGYCINGSERL-----LVYEYMPRGT-LAQHLFEWHDHGYTPLTWKQ 685
+L ++ H H+V +L I +V E + + LT
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA--DSDFKKLF-----RTPVYLTELH 157
Query: 686 RVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733
T+ ++ GV+Y+HS +HRDLKP+N L+ D KV DFGL
Sbjct: 158 IKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGL 202
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 76.6 bits (188), Expect = 1e-14
Identities = 51/183 (27%), Positives = 81/183 (44%), Gaps = 16/183 (8%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKI-AVKRME-SNTMGNKGLSEFQAEIAVLTKV-R 637
+F+ +LG+G FG V E ++ AVK ++ + + + E VL +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 638 HRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARG 696
L L C +RL V EY+ G L +H V A ++A G
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEYVNGG----DLM-YHIQQVGRFKEPHAVFYAAEIAIG 454
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR-LAGTFGYL 755
+ +L S + I+RDLK N+++ + K+ADFG+ K + V T+ GT Y+
Sbjct: 455 LFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYI 509
Query: 756 APE 758
APE
Sbjct: 510 APE 512
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 52/226 (23%), Positives = 87/226 (38%), Gaps = 33/226 (14%)
Query: 547 PSELHSQSSGDVSDRHLFEGGNVAISIEVLRQVT-DNFSEANILGRGGFGVVYGGELPDG 605
L+ Q + E N S + + +F ++GRG + V L
Sbjct: 17 TENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKT 76
Query: 606 TKI-AVKRME-SNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERL-LVYEYM 661
+I A++ ++ ++ + Q E V + H LV L C RL V EY+
Sbjct: 77 DRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYV 135
Query: 662 PRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR--------GVEYLHSLAQQSFIHRDL 713
G L H+ +++ + + AR + YLH + I+RDL
Sbjct: 136 NGGDLMFHM-------------QRQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDL 179
Query: 714 KPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR-LAGTFGYLAPE 758
K N+L+ + K+ D+G+ K + T GT Y+APE
Sbjct: 180 KLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPE 223
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 3e-14
Identities = 52/193 (26%), Positives = 80/193 (41%), Gaps = 33/193 (17%)
Query: 581 DNFSEANILGRGGFGVVY---GGELPDGTKI-AVK--RMESNTMGNKGLSEFQAEIAVLT 634
+ F +LG+GG+G V+ + KI A+K + K + +AE +L
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 635 KVRHRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDV 693
+V+H +V L+ Y +L L+ EY+ G L L ++ D
Sbjct: 77 EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQL-------------EREGIFMEDT 122
Query: 694 AR--------GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVE 745
A + +LH I+RDLKP NI++ K+ DFGL K +
Sbjct: 123 ACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH 179
Query: 746 TRLAGTFGYLAPE 758
T GT Y+APE
Sbjct: 180 T-FCGTIEYMAPE 191
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 4e-14
Identities = 54/237 (22%), Positives = 88/237 (37%), Gaps = 33/237 (13%)
Query: 537 GNGTNGYNGVPSELHSQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGV 596
G + G G ++ ++ +H N+ E + +NF +LG G +G
Sbjct: 12 GGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGI--ENFELLKVLGTGAYGK 69
Query: 597 VY---GGELPDGTKI-AVK--RMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN 650
V+ D K+ A+K + + K + E VL +R + L Y
Sbjct: 70 VFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 129
Query: 651 GSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR--------GVEYLH 701
+L L+ +Y+ G L HL QR + +E+LH
Sbjct: 130 TETKLHLILDYINGGELFTHL-------------SQRERFTEHEVQIYVGEIVLALEHLH 176
Query: 702 SLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
L I+RD+K NIL+ + + DFGL K + GT Y+AP+
Sbjct: 177 KL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 230
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 5e-14
Identities = 46/195 (23%), Positives = 85/195 (43%), Gaps = 36/195 (18%)
Query: 578 QVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQA-----EIA 631
++ + +G G +G V + G K+A+K++ S ++ A E+
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL-SRPFQSEIF----AKRAYRELL 75
Query: 632 VLTKVRHRHLVALL------GYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQ 685
+L ++H +++ LL N + LV +M L + + + ++
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIM-------GLKFSEEK 127
Query: 686 RVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK--YS 743
+ + +G++Y+HS +HRDLKP N+ + +D K+ DFGL ++A Y
Sbjct: 128 IQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY- 183
Query: 744 VETRLAGTFGYLAPE 758
V TR Y APE
Sbjct: 184 VVTRW-----YRAPE 193
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 5e-14
Identities = 55/228 (24%), Positives = 86/228 (37%), Gaps = 33/228 (14%)
Query: 545 GVPSELHSQSSGDVSDRHLFEGGNVAISIEVLRQVT-DNFSEANILGRGGFGVVYGGELP 603
G+ + + + +F ++G+G FG V
Sbjct: 1 GISQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHK 60
Query: 604 DGTKI-AVKRME-SNTMGNKGLSEFQAEIAVLTK-VRHRHLVALLGYCINGSERL-LVYE 659
AVK ++ + K +E VL K V+H LV L + +++L V +
Sbjct: 61 AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLD 119
Query: 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR--------GVEYLHSLAQQSFIHR 711
Y+ G L HL ++ AR + YLHSL + ++R
Sbjct: 120 YINGGELFYHL-------------QRERCFLEPRARFYAAEIASALGYLHSL---NIVYR 163
Query: 712 DLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR-LAGTFGYLAPE 758
DLKP NIL+ + DFGL K + +++ T GT YLAPE
Sbjct: 164 DLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLAPE 209
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 6e-14
Identities = 51/209 (24%), Positives = 84/209 (40%), Gaps = 45/209 (21%)
Query: 571 ISIEVLRQ---VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEF 626
S+E+ V + +G G G+V + +A+K++ S N+
Sbjct: 12 YSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL-SRPFQNQTH--- 67
Query: 627 QA-----EIAVLTKVRHRHLVALL------GYCINGSERLLVYEYMP---RGTLAQHLFE 672
A E+ ++ V H++++ LL + +V E M + L
Sbjct: 68 -AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMEL-- 124
Query: 673 WHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732
H+ + L ++ + G+++LHS IHRDLKPSNI++ D K+ DFG
Sbjct: 125 DHER-MSYLLYQ--------MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 172
Query: 733 LVKNAPDGKYS---VETRLAGTFGYLAPE 758
L + A V TR Y APE
Sbjct: 173 LARTAGTSFMMTPYVVTRY-----YRAPE 196
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 6e-14
Identities = 48/191 (25%), Positives = 78/191 (40%), Gaps = 32/191 (16%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKI-AVKRME-SNTMGNKGLSEFQAEIAVLTKV-R 637
+F ++GRG + V L +I A+K ++ ++ + Q E V +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 638 HRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR- 695
H LV L C RL V EY+ G L H+ +++ + + AR
Sbjct: 69 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHM-------------QRQRKLPEEHARF 114
Query: 696 -------GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR- 747
+ YLH + I+RDLK N+L+ + K+ D+G+ K + T
Sbjct: 115 YSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTST 169
Query: 748 LAGTFGYLAPE 758
GT Y+APE
Sbjct: 170 FCGTPNYIAPE 180
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 9e-14
Identities = 49/183 (26%), Positives = 78/183 (42%), Gaps = 16/183 (8%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKI-AVKRME-SNTMGNKGLSEFQAEIAVLTKV-R 637
DNF +LG+G FG V + + + AVK ++ + + + E +L+
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 638 HRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARG 696
H L L C +RL V E++ G L +H + A ++
Sbjct: 83 HPFLTQLF-CCFQTPDRLFFVMEFVNGG----DLM-FHIQKSRRFDEARARFYAAEIISA 136
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR-LAGTFGYL 755
+ +LH + I+RDLK N+L+ + K+ADFG+ K V T GT Y+
Sbjct: 137 LMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYI 191
Query: 756 APE 758
APE
Sbjct: 192 APE 194
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 1e-13
Identities = 55/233 (23%), Positives = 90/233 (38%), Gaps = 39/233 (16%)
Query: 544 NGVPSELHSQSSGDVSDRHLFEGGNVAISIEVLRQ---VTDNFSEANILGRGGFGVVYGG 600
G ++ + + N S+EV V + +G G G+V
Sbjct: 22 QGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAA 81
Query: 601 -ELPDGTKIAVKRMESNTMGNKGLSEFQA-----EIAVLTKVRHRHLVALL------GYC 648
+ +A+K++ S N+ A E+ ++ V H+++++LL
Sbjct: 82 YDAVLDRNVAIKKL-SRPFQNQTH----AKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 136
Query: 649 INGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSF 708
+ LV E M L Q + L ++ + + G+++LHS
Sbjct: 137 EEFQDVYLVMELMD-ANLCQVI-------QMELDHERMSYLLYQMLCGIKHLHSA---GI 185
Query: 709 IHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY---SVETRLAGTFGYLAPE 758
IHRDLKPSNI++ D K+ DFGL + A V TR Y APE
Sbjct: 186 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPE 233
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 51/183 (27%), Positives = 81/183 (44%), Gaps = 16/183 (8%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKI-AVKRME-SNTMGNKGLSEFQAEIAVLTKV-R 637
+F+ +LG+G FG V E ++ AVK ++ + + + E VL +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 638 HRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARG 696
L L C +RL V EY+ G L +H V A ++A G
Sbjct: 80 PPFLTQLH-SCFQTMDRLYFVMEYVNGG----DLM-YHIQQVGRFKEPHAVFYAAEIAIG 133
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR-LAGTFGYL 755
+ +L S + I+RDLK N+++ + K+ADFG+ K + V T+ GT Y+
Sbjct: 134 LFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYI 188
Query: 756 APE 758
APE
Sbjct: 189 APE 191
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 30/199 (15%), Positives = 61/199 (30%), Gaps = 40/199 (20%)
Query: 589 LGRGGFGVVYGGE---------LPDGTKIAVK--------RMESNTMGNKGLSEFQAEIA 631
R G++Y P K ++K E N +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 632 VLTKVRHRHLVALLGYCINGSE-RLLVYEYMPR-GTLAQHLFEWHDHGYTPLTWKQRVTI 689
L + +G+ ++ + R LV +P G Q + L+ + + +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLV---LPSLGRSLQSALDVSPKH--VLSERSVLQV 164
Query: 690 ALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKV--ADFGLVKNAPDGKYSVETR 747
A + +E+LH ++H ++ NI + + +++V A +G V
Sbjct: 165 ACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYV 221
Query: 748 ------LAGTFGYLAPEYA 760
G E+
Sbjct: 222 EGSRSPHEGD-----LEFI 235
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 43/181 (23%), Positives = 64/181 (35%), Gaps = 52/181 (28%)
Query: 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172
T+ Q +YL +N T + G FD L NL+ L L N L
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSN----------------QLGA----- 78
Query: 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLS 232
L FDS + L L L N T LP+ D L
Sbjct: 79 -----LPVGVFDSLTQLTVLDLGTNQLT-VLPS--------------------AVFDRL- 111
Query: 233 GMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQN 291
L+++++ N+ T +P + + L L+L NQL + + L +L + L
Sbjct: 112 --VHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFG 168
Query: 292 N 292
N
Sbjct: 169 N 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 4e-12
Identities = 34/116 (29%), Positives = 48/116 (41%), Gaps = 13/116 (11%)
Query: 88 SLTQLETLSFQMNNI----AGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLS 143
SL L+ L N + G SL L + L N T +P+ FD L +L+ L
Sbjct: 62 SLINLKELYLGSNQLGALPVGVFDSLTQ---LTVLDLGTNQLTVLPSAVFDRLVHLKELF 118
Query: 144 LSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDF-FDSFSNLQNLRLSYNN 198
+ N P + + T LT L +D N IP FD S+L + L + N
Sbjct: 119 MCCNKLTE---LPRGIERLTHLTHLALDQ-NQLKSIPHGAFDRLSSLTHAYL-FGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 9e-07
Identities = 20/62 (32%), Positives = 28/62 (45%), Gaps = 2/62 (3%)
Query: 88 SLTQLETLSFQMNNIAGAIPS-LANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSD 146
L L+ L N + +P + T L + LD N S+P G FD L++L L
Sbjct: 110 RLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFG 168
Query: 147 NP 148
NP
Sbjct: 169 NP 170
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 41/168 (24%), Positives = 70/168 (41%), Gaps = 27/168 (16%)
Query: 578 QVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQA-----EIA 631
V DN+ +++GRG +G VY + +A+K++ + + EI
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV-NRMFEDLID----CKRILREIT 77
Query: 632 VLTKVRHRHLVALLGYCINGSERL-----LVYEYMPRGT-LAQHLFEWHDHGYTPLTWKQ 685
+L +++ +++ L I +V E + L + LT +
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA--DSDLKKLF-----KTPIFLTEEH 130
Query: 686 RVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733
TI ++ G ++H IHRDLKP+N L+ D KV DFGL
Sbjct: 131 IKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGL 175
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 50/211 (23%), Positives = 83/211 (39%), Gaps = 63/211 (29%)
Query: 578 QVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQA-------- 628
V ++ + +G G +G+V + + ++A+K+ +S F+
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKK----------ISPFEHQTYCQRTL 73
Query: 629 -EIAVLTKVRHRHLVALLGYCINGSERL-----LVYEYMP----RGTLAQHLFEWHDHG- 677
EI +L + RH +++ + + +V + M + QHL DH
Sbjct: 74 REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN--DHIC 131
Query: 678 ---YTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734
Y L RG++Y+HS + +HRDLKPSN+L+ K+ DFGL
Sbjct: 132 YFLYQIL-------------RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLA 175
Query: 735 KNAPDGKYS-------VETRLAGTFGYLAPE 758
+ A V TR Y APE
Sbjct: 176 RVADPDHDHTGFLTEYVATR-----WYRAPE 201
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 29/166 (17%), Positives = 57/166 (34%), Gaps = 25/166 (15%)
Query: 589 LGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYC 648
+G+GGFG +Y ++ + + E+ + +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 649 IN------------GSERLLVYEY----MPR-GTLAQHLFEWHDHGYTPLTWKQRVTIAL 691
G Y M R G+ Q ++E + + K + ++L
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAK---RFSRKTVLQLSL 159
Query: 692 DVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKV--ADFGLVK 735
+ +EY+H ++H D+K SN+L+ +V D+GL
Sbjct: 160 RILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 4e-13
Identities = 50/183 (27%), Positives = 80/183 (43%), Gaps = 16/183 (8%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKI-AVKRME-SNTMGNKGLSEFQAEIAVLTKV-R 637
++F +LG+G FG V+ E + A+K ++ + + + E VL+
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 638 HRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARG 696
H L + E L V EY+ G L H+ L + A ++ G
Sbjct: 77 HPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHI---QSCHKFDL--SRATFYAAEIILG 130
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR-LAGTFGYL 755
+++LHS ++RDLK NIL+ D K+ADFG+ K + +T GT Y+
Sbjct: 131 LQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNTFCGTPDYI 185
Query: 756 APE 758
APE
Sbjct: 186 APE 188
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 4e-13
Identities = 45/177 (25%), Positives = 78/177 (44%), Gaps = 23/177 (12%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH-RHLVALLG 646
+G G FG +Y G + G ++A+K +E + L E + ++ + +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIK-LECVKTKHPQL---HIESKIYKMMQGGVGIPTIRW 72
Query: 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ 706
G ++V E + G + LF + ++ T + +A + +EY+HS +
Sbjct: 73 CGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKT---VLLLADQMISRIEYIHS---K 124
Query: 707 SFIHRDLKPSNILIGDDMRAK---VADFGLVK---NAPDGK---YSVETRLAGTFGY 754
+FIHRD+KP N L+G + + DFGL K +A + Y L GT Y
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 70.3 bits (171), Expect = 4e-13
Identities = 36/228 (15%), Positives = 65/228 (28%), Gaps = 55/228 (24%)
Query: 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVK--RMESNTMGN----KGLSEFQAEIAVL 633
T+ +G G FG V+ D T +A+K +E + N K E EI +
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 634 TKV---------RHRHLVALLGYCI-------------------NGSERL---------- 655
++ R + L GS
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 656 -LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLK 714
+V E+ G L + + +I + + + + F HRDL
Sbjct: 138 FIVLEFEFGGID---LEQMRTK---LSSLATAKSILHQLTASLAVAEASLR--FEHRDLH 189
Query: 715 PSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGK 762
N+L+ K+ K++ ++ + + E G
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSI-IDYTLSRLERDGI 236
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 9e-13
Identities = 42/179 (23%), Positives = 71/179 (39%), Gaps = 25/179 (13%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH-RHLVALLG 646
+G G FGV++ G L + ++A+K E L + E + + +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIK-FEPRRSDAPQLRD---EYRTYKLLAGCTGIPNVYY 73
Query: 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ 706
+ G +LV + + G + L + ++ T A + V+ +H +
Sbjct: 74 FGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKT---VAMAAKQMLARVQSIHE---K 125
Query: 707 SFIHRDLKPSNILIGDDMRAK-----VADFGLVKNAPDGK------YSVETRLAGTFGY 754
S ++RD+KP N LIG V DFG+VK D Y + L+GT Y
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 50/213 (23%), Positives = 77/213 (36%), Gaps = 52/213 (24%)
Query: 574 EVLRQVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQA---- 628
++ ++ +F ++LG G +GVV P G +A+K+ + F
Sbjct: 4 RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKK----------IEPFDKPLFA 53
Query: 629 -----EIAVLTKVRHRHLVALLGYCINGSERL-----LVYEYMP----RGTLAQHLFEWH 674
EI +L +H +++ + S ++ E M R Q L + H
Sbjct: 54 LRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDH 113
Query: 675 DHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734
Q R V+ LH + IHRDLKPSN+LI + KV DFGL
Sbjct: 114 ---------IQ--YFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLA 159
Query: 735 KNAPDGKYSVETRLAGTFG---------YLAPE 758
+ + G Y APE
Sbjct: 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPE 192
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 41/226 (18%), Positives = 67/226 (29%), Gaps = 75/226 (33%)
Query: 587 NILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAE----------- 629
LGRG FG V + +AVK ++ + +E
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHL 86
Query: 630 -----IAVLTKVRHRHLVALLGYCING-------SERLLVYEY----------------- 660
+ TK +V ++ +C G S+R Y
Sbjct: 87 NVVNLLGACTKPGGPLMV-IVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI 145
Query: 661 ------------------------MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARG 696
+ + D LT + + + VA+G
Sbjct: 146 PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKG 205
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742
+E+L A + IHRDL NIL+ + K+ DFGL ++
Sbjct: 206 MEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 69.0 bits (168), Expect = 3e-12
Identities = 28/182 (15%), Positives = 58/182 (31%), Gaps = 8/182 (4%)
Query: 14 VLLLLQLTTTSLGDDGSVMLKLAQSLQNLPSDWSSTSSTGYCEWTGINCDNSNRVTTISL 73
+LL+ L + +++ + + + + + + V + L
Sbjct: 389 ILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHL 448
Query: 74 AKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCF 133
A L T+ + L + L N + P+LA L+ + +N +V
Sbjct: 449 AHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG--V 504
Query: 134 DGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN---ANIFGLIPDFFDSFSNLQ 190
L LQ L L +N L L L L + G+ + ++
Sbjct: 505 ANLPRLQELLLCNN-RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVS 563
Query: 191 NL 192
++
Sbjct: 564 SI 565
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 60.2 bits (145), Expect = 1e-09
Identities = 53/322 (16%), Positives = 96/322 (29%), Gaps = 22/322 (6%)
Query: 4 KKPQVSICAVVLLLLQLTTTSLGDDGSVMLKLAQSLQNLPSDWSSTSSTGYCEWTGINCD 63
+ V C V + +V ++ L + S +
Sbjct: 240 EPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHV 299
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNN 123
+ SL T + + + A L L
Sbjct: 300 WLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVE 359
Query: 124 NFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFF 183
T + + + LQ L + L LT + L L +F
Sbjct: 360 KSTVLQSE-LESCKELQELEPENKWCL--------LTIILLMRALDPLLYEKETL--QYF 408
Query: 184 DSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSG----TLDVLSGMTQLRQ 239
+ + +R +Y + S S ++ + + + L L+ L L + +
Sbjct: 409 STLKAVDPMRAAYLDDLRS-KFLLENSVLKMEYADVRVLHLAHKDLTVLCHLEQLLLVTH 467
Query: 240 VWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYP 299
+ L N+ P L+ L L DN L V V +LP L + L NN+LQ
Sbjct: 468 LDLSHNRLRALPPALAALRCLEVLQASDNALENV--DGVANLPRLQELLLCNNRLQQSAA 525
Query: 300 LFP----SKVQKVSLDHNNFCK 317
+ P ++ ++L N+ C+
Sbjct: 526 IQPLVSCPRLVLLNLQGNSLCQ 547
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 58.2 bits (140), Expect = 7e-09
Identities = 37/227 (16%), Positives = 70/227 (30%), Gaps = 21/227 (9%)
Query: 202 SLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLF 261
+ P+ D+ +NDQ L + +G ++ L K++ D + E LF
Sbjct: 294 NRPSHVWLCDLPAASLNDQ-LPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLF 352
Query: 262 DLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSD 321
L + T V+ + + S L + +N L + + +
Sbjct: 353 RCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKET------- 404
Query: 322 AGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAG 381
+ + + + ++LA+K L
Sbjct: 405 ---------LQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT- 454
Query: 382 NISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428
+ L + +L L N L +P L L L+ L S+N L
Sbjct: 455 VL-CHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE 499
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 50.9 bits (121), Expect = 1e-06
Identities = 54/403 (13%), Positives = 105/403 (26%), Gaps = 86/403 (21%)
Query: 50 SSTGYCEW--TGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAI- 106
S+ Y W + +S ++ LS S ++ +++ TL ++ ++
Sbjct: 227 SAWFYHRWLLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVE 286
Query: 107 ---------PSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPN 157
PS L L++ + G + + L P +
Sbjct: 287 WRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLL---KDRPECWCR 343
Query: 158 ELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWM 217
+ L + + ++ +S LQ L ++ + L
Sbjct: 344 DSATDEQLFRCEL-SVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRA--LDPLLY 400
Query: 218 NDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPAS 277
+ L TL + M L + + L L LT
Sbjct: 401 EKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-----V 455
Query: 278 VISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIA 337
+ L LL V + L HN ++ L
Sbjct: 456 LCHLEQLLL------------------VTHLDLSHN---------------RLRALPPAL 482
Query: 338 GDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLY 397
+ +L S +N + ++ ++ NL L+ L
Sbjct: 483 AALRCLEVLQAS---DN-------------ALENVD--------GVA----NLPRLQELL 514
Query: 398 LQQNNLTG-PIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVK 439
L N L L L L++ N+L + +
Sbjct: 515 LCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLA 556
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 52/203 (25%), Positives = 84/203 (41%), Gaps = 51/203 (25%)
Query: 578 QVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQA-------- 628
+V + + + +G G +G V + G ++AVK K FQ+
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK---------KLSRPFQSIIHAKRTY 76
Query: 629 -EIAVLTKVRHRHLVALL------GYCINGSERLLVYEYMP----RGTLAQHLFEWHDHG 677
E+ +L ++H +++ LL ++ LV M Q L + H
Sbjct: 77 RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-VQ 135
Query: 678 YTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737
+ + + RG++Y+HS IHRDLKPSN+ + +D K+ DFGL ++
Sbjct: 136 F----------LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT 182
Query: 738 PDGK--YSVETRLAGTFGYLAPE 758
D Y V TR Y APE
Sbjct: 183 ADEMTGY-VATRW-----YRAPE 199
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 5e-12
Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 40/206 (19%)
Query: 571 ISIEVLRQ---VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEF 626
EV + V + + +G G +G V + G K+A+K++ ++
Sbjct: 12 YRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-YRPFQSELF--- 67
Query: 627 QA-----EIAVLTKVRHRHLVALL------GYCINGSERLLVYEYMPRGT-LAQHLFEWH 674
A E+ +L +RH +++ LL + ++ LV +M GT L + +
Sbjct: 68 -AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLM---- 120
Query: 675 DHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734
+ L + + + +G+ Y+H+ IHRDLKP N+ + +D K+ DFGL
Sbjct: 121 --KHEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA 175
Query: 735 KNAPDGK--YSVETRLAGTFGYLAPE 758
+ A Y V TR Y APE
Sbjct: 176 RQADSEMTGY-VVTRW-----YRAPE 195
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 6e-12
Identities = 43/193 (22%), Positives = 78/193 (40%), Gaps = 39/193 (20%)
Query: 579 VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQA-----EIAV 632
D++ LGRG + V+ + + K+ VK L + EI +
Sbjct: 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI----------LKPVKKKKIKREIKI 83
Query: 633 LTKVR-HRHLVALLGYCINGSER--LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTI 689
L +R +++ L + R LV+E++ Q Y LT
Sbjct: 84 LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL--------YQTLTDYDIRFY 135
Query: 690 ALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRA-KVADFGLVK-NAPDGKYSVE-- 745
++ + ++Y HS +HRD+KP N++I + R ++ D+GL + P +Y+V
Sbjct: 136 MYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 192
Query: 746 TRLAGTFGYLAPE 758
+R + PE
Sbjct: 193 SRY-----FKGPE 200
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 7e-12
Identities = 44/171 (25%), Positives = 71/171 (41%), Gaps = 20/171 (11%)
Query: 572 SIEVLRQVTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEI 630
S+ VL V NF +G G FG + G+ L +A+K +E L E
Sbjct: 1 SMGVLM-VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHL---EY 55
Query: 631 AVLTKVRH-RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTI 689
++ + + + G +V E + G + LF+ D + K + I
Sbjct: 56 RFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDR---TFSLKTVLMI 110
Query: 690 ALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAK-----VADFGLVK 735
A+ + +EY+HS ++ I+RD+KP N LIG + DF L K
Sbjct: 111 AIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 8e-12
Identities = 40/197 (20%), Positives = 70/197 (35%), Gaps = 39/197 (19%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGL-SEFQ-----AEIAVLTKVRHRHL 641
+G GGFG++Y K A ++ N L SE + A+ + K R
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 642 VALLG-----YC-----INGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIAL 691
+ LG S R +V E + G Q + + + + +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGT----FKKSTVLQLGI 158
Query: 692 DVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKV--ADFGLVKNAPDG------KYS 743
+ +EY+H ++H D+K +N+L+G +V AD+GL + +
Sbjct: 159 RMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQEN 215
Query: 744 VETRLAGTFGYLAPEYA 760
GT E+
Sbjct: 216 PRKGHNGT-----IEFT 227
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 8e-12
Identities = 49/182 (26%), Positives = 66/182 (36%), Gaps = 53/182 (29%)
Query: 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172
+ L+ N+ S+P G FD LT+L L L N L +L
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGN----------------KLQSLP--- 68
Query: 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLS 232
F+ ++L L LS N SLP +G D L
Sbjct: 69 -------NGVFNKLTSLTYLNLSTNQLQ-SLP--------------------NGVFDKL- 99
Query: 233 GMTQLRQVWLHKNQFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQ 290
TQL+++ L+ NQ +PD K L DL L NQL V L +L I L
Sbjct: 100 --TQLKELALNTNQLQS-LPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLH 156
Query: 291 NN 292
+N
Sbjct: 157 DN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 1e-08
Identities = 32/120 (26%), Positives = 51/120 (42%), Gaps = 21/120 (17%)
Query: 63 DNSNRVTTISLAKSGLSGTLSPEI-SSLTQLETLSFQMNNI----AGAIPSLANATSLQD 117
D +T + L + L +L + + LT L L+ N + G L T L++
Sbjct: 49 DELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKL---TQLKE 104
Query: 118 IYLDNNNFTSVPTGCFDGLTNLQVLSLSDN-----PNLAPWPFPNELTKSTSLTTLYMDN 172
+ L+ N S+P G FD LT L+ L L N P+ F TSL +++ +
Sbjct: 105 LALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGV---FDR----LTSLQYIWLHD 157
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 3e-07
Identities = 27/65 (41%), Positives = 34/65 (52%), Gaps = 7/65 (10%)
Query: 88 SLTQLETLSFQMNNI----AGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLS 143
LTQL+ L+ N + G L T L+D+ L N SVP G FD LT+LQ +
Sbjct: 98 KLTQLKELALNTNQLQSLPDGVFDKL---TQLKDLRLYQNQLKSVPDGVFDRLTSLQYIW 154
Query: 144 LSDNP 148
L DNP
Sbjct: 155 LHDNP 159
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-11
Identities = 27/151 (17%), Positives = 46/151 (30%), Gaps = 33/151 (21%)
Query: 100 NNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDN--PNLAPWPFPN 157
I NA +++ L + L + SDN L +P
Sbjct: 7 ELIE-QAAQYTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKLDGFP--- 61
Query: 158 ELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWM 217
L TL ++N I + + +L L L+ N+ + L
Sbjct: 62 ---LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNS-------------LVEL-- 103
Query: 218 NDQQLGLSGTLDVLSGMTQLRQVWLHKNQFT 248
G LD L+ + L + + +N T
Sbjct: 104 --------GDLDPLASLKSLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 6e-10
Identities = 24/99 (24%), Positives = 40/99 (40%), Gaps = 6/99 (6%)
Query: 78 LSGTLSPEI----SSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCF 133
L G P I ++L Q + + F N I + L+ + ++NN + G
Sbjct: 26 LRGYKIPVIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNNRICRIGEGLD 84
Query: 134 DGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172
L +L L L++N +L + L SLT L +
Sbjct: 85 QALPDLTELILTNN-SLVELGDLDPLASLKSLTYLCILR 122
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 5e-05
Identities = 20/137 (14%), Positives = 43/137 (31%), Gaps = 22/137 (16%)
Query: 192 LRLSYNNFTGSLPASFAKSDIQNLW--MNDQQLGLSGTL-----DVLSGMTQLRQVWLHK 244
++L+ + D++L L G ++ + + Q +
Sbjct: 2 VKLTAELIE----------QAAQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSD 51
Query: 245 NQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGP---YPLF 301
N+ + L L + +N++ + +LP L + L NN L PL
Sbjct: 52 NEIR-KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLA 110
Query: 302 P-SKVQKVSLDHNNFCK 317
+ + + N
Sbjct: 111 SLKSLTYLCILRNPVTN 127
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 52/173 (30%), Positives = 79/173 (45%), Gaps = 32/173 (18%)
Query: 574 EVLRQVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQA---- 628
V R V + LG+G +G+V+ + G +AVK++ + N A
Sbjct: 2 RVDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKI-FDAFQNSTD----AQRTF 56
Query: 629 -EIAVLTKVR-HRHLVALLGYCI--NGSERLLVYEYMP----RGTLAQHLFEWHDHGYTP 680
EI +LT++ H ++V LL N + LV++YM A L H
Sbjct: 57 REIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVH------ 110
Query: 681 LTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733
KQ + + + ++YLHS +HRD+KPSNIL+ + KVADFGL
Sbjct: 111 ---KQ--YVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGL 155
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 17/152 (11%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLG 646
+G G FG +Y G + ++A+K +E+ + L E + ++ + +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQL---LYESKIYRILQGGTGIPNVRW 70
Query: 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ 706
+ + G +LV + + G + LF + L+ K + +A + VE++HS +
Sbjct: 71 FGVEGDYNVLVMDLL--GPSLEDLFNFCSR---KLSLKTVLMLADQMINRVEFVHS---K 122
Query: 707 SFIHRDLKPSNILIGDDMRAK---VADFGLVK 735
SF+HRD+KP N L+G RA + DFGL K
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 44/209 (21%), Positives = 79/209 (37%), Gaps = 52/209 (24%)
Query: 579 VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRM--ESNTMGNKGLSEFQAEIAVLTK 635
+ + + LG GG G+V+ + ++A+K++ L E I ++ +
Sbjct: 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALRE----IKIIRR 64
Query: 636 VRHRHLVALL----------GYCINGSERL----LVYEYMP----RGTLAQHLFEWHDHG 677
+ H ++V + + L +V EYM L E H
Sbjct: 65 LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEH--- 121
Query: 678 YTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI-GDDMRAKVADFGLVKN 736
+ L RG++Y+HS + +HRDLKP+N+ I +D+ K+ DFGL +
Sbjct: 122 ------ARLFMYQL--LRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARI 170
Query: 737 APDGKYS-------VETRLAGTFGYLAPE 758
+ T+ Y +P
Sbjct: 171 MDPHYSHKGHLSEGLVTKW-----YRSPR 194
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 3e-10
Identities = 24/92 (26%), Positives = 38/92 (41%), Gaps = 15/92 (16%)
Query: 88 SLTQLETLSFQMNNIAGAIPSLA--NATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145
L L L + N + I A A+ +Q++ L N + F GL L+ L+L
Sbjct: 52 RLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLY 110
Query: 146 DN-----PNLAPWPFPNELTKSTSLTTLYMDN 172
DN + F + L SLT+L + +
Sbjct: 111 DNQISCVMPGS---FEH-L---NSLTSLNLAS 135
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 28/140 (20%), Positives = 50/140 (35%), Gaps = 35/140 (25%)
Query: 113 TSLQDIYLDNNNFTSV-PTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMD 171
++ L++N + G F L +L L L N +LT
Sbjct: 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRN----------QLTG---------- 68
Query: 172 NANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPA-SFAK-SDIQNLWMNDQQLG--LSGT 227
+ P+ F+ S++Q L+L N + F ++ L + D Q+ + G+
Sbjct: 69 ------IEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGS 121
Query: 228 LDVLSGMTQLRQVWLHKNQF 247
+ L L + L N F
Sbjct: 122 FEHL---NSLTSLNLASNPF 138
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 7e-08
Identities = 16/65 (24%), Positives = 27/65 (41%), Gaps = 7/65 (10%)
Query: 88 SLTQLETLSFQMNNI----AGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLS 143
+ ++ L N I L L+ + L +N + V G F+ L +L L+
Sbjct: 76 GASHIQELQLGENKIKEISNKMFLGL---HQLKTLNLYDNQISCVMPGSFEHLNSLTSLN 132
Query: 144 LSDNP 148
L+ NP
Sbjct: 133 LASNP 137
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 3e-10
Identities = 37/192 (19%), Positives = 67/192 (34%), Gaps = 31/192 (16%)
Query: 67 RVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFT 126
+ TTI A S + ++E L + I +L+ + + + L NN
Sbjct: 3 KATTIKDAIRIFEERKSVVATEAEKVE-LHGMIPPIEKMDATLSTLKACKHLALSTNNIE 61
Query: 127 SVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSF 186
+ + G+ NL++LSL N + N + +L L++ I L +
Sbjct: 62 KI-SS-LSGMENLRILSLGRN-LIK--KIENLDAVADTLEELWISYNQIASL--SGIEKL 114
Query: 187 SNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQ 246
NL+ L +S N I N G +D L+ + +L + L N
Sbjct: 115 VNLRVLYMSNNK-------------ITNW----------GEIDKLAALDKLEDLLLAGNP 151
Query: 247 FTGPIPDLSKCE 258
+ +
Sbjct: 152 LYNDYKENNATS 163
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 4e-10
Identities = 40/138 (28%), Positives = 56/138 (40%), Gaps = 34/138 (24%)
Query: 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172
+S + L++N S+P G FD LT L LSLS N++
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQ----------NQIQS----------- 66
Query: 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPAS-FAK-SDIQNLWMNDQQLGL--SGTL 228
L FD + L L L N SLP F K + ++ L ++ QL G
Sbjct: 67 -----LPDGVFDKLTKLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIF 120
Query: 229 DVLSGMTQLRQVWLHKNQ 246
D L T L+++WLH N
Sbjct: 121 DRL---TSLQKIWLHTNP 135
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 2e-08
Identities = 31/94 (32%), Positives = 39/94 (41%), Gaps = 19/94 (20%)
Query: 88 SLTQLETLSFQMNNI----AGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLS 143
LTQL LS N I G L T L +YL N S+P G FD LT L+ L+
Sbjct: 50 KLTQLTKLSLSQNQIQSLPDGVFDKL---TKLTILYLHENKLQSLPNGVFDKLTQLKELA 106
Query: 144 LSDN-----PNLAPWPFPNELTKSTSLTTLYMDN 172
L N P+ F TSL +++
Sbjct: 107 LDTNQLKSVPDGI---FDR----LTSLQKIWLHT 133
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 4e-08
Identities = 36/132 (27%), Positives = 52/132 (39%), Gaps = 27/132 (20%)
Query: 163 TSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQL 222
+S T L +++ + L FD + L L LS N SLP
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPD----------------- 69
Query: 223 GLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASVIS 280
G D L T+L ++LH+N+ +P+ K L +L+L NQL V
Sbjct: 70 ---GVFDKL---TKLTILYLHENKLQS-LPNGVFDKLTQLKELALDTNQLKSVPDGIFDR 122
Query: 281 LPALLNISLQNN 292
L +L I L N
Sbjct: 123 LTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 2e-07
Identities = 24/63 (38%), Positives = 34/63 (53%), Gaps = 3/63 (4%)
Query: 88 SLTQLETLSFQMNNIAGAIPSLA--NATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145
LT+L L N + ++P+ T L+++ LD N SVP G FD LT+LQ + L
Sbjct: 74 KLTKLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLH 132
Query: 146 DNP 148
NP
Sbjct: 133 TNP 135
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 4e-10
Identities = 32/160 (20%), Positives = 53/160 (33%), Gaps = 54/160 (33%)
Query: 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172
+ ++YLD N FT VP +L ++ LS+N ++
Sbjct: 31 RDVTELYLDGNQFTLVP-KELSNYKHLTLIDLSNN----------RIST----------- 68
Query: 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLS 232
L F + + L L LSYN +P
Sbjct: 69 -----LSNQSFSNMTQLLTLILSYNRLR-CIPPR-----------------------TFD 99
Query: 233 GMTQLRQVWLHKNQFTGPIPD--LSKCESLFDLSLRDNQL 270
G+ LR + LH N + +P+ + +L L++ N L
Sbjct: 100 GLKSLRLLSLHGNDISV-VPEGAFNDLSALSHLAIGANPL 138
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 5e-10
Identities = 35/156 (22%), Positives = 55/156 (35%), Gaps = 41/156 (26%)
Query: 55 CEWTGINCDNSNR--------VTTISLAKSGLSGTLSP-EISSLTQLETLSFQMNNIAGA 105
C T + C N L G TL P E+S+ L + N I+
Sbjct: 10 CLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRIS-T 68
Query: 106 IPS--LANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKST 163
+ + +N T L + L N +P FDGL +L++LSL N++
Sbjct: 69 LSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHG----------NDI-SV- 116
Query: 164 SLTTLYMDNANIFGLIPD-FFDSFSNLQNLRLSYNN 198
+P+ F+ S L +L + N
Sbjct: 117 ---------------VPEGAFNDLSALSHLAI-GAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 3e-08
Identities = 30/89 (33%), Positives = 46/89 (51%), Gaps = 5/89 (5%)
Query: 63 DNSNRVTTISLAKSGLSGTLSPEI-SSLTQLETLSFQMNNIAGAIPSLA--NATSLQDIY 119
N +T I L+ + +S TLS + S++TQL TL N + IP SL+ +
Sbjct: 51 SNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLS 108
Query: 120 LDNNNFTSVPTGCFDGLTNLQVLSLSDNP 148
L N+ + VP G F+ L+ L L++ NP
Sbjct: 109 LHGNDISVVPEGAFNDLSALSHLAIGANP 137
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 60.5 bits (146), Expect = 8e-10
Identities = 19/102 (18%), Positives = 32/102 (31%), Gaps = 4/102 (3%)
Query: 122 NNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNE-LTKSTSLTTLYMDNANIFGLIP 180
+ G NL L + + +L L L L + + + + P
Sbjct: 17 RDGALDSLHH-LPGAENLTELYIENQQHL--QHLELRDLRGLGELRNLTIVKSGLRFVAP 73
Query: 181 DFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQL 222
D F L L LS+N + +Q L ++ L
Sbjct: 74 DAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 60.1 bits (145), Expect = 8e-10
Identities = 17/121 (14%), Positives = 34/121 (28%), Gaps = 18/121 (14%)
Query: 55 CEW-TGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP--SLAN 111
+G+ C + ++ + L L + + L
Sbjct: 7 PHGSSGLRCTRDGALDSL------------HHLPGAENLTELYIENQQHLQHLELRDLRG 54
Query: 112 ATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMD 171
L+++ + + V F L L+LS N L + + SL L +
Sbjct: 55 LGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN-ALE--SLSWKTVQGLSLQELVLS 111
Query: 172 N 172
Sbjct: 112 G 112
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 8e-05
Identities = 19/117 (16%), Positives = 34/117 (29%), Gaps = 25/117 (21%)
Query: 156 PNELTKSTSLTTLYMDNANIFGLIPDF-FDSFSNLQNLRLSYNNFTGSLPASFAKSDIQN 214
+ L + +LT LY++N + L+NL + + +
Sbjct: 24 LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAP--------- 73
Query: 215 LWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLT 271
D +L ++ L N + SL +L L N L
Sbjct: 74 --------------DAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 8e-05
Identities = 20/99 (20%), Positives = 39/99 (39%), Gaps = 4/99 (4%)
Query: 221 QLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASV 278
+ G +L L G L ++++ Q + L L +L++ + L V P +
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 279 ISLPALLNISLQNNKLQG--PYPLFPSKVQKVSLDHNNF 315
P L ++L N L+ + +Q++ L N
Sbjct: 77 HFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 43.6 bits (102), Expect = 1e-04
Identities = 19/110 (17%), Positives = 32/110 (29%), Gaps = 16/110 (14%)
Query: 355 ACDGWPFVTCSQGRIITI--------NLANKLLAGN-----ISP-AYANLTSLKNLYLQQ 400
G + C++ + NL + + L L+NL + +
Sbjct: 6 CPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 401 NNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKFTVSP--GNPF 448
+ L PD L L++S N L + GNP
Sbjct: 66 SGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 70/396 (17%), Positives = 121/396 (30%), Gaps = 97/396 (24%)
Query: 90 TQLETLSFQMNNI----AGAIPS-LANATSLQDIYLDNNNFTSVP-----TGCFDGLTNL 139
+++ LS Q + G + S L +LQ+++L +N G D L
Sbjct: 85 CKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRL 144
Query: 140 QVLSLSDNP-------NLAPWPFPNELTKSTSLTTLYMDNANIFG------LIPDFFDSF 186
+ L L LA L L + N N L DS
Sbjct: 145 EKLQLEYCSLSAASCEPLAS-----VLRAKPDFKELTVSN-NDINEAGVRVLCQGLKDSP 198
Query: 187 SNLQNLRLSYNNFTGSLPASFAK-----SDIQNLWMNDQQLGLSGTLD----VLSGMTQL 237
L+ L+L T + ++ L + +LG G + +L ++L
Sbjct: 199 CQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRL 258
Query: 238 RQVWLHKNQFTGP-----IPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNN 292
R +W+ + T L ESL +LSL N+L L L
Sbjct: 259 RTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELG---DEGARLLCETL--LEPGC 313
Query: 293 KLQGPYPLFPSKVQKVSLDHNNF----CKNSSDAGKPCDPQVTTLL----QIAGDMGYPA 344
+L+ + + +F C + S + L ++ D G
Sbjct: 314 QLE-----------SLWVKSCSFTAACCSHFSSVLAQN-RFLLELQISNNRL-EDAGVRE 360
Query: 345 ILSDSWEGNNACDGWPFVTCSQGRIITINLANKLL----AGNISPAYANLTSLKNLYLQQ 400
+ C G + + LA+ + +++ SL+ L L
Sbjct: 361 L----------CQGLGQPGSV---LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSN 407
Query: 401 NNLTGPIPDGLTKLA--------SLQNLDVSNNNLS 428
N L G+ +L L+ L + + S
Sbjct: 408 NCLG---DAGILQLVESVRQPGCLLEQLVLYDIYWS 440
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 3e-09
Identities = 68/431 (15%), Positives = 142/431 (32%), Gaps = 87/431 (20%)
Query: 64 NSNRVTTISLAKSGLSGT-LSPEISSLTQLETLSFQMNNI----AGAIPS-LANATSLQD 117
+ + + ++ + LS + + L Q + + + I S L +L +
Sbjct: 2 SLD-IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 60
Query: 118 IYLDNNNFTSVPTGC---FDGL----TNLQVLSLSDNPNLAP---WPFPNELTKSTSLTT 167
+ L +N G GL +Q LSL + L + L +L
Sbjct: 61 LNLRSNELG--DVGVHCVLQGLQTPSCKIQKLSLQNC-CLTGAGCGVLSSTLRTLPTLQE 117
Query: 168 LYMDNANI-----FGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-----SDIQNLWM 217
L++ + + L D L+ L+L Y + + + A D + L +
Sbjct: 118 LHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTV 177
Query: 218 NDQQLGLSGTLDVLSG----MTQLRQVWLHKNQFTGP-----IPDLSKCESLFDLSLRDN 268
++ + +G + G QL + L T ++ SL +L+L N
Sbjct: 178 SNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSN 237
Query: 269 QLT--GVV---PASVISLPALLNISLQNNKL--QGPYPLFP-----SKVQKVSLDHNNF- 315
+L G+ P + L + + + +G L ++++SL N
Sbjct: 238 KLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELG 297
Query: 316 ---CKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITI 372
+ + Q+ +L + C + V ++ +
Sbjct: 298 DEGARLLCETLLEPGCQLESLW-----------VKSCSFTAACCSHFSSVLAQNRFLLEL 346
Query: 373 NLAN--------KLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLAS-------L 417
++N + L + + L+ L+L +++ + LA+ L
Sbjct: 347 QISNNRLEDAGVRELCQGLG---QPGSVLRVLWLADCDVS---DSSCSSLAATLLANHSL 400
Query: 418 QNLDVSNNNLS 428
+ LD+SNN L
Sbjct: 401 RELDLSNNCLG 411
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 6e-07
Identities = 55/341 (16%), Positives = 109/341 (31%), Gaps = 85/341 (24%)
Query: 15 LLLLQLTTTSLGDDG----SVMLKLAQSLQNLPSDWSSTSSTGYCEWTGINCDNSNRVTT 70
L LQL SL + +L+ + L + + G D+ ++
Sbjct: 144 LEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEA 203
Query: 71 ISLAKSGLS----GTLSPEISSLTQLETLSFQMNNI--AGAIPSLANA-----TSLQDIY 119
+ L G++ L ++S L L+ N + G L + L+ ++
Sbjct: 204 LKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMA-ELCPGLLHPSSRLRTLW 262
Query: 120 LDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFG-- 177
+ T+ GC L L SL L + N G
Sbjct: 263 IWECGITAK--GC-------GDLCRV-------------LRAKESLKELSLAG-NELGDE 299
Query: 178 ----LIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-----SDIQNLWMNDQQLGLSGTL 228
L + L++L + +FT + + F+ + L +++ +L +G
Sbjct: 300 GARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVR 359
Query: 229 DVLSGM----TQLRQVWLHKNQFTGPIPD--------LSKCESLFDLSLRDNQLT--GVV 274
++ G+ + LR +WL + L SL +L L +N L G++
Sbjct: 360 ELCQGLGQPGSVLRVLWLADCDVS---DSSCSSLAATLLANHSLRELDLSNNCLGDAGIL 416
Query: 275 PASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNF 315
L S++ ++++ L +
Sbjct: 417 ---------QLVESVRQPG---------CLLEQLVLYDIYW 439
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 44/255 (17%), Positives = 79/255 (30%), Gaps = 54/255 (21%)
Query: 92 LETLSFQMNNI--AGAIP---SLANATSLQDIYLDNNNFTSVPTGC---FDGL---TNLQ 140
+E S +++ I L S+++I L N + + +L+
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIG--TEAARWLSENIASKKDLE 63
Query: 141 VLSLSDNPNLAPWPFPNE--------LTKSTSLTTLYMDNANIFG-----LIPDFFDSFS 187
+ SD E L K L T+ + + N FG + DF +
Sbjct: 64 IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD-NAFGPTAQEPLIDFLSKHT 122
Query: 188 NLQNLRLSYNNFT--------------GSLPASFAKSDIQNLWMNDQQLGLSGTL---DV 230
L++L L N + ++++ +L
Sbjct: 123 PLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 182
Query: 231 LSGMTQLRQVWLHKNQFT-----GPIPD-LSKCESLFDLSLRDNQLT--GVVP-ASVI-S 280
L V + +N + + L+ C+ L L L+DN T G A + S
Sbjct: 183 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 242
Query: 281 LPALLNISLQNNKLQ 295
P L + L + L
Sbjct: 243 WPNLRELGLNDCLLS 257
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 47/299 (15%), Positives = 87/299 (29%), Gaps = 64/299 (21%)
Query: 18 LQLTTTSLGDDGSV----MLKLAQSLQNLPSDWSSTSSTGYCEWTGINCD-------NSN 66
+ L+ ++G + + + + L+ ++S + +
Sbjct: 37 IVLSGNTIGTEAARWLSENIASKKDLEIA--EFSDIFTGRVKDEIPEALRLLLQALLKCP 94
Query: 67 RVTTISLAKSGLSGT----LSPEISSLTQLETLSFQMNNI--AGAIPSLANATSLQDIYL 120
++ T+ L+ + T L +S T LE L N + +A A L
Sbjct: 95 KLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGA-KIARA-------L 146
Query: 121 DNNNFTSVPTGCFDGLTNLQVLSLSDN-------PNLAPWPFPNELTKSTSLTTLYMDNA 173
L+ + N A L T+ M
Sbjct: 147 QELAVNKKAKNA----PPLRSIICGRNRLENGSMKEWA-----KTFQSHRLLHTVKMVQN 197
Query: 174 NIF-----GLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-----SDIQNLWMNDQQLG 223
I L+ + L+ L L N FT ++ A +++ L +ND L
Sbjct: 198 GIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 257
Query: 224 LSGTLDVLSGM-----TQLRQVWLHKNQFTGP-IPDL-----SKCESLFDLSLRDNQLT 271
G V+ L+ + L N+ + L K L L L N+ +
Sbjct: 258 ARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 5e-06
Identities = 53/330 (16%), Positives = 96/330 (29%), Gaps = 80/330 (24%)
Query: 136 LTN--LQVLSLSDNPNLAP---WPFPNELTKSTSLTTLYMDNANIFG-----LIPDFFDS 185
+ ++ SL + + L + S+ + + N G + + S
Sbjct: 1 MARFSIEGKSLKLD-AITTEDEKSVFAVLLEDDSVKEIVLSG-NTIGTEAARWLSENIAS 58
Query: 186 FSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKN 245
+L+ S + FTG + + L L L +L V L N
Sbjct: 59 KKDLEIAEFS-DIFTGRVKDEIPE-------------ALRLLLQALLKCPKLHTVRLSDN 104
Query: 246 QFTGPI------PDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYP 299
F GP LSK L L L +N L P + + L N K + P
Sbjct: 105 AF-GPTAQEPLIDFLSKHTPLEHLYLHNNGLG---PQAGAKIARALQELAVNKKAKNAPP 160
Query: 300 LFPSKVQKVSLDHNNF----CKNSSDAGKPCDPQVTTLL----QIAGDMGYPAILSDSWE 351
L + + N K + + + T+ I G +L +
Sbjct: 161 L-----RSIICGRNRLENGSMKEWAKTFQSH-RLLHTVKMVQNGI-RPEGIEHLLLEGLA 213
Query: 352 GNNACDGWPFVTCSQGRIITINLANKLL----AGNISPAYANLTSLKNLYLQQNNLTGPI 407
+ ++L + + ++ A + +L+ L L L+
Sbjct: 214 YCQE-------------LKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS--- 257
Query: 408 PDGLTKLA---------SLQNLDVSNNNLS 428
G + LQ L + N +
Sbjct: 258 ARGAAAVVDAFSKLENIGLQTLRLQYNEIE 287
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* Length = 130 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 6e-09
Identities = 12/36 (33%), Positives = 17/36 (47%)
Query: 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNP 148
++ L NN T++P G D L L+ L NP
Sbjct: 31 VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANP 66
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 7e-09
Identities = 23/110 (20%), Positives = 37/110 (33%), Gaps = 3/110 (2%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEI-SSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDN 122
V + L + + + LE LS + ++ +L L+ + L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSNLPKLPKLKKLELSE 80
Query: 123 NNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172
N + L NL L+LS N L L K L +L + N
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGN-KLKDISTLEPLKKLECLKSLDLFN 129
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 4e-08
Identities = 28/141 (19%), Positives = 51/141 (36%), Gaps = 32/141 (22%)
Query: 111 NATSLQDIYLDNNNFTSVPT-GCFDGLTNLQVLSLSDN--PNLAPWPFPNELTKSTSLTT 167
+++++ LDN G NL+ LSL + +++ L K L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSN------LPKLPKLKK 75
Query: 168 LYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGT 227
L + IFG + + NL +L LS N ++++ T
Sbjct: 76 LELSENRIFGGLDMLAEKLPNLTHLNLSGNK-------------LKDI----------ST 112
Query: 228 LDVLSGMTQLRQVWLHKNQFT 248
L+ L + L+ + L + T
Sbjct: 113 LEPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 7e-06
Identities = 17/86 (19%), Positives = 37/86 (43%), Gaps = 1/86 (1%)
Query: 210 SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQ 269
+ ++ L +++ + + + L + L + +L K L L L +N+
Sbjct: 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-VSNLPKLPKLKKLELSENR 82
Query: 270 LTGVVPASVISLPALLNISLQNNKLQ 295
+ G + LP L +++L NKL+
Sbjct: 83 IFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-08
Identities = 28/156 (17%), Positives = 50/156 (32%), Gaps = 38/156 (24%)
Query: 99 MNNIAGAIPSLANATSLQDIYLDNNNFTSVP-TGCFDGLTNLQVLSLSDN-----PNLAP 152
M + ++++ LDN+ G D L+ LS + NL
Sbjct: 3 MGRRIHLELRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLP- 61
Query: 153 WPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDI 212
K L L + + + G + + NL +L LS N I
Sbjct: 62 --------KLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNK-------------I 100
Query: 213 QNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFT 248
++L T++ L + L+ + L + T
Sbjct: 101 KDL----------STIEPLKKLENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-08
Identities = 27/132 (20%), Positives = 49/132 (37%), Gaps = 5/132 (3%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEI-SSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDN 122
+ V + L S + + +LE LS + +I +L L+ + L +
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIANLPKLNKLKKLELSD 73
Query: 123 NNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDF 182
N + + NL L+LS N + L K +L +L + N + D+
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGN-KIKDLSTIEPLKKLENLKSLDLFN-CEVTNLNDY 131
Query: 183 FDS-FSNLQNLR 193
++ F L L
Sbjct: 132 RENVFKLLPQLT 143
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 4e-06
Identities = 21/114 (18%), Positives = 46/114 (40%), Gaps = 5/114 (4%)
Query: 210 SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQ 269
SD++ L +++ + + +L + T I +L K L L L DN+
Sbjct: 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS-IANLPKLNKLKKLELSDNR 75
Query: 270 LTGVVPASVISLPALLNISLQNNKLQGPYPLFP----SKVQKVSLDHNNFCKNS 319
++G + P L +++L NK++ + P ++ + L + +
Sbjct: 76 VSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLN 129
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 37/170 (21%), Positives = 69/170 (40%), Gaps = 37/170 (21%)
Query: 588 ILGRGGFG-VVYGGELPDGTKIAVKRMESNTMGNKGLSEFQA--EIAVLTKVR------- 637
LG G F V ++ + T +A+K + + + + A EI +L +V
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE-----AAEDEIKLLQRVNDADNTKE 80
Query: 638 ----HRHLVALLGY----CINGSERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWKQRVT 688
H++ LL + NG ++V+E L ++L + + +
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFE-----VLGENLLALIKKYEHRGIPLIYVKQ 135
Query: 689 IALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRA------KVADFG 732
I+ + G++Y+H + IH D+KP N+L+ K+AD G
Sbjct: 136 ISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG 183
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 9e-08
Identities = 35/164 (21%), Positives = 72/164 (43%), Gaps = 35/164 (21%)
Query: 587 NILGRGGFG-VVYGGELPDGTKIAVKRMESNT-MGNKGLSEFQAEIAVLTKVRHR----- 639
+++G+G FG VV + + +A+K +++ N+ E + +L +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIE----VRLLELMNKHDTEMK 115
Query: 640 -HLVALLGY-------CINGSERLLVYEYMPRGTLAQHLFEWH-DHGYTPLTWKQRVTIA 690
++V L + C+ V+E L+ +L++ + + ++ A
Sbjct: 116 YYIVHLKRHFMFRNHLCL-------VFEM-----LSYNLYDLLRNTNFRGVSLNLTRKFA 163
Query: 691 LDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRA--KVADFG 732
+ + +L + + S IH DLKP NIL+ + R+ K+ DFG
Sbjct: 164 QQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFG 206
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 38/164 (23%), Positives = 69/164 (42%), Gaps = 39/164 (23%)
Query: 588 ILGRGGFG-VVYGGELPDGTKIAVKRMESNTMGNKGLSEFQA--EIAVLTKVRHR----- 639
++G+G FG VV + +A+K + + ++ QA EI +L +R +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHR-----QAAEEIRILEHLRKQDKDNT 158
Query: 640 -HLVALLGY-------CINGSERLLVYEYMPRGTLAQHLFEWH-DHGYTPLTWKQRVTIA 690
+++ +L C+ +E L+ +L+E + + + A
Sbjct: 159 MNVIHMLENFTFRNHICM-------TFEL-----LSMNLYELIKKNKFQGFSLPLVRKFA 206
Query: 691 LDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRA--KVADFG 732
+ + ++ LH IH DLKP NIL+ R+ KV DFG
Sbjct: 207 HSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFG 247
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 2e-07
Identities = 23/65 (35%), Positives = 31/65 (47%), Gaps = 7/65 (10%)
Query: 88 SLTQLETLSFQMNNI----AGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLS 143
LTQL L N + AG L T L + L++N S+P G FD L +L +
Sbjct: 52 RLTQLTRLDLDNNQLTVLPAGVFDKL---TQLTQLSLNDNQLKSIPRGAFDNLKSLTHIW 108
Query: 144 LSDNP 148
L +NP
Sbjct: 109 LLNNP 113
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 5e-07
Identities = 33/92 (35%), Positives = 40/92 (43%), Gaps = 19/92 (20%)
Query: 90 TQLETLSFQMNNI----AGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145
T + L N I G L T L + LDNN T +P G FD LT L LSL+
Sbjct: 30 TTTQVLYLYDNQITKLEPGVFDRL---TQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN 86
Query: 146 DN-----PNLAPWPFPNELTKSTSLTTLYMDN 172
DN P A F N SLT +++ N
Sbjct: 87 DNQLKSIPRGA---FDN----LKSLTHIWLLN 111
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 4e-05
Identities = 42/137 (30%), Positives = 51/137 (37%), Gaps = 39/137 (28%)
Query: 114 SLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNA 173
S + + SVPTG T QVL L DN ++TK
Sbjct: 10 SGTTVDCSGKSLASVPTGI---PTTTQVLYLYDN----------QITK------------ 44
Query: 174 NIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPAS-FAK-SDIQNLWMNDQQLGLS---GTL 228
L P FD + L L L N T LPA F K + + L +ND QL S G
Sbjct: 45 ----LEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDNQLK-SIPRGAF 98
Query: 229 DVLSGMTQLRQVWLHKN 245
D L L +WL N
Sbjct: 99 DNL---KSLTHIWLLNN 112
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 2e-07
Identities = 21/65 (32%), Positives = 31/65 (47%), Gaps = 7/65 (10%)
Query: 88 SLTQLETLSFQMNNI----AGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLS 143
L L+ L F N + G L T L + L++N+ S+P G FD L +L +
Sbjct: 55 HLVNLQQLYFNSNKLTAIPTGVFDKL---TQLTQLDLNDNHLKSIPRGAFDNLKSLTHIY 111
Query: 144 LSDNP 148
L +NP
Sbjct: 112 LYNNP 116
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 5e-07
Identities = 33/92 (35%), Positives = 42/92 (45%), Gaps = 19/92 (20%)
Query: 90 TQLETLSFQMNNI----AGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145
T + L N I G L N LQ +Y ++N T++PTG FD LT L L L+
Sbjct: 33 TDKQRLWLNNNQITKLEPGVFDHLVN---LQQLYFNSNKLTAIPTGVFDKLTQLTQLDLN 89
Query: 146 DN-----PNLAPWPFPNELTKSTSLTTLYMDN 172
DN P A F N SLT +Y+ N
Sbjct: 90 DNHLKSIPRGA---FDN----LKSLTHIYLYN 114
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 36/137 (26%), Positives = 51/137 (37%), Gaps = 39/137 (28%)
Query: 114 SLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNA 173
+ N SVP G T+ Q L L++N ++TK
Sbjct: 13 DQTLVNCQNIRLASVPAGI---PTDKQRLWLNNN----------QITK------------ 47
Query: 174 NIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPAS-FAK-SDIQNLWMNDQQLGLS---GTL 228
L P FD NLQ L + N T ++P F K + + L +ND L S G
Sbjct: 48 ----LEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDNHLK-SIPRGAF 101
Query: 229 DVLSGMTQLRQVWLHKN 245
D L L ++L+ N
Sbjct: 102 DNL---KSLTHIYLYNN 115
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 9e-07
Identities = 32/169 (18%), Positives = 57/169 (33%), Gaps = 34/169 (20%)
Query: 588 ILGRGGFG-VVYGGELPDGTKIAVKRMESN-TMGNKGLSEFQAEIAVLTKVRHR-----H 640
+G G FG V+ + + AVK + + E +L K+++ +
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE----ADILKKIQNDDINNNN 97
Query: 641 LVALLGY-------CINGSERLLVYEYMPRGTLAQHLFEWH-DHGYTPLTWKQRVTIALD 692
+V G C+ ++E L L+E + Y + ++
Sbjct: 98 IVKYHGKFMYYDHMCL-------IFE-----PLGPSLYEIITRNNYNGFHIEDIKLYCIE 145
Query: 693 VARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK 741
+ + + YL + S H DLKP NIL+ D K
Sbjct: 146 ILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI 191
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 29/107 (27%), Positives = 49/107 (45%), Gaps = 18/107 (16%)
Query: 629 EIAVLTKVR--------HRHLVALLGY----CINGSERLLVYEYMPRGTLAQHLFEWHDH 676
EI +L VR +V LL +NG+ +V+E + L + + + +
Sbjct: 83 EIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQ 141
Query: 677 GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD 723
G K+ I V +G++YLH+ + IH D+KP NIL+ +
Sbjct: 142 GLPLPCVKK---IIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVN 183
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 42/313 (13%), Positives = 89/313 (28%), Gaps = 42/313 (13%)
Query: 15 LLLLQLTTTSLGDDGSVMLKLAQSLQNLPSDWSSTSSTGYCEWTGINCDNSNRVTTISLA 74
L+ +++ + + K A +L+ S + +N ++ + L+
Sbjct: 222 LVSVKVGDFEILELVGF-FKAAANLEEF--CGGSLNEDIGMPEKYMNLVFPRKLCRLGLS 278
Query: 75 KSGLSGTLSPEISSLTQLETLSFQMNNI--AGAIPSLANATSLQDIYLDN----NNFTSV 128
G + + Q+ L + + +L+ + N +
Sbjct: 279 YMGPNE-MPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVL 337
Query: 129 PTGCFDGLTNLQVLSLSDNPNLAPWPFPNEL----------TKSTSLTTLYMDNANI--F 176
C L+ L + + L L + + ++I
Sbjct: 338 AQYC----KQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNE 393
Query: 177 GLIPDFFDSFSNLQNLRLSY----NNFT--------GSLPASFAKSDIQNLWMNDQQLGL 224
L NL + RL T SL K ++ L
Sbjct: 394 SLES-IGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTD 452
Query: 225 SGTLDVLSGMTQLRQVWLHKNQFT--GPIPDLSKCESLFDLSLRDNQLTGV-VPASVISL 281
G + +R + L + G + C +L L +R + + A+V L
Sbjct: 453 LGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKL 512
Query: 282 PALLNISLQNNKL 294
P+L + +Q +
Sbjct: 513 PSLRYLWVQGYRA 525
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 37/181 (20%), Positives = 61/181 (33%), Gaps = 55/181 (30%)
Query: 588 ILGRGGFGVVYGG--ELPDGTKIAVKRMESN-TMGNKGLSEFQAEIAVLTKVRHR----- 639
LG G FG V +++A+K + + E I VL K++ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE----INVLKKIKEKDKENK 81
Query: 640 -HLVALLGY-------CINGSERLLVYEYMPRGTLAQHLFEWH-DHGYTPLTWKQRVTIA 690
V + + CI +E L ++ FE+ ++ + P +A
Sbjct: 82 FLCVLMSDWFNFHGHMCI-------AFE-----LLGKNTFEFLKENNFQPYPLPHVRHMA 129
Query: 691 LDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRA-------------------KVADF 731
+ + +LH H DLKP NIL + +VADF
Sbjct: 130 YQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186
Query: 732 G 732
G
Sbjct: 187 G 187
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 34/241 (14%), Positives = 72/241 (29%), Gaps = 50/241 (20%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISS-LTQLETLSFQMNNI--AGAIPSLA-----NATSL 115
+ + ++LA L + + L Q+N++ L + +
Sbjct: 99 GRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACK-DLRDLLLHDQCQI 157
Query: 116 QDIYLDNNNFTSVPTGC---FDGL---TNLQVLSLSDNP-------NLAPWPFPNELTKS 162
+ L NN T+ G +GL T++ LSL LA +L ++
Sbjct: 158 TTLRLSNNPLTAA--GVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLA-----AQLDRN 210
Query: 163 TSLTTLYMDNANI----FGLIPDFFDSFSNLQNLRLSYNNFTGS--------LPASFAKS 210
L L + + +L+ L L +N + A+ +
Sbjct: 211 RQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGA 270
Query: 211 DIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQL 270
+ + ++ +LS + + W + + L L D++
Sbjct: 271 RVVVSLTEGTAVSEYWSV-ILSEVQRNLNSWDRAR--------VQRHLELLLRDLEDSRG 321
Query: 271 T 271
Sbjct: 322 A 322
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 44/186 (23%), Positives = 62/186 (33%), Gaps = 65/186 (34%)
Query: 588 ILGRGGFG-VV------YGGELPDGTKIAVKRMESN-TMGNKGLSEFQAEIAVLTKVRHR 639
LG G FG VV GG +AVK +++ SE I VL +
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRH-----VAVKIVKNVDRYCEAARSE----IQVLEHLNTT 71
Query: 640 ------HLVALLGY-------CINGSERLLVYEYMPRGTLAQHLFEWH-DHGYTPLTWKQ 685
V +L + CI V+E L +++ ++G+ P
Sbjct: 72 DPNSTFRCVQMLEWFEHHGHICI-------VFE-----LLGLSTYDFIKENGFLPFRLDH 119
Query: 686 RVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRA------------------- 726
+A + + V +LHS H DLKP NIL
Sbjct: 120 IRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176
Query: 727 KVADFG 732
KV DFG
Sbjct: 177 KVVDFG 182
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 782 | |||
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.98 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.98 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.98 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.98 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.98 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.98 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.98 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.98 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.98 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.98 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.98 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.98 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.98 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.98 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.98 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.98 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.98 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.97 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.97 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.97 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.97 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.97 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.97 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.97 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.97 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.97 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.97 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.97 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.97 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.97 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.97 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.97 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.97 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.97 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.97 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.97 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.97 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.97 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.97 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.97 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.97 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.97 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.97 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.97 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.97 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.97 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.97 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.97 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.97 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.97 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.97 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.97 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.97 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.97 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.97 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.97 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.97 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.97 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.97 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.97 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.97 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.97 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.97 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.97 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.97 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.97 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.97 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.97 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.97 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.97 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.97 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.97 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.97 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.97 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.97 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.97 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.97 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.97 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.97 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.97 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.97 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.97 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.97 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.97 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.97 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.97 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.97 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.97 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.97 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.97 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.97 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.97 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.97 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.97 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.97 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.97 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.97 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.97 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.97 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.97 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.97 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.97 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.97 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.97 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.97 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.97 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.97 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.97 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.97 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.97 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.97 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.97 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.97 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.97 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.97 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.97 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.97 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.97 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.97 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.97 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.97 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.97 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.97 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.97 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.97 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.97 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.97 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.97 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.97 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.97 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.97 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.96 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.96 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.96 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.96 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.96 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.96 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.96 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.96 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.96 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.96 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.96 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.96 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.96 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.96 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.96 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.96 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.96 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.96 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.96 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.96 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.96 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.96 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.96 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.96 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.96 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.96 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.96 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.96 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.96 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.96 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.96 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.96 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.96 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.96 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.96 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.96 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.96 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.96 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.96 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.96 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.96 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.96 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.96 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.96 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.96 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.96 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.96 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.96 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.96 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.96 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.96 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.96 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.96 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.96 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.96 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.96 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.96 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.96 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.96 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.96 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.96 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.96 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.96 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.96 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.96 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.96 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.96 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.96 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.96 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.96 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.96 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.96 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.96 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.96 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.96 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.96 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.95 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.95 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.95 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.95 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.95 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.95 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.95 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.94 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.93 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.92 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.91 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.9 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.89 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.89 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.88 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.86 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.86 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.86 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.86 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.85 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.85 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.85 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.83 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.83 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.82 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.82 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.82 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.81 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.81 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.81 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.81 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.8 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.79 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.79 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.78 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.78 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.78 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.77 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.76 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.75 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.75 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.75 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.74 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.74 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.73 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.72 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.71 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.7 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.68 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.67 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.66 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.64 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.62 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.61 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.6 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.59 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.58 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.58 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.57 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.54 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.53 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.5 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.5 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.49 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.48 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.46 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.45 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.45 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.34 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.32 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.32 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.25 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.23 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.17 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.14 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.07 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.03 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.02 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.98 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.86 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.81 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.77 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.76 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.73 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.73 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.51 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.5 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.48 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.33 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.32 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.32 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.31 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.28 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.16 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.06 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.91 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.65 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.64 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.6 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.56 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.41 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.39 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.33 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.31 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.27 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.12 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.03 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.02 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.99 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.74 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.72 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.61 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.45 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.45 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.8 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.62 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 90.6 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 89.69 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.94 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 84.76 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 84.07 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 82.96 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 82.28 |
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=444.34 Aligned_cols=419 Identities=20% Similarity=0.246 Sum_probs=322.1
Q ss_pred cchhHHHHHHHHHhcCCCCCCC---------CCCCCCCCccc---cceEeCCCCCEEEEEeCCCCCCcccCccccCCccC
Q 003982 25 LGDDGSVMLKLAQSLQNLPSDW---------SSTSSTGYCEW---TGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQL 92 (782)
Q Consensus 25 ~~~~~~~l~~~~~~~~~~~~~w---------~~~~~~~~c~w---~gv~c~~~~~v~~L~l~~~~l~~~~~~~l~~l~~L 92 (782)
...|+.||.++++++.+....+ +|..+.++|.| +||+|+..++|+.|+|++++++|.+|++|++|++|
T Consensus 28 ~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~~L~~L 107 (636)
T 4eco_A 28 YIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTEL 107 (636)
T ss_dssp HHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECGGGGGCTTC
T ss_pred HHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcccccCCCCeEEcCCCCEEEEEecCcccCCcCChHHhcCccc
Confidence 3469999999999986643110 13346789999 99999988999999999999999999999999999
Q ss_pred ceeecccCc-----------------------------------------------------------------------
Q 003982 93 ETLSFQMNN----------------------------------------------------------------------- 101 (782)
Q Consensus 93 ~~L~L~~N~----------------------------------------------------------------------- 101 (782)
++|+|++|.
T Consensus 108 ~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~l~ 187 (636)
T 4eco_A 108 EVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQ 187 (636)
T ss_dssp CEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCTTT
T ss_pred eEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhhhh
Confidence 999999984
Q ss_pred -------cCccCCCCCCCCCCCEEeCCCCcccC------------------CCCCCCC--CCCCCCEEeccCCCCCCCCC
Q 003982 102 -------IAGAIPSLANATSLQDIYLDNNNFTS------------------VPTGCFD--GLTNLQVLSLSDNPNLAPWP 154 (782)
Q Consensus 102 -------l~~~~~~l~~l~~L~~L~Ls~n~l~~------------------~~~~~~~--~l~~L~~L~Ls~N~l~~~~~ 154 (782)
++++++.|.++++|++|+|++|+|++ +|.. +. ++++|++|+|++|++.. .
T Consensus 188 l~~~~n~l~~ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~-l~~~~l~~L~~L~L~~n~l~~--~ 264 (636)
T 4eco_A 188 IGQLSNNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTED-LKWDNLKDLTDVEVYNCPNLT--K 264 (636)
T ss_dssp TTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSC-CCGGGCTTCCEEEEECCTTCS--S
T ss_pred hccccCCCccCCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchh-hhhcccCCCCEEEecCCcCCc--c
Confidence 44533479999999999999999999 6655 67 99999999999999988 6
Q ss_pred CCcccCCCcccCeeeccccc-cCC-CCcccccCC------CCCcEEEcccCcCCCCCCc--cccc-cccchhhcccccCC
Q 003982 155 FPNELTKSTSLTTLYMDNAN-IFG-LIPDFFDSF------SNLQNLRLSYNNFTGSLPA--SFAK-SDIQNLWMNDQQLG 223 (782)
Q Consensus 155 ~p~~~~~l~~L~~L~L~~N~-l~~-~~~~~~~~l------~~L~~L~Ls~N~l~~~~p~--~~~~-~~l~~l~l~~~~~~ 223 (782)
+|..+.++++|++|+|++|+ +++ .+|..+..+ ++|++|+|++|+++ .+|. .+.. ..|+.|++++|.+.
T Consensus 265 ~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~ 343 (636)
T 4eco_A 265 LPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLE 343 (636)
T ss_dssp CCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCE
T ss_pred ChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCc
Confidence 88999999999999999998 888 778888776 88999999999998 8887 6665 57888888888765
Q ss_pred CccccccccCCCCCcEEEeecccccCCCCCCCCCCC-CCEEEcCCCcCccCcchhhcCCC--CCCEEEccCCcccCCCCC
Q 003982 224 LSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCES-LFDLSLRDNQLTGVVPASVISLP--ALLNISLQNNKLQGPYPL 300 (782)
Q Consensus 224 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~-L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~l~~N~l~~~~~~ 300 (782)
. ..+.+.++++|++|+|++|+++..+..+..+++ |++|++++|+++ .+|..+..++ +|++|++++|++++.+|.
T Consensus 344 g--~ip~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 420 (636)
T 4eco_A 344 G--KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGK 420 (636)
T ss_dssp E--ECCCCEEEEEESEEECCSSEEEECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTC
T ss_pred c--chhhhCCCCCCCEEECCCCccccccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchh
Confidence 2 222677778888888888888866556777777 888888888887 6777776654 788888888888776665
Q ss_pred CCC----------CccEEEccCCcCCCCCCCCCCC-CChhhh-----hHHHhhcCCCC-C-------cccccCcCCCCCC
Q 003982 301 FPS----------KVQKVSLDHNNFCKNSSDAGKP-CDPQVT-----TLLQIAGDMGY-P-------AILSDSWEGNNAC 356 (782)
Q Consensus 301 ~~~----------~l~~L~l~~N~~~~~~~~~~~~-~~~~~~-----~~~~~~~~~~~-~-------~~~~~~~~~~~~~ 356 (782)
.+. +|+.|+|++|+++.++...... ...+.. .+..++..... . ..+......++.+
T Consensus 421 ~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l 500 (636)
T 4eco_A 421 NFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKL 500 (636)
T ss_dssp SSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCC
T ss_pred hhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcC
Confidence 433 6777777777777654221110 000000 00011111000 0 0233334455666
Q ss_pred CCCCcccc--cCCceeEEEccCcccccccCccccccccCCeEec------ccccccccCCccCCCCCCCCeEecCCCcCC
Q 003982 357 DGWPFVTC--SQGRIITINLANKLLAGNISPAYANLTSLKNLYL------QQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428 (782)
Q Consensus 357 ~~~p~~~~--~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L------s~N~l~g~~p~~~~~l~~L~~L~ls~N~l~ 428 (782)
..+|..+. .+++|+.|+|++|+|++ +|..+.++++|++|+| ++|++.+.+|..+..+++|+.|+|++|++
T Consensus 501 ~~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l- 578 (636)
T 4eco_A 501 TKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI- 578 (636)
T ss_dssp CBCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-
T ss_pred CccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-
Confidence 68898887 88999999999999998 8889999999999999 56788889999999999999999999999
Q ss_pred CCCC-CCCCCcceecCCCCCCCCCC
Q 003982 429 GKVP-DFGSNVKFTVSPGNPFIGTN 452 (782)
Q Consensus 429 g~~p-~~~~~~~~~~~~~n~~~~~~ 452 (782)
+.+| .+...+....+++||+.|-.
T Consensus 579 ~~ip~~~~~~L~~L~Ls~N~l~~~~ 603 (636)
T 4eco_A 579 RKVNEKITPNISVLDIKDNPNISID 603 (636)
T ss_dssp CBCCSCCCTTCCEEECCSCTTCEEE
T ss_pred CccCHhHhCcCCEEECcCCCCcccc
Confidence 5555 56788888899999987744
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=448.17 Aligned_cols=416 Identities=21% Similarity=0.283 Sum_probs=320.7
Q ss_pred cccchhHHHHHHHHHhcCCCCCCCCCCC---CCCC--ccc------------cceEeCCCCCEEEEEeCCCCCCcccCcc
Q 003982 23 TSLGDDGSVMLKLAQSLQNLPSDWSSTS---STGY--CEW------------TGINCDNSNRVTTISLAKSGLSGTLSPE 85 (782)
Q Consensus 23 ~~~~~~~~~l~~~~~~~~~~~~~w~~~~---~~~~--c~w------------~gv~c~~~~~v~~L~l~~~~l~~~~~~~ 85 (782)
+...+|+.||++||+++.+. +|.... ..++ |.| .||+|+..++|+.|+|++++|.|.+|++
T Consensus 265 ~~~~~d~~ALl~~k~~l~~~--~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~ip~~ 342 (876)
T 4ecn_A 265 AEYIKDYKALKAIWEALDGK--NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDA 342 (876)
T ss_dssp CHHHHHHHHHHHHHHHTTGG--GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEEECGG
T ss_pred ccchHHHHHHHHHHHHcCCC--CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCcCchH
Confidence 34457999999999999654 786443 2344 999 9999998899999999999999999999
Q ss_pred ccCCccCceeec-ccCccCcc-----------------------------------------------------------
Q 003982 86 ISSLTQLETLSF-QMNNIAGA----------------------------------------------------------- 105 (782)
Q Consensus 86 l~~l~~L~~L~L-~~N~l~~~----------------------------------------------------------- 105 (782)
|++|++|++|+| ++|.++|.
T Consensus 343 l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~~~ 422 (876)
T 4ecn_A 343 IGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSR 422 (876)
T ss_dssp GGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCCCC
T ss_pred HhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccccccc
Confidence 999999999999 77765443
Q ss_pred -----------------CC-CCCCCCCCCEEeCCCCcccC------------------CCCCC-CCCCCCCCEEeccCCC
Q 003982 106 -----------------IP-SLANATSLQDIYLDNNNFTS------------------VPTGC-FDGLTNLQVLSLSDNP 148 (782)
Q Consensus 106 -----------------~~-~l~~l~~L~~L~Ls~n~l~~------------------~~~~~-~~~l~~L~~L~Ls~N~ 148 (782)
+| .|.++++|++|+|++|+|++ +|... |.++++|++|+|++|+
T Consensus 423 l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~ 502 (876)
T 4ecn_A 423 ISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCP 502 (876)
T ss_dssp CCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCT
T ss_pred cchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCC
Confidence 44 78899999999999999999 77663 3499999999999999
Q ss_pred CCCCCCCCcccCCCcccCeeeccccc-cCC-CCcccccCCC-------CCcEEEcccCcCCCCCCc--cccc-cccchhh
Q 003982 149 NLAPWPFPNELTKSTSLTTLYMDNAN-IFG-LIPDFFDSFS-------NLQNLRLSYNNFTGSLPA--SFAK-SDIQNLW 216 (782)
Q Consensus 149 l~~~~~~p~~~~~l~~L~~L~L~~N~-l~~-~~~~~~~~l~-------~L~~L~Ls~N~l~~~~p~--~~~~-~~l~~l~ 216 (782)
+.. .+|..+.++++|+.|+|++|+ +++ .+|..+..++ +|++|+|++|+++ .+|. .+.. ..|+.|+
T Consensus 503 l~~--~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~ 579 (876)
T 4ecn_A 503 NMT--QLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLD 579 (876)
T ss_dssp TCC--SCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEE
T ss_pred CCc--cChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEE
Confidence 888 688999999999999999998 888 7787666554 9999999999999 8998 7766 5799999
Q ss_pred cccccCCCccccccccCCCCCcEEEeecccccCCCCCCCCCCC-CCEEEcCCCcCccCcchhhcCCCC--CCEEEccCCc
Q 003982 217 MNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCES-LFDLSLRDNQLTGVVPASVISLPA--LLNISLQNNK 293 (782)
Q Consensus 217 l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~-L~~L~L~~N~l~~~~p~~~~~l~~--L~~L~l~~N~ 293 (782)
+++|.+. ..+.+.++++|+.|+|++|+++..+..+..+++ |+.|+|++|+|+ .+|..+..++. |+.|++++|+
T Consensus 580 Ls~N~l~---~lp~~~~L~~L~~L~Ls~N~l~~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~ 655 (876)
T 4ecn_A 580 CVHNKVR---HLEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNK 655 (876)
T ss_dssp CTTSCCC---BCCCCCTTSEESEEECCSSCCSCCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSC
T ss_pred CCCCCcc---cchhhcCCCcceEEECcCCccccchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCc
Confidence 9999887 223789999999999999999966667999998 999999999999 78888887754 9999999999
Q ss_pred ccCCCCCCC--------CCccEEEccCCcCCCCCCCCCC-CCChhh-----hhHHHhhcCCCCC--------cccccCcC
Q 003982 294 LQGPYPLFP--------SKVQKVSLDHNNFCKNSSDAGK-PCDPQV-----TTLLQIAGDMGYP--------AILSDSWE 351 (782)
Q Consensus 294 l~~~~~~~~--------~~l~~L~l~~N~~~~~~~~~~~-~~~~~~-----~~~~~~~~~~~~~--------~~~~~~~~ 351 (782)
+++.+|..+ .+|+.|+|++|+++.++..... ...... -.+..++...... ..+.....
T Consensus 656 l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~L 735 (876)
T 4ecn_A 656 IGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDL 735 (876)
T ss_dssp TTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCTTGGGCCEEEC
T ss_pred CCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHHhccccccccccCCccEEEC
Confidence 998776543 3688888888888765522110 000000 0000111111000 02333334
Q ss_pred CCCCCCCCCcccc--cCCceeEEEccCcccccccCccccccccCCeEeccc------ccccccCCccCCCCCCCCeEecC
Q 003982 352 GNNACDGWPFVTC--SQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQ------NNLTGPIPDGLTKLASLQNLDVS 423 (782)
Q Consensus 352 ~~~~~~~~p~~~~--~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~------N~l~g~~p~~~~~l~~L~~L~ls 423 (782)
.++.+..+|..+. .+++|+.|+|++|.|++ +|..+.++++|+.|+|++ |++.+.+|..|..+++|+.|+|+
T Consensus 736 s~N~L~~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls 814 (876)
T 4ecn_A 736 RFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIG 814 (876)
T ss_dssp CSSCCCCCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECC
T ss_pred CCCCCccchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECC
Confidence 4455567777776 77788888888888876 677777888888887765 67777788888888888888888
Q ss_pred CCcCCCCCC-CCCCCcceecCCCCCCC
Q 003982 424 NNNLSGKVP-DFGSNVKFTVSPGNPFI 449 (782)
Q Consensus 424 ~N~l~g~~p-~~~~~~~~~~~~~n~~~ 449 (782)
+|+| +.+| .+...+..+.+++||+.
T Consensus 815 ~N~L-~~Ip~~l~~~L~~LdLs~N~l~ 840 (876)
T 4ecn_A 815 SNDI-RKVDEKLTPQLYILDIADNPNI 840 (876)
T ss_dssp SSCC-CBCCSCCCSSSCEEECCSCTTC
T ss_pred CCCC-CccCHhhcCCCCEEECCCCCCC
Confidence 8888 5555 45667777777777764
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=439.02 Aligned_cols=421 Identities=24% Similarity=0.382 Sum_probs=272.3
Q ss_pred HhhccccchhHHHHHHHHHhcCCCC--CCCCCCCCCCCccccceEeCCCCCEEEEEeCCCCCCcc---cC----------
Q 003982 19 QLTTTSLGDDGSVMLKLAQSLQNLP--SDWSSTSSTGYCEWTGINCDNSNRVTTISLAKSGLSGT---LS---------- 83 (782)
Q Consensus 19 ~~~~~~~~~~~~~l~~~~~~~~~~~--~~w~~~~~~~~c~w~gv~c~~~~~v~~L~l~~~~l~~~---~~---------- 83 (782)
++++++.++|++||++||+++.+.. ++|. .+++||+|+||+|+ .++|+.|+|+++++.|. +|
T Consensus 4 ~~~~~~~~~~~~all~~k~~~~~~~~l~~W~--~~~~~C~w~gv~C~-~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~ 80 (768)
T 3rgz_A 4 ASPSQSLYREIHQLISFKDVLPDKNLLPDWS--SNKNPCTFDGVTCR-DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLE 80 (768)
T ss_dssp ----CCHHHHHHHHHHHHTTCSCTTSSTTCC--TTSCGGGSTTEEEE-TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCC
T ss_pred CccccCCHHHHHHHHHHHhhCCCcccccCCC--CCCCCcCCcceEEC-CCcEEEEECCCCCcCCccCccChhHhccCccc
Confidence 3445556789999999999997543 3554 56789999999999 78999999999999886 44
Q ss_pred -------------ccccCCccCceeecccCccCccCC---CCCCCCCCCEEeCCCCcccCCCCC-CCCCCCCCCEEeccC
Q 003982 84 -------------PEISSLTQLETLSFQMNNIAGAIP---SLANATSLQDIYLDNNNFTSVPTG-CFDGLTNLQVLSLSD 146 (782)
Q Consensus 84 -------------~~l~~l~~L~~L~L~~N~l~~~~~---~l~~l~~L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~Ls~ 146 (782)
+.|+.+++|++|+|++|.+++.+| .+.++++|++|+|++|.+++..+. .+.++++|++|||++
T Consensus 81 ~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~ 160 (768)
T 3rgz_A 81 SLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSA 160 (768)
T ss_dssp EEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCS
T ss_pred ccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCC
Confidence 467788888899999998887554 577888888888888888754433 336666777777776
Q ss_pred CCCCCCCC-----------------------CCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCC
Q 003982 147 NPNLAPWP-----------------------FPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSL 203 (782)
Q Consensus 147 N~l~~~~~-----------------------~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 203 (782)
|++....+ -...+..+++|++|+|++|++++.+|. +..+++|++|+|++|++++.+
T Consensus 161 n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~ 239 (768)
T 3rgz_A 161 NSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDF 239 (768)
T ss_dssp SCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCH
T ss_pred CccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcc
Confidence 66543100 001125677788888888888887776 888888888888888888777
Q ss_pred Cccccc-cccchhhcccccCCCccccccccCCCCCcEEEeecccccCCCCC-CCC-CCCCCEEEcCCCcCccCcchhhcC
Q 003982 204 PASFAK-SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD-LSK-CESLFDLSLRDNQLTGVVPASVIS 280 (782)
Q Consensus 204 p~~~~~-~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~-l~~L~~L~L~~N~l~~~~p~~~~~ 280 (782)
|..+.. .+|+.|++++|.+... .+.. .+++|++|+|++|++++.+|. +.. +++|++|+|++|++++.+|..|++
T Consensus 240 ~~~l~~l~~L~~L~Ls~n~l~~~--~~~~-~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~ 316 (768)
T 3rgz_A 240 SRAISTCTELKLLNISSNQFVGP--IPPL-PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGS 316 (768)
T ss_dssp HHHTTTCSSCCEEECCSSCCEES--CCCC-CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGG
T ss_pred cHHHhcCCCCCEEECCCCcccCc--cCcc-ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhc
Confidence 777665 5677888877765422 2222 567777777777777765553 433 377777777777777777777777
Q ss_pred CCCCCEEEccCCcccCCCCC----CCCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHh-----------hcCCCC--C
Q 003982 281 LPALLNISLQNNKLQGPYPL----FPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQI-----------AGDMGY--P 343 (782)
Q Consensus 281 l~~L~~L~l~~N~l~~~~~~----~~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~--~ 343 (782)
+++|++|++++|+++|.+|. .+.+|++|++++|++++..+........ .+..+ ...+.. .
T Consensus 317 l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~---~L~~L~Ls~N~l~~~~~~~~~~~~~ 393 (768)
T 3rgz_A 317 CSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSA---SLLTLDLSSNNFSGPILPNLCQNPK 393 (768)
T ss_dssp CTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTT---TCSEEECCSSEEEEECCTTTTCSTT
T ss_pred CCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhc---CCcEEEccCCCcCCCcChhhhhccc
Confidence 77777777777777766553 2456677777777665322110000000 00000 000000 1
Q ss_pred ccccc-CcCCCCCCCCCCcccccCCceeEEEccCcccccccCccccccccCCeEecccccccccCCccCCCCCCCCeEec
Q 003982 344 AILSD-SWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDV 422 (782)
Q Consensus 344 ~~~~~-~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l 422 (782)
..+.. ...+|...+.+|..++.+++|++|+|++|.+++.+|..|+++++|++|+|++|++++.+|..+..+++|+.|+|
T Consensus 394 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 473 (768)
T 3rgz_A 394 NTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLIL 473 (768)
T ss_dssp CCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEEC
T ss_pred CCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEe
Confidence 11111 22222233356666666677777777777777667777777777777777777777667777777777777777
Q ss_pred CCCcCCCCCCC-CC--CCcceecCCCCCCC
Q 003982 423 SNNNLSGKVPD-FG--SNVKFTVSPGNPFI 449 (782)
Q Consensus 423 s~N~l~g~~p~-~~--~~~~~~~~~~n~~~ 449 (782)
++|+++|.+|. +. ..+....+.+|.+.
T Consensus 474 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 503 (768)
T 3rgz_A 474 DFNDLTGEIPSGLSNCTNLNWISLSNNRLT 503 (768)
T ss_dssp CSSCCCSCCCGGGGGCTTCCEEECCSSCCC
T ss_pred cCCcccCcCCHHHhcCCCCCEEEccCCccC
Confidence 77777766663 22 45555566666554
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=422.43 Aligned_cols=392 Identities=27% Similarity=0.374 Sum_probs=324.8
Q ss_pred CCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-C-CCCCCCCCEEeCCCCcccCCCCCCCCCCC-CCCEE
Q 003982 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-S-LANATSLQDIYLDNNNFTSVPTGCFDGLT-NLQVL 142 (782)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~-l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~-~L~~L 142 (782)
.+++.|+|++|.+++.+|..|+.+++|++|+|++|.+++.+| . +.++++|++|+|++|++++..+..+.+++ +|++|
T Consensus 294 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L 373 (768)
T 3rgz_A 294 DTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTL 373 (768)
T ss_dssp TTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEE
T ss_pred CcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEE
Confidence 478999999999999999999999999999999999998777 4 99999999999999999965556677777 99999
Q ss_pred eccCCCCCCCCCCCcccCC--CcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccc-cccchhhccc
Q 003982 143 SLSDNPNLAPWPFPNELTK--STSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMND 219 (782)
Q Consensus 143 ~Ls~N~l~~~~~~p~~~~~--l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~l~l~~ 219 (782)
+|++|++.. .+|..+.. +++|+.|++++|++++.+|..+..+++|++|+|++|++++.+|..+.. ..|+.|++.+
T Consensus 374 ~Ls~N~l~~--~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 451 (768)
T 3rgz_A 374 DLSSNNFSG--PILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWL 451 (768)
T ss_dssp ECCSSEEEE--ECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCS
T ss_pred EccCCCcCC--CcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCC
Confidence 999999887 45666655 889999999999999999999999999999999999999999988876 6789999999
Q ss_pred ccCCCccccccccCCCCCcEEEeecccccCCCC-CCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCC
Q 003982 220 QQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIP-DLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPY 298 (782)
Q Consensus 220 ~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 298 (782)
|.+... ....+..+++|++|++++|++++.+| .+..+++|++|+|++|++++.+|.+++.+++|++|++++|+++|.+
T Consensus 452 n~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 530 (768)
T 3rgz_A 452 NMLEGE-IPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNI 530 (768)
T ss_dssp SCCCSC-CCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEEC
T ss_pred CcccCc-CCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcC
Confidence 886532 23457789999999999999998777 4889999999999999999999999999999999999999999988
Q ss_pred CCC---CCCccEEEccCCcCCCCCCCCC-CCCC-----------------------------------hhhhhHHHhh--
Q 003982 299 PLF---PSKVQKVSLDHNNFCKNSSDAG-KPCD-----------------------------------PQVTTLLQIA-- 337 (782)
Q Consensus 299 ~~~---~~~l~~L~l~~N~~~~~~~~~~-~~~~-----------------------------------~~~~~~~~~~-- 337 (782)
|.. +.+|+.|++++|++++..+... .... .....+..+.
T Consensus 531 p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 610 (768)
T 3rgz_A 531 PAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTR 610 (768)
T ss_dssp CGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGT
T ss_pred CHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccc
Confidence 865 4578999999999985332111 0000 0000000000
Q ss_pred ---------------cCCCC-CcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccccCccccccccCCeEecccc
Q 003982 338 ---------------GDMGY-PAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQN 401 (782)
Q Consensus 338 ---------------~~~~~-~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 401 (782)
..+.. ......+...|+..+.+|..++.+++|+.|+|++|+++|.+|..|+++++|++|||++|
T Consensus 611 ~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N 690 (768)
T 3rgz_A 611 NPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSN 690 (768)
T ss_dssp CCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSS
T ss_pred cccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCC
Confidence 01111 11222455566777899999999999999999999999999999999999999999999
Q ss_pred cccccCCccCCCCCCCCeEecCCCcCCCCCCCCC--CCcceecCCCCCCCCCCCCCCCCCCC
Q 003982 402 NLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFG--SNVKFTVSPGNPFIGTNVDTTPGGAG 461 (782)
Q Consensus 402 ~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~--~~~~~~~~~~n~~~~~~~~~~~~~~~ 461 (782)
+++|.+|..+..+++|+.|||++|+|+|.||+.+ ..+....+.|||.+|+.+.. +|...
T Consensus 691 ~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~-~C~~~ 751 (768)
T 3rgz_A 691 KLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP-RCDPS 751 (768)
T ss_dssp CCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC-CCCSC
T ss_pred cccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCc-CCCCC
Confidence 9999999999999999999999999999999765 34555678999999998864 66544
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=367.26 Aligned_cols=190 Identities=22% Similarity=0.367 Sum_probs=163.2
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
++|++.+.||+|+||+||+|+. .+|+.||||++.+........+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 6899999999999999999954 579999999998876666678889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
||+||+|.+++.... ...+++.+++.|+.||+.||+|||+ +|||||||||+|||+++++.+||+|||+|+....
T Consensus 104 y~~gg~L~~~i~~~~---~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 104 YCEGGDLFKRINAQK---GVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp CCTTCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred CCCCCcHHHHHHHcC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 999999999997532 3457999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.. ......+||+.|||||++.+. +++.++||||+||+
T Consensus 178 ~~-~~~~~~~GT~~YmAPE~l~~~---~y~~~~DiwSlGvi 214 (350)
T 4b9d_A 178 TV-ELARACIGTPYYLSPEICENK---PYNNKSDIWALGCV 214 (350)
T ss_dssp HH-HHHHHHHSCCTTCCHHHHTTC---CCCHHHHHHHHHHH
T ss_pred Cc-ccccccCCCccccCHHHHCCC---CCCcHHHHHHHHHH
Confidence 22 122346799999999999875 56889999999997
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=359.03 Aligned_cols=189 Identities=24% Similarity=0.416 Sum_probs=167.0
Q ss_pred cCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
++|++.+.||+|+||+||+|+ ..+++.||||++.+... .....+.+.+|++++++++||||+++++++++++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 579999999999999999995 46799999999976542 2335678999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
|||+||+|.+++.+. +.+++.++..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|+...
T Consensus 112 Ey~~gG~L~~~i~~~-----~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~ 183 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 183 (311)
T ss_dssp CCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecC
Confidence 999999999999763 458999999999999999999999 899999999999999999999999999999875
Q ss_pred CCC-ceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGK-YSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... .......+||+.|||||++.+. +++.++||||+||+
T Consensus 184 ~~~~~~~~~~~~GTp~YmAPEvl~~~---~y~~~~DiWSlGvi 223 (311)
T 4aw0_A 184 PESKQARANSFVGTAQYVSPELLTEK---SACKSSDLWALGCI 223 (311)
T ss_dssp TTTTCCCBCCCCSCGGGCCHHHHHHS---CBCHHHHHHHHHHH
T ss_pred CCCCcccccCcccCcccCCHHHHcCC---CCCcHHHHHHHHHH
Confidence 433 2233456899999999999875 46789999999996
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=360.86 Aligned_cols=292 Identities=25% Similarity=0.428 Sum_probs=213.8
Q ss_pred cccchhHHHHHHHHHhcCCCC--CCCCCCCCCCCcc--ccceEeCCC---CCEEEEEeCCCCCCc--ccCccccCCccCc
Q 003982 23 TSLGDDGSVMLKLAQSLQNLP--SDWSSTSSTGYCE--WTGINCDNS---NRVTTISLAKSGLSG--TLSPEISSLTQLE 93 (782)
Q Consensus 23 ~~~~~~~~~l~~~~~~~~~~~--~~w~~~~~~~~c~--w~gv~c~~~---~~v~~L~l~~~~l~~--~~~~~l~~l~~L~ 93 (782)
.|.++|++||++||+++.+.. ..|. .+.+||. |.||+|+.. ++|+.|+|+++++++ .+|+.|.++++|+
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~~l~~W~--~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~ 79 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPTTLSSWL--PTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCC--TTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred CCCHHHHHHHHHHHHhcCCcccccCCC--CCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCC
Confidence 577899999999999996543 3553 3567888 999999864 799999999999999 8999999999999
Q ss_pred eeeccc-CccCccCC-CCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeecc
Q 003982 94 TLSFQM-NNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMD 171 (782)
Q Consensus 94 ~L~L~~-N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~ 171 (782)
+|+|++ |.+.+.+| .|.++++|++|+|++|++++..+..|.++ ++|++|+|+
T Consensus 80 ~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l--------------------------~~L~~L~Ls 133 (313)
T 1ogq_A 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI--------------------------KTLVTLDFS 133 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGC--------------------------TTCCEEECC
T ss_pred eeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCC--------------------------CCCCEEeCC
Confidence 999995 99988777 78888888888888888875444444444 445555555
Q ss_pred ccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCC-CCcEEEeecccccCC
Q 003982 172 NANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMT-QLRQVWLHKNQFTGP 250 (782)
Q Consensus 172 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~-~L~~L~L~~N~l~~~ 250 (782)
+|.+++.+|..|..+++|++|+|++|++++.+|..+. .++ +|++|++++|++++.
T Consensus 134 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~------------------------~l~~~L~~L~L~~N~l~~~ 189 (313)
T 1ogq_A 134 YNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYG------------------------SFSKLFTSMTISRNRLTGK 189 (313)
T ss_dssp SSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGG------------------------CCCTTCCEEECCSSEEEEE
T ss_pred CCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHh------------------------hhhhcCcEEECcCCeeecc
Confidence 5555555556666666666666666666655555443 244 566666666666654
Q ss_pred CC-CCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCCCCCCccEEEccCCcCCCCCCCCCCCCChh
Q 003982 251 IP-DLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQ 329 (782)
Q Consensus 251 ~~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~~~ 329 (782)
.| .+..++ |+.|+|++|++++.+|..|..+++|+.|++++|++++.+|.
T Consensus 190 ~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~----------------------------- 239 (313)
T 1ogq_A 190 IPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK----------------------------- 239 (313)
T ss_dssp CCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-----------------------------
T ss_pred CChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-----------------------------
Confidence 44 355555 88888888888888888888888888888888888754331
Q ss_pred hhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccccCccccccccCCeEecccccccccCCc
Q 003982 330 VTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPD 409 (782)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~ 409 (782)
+..+++|++|+|++|.|++.+|..|.++++|++|+|++|+++|.+|.
T Consensus 240 ---------------------------------~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~ 286 (313)
T 1ogq_A 240 ---------------------------------VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286 (313)
T ss_dssp ---------------------------------CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC
T ss_pred ---------------------------------ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCC
Confidence 12235677777777777777788888888888888888888888877
Q ss_pred cCCCCCCCCeEecCCCc-CCCC
Q 003982 410 GLTKLASLQNLDVSNNN-LSGK 430 (782)
Q Consensus 410 ~~~~l~~L~~L~ls~N~-l~g~ 430 (782)
. ..+++|+.|++++|+ ++|.
T Consensus 287 ~-~~l~~L~~l~l~~N~~lc~~ 307 (313)
T 1ogq_A 287 G-GNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp S-TTGGGSCGGGTCSSSEEEST
T ss_pred C-ccccccChHHhcCCCCccCC
Confidence 5 777788888777776 5553
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=360.30 Aligned_cols=185 Identities=25% Similarity=0.410 Sum_probs=164.4
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
+.|++.+.||+|+||+||+|.. .+|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+++..|+|||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5699999999999999999954 5799999999976542 334668899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
||+||+|.+++.. ..+++.++..++.||+.||+|||+ +|||||||||+|||++.++.+||+|||+|+....
T Consensus 152 y~~gg~L~~~l~~------~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 222 (346)
T 4fih_A 152 FLEGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 222 (346)
T ss_dssp CCTTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred CCCCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence 9999999998865 348999999999999999999999 8999999999999999999999999999998765
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... .....+||+.|||||++.+. +++.++||||+||+
T Consensus 223 ~~~-~~~~~~GTp~YmAPEvl~~~---~y~~~~DiWSlGvi 259 (346)
T 4fih_A 223 EVP-RRKSLVGTPYWMAPELISRL---PYGPEVDIWSLGIM 259 (346)
T ss_dssp SSC-CBCCCCSCGGGCCHHHHTTC---CBCTHHHHHHHHHH
T ss_pred CCC-cccccccCcCcCCHHHHCCC---CCCcHHHHHHHHHH
Confidence 432 23456899999999998875 56789999999997
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=352.62 Aligned_cols=192 Identities=31% Similarity=0.526 Sum_probs=163.5
Q ss_pred cCCCccceeecccceEEEEEEeC------CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeE
Q 003982 581 DNFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSER 654 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~ 654 (782)
++|.+.+.||+|+||+||+|++. +++.||||+++... ....++|.+|+++|++++|||||++++++.+++..
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC--hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 56788999999999999999753 47789999997643 45678899999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhhc--------cCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcE
Q 003982 655 LLVYEYMPRGTLAQHLFEWH--------DHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRA 726 (782)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~--------~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~ 726 (782)
++|||||++|+|.++++... ......+++.++..|+.|+++||+|||+ ++||||||||+|||+++++++
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcE
Confidence 99999999999999997642 1223569999999999999999999999 899999999999999999999
Q ss_pred EEEeeccceecCCCCcee-eecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 727 KVADFGLVKNAPDGKYSV-ETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 727 kL~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
||+|||+|+......... .....||+.|||||++.+. .++.++|||||||+
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~---~~~~k~DVwS~Gvv 219 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR---KFTTESDVWSLGVV 219 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC---CCCHHHHHHHHHHH
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCC---CCCchhhHHHHHHH
Confidence 999999998765543322 2335689999999998765 46889999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=362.10 Aligned_cols=186 Identities=25% Similarity=0.408 Sum_probs=164.8
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
.+.|++.+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC--SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 35799999999999999999954 5799999999976542 33467899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
|||+||+|.+++.. ..+++.++..++.||+.||+|||+ +|||||||||+|||++.++.+||+|||+|+...
T Consensus 228 Ey~~gG~L~~~i~~------~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~ 298 (423)
T 4fie_A 228 EFLEGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 298 (423)
T ss_dssp ECCTTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECC
T ss_pred eCCCCCcHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECC
Confidence 99999999999864 348999999999999999999999 899999999999999999999999999999876
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.... .....+||+.|||||++.+. +++.++||||+||+
T Consensus 299 ~~~~-~~~~~~GTp~YmAPEvl~~~---~y~~~~DiWSlGvi 336 (423)
T 4fie_A 299 KEVP-RRKSLVGTPYWMAPELISRL---PYGPEVDIWSLGIM 336 (423)
T ss_dssp SSCC-CBCCCEECTTTCCHHHHTTC---CBCTHHHHHHHHHH
T ss_pred CCCc-cccccccCcCcCCHHHHCCC---CCCcHHHHHHHHHH
Confidence 5332 23456899999999998875 46789999999987
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=389.71 Aligned_cols=395 Identities=19% Similarity=0.167 Sum_probs=280.7
Q ss_pred ccccceEeCCCCCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccC-C-CCCCCCCCCEEeCCCCcccCCCCCC
Q 003982 55 CEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAI-P-SLANATSLQDIYLDNNNFTSVPTGC 132 (782)
Q Consensus 55 c~w~gv~c~~~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~-~-~l~~l~~L~~L~Ls~n~l~~~~~~~ 132 (782)
|.|+.|.+ ...+++.|+|++|.+++..|..|.++++|++|+|++|.+.+.+ | .|.++++|++|+|++|+++.+++..
T Consensus 14 ~~L~~vP~-lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~ 92 (844)
T 3j0a_A 14 CNLTQVPQ-VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDA 92 (844)
T ss_dssp CCSSCCCS-SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTS
T ss_pred CCCCCCCC-CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhH
Confidence 56888887 6678999999999999888999999999999999999665544 5 7999999999999999999999999
Q ss_pred CCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCc-ccccCCCCCcEEEcccCcCCCCCCccccc--
Q 003982 133 FDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIP-DFFDSFSNLQNLRLSYNNFTGSLPASFAK-- 209 (782)
Q Consensus 133 ~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-- 209 (782)
|.++++|++|+|++|++....+....+.++++|++|+|++|.+++..+ ..|+++++|++|+|++|.+++..|..+..
T Consensus 93 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~ 172 (844)
T 3j0a_A 93 FQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQ 172 (844)
T ss_dssp SCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHH
T ss_pred ccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHccccc
Confidence 999999999999999998732223348999999999999999988765 67899999999999999998776665532
Q ss_pred -cc------------------------------cchhhcccccCCCc---------------------------------
Q 003982 210 -SD------------------------------IQNLWMNDQQLGLS--------------------------------- 225 (782)
Q Consensus 210 -~~------------------------------l~~l~l~~~~~~~~--------------------------------- 225 (782)
.. ++.|++++|.+...
T Consensus 173 ~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l 252 (844)
T 3j0a_A 173 GKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNI 252 (844)
T ss_dssp HCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSS
T ss_pred CCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccccccccccccc
Confidence 11 45555555532110
Q ss_pred ----------------------------cccccccCCCCCcEEEeecccccCCCC-CCCCCCCCCEEEcCCCcCccCcch
Q 003982 226 ----------------------------GTLDVLSGMTQLRQVWLHKNQFTGPIP-DLSKCESLFDLSLRDNQLTGVVPA 276 (782)
Q Consensus 226 ----------------------------~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~ 276 (782)
.....+..+++|+.|+|++|++++.++ .|..+++|++|+|++|++++..|.
T Consensus 253 ~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 332 (844)
T 3j0a_A 253 KDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSS 332 (844)
T ss_dssp TTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSC
T ss_pred CCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHH
Confidence 001235556677777777777776555 467777777777777777766677
Q ss_pred hhcCCCCCCEEEccCCcccCCCCCC---CCCccEEEccCCcCCCCCCCCCC-------------CCCh-h----------
Q 003982 277 SVISLPALLNISLQNNKLQGPYPLF---PSKVQKVSLDHNNFCKNSSDAGK-------------PCDP-Q---------- 329 (782)
Q Consensus 277 ~~~~l~~L~~L~l~~N~l~~~~~~~---~~~l~~L~l~~N~~~~~~~~~~~-------------~~~~-~---------- 329 (782)
.|..+++|+.|++++|++++..+.. +.+|+.|+|++|.++++...... +... .
T Consensus 333 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~ 412 (844)
T 3j0a_A 333 NFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENR 412 (844)
T ss_dssp SCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCC
T ss_pred HhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCc
Confidence 7777777777777777776655543 34677777777776654320000 0000 0
Q ss_pred ---hhhHHHh---h--------cC-C---------CCCcccccCcCCCCCC------CCCCcccccCCceeEEEccCccc
Q 003982 330 ---VTTLLQI---A--------GD-M---------GYPAILSDSWEGNNAC------DGWPFVTCSQGRIITINLANKLL 379 (782)
Q Consensus 330 ---~~~~~~~---~--------~~-~---------~~~~~~~~~~~~~~~~------~~~p~~~~~~~~L~~L~Ls~N~l 379 (782)
......+ + .+ + .....+.....+++.+ +..|..+..+++|+.|+|++|+|
T Consensus 413 l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l 492 (844)
T 3j0a_A 413 LENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYL 492 (844)
T ss_dssp CCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHH
T ss_pred cccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcc
Confidence 0000000 0 00 0 0000111111111222 22334566778888999999999
Q ss_pred ccccCccccccccCCeEecccccccccCCccCCCCCCCCeEecCCCcCCCCCCCCCCCcceecCCCCCCCCCC
Q 003982 380 AGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKFTVSPGNPFIGTN 452 (782)
Q Consensus 380 ~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~~~~~~~~~n~~~~~~ 452 (782)
++..|..|.++++|+.|+|++|+|++..|..+. ++|+.|||++|+|++.+|.....+....+.+||+.|..
T Consensus 493 ~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~c 563 (844)
T 3j0a_A 493 NSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICEC 563 (844)
T ss_dssp TTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCSS
T ss_pred cccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhCCcCEEEecCCCccccc
Confidence 888888888899999999999999877666665 78999999999999998876677888899999999953
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=349.54 Aligned_cols=190 Identities=27% Similarity=0.430 Sum_probs=158.3
Q ss_pred cCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEc
Q 003982 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 660 (782)
+++.+.+.||+|+||+||+|++. ..||||+++.........+.|.+|++++++++|||||++++++.+ +..++||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 56778999999999999999874 369999998766556677889999999999999999999998754 568999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~ 740 (782)
|++|+|.++++.. ..++++.++..|+.|+++||+|||+ ++||||||||+|||+++++++||+|||+|+.....
T Consensus 113 ~~gGsL~~~l~~~----~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 113 CEGSSLYKHLHVQ----ETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp CSSCBHHHHHHTS----CCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred CCCCCHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 9999999999652 2469999999999999999999999 89999999999999999999999999999876543
Q ss_pred Cc-eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 741 KY-SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 741 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.. ......+||+.|||||++.+...-.++.++||||||||
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvv 226 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIV 226 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHH
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHH
Confidence 22 22344689999999999865422246889999999996
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=343.12 Aligned_cols=187 Identities=27% Similarity=0.454 Sum_probs=149.5
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCC-hhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
++|++.+.||+|+||+||+|.. .+|+.||||++.+.... ....+++.+|++++++++||||+++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999954 57999999999865433 334678999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+ +|+|.+++.+ .+.+++.++..++.|++.||+|||+ +||+||||||+|||+++++.+||+|||+|+...
T Consensus 93 Ey~-~g~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ-----RDKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp ECC-CEEHHHHHHH-----SCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred eCC-CCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence 999 7899999876 3469999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... .....+||+.|||||++.+.. .+..++||||+||+
T Consensus 164 ~~~--~~~~~~GT~~Y~APE~~~~~~--y~~~~~DiwSlGvi 201 (275)
T 3hyh_A 164 DGN--FLKTSCGSPNYAAPEVISGKL--YAGPEVDVWSCGVI 201 (275)
T ss_dssp -------------CTTSCHHHHSSSS--CCCTHHHHHHHHHH
T ss_pred CCC--ccCCeeECcccCChhhhcCCC--CCCChhhhHHHHHH
Confidence 433 223468999999999998751 13568999999986
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=343.79 Aligned_cols=182 Identities=24% Similarity=0.359 Sum_probs=158.2
Q ss_pred CccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEe----CCeEEEEE
Q 003982 584 SEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN----GSERLLVY 658 (782)
Q Consensus 584 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~----~~~~~lv~ 658 (782)
+..+.||+|+||+||+|.. .++..||+|++..........++|.+|++++++++|||||++++++.+ +...|+||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 5667899999999999954 578999999998776666677889999999999999999999999875 34579999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEEcCCCCCCEEECC-CCcEEEEeeccce
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS--FIHRDLKPSNILIGD-DMRAKVADFGLVK 735 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~--ivHrDikp~NIll~~-~~~~kL~DfG~a~ 735 (782)
|||++|+|.+++.+. ..+++.++..++.|++.||+|||+ +| ||||||||+|||++. ++.+||+|||+|+
T Consensus 109 Ey~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp ECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred eCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 999999999999763 458999999999999999999998 66 999999999999984 7899999999998
Q ss_pred ecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 736 NAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 736 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
...... ....+||+.|||||++.+. ++.++||||+||+
T Consensus 181 ~~~~~~---~~~~~GTp~YmAPE~~~~~----y~~~~DiwSlGvi 218 (290)
T 3fpq_A 181 LKRASF---AKAVIGTPEFMAPEMYEEK----YDESVDVYAFGMC 218 (290)
T ss_dssp GCCTTS---BEESCSSCCCCCGGGGGTC----CCTHHHHHHHHHH
T ss_pred eCCCCc---cCCcccCccccCHHHcCCC----CCcHHHHHHHHHH
Confidence 654322 2346899999999998764 5678999999986
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=352.81 Aligned_cols=192 Identities=31% Similarity=0.518 Sum_probs=157.8
Q ss_pred cCCCccceeecccceEEEEEEeC------CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeE
Q 003982 581 DNFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSER 654 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~ 654 (782)
++|.+.+.||+|+||+||+|++. +++.||||+++... ....++|.+|+++|++++|||||+++++|.+++..
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46777899999999999999753 47889999997543 55678899999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhhccC----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCC
Q 003982 655 LLVYEYMPRGTLAQHLFEWHDH----------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM 724 (782)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~ 724 (782)
|+|||||++|+|.++++..... ...++++.++..|+.|+++||+|||+ ++||||||||+|||+++++
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTT
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCC
Confidence 9999999999999999764321 13469999999999999999999999 8999999999999999999
Q ss_pred cEEEEeeccceecCCCCc-eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 725 RAKVADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 725 ~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.+||+|||+|+....... ......+||+.|||||++.+. .++.++|||||||+
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~---~~~~~sDvwS~Gvv 249 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR---KFTTESDVWSFGVV 249 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTC---CCCHHHHHHHHHHH
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCC---CCCccccccchHHH
Confidence 999999999987654332 233456799999999998875 46889999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=353.72 Aligned_cols=188 Identities=26% Similarity=0.375 Sum_probs=157.1
Q ss_pred cCCCccceeecccceEEEEEEe----CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL----PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 656 (782)
++|++.+.||+|+||+||+|+. .+++.||||++++.........++.+|++++++++||||+++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 5699999999999999999964 246789999998765444445578899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecccee
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~ 736 (782)
|||||+||+|.+++.+. +.+++.++..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+|+.
T Consensus 104 vmEy~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp EECCCTTCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred EEEcCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 99999999999999763 458999999999999999999999 8999999999999999999999999999987
Q ss_pred cCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 737 APDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
...... .....+||+.|||||++.+. +++.++||||+||+
T Consensus 176 ~~~~~~-~~~~~~GT~~YmAPE~~~~~---~y~~~~DiwSlGvi 215 (304)
T 3ubd_A 176 SIDHEK-KAYSFCGTVEYMAPEVVNRR---GHTQSADWWSFGVL 215 (304)
T ss_dssp -----C-CCCSCCCCGGGCCHHHHHTS---CCCTHHHHHHHHHH
T ss_pred ccCCCc-cccccccCcccCCHHHhccC---CCCCCCcccchHHH
Confidence 644332 22346899999999998775 46778999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=348.70 Aligned_cols=182 Identities=24% Similarity=0.338 Sum_probs=156.7
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
+.|++.++||+|+||+||+|+. .+|+.||||+++.... ..+|++++++++|||||++++++.+++..|+|||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE 130 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 4678889999999999999954 5789999999976432 2469999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCC-cEEEEeeccceecC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM-RAKVADFGLVKNAP 738 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~-~~kL~DfG~a~~~~ 738 (782)
||+||+|.+++++. +.+++.++..++.|++.||+|||+ +|||||||||+|||++.++ .+||+|||+|+...
T Consensus 131 y~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~ 202 (336)
T 4g3f_A 131 LLEGGSLGQLIKQM-----GCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQ 202 (336)
T ss_dssp CCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred ccCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence 99999999999763 459999999999999999999998 8999999999999999987 69999999999875
Q ss_pred CCCce----eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYS----VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..... .....+||+.|||||++.+. +++.++||||+||+
T Consensus 203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~---~y~~~~DiwSlGvi 245 (336)
T 4g3f_A 203 PDGLGKSLLTGDYIPGTETHMAPEVVMGK---PCDAKVDIWSSCCM 245 (336)
T ss_dssp -----------CCCCCCGGGCCHHHHTTC---CCCTHHHHHHHHHH
T ss_pred CCCcccceecCCccccCccccCHHHHCCC---CCCcHHHHHHHHHH
Confidence 43221 12335799999999999875 56789999999986
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=348.10 Aligned_cols=192 Identities=26% Similarity=0.432 Sum_probs=162.2
Q ss_pred CCCccceeecccceEEEEEEe------CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEE
Q 003982 582 NFSEANILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL 655 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~ 655 (782)
++++.+.||+|+||+||+|.+ .+++.||||+++... .....++|.+|++++++++|||||+++|++.+++..+
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 456788999999999999975 256789999997543 3445688999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhhccCC-----------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCC
Q 003982 656 LVYEYMPRGTLAQHLFEWHDHG-----------YTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM 724 (782)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~ 724 (782)
+|||||++|+|.+++....... ...+++.++..|+.|+++||+|||+ ++||||||||+|||+++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCC
Confidence 9999999999999997643211 2358999999999999999999999 8999999999999999999
Q ss_pred cEEEEeeccceecCCCCc-eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 725 RAKVADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 725 ~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
++||+|||+|+....... ...+..+||+.|||||++.+. .++.++|||||||+
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~---~~s~ksDVwSfGvv 236 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG---KFSIDSDIWSYGVV 236 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC---CCCHHHHHHHHHHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC---CCCccchhhhHHHH
Confidence 999999999987644332 223446799999999998765 46889999999996
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=344.91 Aligned_cols=192 Identities=28% Similarity=0.388 Sum_probs=152.7
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCC------
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS------ 652 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~------ 652 (782)
.++|++.+.||+|+||+||+|+. .+|+.||||+++... .....+.+.+|+++|++++|||||++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 45699999999999999999954 578999999997644 2445678999999999999999999999987644
Q ss_pred ------eEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcE
Q 003982 653 ------ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRA 726 (782)
Q Consensus 653 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~ 726 (782)
..|+|||||++|+|.+++..... ....++..++.++.|++.||+|||+ +||+||||||+|||++.++.+
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~v 157 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCT--IEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVV 157 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCS--GGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCE
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCC--CChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcE
Confidence 36899999999999999975321 2235667789999999999999999 899999999999999999999
Q ss_pred EEEeeccceecCCCCce-----------eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 727 KVADFGLVKNAPDGKYS-----------VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 727 kL~DfG~a~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
||+|||+|+........ ..+..+||+.|||||++.+. .++.++||||+||+
T Consensus 158 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~---~y~~~~DiwSlGvi 219 (299)
T 4g31_A 158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN---SYSHKVDIFSLGLI 219 (299)
T ss_dssp EECCCCCC--------------------------CCCTTSCHHHHTTC---CCCTHHHHHHHHHH
T ss_pred EEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCC---CCCCHHHHHHHHHH
Confidence 99999999876543211 12335799999999998875 56789999999986
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=361.36 Aligned_cols=358 Identities=20% Similarity=0.228 Sum_probs=243.5
Q ss_pred CCccccc--eEeCCC---------CCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccC-C-CCCCCCCCCEEe
Q 003982 53 GYCEWTG--INCDNS---------NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAI-P-SLANATSLQDIY 119 (782)
Q Consensus 53 ~~c~w~g--v~c~~~---------~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~-~-~l~~l~~L~~L~ 119 (782)
..|.|.+ |.|++. .+++.|+|++|.+++..|..|..+++|++|+|++|.+.+.+ + .|.++++|++|+
T Consensus 6 ~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~ 85 (455)
T 3v47_A 6 SECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILK 85 (455)
T ss_dssp -CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEE
T ss_pred ceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEe
Confidence 4455555 889763 47999999999999888999999999999999999998654 4 699999999999
Q ss_pred CCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCccc-ccCCCCCcEEEcccCc
Q 003982 120 LDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDF-FDSFSNLQNLRLSYNN 198 (782)
Q Consensus 120 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~Ls~N~ 198 (782)
|++|+++.+++..|.++++|++|+|++|++....+....+..+++|++|+|++|++++..|.. +..+++|++|++++|+
T Consensus 86 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~ 165 (455)
T 3v47_A 86 LDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK 165 (455)
T ss_dssp CTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCC
T ss_pred CCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCc
Confidence 999999999999999999999999999999862222234899999999999999999998876 8999999999999999
Q ss_pred CCCCCCccccc---cccchhhcccccCCCcccc-------ccccCCCCCcEEEeecccccCCCCC-C---CCCCCCCEEE
Q 003982 199 FTGSLPASFAK---SDIQNLWMNDQQLGLSGTL-------DVLSGMTQLRQVWLHKNQFTGPIPD-L---SKCESLFDLS 264 (782)
Q Consensus 199 l~~~~p~~~~~---~~l~~l~l~~~~~~~~~~~-------~~~~~l~~L~~L~L~~N~l~~~~~~-~---~~l~~L~~L~ 264 (782)
+++..|..+.. ..++.++++.|.+...... ..+..+++|++|++++|++++..+. + ...++|+.|+
T Consensus 166 l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~ 245 (455)
T 3v47_A 166 VKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLI 245 (455)
T ss_dssp BSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEE
T ss_pred ccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEe
Confidence 99888887765 4677888888876543322 1234567889999999888764432 2 1224555555
Q ss_pred cCCCcCccC----------cchhhcC--CCCCCEEEccCCcccCCCCCCC---CCccEEEccCCcCCCCCCCCCCCCChh
Q 003982 265 LRDNQLTGV----------VPASVIS--LPALLNISLQNNKLQGPYPLFP---SKVQKVSLDHNNFCKNSSDAGKPCDPQ 329 (782)
Q Consensus 265 L~~N~l~~~----------~p~~~~~--l~~L~~L~l~~N~l~~~~~~~~---~~l~~L~l~~N~~~~~~~~~~~~~~~~ 329 (782)
+++|.+.+. .+..+.. .++|+.|++++|++++.+|..+ .+|+.|++++|+++++.
T Consensus 246 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~---------- 315 (455)
T 3v47_A 246 LSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKID---------- 315 (455)
T ss_dssp CTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEEC----------
T ss_pred eccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccC----------
Confidence 555533321 1111221 2455556666666555544432 34555666555554332
Q ss_pred hhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccccCccccccccCCeEecccccccccCCc
Q 003982 330 VTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPD 409 (782)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~ 409 (782)
|..+..+++|++|+|++|.+++..|..|.++++|++|+|++|++++..|.
T Consensus 316 ------------------------------~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 365 (455)
T 3v47_A 316 ------------------------------DNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQ 365 (455)
T ss_dssp ------------------------------TTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTT
T ss_pred ------------------------------hhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChh
Confidence 22333445555555555555555555555555555555555555555555
Q ss_pred cCCCCCCCCeEecCCCcCCCCCCCC-C--CCcceecCCCCCCCC
Q 003982 410 GLTKLASLQNLDVSNNNLSGKVPDF-G--SNVKFTVSPGNPFIG 450 (782)
Q Consensus 410 ~~~~l~~L~~L~ls~N~l~g~~p~~-~--~~~~~~~~~~n~~~~ 450 (782)
.|..+++|+.|+|++|+|++.++.. . ..++...+.+||+.|
T Consensus 366 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 409 (455)
T 3v47_A 366 SFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 409 (455)
T ss_dssp TTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred hccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCccc
Confidence 5555555555555555555544432 1 344445555555554
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=368.84 Aligned_cols=385 Identities=18% Similarity=0.138 Sum_probs=274.5
Q ss_pred CCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEec
Q 003982 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144 (782)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 144 (782)
.+++.|+|++|.+++..+..|.++++|++|+|++|++++++| .|.++++|++|+|++|+++.+++..|.++++|++|+|
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 479999999999998888899999999999999999999887 7999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCCCcccCCCcccCeeeccccccCC-CCcccccCCCCCcEEEcccCcCCCCCCccccc--------------
Q 003982 145 SDNPNLAPWPFPNELTKSTSLTTLYMDNANIFG-LIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-------------- 209 (782)
Q Consensus 145 s~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-------------- 209 (782)
++|++.. ..+..+.++++|++|+|++|.+++ .+|..|+++++|++|++++|++++..|..+..
T Consensus 112 ~~n~l~~--~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~ 189 (606)
T 3vq2_A 112 VETKLAS--LESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMS 189 (606)
T ss_dssp TTSCCCC--SSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECT
T ss_pred cCCcccc--ccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeecc
Confidence 9999988 345679999999999999999987 56999999999999999999998666654432
Q ss_pred --------------cccchhhcccccCCC---------------------------------------------------
Q 003982 210 --------------SDIQNLWMNDQQLGL--------------------------------------------------- 224 (782)
Q Consensus 210 --------------~~l~~l~l~~~~~~~--------------------------------------------------- 224 (782)
.+++.|++.+|.+..
T Consensus 190 ~n~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~ 269 (606)
T 3vq2_A 190 LNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLT 269 (606)
T ss_dssp TCCCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEEC
T ss_pred CCCcceeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheecc
Confidence 134444444443210
Q ss_pred -----cc----------------------ccccccCCCCCcEEEeecccccCCCC--------------------CCCCC
Q 003982 225 -----SG----------------------TLDVLSGMTQLRQVWLHKNQFTGPIP--------------------DLSKC 257 (782)
Q Consensus 225 -----~~----------------------~~~~~~~l~~L~~L~L~~N~l~~~~~--------------------~~~~l 257 (782)
.+ ..+.+..+++|++|++++|+++..+. .+..+
T Consensus 270 ~~~~~~~~~~~~~~l~~L~~L~l~~~~~~~l~~l~~~~~L~~L~l~~n~l~~lp~~~l~~L~~L~l~~n~~~~~~~~~~l 349 (606)
T 3vq2_A 270 YTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVAL 349 (606)
T ss_dssp CCTTCCGGGGSCGGGTTCSEEEEESCCCCCCCCCCTTCCCSEEEEESCCCSSCCCCCCSSCCEEEEESCSSCEECCCCCC
T ss_pred ccccccccccccccCCCCCEEEecCccchhhhhccccccCCEEEcccccCcccccCCCCccceeeccCCcCccchhhccC
Confidence 00 00123334455555555555532210 24567
Q ss_pred CCCCEEEcCCCcCccC--cchhhcCCCCCCEEEccCCcccCCCCCC--CCCccEEEccCCcCCCCCC-CCCC-CCChhhh
Q 003982 258 ESLFDLSLRDNQLTGV--VPASVISLPALLNISLQNNKLQGPYPLF--PSKVQKVSLDHNNFCKNSS-DAGK-PCDPQVT 331 (782)
Q Consensus 258 ~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~l~~L~l~~N~~~~~~~-~~~~-~~~~~~~ 331 (782)
++|++|++++|++++. +|..+..+++|++|++++|.+++..+.+ +.+|+.|++++|++.+... .... ....+..
T Consensus 350 ~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L 429 (606)
T 3vq2_A 350 PSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYL 429 (606)
T ss_dssp TTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEEECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEE
T ss_pred CCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccccchhhccCCCCCCeeECCCCccCCccChhhhhccccCCEE
Confidence 7888888888888765 3777888888888888888877644322 3567777777777766543 1111 0000000
Q ss_pred hHHH------hhcCCCCCcccccCcCCCCCCC--CCCcccccCCceeEEEccCcccccccCccccccccCCeEecccccc
Q 003982 332 TLLQ------IAGDMGYPAILSDSWEGNNACD--GWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNL 403 (782)
Q Consensus 332 ~~~~------~~~~~~~~~~~~~~~~~~~~~~--~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 403 (782)
.+.. .+..+.....+......++.+. .+|..+..+++|++|+|++|.+++..|..|.++++|++|+|++|++
T Consensus 430 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 509 (606)
T 3vq2_A 430 DISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNL 509 (606)
T ss_dssp ECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred ECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcC
Confidence 0000 0001111112222222333332 2677788888888888888888888888888888888888888888
Q ss_pred cccCCccCCCCCCCCeEecCCCcCCCCCCCCC---CCcceecCCCCCCCCCC
Q 003982 404 TGPIPDGLTKLASLQNLDVSNNNLSGKVPDFG---SNVKFTVSPGNPFIGTN 452 (782)
Q Consensus 404 ~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~---~~~~~~~~~~n~~~~~~ 452 (782)
++.+|..|..+++|+.|||++|+|+..++.+. ..+....+.+||+.|..
T Consensus 510 ~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c 561 (606)
T 3vq2_A 510 LFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACIC 561 (606)
T ss_dssp SCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSS
T ss_pred CCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCC
Confidence 88888888888888888888888885555433 34677788888887743
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=337.94 Aligned_cols=191 Identities=26% Similarity=0.363 Sum_probs=154.3
Q ss_pred hcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCC----eEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS----ERL 655 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~----~~~ 655 (782)
.++|.+.+.||+|+||+||+|.+ +|+.||||++.... .....++.|+..+.+++||||+++++++.+++ ..|
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence 35688899999999999999988 68999999996532 22223345666667889999999999998754 579
Q ss_pred EEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCCeEEcCCCCCCEEECCCCcEEEEe
Q 003982 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSL-----AQQSFIHRDLKPSNILIGDDMRAKVAD 730 (782)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-----~~~~ivHrDikp~NIll~~~~~~kL~D 730 (782)
+|||||++|+|.++++. .++++.++..++.|+++||+|||+. +..+||||||||+|||+++++++||+|
T Consensus 78 lV~Ey~~~gsL~~~l~~------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~D 151 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp EEEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred EEecCCCCCcHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEe
Confidence 99999999999999975 3589999999999999999999972 124999999999999999999999999
Q ss_pred eccceecCCCCcee---eecccccccccCccccccch---hhhHHHHHHHHHhccc
Q 003982 731 FGLVKNAPDGKYSV---ETRLAGTFGYLAPEYAGKHW---MILCQMTGLIWLHGSV 780 (782)
Q Consensus 731 fG~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~---~~~~~~~~dvws~Gvv 780 (782)
||+|+......... ....+||+.|||||++.+.. ...++.++||||||||
T Consensus 152 FGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvv 207 (303)
T 3hmm_A 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV 207 (303)
T ss_dssp CTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHH
T ss_pred CCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHH
Confidence 99998765443221 23457999999999987642 2346889999999996
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=361.44 Aligned_cols=372 Identities=18% Similarity=0.230 Sum_probs=240.6
Q ss_pred CccccceEeCCC------------CCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCCEEeC
Q 003982 54 YCEWTGINCDNS------------NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYL 120 (782)
Q Consensus 54 ~c~w~gv~c~~~------------~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~L 120 (782)
.|.|.|+ |+.. .++++|+|++|++++..|.+|..+++|++|+|++|++++.+| .|.++++|++|+|
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 81 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL 81 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence 4999998 8642 379999999999998889999999999999999999999887 7999999999999
Q ss_pred CCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeecccccc-CCCCcccccCCCCCcEEEcccCcC
Q 003982 121 DNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANI-FGLIPDFFDSFSNLQNLRLSYNNF 199 (782)
Q Consensus 121 s~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l-~~~~~~~~~~l~~L~~L~Ls~N~l 199 (782)
++|+++++++..|.++++|++|+|++|++... ..|..+.++++|++|++++|.+ ....+..|..+++|++|++++|++
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l 160 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTL-GVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSL 160 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSS-CSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTC
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCccccc-chhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcc
Confidence 99999999999999999999999999999862 2467899999999999999984 445457899999999999999999
Q ss_pred CCCCCccccc-cccchhhcccccCCCccccccccCCCCCcEEEeecccccCCC---------------------------
Q 003982 200 TGSLPASFAK-SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPI--------------------------- 251 (782)
Q Consensus 200 ~~~~p~~~~~-~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~--------------------------- 251 (782)
++..|..+.. ..++.|++..|.+..... ..+..+++|++|++++|++++..
T Consensus 161 ~~~~~~~l~~l~~L~~L~l~~n~~~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~ 239 (549)
T 2z81_A 161 RNYQSQSLKSIRDIHHLTLHLSESAFLLE-IFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDES 239 (549)
T ss_dssp CEECTTTTTTCSEEEEEEEECSBSTTHHH-HHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHH
T ss_pred cccChhhhhccccCceEecccCcccccch-hhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhH
Confidence 9888877654 334444444443221110 01122333333333333333210
Q ss_pred ----------------------------C----------CC--------------------------CCCCCCCEEEcCC
Q 003982 252 ----------------------------P----------DL--------------------------SKCESLFDLSLRD 267 (782)
Q Consensus 252 ----------------------------~----------~~--------------------------~~l~~L~~L~L~~ 267 (782)
. .+ ...++|+.|++++
T Consensus 240 ~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~ 319 (549)
T 2z81_A 240 FNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVEN 319 (549)
T ss_dssp HHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEES
T ss_pred HHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEecc
Confidence 0 00 0012344444444
Q ss_pred CcCccCcchhh-cCCCCCCEEEccCCcccCCCC------CCCCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCC
Q 003982 268 NQLTGVVPASV-ISLPALLNISLQNNKLQGPYP------LFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDM 340 (782)
Q Consensus 268 N~l~~~~p~~~-~~l~~L~~L~l~~N~l~~~~~------~~~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (782)
|+++ .+|..+ ..+++|++|++++|++++.+| ..+.+|+.|++++|+++++... . . .+
T Consensus 320 n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~--------~----~---~~ 383 (549)
T 2z81_A 320 SKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKT--------G----E---IL 383 (549)
T ss_dssp SCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHH--------H----H---HG
T ss_pred Cccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccc--------h----h---hh
Confidence 4444 334333 345555555555555554321 1234455555555555432100 0 0 00
Q ss_pred CCCcccccCcCCCCCCCCCCcccccCC---------------------ceeEEEccCcccccccCccccccccCCeEecc
Q 003982 341 GYPAILSDSWEGNNACDGWPFVTCSQG---------------------RIITINLANKLLAGNISPAYANLTSLKNLYLQ 399 (782)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~p~~~~~~~---------------------~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 399 (782)
.....+.....+++.+..+|..+..++ +|++|+|++|+|++.+ .++++|++|+|+
T Consensus 384 ~~l~~L~~L~Ls~N~l~~lp~~~~~~~~L~~L~Ls~N~l~~l~~~~~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls 459 (549)
T 2z81_A 384 LTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFS----LFLPRLQELYIS 459 (549)
T ss_dssp GGCTTCCEEECTTCCCCCCCSCCCCCTTCCEEECTTSCCSCCCTTSCTTCSEEECCSSCCSCCC----CCCTTCCEEECC
T ss_pred hcCCCCCEEECCCCCCccCChhhcccccccEEECCCCCcccccchhcCCceEEECCCCChhhhc----ccCChhcEEECC
Confidence 000111111112222333333333333 5556666666555432 467788888888
Q ss_pred cccccccCCccCCCCCCCCeEecCCCcCCCCCCC-CC--CCcceecCCCCCCCC
Q 003982 400 QNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPD-FG--SNVKFTVSPGNPFIG 450 (782)
Q Consensus 400 ~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~-~~--~~~~~~~~~~n~~~~ 450 (782)
+|+|+ .+|. ...+++|+.|||++|+|++.+|. +. ..+....+.+||+.|
T Consensus 460 ~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 511 (549)
T 2z81_A 460 RNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 511 (549)
T ss_dssp SSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCC
T ss_pred CCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccC
Confidence 88887 6676 46688888888888888888775 22 566777888888865
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=357.07 Aligned_cols=378 Identities=16% Similarity=0.156 Sum_probs=230.3
Q ss_pred CCCcc--ccceEeCC----------CCCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCCEE
Q 003982 52 TGYCE--WTGINCDN----------SNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDI 118 (782)
Q Consensus 52 ~~~c~--w~gv~c~~----------~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L 118 (782)
.|.|. +..|.|.. ...++.|+|++|.+++..|..|..+++|++|+|++|++++..| .|.++++|++|
T Consensus 7 ~C~~~~~~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 86 (606)
T 3t6q_A 7 KCIEKEVNKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTL 86 (606)
T ss_dssp CCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEE
T ss_pred ceecccCCceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCee
Confidence 34454 55688865 2479999999999998888899999999999999999999877 79999999999
Q ss_pred eCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCc
Q 003982 119 YLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNN 198 (782)
Q Consensus 119 ~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 198 (782)
+|++|+++.+++..|.++++|++|+|++|++.. ..+..+.++++|++|+|++|++++.....+..+++|++|++++|+
T Consensus 87 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~--l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 164 (606)
T 3t6q_A 87 VLTANPLIFMAETALSGPKALKHLFFIQTGISS--IDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNA 164 (606)
T ss_dssp ECTTCCCSEECTTTTSSCTTCCEEECTTSCCSC--GGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSC
T ss_pred eCCCCcccccChhhhcccccccEeeccccCccc--CCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCc
Confidence 999999999988889999999999999999888 335667888888888888888887554444457888888888888
Q ss_pred CCCCCCccccc-cccc--hhhcccccCCCccc------------------------------------------------
Q 003982 199 FTGSLPASFAK-SDIQ--NLWMNDQQLGLSGT------------------------------------------------ 227 (782)
Q Consensus 199 l~~~~p~~~~~-~~l~--~l~l~~~~~~~~~~------------------------------------------------ 227 (782)
+++..|..+.. ..++ .+++++|.+.....
T Consensus 165 l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~ 244 (606)
T 3t6q_A 165 IHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDIS 244 (606)
T ss_dssp CCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCC
T ss_pred ccccChhhhhhhcccceeEEecCCCccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccC
Confidence 77555554443 2344 45555554331110
Q ss_pred cccccCCC--CCcEEEeecccccCCCCC-CCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCCC---
Q 003982 228 LDVLSGMT--QLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLF--- 301 (782)
Q Consensus 228 ~~~~~~l~--~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--- 301 (782)
...+.++. +|+.|++++|++++.++. |..+++|++|++++|+++ .+|..+..+++|++|++++|++++..|..
T Consensus 245 ~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~ 323 (606)
T 3t6q_A 245 PAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASN 323 (606)
T ss_dssp GGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGG
T ss_pred hhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhc
Confidence 00011111 455555555555554443 555555555555555555 44555555555555555555555443322
Q ss_pred CCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCC---CcccccCCceeEEEccCcc
Q 003982 302 PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGW---PFVTCSQGRIITINLANKL 378 (782)
Q Consensus 302 ~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---p~~~~~~~~L~~L~Ls~N~ 378 (782)
+.+|+.|++++|.+.+..+... +.....+......++.+..+ |..+..+++|++|++++|.
T Consensus 324 l~~L~~L~l~~n~~~~~~~~~~----------------~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~ 387 (606)
T 3t6q_A 324 FPSLTHLSIKGNTKRLELGTGC----------------LENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNE 387 (606)
T ss_dssp CTTCSEEECCSCSSCCBCCSST----------------TTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCS
T ss_pred cCcCCEEECCCCCcccccchhh----------------hhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCc
Confidence 2345555555555442110000 00000111111111111111 3445555566666666666
Q ss_pred cccccCccccccccCCeEecccccccccCCcc-CCCCCCCCeEecCCCcCCCCCCCC-C--CCcceecCCCCCC
Q 003982 379 LAGNISPAYANLTSLKNLYLQQNNLTGPIPDG-LTKLASLQNLDVSNNNLSGKVPDF-G--SNVKFTVSPGNPF 448 (782)
Q Consensus 379 l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~-~~~l~~L~~L~ls~N~l~g~~p~~-~--~~~~~~~~~~n~~ 448 (782)
+.+..|..|.++++|++|+|++|++.+..|.. +..+++|+.|++++|++++.+|.. . ..+....+.+|++
T Consensus 388 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 461 (606)
T 3t6q_A 388 PLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHF 461 (606)
T ss_dssp CEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBC
T ss_pred CCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCC
Confidence 66555556666666666666666665554433 555666666666666666555532 1 3444455555544
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=350.65 Aligned_cols=339 Identities=18% Similarity=0.190 Sum_probs=249.2
Q ss_pred CCCCCCc--cccceEeCCC----------CCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCC
Q 003982 49 TSSTGYC--EWTGINCDNS----------NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSL 115 (782)
Q Consensus 49 ~~~~~~c--~w~gv~c~~~----------~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L 115 (782)
++..|.| .|..|.|... .+++.|+|++|++++..+..|..+++|++|+|++|.+++..| .|.++++|
T Consensus 3 Cp~~C~C~~~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L 82 (477)
T 2id5_A 3 CPPRCECSAQDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNL 82 (477)
T ss_dssp CSTTCEEETTTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred ccCCCeECCCCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccC
Confidence 4555556 4678888752 367788888888887777778888888888888888887766 67888888
Q ss_pred CEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcc
Q 003982 116 QDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLS 195 (782)
Q Consensus 116 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 195 (782)
++|+|++|+++.++...|.++++|++|+|++|++.. ..+..|..+++|++|+|++|.+++..+..|..+++|++|+|+
T Consensus 83 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~--~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 160 (477)
T 2id5_A 83 RTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVI--LLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLE 160 (477)
T ss_dssp CEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCE--ECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEE
T ss_pred CEEECCCCcCCccCcccccCCCCCCEEECCCCcccc--CChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECC
Confidence 888888888888888778888888888888888777 456677788888888888888887777788888888888888
Q ss_pred cCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeecccccCCCC-CCCCCCCCCEEEcCCCcCccCc
Q 003982 196 YNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIP-DLSKCESLFDLSLRDNQLTGVV 274 (782)
Q Consensus 196 ~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~ 274 (782)
+|+++ .+|.. .+.++++|+.|+|++|++++.++ .|..+++|+.|++++|.+.+.+
T Consensus 161 ~n~l~-~~~~~-----------------------~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~ 216 (477)
T 2id5_A 161 KCNLT-SIPTE-----------------------ALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTM 216 (477)
T ss_dssp SCCCS-SCCHH-----------------------HHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEE
T ss_pred CCcCc-ccChh-----------------------HhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCcccccc
Confidence 88887 33332 13457888888888888887665 4777888888888888777777
Q ss_pred chhhcCCCCCCEEEccCCcccCCCC---CCCCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcC
Q 003982 275 PASVISLPALLNISLQNNKLQGPYP---LFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWE 351 (782)
Q Consensus 275 p~~~~~l~~L~~L~l~~N~l~~~~~---~~~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (782)
|..+....+|+.|++++|++++..+ ..+.+|+.|+|++|.++++.
T Consensus 217 ~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~-------------------------------- 264 (477)
T 2id5_A 217 TPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIE-------------------------------- 264 (477)
T ss_dssp CTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEEC--------------------------------
T ss_pred CcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccC--------------------------------
Confidence 7777666788888888888875443 23467888888888776544
Q ss_pred CCCCCCCCCcccccCCceeEEEccCcccccccCccccccccCCeEecccccccccCCccCCCCCCCCeEecCCCcCCCCC
Q 003982 352 GNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKV 431 (782)
Q Consensus 352 ~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~ 431 (782)
+..+..+++|+.|+|++|++++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|++++..
T Consensus 265 --------~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c 336 (477)
T 2id5_A 265 --------GSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDC 336 (477)
T ss_dssp --------TTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSG
T ss_pred --------hhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCcc
Confidence 223455677888888888888888888888888888888888888776777788888888888888887665
Q ss_pred CC--CCCCcceecCCCCCCCCCCC
Q 003982 432 PD--FGSNVKFTVSPGNPFIGTNV 453 (782)
Q Consensus 432 p~--~~~~~~~~~~~~n~~~~~~~ 453 (782)
+. +........+.++...|..+
T Consensus 337 ~~~~~~~~~~~~~~~~~~~~C~~p 360 (477)
T 2id5_A 337 RLLWVFRRRWRLNFNRQQPTCATP 360 (477)
T ss_dssp GGHHHHTTTTSSCCTTCCCBEEES
T ss_pred chHhHHhhhhccccCccCceeCCc
Confidence 41 11222223345555555433
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=338.41 Aligned_cols=200 Identities=25% Similarity=0.414 Sum_probs=167.1
Q ss_pred HHHHHHhcCCCccceeecccceEEEEEEeC------CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCC-CCcceEEe
Q 003982 574 EVLRQVTDNFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH-RHLVALLG 646 (782)
Q Consensus 574 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~nI~~~~~ 646 (782)
+..+.-.++|++.+.||+|+||+||+|.+. .++.||||+++... .....+.|.+|+++|++++| ||||++++
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 334444678999999999999999999653 23579999997644 24456789999999999975 89999999
Q ss_pred EEEeC-CeEEEEEEccCCCCHHHHHHhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCC
Q 003982 647 YCING-SERLLVYEYMPRGTLAQHLFEWHDH-----------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLK 714 (782)
Q Consensus 647 ~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik 714 (782)
+|.++ +..++|||||++|+|.++++..... ....+++.++..++.|+++||+|||+ ++|||||||
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK 212 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLA 212 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCS
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccC
Confidence 99765 5689999999999999999864321 12458999999999999999999999 899999999
Q ss_pred CCCEEECCCCcEEEEeeccceecCCCC-ceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 715 PSNILIGDDMRAKVADFGLVKNAPDGK-YSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 715 p~NIll~~~~~~kL~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|+|||+++++.+||+|||+|+...... +......+||+.|||||++.+. .++.++|||||||+
T Consensus 213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~---~y~~ksDVwS~Gv~ 276 (353)
T 4ase_A 213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR---VYTIQSDVWSFGVL 276 (353)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC---CCCHHHHHHHHHHH
T ss_pred ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC---CCCCcccEeehHHH
Confidence 999999999999999999999775443 3334456799999999998875 56889999999996
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=346.79 Aligned_cols=336 Identities=21% Similarity=0.229 Sum_probs=238.1
Q ss_pred CCCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEe
Q 003982 65 SNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLS 143 (782)
Q Consensus 65 ~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 143 (782)
..+++.|+|++|.+++..+.+|..+++|++|+|++|+|++.+| .|.++++|++|+|++|+|+.+|.. .+++|++|+
T Consensus 51 ~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~---~l~~L~~L~ 127 (562)
T 3a79_B 51 PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISCC---PMASLRHLD 127 (562)
T ss_dssp CTTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCEECSC---CCTTCSEEE
T ss_pred CCCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCccCcc---ccccCCEEE
Confidence 3579999999999998888899999999999999999999877 799999999999999999998876 799999999
Q ss_pred ccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCC--cEEEcccCcC--CCCCCcccccc---------
Q 003982 144 LSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNL--QNLRLSYNNF--TGSLPASFAKS--------- 210 (782)
Q Consensus 144 Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L--~~L~Ls~N~l--~~~~p~~~~~~--------- 210 (782)
|++|++... +.|..|.++++|++|+|++|++++. .+..+++| ++|++++|++ ++..|..+...
T Consensus 128 Ls~N~l~~l-~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l 203 (562)
T 3a79_B 128 LSFNDFDVL-PVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVF 203 (562)
T ss_dssp CCSSCCSBC-CCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEE
T ss_pred CCCCCcccc-CchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccccccCcccccccCcceEEEEe
Confidence 999998872 3467899999999999999999874 34455555 9999999999 77777776542
Q ss_pred ------------------ccchhhcccccCC---Cccccccc---------------------------cCCCCCcEEEe
Q 003982 211 ------------------DIQNLWMNDQQLG---LSGTLDVL---------------------------SGMTQLRQVWL 242 (782)
Q Consensus 211 ------------------~l~~l~l~~~~~~---~~~~~~~~---------------------------~~l~~L~~L~L 242 (782)
.++.+++..|... ..+..+.+ ...++|++|++
T Consensus 204 ~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l 283 (562)
T 3a79_B 204 HPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNI 283 (562)
T ss_dssp CSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEE
T ss_pred cCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEE
Confidence 2233333332100 00000000 01236777777
Q ss_pred ecccccCCCCC-C-----------------------------------------------------CCCCCCCEEEcCCC
Q 003982 243 HKNQFTGPIPD-L-----------------------------------------------------SKCESLFDLSLRDN 268 (782)
Q Consensus 243 ~~N~l~~~~~~-~-----------------------------------------------------~~l~~L~~L~L~~N 268 (782)
++|++++.+|. + ..+++|++|++++|
T Consensus 284 ~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~L~~L~l~~n 363 (562)
T 3a79_B 284 YNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQN 363 (562)
T ss_dssp EEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSS
T ss_pred eccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCCCceEEECCCC
Confidence 77777754442 3 33444444444444
Q ss_pred cCccCcchhhcCCCCCCEEEccCCcccCCC--C---CCCCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCC
Q 003982 269 QLTGVVPASVISLPALLNISLQNNKLQGPY--P---LFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYP 343 (782)
Q Consensus 269 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~--~---~~~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (782)
++++.+|..+.++++|++|++++|++++.. | ..+.+|+.|++++|++++
T Consensus 364 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~-------------------------- 417 (562)
T 3a79_B 364 VFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNS-------------------------- 417 (562)
T ss_dssp CCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBS--------------------------
T ss_pred ccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCC--------------------------
Confidence 444444444444444444444444444321 1 122344444444444433
Q ss_pred cccccCcCCCCCCCCCCcc-cccCCceeEEEccCcccccccCccccccccCCeEecccccccccCCccCCCCCCCCeEec
Q 003982 344 AILSDSWEGNNACDGWPFV-TCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDV 422 (782)
Q Consensus 344 ~~~~~~~~~~~~~~~~p~~-~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l 422 (782)
.+|.. +..+++|++|+|++|++++.+|..+. ++|++|+|++|+|+ .+|..+..+++|+.|+|
T Consensus 418 --------------~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L 480 (562)
T 3a79_B 418 --------------HAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNV 480 (562)
T ss_dssp --------------CCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEEC
T ss_pred --------------ccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEEC
Confidence 24433 55678999999999999988887765 79999999999999 78888889999999999
Q ss_pred CCCcCCCCCCC-CC--CCcceecCCCCCCCC
Q 003982 423 SNNNLSGKVPD-FG--SNVKFTVSPGNPFIG 450 (782)
Q Consensus 423 s~N~l~g~~p~-~~--~~~~~~~~~~n~~~~ 450 (782)
++|+|++.++. +. ..+....+.+|||.|
T Consensus 481 ~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c 511 (562)
T 3a79_B 481 ASNQLKSVPDGVFDRLTSLQYIWLHDNPWDC 511 (562)
T ss_dssp CSSCCCCCCTTSTTTCTTCCCEECCSCCBCC
T ss_pred CCCCCCCCCHHHHhcCCCCCEEEecCCCcCC
Confidence 99999976655 43 566778899999976
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=339.43 Aligned_cols=190 Identities=25% Similarity=0.390 Sum_probs=160.5
Q ss_pred hcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEe------CC
Q 003982 580 TDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN------GS 652 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~------~~ 652 (782)
.++|++.+.||+|+||+||+|. ..+|+.||||+++.........+.+.+|+++|++++||||+++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 3679999999999999999995 4679999999998765555567789999999999999999999998764 35
Q ss_pred eEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeec
Q 003982 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (782)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG 732 (782)
..|+|||||+ |+|.+++.. .+++++.++..+++||+.||+|||+ +|||||||||+|||++.++.+||+|||
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~-----~~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFG 203 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHS-----SQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFG 203 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTS-----SSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEEeCCC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecc
Confidence 7899999995 689998864 3569999999999999999999999 899999999999999999999999999
Q ss_pred cceecCCCCc---eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 733 LVKNAPDGKY---SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 733 ~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+|+....... ......+||+.|||||++.+. -.++.++||||+|||
T Consensus 204 la~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~--~~~~~~~DiWSlG~i 252 (398)
T 4b99_A 204 MARGLCTSPAEHQYFMTEYVATRWYRAPELMLSL--HEYTQAIDLWSVGCI 252 (398)
T ss_dssp TCBCC-------CCCCCSSCCCCTTCCHHHHTTC--SCCCTHHHHHHHHHH
T ss_pred eeeecccCccccccccccceeChHhcCHHHhcCC--CCCCChhheehhHHH
Confidence 9987644321 122446899999999987764 134678999999986
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=346.79 Aligned_cols=368 Identities=17% Similarity=0.166 Sum_probs=267.6
Q ss_pred CCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEec
Q 003982 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144 (782)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 144 (782)
.+++.|+|++|++++..+.+|..+++|++|+|++|++++.++ .|.++++|++|+|++|+++.+++..|.++++|++|++
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 478899999999998878889999999999999999998877 6899999999999999999999888999999999999
Q ss_pred cCCCCCCCCCCCcccCCCcccCeeeccccccCCC-CcccccCCCCCcEEEcccCcCCCCCCccccc-ccc----chhhcc
Q 003982 145 SDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGL-IPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDI----QNLWMN 218 (782)
Q Consensus 145 s~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~l----~~l~l~ 218 (782)
++|++.. ..+..+.++++|++|+|++|.+++. +|..|.++++|++|++++|++++..|..+.. ..+ ..+++.
T Consensus 108 ~~n~l~~--l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~ 185 (570)
T 2z63_A 108 VETNLAS--LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLS 185 (570)
T ss_dssp TTSCCCC--STTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECT
T ss_pred ccccccc--CCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccC
Confidence 9999888 2233588899999999999999874 5888999999999999999887554444432 122 223333
Q ss_pred cccCCCc-------------------------------------------------------------------------
Q 003982 219 DQQLGLS------------------------------------------------------------------------- 225 (782)
Q Consensus 219 ~~~~~~~------------------------------------------------------------------------- 225 (782)
.|.+...
T Consensus 186 ~n~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~ 265 (570)
T 2z63_A 186 LNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265 (570)
T ss_dssp TCCCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEE
T ss_pred CCCceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhh
Confidence 3322100
Q ss_pred -------cccccccCCCCCcEEEeecccccCCCCCC------------------------------------------CC
Q 003982 226 -------GTLDVLSGMTQLRQVWLHKNQFTGPIPDL------------------------------------------SK 256 (782)
Q Consensus 226 -------~~~~~~~~l~~L~~L~L~~N~l~~~~~~~------------------------------------------~~ 256 (782)
.....+..+++|++|++++|++++.+..+ ..
T Consensus 266 ~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~~~ 345 (570)
T 2z63_A 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVD 345 (570)
T ss_dssp ETTEEESCSTTTTGGGTTCSEEEEESCEECSCCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCCCB
T ss_pred cchhhhhhchhhhcCcCcccEEEecCccchhhhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCcccccccccc
Confidence 01123445667777777777666544333 34
Q ss_pred CCCCCEEEcCCCcCccCc--chhhcCCCCCCEEEccCCcccCCCCC--CCCCccEEEccCCcCCCCCCCCCCCCChhhhh
Q 003982 257 CESLFDLSLRDNQLTGVV--PASVISLPALLNISLQNNKLQGPYPL--FPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTT 332 (782)
Q Consensus 257 l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~l~~N~l~~~~~~--~~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~ 332 (782)
+++|++|++++|++++.. |..+..+++|++|++++|++.+..+. .+.+|+.|++++|.+.+.....
T Consensus 346 ~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~---------- 415 (570)
T 2z63_A 346 LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFS---------- 415 (570)
T ss_dssp CTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEEEETCTTCCEEECTTSEEESCTTSC----------
T ss_pred CCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccccccccccCCCCEEEccCCccccccchh----------
Confidence 456666666666666443 56666666677777777666654433 2456777777777766543110
Q ss_pred HHHhhcCCCCCcccc-cCcCCCCCCCCCCcccccCCceeEEEccCcccc-cccCccccccccCCeEecccccccccCCcc
Q 003982 333 LLQIAGDMGYPAILS-DSWEGNNACDGWPFVTCSQGRIITINLANKLLA-GNISPAYANLTSLKNLYLQQNNLTGPIPDG 410 (782)
Q Consensus 333 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~ 410 (782)
.+.....+. .+...|...+..|..+..+++|++|+|++|.++ +.+|..+..+++|++|+|++|++++..|..
T Consensus 416 ------~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~ 489 (570)
T 2z63_A 416 ------VFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 489 (570)
T ss_dssp ------TTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTT
T ss_pred ------hhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhh
Confidence 001111122 223334344556777888899999999999998 679999999999999999999999888999
Q ss_pred CCCCCCCCeEecCCCcCCCCCCCC-C--CCcceecCCCCCCCCC
Q 003982 411 LTKLASLQNLDVSNNNLSGKVPDF-G--SNVKFTVSPGNPFIGT 451 (782)
Q Consensus 411 ~~~l~~L~~L~ls~N~l~g~~p~~-~--~~~~~~~~~~n~~~~~ 451 (782)
|..+++|+.|+|++|++++.+|.. . ..+....+.+||+.|.
T Consensus 490 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 533 (570)
T 2z63_A 490 FNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 533 (570)
T ss_dssp TTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred hhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCC
Confidence 999999999999999999988853 2 5677788999998874
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=336.28 Aligned_cols=334 Identities=20% Similarity=0.187 Sum_probs=282.3
Q ss_pred EEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCccc-CCCCCCCCCCCCCCEEeccCC
Q 003982 70 TISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFT-SVPTGCFDGLTNLQVLSLSDN 147 (782)
Q Consensus 70 ~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~N 147 (782)
.++.++++++ .+|. +. ++|++|+|++|.|++.+| .|.++++|++|+|++|.++ .+++..|.++++|++|+|++|
T Consensus 14 ~~~c~~~~l~-~lp~-l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n 89 (455)
T 3v47_A 14 NAICINRGLH-QVPE-LP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89 (455)
T ss_dssp EEECCSSCCS-SCCC-CC--TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTC
T ss_pred ccCcCCCCcc-cCCC-CC--CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCC
Confidence 5888999988 6666 33 789999999999999877 7999999999999999997 678888999999999999999
Q ss_pred CCCCCCCCCcccCCCcccCeeeccccccCCCCccc--ccCCCCCcEEEcccCcCCCCCCcc-ccc-cccchhhcccccCC
Q 003982 148 PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDF--FDSFSNLQNLRLSYNNFTGSLPAS-FAK-SDIQNLWMNDQQLG 223 (782)
Q Consensus 148 ~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~--~~~l~~L~~L~Ls~N~l~~~~p~~-~~~-~~l~~l~l~~~~~~ 223 (782)
++.. ..|..|.++++|++|+|++|++++..+.. |..+++|++|+|++|++++..|.. +.. ..|++|++++|.+.
T Consensus 90 ~l~~--~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~ 167 (455)
T 3v47_A 90 QFLQ--LETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK 167 (455)
T ss_dssp TTCE--ECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBS
T ss_pred ccCc--cChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCccc
Confidence 9988 56889999999999999999999855544 999999999999999999777876 433 68889999998875
Q ss_pred CccccccccCC--CCCcEEEeecccccCCCCC---------CCCCCCCCEEEcCCCcCccCcchhhcCC---CCCCEEEc
Q 003982 224 LSGTLDVLSGM--TQLRQVWLHKNQFTGPIPD---------LSKCESLFDLSLRDNQLTGVVPASVISL---PALLNISL 289 (782)
Q Consensus 224 ~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~---------~~~l~~L~~L~L~~N~l~~~~p~~~~~l---~~L~~L~l 289 (782)
.... ..+..+ ++|+.|++++|.+++..+. +..+++|++|++++|++++..|..+... ++|+.|++
T Consensus 168 ~~~~-~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l 246 (455)
T 3v47_A 168 SICE-EDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLIL 246 (455)
T ss_dssp CCCT-TTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEEC
T ss_pred ccCh-hhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEee
Confidence 4322 234444 6899999999999886653 3356889999999999999888888755 88999999
Q ss_pred cCCcccCCCCCC---------------CCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCC
Q 003982 290 QNNKLQGPYPLF---------------PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNN 354 (782)
Q Consensus 290 ~~N~l~~~~~~~---------------~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (782)
++|.+.+..... ..+|+.|++++|++.+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~----------------------------------- 291 (455)
T 3v47_A 247 SNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALL----------------------------------- 291 (455)
T ss_dssp TTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEEC-----------------------------------
T ss_pred ccccccccccchhhhccCcccccccccccCceEEEecCccccccc-----------------------------------
Confidence 999776532211 247999999999886543
Q ss_pred CCCCCCcccccCCceeEEEccCcccccccCccccccccCCeEecccccccccCCccCCCCCCCCeEecCCCcCCCCCCC-
Q 003982 355 ACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPD- 433 (782)
Q Consensus 355 ~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~- 433 (782)
|..+..+++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|..+++|+.|+|++|++++.+|.
T Consensus 292 -----~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 366 (455)
T 3v47_A 292 -----KSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQS 366 (455)
T ss_dssp -----TTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTT
T ss_pred -----hhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhh
Confidence 45567788999999999999999999999999999999999999988899999999999999999999999884
Q ss_pred CC--CCcceecCCCCCCCC
Q 003982 434 FG--SNVKFTVSPGNPFIG 450 (782)
Q Consensus 434 ~~--~~~~~~~~~~n~~~~ 450 (782)
+. ..+....+.+|.+..
T Consensus 367 ~~~l~~L~~L~L~~N~l~~ 385 (455)
T 3v47_A 367 FLGLPNLKELALDTNQLKS 385 (455)
T ss_dssp TTTCTTCCEEECCSSCCSC
T ss_pred ccccccccEEECCCCcccc
Confidence 43 577888899998764
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=349.93 Aligned_cols=367 Identities=19% Similarity=0.178 Sum_probs=283.5
Q ss_pred CCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEec
Q 003982 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144 (782)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 144 (782)
..++.|||++|+|++..+.+|.++++|++|+|++|+|++++| +|.++++|++|+|++|+|+.+|+++|.++++|++|+|
T Consensus 52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L 131 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 131 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence 479999999999998777889999999999999999999888 7999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCCCcccCCCcccCeeeccccccCCC-CcccccCCCCCcEEEcccCcCCCCCCcccccc-------------
Q 003982 145 SDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGL-IPDFFDSFSNLQNLRLSYNNFTGSLPASFAKS------------- 210 (782)
Q Consensus 145 s~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~------------- 210 (782)
++|+++. ..+..|.++++|++|+|++|.+++. .|..+..+++|++|+|++|++++..|..+...
T Consensus 132 s~N~l~~--l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls 209 (635)
T 4g8a_A 132 VETNLAS--LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLS 209 (635)
T ss_dssp TTSCCCC--STTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECT
T ss_pred CCCcCCC--CChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcc
Confidence 9999998 4456799999999999999999874 58889999999999999999986555443210
Q ss_pred ---------------ccchhhcccc-------------------------------------------------------
Q 003982 211 ---------------DIQNLWMNDQ------------------------------------------------------- 220 (782)
Q Consensus 211 ---------------~l~~l~l~~~------------------------------------------------------- 220 (782)
.+..+.+..|
T Consensus 210 ~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~ 289 (635)
T 4g8a_A 210 LNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 289 (635)
T ss_dssp TCCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEE
T ss_pred cCcccccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhh
Confidence 0000111100
Q ss_pred -------------------------------------------------cCCCc------------------cccccccC
Q 003982 221 -------------------------------------------------QLGLS------------------GTLDVLSG 233 (782)
Q Consensus 221 -------------------------------------------------~~~~~------------------~~~~~~~~ 233 (782)
.+... .......+
T Consensus 290 ~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~ 369 (635)
T 4g8a_A 290 YLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVD 369 (635)
T ss_dssp CCCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCB
T ss_pred hhcccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCccccc
Confidence 00000 00001124
Q ss_pred CCCCcEEEeecccccCCC--C-CCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCC----CCCCcc
Q 003982 234 MTQLRQVWLHKNQFTGPI--P-DLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPL----FPSKVQ 306 (782)
Q Consensus 234 l~~L~~L~L~~N~l~~~~--~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~----~~~~l~ 306 (782)
+++|+.|++++|.+.... + .+..+.+|+.|++..|.+. ..+..+..+++|+.+++++|++....+. .+.+++
T Consensus 370 l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~ 448 (635)
T 4g8a_A 370 LPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI 448 (635)
T ss_dssp CTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEE-EECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCC
T ss_pred ccccccchhhccccccccccccchhhhhhhhhhhccccccc-cccccccccccccchhhhhccccccccccccccccccc
Confidence 567888888888776422 2 2456778888888888887 4556677888888888888887765543 235778
Q ss_pred EEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCC-CCCCcccccCCceeEEEccCcccccccCc
Q 003982 307 KVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNAC-DGWPFVTCSQGRIITINLANKLLAGNISP 385 (782)
Q Consensus 307 ~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~ 385 (782)
.++++.|.+........... +........+|+.. ...|..+..+++|++|+|++|+|++..|.
T Consensus 449 ~l~ls~n~l~~~~~~~~~~~----------------~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~ 512 (635)
T 4g8a_A 449 YLDISHTHTRVAFNGIFNGL----------------SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT 512 (635)
T ss_dssp EEECTTSCCEECCTTTTTTC----------------TTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTT
T ss_pred cccccccccccccccccccc----------------hhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChH
Confidence 88888888876553221110 11111222333322 24577788899999999999999999999
Q ss_pred cccccccCCeEecccccccccCCccCCCCCCCCeEecCCCcCCCCCCCCC----CCcceecCCCCCCCCC
Q 003982 386 AYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFG----SNVKFTVSPGNPFIGT 451 (782)
Q Consensus 386 ~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~----~~~~~~~~~~n~~~~~ 451 (782)
.|.++++|++|+|++|+|++..|..|..+++|+.|||++|+|++.+|... ..+....+.+|||.|.
T Consensus 513 ~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~ 582 (635)
T 4g8a_A 513 AFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 582 (635)
T ss_dssp TTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCS
T ss_pred HHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCccc
Confidence 99999999999999999999999999999999999999999999999532 5677889999999884
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=350.27 Aligned_cols=364 Identities=18% Similarity=0.193 Sum_probs=247.5
Q ss_pred CEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCC--EEeCCCCcccCCCCCCCCCC-------
Q 003982 67 RVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQ--DIYLDNNNFTSVPTGCFDGL------- 136 (782)
Q Consensus 67 ~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~--~L~Ls~n~l~~~~~~~~~~l------- 136 (782)
++++|+|++|.+.+...+.+..+++|++|++++|.+++.++ .|..+++|+ +|++++|+++++++..|...
T Consensus 130 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l 209 (606)
T 3t6q_A 130 TLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNF 209 (606)
T ss_dssp TCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEEC
T ss_pred cccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhHhhhcccccccc
Confidence 57777777777776443444447777777777777777665 566677777 67777777776666554321
Q ss_pred --------------------------------------------CCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccc
Q 003982 137 --------------------------------------------TNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172 (782)
Q Consensus 137 --------------------------------------------~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~ 172 (782)
.+|++|++++|++.. ..+..|..+++|++|++++
T Consensus 210 ~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~l~~ 287 (606)
T 3t6q_A 210 GGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFN--ISSNTFHCFSGLQELDLTA 287 (606)
T ss_dssp TTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSS--CCTTTTTTCTTCSEEECTT
T ss_pred CCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCc--cCHHHhccccCCCEEeccC
Confidence 045666666666665 3444566667777777777
Q ss_pred cccCCCCcccccCCCCCcEEEcccCcCCCCCCccccc-cccchhhcccccCCCccccccccCCCCCcEEEeecccccCCC
Q 003982 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPI 251 (782)
Q Consensus 173 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 251 (782)
|+++. +|..+..+++|++|++++|++++..|..+.. ..|+.|++++|.+........+.++++|++|++++|++++..
T Consensus 288 n~l~~-lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 366 (606)
T 3t6q_A 288 THLSE-LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSD 366 (606)
T ss_dssp SCCSC-CCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEE
T ss_pred CccCC-CChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCcccccc
Confidence 76663 3556666677777777777766544545444 456666666666554444445666777777777777776643
Q ss_pred ---CCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCC----CCCCccEEEccCCcCCCCCCCCCC
Q 003982 252 ---PDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPL----FPSKVQKVSLDHNNFCKNSSDAGK 324 (782)
Q Consensus 252 ---~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~----~~~~l~~L~l~~N~~~~~~~~~~~ 324 (782)
..+..+++|++|++++|++++..|..|..+++|++|++++|++++..+. .+.+|+.|++++|.+.+.......
T Consensus 367 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 446 (606)
T 3t6q_A 367 CCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFD 446 (606)
T ss_dssp ESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTT
T ss_pred CcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHh
Confidence 3466677777777777777766667777777777777777777665443 234667777777766554322111
Q ss_pred CCChhhhhHHHhhcCCCCCcccccCcCCCCCCC----CCCcccccCCceeEEEccCcccccccCccccccccCCeEeccc
Q 003982 325 PCDPQVTTLLQIAGDMGYPAILSDSWEGNNACD----GWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQ 400 (782)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 400 (782)
....+......++.+. ..+..+..+++|++|+|++|.+++..|..|.++++|++|+|++
T Consensus 447 -----------------~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~ 509 (606)
T 3t6q_A 447 -----------------GLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSH 509 (606)
T ss_dssp -----------------TCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred -----------------CCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCC
Confidence 1111111112222221 2235577889999999999999999999999999999999999
Q ss_pred ccccccCCccCCCCCCCCeEecCCCcCCCCCCCC-C--CCcceecCCCCCCCCC
Q 003982 401 NNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDF-G--SNVKFTVSPGNPFIGT 451 (782)
Q Consensus 401 N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~-~--~~~~~~~~~~n~~~~~ 451 (782)
|++++.+|..|..++.| .|++++|++++.+|.. . ..+....+.+||+.|.
T Consensus 510 N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 562 (606)
T 3t6q_A 510 NRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCT 562 (606)
T ss_dssp SCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECS
T ss_pred CccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCcccc
Confidence 99999999999999999 9999999999988853 2 5677889999999873
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=330.15 Aligned_cols=188 Identities=23% Similarity=0.360 Sum_probs=158.0
Q ss_pred HHHHhcCCCccceeecccceEEEEEEe----CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEe
Q 003982 576 LRQVTDNFSEANILGRGGFGVVYGGEL----PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCIN 650 (782)
Q Consensus 576 l~~~~~~y~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~ 650 (782)
+....++|++.+.||+|+||+||+|.. .+++.||||++.+.. ...++.+|+++++.+ +||||+++++++.+
T Consensus 16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~ 91 (361)
T 4f9c_A 16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRK 91 (361)
T ss_dssp SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence 334678899999999999999999954 246789999986543 346788999999998 69999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCC-CcEEEE
Q 003982 651 GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD-MRAKVA 729 (782)
Q Consensus 651 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~-~~~kL~ 729 (782)
.++.|+||||+++|+|.+++. .+++.++..+++|++.||+|||+ +||+||||||+|||++.+ +.+||+
T Consensus 92 ~~~~~lvmE~~~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~ 160 (361)
T 4f9c_A 92 NDHVVIAMPYLEHESFLDILN--------SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALV 160 (361)
T ss_dssp TTEEEEEEECCCCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEEC
T ss_pred CCEEEEEEeCCCcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEEC
Confidence 999999999999999999883 38999999999999999999999 899999999999999876 799999
Q ss_pred eeccceecCCCCc---------------------------eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 730 DFGLVKNAPDGKY---------------------------SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 730 DfG~a~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|||+|+...+... ......+||+.|||||++.+. ..++.++||||+|||
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~--~~y~~~~DiWSlG~i 236 (361)
T 4f9c_A 161 DFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC--PNQTTAIDMWSAGVI 236 (361)
T ss_dssp CCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTC--SCCCTHHHHHHHHHH
T ss_pred cCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC--CCCCCccchhhhHHH
Confidence 9999986654221 011235799999999998764 235678899999986
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=346.30 Aligned_cols=370 Identities=17% Similarity=0.183 Sum_probs=251.6
Q ss_pred CccccceEeCC----------CCCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCCEEeCCC
Q 003982 54 YCEWTGINCDN----------SNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDN 122 (782)
Q Consensus 54 ~c~w~gv~c~~----------~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~ 122 (782)
.|.++-|.|+. ..+++.|+|++|++++..+..|..+++|++|+|++|.+++.+| .|.++++|++|+|++
T Consensus 3 ~~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~ 82 (680)
T 1ziw_A 3 TVSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQH 82 (680)
T ss_dssp -CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCS
T ss_pred eeECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCC
Confidence 35566677754 2479999999999998777889999999999999999999887 688999999999999
Q ss_pred CcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCC
Q 003982 123 NNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGS 202 (782)
Q Consensus 123 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 202 (782)
|+++.+|+..|.++++|++|+|++|++.. ..|..|.++++|++|+|++|.+++..+..+..+++|++|++++|++++.
T Consensus 83 n~l~~l~~~~~~~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 160 (680)
T 1ziw_A 83 NELSQLSDKTFAFCTNLTELHLMSNSIQK--IKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQAL 160 (680)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCCCC--CCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCB
T ss_pred CccCccChhhhccCCCCCEEECCCCccCc--cChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCccccc
Confidence 99999999899999999999999999987 4557899999999999999999999899999999999999999999866
Q ss_pred CCccccc---cccchhhcccccCCCccc--------------------------------------------------cc
Q 003982 203 LPASFAK---SDIQNLWMNDQQLGLSGT--------------------------------------------------LD 229 (782)
Q Consensus 203 ~p~~~~~---~~l~~l~l~~~~~~~~~~--------------------------------------------------~~ 229 (782)
.+..+.. ..|+.|+++.|.+..... ..
T Consensus 161 ~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~ 240 (680)
T 1ziw_A 161 KSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240 (680)
T ss_dssp CHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTT
T ss_pred CHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChh
Confidence 6655432 567788887776542211 11
Q ss_pred cccCCC--CCcEEEeecccccCCCC-CCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCC-----CCC-
Q 003982 230 VLSGMT--QLRQVWLHKNQFTGPIP-DLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGP-----YPL- 300 (782)
Q Consensus 230 ~~~~l~--~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-----~~~- 300 (782)
.+.+++ +|++|+|++|++++.++ .|..+++|++|+|++|++++..|..|.++++|+.|++++|...+. +|.
T Consensus 241 ~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i 320 (680)
T 1ziw_A 241 TFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKI 320 (680)
T ss_dssp TTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEE
T ss_pred HhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhccccccccccc
Confidence 233332 37777777777766554 366677777777777777766666666666666666665544431 111
Q ss_pred ------CCCCccEEEccCCcCCCCCCCCCCCC-ChhhhhHHHhhcCC---------CCC----cccc-cCcCCCCCCCCC
Q 003982 301 ------FPSKVQKVSLDHNNFCKNSSDAGKPC-DPQVTTLLQIAGDM---------GYP----AILS-DSWEGNNACDGW 359 (782)
Q Consensus 301 ------~~~~l~~L~l~~N~~~~~~~~~~~~~-~~~~~~~~~~~~~~---------~~~----~~~~-~~~~~~~~~~~~ 359 (782)
.+.+|+.|++++|+++++........ .... +.+..+. .+. ..+. .....|...+..
T Consensus 321 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~---L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~ 397 (680)
T 1ziw_A 321 DDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKY---LSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIE 397 (680)
T ss_dssp CTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCE---EECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEEC
T ss_pred ChhhcccCCCCCEEECCCCccCCCChhHhccccCCcE---EECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEC
Confidence 23567888888888877654322211 0000 0000000 000 0111 122223333344
Q ss_pred CcccccCCceeEEEccCcccccccC-ccccccccCCeEecccccccccCCccCCCCCCCCeEecCCCcCC
Q 003982 360 PFVTCSQGRIITINLANKLLAGNIS-PAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428 (782)
Q Consensus 360 p~~~~~~~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~ 428 (782)
|..+..+++|+.|+|++|.+++.+| ..|.++++|++|+|++|++.+..+..|..+++|+.|++++|.++
T Consensus 398 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~ 467 (680)
T 1ziw_A 398 SDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALK 467 (680)
T ss_dssp TTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCB
T ss_pred hhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhcccccc
Confidence 5666677777777777777776665 46777777777777777766555555555555555555555544
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=345.17 Aligned_cols=188 Identities=25% Similarity=0.395 Sum_probs=159.5
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCCh-hh---HHHHHHHHHHHHhcCCCCcceEEeEEEeCCeE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGN-KG---LSEFQAEIAVLTKVRHRHLVALLGYCINGSER 654 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~---~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~ 654 (782)
.++|++.++||+|+||+||+|+. .+|+.||||++++..... .. ....++++.+++.++||||+++++++.+++..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 46799999999999999999954 579999999997643211 12 22334456677788999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccc
Q 003982 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734 (782)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a 734 (782)
|+|||||+||+|.+++.+. +.+++.++..++.||+.||+|||+ +|||||||||+|||++.+|.+||+|||+|
T Consensus 268 ylVmEy~~GGdL~~~l~~~-----~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA 339 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLA 339 (689)
T ss_dssp EEEECCCCSCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEeccccee
Confidence 9999999999999999763 458999999999999999999998 89999999999999999999999999999
Q ss_pred eecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 735 KNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 735 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+....... ...+||+.|||||++.+. .+++.++|+||+||+
T Consensus 340 ~~~~~~~~---~t~~GTp~YmAPEvl~~~--~~y~~~vDiWSLGvi 380 (689)
T 3v5w_A 340 CDFSKKKP---HASVGTHGYMAPEVLQKG--VAYDSSADWFSLGCM 380 (689)
T ss_dssp EECSSCCC---CSCCSCGGGCCHHHHSTT--CCCCTHHHHHHHHHH
T ss_pred eecCCCCC---CCccCCcCccCHHHHhCC--CCCCcHHHHHHHHHH
Confidence 98765432 346899999999998643 246778999999986
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=338.10 Aligned_cols=325 Identities=21% Similarity=0.238 Sum_probs=285.4
Q ss_pred ccccceEeCCCCCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCcccCCCCCCC
Q 003982 55 CEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCF 133 (782)
Q Consensus 55 c~w~gv~c~~~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~ 133 (782)
|.. +..|.... +.++.++++++ .+|..+. ++|+.|+|++|+|++.++ .|.++++|++|+|++|.++.+++..|
T Consensus 3 Cp~-~C~C~~~~--~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~ 76 (477)
T 2id5_A 3 CPP-RCECSAQD--RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAF 76 (477)
T ss_dssp CST-TCEEETTT--TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTT
T ss_pred ccC-CCeECCCC--CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhh
Confidence 553 56676432 46889999998 6777664 689999999999999887 89999999999999999999999999
Q ss_pred CCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccc
Q 003982 134 DGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQ 213 (782)
Q Consensus 134 ~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~ 213 (782)
.++++|++|+|++|++.. ..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|++++..|..
T Consensus 77 ~~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~------- 147 (477)
T 2id5_A 77 NNLFNLRTLGLRSNRLKL--IPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRA------- 147 (477)
T ss_dssp TTCTTCCEEECCSSCCCS--CCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTS-------
T ss_pred hCCccCCEEECCCCcCCc--cCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhh-------
Confidence 999999999999999998 34456899999999999999999999999999999999999999998655554
Q ss_pred hhhcccccCCCccccccccCCCCCcEEEeecccccCCCCC-CCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCC
Q 003982 214 NLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNN 292 (782)
Q Consensus 214 ~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 292 (782)
|.++++|++|+|++|++++.++. +..+++|+.|+|++|++++..+..|..+++|+.|++++|
T Consensus 148 -----------------~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~ 210 (477)
T 2id5_A 148 -----------------FSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHW 210 (477)
T ss_dssp -----------------STTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECC
T ss_pred -----------------ccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCC
Confidence 44689999999999999987764 899999999999999999988899999999999999999
Q ss_pred cccCCCCCC---CCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCce
Q 003982 293 KLQGPYPLF---PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRI 369 (782)
Q Consensus 293 ~l~~~~~~~---~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L 369 (782)
++.+.+|.. ..+|+.|++++|+++.++ +..+..+++|
T Consensus 211 ~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~----------------------------------------~~~~~~l~~L 250 (477)
T 2id5_A 211 PYLDTMTPNCLYGLNLTSLSITHCNLTAVP----------------------------------------YLAVRHLVYL 250 (477)
T ss_dssp TTCCEECTTTTTTCCCSEEEEESSCCCSCC----------------------------------------HHHHTTCTTC
T ss_pred ccccccCcccccCccccEEECcCCcccccC----------------------------------------HHHhcCcccc
Confidence 988766643 248999999999886544 1245667899
Q ss_pred eEEEccCcccccccCccccccccCCeEecccccccccCCccCCCCCCCCeEecCCCcCCCCCCCC-C--CCcceecCCCC
Q 003982 370 ITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDF-G--SNVKFTVSPGN 446 (782)
Q Consensus 370 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~-~--~~~~~~~~~~n 446 (782)
+.|+|++|.+++..+..|.++++|++|+|++|++++..|..|..+++|+.|+|++|+|++.++.. . ..+....+.+|
T Consensus 251 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 330 (477)
T 2id5_A 251 RFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSN 330 (477)
T ss_dssp CEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSS
T ss_pred CeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCC
Confidence 99999999999988889999999999999999999999999999999999999999999987743 2 56778899999
Q ss_pred CCCCC
Q 003982 447 PFIGT 451 (782)
Q Consensus 447 ~~~~~ 451 (782)
|+.|.
T Consensus 331 ~l~c~ 335 (477)
T 2id5_A 331 PLACD 335 (477)
T ss_dssp CEECS
T ss_pred CccCc
Confidence 99885
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=338.37 Aligned_cols=358 Identities=18% Similarity=0.181 Sum_probs=258.4
Q ss_pred CCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEec
Q 003982 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144 (782)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 144 (782)
.+++.|+|++|.+++..|..|..+++|++|+|++|++++..| .|.++++|++|+|++|+|+.+|.. .+++|++|+|
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~---~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCH---PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCEEECC---CCCCCSEEEC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceeecCcc---ccCCccEEec
Confidence 579999999999998888889999999999999999999877 799999999999999999998876 7999999999
Q ss_pred cCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCC--cEEEcccCcC--CCCCCccccc-----------
Q 003982 145 SDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNL--QNLRLSYNNF--TGSLPASFAK----------- 209 (782)
Q Consensus 145 s~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L--~~L~Ls~N~l--~~~~p~~~~~----------- 209 (782)
++|++... .+|..+.++++|++|+|++|++++ ..+..+++| ++|++++|++ .+..|..+..
T Consensus 98 ~~N~l~~~-~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~ 173 (520)
T 2z7x_B 98 SFNAFDAL-PICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFP 173 (520)
T ss_dssp CSSCCSSC-CCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECC
T ss_pred cCCccccc-cchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEec
Confidence 99999862 367899999999999999999987 467777888 9999999999 6677766654
Q ss_pred ----------------cccchhhcccccCC-----CccccccccC---------------------------CCCCcEEE
Q 003982 210 ----------------SDIQNLWMNDQQLG-----LSGTLDVLSG---------------------------MTQLRQVW 241 (782)
Q Consensus 210 ----------------~~l~~l~l~~~~~~-----~~~~~~~~~~---------------------------l~~L~~L~ 241 (782)
..++.+++..|... ..+..+.+.. .++|++|+
T Consensus 174 ~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~ 253 (520)
T 2z7x_B 174 TNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFS 253 (520)
T ss_dssp SSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEE
T ss_pred cCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEE
Confidence 22344444443200 0000001111 23677777
Q ss_pred eecccccCCCC-CC-----CCCCCCCEEEcCCCcCccCcc-hh-------------------------hcCCCCCCEEEc
Q 003982 242 LHKNQFTGPIP-DL-----SKCESLFDLSLRDNQLTGVVP-AS-------------------------VISLPALLNISL 289 (782)
Q Consensus 242 L~~N~l~~~~~-~~-----~~l~~L~~L~L~~N~l~~~~p-~~-------------------------~~~l~~L~~L~l 289 (782)
+++|++++..| .+ ..+++|+.++++.|.+ .+| .. +..+++|++|++
T Consensus 254 l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~L 331 (520)
T 2z7x_B 254 ISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDF 331 (520)
T ss_dssp EEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEEC
T ss_pred eecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCccccccchhhCCcccEEEe
Confidence 77777775444 34 5555555555555554 222 11 156777888888
Q ss_pred cCCcccCCCCCC---CCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCC-CCcc-cc
Q 003982 290 QNNKLQGPYPLF---PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDG-WPFV-TC 364 (782)
Q Consensus 290 ~~N~l~~~~~~~---~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~p~~-~~ 364 (782)
++|++++.+|.. +.+|+.|++++|+++++. .++..+.....+.....+++.+.. +|.. +.
T Consensus 332 s~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~---------------~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~ 396 (520)
T 2z7x_B 332 SNNLLTDTVFENCGHLTELETLILQMNQLKELS---------------KIAEMTTQMKSLQQLDISQNSVSYDEKKGDCS 396 (520)
T ss_dssp CSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHH---------------HHHHHHTTCTTCCEEECCSSCCBCCGGGCSCC
T ss_pred ECCccChhhhhhhccCCCCCEEEccCCccCccc---------------cchHHHhhCCCCCEEECCCCcCCcccccchhc
Confidence 888887766543 356778888888776432 111111111222222223333333 6654 56
Q ss_pred cCCceeEEEccCcccccccCccccccccCCeEecccccccccCCccCCCCCCCCeEecCCCcCCCCCCC-CC--CCccee
Q 003982 365 SQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPD-FG--SNVKFT 441 (782)
Q Consensus 365 ~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~-~~--~~~~~~ 441 (782)
.+++|++|++++|.+++.+|..+. ++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++.++. +. ..+...
T Consensus 397 ~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L 473 (520)
T 2z7x_B 397 WTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKI 473 (520)
T ss_dssp CCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEE
Confidence 678999999999999988888775 79999999999999 8898888999999999999999965554 43 467778
Q ss_pred cCCCCCCCC
Q 003982 442 VSPGNPFIG 450 (782)
Q Consensus 442 ~~~~n~~~~ 450 (782)
.+.+||+.|
T Consensus 474 ~l~~N~~~c 482 (520)
T 2z7x_B 474 WLHTNPWDC 482 (520)
T ss_dssp ECCSSCBCC
T ss_pred ECcCCCCcc
Confidence 899999876
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=350.88 Aligned_cols=338 Identities=17% Similarity=0.219 Sum_probs=285.8
Q ss_pred CCEEEEEeCCCCCCcc-----------------cCcccc--CCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCc-
Q 003982 66 NRVTTISLAKSGLSGT-----------------LSPEIS--SLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNN- 124 (782)
Q Consensus 66 ~~v~~L~l~~~~l~~~-----------------~~~~l~--~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~- 124 (782)
.+++.|+|++|.++|. +|+.++ ++++|++|+|++|++.+.+| .|.++++|++|+|++|+
T Consensus 206 ~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~ 285 (636)
T 4eco_A 206 TKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRG 285 (636)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTT
T ss_pred cCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCC
Confidence 4799999999999996 999999 99999999999999999887 79999999999999998
Q ss_pred ccC--CCCCCCCCC------CCCCEEeccCCCCCCCCCCCc--ccCCCcccCeeeccccccCCCCcccccCCCCCcEEEc
Q 003982 125 FTS--VPTGCFDGL------TNLQVLSLSDNPNLAPWPFPN--ELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRL 194 (782)
Q Consensus 125 l~~--~~~~~~~~l------~~L~~L~Ls~N~l~~~~~~p~--~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 194 (782)
+++ +|.. +.++ ++|++|+|++|++.. +|. .+.++++|++|+|++|+++|.+| .|..+++|++|+|
T Consensus 286 l~~~~lp~~-~~~L~~~~~l~~L~~L~L~~n~l~~---ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L 360 (636)
T 4eco_A 286 ISGEQLKDD-WQALADAPVGEKIQIIYIGYNNLKT---FPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNL 360 (636)
T ss_dssp SCHHHHHHH-HHHHHHSGGGGTCCEEECCSSCCSS---CCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEEC
T ss_pred CccccchHH-HHhhhccccCCCCCEEECCCCcCCc---cCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEEC
Confidence 986 5543 5554 999999999999996 788 89999999999999999998888 8999999999999
Q ss_pred ccCcCCCCCCccccc-cc-cchhhcccccCCCccccccccCC--CCCcEEEeecccccCCCCC-CC-------CCCCCCE
Q 003982 195 SYNNFTGSLPASFAK-SD-IQNLWMNDQQLGLSGTLDVLSGM--TQLRQVWLHKNQFTGPIPD-LS-------KCESLFD 262 (782)
Q Consensus 195 s~N~l~~~~p~~~~~-~~-l~~l~l~~~~~~~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~-~~-------~l~~L~~ 262 (782)
++|+++ .+|..+.. .. |+.|++++|.+. ..+..+..+ ++|++|++++|++++..|. +. .+++|++
T Consensus 361 ~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~--~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~ 437 (636)
T 4eco_A 361 AYNQIT-EIPANFCGFTEQVENLSFAHNKLK--YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSS 437 (636)
T ss_dssp CSSEEE-ECCTTSEEECTTCCEEECCSSCCS--SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEE
T ss_pred CCCccc-cccHhhhhhcccCcEEEccCCcCc--ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCE
Confidence 999999 89988877 45 999999999987 333445554 4899999999999997664 66 7889999
Q ss_pred EEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCCCCC----------CccEEEccCCcCCCCCCCCCCCCChhhhh
Q 003982 263 LSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPS----------KVQKVSLDHNNFCKNSSDAGKPCDPQVTT 332 (782)
Q Consensus 263 L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~----------~l~~L~l~~N~~~~~~~~~~~~~~~~~~~ 332 (782)
|+|++|+|+...+..+..+++|++|++++|+++...+..+. +|+.|+|++|+++.++.....
T Consensus 438 L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~-------- 509 (636)
T 4eco_A 438 INLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRA-------- 509 (636)
T ss_dssp EECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCCBCCGGGST--------
T ss_pred EECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCCccChhhhh--------
Confidence 99999999955555566799999999999999954444443 899999999999866522110
Q ss_pred HHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEc------cCcccccccCccccccccCCeEeccccccccc
Q 003982 333 LLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINL------ANKLLAGNISPAYANLTSLKNLYLQQNNLTGP 406 (782)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~L------s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ 406 (782)
.....+......++.+..+|..+..+++|++|+| ++|++.+.+|..+.++++|++|+|++|+| +.
T Consensus 510 --------~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ 580 (636)
T 4eco_A 510 --------TTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RK 580 (636)
T ss_dssp --------TTCTTCCEEECCSSCCSSCCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CB
T ss_pred --------ccCCCcCEEECCCCCCCCcChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-Cc
Confidence 0112233334445556669999999999999999 56889999999999999999999999999 68
Q ss_pred CCccCCCCCCCCeEecCCCcCCCC
Q 003982 407 IPDGLTKLASLQNLDVSNNNLSGK 430 (782)
Q Consensus 407 ~p~~~~~l~~L~~L~ls~N~l~g~ 430 (782)
+|..+. ++|+.|||++|+++..
T Consensus 581 ip~~~~--~~L~~L~Ls~N~l~~~ 602 (636)
T 4eco_A 581 VNEKIT--PNISVLDIKDNPNISI 602 (636)
T ss_dssp CCSCCC--TTCCEEECCSCTTCEE
T ss_pred cCHhHh--CcCCEEECcCCCCccc
Confidence 998877 8999999999988753
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=342.50 Aligned_cols=369 Identities=21% Similarity=0.231 Sum_probs=287.2
Q ss_pred CCEEEEEeCCCCCCcccCccccCCcc--CceeecccCccCccCC-CCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEE
Q 003982 66 NRVTTISLAKSGLSGTLSPEISSLTQ--LETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVL 142 (782)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~l~~l~~--L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 142 (782)
..++.|++++|.+++..|..+..++. |++|+|++|++++.+| .|..+++|++|+|++|+++++++..|.++++|++|
T Consensus 222 ~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 301 (680)
T 1ziw_A 222 TSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYL 301 (680)
T ss_dssp SCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEE
T ss_pred ccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEE
Confidence 46789999999999988888988865 9999999999999887 79999999999999999999999999999999999
Q ss_pred eccCCCCCCCC---CCCc----ccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCC-CCc-ccc---cc
Q 003982 143 SLSDNPNLAPW---PFPN----ELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGS-LPA-SFA---KS 210 (782)
Q Consensus 143 ~Ls~N~l~~~~---~~p~----~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~p~-~~~---~~ 210 (782)
++++|...... .+|. .|..+++|++|++++|++++..+..|..+++|++|++++|.+... ++. .|. ..
T Consensus 302 ~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~ 381 (680)
T 1ziw_A 302 NLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHS 381 (680)
T ss_dssp ECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTS
T ss_pred eccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccC
Confidence 99987654211 1333 688899999999999999999999999999999999999986532 222 222 24
Q ss_pred ccchhhcccccCCCccccccccCCCCCcEEEeecccccCCCC--CCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEE
Q 003982 211 DIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIP--DLSKCESLFDLSLRDNQLTGVVPASVISLPALLNIS 288 (782)
Q Consensus 211 ~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 288 (782)
.++.|++++|.+... ....+..+++|++|+|++|++++.++ .+..+++|++|++++|++++..+..|..+++|+.|+
T Consensus 382 ~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~ 460 (680)
T 1ziw_A 382 PLHILNLTKNKISKI-ESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLM 460 (680)
T ss_dssp CCCEEECTTSCCCEE-CTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEE
T ss_pred cCceEECCCCCCCeE-ChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccch
Confidence 678888888876532 23567788888888888888887544 478888888888888888888888888888888888
Q ss_pred ccCCccc--CCCCCC---CCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCC-----
Q 003982 289 LQNNKLQ--GPYPLF---PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDG----- 358 (782)
Q Consensus 289 l~~N~l~--~~~~~~---~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 358 (782)
+++|.+. +..|.. +.+|+.|++++|++++++...... ...+......++.+..
T Consensus 461 l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~-----------------l~~L~~L~Ls~N~l~~~~~~~ 523 (680)
T 1ziw_A 461 LRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEG-----------------LEKLEILDLQHNNLARLWKHA 523 (680)
T ss_dssp CTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTT-----------------CTTCCEEECCSSCCGGGGSTT
T ss_pred hccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhcc-----------------ccccCEEeCCCCCccccchhh
Confidence 8888876 344543 356888888888887765332211 1111111122222221
Q ss_pred CC----cccccCCceeEEEccCcccccccCccccccccCCeEecccccccccCCccCCCCCCCCeEecCCCcCCCCCCCC
Q 003982 359 WP----FVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDF 434 (782)
Q Consensus 359 ~p----~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~ 434 (782)
+| ..+..+++|++|+|++|+++...+..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|++.+|..
T Consensus 524 ~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 603 (680)
T 1ziw_A 524 NPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKV 603 (680)
T ss_dssp STTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHH
T ss_pred ccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhH
Confidence 12 23677899999999999999655557999999999999999999777778899999999999999999988842
Q ss_pred ----CCCcceecCCCCCCCCCC
Q 003982 435 ----GSNVKFTVSPGNPFIGTN 452 (782)
Q Consensus 435 ----~~~~~~~~~~~n~~~~~~ 452 (782)
...+....+.+|||.|..
T Consensus 604 ~~~~~~~L~~l~l~~N~~~c~c 625 (680)
T 1ziw_A 604 FGPAFRNLTELDMRFNPFDCTC 625 (680)
T ss_dssp HHHHHTTCSEEECTTCCCCBCC
T ss_pred hcccccccCEEEccCCCcccCC
Confidence 267788899999998853
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=349.81 Aligned_cols=339 Identities=18% Similarity=0.219 Sum_probs=283.6
Q ss_pred CCEEEEEeCCCCCCc-----------------ccCcccc--CCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCc-
Q 003982 66 NRVTTISLAKSGLSG-----------------TLSPEIS--SLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNN- 124 (782)
Q Consensus 66 ~~v~~L~l~~~~l~~-----------------~~~~~l~--~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~- 124 (782)
.+++.|+|++|.|+| .+|+.++ ++++|++|+|++|++.+.+| .|.++++|++|+|++|+
T Consensus 448 ~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~ 527 (876)
T 4ecn_A 448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRG 527 (876)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTT
T ss_pred CCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCC
Confidence 479999999999998 4999988 99999999999999999888 79999999999999998
Q ss_pred ccC--CCCC------CCCCCCCCCEEeccCCCCCCCCCCCc--ccCCCcccCeeeccccccCCCCcccccCCCCCcEEEc
Q 003982 125 FTS--VPTG------CFDGLTNLQVLSLSDNPNLAPWPFPN--ELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRL 194 (782)
Q Consensus 125 l~~--~~~~------~~~~l~~L~~L~Ls~N~l~~~~~~p~--~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 194 (782)
+++ +|.. .+..+++|++|+|++|++.. +|. .+.++++|+.|+|++|+++ .+| .|..+++|++|+|
T Consensus 528 lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~---ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~L 602 (876)
T 4ecn_A 528 ISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEE---FPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKL 602 (876)
T ss_dssp SCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCB---CCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEEC
T ss_pred cccccchHHHHhhhhcccccCCccEEEeeCCcCCc---cCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEEC
Confidence 886 5542 34566799999999999995 788 8999999999999999999 567 8999999999999
Q ss_pred ccCcCCCCCCccccc-cc-cchhhcccccCCCccccccccCCC--CCcEEEeecccccCCCCCCC------CCCCCCEEE
Q 003982 195 SYNNFTGSLPASFAK-SD-IQNLWMNDQQLGLSGTLDVLSGMT--QLRQVWLHKNQFTGPIPDLS------KCESLFDLS 264 (782)
Q Consensus 195 s~N~l~~~~p~~~~~-~~-l~~l~l~~~~~~~~~~~~~~~~l~--~L~~L~L~~N~l~~~~~~~~------~l~~L~~L~ 264 (782)
++|+++ .+|..+.. .. |+.|++++|.+. ..+..+..++ +|+.|+|++|++++.+|.+. .+++|+.|+
T Consensus 603 s~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~--~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~ 679 (876)
T 4ecn_A 603 DYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK--YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVT 679 (876)
T ss_dssp CSSCCS-CCCTTSCEECTTCCEEECCSSCCC--SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEE
T ss_pred cCCccc-cchHHHhhccccCCEEECcCCCCC--cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEE
Confidence 999999 89988876 45 999999999987 3334555554 49999999999999776543 456999999
Q ss_pred cCCCcCccCcchhh-cCCCCCCEEEccCCcccCCCCCCCC----------CccEEEccCCcCCCCCCCCCCCCChhhhhH
Q 003982 265 LRDNQLTGVVPASV-ISLPALLNISLQNNKLQGPYPLFPS----------KVQKVSLDHNNFCKNSSDAGKPCDPQVTTL 333 (782)
Q Consensus 265 L~~N~l~~~~p~~~-~~l~~L~~L~l~~N~l~~~~~~~~~----------~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~ 333 (782)
|++|+|+ .+|..+ ..+++|+.|+|++|+|+...+..+. +|+.|+|++|+++.++....
T Consensus 680 Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~~lp~~l~---------- 748 (876)
T 4ecn_A 680 LSYNEIQ-KFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFR---------- 748 (876)
T ss_dssp CCSSCCC-SCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCCCCCGGGS----------
T ss_pred ccCCcCC-ccCHHHHccCCCCCEEECCCCcCCccChHHhccccccccccCCccEEECCCCCCccchHHhh----------
Confidence 9999999 556554 5899999999999999954444332 89999999999986552111
Q ss_pred HHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccC------cccccccCccccccccCCeEecccccccccC
Q 003982 334 LQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLAN------KLLAGNISPAYANLTSLKNLYLQQNNLTGPI 407 (782)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~------N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~ 407 (782)
......+.....+++.+..+|..+..+++|+.|+|++ |++.+.+|..|.++++|+.|+|++|+| +.+
T Consensus 749 ------~~~l~~L~~L~Ls~N~L~~lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~I 821 (876)
T 4ecn_A 749 ------ATTLPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKV 821 (876)
T ss_dssp ------TTTCTTCCEEECCSSCCSSCCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBC
T ss_pred ------hccCCCcCEEEeCCCCCCccchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-Ccc
Confidence 0011223333445556666999999999999999976 889999999999999999999999999 799
Q ss_pred CccCCCCCCCCeEecCCCcCCCCCC
Q 003982 408 PDGLTKLASLQNLDVSNNNLSGKVP 432 (782)
Q Consensus 408 p~~~~~l~~L~~L~ls~N~l~g~~p 432 (782)
|..+. ++|+.|||++|++...-+
T Consensus 822 p~~l~--~~L~~LdLs~N~l~~i~~ 844 (876)
T 4ecn_A 822 DEKLT--PQLYILDIADNPNISIDV 844 (876)
T ss_dssp CSCCC--SSSCEEECCSCTTCEEEC
T ss_pred CHhhc--CCCCEEECCCCCCCccCh
Confidence 99876 699999999999976554
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=337.45 Aligned_cols=346 Identities=18% Similarity=0.161 Sum_probs=274.3
Q ss_pred CCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEec
Q 003982 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144 (782)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 144 (782)
.+++.|+|++|.+++..|.+|.++++|++|+|++|.+++.+| .|.++++|++|+|++|+++.+++..|.++++|++|+|
T Consensus 56 ~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 135 (606)
T 3vq2_A 56 SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNV 135 (606)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEEC
T ss_pred ccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeC
Confidence 478999999999998888899999999999999999999877 7999999999999999999999888999999999999
Q ss_pred cCCCCCCCCCCCcccCCCcccCeeeccccccCCCCccccc----------------------------------------
Q 003982 145 SDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFD---------------------------------------- 184 (782)
Q Consensus 145 s~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~---------------------------------------- 184 (782)
++|++... .+|..+.++++|++|+|++|++++..+..|.
T Consensus 136 ~~n~l~~~-~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~n 214 (606)
T 3vq2_A 136 AHNFIHSC-KLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGN 214 (606)
T ss_dssp CSSCCCCC-CCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESC
T ss_pred CCCcccce-echHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccCceeeeeeccCC
Confidence 99998752 3688899999999999999988776554332
Q ss_pred --------------------------------------------------------------------------------
Q 003982 185 -------------------------------------------------------------------------------- 184 (782)
Q Consensus 185 -------------------------------------------------------------------------------- 184 (782)
T Consensus 215 ~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~~ 294 (606)
T 3vq2_A 215 FNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAG 294 (606)
T ss_dssp CSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEEEEES
T ss_pred ccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccccccCCCCCEEEecC
Confidence
Q ss_pred ----------CCCCCcEEEcccCcCCCCCCccccc----------------------cccchhhcccccCCCcc-ccccc
Q 003982 185 ----------SFSNLQNLRLSYNNFTGSLPASFAK----------------------SDIQNLWMNDQQLGLSG-TLDVL 231 (782)
Q Consensus 185 ----------~l~~L~~L~Ls~N~l~~~~p~~~~~----------------------~~l~~l~l~~~~~~~~~-~~~~~ 231 (782)
.+++|++|++++|++ +.+|.. .. ..|++|++++|.+...+ ....+
T Consensus 295 ~~~~~l~~l~~~~~L~~L~l~~n~l-~~lp~~-~l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~ 372 (606)
T 3vq2_A 295 VSIKYLEDVPKHFKWQSLSIIRCQL-KQFPTL-DLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSD 372 (606)
T ss_dssp CCCCCCCCCCTTCCCSEEEEESCCC-SSCCCC-CCSSCCEEEEESCSSCEECCCCCCTTCCEEECCSSCEEEEEECCHHH
T ss_pred ccchhhhhccccccCCEEEcccccC-cccccC-CCCccceeeccCCcCccchhhccCCCCCEEECcCCccCCCcchhhhh
Confidence 222444444444444 244421 11 34566666666654332 13457
Q ss_pred cCCCCCcEEEeecccccCCCCCCCCCCCCCEEEcCCCcCccCcc-hhhcCCCCCCEEEccCCcccCCCCCCC---CCccE
Q 003982 232 SGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVP-ASVISLPALLNISLQNNKLQGPYPLFP---SKVQK 307 (782)
Q Consensus 232 ~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~~~~---~~l~~ 307 (782)
..+++|++|++++|++++.+..+..+++|+.|++++|++++..| ..+..+++|++|++++|++++..|..+ .+|+.
T Consensus 373 ~~~~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 452 (606)
T 3vq2_A 373 LGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNT 452 (606)
T ss_dssp HCCSCCCEEECCSCSEEEECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCE
T ss_pred ccCCcccEeECCCCccccchhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCE
Confidence 78899999999999999887789999999999999999998877 688999999999999999998877643 57899
Q ss_pred EEccCCcCCCC-CCCCCCCCChhhhhHHHhhcCCCCCccccc-CcCCCCCCCCCCcccccCCceeEEEccCcccccccCc
Q 003982 308 VSLDHNNFCKN-SSDAGKPCDPQVTTLLQIAGDMGYPAILSD-SWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISP 385 (782)
Q Consensus 308 L~l~~N~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~ 385 (782)
|++++|++++. .+. .+.....+.. +..+|...+..|..+..+++|++|+|++|++++.+|.
T Consensus 453 L~l~~n~l~~~~~~~-----------------~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 515 (606)
T 3vq2_A 453 LKMAGNSFKDNTLSN-----------------VFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSS 515 (606)
T ss_dssp EECTTCEEGGGEECS-----------------CCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGG
T ss_pred EECCCCcCCCcchHH-----------------hhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHH
Confidence 99999998761 111 1111122232 2333333445567788999999999999999999999
Q ss_pred cccccccCCeEecccccccccCCccCCCCC-CCCeEecCCCcCCCCCC
Q 003982 386 AYANLTSLKNLYLQQNNLTGPIPDGLTKLA-SLQNLDVSNNNLSGKVP 432 (782)
Q Consensus 386 ~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~-~L~~L~ls~N~l~g~~p 432 (782)
.|.++++|++|+|++|+|+ .+|..+..++ +|+.|++++|++++..+
T Consensus 516 ~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 516 HYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICE 562 (606)
T ss_dssp GTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred HccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCc
Confidence 9999999999999999999 7888899997 59999999999998777
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=338.27 Aligned_cols=187 Identities=26% Similarity=0.400 Sum_probs=164.9
Q ss_pred hcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
.++|++.+.||+|+||+||+|. ..+|+.||+|++.... ....+.+.+|+++|+.++||||+++++++.++...|+||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 3689999999999999999995 4679999999997654 345677899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCC--CcEEEEeecccee
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD--MRAKVADFGLVKN 736 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~--~~~kL~DfG~a~~ 736 (782)
|||+||+|.+++... ...+++.++..+++||+.||+|||+ +||+||||||+|||++.+ +.+||+|||+|+.
T Consensus 234 E~~~gg~L~~~i~~~----~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~ 306 (573)
T 3uto_A 234 EFMSGGELFEKVADE----HNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 306 (573)
T ss_dssp ECCCCCBHHHHHTCT----TSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred eecCCCcHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeE
Confidence 999999999988542 2458999999999999999999999 899999999999999854 8999999999998
Q ss_pred cCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 737 APDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
...... ....+||+.|||||++.+. +++.++||||+||+
T Consensus 307 ~~~~~~--~~~~~GT~~y~APEv~~~~---~y~~~~DiWSlGvi 345 (573)
T 3uto_A 307 LDPKQS--VKVTTGTAEFAAPEVAEGK---PVGYYTDMWSVGVL 345 (573)
T ss_dssp CCTTSE--EEEECSSGGGCCHHHHTTC---CBCHHHHHHHHHHH
T ss_pred ccCCCc--eeeeEECccccCHHHhCCC---CCCcHHHHHHHHHH
Confidence 865442 2345899999999999876 56889999999986
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-35 Score=339.10 Aligned_cols=327 Identities=20% Similarity=0.232 Sum_probs=261.7
Q ss_pred CEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEecc
Q 003982 67 RVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145 (782)
Q Consensus 67 ~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls 145 (782)
+++.++++++.+....+..+..+++|++|+|++|.|++.+| .|..+++|++|+|++|.|+++++..|.++++|++|+|+
T Consensus 52 ~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 131 (597)
T 3oja_B 52 NQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 131 (597)
T ss_dssp CCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEee
Confidence 56889999999986555568899999999999999999888 89999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCc
Q 003982 146 DNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLS 225 (782)
Q Consensus 146 ~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~ 225 (782)
+|++.. ..+..|.++++|++|+|++|.+++..|..|..+++|++|+|++|.+++..+..+ ..|+.|+++.|.+..
T Consensus 132 ~n~l~~--l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l--~~L~~L~l~~n~l~~- 206 (597)
T 3oja_B 132 RNDLSS--LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLI--PSLFHANVSYNLLST- 206 (597)
T ss_dssp SSCCCC--CCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGC--TTCSEEECCSSCCSE-
T ss_pred CCCCCC--CCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhh--hhhhhhhcccCcccc-
Confidence 999997 344457999999999999999999999999999999999999999995432222 467778888776542
Q ss_pred cccccccCCCCCcEEEeecccccCCCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCCC---C
Q 003982 226 GTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLF---P 302 (782)
Q Consensus 226 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~---~ 302 (782)
+...++|+.|++++|.++..++.+. ++|+.|+|++|.+++ +..+..+++|+.|+|++|.+++.+|.. +
T Consensus 207 -----l~~~~~L~~L~ls~n~l~~~~~~~~--~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l 277 (597)
T 3oja_B 207 -----LAIPIAVEELDASHNSINVVRGPVN--VELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKM 277 (597)
T ss_dssp -----EECCTTCSEEECCSSCCCEEECSCC--SCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTC
T ss_pred -----ccCCchhheeeccCCcccccccccC--CCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCc
Confidence 3445788899999998887655432 688999999999886 467888899999999999998876653 4
Q ss_pred CCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccc
Q 003982 303 SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGN 382 (782)
Q Consensus 303 ~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~ 382 (782)
.+|+.|+|++|.+++++ ..+..+++|+.|+|++|.++ .
T Consensus 278 ~~L~~L~Ls~N~l~~l~-----------------------------------------~~~~~l~~L~~L~Ls~N~l~-~ 315 (597)
T 3oja_B 278 QRLERLYISNNRLVALN-----------------------------------------LYGQPIPTLKVLDLSHNHLL-H 315 (597)
T ss_dssp SSCCEEECTTSCCCEEE-----------------------------------------CSSSCCTTCCEEECCSSCCC-C
T ss_pred cCCCEEECCCCCCCCCC-----------------------------------------cccccCCCCcEEECCCCCCC-c
Confidence 57888888888876543 22344568888889888888 5
Q ss_pred cCccccccccCCeEecccccccccCCccCCCCCCCCeEecCCCcCCCCCC-CCCCCcceecCCCCCCCCCC
Q 003982 383 ISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVP-DFGSNVKFTVSPGNPFIGTN 452 (782)
Q Consensus 383 ~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p-~~~~~~~~~~~~~n~~~~~~ 452 (782)
+|..+..+++|++|+|++|+|++. | +..+++|+.|+|++|++++..+ .+...+....+.+++..|..
T Consensus 316 i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~C~~ 383 (597)
T 3oja_B 316 VERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKI 383 (597)
T ss_dssp CGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHHHHTTTCCTTTBCCCCCCCCT
T ss_pred cCcccccCCCCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCChhHHHHHHHHhhhccccccccCCc
Confidence 777888888888999998888744 3 6677888888898888876543 22233333445566666643
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=320.36 Aligned_cols=326 Identities=21% Similarity=0.254 Sum_probs=249.1
Q ss_pred CCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEec
Q 003982 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144 (782)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 144 (782)
.+++.++++++.++...+..+..+++|++|+|++|.+++.++ .|.++++|++|+|++|+++.+++..|.++++|++|+|
T Consensus 45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 124 (390)
T 3o6n_A 45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 124 (390)
T ss_dssp CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEEC
Confidence 367889999999885444457899999999999999999887 8999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCCCc-ccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCC
Q 003982 145 SDNPNLAPWPFPN-ELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLG 223 (782)
Q Consensus 145 s~N~l~~~~~~p~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~ 223 (782)
++|++.. +|. .|.++++|++|+|++|++++..+..|..+++|++|++++|++++.-...+ ..++.++++.|.+.
T Consensus 125 ~~n~l~~---l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l--~~L~~L~l~~n~l~ 199 (390)
T 3o6n_A 125 ERNDLSS---LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLI--PSLFHANVSYNLLS 199 (390)
T ss_dssp CSSCCCC---CCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGC--TTCSEEECCSSCCS
T ss_pred CCCccCc---CCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccccccc--cccceeeccccccc
Confidence 9999987 444 46899999999999999999989999999999999999999984322222 46777777777654
Q ss_pred CccccccccCCCCCcEEEeecccccCCCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCCC--
Q 003982 224 LSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLF-- 301 (782)
Q Consensus 224 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-- 301 (782)
. +...++|++|++++|+++..+... .++|+.|++++|++++. ..+..+++|++|++++|++++..|..
T Consensus 200 ~------~~~~~~L~~L~l~~n~l~~~~~~~--~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~ 269 (390)
T 3o6n_A 200 T------LAIPIAVEELDASHNSINVVRGPV--NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFV 269 (390)
T ss_dssp E------EECCSSCSEEECCSSCCCEEECCC--CSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGT
T ss_pred c------cCCCCcceEEECCCCeeeeccccc--cccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHcc
Confidence 2 334567888888888887764432 46788888888888853 57788888888888888888766543
Q ss_pred -CCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccc
Q 003982 302 -PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLA 380 (782)
Q Consensus 302 -~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~ 380 (782)
+.+|+.|++++|++++++ .....+++|++|+|++|+++
T Consensus 270 ~l~~L~~L~L~~n~l~~~~-----------------------------------------~~~~~l~~L~~L~L~~n~l~ 308 (390)
T 3o6n_A 270 KMQRLERLYISNNRLVALN-----------------------------------------LYGQPIPTLKVLDLSHNHLL 308 (390)
T ss_dssp TCSSCCEEECCSSCCCEEE-----------------------------------------CSSSCCTTCCEEECCSSCCC
T ss_pred ccccCCEEECCCCcCcccC-----------------------------------------cccCCCCCCCEEECCCCcce
Confidence 457788888888775433 22334567888888888887
Q ss_pred cccCccccccccCCeEecccccccccCCccCCCCCCCCeEecCCCcCCCCCC-CCCCCcceecCCCCCCCCC
Q 003982 381 GNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVP-DFGSNVKFTVSPGNPFIGT 451 (782)
Q Consensus 381 ~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p-~~~~~~~~~~~~~n~~~~~ 451 (782)
.+|..+..+++|++|+|++|+|+.. | +..+++|+.|++++|++++... .+...+....+.+++..|.
T Consensus 309 -~~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~c~ 376 (390)
T 3o6n_A 309 -HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCK 376 (390)
T ss_dssp -CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHHHHTTTCCTTTBCCCCSCCC
T ss_pred -ecCccccccCcCCEEECCCCcccee-C--chhhccCCEEEcCCCCccchhHHHHHHHHHhhcccccCceec
Confidence 4666777888888888888888743 3 6677888888888888876432 2223333333445555554
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=331.70 Aligned_cols=313 Identities=19% Similarity=0.211 Sum_probs=260.6
Q ss_pred CCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCC-CCCCCCCCCCCEEec
Q 003982 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVP-TGCFDGLTNLQVLSL 144 (782)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~-~~~~~~l~~L~~L~L 144 (782)
.+++.|+|++|.+++..|.+|..+++|++|+|++|+|+.+++. .+++|++|+|++|+++.++ +..|.++++|++|+|
T Consensus 76 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L 153 (562)
T 3a79_B 76 SELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGL 153 (562)
T ss_dssp TTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCEECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEE
T ss_pred CCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEec
Confidence 4799999999999988899999999999999999999976555 8999999999999999987 478999999999999
Q ss_pred cCCCCCCCCCCCcccCCCccc--Ceeecccccc--CCCCcccccCCC---------------------------------
Q 003982 145 SDNPNLAPWPFPNELTKSTSL--TTLYMDNANI--FGLIPDFFDSFS--------------------------------- 187 (782)
Q Consensus 145 s~N~l~~~~~~p~~~~~l~~L--~~L~L~~N~l--~~~~~~~~~~l~--------------------------------- 187 (782)
++|++.. ..+..+++| +.|+|++|.+ ++..|..+..+.
T Consensus 154 ~~n~l~~-----~~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l 228 (562)
T 3a79_B 154 SAAKFRQ-----LDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNI 228 (562)
T ss_dssp ECSBCCT-----TTTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEE
T ss_pred CCCcccc-----CchhhhhhceeeEEEeecccccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecc
Confidence 9999877 244555555 9999999999 777777776544
Q ss_pred ------------------------------------------------CCcEEEcccCcCCCCCCccccc----------
Q 003982 188 ------------------------------------------------NLQNLRLSYNNFTGSLPASFAK---------- 209 (782)
Q Consensus 188 ------------------------------------------------~L~~L~Ls~N~l~~~~p~~~~~---------- 209 (782)
+|++|++++|+++|.+|..+..
T Consensus 229 ~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~ 308 (562)
T 3a79_B 229 KLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLM 308 (562)
T ss_dssp ECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEE
T ss_pred cccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchhee
Confidence 7888888888888888876621
Q ss_pred ----------------------cccchhhcccccCCCccccccccCCCCCcEEEeecccccCCCC-CCCCCCCCCEEEcC
Q 003982 210 ----------------------SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIP-DLSKCESLFDLSLR 266 (782)
Q Consensus 210 ----------------------~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~ 266 (782)
.+++.|++++|.+.... ....+++|++|++++|++++..+ .+..+++|+.|+|+
T Consensus 309 ~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~---~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~ 385 (562)
T 3a79_B 309 IEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMV---CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQ 385 (562)
T ss_dssp EEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCC---CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECC
T ss_pred hhhcccceeecChhhhhhhhccCcceEEEccCCCccccc---CccCCCCceEEECCCCccccchhhhhcccCCCCEEECC
Confidence 23555566666543211 12678999999999999999555 68999999999999
Q ss_pred CCcCccC--cchhhcCCCCCCEEEccCCcccCCCCC----CCCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCC
Q 003982 267 DNQLTGV--VPASVISLPALLNISLQNNKLQGPYPL----FPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDM 340 (782)
Q Consensus 267 ~N~l~~~--~p~~~~~l~~L~~L~l~~N~l~~~~~~----~~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (782)
+|++++. +|..|.++++|++|++++|++++.+|. .+.+|+.|++++|++++..
T Consensus 386 ~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~--------------------- 444 (562)
T 3a79_B 386 RNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSV--------------------- 444 (562)
T ss_dssp SSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGG---------------------
T ss_pred CCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcch---------------------
Confidence 9999973 467899999999999999999985553 2468999999999986422
Q ss_pred CCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccccCccccccccCCeEecccccccccCCcc-CCCCCCCCe
Q 003982 341 GYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDG-LTKLASLQN 419 (782)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~-~~~l~~L~~ 419 (782)
|..+. ++|++|+|++|+|+ .+|..+.++++|++|+|++|+|+ .+|.. |..+++|+.
T Consensus 445 -------------------~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~ 501 (562)
T 3a79_B 445 -------------------FRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQY 501 (562)
T ss_dssp -------------------GSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCC
T ss_pred -------------------hhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCE
Confidence 11111 58999999999999 68888889999999999999999 56666 999999999
Q ss_pred EecCCCcCCCCCC
Q 003982 420 LDVSNNNLSGKVP 432 (782)
Q Consensus 420 L~ls~N~l~g~~p 432 (782)
|++++|++++..|
T Consensus 502 L~l~~N~~~c~c~ 514 (562)
T 3a79_B 502 IWLHDNPWDCTCP 514 (562)
T ss_dssp EECCSCCBCCCHH
T ss_pred EEecCCCcCCCcc
Confidence 9999999999877
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=327.80 Aligned_cols=316 Identities=16% Similarity=0.214 Sum_probs=234.8
Q ss_pred CCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCC-CCCCCCCCCCCEEec
Q 003982 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVP-TGCFDGLTNLQVLSL 144 (782)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~-~~~~~~l~~L~~L~L 144 (782)
.+++.|+|++|.+++..|..|..+++|++|+|++|+|+++++. .+++|++|+|++|++++++ +..|+++++|++|+|
T Consensus 45 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L 122 (520)
T 2z7x_B 45 SKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGL 122 (520)
T ss_dssp TTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCEEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEE
T ss_pred ccccEEecCCCccCCcChHHhhcccCCCEEecCCCceeecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEe
Confidence 5799999999999988899999999999999999999976555 8999999999999999864 467999999999999
Q ss_pred cCCCCCCCCCCCcccCCCccc--Ceeecccccc--CCCCcccccCCC---------------------------------
Q 003982 145 SDNPNLAPWPFPNELTKSTSL--TTLYMDNANI--FGLIPDFFDSFS--------------------------------- 187 (782)
Q Consensus 145 s~N~l~~~~~~p~~~~~l~~L--~~L~L~~N~l--~~~~~~~~~~l~--------------------------------- 187 (782)
++|++.. ..+..+++| +.|++++|.+ .+..|..+..+.
T Consensus 123 ~~n~l~~-----~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l 197 (520)
T 2z7x_B 123 STTHLEK-----SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNI 197 (520)
T ss_dssp EESSCCG-----GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCE
T ss_pred cCcccch-----hhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccc
Confidence 9999876 467778888 9999999999 777777766643
Q ss_pred --------------------------------------------------CCcEEEcccCcCCCCCCccc-----cc-cc
Q 003982 188 --------------------------------------------------NLQNLRLSYNNFTGSLPASF-----AK-SD 211 (782)
Q Consensus 188 --------------------------------------------------~L~~L~Ls~N~l~~~~p~~~-----~~-~~ 211 (782)
+|++|++++|+++|.+|..+ .. ..
T Consensus 198 ~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~ 277 (520)
T 2z7x_B 198 KCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKA 277 (520)
T ss_dssp EECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCE
T ss_pred cccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCce
Confidence 67777777788877777766 22 33
Q ss_pred cchhhcccccCCCcc-----------------------ccccccCCCCCcEEEeecccccCCCC-CCCCCCCCCEEEcCC
Q 003982 212 IQNLWMNDQQLGLSG-----------------------TLDVLSGMTQLRQVWLHKNQFTGPIP-DLSKCESLFDLSLRD 267 (782)
Q Consensus 212 l~~l~l~~~~~~~~~-----------------------~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~ 267 (782)
|+.+++..|.+.... ....+..+++|++|++++|++++..+ .+..+++|+.|+|++
T Consensus 278 L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~ 357 (520)
T 2z7x_B 278 LSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQM 357 (520)
T ss_dssp EEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCS
T ss_pred eEeccccccceecchhhhhcccccCceeEEEcCCCccccccchhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccC
Confidence 444444444431110 00011455666666666666666333 456666666666666
Q ss_pred CcCcc--CcchhhcCCCCCCEEEccCCcccCCCCC----CCCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCC
Q 003982 268 NQLTG--VVPASVISLPALLNISLQNNKLQGPYPL----FPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMG 341 (782)
Q Consensus 268 N~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~~~----~~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (782)
|++++ .+|..+..+++|++|++++|++++.+|. .+.+|+.|++++|++++
T Consensus 358 N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~------------------------ 413 (520)
T 2z7x_B 358 NQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTD------------------------ 413 (520)
T ss_dssp SCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCG------------------------
T ss_pred CccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCc------------------------
Confidence 66664 3445566666666666666666653332 23456666666665543
Q ss_pred CCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccccCccccccccCCeEecccccccccCCcc-CCCCCCCCeE
Q 003982 342 YPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDG-LTKLASLQNL 420 (782)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~-~~~l~~L~~L 420 (782)
.+|..+. ++|++|+|++|+|+ .+|..+.++++|++|+|++|+|+ .+|.. |..+++|+.|
T Consensus 414 ----------------~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L 473 (520)
T 2z7x_B 414 ----------------TIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKI 473 (520)
T ss_dssp ----------------GGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEE
T ss_pred ----------------chhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEE
Confidence 2222222 68999999999999 79998889999999999999999 56665 9999999999
Q ss_pred ecCCCcCCCCCC
Q 003982 421 DVSNNNLSGKVP 432 (782)
Q Consensus 421 ~ls~N~l~g~~p 432 (782)
++++|++++..+
T Consensus 474 ~l~~N~~~c~c~ 485 (520)
T 2z7x_B 474 WLHTNPWDCSCP 485 (520)
T ss_dssp ECCSSCBCCCHH
T ss_pred ECcCCCCcccCC
Confidence 999999998776
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=331.57 Aligned_cols=350 Identities=18% Similarity=0.167 Sum_probs=277.6
Q ss_pred CCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEec
Q 003982 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144 (782)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 144 (782)
.+++.|+|++|++++..+..|.++++|++|+|++|.+++.+| .|.++++|++|+|++|+++.++...|.++++|++|+|
T Consensus 52 ~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 131 (570)
T 2z63_A 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131 (570)
T ss_dssp SSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEEC
T ss_pred CCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCCccccccccccEEec
Confidence 479999999999998888889999999999999999999887 7999999999999999999999888999999999999
Q ss_pred cCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCC----cEEEcccCcCCCCCCccccc-----------
Q 003982 145 SDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNL----QNLRLSYNNFTGSLPASFAK----------- 209 (782)
Q Consensus 145 s~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L----~~L~Ls~N~l~~~~p~~~~~----------- 209 (782)
++|++... .+|..+.++++|++|++++|++++..+..+..+++| +.|++++|.+++..|..+..
T Consensus 132 ~~n~l~~~-~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~~L~~L~l~~n 210 (570)
T 2z63_A 132 AHNLIQSF-KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN 210 (570)
T ss_dssp CSSCCCCC-CCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESC
T ss_pred CCCcccee-cChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCceecCHHHhccCcceeEecccc
Confidence 99998862 368899999999999999999998877777766666 67777777665433332221
Q ss_pred -----------------------------------------------------------------------cccchhhc-
Q 003982 210 -----------------------------------------------------------------------SDIQNLWM- 217 (782)
Q Consensus 210 -----------------------------------------------------------------------~~l~~l~l- 217 (782)
..++.|++
T Consensus 211 ~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~ 290 (570)
T 2z63_A 211 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLV 290 (570)
T ss_dssp CSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEE
T ss_pred cccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEec
Confidence 12222233
Q ss_pred ---------------------ccccCCCcccc------------------ccccCCCCCcEEEeecccccCCC---CCCC
Q 003982 218 ---------------------NDQQLGLSGTL------------------DVLSGMTQLRQVWLHKNQFTGPI---PDLS 255 (782)
Q Consensus 218 ---------------------~~~~~~~~~~~------------------~~~~~l~~L~~L~L~~N~l~~~~---~~~~ 255 (782)
.+|.+...... .....+++|++|++++|++++.. ..+.
T Consensus 291 ~~~l~~l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~ 370 (570)
T 2z63_A 291 SVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDF 370 (570)
T ss_dssp SCEECSCCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCCCBCTTCCEEECCSSCCBEEEEEEHHHH
T ss_pred CccchhhhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCccccccccccCCCCCEEeCcCCccCcccccccccc
Confidence 22222200000 00145778888888888888753 3477
Q ss_pred CCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCC----CCCCccEEEccCCcCCCCCCCCCCCCChhhh
Q 003982 256 KCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPL----FPSKVQKVSLDHNNFCKNSSDAGKPCDPQVT 331 (782)
Q Consensus 256 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~----~~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~ 331 (782)
.+++|++|++++|++++..+. +..+++|++|++++|++.+..|. .+.+|+.|++++|.+.+......
T Consensus 371 ~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-------- 441 (570)
T 2z63_A 371 GTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIF-------- 441 (570)
T ss_dssp TCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTT--------
T ss_pred ccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhh--------
Confidence 899999999999999965554 99999999999999999987662 34689999999999877542221
Q ss_pred hHHHhhcCCCCCcccccCcCCCCCC--CCCCcccccCCceeEEEccCcccccccCccccccccCCeEecccccccccCCc
Q 003982 332 TLLQIAGDMGYPAILSDSWEGNNAC--DGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPD 409 (782)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~ 409 (782)
.....+......++.+ +.+|..+..+++|++|+|++|++++..|..|.++++|++|+|++|++++..|.
T Consensus 442 ---------~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 512 (570)
T 2z63_A 442 ---------NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDG 512 (570)
T ss_dssp ---------TTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred ---------hcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHH
Confidence 1112222223333333 36888899999999999999999999999999999999999999999999889
Q ss_pred cCCCCCCCCeEecCCCcCCCCCCCC
Q 003982 410 GLTKLASLQNLDVSNNNLSGKVPDF 434 (782)
Q Consensus 410 ~~~~l~~L~~L~ls~N~l~g~~p~~ 434 (782)
.|..+++|+.|++++|+++|.+|..
T Consensus 513 ~~~~l~~L~~L~l~~N~~~~~~~~~ 537 (570)
T 2z63_A 513 IFDRLTSLQKIWLHTNPWDCSCPRI 537 (570)
T ss_dssp TTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred HhhcccCCcEEEecCCcccCCCcch
Confidence 9999999999999999999999853
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=330.84 Aligned_cols=340 Identities=18% Similarity=0.201 Sum_probs=261.4
Q ss_pred CCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCcccCCC-CCCCCCCCCCCEEe
Q 003982 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVP-TGCFDGLTNLQVLS 143 (782)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~-~~~~~~l~~L~~L~ 143 (782)
.++++|+|++|.+++..|.+|..+++|++|+|++|++++.+| .|.++++|++|+|++|+++.++ +..|.++++|++|+
T Consensus 50 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~ 129 (549)
T 2z81_A 50 ANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLR 129 (549)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEE
T ss_pred CcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEE
Confidence 479999999999998888899999999999999999999888 4999999999999999999764 45789999999999
Q ss_pred ccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccC------------------------CCCCcEEEcccCcC
Q 003982 144 LSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDS------------------------FSNLQNLRLSYNNF 199 (782)
Q Consensus 144 Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~------------------------l~~L~~L~Ls~N~l 199 (782)
+++|++... ..+..+.++++|++|++++|++++..|..+.. +++|++|++++|++
T Consensus 130 L~~n~~~~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l 208 (549)
T 2z81_A 130 IGNVETFSE-IRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNL 208 (549)
T ss_dssp EEESSSCCE-ECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBC
T ss_pred CCCCccccc-cCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCcc
Confidence 999984441 22357889999999999999999887777655 55666777777777
Q ss_pred CCCC--Ccccc--ccc----------------------------------------------------------------
Q 003982 200 TGSL--PASFA--KSD---------------------------------------------------------------- 211 (782)
Q Consensus 200 ~~~~--p~~~~--~~~---------------------------------------------------------------- 211 (782)
++.. |..+. ...
T Consensus 209 ~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l 288 (549)
T 2z81_A 209 ARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTI 288 (549)
T ss_dssp TTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEE
T ss_pred ccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccc
Confidence 6421 11100 011
Q ss_pred -----------------------cchhhcccccCCCccccccccCCCCCcEEEeecccccCCCC----CCCCCCCCCEEE
Q 003982 212 -----------------------IQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIP----DLSKCESLFDLS 264 (782)
Q Consensus 212 -----------------------l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~----~~~~l~~L~~L~ 264 (782)
++.+++++|.+.. .....+.++++|++|+|++|++++..+ .+..+++|++|+
T Consensus 289 ~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~~-ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~ 367 (549)
T 2z81_A 289 RRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFL-VPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLV 367 (549)
T ss_dssp ESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCCC-CCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEE
T ss_pred cccccchhhhcccchhhhhhcccceEEEeccCcccc-CCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEE
Confidence 1122222222110 000112468999999999999998542 378899999999
Q ss_pred cCCCcCccCcc--hhhcCCCCCCEEEccCCcccCCCCC--CCCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCC
Q 003982 265 LRDNQLTGVVP--ASVISLPALLNISLQNNKLQGPYPL--FPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDM 340 (782)
Q Consensus 265 L~~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~~~~--~~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (782)
|++|+|++..+ ..+..+++|++|++++|++++.++. .+.+|+.|++++|+++.++....
T Consensus 368 Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~~~~L~~L~Ls~N~l~~l~~~~~----------------- 430 (549)
T 2z81_A 368 LSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIRVVKTCIP----------------- 430 (549)
T ss_dssp CTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCCCCCSCCCCCTTCCEEECTTSCCSCCCTTSC-----------------
T ss_pred ccCCcccccccchhhhhcCCCCCEEECCCCCCccCChhhcccccccEEECCCCCcccccchhc-----------------
Confidence 99999996543 5689999999999999999954332 34689999999999987653211
Q ss_pred CCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccccCccccccccCCeEecccccccccCCccCCCCCCCCeE
Q 003982 341 GYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNL 420 (782)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L 420 (782)
..+.....+++.+..++ ..+++|++|+|++|+|+ .+|. ...+++|++|+|++|++++.+|..|..+++|+.|
T Consensus 431 ---~~L~~L~Ls~N~l~~~~---~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 502 (549)
T 2z81_A 431 ---QTLEVLDVSNNNLDSFS---LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKI 502 (549)
T ss_dssp ---TTCSEEECCSSCCSCCC---CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEE
T ss_pred ---CCceEEECCCCChhhhc---ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEE
Confidence 12222233444444443 56789999999999999 6776 5789999999999999999999999999999999
Q ss_pred ecCCCcCCCCCC
Q 003982 421 DVSNNNLSGKVP 432 (782)
Q Consensus 421 ~ls~N~l~g~~p 432 (782)
++++|++++.+|
T Consensus 503 ~l~~N~~~~~~~ 514 (549)
T 2z81_A 503 WLHTNPWDCSCP 514 (549)
T ss_dssp ECCSSCBCCCHH
T ss_pred EecCCCccCCCc
Confidence 999999999888
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=307.16 Aligned_cols=303 Identities=19% Similarity=0.180 Sum_probs=252.9
Q ss_pred CCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEecc
Q 003982 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145 (782)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls 145 (782)
.+++.|++++|++++. | .+..+++|++|+|++|+|++.+ +..+++|++|+|++|+|++++ +.++++|++|+|+
T Consensus 42 ~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~~--~~~l~~L~~L~Ls~N~l~~~~---~~~l~~L~~L~L~ 114 (457)
T 3bz5_A 42 ATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTLD--LSQNTNLTYLACDSNKLTNLD---VTPLTKLTYLNCD 114 (457)
T ss_dssp TTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCCC--CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECC
T ss_pred CCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeEc--cccCCCCCEEECcCCCCceee---cCCCCcCCEEECC
Confidence 4689999999999974 5 7999999999999999999863 889999999999999999985 8899999999999
Q ss_pred CCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccc-cccchhhcccccCCC
Q 003982 146 DNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGL 224 (782)
Q Consensus 146 ~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~l~l~~~~~~~ 224 (782)
+|++.. +| +..+++|++|++++|++++. .++.+++|++|++++|+..+.++ +.. ..|+.|++++|.+..
T Consensus 115 ~N~l~~---l~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~~--~~~l~~L~~L~ls~n~l~~ 184 (457)
T 3bz5_A 115 TNKLTK---LD--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE 184 (457)
T ss_dssp SSCCSC---CC--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCCC--CTTCTTCCEEECCSSCCCC
T ss_pred CCcCCe---ec--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCcccccc--cccCCcCCEEECCCCccce
Confidence 999988 34 88999999999999999996 38899999999999997666663 322 578889999888765
Q ss_pred ccccccccCCCCCcEEEeecccccCCCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCCCCCC
Q 003982 225 SGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSK 304 (782)
Q Consensus 225 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~ 304 (782)
. + ++.+++|+.|++++|++++. .+..+++|+.|++++|+|++ +| +..+++|+.|++++|++++..+..+++
T Consensus 185 l---~-l~~l~~L~~L~l~~N~l~~~--~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~ 255 (457)
T 3bz5_A 185 L---D-VSQNKLLNRLNCDTNNITKL--DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLSK 255 (457)
T ss_dssp C---C-CTTCTTCCEEECCSSCCSCC--CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCTT
T ss_pred e---c-cccCCCCCEEECcCCcCCee--ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHCCC
Confidence 2 2 77889999999999999886 48888999999999999997 56 888999999999999999887777888
Q ss_pred ccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccccC
Q 003982 305 VQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNIS 384 (782)
Q Consensus 305 l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p 384 (782)
|+.|++++|++..+. ...|...+.+| ...+++|+.|+|++|.+.+.+|
T Consensus 256 L~~L~l~~n~L~~L~------------------------------l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~ 303 (457)
T 3bz5_A 256 LTTLHCIQTDLLEID------------------------------LTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLD 303 (457)
T ss_dssp CCEEECTTCCCSCCC------------------------------CTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEE
T ss_pred CCEEeccCCCCCEEE------------------------------CCCCccCCccc--ccccccCCEEECCCCcccceec
Confidence 999999888876554 22233344444 3456788899999988877776
Q ss_pred c--------cccccccCCeEecccccccccCCccCCCCCCCCeEecCCCcCCC
Q 003982 385 P--------AYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSG 429 (782)
Q Consensus 385 ~--------~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g 429 (782)
. .+.++++|++|+|++|+|++. + ++.+++|+.||+++|+|+|
T Consensus 304 ~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~ 353 (457)
T 3bz5_A 304 CQAAGITELDLSQNPKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD 353 (457)
T ss_dssp CTTCCCSCCCCTTCTTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB
T ss_pred cCCCcceEechhhcccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC
Confidence 4 355667889999999999874 3 8889999999999999987
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=308.95 Aligned_cols=340 Identities=23% Similarity=0.335 Sum_probs=241.4
Q ss_pred CEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccC
Q 003982 67 RVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSD 146 (782)
Q Consensus 67 ~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~ 146 (782)
+++.|++.++++.. +| .+..+++|++|+|++|.+++.++ +.++++|++|+|++|+++++++ +.++++|++|+|++
T Consensus 47 ~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~ 121 (466)
T 1o6v_A 47 QVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFN 121 (466)
T ss_dssp TCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCS
T ss_pred cccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCchh-hhccccCCEEECCCCccccChh--hcCCCCCCEEECCC
Confidence 57788888888773 44 37778888888888888887766 7888888888888888888776 78888888888888
Q ss_pred CCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccc-cccchhhcccccCCCc
Q 003982 147 NPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLS 225 (782)
Q Consensus 147 N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~l~l~~~~~~~~ 225 (782)
|++.. ++. +.++++|++|++++|.+++. + .+..+++|++|+++ |.+.+ ++. +.. ..|+.|++++|.+...
T Consensus 122 n~l~~---~~~-~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~-~~~-~~~l~~L~~L~l~~n~l~~~ 192 (466)
T 1o6v_A 122 NQITD---IDP-LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTD-LKP-LANLTTLERLDISSNKVSDI 192 (466)
T ss_dssp SCCCC---CGG-GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCC-CGG-GTTCTTCCEEECCSSCCCCC
T ss_pred CCCCC---ChH-HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-CcccC-chh-hccCCCCCEEECcCCcCCCC
Confidence 88777 333 77888888888888888775 2 36777777777775 44442 222 322 4677777777765432
Q ss_pred cccccccCCCCCcEEEeecccccCCCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCC-CCCC
Q 003982 226 GTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPL-FPSK 304 (782)
Q Consensus 226 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~ 304 (782)
+.+..+++|++|++++|++++..+ +..+++|+.|++++|++++. ..+..+++|+.|++++|++++..+. .+.+
T Consensus 193 ---~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~~~~l~~ 266 (466)
T 1o6v_A 193 ---SVLAKLTNLESLIATNNQISDITP-LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAPLSGLTK 266 (466)
T ss_dssp ---GGGGGCTTCSEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGGGTTCTT
T ss_pred ---hhhccCCCCCEEEecCCccccccc-ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchhhhcCCC
Confidence 346667777777777777776554 66677777777777777743 3566777777777777777765542 3456
Q ss_pred ccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccccC
Q 003982 305 VQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNIS 384 (782)
Q Consensus 305 l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p 384 (782)
|+.|++++|.++++.. +.....+......++.+..++. +..+++|+.|+|++|.+++..|
T Consensus 267 L~~L~l~~n~l~~~~~-------------------~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~ 326 (466)
T 1o6v_A 267 LTELKLGANQISNISP-------------------LAGLTALTNLELNENQLEDISP-ISNLKNLTYLTLYFNNISDISP 326 (466)
T ss_dssp CSEEECCSSCCCCCGG-------------------GTTCTTCSEEECCSSCCSCCGG-GGGCTTCSEEECCSSCCSCCGG
T ss_pred CCEEECCCCccCcccc-------------------ccCCCccCeEEcCCCcccCchh-hcCCCCCCEEECcCCcCCCchh
Confidence 7777777777765441 0011112222223334444444 6778899999999999998766
Q ss_pred ccccccccCCeEecccccccccCCccCCCCCCCCeEecCCCcCCCCCC-CCCCCcceecCCCCCCCC
Q 003982 385 PAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVP-DFGSNVKFTVSPGNPFIG 450 (782)
Q Consensus 385 ~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p-~~~~~~~~~~~~~n~~~~ 450 (782)
+..+++|++|++++|++++. ..+..+++|+.|++++|++++.+| .-...+....+.+|++.+
T Consensus 327 --~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 327 --VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp --GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGGGTTCTTCCEEECCCEEEEC
T ss_pred --hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccchhhcCCCCCEEeccCCcccC
Confidence 78899999999999999865 468899999999999999999888 112566777788888764
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-34 Score=303.17 Aligned_cols=276 Identities=14% Similarity=0.201 Sum_probs=147.8
Q ss_pred ccchhHHHHHHHHHhcCCCCCCCC--C----CCCCCCccccceEeCC---------CCCEEEEEeCCCCCCcccCccccC
Q 003982 24 SLGDDGSVMLKLAQSLQNLPSDWS--S----TSSTGYCEWTGINCDN---------SNRVTTISLAKSGLSGTLSPEISS 88 (782)
Q Consensus 24 ~~~~~~~~l~~~~~~~~~~~~~w~--~----~~~~~~c~w~gv~c~~---------~~~v~~L~l~~~~l~~~~~~~l~~ 88 (782)
+..++++||++||+++..++..|. | ....++|.|.|+.|+. ..+|+.|+|++|+++ .+|+.++.
T Consensus 24 ~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~~ 102 (328)
T 4fcg_A 24 ALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFR 102 (328)
T ss_dssp CCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGGG
T ss_pred cCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhhh
Confidence 456899999999999866665542 2 2357889999999953 234555555555554 44444444
Q ss_pred CccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCee
Q 003982 89 LTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTL 168 (782)
Q Consensus 89 l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L 168 (782)
+++|++|+|++|.++.++..+.++++|++|+|++|+++.+ |..+.++++|++|
T Consensus 103 l~~L~~L~L~~n~l~~lp~~~~~l~~L~~L~Ls~n~l~~l---------------------------p~~l~~l~~L~~L 155 (328)
T 4fcg_A 103 LSHLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLRAL---------------------------PASIASLNRLREL 155 (328)
T ss_dssp GTTCSEEEEESSCCCCCCSCGGGGTTCSEEEEESCCCCCC---------------------------CGGGGGCTTCCEE
T ss_pred CCCCCEEECCCCCccchhHHHhccCCCCEEECCCCccccC---------------------------cHHHhcCcCCCEE
Confidence 5555555555554442222344444444444444444332 2333333333333
Q ss_pred eccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeeccccc
Q 003982 169 YMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFT 248 (782)
Q Consensus 169 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 248 (782)
+|++|++.+.+|..+.. .. ....+.++++|++|+|++|+++
T Consensus 156 ~L~~n~~~~~~p~~~~~------------------------~~---------------~~~~~~~l~~L~~L~L~~n~l~ 196 (328)
T 4fcg_A 156 SIRACPELTELPEPLAS------------------------TD---------------ASGEHQGLVNLQSLRLEWTGIR 196 (328)
T ss_dssp EEEEETTCCCCCSCSEE------------------------EC----------------CCCEEESTTCCEEEEEEECCC
T ss_pred ECCCCCCccccChhHhh------------------------cc---------------chhhhccCCCCCEEECcCCCcC
Confidence 33333333333322221 00 0011233445555555555555
Q ss_pred CCCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCCCCCCccEEEccCCcCCCCCCCCCCCCCh
Q 003982 249 GPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDP 328 (782)
Q Consensus 249 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~~ 328 (782)
..+..+..+++|++|+|++|++++ +|..+..+++|++|++++|++.+.+|.
T Consensus 197 ~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~---------------------------- 247 (328)
T 4fcg_A 197 SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPP---------------------------- 247 (328)
T ss_dssp CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCC----------------------------
T ss_pred cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHH----------------------------
Confidence 333334455555555555555552 344455555555555555555433322
Q ss_pred hhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccccCccccccccCCeEecccccccccCC
Q 003982 329 QVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIP 408 (782)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p 408 (782)
.+..+++|++|+|++|.+.+.+|..+.++++|++|+|++|++.+.+|
T Consensus 248 ---------------------------------~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP 294 (328)
T 4fcg_A 248 ---------------------------------IFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLP 294 (328)
T ss_dssp ---------------------------------CTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCC
T ss_pred ---------------------------------HhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhcc
Confidence 22233455555555555555666677777777777777777777777
Q ss_pred ccCCCCCCCCeEecCCCcCC
Q 003982 409 DGLTKLASLQNLDVSNNNLS 428 (782)
Q Consensus 409 ~~~~~l~~L~~L~ls~N~l~ 428 (782)
+.++++++|+.+++..|.+.
T Consensus 295 ~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 295 SLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp GGGGGSCTTCEEECCGGGSC
T ss_pred HHHhhccCceEEeCCHHHHH
Confidence 77777777777777766554
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-32 Score=295.75 Aligned_cols=301 Identities=23% Similarity=0.343 Sum_probs=193.6
Q ss_pred CCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEecc
Q 003982 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145 (782)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls 145 (782)
.+++.|+++++++.. ++ .+..+++|++|++++|++++.++ +..+++|++|+|++|+++.++ .+.++++|++|+++
T Consensus 44 ~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~~~~-~~~l~~L~~L~L~~n~i~~~~--~~~~l~~L~~L~l~ 118 (347)
T 4fmz_A 44 ESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITDISP-LSNLVKLTNLYIGTNKITDIS--ALQNLTNLRELYLN 118 (347)
T ss_dssp TTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCG--GGTTCTTCSEEECT
T ss_pred ccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccccchh-hhcCCcCCEEEccCCcccCch--HHcCCCcCCEEECc
Confidence 468899999999984 44 48999999999999999998766 999999999999999999975 48999999999999
Q ss_pred CCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccc-cccchhhcccccCCC
Q 003982 146 DNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGL 224 (782)
Q Consensus 146 ~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~l~l~~~~~~~ 224 (782)
+|++.. ++. +..+++|+.|++++|.....++. +..+++|++|++++|.+.+ ++. +.. ..|+.|++++|.+..
T Consensus 119 ~n~i~~---~~~-~~~l~~L~~L~l~~n~~~~~~~~-~~~l~~L~~L~l~~~~~~~-~~~-~~~l~~L~~L~l~~n~l~~ 191 (347)
T 4fmz_A 119 EDNISD---ISP-LANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKD-VTP-IANLTDLYSLSLNYNQIED 191 (347)
T ss_dssp TSCCCC---CGG-GTTCTTCCEEECTTCTTCCCCGG-GTTCTTCCEEECCSSCCCC-CGG-GGGCTTCSEEECTTSCCCC
T ss_pred CCcccC---chh-hccCCceeEEECCCCCCcccccc-hhhCCCCcEEEecCCCcCC-chh-hccCCCCCEEEccCCcccc
Confidence 999988 344 88999999999999976665444 8999999999999999983 333 322 345555555554432
Q ss_pred ccccccccCCCCCcEEEeecccccCCCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCC-CCCC
Q 003982 225 SGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYP-LFPS 303 (782)
Q Consensus 225 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~ 303 (782)
.. .+..+++|+.|++++|++++..+ +..+++|++|++++|++++..+ +..+++|++|++++|++++... ..+.
T Consensus 192 ~~---~~~~l~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~l~ 265 (347)
T 4fmz_A 192 IS---PLASLTSLHYFTAYVNQITDITP-VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDINAVKDLT 265 (347)
T ss_dssp CG---GGGGCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGGGTTCT
T ss_pred cc---cccCCCccceeecccCCCCCCch-hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCChhHhcCC
Confidence 11 14445555555555555554333 4445555555555555553322 4555555555555555554211 1233
Q ss_pred CccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCccccccc
Q 003982 304 KVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNI 383 (782)
Q Consensus 304 ~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~ 383 (782)
+|+.|++++|+++++. .+..+++|+.|++++|.+++..
T Consensus 266 ~L~~L~l~~n~l~~~~------------------------------------------~~~~l~~L~~L~L~~n~l~~~~ 303 (347)
T 4fmz_A 266 KLKMLNVGSNQISDIS------------------------------------------VLNNLSQLNSLFLNNNQLGNED 303 (347)
T ss_dssp TCCEEECCSSCCCCCG------------------------------------------GGGGCTTCSEEECCSSCCCGGG
T ss_pred CcCEEEccCCccCCCh------------------------------------------hhcCCCCCCEEECcCCcCCCcC
Confidence 4555555555443221 1233445555555555555555
Q ss_pred CccccccccCCeEecccccccccCCccCCCCCCCCeEecCCCcCC
Q 003982 384 SPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428 (782)
Q Consensus 384 p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~ 428 (782)
|..|.++++|++|+|++|++++..| +..+++|+.|++++|+|+
T Consensus 304 ~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 304 MEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp HHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred hhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 5555555555555555555554444 455555555555555553
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=295.25 Aligned_cols=298 Identities=20% Similarity=0.300 Sum_probs=209.9
Q ss_pred CCCCCC-CCCCCCCccccceEeCCCCCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCCEEe
Q 003982 42 LPSDWS-STSSTGYCEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIY 119 (782)
Q Consensus 42 ~~~~w~-~~~~~~~c~w~gv~c~~~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~ 119 (782)
.|..|. .++..+.|.|+.+.| ++++++ .+|..+. ++|++|+|++|.+++.++ .|.++++|++|+
T Consensus 19 lp~~~~~~cp~~c~c~l~~l~~-----------~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~ 84 (332)
T 2ft3_A 19 LPPTYSAMCPFGCHCHLRVVQC-----------SDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALV 84 (332)
T ss_dssp ------CCCCSSCEEETTEEEC-----------CSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCcccCCCCCCCcccCCEEEC-----------CCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEE
Confidence 444443 233334466655555 455665 5666553 688999999999988877 788899999999
Q ss_pred CCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcC
Q 003982 120 LDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNF 199 (782)
Q Consensus 120 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 199 (782)
|++|+++.+++..|.++++|++|+|++|++.. +|..+. ++|++|++++|++++..+..|..+++|++|++++|.+
T Consensus 85 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~---l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l 159 (332)
T 2ft3_A 85 LVNNKISKIHEKAFSPLRKLQKLYISKNHLVE---IPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPL 159 (332)
T ss_dssp CCSSCCCEECGGGSTTCTTCCEEECCSSCCCS---CCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCC
T ss_pred CCCCccCccCHhHhhCcCCCCEEECCCCcCCc---cCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCcc
Confidence 99999998888888899999999999998886 555554 7899999999999888788888999999999999988
Q ss_pred CC--CCCccccccccchhhcccccCCCccccccccCCCCCcEEEeecccccCCCCCCCCCCCCCEEEcCCCcCccCcchh
Q 003982 200 TG--SLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPAS 277 (782)
Q Consensus 200 ~~--~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~ 277 (782)
+. ..|..+. .+ +|++|++++|++++.+..+. ++|+.|++++|++++..+..
T Consensus 160 ~~~~~~~~~~~------------------------~l-~L~~L~l~~n~l~~l~~~~~--~~L~~L~l~~n~i~~~~~~~ 212 (332)
T 2ft3_A 160 ENSGFEPGAFD------------------------GL-KLNYLRISEAKLTGIPKDLP--ETLNELHLDHNKIQAIELED 212 (332)
T ss_dssp BGGGSCTTSSC------------------------SC-CCSCCBCCSSBCSSCCSSSC--SSCSCCBCCSSCCCCCCTTS
T ss_pred ccCCCCccccc------------------------CC-ccCEEECcCCCCCccCcccc--CCCCEEECCCCcCCccCHHH
Confidence 62 4444433 34 67777777777776554433 56777777777777666677
Q ss_pred hcCCCCCCEEEccCCcccCCCCCC---CCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCC
Q 003982 278 VISLPALLNISLQNNKLQGPYPLF---PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNN 354 (782)
Q Consensus 278 ~~~l~~L~~L~l~~N~l~~~~~~~---~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (782)
|..+++|+.|++++|++++..+.. +.+|+.|++++|+++.
T Consensus 213 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~------------------------------------- 255 (332)
T 2ft3_A 213 LLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSR------------------------------------- 255 (332)
T ss_dssp STTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCCB-------------------------------------
T ss_pred hcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCee-------------------------------------
Confidence 777777777777777777655532 3456666666665532
Q ss_pred CCCCCCcccccCCceeEEEccCcccccccCcccccc------ccCCeEeccccccc--ccCCccCCCCCCCCeEecCCCc
Q 003982 355 ACDGWPFVTCSQGRIITINLANKLLAGNISPAYANL------TSLKNLYLQQNNLT--GPIPDGLTKLASLQNLDVSNNN 426 (782)
Q Consensus 355 ~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l------~~L~~L~Ls~N~l~--g~~p~~~~~l~~L~~L~ls~N~ 426 (782)
+|..+..+++|+.|++++|.|++..+..|..+ ..|+.|++++|.+. +..|..|..++.|+.|++++|+
T Consensus 256 ----lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 256 ----VPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp ----CCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred ----cChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 34445666778888888888877666666543 56788888888877 5677778888888888888875
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-33 Score=303.62 Aligned_cols=310 Identities=18% Similarity=0.166 Sum_probs=221.3
Q ss_pred cCCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCccc
Q 003982 87 SSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSL 165 (782)
Q Consensus 87 ~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L 165 (782)
..+++|++|++++|.++..++ .|..+++|++|+|++|+++.+++..|.++++|++|+|++|++.. ..|..+.++++|
T Consensus 42 ~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L 119 (390)
T 3o6n_A 42 ITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY--LPPHVFQNVPLL 119 (390)
T ss_dssp GGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCC--CCTTTTTTCTTC
T ss_pred cccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCc--CCHHHhcCCCCC
Confidence 457899999999999998887 47889999999999999999999999999999999999999998 566779999999
Q ss_pred CeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccc-cccchhhcccccCCCccccccccCCCCCcEEEeec
Q 003982 166 TTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHK 244 (782)
Q Consensus 166 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~ 244 (782)
++|+|++|+++.+.+..|..+++|++|++++|++++..|..+.. ..|+.|++++|.+... .+..+++|+.|++++
T Consensus 120 ~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~----~~~~l~~L~~L~l~~ 195 (390)
T 3o6n_A 120 TVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV----DLSLIPSLFHANVSY 195 (390)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC----CGGGCTTCSEEECCS
T ss_pred CEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc----ccccccccceeeccc
Confidence 99999999999887777899999999999999999665655543 3444455544444322 123344455555555
Q ss_pred ccccCCCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCC-CCCCccEEEccCCcCCCCCCCCC
Q 003982 245 NQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPL-FPSKVQKVSLDHNNFCKNSSDAG 323 (782)
Q Consensus 245 N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~l~~L~l~~N~~~~~~~~~~ 323 (782)
|.+++. ...++|+.|++++|+++.. |.. ..++|+.|++++|++++.... .+.+|++|++++|.+++
T Consensus 196 n~l~~~----~~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~~~l~~l~~L~~L~Ls~n~l~~------ 262 (390)
T 3o6n_A 196 NLLSTL----AIPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEK------ 262 (390)
T ss_dssp SCCSEE----ECCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCE------
T ss_pred cccccc----CCCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCcccHHHcCCCCccEEECCCCcCCC------
Confidence 544432 1223445555555555422 221 124455555555555443110 12345555555554433
Q ss_pred CCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccccCccccccccCCeEecccccc
Q 003982 324 KPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNL 403 (782)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 403 (782)
..|..+..+++|++|+|++|++++ +|..+..+++|++|+|++|++
T Consensus 263 ----------------------------------~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l 307 (390)
T 3o6n_A 263 ----------------------------------IMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHL 307 (390)
T ss_dssp ----------------------------------EESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCC
T ss_pred ----------------------------------cChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcc
Confidence 225566777888888888888885 566677788888888888888
Q ss_pred cccCCccCCCCCCCCeEecCCCcCCCCCCCCCCCcceecCCCCCCCCC
Q 003982 404 TGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKFTVSPGNPFIGT 451 (782)
Q Consensus 404 ~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~~~~~~~~~n~~~~~ 451 (782)
+ .+|..+..+++|+.|+|++|++++........++...+.+||+.|.
T Consensus 308 ~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~L~~L~l~~N~~~~~ 354 (390)
T 3o6n_A 308 L-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHNDWDCN 354 (390)
T ss_dssp C-CCGGGHHHHTTCSEEECCSSCCCCCCCCTTCCCSEEECCSSCEEHH
T ss_pred e-ecCccccccCcCCEEECCCCccceeCchhhccCCEEEcCCCCccch
Confidence 8 5677778888888888888888876555556777788888888773
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=300.77 Aligned_cols=189 Identities=23% Similarity=0.382 Sum_probs=166.4
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
.++|++.+.||+|+||.||+|.. .+|+.||||++..........+++.+|+++++.++||||+++++++.+.+..|+||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46899999999999999999965 68999999999876655666788999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++|+|.+++... ..+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++....
T Consensus 94 e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH-----GRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp CCCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred ECCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 999999999999763 358999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... .....+||+.|+|||++.+.. ....++||||+||+
T Consensus 166 ~~~--~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~i 203 (328)
T 3fe3_A 166 VGG--KLDAFCGAPPYAAPELFQGKK--YDGPEVDVWSLGVI 203 (328)
T ss_dssp SSC--GGGTTSSSGGGCCHHHHHTCC--CCSHHHHHHHHHHH
T ss_pred CCC--ccccccCCcceeCcccccCCC--cCCchhhhhhhHHH
Confidence 433 223457999999999987651 12478999999986
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-32 Score=291.38 Aligned_cols=291 Identities=20% Similarity=0.277 Sum_probs=228.6
Q ss_pred CCCCCccccceEeCCCCCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCcccCC
Q 003982 50 SSTGYCEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSV 128 (782)
Q Consensus 50 ~~~~~c~w~gv~c~~~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~ 128 (782)
+..+.|.|+.+.|+ +++++ .+|..+. ++|++|+|++|+|++.++ .|.++++|++|+|++|+++++
T Consensus 26 p~~c~c~l~~l~~~-----------~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~ 91 (330)
T 1xku_A 26 PFRCQCHLRVVQCS-----------DLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKI 91 (330)
T ss_dssp CTTCEEETTEEECT-----------TSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCB
T ss_pred CCCCcCCCeEEEec-----------CCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCee
Confidence 34445666655554 45555 4565544 689999999999998887 799999999999999999999
Q ss_pred CCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCC--CCCcc
Q 003982 129 PTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTG--SLPAS 206 (782)
Q Consensus 129 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~p~~ 206 (782)
.+..|.++++|++|+|++|++.. +|..+. ++|++|++++|++++..+..|..+++|++|++++|.++. ..+..
T Consensus 92 ~~~~~~~l~~L~~L~Ls~n~l~~---l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 166 (330)
T 1xku_A 92 SPGAFAPLVKLERLYLSKNQLKE---LPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGA 166 (330)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSB---CCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTG
T ss_pred CHHHhcCCCCCCEEECCCCcCCc---cChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhh
Confidence 88889999999999999999887 565554 789999999999999988899999999999999999863 33333
Q ss_pred ccccccchhhcccccCCCccccccccCCCCCcEEEeecccccCCCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCE
Q 003982 207 FAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLN 286 (782)
Q Consensus 207 ~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 286 (782)
+.++++|++|++++|+++..+..+. ++|++|++++|++++..|..|..+++|+.
T Consensus 167 ------------------------~~~l~~L~~L~l~~n~l~~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 220 (330)
T 1xku_A 167 ------------------------FQGMKKLSYIRIADTNITTIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAK 220 (330)
T ss_dssp ------------------------GGGCTTCCEEECCSSCCCSCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCE
T ss_pred ------------------------ccCCCCcCEEECCCCccccCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCE
Confidence 4568999999999999997665544 89999999999999888999999999999
Q ss_pred EEccCCcccCCCCCC---CCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCccc
Q 003982 287 ISLQNNKLQGPYPLF---PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVT 363 (782)
Q Consensus 287 L~l~~N~l~~~~~~~---~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 363 (782)
|++++|++++..+.. +.+|+.|++++|+++. +|..+
T Consensus 221 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-----------------------------------------lp~~l 259 (330)
T 1xku_A 221 LGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-----------------------------------------VPGGL 259 (330)
T ss_dssp EECCSSCCCEECTTTGGGSTTCCEEECCSSCCSS-----------------------------------------CCTTT
T ss_pred EECCCCcCceeChhhccCCCCCCEEECCCCcCcc-----------------------------------------CChhh
Confidence 999999999876643 3567888888887643 34445
Q ss_pred ccCCceeEEEccCcccccccCcccccc------ccCCeEecccccccc--cCCccCCCCCCCCeEecCCCc
Q 003982 364 CSQGRIITINLANKLLAGNISPAYANL------TSLKNLYLQQNNLTG--PIPDGLTKLASLQNLDVSNNN 426 (782)
Q Consensus 364 ~~~~~L~~L~Ls~N~l~~~~p~~~~~l------~~L~~L~Ls~N~l~g--~~p~~~~~l~~L~~L~ls~N~ 426 (782)
..+++|++|+|++|.|++..+..|... ..|+.|++++|.+.. ..|..|..+..|+.++|++|+
T Consensus 260 ~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 260 ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp TTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred ccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 566778888888888887666666533 677888888888753 456777888888888888875
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-32 Score=325.42 Aligned_cols=314 Identities=19% Similarity=0.207 Sum_probs=225.5
Q ss_pred EEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCc-ccCCCCCCCCCCCCCCEEeccC
Q 003982 69 TTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNN-FTSVPTGCFDGLTNLQVLSLSD 146 (782)
Q Consensus 69 ~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~-l~~~~~~~~~~l~~L~~L~Ls~ 146 (782)
...+.++++++ .+|. ..++|++|+|++|.|++..| .|.++++|++|+|++|. +..+++..|.++++|++|+|++
T Consensus 7 ~~~dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~ 82 (844)
T 3j0a_A 7 RIAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82 (844)
T ss_dssp EEEEESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTT
T ss_pred eEEEccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCC
Confidence 45677788888 5665 45899999999999999877 89999999999999994 5568888999999999999999
Q ss_pred CCCCCCCCCCcccCCCcccCeeeccccccCCCCccc--ccCCCCCcEEEcccCcCCCCCC-ccccc-cccchhhcccccC
Q 003982 147 NPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDF--FDSFSNLQNLRLSYNNFTGSLP-ASFAK-SDIQNLWMNDQQL 222 (782)
Q Consensus 147 N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~--~~~l~~L~~L~Ls~N~l~~~~p-~~~~~-~~l~~l~l~~~~~ 222 (782)
|++.. ..|..|.++++|++|+|++|.+++..|.. |.++++|++|+|++|.+++..+ ..|.. .+|+.|++++|.+
T Consensus 83 N~l~~--~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i 160 (844)
T 3j0a_A 83 SKIYF--LHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQI 160 (844)
T ss_dssp CCCCE--ECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCC
T ss_pred CcCcc--cCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcC
Confidence 99988 56899999999999999999999866654 9999999999999999997655 35554 6788999988877
Q ss_pred CCccccccccCC--CCCcEEEeecccccCCCC-CCCCCCC------CCEEEcCCCcCccCcchhhcCC------------
Q 003982 223 GLSGTLDVLSGM--TQLRQVWLHKNQFTGPIP-DLSKCES------LFDLSLRDNQLTGVVPASVISL------------ 281 (782)
Q Consensus 223 ~~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~-~~~~l~~------L~~L~L~~N~l~~~~p~~~~~l------------ 281 (782)
.... ...+..+ ++|+.|++++|.+++..+ .+..+++ |+.|++++|++++.+|..+...
T Consensus 161 ~~~~-~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~ 239 (844)
T 3j0a_A 161 FLVC-EHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILA 239 (844)
T ss_dssp CCCC-SGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECC
T ss_pred CeeC-HHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecc
Confidence 5432 2334444 788888999888887655 3555544 8888888888877666655432
Q ss_pred --------------------------CCCCEEEccCCcccCCCCCC---CCCccEEEccCCcCCCCCCCCCCCCChhhhh
Q 003982 282 --------------------------PALLNISLQNNKLQGPYPLF---PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTT 332 (782)
Q Consensus 282 --------------------------~~L~~L~l~~N~l~~~~~~~---~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~ 332 (782)
++|+.|++++|.+.+..|.. +.+|+.|+|++|+++++.
T Consensus 240 ~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~------------- 306 (844)
T 3j0a_A 240 HHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIA------------- 306 (844)
T ss_dssp SSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEEC-------------
T ss_pred cccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCC-------------
Confidence 45666666666666655543 245666666666665543
Q ss_pred HHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccccCccccccccCCeEecccccccccCCccCC
Q 003982 333 LLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLT 412 (782)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~ 412 (782)
|..+..+++|++|+|++|.+++..|..|.++++|++|+|++|++.+..+..|.
T Consensus 307 ---------------------------~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~ 359 (844)
T 3j0a_A 307 ---------------------------DEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFK 359 (844)
T ss_dssp ---------------------------TTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSC
T ss_pred ---------------------------hHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhc
Confidence 23334444555555555555554455555555555555555555544444455
Q ss_pred CCCCCCeEecCCCcCCC
Q 003982 413 KLASLQNLDVSNNNLSG 429 (782)
Q Consensus 413 ~l~~L~~L~ls~N~l~g 429 (782)
.+++|+.|+|++|++++
T Consensus 360 ~l~~L~~L~Ls~N~l~~ 376 (844)
T 3j0a_A 360 FLEKLQTLDLRDNALTT 376 (844)
T ss_dssp SCCCCCEEEEETCCSCC
T ss_pred CCCCCCEEECCCCCCCc
Confidence 55555555555555543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=309.66 Aligned_cols=198 Identities=24% Similarity=0.291 Sum_probs=167.1
Q ss_pred HHHHHHhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC
Q 003982 574 EVLRQVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCING 651 (782)
Q Consensus 574 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~ 651 (782)
..++...++|++.+.||+|+||.||+|+. .+++.||+|++.+... .....+.+.+|+++++.++||||+++++++.++
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 34445568899999999999999999965 4688999999976321 112334588999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEee
Q 003982 652 SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADF 731 (782)
Q Consensus 652 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~Df 731 (782)
+..|+||||+++|+|.+++.. ..+++..+..++.|++.||+|||+ .||+||||||+|||++.++.+||+||
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~------~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEeCCCCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEecc
Confidence 999999999999999999865 248999999999999999999999 89999999999999999999999999
Q ss_pred ccceecCCCCceeeecccccccccCccccccchhhh-HHHHHHHHHhccc
Q 003982 732 GLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMIL-CQMTGLIWLHGSV 780 (782)
Q Consensus 732 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~~dvws~Gvv 780 (782)
|+|+.............+||+.|+|||++.+.-.-+ ++.++|+||+||+
T Consensus 213 G~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvi 262 (410)
T 3v8s_A 213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 262 (410)
T ss_dssp TTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHH
T ss_pred ceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHH
Confidence 999887665543444568999999999987541101 5678999999986
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-33 Score=291.36 Aligned_cols=186 Identities=26% Similarity=0.448 Sum_probs=163.6
Q ss_pred hcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
.++|++.+.||+|+||+||+|. ..+++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc--ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 4689999999999999999996 4678999999997654 234577899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++|+|.+++.+ ..+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++....
T Consensus 97 e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (297)
T 3fxz_A 97 EYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (297)
T ss_dssp ECCTTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred ECCCCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 99999999999865 248999999999999999999999 899999999999999999999999999998776
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.... ......||+.|+|||++.+. .++.++||||+|++
T Consensus 168 ~~~~-~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~i 205 (297)
T 3fxz_A 168 PEQS-KRSTMVGTPYWMAPEVVTRK---AYGPKVDIWSLGIM 205 (297)
T ss_dssp STTC-CBCCCCSCGGGCCHHHHHCS---CBCTHHHHHHHHHH
T ss_pred Cccc-ccCCccCCcCccChhhhcCC---CCCcHHHHHHHHHH
Confidence 5432 22345799999999998765 45778999999986
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=312.06 Aligned_cols=202 Identities=22% Similarity=0.284 Sum_probs=168.8
Q ss_pred cHHHHHHHhcCCCccceeecccceEEEEEEeC-CCcEEEEEEeccccCC-hhhHHHHHHHHHHHHhcCCCCcceEEeEEE
Q 003982 572 SIEVLRQVTDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCI 649 (782)
Q Consensus 572 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~ 649 (782)
....++...++|++.++||+|+||+||+|+.. +++.||+|++++.... ......+.+|+.++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34455566789999999999999999999664 5789999999763311 122345889999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEE
Q 003982 650 NGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVA 729 (782)
Q Consensus 650 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~ 729 (782)
+++..|+||||+++|+|.+++.+. ...+++.++..++.|++.||+|||+ .||+||||||+|||++.++.+||+
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~----~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~ 217 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF----EDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLA 217 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEEC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEc
Confidence 999999999999999999999752 2458999999999999999999999 899999999999999999999999
Q ss_pred eeccceecCCCCceeeecccccccccCccccccch--hhhHHHHHHHHHhccc
Q 003982 730 DFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHW--MILCQMTGLIWLHGSV 780 (782)
Q Consensus 730 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~dvws~Gvv 780 (782)
|||+|+.............+||+.|+|||++...- ...++.++|+||+||+
T Consensus 218 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvi 270 (437)
T 4aw2_A 218 DFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVC 270 (437)
T ss_dssp CCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHH
T ss_pred chhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHH
Confidence 99999877655444444568999999999886210 0135678999999986
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-31 Score=299.31 Aligned_cols=305 Identities=21% Similarity=0.259 Sum_probs=196.3
Q ss_pred CCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEecc
Q 003982 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145 (782)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls 145 (782)
.+++.|++++|.+++ +|+. +++|++|++++|++++.+. + .++|++|+|++|+++++| .|.++++|++|+++
T Consensus 91 ~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l~~-~--~~~L~~L~L~~n~l~~lp--~~~~l~~L~~L~l~ 161 (454)
T 1jl5_A 91 PHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKALSD-L--PPLLEYLGVSNNQLEKLP--ELQNSSFLKIIDVD 161 (454)
T ss_dssp TTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCCCS-C--CTTCCEEECCSSCCSSCC--CCTTCTTCCEEECC
T ss_pred CCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCcccC-C--CCCCCEEECcCCCCCCCc--ccCCCCCCCEEECC
Confidence 467777777777776 5543 3677788888887776433 1 167888888888888876 37888888888888
Q ss_pred CCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCc
Q 003982 146 DNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLS 225 (782)
Q Consensus 146 ~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~ 225 (782)
+|++.. +|..+ .+|++|++++|++++. | .+..+++|++|++++|++++ +|... ..++.|++++|.+..
T Consensus 162 ~N~l~~---lp~~~---~~L~~L~L~~n~l~~l-~-~~~~l~~L~~L~l~~N~l~~-l~~~~--~~L~~L~l~~n~l~~- 229 (454)
T 1jl5_A 162 NNSLKK---LPDLP---PSLEFIAAGNNQLEEL-P-ELQNLPFLTAIYADNNSLKK-LPDLP--LSLESIVAGNNILEE- 229 (454)
T ss_dssp SSCCSC---CCCCC---TTCCEEECCSSCCSSC-C-CCTTCTTCCEEECCSSCCSS-CCCCC--TTCCEEECCSSCCSS-
T ss_pred CCcCcc---cCCCc---ccccEEECcCCcCCcC-c-cccCCCCCCEEECCCCcCCc-CCCCc--CcccEEECcCCcCCc-
Confidence 888776 44433 4788888888888774 4 57788888888888888873 55443 367778887777652
Q ss_pred cccccccCCCCCcEEEeecccccCCCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCCCCCCc
Q 003982 226 GTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKV 305 (782)
Q Consensus 226 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l 305 (782)
.+.+.++++|++|++++|++++.+.. +++|+.|++++|++++ +|.. .++|++|++++|++++. |..+.+|
T Consensus 230 --lp~~~~l~~L~~L~l~~N~l~~l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l-~~~~~~L 299 (454)
T 1jl5_A 230 --LPELQNLPFLTTIYADNNLLKTLPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGL-SELPPNL 299 (454)
T ss_dssp --CCCCTTCTTCCEEECCSSCCSSCCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEE-SCCCTTC
T ss_pred --ccccCCCCCCCEEECCCCcCCccccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcc-cCcCCcC
Confidence 22477788888888888888764432 3678888888888875 4443 36788888888888763 3344678
Q ss_pred cEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccccCc
Q 003982 306 QKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISP 385 (782)
Q Consensus 306 ~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~ 385 (782)
+.|++++|+++++... +..+.....+++.+..+|.. .++|++|++++|++++ +|.
T Consensus 300 ~~L~l~~N~l~~i~~~---------------------~~~L~~L~Ls~N~l~~lp~~---~~~L~~L~L~~N~l~~-lp~ 354 (454)
T 1jl5_A 300 YYLNASSNEIRSLCDL---------------------PPSLEELNVSNNKLIELPAL---PPRLERLIASFNHLAE-VPE 354 (454)
T ss_dssp CEEECCSSCCSEECCC---------------------CTTCCEEECCSSCCSCCCCC---CTTCCEEECCSSCCSC-CCC
T ss_pred CEEECcCCcCCcccCC---------------------cCcCCEEECCCCcccccccc---CCcCCEEECCCCcccc-ccc
Confidence 8888888877664310 11122222233444445544 3677777777777773 555
Q ss_pred cccccccCCeEecccccccc--cCCccCCCC-------------CCCCeEecCCCcCCC
Q 003982 386 AYANLTSLKNLYLQQNNLTG--PIPDGLTKL-------------ASLQNLDVSNNNLSG 429 (782)
Q Consensus 386 ~~~~l~~L~~L~Ls~N~l~g--~~p~~~~~l-------------~~L~~L~ls~N~l~g 429 (782)
.+++|++|+|++|++++ .+|..+..+ ++|+.||+++|+++|
T Consensus 355 ---~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls~N~l~~ 410 (454)
T 1jl5_A 355 ---LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLRE 410 (454)
T ss_dssp ---CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC------------------------
T ss_pred ---hhhhccEEECCCCCCCcCCCChHHHHhhhhcccccccccccCcCCEEECCCCcCCc
Confidence 35777777777777777 677777666 667777777777776
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-32 Score=301.54 Aligned_cols=330 Identities=19% Similarity=0.207 Sum_probs=212.9
Q ss_pred CCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCC-------------CEEeCCCCcccCCCCC
Q 003982 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSL-------------QDIYLDNNNFTSVPTG 131 (782)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L-------------~~L~Ls~n~l~~~~~~ 131 (782)
.++++|++++|++ |.+|++|+++++|++|++++|.++|..| .++++.+| ++|++++|+++++|..
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~lp~~ 89 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPEL 89 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCCCSC
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccCCCC
Confidence 3577788888888 6788888888888888888888776655 56655542 5555555555554431
Q ss_pred C----------------CCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcc
Q 003982 132 C----------------FDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLS 195 (782)
Q Consensus 132 ~----------------~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 195 (782)
. -..+++|++|++++|++.. +|.. .++|++|++++|++++ +| .|..+++|++|+++
T Consensus 90 ~~~L~~L~l~~n~l~~lp~~~~~L~~L~l~~n~l~~---l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~ 161 (454)
T 1jl5_A 90 PPHLESLVASCNSLTELPELPQSLKSLLVDNNNLKA---LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVD 161 (454)
T ss_dssp CTTCSEEECCSSCCSSCCCCCTTCCEEECCSSCCSC---CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECC
T ss_pred cCCCCEEEccCCcCCccccccCCCcEEECCCCccCc---ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECC
Confidence 0 0012455555555555544 1211 1578899999999987 46 58899999999999
Q ss_pred cCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeecccccCCCCCCCCCCCCCEEEcCCCcCccCcc
Q 003982 196 YNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVP 275 (782)
Q Consensus 196 ~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p 275 (782)
+|+++ .+|..+ ..|++|++++|.+... +.+.++++|++|++++|++++.+... ++|++|++++|+++ .+|
T Consensus 162 ~N~l~-~lp~~~--~~L~~L~L~~n~l~~l---~~~~~l~~L~~L~l~~N~l~~l~~~~---~~L~~L~l~~n~l~-~lp 231 (454)
T 1jl5_A 162 NNSLK-KLPDLP--PSLEFIAAGNNQLEEL---PELQNLPFLTAIYADNNSLKKLPDLP---LSLESIVAGNNILE-ELP 231 (454)
T ss_dssp SSCCS-CCCCCC--TTCCEEECCSSCCSSC---CCCTTCTTCCEEECCSSCCSSCCCCC---TTCCEEECCSSCCS-SCC
T ss_pred CCcCc-ccCCCc--ccccEEECcCCcCCcC---ccccCCCCCCEEECCCCcCCcCCCCc---CcccEEECcCCcCC-ccc
Confidence 99998 477655 3788999998887642 35888999999999999998754322 58999999999998 677
Q ss_pred hhhcCCCCCCEEEccCCcccCCCCCCCCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCC
Q 003982 276 ASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNA 355 (782)
Q Consensus 276 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (782)
.++.+++|++|++++|++++ +|..+.+|+.|++++|++++++... ..+.....+++.
T Consensus 232 -~~~~l~~L~~L~l~~N~l~~-l~~~~~~L~~L~l~~N~l~~l~~~~---------------------~~L~~L~ls~N~ 288 (454)
T 1jl5_A 232 -ELQNLPFLTTIYADNNLLKT-LPDLPPSLEALNVRDNYLTDLPELP---------------------QSLTFLDVSENI 288 (454)
T ss_dssp -CCTTCTTCCEEECCSSCCSS-CCSCCTTCCEEECCSSCCSCCCCCC---------------------TTCCEEECCSSC
T ss_pred -ccCCCCCCCEEECCCCcCCc-ccccccccCEEECCCCcccccCccc---------------------CcCCEEECcCCc
Confidence 48899999999999999986 5556789999999999998765211 111112222233
Q ss_pred CCCCCcccccCCceeEEEccCcccccccCcccccc-ccCCeEecccccccccCCccCCCCCCCCeEecCCCcCCCCCCCC
Q 003982 356 CDGWPFVTCSQGRIITINLANKLLAGNISPAYANL-TSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDF 434 (782)
Q Consensus 356 ~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~ 434 (782)
+..+|.. .++|++|++++|.+++ ++ .+ ++|++|++++|++++ +|.. +++|+.|++++|++++ +|..
T Consensus 289 l~~l~~~---~~~L~~L~l~~N~l~~-i~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~~ 355 (454)
T 1jl5_A 289 FSGLSEL---PPNLYYLNASSNEIRS-LC----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE-VPEL 355 (454)
T ss_dssp CSEESCC---CTTCCEEECCSSCCSE-EC----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCCC
T ss_pred cCcccCc---CCcCCEEECcCCcCCc-cc----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCcccc-ccch
Confidence 3333221 1577888888888875 22 23 478888888888885 6654 5788888888888885 4445
Q ss_pred CCCcceecCCCCCCCC
Q 003982 435 GSNVKFTVSPGNPFIG 450 (782)
Q Consensus 435 ~~~~~~~~~~~n~~~~ 450 (782)
...++...+.+|++.+
T Consensus 356 l~~L~~L~L~~N~l~~ 371 (454)
T 1jl5_A 356 PQNLKQLHVEYNPLRE 371 (454)
T ss_dssp CTTCCEEECCSSCCSS
T ss_pred hhhccEEECCCCCCCc
Confidence 5677777888887754
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=297.43 Aligned_cols=233 Identities=30% Similarity=0.490 Sum_probs=183.4
Q ss_pred CCCCCCCCEEeccC-CCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccc
Q 003982 133 FDGLTNLQVLSLSD-NPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSD 211 (782)
Q Consensus 133 ~~~l~~L~~L~Ls~-N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~ 211 (782)
|.++++|++|+|++ |.+.. .+|..|.++++|++|+|++|++++.+|..|..+++|++|+|++|++++.+|..+.
T Consensus 72 l~~l~~L~~L~L~~~n~l~~--~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--- 146 (313)
T 1ogq_A 72 LANLPYLNFLYIGGINNLVG--PIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS--- 146 (313)
T ss_dssp GGGCTTCSEEEEEEETTEES--CCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGG---
T ss_pred HhCCCCCCeeeCCCCCcccc--cCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHh---
Confidence 33344444444442 43333 3566677777777777777888777788888888888888888888877776654
Q ss_pred cchhhcccccCCCccccccccCCCCCcEEEeecccccCCCC-CCCCCC-CCCEEEcCCCcCccCcchhhcCCCCCCEEEc
Q 003982 212 IQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIP-DLSKCE-SLFDLSLRDNQLTGVVPASVISLPALLNISL 289 (782)
Q Consensus 212 l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 289 (782)
++++|++|+|++|++++..| .+..++ +|+.|+|++|++++.+|..+..++ |++|++
T Consensus 147 ---------------------~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~L 204 (313)
T 1ogq_A 147 ---------------------SLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDL 204 (313)
T ss_dssp ---------------------GCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEEC
T ss_pred ---------------------cCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEEC
Confidence 47888888888888886555 577776 888888888888888888888876 888888
Q ss_pred cCCcccCCCCCCCCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCce
Q 003982 290 QNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRI 369 (782)
Q Consensus 290 ~~N~l~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L 369 (782)
++|++++.+| ..+..+++|
T Consensus 205 s~N~l~~~~~-------------------------------------------------------------~~~~~l~~L 223 (313)
T 1ogq_A 205 SRNMLEGDAS-------------------------------------------------------------VLFGSDKNT 223 (313)
T ss_dssp CSSEEEECCG-------------------------------------------------------------GGCCTTSCC
T ss_pred cCCcccCcCC-------------------------------------------------------------HHHhcCCCC
Confidence 8888775433 334556789
Q ss_pred eEEEccCcccccccCccccccccCCeEecccccccccCCccCCCCCCCCeEecCCCcCCCCCCCCC--CCcceecCCCCC
Q 003982 370 ITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFG--SNVKFTVSPGNP 447 (782)
Q Consensus 370 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~--~~~~~~~~~~n~ 447 (782)
+.|+|++|.+++.+|. +..+++|++|+|++|+|++.+|..|..+++|+.|+|++|+++|.+|... ..+....+.+||
T Consensus 224 ~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 224 QKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302 (313)
T ss_dssp SEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSS
T ss_pred CEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCC
Confidence 9999999999987776 8899999999999999999999999999999999999999999999775 456677899999
Q ss_pred CCCCCCC
Q 003982 448 FIGTNVD 454 (782)
Q Consensus 448 ~~~~~~~ 454 (782)
+.|+.+.
T Consensus 303 ~lc~~p~ 309 (313)
T 1ogq_A 303 CLCGSPL 309 (313)
T ss_dssp EEESTTS
T ss_pred CccCCCC
Confidence 9998765
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-32 Score=316.92 Aligned_cols=310 Identities=19% Similarity=0.167 Sum_probs=230.5
Q ss_pred cCCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCccc
Q 003982 87 SSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSL 165 (782)
Q Consensus 87 ~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L 165 (782)
-.+.+++.|++++|.++.+++ .|.++++|++|+|++|.|+++++..|.++++|++|+|++|.+.. ..|..|.++++|
T Consensus 48 l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L 125 (597)
T 3oja_B 48 ITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY--LPPHVFQNVPLL 125 (597)
T ss_dssp GGGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCC--CCTTTTTTCTTC
T ss_pred ccCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCC--CCHHHHcCCCCC
Confidence 356889999999999999888 57889999999999999999999999999999999999999998 566778999999
Q ss_pred CeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccc-cccchhhcccccCCCccccccccCCCCCcEEEeec
Q 003982 166 TTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHK 244 (782)
Q Consensus 166 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~ 244 (782)
++|+|++|.|+++.+..|..+++|++|+|++|.+++..|..|.. ..|+.|++++|.+... .++.+++|+.|++++
T Consensus 126 ~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~l~~L~~L~l~~ 201 (597)
T 3oja_B 126 TVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV----DLSLIPSLFHANVSY 201 (597)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC----CGGGCTTCSEEECCS
T ss_pred CEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc----Chhhhhhhhhhhccc
Confidence 99999999999988888999999999999999999777766544 3444444444443321 123344444444444
Q ss_pred ccccCCCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCC-CCCCccEEEccCCcCCCCCCCCC
Q 003982 245 NQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPL-FPSKVQKVSLDHNNFCKNSSDAG 323 (782)
Q Consensus 245 N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~l~~L~l~~N~~~~~~~~~~ 323 (782)
|.+++. ...++|+.|++++|.++...+. + .++|+.|+|++|.+++.... .+.+|+.|+|++|.+++
T Consensus 202 n~l~~l----~~~~~L~~L~ls~n~l~~~~~~-~--~~~L~~L~L~~n~l~~~~~l~~l~~L~~L~Ls~N~l~~------ 268 (597)
T 3oja_B 202 NLLSTL----AIPIAVEELDASHNSINVVRGP-V--NVELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEK------ 268 (597)
T ss_dssp SCCSEE----ECCTTCSEEECCSSCCCEEECS-C--CSCCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCE------
T ss_pred Cccccc----cCCchhheeeccCCcccccccc-c--CCCCCEEECCCCCCCCChhhccCCCCCEEECCCCccCC------
Confidence 444432 1223444444444444422211 1 13444455555544442110 12344445554444433
Q ss_pred CCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccccCccccccccCCeEecccccc
Q 003982 324 KPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNL 403 (782)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 403 (782)
..|..+..+++|+.|+|++|.+++ +|..+..+++|++|+|++|++
T Consensus 269 ----------------------------------~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l 313 (597)
T 3oja_B 269 ----------------------------------IMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHL 313 (597)
T ss_dssp ----------------------------------EESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCC
T ss_pred ----------------------------------CCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCC
Confidence 346678888999999999999997 677888899999999999999
Q ss_pred cccCCccCCCCCCCCeEecCCCcCCCCCCCCCCCcceecCCCCCCCCC
Q 003982 404 TGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKFTVSPGNPFIGT 451 (782)
Q Consensus 404 ~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~~~~~~~~~n~~~~~ 451 (782)
+ .+|..+..+++|+.|+|++|+|++..+.....+....+.+||+.|.
T Consensus 314 ~-~i~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~~~~~ 360 (597)
T 3oja_B 314 L-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHNDWDCN 360 (597)
T ss_dssp C-CCGGGHHHHTTCSEEECCSSCCCCCCCCTTCCCSEEECCSSCEEHH
T ss_pred C-ccCcccccCCCCCEEECCCCCCCCcChhhcCCCCEEEeeCCCCCCh
Confidence 9 7888889999999999999999988766667888899999999884
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-32 Score=303.78 Aligned_cols=326 Identities=24% Similarity=0.312 Sum_probs=249.3
Q ss_pred CCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEecc
Q 003982 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145 (782)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls 145 (782)
.+++.|+|++|.+++..+ +..+++|++|++++|.+++.++ +.++++|++|+|++|+++++++ +.++++|++|+++
T Consensus 68 ~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~ 142 (466)
T 1o6v_A 68 NNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP-LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELS 142 (466)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEE
T ss_pred cCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh-hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEECC
Confidence 479999999999996544 9999999999999999998877 9999999999999999999876 8999999999999
Q ss_pred CCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCc
Q 003982 146 DNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLS 225 (782)
Q Consensus 146 ~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~ 225 (782)
+|++.. ++ .+..+++|+.|+++ |.+.+.. .+..+++|++|++++|+++ .++.--....|+.|++++|.+...
T Consensus 143 ~n~l~~---~~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~-~~~~l~~l~~L~~L~l~~n~l~~~ 214 (466)
T 1o6v_A 143 SNTISD---IS-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKVS-DISVLAKLTNLESLIATNNQISDI 214 (466)
T ss_dssp EEEECC---CG-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCC-CCGGGGGCTTCSEEECCSSCCCCC
T ss_pred CCccCC---Ch-hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcCC-CChhhccCCCCCEEEecCCccccc
Confidence 999887 33 47788888888885 4555543 2778888888888888877 344322225777788877776533
Q ss_pred cccccccCCCCCcEEEeecccccCCCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCC-CCCC
Q 003982 226 GTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPL-FPSK 304 (782)
Q Consensus 226 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~ 304 (782)
.. +..+++|++|++++|++++. +.+..+++|+.|++++|++++..| +..+++|+.|++++|++++..+. .+.+
T Consensus 215 ~~---~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~l~~ 288 (466)
T 1o6v_A 215 TP---LGILTNLDELSLNGNQLKDI-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTA 288 (466)
T ss_dssp GG---GGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTT
T ss_pred cc---ccccCCCCEEECCCCCcccc-hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCccccccCCCc
Confidence 22 56677888888888887764 456777888888888888876554 77788888888888888765542 3457
Q ss_pred ccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccccC
Q 003982 305 VQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNIS 384 (782)
Q Consensus 305 l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p 384 (782)
|+.|++++|+++++.. +.....+......++.+..++. +..+++|+.|++++|.+++.
T Consensus 289 L~~L~L~~n~l~~~~~-------------------~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~-- 346 (466)
T 1o6v_A 289 LTNLELNENQLEDISP-------------------ISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFYNNKVSDV-- 346 (466)
T ss_dssp CSEEECCSSCCSCCGG-------------------GGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSCCCCC--
T ss_pred cCeEEcCCCcccCchh-------------------hcCCCCCCEEECcCCcCCCchh-hccCccCCEeECCCCccCCc--
Confidence 7888888887766441 0011112222223333333433 67789999999999999975
Q ss_pred ccccccccCCeEecccccccccCCccCCCCCCCCeEecCCCcCCCCCCCC
Q 003982 385 PAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDF 434 (782)
Q Consensus 385 ~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~ 434 (782)
..+.++++|++|++++|++++..| +..+++|+.|++++|++++.+..+
T Consensus 347 ~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~~p~~~ 394 (466)
T 1o6v_A 347 SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNY 394 (466)
T ss_dssp GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEECCCBCC
T ss_pred hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccCCchhh
Confidence 579999999999999999998887 899999999999999999965543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=298.54 Aligned_cols=209 Identities=41% Similarity=0.685 Sum_probs=177.0
Q ss_pred CcccccHHHHHHHhcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEe
Q 003982 567 GNVAISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646 (782)
Q Consensus 567 ~~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~ 646 (782)
....++.+++....++|++.+.||+|+||.||+|+..+++.||||++..... ......+.+|++++++++||||+++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccC-chHHHHHHHHHHHHHhccCCCccceEE
Confidence 3456788899999999999999999999999999887899999999976542 222346899999999999999999999
Q ss_pred EEEeCCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcE
Q 003982 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRA 726 (782)
Q Consensus 647 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~ 726 (782)
++.+++..++||||+++|+|.+++..... ...++++..+..++.|++.||+|||+.+..||+||||||+||+++.++.+
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~ 173 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCST-TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence 99999999999999999999999976433 23468999999999999999999999222299999999999999999999
Q ss_pred EEEeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 727 KVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 727 kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
||+|||+++..............||+.|+|||++.+. .++.++||||+|++
T Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~i 224 (326)
T 3uim_A 174 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG---KSSEKTDVFGYGVM 224 (326)
T ss_dssp EECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHS---EECHHHHHHHHHHH
T ss_pred EeccCccccccCcccccccccccCCcCccCHHHhccC---CCCccccchhHHHH
Confidence 9999999988765544444556799999999988654 35778999999986
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-33 Score=296.94 Aligned_cols=189 Identities=28% Similarity=0.360 Sum_probs=163.1
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
.++|++.+.||+|+||.||+|+. .+++.||+|++++... .......+.+|+++++.++||||+++++++.+.+..|+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 36799999999999999999965 4789999999976432 233567789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
|||+++|+|.+++... ..+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++..
T Consensus 84 ~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 155 (337)
T 1o6l_A 84 MEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhc
Confidence 9999999999998762 358999999999999999999999 89999999999999999999999999999864
Q ss_pred CCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 738 PDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..... .....+||+.|+|||++.+. +++.++|+||+||+
T Consensus 156 ~~~~~-~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~i 194 (337)
T 1o6l_A 156 ISDGA-TMKTFCGTPEYLAPEVLEDN---DYGRAVDWWGLGVV 194 (337)
T ss_dssp CCTTC-CBCCCEECGGGCCGGGGSSS---CBCTTHHHHHHHHH
T ss_pred ccCCC-cccccccChhhCChhhhcCC---CCCchhhcccchhH
Confidence 33222 22345799999999998765 45778999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-32 Score=290.94 Aligned_cols=189 Identities=26% Similarity=0.431 Sum_probs=162.2
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
.++|.+.+.||+|+||+||+|.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD--EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT 86 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence 35788999999999999999965 568999999986533 556788999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++++|.+++... ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++...
T Consensus 87 e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 159 (310)
T 3s95_A 87 EYIKGGTLRGIIKSM----DSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMV 159 (310)
T ss_dssp ECCTTCBHHHHHHHC----CTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceecc
Confidence 999999999999763 2458999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCcee-------------eecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSV-------------ETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
...... .....||+.|+|||++.+. .++.++||||+|++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~~ 211 (310)
T 3s95_A 160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR---SYDEKVDVFSFGIV 211 (310)
T ss_dssp --------------------CCCCSCGGGCCHHHHTTC---CCCTHHHHHHHHHH
T ss_pred cccccccccccccccccccccccCCCcceeCHHHhcCC---CCCcHHHHHHHHHH
Confidence 433211 1135799999999998765 45678999999986
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-33 Score=291.82 Aligned_cols=190 Identities=25% Similarity=0.409 Sum_probs=158.5
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
.++|++.+.||+|+||.||+|.. .+++.||+|++..... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 46899999999999999999954 5789999999865443 234567899999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
|||+++++|.+++... .++++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++..
T Consensus 90 ~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 161 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH-----GPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL 161 (294)
T ss_dssp EECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred EeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence 9999999999999763 358999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 738 PDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
............||+.|+|||++.+. .++.++|+||+|++
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~~ 201 (294)
T 4eqm_A 162 SETSLTQTNHVLGTVQYFSPEQAKGE---ATDECTDIYSIGIV 201 (294)
T ss_dssp -------------CCSSCCHHHHHTC---CCCTTHHHHHHHHH
T ss_pred ccccccccCccccCccccCHhHhcCC---CCCchHhHHHHHHH
Confidence 55443333445799999999988765 34667899999986
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-33 Score=299.08 Aligned_cols=189 Identities=25% Similarity=0.390 Sum_probs=159.2
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCCeEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLL 656 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~l 656 (782)
.++|++.+.||+|+||.||+|+. .+++.||||++++... .....+.+.+|.++++.+ +||||+++++++.+.+..|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 47899999999999999999965 5689999999976432 233556788999999988 69999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecccee
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~ 736 (782)
||||+++|+|.+++... ..+++.++..++.|++.||+|||+ .||+||||||+|||++.++.+||+|||+|+.
T Consensus 102 v~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS-----RRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceee
Confidence 99999999999999763 458999999999999999999999 8999999999999999999999999999986
Q ss_pred cCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 737 APDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..... ......+||+.|+|||++.+. +++.++|+||+||+
T Consensus 174 ~~~~~-~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~i 213 (353)
T 3txo_A 174 GICNG-VTTATFCGTPDYIAPEILQEM---LYGPAVDWWAMGVL 213 (353)
T ss_dssp SCC----------CCGGGCCHHHHHHH---HCTTHHHHHHHHHH
T ss_pred cccCC-ccccccCCCcCeEChhhcCCC---CcCCccCCCcchHH
Confidence 44322 123346799999999998764 56778999999986
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=306.46 Aligned_cols=202 Identities=24% Similarity=0.289 Sum_probs=169.0
Q ss_pred cHHHHHHHhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCCCCcceEEeEEE
Q 003982 572 SIEVLRQVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCI 649 (782)
Q Consensus 572 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~ 649 (782)
..++.+...++|++.+.||+|+||.||+|+. .+++.||||++.+... .....+.+.+|.+++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 3444555678999999999999999999965 5789999999976432 1223455889999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEE
Q 003982 650 NGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVA 729 (782)
Q Consensus 650 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~ 729 (782)
+.+..|+||||+++|+|.+++.+.. ..+++..+..++.|++.||+|||+ .||+||||||+|||++.++.+||+
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~ 204 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFG----ERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLA 204 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEEC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEe
Confidence 9999999999999999999997632 358999999999999999999999 899999999999999999999999
Q ss_pred eeccceecCCCCceeeecccccccccCccccccch----hhhHHHHHHHHHhccc
Q 003982 730 DFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHW----MILCQMTGLIWLHGSV 780 (782)
Q Consensus 730 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~~~dvws~Gvv 780 (782)
|||+|+.............+||+.|+|||++.+.- ...++.++|+||+||+
T Consensus 205 DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvi 259 (412)
T 2vd5_A 205 DFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVF 259 (412)
T ss_dssp CCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHH
T ss_pred echhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHH
Confidence 99999887654433334468999999999886310 0135678999999986
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=296.24 Aligned_cols=189 Identities=26% Similarity=0.421 Sum_probs=163.9
Q ss_pred HhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCCh----hhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCe
Q 003982 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGN----KGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE 653 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~ 653 (782)
+.++|++.+.||+|+||.||+|.. .+|+.||+|++++..... ...+.+.+|+.++++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 457899999999999999999955 578999999998654322 245789999999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCC----cEEEE
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM----RAKVA 729 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~----~~kL~ 729 (782)
.++||||+++|+|.+++.. ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++ .+||+
T Consensus 90 ~~lv~e~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~ 161 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ-----KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLI 161 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT-----CSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred EEEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEE
Confidence 9999999999999999854 3468999999999999999999999 8999999999999998776 79999
Q ss_pred eeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 730 DFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 730 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|||+++...... .....+||+.|+|||++.+. .++.++|+||+||+
T Consensus 162 DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslGvi 207 (361)
T 2yab_A 162 DFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYE---PLGLEADMWSIGVI 207 (361)
T ss_dssp CCSSCEECCTTC--CCCCCCSCGGGCCHHHHTTC---CCCTHHHHHHHHHH
T ss_pred ecCCceEcCCCC--ccccCCCCccEECchHHcCC---CCCccccHHHHHHH
Confidence 999998876533 22345799999999998764 45678999999986
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=7.8e-33 Score=300.43 Aligned_cols=190 Identities=24% Similarity=0.356 Sum_probs=163.9
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
++|++.+.||+|+||.||+|.. .+++.||+|++.+... .....+.+.+|+++++.++||||+++++++.+.+..|+||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 6799999999999999999954 5688999999976432 2235678899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++|+|..++.. ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+|+...
T Consensus 95 e~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ-----NVHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp CCCTTEEHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred ecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 99999999999865 3458999999999999999999999 899999999999999999999999999998775
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... .....+||+.|+|||++.+.-..+++.++|+||+||+
T Consensus 167 ~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~i 206 (384)
T 4fr4_A 167 RET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVT 206 (384)
T ss_dssp TTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHH
T ss_pred CCC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHH
Confidence 433 2234679999999999865322345778999999986
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.5e-32 Score=295.15 Aligned_cols=284 Identities=21% Similarity=0.278 Sum_probs=227.5
Q ss_pred CCCCccccceEeCCCCCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCcccCCC
Q 003982 51 STGYCEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVP 129 (782)
Q Consensus 51 ~~~~c~w~gv~c~~~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~ 129 (782)
..+.|.|.|+ |+ +++++++ .+|..+. ++|++|++++|++++.++ .|.++++|++|+|++|++++++
T Consensus 26 ~~~~C~~~~~-c~---------~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 92 (353)
T 2z80_A 26 ASLSCDRNGI-CK---------GSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIE 92 (353)
T ss_dssp -CCEECTTSE-EE---------CCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEEC
T ss_pred cCCCCCCCeE-ee---------CCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccC
Confidence 3577999987 64 4567777 6777655 489999999999999887 7999999999999999999999
Q ss_pred CCCCCCCCCCCEEeccCCCCCCCCCCCc-ccCCCcccCeeeccccccCCCCc-ccccCCCCCcEEEcccCc-CCCCCCcc
Q 003982 130 TGCFDGLTNLQVLSLSDNPNLAPWPFPN-ELTKSTSLTTLYMDNANIFGLIP-DFFDSFSNLQNLRLSYNN-FTGSLPAS 206 (782)
Q Consensus 130 ~~~~~~l~~L~~L~Ls~N~l~~~~~~p~-~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~-l~~~~p~~ 206 (782)
+..|.++++|++|+|++|++.. +|. .+.++++|++|+|++|++++..+ ..|..+++|++|++++|+ +.+..|..
T Consensus 93 ~~~~~~l~~L~~L~Ls~n~l~~---~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~ 169 (353)
T 2z80_A 93 EDSFSSLGSLEHLDLSYNYLSN---LSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKD 169 (353)
T ss_dssp TTTTTTCTTCCEEECCSSCCSS---CCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTT
T ss_pred HhhcCCCCCCCEEECCCCcCCc---CCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHH
Confidence 9899999999999999999987 444 48899999999999999987755 588899999999999995 55333333
Q ss_pred ccccccchhhcccccCCCccccccccCCCCCcEEEeecccccCCCC-CCCCCCCCCEEEcCCCcCccCcchhhcCCCCCC
Q 003982 207 FAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIP-DLSKCESLFDLSLRDNQLTGVVPASVISLPALL 285 (782)
Q Consensus 207 ~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 285 (782)
+.++++|++|++++|++++..+ .+..+++|++|++++|+++...+..+..+++|+
T Consensus 170 ------------------------~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~ 225 (353)
T 2z80_A 170 ------------------------FAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVE 225 (353)
T ss_dssp ------------------------TTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEE
T ss_pred ------------------------ccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhccccc
Confidence 4468999999999999998755 588899999999999999754444455688999
Q ss_pred EEEccCCcccCCCCCCCCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCccccc
Q 003982 286 NISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCS 365 (782)
Q Consensus 286 ~L~l~~N~l~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 365 (782)
.|++++|++++..+..++. ...
T Consensus 226 ~L~L~~n~l~~~~~~~l~~----------------------------------------------------------~~~ 247 (353)
T 2z80_A 226 CLELRDTDLDTFHFSELST----------------------------------------------------------GET 247 (353)
T ss_dssp EEEEESCBCTTCCCC----------------------------------------------------------------C
T ss_pred EEECCCCcccccccccccc----------------------------------------------------------ccc
Confidence 9999999988654432110 011
Q ss_pred CCceeEEEccCccccc----ccCccccccccCCeEecccccccccCCcc-CCCCCCCCeEecCCCcCCCCCCC
Q 003982 366 QGRIITINLANKLLAG----NISPAYANLTSLKNLYLQQNNLTGPIPDG-LTKLASLQNLDVSNNNLSGKVPD 433 (782)
Q Consensus 366 ~~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~-~~~l~~L~~L~ls~N~l~g~~p~ 433 (782)
...++.++|++|.+++ .+|..+.++++|++|+|++|+|+ .+|.. |..+++|+.|+|++|++++.+|.
T Consensus 248 ~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~~~~ 319 (353)
T 2z80_A 248 NSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPR 319 (353)
T ss_dssp CCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred cchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCcCCC
Confidence 2345666666666665 47888999999999999999999 66666 58999999999999999998873
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-31 Score=289.38 Aligned_cols=305 Identities=20% Similarity=0.281 Sum_probs=256.2
Q ss_pred ccCCccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCccc
Q 003982 86 ISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSL 165 (782)
Q Consensus 86 l~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L 165 (782)
+..+++|++|++++|.+... +.+..+++|++|+|++|+++.+++ +.++++|++|+|++|++.. + ..+..+++|
T Consensus 40 ~~~l~~L~~L~l~~~~i~~~-~~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~---~-~~~~~l~~L 112 (347)
T 4fmz_A 40 QEELESITKLVVAGEKVASI-QGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD---I-SALQNLTNL 112 (347)
T ss_dssp HHHHTTCSEEECCSSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC---C-GGGTTCTTC
T ss_pred chhcccccEEEEeCCccccc-hhhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccC---c-hHHcCCCcC
Confidence 56789999999999999865 468899999999999999999887 8999999999999999988 3 469999999
Q ss_pred CeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeecc
Q 003982 166 TTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKN 245 (782)
Q Consensus 166 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N 245 (782)
++|++++|.+++..+ +..+++|++|++++|.....++..-....|++|++++|.+..... +..+++|++|++++|
T Consensus 113 ~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~---~~~l~~L~~L~l~~n 187 (347)
T 4fmz_A 113 RELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP---IANLTDLYSLSLNYN 187 (347)
T ss_dssp SEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCGGGTTCTTCCEEECCSSCCCCCGG---GGGCTTCSEEECTTS
T ss_pred CEEECcCCcccCchh--hccCCceeEEECCCCCCcccccchhhCCCCcEEEecCCCcCCchh---hccCCCCCEEEccCC
Confidence 999999999988744 899999999999999776555553233678888888887654332 778899999999999
Q ss_pred cccCCCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCC-CCCCCccEEEccCCcCCCCCCCCCC
Q 003982 246 QFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYP-LFPSKVQKVSLDHNNFCKNSSDAGK 324 (782)
Q Consensus 246 ~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~l~~N~~~~~~~~~~~ 324 (782)
++++..+ +..+++|+.|++++|++++..+ +..+++|++|++++|++++..+ ..+.+|++|++++|.++.+.
T Consensus 188 ~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~~----- 259 (347)
T 4fmz_A 188 QIEDISP-LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSPLANLSQLTWLEIGTNQISDIN----- 259 (347)
T ss_dssp CCCCCGG-GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCCG-----
T ss_pred ccccccc-ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcchhcCCCCCEEECCCCccCCCh-----
Confidence 9987655 7888999999999999986555 8888999999999999987655 24568999999999875532
Q ss_pred CCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccccCccccccccCCeEeccccccc
Q 003982 325 PCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLT 404 (782)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 404 (782)
.+..+++|++|++++|.+++. +.+..+++|++|+|++|+++
T Consensus 260 -------------------------------------~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~ 300 (347)
T 4fmz_A 260 -------------------------------------AVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLG 300 (347)
T ss_dssp -------------------------------------GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCC
T ss_pred -------------------------------------hHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCC
Confidence 345667999999999999975 56899999999999999999
Q ss_pred ccCCccCCCCCCCCeEecCCCcCCCCCC-CCCCCcceecCCCCCCC
Q 003982 405 GPIPDGLTKLASLQNLDVSNNNLSGKVP-DFGSNVKFTVSPGNPFI 449 (782)
Q Consensus 405 g~~p~~~~~l~~L~~L~ls~N~l~g~~p-~~~~~~~~~~~~~n~~~ 449 (782)
+..|..|..+++|+.|++++|++++.+| .....+....+.+|++.
T Consensus 301 ~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 301 NEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSADFANQVIK 346 (347)
T ss_dssp GGGHHHHHTCTTCSEEECCSSSCCCCGGGGGCTTCSEESSSCC---
T ss_pred CcChhHhhccccCCEEEccCCccccccChhhhhccceeehhhhccc
Confidence 9999999999999999999999999888 22367778888888863
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=298.82 Aligned_cols=190 Identities=17% Similarity=0.232 Sum_probs=162.3
Q ss_pred hcCCCccceeecccceEEEEE------EeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC---CCCcceEEeEEEe
Q 003982 580 TDNFSEANILGRGGFGVVYGG------ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR---HRHLVALLGYCIN 650 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~------~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~nI~~~~~~~~~ 650 (782)
.++|.+.+.||+|+||+||+| +..+++.||||++... ...++.+|++++++++ |+||+++++++..
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 467999999999999999999 3557889999999753 2457788888888886 9999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECC--------
Q 003982 651 GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD-------- 722 (782)
Q Consensus 651 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~-------- 722 (782)
.+..++||||+++|+|.+++..........+++.+++.++.|++.||+|||+ .||+||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCcccc
Confidence 9999999999999999999987655445679999999999999999999998 89999999999999998
Q ss_pred ---CCcEEEEeeccceecCCC-CceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 723 ---DMRAKVADFGLVKNAPDG-KYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 723 ---~~~~kL~DfG~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
++.+||+|||+|+..... ........+||+.|+|||++.+. .++.++||||+||+
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~i 274 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK---PWNYQIDYFGVAAT 274 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC---CBSTHHHHHHHHHH
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC---CCCccccHHHHHHH
Confidence 899999999999765321 22233456799999999998875 35789999999986
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-32 Score=297.42 Aligned_cols=190 Identities=26% Similarity=0.440 Sum_probs=165.5
Q ss_pred HHhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEE
Q 003982 578 QVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656 (782)
Q Consensus 578 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 656 (782)
.+.++|++.+.||+|+||.||+|.. .+++.||+|++..........+.+.+|++++++++||||+++++++.+.+..|+
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 4567899999999999999999954 578999999998766556667889999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCC---CcEEEEeecc
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD---MRAKVADFGL 733 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~---~~~kL~DfG~ 733 (782)
||||+++|+|.+++.. ...+++.++..++.|++.||+|||+ .||+||||||+||+++.+ +.+||+|||+
T Consensus 106 v~e~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~ 177 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVA-----REFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGL 177 (362)
T ss_dssp EECCCCSCBHHHHHTT-----CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence 9999999999998864 3458999999999999999999999 899999999999999865 4599999999
Q ss_pred ceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 734 VKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 734 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+........ .....||+.|+|||++.+. .++.++||||+||+
T Consensus 178 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~i 219 (362)
T 2bdw_A 178 AIEVNDSEA--WHGFAGTPGYLSPEVLKKD---PYSKPVDIWACGVI 219 (362)
T ss_dssp CBCCTTCCS--CCCSCSCTTTCCHHHHTTC---CCCTHHHHHHHHHH
T ss_pred ceEecCCcc--cccCCCCccccCHHHHccC---CCCchhhHHHHHHH
Confidence 987764332 2345799999999998764 35678999999986
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=304.80 Aligned_cols=191 Identities=22% Similarity=0.364 Sum_probs=165.2
Q ss_pred HHhcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEE
Q 003982 578 QVTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656 (782)
Q Consensus 578 ~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 656 (782)
.+.++|++.+.||+|+||.||+|. ..+|+.||+|++..........+.+.+|++++++++||||+++++++.+++..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 456789999999999999999994 4678999999998766555567789999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEC---CCCcEEEEeecc
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIG---DDMRAKVADFGL 733 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~---~~~~~kL~DfG~ 733 (782)
||||+++|+|.+.+.. ...+++.++..++.|++.||+|||+ .||+||||||+||+++ .++.+||+|||+
T Consensus 88 v~E~~~gg~L~~~i~~-----~~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~ 159 (444)
T 3soa_A 88 IFDLVTGGELFEDIVA-----REYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGL 159 (444)
T ss_dssp EECCCBCCBHHHHHHH-----CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred EEEeCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCce
Confidence 9999999999999876 2458999999999999999999999 8999999999999998 467899999999
Q ss_pred ceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 734 VKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 734 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|........ ......||+.|+|||++.+. .++.++||||+||+
T Consensus 160 a~~~~~~~~-~~~~~~gt~~Y~APE~l~~~---~~~~~~DIwSlGvi 202 (444)
T 3soa_A 160 AIEVEGEQQ-AWFGFAGTPGYLSPEVLRKD---PYGKPVDLWACGVI 202 (444)
T ss_dssp CBCCCTTCC-BCCCSCSCGGGCCHHHHTTC---CBCTHHHHHHHHHH
T ss_pred eEEecCCCc-eeecccCCcccCCHHHhcCC---CCCCccccHHHHHH
Confidence 987765332 22345799999999998764 35678999999986
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.98 E-value=1e-32 Score=300.49 Aligned_cols=189 Identities=23% Similarity=0.373 Sum_probs=161.5
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCC-hhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCCeEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLL 656 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~l 656 (782)
.++|++.++||+|+||.||+|+. .+++.||+|++++.... ....+.+.+|..+++++ +||||+++++++.+.+..|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 46799999999999999999965 46789999999875432 22345688999999887 79999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecccee
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~ 736 (782)
||||+++|+|..++... ..+++.++..++.|++.||+|||+ .||+||||||+|||++.++.+||+|||+|+.
T Consensus 131 V~E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp EEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEcCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeee
Confidence 99999999999998763 358999999999999999999999 8999999999999999999999999999986
Q ss_pred cCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 737 APDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..... ......+||+.|+|||++.+. +++.++|+||+||+
T Consensus 203 ~~~~~-~~~~~~~gt~~Y~aPE~l~~~---~~~~~~DiwslGvl 242 (396)
T 4dc2_A 203 GLRPG-DTTSTFCGTPNYIAPEILRGE---DYGFSVDWWALGVL 242 (396)
T ss_dssp CCCTT-CCBCCCCBCGGGCCHHHHTTC---CBCTHHHHHHHHHH
T ss_pred cccCC-CccccccCCcccCCchhhcCC---CCChHHHHHHHHHH
Confidence 43322 123446899999999998875 45778999999986
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.4e-31 Score=294.41 Aligned_cols=313 Identities=18% Similarity=0.132 Sum_probs=258.2
Q ss_pred CCCcccCccccCCccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCC
Q 003982 77 GLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFP 156 (782)
Q Consensus 77 ~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p 156 (782)
+..+..+..++++++|++|++++|.+++. |.+..+++|++|+|++|+|++++ +..+++|++|+|++|++.. ++
T Consensus 29 ~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~~l~~l~~L~~L~Ls~n~l~~~~---~~~l~~L~~L~Ls~N~l~~---~~ 101 (457)
T 3bz5_A 29 EMQATDTISEEQLATLTSLDCHNSSITDM-TGIEKLTGLTKLICTSNNITTLD---LSQNTNLTYLACDSNKLTN---LD 101 (457)
T ss_dssp TCCTTSEEEHHHHTTCCEEECCSSCCCCC-TTGGGCTTCSEEECCSSCCSCCC---CTTCTTCSEEECCSSCCSC---CC
T ss_pred CcCcccccChhHcCCCCEEEccCCCcccC-hhhcccCCCCEEEccCCcCCeEc---cccCCCCCEEECcCCCCce---ee
Confidence 33445556788999999999999999986 58999999999999999999985 8899999999999999988 33
Q ss_pred cccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccc-cccchhhcccccCCCccccccccCCC
Q 003982 157 NELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLSGTLDVLSGMT 235 (782)
Q Consensus 157 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~l~l~~~~~~~~~~~~~~~~l~ 235 (782)
+.++++|++|++++|++++. + +..+++|++|++++|++++ ++ +.. ..|+.|+++.|...... .+..++
T Consensus 102 --~~~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~-l~--l~~l~~L~~L~l~~n~~~~~~---~~~~l~ 170 (457)
T 3bz5_A 102 --VTPLTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTE-ID--VSHNTQLTELDCHLNKKITKL---DVTPQT 170 (457)
T ss_dssp --CTTCTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSC-CC--CTTCTTCCEEECTTCSCCCCC---CCTTCT
T ss_pred --cCCCCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCccce-ec--cccCCcCCEEECCCCCccccc---ccccCC
Confidence 88999999999999999986 3 8999999999999999996 44 333 67899999988533222 477899
Q ss_pred CCcEEEeecccccCCCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCCCCCCccEEEccCCcC
Q 003982 236 QLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNF 315 (782)
Q Consensus 236 ~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~l~~N~~ 315 (782)
+|++|++++|++++.+ +..+++|+.|++++|++++. .+..+++|+.|++++|++++.....+.+|+.|++++|++
T Consensus 171 ~L~~L~ls~n~l~~l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~ip~~~l~~L~~L~l~~N~l 245 (457)
T 3bz5_A 171 QLTTLDCSFNKITELD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEIDVTPLTQLTYFDCSVNPL 245 (457)
T ss_dssp TCCEEECCSSCCCCCC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSCCCCTTCTTCSEEECCSSCC
T ss_pred cCCEEECCCCccceec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccccCccccCCCCEEEeeCCcC
Confidence 9999999999999864 88999999999999999975 488999999999999999995434567899999999999
Q ss_pred CCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccccCccccccccCCe
Q 003982 316 CKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKN 395 (782)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 395 (782)
++++... +..+..-.....+|+.|++++|.+.+.+| ++++++|+.
T Consensus 246 ~~~~~~~---------------------------------l~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~ 290 (457)
T 3bz5_A 246 TELDVST---------------------------------LSKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKE 290 (457)
T ss_dssp SCCCCTT---------------------------------CTTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCC
T ss_pred CCcCHHH---------------------------------CCCCCEEeccCCCCCEEECCCCccCCccc--ccccccCCE
Confidence 8765111 01111112223478899999999988887 578899999
Q ss_pred EecccccccccCCcc--------CCCCCCCCeEecCCCcCCCCCCCCC--CCcceecCCCCCCC
Q 003982 396 LYLQQNNLTGPIPDG--------LTKLASLQNLDVSNNNLSGKVPDFG--SNVKFTVSPGNPFI 449 (782)
Q Consensus 396 L~Ls~N~l~g~~p~~--------~~~l~~L~~L~ls~N~l~g~~p~~~--~~~~~~~~~~n~~~ 449 (782)
|+|++|++.+.+|.. +..+++|+.|++++|+|+|. | +. ..+....+.+|.+.
T Consensus 291 L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l-~-l~~l~~L~~L~l~~N~l~ 352 (457)
T 3bz5_A 291 LDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTEL-D-VSHNTKLKSLSCVNAHIQ 352 (457)
T ss_dssp CCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSCC-C-CTTCTTCSEEECCSSCCC
T ss_pred EECCCCcccceeccCCCcceEechhhcccCCEEECCCCccccc-c-cccCCcCcEEECCCCCCC
Confidence 999999988877753 56678999999999999995 4 43 57777888888875
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-32 Score=291.70 Aligned_cols=186 Identities=28% Similarity=0.411 Sum_probs=162.3
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCC-hhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
.++|++.+.||+|+||.||+|+. .+|+.||+|++++.... ....+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 36799999999999999999965 47899999999764321 23457788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++..
T Consensus 85 ~e~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~ 156 (318)
T 1fot_A 85 MDYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYV 156 (318)
T ss_dssp ECCCCSCBHHHHHHH-----TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred EeCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceec
Confidence 999999999999976 2458999999999999999999998 89999999999999999999999999999876
Q ss_pred CCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 738 PDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.... ...+||+.|+|||++.+. +++.++|+||+||+
T Consensus 157 ~~~~----~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~i 192 (318)
T 1fot_A 157 PDVT----YTLCGTPDYIAPEVVSTK---PYNKSIDWWSFGIL 192 (318)
T ss_dssp SSCB----CCCCSCTTTCCHHHHTTC---CBCTTHHHHHHHHH
T ss_pred CCcc----ccccCCccccCHhHhcCC---CCCcccchhhhHHH
Confidence 5432 235799999999998764 45678899999986
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=295.20 Aligned_cols=194 Identities=21% Similarity=0.352 Sum_probs=163.9
Q ss_pred HhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccC---ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeE
Q 003982 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM---GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSER 654 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~ 654 (782)
+.++|++.+.||+|+||.||+|.. .+++.||||++..... .....+.+.+|+++++.++||||+++++++.+.+..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 346799999999999999999954 5789999999965321 112467899999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCc---EEEEee
Q 003982 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR---AKVADF 731 (782)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~---~kL~Df 731 (782)
|+||||+++++|.+.+...... ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++. +||+||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADA-GFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred EEEEeCCCCCCHHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecC
Confidence 9999999999999888764432 3458999999999999999999999 89999999999999987654 999999
Q ss_pred ccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 732 GLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 732 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|+++....... .....+||+.|+|||++.+. .++.++||||+||+
T Consensus 178 g~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~i 222 (351)
T 3c0i_A 178 GVAIQLGESGL-VAGGRVGTPHFMAPEVVKRE---PYGKPVDVWGCGVI 222 (351)
T ss_dssp TTCEECCTTSC-BCCCCCSCGGGCCHHHHTTC---CBCTHHHHHHHHHH
T ss_pred cceeEecCCCe-eecCCcCCcCccCHHHHcCC---CCCchHhhHHHHHH
Confidence 99988765432 22345799999999998765 34678999999986
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.9e-32 Score=291.94 Aligned_cols=193 Identities=26% Similarity=0.388 Sum_probs=160.0
Q ss_pred HhcCCCccceeecccceEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCC-----
Q 003982 579 VTDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS----- 652 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~----- 652 (782)
+.++|++.+.||+|+||.||+|... +++.||||+++... .....+.+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 4578999999999999999999664 79999999997544 2345678999999999999999999999986643
Q ss_pred ----------------------------------------------------eEEEEEEccCCCCHHHHHHhhccCCCCC
Q 003982 653 ----------------------------------------------------ERLLVYEYMPRGTLAQHLFEWHDHGYTP 680 (782)
Q Consensus 653 ----------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~ 680 (782)
..++||||+++++|.+++..... ...
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~ 160 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS--LED 160 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS--GGG
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC--ccc
Confidence 37999999999999999976322 234
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCc-----------eeeeccc
Q 003982 681 LTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY-----------SVETRLA 749 (782)
Q Consensus 681 l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~-----------~~~~~~~ 749 (782)
.++..++.++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++....... .......
T Consensus 161 ~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T 3qd2_B 161 REHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV 237 (332)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred hhhHHHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccC
Confidence 5777899999999999999999 8999999999999999999999999999988765421 1223356
Q ss_pred ccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 750 GTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 750 gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
||+.|+|||++.+. .++.++||||+|++
T Consensus 238 gt~~y~aPE~~~~~---~~~~~~Di~slG~i 265 (332)
T 3qd2_B 238 GTKLYMSPEQIHGN---NYSHKVDIFSLGLI 265 (332)
T ss_dssp -CGGGSCHHHHHCC---CCCTHHHHHHHHHH
T ss_pred CCcCccChHHhcCC---CCcchhhHHHHHHH
Confidence 99999999998764 45778999999986
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.5e-32 Score=293.36 Aligned_cols=188 Identities=24% Similarity=0.372 Sum_probs=162.7
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCC-hhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCCeEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~lv 657 (782)
++|++.+.||+|+||.||+|+. .+++.||+|++.+.... ....+.+.+|.++++++ +||||+++++++.+.+..|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 5789999999999999999965 46889999999876432 34567788999999988 899999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
|||+++|+|.+++... ..+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++..
T Consensus 89 ~e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp ECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 9999999999998763 358999999999999999999999 89999999999999999999999999999864
Q ss_pred CCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 738 PDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..... .....+||+.|+|||++.+. +++.++|+||+||+
T Consensus 161 ~~~~~-~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~i 199 (345)
T 3a8x_A 161 LRPGD-TTSTFCGTPNYIAPEILRGE---DYGFSVDWWALGVL 199 (345)
T ss_dssp CCTTC-CBCCCCSCGGGCCHHHHTTC---CBCTHHHHHHHHHH
T ss_pred cCCCC-cccccCCCccccCccccCCC---CCChHHhHHHHHHH
Confidence 33221 22346899999999998765 45778999999986
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.3e-32 Score=289.85 Aligned_cols=191 Identities=29% Similarity=0.373 Sum_probs=160.0
Q ss_pred HhcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
..++|++.+.||+|+||+||+|...+++.||+|++..........+.+.+|++++++++||||+++++++.++...++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 35789999999999999999998888999999999766544445678899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||++ +++.+++... ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++...
T Consensus 99 e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 99 EFME-KDLKKVLDEN----KTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp ECCS-EEHHHHHHTC----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred cCCC-CCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 9997 5888887652 2458999999999999999999999 899999999999999999999999999998775
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.... ......||+.|+|||++.+. ..++.++||||+||+
T Consensus 171 ~~~~-~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~i 209 (311)
T 3niz_A 171 IPVR-SYTHEVVTLWYRAPDVLMGS--KKYSTSVDIWSIGCI 209 (311)
T ss_dssp SCCC----CCCCCCTTCCHHHHTTC--CSCCTHHHHHHHHHH
T ss_pred CCcc-cccCCcccCCcCCHHHhcCC--CCCCchHHhHHHHHH
Confidence 4322 22335789999999988653 134678999999986
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.98 E-value=3.6e-32 Score=285.79 Aligned_cols=189 Identities=22% Similarity=0.343 Sum_probs=161.9
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
++|++.+.||+|+||+||+|.. .+++.||||++..........+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 5799999999999999999965 568999999998766555566889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++ ++.+.+... ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~~~~-~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSE-EHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred cCCC-CHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence 9965 666666542 2458999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... ......||+.|+|||++.+. ..++.++||||+||+
T Consensus 154 ~~~-~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~i 191 (292)
T 3o0g_A 154 PVR-CYSAEVVTLWYRPPDVLFGA--KLYSTSIDMWSAGCI 191 (292)
T ss_dssp CCS-CCCSCCSCGGGCCHHHHTTC--SCCCTHHHHHHHHHH
T ss_pred ccc-cccCCccccCCcChHHHcCC--CCcCchHHHHHHHHH
Confidence 322 22345789999999988664 124678999999986
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=4.9e-32 Score=288.45 Aligned_cols=187 Identities=21% Similarity=0.336 Sum_probs=162.9
Q ss_pred HhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
+.++|++.+.||+|+||.||+|.. .+++.||+|++.... .....+.+|+++++.++||||+++++++.+.+..++|
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc---ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 357899999999999999999955 568899999987542 4456789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECC--CCcEEEEeeccce
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD--DMRAKVADFGLVK 735 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~--~~~~kL~DfG~a~ 735 (782)
|||+++|+|.+++... ...+++.++..++.|++.||+|||+ .||+||||||+||+++. ++.+||+|||+++
T Consensus 80 ~e~~~g~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~ 152 (321)
T 1tki_A 80 FEFISGLDIFERINTS----AFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152 (321)
T ss_dssp ECCCCCCBHHHHHTSS----SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred EEeCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCe
Confidence 9999999999998541 2358999999999999999999999 89999999999999987 7899999999998
Q ss_pred ecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 736 NAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 736 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
....... .....||+.|+|||++.+. .++.++||||+|++
T Consensus 153 ~~~~~~~--~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~i 192 (321)
T 1tki_A 153 QLKPGDN--FRLLFTAPEYYAPEVHQHD---VVSTATDMWSLGTL 192 (321)
T ss_dssp ECCTTCE--EEEEESCGGGSCHHHHTTC---EECHHHHHHHHHHH
T ss_pred ECCCCCc--cccccCChhhcCcHHhcCC---CCCchhhHHHHHHH
Confidence 8765432 2345789999999998775 35778999999986
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2e-32 Score=293.71 Aligned_cols=191 Identities=26% Similarity=0.407 Sum_probs=162.8
Q ss_pred HHhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCCeE
Q 003982 578 QVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSER 654 (782)
Q Consensus 578 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~ 654 (782)
...++|.+.+.||+|+||.||+|+. .+++.||||++++... .....+.+..|.++++.+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 3467899999999999999999965 4689999999976432 123456788899999877 899999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccc
Q 003982 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734 (782)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a 734 (782)
|+||||+++|+|.+++... ..+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+|
T Consensus 94 ~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhh
Confidence 9999999999999999763 358999999999999999999999 89999999999999999999999999999
Q ss_pred eecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 735 KNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 735 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+....... .....+||+.|+|||++.+. +++.++|+||+||+
T Consensus 166 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~i 207 (345)
T 1xjd_A 166 KENMLGDA-KTNTFCGTPDYIAPEILLGQ---KYNHSVDWWSFGVL 207 (345)
T ss_dssp BCCCCTTC-CBCCCCSCGGGCCHHHHTTC---CBCTHHHHHHHHHH
T ss_pred hhcccCCC-cccCCCCCcccCChhhhcCC---CCCChhhhHHHHHH
Confidence 86543222 22446899999999998775 45778999999986
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=8e-32 Score=287.01 Aligned_cols=195 Identities=25% Similarity=0.396 Sum_probs=166.7
Q ss_pred ccHHHHHHHhcC----------CCccceeecccceEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCC
Q 003982 571 ISIEVLRQVTDN----------FSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHR 639 (782)
Q Consensus 571 ~~~~~l~~~~~~----------y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 639 (782)
++.++++.+.+. |+..+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||
T Consensus 25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 25 VTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCSHHHHHHHHHHHTTCCCT
T ss_pred CcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCC
Confidence 455666555543 777889999999999999664 79999999997654 34567789999999999999
Q ss_pred CcceEEeEEEeCCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEE
Q 003982 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNIL 719 (782)
Q Consensus 640 nI~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIl 719 (782)
||+++++++...+..++||||+++++|.+++.. ..+++.++..++.|++.||+|||+ .||+||||||+||+
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~------~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIl 173 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ------VRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSIL 173 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEE
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEE
Confidence 999999999999999999999999999998853 358999999999999999999999 89999999999999
Q ss_pred ECCCCcEEEEeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 720 IGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 720 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
++.++.+||+|||++........ ......||+.|+|||++.+. .++.++||||+|++
T Consensus 174 l~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~i 230 (321)
T 2c30_A 174 LTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRS---LYATEVDIWSLGIM 230 (321)
T ss_dssp ECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTC---CBCTHHHHHHHHHH
T ss_pred ECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCC---CCCchhhHHHHHHH
Confidence 99999999999999987754322 22345799999999998764 34678999999986
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-32 Score=294.02 Aligned_cols=185 Identities=29% Similarity=0.362 Sum_probs=162.8
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
++|++.+.||+|+||.||+|+. .+++.||+|++.+... .....+.+.+|+++++.++||||+++++++.+....|+||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 6799999999999999999965 4789999999976432 1235678899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++|+|.+++... ..+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++...
T Consensus 121 e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp ECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred cCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceecc
Confidence 999999999999763 358999999999999999999999 899999999999999999999999999998775
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... ...+||+.|+|||++.+. +++.++|+||+||+
T Consensus 193 ~~~----~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~i 227 (350)
T 1rdq_E 193 GRT----WTLCGTPEALAPEIILSK---GYNKAVDWWALGVL 227 (350)
T ss_dssp SCB----CCCEECGGGCCHHHHTTC---CBCTHHHHHHHHHH
T ss_pred CCc----ccccCCccccCHHHhcCC---CCCCcCCEecccHh
Confidence 432 235799999999998765 45778999999986
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-32 Score=289.34 Aligned_cols=192 Identities=28% Similarity=0.486 Sum_probs=156.6
Q ss_pred HhcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
..++|++.+.||+|+||+||+|+. +++.||||++..........+++.+|++++++++||||+++++++.+.+..++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 356899999999999999999977 6889999999877655666788999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEEcCCCCCCEEECCCCcEEEEeecccee
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS--FIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~--ivHrDikp~NIll~~~~~~kL~DfG~a~~ 736 (782)
||+++|+|.+++..... ...+++.++..++.|++.||+|||+ .| |+||||||+||+++.++.+||+|||+++.
T Consensus 114 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp ECCTTCBHHHHHHSTTH--HHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred ecCCCCcHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 99999999999975211 1238999999999999999999998 78 99999999999999999999999999976
Q ss_pred cCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 737 APDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..... .......||+.|+|||++.+. ..+.++||||+|++
T Consensus 189 ~~~~~-~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~i 228 (309)
T 3p86_A 189 KASTF-LSSKSAAGTPEWMAPEVLRDE---PSNEKSDVYSFGVI 228 (309)
T ss_dssp --------------CCTTSCHHHHTTC---CCCTTHHHHHHHHH
T ss_pred ccccc-cccccCCCCccccChhhhcCC---CCCchhhHHHHHHH
Confidence 54432 122345789999999998765 34678999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8e-33 Score=295.01 Aligned_cols=198 Identities=38% Similarity=0.712 Sum_probs=168.2
Q ss_pred HHHHHHhcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCe
Q 003982 574 EVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE 653 (782)
Q Consensus 574 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~ 653 (782)
.++....++|++.+.||+|+||.||+|...+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus 32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109 (321)
T ss_dssp SCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred HHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 33445678999999999999999999998889999999987654 3456789999999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecc
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~ 733 (782)
.++||||+++|+|.+++..... ....+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDL-PTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCC-CSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred EEEEEEcCCCCcHHHHHhccCC-CccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeeccc
Confidence 9999999999999998865322 12458999999999999999999999 8999999999999999999999999999
Q ss_pred ceecCCCCc-eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 734 VKNAPDGKY-SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 734 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
++....... .......||+.|+|||++.+. .++.++||||+|++
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~i 230 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKG---RLTEKSDVYSFGVV 230 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHC---BCCTHHHHHHHHHH
T ss_pred ccccccccccccccccCCCccccCHHHhcCC---CCCcccchHhHHHH
Confidence 987543221 122334689999999987654 35678999999986
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-32 Score=294.88 Aligned_cols=194 Identities=29% Similarity=0.503 Sum_probs=163.8
Q ss_pred hcCCCccceeecccceEEEEEEe--------CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEe
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL--------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCIN 650 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~ 650 (782)
.++|++.+.||+|+||.||+|.. .++..||||+++... .....+++.+|+++++++ +||||+++++++.+
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 46799999999999999999964 235679999997643 345667899999999999 89999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHHhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEE
Q 003982 651 GSERLLVYEYMPRGTLAQHLFEWHDH-----------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNIL 719 (782)
Q Consensus 651 ~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIl 719 (782)
.+..|+||||+++|+|.+++...... ....+++.++..++.|++.||+|||+ .||+||||||+||+
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEE
Confidence 99999999999999999999874321 12358999999999999999999999 89999999999999
Q ss_pred ECCCCcEEEEeeccceecCCCCc-eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 720 IGDDMRAKVADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 720 l~~~~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
++.++.+||+|||+++....... .......+|+.|+|||++.+. .++.++||||+||+
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~DvwslG~i 294 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR---VYTHQSDVWSFGVL 294 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC---CCCHHHHHHHHHHH
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCC---CCCcHHHHHHHHHH
Confidence 99999999999999987654332 122334578899999988764 45788999999986
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-32 Score=290.71 Aligned_cols=188 Identities=27% Similarity=0.435 Sum_probs=161.9
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCC-hhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
.++|.+.+.||+|+||.||+|.. .+++.||||++...... ......+.+|+++++.++||||+++++++.+++..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46899999999999999999964 67899999999754321 12346789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
|||+ +|+|.+++... ..+++.++..++.|++.||+|||+ .||+||||||+||++++++.+||+|||++...
T Consensus 88 ~E~~-~g~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~ 158 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK-----KRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIM 158 (336)
T ss_dssp ECCC-CEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTT
T ss_pred EECC-CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceec
Confidence 9999 78999988763 458999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 738 PDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..... ....+||+.|+|||++.+.. ..+.++||||+||+
T Consensus 159 ~~~~~--~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~i 197 (336)
T 3h4j_B 159 TDGNF--LKTSCGSPNYAAPEVINGKL--YAGPEVDVWSCGIV 197 (336)
T ss_dssp TTSBT--TCCCTTSTTTSCGGGSCCSG--GGCHHHHHHHHHHH
T ss_pred cCCcc--cccccCCcCcCCHHHHcCCC--CCCCccchhHHHHH
Confidence 55432 23357999999999988752 23678999999986
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.8e-32 Score=287.71 Aligned_cols=189 Identities=28% Similarity=0.426 Sum_probs=163.0
Q ss_pred HhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCCh----hhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCe
Q 003982 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGN----KGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE 653 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~ 653 (782)
+.++|++.+.||+|+||.||+|.. .+++.||+|++....... ...+.+.+|++++++++||||+++++++.+...
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 346799999999999999999965 468999999997654321 246789999999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCC----cEEEE
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM----RAKVA 729 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~----~~kL~ 729 (782)
.++||||+++++|.+++.. ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++ .+||+
T Consensus 89 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 160 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKII 160 (326)
T ss_dssp EEEEEECCCSCBHHHHHTT-----SSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEEC
T ss_pred EEEEEEcCCCCCHHHHHHh-----cCCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEE
Confidence 9999999999999999854 3468999999999999999999999 8999999999999999887 89999
Q ss_pred eeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 730 DFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 730 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|||+++....... .....||+.|+|||++.+. .++.++||||+||+
T Consensus 161 Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~i 206 (326)
T 2y0a_A 161 DFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYE---PLGLEADMWSIGVI 206 (326)
T ss_dssp CCTTCEECCTTSC--CCCCCSCTTTCCHHHHTTC---CCCTHHHHHHHHHH
T ss_pred ECCCCeECCCCCc--cccccCCcCcCCceeecCC---CCCcHHHHHHHHHH
Confidence 9999988754331 2345799999999998754 35678999999986
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7e-32 Score=279.83 Aligned_cols=188 Identities=29% Similarity=0.441 Sum_probs=164.7
Q ss_pred hcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
.++|++.+.||+|+||.||+|+..++..||+|+++... ...+++.+|++++++++||||+++++++.+....++|||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS---MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT---BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC---CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 46799999999999999999988888899999997654 234679999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++++|.+++.... ..+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++.....
T Consensus 84 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 84 YISNGCLLNYLRSHG----KGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp CCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred ccCCCcHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecch
Confidence 999999999997642 348999999999999999999999 8999999999999999999999999999988766
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..........+|+.|+|||++.+. .++.++|+||+|++
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 194 (268)
T 3sxs_A 157 DQYVSSVGTKFPVKWSAPEVFHYF---KYSSKSDVWAFGIL 194 (268)
T ss_dssp TCEEECCSCCCCGGGCCHHHHHHS---EEETTHHHHHHHHH
T ss_pred hhhhcccCCCcCcccCCHHHHhcc---CCchhhhhHHHHHH
Confidence 554444445577889999988654 34678999999986
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-32 Score=293.03 Aligned_cols=190 Identities=25% Similarity=0.338 Sum_probs=162.6
Q ss_pred HhcCCCccceeecccceEEEEEEeC-CCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCCeEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERL 655 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~ 655 (782)
..++|++.+.||+|+||.||+|+.. +++.||||++++... .....+.+.+|.++++.+ +||+|+++++++.+.+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3578999999999999999999664 578999999976532 123557788999999988 7999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccce
Q 003982 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (782)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~ 735 (782)
+||||+++|+|.+++... ..+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+|+
T Consensus 98 lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~ 169 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK 169 (353)
T ss_dssp EEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence 999999999999999763 358999999999999999999999 899999999999999999999999999998
Q ss_pred ecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 736 NAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 736 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
....... .....+||+.|+|||++.+. +++.++|+||+||+
T Consensus 170 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~i 210 (353)
T 2i0e_A 170 ENIWDGV-TTKTFCGTPDYIAPEIIAYQ---PYGKSVDWWAFGVL 210 (353)
T ss_dssp CCCCTTC-CBCCCCSCGGGCCHHHHTTC---CBSTHHHHHHHHHH
T ss_pred ccccCCc-ccccccCCccccChhhhcCC---CcCCcccccchHHH
Confidence 6433221 22346799999999998765 45778999999986
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.2e-31 Score=306.90 Aligned_cols=325 Identities=17% Similarity=0.191 Sum_probs=238.7
Q ss_pred CEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEecc
Q 003982 67 RVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145 (782)
Q Consensus 67 ~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls 145 (782)
+++.|+|++|+|++..+.+|.++++|++|+|++|+|++.++ .|.++++|++|+|++|+|+++++..|+++++|++|+|+
T Consensus 77 ~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls 156 (635)
T 4g8a_A 77 ELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA 156 (635)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECC
T ss_pred CCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccc
Confidence 78999999999998878889999999999999999999887 69999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCC-------------------------------------
Q 003982 146 DNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSN------------------------------------- 188 (782)
Q Consensus 146 ~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~------------------------------------- 188 (782)
+|++... ..|..+..+++|++|+|++|+|++..+..|..+.+
T Consensus 157 ~N~l~~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n~ 235 (635)
T 4g8a_A 157 HNLIQSF-KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNF 235 (635)
T ss_dssp SSCCCCC-CCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCC
T ss_pred cCccccC-CCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccchhhhhhhhhccc
Confidence 9999763 36788999999999999999988776655433221
Q ss_pred --------------------------------------------------------------------------------
Q 003982 189 -------------------------------------------------------------------------------- 188 (782)
Q Consensus 189 -------------------------------------------------------------------------------- 188 (782)
T Consensus 236 ~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~ 315 (635)
T 4g8a_A 236 DSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVS 315 (635)
T ss_dssp SSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEES
T ss_pred ccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccc
Confidence
Q ss_pred --------------CcEEEcccCcCCCCCCccc--------------------cccccchhhcccccCCCccc-------
Q 003982 189 --------------LQNLRLSYNNFTGSLPASF--------------------AKSDIQNLWMNDQQLGLSGT------- 227 (782)
Q Consensus 189 --------------L~~L~Ls~N~l~~~~p~~~--------------------~~~~l~~l~l~~~~~~~~~~------- 227 (782)
|+.|++++|.+.+..+..+ ....++.++++.|.+...+.
T Consensus 316 ~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~ 395 (635)
T 4g8a_A 316 VTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFG 395 (635)
T ss_dssp CEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHHHS
T ss_pred cccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccccccccccchhhccccccccccccchhh
Confidence 2223333332221111000 00234455555555432221
Q ss_pred -----------------cccccCCCCCcEEEeecccccCCCC--CCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEE
Q 003982 228 -----------------LDVLSGMTQLRQVWLHKNQFTGPIP--DLSKCESLFDLSLRDNQLTGVVPASVISLPALLNIS 288 (782)
Q Consensus 228 -----------------~~~~~~l~~L~~L~L~~N~l~~~~~--~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 288 (782)
...+..+++|+.++++.|++....+ .+..+++++.++++.|++.+..+..+..++.|+.|+
T Consensus 396 ~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~ 475 (635)
T 4g8a_A 396 TISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK 475 (635)
T ss_dssp CSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEE
T ss_pred hhhhhhhhccccccccccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhh
Confidence 1223445555555665555554333 255566666666666666666666666666666666
Q ss_pred ccCCcccC-CCCCC---CCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccc
Q 003982 289 LQNNKLQG-PYPLF---PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTC 364 (782)
Q Consensus 289 l~~N~l~~-~~~~~---~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 364 (782)
+++|++.+ ..|.. +.+|+.|+|++|+++++. |..+.
T Consensus 476 Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~----------------------------------------~~~f~ 515 (635)
T 4g8a_A 476 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLS----------------------------------------PTAFN 515 (635)
T ss_dssp CTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEEC----------------------------------------TTTTT
T ss_pred hhhcccccccCchhhhhccccCEEECCCCccCCcC----------------------------------------hHHHc
Confidence 66665432 23332 245666666666665443 56677
Q ss_pred cCCceeEEEccCcccccccCccccccccCCeEecccccccccCCccCCCC-CCCCeEecCCCcCCCCCC
Q 003982 365 SQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKL-ASLQNLDVSNNNLSGKVP 432 (782)
Q Consensus 365 ~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l-~~L~~L~ls~N~l~g~~p 432 (782)
.+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+ ++|+.|+|++|++++...
T Consensus 516 ~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 516 SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp TCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred CCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 88999999999999999999999999999999999999999999999998 689999999999998655
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-32 Score=286.27 Aligned_cols=189 Identities=26% Similarity=0.364 Sum_probs=158.8
Q ss_pred cCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEc
Q 003982 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 660 (782)
++|++.+.||+|+||.||+|...+++.||+|++..........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57999999999999999999878899999999976554344457889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~ 740 (782)
+++ +|.+++... ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~-~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp CSE-EHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred cCC-CHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 975 898888652 2458999999999999999999999 89999999999999999999999999999876532
Q ss_pred CceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 741 KYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.. ......||+.|+|||++.+. ..++.++||||+|++
T Consensus 154 ~~-~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~i 190 (288)
T 1ob3_A 154 VR-KYTHEIVTLWYRAPDVLMGS--KKYSTTIDIWSVGCI 190 (288)
T ss_dssp ---------CCCTTCCHHHHTTC--CSCCTHHHHHHHHHH
T ss_pred cc-ccccccccccccCchheeCC--CCCCcHHHHHHHHHH
Confidence 21 22334689999999988653 134678999999986
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-32 Score=289.50 Aligned_cols=189 Identities=26% Similarity=0.411 Sum_probs=152.1
Q ss_pred hcCCCccceeecccceEEEEEEe----CCCcEEEEEEeccccCC--hhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCe
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL----PDGTKIAVKRMESNTMG--NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE 653 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~ 653 (782)
.++|++.+.||+|+||.||+|+. .+++.||+|++++.... ......+.+|++++++++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 36799999999999999999965 47899999999865421 2345668899999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecc
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~ 733 (782)
.|+||||+++++|.+++... ..+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 167 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE-----GIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGL 167 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred EEEEEeCCCCCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCc
Confidence 99999999999999999762 358999999999999999999999 8999999999999999999999999999
Q ss_pred ceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 734 VKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 734 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
++....... .....+||+.|+|||++.+. +++.++|+||+|++
T Consensus 168 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~i 210 (327)
T 3a62_A 168 CKESIHDGT-VTHTFCGTIEYMAPEILMRS---GHNRAVDWWSLGAL 210 (327)
T ss_dssp C-----------CTTSSCCTTSCHHHHTTS---CCCTHHHHHHHHHH
T ss_pred ccccccCCc-cccccCCCcCccCHhhCcCC---CCCCcccchhHHHH
Confidence 976543221 22345799999999998764 34678999999986
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.4e-32 Score=286.71 Aligned_cols=188 Identities=27% Similarity=0.434 Sum_probs=159.3
Q ss_pred hcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCC----eEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS----ERL 655 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~----~~~ 655 (782)
.++|++.+.||+|+||.||+|+.. ++.||||++.... .....+++|+.++++++||||+++++++.+.. ..+
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 367999999999999999999874 7999999996543 34456677999999999999999999998754 369
Q ss_pred EEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC----------CeEEcCCCCCCEEECCCCc
Q 003982 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ----------SFIHRDLKPSNILIGDDMR 725 (782)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~----------~ivHrDikp~NIll~~~~~ 725 (782)
+||||+++|+|.+++.. ..+++.++..++.|++.||+|||+ . ||+||||||+||+++.++.
T Consensus 99 lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~ 169 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKA------NVVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLT 169 (322)
T ss_dssp EEEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCC
T ss_pred EEEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCe
Confidence 99999999999999965 348999999999999999999998 6 9999999999999999999
Q ss_pred EEEEeeccceecCCCCce-eeecccccccccCccccccc--hhhhHHHHHHHHHhccc
Q 003982 726 AKVADFGLVKNAPDGKYS-VETRLAGTFGYLAPEYAGKH--WMILCQMTGLIWLHGSV 780 (782)
Q Consensus 726 ~kL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~dvws~Gvv 780 (782)
+||+|||+|+........ ......||+.|+|||++.+. ....++.++||||+|++
T Consensus 170 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~i 227 (322)
T 3soc_A 170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLV 227 (322)
T ss_dssp EEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHH
T ss_pred EEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHH
Confidence 999999999876553322 22335799999999998763 12356789999999986
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-32 Score=282.62 Aligned_cols=187 Identities=28% Similarity=0.465 Sum_probs=162.9
Q ss_pred cCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEc
Q 003982 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 660 (782)
++|++.+.||+|+||.||+|...+++.||+|++.... ...+++.+|++++++++||||+++++++.+++..++||||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc---cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 5788999999999999999988889999999998654 2346799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~ 740 (782)
+++++|.+++... ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++.....
T Consensus 87 ~~~~~L~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 87 MEHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp CTTCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCCCcHHHHHHhc----CcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 9999999998652 2458999999999999999999999 89999999999999999999999999999876553
Q ss_pred CceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 741 KYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.........+|+.|+|||++.+. .++.++|+||+|++
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~ 196 (269)
T 4hcu_A 160 QYTSSTGTKFPVKWASPEVFSFS---RYSSKSDVWSFGVL 196 (269)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHC---CCCHHHHHHHHHHH
T ss_pred ccccccCcccccccCCHHHhcCC---CCCchhhhHHHHHH
Confidence 33333344578899999988654 45778999999986
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-32 Score=284.80 Aligned_cols=191 Identities=28% Similarity=0.457 Sum_probs=155.8
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCCh------------------------hhHHHHHHHHHHHH
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGN------------------------KGLSEFQAEIAVLT 634 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~------------------------~~~~~~~~E~~~l~ 634 (782)
.++|++.+.||+|+||.||+|.. .+++.||||++....... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 36899999999999999999954 578899999997653211 12356899999999
Q ss_pred hcCCCCcceEEeEEEe--CCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcC
Q 003982 635 KVRHRHLVALLGYCIN--GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRD 712 (782)
Q Consensus 635 ~l~h~nI~~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrD 712 (782)
+++||||+++++++.+ .+..++||||+++++|.+++. ..++++.++..++.|++.||+|||+ .||+|||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~D 162 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT------LKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRD 162 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC------SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccC
Confidence 9999999999999987 568899999999999987542 2468999999999999999999999 8999999
Q ss_pred CCCCCEEECCCCcEEEEeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 713 LKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 713 ikp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|||+||+++.++.+||+|||+++....... ......||+.|+|||++.+........++||||+|++
T Consensus 163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~ 229 (298)
T 2zv2_A 163 IKPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVT 229 (298)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHH
T ss_pred CCHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHH
Confidence 999999999999999999999987765432 2234579999999999876421123678999999986
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-32 Score=288.88 Aligned_cols=191 Identities=24% Similarity=0.374 Sum_probs=160.0
Q ss_pred HhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
+.++|++.+.||+|+||.||+|.. .+++.||||++..... ....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 357899999999999999999965 4789999999975432 22346789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
|||+++|+|.+++.. ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++..
T Consensus 84 ~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 155 (323)
T 3tki_A 84 LEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVF 155 (323)
T ss_dssp EECCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEcCCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeecccee
Confidence 999999999998854 3458999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCc-eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 738 PDGKY-SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 738 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..... .......||+.|+|||++.+. .....++||||+|++
T Consensus 156 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~i 197 (323)
T 3tki_A 156 RYNNRERLLNKMCGTLPYVAPELLKRR--EFHAEPVDVWSCGIV 197 (323)
T ss_dssp EETTEECCBCSCCSCGGGSCHHHHHCS--SBCHHHHHHHHHHHH
T ss_pred ccCCcccccCCCccCcCccCcHHhccC--CCCCCcccHHHHHHH
Confidence 43221 122345799999999998654 123678999999986
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=283.16 Aligned_cols=188 Identities=29% Similarity=0.353 Sum_probs=157.7
Q ss_pred HhcCCCccceeecccceEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCCeEEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLL 656 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~l 656 (782)
+.++|++.+.||+|+||+||+|... +++.||||++...........++..|+..+.++ +||||+++++++.+++..++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 3467999999999999999999664 799999999876554445555666676666665 89999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecccee
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~ 736 (782)
||||+ +++|.+++.... ..+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++..
T Consensus 135 v~e~~-~~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~ 206 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWG----ASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVE 206 (311)
T ss_dssp EEECC-CCBHHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEE
T ss_pred EEecc-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeee
Confidence 99999 779999887642 358999999999999999999999 8999999999999999999999999999987
Q ss_pred cCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 737 APDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..... ......||+.|+|||++.+. ++.++||||+||+
T Consensus 207 ~~~~~--~~~~~~gt~~y~aPE~~~~~----~~~~~DiwslG~i 244 (311)
T 3p1a_A 207 LGTAG--AGEVQEGDPRYMAPELLQGS----YGTAADVFSLGLT 244 (311)
T ss_dssp CC--------CCCCCGGGCCGGGGGTC----CSTHHHHHHHHHH
T ss_pred cccCC--CCcccCCCccccCHhHhcCC----CCchhhHHHHHHH
Confidence 75433 22335699999999998875 3568999999986
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=285.85 Aligned_cols=190 Identities=26% Similarity=0.418 Sum_probs=159.2
Q ss_pred hcCCCccceeecccceEEEEEEeC----CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGELP----DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL 655 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~ 655 (782)
.++|++.+.||+|+||.||+|... .+..||||+++... .....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 467899999999999999999663 34569999997543 3455678999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccce
Q 003982 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (782)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~ 735 (782)
+||||+++++|.+++... ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++
T Consensus 127 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTH----DGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp EEEECCTTCBHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEeeCCCCCcHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCccc
Confidence 999999999999998652 2458999999999999999999999 899999999999999999999999999998
Q ss_pred ecCCCCce--eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 736 NAPDGKYS--VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 736 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
........ ......+|+.|+|||++.+. .++.++||||+|++
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~Di~slG~i 243 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFR---TFSSASDVWSFGVV 243 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHC---EECHHHHHHHHHHH
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCC---CCCcHHHHHHHHHH
Confidence 77553221 22233567889999998754 45778999999986
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=290.06 Aligned_cols=187 Identities=21% Similarity=0.341 Sum_probs=161.9
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|++++++++||||+++++++.+....++||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence 46899999999999999999955 578999999997643 334567899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECC--CCcEEEEeecccee
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD--DMRAKVADFGLVKN 736 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~--~~~~kL~DfG~a~~ 736 (782)
||+++|+|.+++... ...+++.++..++.|++.||+|||+ .||+||||||+||+++. ++.+||+|||+++.
T Consensus 128 E~~~gg~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~ 200 (387)
T 1kob_A 128 EFLSGGELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATK 200 (387)
T ss_dssp ECCCCCBHHHHTTCT----TCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EcCCCCcHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEeccccee
Confidence 999999999988542 2358999999999999999999999 89999999999999974 47899999999988
Q ss_pred cCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 737 APDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
....... ....||+.|+|||++.+. .++.++||||+||+
T Consensus 201 ~~~~~~~--~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~i 239 (387)
T 1kob_A 201 LNPDEIV--KVTTATAEFAAPEIVDRE---PVGFYTDMWAIGVL 239 (387)
T ss_dssp CCTTSCE--EEECSSGGGCCHHHHTTC---CBCHHHHHHHHHHH
T ss_pred cCCCcce--eeeccCCCccCchhccCC---CCCCcccEeeHhHH
Confidence 7654322 234799999999998765 45778999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-32 Score=303.17 Aligned_cols=190 Identities=26% Similarity=0.348 Sum_probs=148.1
Q ss_pred hcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC-----Ce
Q 003982 580 TDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING-----SE 653 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~-----~~ 653 (782)
.++|++.+.||+|+||+||+|. ..+++.||||++..........+++.+|++++++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 4689999999999999999995 45789999999976554555678899999999999999999999998543 56
Q ss_pred EEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecc
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~ 733 (782)
.|+||||+ +++|.+++.. ...+++.++..++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+
T Consensus 132 ~~lv~e~~-~~~L~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGl 202 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRT-----PVYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGL 202 (458)
T ss_dssp EEEEECCC-SEEHHHHHHS-----SCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEecc-ccchhhhccc-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeeccccc
Confidence 89999998 5789988864 3458999999999999999999999 8999999999999999999999999999
Q ss_pred ceecCCCCc--------------------------eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 734 VKNAPDGKY--------------------------SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 734 a~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|+....... ......+||+.|+|||++... ..++.++||||+||+
T Consensus 203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~~DiwSlG~i 273 (458)
T 3rp9_A 203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ--ENYTEAIDVWSIGCI 273 (458)
T ss_dssp CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTC--CCCCTHHHHHHHHHH
T ss_pred chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCC--CCCCcHhHHHHHHHH
Confidence 987643211 112345789999999975432 135778999999986
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=303.10 Aligned_cols=190 Identities=29% Similarity=0.483 Sum_probs=164.3
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCC-hhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
.++|++.+.||+|+||.||+|.. .+|+.||||++.+.... ......+.+|+++++.++||||+++++++.+.+..|+|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 46799999999999999999965 57999999999764321 23456788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
|||+++|+|.+++.... ...+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+|+..
T Consensus 263 mEy~~gg~L~~~l~~~~---~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG---QAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp ECCCCSCBHHHHHHSSS---SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEcCCCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceec
Confidence 99999999999986532 2358999999999999999999999 89999999999999999999999999999887
Q ss_pred CCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 738 PDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..... ....+||+.|+|||++.+. +++.++|+||+||+
T Consensus 337 ~~~~~--~~~~~GT~~Y~APEvl~~~---~~~~~~DiwSLGvi 374 (576)
T 2acx_A 337 PEGQT--IKGRVGTVGYMAPEVVKNE---RYTFSPDWWALGCL 374 (576)
T ss_dssp CTTCC--EECCCSCGGGCCHHHHTTC---EESSHHHHHHHHHH
T ss_pred ccCcc--ccccCCCccccCHHHHcCC---CCCccchHHHHHHH
Confidence 65432 2335899999999998774 45778999999986
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-30 Score=275.43 Aligned_cols=194 Identities=22% Similarity=0.307 Sum_probs=157.0
Q ss_pred CccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCee
Q 003982 89 LTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTL 168 (782)
Q Consensus 89 l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L 168 (782)
..+|+.++++++.++..+..+. ++|++|+|++|+++++++..|.++++|++|+|++|++.. ..|..|.++++|++|
T Consensus 30 ~c~l~~l~~~~~~l~~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L 105 (330)
T 1xku_A 30 QCHLRVVQCSDLGLEKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK--ISPGAFAPLVKLERL 105 (330)
T ss_dssp EEETTEEECTTSCCCSCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCC--BCTTTTTTCTTCCEE
T ss_pred cCCCeEEEecCCCccccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCe--eCHHHhcCCCCCCEE
Confidence 3468899999999997766554 789999999999999999999999999999999999998 568899999999999
Q ss_pred eccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeeccccc
Q 003982 169 YMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFT 248 (782)
Q Consensus 169 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 248 (782)
+|++|+++.. |..+. ++|++|++++|++++..+.. +.++++|++|++++|+++
T Consensus 106 ~Ls~n~l~~l-~~~~~--~~L~~L~l~~n~l~~~~~~~------------------------~~~l~~L~~L~l~~n~l~ 158 (330)
T 1xku_A 106 YLSKNQLKEL-PEKMP--KTLQELRVHENEITKVRKSV------------------------FNGLNQMIVVELGTNPLK 158 (330)
T ss_dssp ECCSSCCSBC-CSSCC--TTCCEEECCSSCCCBBCHHH------------------------HTTCTTCCEEECCSSCCC
T ss_pred ECCCCcCCcc-Chhhc--ccccEEECCCCcccccCHhH------------------------hcCCccccEEECCCCcCC
Confidence 9999999866 44433 79999999999998444333 446899999999999997
Q ss_pred C--CCC-CCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCCC---CCCccEEEccCCcCC
Q 003982 249 G--PIP-DLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLF---PSKVQKVSLDHNNFC 316 (782)
Q Consensus 249 ~--~~~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~---~~~l~~L~l~~N~~~ 316 (782)
. ..+ .+..+++|++|++++|+++ .+|..+. ++|++|++++|++++..|.. +.+|+.|++++|.++
T Consensus 159 ~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~ 229 (330)
T 1xku_A 159 SSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS 229 (330)
T ss_dssp GGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCC
T ss_pred ccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCc
Confidence 4 333 5889999999999999999 4565554 78999999999988665432 234445555555443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=293.23 Aligned_cols=192 Identities=28% Similarity=0.426 Sum_probs=152.4
Q ss_pred HHHhcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC-CCCcceEEeEEEeCC--
Q 003982 577 RQVTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGS-- 652 (782)
Q Consensus 577 ~~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~-- 652 (782)
..+.++|++.+.||+|+||.||+|. ..+++.||||++..........+++.+|+.+++++. ||||+++++++..++
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 3467899999999999999999995 467899999999765545566778899999999997 999999999998654
Q ss_pred eEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeec
Q 003982 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (782)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG 732 (782)
..|+||||++ ++|.+++.. ..+++..+..++.|++.||+|||+ .||+||||||+|||++.++.+||+|||
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG 154 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRA------NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFG 154 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHH------TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEecccC-cCHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCc
Confidence 6899999996 689988865 358999999999999999999999 899999999999999999999999999
Q ss_pred cceecCCCC--------------------ceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 733 LVKNAPDGK--------------------YSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 733 ~a~~~~~~~--------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+|+...... .......+||+.|+|||++.+. ..++.++||||+||+
T Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlG~i 220 (388)
T 3oz6_A 155 LSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS--TKYTKGIDMWSLGCI 220 (388)
T ss_dssp TCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTC--CCCCTHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCC--CCCCChhhHHHHHHH
Confidence 998754311 1112345799999999988763 235678999999986
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.1e-32 Score=293.50 Aligned_cols=189 Identities=30% Similarity=0.403 Sum_probs=152.8
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCC-hhhHHHHHHHHHH-HHhcCCCCcceEEeEEEeCCeEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAV-LTKVRHRHLVALLGYCINGSERLL 656 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~-l~~l~h~nI~~~~~~~~~~~~~~l 656 (782)
.++|++.+.||+|+||.||+|+. .+++.||||++++.... ......+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 36799999999999999999965 46889999999876532 2344556777776 567899999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecccee
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~ 736 (782)
||||+++|+|.+++... ..+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++.
T Consensus 117 v~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~ 188 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE-----RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE 188 (373)
T ss_dssp EEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred EEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccc
Confidence 99999999999998762 358899999999999999999999 8999999999999999999999999999986
Q ss_pred cCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 737 APDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..... ......+||+.|+|||++.+. +++.++|+||+||+
T Consensus 189 ~~~~~-~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~i 228 (373)
T 2r5t_A 189 NIEHN-STTSTFCGTPEYLAPEVLHKQ---PYDRTVDWWCLGAV 228 (373)
T ss_dssp GBCCC-CCCCSBSCCCCCCCHHHHTTC---CCCTHHHHHHHHHH
T ss_pred cccCC-CccccccCCccccCHHHhCCC---CCCchhhhHHHHHH
Confidence 43322 122346899999999998765 45778999999986
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-31 Score=291.34 Aligned_cols=194 Identities=18% Similarity=0.263 Sum_probs=165.2
Q ss_pred hcCCCccceeecc--cceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEE
Q 003982 580 TDNFSEANILGRG--GFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656 (782)
Q Consensus 580 ~~~y~~~~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 656 (782)
.++|++.+.||+| +||.||+|+. .+++.||||++..........+.+++|++++++++||||+++++++.+++..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3679999999999 9999999965 478999999998776556667889999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecccee
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~ 736 (782)
||||+++|+|.+++.... ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||.+..
T Consensus 104 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHF---MDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEECCTTCBHHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEccCCCCHHHHHhhhc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 999999999999997632 2458999999999999999999999 8999999999999999999999999999875
Q ss_pred cCCCCc------eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 737 APDGKY------SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 737 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
...... .......||+.|+|||++.+.. ..++.++||||+||+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~DiwslG~i 226 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNL-QGYDAKSDIYSVGIT 226 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTS-SCBCTHHHHHHHHHH
T ss_pred eccccccccccccccccccccccccCHHHHhccC-CCCCcHhHHHHHHHH
Confidence 533211 1112246899999999987631 135678999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-31 Score=277.12 Aligned_cols=191 Identities=26% Similarity=0.362 Sum_probs=164.1
Q ss_pred HhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCCeEEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLL 656 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~l 656 (782)
+.++|++.+.||+|+||.||+|.. .+++.||||++...........++.+|+..+.++ +||||+++++++.+++..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 457899999999999999999965 4789999999987655455677889999999999 89999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCC-------------
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD------------- 723 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~------------- 723 (782)
||||+++++|.+++...... ...+++.++..++.|++.||+|||+ .||+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRI-MSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC---------------
T ss_pred EEEecCCCcHHHHHHhhccc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 99999999999999764332 2458999999999999999999999 899999999999999844
Q ss_pred ------CcEEEEeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 724 ------MRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 724 ------~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..+||+|||.+....... ...||+.|+|||++.+.. .++.++||||+|++
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~--~~~~~~Di~slG~i 220 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENY--THLPKADIFALALT 220 (289)
T ss_dssp -----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCC--TTHHHHHHHHHHHH
T ss_pred cccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCC--CCCchhhHHHHHHH
Confidence 479999999998776533 235899999999987752 35679999999986
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=283.66 Aligned_cols=193 Identities=23% Similarity=0.344 Sum_probs=148.7
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
.++|++.+.||+|+||.||+|.. .+++.||+|+++... .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 46799999999999999999965 468999999997654 2334567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 659 EYMPRGTLAQHLFEWHDH-GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
||++ ++|.+++...... ....+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++..
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9997 6999998764322 22458999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 738 PDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..... ......||+.|+|||++.+. ..++.++||||+||+
T Consensus 159 ~~~~~-~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~i 198 (317)
T 2pmi_A 159 GIPVN-TFSSEVVTLWYRAPDVLMGS--RTYSTSIDIWSCGCI 198 (317)
T ss_dssp TSCCC-CCCCCCSCCTTCCHHHHTTC--CCCCTHHHHHHHHHH
T ss_pred CCCcc-cCCCCcccccccCchHhhCC--CCCCcHHHHHHHHHH
Confidence 54321 22334789999999988653 134678999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=301.64 Aligned_cols=193 Identities=27% Similarity=0.450 Sum_probs=165.9
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCC-hhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
.++|.+.+.||+|+||.||+|+. .+|+.||+|++.+.... ....+.+.+|++++++++||||+++++++.+....|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 36799999999999999999966 46899999999765322 23457789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
|||++||+|.+++...... ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++..
T Consensus 264 mE~~~gg~L~~~l~~~~~~-~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDED-NPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTT-SCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEeccCCCHHHHHHHhhcc-cccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 9999999999998764322 3468999999999999999999999 89999999999999999999999999999887
Q ss_pred CCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 738 PDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..... .....+||+.|+|||++.+. +++.++|+||+||+
T Consensus 340 ~~~~~-~~~~~~GT~~Y~APE~l~~~---~~~~~~DiwSlGvi 378 (543)
T 3c4z_A 340 KAGQT-KTKGYAGTPGFMAPELLLGE---EYDFSVDYFALGVT 378 (543)
T ss_dssp CTTCC-CBCCCCSCTTTSCHHHHTTC---CBCTHHHHHHHHHH
T ss_pred cCCCc-ccccccCCccccChhhhcCC---CCChHHhcCcchHH
Confidence 65432 22335899999999998775 45778999999986
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.97 E-value=8.7e-32 Score=281.51 Aligned_cols=188 Identities=30% Similarity=0.467 Sum_probs=160.3
Q ss_pred hcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
.++|++.+.||+|+||.||+|+..++..||+|+++.... ..+++.+|++++++++||||+++++++.+.+..++|||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC---CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 467899999999999999999988888999999986542 34679999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++++|.+++.... ..+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++....
T Consensus 100 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 100 YMANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp CCTTCBHHHHHHCGG----GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred ccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 999999999997632 348999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..........+|+.|+|||++.+. .++.++|+||+|++
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~~ 210 (283)
T 3gen_A 173 DEYTSSVGSKFPVRWSPPEVLMYS---KFSSKSDIWAFGVL 210 (283)
T ss_dssp HHHHSTTSTTSCGGGCCHHHHHHC---CCSHHHHHHHHHHH
T ss_pred cccccccCCccCcccCCHHHhccC---CCCchhhHHHHHHH
Confidence 332222334578889999988754 35778999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-31 Score=279.66 Aligned_cols=187 Identities=26% Similarity=0.418 Sum_probs=156.2
Q ss_pred HhcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHh--cCCCCcceEEeEEEeC----C
Q 003982 579 VTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTK--VRHRHLVALLGYCING----S 652 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~nI~~~~~~~~~~----~ 652 (782)
..++|++.+.||+|+||.||+|.. +++.||||++... ....+.+|.+++.. ++||||+++++++.+. .
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 457899999999999999999987 7899999998653 23556667777766 7899999999987653 4
Q ss_pred eEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCCeEEcCCCCCCEEECCCC
Q 003982 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLH--------SLAQQSFIHRDLKPSNILIGDDM 724 (782)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--------~~~~~~ivHrDikp~NIll~~~~ 724 (782)
..++||||+++|+|.++++. ..+++..+..++.|++.||+||| + .||+||||||+||+++.++
T Consensus 80 ~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~ 150 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNG 150 (301)
T ss_dssp EEEEEECCCTTCBHHHHHTT------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTS
T ss_pred eeEEehhhccCCCHHHHHhh------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCC
Confidence 57999999999999999943 35899999999999999999999 6 8999999999999999999
Q ss_pred cEEEEeeccceecCCCCcee---eecccccccccCccccccchhh---hHHHHHHHHHhccc
Q 003982 725 RAKVADFGLVKNAPDGKYSV---ETRLAGTFGYLAPEYAGKHWMI---LCQMTGLIWLHGSV 780 (782)
Q Consensus 725 ~~kL~DfG~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~---~~~~~~dvws~Gvv 780 (782)
.+||+|||+|+......... .....||+.|+|||++.+.... .++.++||||+|++
T Consensus 151 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~i 212 (301)
T 3q4u_A 151 QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLV 212 (301)
T ss_dssp CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHH
T ss_pred CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHH
Confidence 99999999998765443222 2234799999999998765322 45689999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=296.75 Aligned_cols=190 Identities=27% Similarity=0.363 Sum_probs=158.1
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC-----Ce
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING-----SE 653 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~-----~~ 653 (782)
.++|++.+.||+|+||.||+|.. .+++.||||++..........+++.+|++++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 46899999999999999999954 5688999999986554455678899999999999999999999999776 57
Q ss_pred EEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecc
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~ 733 (782)
.|+||||++ ++|.+++.. ...+++.++..++.|+++||+|||+ .||+||||||+|||++.++.+||+|||+
T Consensus 105 ~~lv~e~~~-~~L~~~~~~-----~~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGl 175 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT-----PIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGL 175 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS-----SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEecCC-cCHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCC
Confidence 899999995 699998864 3458999999999999999999999 8999999999999999999999999999
Q ss_pred ceecCCCCce---------------------eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 734 VKNAPDGKYS---------------------VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 734 a~~~~~~~~~---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|+........ .....+||+.|+|||++... ..++.++||||+||+
T Consensus 176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~~~~~~DiwSlG~i 241 (432)
T 3n9x_A 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ--ENYTKSIDIWSTGCI 241 (432)
T ss_dssp CEEC-------------------------------CCCCCTTCCHHHHTTC--SCCCTHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcC--CCCCcccccchHHHH
Confidence 9876543211 12446799999999986432 135778999999986
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=278.88 Aligned_cols=263 Identities=21% Similarity=0.296 Sum_probs=212.9
Q ss_pred ccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeee
Q 003982 90 TQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLY 169 (782)
Q Consensus 90 ~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~ 169 (782)
.+|+.++++++.++.++..+. ++|++|+|++|+++.+++..|.++++|++|+|++|++.. ..|..|.++++|++|+
T Consensus 33 c~l~~l~~~~~~l~~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~ 108 (332)
T 2ft3_A 33 CHLRVVQCSDLGLKAVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISK--IHEKAFSPLRKLQKLY 108 (332)
T ss_dssp EETTEEECCSSCCSSCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE--ECGGGSTTCTTCCEEE
T ss_pred ccCCEEECCCCCccccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCc--cCHhHhhCcCCCCEEE
Confidence 478999999999997766553 789999999999999999999999999999999999988 5678999999999999
Q ss_pred ccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeecccccC
Q 003982 170 MDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTG 249 (782)
Q Consensus 170 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~ 249 (782)
|++|+++.+ |..+. ++|++|++++|+++ .+|.. .+.++++|++|++++|+++.
T Consensus 109 L~~n~l~~l-~~~~~--~~L~~L~l~~n~i~-~~~~~-----------------------~~~~l~~L~~L~l~~n~l~~ 161 (332)
T 2ft3_A 109 ISKNHLVEI-PPNLP--SSLVELRIHDNRIR-KVPKG-----------------------VFSGLRNMNCIEMGGNPLEN 161 (332)
T ss_dssp CCSSCCCSC-CSSCC--TTCCEEECCSSCCC-CCCSG-----------------------GGSSCSSCCEEECCSCCCBG
T ss_pred CCCCcCCcc-Ccccc--ccCCEEECCCCccC-ccCHh-----------------------HhCCCccCCEEECCCCcccc
Confidence 999999866 44433 89999999999998 44432 14469999999999999974
Q ss_pred --CCC-CCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCCC---CCCccEEEccCCcCCCCCCCCC
Q 003982 250 --PIP-DLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLF---PSKVQKVSLDHNNFCKNSSDAG 323 (782)
Q Consensus 250 --~~~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~---~~~l~~L~l~~N~~~~~~~~~~ 323 (782)
..+ .+..+ +|+.|++++|++++ +|..+. ++|++|++++|++++..+.. +.+|+.|++++|+++++.
T Consensus 162 ~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~---- 233 (332)
T 2ft3_A 162 SGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIE---- 233 (332)
T ss_dssp GGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCC----
T ss_pred CCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCC----
Confidence 444 47777 99999999999995 666554 78999999999999877653 346788888888776543
Q ss_pred CCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccccCccccccccCCeEecccccc
Q 003982 324 KPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNL 403 (782)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 403 (782)
|..+..+++|+.|+|++|+++ .+|..+..+++|++|+|++|+|
T Consensus 234 ------------------------------------~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l 276 (332)
T 2ft3_A 234 ------------------------------------NGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNI 276 (332)
T ss_dssp ------------------------------------TTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCC
T ss_pred ------------------------------------hhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCC
Confidence 234556677888888888887 6777788888888888888888
Q ss_pred cccCCccCCCC------CCCCeEecCCCcCC
Q 003982 404 TGPIPDGLTKL------ASLQNLDVSNNNLS 428 (782)
Q Consensus 404 ~g~~p~~~~~l------~~L~~L~ls~N~l~ 428 (782)
++..+..|... ..|+.|++++|++.
T Consensus 277 ~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~ 307 (332)
T 2ft3_A 277 TKVGVNDFCPVGFGVKRAYYNGISLFNNPVP 307 (332)
T ss_dssp CBCCTTSSSCSSCCSSSCCBSEEECCSSSSC
T ss_pred CccChhHccccccccccccccceEeecCccc
Confidence 86666666543 56778888888876
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-31 Score=276.72 Aligned_cols=189 Identities=26% Similarity=0.446 Sum_probs=165.1
Q ss_pred HhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
+.++|++.+.||+|+||.||+|.. .+++.||+|++..........+.+.+|++++++++||||+++++++.+++..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 457899999999999999999954 5689999999987766666778899999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCc---EEEEeeccc
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR---AKVADFGLV 734 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~---~kL~DfG~a 734 (782)
|||+++++|.+.+... ..+++.++..++.|++.||+|||+ .||+||||||+||+++.++. +||+|||.+
T Consensus 84 ~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~ 155 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLA 155 (284)
T ss_dssp ECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceee
Confidence 9999999999988763 358999999999999999999999 89999999999999986655 999999999
Q ss_pred eecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 735 KNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 735 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
........ .....||+.|+|||++.+. .++.++||||+|++
T Consensus 156 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~ 196 (284)
T 3kk8_A 156 IEVNDSEA--WHGFAGTPGYLSPEVLKKD---PYSKPVDIWACGVI 196 (284)
T ss_dssp EECCSSCB--CCCSCSCGGGCCHHHHTTC---CBCTHHHHHHHHHH
T ss_pred EEcccCcc--ccCCCCCcCCcCchhhcCC---CCCcccchHHHHHH
Confidence 87765332 2335789999999998765 35678999999986
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=297.76 Aligned_cols=188 Identities=30% Similarity=0.484 Sum_probs=163.3
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCC-hhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
++|.+.+.||+|+||.||+|.. .+|+.||||++...... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 6799999999999999999965 47999999999764321 234568999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++|+|.+++.+ ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++...
T Consensus 96 E~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 96 EYVSGGELFDYICK-----NGRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp ECCSSEEHHHHTTS-----SSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred eCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 99999999999854 3468999999999999999999998 899999999999999999999999999998876
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.... ....+||+.|+|||++.+.. ..+.++||||+||+
T Consensus 168 ~~~~--~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwSlGvi 205 (476)
T 2y94_A 168 DGEF--LRTSCGSPNYAAPEVISGRL--YAGPEVDIWSSGVI 205 (476)
T ss_dssp TTCC--BCCCCSCSTTCCHHHHTTCC--BCSHHHHHHHHHHH
T ss_pred cccc--ccccCCCcCeEChhhccCCC--CCCCcceehhhHHH
Confidence 5432 23357999999999988751 23578999999986
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=275.98 Aligned_cols=202 Identities=38% Similarity=0.651 Sum_probs=173.7
Q ss_pred ccccHHHHHHHhcCCCcc------ceeecccceEEEEEEeCCCcEEEEEEeccccC--ChhhHHHHHHHHHHHHhcCCCC
Q 003982 569 VAISIEVLRQVTDNFSEA------NILGRGGFGVVYGGELPDGTKIAVKRMESNTM--GNKGLSEFQAEIAVLTKVRHRH 640 (782)
Q Consensus 569 ~~~~~~~l~~~~~~y~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~n 640 (782)
..++.+++..++++|... +.||+|+||.||+|.. +++.||||++..... .....+.+.+|++++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 457888999999988877 9999999999999987 688999999875431 2335678999999999999999
Q ss_pred cceEEeEEEeCCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE
Q 003982 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI 720 (782)
Q Consensus 641 I~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll 720 (782)
|+++++++.+.+..++||||+++++|.+++..... ..++++..+..++.|++.||+|||+ .||+||||||+||++
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili 166 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG--TPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILL 166 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG--CCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEE
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEE
Confidence 99999999999999999999999999999975433 3468999999999999999999999 899999999999999
Q ss_pred CCCCcEEEEeeccceecCCCCc-eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 721 GDDMRAKVADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 721 ~~~~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+.++.+||+|||++........ .......||+.|+|||++.+. ++.++||||+|++
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~Dv~slG~i 223 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE----ITPKSDIYSFGVV 223 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTE----ECTHHHHHHHHHH
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcCC----CCccchhHHHHHH
Confidence 9999999999999987654332 222345789999999998775 3568999999986
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=291.72 Aligned_cols=190 Identities=28% Similarity=0.444 Sum_probs=161.3
Q ss_pred hcCCCccceeecccceEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
.++|.+.+.||+|+||.||+|... +++.||||+++... .....+++.+|++++++++||||+++++++.+++..++||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS-CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 357888999999999999999764 78999999987542 3344567899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++|+|.+++.... ..+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++...
T Consensus 192 e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEG----ARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp ECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred EcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 9999999999997632 348999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCceee-ecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVE-TRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
...+... ....+++.|+|||++.+. .++.++||||+||+
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~i 304 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYG---RYSSESDVWSFGIL 304 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHC---EEEHHHHHHHHHHH
T ss_pred CCceeecCCCCCCCcCcCCHhHhccC---CCCchhhHHHHHHH
Confidence 4332221 112357789999988654 35778999999986
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.6e-32 Score=287.07 Aligned_cols=190 Identities=26% Similarity=0.388 Sum_probs=154.3
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCC-hhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCe----
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE---- 653 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~---- 653 (782)
.++|++.+.||+|+||.||+|.. .+++.||||++...... ......+.+|++++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46899999999999999999964 67899999999865432 3456789999999999999999999999876543
Q ss_pred EEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecc
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~ 733 (782)
.|+||||+++++|.+++... ..+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 162 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGI 162 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred cEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccC
Confidence 49999999999999999762 358999999999999999999999 8999999999999999999999999999
Q ss_pred ceecCCCCc--eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 734 VKNAPDGKY--SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 734 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
++....... .......||+.|+|||++.+. .++.++||||+|++
T Consensus 163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~~ 208 (311)
T 3ork_A 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGD---SVDARSDVYSLGCV 208 (311)
T ss_dssp C------------------CCTTCCHHHHHTC---CCCHHHHHHHHHHH
T ss_pred cccccccccccccccccCcCcccCCHHHhcCC---CCCchHhHHHHHHH
Confidence 987654322 122335689999999998765 45778999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=285.50 Aligned_cols=184 Identities=26% Similarity=0.405 Sum_probs=157.1
Q ss_pred HhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCCeEEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLL 656 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~l 656 (782)
+.++|++.+.||+|+||.||+|.. .+++.||||++++... ...+|++++.++ +||||+++++++.+++..|+
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 567899999999999999999955 5789999999976542 245788888887 79999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCC----CcEEEEeec
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD----MRAKVADFG 732 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~----~~~kL~DfG 732 (782)
||||+++|+|.+++.. ...+++.++..++.|++.||+|||+ .||+||||||+||++.++ +.+||+|||
T Consensus 94 v~E~~~gg~L~~~i~~-----~~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg 165 (342)
T 2qr7_A 94 VTELMKGGELLDKILR-----QKFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFG 165 (342)
T ss_dssp EECCCCSCBHHHHHHT-----CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred EEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence 9999999999999865 2458999999999999999999999 899999999999998543 359999999
Q ss_pred cceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 733 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+++....... .....+||+.|+|||++.+. +++.++|+||+||+
T Consensus 166 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~i 209 (342)
T 2qr7_A 166 FAKQLRAENG-LLMTPCYTANFVAPEVLERQ---GYDAACDIWSLGVL 209 (342)
T ss_dssp TCEECBCTTC-CBCCSSCCSSCCCHHHHHHH---HHHHHHHHHHHHHH
T ss_pred CcccCcCCCC-ceeccCCCccccCHHHhcCC---CCCCccCeeeHhHH
Confidence 9987654332 22345789999999998764 57889999999986
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-31 Score=281.25 Aligned_cols=190 Identities=24% Similarity=0.306 Sum_probs=157.4
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
.++|++.+.||+|+||.||+|.. .+++.||||++..........+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 46899999999999999999965 46899999999776544555678899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||++++++.+++.. ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++....
T Consensus 82 e~~~~~~l~~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 153 (311)
T 4agu_A 82 EYCDHTVLHELDRY-----QRGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLT 153 (311)
T ss_dssp ECCSEEHHHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EeCCCchHHHHHhh-----hcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhcc
Confidence 99999999887754 2458999999999999999999999 899999999999999999999999999998775
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.... ......||+.|+|||++.+. ..++.++|+||+|++
T Consensus 154 ~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~i 192 (311)
T 4agu_A 154 GPSD-YYDDEVATRWYRSPELLVGD--TQYGPPVDVWAIGCV 192 (311)
T ss_dssp -------------GGGCCHHHHHTC--SCCCTHHHHHHHHHH
T ss_pred Cccc-ccCCCcCCccccChHHHhcC--CCCCcchhhHHHHHH
Confidence 4332 22345789999999988653 234678999999986
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.1e-31 Score=300.73 Aligned_cols=278 Identities=25% Similarity=0.348 Sum_probs=232.1
Q ss_pred CCCCccccceEeCC-------CCCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCCCCCCCCCCCEEeCCCC
Q 003982 51 STGYCEWTGINCDN-------SNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNN 123 (782)
Q Consensus 51 ~~~~c~w~gv~c~~-------~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n 123 (782)
..++|.|+|..|.. ..+++.|++++++|+ .+|..+. ++|++|+|++|.|+.+++ .+++|++|+|++|
T Consensus 18 ~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~lp~---~l~~L~~L~Ls~N 91 (622)
T 3g06_A 18 AAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLPA---LPPELRTLEVSGN 91 (622)
T ss_dssp TCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSCCCC---CCTTCCEEEECSC
T ss_pred cCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCCCCCC---cCCCCCEEEcCCC
Confidence 45789997754321 235899999999999 8888776 899999999999997665 5789999999999
Q ss_pred cccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCC
Q 003982 124 NFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSL 203 (782)
Q Consensus 124 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 203 (782)
+|+.+|. .+++|++|+|++|++.. +|. .+++|+.|++++|+|+++ |.. +++|++|+|++|+++ .+
T Consensus 92 ~l~~lp~----~l~~L~~L~Ls~N~l~~---l~~---~l~~L~~L~L~~N~l~~l-p~~---l~~L~~L~Ls~N~l~-~l 156 (622)
T 3g06_A 92 QLTSLPV----LPPGLLELSIFSNPLTH---LPA---LPSGLCKLWIFGNQLTSL-PVL---PPGLQELSVSDNQLA-SL 156 (622)
T ss_dssp CCSCCCC----CCTTCCEEEECSCCCCC---CCC---CCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCS-CC
T ss_pred cCCcCCC----CCCCCCEEECcCCcCCC---CCC---CCCCcCEEECCCCCCCcC-CCC---CCCCCEEECcCCcCC-Cc
Confidence 9999887 68999999999999988 455 568899999999999886 443 489999999999998 45
Q ss_pred CccccccccchhhcccccCCCccccccccCCCCCcEEEeecccccCCCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCC
Q 003982 204 PASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPA 283 (782)
Q Consensus 204 p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 283 (782)
|.. +++|+.|++++|++++.+ ..+++|+.|+|++|+|++ +|.. +++
T Consensus 157 ~~~---------------------------~~~L~~L~L~~N~l~~l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~ 202 (622)
T 3g06_A 157 PAL---------------------------PSELCKLWAYNNQLTSLP---MLPSGLQELSVSDNQLAS-LPTL---PSE 202 (622)
T ss_dssp CCC---------------------------CTTCCEEECCSSCCSCCC---CCCTTCCEEECCSSCCSC-CCCC---CTT
T ss_pred CCc---------------------------cCCCCEEECCCCCCCCCc---ccCCCCcEEECCCCCCCC-CCCc---cch
Confidence 542 468999999999999865 557899999999999995 4443 478
Q ss_pred CCEEEccCCcccCCCCCCCCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCccc
Q 003982 284 LLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVT 363 (782)
Q Consensus 284 L~~L~l~~N~l~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 363 (782)
|+.|++++|.++. +|..+++|+.|+|++|++++++
T Consensus 203 L~~L~L~~N~l~~-l~~~~~~L~~L~Ls~N~L~~lp-------------------------------------------- 237 (622)
T 3g06_A 203 LYKLWAYNNRLTS-LPALPSGLKELIVSGNRLTSLP-------------------------------------------- 237 (622)
T ss_dssp CCEEECCSSCCSS-CCCCCTTCCEEECCSSCCSCCC--------------------------------------------
T ss_pred hhEEECcCCcccc-cCCCCCCCCEEEccCCccCcCC--------------------------------------------
Confidence 9999999999985 5556788999999999886644
Q ss_pred ccCCceeEEEccCcccccccCccccccccCCeEecccccccccCCccCCCCCCCCeEecCCCcCCCCCCC
Q 003982 364 CSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPD 433 (782)
Q Consensus 364 ~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~ 433 (782)
..+++|+.|+|++|+|++ +|. .+++|++|+|++|+|+ .+|..|..+++|+.|+|++|++++.+|.
T Consensus 238 ~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~ 302 (622)
T 3g06_A 238 VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 302 (622)
T ss_dssp CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHH
T ss_pred CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHH
Confidence 123579999999999984 665 6789999999999999 8899999999999999999999988774
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-31 Score=281.79 Aligned_cols=183 Identities=23% Similarity=0.340 Sum_probs=140.3
Q ss_pred cCCCcc---ceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC-CCCcceEEeEEEeCCeEE
Q 003982 581 DNFSEA---NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSERL 655 (782)
Q Consensus 581 ~~y~~~---~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~~~ 655 (782)
++|++. +.||+|+||.||+|.. .+++.||||++... ....+.+|+++++.+. ||||+++++++.++...+
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~ 82 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTF 82 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEE
Confidence 345543 7899999999999955 56899999999653 3467889999999997 999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCC---cEEEEeec
Q 003982 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM---RAKVADFG 732 (782)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~---~~kL~DfG 732 (782)
+||||+++|+|.+++.. ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++ .+||+|||
T Consensus 83 lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg 154 (325)
T 3kn6_A 83 LVMELLNGGELFERIKK-----KKHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFG 154 (325)
T ss_dssp EEECCCCSCBHHHHHHH-----CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCT
T ss_pred EEEEccCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccc
Confidence 99999999999999976 3468999999999999999999999 8999999999999997665 89999999
Q ss_pred cceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 733 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+++....... .....+||+.|+|||++.+. +++.++||||+|++
T Consensus 155 ~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~---~~~~~~DiwslG~i 198 (325)
T 3kn6_A 155 FARLKPPDNQ-PLKTPCFTLHYAAPELLNQN---GYDESCDLWSLGVI 198 (325)
T ss_dssp TCEECCC-----------------------C---CCCHHHHHHHHHHH
T ss_pred cceecCCCCC-cccccCCCcCccCHHHhcCC---CCCCccchHHHHHH
Confidence 9987654332 22345689999999998765 45778999999986
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=286.47 Aligned_cols=191 Identities=27% Similarity=0.360 Sum_probs=163.3
Q ss_pred HHhcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCCh------hhHHHHHHHHHHHHhcCCCCcceEEeEEEe
Q 003982 578 QVTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGN------KGLSEFQAEIAVLTKVRHRHLVALLGYCIN 650 (782)
Q Consensus 578 ~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~ 650 (782)
.+.++|++.+.||+|+||.||+|. ..+++.||||++....... ...+.+.+|++++++++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 466789999999999999999995 4678999999998654322 134567889999999999999999999999
Q ss_pred CCeEEEEEEccCCC-CHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEE
Q 003982 651 GSERLLVYEYMPRG-TLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVA 729 (782)
Q Consensus 651 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~ 729 (782)
.+..++||||+.+| +|.+++.. ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~ 172 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDR-----HPRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLI 172 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHT-----CCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEEC
T ss_pred CCEEEEEEEeCCCCccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEe
Confidence 99999999999776 99998865 3458999999999999999999999 899999999999999999999999
Q ss_pred eeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 730 DFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 730 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|||+++....... .....||+.|+|||++.+.- ..+.++||||+|++
T Consensus 173 Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~i 219 (335)
T 3dls_A 173 DFGSAAYLERGKL--FYTFCGTIEYCAPEVLMGNP--YRGPELEMWSLGVT 219 (335)
T ss_dssp CCTTCEECCTTCC--BCEECSCGGGCCHHHHTTCC--BCSHHHHHHHHHHH
T ss_pred ecccceECCCCCc--eeccCCCccccChhhhcCCC--CCCCcccchhHHHH
Confidence 9999988765432 22357999999999987641 12678999999986
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=288.16 Aligned_cols=186 Identities=24% Similarity=0.307 Sum_probs=150.7
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
.++|++.+.||+|+||+||+|+. .+++.||||++.... ...+.+++|+.++++++||||+++++++.+++..++||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 95 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA---AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM 95 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST---TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc---cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence 46799999999999999999965 478999999997643 23367889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCc--EEEEeecccee
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR--AKVADFGLVKN 736 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~--~kL~DfG~a~~ 736 (782)
||+++|+|.+++... ..+++.++..++.|++.||+|||+ .||+||||||+||+++.++. +||+|||+|+.
T Consensus 96 e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 96 EYASGGELYERICNA-----GRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp ECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred EeCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 999999999998652 358999999999999999999998 89999999999999987765 99999999975
Q ss_pred cCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 737 APDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..... ......||+.|+|||++.+.- ....++||||+|++
T Consensus 168 ~~~~~--~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~i 207 (361)
T 3uc3_A 168 SVLHS--QPKSTVGTPAYIAPEVLLRQE--YDGKIADVWSCGVT 207 (361)
T ss_dssp ---------------CTTSCHHHHHCSS--CCHHHHHHHHHHHH
T ss_pred ccccC--CCCCCcCCCCcCChhhhcCCC--CCCCeeeeehhHHH
Confidence 43322 223357999999999876541 12455899999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=289.70 Aligned_cols=190 Identities=27% Similarity=0.433 Sum_probs=151.1
Q ss_pred hcCCCccceeecccceEEEEEEeC----CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGELP----DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL 655 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~ 655 (782)
.++|++.+.||+|+||.||+|... ++..||||+++... .....+++.+|++++++++||||+++++++.+.+..+
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 357999999999999999999654 57789999997643 3455678999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccce
Q 003982 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (782)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~ 735 (782)
+||||+++|+|.+++... ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++
T Consensus 123 lv~e~~~~~sL~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 195 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKH----DAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGR 195 (373)
T ss_dssp EEEECCTTCBHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred EEEeCCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCcccc
Confidence 999999999999999652 2358999999999999999999999 899999999999999999999999999998
Q ss_pred ecCCCCcee--eecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 736 NAPDGKYSV--ETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 736 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
......... .....+++.|+|||++.+. .++.++||||+|++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~SlG~i 239 (373)
T 2qol_A 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYR---KFTSASDVWSYGIV 239 (373)
T ss_dssp ------------------CTTSCHHHHHHC---CCCHHHHHHHHHHH
T ss_pred ccccCCccceeccCCCcCCCccChhhhccC---CcCchhcHHHHHHH
Confidence 765432111 1122457789999988754 45778999999986
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=288.77 Aligned_cols=194 Identities=23% Similarity=0.317 Sum_probs=165.1
Q ss_pred cccHHHHHHHhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC-----CCCcce
Q 003982 570 AISIEVLRQVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-----HRHLVA 643 (782)
Q Consensus 570 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~nI~~ 643 (782)
.++.+....+.++|++.+.||+|+||.||+|.. .+++.||||+++.. ....+.+..|+++++.++ ||||++
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 344444555678999999999999999999965 57899999999743 345567888999999986 999999
Q ss_pred EEeEEEeCCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECC-
Q 003982 644 LLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD- 722 (782)
Q Consensus 644 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~- 722 (782)
+++++...+..++||||+ +++|.+++.... ...+++.++..++.|++.||+|||+ .||+||||||+|||++.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~ 173 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNN---YNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDP 173 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCT
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccc
Confidence 999999999999999999 999999997632 2358999999999999999999999 89999999999999975
Q ss_pred ------------------------CCcEEEEeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhc
Q 003982 723 ------------------------DMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHG 778 (782)
Q Consensus 723 ------------------------~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~G 778 (782)
++.+||+|||+|+...... ....||+.|+|||++.+. .++.++||||+|
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG 246 (360)
T 3llt_A 174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNL---GWDVSSDMWSFG 246 (360)
T ss_dssp TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTC---CCCTTHHHHHHH
T ss_pred cccccccchhcccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCC---CCCCccchHHHH
Confidence 7899999999998755432 345789999999998765 457789999999
Q ss_pred cc
Q 003982 779 SV 780 (782)
Q Consensus 779 vv 780 (782)
|+
T Consensus 247 ~i 248 (360)
T 3llt_A 247 CV 248 (360)
T ss_dssp HH
T ss_pred HH
Confidence 86
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=290.23 Aligned_cols=192 Identities=24% Similarity=0.324 Sum_probs=161.9
Q ss_pred hcCCCccceeecccceEEEEEEe----CCCcEEEEEEeccccC--ChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCC
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL----PDGTKIAVKRMESNTM--GNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGS 652 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~ 652 (782)
.++|++.+.||+|+||.||+|+. .+++.||||+++.... .....+.+.+|+++++++ +||||+++++++.+..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36799999999999999999976 4789999999975432 122345678899999999 5999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeec
Q 003982 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (782)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG 732 (782)
..++||||+++++|.+++... ..+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG 204 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFG 204 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred eEEEEeecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCC
Confidence 999999999999999999763 358999999999999999999999 899999999999999999999999999
Q ss_pred cceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 733 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+++.............+||+.|+|||++.+.. ..++.++||||+||+
T Consensus 205 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~DvwslG~i 251 (355)
T 1vzo_A 205 LSKEFVADETERAYDFCGTIEYMAPDIVRGGD-SGHDKAVDWWSLGVL 251 (355)
T ss_dssp EEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC----CTHHHHHHHHHH
T ss_pred CCeecccCCCCcccCcccCcCccChhhhcCCC-CCCCchhhHHHHHHH
Confidence 99876543333334467999999999987531 245678999999986
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=281.53 Aligned_cols=189 Identities=29% Similarity=0.524 Sum_probs=156.4
Q ss_pred hcCCCccceeecccceEEEEEEe-----CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC--C
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-----PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING--S 652 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~--~ 652 (782)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++++++||||+++++++... .
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 46789999999999999999973 468899999997543 45567899999999999999999999998653 5
Q ss_pred eEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeec
Q 003982 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (782)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG 732 (782)
..++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg 159 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFG 159 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCG----GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred ceEEEEEeCCCCCHHHHHHhcc----cccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCc
Confidence 5899999999999999997632 248999999999999999999999 899999999999999999999999999
Q ss_pred cceecCCCCc--eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 733 LVKNAPDGKY--SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 733 ~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+++....... .......++..|+|||++.+. .++.++||||+|++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~ 206 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTES---KFSVASDVWSFGVV 206 (295)
T ss_dssp SCC-------------CTTCGGGGCCHHHHHHC---CCCHHHHHHHHHHH
T ss_pred ccccccCCcceeeeccCCCCccceeCcHHhcCC---CCChHHHHHHHHHH
Confidence 9987654321 122334578889999988764 45789999999986
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-31 Score=280.57 Aligned_cols=193 Identities=25% Similarity=0.371 Sum_probs=160.7
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCC--eEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS--ERLL 656 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~--~~~l 656 (782)
.++|++.+.||+|+||+||+|.. .+++.||||++..... ....+.+.+|++++++++||||+++++++.... ..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 46799999999999999999965 4589999999975432 234677889999999999999999999998765 7799
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE----CCCCcEEEEeec
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI----GDDMRAKVADFG 732 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll----~~~~~~kL~DfG 732 (782)
||||+++++|.+++..... ...+++.++..++.|++.||+|||+ .||+||||||+||++ +.++.+||+|||
T Consensus 87 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg 161 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (319)
T ss_dssp EEECCTTCBHHHHHHSGGG--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred EEeCCCCCCHHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence 9999999999999976433 2348999999999999999999999 899999999999999 788889999999
Q ss_pred cceecCCCCceeeecccccccccCccccccc-----hhhhHHHHHHHHHhccc
Q 003982 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAGKH-----WMILCQMTGLIWLHGSV 780 (782)
Q Consensus 733 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~~dvws~Gvv 780 (782)
+++....... .....||+.|+|||++... ....++.++||||+|++
T Consensus 162 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~i 212 (319)
T 4euu_A 162 AARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT 212 (319)
T ss_dssp TCEECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHH
T ss_pred CceecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHH
Confidence 9988765432 2335689999999987521 01234668899999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-31 Score=288.07 Aligned_cols=194 Identities=31% Similarity=0.496 Sum_probs=164.1
Q ss_pred hcCCCccceeecccceEEEEEEe--------CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEe
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL--------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCIN 650 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~ 650 (782)
.++|.+.+.||+|+||.||+|.. ..+..||||+++... .....+++.+|+++++++ +||||+++++++.+
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-CHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 46889999999999999999964 233579999997653 345667899999999999 89999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHHhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEE
Q 003982 651 GSERLLVYEYMPRGTLAQHLFEWHDH-----------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNIL 719 (782)
Q Consensus 651 ~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIl 719 (782)
++..++||||+++|+|.+++...... ....+++.+++.++.|++.||+|||+ .||+||||||+||+
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEE
Confidence 99999999999999999999875421 12358999999999999999999999 89999999999999
Q ss_pred ECCCCcEEEEeeccceecCCCCc-eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 720 IGDDMRAKVADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 720 l~~~~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
++.++.+||+|||+|+....... .......+|+.|+|||++.+. .++.++||||+|++
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~DiwslG~i 282 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR---IYTHQSDVWSFGVL 282 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC---CCCHHHHHHHHHHH
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC---CCCchhHHHHHHHH
Confidence 99999999999999987654332 222334678999999988764 45788999999986
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-31 Score=286.36 Aligned_cols=185 Identities=28% Similarity=0.411 Sum_probs=145.3
Q ss_pred HhcCCCccceeecccceEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
..++|++.+.||+|+||.||+|... +++.||||+++... ..+.+.+|++++++++||||+++++++.+++..++|
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 4578999999999999999999664 67899999997543 346788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECC---CCcEEEEeeccc
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD---DMRAKVADFGLV 734 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~---~~~~kL~DfG~a 734 (782)
|||+++++|.+++.. ...+++.++..++.|++.||+|||+ .||+||||||+||+++. ++.+||+|||++
T Consensus 127 ~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a 198 (349)
T 2w4o_A 127 LELVTGGELFDRIVE-----KGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLS 198 (349)
T ss_dssp ECCCCSCBHHHHHTT-----CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC--
T ss_pred EEeCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccc
Confidence 999999999999864 3458999999999999999999999 89999999999999975 889999999999
Q ss_pred eecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 735 KNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 735 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+...... ......||+.|+|||++.+. .++.++||||+||+
T Consensus 199 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~i 239 (349)
T 2w4o_A 199 KIVEHQV--LMKTVCGTPGYCAPEILRGC---AYGPEVDMWSVGII 239 (349)
T ss_dssp ----------------CGGGSCHHHHTTC---CCCTHHHHHHHHHH
T ss_pred cccCccc--ccccccCCCCccCHHHhcCC---CCCcccchHHHHHH
Confidence 8765432 12335789999999998764 35678999999986
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-31 Score=284.96 Aligned_cols=191 Identities=24% Similarity=0.328 Sum_probs=158.1
Q ss_pred hcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCC--CCcceEEeEEEeCCeEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH--RHLVALLGYCINGSERLLV 657 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~nI~~~~~~~~~~~~~~lv 657 (782)
.++|++.+.||+|+||.||+|...+++.||||++..........+.+.+|++++++++| |||+++++++.++...++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 45799999999999999999988889999999998766556667889999999999986 9999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
||+ .+++|.+++.. ...+++.++..++.|++.||+|||+ .||+||||||+|||++ ++.+||+|||+++..
T Consensus 88 ~e~-~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 88 MEC-GNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp ECC-CSEEHHHHHHH-----SCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EeC-CCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 995 58899999976 2458999999999999999999999 8999999999999996 678999999999876
Q ss_pred CCCCce-eeecccccccccCccccccch--------hhhHHHHHHHHHhccc
Q 003982 738 PDGKYS-VETRLAGTFGYLAPEYAGKHW--------MILCQMTGLIWLHGSV 780 (782)
Q Consensus 738 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~--------~~~~~~~~dvws~Gvv 780 (782)
...... .....+||+.|+|||++.+.. ...++.++||||+||+
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~i 209 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 209 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHH
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHH
Confidence 543322 223457999999999875410 1245778999999986
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.6e-31 Score=273.44 Aligned_cols=186 Identities=25% Similarity=0.366 Sum_probs=162.1
Q ss_pred HhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
+.++|++.+.||+|+||.||+|.. .++..||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF--VEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc--cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 457899999999999999999955 457799999997654 23467899999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE---CCCCcEEEEeeccc
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLV 734 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll---~~~~~~kL~DfG~a 734 (782)
|||+++++|.+++... ..+++.++..++.|++.||+|||+ .||+||||||+||++ +.++.+||+|||++
T Consensus 85 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~ 156 (277)
T 3f3z_A 85 MELCTGGELFERVVHK-----RVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLA 156 (277)
T ss_dssp EECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EeccCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccc
Confidence 9999999999988762 358999999999999999999999 899999999999999 78889999999999
Q ss_pred eecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 735 KNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 735 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
........ .....||+.|+|||++.+. ++.++||||+|++
T Consensus 157 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~----~~~~~Di~slG~~ 196 (277)
T 3f3z_A 157 ARFKPGKM--MRTKVGTPYYVSPQVLEGL----YGPECDEWSAGVM 196 (277)
T ss_dssp EECCTTSC--BCCCCSCTTTCCHHHHTTC----BCTTHHHHHHHHH
T ss_pred eeccCccc--hhccCCCCCccChHHhccc----CCchhhehhHHHH
Confidence 87765432 2334689999999998775 3567899999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-31 Score=283.65 Aligned_cols=186 Identities=22% Similarity=0.272 Sum_probs=159.8
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCCeEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~lv 657 (782)
.++|++.+.||+|+||.||+|.. .+++.||||++..... .+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 83 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV 83 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence 46799999999999999999964 6789999999875432 24688999999999 899999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCc-----EEEEeec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR-----AKVADFG 732 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~-----~kL~DfG 732 (782)
|||+ +++|.+++... ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++. +||+|||
T Consensus 84 ~e~~-~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg 155 (330)
T 2izr_A 84 LELL-GPSLEDLFDLC----DRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFA 155 (330)
T ss_dssp EECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCT
T ss_pred EEeC-CCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcc
Confidence 9999 99999999763 2458999999999999999999999 89999999999999998887 9999999
Q ss_pred cceecCCCCce------eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 733 LVKNAPDGKYS------VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 733 ~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+|+........ ......||+.|+|||++.+. .++.++||||+|++
T Consensus 156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~i 206 (330)
T 2izr_A 156 LAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGK---EQSRRDDLEALGHM 206 (330)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC---CCCHHHHHHHHHHH
T ss_pred cceeeecCCCCccccccccCCcCCCccccChHHHcCC---CCCchhHHHHHHHH
Confidence 99876543221 12346799999999998875 45789999999986
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=299.55 Aligned_cols=189 Identities=29% Similarity=0.491 Sum_probs=164.0
Q ss_pred hcCCCccceeecccceEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
.++|++.+.||+|+||.||+|.+. ++..||||+++... ...++|.+|++++++++||||+++++++.+.+..++||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc---cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 356888999999999999999765 48899999997643 34678999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++|+|.+++.... ...+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+++...
T Consensus 296 E~~~~g~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 296 EFMTYGNLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp ECCTTCBHHHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred EccCCCCHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 9999999999997632 2458999999999999999999999 899999999999999999999999999998876
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
...........+++.|+|||++.+. .++.++|||||||+
T Consensus 370 ~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~sDvwSlG~~ 408 (495)
T 1opk_A 370 GDTYTAHAGAKFPIKWTAPESLAYN---KFSIKSDVWAFGVL 408 (495)
T ss_dssp TCCEECCTTCCCCGGGCCHHHHHHC---EECHHHHHHHHHHH
T ss_pred CCceeecCCCcCCcceeCHhHHhcC---CCCcHHhHHhHHHH
Confidence 5444333344567899999988754 45788999999986
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.6e-31 Score=285.46 Aligned_cols=181 Identities=29% Similarity=0.434 Sum_probs=151.9
Q ss_pred cceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEccCCC
Q 003982 586 ANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRG 664 (782)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~g 664 (782)
.+.||+|+||.||+|.. .+|+.||+|+++... ....+.+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 67899999999999954 578999999997654 345678999999999999999999999999999999999999999
Q ss_pred CHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE--CCCCcEEEEeeccceecCCCCc
Q 003982 665 TLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI--GDDMRAKVADFGLVKNAPDGKY 742 (782)
Q Consensus 665 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll--~~~~~~kL~DfG~a~~~~~~~~ 742 (782)
+|.+++... ...+++.++..++.|++.||+|||+ .||+||||||+||++ +.++.+||+|||+++.......
T Consensus 172 ~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~ 244 (373)
T 2x4f_A 172 ELFDRIIDE----SYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK 244 (373)
T ss_dssp EEHHHHHHT----GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB
T ss_pred cHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc
Confidence 999988652 2358999999999999999999999 899999999999999 6678999999999988765332
Q ss_pred eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 743 SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 743 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.....||+.|+|||++.+. .++.++||||+||+
T Consensus 245 --~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~i 277 (373)
T 2x4f_A 245 --LKVNFGTPEFLAPEVVNYD---FVSFPTDMWSVGVI 277 (373)
T ss_dssp --CCCCCSSCTTCCHHHHTTC---BCCHHHHHHHHHHH
T ss_pred --cccccCCCcEeChhhccCC---CCCcHHhHHHHHHH
Confidence 2234699999999988764 45778999999986
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.3e-31 Score=279.78 Aligned_cols=189 Identities=26% Similarity=0.425 Sum_probs=163.2
Q ss_pred HhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCCh----hhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCe
Q 003982 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGN----KGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE 653 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~ 653 (782)
+.++|++.+.||+|+||.||+|.. .+++.||||++....... ...+.+.+|++++++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 346799999999999999999965 468999999997654322 246789999999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCC----cEEEE
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM----RAKVA 729 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~----~~kL~ 729 (782)
.++||||+++++|.+++.. ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++ .+||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~ 161 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQ-----KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLI 161 (321)
T ss_dssp EEEEECCCCSCBHHHHHHT-----CSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred EEEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEc
Confidence 9999999999999999965 2458999999999999999999999 8999999999999999887 79999
Q ss_pred eeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 730 DFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 730 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|||++........ .....||+.|+|||++.+. .++.++||||+|++
T Consensus 162 Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~i 207 (321)
T 2a2a_A 162 DFGLAHEIEDGVE--FKNIFGTPEFVAPEIVNYE---PLGLEADMWSIGVI 207 (321)
T ss_dssp CCTTCEECCTTCC--CCCCCSCGGGCCHHHHTTC---CCCTHHHHHHHHHH
T ss_pred cCccceecCcccc--ccccCCCCCccCcccccCC---CCCCccccHHHHHH
Confidence 9999987765332 2335689999999988764 34678999999986
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-31 Score=282.55 Aligned_cols=196 Identities=29% Similarity=0.500 Sum_probs=147.6
Q ss_pred HhcCCCccceeecccceEEEEEEeCCC----cEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeE
Q 003982 579 VTDNFSEANILGRGGFGVVYGGELPDG----TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSER 654 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~ 654 (782)
..++|++.+.||+|+||.||+|..... ..||||+++.........+++.+|++++++++||||+++++++.+....
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 346899999999999999999965433 2799999987654556678899999999999999999999999887665
Q ss_pred ------EEEEEccCCCCHHHHHHhhccCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEE
Q 003982 655 ------LLVYEYMPRGTLAQHLFEWHDHG-YTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAK 727 (782)
Q Consensus 655 ------~lv~e~~~~gsL~~~l~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~k 727 (782)
++||||+++|+|.+++....... ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCEE
Confidence 99999999999999997654321 2358999999999999999999999 8999999999999999999999
Q ss_pred EEeeccceecCCCCce-eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 728 VADFGLVKNAPDGKYS-VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 728 L~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|+|||+|+........ ......+++.|+|||++.+. .++.++||||+|++
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 228 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADN---LYTVHSDVWAFGVT 228 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHC---CCCHHHHHHHHHHH
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCC---CCCCccchhhHHHH
Confidence 9999999876543322 22234578899999988765 35788999999986
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-31 Score=286.03 Aligned_cols=198 Identities=32% Similarity=0.537 Sum_probs=164.6
Q ss_pred HHHHhcCCCccceeecccceEEEEEEeC------CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEE
Q 003982 576 LRQVTDNFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCI 649 (782)
Q Consensus 576 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~ 649 (782)
+....++|++.+.||+|+||.||+|... +++.||||+++... .....+.+.+|++++++++||||+++++++.
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 3445688999999999999999999653 34789999997543 3445678999999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHHhhccC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEE
Q 003982 650 NGSERLLVYEYMPRGTLAQHLFEWHDH-------------------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIH 710 (782)
Q Consensus 650 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH 710 (782)
+.+..++||||+++|+|.+++...... ....+++.+++.++.|+++||+|||+ .||+|
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH 197 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVH 197 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeec
Confidence 999999999999999999999874321 12568999999999999999999999 89999
Q ss_pred cCCCCCCEEECCCCcEEEEeeccceecCCCCc-eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 711 RDLKPSNILIGDDMRAKVADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 711 rDikp~NIll~~~~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|||||+||+++.++.+||+|||+++....... .......||+.|+|||++.+. .++.++||||+|++
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~Di~slG~i 265 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN---RYTTESDVWAYGVV 265 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC---CCCHHHHHHHHHHH
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC---CcCcccccHHHHHH
Confidence 99999999999999999999999986643322 222334679999999987654 35788999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.1e-31 Score=275.35 Aligned_cols=190 Identities=27% Similarity=0.391 Sum_probs=158.7
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
.++|.+.+.||+|+||.||+|.. .+++.||+|++.... .....+.+.+|++++++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR-SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc-cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 46799999999999999999955 568999999997654 2345688999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE---CCCCcEEEEeeccce
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVK 735 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll---~~~~~~kL~DfG~a~ 735 (782)
||+++|+|.+++...... ...+++.++..++.|++.||+|||+ .||+||||||+||++ +.++.+||+|||++.
T Consensus 100 e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 100 ETCEGGELLERIVSAQAR-GKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp CCCSCCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EeCCCCcHHHHHHhhhhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 999999999998764332 2468999999999999999999999 899999999999999 456789999999998
Q ss_pred ecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 736 NAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 736 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
...... ......||+.|+|||++.+. ++.++||||+|++
T Consensus 176 ~~~~~~--~~~~~~~t~~y~aPE~~~~~----~~~~~Di~slG~i 214 (285)
T 3is5_A 176 LFKSDE--HSTNAAGTALYMAPEVFKRD----VTFKCDIWSAGVV 214 (285)
T ss_dssp C------------CTTGGGCCHHHHTTC----CCHHHHHHHHHHH
T ss_pred ecCCcc--cCcCcccccCcCChHHhccC----CCcccCeehHHHH
Confidence 665432 22345689999999998765 4578999999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=285.64 Aligned_cols=190 Identities=23% Similarity=0.339 Sum_probs=151.1
Q ss_pred HhcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
..++|++.+.||+|+||+||+|. ..+++.||||+++.........+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 45789999999999999999995 45789999999976654444566788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE-----CCCCcEEEEeec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI-----GDDMRAKVADFG 732 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll-----~~~~~~kL~DfG 732 (782)
|||++ |+|.+++.. ...+++.++..++.|++.||+|||+ .||+||||||+||++ +.++.+||+|||
T Consensus 112 ~e~~~-~~L~~~~~~-----~~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDK-----NPDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EECCS-EEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EecCC-CCHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 99997 599999876 2458999999999999999999999 899999999999999 455569999999
Q ss_pred cceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 733 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+++....... ......||+.|+|||++.+. ..++.++||||+||+
T Consensus 183 ~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~i 227 (329)
T 3gbz_A 183 LARAFGIPIR-QFTHEIITLWYRPPEILLGS--RHYSTSVDIWSIACI 227 (329)
T ss_dssp HHHHHC------------CCTTCCHHHHTTC--CCCCTHHHHHHHHHH
T ss_pred CccccCCccc-ccCCCcCCccccCHHHhcCC--CCCCcHHHHHHHHHH
Confidence 9987654322 22334689999999998763 124678999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-31 Score=297.83 Aligned_cols=188 Identities=27% Similarity=0.418 Sum_probs=162.4
Q ss_pred HhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
+.++|++.+.||+|+||+||+|.. .+++.||||++............+.+|++++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 457899999999999999999965 4789999999976544445668899999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEC---CCCcEEEEeeccc
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIG---DDMRAKVADFGLV 734 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~---~~~~~kL~DfG~a 734 (782)
|||+++|+|.+.+... ..+++.++..++.|++.||.|||+ .||+||||||+||+++ .++.+||+|||+|
T Consensus 100 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 171 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (486)
T ss_dssp ECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred EEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence 9999999999988763 358999999999999999999999 8999999999999995 4568999999999
Q ss_pred eecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 735 KNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 735 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+...... .....+||+.|+|||++.+. ++.++||||+||+
T Consensus 172 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~----~~~~~DiwslG~i 211 (486)
T 3mwu_A 172 TCFQQNT--KMKDRIGTAYYIAPEVLRGT----YDEKCDVWSAGVI 211 (486)
T ss_dssp TTBCCC------CCTTGGGGCCGGGGGSC----CCHHHHHHHHHHH
T ss_pred eECCCCC--ccCCCcCCCCCCCHHHhCCC----CCchhhHHHHHHH
Confidence 8765433 22345799999999998875 4668999999986
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-30 Score=285.71 Aligned_cols=248 Identities=24% Similarity=0.303 Sum_probs=193.1
Q ss_pred EEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCC
Q 003982 70 TISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNP 148 (782)
Q Consensus 70 ~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 148 (782)
.++..+.+++ .+|..+. ++++.|+|++|+|+++++ .|.++++|++|+|++|+|+.+++..|.++++|++|+|++|+
T Consensus 47 ~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~ 123 (440)
T 3zyj_A 47 KVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123 (440)
T ss_dssp EEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSC
T ss_pred EEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCc
Confidence 4445556666 6776665 689999999999998886 79999999999999999999998899999999999999999
Q ss_pred CCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCcccc
Q 003982 149 NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTL 228 (782)
Q Consensus 149 l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~ 228 (782)
+.. ..+..|..+++|++|+|++|+|+.+.+..|..+++|++|+|++|+..+.++..
T Consensus 124 l~~--~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~---------------------- 179 (440)
T 3zyj_A 124 LTT--IPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEG---------------------- 179 (440)
T ss_dssp CSS--CCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTT----------------------
T ss_pred CCe--eCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcc----------------------
Confidence 887 34457888899999999999998888888888899999999886554455542
Q ss_pred ccccCCCCCcEEEeecccccCCCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCCCCCCccEE
Q 003982 229 DVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKV 308 (782)
Q Consensus 229 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L 308 (782)
.|.++++|++|+|++|+++.. |.+..+++|+.|+|++|+|++..|..|.++++|+.|++++|++++
T Consensus 180 -~~~~l~~L~~L~L~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~------------ 245 (440)
T 3zyj_A 180 -AFEGLSNLRYLNLAMCNLREI-PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQV------------ 245 (440)
T ss_dssp -TTTTCSSCCEEECTTSCCSSC-CCCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCE------------
T ss_pred -hhhcccccCeecCCCCcCccc-cccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeE------------
Confidence 245678888888888888744 457777777777777777777767777777777666666666653
Q ss_pred EccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccccCcccc
Q 003982 309 SLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYA 388 (782)
Q Consensus 309 ~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~ 388 (782)
..+..|.
T Consensus 246 -------------------------------------------------------------------------~~~~~~~ 252 (440)
T 3zyj_A 246 -------------------------------------------------------------------------IERNAFD 252 (440)
T ss_dssp -------------------------------------------------------------------------ECTTSST
T ss_pred -------------------------------------------------------------------------EChhhhc
Confidence 3445667
Q ss_pred ccccCCeEecccccccccCCccCCCCCCCCeEecCCCcCCCCC
Q 003982 389 NLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKV 431 (782)
Q Consensus 389 ~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~ 431 (782)
++++|++|+|++|+|++..+..|..+++|+.|+|++|++....
T Consensus 253 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC 295 (440)
T 3zyj_A 253 NLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNC 295 (440)
T ss_dssp TCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSS
T ss_pred CCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCC
Confidence 7778888888888888777777788888888888888876543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=288.93 Aligned_cols=202 Identities=25% Similarity=0.416 Sum_probs=165.8
Q ss_pred cHHHHHHHhcCCCccceeecccceEEEEEEe------CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceE
Q 003982 572 SIEVLRQVTDNFSEANILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVAL 644 (782)
Q Consensus 572 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~ 644 (782)
.........++|++.+.||+|+||.||+|.+ .+++.||||+++... .....+.+.+|+++++++ +||||+++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 4445555678999999999999999999953 346789999997543 344567899999999999 79999999
Q ss_pred EeEEEeCCe-EEEEEEccCCCCHHHHHHhhccCC----------------------------------------------
Q 003982 645 LGYCINGSE-RLLVYEYMPRGTLAQHLFEWHDHG---------------------------------------------- 677 (782)
Q Consensus 645 ~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~~---------------------------------------------- 677 (782)
++++.+.+. .++||||+++|+|.+++.......
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987654 899999999999999997643210
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCC-
Q 003982 678 ---------------YTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK- 741 (782)
Q Consensus 678 ---------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~- 741 (782)
...+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 1128999999999999999999999 899999999999999999999999999998764432
Q ss_pred ceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 742 YSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 742 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
........||+.|+|||++.+. .++.++||||+|++
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~---~~~~~~Di~slG~i 284 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDR---VYTIQSDVWSFGVL 284 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHC---CCCHHHHHHHHHHH
T ss_pred chhccccCCCceeEChhhhcCC---CCCchhhhhhHHHH
Confidence 2233445689999999988754 45789999999986
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=297.38 Aligned_cols=185 Identities=26% Similarity=0.362 Sum_probs=152.9
Q ss_pred hcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC------C
Q 003982 580 TDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING------S 652 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~------~ 652 (782)
.++|++.+.||+|+||+||+|. ..+++.||||++..........+++.+|+++++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 5789999999999999999995 55789999999987654455678899999999999999999999998654 4
Q ss_pred eEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeec
Q 003982 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (782)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG 732 (782)
..|+||||+++ ++.+.+. ..+++.++..++.|++.||+|||+ .||+||||||+|||++.++.+||+|||
T Consensus 141 ~~~lv~E~~~~-~l~~~~~-------~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG 209 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 209 (464)
T ss_dssp EEEEEEECCSE-EHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred eEEEEEeCCCC-CHHHHHh-------hcCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEE
Confidence 57999999965 5666663 248999999999999999999999 899999999999999999999999999
Q ss_pred cceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 733 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+|+...... .....+||+.|+|||++.+. +++.++||||+||+
T Consensus 210 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~i 252 (464)
T 3ttj_A 210 LARTAGTSF--MMTPYVVTRYYRAPEVILGM---GYKENVDIWSVGCI 252 (464)
T ss_dssp CC-----CC--CC----CCCTTCCHHHHTTC---CCCTTHHHHHHHHH
T ss_pred eeeecCCCc--ccCCCcccccccCHHHHcCC---CCCHHHHHHHHHHH
Confidence 998765432 22345799999999998775 46778999999986
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-30 Score=274.86 Aligned_cols=257 Identities=19% Similarity=0.242 Sum_probs=148.1
Q ss_pred CCCCCccccceEeCCCCCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCcccCC
Q 003982 50 SSTGYCEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSV 128 (782)
Q Consensus 50 ~~~~~c~w~gv~c~~~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~ 128 (782)
+..+.|.|++|.|+.. +++ .+|..+. ++|++|+|++|+++.+++ .|.++++|++|+|++|+++.+
T Consensus 2 P~~C~C~~~~l~c~~~-----------~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~ 67 (306)
T 2z66_A 2 PSRCSCSGTEIRCNSK-----------GLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFK 67 (306)
T ss_dssp CTTCEEETTEEECCSS-----------CCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEE
T ss_pred cCCCeeCCCEEEcCCC-----------Ccc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcc
Confidence 4456689998888752 344 4444332 466666666666665554 356666666666666666543
Q ss_pred C--CCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCc-ccccCCCCCcEEEcccCcCCCCCCc
Q 003982 129 P--TGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIP-DFFDSFSNLQNLRLSYNNFTGSLPA 205 (782)
Q Consensus 129 ~--~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~ 205 (782)
. +..+.++++|++|+|++|++.. +|..+..+++|++|++++|++++..+ ..+..
T Consensus 68 ~~~~~~~~~~~~L~~L~Ls~n~i~~---l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~-------------------- 124 (306)
T 2z66_A 68 GCCSQSDFGTTSLKYLDLSFNGVIT---MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS-------------------- 124 (306)
T ss_dssp EEEEHHHHSCSCCCEEECCSCSEEE---EEEEEETCTTCCEEECTTSEEESSTTTTTTTT--------------------
T ss_pred cCcccccccccccCEEECCCCcccc---ChhhcCCCCCCCEEECCCCcccccccchhhhh--------------------
Confidence 2 1223345555555555555443 33444444444444444444444332 33444
Q ss_pred cccccccchhhcccccCCCccccccccCCCCCcEEEeecccccCCCCC-CCCCCCCCEEEcCCCcCcc-CcchhhcCCCC
Q 003982 206 SFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTG-VVPASVISLPA 283 (782)
Q Consensus 206 ~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~ 283 (782)
+++|++|++++|++++..+. +..+++|++|+|++|++++ .+|..+..+++
T Consensus 125 ----------------------------l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~ 176 (306)
T 2z66_A 125 ----------------------------LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN 176 (306)
T ss_dssp ----------------------------CTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTT
T ss_pred ----------------------------ccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcC
Confidence 44555555555555444332 4455555555555555554 34555555555
Q ss_pred CCEEEccCCcccCCCCCCCCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCccc
Q 003982 284 LLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVT 363 (782)
Q Consensus 284 L~~L~l~~N~l~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 363 (782)
|++|++++|++++..|. .+
T Consensus 177 L~~L~Ls~n~l~~~~~~-------------------------------------------------------------~~ 195 (306)
T 2z66_A 177 LTFLDLSQCQLEQLSPT-------------------------------------------------------------AF 195 (306)
T ss_dssp CCEEECTTSCCCEECTT-------------------------------------------------------------TT
T ss_pred CCEEECCCCCcCCcCHH-------------------------------------------------------------Hh
Confidence 55555555555533221 12
Q ss_pred ccCCceeEEEccCcccccccCccccccccCCeEecccccccccCCccCCCCC-CCCeEecCCCcCCCCCC
Q 003982 364 CSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLA-SLQNLDVSNNNLSGKVP 432 (782)
Q Consensus 364 ~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~-~L~~L~ls~N~l~g~~p 432 (782)
..+++|++|+|++|.+++..+..+.++++|++|+|++|++++..|..+..++ +|+.|+|++|++++..+
T Consensus 196 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~ 265 (306)
T 2z66_A 196 NSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 265 (306)
T ss_dssp TTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGG
T ss_pred cCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccC
Confidence 2233455555555555555555677788888888888888888888888884 88888888888887644
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=276.01 Aligned_cols=189 Identities=26% Similarity=0.498 Sum_probs=158.7
Q ss_pred cCCCccceeecccceEEEEEE-----eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC--Ce
Q 003982 581 DNFSEANILGRGGFGVVYGGE-----LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING--SE 653 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~--~~ 653 (782)
+.|++.+.||+|+||.||+|. ..+++.||||++.... .....+.+.+|++++++++||||+++++++.+. ..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 458889999999999999997 3468899999997654 234567899999999999999999999999876 66
Q ss_pred EEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecc
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~ 733 (782)
.++||||+++++|.+++.... ..+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNK----NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred EEEEEEeCCCCcHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccc
Confidence 899999999999999996532 358999999999999999999999 8999999999999999999999999999
Q ss_pred ceecCCCCc--eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 734 VKNAPDGKY--SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 734 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+........ .......||..|+|||++.+. .++.++|+||+|++
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 218 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQS---KFYIASDVWSFGVT 218 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHC---EEEHHHHHHHHHHH
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCC---CCCcchhHHHHHHH
Confidence 988765432 222345688899999988654 35678999999986
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.1e-31 Score=286.72 Aligned_cols=190 Identities=24% Similarity=0.325 Sum_probs=158.4
Q ss_pred cCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC--CCCcceEEeEEEeCCeEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR--HRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~nI~~~~~~~~~~~~~~lv~ 658 (782)
++|++.+.||+|+||.||+|...+++.||||++..........+.+.+|++++++++ ||||+++++++..++..|+||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 569999999999999999998878999999999876655566788999999999996 599999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
| +.+++|.+++.. ...+++.++..++.|++.||.|||+ .||+||||||+|||++ ++.+||+|||+++...
T Consensus 136 E-~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 136 E-CGNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp E-CCSEEHHHHHHH-----CSSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred e-cCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 9 558899999976 2358999999999999999999998 8999999999999995 5899999999998765
Q ss_pred CCCce-eeecccccccccCccccccch--------hhhHHHHHHHHHhccc
Q 003982 739 DGKYS-VETRLAGTFGYLAPEYAGKHW--------MILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~-~~~~~~gt~~y~aPE~~~~~~--------~~~~~~~~dvws~Gvv 780 (782)
..... .....+||+.|+|||++.+.- ...++.++||||+||+
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvi 256 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 256 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHH
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHH
Confidence 43321 223457999999999886520 1236778999999986
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-31 Score=296.99 Aligned_cols=188 Identities=26% Similarity=0.459 Sum_probs=161.4
Q ss_pred hcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
.++|++.+.||+|+||.||+|...++..||||+++... ...+.|.+|++++++++||||+++++++. .+..++|||
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 46788999999999999999998888999999997644 34678999999999999999999999986 667899999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++|+|.+++..... ..+++.++..++.|++.||+|||+ .||+||||||+|||++.++.+||+|||+++....
T Consensus 263 ~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp CCTTCBHHHHHHSHHH---HTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred ecCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 9999999999975322 247889999999999999999999 8999999999999999999999999999987654
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..........+|+.|+|||++.+. .++.++||||+||+
T Consensus 337 ~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~~ 374 (454)
T 1qcf_A 337 NEYTAREGAKFPIKWTAPEAINFG---SFTIKSDVWSFGIL 374 (454)
T ss_dssp HHHHTTCSSSSCGGGSCHHHHHHC---CCCHHHHHHHHHHH
T ss_pred CceeccCCCcccccccCHHHhccC---CCCcHHHHHhHHHH
Confidence 332222334567899999988654 35789999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.2e-31 Score=289.95 Aligned_cols=192 Identities=24% Similarity=0.347 Sum_probs=151.3
Q ss_pred HHhcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCC------hhhHHHHHHHHHHHHhcCCCCcceEEeEEEe
Q 003982 578 QVTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMG------NKGLSEFQAEIAVLTKVRHRHLVALLGYCIN 650 (782)
Q Consensus 578 ~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~ 650 (782)
...++|.+.+.||+|+||.||+|. ..+++.||||++...... ......+.+|++++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 456899999999999999999995 457899999999765321 112335889999999999999999999975
Q ss_pred CCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCC---CcEE
Q 003982 651 GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD---MRAK 727 (782)
Q Consensus 651 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~---~~~k 727 (782)
.+..++||||+++|+|.+++.. ...+++.++..++.|++.||+|||+ .||+||||||+||+++.+ ..+|
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~k 282 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIK 282 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSS-----SCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEE
T ss_pred cCceEEEEEcCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEE
Confidence 5568999999999999888754 3468999999999999999999999 899999999999999754 4599
Q ss_pred EEeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 728 VADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 728 L~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|+|||+|+...... .....+||+.|+|||++.+.-...++.++||||+||+
T Consensus 283 l~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~i 333 (419)
T 3i6u_A 283 ITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 333 (419)
T ss_dssp ECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHH
T ss_pred EeecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHH
Confidence 99999998765432 2234579999999999864322356789999999986
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=297.54 Aligned_cols=190 Identities=27% Similarity=0.358 Sum_probs=152.5
Q ss_pred hcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
.++|++.+.||+|+||.||+|. ..+++.||||++..... .......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 4679999999999999999995 45789999999976432 233456788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
|||+++|+|.+++... ..+++.++..++.|++.||+|||+ ..||+||||||+|||++.++.+||+|||+|+..
T Consensus 227 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp ECCCSSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EeeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 9999999999998762 358999999999999999999995 269999999999999999999999999999864
Q ss_pred CCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 738 PDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..... .....+||+.|+|||++.+. .++.++||||+||+
T Consensus 300 ~~~~~-~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~i 338 (446)
T 4ejn_A 300 IKDGA-TMKTFCGTPEYLAPEVLEDN---DYGRAVDWWGLGVV 338 (446)
T ss_dssp CC------CCSSSCGGGCCHHHHHTS---CCCTHHHHHHHHHH
T ss_pred cCCCc-ccccccCCccccCHhhcCCC---CCCCccchhhhHHH
Confidence 43222 22346799999999998764 45778999999986
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-31 Score=288.46 Aligned_cols=194 Identities=25% Similarity=0.415 Sum_probs=160.8
Q ss_pred hcCCCccceeecccceEEEEEEeC------CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCe
Q 003982 580 TDNFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE 653 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~ 653 (782)
.++|++.+.||+|+||.||+|... +++.||||+++... ......++.+|+.++++++||||+++++++.+...
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 467899999999999999999742 46789999996532 34456678999999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhhccC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCC---cEEE
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHDH--GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM---RAKV 728 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~---~~kL 728 (782)
.++||||+++|+|.+++...... ....+++.+++.++.|++.||+|||+ .||+||||||+|||++.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEE
Confidence 99999999999999999875432 12458999999999999999999999 8999999999999999554 5999
Q ss_pred EeeccceecCCCC-ceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 729 ADFGLVKNAPDGK-YSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 729 ~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+|||+|+...... ........||+.|+|||++.+. .++.++||||+||+
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~DvwslG~i 275 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG---IFTSKTDTWSFGVL 275 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC---CCCHHHHHHHHHHH
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCC---CCCcHHHHHHHHHH
Confidence 9999997543221 1122334679999999988654 45778999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.3e-31 Score=296.62 Aligned_cols=188 Identities=26% Similarity=0.406 Sum_probs=157.3
Q ss_pred HhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
+.++|++.+.||+|+||+||+|.. .++..||+|++............+.+|+++++.++||||+++++++.+....++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 346799999999999999999965 4788999999987654445567899999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCC---CcEEEEeeccc
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD---MRAKVADFGLV 734 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~---~~~kL~DfG~a 734 (782)
|||+++|+|.+.+... ..+++.++..++.|++.||.|||+ .||+||||||+||+++.. +.+||+|||+|
T Consensus 115 ~e~~~~g~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a 186 (494)
T 3lij_A 115 MECYKGGELFDEIIHR-----MKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLS 186 (494)
T ss_dssp EECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence 9999999999988663 458999999999999999999999 899999999999999764 55999999999
Q ss_pred eecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 735 KNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 735 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+...... .....+||+.|+|||++.+. ++.++||||+||+
T Consensus 187 ~~~~~~~--~~~~~~gt~~y~aPE~l~~~----~~~~~DiwslG~i 226 (494)
T 3lij_A 187 AVFENQK--KMKERLGTAYYIAPEVLRKK----YDEKCDVWSIGVI 226 (494)
T ss_dssp EECBTTB--CBCCCCSCTTTCCHHHHTTC----BCTHHHHHHHHHH
T ss_pred eECCCCc--cccccCCCcCeeCHHHHccc----CCCchhHHHHHHH
Confidence 8775433 22345799999999998765 4568999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-31 Score=274.02 Aligned_cols=187 Identities=28% Similarity=0.463 Sum_probs=162.3
Q ss_pred cCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEc
Q 003982 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 660 (782)
++|++.+.||+|+||.||+|...+++.||+|++..... ..+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 57889999999999999999888889999999986542 346799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~ 740 (782)
+++++|.+++... ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++......
T Consensus 85 ~~~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 85 MEHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CTTCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCCCcHHHHHhhC----cccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 9999999999763 2358999999999999999999999 89999999999999999999999999999876543
Q ss_pred CceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 741 KYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.........+++.|+|||++.+. .++.++|+||+|++
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 194 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFS---RYSSKSDVWSFGVL 194 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHC---CCCHHHHHHHHHHH
T ss_pred cccccccccccccccChhhhcCC---CccchhchhhhHHH
Confidence 32222334578899999988654 35678999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-31 Score=275.28 Aligned_cols=189 Identities=23% Similarity=0.381 Sum_probs=147.6
Q ss_pred hcCCCccceeecccceEEEEEEeC----CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGELP----DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL 655 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~ 655 (782)
.++|++.+.||+|+||.||+|... .+..||+|+++... .....+.+.+|+.++++++||||+++++++. ++..+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 467899999999999999999653 24579999987543 3445678999999999999999999999974 56789
Q ss_pred EEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccce
Q 003982 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (782)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~ 735 (782)
+||||+++++|.+++... ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++
T Consensus 92 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVR----KYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp EEEECCTTEEHHHHHHHT----TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEecCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECcccccc
Confidence 999999999999999752 2358999999999999999999999 899999999999999999999999999998
Q ss_pred ecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 736 NAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 736 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..............+|+.|+|||++.+. .++.++||||+|++
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~ 206 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINFR---RFTSASDVWMFGVC 206 (281)
T ss_dssp --------------CCGGGCCHHHHHHC---CCSHHHHHHHHHHH
T ss_pred ccCcccccccccCCCcccccChhhcccC---CCCCccCchHHHHH
Confidence 7765443333334578899999988653 45778999999985
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-29 Score=284.05 Aligned_cols=248 Identities=23% Similarity=0.287 Sum_probs=197.7
Q ss_pred EEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCC
Q 003982 71 ISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPN 149 (782)
Q Consensus 71 L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 149 (782)
++.++.+++ .+|..+. ++|++|+|++|+|+++++ .|.++++|++|+|++|+|+.+++..|.++++|++|+|++|++
T Consensus 59 v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l 135 (452)
T 3zyi_A 59 VVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135 (452)
T ss_dssp EECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred EEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcC
Confidence 334444565 5666554 689999999999999877 799999999999999999999999999999999999999998
Q ss_pred CCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccc
Q 003982 150 LAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLD 229 (782)
Q Consensus 150 ~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~ 229 (782)
.. ..+..|..+++|++|+|++|+++.+.+..|..+++|++|++++|+..+.++..
T Consensus 136 ~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~----------------------- 190 (452)
T 3zyi_A 136 TV--IPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEG----------------------- 190 (452)
T ss_dssp SB--CCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTT-----------------------
T ss_pred Cc--cChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChh-----------------------
Confidence 87 44556888999999999999998888888999999999999986544455543
Q ss_pred cccCCCCCcEEEeecccccCCCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCCCCCCccEEE
Q 003982 230 VLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVS 309 (782)
Q Consensus 230 ~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 309 (782)
.|.++++|++|+|++|++++. +.+..+++|+.|+|++|+|++..|..|.++++|+.|++++|++++
T Consensus 191 ~~~~l~~L~~L~L~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~------------- 256 (452)
T 3zyi_A 191 AFEGLFNLKYLNLGMCNIKDM-PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSL------------- 256 (452)
T ss_dssp TTTTCTTCCEEECTTSCCSSC-CCCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCE-------------
T ss_pred hccCCCCCCEEECCCCccccc-ccccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCce-------------
Confidence 245688888888888888865 567788888888888888887778888877777777777777663
Q ss_pred ccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccccCccccc
Q 003982 310 LDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYAN 389 (782)
Q Consensus 310 l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~ 389 (782)
..|..|.+
T Consensus 257 ------------------------------------------------------------------------~~~~~~~~ 264 (452)
T 3zyi_A 257 ------------------------------------------------------------------------IERNAFDG 264 (452)
T ss_dssp ------------------------------------------------------------------------ECTTTTTT
T ss_pred ------------------------------------------------------------------------ECHHHhcC
Confidence 33455677
Q ss_pred cccCCeEecccccccccCCccCCCCCCCCeEecCCCcCCCCCC
Q 003982 390 LTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVP 432 (782)
Q Consensus 390 l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p 432 (782)
+++|++|+|++|+|++..+..|..+++|+.|+|++|++.....
T Consensus 265 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 307 (452)
T 3zyi_A 265 LASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCD 307 (452)
T ss_dssp CTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTT
T ss_pred CCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCC
Confidence 7788888888888887777777888888888888888776543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.2e-31 Score=272.04 Aligned_cols=188 Identities=22% Similarity=0.320 Sum_probs=162.1
Q ss_pred hcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC--CeEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING--SERLLV 657 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~--~~~~lv 657 (782)
.++|++.+.||+|+||.||+|.. +++.||||++..........+.+.+|++++++++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 35789999999999999999987 489999999987665566678899999999999999999999999887 778999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEEcCCCCCCEEECCCCcEEEEeeccce
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS--FIHRDLKPSNILIGDDMRAKVADFGLVK 735 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~--ivHrDikp~NIll~~~~~~kL~DfG~a~ 735 (782)
|||+++|+|.+++... ....+++.++..++.|++.||+|||+ .| |+||||||+||+++.++.++|+|||++.
T Consensus 88 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEG---TNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp EECCTTCBHHHHHHSC---SSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred ecccCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEecccee
Confidence 9999999999999752 22358999999999999999999998 78 9999999999999999999999999876
Q ss_pred ecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 736 NAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 736 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..... ...||+.|+|||++.+.-......++||||+|++
T Consensus 162 ~~~~~------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~i 200 (271)
T 3kmu_A 162 SFQSP------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVL 200 (271)
T ss_dssp TTSCT------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHH
T ss_pred eeccc------CccCCccccChhhhccCCCCCCCchhhHHHHHHH
Confidence 54332 2368999999999876533334568999999986
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8e-31 Score=278.50 Aligned_cols=194 Identities=27% Similarity=0.451 Sum_probs=163.7
Q ss_pred hcCCCccceeecccceEEEEEEe------CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCe
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE 653 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~ 653 (782)
.++|.+.+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|++++++++||||+++++++.+.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 46789999999999999999964 345789999997543 34566789999999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhhccC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCC
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHDH-------------------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLK 714 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik 714 (782)
.++||||+++++|.+++...... ....+++.++..++.|++.||+|||+ .||+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccc
Confidence 99999999999999999874321 12348999999999999999999999 899999999
Q ss_pred CCCEEECCCCcEEEEeeccceecCCCCce-eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 715 PSNILIGDDMRAKVADFGLVKNAPDGKYS-VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 715 p~NIll~~~~~~kL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|+||+++.++.+||+|||+++........ ......+|+.|+|||++.+. .++.++||||+|++
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 241 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH---IYTTQSDVWSFGVL 241 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC---EECHHHHHHHHHHH
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCC---CcCchhhHHHHHHH
Confidence 99999999999999999999877554322 22334578899999988764 45788999999986
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-31 Score=285.83 Aligned_cols=201 Identities=25% Similarity=0.329 Sum_probs=159.6
Q ss_pred HHHHhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccC---ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC
Q 003982 576 LRQVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM---GNKGLSEFQAEIAVLTKVRHRHLVALLGYCING 651 (782)
Q Consensus 576 l~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~ 651 (782)
+..+.++|++.+.||+|+||.||+|.. .+++.||+|++..... .....+.+.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 345678899999999999999999954 5788999999975431 234567899999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHHhhccCC-----------------------------------CCCCCHHHHHHHHHHHHHH
Q 003982 652 SERLLVYEYMPRGTLAQHLFEWHDHG-----------------------------------YTPLTWKQRVTIALDVARG 696 (782)
Q Consensus 652 ~~~~lv~e~~~~gsL~~~l~~~~~~~-----------------------------------~~~l~~~~~~~i~~qi~~a 696 (782)
+..++||||+++|+|.+++....... ...+++..+..++.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999985322110 1124677888999999999
Q ss_pred HHHHhhcCCCCeEEcCCCCCCEEECCCC--cEEEEeeccceecCCC---CceeeecccccccccCccccccchhhhHHHH
Q 003982 697 VEYLHSLAQQSFIHRDLKPSNILIGDDM--RAKVADFGLVKNAPDG---KYSVETRLAGTFGYLAPEYAGKHWMILCQMT 771 (782)
Q Consensus 697 L~~LH~~~~~~ivHrDikp~NIll~~~~--~~kL~DfG~a~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 771 (782)
|+|||+ .||+||||||+||+++.++ .+||+|||+++..... .........||+.|+|||++.+. ...++.+
T Consensus 181 l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~ 256 (345)
T 3hko_A 181 LHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT-NESYGPK 256 (345)
T ss_dssp HHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCS-SSCCCTH
T ss_pred HHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccC-CCCCCcH
Confidence 999999 8999999999999998776 8999999999865432 11122345799999999988642 0134668
Q ss_pred HHHHHhccc
Q 003982 772 GLIWLHGSV 780 (782)
Q Consensus 772 ~dvws~Gvv 780 (782)
+||||+|++
T Consensus 257 ~DiwslG~i 265 (345)
T 3hko_A 257 CDAWSAGVL 265 (345)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.9e-31 Score=277.49 Aligned_cols=191 Identities=24% Similarity=0.316 Sum_probs=153.6
Q ss_pred HhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCC-hhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 656 (782)
..++|++.+.||+|+||.||+|.. .+++.||+|++...... ....+.+.+|++++++++||||+++++++.+++..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 357899999999999999999965 47889999999765432 2345789999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecccee
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~ 736 (782)
||||+++++|.+++... ..+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++..
T Consensus 112 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~ 183 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ-----GPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASA 183 (309)
T ss_dssp EEECCCCEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC---
T ss_pred EEEecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCcc
Confidence 99999999999999763 358999999999999999999999 8999999999999999999999999999987
Q ss_pred cCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 737 APDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.............||+.|+|||++.+. .++.++|+||+|++
T Consensus 184 ~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 224 (309)
T 2h34_A 184 TTDEKLTQLGNTVGTLYYMAPERFSES---HATYRADIYALTCV 224 (309)
T ss_dssp -------------CCGGGCCGGGTCC-------CCCHHHHHHHH
T ss_pred ccccccccccccCCCcCccCHHHHcCC---CCCchHhHHHHHHH
Confidence 655433333445789999999998764 45667899999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9e-31 Score=281.76 Aligned_cols=188 Identities=27% Similarity=0.381 Sum_probs=158.7
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCC-hhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
.+.|+..+.||+|+||.||+|.. .+++.||||++...... ....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 34589999999999999999964 67899999999765432 33457789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
|||++ |++.+++... ..++++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++..
T Consensus 133 ~e~~~-g~l~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 204 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 204 (348)
T ss_dssp EECCS-EEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred EecCC-CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceec
Confidence 99996 6888887653 2458999999999999999999999 89999999999999999999999999999766
Q ss_pred CCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 738 PDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... ....||+.|+|||++.+.-.-.++.++||||+||+
T Consensus 205 ~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~i 242 (348)
T 1u5q_A 205 APA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 242 (348)
T ss_dssp SSB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHH
T ss_pred CCC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHH
Confidence 432 23578999999998742111234668999999986
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-31 Score=276.28 Aligned_cols=190 Identities=29% Similarity=0.489 Sum_probs=165.0
Q ss_pred HhcCCCccceeecccceEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
..++|++.+.||+|+||.||+|... ++..||+|++.... ...+.+.+|++++++++||||+++++++.+++..++|
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 3467899999999999999999654 58899999997543 4567899999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
|||+++++|.+++.... ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++...
T Consensus 88 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp EECCTTEEHHHHHHHCC---TTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred EEcCCCCcHHHHHHhcc---cCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 99999999999997632 3458999999999999999999999 89999999999999999999999999999877
Q ss_pred CCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 738 PDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
............+|+.|+|||++.+. .++.++||||+|++
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 201 (288)
T 3kfa_A 162 TGDTYTAHAGAKFPIKWTAPESLAYN---KFSIKSDVWAFGVL 201 (288)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHC---CCCHHHHHHHHHHH
T ss_pred cCCccccccCCccccCcCChhhhccC---CCCchhhHHHHHHH
Confidence 65554444445678899999988654 45778999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=272.29 Aligned_cols=188 Identities=28% Similarity=0.486 Sum_probs=161.4
Q ss_pred hcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
.++|++.+.||+|+||.||+|...+++.||||++.... ...+.+.+|++++++++||||+++++++. .+..++|||
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 87 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITE 87 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc---ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEe
Confidence 46789999999999999999988888899999997644 34578999999999999999999999876 456899999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++++|.+++..... ..+++.++..++.|++.||+|||+ .||+||||||+||++++++.+||+|||++.....
T Consensus 88 ~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 88 YMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp CCTTCBHHHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCHHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 9999999999865321 258999999999999999999999 8999999999999999999999999999988765
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..........+++.|+|||++.+. .++.++||||+|++
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 199 (279)
T 1qpc_A 162 NEYTAREGAKFPIKWTAPEAINYG---TFTIKSDVWSFGIL 199 (279)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHC---EECHHHHHHHHHHH
T ss_pred cccccccCCCCccCccChhhhccC---CCCchhhhHHHHHH
Confidence 544333444578899999988654 35778999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-30 Score=271.86 Aligned_cols=189 Identities=24% Similarity=0.388 Sum_probs=162.9
Q ss_pred hcCCCccceeecccceEEEEEEeC-CCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
.++|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467899999999999999999654 678999999976543 234567789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
|||+++++|.+++... ..+++.++..++.|+++||+|||+ .||+||||||+||+++.++.+||+|||++...
T Consensus 94 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 94 LELCRRRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp EECCTTCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 9999999999988652 358999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 738 PDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..... ......||+.|+|||++.+. ....++|+||+|++
T Consensus 166 ~~~~~-~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~ 204 (294)
T 2rku_A 166 EYDGE-RKKVLCGTPNYIAPEVLSKK---GHSFEVDVWSIGCI 204 (294)
T ss_dssp CSTTC-CBCCCCSCCSSCCHHHHTTS---CBCTHHHHHHHHHH
T ss_pred ccCcc-ccccccCCCCcCCcchhccC---CCCchhhHHHHHHH
Confidence 54322 22335689999999998764 34678999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.9e-31 Score=280.04 Aligned_cols=190 Identities=24% Similarity=0.397 Sum_probs=157.9
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
.++|++.+.||+|+||.||+|.. .+++.||||++..........+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 46799999999999999999965 45899999999766554556677899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||++++++.++... ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++...
T Consensus 104 e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 175 (331)
T 4aaa_A 104 EFVDHTILDDLELF-----PNGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175 (331)
T ss_dssp ECCSEEHHHHHHHS-----TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecCCcchHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence 99999888877643 2458999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.... ......||+.|+|||++.+. ..++.++||||+|++
T Consensus 176 ~~~~-~~~~~~~t~~y~aPE~~~~~--~~~~~~~Di~slG~i 214 (331)
T 4aaa_A 176 APGE-VYDDEVATRWYRAPELLVGD--VKYGKAVDVWAIGCL 214 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTC--TTCCTHHHHHHHHHH
T ss_pred CCcc-ccCCCcCCccccCcccccCC--CCcchHHHHHHHHHH
Confidence 4322 22335689999999988764 234678999999986
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-30 Score=277.98 Aligned_cols=189 Identities=24% Similarity=0.386 Sum_probs=163.2
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
.++|.+.+.||+|+||.||+|.. .+++.||+|++..... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 46799999999999999999965 4578999999976543 234567789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
|||+++++|.+++... ..+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++...
T Consensus 120 ~e~~~~~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 191 (335)
T 2owb_A 120 LELCRRRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 191 (335)
T ss_dssp ECCCTTCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCCCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceec
Confidence 9999999999988652 358999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 738 PDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..... ......||+.|+|||++.+. .+..++||||+|++
T Consensus 192 ~~~~~-~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~i 230 (335)
T 2owb_A 192 EYDGE-RKKVLCGTPNYIAPEVLSKK---GHSFEVDVWSIGCI 230 (335)
T ss_dssp CSTTC-CBCCCCSCCSSCCHHHHHTS---CBCTHHHHHHHHHH
T ss_pred ccCcc-cccccCCCccccCHHHhccC---CCCchhhHHHHHHH
Confidence 54322 22345789999999988764 34678999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-30 Score=277.09 Aligned_cols=194 Identities=25% Similarity=0.416 Sum_probs=156.4
Q ss_pred cHHHHHHHhcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhc--CCCCcceEEeEEE
Q 003982 572 SIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV--RHRHLVALLGYCI 649 (782)
Q Consensus 572 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l--~h~nI~~~~~~~~ 649 (782)
+........++|++.+.||+|+||.||+|+. .++.||||++.... ...+.+|.+++... +||||+++++++.
T Consensus 28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~ 101 (337)
T 3mdy_A 28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADI 101 (337)
T ss_dssp CHHHHTTHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred CcccccccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEc
Confidence 3444556678999999999999999999987 48999999986432 34455566666554 8999999999998
Q ss_pred eC----CeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC--------CeEEcCCCCCC
Q 003982 650 NG----SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ--------SFIHRDLKPSN 717 (782)
Q Consensus 650 ~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~--------~ivHrDikp~N 717 (782)
+. ...++||||+++|+|.+++.. ..+++.++..++.|++.||+|||+ . ||+||||||+|
T Consensus 102 ~~~~~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~~~~ivH~Dikp~N 172 (337)
T 3mdy_A 102 KGTGSWTQLYLITDYHENGSLYDYLKS------TTLDAKSMLKLAYSSVSGLCHLHT---EIFSTQGKPAIAHRDLKSKN 172 (337)
T ss_dssp ESCGGGCEEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHS---CBCSTTCBCCEECSCCCGGG
T ss_pred cCCCCCCceEEEEeccCCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHH---hhhhhccCCCEEecccchHH
Confidence 87 788999999999999999965 358999999999999999999998 6 99999999999
Q ss_pred EEECCCCcEEEEeeccceecCCCCcee---eecccccccccCccccccch---hhhHHHHHHHHHhccc
Q 003982 718 ILIGDDMRAKVADFGLVKNAPDGKYSV---ETRLAGTFGYLAPEYAGKHW---MILCQMTGLIWLHGSV 780 (782)
Q Consensus 718 Ill~~~~~~kL~DfG~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~---~~~~~~~~dvws~Gvv 780 (782)
|+++.++.+||+|||+|+......... .....||+.|+|||++.+.. ......++||||+||+
T Consensus 173 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~i 241 (337)
T 3mdy_A 173 ILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLI 241 (337)
T ss_dssp EEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHH
T ss_pred EEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHH
Confidence 999999999999999998765433221 12357999999999876541 1223456899999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-30 Score=293.55 Aligned_cols=188 Identities=24% Similarity=0.391 Sum_probs=159.0
Q ss_pred HhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCCh-----------hhHHHHHHHHHHHHhcCCCCcceEEe
Q 003982 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGN-----------KGLSEFQAEIAVLTKVRHRHLVALLG 646 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~nI~~~~~ 646 (782)
+.++|++.+.||+|+||+||+|.. .+++.||||++....... ...+.+.+|++++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 467899999999999999999965 468899999997654321 34577899999999999999999999
Q ss_pred EEEeCCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCC--
Q 003982 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM-- 724 (782)
Q Consensus 647 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~-- 724 (782)
++.+....++||||+++|+|.+++... ..+++.++..++.|++.||+|||+ .||+||||||+||+++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~ 185 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR-----HKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSL 185 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCC
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCC
Confidence 999999999999999999999998763 358999999999999999999999 8999999999999998775
Q ss_pred -cEEEEeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 725 -RAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 725 -~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.+||+|||+|........ ....+||+.|+|||++.+. ++.++||||+||+
T Consensus 186 ~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~----~~~~~DiwslG~i 236 (504)
T 3q5i_A 186 LNIKIVDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLKKK----YNEKCDVWSCGVI 236 (504)
T ss_dssp SSEEECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHTTC----BCTHHHHHHHHHH
T ss_pred ccEEEEECCCCEEcCCCCc--cccccCCcCCCCHHHhccC----CCchHHHHHHHHH
Confidence 699999999987765332 2345799999999998765 4568899999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=6.2e-31 Score=285.32 Aligned_cols=185 Identities=25% Similarity=0.402 Sum_probs=153.4
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCC------
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS------ 652 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~------ 652 (782)
.++|++.+.||+|+||.||+|.. .+|+.||||++..........+++.+|+++++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46899999999999999999955 57999999999765544556778999999999999999999999987653
Q ss_pred eEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeec
Q 003982 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (782)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG 732 (782)
..|+||||+ +++|.+++.. ..+++.++..++.|+++||+|||+ .||+||||||+||+++.++.+||+|||
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg 173 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFG 173 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeee
Confidence 459999999 8899998865 358999999999999999999999 899999999999999999999999999
Q ss_pred cceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 733 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+++...... ...+||+.|+|||++.+. ..++.++||||+|++
T Consensus 174 ~a~~~~~~~----~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~i 215 (367)
T 1cm8_A 174 LARQADSEM----TGYVVTRWYRAPEVILNW--MRYTQTVDIWSVGCI 215 (367)
T ss_dssp TCEECCSSC----CSSCSCGGGCCTHHHHTT--TCCCTTHHHHHHHHH
T ss_pred ccccccccc----CcCcCCCCcCCHHHHhCC--CCCChhhhHHHHHHH
Confidence 998765422 345789999999987652 235678999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=281.77 Aligned_cols=191 Identities=25% Similarity=0.356 Sum_probs=159.9
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC-------
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING------- 651 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~------- 651 (782)
.++|++.+.||+|+||.||+|.. .+++.||||++............+.+|++++++++||||+++++++.+.
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 36799999999999999999965 6789999999976654445567788999999999999999999999873
Q ss_pred -CeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEe
Q 003982 652 -SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVAD 730 (782)
Q Consensus 652 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~D 730 (782)
+..++||||+++ ++.+.+... ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~D 167 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLAD 167 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECC
T ss_pred CceEEEEEeccCC-CHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEcc
Confidence 468999999964 787777542 2458999999999999999999999 8999999999999999999999999
Q ss_pred eccceecCCCCc---eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 731 FGLVKNAPDGKY---SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 731 fG~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
||+|+....... .......||+.|+|||++.+. ..++.++||||+||+
T Consensus 168 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~i 218 (351)
T 3mi9_A 168 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE--RDYGPPIDLWGAGCI 218 (351)
T ss_dssp CTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTC--CSCCTHHHHHHHHHH
T ss_pred chhcccccccccccccccCCcccccCccCchhhcCC--CCCCcHhHHHHHHHH
Confidence 999987653221 122345789999999988653 234678999999986
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=276.33 Aligned_cols=191 Identities=26% Similarity=0.377 Sum_probs=154.8
Q ss_pred HHhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCC---hhhHHHHHHHHHHHHhcC---CCCcceEEeEEEe
Q 003982 578 QVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG---NKGLSEFQAEIAVLTKVR---HRHLVALLGYCIN 650 (782)
Q Consensus 578 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~---h~nI~~~~~~~~~ 650 (782)
...++|++.+.||+|+||+||+|.. .+++.||||++...... ......+.+|++++++++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3467999999999999999999964 57899999999754321 122356677887777665 9999999999987
Q ss_pred CC-----eEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCc
Q 003982 651 GS-----ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR 725 (782)
Q Consensus 651 ~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~ 725 (782)
.. ..++||||++ ++|.+++.... ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++.
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~ 158 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAP---PPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGT 158 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCC---TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCC
Confidence 65 5799999996 69999987532 2348999999999999999999999 89999999999999999999
Q ss_pred EEEEeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 726 AKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 726 ~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+||+|||+++...... ......||+.|+|||++.+. .++.++||||+||+
T Consensus 159 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~i 208 (308)
T 3g33_A 159 VKLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQS---TYATPVDMWSVGCI 208 (308)
T ss_dssp EEECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTS---CCCSTHHHHHHHHH
T ss_pred EEEeeCccccccCCCc--ccCCccccccccCchHHcCC---CCCchHHHHHHHHH
Confidence 9999999998665432 22445789999999988654 34668999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-31 Score=293.57 Aligned_cols=188 Identities=30% Similarity=0.495 Sum_probs=154.9
Q ss_pred hcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
.++|++.+.||+|+||.||+|...++..||||+++... ...+.|.+|++++++++||||+++++++.+ +..++|||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 45788999999999999999988888889999997654 235689999999999999999999999876 67899999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++|+|.+++..... ..+++.++..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+++....
T Consensus 259 ~~~~gsL~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 259 YMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp CCTTCBHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred hhcCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 9999999999975322 348999999999999999999999 8999999999999999999999999999987755
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..........+++.|+|||++.+. .++.++||||+||+
T Consensus 333 ~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~sDvwslG~~ 370 (452)
T 1fmk_A 333 NEYTARQGAKFPIKWTAPEAALYG---RFTIKSDVWSFGIL 370 (452)
T ss_dssp ----------CCGGGSCHHHHHHC---CCCHHHHHHHHHHH
T ss_pred CceecccCCcccccccCHhHHhcC---CCCccccHHhHHHH
Confidence 443333344578899999987654 35778999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-30 Score=275.67 Aligned_cols=195 Identities=26% Similarity=0.392 Sum_probs=165.0
Q ss_pred ccHHHHHHHhcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHh--cCCCCcceEEeEE
Q 003982 571 ISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTK--VRHRHLVALLGYC 648 (782)
Q Consensus 571 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~nI~~~~~~~ 648 (782)
.+......+.++|++.+.||+|+||.||+|.. +++.||||++... ..+.+.+|++++.. ++||||+++++++
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~ 105 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAAD 105 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEE
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeee
Confidence 44555667788999999999999999999987 6899999998643 34677889999887 7899999999999
Q ss_pred EeCC----eEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCCeEEcCCCCC
Q 003982 649 INGS----ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLH--------SLAQQSFIHRDLKPS 716 (782)
Q Consensus 649 ~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--------~~~~~~ivHrDikp~ 716 (782)
.... ..++||||+++|+|.+++.+ ..+++.+++.++.|++.||+||| + .||+||||||+
T Consensus 106 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~ 176 (342)
T 1b6c_B 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSK 176 (342)
T ss_dssp ECCCSSCCCEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGG
T ss_pred cccCCccceeEEEEeecCCCcHHHHHhc------cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHH
Confidence 8876 78999999999999999965 25899999999999999999999 6 89999999999
Q ss_pred CEEECCCCcEEEEeeccceecCCCCce---eeecccccccccCccccccchh---hhHHHHHHHHHhccc
Q 003982 717 NILIGDDMRAKVADFGLVKNAPDGKYS---VETRLAGTFGYLAPEYAGKHWM---ILCQMTGLIWLHGSV 780 (782)
Q Consensus 717 NIll~~~~~~kL~DfG~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~---~~~~~~~dvws~Gvv 780 (782)
||+++.++.+||+|||++......... ......||+.|+|||++.+... ..+..++||||+|++
T Consensus 177 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~i 246 (342)
T 1b6c_B 177 NILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV 246 (342)
T ss_dssp GEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHH
T ss_pred HEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHH
Confidence 999999999999999999876554322 1234579999999999876522 134578999999986
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-30 Score=284.79 Aligned_cols=183 Identities=25% Similarity=0.363 Sum_probs=146.6
Q ss_pred hcCCCcc-ceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHh-cCCCCcceEEeEEEe----CC
Q 003982 580 TDNFSEA-NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTK-VRHRHLVALLGYCIN----GS 652 (782)
Q Consensus 580 ~~~y~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~-l~h~nI~~~~~~~~~----~~ 652 (782)
.++|.+. +.||+|+||.||+|.. .+++.||||+++.. ..+.+|++++.+ .+||||+++++++.. ..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~ 132 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 132 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence 3567776 7899999999999954 57899999998642 457788888754 579999999999876 56
Q ss_pred eEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECC---CCcEEEE
Q 003982 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD---DMRAKVA 729 (782)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~---~~~~kL~ 729 (782)
..|+||||+++|+|.+++... +...+++.++..++.|++.||+|||+ .||+||||||+|||++. ++.+||+
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~ 206 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLT 206 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEEC
T ss_pred EEEEEEEeCCCCcHHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEE
Confidence 789999999999999999752 22458999999999999999999999 89999999999999997 7899999
Q ss_pred eeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 730 DFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 730 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|||+++...... .....+||+.|+|||++.+. .++.++||||+||+
T Consensus 207 DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~i 252 (400)
T 1nxk_A 207 DFGFAKETTSHN--SLTTPCYTPYYVAPEVLGPE---KYDKSCDMWSLGVI 252 (400)
T ss_dssp CCTTCEECC-------------CTTCCGGGSCCC---CSSSHHHHHHHHHH
T ss_pred ecccccccCCCC--ccccCCCCCCccCHhhcCCC---CCCCcccHHHHHHH
Confidence 999998765432 22345789999999998764 45678999999986
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=271.73 Aligned_cols=191 Identities=27% Similarity=0.472 Sum_probs=144.9
Q ss_pred HhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCC-hhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 656 (782)
..++|++.+.||+|+||.||+|.. .+++.||||++...... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 346799999999999999999965 57899999999754321 2245789999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecccee
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~ 736 (782)
||||+++++|.+++... ..++++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++..
T Consensus 89 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 161 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNR----VKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQ 161 (278)
T ss_dssp EEECCTTEEHHHHHHTC----SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEecCCCCcHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceee
Confidence 99999999999998652 2468999999999999999999999 8999999999999999999999999999987
Q ss_pred cCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 737 APDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
...... ......||+.|+|||++.+. ....++|+||+|++
T Consensus 162 ~~~~~~-~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 201 (278)
T 3cok_A 162 LKMPHE-KHYTLCGTPNYISPEIATRS---AHGLESDVWSLGCM 201 (278)
T ss_dssp CC--------------------------------CTHHHHHHHH
T ss_pred ccCCCC-cceeccCCCCcCCcchhcCC---CCCchhhHHHHHHH
Confidence 654321 12235689999999988764 45678999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=285.20 Aligned_cols=193 Identities=25% Similarity=0.371 Sum_probs=162.0
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCC--eEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS--ERLL 656 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~--~~~l 656 (782)
.++|.+.+.||+|+||.||+|.. .+++.||||++..... ....+.+.+|++++++++||||+++++++.+.. ..++
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 46799999999999999999965 4589999999975432 234677889999999999999999999998765 7799
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE----CCCCcEEEEeec
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI----GDDMRAKVADFG 732 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll----~~~~~~kL~DfG 732 (782)
||||+++|+|.+++..... ...+++.+++.++.|++.||+|||+ .||+||||||+||++ +.++.+||+|||
T Consensus 87 v~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp EECCCTTEEHHHHTTSGGG--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred EEecCCCCCHHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 9999999999999976433 2348999999999999999999999 899999999999999 777889999999
Q ss_pred cceecCCCCceeeecccccccccCccccccc-----hhhhHHHHHHHHHhccc
Q 003982 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAGKH-----WMILCQMTGLIWLHGSV 780 (782)
Q Consensus 733 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~~dvws~Gvv 780 (782)
+|+....... .....||+.|+|||++.+. ....++.++||||+||+
T Consensus 162 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~i 212 (396)
T 4eut_A 162 AARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT 212 (396)
T ss_dssp GCEECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHH
T ss_pred CceEccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHH
Confidence 9987755332 2235699999999987541 11356889999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-30 Score=270.17 Aligned_cols=188 Identities=27% Similarity=0.451 Sum_probs=159.5
Q ss_pred hcCCCccceeecccceEEEEEEeC-CCcEEEEEEeccccCCh----hhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeE
Q 003982 580 TDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGN----KGLSEFQAEIAVLTKVRHRHLVALLGYCINGSER 654 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~ 654 (782)
.++|++.+.||+|+||.||+|... +++.||+|+++...... ...+.+.+|++++++++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 467999999999999999999654 68999999997654322 2467899999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCC----cEEEEe
Q 003982 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM----RAKVAD 730 (782)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~----~~kL~D 730 (782)
++||||+++++|.+++... ..+++.++..++.|++.||+|||+ .||+||||||+||+++.++ .+||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~d 155 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK-----ESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLID 155 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEeecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEe
Confidence 9999999999999999752 358999999999999999999999 8999999999999998877 899999
Q ss_pred eccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 731 FGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 731 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
||.+........ .....||+.|+|||++.+. .++.++|+||+|++
T Consensus 156 fg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 200 (283)
T 3bhy_A 156 FGIAHKIEAGNE--FKNIFGTPEFVAPEIVNYE---PLGLEADMWSIGVI 200 (283)
T ss_dssp CTTCEECC----------CCCGGGCCHHHHTTC---CCCTHHHHHHHHHH
T ss_pred cccceeccCCCc--ccccCCCcCccCcceecCC---CCCcchhhhhHHHH
Confidence 999987654321 2334689999999988754 34678999999986
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=9.5e-31 Score=273.00 Aligned_cols=187 Identities=29% Similarity=0.518 Sum_probs=157.5
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCC-hhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
.++|++.+.||+|+||.||+|.. .+++.||||++...... ......+.+|++++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 46799999999999999999954 56779999999654321 22356789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
|||+++++|.+++... ..+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++...
T Consensus 88 ~e~~~~~~l~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp ECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 9999999999998763 358999999999999999999998 89999999999999999999999999998655
Q ss_pred CCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 738 PDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.... .....||+.|+|||++.+. .++.++||||+|++
T Consensus 160 ~~~~---~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 196 (279)
T 3fdn_A 160 PSSR---RTDLCGTLDYLPPEMIEGR---MHDEKVDLWSLGVL 196 (279)
T ss_dssp -----------CCCCTTCCHHHHTTC---CCCTTHHHHHHHHH
T ss_pred Cccc---ccccCCCCCccCHhHhccC---CCCccchhHhHHHH
Confidence 4322 2335789999999988765 34668899999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=304.65 Aligned_cols=190 Identities=25% Similarity=0.336 Sum_probs=163.1
Q ss_pred HhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCCeEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERL 655 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~ 655 (782)
..++|++.+.||+|+||.||+|+. .+++.||||++++... .....+.+..|.+++..+ +||+|+++++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 457899999999999999999955 5688999999976432 223456788899999987 6999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccce
Q 003982 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (782)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~ 735 (782)
+||||+++|+|.+++... ..+++.++..++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+|+
T Consensus 419 lV~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp EEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred EEEeCcCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceee
Confidence 999999999999999763 358999999999999999999999 899999999999999999999999999998
Q ss_pred ecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 736 NAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 736 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
....... .....+||+.|+|||++.+. +++.++|+||+||+
T Consensus 491 ~~~~~~~-~~~~~~GT~~Y~APE~l~~~---~~~~~~DvwSlGvi 531 (674)
T 3pfq_A 491 ENIWDGV-TTKTFCGTPDYIAPEIIAYQ---PYGKSVDWWAFGVL 531 (674)
T ss_dssp ECCCTTC-CBCCCCSCSSSCCHHHHTCC---CBSTHHHHHHHHHH
T ss_pred ccccCCc-ccccccCCCcccCHhhhcCC---CCCccceEechHHH
Confidence 6543322 23446899999999998765 45788999999986
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-30 Score=276.89 Aligned_cols=194 Identities=29% Similarity=0.504 Sum_probs=161.9
Q ss_pred hcCCCccceeecccceEEEEEEe--------CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEe
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL--------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCIN 650 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~ 650 (782)
.++|++.+.||+|+||.||+|.. .++..||||+++... .....+.+.+|+++++++ +||||+++++++.+
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 46899999999999999999965 356789999997543 345667899999999999 89999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHHhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEE
Q 003982 651 GSERLLVYEYMPRGTLAQHLFEWHDH-----------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNIL 719 (782)
Q Consensus 651 ~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIl 719 (782)
.+..++||||+++|+|.+++...... ....+++.++..++.|++.||+|||+ .||+||||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEE
Confidence 99999999999999999999764321 11348999999999999999999999 89999999999999
Q ss_pred ECCCCcEEEEeeccceecCCCCce-eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 720 IGDDMRAKVADFGLVKNAPDGKYS-VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 720 l~~~~~~kL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
++.++.+||+|||+++........ ......+|+.|+|||++.+. .++.++||||+|++
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 248 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR---VYTHQSDVWSFGVL 248 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC---EECHHHHHHHHHHH
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCC---CcChHHHHHHHHHH
Confidence 999999999999999877654322 22334578899999988654 35788999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-30 Score=280.21 Aligned_cols=199 Identities=29% Similarity=0.431 Sum_probs=167.0
Q ss_pred cHHHHHHHhcCCCccceeecccceEEEEEEeC-CCcEEEEEEeccccCC------hhhHHHHHHHHHHHHhc-CCCCcce
Q 003982 572 SIEVLRQVTDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMG------NKGLSEFQAEIAVLTKV-RHRHLVA 643 (782)
Q Consensus 572 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l-~h~nI~~ 643 (782)
.......+.++|++.+.||+|+||.||+|... +|+.||||++...... ....+.+.+|+++++++ +||||++
T Consensus 85 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 164 (365)
T 2y7j_A 85 DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164 (365)
T ss_dssp HHHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred cchhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 34555667788999999999999999999764 7999999998765321 11245688999999999 7999999
Q ss_pred EEeEEEeCCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCC
Q 003982 644 LLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD 723 (782)
Q Consensus 644 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~ 723 (782)
+++++......++||||+++++|.+++... ..+++..+..++.|++.||.|||+ .||+||||||+||+++.+
T Consensus 165 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~ 236 (365)
T 2y7j_A 165 LIDSYESSSFMFLVFDLMRKGELFDYLTEK-----VALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDN 236 (365)
T ss_dssp EEEEEEBSSEEEEEECCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTT
T ss_pred EEEEEeeCCEEEEEEEeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCC
Confidence 999999999999999999999999999752 358999999999999999999999 899999999999999999
Q ss_pred CcEEEEeeccceecCCCCceeeecccccccccCccccccch---hhhHHHHHHHHHhccc
Q 003982 724 MRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHW---MILCQMTGLIWLHGSV 780 (782)
Q Consensus 724 ~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~dvws~Gvv 780 (782)
+.+||+|||++........ .....||+.|+|||++.+.. ..+++.++||||+||+
T Consensus 237 ~~ikl~DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~i 294 (365)
T 2y7j_A 237 MQIRLSDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVI 294 (365)
T ss_dssp CCEEECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHH
T ss_pred CCEEEEecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHH
Confidence 9999999999987765332 23457999999999875321 1134668999999986
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=275.94 Aligned_cols=191 Identities=24% Similarity=0.355 Sum_probs=154.8
Q ss_pred hcCCCcc-ceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCCeEEE
Q 003982 580 TDNFSEA-NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLL 656 (782)
Q Consensus 580 ~~~y~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~l 656 (782)
.+.|++. +.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++.++ +||||+++++++.+++..++
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l 88 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL 88 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 4678885 7899999999999964 578999999997653 34567899999999985 79999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCc---EEEEeecc
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR---AKVADFGL 733 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~---~kL~DfG~ 733 (782)
||||+++++|.+++... ..+++.++..++.|++.||+|||+ .||+||||||+||+++.++. +||+|||+
T Consensus 89 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~ 160 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHKR-----RHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDL 160 (316)
T ss_dssp EEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTC
T ss_pred EEEcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccC
Confidence 99999999999999763 358999999999999999999999 89999999999999998765 99999999
Q ss_pred ceecCCCCc------eeeecccccccccCccccccch--hhhHHHHHHHHHhccc
Q 003982 734 VKNAPDGKY------SVETRLAGTFGYLAPEYAGKHW--MILCQMTGLIWLHGSV 780 (782)
Q Consensus 734 a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~dvws~Gvv 780 (782)
+........ ......+||+.|+|||++.+.. ...++.++||||+|++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~i 215 (316)
T 2ac3_A 161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215 (316)
T ss_dssp CC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHH
T ss_pred ccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHH
Confidence 876542211 1112346999999999886421 1235678999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.7e-31 Score=274.38 Aligned_cols=185 Identities=22% Similarity=0.375 Sum_probs=158.5
Q ss_pred hcCCCccceeecccceEEEEEEeC-CC-------cEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC
Q 003982 580 TDNFSEANILGRGGFGVVYGGELP-DG-------TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING 651 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~ 651 (782)
.++|.+.+.||+|+||.||+|... ++ ..||+|++.... ....+.+.+|++++++++||||+++++++.++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 467899999999999999999543 33 479999997644 45567899999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCc------
Q 003982 652 SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR------ 725 (782)
Q Consensus 652 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~------ 725 (782)
+..++||||+++++|.+++.... ..+++..+..++.|++.||+|||+ .||+||||||+||+++.++.
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~ 157 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNK----NCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNP 157 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBC
T ss_pred CCCEEEEECCCCCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCccccccc
Confidence 99999999999999999997632 248999999999999999999999 89999999999999998876
Q ss_pred --EEEEeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 726 --AKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 726 --~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+||+|||++...... ....||+.|+|||++.+. ..++.++||||+|++
T Consensus 158 ~~~kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~i 207 (289)
T 4fvq_A 158 PFIKLSDPGISITVLPK-----DILQERIPWVPPECIENP--KNLNLATDKWSFGTT 207 (289)
T ss_dssp CEEEECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCG--GGCCHHHHHHHHHHH
T ss_pred ceeeeccCcccccccCc-----cccCCcCcccCHHHhCCC--CCCCchhHHHHHHHH
Confidence 999999998655332 224578999999998763 245789999999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-30 Score=268.18 Aligned_cols=191 Identities=24% Similarity=0.371 Sum_probs=162.9
Q ss_pred HhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
+.++|++.+.||+|+||.||+|.. .+++.||||++..... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence 457899999999999999999965 4789999999975442 34567899999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
|||+++++|.+++.. ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||.+...
T Consensus 84 ~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 155 (276)
T 2yex_A 84 LEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVF 155 (276)
T ss_dssp EECCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEecCCCcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCcccc
Confidence 999999999988754 3458999999999999999999999 89999999999999999999999999999866
Q ss_pred CCCCc-eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 738 PDGKY-SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 738 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..... .......||+.|+|||++.+.- ....++|+||+|++
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~~Di~slG~i 197 (276)
T 2yex_A 156 RYNNRERLLNKMCGTLPYVAPELLKRRE--FHAEPVDVWSCGIV 197 (276)
T ss_dssp EETTEECCBCCCCSCGGGCCGGGGTCSS--BCHHHHHHHHHHHH
T ss_pred CCCcchhcccCCccccCccChHHHhcCC--CCCCcchHHHHHHH
Confidence 43221 1223457899999999987641 13678999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-30 Score=275.92 Aligned_cols=188 Identities=29% Similarity=0.447 Sum_probs=161.1
Q ss_pred cCCCccceeecccceEEEEEEe-----CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEE--eCCe
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-----PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCI--NGSE 653 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~--~~~~ 653 (782)
++|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++++++||||+++++++. +...
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 6789999999999999999973 468899999997653 455678999999999999999999999887 4566
Q ss_pred EEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecc
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~ 733 (782)
.++||||+++++|.+++.... ..+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHR----ARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred EEEEEeecCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEccccc
Confidence 899999999999999997643 248999999999999999999999 8999999999999999999999999999
Q ss_pred ceecCCCCce--eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 734 VKNAPDGKYS--VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 734 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+......... ......||+.|+|||++.+. .++.++||||+|++
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 219 (327)
T 3lxl_A 174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDN---IFSRQSDVWSFGVV 219 (327)
T ss_dssp CEECCTTCSEEECSSCCCSCGGGSCHHHHHHC---EEEHHHHHHHHHHH
T ss_pred ceecccCCccceeeccCCccccccCHHHhccC---CCChHHhHHHHHHH
Confidence 9877544322 22334688899999988664 35778999999986
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=279.09 Aligned_cols=197 Identities=26% Similarity=0.359 Sum_probs=164.0
Q ss_pred HHHHHHHhcCCCcc-ceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC-CCCcceEEeEEE
Q 003982 573 IEVLRQVTDNFSEA-NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCI 649 (782)
Q Consensus 573 ~~~l~~~~~~y~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~ 649 (782)
++....+.++|.+. +.||+|+||.||+|.. .+++.||+|++............+.+|+.++++++ ||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 33456677888887 8999999999999955 46899999999876655556788999999999995 699999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECC---CCcE
Q 003982 650 NGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD---DMRA 726 (782)
Q Consensus 650 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~---~~~~ 726 (782)
+.+..++||||+++|+|.+++... ....+++.++..++.|++.||+|||+ .||+||||||+||+++. ++.+
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPE---LAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDI 173 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSC---C-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCE
T ss_pred eCCeEEEEEEecCCCcHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcE
Confidence 999999999999999999987542 23468999999999999999999999 89999999999999997 7899
Q ss_pred EEEeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 727 KVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 727 kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
||+|||+++....... .....||+.|+|||++.+. .++.++||||+|++
T Consensus 174 kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~i 222 (327)
T 3lm5_A 174 KIVDFGMSRKIGHACE--LREIMGTPEYLAPEILNYD---PITTATDMWNIGII 222 (327)
T ss_dssp EECCGGGCEEC-----------CCCGGGCCHHHHTTC---CCCTHHHHHHHHHH
T ss_pred EEeeCccccccCCccc--cccccCCcCccCCeeecCC---CCCchhhHHHHHHH
Confidence 9999999987754322 2335799999999998764 35678999999986
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=288.05 Aligned_cols=181 Identities=18% Similarity=0.204 Sum_probs=151.9
Q ss_pred hcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccC------ChhhHHHHHHHHHHHHhcC---------CCCcceE
Q 003982 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTM------GNKGLSEFQAEIAVLTKVR---------HRHLVAL 644 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~---------h~nI~~~ 644 (782)
.++|++.+.||+|+||+||+|.. +++.||||++..... .....+.+.+|++++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 45788999999999999999987 789999999986542 2334578999999999886 8888877
Q ss_pred EeEEE------------------------------eCCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 003982 645 LGYCI------------------------------NGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVA 694 (782)
Q Consensus 645 ~~~~~------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~ 694 (782)
.+++. +.+..|+||||+++|++.+.+.+ ..+++.++..++.|++
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHH
Confidence 77643 26789999999999987666632 3579999999999999
Q ss_pred HHHHHHh-hcCCCCeEEcCCCCCCEEECCCC--------------------cEEEEeeccceecCCCCceeeeccccccc
Q 003982 695 RGVEYLH-SLAQQSFIHRDLKPSNILIGDDM--------------------RAKVADFGLVKNAPDGKYSVETRLAGTFG 753 (782)
Q Consensus 695 ~aL~~LH-~~~~~~ivHrDikp~NIll~~~~--------------------~~kL~DfG~a~~~~~~~~~~~~~~~gt~~ 753 (782)
.||+||| + .||+||||||+|||++.++ .+||+|||+|+..... ..+||+.
T Consensus 172 ~aL~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~ 242 (336)
T 2vuw_A 172 ASLAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDV 242 (336)
T ss_dssp HHHHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCC
T ss_pred HHHHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeec
Confidence 9999999 8 8999999999999999887 8999999999876542 2379999
Q ss_pred ccCccccccchhhhHHHHHHHHHhccc
Q 003982 754 YLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 754 y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|+|||++.+.. +.++||||++..
T Consensus 243 y~aPE~~~g~~----~~~~Diwsl~~~ 265 (336)
T 2vuw_A 243 SMDEDLFTGDG----DYQFDIYRLMKK 265 (336)
T ss_dssp TTCSGGGCCCS----SHHHHHHHHHHH
T ss_pred ccChhhhcCCC----ccceehhhhhCC
Confidence 99999998863 678999998654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-30 Score=287.82 Aligned_cols=183 Identities=32% Similarity=0.516 Sum_probs=156.8
Q ss_pred hcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCC-eEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS-ERLLVY 658 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~-~~~lv~ 658 (782)
.++|++.+.||+|+||.||+|.. .++.||||+++... ..+.|.+|++++++++||||+++++++.+.. ..++||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 46788999999999999999987 47899999997643 4478999999999999999999999987765 789999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++|+|.+++.... ...+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+++...
T Consensus 267 e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp ECCTTCBHHHHHHHHC---TTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 9999999999997642 2347899999999999999999999 899999999999999999999999999998654
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... ....+++.|+|||++.+. .++.++||||+||+
T Consensus 341 ~~~----~~~~~~~~y~aPE~~~~~---~~~~~sDvwslG~~ 375 (450)
T 1k9a_A 341 STQ----DTGKLPVKWTAPEALREK---KFSTKSDVWSFGIL 375 (450)
T ss_dssp ----------CCCTTTSCHHHHHSS---CCCHHHHHHHHHHH
T ss_pred ccc----cCCCCCcceeCHHHhcCC---CCCcHHHHHHHHHH
Confidence 322 123578899999998764 45789999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-30 Score=273.10 Aligned_cols=185 Identities=30% Similarity=0.507 Sum_probs=156.9
Q ss_pred CCccceeecccceEEEEEEe-----CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC--CeEE
Q 003982 583 FSEANILGRGGFGVVYGGEL-----PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING--SERL 655 (782)
Q Consensus 583 y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~--~~~~ 655 (782)
|++.+.||+|+||.||++.. .+++.||||++.... .....+.+.+|++++++++||||+++++++.+. ...+
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc-ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 38899999999999988854 368899999997653 345567899999999999999999999999884 6789
Q ss_pred EEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccce
Q 003982 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (782)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~ 735 (782)
+||||+++++|.+++.. ..+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++.
T Consensus 112 lv~e~~~~~~L~~~l~~------~~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPR------HSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp EEECCCTTCBHHHHGGG------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEecccCCcHHHHHhh------CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCccccc
Confidence 99999999999999865 248999999999999999999999 899999999999999999999999999998
Q ss_pred ecCCCCce--eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 736 NAPDGKYS--VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 736 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
........ ......||+.|+|||++.+. .++.++||||+|++
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 226 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEY---KFYYASDVWSFGVT 226 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHC---EEEHHHHHHHHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCC---CCCcHHHHHHHHHH
Confidence 87654321 22334678899999988764 34678999999986
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-30 Score=269.44 Aligned_cols=185 Identities=24% Similarity=0.345 Sum_probs=159.4
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEe----CCeEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN----GSERL 655 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~----~~~~~ 655 (782)
+.|++.+.||+|+||.||+|.. .++..||+|++..........+.+.+|++++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 3477889999999999999954 568899999998776666677889999999999999999999999875 35689
Q ss_pred EEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEEcCCCCCCEEEC-CCCcEEEEeec
Q 003982 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS--FIHRDLKPSNILIG-DDMRAKVADFG 732 (782)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~--ivHrDikp~NIll~-~~~~~kL~DfG 732 (782)
+||||+++++|.+++... ..+++..+..++.|++.||+|||+ .| |+||||||+||+++ .++.+||+|||
T Consensus 106 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg 177 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLG 177 (290)
T ss_dssp EEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred EEEEecCCCCHHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence 999999999999999763 458999999999999999999998 77 99999999999998 78999999999
Q ss_pred cceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 733 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
++........ ....||+.|+|||++.+. ++.++||||+|++
T Consensus 178 ~~~~~~~~~~---~~~~~t~~y~aPE~~~~~----~~~~~Di~slG~~ 218 (290)
T 1t4h_A 178 LATLKRASFA---KAVIGTPEFMAPEMYEEK----YDESVDVYAFGMC 218 (290)
T ss_dssp GGGGCCTTSB---EESCSSCCCCCGGGGGTC----CCTHHHHHHHHHH
T ss_pred Cccccccccc---ccccCCcCcCCHHHHhcc----CCCcchHHHHHHH
Confidence 9976544322 235689999999988765 4568999999986
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-30 Score=276.02 Aligned_cols=194 Identities=27% Similarity=0.428 Sum_probs=163.4
Q ss_pred hcCCCccceeecccceEEEEEEe------CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCC
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGS 652 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~ 652 (782)
.++|++.+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|+++++++ +||||+++++++.+++
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 46789999999999999999964 356789999997543 234567899999999999 8999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHHhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEE
Q 003982 653 ERLLVYEYMPRGTLAQHLFEWHDH-------------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNIL 719 (782)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIl 719 (782)
..++||||+++|+|.+++...... ....+++.++..++.|++.||+|||+ .||+||||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEE
Confidence 999999999999999999764321 12358999999999999999999999 89999999999999
Q ss_pred ECCCCcEEEEeeccceecCCCCc-eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 720 IGDDMRAKVADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 720 l~~~~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
++.++.+||+|||+++....... .......||+.|+|||++.+. .++.++||||+|++
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 236 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC---VYTFESDVWSYGIF 236 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC---CCCHHHHHHHHHHH
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC---CCChHHHHHHHHHH
Confidence 99999999999999987755432 222334578899999987654 45788999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-30 Score=279.97 Aligned_cols=194 Identities=26% Similarity=0.470 Sum_probs=159.4
Q ss_pred hcCCCccceeecccceEEEEEEe------CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCC
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGS 652 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~ 652 (782)
.++|++.+.||+|+||.||+|.. .++..||||++.... .....+.+.+|+++++++ +||||+++++++.+.+
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 47899999999999999999964 245689999997543 233457899999999999 8999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHHhhccC------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCC
Q 003982 653 ERLLVYEYMPRGTLAQHLFEWHDH------------------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLK 714 (782)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik 714 (782)
..++||||+++|+|.+++...... ....+++.++..++.|++.||+|||+ .||+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCC
Confidence 999999999999999999764321 01347999999999999999999999 899999999
Q ss_pred CCCEEECCCCcEEEEeeccceecCCCC-ceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 715 PSNILIGDDMRAKVADFGLVKNAPDGK-YSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 715 p~NIll~~~~~~kL~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|+||+++.++.+||+|||++....... ........||+.|+|||++.+. .++.++||||+|++
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~Di~slG~i 263 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG---IYTIKSDVWSYGIL 263 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC---CCCHHHHHHHHHHH
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC---CCChhHhHHHHHHH
Confidence 999999999999999999998664433 2223345678899999987654 35778999999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=271.72 Aligned_cols=193 Identities=21% Similarity=0.372 Sum_probs=162.3
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEe--CCeEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN--GSERLL 656 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~--~~~~~l 656 (782)
.++|++.+.||+|+||.||+|.. .+++.||+|++..........+.+.+|++++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 46899999999999999999965 478999999998766556667889999999999999999999998854 568899
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-----eEEcCCCCCCEEECCCCcEEEEee
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS-----FIHRDLKPSNILIGDDMRAKVADF 731 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~-----ivHrDikp~NIll~~~~~~kL~Df 731 (782)
||||+++++|.+++...... ...+++.+++.++.|++.||+|||+ .| |+||||||+||+++.++.+||+||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred EEeCCCCCCHHHHHHhhccc-CCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 99999999999999775433 3458999999999999999999998 67 999999999999999999999999
Q ss_pred ccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 732 GLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 732 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|.+........ ......||+.|+|||++.+. .++.++||||+|++
T Consensus 161 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 205 (279)
T 2w5a_A 161 GLARILNHDTS-FAKTFVGTPYYMSPEQMNRM---SYNEKSDIWSLGCL 205 (279)
T ss_dssp CHHHHC---CH-HHHHHHSCCTTCCHHHHHCC----CCHHHHHHHHHHH
T ss_pred chheeeccccc-cccccCCCccccChHHhccC---CCCchhhHHHHHHH
Confidence 99987654321 12234689999999988764 45678999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=294.26 Aligned_cols=188 Identities=25% Similarity=0.418 Sum_probs=163.2
Q ss_pred HhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCC-hhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 656 (782)
+.++|++.+.||+|+||.||+|.. .+++.||||++...... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 456799999999999999999965 47899999999765432 3456789999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE---CCCCcEEEEeecc
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGL 733 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll---~~~~~~kL~DfG~ 733 (782)
||||+++|+|.+++.. ...+++.++..++.|++.||+|||+ .||+||||||+||++ +.++.+||+|||+
T Consensus 104 v~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 175 (484)
T 3nyv_A 104 VGEVYTGGELFDEIIS-----RKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGL 175 (484)
T ss_dssp EECCCCSCBHHHHHHT-----CSCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred EEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence 9999999999998865 3458999999999999999999999 899999999999999 4678999999999
Q ss_pred ceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 734 VKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 734 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|+....... ....+||+.|+|||++.+. ++.++||||+||+
T Consensus 176 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~----~~~~~DiwslG~i 216 (484)
T 3nyv_A 176 STHFEASKK--MKDKIGTAYYIAPEVLHGT----YDEKCDVWSTGVI 216 (484)
T ss_dssp HHHBCCCCS--HHHHTTGGGTCCHHHHHTC----CCTHHHHHHHHHH
T ss_pred eEEcccccc--cccCCCCccccCceeecCC----CCCcceeHHHHHH
Confidence 987755332 2335799999999998775 4568999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=284.92 Aligned_cols=189 Identities=23% Similarity=0.362 Sum_probs=154.3
Q ss_pred HHHhcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC----
Q 003982 577 RQVTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING---- 651 (782)
Q Consensus 577 ~~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~---- 651 (782)
....++|++.+.||+|+||+||+|. ..+++.||||++.... ....+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP------RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 3456789999999999999999995 4679999999987543 2234799999999999999999998543
Q ss_pred ----------------------------------CeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHH
Q 003982 652 ----------------------------------SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697 (782)
Q Consensus 652 ----------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL 697 (782)
...++||||++ ++|.+.+...... ...+++..+..++.|+++||
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS-GRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHH
Confidence 34789999997 5888888765443 35689999999999999999
Q ss_pred HHHhhcCCCCeEEcCCCCCCEEEC-CCCcEEEEeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHH
Q 003982 698 EYLHSLAQQSFIHRDLKPSNILIG-DDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWL 776 (782)
Q Consensus 698 ~~LH~~~~~~ivHrDikp~NIll~-~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws 776 (782)
+|||+ .||+||||||+||+++ .++.+||+|||+|+....... .....||+.|+|||++.+. ..++.++||||
T Consensus 155 ~~LH~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~--~~~~~~~Diws 227 (383)
T 3eb0_A 155 GFIHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGA--TEYTPSIDLWS 227 (383)
T ss_dssp HHHHT---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTC--SSCCTHHHHHH
T ss_pred HHHHH---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCC--CCCCcchhhhh
Confidence 99998 8999999999999997 688999999999987754332 2334689999999987653 22567899999
Q ss_pred hccc
Q 003982 777 HGSV 780 (782)
Q Consensus 777 ~Gvv 780 (782)
+|++
T Consensus 228 lG~i 231 (383)
T 3eb0_A 228 IGCV 231 (383)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-30 Score=272.14 Aligned_cols=193 Identities=24% Similarity=0.391 Sum_probs=153.9
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
.++|++.+.||+|+||.||+|.. .+++.||||++..... .......+.+|++++++++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 45799999999999999999964 5789999999976432 344567899999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
|||+++++|.+++...... ...+++.++..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++...
T Consensus 111 ~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQ-KRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EECCCSCBHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EecCCCCCHHHHHHHhccc-ccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 9999999999999765433 3568999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 738 PDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..... ......|++.|+|||++.+. .++.++||||+|++
T Consensus 187 ~~~~~-~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~i 225 (310)
T 2wqm_A 187 SSKTT-AAHSLVGTPYYMSPERIHEN---GYNFKSDIWSLGCL 225 (310)
T ss_dssp -------------CCSSCCHHHHTTC---CCCHHHHHHHHHHH
T ss_pred cCCCc-cccccCCCeeEeChHHhCCC---CCCchhhHHHHHHH
Confidence 54322 22334689999999988764 45778999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-30 Score=270.96 Aligned_cols=186 Identities=29% Similarity=0.495 Sum_probs=159.3
Q ss_pred HHhcCCCccceeecccceEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEe------
Q 003982 578 QVTDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN------ 650 (782)
Q Consensus 578 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~------ 650 (782)
.+..+|++.+.||+|+||.||+|... +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 35678999999999999999999664 78999999997643 357789999999999999999998864
Q ss_pred ----------CCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE
Q 003982 651 ----------GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI 720 (782)
Q Consensus 651 ----------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll 720 (782)
....++||||+++++|.+++..... ..+++..+..++.|++.||.|||+ .||+||||||+||++
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~ 155 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG---EKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFL 155 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEE
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEE
Confidence 3457999999999999999976432 358999999999999999999999 899999999999999
Q ss_pred CCCCcEEEEeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 721 GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 721 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
++++.+||+|||++........ .....||+.|+|||++.+. .++.++|+||+|++
T Consensus 156 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 210 (284)
T 2a19_B 156 VDTKQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQ---DYGKEVDLYALGLI 210 (284)
T ss_dssp EETTEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCS---CCCTHHHHHHHHHH
T ss_pred cCCCCEEECcchhheecccccc--ccccCCcccccChhhhccC---CCcchhhhHHHHHH
Confidence 9999999999999987765432 2334689999999988764 35678999999986
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-30 Score=271.02 Aligned_cols=186 Identities=22% Similarity=0.282 Sum_probs=159.4
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCCeEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~lv 657 (782)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|+++++++ +|++|+++++++.+....++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 46799999999999999999964 678999999986543 234578899999999 799999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCc-----EEEEeec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR-----AKVADFG 732 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~-----~kL~DfG 732 (782)
|||+ +++|.+++... ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++. +||+|||
T Consensus 85 ~e~~-~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg 156 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLC----GRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 156 (298)
T ss_dssp EECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred EEec-CCCHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence 9999 99999999763 2358999999999999999999998 89999999999999987776 9999999
Q ss_pred cceecCCCCce------eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 733 LVKNAPDGKYS------VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 733 ~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+++........ ......||+.|+|||++.+. .++.++||||+|++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~i 207 (298)
T 1csn_A 157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR---EQSRRDDLEALGHV 207 (298)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC---CCCHHHHHHHHHHH
T ss_pred cccccccccccccccccCccCCCCCcccCCchhhcCC---CCChHHHHHHHHHH
Confidence 99876543321 22345799999999998765 35789999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-30 Score=272.45 Aligned_cols=194 Identities=27% Similarity=0.334 Sum_probs=148.7
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
.++|++.+.||+|+||.||+|.. .+++.||||++..........+.+.++...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46899999999999999999965 67899999999765433334444556666688889999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ-SFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~-~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
||++ |+|.+++...... ...+++.++..++.|++.||+|||+ . ||+||||||+||+++.++.+||+|||++...
T Consensus 86 e~~~-~~l~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDK-GQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp ECCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred ehhc-cchHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 9996 5898888764433 3568999999999999999999998 6 9999999999999999999999999999876
Q ss_pred CCCCceeeecccccccccCccccccc-hhhhHHHHHHHHHhccc
Q 003982 738 PDGKYSVETRLAGTFGYLAPEYAGKH-WMILCQMTGLIWLHGSV 780 (782)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~dvws~Gvv 780 (782)
..... .....||+.|+|||++... ....++.++||||+|++
T Consensus 161 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~i 202 (290)
T 3fme_A 161 VDDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGIT 202 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHH
T ss_pred ccccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHH
Confidence 54332 2234689999999996321 12346788999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-30 Score=272.84 Aligned_cols=191 Identities=29% Similarity=0.491 Sum_probs=149.4
Q ss_pred hcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
.++|++.+.||+|+||.||+|... ..||||+++.........+.+.+|++++++++||||++++++. .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 467999999999999999999763 3699999987665566778899999999999999999999965 5567899999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++++|.+++... ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++.....
T Consensus 100 ~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 100 WCEGSSLYHHLHAS----ETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp CCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred ecCCCcHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceecccccc
Confidence 99999999998542 3458999999999999999999999 8999999999999999999999999999976543
Q ss_pred CC-ceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GK-YSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.. ........||+.|+|||++...-...++.++||||+|++
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~i 214 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIV 214 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHH
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHH
Confidence 22 112234568999999998863212245678999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-30 Score=267.76 Aligned_cols=189 Identities=29% Similarity=0.461 Sum_probs=155.3
Q ss_pred hcCCCccceeecccceEEEEEEeC-CCcEEEEEEeccccCC-hhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
.++|++.+.||+|+||.||+|... +++.||||++...... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 468999999999999999999654 7899999999754321 23456889999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
|||+++++|.+++... ..+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++...
T Consensus 90 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH-----GRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp EECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred EeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeeccccccc
Confidence 9999999999999763 358999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 738 PDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..... .....||+.|+|||++.+.. ..+.++|+||+|++
T Consensus 162 ~~~~~--~~~~~~~~~y~aPE~~~~~~--~~~~~~Di~slG~~ 200 (276)
T 2h6d_A 162 SDGEF--LRTSCGSPNYAAPEVISGRL--YAGPEVDIWSCGVI 200 (276)
T ss_dssp CC---------------CCTGGGTTSC--CCHHHHHHHHHHHH
T ss_pred CCCcc--eecccCCccccCHHHHcCCC--CCCccchHHHHHHH
Confidence 54332 22346899999999987651 23678999999986
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-30 Score=278.53 Aligned_cols=189 Identities=27% Similarity=0.469 Sum_probs=151.1
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcE----EEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTK----IAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSER 654 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~ 654 (782)
.++|++.+.||+|+||.||+|.. .+++. ||+|.+.... .....+++.+|++++++++||||+++++++.++. .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~ 91 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence 35789999999999999999964 34443 5888775432 2345678999999999999999999999998754 7
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccc
Q 003982 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734 (782)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a 734 (782)
++|+||+++|+|.+++... ...+++.+++.++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+|
T Consensus 92 ~~v~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 164 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp EEEEECCTTCBHHHHHHHS----TTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred EEEEEecCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcce
Confidence 8999999999999999763 2458999999999999999999999 89999999999999999999999999999
Q ss_pred eecCCCCce-eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 735 KNAPDGKYS-VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 735 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+........ ......||+.|+|||++.+. .++.++||||+||+
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~Di~slG~i 208 (327)
T 3poz_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHR---IYTHQSDVWSYGVT 208 (327)
T ss_dssp HHHTTTCC-------CCCGGGSCHHHHHHC---CCCHHHHHHHHHHH
T ss_pred eEccCCcccccccCCCccccccChHHhccC---CCCchhhhhhhHHH
Confidence 876543321 22334578899999988764 45789999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-30 Score=281.49 Aligned_cols=185 Identities=25% Similarity=0.355 Sum_probs=149.8
Q ss_pred hcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCC------
Q 003982 580 TDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS------ 652 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~------ 652 (782)
.++|++.+.||+|+||.||+|. ..+++.||||++..........+.+.+|+++++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 4789999999999999999995 457899999999865544556678999999999999999999999997665
Q ss_pred eEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeec
Q 003982 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (782)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG 732 (782)
..++||||++ ++|.+.+.. .+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 172 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 172 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred ceEEEEEcCC-CCHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEee
Confidence 7899999996 578887742 48899999999999999999999 899999999999999999999999999
Q ss_pred cceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 733 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+|+...... ......||+.|+|||++.+. .++.++||||+||+
T Consensus 173 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~i 215 (371)
T 2xrw_A 173 LARTAGTSF--MMTPYVVTRYYRAPEVILGM---GYKENVDIWSVGCI 215 (371)
T ss_dssp C------------------CTTCCHHHHTTC---CCCTTHHHHHHHHH
T ss_pred ccccccccc--ccCCceecCCccCHHHhcCC---CCCchHhHHHHHHH
Confidence 998765422 22345789999999998764 45678999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.8e-30 Score=269.95 Aligned_cols=187 Identities=27% Similarity=0.467 Sum_probs=162.6
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
.+.|++.+.||+|+||.||+|.. .+++.||||++..... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 35689999999999999999954 5789999999976542 345688999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++++|.+++.. ..+++.++..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++....
T Consensus 100 e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 170 (303)
T 3a7i_A 100 EYLGGGSALDLLEP------GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT 170 (303)
T ss_dssp ECCTTEEHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECB
T ss_pred EeCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecC
Confidence 99999999998853 458999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.... ......||+.|+|||++.+. .++.++|+||+|++
T Consensus 171 ~~~~-~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 208 (303)
T 3a7i_A 171 DTQI-KRNTFVGTPFWMAPEVIKQS---AYDSKADIWSLGIT 208 (303)
T ss_dssp TTBC-CBCCCCSCGGGCCHHHHTTC---CBCTHHHHHHHHHH
T ss_pred cccc-ccCccCCCcCccCHHHHhcC---CCCchhhhHHHHHH
Confidence 4332 22345789999999998764 34668999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-30 Score=279.81 Aligned_cols=192 Identities=26% Similarity=0.355 Sum_probs=153.1
Q ss_pred HHhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCCh---hhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCe
Q 003982 578 QVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGN---KGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE 653 (782)
Q Consensus 578 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~ 653 (782)
...++|++.+.||+|+||.||+|.. .+++.||||++....... ...+.+.+|++++++++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 3457899999999999999999965 468999999997543221 123468899999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecc
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~ 733 (782)
.++||||+++ +|.+++... ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGL 158 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred eEEEEEcCCC-CHHHHHHhc----CcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEeccc
Confidence 9999999975 888887542 3458889999999999999999999 8999999999999999999999999999
Q ss_pred ceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 734 VKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 734 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
++....... ......||+.|+|||++.+. ..++.++||||+|++
T Consensus 159 a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~i 202 (346)
T 1ua2_A 159 AKSFGSPNR-AYTHQVVTRWYRAPELLFGA--RMYGVGVDMWAVGCI 202 (346)
T ss_dssp GSTTTSCCC-CCCCSCCCCTTCCHHHHTTC--SCCCHHHHHHHHHHH
T ss_pred ceeccCCcc-cCCcccccccccCchHhhCC--CCCCchhhhHhHHHH
Confidence 987654322 22345789999999988653 134678999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-30 Score=275.74 Aligned_cols=195 Identities=29% Similarity=0.400 Sum_probs=160.2
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEe----CCeE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN----GSER 654 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~----~~~~ 654 (782)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+++++.++||||+++++++.. ....
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE--QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS--HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC--HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 46899999999999999999965 678999999986643 4566789999999999999999999999873 3477
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccc
Q 003982 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734 (782)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a 734 (782)
++||||+++|+|.+++...... ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||.+
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDK-GNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred EEEEEeCCCCcHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 9999999999999999875443 3568999999999999999999999 89999999999999999999999999998
Q ss_pred eecCCCCce--------eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 735 KNAPDGKYS--------VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 735 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
......... ......||+.|+|||++.+.....++.++||||+|++
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~i 235 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCV 235 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHH
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHH
Confidence 765421100 0112357999999999875422234678999999986
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-30 Score=272.42 Aligned_cols=186 Identities=29% Similarity=0.453 Sum_probs=158.7
Q ss_pred HhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
+.++|.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP--AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 456899999999999999999965 478999999997643 22346788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE---CCCCcEEEEeeccc
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLV 734 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll---~~~~~~kL~DfG~a 734 (782)
|||+++++|.+++... ..+++.++..++.|++.||+|||+ .||+||||||+||++ +.++.+||+|||++
T Consensus 85 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~ 156 (304)
T 2jam_A 85 MQLVSGGELFDRILER-----GVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLS 156 (304)
T ss_dssp ECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTT
T ss_pred EEcCCCccHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcc
Confidence 9999999999998763 358999999999999999999999 899999999999999 77889999999998
Q ss_pred eecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 735 KNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 735 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
....... .....||+.|+|||++.+. .++.++||||+|++
T Consensus 157 ~~~~~~~---~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 196 (304)
T 2jam_A 157 KMEQNGI---MSTACGTPGYVAPEVLAQK---PYSKAVDCWSIGVI 196 (304)
T ss_dssp CCCCCBT---THHHHSCCCBCCTTTBSSC---SCCHHHHHHHHHHH
T ss_pred eecCCCc---cccccCCCCccChHHhccC---CCCchhhHHHHHHH
Confidence 7654322 1234689999999998765 45789999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-30 Score=276.40 Aligned_cols=186 Identities=28% Similarity=0.458 Sum_probs=150.0
Q ss_pred hcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHH--HHhcCCCCcceEEeEEEe-----CC
Q 003982 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAV--LTKVRHRHLVALLGYCIN-----GS 652 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~--l~~l~h~nI~~~~~~~~~-----~~ 652 (782)
.++|++.+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++||||+++++++.. ..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 46899999999999999999977 78999999996532 3444445444 445899999999986543 23
Q ss_pred eEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC---------CeEEcCCCCCCEEECCC
Q 003982 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ---------SFIHRDLKPSNILIGDD 723 (782)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~---------~ivHrDikp~NIll~~~ 723 (782)
..++||||+++|+|.+++.. ...++..+..++.|++.||+|||+ . ||+||||||+||+++.+
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~ 156 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSL------HTSDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKND 156 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTT
T ss_pred eEEEEEecCCCCcHHHHHhh------cccchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCC
Confidence 56899999999999999965 235889999999999999999998 6 99999999999999999
Q ss_pred CcEEEEeeccceecCCCCc-------eeeecccccccccCccccccch----hhhHHHHHHHHHhccc
Q 003982 724 MRAKVADFGLVKNAPDGKY-------SVETRLAGTFGYLAPEYAGKHW----MILCQMTGLIWLHGSV 780 (782)
Q Consensus 724 ~~~kL~DfG~a~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~----~~~~~~~~dvws~Gvv 780 (782)
+.+||+|||+++....... .......||+.|+|||++.+.. ...++.++||||+|++
T Consensus 157 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~i 224 (336)
T 3g2f_A 157 GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLI 224 (336)
T ss_dssp SCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHH
T ss_pred CcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHH
Confidence 9999999999987654321 1122346999999999987631 1356788999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.2e-30 Score=268.60 Aligned_cols=186 Identities=30% Similarity=0.567 Sum_probs=155.2
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhh-----HHHHHHHHHHHHhcCCCCcceEEeEEEeCCeE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKG-----LSEFQAEIAVLTKVRHRHLVALLGYCINGSER 654 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~-----~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~ 654 (782)
++|++.+.||+|+||.||+|.. .+++.||+|++......... .+.+.+|++++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 6789999999999999999965 57899999999765432221 267899999999999999999999986655
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEEcCCCCCCEEECCCCc-----EE
Q 003982 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS--FIHRDLKPSNILIGDDMR-----AK 727 (782)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~--ivHrDikp~NIll~~~~~-----~k 727 (782)
++||||+++|+|.+++.+. ...+++..+..++.|++.||+|||+ .| |+||||||+||+++.++. +|
T Consensus 97 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDK----AHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp EEEEECCTTCBHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred eEEEEecCCCCHHHHHhcc----cCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEE
Confidence 6999999999999988652 3468999999999999999999998 78 999999999999988776 99
Q ss_pred EEeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 728 VADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 728 L~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|+|||+++..... .....||+.|+|||++.+. ...++.++||||+|++
T Consensus 170 l~Dfg~~~~~~~~----~~~~~g~~~y~aPE~~~~~-~~~~~~~~Di~slG~~ 217 (287)
T 4f0f_A 170 VADFGLSQQSVHS----VSGLLGNFQWMAPETIGAE-EESYTEKADTYSFAMI 217 (287)
T ss_dssp ECCCTTCBCCSSC----EECCCCCCTTSCGGGSSCS-SCEECHHHHHHHHHHH
T ss_pred eCCCCcccccccc----ccccCCCccccCchhhccC-CCCcCchhhHHHHHHH
Confidence 9999999754432 2345789999999998432 1235778999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-30 Score=272.50 Aligned_cols=190 Identities=27% Similarity=0.381 Sum_probs=154.7
Q ss_pred HhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEe-------
Q 003982 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN------- 650 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~------- 650 (782)
+.++|++.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|++++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP 80 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence 467899999999999999999965 57899999999653 3456789999999999999999999998865
Q ss_pred ------CCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCC
Q 003982 651 ------GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM 724 (782)
Q Consensus 651 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~ 724 (782)
....++||||+++++|.+++... ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~ 153 (303)
T 1zy4_A 81 MTAVKKKSTLFIQMEYCENGTLYDLIHSE----NLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESR 153 (303)
T ss_dssp -----CEEEEEEEEECCCSCBHHHHHHHS----CGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTS
T ss_pred hcccccCCceEEEEecCCCCCHHHhhhcc----ccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCC
Confidence 35679999999999999999752 2357889999999999999999999 8999999999999999999
Q ss_pred cEEEEeeccceecCCCC-------------ceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 725 RAKVADFGLVKNAPDGK-------------YSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 725 ~~kL~DfG~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.+||+|||++....... ........||+.|+|||++.+. ..++.++||||+|++
T Consensus 154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~i 220 (303)
T 1zy4_A 154 NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT--GHYNEKIDMYSLGII 220 (303)
T ss_dssp CEEECCCCCCSCTTC-------------------------CTTSCHHHHTSC--SCCCTHHHHHHHHHH
T ss_pred CEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCC--CCCcchhhHHHHHHH
Confidence 99999999998664321 1112334689999999998753 124678999999986
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-30 Score=268.40 Aligned_cols=185 Identities=30% Similarity=0.509 Sum_probs=147.3
Q ss_pred hcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCC--hhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMG--NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
.++|++.+.||+|+||.||+|.. .++.||||++...... ....+.+++|+++++.++||||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 36789999999999999999987 4899999998765322 23457899999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC---eEEcCCCCCCEEECC--------CCcE
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS---FIHRDLKPSNILIGD--------DMRA 726 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~---ivHrDikp~NIll~~--------~~~~ 726 (782)
|||+++++|.+++.. ..+++.++..++.|++.||+|||+ .| |+||||||+||+++. ++.+
T Consensus 85 ~e~~~~~~L~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~ 155 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG------KRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKIL 155 (271)
T ss_dssp EECCTTEEHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred EEcCCCCCHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcce
Confidence 999999999998843 458999999999999999999999 67 999999999999986 6789
Q ss_pred EEEeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 727 KVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 727 kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
||+|||++........ ....||+.|+|||++.+. .++.++|+||+|++
T Consensus 156 kl~Dfg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~ 203 (271)
T 3dtc_A 156 KITDFGLAREWHRTTK---MSAAGAYAWMAPEVIRAS---MFSKGSDVWSYGVL 203 (271)
T ss_dssp EECCCCC----------------CCGGGSCHHHHHHC---CCSHHHHHHHHHHH
T ss_pred EEccCCcccccccccc---cCCCCccceeCHHHhccC---CCCchhhHHHHHHH
Confidence 9999999986654322 234689999999987654 35778999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.4e-31 Score=279.22 Aligned_cols=188 Identities=24% Similarity=0.361 Sum_probs=150.9
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
++|++.+.||+|+||.||+|.. .+++.||||++..... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 5799999999999999999965 4789999999975431 1122245679999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|++ |+|.+++... ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 152 (324)
T 3mtl_A 81 YLD-KDLKQYLDDC----GNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSI 152 (324)
T ss_dssp CCS-EEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred ccc-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence 996 5898888763 2358999999999999999999999 8999999999999999999999999999986653
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... ......||+.|+|||++.+. ..++.++||||+|++
T Consensus 153 ~~~-~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~i 190 (324)
T 3mtl_A 153 PTK-TYDNEVVTLWYRPPDILLGS--TDYSTQIDMWGVGCI 190 (324)
T ss_dssp -----------CGGGCCHHHHTTC--CCCCTHHHHHHHHHH
T ss_pred Ccc-ccccccCcccccChhhhcCC--CCCCcHHHHHHHHHH
Confidence 322 22334689999999987653 234678999999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-30 Score=269.91 Aligned_cols=187 Identities=27% Similarity=0.484 Sum_probs=160.7
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCC-hhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
.++|++.+.||+|+||.||+|.. .+++.||+|++...... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 36799999999999999999965 46789999999754321 22356789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
|||+++++|.+++... ..+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++...
T Consensus 93 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 164 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH-----GRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHA 164 (284)
T ss_dssp ECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccC
Confidence 9999999999999763 358999999999999999999998 89999999999999999999999999999766
Q ss_pred CCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 738 PDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.... .....|++.|+|||++.+. .++.++|+||+|++
T Consensus 165 ~~~~---~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 201 (284)
T 2vgo_A 165 PSLR---RRTMCGTLDYLPPEMIEGK---THDEKVDLWCAGVL 201 (284)
T ss_dssp SSSC---BCCCCSCGGGCCHHHHTTC---CBCTTHHHHHHHHH
T ss_pred cccc---cccccCCCCcCCHHHhccC---CCCcccchhhHHHH
Confidence 5422 1235689999999998765 34668999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-30 Score=276.19 Aligned_cols=191 Identities=25% Similarity=0.341 Sum_probs=154.3
Q ss_pred HhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCC------hhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC
Q 003982 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG------NKGLSEFQAEIAVLTKVRHRHLVALLGYCING 651 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~ 651 (782)
..++|++.+.||+|+||.||+|.. .+++.||||++...... ......+.+|++++++++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 457899999999999999999955 56889999999764321 12334688999999999999999999998765
Q ss_pred CeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCc---EEE
Q 003982 652 SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR---AKV 728 (782)
Q Consensus 652 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~---~kL 728 (782)
. .++||||+++++|.+++.. ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++. +||
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl 158 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKI 158 (322)
T ss_dssp S-EEEEEECCTTEETHHHHST-----TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEE
T ss_pred c-eEEEEecCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEE
Confidence 4 8999999999999998854 3468999999999999999999999 89999999999999987654 999
Q ss_pred EeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 729 ADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 729 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+|||+++....... .....||+.|+|||++.+.-...++.++||||+|++
T Consensus 159 ~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~i 208 (322)
T 2ycf_A 159 TDFGHSKILGETSL--MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 208 (322)
T ss_dssp CCCTTCEECCCCHH--HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHH
T ss_pred ccCccceecccccc--cccccCCcCccCchhhccCCCCCCCchhhHHHHHHH
Confidence 99999987754321 223468999999998742211245678999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-30 Score=268.33 Aligned_cols=189 Identities=24% Similarity=0.409 Sum_probs=154.9
Q ss_pred hcCCCccceeecccceEEEEEEeCC----CcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGELPD----GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL 655 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~ 655 (782)
.++|++.+.||+|+||.||+|.... +..||+|++.... .....+.+.+|++++++++||||+++++++.+ +..+
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 4678999999999999999996432 3469999987653 24456789999999999999999999999765 4568
Q ss_pred EEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccce
Q 003982 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (782)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~ 735 (782)
+||||+++++|.+++... ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++.
T Consensus 89 ~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERN----KNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp EEEECCTTCBHHHHHHHH----TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred EEEecCCCCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCc
Confidence 999999999999999763 2358999999999999999999999 899999999999999999999999999998
Q ss_pred ecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 736 NAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 736 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..............+|+.|+|||++.+. .++.++||||+|++
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 203 (281)
T 3cc6_A 162 YIEDEDYYKASVTRLPIKWMSPESINFR---RFTTASDVWMFAVC 203 (281)
T ss_dssp CC---------CCCCCGGGCCHHHHHHC---CCCHHHHHHHHHHH
T ss_pred ccccccccccccCCCCcceeCchhhccC---CCCchhccHHHHHH
Confidence 7765443333344678899999988654 45778999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.8e-30 Score=273.19 Aligned_cols=197 Identities=29% Similarity=0.485 Sum_probs=152.7
Q ss_pred HHhcCCCccceeecccceEEEEEEeC----CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCe
Q 003982 578 QVTDNFSEANILGRGGFGVVYGGELP----DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE 653 (782)
Q Consensus 578 ~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~ 653 (782)
...++|.+.+.||+|+||.||+|... ++..||+|+++.........+.+.+|++++++++||||+++++++.+...
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 34578999999999999999999543 34589999998765555667889999999999999999999999987653
Q ss_pred -----EEEEEEccCCCCHHHHHHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEE
Q 003982 654 -----RLLVYEYMPRGTLAQHLFEWHD-HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAK 727 (782)
Q Consensus 654 -----~~lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~k 727 (782)
.++||||+++++|.+++..... .....+++.+++.++.|+++||.|||+ .||+||||||+||+++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEE
Confidence 4999999999999999865332 234568999999999999999999998 8999999999999999999999
Q ss_pred EEeeccceecCCCCce-eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 728 VADFGLVKNAPDGKYS-VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 728 L~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|+|||+++........ ......+++.|+|||++.+. .++.++||||+|++
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 238 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR---VYTSKSDVWAFGVT 238 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSS---CCCHHHHHHHHHHH
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCC---CccchhhhHHHHHH
Confidence 9999999876543321 22334578899999998764 45778999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.7e-30 Score=268.31 Aligned_cols=189 Identities=25% Similarity=0.380 Sum_probs=156.2
Q ss_pred hcCCCccc-eeecccceEEEEEEe---CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEE
Q 003982 580 TDNFSEAN-ILGRGGFGVVYGGEL---PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL 655 (782)
Q Consensus 580 ~~~y~~~~-~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~ 655 (782)
.++|.+.+ .||+|+||.||+|.. .+++.||||+++.........+++.+|++++++++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 35678887 999999999999943 3468899999987654445578899999999999999999999998 567789
Q ss_pred EEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccce
Q 003982 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (782)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~ 735 (782)
+||||+++++|.+++.. ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++.
T Consensus 94 lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp EEEECCTTEEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEeCCCCCHHHHHHh-----CcCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 99999999999999976 2458999999999999999999999 899999999999999999999999999998
Q ss_pred ecCCCCcee--eecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 736 NAPDGKYSV--ETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 736 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
......... .....+++.|+|||++.+. .++.++||||+|++
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 209 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYY---KFSSKSDVWSFGVL 209 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHC---EEEHHHHHHHHHHH
T ss_pred eeccCCCcccccccCCCCceeeChHHhccC---CCChhhhHHHHHHH
Confidence 775543222 2223467899999988654 45778999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-30 Score=296.63 Aligned_cols=188 Identities=30% Similarity=0.495 Sum_probs=160.5
Q ss_pred hcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
.++|++.+.||+|+||.||+|.+.++..||||+++... ...++|.+|+++|++++||||+++++++.+ +..++|||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 45788999999999999999988888889999998654 235689999999999999999999999866 67899999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++|+|.+++..... ..+++.++..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+++....
T Consensus 342 ~~~~gsL~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 342 YMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp CCTTEEHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred hhcCCcHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 9999999999975322 348999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..........++..|+|||++.+. .++.++|||||||+
T Consensus 416 ~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~sDvwSlGv~ 453 (535)
T 2h8h_A 416 NEYTARQGAKFPIKWTAPEAALYG---RFTIKSDVWSFGIL 453 (535)
T ss_dssp HHHHTTCSTTSCGGGSCHHHHHHC---CCCHHHHHHHHHHH
T ss_pred CceecccCCcCcccccCHHHhccC---CCCchhhHHHHHHH
Confidence 332222334567899999987654 35778999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-30 Score=279.76 Aligned_cols=187 Identities=27% Similarity=0.392 Sum_probs=160.6
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 46799999999999999999965 478999999997653 3445678999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++++|.+++... ..+++..+..++.|++.||+|||+. .||+||||||+||+++.++.+||+|||++....
T Consensus 111 e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp CCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred ECCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 999999999999763 3589999999999999999999971 389999999999999999999999999987553
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... .....||+.|+|||++.+. .++.++||||+|++
T Consensus 184 ~~~---~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~i 219 (360)
T 3eqc_A 184 DSM---ANSFVGTRSYMSPERLQGT---HYSVQSDIWSMGLS 219 (360)
T ss_dssp HHC-------CCCCTTCCHHHHTTC---CCSHHHHHHHHHHH
T ss_pred ccc---ccCCCCCCCeECHHHHcCC---CCCchhhHHHHHHH
Confidence 211 2234789999999998765 45788999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=3.8e-30 Score=274.41 Aligned_cols=195 Identities=26% Similarity=0.489 Sum_probs=162.8
Q ss_pred HhcCCCccceeecccceEEEEEEeC------CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCC
Q 003982 579 VTDNFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS 652 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~ 652 (782)
..++|++.+.||+|+||.||+|... +++.||||++.... .......+.+|++++++++||||+++++++.+.+
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 101 (322)
T 1p4o_A 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 101 (322)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence 4578999999999999999999543 46789999997543 2345667999999999999999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHHhhcc-----CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEE
Q 003982 653 ERLLVYEYMPRGTLAQHLFEWHD-----HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAK 727 (782)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~k 727 (782)
..++||||+++|+|.+++..... .....+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+|
T Consensus 102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEE
T ss_pred ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCCeEE
Confidence 99999999999999999976432 112457899999999999999999999 8999999999999999999999
Q ss_pred EEeeccceecCCCCce-eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 728 VADFGLVKNAPDGKYS-VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 728 L~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|+|||+++........ ......||+.|+|||++.+. .++.++||||+|++
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 229 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG---VFTTYSDVWSFGVV 229 (322)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC---CCCHHHHHHHHHHH
T ss_pred ECcCccccccccccccccccCCCCCCCccChhhhccC---CCCchhhHHHHHHH
Confidence 9999999866443322 12234578899999987654 35778999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=272.07 Aligned_cols=181 Identities=21% Similarity=0.365 Sum_probs=156.0
Q ss_pred hcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC-CCCcceEEeEEEe--CCeEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCIN--GSERL 655 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~--~~~~~ 655 (782)
.++|++.+.||+|+||.||+|. ..+++.||||+++.. ..+.+.+|++++++++ ||||+++++++.+ ....+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 3679999999999999999995 467899999998743 3477999999999997 9999999999988 66789
Q ss_pred EEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCC-cEEEEeeccc
Q 003982 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM-RAKVADFGLV 734 (782)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~-~~kL~DfG~a 734 (782)
+||||+++++|.+++.. +++.++..++.|++.||+|||+ .||+||||||+||+++.++ .+||+|||+|
T Consensus 110 lv~e~~~~~~l~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a 178 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQT--------LTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 178 (330)
T ss_dssp EEEECCCCCCHHHHGGG--------CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEeccCchhHHHHHHh--------CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCc
Confidence 99999999999988743 7899999999999999999999 8999999999999999776 8999999999
Q ss_pred eecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 735 KNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 735 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+....... .....||+.|+|||++.+. ..++.++||||+||+
T Consensus 179 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~i 220 (330)
T 3nsz_A 179 EFYHPGQE--YNVRVASRYFKGPELLVDY--QMYDYSLDMWSLGCM 220 (330)
T ss_dssp EECCTTCC--CCSCCSCGGGCCHHHHTTC--CCCCTHHHHHHHHHH
T ss_pred eEcCCCCc--cccccccccccChhhhcCC--CcCCchhhHHHHHHH
Confidence 87654332 2334789999999988653 134678999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.96 E-value=9e-31 Score=285.52 Aligned_cols=192 Identities=16% Similarity=0.235 Sum_probs=153.0
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHH---HHHhcCCCCcceEE-------eE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIA---VLTKVRHRHLVALL-------GY 647 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~---~l~~l~h~nI~~~~-------~~ 647 (782)
.++|++.+.||+|+||+||+|.. .+|+.||||++..... .....+.+.+|++ ++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788999999999999999965 5799999999976532 2345678999994 55556799999998 66
Q ss_pred EEeCCe-----------------EEEEEEccCCCCHHHHHHhhccCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 003982 648 CINGSE-----------------RLLVYEYMPRGTLAQHLFEWHDHG--YTPLTWKQRVTIALDVARGVEYLHSLAQQSF 708 (782)
Q Consensus 648 ~~~~~~-----------------~~lv~e~~~~gsL~~~l~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~i 708 (782)
+.+++. .|+||||+ +|+|.+++....... ...+++..+..++.|++.||+|||+ .||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 665532 78999999 689999998643221 1234468888999999999999999 899
Q ss_pred EEcCCCCCCEEECCCCcEEEEeeccceecCCCCceeeecccccccccCccccccc--------hhhhHHHHHHHHHhccc
Q 003982 709 IHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKH--------WMILCQMTGLIWLHGSV 780 (782)
Q Consensus 709 vHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~~~~dvws~Gvv 780 (782)
+||||||+|||++.++.+||+|||+|+.... .....+| +.|+|||++.+. -...++.++||||+||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999986543 2234567 999999998763 00135789999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-30 Score=278.99 Aligned_cols=198 Identities=23% Similarity=0.325 Sum_probs=158.5
Q ss_pred ccHHHHHHHhcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCC---------hhhHHHHHHHHHHHHhcCCCCc
Q 003982 571 ISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMG---------NKGLSEFQAEIAVLTKVRHRHL 641 (782)
Q Consensus 571 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------~~~~~~~~~E~~~l~~l~h~nI 641 (782)
...+++....++|++.+.||+|+||.||+|...+++.||||++...... ....+.+.+|++++++++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 4567788899999999999999999999998888999999999654322 1234789999999999999999
Q ss_pred ceEEeEEEeC-----CeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCC
Q 003982 642 VALLGYCING-----SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPS 716 (782)
Q Consensus 642 ~~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~ 716 (782)
+++++++... ...++||||++ |++.+++... ...+++.++..++.|++.||.|||+ .||+||||||+
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~ 163 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ----RIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPG 163 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGG
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChH
Confidence 9999998543 36799999997 6888888642 3468999999999999999999999 89999999999
Q ss_pred CEEECCCCcEEEEeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 717 NILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 717 NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
||+++.++.+||+|||+++...... ......||+.|+|||++.+. ..++.++||||+|++
T Consensus 164 NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~i 223 (362)
T 3pg1_A 164 NILLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQF--KGFTKLVDMWSAGCV 223 (362)
T ss_dssp GEEECTTCCEEECCTTC-----------------CGGGCCHHHHTTC--TTCCTHHHHHHHHHH
T ss_pred HEEEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCC--CCCCcHhHHHhHHHH
Confidence 9999999999999999997554322 22345789999999988763 235778999999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-30 Score=277.20 Aligned_cols=189 Identities=25% Similarity=0.482 Sum_probs=153.7
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcE----EEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTK----IAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSER 654 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~ 654 (782)
.++|++.+.||+|+||.||+|.. .+++. ||+|.+.... .....+.+.+|+.++++++||||+++++++. .+..
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 89 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSL 89 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCcc
Confidence 35789999999999999999965 34554 7888775432 2233456789999999999999999999886 4668
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccc
Q 003982 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734 (782)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a 734 (782)
++||||+++|+|.+++... ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++
T Consensus 90 ~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a 162 (325)
T 3kex_A 90 QLVTQYLPLGSLLDHVRQH----RGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVA 162 (325)
T ss_dssp EEEEECCTTCBSHHHHHSS----GGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGG
T ss_pred EEEEEeCCCCCHHHHHHHc----cccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcc
Confidence 9999999999999998653 2358889999999999999999999 89999999999999999999999999999
Q ss_pred eecCCCCce-eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 735 KNAPDGKYS-VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 735 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+........ ......||+.|+|||++.+. .++.++||||+|++
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~ 206 (325)
T 3kex_A 163 DLLPPDDKQLLYSEAKTPIKWMALESIHFG---KYTHQSDVWSYGVT 206 (325)
T ss_dssp GGSCCCTTCCC-----CCTTTSCHHHHHHC---CCCHHHHHHHHHHH
T ss_pred cccCcccccccccCCCCcccccChHHhccC---CCChhhHhHHhHHH
Confidence 877544322 22345678899999998754 35778999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=8.8e-30 Score=266.86 Aligned_cols=188 Identities=26% Similarity=0.400 Sum_probs=158.0
Q ss_pred cCCCccc-eeecccceEEEEEEeC---CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEE
Q 003982 581 DNFSEAN-ILGRGGFGVVYGGELP---DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656 (782)
Q Consensus 581 ~~y~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 656 (782)
++|.+.+ .||+|+||.||+|... ++..||||+++... .....+.+.+|++++++++||||+++++++ ..+..++
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 4566666 9999999999999643 57789999997643 345667899999999999999999999998 5567899
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecccee
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~ 736 (782)
||||+++++|.+++... ...+++.++..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++..
T Consensus 87 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp EEECCTTEEHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEeCCCCCHHHHHHhC----CccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceee
Confidence 99999999999998642 3458999999999999999999999 8999999999999999999999999999988
Q ss_pred cCCCCcee--eecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 737 APDGKYSV--ETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 737 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
........ .....||+.|+|||++.+. .++.++|+||+|++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 202 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINFR---KFSSRSDVWSYGVT 202 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHC---EECHHHHHHHHHHH
T ss_pred eccCcceeeccccccccccccCHHHhccC---CCCchhhHHHHHHH
Confidence 75433221 2233568999999988654 45778999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-30 Score=281.87 Aligned_cols=185 Identities=27% Similarity=0.425 Sum_probs=141.9
Q ss_pred hcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC------C
Q 003982 580 TDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING------S 652 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~------~ 652 (782)
.++|++.+.||+|+||.||+|. ..+|+.||||++..........+++.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 4789999999999999999995 56789999999976554455677889999999999999999999998754 5
Q ss_pred eEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeec
Q 003982 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (782)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG 732 (782)
..++||||+ +++|.+++.. ..+++.++..++.|+++||+|||+ .||+||||||+||+++.++.+||+|||
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG 177 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG 177 (367)
T ss_dssp CCEEEEECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC--
T ss_pred eEEEEeccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeecc
Confidence 679999999 7899888754 358999999999999999999999 899999999999999999999999999
Q ss_pred cceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 733 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+++..... .....||+.|+|||++.+. ..++.++||||+|++
T Consensus 178 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~i 219 (367)
T 2fst_X 178 LARHTADE----MTGYVATRWYRAPEIMLNW--MHYNQTVDIWSVGCI 219 (367)
T ss_dssp -----------------CCCTTCCHHHHTTC--CSCCTTHHHHHHHHH
T ss_pred cccccccc----CCCcCcCcCccChHHHcCC--cCCCchhhHHHHHHH
Confidence 99875432 2335789999999987652 134667899999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-30 Score=273.81 Aligned_cols=202 Identities=24% Similarity=0.399 Sum_probs=165.5
Q ss_pred cHHHHHHHhcCCCccceeecccceEEEEEEe------CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceE
Q 003982 572 SIEVLRQVTDNFSEANILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVAL 644 (782)
Q Consensus 572 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~ 644 (782)
.........++|++.+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|+++++++ +||||+++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 3444445578899999999999999999963 356889999997643 344567899999999999 69999999
Q ss_pred EeEEEeCC-eEEEEEEccCCCCHHHHHHhhccCC-----------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcC
Q 003982 645 LGYCINGS-ERLLVYEYMPRGTLAQHLFEWHDHG-----------YTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRD 712 (782)
Q Consensus 645 ~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrD 712 (782)
++++...+ ..++||||+++++|.+++....... ...+++.++..++.|++.||.|||+ .||+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCccccc
Confidence 99988754 4899999999999999997633210 1227899999999999999999999 8999999
Q ss_pred CCCCCEEECCCCcEEEEeeccceecCCCCc-eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 713 LKPSNILIGDDMRAKVADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 713 ikp~NIll~~~~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|||+||+++.++.+||+|||+++....... .......||+.|+|||++.+. .++.++||||+|++
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~Di~slG~i 239 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR---VYTIQSDVWSFGVL 239 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC---CCCHHHHHHHHHHH
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccc---cccchhHHHHHHHH
Confidence 999999999999999999999987654332 233345678999999988654 45788999999986
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.7e-30 Score=271.72 Aligned_cols=189 Identities=29% Similarity=0.509 Sum_probs=159.7
Q ss_pred hcCCCccceeecccceEEEEEEe-----CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCC--
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-----PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS-- 652 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~-- 652 (782)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++++++||||+++++++...+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC--SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 45788999999999999999973 468899999997643 455678999999999999999999999987654
Q ss_pred eEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeec
Q 003982 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (782)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG 732 (782)
..++||||+++++|.+++... ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg 190 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFG 190 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHS----TTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred ceEEEEECCCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCc
Confidence 679999999999999999763 2358999999999999999999999 899999999999999999999999999
Q ss_pred cceecCCCCcee--eecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 733 LVKNAPDGKYSV--ETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 733 ~a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
++.......... .....++..|+|||++.+. .++.++||||+|++
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 237 (326)
T 2w1i_A 191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTES---KFSVASDVWSFGVV 237 (326)
T ss_dssp TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHC---EEEHHHHHHHHHHH
T ss_pred chhhccccccccccccCCCCceeEECchhhcCC---CCCchhhHHHHHHH
Confidence 998876543221 2234577889999988664 35778999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.9e-30 Score=272.22 Aligned_cols=184 Identities=30% Similarity=0.487 Sum_probs=149.2
Q ss_pred cCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEc
Q 003982 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 660 (782)
++|++.+.||+|+||.||+|.. .++.||||++... ...+.+.+|++++++++||||+++++++.+ ..++||||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~ 80 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY 80 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence 5788999999999999999987 4789999998643 345789999999999999999999998763 47899999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCc-EEEEeeccceecCC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR-AKVADFGLVKNAPD 739 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~-~kL~DfG~a~~~~~ 739 (782)
+++++|.+++..... ...+++.++..++.|+++||+|||+.+.+||+||||||+||+++.++. +||+|||++.....
T Consensus 81 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 81 AEGGSLYNVLHGAEP--LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp CTTCBHHHHHHCSSS--EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred CCCCCHHHHHhccCC--CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 999999999975321 224788999999999999999999744468999999999999988876 79999999976543
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.. ....||+.|+|||++.+. .++.++||||+|++
T Consensus 159 ~~----~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~i 192 (307)
T 2eva_A 159 HM----TNNKGSAAWMAPEVFEGS---NYSEKCDVFSWGII 192 (307)
T ss_dssp ----------CCTTSSCHHHHTCC---CCCTHHHHHHHHHH
T ss_pred cc----ccCCCCCceEChhhhCCC---CCCcHHHHHHHHHH
Confidence 22 234689999999998764 45678999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=8.6e-30 Score=276.44 Aligned_cols=188 Identities=24% Similarity=0.369 Sum_probs=157.8
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC-----Ce
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING-----SE 653 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~-----~~ 653 (782)
.++|++.+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|++++++++||||+++++++... ..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 46799999999999999999954 578899999997533 234567899999999999999999999998765 46
Q ss_pred EEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecc
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~ 733 (782)
.++||||++ ++|.+++.. ..+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+
T Consensus 105 ~~iv~e~~~-~~L~~~l~~------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 174 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT------QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGL 174 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEcccC-cCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcc
Confidence 899999996 589998865 358999999999999999999999 8999999999999999999999999999
Q ss_pred ceecCCCCcee--eecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 734 VKNAPDGKYSV--ETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 734 a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
++......... ....+||+.|+|||++.+. ..++.++||||+|++
T Consensus 175 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~i 221 (364)
T 3qyz_A 175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNS--KGYTKSIDIWSVGCI 221 (364)
T ss_dssp CEECCGGGCBCCTTCCCCSCGGGCCHHHHHTB--CSCSTHHHHHHHHHH
T ss_pred eEecCCCCCccccccccccccCCCCCHHhcCC--CCCCcchhHHHHHHH
Confidence 98765432211 2335799999999986543 235678999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=9.5e-30 Score=272.49 Aligned_cols=190 Identities=26% Similarity=0.432 Sum_probs=153.1
Q ss_pred hcCCCccceeecccceEEEEEEeCC-----CcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeE
Q 003982 580 TDNFSEANILGRGGFGVVYGGELPD-----GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSER 654 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~ 654 (782)
.++|++.+.||+|+||.||+|.... +..||||+++... .......+.+|++++++++||||+++++++.+.+..
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 3578889999999999999996432 2359999997543 344567799999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccc
Q 003982 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734 (782)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a 734 (782)
++||||+++++|.+++... ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++
T Consensus 122 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 194 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREK----DGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLS 194 (333)
T ss_dssp EEEEECCTTEEHHHHHHHT----TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred EEEEeCCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcc
Confidence 9999999999999999752 2458999999999999999999999 89999999999999999999999999999
Q ss_pred eecCCCCce--eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 735 KNAPDGKYS--VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 735 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+........ ......+|+.|+|||++.+. .++.++||||+|++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 239 (333)
T 1mqb_A 195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYR---KFTSASDVWSFGIV 239 (333)
T ss_dssp ----------------CCCGGGSCHHHHHSC---CCCHHHHHHHHHHH
T ss_pred hhhccccccccccCCCCccccccCchhcccC---CCCchhhhHHHHHH
Confidence 876543211 11223468899999988654 45778999999986
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=280.14 Aligned_cols=184 Identities=21% Similarity=0.279 Sum_probs=157.2
Q ss_pred hcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhc------CCCCcceEEeEEEeCC
Q 003982 580 TDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV------RHRHLVALLGYCINGS 652 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~nI~~~~~~~~~~~ 652 (782)
..+|++.+.||+|+||.||+|. ..+++.||||++... ....+.+.+|+++++.+ +|+||+++++++....
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 4679999999999999999995 456899999999753 24456788899888887 5779999999999999
Q ss_pred eEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCc--EEEEe
Q 003982 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR--AKVAD 730 (782)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~--~kL~D 730 (782)
..++||||+. ++|.+++.... ...+++..+..++.|++.||+|||+ .||+||||||+|||++.++. +||+|
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~D 245 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKNK---FQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVID 245 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECC
T ss_pred eEEEEEeccC-CCHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEee
Confidence 9999999995 69999987632 2458999999999999999999999 89999999999999999887 99999
Q ss_pred eccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 731 FGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 731 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
||+|+...... ...+||+.|+|||++.+. .++.++||||+||+
T Consensus 246 FG~a~~~~~~~----~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~i 288 (429)
T 3kvw_A 246 FGSSCYEHQRV----YTYIQSRFYRAPEVILGA---RYGMPIDMWSLGCI 288 (429)
T ss_dssp CTTCEETTCCC----CSSCSCGGGCCHHHHHTB---CCCTHHHHHHHHHH
T ss_pred cccceecCCcc----cccCCCCCccChHHHhCC---CCCchHHHHhHHHH
Confidence 99998765432 235789999999998765 45778999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=269.41 Aligned_cols=188 Identities=29% Similarity=0.433 Sum_probs=156.3
Q ss_pred HHhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEE
Q 003982 578 QVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656 (782)
Q Consensus 578 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 656 (782)
...++|++.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|++++++++||||+++++++.+.+..++
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 4567899999999999999999965 468999999997543 34678999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecccee
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~ 736 (782)
||||+++++|.+++... ...+++.++..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++..
T Consensus 102 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 174 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLR----NKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQ 174 (314)
T ss_dssp EEECCTTEEHHHHHHHH----TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EeecCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchh
Confidence 99999999999998642 2458999999999999999999999 8999999999999999999999999999987
Q ss_pred cCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 737 APDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
...... ......||+.|+|||++.+. .++.++||||+|++
T Consensus 175 ~~~~~~-~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 214 (314)
T 3com_A 175 LTDTMA-KRNTVIGTPFWMAPEVIQEI---GYNCVADIWSLGIT 214 (314)
T ss_dssp CBTTBS-CBCCCCSCGGGCCHHHHSSS---CBCTTHHHHHHHHH
T ss_pred hhhhcc-ccCccCCCCCccChhhcCCC---CCCccccHHHHHHH
Confidence 654322 22345689999999998764 35668899999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-29 Score=263.64 Aligned_cols=190 Identities=26% Similarity=0.406 Sum_probs=156.9
Q ss_pred CCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEc
Q 003982 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 660 (782)
+|.....||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence 455567999999999999964 578899999997653 34567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECC-CCcEEEEeeccceecCC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD-DMRAKVADFGLVKNAPD 739 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~-~~~~kL~DfG~a~~~~~ 739 (782)
+++++|.+++.... +...+++..+..++.|++.||+|||+ .||+||||||+||+++. ++.+||+|||++.....
T Consensus 101 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 101 VPGGSLSALLRSKW--GPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp CSEEEHHHHHHHTT--CCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred CCCCCHHHHHHhhc--cCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 99999999997632 22356789999999999999999999 89999999999999987 89999999999987654
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... ......||+.|+|||++.+.. ..++.++|+||+|++
T Consensus 176 ~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~~~Di~slG~i 214 (295)
T 2clq_A 176 INP-CTETFTGTLQYMAPEIIDKGP-RGYGKAADIWSLGCT 214 (295)
T ss_dssp ------CCCCCCGGGCCHHHHHHGG-GGCSHHHHHHHHHHH
T ss_pred CCC-cccccCCCccccChhhhcCCC-CCCCcHHHHHHHHHH
Confidence 321 123356899999999886531 135778999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-30 Score=275.35 Aligned_cols=194 Identities=26% Similarity=0.431 Sum_probs=161.6
Q ss_pred hcCCCccceeecccceEEEEEEeC-CC-----cEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCC
Q 003982 580 TDNFSEANILGRGGFGVVYGGELP-DG-----TKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGS 652 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~ 652 (782)
.++|++.+.||+|+||.||+|... ++ ..||+|++.... .....+.+.+|+++++++ +||||+++++++.+.+
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 468999999999999999999653 22 479999997643 234567899999999999 8999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHHhhccC---------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCC
Q 003982 653 ERLLVYEYMPRGTLAQHLFEWHDH---------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD 723 (782)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~---------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~ 723 (782)
..++||||+++|+|.+++...... ....+++.++..++.|++.||+|||+ .||+||||||+||+++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECCC
Confidence 999999999999999999764321 12357999999999999999999999 899999999999999999
Q ss_pred CcEEEEeeccceecCCCCc-eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 724 MRAKVADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 724 ~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+.+||+|||+++....... .......||+.|+|||++.+. .++.++||||+|++
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 255 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC---VYTVQSDVWSYGIL 255 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC---CCCHHHHHHHHHHH
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccC---CCChHHHHHHHHHH
Confidence 9999999999986543322 222334578899999987654 35788999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=7.7e-30 Score=268.81 Aligned_cols=190 Identities=30% Similarity=0.492 Sum_probs=156.0
Q ss_pred hcCCCccceeecccceEEEEEEeCC----CcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEE-eCCeE
Q 003982 580 TDNFSEANILGRGGFGVVYGGELPD----GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCI-NGSER 654 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~-~~~~~ 654 (782)
..+|++.+.||+|+||.||+|...+ ...||+|.+.... .....+.+.+|++++++++||||+++++++. .++..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 3568889999999999999996532 2358999987533 3445678999999999999999999999865 45678
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccc
Q 003982 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734 (782)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a 734 (782)
++||||+++|+|.+++... ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++
T Consensus 103 ~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a 175 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLA 175 (298)
T ss_dssp EEEEECCTTCBHHHHHHCT----TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGG
T ss_pred EEEEeCCCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECccccc
Confidence 9999999999999999652 3457999999999999999999999 89999999999999999999999999999
Q ss_pred eecCCCCc---eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 735 KNAPDGKY---SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 735 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+....... .......||+.|+|||++.+. .++.++|+||+|++
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 221 (298)
T 3f66_A 176 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ---KFTTKSDVWSFGVL 221 (298)
T ss_dssp CCCSCGGGCBC-----CCBCGGGSCHHHHHHC---CCCHHHHHHHHHHH
T ss_pred ccccccchhccccccCCCCCccccChHHhcCC---CCChHHHHHHHHHH
Confidence 87654332 122334678899999988664 45778999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-30 Score=283.56 Aligned_cols=185 Identities=25% Similarity=0.398 Sum_probs=150.4
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC------Ce
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING------SE 653 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~------~~ 653 (782)
.+|++.+.||+|+||.||+|.. .+++.||||++.... ..+.+|++++++++||||+++++++... ..
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 4688999999999999999966 468999999986543 2234799999999999999999988642 23
Q ss_pred EEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCC-CcEEEEeec
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD-MRAKVADFG 732 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~-~~~kL~DfG 732 (782)
.++||||+++ ++.+.+...... ...+++..+..++.|+++||+|||+ .||+||||||+|||++.+ +.+||+|||
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSRA-KQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEeehhcccc-cHHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccch
Confidence 5799999965 777776654332 3568999999999999999999998 899999999999999965 678999999
Q ss_pred cceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 733 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+|+....... ....+||+.|+|||++.+. ..++.++||||+||+
T Consensus 203 ~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlG~i 246 (420)
T 1j1b_A 203 SAKQLVRGEP--NVSYICSRYYRAPELIFGA--TDYTSSIDVWSAGCV 246 (420)
T ss_dssp TCEECCTTCC--CCSCCSCTTSCCHHHHTTC--SSCCTHHHHHHHHHH
T ss_pred hhhhcccCCC--ceeeeeCCCcCCHHHHcCC--CCCCchhhhHHHHHH
Confidence 9987654332 2335789999999988653 135678999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=266.76 Aligned_cols=193 Identities=30% Similarity=0.383 Sum_probs=161.7
Q ss_pred HHhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCC-------hhhHHHHHHHHHHHHhcC-CCCcceEEeEE
Q 003982 578 QVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-------NKGLSEFQAEIAVLTKVR-HRHLVALLGYC 648 (782)
Q Consensus 578 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~ 648 (782)
.+.++|++.+.||+|+||.||+|.. .+++.||||+++..... ....+.+.+|+++++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 4567899999999999999999965 46899999999754311 123466889999999996 99999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEE
Q 003982 649 INGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKV 728 (782)
Q Consensus 649 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL 728 (782)
.+....++||||+++++|.+++... ..+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl 165 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKL 165 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEE
T ss_pred ccCCeEEEEEeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEE
Confidence 9999999999999999999999762 358999999999999999999999 89999999999999999999999
Q ss_pred EeeccceecCCCCceeeecccccccccCccccccch---hhhHHHHHHHHHhccc
Q 003982 729 ADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHW---MILCQMTGLIWLHGSV 780 (782)
Q Consensus 729 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~dvws~Gvv 780 (782)
+|||++........ .....||+.|+|||++.+.. ...++.++|+||+|++
T Consensus 166 ~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~ 218 (298)
T 1phk_A 166 TDFGFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 218 (298)
T ss_dssp CCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHH
T ss_pred ecccchhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHH
Confidence 99999987754332 23356899999999875321 1134668999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=271.31 Aligned_cols=191 Identities=31% Similarity=0.526 Sum_probs=154.8
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEE--EEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCCeEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKI--AVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLL 656 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~v--avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~l 656 (782)
++|++.+.||+|+||.||+|.. .++..+ |+|+++... .....+.+.+|+++++++ +||||+++++++.+.+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 5789999999999999999954 456644 999887532 234556789999999999 89999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhcc-----------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCc
Q 003982 657 VYEYMPRGTLAQHLFEWHD-----------HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR 725 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~ 725 (782)
||||+++++|.+++..... .....+++.+++.++.|++.||+|||+ .||+||||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCe
Confidence 9999999999999976320 113468999999999999999999999 89999999999999999999
Q ss_pred EEEEeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 726 AKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 726 ~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+||+|||+++...... ......+++.|+|||++.+. .++.++||||+|++
T Consensus 181 ~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 230 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYS---VYTTNSDVWSYGVL 230 (327)
T ss_dssp EEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHC---EECHHHHHHHHHHH
T ss_pred EEEcccCcCccccccc--cccCCCCCccccChhhhccc---cCCchhcchHHHHH
Confidence 9999999987543211 11223568899999988654 35778999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.9e-30 Score=280.37 Aligned_cols=186 Identities=24% Similarity=0.384 Sum_probs=151.3
Q ss_pred hcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCe------
Q 003982 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE------ 653 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~------ 653 (782)
..+|++.+.||+|+||+||+|+...+..||+|++..... ...+|+++++.++||||+++++++...+.
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 457999999999999999999887777799998865431 22479999999999999999999865443
Q ss_pred EEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEC-CCCcEEEEeec
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIG-DDMRAKVADFG 732 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~-~~~~~kL~DfG 732 (782)
.++||||+++ ++.+.+...... ...+++..+..++.|+++||+|||+ .||+||||||+||+++ .++.+||+|||
T Consensus 113 ~~lv~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 113 LNLVLEYVPE-TVYRASRHYAKL-KQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp EEEEEECCSE-EHHHHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEeeccCc-cHHHHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 7899999976 455554433222 3468999999999999999999999 8999999999999998 78999999999
Q ss_pred cceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 733 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+|+....... .....||+.|+|||++.+. ..++.++||||+||+
T Consensus 188 ~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlG~i 231 (394)
T 4e7w_A 188 SAKILIAGEP--NVSYICSRYYRAPELIFGA--TNYTTNIDIWSTGCV 231 (394)
T ss_dssp TCEECCTTCC--CCSSCSCGGGCCHHHHTTC--SSCCTHHHHHHHHHH
T ss_pred CcccccCCCC--CcccccCcCccCHHHHcCC--CCCCcHHHHHHHHHH
Confidence 9987754332 2345789999999988653 235678999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=265.96 Aligned_cols=191 Identities=26% Similarity=0.399 Sum_probs=164.5
Q ss_pred HHHHhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeE
Q 003982 576 LRQVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSER 654 (782)
Q Consensus 576 l~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~ 654 (782)
...+.++|++.+.||+|+||.||+|.. .+++.||||++..........+.+.+|++++++++||||+++++++.+.+..
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 455678999999999999999999965 4789999999977655455678899999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCC---CcEEEEee
Q 003982 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD---MRAKVADF 731 (782)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~---~~~kL~Df 731 (782)
++||||+++++|.+++... ..+++.++..++.|++.||+|||+ .||+||||||+||+++.+ +.+||+||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Df 168 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDF 168 (287)
T ss_dssp EEEECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECST
T ss_pred EEEEEccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEecc
Confidence 9999999999999988653 358999999999999999999999 899999999999999754 47999999
Q ss_pred ccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 732 GLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 732 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|++........ .....||+.|+|||++.+. ++.++|+||+|++
T Consensus 169 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~----~~~~~Di~slG~~ 211 (287)
T 2wei_A 169 GLSTCFQQNTK--MKDRIGTAYYIAPEVLRGT----YDEKCDVWSAGVI 211 (287)
T ss_dssp TGGGTBCCCSS--CSCHHHHHTTCCHHHHTTC----CCTHHHHHHHHHH
T ss_pred CcceeecCCCc--cccccCcccccChHHhcCC----CCCchhhHhHHHH
Confidence 99986654331 1234589999999998775 3568999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.2e-30 Score=277.80 Aligned_cols=187 Identities=13% Similarity=0.095 Sum_probs=140.2
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCC-hhhHHHHHHHHHHHHhc--CCCCcceEE-------eEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKV--RHRHLVALL-------GYCI 649 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l--~h~nI~~~~-------~~~~ 649 (782)
.+|.+.+.||+|+||.||+|.. .+++.||||++...... ....+.+++|+++++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 4588999999999999999965 57899999999876542 34556778886555555 699988865 4444
Q ss_pred eC-----------------CeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHH------HHHHHHHHHHHHHHhhcCCC
Q 003982 650 NG-----------------SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQR------VTIALDVARGVEYLHSLAQQ 706 (782)
Q Consensus 650 ~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~------~~i~~qi~~aL~~LH~~~~~ 706 (782)
.+ ...|+||||++ |+|.+++..... .+++..+ ..++.|++.||+|||+ .
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~ 213 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF----VYVFRGDEGILALHILTAQLIRLAANLQS---K 213 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHHHHH---T
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc----ccchhhhhhhhhHHHHHHHHHHHHHHHHH---C
Confidence 33 23799999998 899999987532 2344455 6788999999999999 8
Q ss_pred CeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 707 SFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 707 ~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
||+||||||+|||++.++.+||+|||+|+...... ....+|+.|+|||++.+. ...++.++||||+||+
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~-~~~~~~~~DiwSlG~i 282 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNAS-TATFTHALNAWQLGLS 282 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTCS-EEECCHHHHHHHHHHH
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCCCc----cCccCCcCCcChhhccCC-CCCcCccccHHHHHHH
Confidence 99999999999999999999999999998765321 134577999999998751 0145789999999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.96 E-value=8.8e-30 Score=276.36 Aligned_cols=190 Identities=17% Similarity=0.238 Sum_probs=152.2
Q ss_pred hcCCCccceeecccceEEEEEEeCC------CcEEEEEEeccccCChh---------hHHHHHHHHHHHHhcCCCCcceE
Q 003982 580 TDNFSEANILGRGGFGVVYGGELPD------GTKIAVKRMESNTMGNK---------GLSEFQAEIAVLTKVRHRHLVAL 644 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~---------~~~~~~~E~~~l~~l~h~nI~~~ 644 (782)
.++|++.+.||+|+||.||+|.... ++.||||++........ ....+.+|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4689999999999999999996644 47899999875431100 01123456667778889999999
Q ss_pred EeEEEeC----CeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE
Q 003982 645 LGYCING----SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI 720 (782)
Q Consensus 645 ~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll 720 (782)
++++... ...++||||+ +++|.+++... ...+++.++..++.|++.||+|||+ .||+||||||+|||+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill 185 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN----AKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEE
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEE
Confidence 9998775 4579999999 99999999762 2458999999999999999999999 899999999999999
Q ss_pred C--CCCcEEEEeeccceecCCCCce------eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 721 G--DDMRAKVADFGLVKNAPDGKYS------VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 721 ~--~~~~~kL~DfG~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+ .++.+||+|||+|+........ ......||+.|+|||++.+. .++.++||||+||+
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~~ 250 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV---APSRRGDLEILGYC 250 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC---CCCHHHHHHHHHHH
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC---CCCchhhHHHHHHH
Confidence 8 8899999999999876543211 11234599999999998875 35789999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=4.1e-30 Score=279.06 Aligned_cols=189 Identities=30% Similarity=0.496 Sum_probs=146.9
Q ss_pred cCCCccceeecccceEEEEEEeC--CC--cEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEe-CCeEE
Q 003982 581 DNFSEANILGRGGFGVVYGGELP--DG--TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN-GSERL 655 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~-~~~~~ 655 (782)
..|++.+.||+|+||.||+|... ++ ..||||.++... .....+++.+|++++++++||||+++++++.+ ++..+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 34777899999999999999643 22 368999986532 34566889999999999999999999998754 45789
Q ss_pred EEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccce
Q 003982 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (782)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~ 735 (782)
+||||+++|+|.+++... ...+++.++..++.|+++||+|||+ .||+||||||+||+++.++.+||+|||+++
T Consensus 168 lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~ 240 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLAR 240 (373)
T ss_dssp EEEECCTTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred EEEECCCCCCHHHHHhhc----ccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeeccccc
Confidence 999999999999999652 2457899999999999999999999 899999999999999999999999999998
Q ss_pred ecCCCCce---eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 736 NAPDGKYS---VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 736 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
........ ......+|+.|+|||++.+. .++.++||||+|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwSlG~i 285 (373)
T 3c1x_A 241 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQ---KFTTKSDVWSFGVL 285 (373)
T ss_dssp -----------------CCGGGSCHHHHHHC---CCCHHHHHHHHHHH
T ss_pred cccccccccccccCCCCCcccccChHHhcCC---CCCcHHHHHHHHHH
Confidence 76443221 12334578899999988754 45789999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.6e-30 Score=269.88 Aligned_cols=192 Identities=26% Similarity=0.406 Sum_probs=155.6
Q ss_pred HhcCCCccceeecccceEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
..++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 3578999999999999999999664 68999999987653 34567899999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
|||+++++|.+++.... ..+++.++..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++...
T Consensus 95 ~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 167 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELD----RGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKN 167 (302)
T ss_dssp EECCTTEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred EEeCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence 99999999999886632 358999999999999999999999 89999999999999999999999999987543
Q ss_pred CCCCceeeecccccccccCccccccc--hhhhHHHHHHHHHhccc
Q 003982 738 PDGKYSVETRLAGTFGYLAPEYAGKH--WMILCQMTGLIWLHGSV 780 (782)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~dvws~Gvv 780 (782)
.... .......||+.|+|||++... -...++.++||||+|++
T Consensus 168 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~i 211 (302)
T 2j7t_A 168 LKTL-QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGIT 211 (302)
T ss_dssp HHHH-HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHH
T ss_pred cccc-cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHH
Confidence 2111 111234689999999987421 01235678999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.2e-30 Score=294.60 Aligned_cols=182 Identities=26% Similarity=0.394 Sum_probs=151.3
Q ss_pred ceeecccceEEEEEEe---CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEccCC
Q 003982 587 NILGRGGFGVVYGGEL---PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPR 663 (782)
Q Consensus 587 ~~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~ 663 (782)
+.||+|+||.||+|.+ ..++.||||+++.........+++.+|++++++++||||+++++++.+ +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 5799999999999944 346789999998765555567889999999999999999999999864 568999999999
Q ss_pred CCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCc-
Q 003982 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY- 742 (782)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~- 742 (782)
|+|.+++.. ...+++.++..++.|++.||+|||+ .||+||||||+|||++.++.+||+|||+|+.......
T Consensus 454 g~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 454 GPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp EEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred CCHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 999999965 3458999999999999999999999 8999999999999999999999999999987654331
Q ss_pred -eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 743 -SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 743 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.......+|+.|+|||++.+. .++.++||||+||+
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~---~~~~~sDvwSlGv~ 561 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYY---KFSSKSDVWSFGVL 561 (635)
T ss_dssp ---------CGGGSCHHHHHHC---CCCHHHHHHHHHHH
T ss_pred cccccCCCCceeeeChhhhcCC---CCCcHHHHHHHHHH
Confidence 222334568899999998654 45789999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-30 Score=272.10 Aligned_cols=196 Identities=27% Similarity=0.417 Sum_probs=144.8
Q ss_pred HhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
..++|++.+.||+|+||.||+|.. .+++.||||++..... ....+++.+|++++++++||||+++++++...+..++|
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 357899999999999999999964 4789999999865432 23456788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccc
Q 003982 658 YEYMPRGTLAQHLFEWHDH---GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a 734 (782)
|||+++++|.+++...... ....+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 9999999999998764322 23458999999999999999999999 89999999999999999999999999998
Q ss_pred eecCCCCc----eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 735 KNAPDGKY----SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 735 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
........ .......||+.|+|||++.+. ..++.++||||+|++
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~i 216 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQV--RGYDFKADIWSFGIT 216 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHH--HCCCTHHHHHHHHHH
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccc--cCCCchhhHHHHHHH
Confidence 76643221 112335689999999987652 134678999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-29 Score=265.26 Aligned_cols=194 Identities=22% Similarity=0.340 Sum_probs=156.9
Q ss_pred HhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCC--hhhHHHHHHHHHHHHhcCCCCcceEEeEEE--eCCe
Q 003982 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG--NKGLSEFQAEIAVLTKVRHRHLVALLGYCI--NGSE 653 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~--~~~~ 653 (782)
..++|++.+.||+|+||.||+|.. .+++.||+|++...... ....+.+.+|++++++++||||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 457899999999999999999965 56889999999764321 234578999999999999999999999984 4457
Q ss_pred EEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecc
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~ 733 (782)
.++||||++++ +.+++.... ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~ 155 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVP---EKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGV 155 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHST---TCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEEehhccCC-HHHHHHhCc---ccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeecccc
Confidence 89999999876 777776532 3468999999999999999999999 8999999999999999999999999999
Q ss_pred ceecCCCCc-eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 734 VKNAPDGKY-SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 734 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+........ .......||+.|+|||++.+. ......++||||+|++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~i 202 (305)
T 2wtk_C 156 AEALHPFAADDTCRTSQGSPAFQPPEIANGL-DTFSGFKVDIWSAGVT 202 (305)
T ss_dssp CEECCTTCSSCEECCCCSCGGGCCHHHHTCC-SCEESHHHHHHHHHHH
T ss_pred ccccCccccccccccCCCCCCCcChhhccCc-ccCCcchhhHHHHHHH
Confidence 987654221 222345689999999988653 1123678999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=271.32 Aligned_cols=193 Identities=26% Similarity=0.352 Sum_probs=145.3
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC-CCCcceEEeEEE--------
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCI-------- 649 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~-------- 649 (782)
..+|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+++++++. ||||+++++++.
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS--HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc--hHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 35789999999999999999964 578999999986543 455678899999999996 999999999984
Q ss_pred eCCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEEcCCCCCCEEECCCCcEE
Q 003982 650 NGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS--FIHRDLKPSNILIGDDMRAK 727 (782)
Q Consensus 650 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~--ivHrDikp~NIll~~~~~~k 727 (782)
.....++||||++ |+|.+++...... ..+++.+++.++.|++.||+|||+ .| |+||||||+||+++.++.+|
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESR--GPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTT--CSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEE
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEE
Confidence 3345799999995 7999998764432 468999999999999999999998 78 99999999999999999999
Q ss_pred EEeeccceecCCCCce-----------eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 728 VADFGLVKNAPDGKYS-----------VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 728 L~DfG~a~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|+|||+++........ ......||+.|+|||++...-...++.++||||+|++
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~i 242 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCI 242 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHH
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHH
Confidence 9999999876543211 1113458999999999843222345779999999986
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.3e-30 Score=272.12 Aligned_cols=189 Identities=27% Similarity=0.469 Sum_probs=150.3
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcE----EEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTK----IAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSER 654 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~ 654 (782)
.++|++.+.||+|+||.||+|.. .+++. ||+|.+.... .....+.+.+|++++++++||||+++++++.++. .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~ 91 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence 36799999999999999999964 44554 5777765432 2446788999999999999999999999998754 7
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccc
Q 003982 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734 (782)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a 734 (782)
++|+||+++|+|.+++... ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++
T Consensus 92 ~~v~~~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a 164 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp EEEECCCSSCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred eEEEEecCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence 8999999999999999763 2358999999999999999999999 89999999999999999999999999999
Q ss_pred eecCCCCce-eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 735 KNAPDGKYS-VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 735 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+........ ......+|+.|+|||++.+. .++.++||||+|++
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~Di~slG~i 208 (327)
T 3lzb_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHR---IYTHQSDVWSYGVT 208 (327)
T ss_dssp ---------------CCCGGGSCHHHHHHC---CCCHHHHHHHHHHH
T ss_pred eEccCccccccccCCCccccccCHHHHcCC---CCChHHHHHHHHHH
Confidence 876543221 12234568899999988764 45778999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=265.66 Aligned_cols=188 Identities=28% Similarity=0.444 Sum_probs=156.3
Q ss_pred CCCccceeecccceEEEEEEeC-CC---cEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeE-EE
Q 003982 582 NFSEANILGRGGFGVVYGGELP-DG---TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSER-LL 656 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~-~l 656 (782)
.|...+.||+|+||.||+|... ++ ..||+|++.... .....+.+.+|++++++++||||+++++++.+.+.. ++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 4566799999999999999642 22 379999987533 344567899999999999999999999999876665 99
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecccee
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~ 736 (782)
||||+.+++|.+++... ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++.
T Consensus 101 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 173 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSP----QRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARD 173 (298)
T ss_dssp EECCCTTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred EEecccCCCHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence 99999999999998652 3458999999999999999999999 8999999999999999999999999999986
Q ss_pred cCCCCc---eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 737 APDGKY---SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 737 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
...... .......+|+.|+|||.+.+. .++.++||||+|++
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 217 (298)
T 3pls_A 174 ILDREYYSVQQHRHARLPVKWTALESLQTY---RFTTKSDVWSFGVL 217 (298)
T ss_dssp TTTGGGGCSCCSSCTTCGGGGSCHHHHTTC---CCCHHHHHHHHHHH
T ss_pred ccCCcccccccCcCCCCCccccChhhhccC---CCChhhchhhHHHH
Confidence 644321 112234678999999998764 45778999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.96 E-value=9e-30 Score=276.89 Aligned_cols=184 Identities=25% Similarity=0.404 Sum_probs=154.3
Q ss_pred hcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeE----
Q 003982 580 TDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSER---- 654 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~---- 654 (782)
.++|.+.+.||+|+||.||+|. ..+++.||||++..........+.+.+|+++++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 5789999999999999999995 45789999999987655555678899999999999999999999999877654
Q ss_pred --EEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeec
Q 003982 655 --LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (782)
Q Consensus 655 --~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG 732 (782)
++||||++ ++|.+.+. ..+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||
T Consensus 121 ~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg 189 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG-------MEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFG 189 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTT
T ss_pred eEEEEEcccc-ccHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecC
Confidence 99999996 68877762 348999999999999999999999 899999999999999999999999999
Q ss_pred cceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 733 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+++..... .....||+.|+|||++.+. ..++.++||||+|++
T Consensus 190 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~i 231 (371)
T 4exu_A 190 LARHADAE----MTGYVVTRWYRAPEVILSW--MHYNQTVDIWSVGCI 231 (371)
T ss_dssp CC------------CTTCCCTTSCHHHHSCC--SCCCTTHHHHHHHHH
T ss_pred cccccccC----cCCcccCccccCHHHhcCC--CCCCcHHhHHHHHHH
Confidence 99865432 2345789999999988763 134668999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-29 Score=271.66 Aligned_cols=189 Identities=26% Similarity=0.393 Sum_probs=156.1
Q ss_pred HhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC-----C
Q 003982 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING-----S 652 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~-----~ 652 (782)
+.++|++.+.||+|+||.||+|.. .+++.||||++.... .......+.+|++++++++||||+++++++... .
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 346899999999999999999965 478999999996533 234567788999999999999999999988754 6
Q ss_pred eEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeec
Q 003982 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (782)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG 732 (782)
..++||||++ ++|.+++.. ..+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 157 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVIST------QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFG 157 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEeccC-ccHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEecc
Confidence 7899999996 689988865 358999999999999999999999 899999999999999999999999999
Q ss_pred cceecCCCCce---------eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 733 LVKNAPDGKYS---------VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 733 ~a~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+++........ ......||+.|+|||++.+. ..++.++||||+|++
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~Di~slG~i 212 (353)
T 2b9h_A 158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS--AKYSRAMDVWSCGCI 212 (353)
T ss_dssp TCEECC----------------CCCCCCGGGCCHHHHHSC--CCCCHHHHHHHHHHH
T ss_pred cccccccccccccCccccccchhhccccccccCCeeeccC--CCccchhhHHHHHHH
Confidence 99876542211 11234689999999986542 135778999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.4e-30 Score=275.90 Aligned_cols=189 Identities=16% Similarity=0.198 Sum_probs=150.4
Q ss_pred hcCCCccceeecccceEEEEEEeC----CCcEEEEEEeccccCCh---------hhHHHHHHHHHHHHhcCCCCcceEEe
Q 003982 580 TDNFSEANILGRGGFGVVYGGELP----DGTKIAVKRMESNTMGN---------KGLSEFQAEIAVLTKVRHRHLVALLG 646 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~---------~~~~~~~~E~~~l~~l~h~nI~~~~~ 646 (782)
.++|++.+.||+|+||.||+|... ++..||||++....... .....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367999999999999999999664 57889999987653210 01234668889999999999999999
Q ss_pred EEEe----CCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECC
Q 003982 647 YCIN----GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD 722 (782)
Q Consensus 647 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~ 722 (782)
++.+ ....++||||+ +++|.+++... ..+++.+++.++.|++.||+|||+ .||+||||||+||+++.
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~ 186 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN-----GTFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGY 186 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG-----GBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEES
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEcc
Confidence 9988 77889999999 99999998653 268999999999999999999999 89999999999999988
Q ss_pred CC--cEEEEeeccceecCCCCce------eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 723 DM--RAKVADFGLVKNAPDGKYS------VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 723 ~~--~~kL~DfG~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
++ .+||+|||+|+........ ......||+.|+|||++.+. .++.++||||+||+
T Consensus 187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~i 249 (345)
T 2v62_A 187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV---ALSRRSDVEILGYC 249 (345)
T ss_dssp SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC---CCCHHHHHHHHHHH
T ss_pred CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC---CCCchhhHHHHHHH
Confidence 77 9999999999876432211 11335799999999998765 35789999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-29 Score=264.55 Aligned_cols=188 Identities=23% Similarity=0.347 Sum_probs=152.0
Q ss_pred HHhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEE-EeCCeEE
Q 003982 578 QVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYC-INGSERL 655 (782)
Q Consensus 578 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~-~~~~~~~ 655 (782)
.+.++|++.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|++++++++|++++..+.++ .+....+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc----cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence 4567899999999999999999964 678999999876543 224588899999999987766665554 6778889
Q ss_pred EEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE---CCCCcEEEEeec
Q 003982 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFG 732 (782)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll---~~~~~~kL~DfG 732 (782)
+||||+ +++|.+++... ...+++.++..++.|++.||+|||+ .||+||||||+||++ +.++.+||+|||
T Consensus 82 lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg 153 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFG 153 (296)
T ss_dssp EEEECC-CCBHHHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCT
T ss_pred EEEEcc-CCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCc
Confidence 999999 99999998753 2358999999999999999999999 899999999999999 788999999999
Q ss_pred cceecCCCCc------eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 733 LVKNAPDGKY------SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 733 ~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+++....... .......||+.|+|||++.+. .++.++||||+||+
T Consensus 154 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~i 204 (296)
T 4hgt_A 154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI---EQSRRDDLESLGYV 204 (296)
T ss_dssp TCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTC---CCCHHHHHHHHHHH
T ss_pred cceeccCcccCccCCCCcccccCCCccccchHHhcCC---CCCchhHHHHHHHH
Confidence 9987654332 122345789999999998775 35788999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.4e-30 Score=280.27 Aligned_cols=192 Identities=26% Similarity=0.377 Sum_probs=143.2
Q ss_pred HhcCCCc-cceeecccceEEEEEEeC---CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEe--CC
Q 003982 579 VTDNFSE-ANILGRGGFGVVYGGELP---DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN--GS 652 (782)
Q Consensus 579 ~~~~y~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~--~~ 652 (782)
+.+.|++ .++||+|+||.||+|... +++.||||++..... ...+.+|++++++++||||+++++++.. ..
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADR 93 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence 3455666 568999999999999754 578999999975432 3568899999999999999999999965 67
Q ss_pred eEEEEEEccCCCCHHHHHHhhccC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE----CCCC
Q 003982 653 ERLLVYEYMPRGTLAQHLFEWHDH----GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI----GDDM 724 (782)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll----~~~~ 724 (782)
..++||||++ ++|.+++...... ....+++.+++.++.|++.||+|||+ .||+||||||+|||+ +.++
T Consensus 94 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 94 KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTT
T ss_pred eEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCC
Confidence 8899999996 5888887643321 12358999999999999999999999 899999999999999 6778
Q ss_pred cEEEEeeccceecCCCCc--eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 725 RAKVADFGLVKNAPDGKY--SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 725 ~~kL~DfG~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.+||+|||+|+....... ......+||+.|+|||++.+. ..++.++||||+||+
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlG~i 225 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA--RHYTKAIDIWAIGCI 225 (405)
T ss_dssp CEEECCTTCCC----------------CCCTTCCHHHHTTC--CSCCHHHHHHHHHHH
T ss_pred cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCC--CcccchhhhHHHHHH
Confidence 999999999987654321 222345799999999988763 125778999999986
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=263.12 Aligned_cols=230 Identities=17% Similarity=0.230 Sum_probs=173.5
Q ss_pred CCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEE
Q 003982 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNL 192 (782)
Q Consensus 113 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 192 (782)
.++++|+|++|+++.+|.. +.++++|++|+|++|++.. +|..+.++++|++|+|++|+++ .+|..+..+++|++|
T Consensus 81 ~~l~~L~L~~n~l~~lp~~-l~~l~~L~~L~L~~n~l~~---lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L 155 (328)
T 4fcg_A 81 PGRVALELRSVPLPQFPDQ-AFRLSHLQHMTIDAAGLME---LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLREL 155 (328)
T ss_dssp TTCCEEEEESSCCSSCCSC-GGGGTTCSEEEEESSCCCC---CCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEE
T ss_pred cceeEEEccCCCchhcChh-hhhCCCCCEEECCCCCccc---hhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEE
Confidence 4566666666666655554 3346666666666666553 5666667777777777777776 446677777777777
Q ss_pred EcccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeecccccCCCCCCCCCCCCCEEEcCCCcCcc
Q 003982 193 RLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTG 272 (782)
Q Consensus 193 ~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~ 272 (782)
+|++|++.+.+|.. +... . ....+..+++|++|+|++|+|+
T Consensus 156 ~L~~n~~~~~~p~~------------------------------~~~~-----~---~~~~~~~l~~L~~L~L~~n~l~- 196 (328)
T 4fcg_A 156 SIRACPELTELPEP------------------------------LAST-----D---ASGEHQGLVNLQSLRLEWTGIR- 196 (328)
T ss_dssp EEEEETTCCCCCSC------------------------------SEEE-----C----CCCEEESTTCCEEEEEEECCC-
T ss_pred ECCCCCCccccChh------------------------------Hhhc-----c---chhhhccCCCCCEEECcCCCcC-
Confidence 77777766666532 1111 1 1123567999999999999999
Q ss_pred CcchhhcCCCCCCEEEccCCcccCCCCCCCCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCC
Q 003982 273 VVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEG 352 (782)
Q Consensus 273 ~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (782)
.+|..+..+++|++|++++|++++.
T Consensus 197 ~lp~~l~~l~~L~~L~L~~N~l~~l------------------------------------------------------- 221 (328)
T 4fcg_A 197 SLPASIANLQNLKSLKIRNSPLSAL------------------------------------------------------- 221 (328)
T ss_dssp CCCGGGGGCTTCCEEEEESSCCCCC-------------------------------------------------------
T ss_pred cchHhhcCCCCCCEEEccCCCCCcC-------------------------------------------------------
Confidence 8899999999999999999998842
Q ss_pred CCCCCCCCcccccCCceeEEEccCcccccccCccccccccCCeEecccccccccCCccCCCCCCCCeEecCCCcCCCCCC
Q 003982 353 NNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVP 432 (782)
Q Consensus 353 ~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p 432 (782)
|..+..+++|++|+|++|.+.+.+|..|+++++|++|+|++|++.+.+|..+..+++|+.|+|++|++.|.+|
T Consensus 222 -------~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP 294 (328)
T 4fcg_A 222 -------GPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLP 294 (328)
T ss_dssp -------CGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCC
T ss_pred -------chhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhcc
Confidence 3345667899999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCC---CCcceecCCCCCC
Q 003982 433 DFG---SNVKFTVSPGNPF 448 (782)
Q Consensus 433 ~~~---~~~~~~~~~~n~~ 448 (782)
... ..+....++.|..
T Consensus 295 ~~l~~L~~L~~l~l~~~~~ 313 (328)
T 4fcg_A 295 SLIAQLPANCIILVPPHLQ 313 (328)
T ss_dssp GGGGGSCTTCEEECCGGGS
T ss_pred HHHhhccCceEEeCCHHHH
Confidence 532 3344445554443
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=269.98 Aligned_cols=194 Identities=26% Similarity=0.433 Sum_probs=156.9
Q ss_pred hcCCCccceeecccceEEEEEEe------CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCe
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE 653 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~ 653 (782)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ......++.+|+.++++++||||+++++++.+...
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 46899999999999999999963 357789999996432 34456789999999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhhccC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECC---CCcEEE
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHDH--GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD---DMRAKV 728 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~---~~~~kL 728 (782)
.++||||+++++|.+++...... ....+++.+++.++.|++.||.|||+ .||+||||||+||+++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEE
Confidence 99999999999999999874322 12358999999999999999999999 89999999999999984 446999
Q ss_pred EeeccceecCCCCc-eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 729 ADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 729 ~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+|||++........ .......||+.|+|||++.+. .++.++||||+|++
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 234 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG---IFTSKTDTWSFGVL 234 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC---CCCHHHHHHHHHHH
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCC---CCCchhhHHHHHHH
Confidence 99999975533222 222334679999999988654 35778999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-29 Score=269.36 Aligned_cols=190 Identities=26% Similarity=0.382 Sum_probs=156.8
Q ss_pred HhcCCCccceeecccceEEEEEEe--CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhc---CCCCcceEEeEEE----
Q 003982 579 VTDNFSEANILGRGGFGVVYGGEL--PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV---RHRHLVALLGYCI---- 649 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~nI~~~~~~~~---- 649 (782)
..++|++.+.||+|+||.||+|.. .+++.||+|++............+.+|+++++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999976 4688999999976543333334566777777766 8999999999987
Q ss_pred -eCCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEE
Q 003982 650 -NGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKV 728 (782)
Q Consensus 650 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL 728 (782)
.....++||||++ |+|.+++.... ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl 161 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKL 161 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEE
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEE
Confidence 4567899999997 69999987632 2348999999999999999999999 89999999999999999999999
Q ss_pred EeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 729 ADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 729 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+|||+++...... ......||+.|+|||++.+. .++.++||||+|++
T Consensus 162 ~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 208 (326)
T 1blx_A 162 ADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQS---SYATPVDLWSVGCI 208 (326)
T ss_dssp CSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTC---CCCTHHHHHHHHHH
T ss_pred ecCcccccccCCC--CccccccccceeCHHHHhcC---CCCcchhHHHHHHH
Confidence 9999997664322 22335689999999988764 35678999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=273.38 Aligned_cols=193 Identities=23% Similarity=0.381 Sum_probs=161.7
Q ss_pred hcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChh---------------hHHHHHHHHHHHHhcCCCCcceE
Q 003982 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNK---------------GLSEFQAEIAVLTKVRHRHLVAL 644 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~---------------~~~~~~~E~~~l~~l~h~nI~~~ 644 (782)
.++|++.+.||+|+||.||+|.. +++.||||++........ ..+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999988 999999999976432211 12789999999999999999999
Q ss_pred EeEEEeCCeEEEEEEccCCCCHHHHHHhh---ccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEC
Q 003982 645 LGYCINGSERLLVYEYMPRGTLAQHLFEW---HDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIG 721 (782)
Q Consensus 645 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~ 721 (782)
++++.+.+..++||||+++++|.+++... .......+++.++..++.|++.||+|||+ ..||+||||||+||+++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMD 186 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEEC
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEc
Confidence 99999999999999999999999883211 11113568999999999999999999996 37999999999999999
Q ss_pred CCCcEEEEeeccceecCCCCceeeecccccccccCccccccchhhhHH-HHHHHHHhccc
Q 003982 722 DDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQ-MTGLIWLHGSV 780 (782)
Q Consensus 722 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~dvws~Gvv 780 (782)
.++.+||+|||.+...... ......||+.|+|||++.+.. .+. .++||||+|++
T Consensus 187 ~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~--~~~~~~~Di~slG~i 241 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNES--SYNGAKVDIWSLGIC 241 (348)
T ss_dssp TTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCC--CEEHHHHHHHHHHHH
T ss_pred CCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCC--CCCcchhhHHHHHHH
Confidence 9999999999999876543 223457899999999987651 223 48999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-29 Score=268.13 Aligned_cols=193 Identities=25% Similarity=0.387 Sum_probs=154.2
Q ss_pred HHhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEe-----
Q 003982 578 QVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCIN----- 650 (782)
Q Consensus 578 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~----- 650 (782)
...++|++.+.||+|+||.||+|.. .+++.||||++.... ...+.+.+|+++++++ +||||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 3467899999999999999999965 578999999997543 3346789999999999 79999999999987
Q ss_pred -CCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEE
Q 003982 651 -GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVA 729 (782)
Q Consensus 651 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~ 729 (782)
....++||||+++++|.+++.... ...+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+||+
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEEC
T ss_pred ccceEEEEEEcCCCCcHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEEe
Confidence 467899999999999999997642 2358999999999999999999999 899999999999999999999999
Q ss_pred eeccceecCCCCceeeecccccccccCccccccch--hhhHHHHHHHHHhccc
Q 003982 730 DFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHW--MILCQMTGLIWLHGSV 780 (782)
Q Consensus 730 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~dvws~Gvv 780 (782)
|||++........ ......||+.|+|||++.... ...++.++||||+|++
T Consensus 172 Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~i 223 (326)
T 2x7f_A 172 DFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGIT 223 (326)
T ss_dssp CCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHH
T ss_pred eCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHH
Confidence 9999987653221 223346899999999876321 1234667899999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=264.77 Aligned_cols=183 Identities=32% Similarity=0.520 Sum_probs=149.5
Q ss_pred hcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC-CeEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING-SERLLVY 658 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~-~~~~lv~ 658 (782)
.++|++.+.||+|+||.||+|.. +++.||||+++... ..+.+.+|++++++++||||+++++++.+. +..++||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 46799999999999999999987 58899999997532 457899999999999999999999997654 4789999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++++|.+++..... ..+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++....
T Consensus 95 e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp CCCTTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred ecCCCCCHHHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 99999999999976422 237889999999999999999999 899999999999999999999999999987654
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... ....+++.|+|||++.+. .++.++|+||+|++
T Consensus 169 ~~~----~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 203 (278)
T 1byg_A 169 STQ----DTGKLPVKWTAPEALREK---KFSTKSDVWSFGIL 203 (278)
T ss_dssp -----------CCTTTSCHHHHHHC---CCCHHHHHHHHHHH
T ss_pred ccc----cCCCccccccCHHHhCCC---CCCchhcHHHHHHH
Confidence 322 123578899999988654 45778999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.7e-29 Score=267.10 Aligned_cols=184 Identities=25% Similarity=0.377 Sum_probs=157.7
Q ss_pred hcCCCccceeecccceEEEEEEe--CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCC------CcceEEeEEEeC
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL--PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHR------HLVALLGYCING 651 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~------nI~~~~~~~~~~ 651 (782)
.++|++.+.||+|+||.||+|.. .+++.||||+++.. ....+.+.+|+++++.++|+ +|+++++++.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 46899999999999999999964 46889999999753 34567789999999998765 499999999999
Q ss_pred CeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECC---------
Q 003982 652 SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD--------- 722 (782)
Q Consensus 652 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~--------- 722 (782)
+..++||||+ +++|.+++.... ..++++.++..++.|++.||+|||+ .||+||||||+||+++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKENG---FLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred CcEEEEEcCC-CCCHHHHHHhcC---CCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCC
Confidence 9999999999 899999987632 2468999999999999999999999 89999999999999987
Q ss_pred ----------CCcEEEEeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 723 ----------DMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 723 ----------~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
++.+||+|||+++...... ....||+.|+|||++.+. .++.++||||+|++
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~i 223 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATYDDEHH----STLVSTRHYRAPEVILAL---GWSQPCDVWSIGCI 223 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEETTSCC----CSSCSCGGGCCHHHHTTS---CCCTHHHHHHHHHH
T ss_pred ccccccccccCCCceEeeCcccccCcccc----ccccCCccccChHHhhCC---CCCcchhhHHHHHH
Confidence 6689999999998755422 235789999999998764 45778999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=291.81 Aligned_cols=187 Identities=25% Similarity=0.386 Sum_probs=151.4
Q ss_pred CCCccc-eeecccceEEEEEEeC---CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 582 NFSEAN-ILGRGGFGVVYGGELP---DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 582 ~y~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
++.+.+ .||+|+||.||+|... ++..||||+++... .....+++.+|++++++++||||+++++++.+ +..++|
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 344444 7999999999999553 45679999997653 23467889999999999999999999999876 568999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
|||+++|+|.+++... ...+++.++..++.|++.||+|||+ .||+||||||+|||++.++.+||+|||+|+..
T Consensus 414 ~E~~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp EECCTTCBHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred EEeCCCCcHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 9999999999998642 3458999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCce--eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 738 PDGKYS--VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 738 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
...... ......+|+.|+|||++.+. .++.++|||||||+
T Consensus 487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~---~~~~~sDvwSlGv~ 528 (613)
T 2ozo_A 487 GADDSYYTARSAGKWPLKWYAPECINFR---KFSSRSDVWSYGVT 528 (613)
T ss_dssp C--------------CCTTSCHHHHHHC---CCCHHHHHHHHHHH
T ss_pred cCCCceeeeccCCCCccceeCHhhhcCC---CCCcHHHHHHHHHH
Confidence 543211 11223457899999998654 45779999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4.8e-29 Score=262.42 Aligned_cols=187 Identities=24% Similarity=0.335 Sum_probs=155.7
Q ss_pred HhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeE-EEeCCeEEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY-CINGSERLL 656 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~-~~~~~~~~l 656 (782)
..++|++.+.||+|+||.||+|.. .+++.||||++..... .+.+.+|++++++++|++++..+.+ ..+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 357899999999999999999964 6889999999875432 2468899999999998876655554 466778899
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEC---CCCcEEEEeecc
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIG---DDMRAKVADFGL 733 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~---~~~~~kL~DfG~ 733 (782)
||||+ +++|.+++... ...+++.++..++.|++.||+|||+ .||+||||||+||+++ +++.+||+|||+
T Consensus 83 v~e~~-~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 154 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp EEECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred EEEec-CCCHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCC
Confidence 99999 99999999743 2358999999999999999999999 8999999999999994 788999999999
Q ss_pred ceecCCCCce------eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 734 VKNAPDGKYS------VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 734 a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+......... ......||+.|+|||++.+. .++.++||||+|++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~i 204 (296)
T 3uzp_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI---EQSRRDDLESLGYV 204 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTC---CCCHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCChhhhcCC---CCCcchhhHHHHHH
Confidence 9876554321 12345799999999998775 35788999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-29 Score=276.07 Aligned_cols=184 Identities=26% Similarity=0.328 Sum_probs=155.0
Q ss_pred hcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC--------CCCcceEEeEEE-
Q 003982 580 TDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR--------HRHLVALLGYCI- 649 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~nI~~~~~~~~- 649 (782)
.++|++.+.||+|+||+||+|. ..+++.||||+++.. ....+.+.+|++++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 4789999999999999999995 457889999999753 345678899999999986 788999999987
Q ss_pred ---eCCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CeEEcCCCCCCEEECCCC-
Q 003982 650 ---NGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ-SFIHRDLKPSNILIGDDM- 724 (782)
Q Consensus 650 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~-~ivHrDikp~NIll~~~~- 724 (782)
.....++||||+ ++++.+.+.... ...+++.++..++.|++.||+|||+ + ||+||||||+|||++.++
T Consensus 113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~ 185 (397)
T 1wak_A 113 SGVNGTHICMVFEVL-GHHLLKWIIKSN---YQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQ 185 (397)
T ss_dssp EETTEEEEEEEECCC-CCBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHH
T ss_pred cCCCCceEEEEEecc-CccHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccch
Confidence 456789999999 677777775522 2458999999999999999999998 7 999999999999999775
Q ss_pred ------------------------------------------------cEEEEeeccceecCCCCceeeecccccccccC
Q 003982 725 ------------------------------------------------RAKVADFGLVKNAPDGKYSVETRLAGTFGYLA 756 (782)
Q Consensus 725 ------------------------------------------------~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~a 756 (782)
.+||+|||+|+...... ....||+.|+|
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~----~~~~gt~~y~a 261 (397)
T 1wak_A 186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF----TEDIQTRQYRS 261 (397)
T ss_dssp HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS----CSCCSCGGGCC
T ss_pred hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC----ccCCCCCcccC
Confidence 79999999998765432 33478999999
Q ss_pred ccccccchhhhHHHHHHHHHhccc
Q 003982 757 PEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 757 PE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
||++.+. .++.++||||+||+
T Consensus 262 PE~~~~~---~~~~~~DiwslG~i 282 (397)
T 1wak_A 262 LEVLIGS---GYNTPADIWSTACM 282 (397)
T ss_dssp HHHHHTS---CCCTHHHHHHHHHH
T ss_pred ChhhcCC---CCCcHHHHHHHHHH
Confidence 9998765 35678999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-29 Score=272.19 Aligned_cols=195 Identities=25% Similarity=0.337 Sum_probs=148.1
Q ss_pred HHHHHHhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCC
Q 003982 574 EVLRQVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS 652 (782)
Q Consensus 574 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~ 652 (782)
+......++|++.+.||+|+||.||+|.. .+++.||||++.... .....+.+|++.++.++||||+++++++...+
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~ 92 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP---RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLG 92 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT---TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEEC
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc---cccHHHHHHHHHHHhcCCCCcccHHHhhhccc
Confidence 34556678999999999999999999965 578999999986543 23346677888889999999999999997644
Q ss_pred e-------EEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHh--hcCCCCeEEcCCCCCCEEECC-
Q 003982 653 E-------RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLH--SLAQQSFIHRDLKPSNILIGD- 722 (782)
Q Consensus 653 ~-------~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~~~~ivHrDikp~NIll~~- 722 (782)
. .++||||+++ ++.+.+...... ...+++..+..++.|++.||.||| + .||+||||||+||+++.
T Consensus 93 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~ 167 (360)
T 3e3p_A 93 ERDRRDIYLNVVMEYVPD-TLHRCCRNYYRR-QVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEA 167 (360)
T ss_dssp SSCTTCEEEEEEEECCSC-BHHHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETT
T ss_pred cccccceeEEEEeecccc-cHHHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCC
Confidence 3 7899999975 666655543322 356899999999999999999999 6 89999999999999996
Q ss_pred CCcEEEEeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 723 DMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 723 ~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
++.+||+|||+++....... .....||+.|+|||++.+. ..++.++||||+||+
T Consensus 168 ~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~~Di~slG~i 221 (360)
T 3e3p_A 168 DGTLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGN--QHYTTAVDIWSVGCI 221 (360)
T ss_dssp TTEEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTC--SSCCTHHHHHHHHHH
T ss_pred CCcEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCC--CCCCcHHHHHHHHHH
Confidence 89999999999987764332 2345789999999987653 125678999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.9e-30 Score=275.05 Aligned_cols=184 Identities=14% Similarity=0.212 Sum_probs=153.7
Q ss_pred hcCCCccceeecccceEEEEEEeC---------CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcce-------
Q 003982 580 TDNFSEANILGRGGFGVVYGGELP---------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVA------- 643 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~------- 643 (782)
.++|++.+.||+|+||.||+|... +++.||||++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 367999999999999999999665 3789999998753 36889999999999999887
Q ss_pred --------EEeEEEe-CCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCC
Q 003982 644 --------LLGYCIN-GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLK 714 (782)
Q Consensus 644 --------~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik 714 (782)
+++++.. ....++||||+ +++|.+++.... ...+++.++..++.|++.||+|||+ .||+|||||
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dik 186 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP---KHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVT 186 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCC
T ss_pred CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC---cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCC
Confidence 6777776 67889999999 999999997632 2458999999999999999999999 899999999
Q ss_pred CCCEEECCCC--cEEEEeeccceecCCCCce------eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 715 PSNILIGDDM--RAKVADFGLVKNAPDGKYS------VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 715 p~NIll~~~~--~~kL~DfG~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|+||+++.++ .+||+|||+++........ ......||+.|+|||++.+. .++.++||||+|++
T Consensus 187 p~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~i 257 (352)
T 2jii_A 187 AENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC---GPSRRSDLQSLGYC 257 (352)
T ss_dssp GGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC---CCCHHHHHHHHHHH
T ss_pred HHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC---CCCchhhHHHHHHH
Confidence 9999999998 9999999999876532211 11334799999999998775 45789999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-29 Score=264.93 Aligned_cols=192 Identities=24% Similarity=0.320 Sum_probs=157.0
Q ss_pred HhcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC--CCCcceEEeEEEeCCeEEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR--HRHLVALLGYCINGSERLL 656 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~nI~~~~~~~~~~~~~~l 656 (782)
..++|++.+.||+|+||.||+|...+++.||||++..........+.+.+|++++++++ ||||+++++++.+++..++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 35679999999999999999998888999999999876555566788999999999997 5999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecccee
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~ 736 (782)
||| +.+++|.+++.. ...+++.++..++.|++.||+|||+ .||+||||||+||+++ ++.+||+|||+++.
T Consensus 106 v~e-~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 106 VME-CGNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQ 175 (313)
T ss_dssp EEC-CCSEEHHHHHHH-----CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred EEe-cCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEE-CCeEEEeecccccc
Confidence 999 558899999976 2468999999999999999999999 8999999999999996 48999999999987
Q ss_pred cCCCCce-eeecccccccccCccccccc--------hhhhHHHHHHHHHhccc
Q 003982 737 APDGKYS-VETRLAGTFGYLAPEYAGKH--------WMILCQMTGLIWLHGSV 780 (782)
Q Consensus 737 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~--------~~~~~~~~~dvws~Gvv 780 (782)
....... ......||+.|+|||++.+. ....++.++||||+|++
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~i 228 (313)
T 3cek_A 176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 228 (313)
T ss_dssp --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHH
T ss_pred ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHH
Confidence 6543221 22345689999999987652 01235778999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=269.45 Aligned_cols=193 Identities=26% Similarity=0.396 Sum_probs=160.8
Q ss_pred HHHHHhcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCCh----hhHHHHHHHHHHHHhcC--CCCcceEEeE
Q 003982 575 VLRQVTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGN----KGLSEFQAEIAVLTKVR--HRHLVALLGY 647 (782)
Q Consensus 575 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~--h~nI~~~~~~ 647 (782)
......++|++.+.||+|+||.||+|. ..+++.||||++....... ...+.+.+|++++++++ ||||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 344467889999999999999999995 4678999999997654322 12356778999999996 5999999999
Q ss_pred EEeCCeEEEEEEccCC-CCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEC-CCCc
Q 003982 648 CINGSERLLVYEYMPR-GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIG-DDMR 725 (782)
Q Consensus 648 ~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~-~~~~ 725 (782)
+.+++..++||||+.+ ++|.+++... ..+++.++..++.|++.||+|||+ .||+||||||+||+++ +++.
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~ 188 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGE 188 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTE
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCC
Confidence 9999999999999976 8999998762 458999999999999999999999 8999999999999999 7889
Q ss_pred EEEEeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 726 AKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 726 ~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+||+|||+++....... ....||+.|+|||++.+. .....++||||+|++
T Consensus 189 ~kL~Dfg~~~~~~~~~~---~~~~gt~~y~aPE~~~~~--~~~~~~~Di~slG~i 238 (320)
T 3a99_A 189 LKLIDFGSGALLKDTVY---TDFDGTRVYSPPEWIRYH--RYHGRSAAVWSLGIL 238 (320)
T ss_dssp EEECCCTTCEECCSSCB---CCCCSCGGGSCHHHHHHS--CBCHHHHHHHHHHHH
T ss_pred EEEeeCccccccccccc---cCCCCCccCCChHHhccC--CCCCccchHHhHHHH
Confidence 99999999988765332 234689999999987653 123678999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-29 Score=263.27 Aligned_cols=190 Identities=28% Similarity=0.512 Sum_probs=149.0
Q ss_pred hcCCCccceeecccceEEEEEEe--CCCc--EEEEEEeccccCC-hhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL--PDGT--KIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSER 654 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~--~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~ 654 (782)
.++|++.+.||+|+||+||+|.+ .+++ .||||+++..... ....+.+.+|++++++++||||+++++++.++. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 35789999999999999999964 2333 6899998765432 345678999999999999999999999988755 8
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccc
Q 003982 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734 (782)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a 734 (782)
++||||+++++|.+++.... ..+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~ 168 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLM 168 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred eeeEecccCCCHHHHHHhcc----CCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEcccccc
Confidence 89999999999999997642 348999999999999999999999 89999999999999999999999999999
Q ss_pred eecCCCCce--eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 735 KNAPDGKYS--VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 735 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
......... ......+|+.|+|||++.+. .++.++||||+|++
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~i 213 (291)
T 1u46_A 169 RALPQNDDHYVMQEHRKVPFAWCAPESLKTR---TFSHASDTWMFGVT 213 (291)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHHHC---EEEHHHHHHHHHHH
T ss_pred ccccccccchhhhccCCCCceeeCchhhcCC---CCCchhhHHHHHHH
Confidence 887554322 12234578899999988654 35788999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.7e-29 Score=267.33 Aligned_cols=194 Identities=24% Similarity=0.337 Sum_probs=140.2
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHH-HHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIA-VLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ......++.+|+. +++.++||||+++++++.+++..++|
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 36789999999999999999965 578999999997653 2334455556665 67778999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CeEEcCCCCCCEEECCCCcEEEEeecccee
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ-SFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~-~ivHrDikp~NIll~~~~~~kL~DfG~a~~ 736 (782)
|||+++ +|.+++..........+++..+..++.|++.||.|||+ . ||+||||||+||+++.++.+||+|||+++.
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 999975 88888765443334568999999999999999999998 7 999999999999999999999999999987
Q ss_pred cCCCCceeeecccccccccCccccccch-hhhHHHHHHHHHhccc
Q 003982 737 APDGKYSVETRLAGTFGYLAPEYAGKHW-MILCQMTGLIWLHGSV 780 (782)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~dvws~Gvv 780 (782)
...... .....||+.|+|||++.... ...++.++||||+|++
T Consensus 176 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~i 218 (327)
T 3aln_A 176 LVDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGIT 218 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHH
T ss_pred cccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHH
Confidence 654322 22346899999999984321 1235678999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=268.17 Aligned_cols=192 Identities=29% Similarity=0.425 Sum_probs=151.5
Q ss_pred HHHHhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCCh----hhHHHHHHHHHHHHhc----CCCCcceEEe
Q 003982 576 LRQVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGN----KGLSEFQAEIAVLTKV----RHRHLVALLG 646 (782)
Q Consensus 576 l~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l----~h~nI~~~~~ 646 (782)
...+.++|++.+.||+|+||.||+|.. .+++.||||++....... .....+.+|+++++++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 445678899999999999999999965 578899999997654321 1233466799999998 8999999999
Q ss_pred EEEeCCeEEEEEEc-cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEC-CCC
Q 003982 647 YCINGSERLLVYEY-MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIG-DDM 724 (782)
Q Consensus 647 ~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~-~~~ 724 (782)
++.+.+..++|||| +++++|.+++... ..+++.++..++.|++.||+|||+ .||+||||||+||+++ .++
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~ 177 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEK-----GPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRG 177 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTT
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCC
Confidence 99999999999999 7899999999762 358999999999999999999999 8999999999999999 889
Q ss_pred cEEEEeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 725 RAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 725 ~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.+||+|||++........ ....||+.|+|||++.+. .....++||||+|++
T Consensus 178 ~~kl~dfg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~i 228 (312)
T 2iwi_A 178 CAKLIDFGSGALLHDEPY---TDFDGTRVYSPPEWISRH--QYHALPATVWSLGIL 228 (312)
T ss_dssp EEEECCCSSCEECCSSCB---CCCCSCTTTSCHHHHHHS--CBCHHHHHHHHHHHH
T ss_pred eEEEEEcchhhhcccCcc---cccCCcccccCceeeecC--CCCCccchHHHHHHH
Confidence 999999999987765332 334689999999987654 123568999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-29 Score=265.47 Aligned_cols=187 Identities=24% Similarity=0.371 Sum_probs=148.8
Q ss_pred hcCCCccceeecccceEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEE---------
Q 003982 580 TDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCI--------- 649 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~--------- 649 (782)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC--hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 478999999999999999999654 58999999987543 456678999999999999999999999873
Q ss_pred -----eCCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEC-CC
Q 003982 650 -----NGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIG-DD 723 (782)
Q Consensus 650 -----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~-~~ 723 (782)
+....++||||++ |+|.+++.. .++++.++..++.|++.||+|||+ .||+||||||+||+++ ++
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~ 157 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTED 157 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTT
T ss_pred cccccccCceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCC
Confidence 3467899999997 699998853 458999999999999999999999 8999999999999997 56
Q ss_pred CcEEEEeeccceecCCCCc--eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 724 MRAKVADFGLVKNAPDGKY--SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 724 ~~~kL~DfG~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+.+||+|||+++....... .......+|+.|+|||++.+. ..++.++||||+|++
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~i 214 (320)
T 2i6l_A 158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP--NNYTKAIDMWAAGCI 214 (320)
T ss_dssp TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCT--TCCCHHHHHHHHHHH
T ss_pred CeEEEccCccccccCCCcccccccccccccccccCcHHhcCc--ccCCchhhhHhHHHH
Confidence 7999999999987643221 112334679999999987542 135678999999986
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.4e-29 Score=292.92 Aligned_cols=180 Identities=23% Similarity=0.371 Sum_probs=154.0
Q ss_pred hcCCCccceeecccceEEEEEEeC--CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCe----
Q 003982 580 TDNFSEANILGRGGFGVVYGGELP--DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE---- 653 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~---- 653 (782)
.++|++.+.||+|+||.||+|... +++.||||++.... .......+.+|++++++++||||+++++++.+.+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 478999999999999999999664 68999999986532 23456778999999999999999999999987665
Q ss_pred -EEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeec
Q 003982 654 -RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (782)
Q Consensus 654 -~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG 732 (782)
.|+||||+++++|.+++.. .+++.+++.++.|++.||+|||+ .||+||||||+||+++.+ .+||+|||
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG 226 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLG 226 (681)
T ss_dssp EEEEEEECCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCT
T ss_pred eeEEEEEeCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecc
Confidence 7999999999999887632 58999999999999999999999 899999999999999886 89999999
Q ss_pred cceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 733 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+++..... ....||+.|+|||++.+. .+.++||||+||+
T Consensus 227 ~a~~~~~~-----~~~~gt~~y~aPE~~~~~----~~~~sDi~slG~~ 265 (681)
T 2pzi_A 227 AVSRINSF-----GYLYGTPGFQAPEIVRTG----PTVATDIYTVGRT 265 (681)
T ss_dssp TCEETTCC-----SCCCCCTTTSCTTHHHHC----SCHHHHHHHHHHH
T ss_pred cchhcccC-----CccCCCccccCHHHHcCC----CCCceehhhhHHH
Confidence 99877543 235699999999988764 2678999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-29 Score=272.18 Aligned_cols=184 Identities=25% Similarity=0.398 Sum_probs=153.2
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCe-----
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE----- 653 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~----- 653 (782)
.++|.+.+.||+|+||.||+|.. .+|+.||||++..........+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 46799999999999999999955 578999999997755445567789999999999999999999999987654
Q ss_pred -EEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeec
Q 003982 654 -RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (782)
Q Consensus 654 -~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG 732 (782)
.++||||++ ++|.+++. ..+++.++..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg 171 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-------LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFG 171 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTT
T ss_pred eEEEEecccc-CCHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecc
Confidence 499999996 68877662 248999999999999999999999 899999999999999999999999999
Q ss_pred cceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 733 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+++..... .....||+.|+|||++.+. ..++.++||||+|++
T Consensus 172 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~--~~~~~~~Di~slG~i 213 (353)
T 3coi_A 172 LARHADAE----MTGYVVTRWYRAPEVILSW--MHYNQTVDIWSVGCI 213 (353)
T ss_dssp CTTC------------CCSBCCSCHHHHSCC--SCCCTTHHHHHHHHH
T ss_pred cccCCCCC----ccccccCcCcCCHHHHhCc--CCCCchhhHHHHHHH
Confidence 99765432 2334689999999987653 134667899999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-28 Score=263.58 Aligned_cols=184 Identities=27% Similarity=0.368 Sum_probs=133.8
Q ss_pred HhcCCCccc-eeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEe----CC
Q 003982 579 VTDNFSEAN-ILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN----GS 652 (782)
Q Consensus 579 ~~~~y~~~~-~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~----~~ 652 (782)
+.++|.+.+ .||+|+||.||+|.. .+++.||||++.... ....+....++.++||||+++++++.. ..
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP------KARQEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH------HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 457888855 699999999999965 478999999986532 222223334566789999999999876 44
Q ss_pred eEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECC---CCcEEEE
Q 003982 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD---DMRAKVA 729 (782)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~---~~~~kL~ 729 (782)
..++||||+++|+|.+++.... ...+++.++..++.|++.||+|||+ .||+||||||+||+++. ++.+||+
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~---~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~ 173 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERG---DQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLT 173 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC----CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred eEEEEEeccCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEe
Confidence 5799999999999999997532 2468999999999999999999999 89999999999999976 4569999
Q ss_pred eeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 730 DFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 730 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|||+++....... ....||+.|+|||++.+. .++.++||||+|++
T Consensus 174 Dfg~~~~~~~~~~---~~~~~t~~y~aPE~~~~~---~~~~~~Di~slG~i 218 (336)
T 3fhr_A 174 DFGFAKETTQNAL---QTPCYTPYYVAPEVLGPE---KYDKSCDMWSLGVI 218 (336)
T ss_dssp CCTTCEEC-------------------------C---HHHHHHHHHHHHHH
T ss_pred ccccceecccccc---ccCCCCcCccChhhhCCC---CCCchhhHHHHHHH
Confidence 9999987654322 234689999999998664 56889999999986
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-28 Score=253.96 Aligned_cols=200 Identities=25% Similarity=0.324 Sum_probs=168.3
Q ss_pred EEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCC
Q 003982 69 TTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDN 147 (782)
Q Consensus 69 ~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 147 (782)
+.++.++++++ .+|..+ .++|++|+|++|.+++.++ .|.++++|++|+|++|+++++++..|.++++|++|+|++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 56777888887 566544 4689999999999998887 6899999999999999999998888999999999999999
Q ss_pred C-CCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCcc
Q 003982 148 P-NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSG 226 (782)
Q Consensus 148 ~-l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~ 226 (782)
+ +.. ..|..+..+++|++|+|++|++++..+..|..+++|++|++++|++++..+..
T Consensus 91 ~~l~~--~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~-------------------- 148 (285)
T 1ozn_A 91 AQLRS--VDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDT-------------------- 148 (285)
T ss_dssp TTCCC--CCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTT--------------------
T ss_pred CCccc--cCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhH--------------------
Confidence 7 666 34778889999999999999999888888999999999999999998433333
Q ss_pred ccccccCCCCCcEEEeecccccCCCCC-CCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCC
Q 003982 227 TLDVLSGMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGP 297 (782)
Q Consensus 227 ~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 297 (782)
+.++++|++|+|++|++++.++. +..+++|+.|+|++|++++..|..|..+++|+.|++++|++++.
T Consensus 149 ----~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 216 (285)
T 1ozn_A 149 ----FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSAL 216 (285)
T ss_dssp ----TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCC
T ss_pred ----hccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcC
Confidence 34588899999999988887764 88888899999999988888888888888888888888888754
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.2e-29 Score=289.38 Aligned_cols=190 Identities=23% Similarity=0.378 Sum_probs=155.9
Q ss_pred HhcCCCccceeecccceEEEEEEeC----CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeE
Q 003982 579 VTDNFSEANILGRGGFGVVYGGELP----DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSER 654 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~ 654 (782)
..++|++.+.||+|+||.||+|... .+..||||+++... .....+.+.+|+.++++++||||+++++++. ++..
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 3467999999999999999999653 24579999986533 2445678999999999999999999999985 5678
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccc
Q 003982 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734 (782)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a 734 (782)
++||||+++|+|.+++... ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++
T Consensus 466 ~lv~E~~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVR----KFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp EEEEECCTTCBHHHHHHHT----TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred EEEEEcCCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCC
Confidence 9999999999999999752 2358999999999999999999999 89999999999999999999999999999
Q ss_pred eecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 735 KNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 735 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+..............+|+.|+|||++.+. .++.++||||+|++
T Consensus 539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~DiwSlG~i 581 (656)
T 2j0j_A 539 RYMEDSTYYKASKGKLPIKWMAPESINFR---RFTSASDVWMFGVC 581 (656)
T ss_dssp CSCCC----------CCGGGCCHHHHHHC---CCCHHHHHHHHHHH
T ss_pred eecCCCcceeccCCCCCcceeCHHHhcCC---CCCchhhHHHHHHH
Confidence 87765443333344678899999988654 45778999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-28 Score=274.19 Aligned_cols=187 Identities=24% Similarity=0.322 Sum_probs=157.1
Q ss_pred HhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCC-CCcceEEeEEEeCCeEEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH-RHLVALLGYCINGSERLL 656 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~nI~~~~~~~~~~~~~~l 656 (782)
+.++|++.+.||+|+||.||+|.. .+++.||||++..... ...+.+|+++++.++| ++|..+..++.+.+..++
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 357899999999999999999964 6789999998865432 2357899999999986 667777777788889999
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE---CCCCcEEEEeecc
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGL 733 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll---~~~~~~kL~DfG~ 733 (782)
||||+ +++|.+++... ...+++.+++.++.||+.||+|||+ .||+||||||+|||+ +.++.+||+|||+
T Consensus 81 vme~~-g~sL~~ll~~~----~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl 152 (483)
T 3sv0_A 81 VMDLL-GPSLEDLFNFC----SRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 152 (483)
T ss_dssp EEECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred EEECC-CCCHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCc
Confidence 99999 99999999753 2358999999999999999999999 899999999999999 5788999999999
Q ss_pred ceecCCCCc------eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 734 VKNAPDGKY------SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 734 a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
++....... .......||+.|+|||++.+. .++.++||||||||
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~---~~s~~sDvwSlGvi 202 (483)
T 3sv0_A 153 AKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGI---EQSRRDDLESLGYV 202 (483)
T ss_dssp CEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC---CCCHHHHHHHHHHH
T ss_pred ceeccCCccccccccccccccCCCccccCHHHhcCC---CCChHHHHHHHHHH
Confidence 987755332 122346799999999998775 45778999999986
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.6e-28 Score=248.81 Aligned_cols=217 Identities=28% Similarity=0.421 Sum_probs=193.1
Q ss_pred CCCccccceEeCCCCCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCcccCCCC
Q 003982 52 TGYCEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPT 130 (782)
Q Consensus 52 ~~~c~w~gv~c~~~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~ 130 (782)
.++|.|.|+.|...++.+.+++++++++ .+|..+. ++|++|+|++|++++.++ .|.++++|++|+|++|+++.+++
T Consensus 2 ~~~C~~~~~~C~c~~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~ 78 (270)
T 2o6q_A 2 EALCKKDGGVCSCNNNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPA 78 (270)
T ss_dssp CCCBGGGTCSBEEETTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCT
T ss_pred CccCCCCCCCCEeCCCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeCh
Confidence 3789999999987677889999999999 5777665 689999999999999887 79999999999999999999999
Q ss_pred CCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCcccccc
Q 003982 131 GCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKS 210 (782)
Q Consensus 131 ~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 210 (782)
..|.++++|++|+|++|++.. ..+..+..+++|++|+|++|++++..+..|..+++|++|+|++|+++ .+|..
T Consensus 79 ~~~~~l~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~---- 151 (270)
T 2o6q_A 79 GIFKELKNLETLWVTDNKLQA--LPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKG---- 151 (270)
T ss_dssp TTTSSCTTCCEEECCSSCCCC--CCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTT----
T ss_pred hhhcCCCCCCEEECCCCcCCc--CCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCC-ccCHh----
Confidence 999999999999999999988 44567889999999999999999999999999999999999999998 44432
Q ss_pred ccchhhcccccCCCccccccccCCCCCcEEEeecccccCCCCC-CCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEc
Q 003982 211 DIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISL 289 (782)
Q Consensus 211 ~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 289 (782)
.|.++++|++|+|++|++++.++. |..+++|++|+|++|+|++..+..|..+++|+.|++
T Consensus 152 -------------------~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 212 (270)
T 2o6q_A 152 -------------------VFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQL 212 (270)
T ss_dssp -------------------TTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEEC
T ss_pred -------------------HccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEe
Confidence 144689999999999999988775 888999999999999999877778999999999999
Q ss_pred cCCcccCC
Q 003982 290 QNNKLQGP 297 (782)
Q Consensus 290 ~~N~l~~~ 297 (782)
++|++...
T Consensus 213 ~~N~~~c~ 220 (270)
T 2o6q_A 213 QENPWDCT 220 (270)
T ss_dssp CSSCBCCS
T ss_pred cCCCeeCC
Confidence 99998753
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-28 Score=268.34 Aligned_cols=187 Identities=22% Similarity=0.295 Sum_probs=156.9
Q ss_pred HhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC-CC-----CcceEEeEEEeC
Q 003982 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HR-----HLVALLGYCING 651 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----nI~~~~~~~~~~ 651 (782)
+.++|++.+.||+|+||+||+|.. .+++.||||+++.. ......+.+|+++++.++ |+ +|+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 457899999999999999999954 47889999999753 344567888999998885 55 499999999999
Q ss_pred CeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEC--CCCcEEEE
Q 003982 652 SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIG--DDMRAKVA 729 (782)
Q Consensus 652 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~--~~~~~kL~ 729 (782)
+..++||||++ ++|.+++.... ...+++..+..++.|++.||.|||+ ++.||+||||||+|||++ .++.+||+
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTN---FRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred CceEEEEecCC-CCHHHHHhhcC---cCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcEEEE
Confidence 99999999995 59999987632 2458999999999999999999994 137999999999999995 47789999
Q ss_pred eeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 730 DFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 730 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|||+|+...... ....||+.|+|||++.+. .++.++||||+||+
T Consensus 204 DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~---~~~~~~DiwSlG~i 247 (382)
T 2vx3_A 204 DFGSSCQLGQRI----YQYIQSRFYRSPEVLLGM---PYDLAIDMWSLGCI 247 (382)
T ss_dssp CCTTCEETTCCC----CSSCSCGGGCCHHHHTTC---CCCTHHHHHHHHHH
T ss_pred eccCceeccccc----ccccCCccccChHHHcCC---CCCcHHHHHHHHHH
Confidence 999998875432 235789999999998775 35778999999986
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.6e-28 Score=262.52 Aligned_cols=270 Identities=18% Similarity=0.199 Sum_probs=221.4
Q ss_pred ceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccc
Q 003982 93 ETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172 (782)
Q Consensus 93 ~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~ 172 (782)
...++++|.++.++..+. ++|++|+|++|+++.+++..|.++++|++|+|++|++.. ..|..|.++++|++|+|++
T Consensus 34 ~~c~~~~~~l~~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~Ls~ 109 (353)
T 2z80_A 34 GICKGSSGSLNSIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINT--IEEDSFSSLGSLEHLDLSY 109 (353)
T ss_dssp SEEECCSTTCSSCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCE--ECTTTTTTCTTCCEEECCS
T ss_pred eEeeCCCCCccccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCc--cCHhhcCCCCCCCEEECCC
Confidence 347889999998776654 589999999999999999899999999999999999988 4567899999999999999
Q ss_pred cccCCCCcccccCCCCCcEEEcccCcCCCCCCc-cccccccchhhcccccCCCccccccccCCCCCcEEEeecc-cccCC
Q 003982 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPA-SFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKN-QFTGP 250 (782)
Q Consensus 173 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N-~l~~~ 250 (782)
|++++..+..|..+++|++|+|++|+++ .+|. . .+.++++|++|++++| .+++.
T Consensus 110 n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~-----------------------~~~~l~~L~~L~l~~n~~~~~~ 165 (353)
T 2z80_A 110 NYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETS-----------------------LFSHLTKLQILRVGNMDTFTKI 165 (353)
T ss_dssp SCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSC-----------------------SCTTCTTCCEEEEEESSSCCEE
T ss_pred CcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchh-----------------------hhccCCCCcEEECCCCcccccc
Confidence 9999987777999999999999999998 5654 2 2456899999999999 47766
Q ss_pred CC-CCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCCCCCCccEEEccCCcCCCCCCCCCCCCChh
Q 003982 251 IP-DLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQ 329 (782)
Q Consensus 251 ~~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~~~ 329 (782)
++ .+..+++|++|++++|++++..|..+..+++|++|++++|+++...+.
T Consensus 166 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~----------------------------- 216 (353)
T 2z80_A 166 QRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEI----------------------------- 216 (353)
T ss_dssp CTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHH-----------------------------
T ss_pred CHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhh-----------------------------
Confidence 55 588999999999999999988899999999999999999988632111
Q ss_pred hhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccccCcccc---ccccCCeEecccccccc-
Q 003982 330 VTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYA---NLTSLKNLYLQQNNLTG- 405 (782)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~g- 405 (782)
.+..+++|++|++++|.+++..+..+. ....++.++|++|++++
T Consensus 217 --------------------------------~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~ 264 (353)
T 2z80_A 217 --------------------------------FVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDE 264 (353)
T ss_dssp --------------------------------HHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHH
T ss_pred --------------------------------hhhhcccccEEECCCCccccccccccccccccchhhccccccccccCc
Confidence 112245777788888877765554443 45678889999998887
Q ss_pred ---cCCccCCCCCCCCeEecCCCcCCCCCCCC-C--CCcceecCCCCCCCCC
Q 003982 406 ---PIPDGLTKLASLQNLDVSNNNLSGKVPDF-G--SNVKFTVSPGNPFIGT 451 (782)
Q Consensus 406 ---~~p~~~~~l~~L~~L~ls~N~l~g~~p~~-~--~~~~~~~~~~n~~~~~ 451 (782)
.+|+.+..+++|+.|||++|+++..++.+ . ..+....+.+||+.|.
T Consensus 265 ~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~ 316 (353)
T 2z80_A 265 SLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 316 (353)
T ss_dssp HHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred chhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCc
Confidence 57888999999999999999999655553 3 5677889999999773
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.5e-28 Score=254.61 Aligned_cols=247 Identities=22% Similarity=0.257 Sum_probs=190.4
Q ss_pred ceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccc
Q 003982 93 ETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172 (782)
Q Consensus 93 ~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~ 172 (782)
+.++++++.++.++..+. ++|++|+|++|+++.++...|.++++|++|+|++|++...
T Consensus 10 ~~l~c~~~~l~~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-------------------- 67 (306)
T 2z66_A 10 TEIRCNSKGLTSVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFK-------------------- 67 (306)
T ss_dssp TEEECCSSCCSSCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEE--------------------
T ss_pred CEEEcCCCCcccCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcc--------------------
Confidence 356666666665554332 4666666666666666666666666666666666655431
Q ss_pred cccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeecccccCCCC
Q 003982 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIP 252 (782)
Q Consensus 173 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 252 (782)
+..+..+..+++|++|+|++|.++ .+|..+ .++++|++|++++|++++.++
T Consensus 68 ----~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~------------------------~~l~~L~~L~l~~n~l~~~~~ 118 (306)
T 2z66_A 68 ----GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNF------------------------LGLEQLEHLDFQHSNLKQMSE 118 (306)
T ss_dssp ----EEEEHHHHSCSCCCEEECCSCSEE-EEEEEE------------------------ETCTTCCEEECTTSEEESSTT
T ss_pred ----cCcccccccccccCEEECCCCccc-cChhhc------------------------CCCCCCCEEECCCCccccccc
Confidence 222455556778888888888776 455433 347888888888888887665
Q ss_pred --CCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccC-CCCCCCCCccEEEccCCcCCCCCCCCCCCCChh
Q 003982 253 --DLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG-PYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQ 329 (782)
Q Consensus 253 --~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~~~ 329 (782)
.+..+++|++|++++|++++..+..|..+++|++|++++|++++ ..
T Consensus 119 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~------------------------------- 167 (306)
T 2z66_A 119 FSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL------------------------------- 167 (306)
T ss_dssp TTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEE-------------------------------
T ss_pred chhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccc-------------------------------
Confidence 58899999999999999999999999999999999999999885 22
Q ss_pred hhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccccCccccccccCCeEecccccccccCCc
Q 003982 330 VTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPD 409 (782)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~ 409 (782)
|..+..+++|++|+|++|.+++..|..|.++++|++|+|++|++++..+.
T Consensus 168 ------------------------------~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 217 (306)
T 2z66_A 168 ------------------------------PDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTF 217 (306)
T ss_dssp ------------------------------CSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSG
T ss_pred ------------------------------hhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChh
Confidence 23344567899999999999998899999999999999999999988888
Q ss_pred cCCCCCCCCeEecCCCcCCCCCCC-CC---CCcceecCCCCCCCCC
Q 003982 410 GLTKLASLQNLDVSNNNLSGKVPD-FG---SNVKFTVSPGNPFIGT 451 (782)
Q Consensus 410 ~~~~l~~L~~L~ls~N~l~g~~p~-~~---~~~~~~~~~~n~~~~~ 451 (782)
.+..+++|+.|||++|++++.+|. +. ..+....+.+|++.|.
T Consensus 218 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~ 263 (306)
T 2z66_A 218 PYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 263 (306)
T ss_dssp GGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECS
T ss_pred hccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecc
Confidence 899999999999999999998884 32 4677888999999763
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-28 Score=263.73 Aligned_cols=184 Identities=23% Similarity=0.352 Sum_probs=155.3
Q ss_pred hcCCCccceeecccceEEEEEEe-CCC-cEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCC------cceEEeEEEeC
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDG-TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH------LVALLGYCING 651 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------I~~~~~~~~~~ 651 (782)
.++|++.+.||+|+||.||+|.. .++ +.||+|+++.. ....+.+.+|++++++++|++ ++.+++++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 47899999999999999999965 344 68999999753 345677889999999997665 99999999999
Q ss_pred CeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE-----------
Q 003982 652 SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI----------- 720 (782)
Q Consensus 652 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll----------- 720 (782)
+..++||||+ ++++.+++... ....+++.++..++.|++.||+|||+ .||+||||||+||++
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~---~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~ 167 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKEN---NFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNE 167 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECC
T ss_pred CeEEEEEecc-CCChHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecccccccccc
Confidence 9999999999 67788877652 22468999999999999999999998 899999999999999
Q ss_pred --------CCCCcEEEEeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 721 --------GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 721 --------~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+.++.+||+|||+++...... ....||+.|+|||++.+. .++.++||||+|++
T Consensus 168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~i 228 (355)
T 2eu9_A 168 HKSCEEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILEL---GWAQPCDVWSIGCI 228 (355)
T ss_dssp C-CCCEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTC---CCCTHHHHHHHHHH
T ss_pred cccccccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecC---CCCCccchHHHHHH
Confidence 567899999999998754422 335789999999998764 45678999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.5e-29 Score=273.47 Aligned_cols=187 Identities=27% Similarity=0.367 Sum_probs=146.6
Q ss_pred cCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCCeEEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
.+|.+.++||+|+||+||.....+++.||||++..... ..+.+|+++++++ +||||+++++++.+....|+|||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 46888999999999997666556899999999965432 2357899999999 79999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECC-----CCcEEEEeeccc
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD-----DMRAKVADFGLV 734 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~-----~~~~kL~DfG~a 734 (782)
|++ |+|.+++.... ....+.++..++.|++.||+|||+ .||+||||||+||+++. ...+||+|||+|
T Consensus 99 ~~~-g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 99 LCA-ATLQEYVEQKD----FAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp CCS-EEHHHHHHSSS----CCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred CCC-CCHHHHHHhcC----CCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 995 69999987532 234455678899999999999999 89999999999999953 236889999999
Q ss_pred eecCCCCc--eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 735 KNAPDGKY--SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 735 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+....... .......||+.|+|||++.+......+.++||||+||+
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~i 218 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCV 218 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHH
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHH
Confidence 87754321 22344679999999999875433345668999999986
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.1e-27 Score=263.10 Aligned_cols=246 Identities=18% Similarity=0.214 Sum_probs=174.1
Q ss_pred CceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeecc
Q 003982 92 LETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMD 171 (782)
Q Consensus 92 L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~ 171 (782)
...++.+++.++.+++.+. ++++.|+|++|+|+.+++..|.++++|++|+|++|++.. ..+..|.++++|++|+|+
T Consensus 45 ~~~v~c~~~~l~~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~--i~~~~~~~l~~L~~L~L~ 120 (440)
T 3zyj_A 45 FSKVICVRKNLREVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRT--IEIGAFNGLANLNTLELF 120 (440)
T ss_dssp SCEEECCSCCCSSCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCE--ECGGGGTTCSSCCEEECC
T ss_pred CCEEEeCCCCcCcCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCc--cChhhccCCccCCEEECC
Confidence 4468888888887766554 678888888888888887777777777777777777665 233445555555555555
Q ss_pred ccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeecccccCCC
Q 003982 172 NANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPI 251 (782)
Q Consensus 172 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 251 (782)
+|+|+.+.+..|..+++|++|+| ++|+++..+
T Consensus 121 ~n~l~~~~~~~~~~l~~L~~L~L------------------------------------------------~~N~i~~~~ 152 (440)
T 3zyj_A 121 DNRLTTIPNGAFVYLSKLKELWL------------------------------------------------RNNPIESIP 152 (440)
T ss_dssp SSCCSSCCTTTSCSCSSCCEEEC------------------------------------------------CSCCCCEEC
T ss_pred CCcCCeeCHhHhhccccCceeeC------------------------------------------------CCCcccccC
Confidence 55555444444444444444444 444444433
Q ss_pred C-CCCCCCCCCEEEcCCC-cCccCcchhhcCCCCCCEEEccCCcccCCCCCCCCCccEEEccCCcCCCCCCCCCCCCChh
Q 003982 252 P-DLSKCESLFDLSLRDN-QLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQ 329 (782)
Q Consensus 252 ~-~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~~~ 329 (782)
+ .|..+++|++|+|++| .+....+..|.++++|++|++++|+++.. |
T Consensus 153 ~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~------------------------------ 201 (440)
T 3zyj_A 153 SYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI-P------------------------------ 201 (440)
T ss_dssp TTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSC-C------------------------------
T ss_pred HHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCccc-c------------------------------
Confidence 3 3555666666666663 34433444666777777777777766621 1
Q ss_pred hhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccccCccccccccCCeEecccccccccCCc
Q 003982 330 VTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPD 409 (782)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~ 409 (782)
.+..+++|+.|+|++|.|++..|..|.++++|++|+|++|+|++..|.
T Consensus 202 --------------------------------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 249 (440)
T 3zyj_A 202 --------------------------------NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERN 249 (440)
T ss_dssp --------------------------------CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTT
T ss_pred --------------------------------ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChh
Confidence 022345788888888888888889999999999999999999999999
Q ss_pred cCCCCCCCCeEecCCCcCCCCCCCCC---CCcceecCCCCCCCCCC
Q 003982 410 GLTKLASLQNLDVSNNNLSGKVPDFG---SNVKFTVSPGNPFIGTN 452 (782)
Q Consensus 410 ~~~~l~~L~~L~ls~N~l~g~~p~~~---~~~~~~~~~~n~~~~~~ 452 (782)
.|..+++|+.|||++|+|++.++... ..+....+.+|||.|..
T Consensus 250 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC 295 (440)
T 3zyj_A 250 AFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNC 295 (440)
T ss_dssp SSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSS
T ss_pred hhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCC
Confidence 99999999999999999998888543 56778899999998853
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.1e-28 Score=251.60 Aligned_cols=222 Identities=22% Similarity=0.288 Sum_probs=196.3
Q ss_pred CCCCCCcccc---ceEeCC----------CCCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCC
Q 003982 49 TSSTGYCEWT---GINCDN----------SNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATS 114 (782)
Q Consensus 49 ~~~~~~c~w~---gv~c~~----------~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~ 114 (782)
++..|.|... .|.|+. ..+++.|+|++|++++..+..|..+++|++|+|++|.+++..| .|.++++
T Consensus 2 CP~~C~C~~~~~~~~~c~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~ 81 (285)
T 1ozn_A 2 CPGACVCYNEPKVTTSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLAL 81 (285)
T ss_dssp CCTTCEEECSSSCEEECCSSCCSSCCTTCCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTT
T ss_pred cCCCceECCCCCeEEEcCcCCcccCCcCCCCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccC
Confidence 3445556543 377764 2478999999999998777889999999999999999999877 7999999
Q ss_pred CCEEeCCCCc-ccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEE
Q 003982 115 LQDIYLDNNN-FTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLR 193 (782)
Q Consensus 115 L~~L~Ls~n~-l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 193 (782)
|++|+|++|+ ++.+++..|.++++|++|+|++|++.. ..|..+.++++|++|+|++|++++..+..|..+++|++|+
T Consensus 82 L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 159 (285)
T 1ozn_A 82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE--LGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLF 159 (285)
T ss_dssp CCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCC--CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCE--ECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEE
Confidence 9999999997 999999999999999999999999998 5677899999999999999999999888899999999999
Q ss_pred cccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeecccccCCCC-CCCCCCCCCEEEcCCCcCcc
Q 003982 194 LSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIP-DLSKCESLFDLSLRDNQLTG 272 (782)
Q Consensus 194 Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~ 272 (782)
|++|++++..+.. +.++++|++|+|++|++++..+ .+..+++|+.|+|++|++++
T Consensus 160 l~~n~l~~~~~~~------------------------~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 215 (285)
T 1ozn_A 160 LHGNRISSVPERA------------------------FRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSA 215 (285)
T ss_dssp CCSSCCCEECTTT------------------------TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred CCCCcccccCHHH------------------------hcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCc
Confidence 9999998433333 4468999999999999999765 58999999999999999998
Q ss_pred CcchhhcCCCCCCEEEccCCcccC
Q 003982 273 VVPASVISLPALLNISLQNNKLQG 296 (782)
Q Consensus 273 ~~p~~~~~l~~L~~L~l~~N~l~~ 296 (782)
..+..+..+++|+.|++++|++..
T Consensus 216 ~~~~~~~~l~~L~~L~l~~N~~~c 239 (285)
T 1ozn_A 216 LPTEALAPLRALQYLRLNDNPWVC 239 (285)
T ss_dssp CCHHHHTTCTTCCEEECCSSCEEC
T ss_pred CCHHHcccCcccCEEeccCCCccC
Confidence 888889999999999999999984
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-27 Score=264.15 Aligned_cols=246 Identities=19% Similarity=0.207 Sum_probs=174.8
Q ss_pred CceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeecc
Q 003982 92 LETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMD 171 (782)
Q Consensus 92 L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~ 171 (782)
...++.+++.++.++..+. ++|++|+|++|+|+.+++..|.++++|++|+|++|++.. ..+..|.++++|++|+|+
T Consensus 56 ~~~v~c~~~~l~~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~--~~~~~~~~l~~L~~L~L~ 131 (452)
T 3zyi_A 56 FSKVVCTRRGLSEVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQ--IEVGAFNGLASLNTLELF 131 (452)
T ss_dssp SCEEECCSSCCSSCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE--ECTTTTTTCTTCCEEECC
T ss_pred CcEEEECCCCcCccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCC--cChhhccCcccCCEEECC
Confidence 3467788888887665553 678888888888888877777777777777777777666 334455555555555555
Q ss_pred ccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeecccccCCC
Q 003982 172 NANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPI 251 (782)
Q Consensus 172 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 251 (782)
+|+|+++.+..|..+++|++|+|++|+++ ..+
T Consensus 132 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~------------------------------------------------~~~ 163 (452)
T 3zyi_A 132 DNWLTVIPSGAFEYLSKLRELWLRNNPIE------------------------------------------------SIP 163 (452)
T ss_dssp SSCCSBCCTTTSSSCTTCCEEECCSCCCC------------------------------------------------EEC
T ss_pred CCcCCccChhhhcccCCCCEEECCCCCcc------------------------------------------------eeC
Confidence 55555555555555555555555555554 333
Q ss_pred C-CCCCCCCCCEEEcCC-CcCccCcchhhcCCCCCCEEEccCCcccCCCCCCCCCccEEEccCCcCCCCCCCCCCCCChh
Q 003982 252 P-DLSKCESLFDLSLRD-NQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQ 329 (782)
Q Consensus 252 ~-~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~~~ 329 (782)
+ .|..+++|+.|+|++ |.+....+..|.++++|++|++++|++++. |.
T Consensus 164 ~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~~----------------------------- 213 (452)
T 3zyi_A 164 SYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-PN----------------------------- 213 (452)
T ss_dssp TTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-CC-----------------------------
T ss_pred HhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-cc-----------------------------
Confidence 3 245555566666665 334433344566677777777777766632 10
Q ss_pred hhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccccCccccccccCCeEecccccccccCCc
Q 003982 330 VTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPD 409 (782)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~ 409 (782)
+..+++|+.|+|++|.|++..|..|.++++|++|+|++|++++..|.
T Consensus 214 ---------------------------------~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 260 (452)
T 3zyi_A 214 ---------------------------------LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERN 260 (452)
T ss_dssp ---------------------------------CTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTT
T ss_pred ---------------------------------ccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHH
Confidence 22345788888888888888889999999999999999999999999
Q ss_pred cCCCCCCCCeEecCCCcCCCCCCCCC---CCcceecCCCCCCCCCC
Q 003982 410 GLTKLASLQNLDVSNNNLSGKVPDFG---SNVKFTVSPGNPFIGTN 452 (782)
Q Consensus 410 ~~~~l~~L~~L~ls~N~l~g~~p~~~---~~~~~~~~~~n~~~~~~ 452 (782)
.|..+++|+.|+|++|+|++.++... ..+....+.+|||.|..
T Consensus 261 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC 306 (452)
T 3zyi_A 261 AFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDC 306 (452)
T ss_dssp TTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECST
T ss_pred HhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCC
Confidence 99999999999999999998887543 56778899999998853
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-28 Score=273.21 Aligned_cols=191 Identities=27% Similarity=0.279 Sum_probs=145.0
Q ss_pred cCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCCeEEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
+.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++.+++..++|||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence 345667899999999998776678999999998653 235678999999986 89999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCC-------------C
Q 003982 660 YMPRGTLAQHLFEWHDHGY--TPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD-------------M 724 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~-------------~ 724 (782)
|++ |+|.+++........ ...++.++..++.|++.||+|||+ .||+||||||+||+++.+ +
T Consensus 90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCce
Confidence 995 699999976322111 111334567899999999999999 899999999999999654 4
Q ss_pred cEEEEeeccceecCCCCce---eeecccccccccCccccccch----hhhHHHHHHHHHhccc
Q 003982 725 RAKVADFGLVKNAPDGKYS---VETRLAGTFGYLAPEYAGKHW----MILCQMTGLIWLHGSV 780 (782)
Q Consensus 725 ~~kL~DfG~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~----~~~~~~~~dvws~Gvv 780 (782)
.+||+|||+++........ ......||+.|+|||++.+.. ...++.++||||+||+
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~i 228 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCV 228 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHH
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHH
Confidence 8999999999987654321 122357999999999986521 1245788999999986
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.5e-30 Score=272.26 Aligned_cols=59 Identities=22% Similarity=0.305 Sum_probs=45.8
Q ss_pred CCceeEEEccCcccccccCccccccccCCeEecccccccccCCccCCCCCCCCeEecCCCcCCC
Q 003982 366 QGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSG 429 (782)
Q Consensus 366 ~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g 429 (782)
+++|++|+|++|+|+ .+|..+. ++|++|+|++|+|++. |. +..+++|+.|+|++|++++
T Consensus 252 l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 252 PSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp CTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred cCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 356777777777777 5666666 7888888888888865 65 8888888888888888876
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-29 Score=267.67 Aligned_cols=191 Identities=21% Similarity=0.379 Sum_probs=154.7
Q ss_pred hcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
.++|++.+.||+|+||.||+|.... .||+|+++.........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 5789999999999999999997643 59999997655444455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++++|.+++... ...+++.++..++.|++.||+|||+ .||+||||||+||+++ ++.+||+|||++.....
T Consensus 110 ~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 110 LCKGRTLYSVVRDA----KIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp CCCSEEHHHHTTSS----CCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred cccCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 99999999998652 2358999999999999999999999 8999999999999998 67999999999875532
Q ss_pred CC----ceeeecccccccccCccccccch------hhhHHHHHHHHHhccc
Q 003982 740 GK----YSVETRLAGTFGYLAPEYAGKHW------MILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~----~~~~~~~~gt~~y~aPE~~~~~~------~~~~~~~~dvws~Gvv 780 (782)
.. ........||+.|+|||++.+.. ...++.++||||+|++
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~i 232 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTI 232 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHH
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHH
Confidence 11 11122345899999999876521 1235778999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-28 Score=259.59 Aligned_cols=191 Identities=24% Similarity=0.341 Sum_probs=139.4
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
.++|++.+.||+|+||.||+|.. .+++.||||++..........+.+.++..+++.++||||+++++++.+++..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 36789999999999999999965 47899999999765433333445556666788889999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ-SFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~-~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
||+ ++.+..+.... ...+++..+..++.|++.||.|||+ . ||+||||||+||+++.++.+||+|||++...
T Consensus 104 e~~-~~~~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRM----QGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRL 175 (318)
T ss_dssp CCC-SEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred ecc-CCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence 999 55555544332 2458999999999999999999997 5 9999999999999999999999999999766
Q ss_pred CCCCceeeecccccccccCccccccc--hhhhHHHHHHHHHhccc
Q 003982 738 PDGKYSVETRLAGTFGYLAPEYAGKH--WMILCQMTGLIWLHGSV 780 (782)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~dvws~Gvv 780 (782)
..... .....||+.|+|||++.+. ....++.++||||+|++
T Consensus 176 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~i 218 (318)
T 2dyl_A 176 VDDKA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGIS 218 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHH
T ss_pred cCCcc--ccccCCCccccChhhcccccccccCCccccchhhHHHH
Confidence 54322 2234689999999998532 11235678999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-28 Score=267.21 Aligned_cols=184 Identities=22% Similarity=0.321 Sum_probs=155.3
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC-----------CCCcceEEeE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-----------HRHLVALLGY 647 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~nI~~~~~~ 647 (782)
.++|++.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|++++++++ ||||++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 36799999999999999999964 67899999999753 244577889999999886 8999999999
Q ss_pred EEeCC----eEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CeEEcCCCCCCEEEC-
Q 003982 648 CINGS----ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ-SFIHRDLKPSNILIG- 721 (782)
Q Consensus 648 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~-~ivHrDikp~NIll~- 721 (782)
+...+ ..++||||+ +++|.+++..... ..+++.++..++.|++.||+|||+ . ||+||||||+||+++
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~ 167 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVL-GENLLALIKKYEH---RGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEI 167 (373)
T ss_dssp EEEEETTEEEEEEEECCC-CEEHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEE
T ss_pred hhccCCCCceEEEEEecC-CCCHHHHHHHhhc---cCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEec
Confidence 88654 789999999 8999999976432 358999999999999999999998 7 999999999999994
Q ss_pred -----CCCcEEEEeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 722 -----DDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 722 -----~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..+.+||+|||++....... ....||+.|+|||++.+. .++.++||||+|++
T Consensus 168 ~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~t~~y~aPE~~~~~---~~~~~~Di~slG~i 224 (373)
T 1q8y_A 168 VDSPENLIQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGA---PWGCGADIWSTACL 224 (373)
T ss_dssp EETTTTEEEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTC---CCCTHHHHHHHHHH
T ss_pred cCCCcCcceEEEcccccccccCCCC----CCCCCCccccCcHHHhCC---CCCchHhHHHHHHH
Confidence 44589999999998765422 234789999999998765 35678999999986
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-26 Score=263.58 Aligned_cols=257 Identities=23% Similarity=0.265 Sum_probs=216.8
Q ss_pred ccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeee
Q 003982 90 TQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLY 169 (782)
Q Consensus 90 ~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~ 169 (782)
.+++.|++++|.|+.+++.+. ++|++|+|++|+|+.+|. .+++|++|+|++|+++. +|. .+++|++|+
T Consensus 40 ~~l~~L~ls~n~L~~lp~~l~--~~L~~L~L~~N~l~~lp~----~l~~L~~L~Ls~N~l~~---lp~---~l~~L~~L~ 107 (622)
T 3g06_A 40 NGNAVLNVGESGLTTLPDCLP--AHITTLVIPDNNLTSLPA----LPPELRTLEVSGNQLTS---LPV---LPPGLLELS 107 (622)
T ss_dssp HCCCEEECCSSCCSCCCSCCC--TTCSEEEECSCCCSCCCC----CCTTCCEEEECSCCCSC---CCC---CCTTCCEEE
T ss_pred CCCcEEEecCCCcCccChhhC--CCCcEEEecCCCCCCCCC----cCCCCCEEEcCCCcCCc---CCC---CCCCCCEEE
Confidence 469999999999997666665 899999999999999887 57999999999999987 555 678999999
Q ss_pred ccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeecccccC
Q 003982 170 MDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTG 249 (782)
Q Consensus 170 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~ 249 (782)
|++|+++++.+ .+++|++|++++|+++ .+|.. +++|++|+|++|++++
T Consensus 108 Ls~N~l~~l~~----~l~~L~~L~L~~N~l~-~lp~~---------------------------l~~L~~L~Ls~N~l~~ 155 (622)
T 3g06_A 108 IFSNPLTHLPA----LPSGLCKLWIFGNQLT-SLPVL---------------------------PPGLQELSVSDNQLAS 155 (622)
T ss_dssp ECSCCCCCCCC----CCTTCCEEECCSSCCS-CCCCC---------------------------CTTCCEEECCSSCCSC
T ss_pred CcCCcCCCCCC----CCCCcCEEECCCCCCC-cCCCC---------------------------CCCCCEEECcCCcCCC
Confidence 99999998644 6789999999999998 56642 5889999999999998
Q ss_pred CCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCCCCCCccEEEccCCcCCCCCCCCCCCCChh
Q 003982 250 PIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQ 329 (782)
Q Consensus 250 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~~~ 329 (782)
.+. .+++|+.|++++|+|++ +| ..+++|+.|++++|++++ +|..+++|+.|++++|.++.++.
T Consensus 156 l~~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~~~~L~~L~L~~N~l~~l~~--------- 218 (622)
T 3g06_A 156 LPA---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPTLPSELYKLWAYNNRLTSLPA--------- 218 (622)
T ss_dssp CCC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCSSCCC---------
T ss_pred cCC---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCCccchhhEEECcCCcccccCC---------
Confidence 654 35789999999999995 56 567899999999999996 55567899999999999876541
Q ss_pred hhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccccCccccccccCCeEecccccccccCCc
Q 003982 330 VTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPD 409 (782)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~ 409 (782)
..++|++|+|++|.|++ +| ..+++|++|+|++|+|+ .+|.
T Consensus 219 -----------------------------------~~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~ 258 (622)
T 3g06_A 219 -----------------------------------LPSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM 258 (622)
T ss_dssp -----------------------------------CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC
T ss_pred -----------------------------------CCCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc
Confidence 12579999999999996 66 55689999999999999 6776
Q ss_pred cCCCCCCCCeEecCCCcCCCCCCCCC--CCcceecCCCCCCCC
Q 003982 410 GLTKLASLQNLDVSNNNLSGKVPDFG--SNVKFTVSPGNPFIG 450 (782)
Q Consensus 410 ~~~~l~~L~~L~ls~N~l~g~~p~~~--~~~~~~~~~~n~~~~ 450 (782)
.+++|+.|+|++|+|+..++.+. ..+....+.+|++.+
T Consensus 259 ---~~~~L~~L~Ls~N~L~~lp~~l~~l~~L~~L~L~~N~l~~ 298 (622)
T 3g06_A 259 ---LPSGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLSE 298 (622)
T ss_dssp ---CCTTCCEEECCSSCCCSCCGGGGGSCTTCEEECCSCCCCH
T ss_pred ---ccccCcEEeCCCCCCCcCCHHHhhccccCEEEecCCCCCC
Confidence 67899999999999995443443 567778899999864
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-28 Score=279.34 Aligned_cols=176 Identities=20% Similarity=0.187 Sum_probs=125.7
Q ss_pred eecccceEEEEE-EeCCCcEEEEEEeccccCC--------hhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCCeEEEEE
Q 003982 589 LGRGGFGVVYGG-ELPDGTKIAVKRMESNTMG--------NKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 589 lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~--------~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
.+.|+.|.+..+ +.-.|+.||||++.+.... ....++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 456666666655 3346889999999764321 22456799999999999 6999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||++|++|.+++.+ .+++++. +|+.||+.||+|+|+ +|||||||||+|||+++++.+||+|||+|+...
T Consensus 322 Eyv~G~~L~d~i~~-----~~~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 322 EKLPGRLLSDMLAA-----GEEIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp ECCCSEEHHHHHHT-----TCCCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred ecCCCCcHHHHHHh-----CCCCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 99999999999976 2456654 478999999999999 999999999999999999999999999998775
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.... .....+||+.|||||++.+. ....+|+|++|++
T Consensus 391 ~~~~-~~~t~vGTp~YmAPE~l~g~----~~~~~d~~s~g~~ 427 (569)
T 4azs_A 391 QDCS-WPTNLVQSFFVFVNELFAEN----KSWNGFWRSAPVH 427 (569)
T ss_dssp ---C-CSHHHHHHHHHHHHHHC--------------------
T ss_pred CCCc-cccCceechhhccHHHhCCC----CCCcccccccccc
Confidence 5332 22346899999999999875 3456889999875
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-28 Score=281.13 Aligned_cols=190 Identities=28% Similarity=0.444 Sum_probs=158.2
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEe------CC
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN------GS 652 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~------~~ 652 (782)
.++|++.+.||+|+||.||+|.. .+|+.||||++.... .....+.+.+|++++++++||||+++++++.. .+
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL-SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC-CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 47899999999999999999954 578999999987542 34566789999999999999999999998765 66
Q ss_pred eEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCc---EEEE
Q 003982 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR---AKVA 729 (782)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~---~kL~ 729 (782)
..++||||+++|+|.+++..... ...+++.++..++.|++.||+|||+ .||+||||||+||+++.++. +||+
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~--~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFEN--CCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSC--TTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred eEEEEEEeCCCCCHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEc
Confidence 77999999999999999976322 2358889999999999999999999 89999999999999987664 9999
Q ss_pred eeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 730 DFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 730 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|||.+........ .....||+.|+|||++.+. .++.++||||+|++
T Consensus 167 DFG~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~---~~s~ksDIwSLGvi 212 (676)
T 3qa8_A 167 DLGYAKELDQGEL--CTEFVGTLQYLAPELLEQK---KYTVTVDYWSFGTL 212 (676)
T ss_dssp SCCCCCBTTSCCC--CCCCCSCCTTCSSCSSCCS---CCSTTHHHHHHHHH
T ss_pred ccccccccccccc--cccccCCcccCChHHhccC---CCCchhHHHHHHHH
Confidence 9999987755432 2345789999999998764 45678999999986
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.95 E-value=6.3e-31 Score=295.16 Aligned_cols=326 Identities=18% Similarity=0.229 Sum_probs=223.2
Q ss_pred CEEEEEeCCCCCCc----ccCccccCCccCceeecccCccCccCC-C-CCCCC----CCCEEeCCCCcccCC----CCCC
Q 003982 67 RVTTISLAKSGLSG----TLSPEISSLTQLETLSFQMNNIAGAIP-S-LANAT----SLQDIYLDNNNFTSV----PTGC 132 (782)
Q Consensus 67 ~v~~L~l~~~~l~~----~~~~~l~~l~~L~~L~L~~N~l~~~~~-~-l~~l~----~L~~L~Ls~n~l~~~----~~~~ 132 (782)
+++.|+|++|+++. .++..+..+++|++|+|++|.+++..+ . +..++ +|++|+|++|+++.. .+..
T Consensus 29 ~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~ 108 (461)
T 1z7x_W 29 QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSST 108 (461)
T ss_dssp TCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred CccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHH
Confidence 56777777777764 345667777778888888887765332 2 22233 688888888877742 2445
Q ss_pred CCCCCCCCEEeccCCCCCCCCCCCcc-----cCCCcccCeeeccccccCCCC----cccccCCCCCcEEEcccCcCCCCC
Q 003982 133 FDGLTNLQVLSLSDNPNLAPWPFPNE-----LTKSTSLTTLYMDNANIFGLI----PDFFDSFSNLQNLRLSYNNFTGSL 203 (782)
Q Consensus 133 ~~~l~~L~~L~Ls~N~l~~~~~~p~~-----~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~~ 203 (782)
+.++++|++|+|++|++... .+.. ....++|++|+|++|++++.. +..+..+++|++|++++|.++...
T Consensus 109 l~~~~~L~~L~Ls~n~i~~~--~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~ 186 (461)
T 1z7x_W 109 LRTLPTLQELHLSDNLLGDA--GLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAG 186 (461)
T ss_dssp TTSCTTCCEEECCSSBCHHH--HHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred HccCCceeEEECCCCcCchH--HHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHH
Confidence 67777888888888776541 1111 223456888888888777643 455666778888888888876443
Q ss_pred Cccccc------cccchhhcccccCCCcc---ccccccCCCCCcEEEeecccccCCC-----CC-CCCCCCCCEEEcCCC
Q 003982 204 PASFAK------SDIQNLWMNDQQLGLSG---TLDVLSGMTQLRQVWLHKNQFTGPI-----PD-LSKCESLFDLSLRDN 268 (782)
Q Consensus 204 p~~~~~------~~l~~l~l~~~~~~~~~---~~~~~~~l~~L~~L~L~~N~l~~~~-----~~-~~~l~~L~~L~L~~N 268 (782)
+..+.. ..++.|++++|.+...+ ....+..+++|++|++++|++++.. +. +..+++|++|++++|
T Consensus 187 ~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n 266 (461)
T 1z7x_W 187 VRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWEC 266 (461)
T ss_dssp HHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred HHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCC
Confidence 333322 36777888877765443 1234556788888888888876532 22 345778888888888
Q ss_pred cCccC----cchhhcCCCCCCEEEccCCcccCCCCC--------CCCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHh
Q 003982 269 QLTGV----VPASVISLPALLNISLQNNKLQGPYPL--------FPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQI 336 (782)
Q Consensus 269 ~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~~~--------~~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~ 336 (782)
++++. ++..+..+++|++|++++|++++..+. ...+|+.|++++|.++...
T Consensus 267 ~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~----------------- 329 (461)
T 1z7x_W 267 GITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAAC----------------- 329 (461)
T ss_dssp CCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGG-----------------
T ss_pred CCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHH-----------------
Confidence 88754 566777788888888888887643221 1247888888888775422
Q ss_pred hcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccccCccccc-----cccCCeEecccccccc----cC
Q 003982 337 AGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYAN-----LTSLKNLYLQQNNLTG----PI 407 (782)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~g----~~ 407 (782)
+..+|..+..+++|++|+|++|.+++..+..+.. .++|++|+|++|++++ .+
T Consensus 330 -------------------~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l 390 (461)
T 1z7x_W 330 -------------------CSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSL 390 (461)
T ss_dssp -------------------HHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHH
T ss_pred -------------------HHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHH
Confidence 1123445566788999999999998776665553 6799999999999986 78
Q ss_pred CccCCCCCCCCeEecCCCcCCCC
Q 003982 408 PDGLTKLASLQNLDVSNNNLSGK 430 (782)
Q Consensus 408 p~~~~~l~~L~~L~ls~N~l~g~ 430 (782)
|..+..+++|+.|||++|++++.
T Consensus 391 ~~~l~~~~~L~~L~l~~N~i~~~ 413 (461)
T 1z7x_W 391 AATLLANHSLRELDLSNNCLGDA 413 (461)
T ss_dssp HHHHHHCCCCCEEECCSSSCCHH
T ss_pred HHHHHhCCCccEEECCCCCCCHH
Confidence 88888899999999999998764
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-29 Score=268.46 Aligned_cols=262 Identities=20% Similarity=0.197 Sum_probs=144.6
Q ss_pred ceeecccCccCccCC-CCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeecc
Q 003982 93 ETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMD 171 (782)
Q Consensus 93 ~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~ 171 (782)
+.++++.+.+...+. .+..+++|++|+|++|+++.+++..|.++++|++|+|++|++.. .+. +..+++|++|+|+
T Consensus 13 ~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~---~~~-~~~l~~L~~L~Ls 88 (317)
T 3o53_A 13 KIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE---TLD-LESLSTLRTLDLN 88 (317)
T ss_dssp EEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEE---EEE-ETTCTTCCEEECC
T ss_pred eEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCc---chh-hhhcCCCCEEECc
Confidence 333444444433332 23334455555555555555554445555555555555555544 111 5555566666666
Q ss_pred ccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeecccccCCC
Q 003982 172 NANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPI 251 (782)
Q Consensus 172 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 251 (782)
+|++++.. ..++|++|++++|++++..+. .+++|++|++++|++++.+
T Consensus 89 ~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~---------------------------~~~~L~~L~l~~N~l~~~~ 136 (317)
T 3o53_A 89 NNYVQELL-----VGPSIETLHAANNNISRVSCS---------------------------RGQGKKNIYLANNKITMLR 136 (317)
T ss_dssp SSEEEEEE-----ECTTCCEEECCSSCCSEEEEC---------------------------CCSSCEEEECCSSCCCSGG
T ss_pred CCcccccc-----CCCCcCEEECCCCccCCcCcc---------------------------ccCCCCEEECCCCCCCCcc
Confidence 66655432 236777777777777632221 2466777777777777765
Q ss_pred C-CCCCCCCCCEEEcCCCcCccCcchhhc-CCCCCCEEEccCCcccCCCCC-CCCCccEEEccCCcCCCCCCCCCCCCCh
Q 003982 252 P-DLSKCESLFDLSLRDNQLTGVVPASVI-SLPALLNISLQNNKLQGPYPL-FPSKVQKVSLDHNNFCKNSSDAGKPCDP 328 (782)
Q Consensus 252 ~-~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~~~-~~~~l~~L~l~~N~~~~~~~~~~~~~~~ 328 (782)
+ .+..+++|++|+|++|++++..+..+. .+++|++|++++|++++..+. .+.+|+.|+|++|++++++
T Consensus 137 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~l~~L~~L~Ls~N~l~~l~--------- 207 (317)
T 3o53_A 137 DLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLAFMG--------- 207 (317)
T ss_dssp GBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEECCSSCCCEEC---------
T ss_pred chhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcccccccccccCCEEECCCCcCCcch---------
Confidence 5 466777788888888887776666664 677788888888877754222 2344555555554443221
Q ss_pred hhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccccCccccccccCCeEeccccccc-ccC
Q 003982 329 QVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLT-GPI 407 (782)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-g~~ 407 (782)
..+..+++|+.|+|++|.|+ .+|..+..+++|++|+|++|++. +.+
T Consensus 208 --------------------------------~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~ 254 (317)
T 3o53_A 208 --------------------------------PEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTL 254 (317)
T ss_dssp --------------------------------GGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHH
T ss_pred --------------------------------hhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCH
Confidence 22333445555555555555 24555555555555555555555 455
Q ss_pred CccCCCCCCCCeEecC-CCcCCCCCC
Q 003982 408 PDGLTKLASLQNLDVS-NNNLSGKVP 432 (782)
Q Consensus 408 p~~~~~l~~L~~L~ls-~N~l~g~~p 432 (782)
|..+..++.|+.|+++ .+.++|..|
T Consensus 255 ~~~~~~~~~L~~l~l~~~~~l~~~~~ 280 (317)
T 3o53_A 255 RDFFSKNQRVQTVAKQTVKKLTGQNE 280 (317)
T ss_dssp HHHHHTCHHHHHHHHHHHHHHHSSSS
T ss_pred HHHHhccccceEEECCCchhccCCch
Confidence 5555555555555555 333444333
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=6e-29 Score=263.60 Aligned_cols=199 Identities=19% Similarity=0.216 Sum_probs=110.0
Q ss_pred CCCCCEEeccCCCCCCCCCCCccc--CCCcccCeeeccccccCCCCcccccCC-----CCCcEEEcccCcCCCCCCcccc
Q 003982 136 LTNLQVLSLSDNPNLAPWPFPNEL--TKSTSLTTLYMDNANIFGLIPDFFDSF-----SNLQNLRLSYNNFTGSLPASFA 208 (782)
Q Consensus 136 l~~L~~L~Ls~N~l~~~~~~p~~~--~~l~~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~~ 208 (782)
+++|++|+|++|++.. .+|..+ ..+++|++|+|++|++++. |..+..+ ++|++|+|++|++++..|..+
T Consensus 94 l~~L~~L~L~~n~l~~--~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~- 169 (312)
T 1wwl_A 94 ISGLQELTLENLEVTG--TAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQV- 169 (312)
T ss_dssp TSCCCEEEEEEEBCBS--CCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTC-
T ss_pred cCCccEEEccCCcccc--hhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHh-
Confidence 4444444444444443 233332 4444444445555554444 4444443 455555555555543333332
Q ss_pred ccccchhhcccccCCCccccccccCCCCCcEEEeecccccCC---CCC--CCCCCCCCEEEcCCCcCcc---CcchhhcC
Q 003982 209 KSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGP---IPD--LSKCESLFDLSLRDNQLTG---VVPASVIS 280 (782)
Q Consensus 209 ~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~--~~~l~~L~~L~L~~N~l~~---~~p~~~~~ 280 (782)
.++++|++|+|++|++.+. ++. +..+++|++|+|++|+|++ .....+..
T Consensus 170 -----------------------~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~ 226 (312)
T 1wwl_A 170 -----------------------RVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAA 226 (312)
T ss_dssp -----------------------CCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHT
T ss_pred -----------------------ccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhc
Confidence 2345555555555554432 112 2555666666666666652 11233345
Q ss_pred CCCCCEEEccCCcccCCCCC----CCCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCC
Q 003982 281 LPALLNISLQNNKLQGPYPL----FPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNAC 356 (782)
Q Consensus 281 l~~L~~L~l~~N~l~~~~~~----~~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (782)
+++|++|++++|++++.+|. .+.+|+.|+|++|+++.++
T Consensus 227 l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~ip------------------------------------- 269 (312)
T 1wwl_A 227 RVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVP------------------------------------- 269 (312)
T ss_dssp TCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCSSCC-------------------------------------
T ss_pred CCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccChhh-------------------------------------
Confidence 56666666666666654431 1346666666666664332
Q ss_pred CCCCcccccCCceeEEEccCcccccccCccccccccCCeEeccccccccc
Q 003982 357 DGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGP 406 (782)
Q Consensus 357 ~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ 406 (782)
..+. ++|++|+|++|+|++. |. +..+++|++|+|++|++++.
T Consensus 270 ----~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~~ 311 (312)
T 1wwl_A 270 ----KGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLDS 311 (312)
T ss_dssp ----SSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTCC
T ss_pred ----hhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCCC
Confidence 2222 6899999999999876 55 89999999999999999853
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.9e-28 Score=257.19 Aligned_cols=267 Identities=20% Similarity=0.180 Sum_probs=160.8
Q ss_pred CEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEecc
Q 003982 67 RVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145 (782)
Q Consensus 67 ~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls 145 (782)
+....+++.+.+...+...+..+++|++|+|++|.+++.+| .|.++++|++|+|++|+++++++ +..+++|++|+|+
T Consensus 11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls 88 (317)
T 3o53_A 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLN 88 (317)
T ss_dssp EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECC
T ss_pred ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECc
Confidence 34455555565554444445555666666666666666655 56666666666666666665554 6666666666666
Q ss_pred CCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCc
Q 003982 146 DNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLS 225 (782)
Q Consensus 146 ~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~ 225 (782)
+|++.. + ...++|++|++++|++++..+.. +++|++|++++|++++..|..+
T Consensus 89 ~n~l~~---l----~~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~------------------ 140 (317)
T 3o53_A 89 NNYVQE---L----LVGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDE------------------ 140 (317)
T ss_dssp SSEEEE---E----EECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCT------------------
T ss_pred CCcccc---c----cCCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhh------------------
Confidence 666554 1 12356666666666666654332 4566667777666664333332
Q ss_pred cccccccCCCCCcEEEeecccccCCCCC-C-CCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCCC--
Q 003982 226 GTLDVLSGMTQLRQVWLHKNQFTGPIPD-L-SKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLF-- 301 (782)
Q Consensus 226 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~-~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-- 301 (782)
..+++|++|+|++|++++..+. + ..+++|++|+|++|+|++. | ....+++|++|++++|++++.++.+
T Consensus 141 ------~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~l~~~~~~ 212 (317)
T 3o53_A 141 ------GCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFMGPEFQS 212 (317)
T ss_dssp ------GGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEECGGGGG
T ss_pred ------hccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCcchhhhcc
Confidence 2345555555555555554332 2 2455555555555555533 1 1223555555555555555443332
Q ss_pred CCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccc-
Q 003982 302 PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLA- 380 (782)
Q Consensus 302 ~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~- 380 (782)
+.+|+.|+|++|+++.+ |..+..+++|+.|+|++|.+.
T Consensus 213 l~~L~~L~L~~N~l~~l-----------------------------------------~~~~~~l~~L~~L~l~~N~~~~ 251 (317)
T 3o53_A 213 AAGVTWISLRNNKLVLI-----------------------------------------EKALRFSQNLEHFDLRGNGFHC 251 (317)
T ss_dssp GTTCSEEECTTSCCCEE-----------------------------------------CTTCCCCTTCCEEECTTCCCBH
T ss_pred cCcccEEECcCCcccch-----------------------------------------hhHhhcCCCCCEEEccCCCccC
Confidence 23555555555555332 333455678999999999999
Q ss_pred cccCccccccccCCeEecc-cccccccCCccCC
Q 003982 381 GNISPAYANLTSLKNLYLQ-QNNLTGPIPDGLT 412 (782)
Q Consensus 381 ~~~p~~~~~l~~L~~L~Ls-~N~l~g~~p~~~~ 412 (782)
+.+|..+..+++|+.|+++ .+.+.|..|....
T Consensus 252 ~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~~~~ 284 (317)
T 3o53_A 252 GTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECT 284 (317)
T ss_dssp HHHHHHHHTCHHHHHHHHHHHHHHHSSSSCCCS
T ss_pred cCHHHHHhccccceEEECCCchhccCCchhccC
Confidence 8889999999999999999 5557877766543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.94 E-value=8.4e-27 Score=243.58 Aligned_cols=142 Identities=12% Similarity=0.057 Sum_probs=125.9
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCC-hhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
.++|++.+.||+|+||.||+|.. .+++.||||++...... ....+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 46799999999999999999965 45899999999876433 34567899999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEee
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADF 731 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~Df 731 (782)
|||+++++|.+++.. + ....++..++.|++.||+|||+ .||+||||||+||+++.++.+||+++
T Consensus 110 ~e~~~g~~L~~~l~~------~-~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~ 173 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT------S-PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYP 173 (286)
T ss_dssp EECCCEEEHHHHHTT------C-CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSC
T ss_pred EEecCCCCHHHHHhc------C-CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEec
Confidence 999999999999843 1 3566789999999999999999 89999999999999999999999743
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-27 Score=268.14 Aligned_cols=171 Identities=22% Similarity=0.189 Sum_probs=121.3
Q ss_pred CCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccC
Q 003982 88 SLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLT 166 (782)
Q Consensus 88 ~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~ 166 (782)
.+++|++|+|++|.|++.+| .|..+++|++|+|++|.++++++ |..+++|++|+|++|++.. +| ..++|+
T Consensus 32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~---l~----~~~~L~ 102 (487)
T 3oja_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE---LL----VGPSIE 102 (487)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEE---EE----ECTTCC
T ss_pred cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCC---CC----CCCCcC
Confidence 33478888888888877766 67778888888888888876655 7777888888888887665 22 236788
Q ss_pred eeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeeccc
Q 003982 167 TLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQ 246 (782)
Q Consensus 167 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~ 246 (782)
+|+|++|.|++..+. .+++|++|+|++|++++..|..+ +++++|+.|+|++|+
T Consensus 103 ~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~------------------------~~l~~L~~L~Ls~N~ 155 (487)
T 3oja_A 103 TLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDE------------------------GCRSRVQYLDLKLNE 155 (487)
T ss_dssp EEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCG------------------------GGGSSEEEEECTTSC
T ss_pred EEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhh------------------------cCCCCCCEEECCCCC
Confidence 888888888776544 35678888888888876555443 347788888888888
Q ss_pred ccCCCC-CCC-CCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccC
Q 003982 247 FTGPIP-DLS-KCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG 296 (782)
Q Consensus 247 l~~~~~-~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 296 (782)
+++.++ .+. .+++|++|+|++|.|++..+ +..+++|+.|+|++|+|++
T Consensus 156 l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~ 205 (487)
T 3oja_A 156 IDTVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAF 205 (487)
T ss_dssp CCEEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCE
T ss_pred CCCcChHHHhhhCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCC
Confidence 887555 344 67888888888888886532 2346677777777776663
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.2e-27 Score=258.53 Aligned_cols=191 Identities=16% Similarity=0.225 Sum_probs=141.2
Q ss_pred cCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCC-CCc----------------
Q 003982 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRH-RHL---------------- 641 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h-~nI---------------- 641 (782)
..|...+.||+|+||+||+|. ..+|+.||||++..... .....+.+++|+.+++.++| ++.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 457778999999999999996 56799999999874332 23346789999999999987 211
Q ss_pred -----ceEEeEEEe-----CCeEEEEEEccCCCCHHHHHHhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 003982 642 -----VALLGYCIN-----GSERLLVYEYMPRGTLAQHLFEWHD--HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFI 709 (782)
Q Consensus 642 -----~~~~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iv 709 (782)
..++.++.. ....+++|+++ +++|.+++..... .....+++..+..++.|+++||+|||+ .||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcc
Confidence 111111111 22457777766 7899998864321 123457888999999999999999999 8999
Q ss_pred EcCCCCCCEEECCCCcEEEEeeccceecCCCCceeeecccccccccCccccccc-------hhhhHHHHHHHHHhccc
Q 003982 710 HRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKH-------WMILCQMTGLIWLHGSV 780 (782)
Q Consensus 710 HrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~~~dvws~Gvv 780 (782)
||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++... -...++.++||||+||+
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 9999999999999999999999999876432 234567 999999988311 01245779999999986
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.5e-27 Score=265.25 Aligned_cols=222 Identities=21% Similarity=0.253 Sum_probs=181.8
Q ss_pred CCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCC
Q 003982 110 ANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNL 189 (782)
Q Consensus 110 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 189 (782)
..+++|++|+|++|.++++++..|.++++|++|+|++|.+.. .++ +..+++|++|+|++|.|++..+ .++|
T Consensus 31 ~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~---~~~-l~~l~~L~~L~Ls~N~l~~l~~-----~~~L 101 (487)
T 3oja_A 31 QSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE---TLD-LESLSTLRTLDLNNNYVQELLV-----GPSI 101 (487)
T ss_dssp TTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEE---EEE-CTTCTTCCEEECCSSEEEEEEE-----CTTC
T ss_pred ccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCC---Ccc-cccCCCCCEEEecCCcCCCCCC-----CCCc
Confidence 345689999999999999999899999999999999999887 222 8899999999999999987632 3899
Q ss_pred cEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeecccccCCCC-CCCCCCCCCEEEcCCC
Q 003982 190 QNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIP-DLSKCESLFDLSLRDN 268 (782)
Q Consensus 190 ~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N 268 (782)
++|++++|++++..+. .+++|+.|+|++|++++.++ .+..+++|++|+|++|
T Consensus 102 ~~L~L~~N~l~~~~~~---------------------------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 154 (487)
T 3oja_A 102 ETLHAANNNISRVSCS---------------------------RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLN 154 (487)
T ss_dssp CEEECCSSCCCCEEEC---------------------------CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTS
T ss_pred CEEECcCCcCCCCCcc---------------------------ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCC
Confidence 9999999999854332 25789999999999998766 5888999999999999
Q ss_pred cCccCcchhhc-CCCCCCEEEccCCcccCCCCCCCCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccc
Q 003982 269 QLTGVVPASVI-SLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILS 347 (782)
Q Consensus 269 ~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (782)
.|++.+|..+. .+++|+.|+|++|.|++..+.
T Consensus 155 ~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~~----------------------------------------------- 187 (487)
T 3oja_A 155 EIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQ----------------------------------------------- 187 (487)
T ss_dssp CCCEEEGGGGGGGTTTCCEEECTTSCCCEEECC-----------------------------------------------
T ss_pred CCCCcChHHHhhhCCcccEEecCCCcccccccc-----------------------------------------------
Confidence 99988888886 789999999999998864221
Q ss_pred cCcCCCCCCCCCCcccccCCceeEEEccCcccccccCccccccccCCeEecccccccccCCccCCCCCCCCeEecCCCcC
Q 003982 348 DSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNL 427 (782)
Q Consensus 348 ~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l 427 (782)
..+++|++|+|++|.|++ +|+.+..+++|+.|+|++|+|++ +|..+..+++|+.|++++|++
T Consensus 188 ----------------~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l 249 (487)
T 3oja_A 188 ----------------VVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGF 249 (487)
T ss_dssp ----------------CCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCB
T ss_pred ----------------ccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCC
Confidence 124577888888888886 44558888889999999999884 677788888899999999988
Q ss_pred C-CCCC
Q 003982 428 S-GKVP 432 (782)
Q Consensus 428 ~-g~~p 432 (782)
+ +.+|
T Consensus 250 ~c~~~~ 255 (487)
T 3oja_A 250 HCGTLR 255 (487)
T ss_dssp CHHHHH
T ss_pred cCcchH
Confidence 7 4444
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-25 Score=232.40 Aligned_cols=63 Identities=22% Similarity=0.235 Sum_probs=44.1
Q ss_pred EEEccCcccccccCccccccccCCeEecccccccccCCccCCCCCCCCeEecCCCcCCCCCCCC
Q 003982 371 TINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDF 434 (782)
Q Consensus 371 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~ 434 (782)
.|++++|.+++..+..+. ..+|++|+|++|++++..+..|..+++|+.|+|++|++++..|.+
T Consensus 181 ~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~l 243 (276)
T 2z62_A 181 SLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 243 (276)
T ss_dssp EEECCSSCCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTTT
T ss_pred eeecCCCcccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCch
Confidence 444444544433333333 347888888888888766667788999999999999998877754
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-25 Score=236.42 Aligned_cols=146 Identities=25% Similarity=0.372 Sum_probs=126.6
Q ss_pred hcCCCcc-ceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHH-HhcCCCCcceEEeEEEe----CC
Q 003982 580 TDNFSEA-NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVL-TKVRHRHLVALLGYCIN----GS 652 (782)
Q Consensus 580 ~~~y~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l-~~l~h~nI~~~~~~~~~----~~ 652 (782)
.++|.+. +.||+|+||.||+|.. .+++.||+|+++.. ..+.+|++++ +..+||||+++++++.. ..
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 4567777 7899999999999954 67899999999642 4577888888 55689999999999887 67
Q ss_pred eEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECC---CCcEEEE
Q 003982 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD---DMRAKVA 729 (782)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~---~~~~kL~ 729 (782)
..++||||+++|+|.+++.... ...+++.++..++.|++.||+|||+ .||+||||||+||+++. ++.+||+
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~ 162 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLT 162 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred eEEEEEeecCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEe
Confidence 7899999999999999997632 2468999999999999999999999 89999999999999998 7899999
Q ss_pred eeccceecC
Q 003982 730 DFGLVKNAP 738 (782)
Q Consensus 730 DfG~a~~~~ 738 (782)
|||++....
T Consensus 163 Dfg~a~~~~ 171 (299)
T 3m2w_A 163 DFGFAKETT 171 (299)
T ss_dssp CCTTCEECT
T ss_pred ccccccccc
Confidence 999987654
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-29 Score=285.35 Aligned_cols=348 Identities=16% Similarity=0.159 Sum_probs=242.3
Q ss_pred CCEEEEEeCCCCCCcccCcc-ccCCccCceeecccCccCcc-----CCCCCCCCCCCEEeCCCCcccCCCC-CCCCCCC-
Q 003982 66 NRVTTISLAKSGLSGTLSPE-ISSLTQLETLSFQMNNIAGA-----IPSLANATSLQDIYLDNNNFTSVPT-GCFDGLT- 137 (782)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~-l~~l~~L~~L~L~~N~l~~~-----~~~l~~l~~L~~L~Ls~n~l~~~~~-~~~~~l~- 137 (782)
.++++|+|++++++...... +..+++|++|+|++|.++.. ...+..+++|++|+|++|+++.... ..+..++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 36899999999998654444 78899999999999999853 2357888999999999999986332 2233444
Q ss_pred ---CCCEEeccCCCCCCCC--CCCcccCCCcccCeeeccccccCCCCcccc-----cCCCCCcEEEcccCcCCCCCCccc
Q 003982 138 ---NLQVLSLSDNPNLAPW--PFPNELTKSTSLTTLYMDNANIFGLIPDFF-----DSFSNLQNLRLSYNNFTGSLPASF 207 (782)
Q Consensus 138 ---~L~~L~Ls~N~l~~~~--~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~Ls~N~l~~~~p~~~ 207 (782)
+|++|+|++|++.... .++..+..+++|++|+|++|.++...+..+ ...++|++|+|++|++++.....+
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l 162 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 162 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH
Confidence 7999999999988521 357788999999999999999876544333 336789999999999986443222
Q ss_pred c----c-cccchhhcccccCCCccccccc----cCCCCCcEEEeecccccCC-----CCCCCCCCCCCEEEcCCCcCccC
Q 003982 208 A----K-SDIQNLWMNDQQLGLSGTLDVL----SGMTQLRQVWLHKNQFTGP-----IPDLSKCESLFDLSLRDNQLTGV 273 (782)
Q Consensus 208 ~----~-~~l~~l~l~~~~~~~~~~~~~~----~~l~~L~~L~L~~N~l~~~-----~~~~~~l~~L~~L~L~~N~l~~~ 273 (782)
. . ..|+.|++++|.+...+..... ...++|++|++++|++++. +..+..+++|++|++++|++++.
T Consensus 163 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~ 242 (461)
T 1z7x_W 163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 242 (461)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred HHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChH
Confidence 2 2 4677777777765433222111 1245777888888877763 22355677788888888877654
Q ss_pred c-----chhhcCCCCCCEEEccCCcccCC----CCCC---CCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCC
Q 003982 274 V-----PASVISLPALLNISLQNNKLQGP----YPLF---PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMG 341 (782)
Q Consensus 274 ~-----p~~~~~l~~L~~L~l~~N~l~~~----~~~~---~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (782)
. +..+..+++|++|++++|++++. ++.. ..+|+.|++++|.++... ...+
T Consensus 243 ~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~-------------~~~l----- 304 (461)
T 1z7x_W 243 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEG-------------ARLL----- 304 (461)
T ss_dssp HHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHH-------------HHHH-----
T ss_pred HHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHH-------------HHHH-----
Confidence 3 22223567788888888877753 2221 356777888777664211 0000
Q ss_pred CCcccccCcCCCCCCCCCCcccc-cCCceeEEEccCcccccc----cCccccccccCCeEecccccccccCCccCCC---
Q 003982 342 YPAILSDSWEGNNACDGWPFVTC-SQGRIITINLANKLLAGN----ISPAYANLTSLKNLYLQQNNLTGPIPDGLTK--- 413 (782)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~p~~~~-~~~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~--- 413 (782)
...+. ..++|++|+|++|.+++. ++..+..+++|++|+|++|++++..+..+..
T Consensus 305 ------------------~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~ 366 (461)
T 1z7x_W 305 ------------------CETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLG 366 (461)
T ss_dssp ------------------HHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHT
T ss_pred ------------------HHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHc
Confidence 00111 125899999999999876 5677788899999999999998765554443
Q ss_pred --CCCCCeEecCCCcCCC----CCCCC---CCCcceecCCCCCCC
Q 003982 414 --LASLQNLDVSNNNLSG----KVPDF---GSNVKFTVSPGNPFI 449 (782)
Q Consensus 414 --l~~L~~L~ls~N~l~g----~~p~~---~~~~~~~~~~~n~~~ 449 (782)
.++|+.|+|++|++++ .+|.. ...+....+.+|++.
T Consensus 367 ~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~ 411 (461)
T 1z7x_W 367 QPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411 (461)
T ss_dssp STTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred CCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCC
Confidence 6799999999999986 55522 256777788888763
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.4e-25 Score=229.63 Aligned_cols=209 Identities=23% Similarity=0.252 Sum_probs=142.3
Q ss_pred CEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEecc
Q 003982 67 RVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145 (782)
Q Consensus 67 ~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls 145 (782)
.++.|+|++|++++..+..|..+++|++|+|++|++++.++ .|.++++|++|+|++|+++.+++..|.++++|++|+++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 46777777777776555567777777777777777776665 57777777777777777777777777777777777777
Q ss_pred CCCCCCCCCCCcccCCCcccCeeeccccccCCC-CcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCC
Q 003982 146 DNPNLAPWPFPNELTKSTSLTTLYMDNANIFGL-IPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGL 224 (782)
Q Consensus 146 ~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~ 224 (782)
+|++.. ..+..+..+++|++|+|++|++++. +|..|..+++|++|+|++|++++..+..+..
T Consensus 109 ~n~l~~--~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~--------------- 171 (276)
T 2z62_A 109 ETNLAS--LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRV--------------- 171 (276)
T ss_dssp TSCCCC--STTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHH---------------
T ss_pred CCCccc--cCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhh---------------
Confidence 777766 2333567777777777777777664 4677777777777777777776443333321
Q ss_pred ccccccccCCCCCc-EEEeecccccCCCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCC
Q 003982 225 SGTLDVLSGMTQLR-QVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPY 298 (782)
Q Consensus 225 ~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 298 (782)
+..++.|. .|++++|++++.++......+|+.|+|++|+|++..+..|..+++|+.|++++|++++..
T Consensus 172 ------l~~L~~l~l~L~ls~n~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 240 (276)
T 2z62_A 172 ------LHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 240 (276)
T ss_dssp ------HHTCTTCCEEEECCSSCCCEECTTSSCSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCT
T ss_pred ------hhhccccceeeecCCCcccccCccccCCCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccC
Confidence 12233333 677777777776666555557777777777777666666677777777777777777543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.1e-26 Score=257.87 Aligned_cols=175 Identities=16% Similarity=0.146 Sum_probs=134.5
Q ss_pred CccceeecccceEEEEEEeCCCcEEEEEEeccccCChh------hHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 584 SEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNK------GLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 584 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
...+.||+|+||.||+|.. .++.+|+|+......... ..+++.+|++++++++||||+++..++...+..|+|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3467899999999999955 678899998755433221 245689999999999999999666666677888999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
|||+++++|.+++.. +..++.|+++||+|||+ +||+||||||+|||++. .+||+|||+|+..
T Consensus 418 mE~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 418 MSYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp EECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred EECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 999999999999853 45799999999999999 89999999999999998 9999999999987
Q ss_pred CCCCcee------eecccccccccCccccccchhhhHHHHHHHHHhc
Q 003982 738 PDGKYSV------ETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHG 778 (782)
Q Consensus 738 ~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~G 778 (782)
....... .....||+.|||||++.+.. .++....|+|+..
T Consensus 480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~-~~Y~~~~d~ws~v 525 (540)
T 3en9_A 480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFL-EGYKSVYDRWEII 525 (540)
T ss_dssp CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHH-HHHHHHCTTHHHH
T ss_pred CCccccccchhhhhhhhcCCCCcCCHHHHHHHH-HHHHHHHhHHHHH
Confidence 6532211 13457999999999988743 2566667778754
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-24 Score=225.69 Aligned_cols=228 Identities=21% Similarity=0.233 Sum_probs=149.0
Q ss_pred ccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeee
Q 003982 90 TQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLY 169 (782)
Q Consensus 90 ~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~ 169 (782)
.++..+++..+.+.... .+..+++|++|++++|.++.++. +..+++|++|+|++|++.. + ..+..+++|++|+
T Consensus 19 ~~l~~l~l~~~~~~~~~-~~~~l~~L~~L~l~~~~i~~~~~--l~~l~~L~~L~l~~n~l~~---~-~~l~~l~~L~~L~ 91 (272)
T 3rfs_A 19 AETIKANLKKKSVTDAV-TQNELNSIDQIIANNSDIKSVQG--IQYLPNVRYLALGGNKLHD---I-SALKELTNLTYLI 91 (272)
T ss_dssp HHHHHHHHTCSCTTSEE-CHHHHTTCCEEECTTSCCCCCTT--GGGCTTCCEEECTTSCCCC---C-GGGTTCTTCCEEE
T ss_pred HHHHHHHhcCccccccc-ccccccceeeeeeCCCCcccccc--cccCCCCcEEECCCCCCCC---c-hhhcCCCCCCEEE
Confidence 34455556666555433 24455666777777776666542 5666777777777776665 2 3566677777777
Q ss_pred ccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeecccccC
Q 003982 170 MDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTG 249 (782)
Q Consensus 170 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~ 249 (782)
|++|.+++..+..|..+++|++|+|++|++++..+.. +.++++|++|++++|++++
T Consensus 92 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~------------------------~~~l~~L~~L~L~~n~l~~ 147 (272)
T 3rfs_A 92 LTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGV------------------------FDKLTNLTYLNLAHNQLQS 147 (272)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTT------------------------TTTCTTCCEEECCSSCCCC
T ss_pred CCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHH------------------------hccCCCCCEEECCCCccCc
Confidence 7777777766666777777777777777776433332 2346777777777777776
Q ss_pred CCCC-CCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCCCCCCccEEEccCCcCCCCCCCCCCCCCh
Q 003982 250 PIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDP 328 (782)
Q Consensus 250 ~~~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~~ 328 (782)
.++. +..+++|+.|++++|+|++..+..|..+++|++|++++|++++.++..
T Consensus 148 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~--------------------------- 200 (272)
T 3rfs_A 148 LPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGV--------------------------- 200 (272)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTT---------------------------
T ss_pred cCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHH---------------------------
Confidence 6654 567777777777777777666666777777777777777777544321
Q ss_pred hhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccccCccccccccCCeEecccccccccCC
Q 003982 329 QVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIP 408 (782)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p 408 (782)
+..+++|++|+|++|.+.+. +++|++|+++.|+++|.+|
T Consensus 201 ----------------------------------~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip 239 (272)
T 3rfs_A 201 ----------------------------------FDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVR 239 (272)
T ss_dssp ----------------------------------TTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBB
T ss_pred ----------------------------------HhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCccc
Confidence 22334566666666665533 3467888888888888888
Q ss_pred ccCCCCCC
Q 003982 409 DGLTKLAS 416 (782)
Q Consensus 409 ~~~~~l~~ 416 (782)
..++.++.
T Consensus 240 ~~~~~~~~ 247 (272)
T 3rfs_A 240 NSAGSVAP 247 (272)
T ss_dssp CTTSCBCG
T ss_pred CcccccCC
Confidence 88877654
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=7.1e-25 Score=227.37 Aligned_cols=219 Identities=19% Similarity=0.212 Sum_probs=129.8
Q ss_pred CCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEc
Q 003982 115 LQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRL 194 (782)
Q Consensus 115 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 194 (782)
+..+++..+.+..+.. ...+++|+.|++++|.+.. + ..+..+++|++|+|++|.+++. ..+..+++|++|+|
T Consensus 21 l~~l~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~---~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L 92 (272)
T 3rfs_A 21 TIKANLKKKSVTDAVT--QNELNSIDQIIANNSDIKS---V-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLIL 92 (272)
T ss_dssp HHHHHHTCSCTTSEEC--HHHHTTCCEEECTTSCCCC---C-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEEC
T ss_pred HHHHHhcCcccccccc--cccccceeeeeeCCCCccc---c-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEEC
Confidence 3344555555544321 3455666666666666655 1 2456666666666666666653 35666666666666
Q ss_pred ccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeecccccCCCCC-CCCCCCCCEEEcCCCcCccC
Q 003982 195 SYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGV 273 (782)
Q Consensus 195 s~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~L~~N~l~~~ 273 (782)
++|++++..+.. +.++++|++|+|++|++++.++. +..+++|++|+|++|++++.
T Consensus 93 ~~n~l~~~~~~~------------------------~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 148 (272)
T 3rfs_A 93 TGNQLQSLPNGV------------------------FDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSL 148 (272)
T ss_dssp TTSCCCCCCTTT------------------------TTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred CCCccCccChhH------------------------hcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCcc
Confidence 666666333322 23466666666666666665554 56666666666666666655
Q ss_pred cchhhcCCCCCCEEEccCCcccCCCCCCCCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCC
Q 003982 274 VPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGN 353 (782)
Q Consensus 274 ~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (782)
.+..|..+++|+.|++++|++++..+.
T Consensus 149 ~~~~~~~l~~L~~L~l~~n~l~~~~~~----------------------------------------------------- 175 (272)
T 3rfs_A 149 PKGVFDKLTNLTELDLSYNQLQSLPEG----------------------------------------------------- 175 (272)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCCCCTT-----------------------------------------------------
T ss_pred CHHHhccCccCCEEECCCCCcCccCHH-----------------------------------------------------
Confidence 555666666666666666666643321
Q ss_pred CCCCCCCcccccCCceeEEEccCcccccccCccccccccCCeEecccccccccCCccCCCCCCCCeEecCCCcCCCCCCC
Q 003982 354 NACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPD 433 (782)
Q Consensus 354 ~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~ 433 (782)
.+..+++|++|+|++|.+++..|..|.++++|++|+|++|.+.+. ++.|+.|+++.|+++|.+|.
T Consensus 176 --------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~ 240 (272)
T 3rfs_A 176 --------VFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRN 240 (272)
T ss_dssp --------TTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBC
T ss_pred --------HhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccC
Confidence 122334566666666666665555566666666666666666543 33566666666666666664
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-24 Score=220.18 Aligned_cols=202 Identities=14% Similarity=0.175 Sum_probs=170.8
Q ss_pred ccCccccCCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCc-ccCCCCCCCCCCCCCCEEeccC-CCCCCCCCCCc
Q 003982 81 TLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNN-FTSVPTGCFDGLTNLQVLSLSD-NPNLAPWPFPN 157 (782)
Q Consensus 81 ~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~-l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~p~ 157 (782)
.+|. +. ++|++|++++|+|+++++ .|.++++|++|+|++|+ ++.+++..|.++++|++|+|++ |++.. ..+.
T Consensus 25 ~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~--i~~~ 99 (239)
T 2xwt_C 25 RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTY--IDPD 99 (239)
T ss_dssp SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCE--ECTT
T ss_pred ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeE--cCHH
Confidence 4555 33 389999999999998888 78999999999999997 9999998899999999999998 99887 4456
Q ss_pred ccCCCcccCeeeccccccCCCCcccccCCCCCc---EEEcccC-cCCCCCCccccccccchhhcccccCCCccccccccC
Q 003982 158 ELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQ---NLRLSYN-NFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSG 233 (782)
Q Consensus 158 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~---~L~Ls~N-~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~ 233 (782)
.|.++++|++|++++|++++. |. |..+++|+ +|++++| +++ .+|.. .|.+
T Consensus 100 ~f~~l~~L~~L~l~~n~l~~l-p~-~~~l~~L~~L~~L~l~~N~~l~-~i~~~-----------------------~~~~ 153 (239)
T 2xwt_C 100 ALKELPLLKFLGIFNTGLKMF-PD-LTKVYSTDIFFILEITDNPYMT-SIPVN-----------------------AFQG 153 (239)
T ss_dssp SEECCTTCCEEEEEEECCCSC-CC-CTTCCBCCSEEEEEEESCTTCC-EECTT-----------------------TTTT
T ss_pred HhCCCCCCCEEeCCCCCCccc-cc-cccccccccccEEECCCCcchh-hcCcc-----------------------cccc
Confidence 788999999999999999884 55 88888888 9999999 887 44432 2456
Q ss_pred CCCCc-EEEeecccccCCCCCCCCCCCCCEEEcCCCc-CccCcchhhcCC-CCCCEEEccCCcccCCCCCCCCCccEEEc
Q 003982 234 MTQLR-QVWLHKNQFTGPIPDLSKCESLFDLSLRDNQ-LTGVVPASVISL-PALLNISLQNNKLQGPYPLFPSKVQKVSL 310 (782)
Q Consensus 234 l~~L~-~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l-~~L~~L~l~~N~l~~~~~~~~~~l~~L~l 310 (782)
+++|+ +|++++|+++..++.....++|+.|+|++|+ +++..+..|..+ ++|+.|++++|++++..+..+.+|+.|++
T Consensus 154 l~~L~~~L~l~~n~l~~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~~~~~L~~L~l 233 (239)
T 2xwt_C 154 LCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIA 233 (239)
T ss_dssp TBSSEEEEECCSCCCCEECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCTTCTTCSEEEC
T ss_pred hhcceeEEEcCCCCCcccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChhHhccCceeec
Confidence 89999 9999999999766653333899999999995 997778889999 99999999999999877777889999998
Q ss_pred cCC
Q 003982 311 DHN 313 (782)
Q Consensus 311 ~~N 313 (782)
+++
T Consensus 234 ~~~ 236 (239)
T 2xwt_C 234 RNT 236 (239)
T ss_dssp TTC
T ss_pred cCc
Confidence 876
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-23 Score=215.68 Aligned_cols=64 Identities=25% Similarity=0.290 Sum_probs=43.9
Q ss_pred eeEEEccCcccccccCccccccccCCeEecccccccccCCccCCCCCCCCeEecCCCcCCCCCC
Q 003982 369 IITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVP 432 (782)
Q Consensus 369 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p 432 (782)
|+.|+|++|.+++..+..|.++++|++|+|++|++++..+..|..+++|+.|+|++|++.+..+
T Consensus 159 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 159 LKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp CCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred cceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 3333334444443344456777888888888888886666678888889999888888766544
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.91 E-value=8.5e-24 Score=216.50 Aligned_cols=190 Identities=26% Similarity=0.349 Sum_probs=120.3
Q ss_pred CCccccceEeCCCCCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCcccCCCCC
Q 003982 53 GYCEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTG 131 (782)
Q Consensus 53 ~~c~w~gv~c~~~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~ 131 (782)
+||.|.|+.|.. ..+.+++++++++ .+|..+. ++|+.|+|++|.+++..+ .|.++++|++|+|++|+|+++++.
T Consensus 3 ~Cp~~~gC~C~~--~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 77 (251)
T 3m19_A 3 TCETVTGCTCNE--GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAG 77 (251)
T ss_dssp -CHHHHSSEEEG--GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTT
T ss_pred cCCCCCceEcCC--CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHh
Confidence 578999999953 2456888888887 5666554 577888888888877766 577777888888888877777777
Q ss_pred CCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccc
Q 003982 132 CFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSD 211 (782)
Q Consensus 132 ~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~ 211 (782)
.|.++++|++|+|++|++.. ..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|
T Consensus 78 ~~~~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l------------ 143 (251)
T 3m19_A 78 VFDDLTELGTLGLANNQLAS--LPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQL------------ 143 (251)
T ss_dssp TTTTCTTCCEEECTTSCCCC--CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC------------
T ss_pred HhccCCcCCEEECCCCcccc--cChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcC------------
Confidence 77777777777777776665 2333445555555555555555554444444455555555555554
Q ss_pred cchhhcccccCCCccccccccCCCCCcEEEeecccccCCCC-CCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEcc
Q 003982 212 IQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIP-DLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQ 290 (782)
Q Consensus 212 l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 290 (782)
++.++ .|..+++|++|+|++|+|++..+..|..+++|+.|+++
T Consensus 144 ------------------------------------~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 187 (251)
T 3m19_A 144 ------------------------------------QSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLF 187 (251)
T ss_dssp ------------------------------------CCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECC
T ss_pred ------------------------------------CccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEee
Confidence 44444 24555555555555555555555555556666666666
Q ss_pred CCcccCC
Q 003982 291 NNKLQGP 297 (782)
Q Consensus 291 ~N~l~~~ 297 (782)
+|++.+.
T Consensus 188 ~N~~~c~ 194 (251)
T 3m19_A 188 GNQFDCS 194 (251)
T ss_dssp SCCBCTT
T ss_pred CCceeCC
Confidence 6665543
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-23 Score=220.04 Aligned_cols=200 Identities=23% Similarity=0.254 Sum_probs=154.4
Q ss_pred CCCCCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCE
Q 003982 63 DNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQV 141 (782)
Q Consensus 63 ~~~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 141 (782)
.+-.+++++++++++++ .+|..+. ++|+.|+|++|.|++..+ .|.++++|++|+|++|+|+.++.. ..+++|++
T Consensus 7 ~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~~ 81 (290)
T 1p9a_G 7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLGT 81 (290)
T ss_dssp ECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCCE
T ss_pred cccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCCE
Confidence 33346778888888887 5666554 678888888888887766 688888888888888888887664 67888888
Q ss_pred EeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhccccc
Q 003982 142 LSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQ 221 (782)
Q Consensus 142 L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~ 221 (782)
|+|++|++.. +|..+..+++|++|+|++|+|++..+..|..+++|++|+|++|++++ +|...
T Consensus 82 L~Ls~N~l~~---l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~-~~~~~-------------- 143 (290)
T 1p9a_G 82 LDLSHNQLQS---LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT-LPPGL-------------- 143 (290)
T ss_dssp EECCSSCCSS---CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCC-CCTTT--------------
T ss_pred EECCCCcCCc---CchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCc-cChhh--------------
Confidence 8888888876 67777888888888888888888877888888888888888888873 44321
Q ss_pred CCCccccccccCCCCCcEEEeecccccCCCCC-CCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCccc
Q 003982 222 LGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQ 295 (782)
Q Consensus 222 ~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 295 (782)
|..+++|+.|+|++|+|+..++. |..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|++.
T Consensus 144 ---------~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 144 ---------LTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp ---------TTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred ---------cccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence 34578888888888888876664 577888888888888888 66777777778888888888776
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-23 Score=219.84 Aligned_cols=204 Identities=21% Similarity=0.213 Sum_probs=123.9
Q ss_pred CCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCC
Q 003982 109 LANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSN 188 (782)
Q Consensus 109 l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 188 (782)
+.++++|+++++++|+++.+|...+ + +++.|+|++|++++..+..|..+++
T Consensus 6 ~~~l~~l~~l~~~~~~l~~ip~~~~---~--------------------------~l~~L~L~~N~l~~~~~~~~~~l~~ 56 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLTALPPDLP---K--------------------------DTTILHLSENLLYTFSLATLMPYTR 56 (290)
T ss_dssp EECSTTCCEEECTTSCCSSCCSCCC---T--------------------------TCCEEECTTSCCSEEEGGGGTTCTT
T ss_pred ccccCCccEEECCCCCCCcCCCCCC---C--------------------------CCCEEEcCCCcCCccCHHHhhcCCC
Confidence 4556666666776666666665432 3 4445555555555555555666666
Q ss_pred CcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeecccccCCCCCCCCCCCCCEEEcCCC
Q 003982 189 LQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDN 268 (782)
Q Consensus 189 L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N 268 (782)
|++|+|++|.+++ ++. ...+++|++|+|++|+++..+..+..+++|++|+|++|
T Consensus 57 L~~L~L~~n~l~~-~~~-------------------------~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~l~~N 110 (290)
T 1p9a_G 57 LTQLNLDRAELTK-LQV-------------------------DGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFN 110 (290)
T ss_dssp CCEEECTTSCCCE-EEC-------------------------CSCCTTCCEEECCSSCCSSCCCCTTTCTTCCEEECCSS
T ss_pred CCEEECCCCccCc-ccC-------------------------CCCCCcCCEEECCCCcCCcCchhhccCCCCCEEECCCC
Confidence 6666666666652 221 12356666666666666655555666666667777777
Q ss_pred cCccCcchhhcCCCCCCEEEccCCcccCCCCCCCCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCccccc
Q 003982 269 QLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSD 348 (782)
Q Consensus 269 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (782)
+|++..|..|..+++|++|+|++|++++..+.
T Consensus 111 ~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~------------------------------------------------ 142 (290)
T 1p9a_G 111 RLTSLPLGALRGLGELQELYLKGNELKTLPPG------------------------------------------------ 142 (290)
T ss_dssp CCCCCCSSTTTTCTTCCEEECTTSCCCCCCTT------------------------------------------------
T ss_pred cCcccCHHHHcCCCCCCEEECCCCCCCccChh------------------------------------------------
Confidence 76665566666666666666666666643221
Q ss_pred CcCCCCCCCCCCcccccCCceeEEEccCcccccccCccccccccCCeEecccccccccCCccCCCCCCCCeEecCCCcCC
Q 003982 349 SWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428 (782)
Q Consensus 349 ~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~ 428 (782)
.+..+++|+.|+|++|+|++..+..|.++++|++|+|++|+|+ .+|..+..++.|+.|+|++|++.
T Consensus 143 -------------~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 143 -------------LLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp -------------TTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred -------------hcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence 1222345555555555555444445677778888888888887 67777777777777777766664
Q ss_pred C
Q 003982 429 G 429 (782)
Q Consensus 429 g 429 (782)
+
T Consensus 209 C 209 (290)
T 1p9a_G 209 C 209 (290)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.4e-24 Score=229.70 Aligned_cols=203 Identities=17% Similarity=0.142 Sum_probs=132.1
Q ss_pred CCCCEEeccCCCCCCCCCCCccc--CCCcccCeeeccccccCCCCc----ccccCCCCCcEEEcccCcCCCCCCcccccc
Q 003982 137 TNLQVLSLSDNPNLAPWPFPNEL--TKSTSLTTLYMDNANIFGLIP----DFFDSFSNLQNLRLSYNNFTGSLPASFAKS 210 (782)
Q Consensus 137 ~~L~~L~Ls~N~l~~~~~~p~~~--~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 210 (782)
++|++|+|++|++.. ..|..+ ..+++|++|+|++|.+++..+ ..+..+++|++|+|++|++++..|..+
T Consensus 91 ~~L~~L~l~~n~l~~--~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~--- 165 (310)
T 4glp_A 91 SRLKELTLEDLKITG--TMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQV--- 165 (310)
T ss_dssp SCCCEEEEESCCCBS--CCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSC---
T ss_pred CceeEEEeeCCEecc--chhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHh---
Confidence 345555555555554 344444 556666666666666655433 333456677777777777764444433
Q ss_pred ccchhhcccccCCCccccccccCCCCCcEEEeecccccC---CCC--CCCCCCCCCEEEcCCCcCccCcch----hhcCC
Q 003982 211 DIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTG---PIP--DLSKCESLFDLSLRDNQLTGVVPA----SVISL 281 (782)
Q Consensus 211 ~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~---~~~--~~~~l~~L~~L~L~~N~l~~~~p~----~~~~l 281 (782)
+++++|++|+|++|++.+ .++ .+..+++|++|+|++|+|+. ++. .+..+
T Consensus 166 ---------------------~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l 223 (310)
T 4glp_A 166 ---------------------RAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAG 223 (310)
T ss_dssp ---------------------CCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHT
T ss_pred ---------------------ccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcC
Confidence 346777777777777654 222 24677888888888888873 333 35678
Q ss_pred CCCCEEEccCCcccCCCCCCCCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCc
Q 003982 282 PALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPF 361 (782)
Q Consensus 282 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 361 (782)
++|++|+|++|++++..|..+..
T Consensus 224 ~~L~~L~Ls~N~l~~~~p~~~~~--------------------------------------------------------- 246 (310)
T 4glp_A 224 VQPHSLDLSHNSLRATVNPSAPR--------------------------------------------------------- 246 (310)
T ss_dssp CCCSSEECTTSCCCCCCCSCCSS---------------------------------------------------------
T ss_pred CCCCEEECCCCCCCccchhhHHh---------------------------------------------------------
Confidence 88888888888888765532211
Q ss_pred ccccCCceeEEEccCcccccccCccccccccCCeEecccccccccCCccCCCCCCCCeEecCCCcCCC
Q 003982 362 VTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSG 429 (782)
Q Consensus 362 ~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g 429 (782)
....++|++|+|++|+|+ .+|..+. ++|++|+|++|+|++. |. +..+++|+.|+|++|+|+.
T Consensus 247 -~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 247 -CMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp -CCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred -ccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence 001246777777777777 5666664 7899999999999854 43 6778899999999999874
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.3e-25 Score=241.18 Aligned_cols=64 Identities=14% Similarity=0.273 Sum_probs=41.0
Q ss_pred ceeEEEccCcccccccC----ccccccccCCeEecccccccc-------cCCccCCCCCCCCeEecCCCcCCCCC
Q 003982 368 RIITINLANKLLAGNIS----PAYANLTSLKNLYLQQNNLTG-------PIPDGLTKLASLQNLDVSNNNLSGKV 431 (782)
Q Consensus 368 ~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~g-------~~p~~~~~l~~L~~L~ls~N~l~g~~ 431 (782)
+|++|+|++|.|++..+ ..+..+++|++|+|++|++.+ .++..+..+++|+.||+++|++.+..
T Consensus 226 ~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~ 300 (362)
T 3goz_A 226 HVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSH 300 (362)
T ss_dssp TCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGG
T ss_pred CceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcc
Confidence 55666666666654333 334566777777777777443 23446777788888888888876653
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.89 E-value=3.5e-25 Score=237.35 Aligned_cols=211 Identities=19% Similarity=0.259 Sum_probs=136.4
Q ss_pred CCCccccceEeCCCCCEEEEEeCCCCCCcccCccccCC--ccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCC-
Q 003982 52 TGYCEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSL--TQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSV- 128 (782)
Q Consensus 52 ~~~c~w~gv~c~~~~~v~~L~l~~~~l~~~~~~~l~~l--~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~- 128 (782)
..|..|.++.|+ ...++.++++++.+. +..+..+ ++++.|++++|.+++.++.+..+++|++|+|++|.++..
T Consensus 34 ~vc~~W~~~~~~-~~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~ 109 (336)
T 2ast_B 34 GVCKRWYRLASD-ESLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVST 109 (336)
T ss_dssp SSCHHHHHHHTC-STTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHH
T ss_pred HHHHHHHHHhcC-chhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHH
Confidence 355689999987 345889999999887 5567777 889999999999998888777889999999999988753
Q ss_pred CCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeecccc-ccCCC-CcccccCCCCCcEEEcccC-cCCCC-CC
Q 003982 129 PTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNA-NIFGL-IPDFFDSFSNLQNLRLSYN-NFTGS-LP 204 (782)
Q Consensus 129 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~~L~~L~Ls~N-~l~~~-~p 204 (782)
.+..+..+++|++|+|++|++.. ..+..+..+++|++|+|++| .+++. ++..+..+++|++|++++| ++++. ++
T Consensus 110 ~~~~~~~~~~L~~L~L~~~~l~~--~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~ 187 (336)
T 2ast_B 110 LHGILSQCSKLQNLSLEGLRLSD--PIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQ 187 (336)
T ss_dssp HHHHHTTBCCCSEEECTTCBCCH--HHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHH
T ss_pred HHHHHhhCCCCCEEeCcCcccCH--HHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHH
Confidence 33446677777777777776654 34555666666777777766 45532 4555666666666666666 65522 22
Q ss_pred ccccccccchhhcccccCCCccccccccCCC-CCcEEEeeccc--ccC--CCCCCCCCCCCCEEEcCCCc-CccCcchhh
Q 003982 205 ASFAKSDIQNLWMNDQQLGLSGTLDVLSGMT-QLRQVWLHKNQ--FTG--PIPDLSKCESLFDLSLRDNQ-LTGVVPASV 278 (782)
Q Consensus 205 ~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~-~L~~L~L~~N~--l~~--~~~~~~~l~~L~~L~L~~N~-l~~~~p~~~ 278 (782)
.. +..++ +|++|++++|. ++. .+..+..+++|+.|++++|. +++..+..+
T Consensus 188 ~~------------------------~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l 243 (336)
T 2ast_B 188 VA------------------------VAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEF 243 (336)
T ss_dssp HH------------------------HHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGG
T ss_pred HH------------------------HHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHH
Confidence 21 22355 66666666653 321 11123445555555555555 444445555
Q ss_pred cCCCCCCEEEccCC
Q 003982 279 ISLPALLNISLQNN 292 (782)
Q Consensus 279 ~~l~~L~~L~l~~N 292 (782)
.++++|++|++++|
T Consensus 244 ~~l~~L~~L~l~~~ 257 (336)
T 2ast_B 244 FQLNYLQHLSLSRC 257 (336)
T ss_dssp GGCTTCCEEECTTC
T ss_pred hCCCCCCEeeCCCC
Confidence 55555555555555
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.6e-23 Score=221.55 Aligned_cols=225 Identities=22% Similarity=0.280 Sum_probs=154.6
Q ss_pred CEEEEEeCCCCCCcccCc---cccCCccCceeecccCccCccCC-CC--CCCCCCCEEeCCCCcccCCCC----CCCCCC
Q 003982 67 RVTTISLAKSGLSGTLSP---EISSLTQLETLSFQMNNIAGAIP-SL--ANATSLQDIYLDNNNFTSVPT----GCFDGL 136 (782)
Q Consensus 67 ~v~~L~l~~~~l~~~~~~---~l~~l~~L~~L~L~~N~l~~~~~-~l--~~l~~L~~L~Ls~n~l~~~~~----~~~~~l 136 (782)
+++.+.+.++.++...-. .+..+++|++|++++|.+++..| .+ ..+++|++|+|++|++++..+ ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 467777777776532111 12234568888888888887766 45 778888888888888876333 234467
Q ss_pred CCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCC---C-cccccCCCCCcEEEcccCcCCCCCCcccccccc
Q 003982 137 TNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGL---I-PDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDI 212 (782)
Q Consensus 137 ~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~---~-~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l 212 (782)
++|++|+|++|++.. ..+..+..+++|++|+|++|++.+. . +..+..+++|++|+|++|+++ .++....
T Consensus 145 ~~L~~L~Ls~n~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~---- 217 (310)
T 4glp_A 145 PGLKVLSIAQAHSPA--FSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCA---- 217 (310)
T ss_dssp SCCCEEEEECCSSCC--CCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHH----
T ss_pred cCCCEEEeeCCCcch--hhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHH----
Confidence 888888888888866 4566778888888888888887642 1 233467788888888888886 3332110
Q ss_pred chhhcccccCCCccccccccCCCCCcEEEeecccccCCC-CCCCCC---CCCCEEEcCCCcCccCcchhhcCCCCCCEEE
Q 003982 213 QNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPI-PDLSKC---ESLFDLSLRDNQLTGVVPASVISLPALLNIS 288 (782)
Q Consensus 213 ~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 288 (782)
..+.++++|++|+|++|++++.. +.+..+ ++|++|+|++|+|+ .+|..+. ++|++|+
T Consensus 218 ----------------~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~ 278 (310)
T 4glp_A 218 ----------------ALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLD 278 (310)
T ss_dssp ----------------HHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEE
T ss_pred ----------------HHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEE
Confidence 01234678888888888888763 345444 68888888888888 5666664 6888888
Q ss_pred ccCCcccC-CCCCCCCCccEEEccCCcCCC
Q 003982 289 LQNNKLQG-PYPLFPSKVQKVSLDHNNFCK 317 (782)
Q Consensus 289 l~~N~l~~-~~~~~~~~l~~L~l~~N~~~~ 317 (782)
|++|+|++ +.+..+++|+.|+|++|.|+.
T Consensus 279 Ls~N~l~~~~~~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 279 LSSNRLNRAPQPDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp CCSCCCCSCCCTTSCCCCSCEECSSTTTSC
T ss_pred CCCCcCCCCchhhhCCCccEEECcCCCCCC
Confidence 88888887 445556778888888887754
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.9e-25 Score=240.45 Aligned_cols=226 Identities=19% Similarity=0.167 Sum_probs=154.2
Q ss_pred EEEeCCCCCCcccCccccCCccCceeecccCccCccCC-----CCCCCC-CCCEEeCCCCcccCCCCCCCCCC-----CC
Q 003982 70 TISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-----SLANAT-SLQDIYLDNNNFTSVPTGCFDGL-----TN 138 (782)
Q Consensus 70 ~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-----~l~~l~-~L~~L~Ls~n~l~~~~~~~~~~l-----~~ 138 (782)
...|++++++|.+|..+...++|++|+|++|.|++..+ .|.+++ +|++|+|++|+|+......+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 35778888888888877777778888888888887664 366777 88888888888888766656554 78
Q ss_pred CCEEeccCCCCCCCCCCCcc----cCCC-cccCeeeccccccCCCCccccc----C-CCCCcEEEcccCcCCCCCCcccc
Q 003982 139 LQVLSLSDNPNLAPWPFPNE----LTKS-TSLTTLYMDNANIFGLIPDFFD----S-FSNLQNLRLSYNNFTGSLPASFA 208 (782)
Q Consensus 139 L~~L~Ls~N~l~~~~~~p~~----~~~l-~~L~~L~L~~N~l~~~~~~~~~----~-l~~L~~L~Ls~N~l~~~~p~~~~ 208 (782)
|++|+|++|++.. ..+.. +..+ ++|++|+|++|++++..+..+. . .++|++|+|++|++++..+..+.
T Consensus 82 L~~L~Ls~n~l~~--~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~ 159 (362)
T 3goz_A 82 VTSLNLSGNFLSY--KSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELI 159 (362)
T ss_dssp CCEEECCSSCGGG--SCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHH
T ss_pred ccEEECcCCcCCh--HHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHH
Confidence 8888888888776 23332 3344 7788888888888777665443 3 25788888888888744433332
Q ss_pred ccccchhhcccccCCCccccccccCCC-CCcEEEeecccccCCCCC-----CCCC-CCCCEEEcCCCcCccC----cchh
Q 003982 209 KSDIQNLWMNDQQLGLSGTLDVLSGMT-QLRQVWLHKNQFTGPIPD-----LSKC-ESLFDLSLRDNQLTGV----VPAS 277 (782)
Q Consensus 209 ~~~l~~l~l~~~~~~~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~-----~~~l-~~L~~L~L~~N~l~~~----~p~~ 277 (782)
. .+..++ +|++|+|++|++++..+. +..+ ++|++|+|++|+|++. ++..
T Consensus 160 ~--------------------~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~ 219 (362)
T 3goz_A 160 Q--------------------ILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYI 219 (362)
T ss_dssp H--------------------HHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred H--------------------HHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHH
Confidence 1 122344 788888888888765542 3444 4788888888888753 4555
Q ss_pred hcC-CCCCCEEEccCCcccCCCC-------CCCCCccEEEccCCcCCC
Q 003982 278 VIS-LPALLNISLQNNKLQGPYP-------LFPSKVQKVSLDHNNFCK 317 (782)
Q Consensus 278 ~~~-l~~L~~L~l~~N~l~~~~~-------~~~~~l~~L~l~~N~~~~ 317 (782)
+.. .++|++|+|++|++++..+ ....+|+.|+|++|.+..
T Consensus 220 l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~ 267 (362)
T 3goz_A 220 FSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKN 267 (362)
T ss_dssp HHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTT
T ss_pred HhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccc
Confidence 555 3478888888888876544 223456666666665443
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.2e-22 Score=216.60 Aligned_cols=221 Identities=15% Similarity=0.168 Sum_probs=174.4
Q ss_pred CCccccceEeCCCCCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCccc-CCCC
Q 003982 53 GYCEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFT-SVPT 130 (782)
Q Consensus 53 ~~c~w~gv~c~~~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~-~~~~ 130 (782)
|.|+|..|.|++ ++|+ .+|..+ .+++++|+|++|+|+.+++ .|.++++|++|+|++|++. .++.
T Consensus 7 C~C~~~~v~C~~-----------~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~ 72 (350)
T 4ay9_X 7 CHCSNRVFLCQE-----------SKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA 72 (350)
T ss_dssp SEEETTEEEEES-----------TTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECT
T ss_pred cEeeCCEEEecC-----------CCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccCh
Confidence 557888777753 4565 667665 3689999999999998887 6899999999999999975 4788
Q ss_pred CCCCCCCCCCE-EeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEccc-CcCCCCCCcccc
Q 003982 131 GCFDGLTNLQV-LSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSY-NNFTGSLPASFA 208 (782)
Q Consensus 131 ~~~~~l~~L~~-L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~ 208 (782)
++|.++++|++ ++++.|++.. ..|..|..+++|++|++++|+++...+..+....++..|++.+ |++. .+|...
T Consensus 73 ~~f~~L~~l~~~l~~~~N~l~~--l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~-~l~~~~- 148 (350)
T 4ay9_X 73 DVFSNLPKLHEIRIEKANNLLY--INPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH-TIERNS- 148 (350)
T ss_dssp TSBCSCTTCCEEEEEEETTCCE--ECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCC-EECTTS-
T ss_pred hHhhcchhhhhhhcccCCcccc--cCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccc-cccccc-
Confidence 88999988775 6667788888 4567889999999999999999988777777888888898866 4555 444321
Q ss_pred ccccchhhcccccCCCccccccccCC-CCCcEEEeecccccCCCCCCCCCCCCCEEEcCC-CcCccCcchhhcCCCCCCE
Q 003982 209 KSDIQNLWMNDQQLGLSGTLDVLSGM-TQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRD-NQLTGVVPASVISLPALLN 286 (782)
Q Consensus 209 ~~~l~~l~l~~~~~~~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~ 286 (782)
|..+ ..++.|+|++|+|+.+++......+|+.|++++ |.++...++.|..+++|++
T Consensus 149 ----------------------f~~~~~~l~~L~L~~N~i~~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~ 206 (350)
T 4ay9_X 149 ----------------------FVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVI 206 (350)
T ss_dssp ----------------------STTSBSSCEEEECCSSCCCEECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSE
T ss_pred ----------------------hhhcchhhhhhccccccccCCChhhccccchhHHhhccCCcccCCCHHHhccCcccch
Confidence 2234 468899999999998877766678899999975 6677555567899999999
Q ss_pred EEccCCcccCCCCCCCCCccEEEccCC
Q 003982 287 ISLQNNKLQGPYPLFPSKVQKVSLDHN 313 (782)
Q Consensus 287 L~l~~N~l~~~~~~~~~~l~~L~l~~N 313 (782)
|++++|+|+..++..+.+|+.|.+.++
T Consensus 207 LdLs~N~l~~lp~~~~~~L~~L~~l~~ 233 (350)
T 4ay9_X 207 LDISRTRIHSLPSYGLENLKKLRARST 233 (350)
T ss_dssp EECTTSCCCCCCSSSCTTCCEEECTTC
T ss_pred hhcCCCCcCccChhhhccchHhhhccC
Confidence 999999999777767777777775544
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.89 E-value=3.4e-23 Score=218.70 Aligned_cols=166 Identities=21% Similarity=0.331 Sum_probs=87.8
Q ss_pred CceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeecc
Q 003982 92 LETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMD 171 (782)
Q Consensus 92 L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~ 171 (782)
+..+.+..+.++... .+..+++|++|++++|.++.++ .+..+++|++|+|++|++.. ++. +..+++|++|+|+
T Consensus 21 ~~~~~l~~~~~~~~~-~~~~l~~L~~L~l~~~~i~~l~--~~~~l~~L~~L~L~~n~i~~---~~~-~~~l~~L~~L~L~ 93 (308)
T 1h6u_A 21 AIKIAAGKSNVTDTV-TQADLDGITTLSAFGTGVTTIE--GVQYLNNLIGLELKDNQITD---LAP-LKNLTKITELELS 93 (308)
T ss_dssp HHHHHTTCSSTTSEE-CHHHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCC---CGG-GTTCCSCCEEECC
T ss_pred HHHHHhCCCCcCcee-cHHHcCCcCEEEeeCCCccCch--hhhccCCCCEEEccCCcCCC---Chh-HccCCCCCEEEcc
Confidence 333445555554432 2344566666667666666654 25566666666666666655 222 5555555555555
Q ss_pred ccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeecccccCCC
Q 003982 172 NANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPI 251 (782)
Q Consensus 172 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 251 (782)
+|++++. ..+..+++|++|+|++|++++ ++. +..+++|++|++++|++++.+
T Consensus 94 ~n~l~~~--~~~~~l~~L~~L~l~~n~l~~-~~~-------------------------l~~l~~L~~L~l~~n~l~~~~ 145 (308)
T 1h6u_A 94 GNPLKNV--SAIAGLQSIKTLDLTSTQITD-VTP-------------------------LAGLSNLQVLYLDLNQITNIS 145 (308)
T ss_dssp SCCCSCC--GGGTTCTTCCEEECTTSCCCC-CGG-------------------------GTTCTTCCEEECCSSCCCCCG
T ss_pred CCcCCCc--hhhcCCCCCCEEECCCCCCCC-chh-------------------------hcCCCCCCEEECCCCccCcCc
Confidence 5555553 245556666666666666552 221 223555555555555555433
Q ss_pred CCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCccc
Q 003982 252 PDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQ 295 (782)
Q Consensus 252 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 295 (782)
+ +..+++|+.|+|++|++++..+ +..+++|+.|++++|+++
T Consensus 146 ~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~ 186 (308)
T 1h6u_A 146 P-LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKIS 186 (308)
T ss_dssp G-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred c-ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccC
Confidence 3 4455555555555555553222 445555555555555444
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=7.6e-23 Score=207.81 Aligned_cols=213 Identities=18% Similarity=0.198 Sum_probs=127.7
Q ss_pred eecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCC-CCCCCCCCcccCCCcccCeeeccc-
Q 003982 95 LSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNP-NLAPWPFPNELTKSTSLTTLYMDN- 172 (782)
Q Consensus 95 L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~p~~~~~l~~L~~L~L~~- 172 (782)
+++..+.++.+++ +. ++|++|+|++|+++.+++..|.++++|++|+|++|+ +.. ..+..|.++++|++|+|++
T Consensus 16 ~~v~c~~l~~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~--i~~~~f~~l~~L~~L~l~~~ 90 (239)
T 2xwt_C 16 FRVTCKDIQRIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQ--LESHSFYNLSKVTHIEIRNT 90 (239)
T ss_dssp TEEEECSCSSCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCE--ECTTTEESCTTCCEEEEEEE
T ss_pred ceeEccCccccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcce--eCHhHcCCCcCCcEEECCCC
Confidence 3333334554444 32 367777777777777777767777777777777665 544 2222444444444444444
Q ss_pred cccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeecccccCCCC
Q 003982 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIP 252 (782)
Q Consensus 173 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 252 (782)
|+++++.+..|.. +++|++|++++|++++.+
T Consensus 91 n~l~~i~~~~f~~------------------------------------------------l~~L~~L~l~~n~l~~lp- 121 (239)
T 2xwt_C 91 RNLTYIDPDALKE------------------------------------------------LPLLKFLGIFNTGLKMFP- 121 (239)
T ss_dssp TTCCEECTTSEEC------------------------------------------------CTTCCEEEEEEECCCSCC-
T ss_pred CCeeEcCHHHhCC------------------------------------------------CCCCCEEeCCCCCCcccc-
Confidence 4444443444444 455555555555555432
Q ss_pred CCCCCCCCC---EEEcCCC-cCccCcchhhcCCCCCC-EEEccCCcccCCCCCCCCCccEEEccCCcCCCCCCCCCCCCC
Q 003982 253 DLSKCESLF---DLSLRDN-QLTGVVPASVISLPALL-NISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCD 327 (782)
Q Consensus 253 ~~~~l~~L~---~L~L~~N-~l~~~~p~~~~~l~~L~-~L~l~~N~l~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~ 327 (782)
.+..+++|+ +|++++| ++++..+..|.++++|+ +|++++|+++...+.
T Consensus 122 ~~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~--------------------------- 174 (239)
T 2xwt_C 122 DLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGY--------------------------- 174 (239)
T ss_dssp CCTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTT---------------------------
T ss_pred ccccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHh---------------------------
Confidence 245555555 6666666 66655555666666676 676666666522111
Q ss_pred hhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcc-cccccCcccccc-ccCCeEecccccccc
Q 003982 328 PQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKL-LAGNISPAYANL-TSLKNLYLQQNNLTG 405 (782)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~g 405 (782)
....++|+.|+|++|. +++..+..|.++ ++|++|+|++|+|+
T Consensus 175 -----------------------------------~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~- 218 (239)
T 2xwt_C 175 -----------------------------------AFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT- 218 (239)
T ss_dssp -----------------------------------TTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCC-
T ss_pred -----------------------------------hcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccc-
Confidence 0111467777777774 776666778888 89999999999998
Q ss_pred cCCccCCCCCCCCeEecCCCc
Q 003982 406 PIPDGLTKLASLQNLDVSNNN 426 (782)
Q Consensus 406 ~~p~~~~~l~~L~~L~ls~N~ 426 (782)
.+|.. .+++|+.|+++++.
T Consensus 219 ~l~~~--~~~~L~~L~l~~~~ 237 (239)
T 2xwt_C 219 ALPSK--GLEHLKELIARNTW 237 (239)
T ss_dssp CCCCT--TCTTCSEEECTTC-
T ss_pred cCChh--HhccCceeeccCcc
Confidence 45544 67788889888764
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.88 E-value=6.2e-22 Score=202.64 Aligned_cols=174 Identities=24% Similarity=0.288 Sum_probs=119.6
Q ss_pred CEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcc
Q 003982 116 QDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLS 195 (782)
Q Consensus 116 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 195 (782)
++++++++.++.+|.... ++|++|+|++|++.. ..+..|.++++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus 17 ~~l~~~~~~l~~~p~~~~---~~l~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 17 KEVDCQGKSLDSVPSGIP---ADTEKLDLQSTGLAT--LSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp TEEECTTCCCSSCCSCCC---TTCCEEECTTSCCCC--CCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred eEEecCCCCccccCCCCC---CCCCEEEccCCCcCc--cCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 344444444444443321 244444444444444 233345555555555555555555666667777777777777
Q ss_pred cCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeecccccCCCCC-CCCCCCCCEEEcCCCcCccCc
Q 003982 196 YNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVV 274 (782)
Q Consensus 196 ~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~ 274 (782)
+|++++..+.. |.++++|++|+|++|++++.++. |..+++|+.|+|++|+|++..
T Consensus 92 ~n~l~~~~~~~------------------------~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 147 (251)
T 3m19_A 92 NNQLASLPLGV------------------------FDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIP 147 (251)
T ss_dssp TSCCCCCCTTT------------------------TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CCcccccChhH------------------------hcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccC
Confidence 77777333332 33577778888888887776665 688999999999999999888
Q ss_pred chhhcCCCCCCEEEccCCcccCCCCCC---CCCccEEEccCCcCCCC
Q 003982 275 PASVISLPALLNISLQNNKLQGPYPLF---PSKVQKVSLDHNNFCKN 318 (782)
Q Consensus 275 p~~~~~l~~L~~L~l~~N~l~~~~~~~---~~~l~~L~l~~N~~~~~ 318 (782)
+..|..+++|++|+|++|++++..+.. +.+|+.|+|++|.+...
T Consensus 148 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 148 AGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred HHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 889999999999999999999887754 46899999999999654
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.5e-22 Score=200.89 Aligned_cols=188 Identities=28% Similarity=0.423 Sum_probs=137.3
Q ss_pred CCCCCccccceEeCCCCCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCcccCC
Q 003982 50 SSTGYCEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSV 128 (782)
Q Consensus 50 ~~~~~c~w~gv~c~~~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~ 128 (782)
+..+.|.|++|.|+.. +++ .+|..+ .++|++|++++|++++.++ .|.++++|++|+|++|+++.+
T Consensus 2 p~~C~C~~~~v~c~~~-----------~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 67 (208)
T 2o6s_A 2 PSRCSCSGTTVECYSQ-----------GRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSL 67 (208)
T ss_dssp CTTCEEETTEEECCSS-----------CCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCC
T ss_pred cCCCEECCCEEEecCC-----------Ccc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCcc
Confidence 4556799999999753 333 344433 3588999999999988777 578899999999999999998
Q ss_pred CCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCcccc
Q 003982 129 PTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFA 208 (782)
Q Consensus 129 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 208 (782)
++..|.++++|++|+|++|++.. ..+..+..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..
T Consensus 68 ~~~~~~~l~~L~~L~Ls~n~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-- 143 (208)
T 2o6s_A 68 PNGVFNKLTSLTYLNLSTNQLQS--LPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGV-- 143 (208)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCC--CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTT--
T ss_pred ChhhcCCCCCcCEEECCCCcCCc--cCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHH--
Confidence 88888888899999998888877 34445677888888888888887777777777788888888888777333322
Q ss_pred ccccchhhcccccCCCccccccccCCCCCcEEEeecccccCCCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCC
Q 003982 209 KSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPA 283 (782)
Q Consensus 209 ~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 283 (782)
+.++++|++|++++|.+.+ .+++|+.|+++.|+++|.+|..++.++.
T Consensus 144 ----------------------~~~l~~L~~L~l~~N~~~~------~~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 144 ----------------------FDRLTSLQYIWLHDNPWDC------TCPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp ----------------------TTTCTTCCEEECCSCCBCC------CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred ----------------------hccCCCccEEEecCCCeec------CCCCHHHHHHHHHhCCceeeccCccccC
Confidence 2346777777777776653 3456666666777777666666665543
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=2.1e-22 Score=212.53 Aligned_cols=196 Identities=23% Similarity=0.430 Sum_probs=157.3
Q ss_pred CCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEecc
Q 003982 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145 (782)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls 145 (782)
.+++.|+++++++.. ++ .+..+++|++|+|++|.+++.++ +..+++|++|+|++|+++.++ .+.++++|++|+|+
T Consensus 41 ~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~-~~~l~~L~~L~L~~n~l~~~~--~~~~l~~L~~L~l~ 115 (308)
T 1h6u_A 41 DGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLKNVS--AIAGLQSIKTLDLT 115 (308)
T ss_dssp HTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCSCCG--GGTTCTTCCEEECT
T ss_pred CCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh-HccCCCCCEEEccCCcCCCch--hhcCCCCCCEEECC
Confidence 367888888888874 44 57888888999998888887776 888888899999888888875 47888888888988
Q ss_pred CCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCc
Q 003982 146 DNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLS 225 (782)
Q Consensus 146 ~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~ 225 (782)
+|++.. ++ .+..+++|++|+|++|++++..+ +..+++|++|+|++|++++ ++.
T Consensus 116 ~n~l~~---~~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~~-------------------- 168 (308)
T 1h6u_A 116 STQITD---VT-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD-LTP-------------------- 168 (308)
T ss_dssp TSCCCC---CG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG--------------------
T ss_pred CCCCCC---ch-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCC-Chh--------------------
Confidence 888877 33 38888888888888888887644 7888888888888888873 332
Q ss_pred cccccccCCCCCcEEEeecccccCCCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCCC
Q 003982 226 GTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLF 301 (782)
Q Consensus 226 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~ 301 (782)
+.++++|+.|++++|++++.++ +..+++|+.|+|++|++++..+ +..+++|+.|++++|++++....+
T Consensus 169 -----l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~~~~~~ 236 (308)
T 1h6u_A 169 -----LANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFY 236 (308)
T ss_dssp -----GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEECCCEEC
T ss_pred -----hcCCCCCCEEECCCCccCcChh-hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeecCCeee
Confidence 3458889999999999987654 7888899999999999986553 788899999999999988644433
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=3e-25 Score=242.76 Aligned_cols=205 Identities=18% Similarity=0.235 Sum_probs=122.4
Q ss_pred CCCcccCeeeccccccCC----CCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCC
Q 003982 160 TKSTSLTTLYMDNANIFG----LIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMT 235 (782)
Q Consensus 160 ~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~ 235 (782)
..+++|++|+|++|.++. .++..+..+++|++|+|++|.++...+..+... +..+. .+.+ -+..+
T Consensus 91 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~-l~~l~--~~~~--------~~~~~ 159 (386)
T 2ca6_A 91 LKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARA-LQELA--VNKK--------AKNAP 159 (386)
T ss_dssp TTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHH-HHHHH--HHHH--------HHTCC
T ss_pred hhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHH-HHHHh--hhhh--------cccCC
Confidence 455666666666666655 345666677777777777777753323222210 00000 0000 00015
Q ss_pred CCcEEEeecccccC-CCC----CCCCCCCCCEEEcCCCcCcc-----CcchhhcCCCCCCEEEccCCcccCCCCCCCCCc
Q 003982 236 QLRQVWLHKNQFTG-PIP----DLSKCESLFDLSLRDNQLTG-----VVPASVISLPALLNISLQNNKLQGPYPLFPSKV 305 (782)
Q Consensus 236 ~L~~L~L~~N~l~~-~~~----~~~~l~~L~~L~L~~N~l~~-----~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l 305 (782)
+|++|+|++|+++. ..+ .+..+++|++|+|++|+|+. ..|..+..+++|+.|+|++|.+++..
T Consensus 160 ~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g------- 232 (386)
T 2ca6_A 160 PLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLG------- 232 (386)
T ss_dssp CCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHH-------
T ss_pred CCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHH-------
Confidence 66666666666652 222 24456667777777776662 23336666666777766666664100
Q ss_pred cEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccc---
Q 003982 306 QKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGN--- 382 (782)
Q Consensus 306 ~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~--- 382 (782)
...+|..+..+++|+.|+|++|.|++.
T Consensus 233 --------------------------------------------------~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~ 262 (386)
T 2ca6_A 233 --------------------------------------------------SSALAIALKSWPNLRELGLNDCLLSARGAA 262 (386)
T ss_dssp --------------------------------------------------HHHHHHHGGGCTTCCEEECTTCCCCHHHHH
T ss_pred --------------------------------------------------HHHHHHHHccCCCcCEEECCCCCCchhhHH
Confidence 001233344556777777777777765
Q ss_pred -cCcccc--ccccCCeEecccccccc----cCCccC-CCCCCCCeEecCCCcCCCCCC
Q 003982 383 -ISPAYA--NLTSLKNLYLQQNNLTG----PIPDGL-TKLASLQNLDVSNNNLSGKVP 432 (782)
Q Consensus 383 -~p~~~~--~l~~L~~L~Ls~N~l~g----~~p~~~-~~l~~L~~L~ls~N~l~g~~p 432 (782)
+|..+. .+++|++|+|++|+|++ .+|..+ .++++|+.|+|++|++++..|
T Consensus 263 ~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 263 AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp HHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred HHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 566663 48899999999999987 478777 668999999999999886543
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.9e-22 Score=208.03 Aligned_cols=155 Identities=13% Similarity=0.068 Sum_probs=121.3
Q ss_pred HHHHHHhcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCCh----------------hhHHHHHHHHHHHHhcC
Q 003982 574 EVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGN----------------KGLSEFQAEIAVLTKVR 637 (782)
Q Consensus 574 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------~~~~~~~~E~~~l~~l~ 637 (782)
..+......|.+.+.||+|+||.||+|...+|+.||||+++...... .....+.+|++++++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 34444556677889999999999999977789999999996532111 13567899999999998
Q ss_pred CCCcceEEeEEEeCCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCC
Q 003982 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSN 717 (782)
Q Consensus 638 h~nI~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~N 717 (782)
|++++. ++.. +..++||||+++++|.+ +.. .+...++.|++.||+|||+ .||+||||||+|
T Consensus 163 ~~~v~~---~~~~-~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~N 223 (282)
T 1zar_A 163 GLAVPK---VYAW-EGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYN 223 (282)
T ss_dssp TSSSCC---EEEE-ETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTS
T ss_pred CCCcCe---EEec-cceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHH
Confidence 544444 4333 45699999999999988 411 2345799999999999998 899999999999
Q ss_pred EEECCCCcEEEEeeccceecCCCCceeeecccccccccCcccccc
Q 003982 718 ILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGK 762 (782)
Q Consensus 718 Ill~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 762 (782)
||++ ++.+||+|||+|+. +..|+|||++..
T Consensus 224 ILl~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 224 VLVS-EEGIWIIDFPQSVE--------------VGEEGWREILER 253 (282)
T ss_dssp EEEE-TTEEEECCCTTCEE--------------TTSTTHHHHHHH
T ss_pred EEEE-CCcEEEEECCCCeE--------------CCCCCHHHHHHH
Confidence 9999 99999999999863 335789998764
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.3e-21 Score=210.71 Aligned_cols=242 Identities=16% Similarity=0.148 Sum_probs=162.8
Q ss_pred ceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCe-eecc
Q 003982 93 ETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTT-LYMD 171 (782)
Q Consensus 93 ~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~-L~L~ 171 (782)
++++.++++++.+|..+ .+++++|+|++|+|+.+++++|.++++|++|+|++|++.+. ..+..|.++++|.. +.+.
T Consensus 12 ~~v~C~~~~Lt~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~-i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEV-IEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCCSCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCE-ECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCCccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCc-cChhHhhcchhhhhhhccc
Confidence 46788999999776655 36899999999999999999999999999999999998662 12346788888764 6667
Q ss_pred ccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeec-ccccCC
Q 003982 172 NANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHK-NQFTGP 250 (782)
Q Consensus 172 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~-N~l~~~ 250 (782)
.|+|+.+.|..|..+++|++|++++|+++...+..+ ....++..|++.+ |+++..
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~------------------------~~~~~l~~l~l~~~~~i~~l 144 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHK------------------------IHSLQKVLLDIQDNINIHTI 144 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTT------------------------CCBSSCEEEEEESCTTCCEE
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhh------------------------cccchhhhhhhccccccccc
Confidence 788888888888889999999999998883333222 2356677777755 566655
Q ss_pred CC-CCCCC-CCCCEEEcCCCcCccCcchhhcCCCCCCEEEccC-CcccCCCCCCCCCccEEEccCCcCCCCCCCCCCCCC
Q 003982 251 IP-DLSKC-ESLFDLSLRDNQLTGVVPASVISLPALLNISLQN-NKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCD 327 (782)
Q Consensus 251 ~~-~~~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~ 327 (782)
++ .|..+ ..++.|+|++|+|+. +|......++|+.|++++ |.++...+.
T Consensus 145 ~~~~f~~~~~~l~~L~L~~N~i~~-i~~~~f~~~~L~~l~l~~~n~l~~i~~~--------------------------- 196 (350)
T 4ay9_X 145 ERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELPND--------------------------- 196 (350)
T ss_dssp CTTSSTTSBSSCEEEECCSSCCCE-ECTTSSTTEEEEEEECTTCTTCCCCCTT---------------------------
T ss_pred cccchhhcchhhhhhccccccccC-CChhhccccchhHHhhccCCcccCCCHH---------------------------
Confidence 54 35554 357778888888874 444444456677777764 444422111
Q ss_pred hhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccccCccccccccCCeEecccccccccC
Q 003982 328 PQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPI 407 (782)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~ 407 (782)
.+..+++|++|||++|+|+...+..|.+ |+.|.+.++.-...+
T Consensus 197 ----------------------------------~f~~l~~L~~LdLs~N~l~~lp~~~~~~---L~~L~~l~~~~l~~l 239 (350)
T 4ay9_X 197 ----------------------------------VFHGASGPVILDISRTRIHSLPSYGLEN---LKKLRARSTYNLKKL 239 (350)
T ss_dssp ----------------------------------TTTTEECCSEEECTTSCCCCCCSSSCTT---CCEEECTTCTTCCCC
T ss_pred ----------------------------------HhccCcccchhhcCCCCcCccChhhhcc---chHhhhccCCCcCcC
Confidence 2334456677777777776443334443 444443333333356
Q ss_pred CccCCCCCCCCeEecCCCcC
Q 003982 408 PDGLTKLASLQNLDVSNNNL 427 (782)
Q Consensus 408 p~~~~~l~~L~~L~ls~N~l 427 (782)
|. +..+++|+.++++++.-
T Consensus 240 P~-l~~l~~L~~l~l~~~~~ 258 (350)
T 4ay9_X 240 PT-LEKLVALMEASLTYPSH 258 (350)
T ss_dssp CC-TTTCCSCCEEECSCHHH
T ss_pred CC-chhCcChhhCcCCCCcc
Confidence 63 67777788888776543
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.86 E-value=6.9e-22 Score=223.87 Aligned_cols=192 Identities=21% Similarity=0.300 Sum_probs=162.6
Q ss_pred cccce-EeCCCCCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCC
Q 003982 56 EWTGI-NCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFD 134 (782)
Q Consensus 56 ~w~gv-~c~~~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~ 134 (782)
.|.|+ .|.. .+++.|+|++|+|++ +|..+. ++|++|+|++|+|+.++ ..+++|++|+|++|+|+++|. +.
T Consensus 49 ~~~~l~~C~~-~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~~ip---~~l~~L~~L~Ls~N~l~~ip~--l~ 119 (571)
T 3cvr_A 49 AVSLLKECLI-NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALISLP---ELPASLEYLDACDNRLSTLPE--LP 119 (571)
T ss_dssp HHHHHHHHHH-TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCSCCC---CCCTTCCEEECCSSCCSCCCC--CC
T ss_pred hhhhcccccc-CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCcccc---cccCCCCEEEccCCCCCCcch--hh
Confidence 79999 6864 479999999999997 887664 88999999999999554 567999999999999999887 55
Q ss_pred CCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccch
Q 003982 135 GLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQN 214 (782)
Q Consensus 135 ~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~ 214 (782)
+ +|++|+|++|++.. +|. .+++|+.|+|++|+|+++ |. .+++|++|+|++|+|++ +|. +
T Consensus 120 ~--~L~~L~Ls~N~l~~---lp~---~l~~L~~L~Ls~N~l~~l-p~---~l~~L~~L~Ls~N~L~~-lp~-l------- 178 (571)
T 3cvr_A 120 A--SLKHLDVDNNQLTM---LPE---LPALLEYINADNNQLTML-PE---LPTSLEVLSVRNNQLTF-LPE-L------- 178 (571)
T ss_dssp T--TCCEEECCSSCCSC---CCC---CCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSC-CCC-C-------
T ss_pred c--CCCEEECCCCcCCC---CCC---cCccccEEeCCCCccCcC-CC---cCCCcCEEECCCCCCCC-cch-h-------
Confidence 4 99999999999988 565 689999999999999985 54 57899999999999994 775 4
Q ss_pred hhcccccCCCccccccccCCCCCcEEEeecccccCCCCCCCCCCCC-------CEEEcCCCcCccCcchhhcCCCCCCEE
Q 003982 215 LWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESL-------FDLSLRDNQLTGVVPASVISLPALLNI 287 (782)
Q Consensus 215 l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L-------~~L~L~~N~l~~~~p~~~~~l~~L~~L 287 (782)
.++|+.|+|++|+|+..+. +.. +| +.|+|++|+|+ .+|..+..+++|+.|
T Consensus 179 -------------------~~~L~~L~Ls~N~L~~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L 235 (571)
T 3cvr_A 179 -------------------PESLEALDVSTNLLESLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTI 235 (571)
T ss_dssp -------------------CTTCCEEECCSSCCSSCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEE
T ss_pred -------------------hCCCCEEECcCCCCCchhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEE
Confidence 1789999999999996665 554 77 99999999999 688888889999999
Q ss_pred EccCCcccCCCCC
Q 003982 288 SLQNNKLQGPYPL 300 (782)
Q Consensus 288 ~l~~N~l~~~~~~ 300 (782)
+|++|+|++.+|.
T Consensus 236 ~L~~N~l~~~~p~ 248 (571)
T 3cvr_A 236 ILEDNPLSSRIRE 248 (571)
T ss_dssp ECCSSSCCHHHHH
T ss_pred EeeCCcCCCcCHH
Confidence 9999999986664
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.86 E-value=1.3e-23 Score=229.75 Aligned_cols=250 Identities=19% Similarity=0.210 Sum_probs=194.7
Q ss_pred ccCccccCCccCceeecccCccCccCC-----CCCCCCCCCEEeCCCCcccCC----CCCC------CCCCCCCCEEecc
Q 003982 81 TLSPEISSLTQLETLSFQMNNIAGAIP-----SLANATSLQDIYLDNNNFTSV----PTGC------FDGLTNLQVLSLS 145 (782)
Q Consensus 81 ~~~~~l~~l~~L~~L~L~~N~l~~~~~-----~l~~l~~L~~L~Ls~n~l~~~----~~~~------~~~l~~L~~L~Ls 145 (782)
.++..+..+++|++|+|++|.|+...+ .|..+++|++|+|++|.+..+ |... +.++++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 566778889999999999999987533 478899999999999766543 2222 3688999999999
Q ss_pred CCCCCCCC--CCCcccCCCcccCeeeccccccCCCCcccc----cCC---------CCCcEEEcccCcCC-CCCCccccc
Q 003982 146 DNPNLAPW--PFPNELTKSTSLTTLYMDNANIFGLIPDFF----DSF---------SNLQNLRLSYNNFT-GSLPASFAK 209 (782)
Q Consensus 146 ~N~l~~~~--~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~----~~l---------~~L~~L~Ls~N~l~-~~~p~~~~~ 209 (782)
+|++.... .+|..+..+++|++|+|++|.++...+..+ ..+ ++|++|+|++|+++ +.+|. +.
T Consensus 103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~-l~- 180 (386)
T 2ca6_A 103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKE-WA- 180 (386)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHH-HH-
T ss_pred CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHH-HH-
Confidence 99987722 145678889999999999999975444444 334 89999999999997 33332 11
Q ss_pred cccchhhcccccCCCccccccccCCCCCcEEEeeccccc--C---CCC-CCCCCCCCCEEEcCCCcCc----cCcchhhc
Q 003982 210 SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFT--G---PIP-DLSKCESLFDLSLRDNQLT----GVVPASVI 279 (782)
Q Consensus 210 ~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~--~---~~~-~~~~l~~L~~L~L~~N~l~----~~~p~~~~ 279 (782)
..+..+++|++|+|++|+++ + ..+ .+..+++|++|+|++|+|+ +.+|..+.
T Consensus 181 -------------------~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~ 241 (386)
T 2ca6_A 181 -------------------KTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALK 241 (386)
T ss_dssp -------------------HHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGG
T ss_pred -------------------HHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHc
Confidence 12445889999999999998 3 344 6889999999999999996 67889999
Q ss_pred CCCCCCEEEccCCcccCCCCCCCCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCC
Q 003982 280 SLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGW 359 (782)
Q Consensus 280 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (782)
.+++|++|+|++|++++.... .+
T Consensus 242 ~~~~L~~L~L~~n~i~~~~~~---------------------------------------------------------~l 264 (386)
T 2ca6_A 242 SWPNLRELGLNDCLLSARGAA---------------------------------------------------------AV 264 (386)
T ss_dssp GCTTCCEEECTTCCCCHHHHH---------------------------------------------------------HH
T ss_pred cCCCcCEEECCCCCCchhhHH---------------------------------------------------------HH
Confidence 999999999999998742110 01
Q ss_pred Cccc--ccCCceeEEEccCccccc----ccCccc-cccccCCeEecccccccccCC
Q 003982 360 PFVT--CSQGRIITINLANKLLAG----NISPAY-ANLTSLKNLYLQQNNLTGPIP 408 (782)
Q Consensus 360 p~~~--~~~~~L~~L~Ls~N~l~~----~~p~~~-~~l~~L~~L~Ls~N~l~g~~p 408 (782)
|..+ +.+++|++|+|++|.|++ .+|..+ .++++|++|+|++|++++..+
T Consensus 265 ~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 265 VDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp HHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred HHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 2222 235789999999999998 588877 678999999999999997764
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.86 E-value=5.1e-21 Score=216.76 Aligned_cols=45 Identities=18% Similarity=0.254 Sum_probs=25.5
Q ss_pred eeEEEccCcccccccCccccccccCCeEecccccccccCCccCCCC
Q 003982 369 IITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKL 414 (782)
Q Consensus 369 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l 414 (782)
|+.|+|++|.|+ .+|..+..+++|++|+|++|+|++.+|..|..+
T Consensus 209 L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l 253 (571)
T 3cvr_A 209 EIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQ 253 (571)
T ss_dssp CEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHH
T ss_pred ceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHh
Confidence 355555555555 355555556666666666666666555555443
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.85 E-value=4.7e-23 Score=220.81 Aligned_cols=251 Identities=16% Similarity=0.157 Sum_probs=168.2
Q ss_pred cCceeecccCccCccCCCCCCC--CCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCee
Q 003982 91 QLETLSFQMNNIAGAIPSLANA--TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTL 168 (782)
Q Consensus 91 ~L~~L~L~~N~l~~~~~~l~~l--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L 168 (782)
.++.|++++|.+.. ..+..+ ++++.|++++|.+++.++. +..+++|++|+|++|.+... .++..+..+++|++|
T Consensus 48 ~~~~l~l~~~~~~~--~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~-~~~~~~~~~~~L~~L 123 (336)
T 2ast_B 48 LWQTLDLTGKNLHP--DVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVS-TLHGILSQCSKLQNL 123 (336)
T ss_dssp TSSEEECTTCBCCH--HHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHH-HHHHHHTTBCCCSEE
T ss_pred hheeeccccccCCH--HHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHH-HHHHHHhhCCCCCEE
Confidence 36778888887762 234455 7788888888888877666 44678888888888876541 145567777888888
Q ss_pred eccccccCCCCcccccCCCCCcEEEcccC-cCCCC-CCccccccccchhhcccccCCCccccccccCCCCCcEEEeecc-
Q 003982 169 YMDNANIFGLIPDFFDSFSNLQNLRLSYN-NFTGS-LPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKN- 245 (782)
Q Consensus 169 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N- 245 (782)
+|++|.+++..+..+..+++|++|+|++| .+++. ++.. +.++++|++|++++|
T Consensus 124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~------------------------~~~~~~L~~L~l~~~~ 179 (336)
T 2ast_B 124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTL------------------------LSSCSRLDELNLSWCF 179 (336)
T ss_dssp ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHH------------------------HHHCTTCCEEECCCCT
T ss_pred eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHH------------------------HhcCCCCCEEcCCCCC
Confidence 88888777766777777888888888887 55531 2222 234677888888877
Q ss_pred cccCC--CCCCCCCC-CCCEEEcCCC--cCc-cCcchhhcCCCCCCEEEccCCc-ccCCCCCCCCCccEEEccCCcCCCC
Q 003982 246 QFTGP--IPDLSKCE-SLFDLSLRDN--QLT-GVVPASVISLPALLNISLQNNK-LQGPYPLFPSKVQKVSLDHNNFCKN 318 (782)
Q Consensus 246 ~l~~~--~~~~~~l~-~L~~L~L~~N--~l~-~~~p~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~l~~L~l~~N~~~~~ 318 (782)
++++. +..+..++ +|++|+|++| .++ +.+|..+..+++|++|++++|. +++..
T Consensus 180 ~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~-------------------- 239 (336)
T 2ast_B 180 DFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDC-------------------- 239 (336)
T ss_dssp TCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGG--------------------
T ss_pred CcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHH--------------------
Confidence 77652 22356677 7888888777 454 3566667777777777777777 44321
Q ss_pred CCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcc-cccccCccccccccCCeEe
Q 003982 319 SSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKL-LAGNISPAYANLTSLKNLY 397 (782)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~ 397 (782)
+..+..+++|++|++++|. +.......++++++|++|+
T Consensus 240 -----------------------------------------~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~ 278 (336)
T 2ast_B 240 -----------------------------------------FQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQ 278 (336)
T ss_dssp -----------------------------------------GGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEE
T ss_pred -----------------------------------------HHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEe
Confidence 1234445678888888874 3322223577888889999
Q ss_pred cccccccccCCccCCCC-CCCCeEecCCCcCCCCCCCC
Q 003982 398 LQQNNLTGPIPDGLTKL-ASLQNLDVSNNNLSGKVPDF 434 (782)
Q Consensus 398 Ls~N~l~g~~p~~~~~l-~~L~~L~ls~N~l~g~~p~~ 434 (782)
|++| ++. +.+..+ ..|+.|++++|++++..|..
T Consensus 279 l~~~-i~~---~~~~~l~~~l~~L~l~~n~l~~~~~~~ 312 (336)
T 2ast_B 279 VFGI-VPD---GTLQLLKEALPHLQINCSHFTTIARPT 312 (336)
T ss_dssp CTTS-SCT---TCHHHHHHHSTTSEESCCCSCCTTCSS
T ss_pred ccCc-cCH---HHHHHHHhhCcceEEecccCccccCCc
Confidence 9888 332 233333 34777788899998888853
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.85 E-value=7.6e-24 Score=245.32 Aligned_cols=350 Identities=14% Similarity=0.059 Sum_probs=208.8
Q ss_pred CEEEEEeCCCC-CCc-ccCccccCCccCceeecccCccCccCC-----CCCCCCCCCEEeCCCCcccCCCCC----CCCC
Q 003982 67 RVTTISLAKSG-LSG-TLSPEISSLTQLETLSFQMNNIAGAIP-----SLANATSLQDIYLDNNNFTSVPTG----CFDG 135 (782)
Q Consensus 67 ~v~~L~l~~~~-l~~-~~~~~l~~l~~L~~L~L~~N~l~~~~~-----~l~~l~~L~~L~Ls~n~l~~~~~~----~~~~ 135 (782)
++++|+|+++. ++. .++..+..+++|++|+|++|.+++... .+.++++|++|+|++|.++.+... .+.+
T Consensus 139 ~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~ 218 (592)
T 3ogk_B 139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARN 218 (592)
T ss_dssp GCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHH
T ss_pred cCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhh
Confidence 48888888876 221 122234477889999999988865532 245678888889988888744432 2456
Q ss_pred CCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccC---CCCcccccCCCCCcEEEcccCcCCCCCCccccc-cc
Q 003982 136 LTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIF---GLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SD 211 (782)
Q Consensus 136 l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~---~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~ 211 (782)
+++|++|+|++|.+.. +|..+..+++|+.|+++.+... ...+..+..+++|+.|+++++... .+|..+.. .+
T Consensus 219 ~~~L~~L~L~~~~~~~---l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~ 294 (592)
T 3ogk_B 219 CRSLVSVKVGDFEILE---LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQ 294 (592)
T ss_dssp CTTCCEEECSSCBGGG---GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGG
T ss_pred CCCCcEEeccCccHHH---HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCC
Confidence 7888888888887776 5677778888888888753332 233455667777888887775433 55555443 46
Q ss_pred cchhhcccccCCCccccccccCCCCCcEEEeecccccC-CCCC-CCCCCCCCEEEcC-----------CCcCccCc-chh
Q 003982 212 IQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTG-PIPD-LSKCESLFDLSLR-----------DNQLTGVV-PAS 277 (782)
Q Consensus 212 l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~-~~~l~~L~~L~L~-----------~N~l~~~~-p~~ 277 (782)
|++|++++|.+...+....+.++++|++|+++ |.++. ..+. +..+++|++|+|+ .|.+++.. +..
T Consensus 295 L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l 373 (592)
T 3ogk_B 295 IRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIAL 373 (592)
T ss_dssp CCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHH
T ss_pred CcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHH
Confidence 77777777775444333445677888888887 44432 2222 3456778888888 35666442 233
Q ss_pred hcCCCCCCEEEccCCcccCCCCC----CCCCccEEEcc----CCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccC
Q 003982 278 VISLPALLNISLQNNKLQGPYPL----FPSKVQKVSLD----HNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDS 349 (782)
Q Consensus 278 ~~~l~~L~~L~l~~N~l~~~~~~----~~~~l~~L~l~----~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (782)
+..+++|++|+++.|++++..+. ...+|+.|+++ .|.+++.+. +.....+ .........+...
T Consensus 374 ~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~------~~~~~~~---~~~~~~L~~L~L~ 444 (592)
T 3ogk_B 374 AQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPL------DNGVRSL---LIGCKKLRRFAFY 444 (592)
T ss_dssp HHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCC------HHHHHHH---HHHCTTCCEEEEE
T ss_pred HhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchH------HHHHHHH---HHhCCCCCEEEEe
Confidence 44577888888877777764332 24567888875 555544320 0001111 0001111111111
Q ss_pred cCCCCCCCCCCcccc-cCCceeEEEccCccccc-ccCccccccccCCeEeccccccccc-CCccCCCCCCCCeEecCCCc
Q 003982 350 WEGNNACDGWPFVTC-SQGRIITINLANKLLAG-NISPAYANLTSLKNLYLQQNNLTGP-IPDGLTKLASLQNLDVSNNN 426 (782)
Q Consensus 350 ~~~~~~~~~~p~~~~-~~~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~g~-~p~~~~~l~~L~~L~ls~N~ 426 (782)
+..+...+..+..+. .+++|++|+|++|.+++ .++..+.++++|++|+|++|++++. ++..+..+++|+.|+|++|+
T Consensus 445 ~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~ 524 (592)
T 3ogk_B 445 LRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYR 524 (592)
T ss_dssp CCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCB
T ss_pred cCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCc
Confidence 000000001111111 24667778888777776 3445556777788888888877654 34444567777888888887
Q ss_pred CCCC
Q 003982 427 LSGK 430 (782)
Q Consensus 427 l~g~ 430 (782)
+++.
T Consensus 525 it~~ 528 (592)
T 3ogk_B 525 ASMT 528 (592)
T ss_dssp CCTT
T ss_pred CCHH
Confidence 7654
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.1e-20 Score=187.49 Aligned_cols=104 Identities=26% Similarity=0.340 Sum_probs=48.9
Q ss_pred ceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccc
Q 003982 93 ETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172 (782)
Q Consensus 93 ~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~ 172 (782)
+.++++++.++.++..+ .++|++|+|++|+++.+++..|.++++|++|+|++|++.. ..+..|..+++|++|+|++
T Consensus 10 ~~v~c~~~~l~~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~Ls~ 85 (208)
T 2o6s_A 10 TTVECYSQGRTSVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS--LPNGVFNKLTSLTYLNLST 85 (208)
T ss_dssp TEEECCSSCCSSCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCC--CCTTTTTTCTTCCEEECCS
T ss_pred CEEEecCCCccCCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCc--cChhhcCCCCCcCEEECCC
Confidence 34555555555444333 2456666666666665555555555555555555555544 1222233444444444444
Q ss_pred cccCCCCcccccCCCCCcEEEcccCcCC
Q 003982 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFT 200 (782)
Q Consensus 173 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 200 (782)
|++++..+..|..+++|++|+|++|+++
T Consensus 86 n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 113 (208)
T 2o6s_A 86 NQLQSLPNGVFDKLTQLKELALNTNQLQ 113 (208)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred CcCCccCHhHhcCccCCCEEEcCCCcCc
Confidence 4444333333333344444444444333
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.83 E-value=3e-20 Score=187.02 Aligned_cols=152 Identities=22% Similarity=0.303 Sum_probs=138.4
Q ss_pred CCCCCccccceEeCCC----------CCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCCEE
Q 003982 50 SSTGYCEWTGINCDNS----------NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDI 118 (782)
Q Consensus 50 ~~~~~c~w~gv~c~~~----------~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L 118 (782)
.+.+.|+|++|.|+.. .+++.|+|++|.+++..|..|..+++|++|+|++|+|+.+++ .|.++++|++|
T Consensus 14 ~~~~~Cs~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L 93 (229)
T 3e6j_A 14 PSQCSCSGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVL 93 (229)
T ss_dssp CTTCEEETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCCEEeCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEE
Confidence 4668899999999852 368899999999999889999999999999999999988877 57899999999
Q ss_pred eCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCc
Q 003982 119 YLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNN 198 (782)
Q Consensus 119 ~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 198 (782)
+|++|+|+.+++..|..+++|++|+|++|++.. +|..+..+++|++|+|++|+|++..+..|..+++|++|+|++|.
T Consensus 94 ~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~---lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 170 (229)
T 3e6j_A 94 DLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTE---LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNP 170 (229)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCS---CCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred ECCCCcCCccChhHhCcchhhCeEeccCCcccc---cCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCC
Confidence 999999999999999999999999999999997 78889999999999999999999888889999999999999999
Q ss_pred CCCCCC
Q 003982 199 FTGSLP 204 (782)
Q Consensus 199 l~~~~p 204 (782)
+.+..+
T Consensus 171 ~~c~c~ 176 (229)
T 3e6j_A 171 WDCECR 176 (229)
T ss_dssp BCTTBG
T ss_pred ccCCcc
Confidence 986544
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.83 E-value=5.2e-20 Score=210.90 Aligned_cols=196 Identities=20% Similarity=0.302 Sum_probs=158.4
Q ss_pred EeCCCCCCcccCccccCCccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCC
Q 003982 72 SLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLA 151 (782)
Q Consensus 72 ~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 151 (782)
.+..+.+...++ +..|++|+.|++++|.|... +.+..+++|++|+|++|+|+++++ +..+++|++|+|++|++..
T Consensus 27 ~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l-~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~ 101 (605)
T 1m9s_A 27 NLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD 101 (605)
T ss_dssp HTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC-TTGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred hccCCCcccccc--hhcCCCCCEEECcCCCCCCC-hHHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC
Confidence 344445543332 56788899999999998865 468889999999999999998877 8889999999999998887
Q ss_pred CCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccc
Q 003982 152 PWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVL 231 (782)
Q Consensus 152 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~ 231 (782)
+| .+..+++|+.|+|++|+|+++ ..+..+++|+.|+|++|+|++. .. +
T Consensus 102 ---l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~------------------------l 149 (605)
T 1m9s_A 102 ---LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TV------------------------L 149 (605)
T ss_dssp ---CT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GG------------------------G
T ss_pred ---Ch-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hh------------------------h
Confidence 33 688899999999999999875 4588899999999999998843 22 4
Q ss_pred cCCCCCcEEEeecccccCCCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCCCCCCccE
Q 003982 232 SGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQK 307 (782)
Q Consensus 232 ~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~ 307 (782)
..+++|+.|+|++|+|++.++ +..+++|+.|+|++|+|++. ..+..+++|+.|+|++|++++.+...+..+..
T Consensus 150 ~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~~~~~~l~~ 222 (605)
T 1m9s_A 150 SRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVV 222 (605)
T ss_dssp GSCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCCCCCSSCEE
T ss_pred cccCCCCEEECcCCcCCCchh-hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCcccccccEEe
Confidence 568999999999999998777 88899999999999999964 46889999999999999998765555554443
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.82 E-value=3.6e-20 Score=193.65 Aligned_cols=180 Identities=21% Similarity=0.310 Sum_probs=146.6
Q ss_pred ccCCccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCccc
Q 003982 86 ISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSL 165 (782)
Q Consensus 86 l~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L 165 (782)
+..+++|+.|++++|.++.. +.+..+++|++|+|++|+++++++ +.++++|++|+|++|++.. + ..+..+++|
T Consensus 42 ~~~l~~L~~L~l~~~~i~~~-~~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~---~-~~l~~l~~L 114 (291)
T 1h6t_A 42 QNELNSIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD---L-SSLKDLKKL 114 (291)
T ss_dssp HHHHHTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC---G-GGGTTCTTC
T ss_pred hhhcCcccEEEccCCCcccC-hhHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC---C-hhhccCCCC
Confidence 45678888888888888765 457788888888888888888776 8888888888888888877 3 348888889
Q ss_pred CeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeecc
Q 003982 166 TTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKN 245 (782)
Q Consensus 166 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N 245 (782)
++|+|++|++++. ..+..+++|++|++++|++++ + .. +..+++|++|++++|
T Consensus 115 ~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~-~-~~------------------------l~~l~~L~~L~L~~N 166 (291)
T 1h6t_A 115 KSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITD-I-TV------------------------LSRLTKLDTLSLEDN 166 (291)
T ss_dssp CEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCC-C-GG------------------------GGGCTTCSEEECCSS
T ss_pred CEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCc-c-hh------------------------hccCCCCCEEEccCC
Confidence 9999999988875 468888999999999999884 3 22 446899999999999
Q ss_pred cccCCCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCCCCC
Q 003982 246 QFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPS 303 (782)
Q Consensus 246 ~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~ 303 (782)
++++.++ +..+++|+.|+|++|+|++. | .+..+++|+.|++++|+++........
T Consensus 167 ~l~~~~~-l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~~~~~~~~ 221 (291)
T 1h6t_A 167 QISDIVP-LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLNKPINHQS 221 (291)
T ss_dssp CCCCCGG-GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEECCCEECCS
T ss_pred ccccchh-hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccCCcccccc
Confidence 9998766 88899999999999999954 4 488999999999999999875444433
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.82 E-value=3.7e-21 Score=226.02 Aligned_cols=235 Identities=20% Similarity=0.199 Sum_probs=125.5
Q ss_pred cchhHHHHHHHHHhcCCC----CCCCCCCCCCCCccccceEeCCCCCEEEEEeCCCCCCcccCccccCCccCceeecccC
Q 003982 25 LGDDGSVMLKLAQSLQNL----PSDWSSTSSTGYCEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMN 100 (782)
Q Consensus 25 ~~~~~~~l~~~~~~~~~~----~~~w~~~~~~~~c~w~gv~c~~~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N 100 (782)
...++++|.++..+.... ...|.. ..+..+.|.++.++. .+++.|+|.++++.. ++. ..|+.++|+.|
T Consensus 130 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~-~~~~~l~L~~n~~~~-~~~-----~~l~~l~Ls~~ 201 (727)
T 4b8c_D 130 VDCTKQALMEMADTLTDSKTAKKQQPTG-DSTPSGTATNSAVST-PLTPKIELFANGKDE-ANQ-----ALLQHKKLSQY 201 (727)
T ss_dssp --CCCHHHHHHHHHHHHHHTTC----------------------------------------------------------
T ss_pred cccchhhhhhhhhhcccccCcccCCCcC-CCCccccCCCceecC-CccceEEeeCCCCCc-chh-----hHhhcCccCcc
Confidence 356778888888776322 223432 334567899998876 579999999999875 232 33556666666
Q ss_pred ccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCc
Q 003982 101 NIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIP 180 (782)
Q Consensus 101 ~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~ 180 (782)
.|.+ ++++.|++. +++..|..+++|+.|+|++|++.. +|..+..+++|++|+|++|.|+ .+|
T Consensus 202 ~i~~-------------~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~~---l~~~~~~l~~L~~L~Ls~N~l~-~lp 263 (727)
T 4b8c_D 202 SIDE-------------DDDIENRMV-MPKDSKYDDQLWHALDLSNLQIFN---ISANIFKYDFLTRLYLNGNSLT-ELP 263 (727)
T ss_dssp ----------------------------------CCCCCCEEECTTSCCSC---CCGGGGGCCSCSCCBCTTSCCS-CCC
T ss_pred cccC-------------cccccccee-cChhhhccCCCCcEEECCCCCCCC---CChhhcCCCCCCEEEeeCCcCc-ccC
Confidence 6553 244455555 556667778888888888888776 6777778888888899888888 568
Q ss_pred ccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeecccccCCCCCCCCCCCC
Q 003982 181 DFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESL 260 (782)
Q Consensus 181 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L 260 (782)
..|..+++|++|+|++|+|+ .+|..|. ++++|++|+|++|.|+.++..|..+++|
T Consensus 264 ~~~~~l~~L~~L~Ls~N~l~-~lp~~~~------------------------~l~~L~~L~L~~N~l~~lp~~~~~l~~L 318 (727)
T 4b8c_D 264 AEIKNLSNLRVLDLSHNRLT-SLPAELG------------------------SCFQLKYFYFFDNMVTTLPWEFGNLCNL 318 (727)
T ss_dssp GGGGGGTTCCEEECTTSCCS-SCCSSGG------------------------GGTTCSEEECCSSCCCCCCSSTTSCTTC
T ss_pred hhhhCCCCCCEEeCcCCcCC-ccChhhc------------------------CCCCCCEEECCCCCCCccChhhhcCCCc
Confidence 88899999999999999998 7887654 4889999999999998776679999999
Q ss_pred CEEEcCCCcCccCcchhhcCCCC-CCEEEccCCcccCCCCCCCCCccEEEccCC
Q 003982 261 FDLSLRDNQLTGVVPASVISLPA-LLNISLQNNKLQGPYPLFPSKVQKVSLDHN 313 (782)
Q Consensus 261 ~~L~L~~N~l~~~~p~~~~~l~~-L~~L~l~~N~l~~~~~~~~~~l~~L~l~~N 313 (782)
++|+|++|.|++.+|..+..+.. +..|+|++|.+++.+|. .|+.|++++|
T Consensus 319 ~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~---~l~~l~l~~n 369 (727)
T 4b8c_D 319 QFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH---ERRFIEINTD 369 (727)
T ss_dssp CCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC---C---------
T ss_pred cEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc---ccceeEeecc
Confidence 99999999999999988876532 23478899999887664 3445555554
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.82 E-value=2.9e-22 Score=231.99 Aligned_cols=342 Identities=15% Similarity=0.117 Sum_probs=193.0
Q ss_pred CCEEEEEeCCCCCCcc----cCccccCCccCceeecccCccCccC----C-CCCCCCCCCEEeCCCCcccCCCCCCCCCC
Q 003982 66 NRVTTISLAKSGLSGT----LSPEISSLTQLETLSFQMNNIAGAI----P-SLANATSLQDIYLDNNNFTSVPTGCFDGL 136 (782)
Q Consensus 66 ~~v~~L~l~~~~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~~----~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l 136 (782)
.++++|+|++|.+++. ++..+..+++|++|++++|.+++.. + .+.++++|++|+|++|.+.+++ ..+.++
T Consensus 164 ~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~l~-~~~~~~ 242 (592)
T 3ogk_B 164 RKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELV-GFFKAA 242 (592)
T ss_dssp TTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGGGH-HHHHHC
T ss_pred CCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHHHH-HHHhhh
Confidence 4688999999988765 4445677889999999999987432 2 3567889999999999888866 447777
Q ss_pred CCCCEEeccCCCCC-CCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCcc-ccc-cccc
Q 003982 137 TNLQVLSLSDNPNL-APWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPAS-FAK-SDIQ 213 (782)
Q Consensus 137 ~~L~~L~Ls~N~l~-~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~-~~l~ 213 (782)
++|++|+++.+... .....+..+..+++|+.|+++++. ...+|..+..+++|++|+|++|.+++..... +.. .+|+
T Consensus 243 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~-~~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~ 321 (592)
T 3ogk_B 243 ANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMG-PNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLE 321 (592)
T ss_dssp TTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCC-TTTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCC
T ss_pred hHHHhhcccccccccchHHHHHHhhccccccccCccccc-hhHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCC
Confidence 88888888743222 112234455566666666666543 2334556666666666666666654322211 111 3455
Q ss_pred hhhcccccCCCccccccccCCCCCcEEEee-----------cccccCCC-CC-CCCCCCCCEEEcCCCcCccCcchhhcC
Q 003982 214 NLWMNDQQLGLSGTLDVLSGMTQLRQVWLH-----------KNQFTGPI-PD-LSKCESLFDLSLRDNQLTGVVPASVIS 280 (782)
Q Consensus 214 ~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~-----------~N~l~~~~-~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~ 280 (782)
.|++. +.+...+....+..+++|++|+++ .|.+++.. .. +..+++|++|+++.|++++..+..+..
T Consensus 322 ~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~ 400 (592)
T 3ogk_B 322 VLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGT 400 (592)
T ss_dssp EEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHH
T ss_pred EEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHh
Confidence 55555 222222222223445566666666 23444311 11 233556666666666665555555544
Q ss_pred -CCCCCEEEcc----CCcccCCCCC--------CCCCccEEEccCCc--CCCCCCCCCCCCChhhhhHHHhhcCCCCCcc
Q 003982 281 -LPALLNISLQ----NNKLQGPYPL--------FPSKVQKVSLDHNN--FCKNSSDAGKPCDPQVTTLLQIAGDMGYPAI 345 (782)
Q Consensus 281 -l~~L~~L~l~----~N~l~~~~~~--------~~~~l~~L~l~~N~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (782)
+++|+.|+++ .|.+++.+.. .+.+|+.|++++++ ++. ..+..+.........
T Consensus 401 ~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~-------------~~~~~~~~~~~~L~~ 467 (592)
T 3ogk_B 401 YLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTD-------------LGLSYIGQYSPNVRW 467 (592)
T ss_dssp HCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCH-------------HHHHHHHHSCTTCCE
T ss_pred hCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccH-------------HHHHHHHHhCccceE
Confidence 5566666664 4455542110 13455555554322 211 011111111111111
Q ss_pred cccCcCCCCCCC--CCCcccccCCceeEEEccCcccccc-cCccccccccCCeEecccccccccCCccC-CCCCCCCeEe
Q 003982 346 LSDSWEGNNACD--GWPFVTCSQGRIITINLANKLLAGN-ISPAYANLTSLKNLYLQQNNLTGPIPDGL-TKLASLQNLD 421 (782)
Q Consensus 346 ~~~~~~~~~~~~--~~p~~~~~~~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~-~~l~~L~~L~ 421 (782)
+. . +++.+. .++..+..+++|+.|+|++|.+++. ++..+..+++|++|+|++|++++.-...+ ..++.|....
T Consensus 468 L~--L-~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~ 544 (592)
T 3ogk_B 468 ML--L-GYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIEL 544 (592)
T ss_dssp EE--E-CSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEE
T ss_pred ee--c-cCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEE
Confidence 11 1 111111 2233445668999999999999866 44455789999999999999987643333 3567777666
Q ss_pred cCCCc
Q 003982 422 VSNNN 426 (782)
Q Consensus 422 ls~N~ 426 (782)
+..++
T Consensus 545 ~~~~~ 549 (592)
T 3ogk_B 545 IPSRR 549 (592)
T ss_dssp ECCC-
T ss_pred ecCcc
Confidence 65543
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1.4e-19 Score=181.00 Aligned_cols=152 Identities=20% Similarity=0.329 Sum_probs=132.2
Q ss_pred CCCCCCCccccceEeCCC----------CCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCC
Q 003982 48 STSSTGYCEWTGINCDNS----------NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQ 116 (782)
Q Consensus 48 ~~~~~~~c~w~gv~c~~~----------~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~ 116 (782)
.++..+.|.|..|.|... ..++.|+|++|+|++..+..|..+++|++|+|++|+|++..| .|.++++|+
T Consensus 4 ~CP~~C~C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~ 83 (220)
T 2v9t_B 4 HCPAACTCSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLN 83 (220)
T ss_dssp CSCTTSEEETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCC
T ss_pred CCCCCCEECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCC
Confidence 456667799999999752 368899999999987777788999999999999999998876 789999999
Q ss_pred EEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEccc
Q 003982 117 DIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSY 196 (782)
Q Consensus 117 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 196 (782)
+|+|++|+|+.+++..|.++++|++|+|++|++.. ..|..|..+++|++|+|++|+|+++.+..|..+++|++|+|++
T Consensus 84 ~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 161 (220)
T 2v9t_B 84 SLVLYGNKITELPKSLFEGLFSLQLLLLNANKINC--LRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQ 161 (220)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC--CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCS
T ss_pred EEECCCCcCCccCHhHccCCCCCCEEECCCCCCCE--eCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCC
Confidence 99999999999999889999999999999999888 5677888999999999999999998888899999999999999
Q ss_pred CcCCC
Q 003982 197 NNFTG 201 (782)
Q Consensus 197 N~l~~ 201 (782)
|.+..
T Consensus 162 N~~~c 166 (220)
T 2v9t_B 162 NPFIC 166 (220)
T ss_dssp SCEEC
T ss_pred CCcCC
Confidence 98874
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.9e-19 Score=179.93 Aligned_cols=152 Identities=22% Similarity=0.277 Sum_probs=130.1
Q ss_pred EEEeCCCCCCcccCccccCCccCceeecccCccCccCC--CCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCC
Q 003982 70 TISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP--SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDN 147 (782)
Q Consensus 70 ~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~--~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 147 (782)
.+++++++++ .+|..+. ..+++|+|++|+|++.++ .|..+++|++|+|++|+|+.+++..|.++++|++|+|++|
T Consensus 15 ~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 4566667776 4676654 356899999999999865 4889999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccc
Q 003982 148 PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGT 227 (782)
Q Consensus 148 ~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~ 227 (782)
++.. ..+..|..+++|++|+|++|+|+++.|..|..+++|++|+|++|+|++..|..|
T Consensus 92 ~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-------------------- 149 (220)
T 2v70_A 92 RLEN--VQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAF-------------------- 149 (220)
T ss_dssp CCCC--CCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTT--------------------
T ss_pred ccCc--cCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHh--------------------
Confidence 9988 456679999999999999999999999999999999999999999997667654
Q ss_pred cccccCCCCCcEEEeecccccCC
Q 003982 228 LDVLSGMTQLRQVWLHKNQFTGP 250 (782)
Q Consensus 228 ~~~~~~l~~L~~L~L~~N~l~~~ 250 (782)
..+++|+.|+|++|.+...
T Consensus 150 ----~~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 150 ----DTLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp ----TTCTTCCEEECCSCCEECS
T ss_pred ----cCCCCCCEEEecCcCCcCC
Confidence 3578888888888887753
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.81 E-value=2.3e-20 Score=195.18 Aligned_cols=168 Identities=25% Similarity=0.379 Sum_probs=97.2
Q ss_pred CccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCee
Q 003982 89 LTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTL 168 (782)
Q Consensus 89 l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L 168 (782)
+.++..+.+..+.+++.. .+..+++|++|++++|.++.++. +..+++|++|+|++|++.. ++. +..+++|++|
T Consensus 23 l~~~~~~~l~~~~~~~~~-~~~~l~~L~~L~l~~~~i~~~~~--~~~l~~L~~L~L~~n~l~~---~~~-l~~l~~L~~L 95 (291)
T 1h6t_A 23 FAETIKDNLKKKSVTDAV-TQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTD---IKP-LANLKNLGWL 95 (291)
T ss_dssp HHHHHHHHTTCSCTTSEE-CHHHHHTCCEEECTTSCCCCCTT--GGGCTTCCEEECCSSCCCC---CGG-GTTCTTCCEE
T ss_pred HHHHHHHHhcCCCccccc-chhhcCcccEEEccCCCcccChh--HhcCCCCCEEEccCCccCC---Ccc-cccCCCCCEE
Confidence 344555667777766543 34567888888888888887753 6777788888888877776 333 6666666777
Q ss_pred eccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeeccccc
Q 003982 169 YMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFT 248 (782)
Q Consensus 169 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 248 (782)
+|++|++++. ..+..+++|++|+|++|++++ ++ . +..+++|++|++++|+++
T Consensus 96 ~l~~n~l~~~--~~l~~l~~L~~L~L~~n~i~~-~~-~------------------------l~~l~~L~~L~l~~n~l~ 147 (291)
T 1h6t_A 96 FLDENKVKDL--SSLKDLKKLKSLSLEHNGISD-IN-G------------------------LVHLPQLESLYLGNNKIT 147 (291)
T ss_dssp ECCSSCCCCG--GGGTTCTTCCEEECTTSCCCC-CG-G------------------------GGGCTTCCEEECCSSCCC
T ss_pred ECCCCcCCCC--hhhccCCCCCEEECCCCcCCC-Ch-h------------------------hcCCCCCCEEEccCCcCC
Confidence 7766666553 236666666666666666652 21 1 223455555555555555
Q ss_pred CCCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcc
Q 003982 249 GPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKL 294 (782)
Q Consensus 249 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 294 (782)
+. +.+..+++|+.|+|++|+|++..| +..+++|+.|++++|++
T Consensus 148 ~~-~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i 190 (291)
T 1h6t_A 148 DI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI 190 (291)
T ss_dssp CC-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred cc-hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcC
Confidence 43 334444444444444444443322 44444444444444443
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.81 E-value=4.2e-20 Score=211.65 Aligned_cols=194 Identities=23% Similarity=0.318 Sum_probs=159.3
Q ss_pred CCccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCe
Q 003982 88 SLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTT 167 (782)
Q Consensus 88 ~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~ 167 (782)
.+..+..+.++.+.+....+ +..+++|+.|+|++|.|+.++ .+..+++|+.|+|++|++.. ++. +..+++|+.
T Consensus 19 ~l~~l~~l~l~~~~i~~~~~-~~~L~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~Ls~N~l~~---~~~-l~~l~~L~~ 91 (605)
T 1m9s_A 19 AFAETIKDNLKKKSVTDAVT-QNELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTD---IKP-LTNLKNLGW 91 (605)
T ss_dssp HHHHHHHHHTTCSCTTSEEC-HHHHTTCCCCBCTTCCCCCCT--TGGGCTTCCEEECTTSCCCC---CGG-GGGCTTCCE
T ss_pred HHHHHHHHhccCCCcccccc-hhcCCCCCEEECcCCCCCCCh--HHccCCCCCEEEeeCCCCCC---Chh-hccCCCCCE
Confidence 34556677888888886554 567899999999999999987 38899999999999999988 343 889999999
Q ss_pred eeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeecccc
Q 003982 168 LYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQF 247 (782)
Q Consensus 168 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l 247 (782)
|+|++|.|+++ ..+..+++|++|+|++|++++ ++ . +..+++|+.|+|++|++
T Consensus 92 L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~-l~-~------------------------l~~l~~L~~L~Ls~N~l 143 (605)
T 1m9s_A 92 LFLDENKIKDL--SSLKDLKKLKSLSLEHNGISD-IN-G------------------------LVHLPQLESLYLGNNKI 143 (605)
T ss_dssp EECCSSCCCCC--TTSTTCTTCCEEECTTSCCCC-CG-G------------------------GGGCTTCSEEECCSSCC
T ss_pred EECcCCCCCCC--hhhccCCCCCEEEecCCCCCC-Cc-c------------------------ccCCCccCEEECCCCcc
Confidence 99999999875 378899999999999999984 33 2 34589999999999999
Q ss_pred cCCCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCC-CCCCCccEEEccCCcCCCCC
Q 003982 248 TGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYP-LFPSKVQKVSLDHNNFCKNS 319 (782)
Q Consensus 248 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~l~~N~~~~~~ 319 (782)
++. +.+..+++|+.|+|++|+|++..| +..+++|+.|+|++|+|++..+ ..+.+|+.|+|++|.+.+.+
T Consensus 144 ~~l-~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l~~l~~l~~L~~L~L~~N~l~~~p 213 (605)
T 1m9s_A 144 TDI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFSQECLNKP 213 (605)
T ss_dssp CCC-GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBCGGGTTCTTCSEEECCSEEEECCC
T ss_pred CCc-hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCChHHccCCCCCEEEccCCcCcCCc
Confidence 986 678899999999999999997766 8999999999999999987422 12456777777777765543
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.6e-19 Score=195.13 Aligned_cols=177 Identities=25% Similarity=0.317 Sum_probs=126.0
Q ss_pred EEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCC-CCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCC
Q 003982 70 TISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLA-NATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDN 147 (782)
Q Consensus 70 ~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~-~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 147 (782)
.+++++++|+ .+|..+. ..++.|+|++|+|++.++ .|. ++++|++|+|++|+|+.+++..|.++++|++|+|++|
T Consensus 22 ~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 98 (361)
T 2xot_A 22 ILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98 (361)
T ss_dssp EEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence 4566666777 4676554 358889999999988877 466 8888999999999998888888888888888888888
Q ss_pred CCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccc
Q 003982 148 PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGT 227 (782)
Q Consensus 148 ~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~ 227 (782)
++.. ..+..|.++++|+.|+|++|+|+++.+..|..+++|++|+|++|+|+ .+|..+..
T Consensus 99 ~l~~--~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~------------------ 157 (361)
T 2xot_A 99 HLHT--LDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIK------------------ 157 (361)
T ss_dssp CCCE--ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-SCCGGGTC------------------
T ss_pred cCCc--CCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCC-eeCHHHhc------------------
Confidence 8776 33445667777777777777777666666666777777777777666 34433210
Q ss_pred cccccCCCCCcEEEeecccccCCCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCC--CCEEEccCCccc
Q 003982 228 LDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPA--LLNISLQNNKLQ 295 (782)
Q Consensus 228 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~--L~~L~l~~N~l~ 295 (782)
.+..+++|+.|+|++|+|++..+..+..++. |+.|+|++|++.
T Consensus 158 -------------------------~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 158 -------------------------DGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp -----------------------------CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred -------------------------CcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCcc
Confidence 0145677777777788877666677777776 377888888876
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=4.1e-19 Score=177.50 Aligned_cols=155 Identities=18% Similarity=0.243 Sum_probs=131.8
Q ss_pred cEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeecccccCCCCC--CCCCCCCCEEEcCC
Q 003982 190 QNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD--LSKCESLFDLSLRD 267 (782)
Q Consensus 190 ~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~--~~~l~~L~~L~L~~ 267 (782)
+.+++++|.++ .+|..+. +.+++|+|++|+|++.++. |..+++|++|+|++
T Consensus 14 ~~l~~s~n~l~-~iP~~~~--------------------------~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~ 66 (220)
T 2v70_A 14 TTVDCSNQKLN-KIPEHIP--------------------------QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSN 66 (220)
T ss_dssp TEEECCSSCCS-SCCSCCC--------------------------TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCS
T ss_pred CEeEeCCCCcc-cCccCCC--------------------------CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCC
Confidence 58889999988 6776542 4568899999999987553 78899999999999
Q ss_pred CcCccCcchhhcCCCCCCEEEccCCcccCCCCCCCCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccc
Q 003982 268 NQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILS 347 (782)
Q Consensus 268 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (782)
|+|++..+..|.++++|++|+|++|++++..+
T Consensus 67 N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~------------------------------------------------ 98 (220)
T 2v70_A 67 NKITDIEEGAFEGASGVNEILLTSNRLENVQH------------------------------------------------ 98 (220)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCCCCG------------------------------------------------
T ss_pred CcCCEECHHHhCCCCCCCEEECCCCccCccCH------------------------------------------------
Confidence 99998888889999999999999888875433
Q ss_pred cCcCCCCCCCCCCcccccCCceeEEEccCcccccccCccccccccCCeEecccccccccCCccCCCCCCCCeEecCCCcC
Q 003982 348 DSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNL 427 (782)
Q Consensus 348 ~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l 427 (782)
..+..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|++
T Consensus 99 -------------~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 165 (220)
T 2v70_A 99 -------------KMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPF 165 (220)
T ss_dssp -------------GGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCE
T ss_pred -------------hHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCC
Confidence 2345567899999999999998899999999999999999999998899999999999999999999
Q ss_pred CCCCC
Q 003982 428 SGKVP 432 (782)
Q Consensus 428 ~g~~p 432 (782)
++..+
T Consensus 166 ~c~c~ 170 (220)
T 2v70_A 166 NCNCY 170 (220)
T ss_dssp ECSGG
T ss_pred cCCCc
Confidence 98766
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.79 E-value=3.2e-22 Score=231.77 Aligned_cols=326 Identities=15% Similarity=0.183 Sum_probs=193.4
Q ss_pred CCEEEEEeCCCCCCcccCcccc-CCccCceeecccC-ccCcc-CC-CCCCCCCCCEEeCCCCcccCCCCCCC----CCCC
Q 003982 66 NRVTTISLAKSGLSGTLSPEIS-SLTQLETLSFQMN-NIAGA-IP-SLANATSLQDIYLDNNNFTSVPTGCF----DGLT 137 (782)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~l~-~l~~L~~L~L~~N-~l~~~-~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~----~~l~ 137 (782)
.++++|+|+++.+++..+..+. .+++|++|+|++| .++.. .+ .+.++++|++|+|++|.++......+ ..++
T Consensus 105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~ 184 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT 184 (594)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence 4688999999988877766665 6889999999988 55542 23 34478999999999999876554333 3677
Q ss_pred CCCEEeccCCC--CCCCCCCCcccCCCcccCeeecccc-ccCCCCcccccCCCCCcEEEcccCcC---------------
Q 003982 138 NLQVLSLSDNP--NLAPWPFPNELTKSTSLTTLYMDNA-NIFGLIPDFFDSFSNLQNLRLSYNNF--------------- 199 (782)
Q Consensus 138 ~L~~L~Ls~N~--l~~~~~~p~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l--------------- 199 (782)
+|++|+|++|. +.. ..++..+.++++|++|+|++| .+.+ ++..+..+++|++|+++.+..
T Consensus 185 ~L~~L~l~~~~~~~~~-~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~ 262 (594)
T 2p1m_B 185 SLVSLNISCLASEVSF-SALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALS 262 (594)
T ss_dssp CCCEEECTTCCSCCCH-HHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHH
T ss_pred cCcEEEecccCCcCCH-HHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHHHHHHHh
Confidence 99999999886 111 001122345689999999988 4444 677778888888888665521
Q ss_pred -----------CCCCCcccc-----ccccchhhcccccCCCccccccccCCCCCcEEEeecccccC-CCCC-CCCCCCCC
Q 003982 200 -----------TGSLPASFA-----KSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTG-PIPD-LSKCESLF 261 (782)
Q Consensus 200 -----------~~~~p~~~~-----~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~-~~~l~~L~ 261 (782)
....+..+. ..+|+.|+++.|.+...+....+..+++|++|++++| ++. ..+. ...+++|+
T Consensus 263 ~~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~ 341 (594)
T 2p1m_B 263 GCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLR 341 (594)
T ss_dssp TCTTCCEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCC
T ss_pred cCCCcccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCC
Confidence 111111111 1455666666665433222233445666666666666 332 1111 12356666
Q ss_pred EEEc---------CCCcCccCcchhhc-CCCCCCEEEccCCcccCCCCC----CCCCccEEEccC------CcCCCCCCC
Q 003982 262 DLSL---------RDNQLTGVVPASVI-SLPALLNISLQNNKLQGPYPL----FPSKVQKVSLDH------NNFCKNSSD 321 (782)
Q Consensus 262 ~L~L---------~~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~~~----~~~~l~~L~l~~------N~~~~~~~~ 321 (782)
.|++ ..|.+++.....+. .+++|+.|+++.|.+++..+. .+++|+.|+++. |+++..+
T Consensus 342 ~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~-- 419 (594)
T 2p1m_B 342 ELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEP-- 419 (594)
T ss_dssp EEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCC--
T ss_pred EEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCc--
Confidence 6666 23445443333333 356666666666666543221 134566666662 2222111
Q ss_pred CCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccccCccccc-cccCCeEeccc
Q 003982 322 AGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYAN-LTSLKNLYLQQ 400 (782)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls~ 400 (782)
.+. .++..+..+++|+.|+|++ .+++..+..+.. +++|++|+|++
T Consensus 420 ----~~~-----------------------------~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~ 465 (594)
T 2p1m_B 420 ----LDI-----------------------------GFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAF 465 (594)
T ss_dssp ----THH-----------------------------HHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEES
T ss_pred ----hhh-----------------------------HHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccC
Confidence 000 0111133456778888866 666655555554 77788888888
Q ss_pred ccccccCCccC-CCCCCCCeEecCCCcCCCC
Q 003982 401 NNLTGPIPDGL-TKLASLQNLDVSNNNLSGK 430 (782)
Q Consensus 401 N~l~g~~p~~~-~~l~~L~~L~ls~N~l~g~ 430 (782)
|++++..+..+ ..+++|+.|+|++|++++.
T Consensus 466 ~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~ 496 (594)
T 2p1m_B 466 AGDSDLGMHHVLSGCDSLRKLEIRDCPFGDK 496 (594)
T ss_dssp CCSSHHHHHHHHHHCTTCCEEEEESCSCCHH
T ss_pred CCCcHHHHHHHHhcCCCcCEEECcCCCCcHH
Confidence 88766554444 5577788888888877543
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=1.7e-19 Score=184.87 Aligned_cols=139 Identities=22% Similarity=0.215 Sum_probs=108.0
Q ss_pred CCccceeecccceEEEEEEe-CCCcE--EEEEEeccccCCh----------------------hhHHHHHHHHHHHHhcC
Q 003982 583 FSEANILGRGGFGVVYGGEL-PDGTK--IAVKRMESNTMGN----------------------KGLSEFQAEIAVLTKVR 637 (782)
Q Consensus 583 y~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~~----------------------~~~~~~~~E~~~l~~l~ 637 (782)
|.+.+.||+|+||.||+|.. .+|+. ||||+++...... .....+.+|++++++++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 67889999999999999976 68888 9999976532110 11246889999999998
Q ss_pred CCCc--ceEEeEEEeCCeEEEEEEccCC-C----CHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCCCeE
Q 003982 638 HRHL--VALLGYCINGSERLLVYEYMPR-G----TLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLH-SLAQQSFI 709 (782)
Q Consensus 638 h~nI--~~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~~~~iv 709 (782)
|++| +.++++ ...++||||+.+ | +|.+.... .++.++..++.|++.|+.||| + .||+
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~---~giv 193 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQE---AELV 193 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHT---SCEE
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHH---CCEE
Confidence 8764 444443 356899999942 4 56555422 234567889999999999999 7 8999
Q ss_pred EcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 710 HRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 710 HrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||||||+|||+++ .++|+|||+|....
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred eCCCCHHHEEEcC--cEEEEECcccccCC
Confidence 9999999999998 99999999997654
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.78 E-value=1.5e-18 Score=173.41 Aligned_cols=79 Identities=22% Similarity=0.377 Sum_probs=41.7
Q ss_pred EEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCC
Q 003982 70 TISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNP 148 (782)
Q Consensus 70 ~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 148 (782)
.+++++++++ .+|..+. ++|+.|+|++|+|+++++ .|..+++|++|+|++|+|+.+++..|.++++|++|+|++|+
T Consensus 15 ~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~ 91 (220)
T 2v9t_B 15 IVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91 (220)
T ss_dssp EEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred EEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence 4666666665 4444433 455555555555555544 45555555555555555555544445555555555544444
Q ss_pred CCC
Q 003982 149 NLA 151 (782)
Q Consensus 149 l~~ 151 (782)
+..
T Consensus 92 l~~ 94 (220)
T 2v9t_B 92 ITE 94 (220)
T ss_dssp CCC
T ss_pred CCc
Confidence 443
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.78 E-value=1.8e-19 Score=185.30 Aligned_cols=177 Identities=21% Similarity=0.220 Sum_probs=139.1
Q ss_pred CCccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCe
Q 003982 88 SLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTT 167 (782)
Q Consensus 88 ~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~ 167 (782)
.+.+++.+++++|.+++.+ .+..+++|++|++++|+++.++ .+..+++|++|+|++|++.. ++. +..+++|++
T Consensus 17 ~l~~l~~l~l~~~~i~~~~-~~~~l~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~L~~N~i~~---~~~-l~~l~~L~~ 89 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDLV-SQKELSGVQNFNGDNSNIQSLA--GMQFFTNLKELHLSHNQISD---LSP-LKDLTKLEE 89 (263)
T ss_dssp HHHHHHHHHHTCSCTTSEE-CHHHHTTCSEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCC---CGG-GTTCSSCCE
T ss_pred HHHHHHHHHhcCCCccccc-chhhcCcCcEEECcCCCcccch--HHhhCCCCCEEECCCCccCC---Chh-hccCCCCCE
Confidence 5667778888888888665 5777888888888888888877 47788888888888888887 444 888888888
Q ss_pred eeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeecccc
Q 003982 168 LYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQF 247 (782)
Q Consensus 168 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l 247 (782)
|+|++|++++..+ . .. ++|++|+|++|++++ ++ . +.++++|++|+|++|++
T Consensus 90 L~L~~N~l~~l~~-~-~~-~~L~~L~L~~N~l~~-~~-~------------------------l~~l~~L~~L~Ls~N~i 140 (263)
T 1xeu_A 90 LSVNRNRLKNLNG-I-PS-ACLSRLFLDNNELRD-TD-S------------------------LIHLKNLEILSIRNNKL 140 (263)
T ss_dssp EECCSSCCSCCTT-C-CC-SSCCEEECCSSCCSB-SG-G------------------------GTTCTTCCEEECTTSCC
T ss_pred EECCCCccCCcCc-c-cc-CcccEEEccCCccCC-Ch-h------------------------hcCcccccEEECCCCcC
Confidence 8888888887532 2 22 888889999888873 32 1 44688899999999998
Q ss_pred cCCCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCCCCC
Q 003982 248 TGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPS 303 (782)
Q Consensus 248 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~ 303 (782)
++. +.+..+++|+.|+|++|+|++. ..+..+++|+.|++++|++++.......
T Consensus 141 ~~~-~~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~~~~~~~ 193 (263)
T 1xeu_A 141 KSI-VMLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNEPVKYQP 193 (263)
T ss_dssp CBC-GGGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECCCEECCS
T ss_pred CCC-hHHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCCcccccc
Confidence 876 4678889999999999999866 6788899999999999999876444433
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.78 E-value=6.3e-19 Score=190.38 Aligned_cols=156 Identities=21% Similarity=0.299 Sum_probs=138.7
Q ss_pred CCCCCCCCccccceEeCCC----------CCEEEEEeCCCCCCcccCcccc-CCccCceeecccCccCccCC-CCCCCCC
Q 003982 47 SSTSSTGYCEWTGINCDNS----------NRVTTISLAKSGLSGTLSPEIS-SLTQLETLSFQMNNIAGAIP-SLANATS 114 (782)
Q Consensus 47 ~~~~~~~~c~w~gv~c~~~----------~~v~~L~l~~~~l~~~~~~~l~-~l~~L~~L~L~~N~l~~~~~-~l~~l~~ 114 (782)
..++..|.|.|..|.|.+. ..++.|+|++|+|++..+..+. .+++|++|+|++|+|+++++ .|.++++
T Consensus 10 ~~Cp~~C~C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~ 89 (361)
T 2xot_A 10 VSCPANCLCASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPN 89 (361)
T ss_dssp TTCCTTCEEETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTT
T ss_pred CCCCCCCEECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCC
Confidence 3466677799999999752 3588999999999987777787 99999999999999999887 7999999
Q ss_pred CCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccc---cCCCCCcE
Q 003982 115 LQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFF---DSFSNLQN 191 (782)
Q Consensus 115 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~---~~l~~L~~ 191 (782)
|++|+|++|+|+.+++..|.++++|++|+|++|++.. ..|..|..+++|+.|+|++|+|+++.+..| ..+++|++
T Consensus 90 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~--~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~ 167 (361)
T 2xot_A 90 LRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVV--VDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLML 167 (361)
T ss_dssp CCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE--ECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCE
T ss_pred CCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccE--ECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCE
Confidence 9999999999999999999999999999999999998 567889999999999999999999877777 67999999
Q ss_pred EEcccCcCCCCCCc
Q 003982 192 LRLSYNNFTGSLPA 205 (782)
Q Consensus 192 L~Ls~N~l~~~~p~ 205 (782)
|+|++|+|+ .+|.
T Consensus 168 L~L~~N~l~-~l~~ 180 (361)
T 2xot_A 168 LDLSSNKLK-KLPL 180 (361)
T ss_dssp EECCSSCCC-CCCH
T ss_pred EECCCCCCC-ccCH
Confidence 999999999 5553
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.77 E-value=3.4e-18 Score=172.00 Aligned_cols=151 Identities=26% Similarity=0.312 Sum_probs=85.3
Q ss_pred CceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeecc
Q 003982 92 LETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMD 171 (782)
Q Consensus 92 L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~ 171 (782)
.+.++++++.++.++..+. ++|++|+|++|+|+++++..|.++++|++|+|++|++.. ..+..|..+++|++|+|+
T Consensus 21 ~~~v~c~~~~l~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~--i~~~~~~~l~~L~~L~Ls 96 (229)
T 3e6j_A 21 GTTVDCRSKRHASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA--LPVGVFDSLTQLTVLDLG 96 (229)
T ss_dssp TTEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC--CCTTTTTTCTTCCEEECC
T ss_pred CCEeEccCCCcCccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCC--cChhhcccCCCcCEEECC
Confidence 4556677777665554443 667777777777777666666666666666666666655 223345556666666666
Q ss_pred ccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeecccccCCC
Q 003982 172 NANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPI 251 (782)
Q Consensus 172 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 251 (782)
+|+|+++.+..|..+++|++|+|++|+|+ .+|..+. ++++|++|+|++|+|++.+
T Consensus 97 ~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~------------------------~l~~L~~L~L~~N~l~~~~ 151 (229)
T 3e6j_A 97 TNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIE------------------------RLTHLTHLALDQNQLKSIP 151 (229)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGG------------------------GCTTCSEEECCSSCCCCCC
T ss_pred CCcCCccChhHhCcchhhCeEeccCCccc-ccCcccc------------------------cCCCCCEEECCCCcCCccC
Confidence 66666555555555566666666666555 4444332 2455555555555555443
Q ss_pred CC-CCCCCCCCEEEcCCCcCc
Q 003982 252 PD-LSKCESLFDLSLRDNQLT 271 (782)
Q Consensus 252 ~~-~~~l~~L~~L~L~~N~l~ 271 (782)
+. |..+++|+.|+|++|.+.
T Consensus 152 ~~~~~~l~~L~~L~l~~N~~~ 172 (229)
T 3e6j_A 152 HGAFDRLSSLTHAYLFGNPWD 172 (229)
T ss_dssp TTTTTTCTTCCEEECTTSCBC
T ss_pred HHHHhCCCCCCEEEeeCCCcc
Confidence 32 444444444444444444
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.76 E-value=2.3e-21 Score=224.62 Aligned_cols=318 Identities=16% Similarity=0.174 Sum_probs=219.4
Q ss_pred CCEEEEEeCCC-CCCcc-cCccccCCccCceeecccCccCccCC-C----CCCCCCCCEEeCCCCcccCCCCCCC----C
Q 003982 66 NRVTTISLAKS-GLSGT-LSPEISSLTQLETLSFQMNNIAGAIP-S----LANATSLQDIYLDNNNFTSVPTGCF----D 134 (782)
Q Consensus 66 ~~v~~L~l~~~-~l~~~-~~~~l~~l~~L~~L~L~~N~l~~~~~-~----l~~l~~L~~L~Ls~n~l~~~~~~~~----~ 134 (782)
.++++|+|++| .++.. ++..+..+++|++|+|++|.+++..+ . ...+++|++|+|++|. ..+....+ .
T Consensus 130 ~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~-~~~~~~~l~~l~~ 208 (594)
T 2p1m_B 130 KNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA-SEVSFSALERLVT 208 (594)
T ss_dssp TTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCC-SCCCHHHHHHHHH
T ss_pred CCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccC-CcCCHHHHHHHHH
Confidence 47899999998 55533 44445689999999999999876443 2 3467899999999997 33332222 3
Q ss_pred CCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccc--------------------------cCCC----Cccccc
Q 003982 135 GLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNAN--------------------------IFGL----IPDFFD 184 (782)
Q Consensus 135 ~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~--------------------------l~~~----~~~~~~ 184 (782)
++++|++|+|++|.... .++..+..+++|+.|+++.+. +... ++..+.
T Consensus 209 ~~~~L~~L~L~~~~~~~--~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L~~Ls~~~~~~~~~l~~~~~ 286 (594)
T 2p1m_B 209 RCPNLKSLKLNRAVPLE--KLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYS 286 (594)
T ss_dssp HCTTCCEEECCTTSCHH--HHHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHTCTTCCEEECCBTCCGGGGGGGHH
T ss_pred hCCCCcEEecCCCCcHH--HHHHHHhcCCcceEcccccccCccchhhHHHHHHHHhcCCCcccccCCcccchhhHHHHHH
Confidence 46999999999983222 145566667777777755441 1111 233344
Q ss_pred CCCCCcEEEcccCcCCCCCCccc--cccccchhhcccccCCCccccccccCCCCCcEEEeec---------ccccCCCC-
Q 003982 185 SFSNLQNLRLSYNNFTGSLPASF--AKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHK---------NQFTGPIP- 252 (782)
Q Consensus 185 ~l~~L~~L~Ls~N~l~~~~p~~~--~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~---------N~l~~~~~- 252 (782)
.+++|++|+|++|.+++.....+ ...+|+.|++.++ +...+.......+++|++|++++ |.+++...
T Consensus 287 ~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~ 365 (594)
T 2p1m_B 287 VCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLV 365 (594)
T ss_dssp HHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHH
T ss_pred hhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHH
Confidence 67899999999999764322221 1157888888877 33222222334589999999954 44443211
Q ss_pred CC-CCCCCCCEEEcCCCcCccCcchhhc-CCCCCCEEEcc--C----CcccCCCC--------CCCCCccEEEccCCcCC
Q 003982 253 DL-SKCESLFDLSLRDNQLTGVVPASVI-SLPALLNISLQ--N----NKLQGPYP--------LFPSKVQKVSLDHNNFC 316 (782)
Q Consensus 253 ~~-~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~l~--~----N~l~~~~~--------~~~~~l~~L~l~~N~~~ 316 (782)
.+ ..+++|+.|++..|++++..+..+. .+++|+.|+++ + |.+++... ..+.+|+.|++++ .++
T Consensus 366 ~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~ 444 (594)
T 2p1m_B 366 SVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLT 444 (594)
T ss_dssp HHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCC
T ss_pred HHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-ccc
Confidence 12 3479999999999999987777776 58999999999 4 66663221 1246899999976 442
Q ss_pred CCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCccccc-CCceeEEEccCcccccccCccc-cccccCC
Q 003982 317 KNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCS-QGRIITINLANKLLAGNISPAY-ANLTSLK 394 (782)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-~~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~ 394 (782)
... +..++. .++|+.|+|++|.+++..+..+ .++++|+
T Consensus 445 ~~~----------------------------------------~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~ 484 (594)
T 2p1m_B 445 DKV----------------------------------------FEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLR 484 (594)
T ss_dssp HHH----------------------------------------HHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCC
T ss_pred HHH----------------------------------------HHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcC
Confidence 211 111222 5689999999999987766665 6789999
Q ss_pred eEecccccccccCCc-cCCCCCCCCeEecCCCcCC
Q 003982 395 NLYLQQNNLTGPIPD-GLTKLASLQNLDVSNNNLS 428 (782)
Q Consensus 395 ~L~Ls~N~l~g~~p~-~~~~l~~L~~L~ls~N~l~ 428 (782)
+|+|++|++++..+. .+..+++|+.|++++|+++
T Consensus 485 ~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~ 519 (594)
T 2p1m_B 485 KLEIRDCPFGDKALLANASKLETMRSLWMSSCSVS 519 (594)
T ss_dssp EEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCB
T ss_pred EEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCC
Confidence 999999999765544 3455899999999999984
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=8.4e-21 Score=216.18 Aligned_cols=140 Identities=18% Similarity=0.211 Sum_probs=80.7
Q ss_pred CCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccc-------------cCCCCcccccCCCCCcEEE-cccCcC
Q 003982 134 DGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNAN-------------IFGLIPDFFDSFSNLQNLR-LSYNNF 199 (782)
Q Consensus 134 ~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~-------------l~~~~~~~~~~l~~L~~L~-Ls~N~l 199 (782)
..+++|+.|+|++|++.. +|..++++++|+.|++++|. +.+.+|..++.+++|+.|+ ++.|.+
T Consensus 346 ~~~~~L~~L~Ls~n~L~~---Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~ 422 (567)
T 1dce_A 346 ATDEQLFRCELSVEKSTV---LQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL 422 (567)
T ss_dssp STTTTSSSCCCCHHHHHH---HHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHH
T ss_pred ccCccceeccCChhhHHh---hHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhccc
Confidence 345566666666666654 56666666667776665554 4455566666677777776 555544
Q ss_pred CCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeecccccCCCCCCCCCCCCCEEEcCCCcCccCcchhhc
Q 003982 200 TGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVI 279 (782)
Q Consensus 200 ~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 279 (782)
. .+..+.+..|.+.... ...|+.|+|++|+|++.+ .+..+++|+.|+|++|+|+ .+|..|+
T Consensus 423 ~----------~L~~l~l~~n~i~~l~-------~~~L~~L~Ls~n~l~~lp-~~~~l~~L~~L~Ls~N~l~-~lp~~~~ 483 (567)
T 1dce_A 423 D----------DLRSKFLLENSVLKME-------YADVRVLHLAHKDLTVLC-HLEQLLLVTHLDLSHNRLR-ALPPALA 483 (567)
T ss_dssp H----------HHHHHHHHHHHHHHHH-------HTTCSEEECTTSCCSSCC-CGGGGTTCCEEECCSSCCC-CCCGGGG
T ss_pred c----------hhhhhhhhcccccccC-------ccCceEEEecCCCCCCCc-CccccccCcEeecCccccc-ccchhhh
Confidence 2 2333333333322100 123666666666666543 3666666666666666666 5566666
Q ss_pred CCCCCCEEEccCCccc
Q 003982 280 SLPALLNISLQNNKLQ 295 (782)
Q Consensus 280 ~l~~L~~L~l~~N~l~ 295 (782)
++++|+.|+|++|+|+
T Consensus 484 ~l~~L~~L~Ls~N~l~ 499 (567)
T 1dce_A 484 ALRCLEVLQASDNALE 499 (567)
T ss_dssp GCTTCCEEECCSSCCC
T ss_pred cCCCCCEEECCCCCCC
Confidence 6666666666666655
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=1.8e-18 Score=169.67 Aligned_cols=153 Identities=17% Similarity=0.185 Sum_probs=91.7
Q ss_pred CCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCC
Q 003982 110 ANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNL 189 (782)
Q Consensus 110 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 189 (782)
..+++|++|++++|+++.++ .+..+++|++|++++|.+.. +..+..+++|++|++++|++++..+..+..+++|
T Consensus 41 ~~l~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~l~~n~~~~----~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L 114 (197)
T 4ezg_A 41 AQMNSLTYITLANINVTDLT--GIEYAHNIKDLTINNIHATN----YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSL 114 (197)
T ss_dssp HHHHTCCEEEEESSCCSCCT--TGGGCTTCSEEEEESCCCSC----CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTC
T ss_pred hhcCCccEEeccCCCccChH--HHhcCCCCCEEEccCCCCCc----chhhhcCCCCCEEEeECCccCcccChhhcCCCCC
Confidence 34455556666666655555 25555666666666664433 2355566666666666666666556666666667
Q ss_pred cEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeeccc-ccCCCCCCCCCCCCCEEEcCCC
Q 003982 190 QNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQ-FTGPIPDLSKCESLFDLSLRDN 268 (782)
Q Consensus 190 ~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~l~~L~~L~L~~N 268 (782)
++|++++|++++..|..+ ..+++|++|++++|+ ++. .+.+..+++|+.|++++|
T Consensus 115 ~~L~Ls~n~i~~~~~~~l------------------------~~l~~L~~L~L~~n~~i~~-~~~l~~l~~L~~L~l~~n 169 (197)
T 4ezg_A 115 TLLDISHSAHDDSILTKI------------------------NTLPKVNSIDLSYNGAITD-IMPLKTLPELKSLNIQFD 169 (197)
T ss_dssp CEEECCSSBCBGGGHHHH------------------------TTCSSCCEEECCSCTBCCC-CGGGGGCSSCCEEECTTB
T ss_pred CEEEecCCccCcHhHHHH------------------------hhCCCCCEEEccCCCCccc-cHhhcCCCCCCEEECCCC
Confidence 777777666664444332 346666666666666 443 335666777777777777
Q ss_pred cCccCcchhhcCCCCCCEEEccCCccc
Q 003982 269 QLTGVVPASVISLPALLNISLQNNKLQ 295 (782)
Q Consensus 269 ~l~~~~p~~~~~l~~L~~L~l~~N~l~ 295 (782)
++++ ++ .+..+++|++|++++|++.
T Consensus 170 ~i~~-~~-~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 170 GVHD-YR-GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp CCCC-CT-TGGGCSSCCEEEECBC---
T ss_pred CCcC-hH-HhccCCCCCEEEeeCcccC
Confidence 7764 33 6667777777777777765
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=2.4e-18 Score=168.85 Aligned_cols=154 Identities=18% Similarity=0.249 Sum_probs=113.1
Q ss_pred cCCccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccC
Q 003982 87 SSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLT 166 (782)
Q Consensus 87 ~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~ 166 (782)
..+++|++|++++|.|+..+ .+..+++|++|++++|.++.++ .+..+++|++|++++|++.. ..+..+..+++|+
T Consensus 41 ~~l~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~l~~n~l~~--~~~~~l~~l~~L~ 115 (197)
T 4ezg_A 41 AQMNSLTYITLANINVTDLT-GIEYAHNIKDLTINNIHATNYN--PISGLSNLERLRIMGKDVTS--DKIPNLSGLTSLT 115 (197)
T ss_dssp HHHHTCCEEEEESSCCSCCT-TGGGCTTCSEEEEESCCCSCCG--GGTTCTTCCEEEEECTTCBG--GGSCCCTTCTTCC
T ss_pred hhcCCccEEeccCCCccChH-HHhcCCCCCEEEccCCCCCcch--hhhcCCCCCEEEeECCccCc--ccChhhcCCCCCC
Confidence 55677777777777777444 6777777888888877776654 46777888888888887765 3466777888888
Q ss_pred eeeccccccCCCCcccccCCCCCcEEEcccCc-CCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeecc
Q 003982 167 TLYMDNANIFGLIPDFFDSFSNLQNLRLSYNN-FTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKN 245 (782)
Q Consensus 167 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N 245 (782)
+|+|++|++++..+..+..+++|++|++++|+ ++ .+| . +..+++|++|++++|
T Consensus 116 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~------------------------l~~l~~L~~L~l~~n 169 (197)
T 4ezg_A 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-P------------------------LKTLPELKSLNIQFD 169 (197)
T ss_dssp EEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-G------------------------GGGCSSCCEEECTTB
T ss_pred EEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-h------------------------hcCCCCCCEEECCCC
Confidence 88888888887777888888888888888887 54 444 2 335788888888888
Q ss_pred cccCCCCCCCCCCCCCEEEcCCCcCcc
Q 003982 246 QFTGPIPDLSKCESLFDLSLRDNQLTG 272 (782)
Q Consensus 246 ~l~~~~~~~~~l~~L~~L~L~~N~l~~ 272 (782)
++++.. .+..+++|++|++++|+|.+
T Consensus 170 ~i~~~~-~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 170 GVHDYR-GIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp CCCCCT-TGGGCSSCCEEEECBC----
T ss_pred CCcChH-HhccCCCCCEEEeeCcccCC
Confidence 888644 67778888888888888763
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=3e-18 Score=176.14 Aligned_cols=167 Identities=19% Similarity=0.273 Sum_probs=139.5
Q ss_pred EEEEEeCCCCCCcccCccccCCccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCC
Q 003982 68 VTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDN 147 (782)
Q Consensus 68 v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 147 (782)
++.+++.++.+++. + .+..+++|++|++++|.|+..+ .+..+++|++|+|++|+|+++++ +.++++|++|+|++|
T Consensus 21 l~~l~l~~~~i~~~-~-~~~~l~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N 95 (263)
T 1xeu_A 21 AVKQNLGKQSVTDL-V-SQKELSGVQNFNGDNSNIQSLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRN 95 (263)
T ss_dssp HHHHHHTCSCTTSE-E-CHHHHTTCSEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSS
T ss_pred HHHHHhcCCCcccc-c-chhhcCcCcEEECcCCCcccch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCC
Confidence 44566777777743 3 5788999999999999998654 78889999999999999999887 889999999999999
Q ss_pred CCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccc
Q 003982 148 PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGT 227 (782)
Q Consensus 148 ~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~ 227 (782)
++.. +|... . ++|+.|+|++|++++. ..+..+++|++|+|++|++++ ++ .
T Consensus 96 ~l~~---l~~~~-~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~-~~-~--------------------- 145 (263)
T 1xeu_A 96 RLKN---LNGIP-S-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKS-IV-M--------------------- 145 (263)
T ss_dssp CCSC---CTTCC-C-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCB-CG-G---------------------
T ss_pred ccCC---cCccc-c-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCC-Ch-H---------------------
Confidence 9988 33322 2 8999999999999886 358899999999999999983 43 2
Q ss_pred cccccCCCCCcEEEeecccccCCCCCCCCCCCCCEEEcCCCcCccC
Q 003982 228 LDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGV 273 (782)
Q Consensus 228 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~ 273 (782)
+..+++|++|+|++|++++. +.+..+++|+.|++++|++++.
T Consensus 146 ---l~~l~~L~~L~L~~N~i~~~-~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 146 ---LGFLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp ---GGGCTTCCEEECTTSCCCBC-TTSTTCCCCCEEEEEEEEEECC
T ss_pred ---HccCCCCCEEECCCCcCcch-HHhccCCCCCEEeCCCCcccCC
Confidence 34589999999999999987 7788999999999999999855
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=8.8e-21 Score=216.00 Aligned_cols=193 Identities=17% Similarity=0.180 Sum_probs=154.4
Q ss_pred cCCccCceeecccCccCccCCCCCCCCCCCEEeCCCCc-------------ccCCCCCCCCCCCCCCEEe-ccCCCCCCC
Q 003982 87 SSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNN-------------FTSVPTGCFDGLTNLQVLS-LSDNPNLAP 152 (782)
Q Consensus 87 ~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~-------------l~~~~~~~~~~l~~L~~L~-Ls~N~l~~~ 152 (782)
...++|+.|+|++|+++.+++.++++++|+.|++++|. +.+.++..+.++++|+.|+ ++.|.+..
T Consensus 346 ~~~~~L~~L~Ls~n~L~~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~~- 424 (567)
T 1dce_A 346 ATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDD- 424 (567)
T ss_dssp STTTTSSSCCCCHHHHHHHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHHH-
T ss_pred ccCccceeccCChhhHHhhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccch-
Confidence 57889999999999998776689999999999998775 4555666677888888888 56554322
Q ss_pred CCCCc------ccCC--CcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCC
Q 003982 153 WPFPN------ELTK--STSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGL 224 (782)
Q Consensus 153 ~~~p~------~~~~--l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~ 224 (782)
++. .+.. ...|+.|+|++|+|+++ |. |..+++|++|+|++|+|+ .+|..+.
T Consensus 425 --L~~l~l~~n~i~~l~~~~L~~L~Ls~n~l~~l-p~-~~~l~~L~~L~Ls~N~l~-~lp~~~~---------------- 483 (567)
T 1dce_A 425 --LRSKFLLENSVLKMEYADVRVLHLAHKDLTVL-CH-LEQLLLVTHLDLSHNRLR-ALPPALA---------------- 483 (567)
T ss_dssp --HHHHHHHHHHHHHHHHTTCSEEECTTSCCSSC-CC-GGGGTTCCEEECCSSCCC-CCCGGGG----------------
T ss_pred --hhhhhhhcccccccCccCceEEEecCCCCCCC-cC-ccccccCcEeecCccccc-ccchhhh----------------
Confidence 110 1111 12588899999999885 55 888999999999999998 7887654
Q ss_pred ccccccccCCCCCcEEEeecccccCCCCCCCCCCCCCEEEcCCCcCccCc-chhhcCCCCCCEEEccCCcccCCCCCC--
Q 003982 225 SGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVV-PASVISLPALLNISLQNNKLQGPYPLF-- 301 (782)
Q Consensus 225 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~~~~-- 301 (782)
++++|+.|+|++|+|++.+ .+..+++|+.|+|++|+|++.. |..|+.+++|+.|+|++|+|++.+|..
T Consensus 484 --------~l~~L~~L~Ls~N~l~~lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~ 554 (567)
T 1dce_A 484 --------ALRCLEVLQASDNALENVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQER 554 (567)
T ss_dssp --------GCTTCCEEECCSSCCCCCG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTH
T ss_pred --------cCCCCCEEECCCCCCCCCc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHH
Confidence 5899999999999999854 8999999999999999999887 999999999999999999999887753
Q ss_pred ----CCCccEEEc
Q 003982 302 ----PSKVQKVSL 310 (782)
Q Consensus 302 ----~~~l~~L~l 310 (782)
+++|+.|++
T Consensus 555 l~~~lp~L~~L~l 567 (567)
T 1dce_A 555 LAEMLPSVSSILT 567 (567)
T ss_dssp HHHHCTTCSEEEC
T ss_pred HHHHCcccCccCC
Confidence 457777753
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.73 E-value=6.5e-18 Score=164.93 Aligned_cols=141 Identities=21% Similarity=0.307 Sum_probs=122.9
Q ss_pred CCCCCCccccceEeCCCCCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCCC--CCCCCCCCEEeCCCCccc
Q 003982 49 TSSTGYCEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPS--LANATSLQDIYLDNNNFT 126 (782)
Q Consensus 49 ~~~~~~c~w~gv~c~~~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~--l~~l~~L~~L~Ls~n~l~ 126 (782)
++..+.|.|+. +++++++++ .+|..+.. +|++|+|++|+|++.++. |..+++|++|+|++|+|+
T Consensus 2 CP~~C~C~~~~-----------l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~ 67 (192)
T 1w8a_A 2 CPAMCHCEGTT-----------VDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67 (192)
T ss_dssp CCTTSEEETTE-----------EECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCC
T ss_pred cCCCCEECCCE-----------EEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCC
Confidence 34455677744 555666775 67776654 899999999999998873 899999999999999999
Q ss_pred CCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCc
Q 003982 127 SVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPA 205 (782)
Q Consensus 127 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 205 (782)
++++..|.++++|++|+|++|++.. ..+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+++..+.
T Consensus 68 ~~~~~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l 144 (192)
T 1w8a_A 68 GIEPNAFEGASHIQELQLGENKIKE--ISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL 144 (192)
T ss_dssp CBCTTTTTTCTTCCEEECCSCCCCE--ECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG
T ss_pred CcCHhHcCCcccCCEEECCCCcCCc--cCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcc
Confidence 9999999999999999999999998 5566799999999999999999999999999999999999999999977653
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.72 E-value=6.2e-19 Score=207.10 Aligned_cols=116 Identities=24% Similarity=0.295 Sum_probs=61.7
Q ss_pred CCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCC
Q 003982 155 FPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGM 234 (782)
Q Consensus 155 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l 234 (782)
.+..+..++.|+.|+|++|.+..+ |..+..+++|++|+|++|+|+ .+|..|. ++
T Consensus 216 ~~~~~~~l~~L~~L~Ls~n~l~~l-~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~------------------------~l 269 (727)
T 4b8c_D 216 PKDSKYDDQLWHALDLSNLQIFNI-SANIFKYDFLTRLYLNGNSLT-ELPAEIK------------------------NL 269 (727)
T ss_dssp ------CCCCCCEEECTTSCCSCC-CGGGGGCCSCSCCBCTTSCCS-CCCGGGG------------------------GG
T ss_pred ChhhhccCCCCcEEECCCCCCCCC-ChhhcCCCCCCEEEeeCCcCc-ccChhhh------------------------CC
Confidence 345555666666666666666533 333445666666666666665 5554432 35
Q ss_pred CCCcEEEeecccccCCCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCC
Q 003982 235 TQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGP 297 (782)
Q Consensus 235 ~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 297 (782)
++|++|+|++|+|+.++..|..+++|++|+|++|.|+ .+|..|+.+++|+.|+|++|+|++.
T Consensus 270 ~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~ 331 (727)
T 4b8c_D 270 SNLRVLDLSHNRLTSLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQ 331 (727)
T ss_dssp TTCCEEECTTSCCSSCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSH
T ss_pred CCCCEEeCcCCcCCccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCC
Confidence 5566666666666544444555555666666655555 4455555555555555555555543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.71 E-value=8e-17 Score=155.00 Aligned_cols=139 Identities=27% Similarity=0.418 Sum_probs=119.7
Q ss_pred CCCCCccccceEeCCCCCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCcccCC
Q 003982 50 SSTGYCEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSV 128 (782)
Q Consensus 50 ~~~~~c~w~gv~c~~~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~ 128 (782)
+..+.|+|++|.|+. ++++ .+|..+ .++|++|++++|++++.++ .|.++++|++|+|++|+|+.+
T Consensus 2 p~~C~C~~~~l~~~~-----------~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 67 (177)
T 2o6r_A 2 PSRCSCSGTEIRCNS-----------KGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSL 67 (177)
T ss_dssp CTTCEEETTEEECCS-----------SCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCC
T ss_pred cCCCEeCCCEEEecC-----------CCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEe
Confidence 345668998888864 3444 455443 3689999999999998887 579999999999999999999
Q ss_pred CCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCC
Q 003982 129 PTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLP 204 (782)
Q Consensus 129 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 204 (782)
++..|.++++|++|+|++|++.. ..+..+..+++|++|+|++|+++++.+..|..+++|++|+|++|++.+..|
T Consensus 68 ~~~~~~~l~~L~~L~l~~N~l~~--~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 68 PDGVFDKLTKLTILYLHENKLQS--LPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCC--CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred ChhHccCCCccCEEECCCCCccc--cCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 99999999999999999999998 445568999999999999999999888888999999999999999997655
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.70 E-value=2.8e-17 Score=160.44 Aligned_cols=64 Identities=22% Similarity=0.367 Sum_probs=36.7
Q ss_pred eeEEEccCcccccccCccccccccCCeEecccccccccCCccCCCCCCCCeEecCCCcCCCCCC
Q 003982 369 IITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVP 432 (782)
Q Consensus 369 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p 432 (782)
|++|+|++|+|++..|..|.++++|++|+|++|+|++.+|..|..+++|+.|+|++|++++..+
T Consensus 80 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 80 IQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 3333333333333444445566666666666666666666666666666666666666666554
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.68 E-value=2.7e-16 Score=153.44 Aligned_cols=128 Identities=23% Similarity=0.267 Sum_probs=113.9
Q ss_pred EEEeCCCCCCcccCccccCCccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCC
Q 003982 70 TISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPN 149 (782)
Q Consensus 70 ~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 149 (782)
.+++++++++ .+|..+. ++|++|+|++|+|+.+++.|.++++|++|+|++|+|+.+++..|.++++|++|+|++|++
T Consensus 14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l 90 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL 90 (193)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCCSCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCchhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCcc
Confidence 3555566776 6676554 689999999999997666899999999999999999999999999999999999999999
Q ss_pred CCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCC
Q 003982 150 LAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGS 202 (782)
Q Consensus 150 ~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 202 (782)
.. ..|..|..+++|++|+|++|+|+.+.+..|..+++|++|+|++|.+...
T Consensus 91 ~~--i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~ 141 (193)
T 2wfh_A 91 RC--IPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD 141 (193)
T ss_dssp CB--CCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred CE--eCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence 98 5567899999999999999999999888999999999999999999753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.67 E-value=6.9e-17 Score=171.57 Aligned_cols=141 Identities=14% Similarity=0.121 Sum_probs=104.7
Q ss_pred CCccceeecccceEEEEEEeCCCcEEEEEEeccccCC------------hhh--------HHHHHHHHHHHHhcCCCCcc
Q 003982 583 FSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMG------------NKG--------LSEFQAEIAVLTKVRHRHLV 642 (782)
Q Consensus 583 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------~~~--------~~~~~~E~~~l~~l~h~nI~ 642 (782)
|++.+.||+|++|.||+|...+|+.||||+++..... ... .....+|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 9999999999999999998889999999987643110 000 11235678888888665553
Q ss_pred eEEeEEEeCCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECC
Q 003982 643 ALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD 722 (782)
Q Consensus 643 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~ 722 (782)
...-+... ..++||||++|+++.++.. ..+...++.|++.+|.|||+ .|||||||||.|||+++
T Consensus 177 vp~p~~~~--~~~LVME~i~G~~L~~l~~-----------~~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 177 VPEPIAQS--RHTIVMSLVDALPMRQVSS-----------VPDPASLYADLIALILRLAK---HGLIHGDFNEFNILIRE 240 (397)
T ss_dssp CCCEEEEE--TTEEEEECCSCEEGGGCCC-----------CSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEE
T ss_pred CCeeeecc--CceEEEEecCCccHhhhcc-----------cHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeC
Confidence 32222222 2379999999888755421 12345688999999999998 89999999999999987
Q ss_pred CC----------cEEEEeeccceecCC
Q 003982 723 DM----------RAKVADFGLVKNAPD 739 (782)
Q Consensus 723 ~~----------~~kL~DfG~a~~~~~ 739 (782)
++ .+.|+||+-+.....
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~~~h 267 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVSMDH 267 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEETTS
T ss_pred CCCcccccccccceEEEEeCCcccCCC
Confidence 76 389999998876543
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.66 E-value=1.1e-16 Score=152.49 Aligned_cols=136 Identities=21% Similarity=0.207 Sum_probs=123.8
Q ss_pred CCEEEEEeCCCCCC-cccCccccCCccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEec
Q 003982 66 NRVTTISLAKSGLS-GTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144 (782)
Q Consensus 66 ~~v~~L~l~~~~l~-~~~~~~l~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 144 (782)
.+++.|++++|+++ +.+|..+..+++|++|++++|.|++. +.+..+++|++|+|++|++++..+..+.++++|++|+|
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 102 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL 102 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEEC
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEec
Confidence 57899999999998 88999999999999999999999988 88999999999999999999977777888999999999
Q ss_pred cCCCCCCCCCCC--cccCCCcccCeeeccccccCCCCc---ccccCCCCCcEEEcccCcCCCCCCcc
Q 003982 145 SDNPNLAPWPFP--NELTKSTSLTTLYMDNANIFGLIP---DFFDSFSNLQNLRLSYNNFTGSLPAS 206 (782)
Q Consensus 145 s~N~l~~~~~~p--~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~Ls~N~l~~~~p~~ 206 (782)
++|++.. +| ..+..+++|++|++++|.+++..+ ..+..+++|++|++++|.+. .+|.+
T Consensus 103 s~N~l~~---~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~~ 165 (168)
T 2ell_A 103 SGNKLKD---ISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPDS 165 (168)
T ss_dssp BSSSCCS---SGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCSS
T ss_pred cCCccCc---chhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hcccc
Confidence 9999988 44 688999999999999999998866 58999999999999999998 66654
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.64 E-value=7e-17 Score=172.03 Aligned_cols=103 Identities=17% Similarity=0.131 Sum_probs=74.3
Q ss_pred CCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCCCCCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHh
Q 003982 257 CESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQI 336 (782)
Q Consensus 257 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~ 336 (782)
+++|+.|+|++|+++.+.+.+|.++++|+.|+|.+| ++...+
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~------------------------------------- 266 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQ------------------------------------- 266 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECT-------------------------------------
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehH-------------------------------------
Confidence 567777777777777666667777777777777766 442211
Q ss_pred hcCCCCCcccccCcCCCCCCCCCCcccccCCcee-EEEccCcccccccCccccccccCCeEecccccccccCCccCCCCC
Q 003982 337 AGDMGYPAILSDSWEGNNACDGWPFVTCSQGRII-TINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLA 415 (782)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~ 415 (782)
.+|..+.+|+ .|++.+ .++..-+..|.++++|+.|++++|+++..-+..|.+++
T Consensus 267 ------------------------~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~ 321 (329)
T 3sb4_A 267 ------------------------RVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGV 321 (329)
T ss_dssp ------------------------TTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTC
T ss_pred ------------------------HHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCc
Confidence 1244455677 777777 66656667888899999999988998877777888899
Q ss_pred CCCeEec
Q 003982 416 SLQNLDV 422 (782)
Q Consensus 416 ~L~~L~l 422 (782)
+|+.++.
T Consensus 322 ~L~~ly~ 328 (329)
T 3sb4_A 322 PSKLIYK 328 (329)
T ss_dssp CCCEEEC
T ss_pred chhhhcc
Confidence 9988864
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.62 E-value=8.4e-16 Score=146.46 Aligned_cols=83 Identities=25% Similarity=0.355 Sum_probs=45.0
Q ss_pred CCCCEEeCCCCccc--CCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCc
Q 003982 113 TSLQDIYLDNNNFT--SVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQ 190 (782)
Q Consensus 113 ~~L~~L~Ls~n~l~--~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 190 (782)
++|++|+|++|+++ .+|.. +..+++|++|+|++|++.. + ..+..+++|++|+|++|++++.+|..+..+++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~-~~~l~~L~~L~l~~n~l~~---~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 98 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGL-TAEFVNLEFLSLINVGLIS---V-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLT 98 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSC-CGGGGGCCEEEEESSCCCC---C-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCC
T ss_pred ccCCEEECCCCCCChhhHHHH-HHhCCCCCEEeCcCCCCCC---h-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCC
Confidence 66777777777776 44332 5555666666666665554 1 4444455555555555555544444444445555
Q ss_pred EEEcccCcCC
Q 003982 191 NLRLSYNNFT 200 (782)
Q Consensus 191 ~L~Ls~N~l~ 200 (782)
+|+|++|+++
T Consensus 99 ~L~Ls~N~l~ 108 (168)
T 2ell_A 99 HLNLSGNKLK 108 (168)
T ss_dssp EEECBSSSCC
T ss_pred EEeccCCccC
Confidence 5555555444
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.61 E-value=4.4e-15 Score=144.78 Aligned_cols=79 Identities=27% Similarity=0.365 Sum_probs=41.6
Q ss_pred CEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcc
Q 003982 116 QDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLS 195 (782)
Q Consensus 116 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 195 (782)
+++++++|+++.+|...+ ++|++|+|++|++.. +|..|.++++|+.|+|++|+|+++.+..|..+++|++|+|+
T Consensus 13 ~~l~~~~~~l~~ip~~~~---~~l~~L~L~~n~i~~---ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls 86 (193)
T 2wfh_A 13 TVVRCSNKGLKVLPKGIP---RDVTELYLDGNQFTL---VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILS 86 (193)
T ss_dssp TEEECTTSCCSSCCSCCC---TTCCEEECCSSCCCS---CCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CEEEcCCCCCCcCCCCCC---CCCCEEECCCCcCch---hHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECC
Confidence 345555555555554322 345555555555543 34455555555555555555555555555555555555555
Q ss_pred cCcCC
Q 003982 196 YNNFT 200 (782)
Q Consensus 196 ~N~l~ 200 (782)
+|+|+
T Consensus 87 ~N~l~ 91 (193)
T 2wfh_A 87 YNRLR 91 (193)
T ss_dssp SSCCC
T ss_pred CCccC
Confidence 55555
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.60 E-value=5.6e-16 Score=144.45 Aligned_cols=128 Identities=22% Similarity=0.201 Sum_probs=96.0
Q ss_pred CCEEEEEeCCCCCC-cccCccccCCccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEec
Q 003982 66 NRVTTISLAKSGLS-GTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144 (782)
Q Consensus 66 ~~v~~L~l~~~~l~-~~~~~~l~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 144 (782)
.+++.|++++|+++ +.+|..+..+++|++|++++|.+++. +.+.++++|++|+|++|++++..+..+.++++|++|++
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l 95 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEEC
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEEC
Confidence 35777888888887 67777778888888888888888776 66777888888888888888755555667788888888
Q ss_pred cCCCCCCCCCCCcccCCCcccCeeeccccccCCCCc---ccccCCCCCcEEEcc
Q 003982 145 SDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIP---DFFDSFSNLQNLRLS 195 (782)
Q Consensus 145 s~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~Ls 195 (782)
++|++... +.+..+..+++|++|++++|.+++..+ ..+..+++|++|+++
T Consensus 96 s~N~i~~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 96 SGNKIKDL-STIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp TTSCCCSH-HHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCcCCCh-HHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 88877661 112667777888888888888877755 567777888888775
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.59 E-value=1.1e-14 Score=139.92 Aligned_cols=134 Identities=28% Similarity=0.481 Sum_probs=114.5
Q ss_pred cCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeec
Q 003982 91 QLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYM 170 (782)
Q Consensus 91 ~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L 170 (782)
+.+.+++++|+++..+..+. ++|++|+|++|+++++++..|.++++|++|+|++|++.. ..+..+..+++|+.|+|
T Consensus 8 ~~~~l~~~~~~l~~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~l 83 (177)
T 2o6r_A 8 SGTEIRCNSKGLTSVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS--LPDGVFDKLTKLTILYL 83 (177)
T ss_dssp ETTEEECCSSCCSSCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCC--CCTTTTTTCTTCCEEEC
T ss_pred CCCEEEecCCCCccCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceE--eChhHccCCCccCEEEC
Confidence 35789999999997765443 799999999999999999999999999999999999987 44556899999999999
Q ss_pred cccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeecccccCC
Q 003982 171 DNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGP 250 (782)
Q Consensus 171 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~ 250 (782)
++|+|++..+..|..+++|++|+|++|+++ .+|... +..+++|++|+|++|.+++.
T Consensus 84 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~-----------------------~~~l~~L~~L~l~~N~~~~~ 139 (177)
T 2o6r_A 84 HENKLQSLPNGVFDKLTQLKELALDTNQLK-SVPDGI-----------------------FDRLTSLQKIWLHTNPWDCS 139 (177)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCS-CCCTTT-----------------------TTTCTTCCEEECCSSCBCCC
T ss_pred CCCCccccCHHHhhCCcccCEEECcCCcce-EeCHHH-----------------------hcCCcccCEEEecCCCeecc
Confidence 999999998888999999999999999999 555432 34578888888888887754
Q ss_pred CC
Q 003982 251 IP 252 (782)
Q Consensus 251 ~~ 252 (782)
.+
T Consensus 140 ~~ 141 (177)
T 2o6r_A 140 CP 141 (177)
T ss_dssp HH
T ss_pred Cc
Confidence 33
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.58 E-value=5.9e-15 Score=157.08 Aligned_cols=102 Identities=13% Similarity=0.048 Sum_probs=86.1
Q ss_pred CCCCcEEEeecccccCCCC-CCCCCCCCCEEEcCCCcCccCcchhhcCCCCCC-EEEccCCcccCCCCCCCCCccEEEcc
Q 003982 234 MTQLRQVWLHKNQFTGPIP-DLSKCESLFDLSLRDNQLTGVVPASVISLPALL-NISLQNNKLQGPYPLFPSKVQKVSLD 311 (782)
Q Consensus 234 l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~-~L~l~~N~l~~~~~~~~~~l~~L~l~ 311 (782)
+++|+.|+|++|+++.++. .|.++++|+.|+|.+| ++.+.+.+|.++++|+ .|++.+ +++...+
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~------------ 290 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEF------------ 290 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECT------------
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEch------------
Confidence 7899999999999998777 4999999999999998 8878888999999999 999988 5552211
Q ss_pred CCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccccCccccccc
Q 003982 312 HNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLT 391 (782)
Q Consensus 312 ~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~ 391 (782)
..|..+++|+.|++++|.++..-+..|.+++
T Consensus 291 -------------------------------------------------~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~ 321 (329)
T 3sb4_A 291 -------------------------------------------------GAFMGCDNLRYVLATGDKITTLGDELFGNGV 321 (329)
T ss_dssp -------------------------------------------------TTTTTCTTEEEEEECSSCCCEECTTTTCTTC
T ss_pred -------------------------------------------------hhhhCCccCCEEEeCCCccCccchhhhcCCc
Confidence 2345567899999999999987778999999
Q ss_pred cCCeEec
Q 003982 392 SLKNLYL 398 (782)
Q Consensus 392 ~L~~L~L 398 (782)
+|+.|+.
T Consensus 322 ~L~~ly~ 328 (329)
T 3sb4_A 322 PSKLIYK 328 (329)
T ss_dssp CCCEEEC
T ss_pred chhhhcc
Confidence 9998864
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.58 E-value=1.4e-15 Score=141.80 Aligned_cols=84 Identities=21% Similarity=0.289 Sum_probs=50.6
Q ss_pred CCCCCEEeCCCCccc--CCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCC
Q 003982 112 ATSLQDIYLDNNNFT--SVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNL 189 (782)
Q Consensus 112 l~~L~~L~Ls~n~l~--~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 189 (782)
.++|++|++++|+++ .+|. .+..+++|++|+|++|++.. + ..+..+++|++|+|++|.+++.+|..+..+++|
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~-~~~~l~~L~~L~l~~n~l~~---~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L 90 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEG-LTDEFEELEFLSTINVGLTS---I-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNL 90 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCS-CCTTCTTCCEEECTTSCCCC---C-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTC
T ss_pred CccCeEEEccCCcCChhHHHH-HHhhcCCCcEEECcCCCCCC---c-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCC
Confidence 366777777777777 4443 46666777777777776665 1 445555555555555555555455555555555
Q ss_pred cEEEcccCcCC
Q 003982 190 QNLRLSYNNFT 200 (782)
Q Consensus 190 ~~L~Ls~N~l~ 200 (782)
++|++++|+++
T Consensus 91 ~~L~ls~N~i~ 101 (149)
T 2je0_A 91 THLNLSGNKIK 101 (149)
T ss_dssp CEEECTTSCCC
T ss_pred CEEECCCCcCC
Confidence 55555555554
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.57 E-value=9.2e-14 Score=151.20 Aligned_cols=171 Identities=11% Similarity=0.183 Sum_probs=111.2
Q ss_pred CccCceeecccCccCccCC-CCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCe
Q 003982 89 LTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTT 167 (782)
Q Consensus 89 l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~ 167 (782)
...++.+.+.+ .++.+.+ .|.+. +|+.+.|.+| ++.+...+|.+. +|+.++|.. .+.. ..+.+|.++++|+.
T Consensus 112 ~~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~--I~~~aF~~c~~L~~ 184 (401)
T 4fdw_A 112 LKGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQ--LKEDIFYYCYNLKK 184 (401)
T ss_dssp CSSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCE--ECSSTTTTCTTCCE
T ss_pred cCCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccE--ehHHHhhCcccCCe
Confidence 35666666654 3554555 56663 6888887665 777777777774 688888775 4444 34567777788888
Q ss_pred eeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeecccc
Q 003982 168 LYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQF 247 (782)
Q Consensus 168 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l 247 (782)
++|.+|+++.+....|. ..+|+.+.|..+ ++ .++.. +|.++++|+.+++..| +
T Consensus 185 l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~-~I~~~-----------------------aF~~~~~L~~l~l~~~-l 237 (401)
T 4fdw_A 185 ADLSKTKITKLPASTFV-YAGIEEVLLPVT-LK-EIGSQ-----------------------AFLKTSQLKTIEIPEN-V 237 (401)
T ss_dssp EECTTSCCSEECTTTTT-TCCCSEEECCTT-CC-EECTT-----------------------TTTTCTTCCCEECCTT-C
T ss_pred eecCCCcceEechhhEe-ecccCEEEeCCc-hh-eehhh-----------------------HhhCCCCCCEEecCCC-c
Confidence 88887777777666776 477888877643 44 33322 3456777777777654 4
Q ss_pred cCCCC-CCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCccc
Q 003982 248 TGPIP-DLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQ 295 (782)
Q Consensus 248 ~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 295 (782)
+.+.. .|.+ .+|+.+.| .|.++.+...+|.++++|+.+++.+|.+.
T Consensus 238 ~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~ 284 (401)
T 4fdw_A 238 STIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFN 284 (401)
T ss_dssp CEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCC
T ss_pred cCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCcccc
Confidence 44333 3555 67777777 44466566677777777777777777654
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.54 E-value=5.6e-15 Score=141.89 Aligned_cols=128 Identities=16% Similarity=0.227 Sum_probs=112.3
Q ss_pred CCEEEEEeCCCCCCcccCccccCCc-cCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEec
Q 003982 66 NRVTTISLAKSGLSGTLSPEISSLT-QLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144 (782)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~l~~l~-~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 144 (782)
.+++.|++++|+++. ++. +..+. +|++|+|++|.|++. +.|..+++|++|+|++|+|+++++..|..+++|++|+|
T Consensus 19 ~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 95 (176)
T 1a9n_A 19 VRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL 95 (176)
T ss_dssp TSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEEC
T ss_pred CCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc-cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEEC
Confidence 468999999999994 554 55555 999999999999987 78999999999999999999999888899999999999
Q ss_pred cCCCCCCCCCCCc--ccCCCcccCeeeccccccCCCCcc----cccCCCCCcEEEcccCcCC
Q 003982 145 SDNPNLAPWPFPN--ELTKSTSLTTLYMDNANIFGLIPD----FFDSFSNLQNLRLSYNNFT 200 (782)
Q Consensus 145 s~N~l~~~~~~p~--~~~~l~~L~~L~L~~N~l~~~~~~----~~~~l~~L~~L~Ls~N~l~ 200 (782)
++|++.. +|. .+..+++|+.|++++|.++.. |. .+..+++|++||+++|.+.
T Consensus 96 ~~N~i~~---~~~~~~l~~l~~L~~L~l~~N~i~~~-~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 96 TNNSLVE---LGDLDPLASLKSLTYLCILRNPVTNK-KHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CSCCCCC---GGGGGGGGGCTTCCEEECCSSGGGGS-TTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CCCcCCc---chhhHhhhcCCCCCEEEecCCCCCCc-HhHHHHHHHHCCccceeCCCcCCHH
Confidence 9999976 565 788999999999999999866 44 4889999999999999875
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.53 E-value=3.6e-15 Score=143.18 Aligned_cols=87 Identities=18% Similarity=0.246 Sum_probs=40.8
Q ss_pred CCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCC
Q 003982 109 LANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSN 188 (782)
Q Consensus 109 l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 188 (782)
+.++.+|++|+|++|+++.++ ......++|++|+|++|++.. + ..+..+++|++|+|++|+|++..+..|..+++
T Consensus 15 ~~~~~~L~~L~l~~n~l~~i~-~~~~~~~~L~~L~Ls~N~l~~---~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPVIE-NLGATLDQFDAIDFSDNEIRK---L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp EECTTSCEEEECTTSCCCSCC-CGGGGTTCCSEEECCSSCCCE---E-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred cCCcCCceEEEeeCCCCchhH-HhhhcCCCCCEEECCCCCCCc---c-cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 444455555555555555442 111212255555555554444 1 23444444444444444444443344455555
Q ss_pred CcEEEcccCcCC
Q 003982 189 LQNLRLSYNNFT 200 (782)
Q Consensus 189 L~~L~Ls~N~l~ 200 (782)
|++|+|++|+++
T Consensus 90 L~~L~L~~N~i~ 101 (176)
T 1a9n_A 90 LTELILTNNSLV 101 (176)
T ss_dssp CCEEECCSCCCC
T ss_pred CCEEECCCCcCC
Confidence 555555555553
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.50 E-value=1.2e-13 Score=131.57 Aligned_cols=103 Identities=31% Similarity=0.437 Sum_probs=64.7
Q ss_pred EEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCC
Q 003982 70 TISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNP 148 (782)
Q Consensus 70 ~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 148 (782)
.+++++++|+ .+|..+. ++|++|+|++|+|++++| .|.++++|++|+|++|+|+.+++..|.++++|++|+|++|+
T Consensus 13 ~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~ 89 (170)
T 3g39_A 13 TVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ 89 (170)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCc
Confidence 3455556666 4555543 667777777777776655 56667777777777777776666666666666666666555
Q ss_pred CCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCC
Q 003982 149 NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTG 201 (782)
Q Consensus 149 l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 201 (782)
+.. +.+..|..+++|++|+|++|.++.
T Consensus 90 l~~--------------------------~~~~~~~~l~~L~~L~L~~N~~~c 116 (170)
T 3g39_A 90 LKS--------------------------IPRGAFDNLKSLTHIWLLNNPWDC 116 (170)
T ss_dssp CCC--------------------------CCTTTTTTCTTCCEEECCSSCBCT
T ss_pred cCE--------------------------eCHHHhcCCCCCCEEEeCCCCCCC
Confidence 544 444556666666666666666663
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.50 E-value=6e-13 Score=144.79 Aligned_cols=260 Identities=11% Similarity=0.153 Sum_probs=187.8
Q ss_pred EEEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccC
Q 003982 68 VTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSD 146 (782)
Q Consensus 68 v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~ 146 (782)
++.+.+.+ +++..-..+|.+ .+|+.+.+..| ++.+.. +|.+ .+|+.+.|.+ .++.+...+|.++++|+.++|++
T Consensus 115 l~~i~ip~-~i~~I~~~aF~~-~~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~ 189 (401)
T 4fdw_A 115 YNEIILPN-SVKSIPKDAFRN-SQIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSK 189 (401)
T ss_dssp CSEEECCT-TCCEECTTTTTT-CCCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTT
T ss_pred ccEEEECC-ccCEehHhhccc-CCccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeecCC
Confidence 44455543 355344456776 48999999877 777766 7877 5799999986 89999999999999999999999
Q ss_pred CCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCcc
Q 003982 147 NPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSG 226 (782)
Q Consensus 147 N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~ 226 (782)
|++.. .....|. ..+|+.+.|.+ .++.+...+|.++++|+.+++..| ++ .++..
T Consensus 190 n~l~~--I~~~aF~-~~~L~~l~lp~-~l~~I~~~aF~~~~~L~~l~l~~~-l~-~I~~~-------------------- 243 (401)
T 4fdw_A 190 TKITK--LPASTFV-YAGIEEVLLPV-TLKEIGSQAFLKTSQLKTIEIPEN-VS-TIGQE-------------------- 243 (401)
T ss_dssp SCCSE--ECTTTTT-TCCCSEEECCT-TCCEECTTTTTTCTTCCCEECCTT-CC-EECTT--------------------
T ss_pred CcceE--echhhEe-ecccCEEEeCC-chheehhhHhhCCCCCCEEecCCC-cc-Ccccc--------------------
Confidence 99988 3344555 68999999984 488888899999999999999875 44 34332
Q ss_pred ccccccCCCCCcEEEeecccccCCCC-CCCCCCCCCEEEcCCCcCc-----cCcchhhcCCCCCCEEEccCCcccCCCCC
Q 003982 227 TLDVLSGMTQLRQVWLHKNQFTGPIP-DLSKCESLFDLSLRDNQLT-----GVVPASVISLPALLNISLQNNKLQGPYPL 300 (782)
Q Consensus 227 ~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~-----~~~p~~~~~l~~L~~L~l~~N~l~~~~~~ 300 (782)
+|.+ .+|+.+.+ .|.++.+.. .|.++++|+.+++.+|.+. .+.+.+|.++++|+.++|.+ .++....
T Consensus 244 ---aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~- 316 (401)
T 4fdw_A 244 ---AFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQ- 316 (401)
T ss_dssp ---TTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECT-
T ss_pred ---cccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhh-
Confidence 2334 67888888 445655544 4888888888888877765 45667788888888888773 3442111
Q ss_pred CCCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccc
Q 003982 301 FPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLA 380 (782)
Q Consensus 301 ~~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~ 380 (782)
..|..+.+|+.|+|.+| ++
T Consensus 317 ------------------------------------------------------------~aF~~c~~L~~l~lp~~-l~ 335 (401)
T 4fdw_A 317 ------------------------------------------------------------GLLGGNRKVTQLTIPAN-VT 335 (401)
T ss_dssp ------------------------------------------------------------TTTTTCCSCCEEEECTT-CC
T ss_pred ------------------------------------------------------------hhhcCCCCccEEEECcc-cc
Confidence 12333456677777544 55
Q ss_pred cccCccccccccCCeEecccccccccCCccCCCCC-CCCeEecCCCcC
Q 003982 381 GNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLA-SLQNLDVSNNNL 427 (782)
Q Consensus 381 ~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~-~L~~L~ls~N~l 427 (782)
..-+..|.++ +|+.|++++|.+....+..|..++ .++.|++..|.+
T Consensus 336 ~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~ 382 (401)
T 4fdw_A 336 QINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESV 382 (401)
T ss_dssp EECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGH
T ss_pred EEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHH
Confidence 4555678888 888888888888766667777774 678888877654
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.49 E-value=1.7e-13 Score=130.55 Aligned_cols=104 Identities=27% Similarity=0.378 Sum_probs=75.2
Q ss_pred CCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEc
Q 003982 115 LQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRL 194 (782)
Q Consensus 115 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 194 (782)
.++|++++|+++.+|...+ ++|++|+|++|++.. ..|..|.++++|++|+|++|+|+++.+..|..+++|++|+|
T Consensus 11 ~~~l~~s~n~l~~ip~~~~---~~l~~L~L~~N~i~~--~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L 85 (170)
T 3g39_A 11 GTTVDCSGKSLASVPTGIP---TTTQVLYLYDNQITK--LEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSL 85 (170)
T ss_dssp TTEEECTTSCCSSCCSCCC---TTCSEEECCSSCCCC--CCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCEEEeCCCCcCccCccCC---CCCcEEEcCCCcCCc--cChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEEC
Confidence 3455666666666555432 556666666666666 34556677777777777777777777888899999999999
Q ss_pred ccCcCCCCCCccccc-cccchhhcccccCC
Q 003982 195 SYNNFTGSLPASFAK-SDIQNLWMNDQQLG 223 (782)
Q Consensus 195 s~N~l~~~~p~~~~~-~~l~~l~l~~~~~~ 223 (782)
++|+|++..+..|.. ..|+.|++++|.+.
T Consensus 86 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 115 (170)
T 3g39_A 86 NDNQLKSIPRGAFDNLKSLTHIWLLNNPWD 115 (170)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred CCCccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence 999999555555655 68999999999865
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.48 E-value=4e-16 Score=153.07 Aligned_cols=106 Identities=25% Similarity=0.337 Sum_probs=54.7
Q ss_pred CcccCeeeccccccCCCCcc------cccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCC
Q 003982 162 STSLTTLYMDNANIFGLIPD------FFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMT 235 (782)
Q Consensus 162 l~~L~~L~L~~N~l~~~~~~------~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~ 235 (782)
...++.++++.+.+++..|. .|..+++|++|+|++|++++ +| .+ .+++
T Consensus 17 ~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~------------------------~~l~ 70 (198)
T 1ds9_A 17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SL------------------------SGME 70 (198)
T ss_dssp TTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CH------------------------HHHT
T ss_pred cccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-cc------------------------ccCC
Confidence 34455555555555555444 55666666666666666653 44 22 2355
Q ss_pred CCcEEEeecccccCCCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCccc
Q 003982 236 QLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQ 295 (782)
Q Consensus 236 ~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 295 (782)
+|+.|++++|+++..+..+..+++|++|+|++|+|++ +| .+..+++|++|++++|+++
T Consensus 71 ~L~~L~l~~n~l~~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~ 128 (198)
T 1ds9_A 71 NLRILSLGRNLIKKIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKIT 128 (198)
T ss_dssp TCCEEEEEEEEECSCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECC
T ss_pred CCCEEECCCCCcccccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCC
Confidence 5666666666555433333334555555555555553 22 3444555555555555444
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.46 E-value=2.8e-16 Score=154.17 Aligned_cols=153 Identities=22% Similarity=0.304 Sum_probs=86.7
Q ss_pred ccCCccCceeecccCccCccCCC-------CCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcc
Q 003982 86 ISSLTQLETLSFQMNNIAGAIPS-------LANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNE 158 (782)
Q Consensus 86 l~~l~~L~~L~L~~N~l~~~~~~-------l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~ 158 (782)
+.....++.++++.+.+++..|. +..+++|++|+|++|+++.+| .
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~l~----------------------------~ 65 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKIS----------------------------S 65 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESCCC----------------------------C
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcccc----------------------------c
Confidence 45566777778888887776553 444555555555555555443 3
Q ss_pred cCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCc
Q 003982 159 LTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLR 238 (782)
Q Consensus 159 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~ 238 (782)
+.++++|++|+|++|+++. +|..+..+++|++|+|++|++++ +| . +.++++|+
T Consensus 66 ~~~l~~L~~L~l~~n~l~~-l~~~~~~~~~L~~L~L~~N~l~~-l~-~------------------------~~~l~~L~ 118 (198)
T 1ds9_A 66 LSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIAS-LS-G------------------------IEKLVNLR 118 (198)
T ss_dssp HHHHTTCCEEEEEEEEECS-CSSHHHHHHHCSEEEEEEEECCC-HH-H------------------------HHHHHHSS
T ss_pred cccCCCCCEEECCCCCccc-ccchhhcCCcCCEEECcCCcCCc-CC-c------------------------cccCCCCC
Confidence 4444444444444454442 24444445555555555555552 22 1 12355666
Q ss_pred EEEeecccccCCCC--CCCCCCCCCEEEcCCCcCccCcch----------hhcCCCCCCEEEccCCccc
Q 003982 239 QVWLHKNQFTGPIP--DLSKCESLFDLSLRDNQLTGVVPA----------SVISLPALLNISLQNNKLQ 295 (782)
Q Consensus 239 ~L~L~~N~l~~~~~--~~~~l~~L~~L~L~~N~l~~~~p~----------~~~~l~~L~~L~l~~N~l~ 295 (782)
+|++++|++++.++ .+..+++|++|++++|.+++.+|. .+..+++|+.|| +|.++
T Consensus 119 ~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 119 VLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp EEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred EEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 66666666654332 355666666777777766655444 367777787775 66665
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.45 E-value=4.8e-13 Score=127.82 Aligned_cols=103 Identities=29% Similarity=0.467 Sum_probs=69.3
Q ss_pred EEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCC
Q 003982 69 TTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDN 147 (782)
Q Consensus 69 ~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 147 (782)
+.+++++++++ .+|..+. ++|++|+|++|+|++.+| .|.++++|++|+|++|+|+++|+..|.++++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 46777777775 6666554 677777777777777766 5777777777777777777777666666666666666666
Q ss_pred CCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCC
Q 003982 148 PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFT 200 (782)
Q Consensus 148 ~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 200 (782)
++.. +.+..|..+++|++|+|++|.+.
T Consensus 92 ~l~~--------------------------l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKS--------------------------IPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCC--------------------------CCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccce--------------------------eCHHHhccccCCCEEEeCCCCcc
Confidence 5554 43444566666666666666666
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.45 E-value=4.3e-13 Score=128.20 Aligned_cols=103 Identities=20% Similarity=0.337 Sum_probs=72.6
Q ss_pred CEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcc
Q 003982 116 QDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLS 195 (782)
Q Consensus 116 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 195 (782)
+.+++++|+++.+|.... ++|++|+|++|++.. ..|..|.++++|++|+|++|+|+++.+..|..+++|++|+|+
T Consensus 15 ~~l~~~~n~l~~iP~~~~---~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~ 89 (174)
T 2r9u_A 15 TLVNCQNIRLASVPAGIP---TDKQRLWLNNNQITK--LEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLN 89 (174)
T ss_dssp SEEECCSSCCSSCCSCCC---TTCSEEECCSSCCCC--CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred cEEEeCCCCCCccCCCcC---CCCcEEEeCCCCccc--cCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECC
Confidence 455555555555555432 556666666666655 345566667777777777777777777778999999999999
Q ss_pred cCcCCCCCCccccc-cccchhhcccccCC
Q 003982 196 YNNFTGSLPASFAK-SDIQNLWMNDQQLG 223 (782)
Q Consensus 196 ~N~l~~~~p~~~~~-~~l~~l~l~~~~~~ 223 (782)
+|+|++..+..|.. ..|+.|++++|.+.
T Consensus 90 ~N~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 90 DNHLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp SSCCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred CCccceeCHHHhccccCCCEEEeCCCCcc
Confidence 99999444444654 68999999999865
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.34 E-value=3.6e-11 Score=131.08 Aligned_cols=290 Identities=13% Similarity=0.137 Sum_probs=182.4
Q ss_pred CccccCCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCC-----------
Q 003982 83 SPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNL----------- 150 (782)
Q Consensus 83 ~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~----------- 150 (782)
..+|.+.++|+.+.|.. .++.+.. +|.++++|+.++|.++ ++.+...+|.++++|+.+.+..+-..
T Consensus 64 ~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~l~~i~~~aF~~~~~ 141 (394)
T 4fs7_A 64 YAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLMLKSIGVEAFKGCDF 141 (394)
T ss_dssp TTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTTCCEECTTTTTTCCC
T ss_pred HHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCceeeecceeeecccc
Confidence 34566777777777753 3555555 6777777777777644 66677777777777766665433100
Q ss_pred -C-------CCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCc-cccc-cccchhhcccc
Q 003982 151 -A-------PWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPA-SFAK-SDIQNLWMNDQ 220 (782)
Q Consensus 151 -~-------~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~-~~l~~l~l~~~ 220 (782)
. ......+|.++++|+.+.+.++ +..+....|.++.+|+.+++..| ++ .++. .|.. ..|+.+.+..+
T Consensus 142 ~~~~~~~~~~~i~~~aF~~c~~L~~i~l~~~-~~~I~~~~F~~c~~L~~i~l~~~-~~-~I~~~~F~~~~~L~~i~~~~~ 218 (394)
T 4fs7_A 142 KEITIPEGVTVIGDEAFATCESLEYVSLPDS-METLHNGLFSGCGKLKSIKLPRN-LK-IIRDYCFAECILLENMEFPNS 218 (394)
T ss_dssp SEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCBCCCCTT-CC-EECTTTTTTCTTCCBCCCCTT
T ss_pred cccccCccccccchhhhcccCCCcEEecCCc-cceeccccccCCCCceEEEcCCC-ce-EeCchhhccccccceeecCCC
Confidence 0 0012356888899999999754 45566778889999999988766 44 3332 3322 23444444333
Q ss_pred cCCCccccccccCCCCCcEEEeecccccCCC-CCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCC
Q 003982 221 QLGLSGTLDVLSGMTQLRQVWLHKNQFTGPI-PDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYP 299 (782)
Q Consensus 221 ~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~ 299 (782)
..... +......+|+.+.+..+. +... ..+..+.+|+.+.+..+..+ .....|..+..++.+.+..+.+....-
T Consensus 219 ~~~i~---~~~~~~~~l~~i~ip~~~-~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~~~~F 293 (394)
T 4fs7_A 219 LYYLG---DFALSKTGVKNIIIPDSF-TELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVPEKTF 293 (394)
T ss_dssp CCEEC---TTTTTTCCCCEEEECTTC-CEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEECTTTT
T ss_pred ceEee---hhhcccCCCceEEECCCc-eecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeeccccc
Confidence 22111 112234677777776432 3222 24777888888888777554 666778888888888877766544333
Q ss_pred CCCCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCccc
Q 003982 300 LFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLL 379 (782)
Q Consensus 300 ~~~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l 379 (782)
....+|+.+.+.++ ++.+. ..++..+.+|+.++|.++ +
T Consensus 294 ~~~~~L~~i~l~~~-i~~I~----------------------------------------~~aF~~c~~L~~i~lp~~-v 331 (394)
T 4fs7_A 294 YGCSSLTEVKLLDS-VKFIG----------------------------------------EEAFESCTSLVSIDLPYL-V 331 (394)
T ss_dssp TTCTTCCEEEECTT-CCEEC----------------------------------------TTTTTTCTTCCEECCCTT-C
T ss_pred cccccccccccccc-cceec----------------------------------------hhhhcCCCCCCEEEeCCc-c
Confidence 33456777776543 33222 123455678888888654 6
Q ss_pred ccccCccccccccCCeEecccccccccCCccCCCCCCCCeEecCCC
Q 003982 380 AGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNN 425 (782)
Q Consensus 380 ~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N 425 (782)
+..-..+|.++++|+.+++..| ++..-..+|.++++|+.+++..|
T Consensus 332 ~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 332 EEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp CEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred cEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence 6555668888888998888876 66555678888888888888643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=6.1e-12 Score=129.03 Aligned_cols=148 Identities=15% Similarity=0.108 Sum_probs=116.5
Q ss_pred HHHHhcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC-CCCcceEEeEEEeCCeE
Q 003982 576 LRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSER 654 (782)
Q Consensus 576 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~~ 654 (782)
+....+.|++...++.|+.+.||++.. .++.+++|+...... .....+.+|+++++.+. +..++++++++.+.+..
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~ 85 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCce
Confidence 345667899889999999999999976 468999999875321 12246889999999885 67889999999999999
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC------------------------------
Q 003982 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA------------------------------ 704 (782)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~------------------------------ 704 (782)
|+||||++|.++.+.+. +......++.++++++..||+..
T Consensus 86 ~lv~e~i~G~~l~~~~~----------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEYE----------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp EEEEECCSSEEHHHHCC----------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSG
T ss_pred EEEEEecCCeehhhccC----------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccc
Confidence 99999999999876531 11223467889999999999721
Q ss_pred --------------------------CCCeEEcCCCCCCEEECCCCcEEEEeecccee
Q 003982 705 --------------------------QQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (782)
Q Consensus 705 --------------------------~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~ 736 (782)
...++|+|++|.||+++++..+.|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 14599999999999998766667999998754
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.32 E-value=4.3e-12 Score=135.99 Aligned_cols=86 Identities=17% Similarity=0.221 Sum_probs=65.5
Q ss_pred CccccceEeCCCCCEEEEEeCCCCCCcccCccccCCccCceeeccc-CccCccCC-CCCCCCCCCEEeCCCCcccCCCCC
Q 003982 54 YCEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQM-NNIAGAIP-SLANATSLQDIYLDNNNFTSVPTG 131 (782)
Q Consensus 54 ~c~w~gv~c~~~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~-N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~ 131 (782)
.|.|..|.|++. |+|+ .+|. |..+++|++|+|++ |.|+++++ .|.++++|++|+|++|+|+++++.
T Consensus 7 ~C~~~~v~~~~~----------n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 74 (347)
T 2ifg_A 7 PHGSSGLRCTRD----------GALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74 (347)
T ss_dssp CSSSSCEECCSS----------CCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTT
T ss_pred cccCCEEEcCCC----------CCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHH
Confidence 588877777541 1566 4777 88888888888885 88888776 688888888888888888888777
Q ss_pred CCCCCCCCCEEeccCCCCCC
Q 003982 132 CFDGLTNLQVLSLSDNPNLA 151 (782)
Q Consensus 132 ~~~~l~~L~~L~Ls~N~l~~ 151 (782)
.|.++++|++|+|++|+|..
T Consensus 75 ~~~~l~~L~~L~l~~N~l~~ 94 (347)
T 2ifg_A 75 AFHFTPRLSRLNLSFNALES 94 (347)
T ss_dssp GGGSCSCCCEEECCSSCCSC
T ss_pred HhcCCcCCCEEeCCCCccce
Confidence 77777777777777776655
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.25 E-value=1.2e-11 Score=132.50 Aligned_cols=105 Identities=20% Similarity=0.248 Sum_probs=96.1
Q ss_pred ceeecccC-ccCccCCCCCCCCCCCEEeCCC-CcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeec
Q 003982 93 ETLSFQMN-NIAGAIPSLANATSLQDIYLDN-NNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYM 170 (782)
Q Consensus 93 ~~L~L~~N-~l~~~~~~l~~l~~L~~L~Ls~-n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L 170 (782)
..++++++ +|+++++ |..+++|++|+|++ |+|+++++..|.++++|++|+|++|+|+. ..|..|.++++|+.|+|
T Consensus 11 ~~v~~~~~n~l~~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~--~~~~~~~~l~~L~~L~l 87 (347)
T 2ifg_A 11 SGLRCTRDGALDSLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRF--VAPDAFHFTPRLSRLNL 87 (347)
T ss_dssp SCEECCSSCCCTTTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCE--ECTTGGGSCSCCCEEEC
T ss_pred CEEEcCCCCCCCccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccce--eCHHHhcCCcCCCEEeC
Confidence 35788988 9998877 99999999999996 99999999999999999999999999998 56778999999999999
Q ss_pred cccccCCCCcccccCCCCCcEEEcccCcCCC
Q 003982 171 DNANIFGLIPDFFDSFSNLQNLRLSYNNFTG 201 (782)
Q Consensus 171 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 201 (782)
++|+|+++.+..|..++ |++|+|++|.+..
T Consensus 88 ~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 88 SFNALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp CSSCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred CCCccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 99999999888887777 9999999999984
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.23 E-value=3.5e-14 Score=153.00 Aligned_cols=61 Identities=20% Similarity=0.208 Sum_probs=30.0
Q ss_pred CCCcEEEeecccccCCCCC-C-----CCCCCCCEEEcCCCcCccC----cchhhcCCCCCCEEEccCCccc
Q 003982 235 TQLRQVWLHKNQFTGPIPD-L-----SKCESLFDLSLRDNQLTGV----VPASVISLPALLNISLQNNKLQ 295 (782)
Q Consensus 235 ~~L~~L~L~~N~l~~~~~~-~-----~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~ 295 (782)
++|+.|+|++|+|+..... + ...++|++|+|++|.|+.. ++..+..+++|++|+|++|+|+
T Consensus 126 ~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~ 196 (372)
T 3un9_A 126 LRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLG 196 (372)
T ss_dssp HTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCH
T ss_pred HhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCC
Confidence 4455555555555432211 1 2345566666666655432 3333345555555555555554
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.17 E-value=1.9e-13 Score=147.34 Aligned_cols=163 Identities=18% Similarity=0.147 Sum_probs=90.8
Q ss_pred CCCCEEeCCCCcccCCCCCCCC-----CCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccc----
Q 003982 113 TSLQDIYLDNNNFTSVPTGCFD-----GLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFF---- 183 (782)
Q Consensus 113 ~~L~~L~Ls~n~l~~~~~~~~~-----~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~---- 183 (782)
+.|++|+|++|.|+......+. ..++|++|+|++|.+.... .......+++|+.|+|++|.|+......+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~-~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L 150 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAG-LRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL 150 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHH-HHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHH-HHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence 4566666666666543222221 2256666666666654310 01112234566677777776654333333
Q ss_pred -cCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeecccccCCC-----CCCCCC
Q 003982 184 -DSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPI-----PDLSKC 257 (782)
Q Consensus 184 -~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~-----~~~~~l 257 (782)
...++|++|+|++|.|+..-...+. ..+..+++|++|+|++|+|+... ..+...
T Consensus 151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~--------------------~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~ 210 (372)
T 3un9_A 151 LHDQCQITTLRLSNNPLTAAGVAVLM--------------------EGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRN 210 (372)
T ss_dssp HSTTCCCCEEECCSSCCHHHHHHHHH--------------------HHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGC
T ss_pred HhcCCccceeeCCCCCCChHHHHHHH--------------------HHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcC
Confidence 2456777777777777521111111 12334667777777777776432 124556
Q ss_pred CCCCEEEcCCCcCccC----cchhhcCCCCCCEEEccCCcccC
Q 003982 258 ESLFDLSLRDNQLTGV----VPASVISLPALLNISLQNNKLQG 296 (782)
Q Consensus 258 ~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~ 296 (782)
++|+.|+|++|.|++. ++..+...++|++|+|++|.|++
T Consensus 211 ~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 211 RQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSS 253 (372)
T ss_dssp SCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCH
T ss_pred CCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCH
Confidence 6777788887777653 33444556777777777777763
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.14 E-value=3.1e-11 Score=123.52 Aligned_cols=139 Identities=20% Similarity=0.139 Sum_probs=102.0
Q ss_pred cCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCC--cceEEeEEEeCCeEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH--LVALLGYCINGSERLLVY 658 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--I~~~~~~~~~~~~~~lv~ 658 (782)
.+|.+....+.|..+.||++...+|+.+++|+.... ....+.+|+++++.+.+.+ +++++++...++..++||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 345444333456679999998777888999987643 1245788999999886544 567888888888899999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA---------------------------------- 704 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---------------------------------- 704 (782)
||++|.++. ... .+ ...++.++++.+..||+..
T Consensus 95 e~i~G~~l~--~~~--------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (264)
T 1nd4_A 95 GEVPGQDLL--SSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE 161 (264)
T ss_dssp ECCSSEETT--TSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred EecCCcccC--cCc--------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence 999998873 210 11 2256777788888888631
Q ss_pred ---------------------CCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 705 ---------------------QQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 705 ---------------------~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
..+++|+|++|.||+++++..+.|+|||.+...
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 123999999999999987766779999987654
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.07 E-value=4.8e-09 Score=114.22 Aligned_cols=292 Identities=12% Similarity=0.104 Sum_probs=158.0
Q ss_pred ccCccCC-CCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCC
Q 003982 101 NIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLI 179 (782)
Q Consensus 101 ~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 179 (782)
.++.+.. +|.++.+|+.+.|.. .++.+...+|.++++|+.++|..+ +.. .....|.++.+|+.+.+..+ +..+.
T Consensus 58 ~VtsIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~--I~~~aF~~c~~L~~i~~p~~-l~~i~ 132 (394)
T 4fs7_A 58 DVVSIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKM--IGRCTFSGCYALKSILLPLM-LKSIG 132 (394)
T ss_dssp EEEEECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCE--ECTTTTTTCTTCCCCCCCTT-CCEEC
T ss_pred eEeEhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceE--ccchhhcccccchhhcccCc-eeeec
Confidence 3555555 799999999999974 599999999999999999999865 444 34567888888888776543 33333
Q ss_pred cccccCCCCCcEEEcccCcCCCCCCccccc-cccchhhcccccCCCccccccccCCCCCcEEEeecccccCCCC-CCCCC
Q 003982 180 PDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIP-DLSKC 257 (782)
Q Consensus 180 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l 257 (782)
..+|.+...++......... .-...|.. ..|+.+.+.++.. .....+|.++++|+.+.+..| ++.... .|.++
T Consensus 133 ~~aF~~~~~~~~~~~~~~~~--i~~~aF~~c~~L~~i~l~~~~~--~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~ 207 (394)
T 4fs7_A 133 VEAFKGCDFKEITIPEGVTV--IGDEAFATCESLEYVSLPDSME--TLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAEC 207 (394)
T ss_dssp TTTTTTCCCSEEECCTTCCE--ECTTTTTTCTTCCEEECCTTCC--EECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTC
T ss_pred ceeeecccccccccCccccc--cchhhhcccCCCcEEecCCccc--eeccccccCCCCceEEEcCCC-ceEeCchhhccc
Confidence 33333333222221111110 00111211 2233333322111 111234556666776666655 333322 36666
Q ss_pred CCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCccc--CCCCCCCCCccEEEccCCcCCCCCCCCCCCCChhhhhHHH
Q 003982 258 ESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQ--GPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQ 335 (782)
Q Consensus 258 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~--~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~ 335 (782)
..|+.+.+..+... +.+.+....+|+.+.+.++.-. .........++.+.+..+... +....+..+.
T Consensus 208 ~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~-------- 276 (394)
T 4fs7_A 208 ILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDSFTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCS-------- 276 (394)
T ss_dssp TTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTTCCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCT--------
T ss_pred cccceeecCCCceE--eehhhcccCCCceEEECCCceecccccccccccceeEEcCCCcce-eecccccccc--------
Confidence 66666666555433 2233334455666655433211 111112234555555444221 1100000000
Q ss_pred hhcCCCCCcccccCcCCCCCCCCCC-cccccCCceeEEEccCcccccccCccccccccCCeEecccccccccCCccCCCC
Q 003982 336 IAGDMGYPAILSDSWEGNNACDGWP-FVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKL 414 (782)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~p-~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l 414 (782)
.+........ .++ ..+....+|+.+.+.++ ++..-...|.++++|+.++|.++ ++..-..+|.++
T Consensus 277 ---------~l~~~~~~~~---~i~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c 342 (394)
T 4fs7_A 277 ---------GLKKVIYGSV---IVPEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGC 342 (394)
T ss_dssp ---------TCCEEEECSS---EECTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTC
T ss_pred ---------ccceeccCce---eeccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCC
Confidence 0000000000 011 23455678888888765 66555678999999999999754 665557889999
Q ss_pred CCCCeEecCCCcCC
Q 003982 415 ASLQNLDVSNNNLS 428 (782)
Q Consensus 415 ~~L~~L~ls~N~l~ 428 (782)
++|+.+++..| ++
T Consensus 343 ~~L~~i~lp~~-l~ 355 (394)
T 4fs7_A 343 TSLSNINFPLS-LR 355 (394)
T ss_dssp TTCCEECCCTT-CC
T ss_pred CCCCEEEECcc-cc
Confidence 99999998766 54
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.03 E-value=1.1e-08 Score=111.42 Aligned_cols=128 Identities=14% Similarity=0.233 Sum_probs=69.2
Q ss_pred CCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCCCC---CCccEEEccCCcCCCCCCCCCCCCChh
Q 003982 253 DLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFP---SKVQKVSLDHNNFCKNSSDAGKPCDPQ 329 (782)
Q Consensus 253 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~---~~l~~L~l~~N~~~~~~~~~~~~~~~~ 329 (782)
.|..+.+|+.+.+.++..+ ....+|.+++.|+.+.+. +.++......+ .+|+.++|..+ ++.+.
T Consensus 260 aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~---------- 326 (394)
T 4gt6_A 260 AFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQIL---------- 326 (394)
T ss_dssp TTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEEC----------
T ss_pred eeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEeh----------
Confidence 4777788888888766544 566777788888888875 33443222222 34555555432 22211
Q ss_pred hhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccccCccccccccCCeEecccccccccCCc
Q 003982 330 VTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPD 409 (782)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~ 409 (782)
..+|..+.+|+.+.|..+ ++..-..+|.++++|+.+++.+|.... .
T Consensus 327 ------------------------------~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~ 372 (394)
T 4gt6_A 327 ------------------------------DDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---N 372 (394)
T ss_dssp ------------------------------TTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---H
T ss_pred ------------------------------HhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---h
Confidence 123444566777777544 444444567777777777777765442 3
Q ss_pred cCCCCCCCCeEecCCCcC
Q 003982 410 GLTKLASLQNLDVSNNNL 427 (782)
Q Consensus 410 ~~~~l~~L~~L~ls~N~l 427 (782)
.+.....|+.+.+..|.+
T Consensus 373 ~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 373 AISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp TCBCCCCC----------
T ss_pred hhhccCCCCEEEeCCCCE
Confidence 556666777776665544
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.02 E-value=8.8e-10 Score=118.47 Aligned_cols=144 Identities=13% Similarity=0.226 Sum_probs=108.1
Q ss_pred CccceeecccceEEEEEEeCCCcEEEEEEec--cccCChhhHHHHHHHHHHHHhcC--CCCcceEEeEEEeC---CeEEE
Q 003982 584 SEANILGRGGFGVVYGGELPDGTKIAVKRME--SNTMGNKGLSEFQAEIAVLTKVR--HRHLVALLGYCING---SERLL 656 (782)
Q Consensus 584 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~E~~~l~~l~--h~nI~~~~~~~~~~---~~~~l 656 (782)
...+.++.|.++.||+.... +..+++|+.. .... ......+.+|+++++.+. +..++++++++.+. +..|+
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS-SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred ceEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 34678899999999999874 4688899876 3221 122357889999999997 45688999888776 45899
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--------------------------------
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA-------------------------------- 704 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-------------------------------- 704 (782)
||||++|..+.+.. ...++..++..++.+++++|..||+..
T Consensus 119 vme~v~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (359)
T 3dxp_A 119 IMEFVSGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSET 191 (359)
T ss_dssp EEECCCCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCC
T ss_pred EEEecCCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCC
Confidence 99999987774321 123678888999999999999999721
Q ss_pred -----------------------CCCeEEcCCCCCCEEECCCCc--EEEEeecccee
Q 003982 705 -----------------------QQSFIHRDLKPSNILIGDDMR--AKVADFGLVKN 736 (782)
Q Consensus 705 -----------------------~~~ivHrDikp~NIll~~~~~--~kL~DfG~a~~ 736 (782)
..+++|+|+++.||+++.++. +.|+||+.+..
T Consensus 192 ~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 192 ESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp SCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred cCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999997753 68999998864
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.98 E-value=2.5e-08 Score=108.44 Aligned_cols=291 Identities=11% Similarity=0.123 Sum_probs=182.9
Q ss_pred ccccCC-ccCceeecccCccCccCC-CCCCCCCCCEEeCCCCc---ccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcc
Q 003982 84 PEISSL-TQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNN---FTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNE 158 (782)
Q Consensus 84 ~~l~~l-~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~---l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~ 158 (782)
.+|.+. ..|+.+.+..+ ++.+.. +|.++.+|+.+.+..|. ++.+...+|.++.+|+.+.+..+ +.. .....
T Consensus 57 ~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~--I~~~a 132 (394)
T 4gt6_A 57 RVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTE--IDSEA 132 (394)
T ss_dssp TTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSE--ECTTT
T ss_pred hhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cce--ehhhh
Confidence 346555 35888888654 666665 78888888888887764 77788888888888888887655 333 23456
Q ss_pred cCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCc
Q 003982 159 LTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLR 238 (782)
Q Consensus 159 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~ 238 (782)
|..+.+|+.+.+.. .+..+....|..+.+|+.+.+..+ ++..-...|....|+.+.+..+-. .....+|.++.++.
T Consensus 133 F~~c~~L~~i~lp~-~~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~~~l~~i~ip~~~~--~i~~~af~~c~~l~ 208 (394)
T 4gt6_A 133 FHHCEELDTVTIPE-GVTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTGTALTQIHIPAKVT--RIGTNAFSECFALS 208 (394)
T ss_dssp TTTCTTCCEEECCT-TCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCCCSEEEECTTCC--EECTTTTTTCTTCC
T ss_pred hhhhcccccccccc-eeeeecccceecccccccccccce-eeEeccccccccceeEEEECCccc--ccccchhhhccccc
Confidence 78888888888864 455566677888888888888655 331223334334444444432211 11123456666676
Q ss_pred EEEeecccccCCCCC--------------CCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCC---C
Q 003982 239 QVWLHKNQFTGPIPD--------------LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPL---F 301 (782)
Q Consensus 239 ~L~L~~N~l~~~~~~--------------~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~---~ 301 (782)
......+........ +.....+..+.+. +.++.....+|.+++.|+.+.+.++... .... .
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~ 286 (394)
T 4gt6_A 209 TITSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMN 286 (394)
T ss_dssp EEEECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTT
T ss_pred eecccccccccccceeecccccccccccccccccccceEEcC-CcceEcccceeeecccccEEecccccce-ecCccccc
Confidence 666655544322111 1122344444443 2344455667888888888888765433 1111 1
Q ss_pred CCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCccccc
Q 003982 302 PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAG 381 (782)
Q Consensus 302 ~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~ 381 (782)
...|+.+.+.. .++.+. ...|..+.+|+.++|..+ ++.
T Consensus 287 c~~L~~i~l~~-~i~~I~----------------------------------------~~aF~~c~~L~~i~lp~~-v~~ 324 (394)
T 4gt6_A 287 CPALQDIEFSS-RITELP----------------------------------------ESVFAGCISLKSIDIPEG-ITQ 324 (394)
T ss_dssp CTTCCEEECCT-TCCEEC----------------------------------------TTTTTTCTTCCEEECCTT-CCE
T ss_pred ccccccccCCC-cccccC----------------------------------------ceeecCCCCcCEEEeCCc-ccE
Confidence 24566666642 232222 123555678999999765 665
Q ss_pred ccCccccccccCCeEecccccccccCCccCCCCCCCCeEecCCCcC
Q 003982 382 NISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNL 427 (782)
Q Consensus 382 ~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l 427 (782)
.-...|.++++|+.+.|..+ ++..-..+|.++++|+.+++.+|..
T Consensus 325 I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~ 369 (394)
T 4gt6_A 325 ILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRS 369 (394)
T ss_dssp ECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHH
T ss_pred ehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCcee
Confidence 55678999999999999755 6645567899999999999988754
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.86 E-value=1.9e-10 Score=122.72 Aligned_cols=158 Identities=15% Similarity=0.111 Sum_probs=86.7
Q ss_pred CCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCccccc--CCCCCcEEEccc--CcCCCCC-Ccccc
Q 003982 134 DGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFD--SFSNLQNLRLSY--NNFTGSL-PASFA 208 (782)
Q Consensus 134 ~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~Ls~--N~l~~~~-p~~~~ 208 (782)
..+|+|+.|+|++|.-.. ++. + .+++|+.|+|..|.+.......+. .+++|++|+|+. |...+.. ...+.
T Consensus 169 ~~~P~L~~L~L~g~~~l~---l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~ 243 (362)
T 2ra8_A 169 DAMPLLNNLKIKGTNNLS---IGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFR 243 (362)
T ss_dssp HTCTTCCEEEEECCBTCB---CCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTG
T ss_pred hcCCCCcEEEEeCCCCce---ecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHH
Confidence 344556666665552111 222 2 256777777776665433223333 677888887753 2222111 00110
Q ss_pred ccccchhhcccccCCCccccccccCCCCCcEEEeecccccCCCC-C---CCCCCCCCEEEcCCCcCccCc----chhhcC
Q 003982 209 KSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIP-D---LSKCESLFDLSLRDNQLTGVV----PASVIS 280 (782)
Q Consensus 209 ~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~---~~~l~~L~~L~L~~N~l~~~~----p~~~~~ 280 (782)
. + -....+++|+.|+|++|++++... . ...+++|++|+|+.|.|++.. +..+..
T Consensus 244 ~-----~-------------l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~ 305 (362)
T 2ra8_A 244 P-----L-------------FSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDK 305 (362)
T ss_dssp G-----G-------------SCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHH
T ss_pred H-----H-------------HhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhccc
Confidence 0 0 001236788888888888764221 1 235678888888888887643 333445
Q ss_pred CCCCCEEEccCCcccCCCCCCCCC-c-cEEEccCCc
Q 003982 281 LPALLNISLQNNKLQGPYPLFPSK-V-QKVSLDHNN 314 (782)
Q Consensus 281 l~~L~~L~l~~N~l~~~~~~~~~~-l-~~L~l~~N~ 314 (782)
+++|+.|+|++|.+++..-..+.. + ..+++++++
T Consensus 306 l~~L~~L~L~~n~i~d~~~~~l~~alg~~~~~~~~~ 341 (362)
T 2ra8_A 306 IKHLKFINMKYNYLSDEMKKELQKSLPMKIDVSDSQ 341 (362)
T ss_dssp HTTCSEEECCSBBCCHHHHHHHHHHCCSEEECCSBC
T ss_pred CCcceEEECCCCcCCHHHHHHHHHHcCCEEEecCCc
Confidence 688888888888877533222221 2 457777776
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.81 E-value=2.8e-09 Score=113.62 Aligned_cols=141 Identities=16% Similarity=0.177 Sum_probs=85.9
Q ss_pred ccCCCCCcEEEeeccc-ccCCCCCCCCCCCCCEEEcCCCcCccCcchhhc--CCCCCCEEEccC--CcccCCCCCCCCCc
Q 003982 231 LSGMTQLRQVWLHKNQ-FTGPIPDLSKCESLFDLSLRDNQLTGVVPASVI--SLPALLNISLQN--NKLQGPYPLFPSKV 305 (782)
Q Consensus 231 ~~~l~~L~~L~L~~N~-l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~l~~--N~l~~~~~~~~~~l 305 (782)
+..+|+|+.|+|++|. +. .+.+. +++|+.|+|..|.++......+. .+++|+.|+|+. |...+... ...+
T Consensus 168 l~~~P~L~~L~L~g~~~l~--l~~~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~--~~~l 242 (362)
T 2ra8_A 168 LDAMPLLNNLKIKGTNNLS--IGKKP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGD--MNVF 242 (362)
T ss_dssp HHTCTTCCEEEEECCBTCB--CCSCB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSC--GGGT
T ss_pred HhcCCCCcEEEEeCCCCce--ecccc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchh--HHHH
Confidence 4567889999998873 22 22343 78899999988888765555554 688888888863 22111100 0000
Q ss_pred cEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccccCc
Q 003982 306 QKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISP 385 (782)
Q Consensus 306 ~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~ 385 (782)
.. .+. ...+++|++|+|.+|.+.+..+.
T Consensus 243 ~~--------------------------------------------------~l~--~~~~p~Lr~L~L~~~~i~~~~~~ 270 (362)
T 2ra8_A 243 RP--------------------------------------------------LFS--KDRFPNLKWLGIVDAEEQNVVVE 270 (362)
T ss_dssp GG--------------------------------------------------GSC--TTTCTTCCEEEEESCTTHHHHHH
T ss_pred HH--------------------------------------------------HHh--cCCCCCcCEEeCCCCCCchHHHH
Confidence 00 000 01235777777777777654443
Q ss_pred ccc---ccccCCeEeccccccccc----CCccCCCCCCCCeEecCCCcCC
Q 003982 386 AYA---NLTSLKNLYLQQNNLTGP----IPDGLTKLASLQNLDVSNNNLS 428 (782)
Q Consensus 386 ~~~---~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~ls~N~l~ 428 (782)
.+. .+++|++|+|+.|+|.+. ++..+..+++|+.|+|++|.++
T Consensus 271 ~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~ 320 (362)
T 2ra8_A 271 MFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320 (362)
T ss_dssp HHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred HHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence 333 467788888888887763 3444455678888888888775
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.77 E-value=1e-08 Score=107.28 Aligned_cols=137 Identities=19% Similarity=0.268 Sum_probs=101.6
Q ss_pred cceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC-CCC--cceEEeEEEeCC---eEEEEEE
Q 003982 586 ANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRH--LVALLGYCINGS---ERLLVYE 659 (782)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--I~~~~~~~~~~~---~~~lv~e 659 (782)
.+.++.|....||+.. ..+++|+.... .....+.+|+++++.+. +.. +++++....... ..|+|||
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT 96 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence 5668999999999863 56889986432 34577899999999884 333 455655543333 3489999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----------------------------------
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA----------------------------------- 704 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~----------------------------------- 704 (782)
+++|.++.+.... .++..++..++.++++.+..||+..
T Consensus 97 ~i~G~~l~~~~~~-------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (304)
T 3sg8_A 97 KIKGVPLTPLLLN-------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQ 169 (304)
T ss_dssp CCCCEECCHHHHH-------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHH
T ss_pred ccCCeECCccccc-------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCccc
Confidence 9999888754322 3677888888899999888888611
Q ss_pred --------------------CCCeEEcCCCCCCEEECC--CCcEEEEeeccceec
Q 003982 705 --------------------QQSFIHRDLKPSNILIGD--DMRAKVADFGLVKNA 737 (782)
Q Consensus 705 --------------------~~~ivHrDikp~NIll~~--~~~~kL~DfG~a~~~ 737 (782)
...++|+|++|.||++++ ...+.++||+.+...
T Consensus 170 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 170 MKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 135899999999999988 456789999988654
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.76 E-value=4.3e-11 Score=121.06 Aligned_cols=147 Identities=17% Similarity=0.172 Sum_probs=86.3
Q ss_pred CccccceEeCCC-CCEEEEEeCC---CCCCcccCc-cccCCccCceeecccCccCccCC--CCCCCCCCCE--EeCCCCc
Q 003982 54 YCEWTGINCDNS-NRVTTISLAK---SGLSGTLSP-EISSLTQLETLSFQMNNIAGAIP--SLANATSLQD--IYLDNNN 124 (782)
Q Consensus 54 ~c~w~gv~c~~~-~~v~~L~l~~---~~l~~~~~~-~l~~l~~L~~L~L~~N~l~~~~~--~l~~l~~L~~--L~Ls~n~ 124 (782)
.|.|.|+.|+.. .+|+.+...+ ..+.+.+++ .+..++. .|...+|.-++..+ .|...+.|.. ++++.|+
T Consensus 77 l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~ 154 (267)
T 3rw6_A 77 LKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNR 154 (267)
T ss_dssp HHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTS
T ss_pred HHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCCH
Confidence 588999999864 3666655544 233333332 2333322 23344444444332 2444455554 5666664
Q ss_pred ccCCCC---CCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCC--CCcEEEcccCcC
Q 003982 125 FTSVPT---GCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFS--NLQNLRLSYNNF 199 (782)
Q Consensus 125 l~~~~~---~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~Ls~N~l 199 (782)
...++. ....++++|+.|+|++|++.....+|..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|.+
T Consensus 155 ~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl 232 (267)
T 3rw6_A 155 RSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSL 232 (267)
T ss_dssp HHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTT
T ss_pred HHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcC
Confidence 443221 122456777777777777776433455666778888888888888775 2233333 888889998888
Q ss_pred CCCCC
Q 003982 200 TGSLP 204 (782)
Q Consensus 200 ~~~~p 204 (782)
.+.+|
T Consensus 233 ~~~~~ 237 (267)
T 3rw6_A 233 CDTFR 237 (267)
T ss_dssp GGGCS
T ss_pred ccccC
Confidence 87666
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.73 E-value=6.5e-07 Score=96.68 Aligned_cols=293 Identities=10% Similarity=0.107 Sum_probs=152.7
Q ss_pred CEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEecc
Q 003982 67 RVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145 (782)
Q Consensus 67 ~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls 145 (782)
+++++.+.. +++..-..+|.+..+|+.++|..+ ++.+.. +|.+. +|+.+.+.. +++.+...+|.+. +|+.+++.
T Consensus 47 ~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~-~l~~I~~~aF~~~-~L~~i~lp 121 (379)
T 4h09_A 47 RISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGME-RVKKFGDYVFQGT-DLDDFEFP 121 (379)
T ss_dssp GCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECT-TCCEECTTTTTTC-CCSEEECC
T ss_pred CCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCc-eeeEeccceeccC-CcccccCC
Confidence 355555542 344333445666667777766543 554444 55554 566666543 3666666666554 56777665
Q ss_pred CCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCc
Q 003982 146 DNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLS 225 (782)
Q Consensus 146 ~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~ 225 (782)
.+- .. .....|.+. +|+.+.+.. .++.+....|....+++.+.+..+.........+... .. .
T Consensus 122 ~~~-~~--i~~~~F~~~-~l~~~~~~~-~v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~--------~~----~ 184 (379)
T 4h09_A 122 GAT-TE--IGNYIFYNS-SVKRIVIPK-SVTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYN--------KN----K 184 (379)
T ss_dssp TTC-CE--ECTTTTTTC-CCCEEEECT-TCCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEE--------TT----S
T ss_pred Ccc-cc--ccccccccc-eeeeeeccc-eeeccccchhcccccccccccccccceeecccceecc--------cc----c
Confidence 442 11 112233332 444444432 3444445566666777777666554331111000000 00 0
Q ss_pred cccccccCCCCCcEEEeecccccCCCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCCC---C
Q 003982 226 GTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLF---P 302 (782)
Q Consensus 226 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~---~ 302 (782)
.....+.....+..+.+..+.-.-....+..+.+|+.+.+..+ +......+|.++..|+.+.+..+ ++...... .
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~ 262 (379)
T 4h09_A 185 TILESYPAAKTGTEFTIPSTVKTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNC 262 (379)
T ss_dssp SEEEECCTTCCCSEEECCTTCCEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTC
T ss_pred ceeccccccccccccccccceeEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCcccccee
Confidence 0001122334444444433322222233555666666666544 33344556666666666666554 33222221 2
Q ss_pred CCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccc
Q 003982 303 SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGN 382 (782)
Q Consensus 303 ~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~ 382 (782)
.+|+.+.+..+ +..+. ...+..+.+|+.+++.++.++..
T Consensus 263 ~~l~~i~l~~~-i~~i~----------------------------------------~~aF~~c~~L~~i~l~~~~i~~I 301 (379)
T 4h09_A 263 TALKTLNFYAK-VKTVP----------------------------------------YLLCSGCSNLTKVVMDNSAIETL 301 (379)
T ss_dssp TTCCEEEECCC-CSEEC----------------------------------------TTTTTTCTTCCEEEECCTTCCEE
T ss_pred ehhcccccccc-ceecc----------------------------------------cccccccccccccccccccccee
Confidence 24455544322 21111 11244557888888888888866
Q ss_pred cCccccccccCCeEecccccccccCCccCCCCCCCCeEecCCC
Q 003982 383 ISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNN 425 (782)
Q Consensus 383 ~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N 425 (782)
-...|.++.+|+.+.|..+ ++..-..+|.++++|+.+.+..|
T Consensus 302 ~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~ 343 (379)
T 4h09_A 302 EPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS 343 (379)
T ss_dssp CTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred hhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc
Confidence 6778889999999999755 66455677888888988887543
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.50 E-value=1.1e-06 Score=91.88 Aligned_cols=137 Identities=18% Similarity=0.196 Sum_probs=97.7
Q ss_pred cceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCC---CcceEEeEEE-eCCeEEEEEEcc
Q 003982 586 ANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHR---HLVALLGYCI-NGSERLLVYEYM 661 (782)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~---nI~~~~~~~~-~~~~~~lv~e~~ 661 (782)
.+.++.|....||+. +..+++|+... ......+.+|+++++.+.+. .+++++.+.. ..+..++||||+
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i 95 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV 95 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence 466888888899987 56788997532 23457899999999999742 4677777774 445678999999
Q ss_pred CCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc--------------------------------------
Q 003982 662 PRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSL-------------------------------------- 703 (782)
Q Consensus 662 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-------------------------------------- 703 (782)
+|..+.+... ..++..+...++.++++.|..||+.
T Consensus 96 ~G~~l~~~~~-------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~ 168 (306)
T 3tdw_A 96 QGQILGEDGM-------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL 168 (306)
T ss_dssp CSEECHHHHH-------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred CCeECchhhh-------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence 9988766321 1234555555566666666555542
Q ss_pred -------------------CCCCeEEcCCCCCCEEECC---CCc-EEEEeeccceec
Q 003982 704 -------------------AQQSFIHRDLKPSNILIGD---DMR-AKVADFGLVKNA 737 (782)
Q Consensus 704 -------------------~~~~ivHrDikp~NIll~~---~~~-~kL~DfG~a~~~ 737 (782)
....++|+|++|.||+++. ++. +.|+||+.+..-
T Consensus 169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 1236799999999999987 455 589999987654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.48 E-value=1.1e-06 Score=89.96 Aligned_cols=137 Identities=18% Similarity=0.148 Sum_probs=100.9
Q ss_pred ceeecccce-EEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC-CCCcceEEeEEEeCCeEEEEEEccCC
Q 003982 587 NILGRGGFG-VVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSERLLVYEYMPR 663 (782)
Q Consensus 587 ~~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~~~lv~e~~~~ 663 (782)
+.+..|..+ .||+.... ++..+++|+-... ....+.+|.+.++.+. +--++++++++.+++..++|||+++|
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence 345556655 68988654 5678999986532 3467889999998885 44478899999999999999999999
Q ss_pred CCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC---------------------------------------
Q 003982 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA--------------------------------------- 704 (782)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--------------------------------------- 704 (782)
.++.+.... ...+...++.+++..|..||...
T Consensus 105 ~~~~~~~~~---------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (272)
T 4gkh_A 105 KTAFQVLEE---------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWP 175 (272)
T ss_dssp EEHHHHHHH---------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCC
T ss_pred ccccccccC---------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchH
Confidence 888776533 11233456677777777777520
Q ss_pred ----------------CCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 705 ----------------QQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 705 ----------------~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
...++|+|+.+.||++++++.+-|+||+.+..-
T Consensus 176 ~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 176 VEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp HHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 123899999999999998777789999987643
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.32 E-value=4.1e-08 Score=94.40 Aligned_cols=42 Identities=26% Similarity=0.219 Sum_probs=21.3
Q ss_pred cccccccCCeEec--cccccccc----CCccCCCCCCCCeEecCCCcC
Q 003982 386 AYANLTSLKNLYL--QQNNLTGP----IPDGLTKLASLQNLDVSNNNL 427 (782)
Q Consensus 386 ~~~~l~~L~~L~L--s~N~l~g~----~p~~~~~l~~L~~L~ls~N~l 427 (782)
.+...+.|++|+| ++|+|... +.+.+...+.|+.|+|++|.+
T Consensus 116 ~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i 163 (185)
T 1io0_A 116 ALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 163 (185)
T ss_dssp GGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCC
Confidence 3444455555555 55555432 223333445566666666654
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.32 E-value=3.6e-08 Score=94.80 Aligned_cols=116 Identities=14% Similarity=0.218 Sum_probs=65.2
Q ss_pred CCCcccCeeecccc-ccCC----CCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCC
Q 003982 160 TKSTSLTTLYMDNA-NIFG----LIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGM 234 (782)
Q Consensus 160 ~~l~~L~~L~L~~N-~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l 234 (782)
...++|++|+|++| .|.. .+...+...++|++|+|++|+|...-...++ ..+...
T Consensus 33 ~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~--------------------~~L~~n 92 (185)
T 1io0_A 33 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALA--------------------EMLKVN 92 (185)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHH--------------------HHHHHC
T ss_pred hcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHH--------------------HHHHhC
Confidence 33444555555554 4432 1234455566677777777776521111111 112234
Q ss_pred CCCcEEEeecccccCC-----CCCCCCCCCCCEEEc--CCCcCccC----cchhhcCCCCCCEEEccCCccc
Q 003982 235 TQLRQVWLHKNQFTGP-----IPDLSKCESLFDLSL--RDNQLTGV----VPASVISLPALLNISLQNNKLQ 295 (782)
Q Consensus 235 ~~L~~L~L~~N~l~~~-----~~~~~~l~~L~~L~L--~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~ 295 (782)
++|++|+|++|+|+.. ...+...++|++|+| ++|.|+.. +...+...+.|++|+|++|.+.
T Consensus 93 ~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 93 NTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp SSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred CCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 6677777777777652 123556667778888 67777754 3344555677888888777775
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.31 E-value=4.7e-08 Score=98.74 Aligned_cols=104 Identities=22% Similarity=0.313 Sum_probs=77.8
Q ss_pred ccCCccCce--eecccCccC---ccCC-CCCCCCCCCEEeCCCCcccCCCC--CCCCCCCCCCEEeccCCCCCCCCCCCc
Q 003982 86 ISSLTQLET--LSFQMNNIA---GAIP-SLANATSLQDIYLDNNNFTSVPT--GCFDGLTNLQVLSLSDNPNLAPWPFPN 157 (782)
Q Consensus 86 l~~l~~L~~--L~L~~N~l~---~~~~-~l~~l~~L~~L~Ls~n~l~~~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~p~ 157 (782)
+...+.|+. ++++.|... +..+ ...++++|++|+|++|+|++++. ..+..+++|+.|+|++|++... .
T Consensus 137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~----~ 212 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE----R 212 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG----G
T ss_pred cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc----h
Confidence 455556665 777777543 2222 22568899999999999998763 5567899999999999999883 3
Q ss_pred ccCCCc--ccCeeeccccccCCCCc-------ccccCCCCCcEEE
Q 003982 158 ELTKST--SLTTLYMDNANIFGLIP-------DFFDSFSNLQNLR 193 (782)
Q Consensus 158 ~~~~l~--~L~~L~L~~N~l~~~~~-------~~~~~l~~L~~L~ 193 (782)
.+..++ +|+.|+|++|.+.+.+| ..+..+++|+.||
T Consensus 213 ~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 213 ELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp GGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred hhhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 444444 89999999999987655 3477899999987
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.28 E-value=6.4e-05 Score=80.84 Aligned_cols=270 Identities=13% Similarity=0.080 Sum_probs=145.3
Q ss_pred CEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEecc
Q 003982 67 RVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145 (782)
Q Consensus 67 ~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls 145 (782)
.+++++|.. .++..-..+|.+. +|+.+.+..+ ++.+.. .|.+ .+|+.+.+..+ ++.+...+|.+. +|+.+.+.
T Consensus 70 ~L~~I~lp~-~v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L~~i~lp~~-~~~i~~~~F~~~-~l~~~~~~ 143 (379)
T 4h09_A 70 NMTKVTVAS-TVTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDLDDFEFPGA-TTEIGNYIFYNS-SVKRIVIP 143 (379)
T ss_dssp TCCEEEECT-TCCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCCSEEECCTT-CCEECTTTTTTC-CCCEEEEC
T ss_pred CCCEEEeCC-cceEechhhhcCC-CCceEECCce-eeEeccceecc-CCcccccCCCc-cccccccccccc-eeeeeecc
Confidence 578888864 3664444556665 6888777644 555555 5655 48999999754 667777777765 56666665
Q ss_pred CCCCCCCCCCCcccCCCcccCeeeccccccCCC------------CcccccCCCCCcEEEcccCcCCCCCCccccccccc
Q 003982 146 DNPNLAPWPFPNELTKSTSLTTLYMDNANIFGL------------IPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQ 213 (782)
Q Consensus 146 ~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~------------~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~ 213 (782)
.+ +.. .....+..+..++.+.+..+..... ....+.....+..+.+..+.-. ...
T Consensus 144 ~~-v~~--i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-i~~--------- 210 (379)
T 4h09_A 144 KS-VTT--IKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPSTVKT-VTA--------- 210 (379)
T ss_dssp TT-CCE--ECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEEECCTTCCE-ECT---------
T ss_pred ce-eec--cccchhcccccccccccccccceeecccceecccccceeccccccccccccccccceeE-Eee---------
Confidence 44 222 2345667777777777665443211 1122333333444333222111 111
Q ss_pred hhhcccccCCCccccccccCCCCCcEEEeecccccCCC-CCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCC
Q 003982 214 NLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPI-PDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNN 292 (782)
Q Consensus 214 ~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 292 (782)
..+....+|+.+.+..+ ++... ..|..+..|+.+.+..+ ++.+...+|.++.+|+.+.+..+
T Consensus 211 ---------------~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~ 273 (379)
T 4h09_A 211 ---------------YGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK 273 (379)
T ss_dssp ---------------TTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC
T ss_pred ---------------cccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc
Confidence 12333445555555433 22121 23455555555555444 44344445555555555555433
Q ss_pred cccCCCCC---CCCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCce
Q 003982 293 KLQGPYPL---FPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRI 369 (782)
Q Consensus 293 ~l~~~~~~---~~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L 369 (782)
+...... ...+|+.+.+.++.++.+. +..|..+.+|
T Consensus 274 -i~~i~~~aF~~c~~L~~i~l~~~~i~~I~----------------------------------------~~aF~~c~~L 312 (379)
T 4h09_A 274 -VKTVPYLLCSGCSNLTKVVMDNSAIETLE----------------------------------------PRVFMDCVKL 312 (379)
T ss_dssp -CSEECTTTTTTCTTCCEEEECCTTCCEEC----------------------------------------TTTTTTCTTC
T ss_pred -ceeccccccccccccccccccccccceeh----------------------------------------hhhhcCCCCC
Confidence 2211111 1234555555554443333 1234455678
Q ss_pred eEEEccCcccccccCccccccccCCeEecccccccccCCccCCCCC
Q 003982 370 ITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLA 415 (782)
Q Consensus 370 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~ 415 (782)
+.++|..+ ++..-..+|.++++|+.+.+..+ ++..-..+|.+..
T Consensus 313 ~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c~ 356 (379)
T 4h09_A 313 SSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGSS 356 (379)
T ss_dssp CEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTSS
T ss_pred CEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCCC
Confidence 88888755 66555668999999999999765 5544456666554
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.16 E-value=2.9e-06 Score=90.70 Aligned_cols=82 Identities=7% Similarity=-0.051 Sum_probs=56.2
Q ss_pred ccee-ecccceEEEEEEeC-------CCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcC-C--CCcceEEeEEEeC--
Q 003982 586 ANIL-GRGGFGVVYGGELP-------DGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVR-H--RHLVALLGYCING-- 651 (782)
Q Consensus 586 ~~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h--~nI~~~~~~~~~~-- 651 (782)
.+.| +.|....+|+.... +++.+++|+...... .......+.+|+++++.+. + -.++++++++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4567 78888999988653 267899998654320 0001245788889888885 3 3577888877654
Q ss_pred -CeEEEEEEccCCCCHH
Q 003982 652 -SERLLVYEYMPRGTLA 667 (782)
Q Consensus 652 -~~~~lv~e~~~~gsL~ 667 (782)
+..++||||++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3568999999886653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.06 E-value=2.8e-05 Score=82.39 Aligned_cols=144 Identities=17% Similarity=0.242 Sum_probs=82.1
Q ss_pred ceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC--CCCcceEEe------EEEeCCeEEEEE
Q 003982 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR--HRHLVALLG------YCINGSERLLVY 658 (782)
Q Consensus 587 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~nI~~~~~------~~~~~~~~~lv~ 658 (782)
+.|+.|..+.||+....++ .+++|+.... ..++..|.++++.+. .-.+++++. +....+..+++|
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~ 110 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY 110 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence 4455577889999977544 5899998752 133445555555553 113344443 123467789999
Q ss_pred EccCCCCHH-----------HHHHhhc---cCC--C-------CCCCHHHH-----------------------------
Q 003982 659 EYMPRGTLA-----------QHLFEWH---DHG--Y-------TPLTWKQR----------------------------- 686 (782)
Q Consensus 659 e~~~~gsL~-----------~~l~~~~---~~~--~-------~~l~~~~~----------------------------- 686 (782)
||++|..+. +.+.+.+ ..- . ..-.|...
T Consensus 111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 190 (346)
T 2q83_A 111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ 190 (346)
T ss_dssp ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence 999986542 1122211 110 0 00122111
Q ss_pred --HHHHHHHHHHHHHHhh----------cCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 687 --VTIALDVARGVEYLHS----------LAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 687 --~~i~~qi~~aL~~LH~----------~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
..+..++..++++|++ ....+++|+|+++.||+++.++.+.++||+.+..-
T Consensus 191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~g 253 (346)
T 2q83_A 191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSFD 253 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcccC
Confidence 1111223445666652 02478999999999999988889999999987543
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.91 E-value=4.2e-05 Score=82.90 Aligned_cols=77 Identities=12% Similarity=0.113 Sum_probs=51.3
Q ss_pred cceeecccceEEEEEEeC-CCcEEEEEEeccccC--C---hhhHHHHHHHHHHHHhcCC--C-CcceEEeEEEeCCeEEE
Q 003982 586 ANILGRGGFGVVYGGELP-DGTKIAVKRMESNTM--G---NKGLSEFQAEIAVLTKVRH--R-HLVALLGYCINGSERLL 656 (782)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~---~~~~~~~~~E~~~l~~l~h--~-nI~~~~~~~~~~~~~~l 656 (782)
.+.+|.|..+.||++... +++.|+||....... . .....++..|.++++.+.. | .+++++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 567899999999999653 468899998754321 0 1123467789999888742 3 45566644 4556789
Q ss_pred EEEccCCC
Q 003982 657 VYEYMPRG 664 (782)
Q Consensus 657 v~e~~~~g 664 (782)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00032 Score=73.40 Aligned_cols=161 Identities=15% Similarity=0.179 Sum_probs=90.1
Q ss_pred ccHHHHHHHhcCCCc-----cceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCC--cce
Q 003982 571 ISIEVLRQVTDNFSE-----ANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH--LVA 643 (782)
Q Consensus 571 ~~~~~l~~~~~~y~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--I~~ 643 (782)
++.+.+..+...|.+ .+.|+.|....+|+....++ .+++|+..... ....+..|+++++.+.... +++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~ 81 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPL 81 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCc
Confidence 455666666666765 24466688889999977555 68899887521 1234566777777664212 333
Q ss_pred EEeE------EEeCCeEEEEEEccCCCCHH-----------HHHHhhccC--CC--C---CC---CHHHHHH--------
Q 003982 644 LLGY------CINGSERLLVYEYMPRGTLA-----------QHLFEWHDH--GY--T---PL---TWKQRVT-------- 688 (782)
Q Consensus 644 ~~~~------~~~~~~~~lv~e~~~~gsL~-----------~~l~~~~~~--~~--~---~l---~~~~~~~-------- 688 (782)
++.. ....+..+++|+|++|..+. +.+.+.+.. +. . .. .|.....
T Consensus 82 ~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~ 161 (322)
T 2ppq_A 82 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 161 (322)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred ccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence 3321 12346678999999886531 112121110 00 0 01 1221100
Q ss_pred ----HHHHHHHHHHHHhhc----CCCCeEEcCCCCCCEEECCCCcEEEEeecccee
Q 003982 689 ----IALDVARGVEYLHSL----AQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (782)
Q Consensus 689 ----i~~qi~~aL~~LH~~----~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~ 736 (782)
+...+...++++++. ...+++|+|+++.||+++++..+.++||+.+..
T Consensus 162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 162 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011234445555531 135899999999999998876668999987753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00087 Score=69.46 Aligned_cols=141 Identities=18% Similarity=0.162 Sum_probs=95.1
Q ss_pred ccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC---CCCcceEEeEEEeCCeEEEEEEcc
Q 003982 585 EANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR---HRHLVALLGYCINGSERLLVYEYM 661 (782)
Q Consensus 585 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~nI~~~~~~~~~~~~~~lv~e~~ 661 (782)
..+.|+.|....+|+... ++..+++|+.... ....+.+|++.|+.+. ...+++++++....+..++||||+
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence 356789999999999976 5778899987542 3567899999999884 367889999988888999999999
Q ss_pred CCCCH--------HHHHHhhccCCC-C-------------------CCCHHHHH---HHH----------------HHHH
Q 003982 662 PRGTL--------AQHLFEWHDHGY-T-------------------PLTWKQRV---TIA----------------LDVA 694 (782)
Q Consensus 662 ~~gsL--------~~~l~~~~~~~~-~-------------------~l~~~~~~---~i~----------------~qi~ 694 (782)
++..+ .+.+.+.+.... . .-+|.+.. ++. .+++
T Consensus 114 ~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~ 193 (312)
T 3jr1_A 114 NKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIV 193 (312)
T ss_dssp CCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHH
T ss_pred cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHH
Confidence 98754 223333332211 0 01344321 111 1111
Q ss_pred HHH-HHHhh-cCCCCeEEcCCCCCCEEECCCCcEEEEeec
Q 003982 695 RGV-EYLHS-LAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (782)
Q Consensus 695 ~aL-~~LH~-~~~~~ivHrDikp~NIll~~~~~~kL~DfG 732 (782)
..+ ..|.. .....++|+|+.+.|++++.++ +.++||.
T Consensus 194 ~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 194 QIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 111 23321 1246899999999999999887 8999984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00032 Score=76.46 Aligned_cols=76 Identities=16% Similarity=0.214 Sum_probs=48.3
Q ss_pred ccceeecccceEEEEEEeCCCcEEEEEEeccccC--Ch-----hhHHHHHHHHHHHHh-cCCCCcceEEeEEEeCCeEEE
Q 003982 585 EANILGRGGFGVVYGGELPDGTKIAVKRMESNTM--GN-----KGLSEFQAEIAVLTK-VRHRHLVALLGYCINGSERLL 656 (782)
Q Consensus 585 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~-----~~~~~~~~E~~~l~~-l~h~nI~~~~~~~~~~~~~~l 656 (782)
..+.+|.|....||++.. +++.++||....... .. .....++.|+..+.. .....+++++.+. ++..++
T Consensus 38 ~i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l 114 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI 114 (420)
T ss_dssp EEEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred EEEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence 357789999999999965 567899995432111 01 123344444443332 2235677777665 567799
Q ss_pred EEEcc-CC
Q 003982 657 VYEYM-PR 663 (782)
Q Consensus 657 v~e~~-~~ 663 (782)
||||+ ++
T Consensus 115 v~e~l~~g 122 (420)
T 2pyw_A 115 GMRYLEPP 122 (420)
T ss_dssp EECCCCTT
T ss_pred EEeecCCc
Confidence 99999 76
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00053 Score=70.53 Aligned_cols=79 Identities=22% Similarity=0.249 Sum_probs=58.1
Q ss_pred CCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC-C--CCcceEEeEEEeCCeEEEEE
Q 003982 582 NFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-H--RHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h--~nI~~~~~~~~~~~~~~lv~ 658 (782)
....++.+|.|..+.||+.+..+|+.|+||+..... ......|..|++.|+.+. . -.+++++++ + ..++||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~ 89 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDA--PALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAM 89 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC--CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEE
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC--cchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEE
Confidence 445578899999999999999999999999875433 222356889999999885 2 235566654 2 247899
Q ss_pred EccCCCCH
Q 003982 659 EYMPRGTL 666 (782)
Q Consensus 659 e~~~~gsL 666 (782)
||++++..
T Consensus 90 e~l~~~~~ 97 (288)
T 3f7w_A 90 EWVDERPP 97 (288)
T ss_dssp ECCCCCCC
T ss_pred EeecccCC
Confidence 99987653
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00043 Score=72.85 Aligned_cols=146 Identities=16% Similarity=0.127 Sum_probs=76.2
Q ss_pred cceeecccceE-EEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCC--CCcceEEeEEEeCCeEEEEEEccC
Q 003982 586 ANILGRGGFGV-VYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH--RHLVALLGYCINGSERLLVYEYMP 662 (782)
Q Consensus 586 ~~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~nI~~~~~~~~~~~~~~lv~e~~~ 662 (782)
.+.|+.|.... +|+....++..+++|...... ...+..|+++++.+.. -.+++++.+..+.+ +++||++.
T Consensus 23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~-----~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~ 95 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE-----GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLG 95 (333)
T ss_dssp ECC--------CCEEEECTTCCEEEEEECCTTT-----TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCC
T ss_pred eeECCCCCCCceEEEEEcCCCCeEEEEECCCCC-----CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCC
Confidence 34565555444 667765447778888654422 0234556777776642 23567776643333 78999997
Q ss_pred CCCHHHHHHh------------------hccCC---CCCCCHHHHH-------H-H------------HHHHHHHHHHHh
Q 003982 663 RGTLAQHLFE------------------WHDHG---YTPLTWKQRV-------T-I------------ALDVARGVEYLH 701 (782)
Q Consensus 663 ~gsL~~~l~~------------------~~~~~---~~~l~~~~~~-------~-i------------~~qi~~aL~~LH 701 (782)
+..+.+.+.. .+... ...++..... . + ...+...++.+.
T Consensus 96 ~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~ 175 (333)
T 3csv_A 96 DALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQIL 175 (333)
T ss_dssp SCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHH
T ss_pred CcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHH
Confidence 7666543321 11110 1112221110 0 0 001112222221
Q ss_pred ---hcCCCCeEEcCCCCCCEEECCC----CcEEEEeeccceecC
Q 003982 702 ---SLAQQSFIHRDLKPSNILIGDD----MRAKVADFGLVKNAP 738 (782)
Q Consensus 702 ---~~~~~~ivHrDikp~NIll~~~----~~~kL~DfG~a~~~~ 738 (782)
......++|+|+.+.||+++.+ +.+.++||+.+..-.
T Consensus 176 ~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 176 SAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp HHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred HhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 1123689999999999999875 689999999886543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.39 E-value=0.0012 Score=69.14 Aligned_cols=144 Identities=13% Similarity=0.077 Sum_probs=82.6
Q ss_pred ceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCC--CcceEEeE-----EEeCCeEEEEEE
Q 003982 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHR--HLVALLGY-----CINGSERLLVYE 659 (782)
Q Consensus 587 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~--nI~~~~~~-----~~~~~~~~lv~e 659 (782)
+.++ |....||+....+|+.+++|+...... ....+..|.++++.+... .+++++.. ....+..+++||
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~---~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC---CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence 4566 778899998776787899999864321 235667788888777422 23444432 223556789999
Q ss_pred ccCCCCHH-----------HHHHhhcc---C-C---CCCCCHHHH----HHH---------------HHHHHHHHHHHhh
Q 003982 660 YMPRGTLA-----------QHLFEWHD---H-G---YTPLTWKQR----VTI---------------ALDVARGVEYLHS 702 (782)
Q Consensus 660 ~~~~gsL~-----------~~l~~~~~---~-~---~~~l~~~~~----~~i---------------~~qi~~aL~~LH~ 702 (782)
|++|..+. +.+.+.+. . . ....++... ..+ ...+-..++.+.+
T Consensus 108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~ 187 (328)
T 1zyl_A 108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA 187 (328)
T ss_dssp CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence 99874431 11111111 0 0 011222111 001 1111112223321
Q ss_pred c----CCCCeEEcCCCCCCEEECCCCcEEEEeecccee
Q 003982 703 L----AQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (782)
Q Consensus 703 ~----~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~ 736 (782)
. ....++|+|+++.||+++ + .+.++||+.+..
T Consensus 188 ~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 188 HWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1 235789999999999999 4 899999987654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00043 Score=71.73 Aligned_cols=141 Identities=13% Similarity=0.071 Sum_probs=78.5
Q ss_pred cceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCc-ceEEeEEEeCCeEEEEEEcc-CC
Q 003982 586 ANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHL-VALLGYCINGSERLLVYEYM-PR 663 (782)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-~~~~~~~~~~~~~~lv~e~~-~~ 663 (782)
.+.|+.|....+|+. ..+++|+..... ....+..+|+++++.+....+ ++++++ +++.-++++||+ ++
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGT---EEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGA 92 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCc---cceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCC
Confidence 678899999999998 568899876532 111223568888877753233 566554 444457899999 65
Q ss_pred CCHHH---------------HHHhhccCCC---CCCCH-HHHHHHHHH--------------HHHHHHHHh----h-cCC
Q 003982 664 GTLAQ---------------HLFEWHDHGY---TPLTW-KQRVTIALD--------------VARGVEYLH----S-LAQ 705 (782)
Q Consensus 664 gsL~~---------------~l~~~~~~~~---~~l~~-~~~~~i~~q--------------i~~aL~~LH----~-~~~ 705 (782)
.++.. .+.+.+.... ..... ..+..+..+ +.+.+..+. . ...
T Consensus 93 ~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~ 172 (301)
T 3dxq_A 93 QTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLP 172 (301)
T ss_dssp EECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCC
T ss_pred ccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCC
Confidence 44421 1222222211 00111 111111111 111111111 0 123
Q ss_pred CCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 706 QSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 706 ~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
..++|+|+.+.||+ ..++.+.++||..+..-
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 56899999999999 55667899999987643
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.31 E-value=0.00033 Score=62.35 Aligned_cols=56 Identities=21% Similarity=0.375 Sum_probs=39.1
Q ss_pred eeecccCccC--ccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCC
Q 003982 94 TLSFQMNNIA--GAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLA 151 (782)
Q Consensus 94 ~L~L~~N~l~--~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 151 (782)
.++.+++.++ .++..+. ++|++|+|++|+|+.++.+.|..+++|++|+|++|.+.=
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~C 69 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRC 69 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBC
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeec
Confidence 3444555554 3332222 468888888888888888888888888888888886543
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.27 E-value=5.7e-05 Score=70.59 Aligned_cols=35 Identities=20% Similarity=0.070 Sum_probs=22.7
Q ss_pred ccCeeeccccc-cCCCCcccccCCCCCcEEEcccCc
Q 003982 164 SLTTLYMDNAN-IFGLIPDFFDSFSNLQNLRLSYNN 198 (782)
Q Consensus 164 ~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~Ls~N~ 198 (782)
+|++|+|++|. |+..--..+..+++|++|+|+++.
T Consensus 115 ~L~~L~Ls~C~~ITD~Gl~~L~~~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 115 SMLEMEIISCGNVTDKGIIALHHFRNLKYLFLSDLP 150 (176)
T ss_dssp HCCEEEEESCTTCCHHHHHHGGGCTTCCEEEEESCT
T ss_pred CCCEEEcCCCCcCCHHHHHHHhcCCCCCEEECCCCC
Confidence 46666666653 554333456677888888888775
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0013 Score=70.04 Aligned_cols=144 Identities=14% Similarity=0.199 Sum_probs=86.0
Q ss_pred cceeecccceEEEEEEeC--------CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC-CCCcceEEeEEEeCCeEEE
Q 003982 586 ANILGRGGFGVVYGGELP--------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSERLL 656 (782)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~~~l 656 (782)
.+.+..|-...+|++... +++.|++|+.... ......+.+|.++++.+. +.-.+++++++.+ .+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 456777888899999764 3478999986332 123466779999998885 3334667666533 29
Q ss_pred EEEccCCCCHH--------------HHHHhhccCC---CCCC--CHHHHHHHHHHHHH-------------------HHH
Q 003982 657 VYEYMPRGTLA--------------QHLFEWHDHG---YTPL--TWKQRVTIALDVAR-------------------GVE 698 (782)
Q Consensus 657 v~e~~~~gsL~--------------~~l~~~~~~~---~~~l--~~~~~~~i~~qi~~-------------------aL~ 698 (782)
||||++|..+. +.+.+.+... ..+. -+.++.++..++-. .++
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 99999875432 2233333321 1112 23455555544322 233
Q ss_pred HHhh-----cCCCCeEEcCCCCCCEEECCC----CcEEEEeecccee
Q 003982 699 YLHS-----LAQQSFIHRDLKPSNILIGDD----MRAKVADFGLVKN 736 (782)
Q Consensus 699 ~LH~-----~~~~~ivHrDikp~NIll~~~----~~~kL~DfG~a~~ 736 (782)
.|.+ .....++|+|+.+.||+++.+ +.+.++||..|..
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 3321 123579999999999999876 7899999997753
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.03 E-value=7.8e-05 Score=71.05 Aligned_cols=113 Identities=12% Similarity=0.176 Sum_probs=60.7
Q ss_pred cccCeeecccc-ccCC----CCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCC
Q 003982 163 TSLTTLYMDNA-NIFG----LIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQL 237 (782)
Q Consensus 163 ~~L~~L~L~~N-~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L 237 (782)
+.|+.|+|++| +|.. .+.+.+..-+.|+.|+|++|+|...--..++. ++..-+.|
T Consensus 41 ~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~--------------------aL~~N~tL 100 (197)
T 1pgv_A 41 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIE--------------------LIETSPSL 100 (197)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHH--------------------HHHHCSSC
T ss_pred CCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHH--------------------HHhcCCcc
Confidence 34555555543 4321 12344555566777777777765222222211 22234667
Q ss_pred cEEEeecccccCCCC-----CCCCCCCCCEEEcCCC---cCccC----cchhhcCCCCCCEEEccCCccc
Q 003982 238 RQVWLHKNQFTGPIP-----DLSKCESLFDLSLRDN---QLTGV----VPASVISLPALLNISLQNNKLQ 295 (782)
Q Consensus 238 ~~L~L~~N~l~~~~~-----~~~~l~~L~~L~L~~N---~l~~~----~p~~~~~l~~L~~L~l~~N~l~ 295 (782)
+.|+|++|+|+.... .+...+.|+.|+|++| .+... +.+.+..-+.|+.|+++.|.+.
T Consensus 101 ~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 101 RVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp CEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred CeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 777777777764222 2555666777777754 33322 3444555667777777766543
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.02 E-value=0.00068 Score=60.29 Aligned_cols=57 Identities=23% Similarity=0.325 Sum_probs=44.6
Q ss_pred eEEEccCcccc-cccCccccccccCCeEecccccccccCCccCCCCCCCCeEecCCCcCC
Q 003982 370 ITINLANKLLA-GNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428 (782)
Q Consensus 370 ~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~ 428 (782)
..++.+++.|+ ..+|..+. .+|++|+|++|+|+..-+..|..+++|+.|+|++|++.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 47888999887 35666554 47899999999999666777888999999888877664
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.99 E-value=0.00014 Score=69.30 Aligned_cols=37 Identities=14% Similarity=0.114 Sum_probs=17.7
Q ss_pred cccCCeEecccc---cccc----cCCccCCCCCCCCeEecCCCc
Q 003982 390 LTSLKNLYLQQN---NLTG----PIPDGLTKLASLQNLDVSNNN 426 (782)
Q Consensus 390 l~~L~~L~Ls~N---~l~g----~~p~~~~~l~~L~~L~ls~N~ 426 (782)
-+.|++|+|++| .+.. .+-+.+..-+.|+.|+++.|.
T Consensus 125 N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~ 168 (197)
T 1pgv_A 125 TQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 168 (197)
T ss_dssp TCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred CCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCC
Confidence 344566666543 2221 133344445566666665443
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.74 E-value=0.00034 Score=65.30 Aligned_cols=84 Identities=14% Similarity=0.143 Sum_probs=48.4
Q ss_pred ccCeeeccccccCCCCcccccCCCCCcEEEcccCc-CCCCCCccccccccchhhcccccCCCccccccccCC----CCCc
Q 003982 164 SLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNN-FTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGM----TQLR 238 (782)
Q Consensus 164 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l----~~L~ 238 (782)
+|+.|||+++.|+..--..+..+++|++|+|++|. ++..--. .++.+ ++|+
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~------------------------~L~~~~~~~~~L~ 117 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLE------------------------RLSQLENLQKSML 117 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHH------------------------HHHTCHHHHHHCC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHH------------------------HHHhcccccCCCC
Confidence 45666666665554444455677777777777774 4411111 12222 3677
Q ss_pred EEEeeccc-ccCCC-CCCCCCCCCCEEEcCCCc-Cc
Q 003982 239 QVWLHKNQ-FTGPI-PDLSKCESLFDLSLRDNQ-LT 271 (782)
Q Consensus 239 ~L~L~~N~-l~~~~-~~~~~l~~L~~L~L~~N~-l~ 271 (782)
+|+|++|. ++... ..+..+++|++|+|+++. ++
T Consensus 118 ~L~Ls~C~~ITD~Gl~~L~~~~~L~~L~L~~c~~It 153 (176)
T 3e4g_A 118 EMEIISCGNVTDKGIIALHHFRNLKYLFLSDLPGVK 153 (176)
T ss_dssp EEEEESCTTCCHHHHHHGGGCTTCCEEEEESCTTCC
T ss_pred EEEcCCCCcCCHHHHHHHhcCCCCCEEECCCCCCCC
Confidence 77777763 65422 235667888888888775 44
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.72 E-value=0.0053 Score=66.81 Aligned_cols=72 Identities=19% Similarity=0.218 Sum_probs=49.0
Q ss_pred cceeecccceEEEEEEeCC--------CcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCC-cceEEeEEEeCCeEEE
Q 003982 586 ANILGRGGFGVVYGGELPD--------GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH-LVALLGYCINGSERLL 656 (782)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-I~~~~~~~~~~~~~~l 656 (782)
.+.|+.|-...+|++...+ ++.+++|+..... ....+.+|..+++.+...+ .+++++.+. + .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~----~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----TESHLVAESVIFTLLSERHLGPKLYGIFS--G--GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC----cHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CE
Confidence 4667888889999997653 5789999884321 1145557999988885333 367776543 2 38
Q ss_pred EEEccCCCC
Q 003982 657 VYEYMPRGT 665 (782)
Q Consensus 657 v~e~~~~gs 665 (782)
|+||++|.+
T Consensus 150 v~e~l~G~~ 158 (429)
T 1nw1_A 150 LEEYIPSRP 158 (429)
T ss_dssp EECCCCEEE
T ss_pred EEEEeCCcc
Confidence 999998633
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.61 E-value=0.0081 Score=63.14 Aligned_cols=135 Identities=11% Similarity=0.189 Sum_probs=77.9
Q ss_pred ceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC---CCCcceEEeE------EEeCCeEEEEEEccCCC
Q 003982 594 FGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR---HRHLVALLGY------CINGSERLLVYEYMPRG 664 (782)
Q Consensus 594 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~nI~~~~~~------~~~~~~~~lv~e~~~~g 664 (782)
...||+....+| .+++|+...... ..|+++++.+. -|.+++++.. ....+..+++|+|++|.
T Consensus 36 ~N~vy~v~~~~g-~~vLK~~~~~~~--------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~ 106 (339)
T 3i1a_A 36 NAFAYQADSESK-SYFIKLKYGYHD--------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAP 106 (339)
T ss_dssp SCEEEEEECSSC-EEEEEEEECSSC--------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCC
T ss_pred ccceEEEEeCCC-CEEEEEecCccc--------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCC
Confidence 679999987667 899998765431 34556665553 2335555432 23356789999999986
Q ss_pred CHH-------------HHHHhhccCCCC----------CCC--HH-HHHHHH---------------------------H
Q 003982 665 TLA-------------QHLFEWHDHGYT----------PLT--WK-QRVTIA---------------------------L 691 (782)
Q Consensus 665 sL~-------------~~l~~~~~~~~~----------~l~--~~-~~~~i~---------------------------~ 691 (782)
.+. +.+.+.+..... .+. |. .+..+. .
T Consensus 107 ~~~~~~~~~~~~~~lg~~La~LH~~~~~~~~~~~~~~~~~~~~w~~~i~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 186 (339)
T 3i1a_A 107 NGFTQNLTGKQWKQLGKVLRQIHETSVPISIQQQLRKEIYSPKWREIVRSFYNQIEFDNSDDKLTAAFKSFFNQNSAAIH 186 (339)
T ss_dssp BTTTSCCCHHHHHHHHHHHHHHHTCCCCHHHHTTSEECCCCCHHHHHHHHHGGGGSCCTTCCHHHHHHHHHHHHTHHHHH
T ss_pred cCcccCCCHHHHHHHHHHHHHHhCcCCCCCCccCccccccCcchHHHHHHHHHhhhccccCCcHHHHHHHHHHHhHHHHH
Confidence 551 223333322110 011 11 111111 1
Q ss_pred HHHHHHHH----Hhh-cCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 692 DVARGVEY----LHS-LAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 692 qi~~aL~~----LH~-~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
.++..++. +.. .....++|+|+.+.||++++++.+.++||+.+...
T Consensus 187 ~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 187 RLVDTSEKLSKKIQPDLDKYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp HHHHHHHHHHHHCCCCGGGCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred HHHHHHHHHHHHHhhCCCCceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 11222222 211 01358999999999999998888999999877543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.45 E-value=0.013 Score=64.20 Aligned_cols=73 Identities=10% Similarity=0.098 Sum_probs=47.5
Q ss_pred cceeecccceEEEEEEeCC-CcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCc-ceEEeEEEeCCeEEEEEEccCC
Q 003982 586 ANILGRGGFGVVYGGELPD-GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHL-VALLGYCINGSERLLVYEYMPR 663 (782)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-~~~~~~~~~~~~~~lv~e~~~~ 663 (782)
.+.|+.|-...+|++...+ +..+++|+..... .. .-+..+|..+++.+...++ +++++++ .+ ..||||++|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~--~~-~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT--DE-IINREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C--CS-CSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh--hh-hcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCC
Confidence 4667888889999998754 4788999875432 11 1122688999998864444 5677665 22 259999987
Q ss_pred CC
Q 003982 664 GT 665 (782)
Q Consensus 664 gs 665 (782)
.+
T Consensus 186 ~~ 187 (458)
T 2qg7_A 186 YA 187 (458)
T ss_dssp EE
T ss_pred cc
Confidence 44
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.45 E-value=0.0041 Score=66.30 Aligned_cols=73 Identities=12% Similarity=0.103 Sum_probs=44.6
Q ss_pred cceeecccceEEEEEEeCC---------CcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCC-cceEEeEEEeCCeEE
Q 003982 586 ANILGRGGFGVVYGGELPD---------GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH-LVALLGYCINGSERL 655 (782)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-I~~~~~~~~~~~~~~ 655 (782)
.+.++.|....+|+....+ ++.+++|+..... ....+...|.++++.+...+ ++++++.. . -+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~ 110 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GG 110 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEec--C--Cc
Confidence 4567778888999997643 2688899875432 11113467888888775333 45776543 2 26
Q ss_pred EEEEccCCCC
Q 003982 656 LVYEYMPRGT 665 (782)
Q Consensus 656 lv~e~~~~gs 665 (782)
+||||++|..
T Consensus 111 ~v~e~i~G~~ 120 (369)
T 3c5i_A 111 RIEEWLYGDP 120 (369)
T ss_dssp EEEECCCSEE
T ss_pred EEEEEecCCc
Confidence 8999998754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.62 E-value=0.028 Score=60.68 Aligned_cols=143 Identities=12% Similarity=0.150 Sum_probs=85.2
Q ss_pred cceeecccceEEEEEEeCC--------CcEEEEEEeccccCChhhHHHHHHHHHHHHhcC-CCCcceEEeEEEeCCeEEE
Q 003982 586 ANILGRGGFGVVYGGELPD--------GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSERLL 656 (782)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~~~l 656 (782)
.+.+..|-...+|+....+ ++.|++|+..... ...-+..+|.++++.+. +.-.+++++.+ . -++
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~ 147 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGR 147 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCE
Confidence 4567778888999997653 5789999875432 11123467888888875 33346666533 2 278
Q ss_pred EEEccCCCCHH--------------HHHHhhccC-----------CCCCCCHHHHHHHHHHH------------------
Q 003982 657 VYEYMPRGTLA--------------QHLFEWHDH-----------GYTPLTWKQRVTIALDV------------------ 693 (782)
Q Consensus 657 v~e~~~~gsL~--------------~~l~~~~~~-----------~~~~l~~~~~~~i~~qi------------------ 693 (782)
||||++|..+. +.+.+.+.. +..+.-+.++..+..++
T Consensus 148 I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~ 227 (424)
T 3mes_A 148 IEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSK 227 (424)
T ss_dssp EEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHH
T ss_pred EEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHH
Confidence 99999986531 112221110 11122244444443322
Q ss_pred -HHHHHHHhh---------------------cCCCCeEEcCCCCCCEEECCCCcEEEEeecccee
Q 003982 694 -ARGVEYLHS---------------------LAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (782)
Q Consensus 694 -~~aL~~LH~---------------------~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~ 736 (782)
...+++|.+ .....++|+|+.+.||+ +.++.+.++||..|..
T Consensus 228 l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 228 ILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 122333321 11347899999999999 7788999999988753
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.60 E-value=0.18 Score=34.43 Aligned_cols=27 Identities=26% Similarity=0.363 Sum_probs=12.6
Q ss_pred eeehhHHHHHHHHHHHHHHHHHHHhhh
Q 003982 487 IVAIVVVVVIFIAVVFFVVYKFIARRK 513 (782)
Q Consensus 487 i~~~~~~~~~~~~~~~~~~~~~~~~~k 513 (782)
|.+.++++++++++++++++++.|||+
T Consensus 13 IA~gVVgGv~~~~ii~~~~~~~~RRr~ 39 (44)
T 2ks1_B 13 IATGMVGALLLLLVVALGIGLFMRRRH 39 (44)
T ss_dssp STHHHHHHHHHHHHHHHHHHHHHHTTT
T ss_pred EEeehhHHHHHHHHHHHHHHHHhhhhH
Confidence 444444444444444444444444443
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.69 E-value=0.19 Score=34.24 Aligned_cols=27 Identities=19% Similarity=0.288 Sum_probs=12.2
Q ss_pred eeehhHHHHHHHHHHHHHHHHHHHhhh
Q 003982 487 IVAIVVVVVIFIAVVFFVVYKFIARRK 513 (782)
Q Consensus 487 i~~~~~~~~~~~~~~~~~~~~~~~~~k 513 (782)
|.+.+++++++++++.+.++++.|||+
T Consensus 12 IA~gVVgGv~~v~ii~~~~~~~~RRRr 38 (44)
T 2l2t_A 12 IAAGVIGGLFILVIVGLTFAVYVRRKS 38 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEeehHHHHHHHHHHHHHHHHhhhhh
Confidence 444444444444444444444444443
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=88.94 E-value=1.3 Score=47.28 Aligned_cols=30 Identities=27% Similarity=0.475 Sum_probs=25.0
Q ss_pred CeEEcCCCCCCEEE------CCCCcEEEEeecccee
Q 003982 707 SFIHRDLKPSNILI------GDDMRAKVADFGLVKN 736 (782)
Q Consensus 707 ~ivHrDikp~NIll------~~~~~~kL~DfG~a~~ 736 (782)
.++|+|+.+.||++ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 4557799999988754
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=84.76 E-value=2.5 Score=40.46 Aligned_cols=83 Identities=11% Similarity=0.053 Sum_probs=62.0
Q ss_pred CCCCcceEEeEEEeCCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHH-HHhhcCCCCeEEcCCCC
Q 003982 637 RHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE-YLHSLAQQSFIHRDLKP 715 (782)
Q Consensus 637 ~h~nI~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~-~LH~~~~~~ivHrDikp 715 (782)
.||++ -..+-.+++...+.++.-+++--...++. ++..++++++.+++.... ++++ -+|--++|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~--------~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P 112 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK--------TTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCP 112 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT--------SCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh--------cCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeC
Confidence 58888 44455677777777776544443444432 788999999999988776 5553 57889999
Q ss_pred CCEEECCCCcEEEEeeccc
Q 003982 716 SNILIGDDMRAKVADFGLV 734 (782)
Q Consensus 716 ~NIll~~~~~~kL~DfG~a 734 (782)
+||+++.++.+++.-.|+-
T Consensus 113 ~NL~f~~~~~p~i~hRGi~ 131 (219)
T 4ano_A 113 ENLMFNRALEPFFLHVGVK 131 (219)
T ss_dssp GGEEECTTCCEEESCCEET
T ss_pred ceEEEeCCCcEEEEEcCCc
Confidence 9999999999999877764
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=84.07 E-value=0.56 Score=31.85 Aligned_cols=26 Identities=31% Similarity=0.462 Sum_probs=10.0
Q ss_pred eeehhHHHHHHHHHHHHHHHHHHHhhh
Q 003982 487 IVAIVVVVVIFIAVVFFVVYKFIARRK 513 (782)
Q Consensus 487 i~~~~~~~~~~~~~~~~~~~~~~~~~k 513 (782)
+.+++++ +++++++.+++.++.|||+
T Consensus 14 Ia~~vVG-vll~vi~~l~~~~~~RRR~ 39 (44)
T 2jwa_A 14 IISAVVG-ILLVVVLGVVFGILIKRRQ 39 (44)
T ss_dssp HHHHHHH-HHHHHHHHHHHHHHHHHHC
T ss_pred hHHHHHH-HHHHHHHHHHHHhheehhh
Confidence 3344443 3333333333344444333
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=82.96 E-value=1.8 Score=41.32 Aligned_cols=93 Identities=17% Similarity=0.100 Sum_probs=57.3
Q ss_pred CCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCce
Q 003982 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743 (782)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~ 743 (782)
.+|.+.|..+ ..++++++++.++.|.+.+|.-+-.. ..-..+=+.|..|++..+|.|...+ +.+.
T Consensus 33 vSL~eIL~~~----~~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------- 97 (229)
T 2yle_A 33 LSLEEILRLY----NQPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------- 97 (229)
T ss_dssp EEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred ccHHHHHHHc----CCCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc--------
Confidence 4788998775 35799999999999999998776210 1111334556889999999887753 1110
Q ss_pred eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 744 VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 744 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.....+.|||... .++..+.-|||+|++
T Consensus 98 -----~~~~~~~~pe~~~----~~~te~~~IysLG~t 125 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY----SQCMETEVIESLGII 125 (229)
T ss_dssp --------------CCSS----SSSCHHHHHHHHHHH
T ss_pred -----ccccCCCChhhcc----ccchHHHHHHHHHHH
Confidence 1123467888753 245667778888874
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=82.28 E-value=0.16 Score=55.60 Aligned_cols=63 Identities=5% Similarity=0.067 Sum_probs=18.1
Q ss_pred ccceeecccceEEEEEEeCC-CcEEEE------EEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEe
Q 003982 585 EANILGRGGFGVVYGGELPD-GTKIAV------KRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN 650 (782)
Q Consensus 585 ~~~~lg~G~~g~Vy~~~~~~-~~~vav------K~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~ 650 (782)
+.+.+| ||.||+|.+.. ..+||| |..+......+....+.+|..+++..+|||+++.+++...
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 456666 99999997643 367888 7766555445556678899999999999999999887543
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 782 | ||||
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-50 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-50 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-49 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-48 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-47 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-46 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-46 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-46 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-45 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 9e-45 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-44 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-44 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-44 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-44 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 8e-44 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-43 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-43 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-43 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-43 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-42 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-42 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-41 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-41 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-40 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-40 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-40 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-39 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-39 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-39 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-39 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 9e-39 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-38 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-37 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-37 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-36 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-36 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-35 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-35 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-35 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-35 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-34 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-34 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-33 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-33 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-33 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-33 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-33 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-32 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-32 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-31 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-31 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-30 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-30 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-30 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-30 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-30 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-29 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-28 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-26 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-26 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-24 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-23 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-08 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-07 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-04 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-10 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-15 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-07 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-05 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-13 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-13 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 0.002 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-11 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-11 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 7e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 8e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 4e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-08 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.001 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.001 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.004 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.003 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-07 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-07 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 4e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 5e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.002 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.002 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 2e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 3e-04 |
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 2e-50
Identities = 51/179 (28%), Positives = 85/179 (47%), Gaps = 10/179 (5%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
+ LG G FG V+ G TK+AVK ++ +M F AE ++ +++H+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQR 69
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYL 700
LV L ++ EYM G+L L LT + + +A +A G+ ++
Sbjct: 70 LVRLYAVVTQE-PIYIITEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 701 HSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEY 759
+++IHRDL+ +NIL+ D + K+ADFGL + D +Y+ + APE
Sbjct: 126 EE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 3e-50
Identities = 53/180 (29%), Positives = 87/180 (48%), Gaps = 11/180 (6%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
+ +G G FG VY G+ +AVK + + L F+ E+ VL K RH +
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYL 700
++ +GY + +V ++ +L HL T + + IA A+G++YL
Sbjct: 66 ILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYL 120
Query: 701 HSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVE-TRLAGTFGYLAPEY 759
H +S IHRDLK +NI + +D+ K+ DFGL S + +L+G+ ++APE
Sbjct: 121 H---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 2e-49
Identities = 47/182 (25%), Positives = 79/182 (43%), Gaps = 12/182 (6%)
Query: 580 TDNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH 638
D+F + + LG G GVV+ P G +A K + + ++ E+ VL +
Sbjct: 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNS 63
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
++V G + E + E+M G+L Q L + + +++ V +G+
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-----KKAGRIPEQILGKVSIAVIKGLT 118
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
YL + +HRD+KPSNIL+ K+ DFG+ D GT Y++PE
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPE 173
Query: 759 YA 760
Sbjct: 174 RL 175
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 5e-48
Identities = 52/179 (29%), Positives = 77/179 (43%), Gaps = 10/179 (5%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
+ + LG G FGVV G+ +A+K ++ +M EF E V+ + H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEK 60
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYL 700
LV L G C ++ EYM G L +L E +Q + + DV +EYL
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYL 116
Query: 701 HSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEY 759
+ F+HRDL N L+ D KV+DFGL + D +Y+ + PE
Sbjct: 117 E---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 172
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 2e-47
Identities = 50/180 (27%), Positives = 83/180 (46%), Gaps = 10/180 (5%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
+ +G G FG+V+ G + K+A+K + M + +F E V+ K+ H
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPK 61
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYL 700
LV L G C+ + LV+E+M G L ++ + + + LDV G+ YL
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCL----SDYLRTQRGLFAAETLLGMCLDVCEGMAYL 117
Query: 701 HSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYA 760
+ IHRDL N L+G++ KV+DFG+ + D +Y+ T + +PE
Sbjct: 118 E---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 174
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 1e-46
Identities = 53/181 (29%), Positives = 87/181 (48%), Gaps = 13/181 (7%)
Query: 581 DNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSE-FQAEIAVLTKVRH 638
++F LG+G FG VY +A+K + + G+ + E+ + + +RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
+++ L GY + + L+ EY P GT+ + L + ++ T ++A +
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-----KFDEQRTATYITELANALS 120
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
Y HS + IHRD+KP N+L+G K+ADFG +AP + T L GT YL PE
Sbjct: 121 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPPE 174
Query: 759 Y 759
Sbjct: 175 M 175
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (422), Expect = 1e-46
Identities = 47/182 (25%), Positives = 73/182 (40%), Gaps = 15/182 (8%)
Query: 580 TDNFSEANILGRGGFGVVY-GGELPDGTKIAVKRME-SNTMGNKGLSEFQAEIAVLTKVR 637
FS+ +G G FG VY ++ + +A+K+M S N+ + E+ L K+R
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697
H + + G + LV EY PL + + +G+
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE-----VHKKPLQEVEIAAVTHGALQGL 128
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAP 757
YLHS + IHRD+K NIL+ + K+ DFG GT ++AP
Sbjct: 129 AYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NSFVGTPYWMAP 180
Query: 758 EY 759
E
Sbjct: 181 EV 182
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 5e-46
Identities = 55/180 (30%), Positives = 88/180 (48%), Gaps = 10/180 (5%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
++ LG+G FG V+ G T++A+K ++ TM + F E V+ K+RH
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEK 73
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYL 700
LV L +V EYM +G+L L Q V +A +A G+ Y+
Sbjct: 74 LVQLYAVVSEE-PIYIVTEYMSKGSLLDF---LKGETGKYLRLPQLVDMAAQIASGMAYV 129
Query: 701 HSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYA 760
+ +++HRDL+ +NIL+G+++ KVADFGL + D +Y+ + APE A
Sbjct: 130 E---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 186
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 2e-45
Identities = 60/181 (33%), Positives = 90/181 (49%), Gaps = 16/181 (8%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
+G+G FG V G+ G K+AVK ++++ F AE +V+T++RH +
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT----AQAFLAEASVMTQLRHSN 61
Query: 641 LVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
LV LLG + L +V EYM +G+L +L G + L + +LDV +EY
Sbjct: 62 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEY 118
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEY 759
L +F+HRDL N+L+ +D AKV+DFGL K A S + + APE
Sbjct: 119 LEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEA 171
Query: 760 A 760
Sbjct: 172 L 172
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 9e-45
Identities = 48/182 (26%), Positives = 73/182 (40%), Gaps = 11/182 (6%)
Query: 580 TDNFSEANILGRGGFGVVYGGELPD-GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH 638
D + LG G FG VY + + A K +++ + + L ++ EI +L H
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE--EELEDYMVEIDILASCDH 68
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
++V LL + ++ E+ G + + E PLT Q + +
Sbjct: 69 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER----PLTESQIQVVCKQTLDALN 124
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
YLH IHRDLK NIL D K+ADFG+ GT ++APE
Sbjct: 125 YLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQRRDSFIGTPYWMAPE 180
Query: 759 YA 760
Sbjct: 181 VV 182
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 2e-44
Identities = 39/188 (20%), Positives = 76/188 (40%), Gaps = 7/188 (3%)
Query: 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHR 639
+++ +G G +G DG + K ++ +M +E+ +L +++H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 640 HLVALLGYCINGSERLL--VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697
++V I+ + L V EY G LA + + L + + + + +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK-GTKERQYLDEEFVLRVMTQLTLAL 122
Query: 698 EYLHSL--AQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYL 755
+ H + +HRDLKP+N+ + K+ DFGL + S GT Y+
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT-SFAKAFVGTPYYM 181
Query: 756 APEYAGKH 763
+PE +
Sbjct: 182 SPEQMNRM 189
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (403), Expect = 2e-44
Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 30/210 (14%)
Query: 581 DNFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLT 634
+N +G G FG V+ P T +AVK ++ ++FQ E A++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMA 71
Query: 635 KVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFE-------------------WHD 675
+ + ++V LLG C G L++EYM G L + L
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 676 HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735
G PL+ +++ IA VA G+ YL + F+HRDL N L+G++M K+ADFGL +
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSR 188
Query: 736 NAPDGK-YSVETRLAGTFGYLAPEYAGKHW 764
N Y + A ++ PE +
Sbjct: 189 NIYSADYYKADGNDAIPIRWMPPESIFYNR 218
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 3e-44
Identities = 49/186 (26%), Positives = 82/186 (44%), Gaps = 14/186 (7%)
Query: 585 EANILGRGGFGVVYGGELPD---GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHL 641
E LG G FG V G +AVK +++ E AE V+ ++ + ++
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 642 VALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLH 701
V ++G C S +LV E G L ++L + + K + + V+ G++YL
Sbjct: 71 VRMIGICEAES-WMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLE 124
Query: 702 SLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK--YSVETRLAGTFGYLAPEY 759
+ +F+HRDL N+L+ AK++DFGL K + Y +T + APE
Sbjct: 125 ---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 181
Query: 760 AGKHWM 765
+
Sbjct: 182 INYYKF 187
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 158 bits (400), Expect = 5e-44
Identities = 53/180 (29%), Positives = 87/180 (48%), Gaps = 10/180 (5%)
Query: 581 DNFSEANILGRGGFGVVYGGELPD-GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHR 639
+ + + LG G +G VY G +AVK ++ +TM + EF E AV+ +++H
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHP 73
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
+LV LLG C ++ E+M G L +L + ++ + +A ++ +EY
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEY 130
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEY 759
L ++FIHRDL N L+G++ KVADFGL + Y+ + APE
Sbjct: 131 LEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 187
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 8e-44
Identities = 42/181 (23%), Positives = 72/181 (39%), Gaps = 11/181 (6%)
Query: 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHR 639
+++ LG G +G V +AVK ++ + EI + + H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHE 63
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
++V G+ G+ + L EY G L + + + GV Y
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVY 118
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA-PDGKYSVETRLAGTFGYLAPE 758
LH HRD+KP N+L+ + K++DFGL + + + ++ GT Y+APE
Sbjct: 119 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175
Query: 759 Y 759
Sbjct: 176 L 176
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 1e-43
Identities = 50/186 (26%), Positives = 83/186 (44%), Gaps = 15/186 (8%)
Query: 580 TDNFSEANI-LGRGGFGVVYGGEL---PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTK 635
DN A+I LG G FG V G +A+K ++ T E E ++ +
Sbjct: 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQ 65
Query: 636 VRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR 695
+ + ++V L+G C +LV E G L + L + + + V+
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE----EIPVSNVAELLHQVSM 120
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK--NAPDGKYSVETRLAGTFG 753
G++YL +++F+HRDL N+L+ + AK++DFGL K A D Y+ +
Sbjct: 121 GMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177
Query: 754 YLAPEY 759
+ APE
Sbjct: 178 WYAPEC 183
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 2e-43
Identities = 50/206 (24%), Positives = 85/206 (41%), Gaps = 30/206 (14%)
Query: 581 DNFSEANILGRGGFGVVY------GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLT 634
+N +LG G FG V + ++AVK ++ + +E+ ++T
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK-ADSSEREALMSELKMMT 95
Query: 635 KV-RHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDH----------------- 676
++ H ++V LLG C L++EY G L +L +
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 677 -GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735
LT++ + A VA+G+E+L +S +HRDL N+L+ K+ DFGL +
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLAR 212
Query: 736 NA-PDGKYSVETRLAGTFGYLAPEYA 760
+ D Y V ++APE
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESL 238
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 2e-43
Identities = 45/179 (25%), Positives = 75/179 (41%), Gaps = 15/179 (8%)
Query: 587 NILGRGGFGVVYGGELPD-GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
+GRG F VY G + ++A ++ + F+ E +L ++H ++V
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 646 GYCINGSER----LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLH 701
+ + +LV E M GTL +L + + K + + +G+++LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYL-----KRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 702 SLAQQSFIHRDLKPSNILI-GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEY 759
+ IHRDLK NI I G K+ D GL S + GT ++APE
Sbjct: 130 TRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA---SFAKAVIGTPEFMAPEM 184
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 5e-43
Identities = 47/183 (25%), Positives = 80/183 (43%), Gaps = 22/183 (12%)
Query: 589 LGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYC 648
+G+G FG V+ G+ G ++AVK S + +AEI +RH +++ +
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW---FREAEIYQTVMLRHENILGFIAAD 66
Query: 649 I----NGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHS-- 702
++ LV +Y G+L +L +T + + +AL A G+ +LH
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 703 ---LAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVE---TRLAGTFGYLA 756
+ + HRDLK NIL+ + +AD GL +++ GT Y+A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 757 PEY 759
PE
Sbjct: 181 PEV 183
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 1e-42
Identities = 52/206 (25%), Positives = 81/206 (39%), Gaps = 25/206 (12%)
Query: 581 DNFSEANILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLT 634
+ S LG G FG V +AVK ++ + +E+ VL+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLS 81
Query: 635 KV-RHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYT-------------P 680
+ H ++V LLG C G L++ EY G L L D
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 681 LTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP-D 739
L + ++ + VA+G+ +L S ++ IHRDL NIL+ K+ DFGL ++ D
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKND 198
Query: 740 GKYSVETRLAGTFGYLAPEYAGKHWM 765
Y V+ ++APE
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVY 224
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 154 bits (389), Expect = 2e-42
Identities = 48/205 (23%), Positives = 87/205 (42%), Gaps = 25/205 (12%)
Query: 572 SIEVLRQVTDNFSEA---------NILGRGGFGVVYGGELPDGTK----IAVKRMESNTM 618
+ E + F++ ++G G FG V G L K +A+K ++S
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 619 GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGY 678
K +F +E +++ + H +++ L G + +++ E+M G+L +
Sbjct: 68 -EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL----DSFLRQND 122
Query: 679 TPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738
T Q V + +A G++YL +++HRDL NIL+ ++ KV+DFGL +
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179
Query: 739 DGKYSVETRLA----GTFGYLAPEY 759
D A + APE
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEA 204
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 1e-41
Identities = 47/186 (25%), Positives = 80/186 (43%), Gaps = 11/186 (5%)
Query: 577 RQVTDNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKG-LSEFQAEIAVLT 634
++ ++F ILG G F V EL + A+K +E + + + E V++
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 635 KVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVA 694
++ H V L + + Y G L +++ + ++
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-----SFDETCTRFYTAEIV 118
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK-NAPDGKYSVETRLAGTFG 753
+EYLH + IHRDLKP NIL+ +DM ++ DFG K +P+ K + GT
Sbjct: 119 SALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 175
Query: 754 YLAPEY 759
Y++PE
Sbjct: 176 YVSPEL 181
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 6e-41
Identities = 58/200 (29%), Positives = 89/200 (44%), Gaps = 21/200 (10%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDG---TKIAVKRMESNTMGNKGLSEFQAEIAVLTKV- 636
++ +++G G FG V + A+KRM+ +F E+ VL K+
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLG 68
Query: 637 RHRHLVALLGYCINGSERLLVYEYMPRGTLAQHL-----------FEWHDHGYTPLTWKQ 685
H +++ LLG C + L EY P G L L F + + L+ +Q
Sbjct: 69 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128
Query: 686 RVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVE 745
+ A DVARG++YL + FIHRDL NIL+G++ AK+ADFGL + Y +
Sbjct: 129 LLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEV--YVKK 183
Query: 746 TRLAGTFGYLAPEYAGKHWM 765
T ++A E
Sbjct: 184 TMGRLPVRWMAIESLNYSVY 203
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 1e-40
Identities = 47/187 (25%), Positives = 83/187 (44%), Gaps = 15/187 (8%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGT-----KIAVKRMESNTMGNKGLSEFQAEIAVLTK 635
+ ++G G FG VY G L + +A+K +++ K +F E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT-EKQRVDFLGEAGIMGQ 65
Query: 636 VRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR 695
H +++ L G +++ EYM G L + L E + Q V + +A
Sbjct: 66 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE----FSVLQLVGMLRGIAA 121
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLA--GTFG 753
G++YL + +++HRDL NIL+ ++ KV+DFGL + D + T
Sbjct: 122 GMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 754 YLAPEYA 760
+ APE
Sbjct: 179 WTAPEAI 185
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 2e-40
Identities = 48/191 (25%), Positives = 89/191 (46%), Gaps = 16/191 (8%)
Query: 581 DNFSEANILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLT 634
+ + + LG+G FG+VY G T++A+K + + + EF E +V+
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFLNEASVMK 78
Query: 635 KVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHG-----YTPLTWKQRVTI 689
+ H+V LLG G L++ E M RG L +L P + + + +
Sbjct: 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 690 ALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVE-TRL 748
A ++A G+ YL++ F+HRDL N ++ +D K+ DFG+ ++ + Y + +
Sbjct: 139 AGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195
Query: 749 AGTFGYLAPEY 759
+++PE
Sbjct: 196 LLPVRWMSPES 206
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 5e-40
Identities = 50/187 (26%), Positives = 80/187 (42%), Gaps = 15/187 (8%)
Query: 581 DNFSEANILGRGGFGVVYGGELP----DGTKIAVKRMESNTMGN-KGLSEFQAEIAVLTK 635
+ LG G FGVV GE +AVK ++ + + + + +F E+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 636 VRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR 695
+ HR+L+ L G + ++ V E P G+L + A+ VA
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK--YSVETRLAGTFG 753
G+ YL S + FIHRDL N+L+ K+ DFGL++ P Y ++ F
Sbjct: 123 GMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 754 YLAPEYA 760
+ APE
Sbjct: 180 WCAPESL 186
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 1e-39
Identities = 49/194 (25%), Positives = 85/194 (43%), Gaps = 17/194 (8%)
Query: 573 IEVLRQVTDNFSEANILGRGGFGVVYGGE-LPDGT----KIAVKRMESNTMGNKGLSEFQ 627
+ +L++ F + +LG G FG VY G +P+G +A+K + T K E
Sbjct: 3 LRILKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEIL 59
Query: 628 AEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRV 687
E V+ V + H+ LLG C+ + +L + + MP G L ++ + + +
Sbjct: 60 DEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCL----LDYVREHKDNIGSQYLL 114
Query: 688 TIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN-APDGKYSVET 746
+ +A+G+ YL + +HRDL N+L+ K+ DFGL K + K
Sbjct: 115 NWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 171
Query: 747 RLAGTFGYLAPEYA 760
++A E
Sbjct: 172 GGKVPIKWMALESI 185
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 147 bits (372), Expect = 2e-39
Identities = 51/186 (27%), Positives = 85/186 (45%), Gaps = 14/186 (7%)
Query: 578 QVTDNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV 636
V D++ LG G FGVV+ E G A K + + +K + EI ++ +
Sbjct: 23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK--ETVRKEIQTMSVL 80
Query: 637 RHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARG 696
RH LV L + +E +++YE+M G L + + + H ++ + V V +G
Sbjct: 81 RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH----NKMSEDEAVEYMRQVCKG 136
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDM--RAKVADFGLVKNAPDGKYSVETRLAGTFGY 754
+ ++H +++H DLKP NI+ K+ DFGL + + T GT +
Sbjct: 137 LCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEF 191
Query: 755 LAPEYA 760
APE A
Sbjct: 192 AAPEVA 197
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 3e-39
Identities = 51/202 (25%), Positives = 87/202 (43%), Gaps = 16/202 (7%)
Query: 559 SDRHLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNT 617
SD + E +S+ ++ +G+G G VY ++ G ++A+++M
Sbjct: 1 SDEEILEKLRSIVSVG---DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ 57
Query: 618 MGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHG 677
K EI V+ + ++ ++V L + G E +V EY+ G+L + E
Sbjct: 58 QPKK--ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-- 113
Query: 678 YTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737
Q + + + +E+LHS IHRD+K NIL+G D K+ DFG
Sbjct: 114 ----DEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166
Query: 738 PDGKYSVETRLAGTFGYLAPEY 759
+ T GT ++APE
Sbjct: 167 TPEQSKRSTM-VGTPYWMAPEV 187
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 143 bits (362), Expect = 7e-39
Identities = 55/188 (29%), Positives = 81/188 (43%), Gaps = 19/188 (10%)
Query: 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSE-------FQAEIAV 632
+N+ ILGRG VV P + AVK ++ G+ E E+ +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 633 LTKVR-HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIAL 691
L KV H +++ L + LV++ M +G L +L L+ K+ I
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-----TEKVTLSEKETRKIMR 117
Query: 692 DVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGT 751
+ + LH + +HRDLKP NIL+ DDM K+ DFG G+ + GT
Sbjct: 118 ALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGT 172
Query: 752 FGYLAPEY 759
YLAPE
Sbjct: 173 PSYLAPEI 180
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 9e-39
Identities = 42/190 (22%), Positives = 75/190 (39%), Gaps = 16/190 (8%)
Query: 574 EVLRQVTDNFSEANILGRGGFGVVYGGELPD----GTKIAVKRMESNTMGNKGLSEFQAE 629
E+ R + +G G FG V+ G +A+K ++ T + +F E
Sbjct: 3 EIQR---ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-DSVREKFLQE 58
Query: 630 IAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTI 689
+ + H H+V L+G ++ E G L + L +
Sbjct: 59 ALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGEL----RSFLQVRKYSLDLASLILY 113
Query: 690 ALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLA 749
A ++ + YL S + F+HRD+ N+L+ + K+ DFGL + D Y ++
Sbjct: 114 AYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 170
Query: 750 GTFGYLAPEY 759
++APE
Sbjct: 171 LPIKWMAPES 180
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 3e-38
Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 21/201 (10%)
Query: 568 NVAISIEVLRQVTDNFSEANILGRGGFGVVYGGELPD----GTKIAVKRMESNTMGNKGL 623
+V I + +F+E ++GRG FG VY G L D AVK + T +
Sbjct: 19 HVVIGPS---SLIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEV 72
Query: 624 SEFQAEIAVLTKVRHRHLVALLGYCING-SERLLVYEYMPRGTLAQHLFEWHDHGYTPLT 682
S+F E ++ H ++++LLG C+ L+V YM G L + + T
Sbjct: 73 SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL----RNFIRNETHNPT 128
Query: 683 WKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742
K + L VA+G+++L + F+HRDL N ++ + KVADFGL ++ D ++
Sbjct: 129 VKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185
Query: 743 ---SVETRLAGTFGYLAPEYA 760
+T ++A E
Sbjct: 186 DSVHNKTGAKLPVKWMALESL 206
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 2e-37
Identities = 44/205 (21%), Positives = 82/205 (40%), Gaps = 11/205 (5%)
Query: 579 VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR 637
V ++ + +G G +G+V + + ++A+K++ EI +L + R
Sbjct: 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFR 64
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697
H +++ + + + Y+ + L++ L+ + RG+
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGL 122
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK--YSVETRLAGTFGYL 755
+Y+HS + +HRDLKPSN+L+ K+ DFGL + A T T Y
Sbjct: 123 KYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 179
Query: 756 APEYAGKHWMILCQMTGLIWLHGSV 780
APE + IW G +
Sbjct: 180 APEIMLNSKGYTKSID--IWSVGCI 202
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 141 bits (357), Expect = 2e-37
Identities = 43/186 (23%), Positives = 75/186 (40%), Gaps = 14/186 (7%)
Query: 577 RQVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTK 635
V D + LG G FGVV+ E G K + + +K + EI+++ +
Sbjct: 25 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK--YTVKNEISIMNQ 82
Query: 636 VRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR 695
+ H L+ L + E +L+ E++ G L + Y ++ + +
Sbjct: 83 LHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI---AAEDY-KMSEAEVINYMRQACE 138
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILI--GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFG 753
G++++H S +H D+KP NI+ K+ DFGL + T T
Sbjct: 139 GLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAE 193
Query: 754 YLAPEY 759
+ APE
Sbjct: 194 FAAPEI 199
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 139 bits (352), Expect = 1e-36
Identities = 46/184 (25%), Positives = 83/184 (45%), Gaps = 16/184 (8%)
Query: 581 DNFSEANILGRGGFGVVYGGELPD-GTKIAVKRMESNTMGNKGLSEF----QAEIAVLTK 635
++FS I+GRGGFG VYG D G A+K ++ + K + +++++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 636 VRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR 695
+V + + + + M G L HL + + A ++
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF-----SEADMRFYAAEIIL 118
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYL 755
G+E++H+ + ++RDLKP+NIL+ + +++D GL + K GT GY+
Sbjct: 119 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHGYM 172
Query: 756 APEY 759
APE
Sbjct: 173 APEV 176
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 135 bits (341), Expect = 4e-36
Identities = 51/191 (26%), Positives = 81/191 (42%), Gaps = 16/191 (8%)
Query: 578 QVTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKG-LSEFQAEIAVLTK 635
++D + ILG GG V+ L +AVK + ++ + F+ E
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 636 VRHRHLVALLGYCIN----GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIAL 691
+ H +VA+ G +V EY+ TL + P+T K+ + +
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIA 118
Query: 692 DVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVE--TRLA 749
D + + + H IHRD+KP+NI+I KV DFG+ + D SV +
Sbjct: 119 DACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 175
Query: 750 GTFGYLAPEYA 760
GT YL+PE A
Sbjct: 176 GTAQYLSPEQA 186
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 1e-35
Identities = 60/200 (30%), Positives = 93/200 (46%), Gaps = 25/200 (12%)
Query: 581 DNFSEANILGRGGFGVVYGGELP--------DGTKIAVKRMESNTMGNKGLSEFQAEIAV 632
D LG G FG V E TK+AVK ++S+ K LS+ +E+ +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEM 71
Query: 633 LTKV-RHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGY-----------TP 680
+ + +H++++ LLG C ++ EY +G L ++L G
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 681 LTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740
L+ K V+ A VARG+EYL S + IHRDL N+L+ +D K+ADFGL ++
Sbjct: 132 LSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 741 KYSVETRL-AGTFGYLAPEY 759
Y +T ++APE
Sbjct: 189 DYYKKTTNGRLPVKWMAPEA 208
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 133 bits (335), Expect = 2e-35
Identities = 43/183 (23%), Positives = 74/183 (40%), Gaps = 8/183 (4%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
+ + +G G +GVVY + G A+K++ S EI++L +++H +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYL 700
+V L +LV+E++ Q L + D L + L + G+ Y
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLD-----QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 701 HSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYA 760
H + +HRDLKP N+LI + K+ADFGL + + +
Sbjct: 117 HD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM 173
Query: 761 GKH 763
G
Sbjct: 174 GSK 176
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 133 bits (336), Expect = 5e-35
Identities = 50/181 (27%), Positives = 80/181 (44%), Gaps = 14/181 (7%)
Query: 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGN-KGLSEFQAEIAVLTKVRH 638
+F LG G FG V+ +G A+K ++ + K + E +L+ V H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
++ + G + + ++ +Y+ G L L + A +V +E
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF-----PNPVAKFYAAEVCLALE 118
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
YLHS + I+RDLKP NIL+ + K+ DFG K PD Y++ GT Y+APE
Sbjct: 119 YLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL----CGTPDYIAPE 171
Query: 759 Y 759
Sbjct: 172 V 172
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 132 bits (333), Expect = 9e-35
Identities = 54/185 (29%), Positives = 83/185 (44%), Gaps = 15/185 (8%)
Query: 579 VTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR 637
+ D + ++LG G F V E +A+K + + K + EIAVL K++
Sbjct: 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK-EGSMENEIAVLHKIK 65
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697
H ++VAL +G L+ + + G L + T + + V V
Sbjct: 66 HPNIVALDDIYESGGHLYLIMQLVSGGELFDRI-----VEKGFYTERDASRLIFQVLDAV 120
Query: 698 EYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGY 754
+YLH +HRDLKP N+L +D + ++DFGL K G SV + GT GY
Sbjct: 121 KYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--SVLSTACGTPGY 175
Query: 755 LAPEY 759
+APE
Sbjct: 176 VAPEV 180
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 1e-34
Identities = 48/200 (24%), Positives = 78/200 (39%), Gaps = 24/200 (12%)
Query: 581 DNFSEANILGRGGFGVVY------GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLT 634
D LGRG FG V + +AVK ++ + +E+ +L
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILI 71
Query: 635 KVRHRHLVALLGYCI--NGSERLLVYEYMPRGTLAQHLFE-----------WHDHGYTPL 681
+ H V L G +++ E+ G L+ +L D L
Sbjct: 72 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 682 TWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP-DG 740
T + + + VA+G+E+L S + IHRDL NIL+ + K+ DFGL ++ D
Sbjct: 132 TLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 188
Query: 741 KYSVETRLAGTFGYLAPEYA 760
Y + ++APE
Sbjct: 189 DYVRKGDARLPLKWMAPETI 208
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 2e-34
Identities = 48/182 (26%), Positives = 78/182 (42%), Gaps = 12/182 (6%)
Query: 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKV-R 637
++F +LG+G FG V+ E A+K ++ + + + + E VL+
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697
H L + V EY+ G L H+ H + A ++ G+
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGL 116
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAP 757
++LHS + ++RDLK NIL+ D K+ADFG+ K G + GT Y+AP
Sbjct: 117 QFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-AKTNTFCGTPDYIAP 172
Query: 758 EY 759
E
Sbjct: 173 EI 174
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 2e-33
Identities = 49/179 (27%), Positives = 81/179 (45%), Gaps = 9/179 (5%)
Query: 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHR 639
+NF + +G G +GVVY G +A+K++ +T S EI++L ++ H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
++V LL ++ LV+E++ + T + + + +G+ +
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASAL----TGIPLPLIKSYLFQLLQGLAF 117
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
HS +HRDLKP N+LI + K+ADFGL + A T T Y APE
Sbjct: 118 CHS---HRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYRAPE 172
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 4e-33
Identities = 43/185 (23%), Positives = 70/185 (37%), Gaps = 24/185 (12%)
Query: 588 ILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALL 645
+LG G G V K A+K + + + + E+ + + + H+V ++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIV 71
Query: 646 GYCINGSER----LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLH 701
N L+V E + G L + D G T ++ I + ++YLH
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRI---QDRGDQAFTEREASEIMKSIGEAIQYLH 128
Query: 702 SLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
S + HRD+KP N+L + K+ DFG K T Y+APE
Sbjct: 129 S---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC--YTPYYVAPE 183
Query: 759 YAGKH 763
G
Sbjct: 184 VLGPE 188
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 4e-33
Identities = 48/184 (26%), Positives = 74/184 (40%), Gaps = 13/184 (7%)
Query: 587 NILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKG---LSEFQAEIAVLTKVRHRHLV 642
+ LG G F VY +A+K+++ EI +L ++ H +++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 643 ALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHS 702
LL + S LV+++M LT L +G+EYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLE-----VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 703 LAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGK 762
+HRDLKP+N+L+ ++ K+ADFGL K+ T T Y APE
Sbjct: 119 ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-NRAYTHQVVTRWYRAPELLFG 174
Query: 763 HWMI 766
M
Sbjct: 175 ARMY 178
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 5e-33
Identities = 39/186 (20%), Positives = 79/186 (42%), Gaps = 15/186 (8%)
Query: 577 RQVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTK 635
+++ + + A LGRG FG+V+ E K ++ + EI++L
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV---LVKKEISILNI 57
Query: 636 VRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR 695
RHR+++ L + E ++++E++ + + + + + L ++ V+ V
Sbjct: 58 ARHRNILHLHESFESMEELVMIFEFISGLDIFERI---NTSAF-ELNEREIVSYVHQVCE 113
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIG--DDMRAKVADFGLVKNAPDGKYSVETRLAGTFG 753
+++LHS + H D++P NI+ K+ +FG + G L
Sbjct: 114 ALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPE 168
Query: 754 YLAPEY 759
Y APE
Sbjct: 169 YYAPEV 174
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 6e-33
Identities = 50/212 (23%), Positives = 86/212 (40%), Gaps = 23/212 (10%)
Query: 577 RQVTDNFSEANILGRGGFGVVYGGELPD-GTKIAVKRMESNTMGNKGLSEFQAEIAVLTK 635
R ++++ ++G G FGVVY +L D G +A+K++ + E+ ++ K
Sbjct: 16 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRK 69
Query: 636 VRHRHLVALLGYCINGSER------LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTI 689
+ H ++V L + + E+ LV +Y+P + + L
Sbjct: 70 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLY 127
Query: 690 ALDVARGVEYLHSLAQQSFIHRDLKPSNI-LIGDDMRAKVADFGLVKNAPDGKYSVETRL 748
+ R + Y+HS HRD+KP N+ L D K+ DFG K G+ +V
Sbjct: 128 MYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-- 182
Query: 749 AGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780
+ Y APE + +W G V
Sbjct: 183 ICSRYYRAPELIFGATDYTSSID--VWSAGCV 212
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 4e-32
Identities = 46/180 (25%), Positives = 71/180 (39%), Gaps = 18/180 (10%)
Query: 588 ILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKG----LSEFQAEIAVLTKVRHRH-- 640
+LG GGFG VY G + D +A+K +E + + + G + E+ +L KV
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYL 700
++ LL + +L+ E L + + V V +
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHC 126
Query: 701 HSLAQQSFIHRDLKPSNILI-GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEY 759
H+ +HRD+K NILI + K+ DFG D Y T GT Y PE+
Sbjct: 127 HN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSPPEW 180
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 8e-32
Identities = 47/186 (25%), Positives = 73/186 (39%), Gaps = 11/186 (5%)
Query: 580 TDNFSEANILGRGGFGVVYGGE--LPDGTKIAVKRMESNTMGNKGLSEFQAEIAV---LT 634
+ +G G +G V+ G +A+KR+ T E+AV L
Sbjct: 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 65
Query: 635 KVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTP-LTWKQRVTIALDV 693
H ++V L C + + Q L + D P + + + +
Sbjct: 66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 125
Query: 694 ARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFG 753
RG+++LHS +HRDLKP NIL+ + K+ADFGL + T + T
Sbjct: 126 LRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTSVVVTLW 180
Query: 754 YLAPEY 759
Y APE
Sbjct: 181 YRAPEV 186
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 121 bits (304), Expect = 6e-31
Identities = 43/193 (22%), Positives = 77/193 (39%), Gaps = 23/193 (11%)
Query: 578 QVTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV 636
+V + + +G G FG +Y G + G ++A+K T + E + +
Sbjct: 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMM 59
Query: 637 RHRHLVALLGYCI-NGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR 695
+ + + +C G ++V E + L + + + K + +A +
Sbjct: 60 QGGVGIPTIRWCGAEGDYNVMVMELLGPS-----LEDLFNFCSRKFSLKTVLLLADQMIS 114
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGK------YSVET 746
+EY+HS ++FIHRD+KP N L+ + DFGL K D + Y
Sbjct: 115 RIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 171
Query: 747 RLAGTFGYLAPEY 759
L GT Y +
Sbjct: 172 NLTGTARYASINT 184
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 7e-31
Identities = 54/196 (27%), Positives = 84/196 (42%), Gaps = 21/196 (10%)
Query: 575 VLRQ--VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNK----GLSEFQ 627
V RQ V D + LG G F VV E G + A K ++ + + +
Sbjct: 2 VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 61
Query: 628 AEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRV 687
E+++L +++H +++ L N ++ +L+ E + G L L E LT ++
Sbjct: 62 REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-----SLTEEEAT 116
Query: 688 TIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD----MRAKVADFGLVKNAPDGKYS 743
+ GV YLHS H DLKP NI++ D R K+ DFGL G
Sbjct: 117 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 173
Query: 744 VETRLAGTFGYLAPEY 759
+ GT ++APE
Sbjct: 174 --KNIFGTPEFVAPEI 187
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 2e-30
Identities = 50/181 (27%), Positives = 74/181 (40%), Gaps = 11/181 (6%)
Query: 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNK-GLSEFQAEIAVLTKVRH 638
++F +LG+G FG V G A+K + + K ++ E VL RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
L AL V EY G L HL T ++ ++ +E
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-----VFTEERARFYGAEIVSALE 119
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
YLHS + ++RD+K N+++ D K+ DFGL K ++ GT YLAPE
Sbjct: 120 YLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM-KTFCGTPEYLAPE 175
Query: 759 Y 759
Sbjct: 176 V 176
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 4e-30
Identities = 41/191 (21%), Positives = 76/191 (39%), Gaps = 20/191 (10%)
Query: 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHR 639
+ + +G+G FG V+ G K+A+K++ EI +L ++H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 640 HLVALLGYCINGSER--------LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIAL 691
++V L+ C + LV+++ + T + +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA-----GLLSNVLVKFTLSEIKRVMQ 124
Query: 692 DVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK---NAPDGKYSVETRL 748
+ G L+ + + +HRD+K +N+LI D K+ADFGL + A + + + T
Sbjct: 125 MLLNG---LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 181
Query: 749 AGTFGYLAPEY 759
T Y PE
Sbjct: 182 VVTLWYRPPEL 192
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 119 bits (300), Expect = 5e-30
Identities = 51/181 (28%), Positives = 70/181 (38%), Gaps = 14/181 (7%)
Query: 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGN-KGLSEFQAEIAVLTKVRH 638
D F LG G FG V + G A+K ++ + K + E +L V
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
LV L + S +V EY+ G + HL + A + E
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFE 155
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
YLHS I+RDLKP N+LI +V DFG K +++ GT LAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC----GTPEALAPE 208
Query: 759 Y 759
Sbjct: 209 I 209
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 5e-30
Identities = 45/190 (23%), Positives = 77/190 (40%), Gaps = 21/190 (11%)
Query: 578 QVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV 636
+V + + +G G +G V + G K+A+K++ E+ +L +
Sbjct: 15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 74
Query: 637 RHRHLVALLGYCINGS------ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIA 690
RH +++ LL + LV +M L + H L + +
Sbjct: 75 RHENVIGLLDVFTPDETLDDFTDFYLVMPFMG-----TDLGKLMKHE--KLGEDRIQFLV 127
Query: 691 LDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAG 750
+ +G+ Y+H+ IHRDLKP N+ + +D K+ DFGL + D + T
Sbjct: 128 YQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ-ADSEM---TGYVV 180
Query: 751 TFGYLAPEYA 760
T Y APE
Sbjct: 181 TRWYRAPEVI 190
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 5e-30
Identities = 35/185 (18%), Positives = 74/185 (40%), Gaps = 9/185 (4%)
Query: 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHR 639
+ + +G G +G V+ + +A+KR+ + S EI +L +++H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
++V L + + LV+E+ + +G + + + +G+ +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYF---DSCNGDLD--PEIVKSFLFQLLKGLGF 116
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEY 759
H ++ +HRDLKP N+LI + K+A+FGL + + +
Sbjct: 117 CH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 760 AGKHW 764
G
Sbjct: 174 FGAKL 178
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 115 bits (289), Expect = 5e-29
Identities = 39/184 (21%), Positives = 70/184 (38%), Gaps = 25/184 (13%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHR-HLVALLG 646
+G G FGV++ G L + ++A+K + + + E + + +
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYY 68
Query: 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ 706
+ G +LV + + + D + K A + V+ +H +
Sbjct: 69 FGQEGLHNVLVIDLLGPSL-----EDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---K 120
Query: 707 SFIHRDLKPSNILIGDDM-----RAKVADFGLVKNAPDG------KYSVETRLAGTFGYL 755
S ++RD+KP N LIG V DFG+VK D Y + L+GT Y+
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 756 APEY 759
+
Sbjct: 181 SINT 184
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (287), Expect = 3e-28
Identities = 44/194 (22%), Positives = 72/194 (37%), Gaps = 20/194 (10%)
Query: 579 VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR 637
V + +G G G+V + +A+K++ E+ ++ V
Sbjct: 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 74
Query: 638 HRHLVALLGYCI------NGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIAL 691
H+++++LL + LV E M E ++ +
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL--------DHERMSYLLY 126
Query: 692 DVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGT 751
+ G+++LHS IHRDLKPSNI++ D K+ DFGL + A T T
Sbjct: 127 QMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVT 181
Query: 752 FGYLAPEYAGKHWM 765
Y APE
Sbjct: 182 RYYRAPEVILGMGY 195
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 109 bits (272), Expect = 1e-26
Identities = 38/189 (20%), Positives = 77/189 (40%), Gaps = 23/189 (12%)
Query: 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-H 638
D++ LGRG + V+ + + K+ VK ++ + + EI +L +R
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK-----KKIKREIKILENLRGG 89
Query: 639 RHLVALLGYCINGSERL--LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARG 696
+++ L + R LV+E++ Q Y LT ++ +
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQL--------YQTLTDYDIRFYMYEILKA 141
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIG-DDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYL 755
++Y HS +HRD+KP N++I + + ++ D+GL + G+ + +
Sbjct: 142 LDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--YNVRVASRYFK 196
Query: 756 APEYAGKHW 764
PE +
Sbjct: 197 GPELLVDYQ 205
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (269), Expect = 3e-26
Identities = 46/186 (24%), Positives = 76/186 (40%), Gaps = 15/186 (8%)
Query: 581 DNFSEANILGRGGFGVVYGGEL----PDGTKIAVKRMESNTMGN--KGLSEFQAEIAVLT 634
+NF +LG G +G V+ G A+K ++ T+ K + E VL
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 635 KVRHR-HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDV 693
+R LV L ++ L+ +Y+ G L HL + T + ++
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-----RFTEHEVQIYVGEI 138
Query: 694 ARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFG 753
+E+LH + I+RD+K NIL+ + + DFGL K + GT
Sbjct: 139 VLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 195
Query: 754 YLAPEY 759
Y+AP+
Sbjct: 196 YMAPDI 201
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 4e-25
Identities = 39/192 (20%), Positives = 71/192 (36%), Gaps = 18/192 (9%)
Query: 579 VTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR 637
V + + + +G G +G V G ++AVK++ E+ +L ++
Sbjct: 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 75
Query: 638 HRHLVALLGYCINGS-----ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALD 692
H +++ LL + + ++ L LT +
Sbjct: 76 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQ--KLTDDHVQFLIYQ 129
Query: 693 VARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTF 752
+ RG++Y+HS IHRDLKPSN+ + +D K+ DFGL A + +A +
Sbjct: 130 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL---ARHTDDEMTGYVATRW 183
Query: 753 GYLAPEYAGKHW 764
Sbjct: 184 YRAPEIMLNWMH 195
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 97.9 bits (243), Expect = 6e-24
Identities = 23/155 (14%), Positives = 44/155 (28%), Gaps = 20/155 (12%)
Query: 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNK--------GLSEFQAEIAVLTKVRH 638
++G G V+ + VK + K G F +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
R L L G + VY + + L + + + + + V
Sbjct: 66 RALQKLQGLAVPK-----VYAWE-GNAVLMELIDAKELYRVRVENPDE--VLDMILEEVA 117
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733
+ + +H DL N+L+ + + DF
Sbjct: 118 KFY---HRGIVHGDLSQYNVLV-SEEGIWIIDFPQ 148
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 98.3 bits (243), Expect = 5e-23
Identities = 58/300 (19%), Positives = 107/300 (35%), Gaps = 13/300 (4%)
Query: 27 DDGSVMLKLAQSLQNLP--SDWSSTSSTGYCEWTGINCDNSN---RVTTISLAKSGLSG- 80
D +L++ + L N S W T+ W G+ CD RV + L+ L
Sbjct: 6 QDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKP 65
Query: 81 -TLSPEISSLTQLE--TLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLT 137
+ +++L L + N + P++A T L +Y+ + N + +
Sbjct: 66 YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIK 125
Query: 138 NLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYN 197
L L S N P ++ +L + D I G IPD + SFS L
Sbjct: 126 TLVTLDFSYNAL--SGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISR 183
Query: 198 NFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKC 257
N + + + + +++ L KN + +
Sbjct: 184 NRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLS 243
Query: 258 ESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFP--SKVQKVSLDHNNF 315
++L L LR+N++ G +P + L L ++++ N L G P + + +N
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 71.3 bits (173), Expect = 5e-14
Identities = 69/312 (22%), Positives = 112/312 (35%), Gaps = 31/312 (9%)
Query: 143 SLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTG- 201
L + L+ W +T N G++ D + NL LS N
Sbjct: 17 DLGNPTTLSSW------LPTTDCC-----NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKP 65
Query: 202 -SLPASFAK-SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCES 259
+P+S A + L++ + ++ +TQL +++ +G IPD
Sbjct: 66 YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIK 125
Query: 260 -LFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKN 318
L L N L+G +P S+ SLP L+ I+ N++ G + S L +
Sbjct: 126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGA--IPDSYGSFSKLFTSMTISR 183
Query: 319 SSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKL 378
+ L L+ N +G V + K
Sbjct: 184 NR------------LTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKN 231
Query: 379 LAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNV 438
+L L L+ N + G +P GLT+L L +L+VS NNL G++P G+
Sbjct: 232 SLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQ 291
Query: 439 KFTVS--PGNPF 448
+F VS N
Sbjct: 292 RFDVSAYANNKC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 54.4 bits (129), Expect = 2e-08
Identities = 36/110 (32%), Positives = 50/110 (45%), Gaps = 9/110 (8%)
Query: 326 CDP-QVTTLLQIAGDMGYPAILSDSWEGNNACDG-WPFVTCSQ----GRIITINLANKLL 379
C+P LLQI D+G P LS + C+ W V C R+ ++L+ L
Sbjct: 3 CNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL 62
Query: 380 AGN--ISPAYANLTSLKNLYLQQN-NLTGPIPDGLTKLASLQNLDVSNNN 426
I + ANL L LY+ NL GPIP + KL L L +++ N
Sbjct: 63 PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTN 112
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 49.7 bits (117), Expect = 6e-07
Identities = 16/59 (27%), Positives = 23/59 (38%), Gaps = 4/59 (6%)
Query: 100 NNIAGAIP-SLANATSLQDIYLDNNNFT-SVPTGCFDGLTNLQVLSLSDNPNLAPWPFP 156
N I G +P L L + + NN +P G L V + ++N L P P
Sbjct: 254 NRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG--NLQRFDVSAYANNKCLCGSPLP 310
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 41.7 bits (96), Expect = 2e-04
Identities = 11/51 (21%), Positives = 17/51 (33%), Gaps = 1/51 (1%)
Query: 154 PFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLP 204
P LT+ L +L + N+ G IP + + N P
Sbjct: 259 TLPQGLTQLKFLHSLNVSFNNLCGEIPQGG-NLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 40.9 bits (94), Expect = 4e-04
Identities = 18/106 (16%), Positives = 31/106 (29%), Gaps = 26/106 (24%)
Query: 152 PWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSD 211
++ S +L L + N I+G +P L +L +S+NN G +P
Sbjct: 233 LAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP------- 285
Query: 212 IQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKC 257
+ + N+ P L C
Sbjct: 286 ------------------QGGNLQRFDVSAYANNKCLCGSP-LPAC 312
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 92.4 bits (228), Expect = 1e-20
Identities = 69/382 (18%), Positives = 124/382 (32%), Gaps = 44/382 (11%)
Query: 63 DNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDN 122
L K+ ++ T+S + L Q+ TL I +I + +L I N
Sbjct: 19 TALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDGVEYLNNLTQINFSN 75
Query: 123 NNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDF 182
N T + LT L + +++N P N +
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 183 FDSFSNLQNL-----------RLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVL 231
+ N L +F + +++ L D + VL
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 232 SGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQN 291
+ +T L + NQ + P +L +LSL NQL ++ SL L ++ L N
Sbjct: 194 AKLTNLESLIATNNQISDITPL-GILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLAN 250
Query: 292 NKLQGPYPL-FPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSW 350
N++ PL +K+ ++ L N I+ G A+ +
Sbjct: 251 NQISNLAPLSGLTKLTELKLGANQISN------------------ISPLAGLTALTNLEL 292
Query: 351 EGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDG 410
N D P + + L ++ ++LT L+ L+ N ++
Sbjct: 293 NENQLEDISPISNLKN--LTYLTLYFNNISD--ISPVSSLTKLQRLFFANNKVSDV--SS 346
Query: 411 LTKLASLQNLDVSNNNLSGKVP 432
L L ++ L +N +S P
Sbjct: 347 LANLTNINWLSAGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 61.9 bits (149), Expect = 1e-10
Identities = 23/104 (22%), Positives = 45/104 (43%), Gaps = 5/104 (4%)
Query: 44 SDWSSTSSTGYCEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIA 103
+ ++ N +T ++L + +S +SSLT+L+ L F N ++
Sbjct: 285 TALTNLELNENQLEDISPISNLKNLTYLTLYFNNISD--ISPVSSLTKLQRLFFANNKVS 342
Query: 104 GAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDN 147
+ SLAN T++ + +N + + LT + L L+D
Sbjct: 343 D-VSSLANLTNINWLSAGHNQISDLT--PLANLTRITQLGLNDQ 383
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 91.2 bits (225), Expect = 3e-20
Identities = 35/189 (18%), Positives = 73/189 (38%), Gaps = 27/189 (14%)
Query: 589 LGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH--------- 638
LG G F V+ ++ + T +A+K + + + + + EI +L +V
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE---AAEDEIKLLQRVNDADNTKEDSM 77
Query: 639 --RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARG 696
H++ LL + + + + L + + + I+ + G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 697 VEYLHSLAQQSFIHRDLKPSNILI------GDDMRAKVADFGLVKNAPDGKYSVETRLAG 750
++Y+H + IH D+KP N+L+ + ++ K+AD G + +
Sbjct: 138 LDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI----Q 191
Query: 751 TFGYLAPEY 759
T Y +PE
Sbjct: 192 TREYRSPEV 200
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 88.6 bits (218), Expect = 8e-20
Identities = 48/321 (14%), Positives = 97/321 (30%), Gaps = 52/321 (16%)
Query: 114 SLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNA 173
L+ + + VP + +L L +N + + +L TL + N
Sbjct: 11 HLRVVQCSDLGLEKVPKDLP---PDTALLDLQNN-KITEIK-DGDFKNLKNLHTLILINN 65
Query: 174 NIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSG 233
I + P F L+ L LS N LP K+
Sbjct: 66 KISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKT----------------------- 101
Query: 234 MTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNK 293
+ +LR + + + + +L + +G+ + + L I + +
Sbjct: 102 LQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN 161
Query: 294 LQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGN 353
+ P + ++ LD N K + + G + N
Sbjct: 162 ITTIPQGLPPSLTELHLDGNKITKVDAAS----------------LKGLNNLAKLGLSFN 205
Query: 354 NACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTG------PI 407
+ + + ++L N L A+ ++ +YL NN++
Sbjct: 206 SISAVDNGSLANTPHLRELHLNNNKLVKVP-GGLADHKYIQVVYLHNNNISAIGSNDFCP 264
Query: 408 PDGLTKLASLQNLDVSNNNLS 428
P TK AS + + +N +
Sbjct: 265 PGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 74.3 bits (181), Expect = 5e-15
Identities = 43/290 (14%), Positives = 77/290 (26%), Gaps = 63/290 (21%)
Query: 55 CEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANAT 113
C + C + + + L L Q N I N
Sbjct: 10 CHLRVVQCSD-LGLEKVP---KDLP----------PDTALLDLQNNKITEIKDGDFKNLK 55
Query: 114 SLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNP-------------------NLAPWP 154
+L + L NN + + G F L L+ L LS N N
Sbjct: 56 NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKV 115
Query: 155 FPNELTKSTSLTTLYMDNANI--FGLIPDFFDSFSNL---------------------QN 191
+ + + + + G+ F L
Sbjct: 116 RKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTE 175
Query: 192 LRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPI 251
L L N T AS + + L+ LR++ L+ N+
Sbjct: 176 LHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVP 235
Query: 252 PDLSKCESLFDLSLRDNQLTGV------VPASVISLPALLNISLQNNKLQ 295
L+ + + + L +N ++ + P + +SL +N +Q
Sbjct: 236 GGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 54.7 bits (130), Expect = 2e-08
Identities = 34/201 (16%), Positives = 67/201 (33%), Gaps = 18/201 (8%)
Query: 235 TQLRQVWLHKNQFTGPIP-DLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNK 293
+ L N+ T D ++L L L +N+++ + P + L L + L N+
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 294 LQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGN 353
L+ P +Q++ + N K + + ++
Sbjct: 91 LKELPEKMPKTLQELRVHENEITKVRKS--------------VFNGLNQMIVVELGTNPL 136
Query: 354 NACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTK 413
+ ++ I +A+ + I SL L+L N +T L
Sbjct: 137 KSSGIENGAFQGMKKLSYIRIADTNI-TTIPQG--LPPSLTELHLDGNKITKVDAASLKG 193
Query: 414 LASLQNLDVSNNNLSGKVPDF 434
L +L L +S N++S
Sbjct: 194 LNNLAKLGLSFNSISAVDNGS 214
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 51.6 bits (122), Expect = 1e-07
Identities = 31/216 (14%), Positives = 71/216 (32%), Gaps = 25/216 (11%)
Query: 76 SGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDG 135
+ + ++ ++ + +E + + + + L I + + N T++P G
Sbjct: 113 TKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLP-- 170
Query: 136 LTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLS 195
+L L L N L +L L + +I + + +L+ L L+
Sbjct: 171 -PSLTELHLDGNKIT--KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLN 227
Query: 196 YNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLS 255
N IQ +++++ + + N F P +
Sbjct: 228 NNKLVKVPGGLADHKYIQVVYLHNNNI-----------------SAIGSNDFCPPGY-NT 269
Query: 256 KCESLFDLSLRDNQLT--GVVPASVISLPALLNISL 289
K S +SL N + + P++ + + L
Sbjct: 270 KKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 43.5 bits (101), Expect = 6e-05
Identities = 26/148 (17%), Positives = 48/148 (32%), Gaps = 6/148 (4%)
Query: 53 GYCEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANA 112
T I +T + L + ++ + + L L L N+I+
Sbjct: 158 ADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLAN 217
Query: 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNP--NLAPWPF--PNELTKSTSLTTL 168
T NNN G +QV+ L +N + F P TK S + +
Sbjct: 218 TPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGV 277
Query: 169 YMDNANI--FGLIPDFFDSFSNLQNLRL 194
+ + + + + P F ++L
Sbjct: 278 SLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.5 bits (168), Expect = 2e-13
Identities = 46/318 (14%), Positives = 82/318 (25%), Gaps = 67/318 (21%)
Query: 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172
+ Q I+L N + VP F NL + + LA + DN
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTI-LWLHSNVLARIDAAAFTGLALLEQLDLSDN 90
Query: 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLS 232
A + + P F L L L Q L +
Sbjct: 91 AQLRSVDPATFHGLGRLHTLHLDRCGL-------------QELGPGLFR----------- 126
Query: 233 GMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQN 291
G+ L+ ++L N D +L L L N+++ V + L +L + L
Sbjct: 127 GLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQ 186
Query: 292 NKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWE 351
N++ +P +
Sbjct: 187 NRVAHVHPH--------AFRDLGRLMT-----------------------------LYLF 209
Query: 352 GNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGL 411
NN + + L + + L+ + + +P
Sbjct: 210 ANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARP-LWAWLQKFRGSSSEVPCSLPQ-- 266
Query: 412 TKLASLQNLDVSNNNLSG 429
+LA ++ N+L G
Sbjct: 267 -RLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.1 bits (167), Expect = 2e-13
Identities = 44/278 (15%), Positives = 76/278 (27%), Gaps = 30/278 (10%)
Query: 46 WSSTSSTGYCEWTG---INCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNI 102
++ T C G + I L + +S + + L L N +
Sbjct: 9 YNEPKVTTSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL 68
Query: 103 AGAIPSLANATSLQ--DIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNP------------ 148
A + +L DN SV F GL L L L
Sbjct: 69 ARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGL 128
Query: 149 ----------NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNN 198
N + +LT L++ I + F +L L L N
Sbjct: 129 AALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNR 188
Query: 199 FTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCE 258
P +F + + L+ + L+ + L+ N +
Sbjct: 189 VAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWA 248
Query: 259 SLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG 296
L +++ +P + L ++ N LQG
Sbjct: 249 WLQKFRGSSSEVPCSLPQRLAGRD-LKRLA--ANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.3 bits (87), Expect = 0.002
Identities = 25/172 (14%), Positives = 52/172 (30%), Gaps = 12/172 (6%)
Query: 263 LSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDA 322
+ L N+++ V AS + L + L +N L + + + +
Sbjct: 37 IFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSV 96
Query: 323 GKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGN 382
+ L + D L A + ++ + L
Sbjct: 97 DPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNA------------LQAL 144
Query: 383 ISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDF 434
+ +L +L +L+L N ++ L SL L + N ++ P
Sbjct: 145 PDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHA 196
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.4 bits (150), Expect = 3e-11
Identities = 33/212 (15%), Positives = 61/212 (28%), Gaps = 9/212 (4%)
Query: 85 EISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144
E+S + ++ N+ A+P ++L N + T L L+L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPP-DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 145 SDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLP 204
L L +L + ++ L + +N T
Sbjct: 63 D-RAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVS----FNRLTSLPL 117
Query: 205 ASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD-LSKCESLFDL 263
+ + +L+ +L ++ L N T L+ E+L L
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177
Query: 264 SLRDNQLTGVVPASVISLPALLNISLQNNKLQ 295
L++N L +P L L N
Sbjct: 178 LLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.0 bits (128), Expect = 2e-08
Identities = 38/204 (18%), Positives = 63/204 (30%), Gaps = 11/204 (5%)
Query: 232 SGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQN 291
S + +V K T PDL K L L +N L A+++ L ++L
Sbjct: 7 SKVASHLEVNCDKRNLTALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 292 NKLQGPYP--------LFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYP 343
+L ++ + T L + G
Sbjct: 65 AELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLG 124
Query: 344 AILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNL 403
+ +GN P + ++ ++LAN L + L +L L LQ+N+L
Sbjct: 125 ELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 184
Query: 404 TGPIPDGLTKLASLQNLDVSNNNL 427
IP G L + N
Sbjct: 185 Y-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 62.0 bits (149), Expect = 3e-11
Identities = 30/216 (13%), Positives = 66/216 (30%), Gaps = 18/216 (8%)
Query: 88 SLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDN 147
+L ++ +N+ + + A+ + + T++ L NL L L DN
Sbjct: 17 ALANAIKIAAGKSNVTDTV-TQADLDGITTLSAFGTGVTTIE--GVQYLNNLIGLELKDN 73
Query: 148 PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASF 207
P N + + + G
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 208 AKSDIQNLWM------------NDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLS 255
D+ + L L+ +++L + N+ + I L+
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD-ISPLA 192
Query: 256 KCESLFDLSLRDNQLTGVVPASVISLPALLNISLQN 291
+L ++ L++NQ++ V P + + L ++L N
Sbjct: 193 SLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 51.6 bits (122), Expect = 7e-08
Identities = 35/257 (13%), Positives = 73/257 (28%), Gaps = 38/257 (14%)
Query: 171 DNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDV 230
I + PD + +N + +N T ++
Sbjct: 5 QPTAINVIFPD--PALANAIKIAAGKSNVTDTVT-------------------------- 36
Query: 231 LSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQ 290
+ + + + T I + +L L L+DNQ+T + P ++ L +S
Sbjct: 37 QADLDGITTLSAFGTGVTT-IEGVQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGN 95
Query: 291 NNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSW 350
K S + + + L + + L+
Sbjct: 96 PLKNVSAIAGLQSIKT----LDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLT 151
Query: 351 EGNNACDGWPFVTCSQGRIITINLANKLLAGNI---SPAYANLTSLKNLYLQQNNLTGPI 407
G V+ L N A+L +L ++L+ N ++
Sbjct: 152 NLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVS 211
Query: 408 PDGLTKLASLQNLDVSN 424
P L ++L + ++N
Sbjct: 212 P--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.6 bits (109), Expect = 3e-06
Identities = 17/63 (26%), Positives = 35/63 (55%), Gaps = 3/63 (4%)
Query: 84 PEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLS 143
+++L++L TL N I+ I LA+ +L +++L NN + V +NL +++
Sbjct: 167 TPLANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVT 223
Query: 144 LSD 146
L++
Sbjct: 224 LTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 8e-06
Identities = 36/201 (17%), Positives = 72/201 (35%), Gaps = 6/201 (2%)
Query: 233 GMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNN 292
+ ++ K+ T + + + + LS +T + V L L+ + L++N
Sbjct: 17 ALANAIKIAAGKSNVTDTVT-QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 293 KL-QGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWE 351
++ +K+ ++ L N S+ AG + D+ A LS+
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 352 GNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGL 411
+ ++ G L+ + ANL+ L L N ++ P L
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191
Query: 412 TKLASLQNLDVSNNNLSGKVP 432
L +L + + NN +S P
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP 212
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.4 bits (137), Expect = 2e-09
Identities = 35/251 (13%), Positives = 74/251 (29%), Gaps = 9/251 (3%)
Query: 190 QNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFT- 248
Q L L+ N + + + + L +++ + L +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQGVIAFRCP--RSFMDQPLAEHFSPFRVQHMDLSNSVIEV 60
Query: 249 -GPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQK 307
LS+C L +LSL +L+ + ++ L+ ++L + L
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 308 VSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQG 367
LD N K + + LS + D V
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVA----VAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPN 176
Query: 368 RIITINLANKLLAGNISPAYANLTSLKNLYLQQ-NNLTGPIPDGLTKLASLQNLDVSNNN 426
+ + +L + + L L++L L + ++ L ++ +L+ L V
Sbjct: 177 LVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIV 236
Query: 427 LSGKVPDFGSN 437
G +
Sbjct: 237 PDGTLQLLKEA 247
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.9 bits (102), Expect = 4e-05
Identities = 40/271 (14%), Positives = 79/271 (29%), Gaps = 21/271 (7%)
Query: 69 TTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFT-S 127
T+ L L ++ + S + + + + + +Q + L N+ S
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVS 61
Query: 128 VPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFS 187
G + LQ LSL P N L K+++L L + + F S
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPI--VNTLAKNSNLVRLNLSGCSGFSEFA-LQTLLS 118
Query: 188 NLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLH---- 243
+ L ++ + + ++ QL LSG L V
Sbjct: 119 SCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLV 178
Query: 244 -------KNQFTGPIPDLSKCESLFDLSLRD-NQLTGVVPASVISLPALLNISLQNNKLQ 295
+ + L LSL + + +P L + +
Sbjct: 179 HLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPD 238
Query: 296 GPYPLFPSKVQKVSLDHNNFCKNSSDAGKPC 326
G L + + ++ C + + +P
Sbjct: 239 GTLQLLKEALPHLQIN----CSHFTTIARPT 265
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.8 bits (99), Expect = 1e-04
Identities = 26/108 (24%), Positives = 44/108 (40%), Gaps = 8/108 (7%)
Query: 119 YLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGL 178
D+ + F L LQ LSLS ++ EL + +L TL +FG+
Sbjct: 182 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDI-IPETLLELGEIPTLKTL-----QVFGI 235
Query: 179 IPD--FFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGL 224
+PD L +L+++ ++FT + Q +W +L L
Sbjct: 236 VPDGTLQLLKEALPHLQINCSHFTTIARPTIGNKKNQEIWGIKCRLTL 283
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 53.1 bits (126), Expect = 2e-08
Identities = 33/194 (17%), Positives = 63/194 (32%), Gaps = 6/194 (3%)
Query: 232 SGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQN 291
+ + L K T + ++ S+ + ++ + V LP + + L
Sbjct: 21 DAFAETIKDNLKKKSVTDAVT-QNELNSIDQIIANNSDIKSVQGIQ--YLPNVTKLFLNG 77
Query: 292 NKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWE 351
NKL PL K N K+ S + +L + E
Sbjct: 78 NKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLE 137
Query: 352 GNNACDGWPFVTCSQGRIITINLANKLLAGNIS-PAYANLTSLKNLYLQQNNLTGPIPDG 410
+ R+ ++ + A LT L+NLYL +N+++
Sbjct: 138 SLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD--LRA 195
Query: 411 LTKLASLQNLDVSN 424
L L +L L++ +
Sbjct: 196 LAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 47.7 bits (112), Expect = 1e-06
Identities = 31/206 (15%), Positives = 63/206 (30%), Gaps = 18/206 (8%)
Query: 87 SSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSD 146
+ + + + ++ A+ + S+ I +N++ SV L N+ L L+
Sbjct: 21 DAFAETIKDNLKKKSVTDAV-TQNELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNG 77
Query: 147 NPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPAS 206
N L L L ++ L +L++ +S N LP
Sbjct: 78 N-KLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQL 136
Query: 207 FAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLR 266
+ N + ++ I L+ L +L L
Sbjct: 137 ESLYLGNNKITDITV----------LSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLS 186
Query: 267 DNQLTGVVPASVISLPAL--LNISLQ 290
N ++ + ++ L L L + Q
Sbjct: 187 KNHISDL--RALAGLKNLDVLELFSQ 210
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 4e-05
Identities = 33/191 (17%), Positives = 62/191 (32%), Gaps = 9/191 (4%)
Query: 250 PIPDL---SKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPL-FPSKV 305
PI + +L+ +T V + L ++ I N+ ++ + + V
Sbjct: 13 PIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQYLPNV 70
Query: 306 QKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCS 365
K+ L+ N A + D+ L + +G +
Sbjct: 71 TKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGL 130
Query: 366 QGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNN 425
+L + LT L L L+ N ++ +P L L LQNL +S N
Sbjct: 131 VHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKN 188
Query: 426 NLSGKVPDFGS 436
++S +
Sbjct: 189 HISD-LRALAG 198
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.9 bits (116), Expect = 1e-07
Identities = 16/109 (14%), Positives = 28/109 (25%), Gaps = 7/109 (6%)
Query: 94 TLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPW 153
L ++ + L + + L +N L L+ L + + A
Sbjct: 2 VLHLAHKDLTV-LCHLEQLLLVTHLDLSHNRLR----ALPPALAALRCLEVLQASDNALE 56
Query: 154 PFPNELTKSTSLTTLYMDNANIFGL-IPDFFDSFSNLQNLRLSYNNFTG 201
L L + N + S L L L N+
Sbjct: 57 NVDGV-ANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.0 bits (111), Expect = 5e-07
Identities = 24/126 (19%), Positives = 53/126 (42%), Gaps = 10/126 (7%)
Query: 167 TLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSG 226
L++ + ++ L + + +L LS+N PA + ++ L +
Sbjct: 2 VLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPPAL---AALRCLEVLQASDNALE 56
Query: 227 TLDVLSGMTQLRQVWLHKNQFTG--PIPDLSKCESLFDLSLRDNQLTGV--VPASVIS-L 281
+D ++ + +L+++ L N+ I L C L L+L+ N L + + L
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
Query: 282 PALLNI 287
P++ +I
Sbjct: 117 PSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.9 bits (108), Expect = 1e-06
Identities = 20/115 (17%), Positives = 37/115 (32%), Gaps = 6/115 (5%)
Query: 81 TLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQ 140
T+ + L + L N + P+LA L+ + +N +V LQ
Sbjct: 11 TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVANL--PRLQ 68
Query: 141 VLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN---ANIFGLIPDFFDSFSNLQNL 192
L L +N L L L L + G+ + ++ ++
Sbjct: 69 ELLLCNN-RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.4 bits (86), Expect = 0.001
Identities = 25/114 (21%), Positives = 45/114 (39%), Gaps = 8/114 (7%)
Query: 227 TLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLN 286
L L + + + L N+ P L+ L L DN L V + + L
Sbjct: 12 VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVANLPRLQELL 71
Query: 287 ISLQNNKLQGPYPLFP----SKVQKVSLDHNNFCKNSSDAGKPCD--PQVTTLL 334
L NN+LQ + P ++ ++L N+ C+ + + P V+++L
Sbjct: 72 --LCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 123
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.4 bits (86), Expect = 0.001
Identities = 12/43 (27%), Positives = 22/43 (51%), Gaps = 2/43 (4%)
Query: 394 KNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGS 436
+ L+L +LT + L +L + +LD+S+N L P +
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAA 41
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 35.8 bits (82), Expect = 0.004
Identities = 13/47 (27%), Positives = 18/47 (38%), Gaps = 1/47 (2%)
Query: 385 PAYANLTSLKNLYLQQNNLTG-PIPDGLTKLASLQNLDVSNNNLSGK 430
ANL L+ L L N L L L L++ N+L +
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.1 bits (123), Expect = 1e-07
Identities = 50/332 (15%), Positives = 90/332 (27%), Gaps = 47/332 (14%)
Query: 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172
++ L+N +S+P + +L+ L S N SLT L
Sbjct: 38 RQAHELELNNLGLSSLP----ELPPHLESLVASCN----------------SLTELP--- 74
Query: 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFTG-----SLPASFAKSDIQNLWMNDQQLGLSGT 227
+ +L++L + NN L S+ Q + + Q
Sbjct: 75 -----------ELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLK 123
Query: 228 LDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNI 287
+ + + + L + + E +L S+ LP L
Sbjct: 124 IIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLS 183
Query: 288 SLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILS 347
P L N P + + Y L
Sbjct: 184 LESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPDLPPSLE---ALNVRDNYLTDLP 240
Query: 348 DSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPI 407
+ + D + + + I SL+ L + N L +
Sbjct: 241 ELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-L 299
Query: 408 PDGLTKLASLQNLDVSNNNLSGKVPDFGSNVK 439
P L+ L S N+L+ +VP+ N+K
Sbjct: 300 PALPP---RLERLIASFNHLA-EVPELPQNLK 327
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 50.6 bits (119), Expect = 4e-07
Identities = 46/350 (13%), Positives = 94/350 (26%), Gaps = 40/350 (11%)
Query: 90 TQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPN 149
Q L ++ ++P L L+ + N+ T +P + +L+ L + +N
Sbjct: 38 RQAHELELNNLGLS-SLPELP--PHLESLVASCNSLTELP----ELPQSLKSLLVDNNNL 90
Query: 150 LAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK 209
A P L + N +L + A+
Sbjct: 91 KALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNN 150
Query: 210 SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQ 269
+ + + + D S ++ G E L
Sbjct: 151 QLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIY 210
Query: 270 LTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQ 329
+N L P P ++ +++ N
Sbjct: 211 --------------------ADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLD 250
Query: 330 VTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYAN 389
V+ + P + + N + + +N++N + A
Sbjct: 251 VSENIFSGLSELPPNLYYLNASSNE----IRSLCDLPPSLEELNVSN----NKLIELPAL 302
Query: 390 LTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVK 439
L+ L N+L +P+ +L+ L V N L + PD +V+
Sbjct: 303 PPRLERLIASFNHLAE-VPELPQ---NLKQLHVEYNPLR-EFPDIPESVE 347
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.5 bits (111), Expect = 4e-06
Identities = 18/78 (23%), Positives = 33/78 (42%), Gaps = 11/78 (14%)
Query: 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172
SL+++ + NN +P L+ L S N +LA P +L L+++
Sbjct: 284 PSLEELNVSNNKLIELP----ALPPRLERLIASFN-HLA--EVPELP---QNLKQLHVEY 333
Query: 173 ANIFGLIPDFFDSFSNLQ 190
+ PD +S +L+
Sbjct: 334 NPLREF-PDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.4 bits (108), Expect = 8e-06
Identities = 20/100 (20%), Positives = 35/100 (35%), Gaps = 13/100 (13%)
Query: 119 YLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGL 178
N ++ D +L+ L++S+N + P L L N
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE---LPALP---PRLERLIASF-NHLAE 318
Query: 179 IPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMN 218
+P + NL+ L + YN P +++L MN
Sbjct: 319 VP---ELPQNLKQLHVEYNPLR-EFPDIPES--VEDLRMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.4 bits (90), Expect = 0.001
Identities = 10/55 (18%), Positives = 26/55 (47%), Gaps = 4/55 (7%)
Query: 87 SSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQV 141
+ +LE L N++ +P L +L+ ++++ N P + + +L++
Sbjct: 301 ALPPRLERLIASFNHL-AEVPELP--QNLKQLHVEYNPLREFPD-IPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.3 bits (87), Expect = 0.003
Identities = 20/116 (17%), Positives = 32/116 (27%), Gaps = 32/116 (27%)
Query: 169 YMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTL 228
I D +L+ L +S N LPA
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP--------------------- 303
Query: 229 DVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPAL 284
+L ++ N +P+L ++L L + N L P S+ L
Sbjct: 304 ------PRLERLIASFNHLAE-VPEL--PQNLKQLHVEYNPLRE-FPDIPESVEDL 349
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 50.2 bits (118), Expect = 2e-07
Identities = 29/179 (16%), Positives = 53/179 (29%), Gaps = 7/179 (3%)
Query: 114 SLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNA 173
+ +P + L L+DN + L L +
Sbjct: 9 EGTTVDCTGRGLKEIPRDIP---LHTTELLLNDNEL-GRISSDGLFGRLPHLVKLELKRN 64
Query: 174 NIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLSGTLDVLS 232
+ G+ P+ F+ S++Q L+L N F ++ L + D Q+
Sbjct: 65 QLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQI-SCVMPGSFE 123
Query: 233 GMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQN 291
+ L + L N F E L SL P+ V + + ++
Sbjct: 124 HLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVRDVQ-IKDLPHSE 181
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 40.9 bits (94), Expect = 2e-04
Identities = 34/203 (16%), Positives = 67/203 (33%), Gaps = 18/203 (8%)
Query: 55 CEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATS 114
CE T ++C + I +I T L+ +
Sbjct: 8 CEGTTVDCTG-RGLKEI-----------PRDIPLHTTELLLNDNELGRISSDGLFGRLPH 55
Query: 115 LQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNAN 174
L + L N T + F+G +++Q L L +N L TL + +
Sbjct: 56 LVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK--EISNKMFLGLHQLKTLNLYDNQ 113
Query: 175 IFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGM 234
I ++P F+ ++L +L L+ N F + ++ ++ +N G + +
Sbjct: 114 ISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAA-RCGAPSKVRDV 172
Query: 235 TQLRQVWLHKNQFTGPIPDLSKC 257
L ++F + C
Sbjct: 173 QIKD---LPHSEFKCSSENSEGC 192
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.0 bits (116), Expect = 2e-07
Identities = 16/123 (13%), Positives = 40/123 (32%), Gaps = 2/123 (1%)
Query: 82 LSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQV 141
L +S + + + + P L + ++ ++ + + L
Sbjct: 12 LKLIMSKRYDGSQQALDLKGL-RSDPDLVAQNIDVVLNRRSSMAATLR-IIEENIPELLS 69
Query: 142 LSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTG 201
L+LS+N + + K+ +L L + + L+ L L N+ +
Sbjct: 70 LNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSD 129
Query: 202 SLP 204
+
Sbjct: 130 TFR 132
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 50.6 bits (119), Expect = 3e-07
Identities = 31/326 (9%), Positives = 69/326 (21%), Gaps = 30/326 (9%)
Query: 114 SLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNP--NLAPWPFPNELTKSTSLTTLYMD 171
SL+ + + SV + +++ + LS N A + L
Sbjct: 9 SLKLDAITTEDEKSVFAVLLE-DDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 172 NANIFGLIPDFFDSFSNL----QNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGT 227
+ + + ++ L + + +++
Sbjct: 68 DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127
Query: 228 LDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNI 287
L Q Q L + N+L +
Sbjct: 128 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL 187
Query: 288 SLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILS 347
+Q + + D + L+
Sbjct: 188 LHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT-----------HLGSSALA 236
Query: 348 DSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPI 407
+ + C + + + L+ L LQ N +
Sbjct: 237 IALKSWPNLRELGLNDCLLSARGAAAVVDAF-------SKLENIGLQTLRLQYNEIELDA 289
Query: 408 PDGL-----TKLASLQNLDVSNNNLS 428
L K+ L L+++ N S
Sbjct: 290 VRTLKTVIDEKMPDLLFLELNGNRFS 315
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 4e-06
Identities = 26/159 (16%), Positives = 44/159 (27%), Gaps = 5/159 (3%)
Query: 211 DIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD-----LSKCESLFDLSL 265
DIQ+L + ++L + ++L + Q + V L T L +L +L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 266 RDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKP 325
R N+L V V+ + +Q LQ S
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 122
Query: 326 CDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTC 364
L G + L +
Sbjct: 123 LLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 161
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (107), Expect = 1e-05
Identities = 14/93 (15%), Positives = 26/93 (27%), Gaps = 6/93 (6%)
Query: 138 NLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANI----FGLIPDFFDSFSNLQNLR 193
++Q L + L+ + L + +D+ + I L L
Sbjct: 3 DIQSLDIQCE-ELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 194 LSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSG 226
L N + +Q Q+L L
Sbjct: 62 LRSNELGDVGVHCVLQG-LQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 3e-05
Identities = 50/437 (11%), Positives = 101/437 (23%), Gaps = 49/437 (11%)
Query: 15 LLLLQLTTTSLGDDGSVMLKLAQSLQNLPSDWSSTSSTGYCEWTGINCDNSNRVTTISLA 74
+ L + L D +L LQ + L
Sbjct: 4 IQSLDIQCEELSDAR--WAELLPLLQQC--------------------------QVVRLD 35
Query: 75 KSGLSG----TLSPEISSLTQLETLSFQMNNIAG-AIPSLANA-----TSLQDIYLDNNN 124
GL+ +S + L L+ + N + + + +Q + L N
Sbjct: 36 DCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
Query: 125 FTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFD 184
T G + + L +
Sbjct: 96 LTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSA 155
Query: 185 SFSNLQNLRLSYNNFTGSLPASF-------AKSDIQNLWMNDQQLGLSGTLDVLSGMTQL 237
+ L L S + Q L + QL
Sbjct: 156 ASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNC 215
Query: 238 RQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGP 297
R + L D+ + + + P+S + + +
Sbjct: 216 RDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDL 275
Query: 298 YPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACD 357
+ +K L A C+ + Q+ + + + +
Sbjct: 276 CRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSV 335
Query: 358 GWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTG----PIPDGLTK 413
+ +I L + + + L+ L+L +++ + L
Sbjct: 336 LAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLA 395
Query: 414 LASLQNLDVSNNNLSGK 430
SL+ LD+SNN L
Sbjct: 396 NHSLRELDLSNNCLGDA 412
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 1e-04
Identities = 15/94 (15%), Positives = 29/94 (30%), Gaps = 11/94 (11%)
Query: 350 WEGNNACDGWPFVTCSQGRIITINLANKLL----AGNISPAYANLTSLKNLYLQQNNLTG 405
G S + + LA+ + +++ SL+ L L N L
Sbjct: 354 DAGVRELCQGLGQPGSV--LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 411
Query: 406 PIPDGLTK-----LASLQNLDVSNNNLSGKVPDF 434
L + L+ L + + S ++ D
Sbjct: 412 AGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDR 445
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 2e-04
Identities = 15/90 (16%), Positives = 30/90 (33%), Gaps = 7/90 (7%)
Query: 122 NNNFTSVPTGCFDGLTNLQVLSLSDNP--NLAPWPFPNELTKSTSLTTLYMDNANI---- 175
+ + G + L+VL L+D + + L + SL L + N +
Sbjct: 354 DAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAG 413
Query: 176 -FGLIPDFFDSFSNLQNLRLSYNNFTGSLP 204
L+ L+ L L ++ +
Sbjct: 414 ILQLVESVRQPGCLLEQLVLYDIYWSEEME 443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 3e-04
Identities = 12/94 (12%), Positives = 26/94 (27%), Gaps = 8/94 (8%)
Query: 114 SLQDIYLDNNNFTSVP-TGCFDGLTNLQVLSLSDNP--NLAPWPFPNELTKSTSLTTLYM 170
+Q + + + L QV+ L D + L + +L L +
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 171 DNANI-----FGLIPDFFDSFSNLQNLRLSYNNF 199
+ + ++ +Q L L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 7e-04
Identities = 18/100 (18%), Positives = 32/100 (32%), Gaps = 11/100 (11%)
Query: 65 SNRVTTISLAKSGLSGTLSPEI-SSLTQLETLSFQMNNI----AGAIPS-LANATSLQDI 118
S + ++ + LS E+ L Q + + + I S L +L ++
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 119 YLDNNNFT-----SVPTGCFDGLTNLQVLSLSDNPNLAPW 153
L +N V G +Q LSL +
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAG 100
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 8e-04
Identities = 19/101 (18%), Positives = 39/101 (38%), Gaps = 14/101 (13%)
Query: 180 PDFFDSFSNLQNLRLSYNNFTGSLPASFAKS-----DIQNLWMNDQQLGLSGTLDVLSGM 234
S L+ L L+ + + S +S A + ++ L +++ LG +G L ++ +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 235 ----TQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLT 271
L Q+ L+ ++ + D L L L
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDR-----LQALEKDKPSLR 457
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.8 bits (109), Expect = 4e-06
Identities = 7/45 (15%), Positives = 15/45 (33%)
Query: 108 SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAP 152
A+ + + S+P+ + L L+ S + L
Sbjct: 196 VFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.3 bits (105), Expect = 1e-05
Identities = 27/208 (12%), Positives = 51/208 (24%), Gaps = 27/208 (12%)
Query: 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172
+ ++ + G F G +L+ + +S N L
Sbjct: 29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88
Query: 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLS 232
N+ + P+ F + NLQ L +S S + L + +
Sbjct: 89 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSF 148
Query: 233 GMTQLRQVWL-------------------------HKNQFTGPIPD--LSKCESLFDLSL 265
V L N +P+ L +
Sbjct: 149 VGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDI 208
Query: 266 RDNQLTGVVPASVISLPALLNISLQNNK 293
++ + + +L L S N K
Sbjct: 209 SRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (94), Expect = 3e-04
Identities = 8/43 (18%), Positives = 14/43 (32%), Gaps = 2/43 (4%)
Query: 386 AYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428
+ + L + + + GL L L+ S NL
Sbjct: 196 VFHGASGPVILDISRTRIHSLPSYGLENLKKLRAR--STYNLK 236
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (98), Expect = 5e-05
Identities = 9/44 (20%), Positives = 17/44 (38%), Gaps = 1/44 (2%)
Query: 384 SPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNL 427
+ Y N + L L+ + I + L +D S+N +
Sbjct: 11 AAQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEI 53
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (86), Expect = 0.002
Identities = 24/130 (18%), Positives = 46/130 (35%), Gaps = 3/130 (2%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNN 123
N+ R + L + + ++L Q + + F N I + L+ + ++NN
Sbjct: 16 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI-RKLDGFPLLRRLKTLLVNNN 73
Query: 124 NFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFF 183
+ G L +L L L+ N +L + L SLT L + +
Sbjct: 74 RICRIGEGLDQALPDLTELILT-NNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRL 132
Query: 184 DSFSNLQNLR 193
+ +R
Sbjct: 133 YVIYKVPQVR 142
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.2 bits (85), Expect = 0.002
Identities = 20/119 (16%), Positives = 41/119 (34%), Gaps = 5/119 (4%)
Query: 83 SPEISSLTQLETLSFQMNNIAGAIPSL-ANATSLQDIYLDNNNFTSVPTGCFDGLTNLQV 141
+ + ++ + L + I I +L A I +N + F L L+
Sbjct: 11 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLD--GFPLLRRLKT 67
Query: 142 LSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFT 200
L +++N ++ + L ++ G + D S +L L + N T
Sbjct: 68 LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRNPVT 125
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (93), Expect = 2e-04
Identities = 19/117 (16%), Positives = 38/117 (32%), Gaps = 4/117 (3%)
Query: 84 PEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNF-TSVPTGCFDGLTNLQVL 142
P+ L + ++ L A +L ++Y++N + GL L+ L
Sbjct: 2 PDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNL 61
Query: 143 SLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNF 199
++ + P + L+ L + + L S + LS N
Sbjct: 62 TIVKSGLRFVAPDAF--HFTPRLSRLNLSFNALESLSWKTVQGLSLQEL-VLSGNPL 115
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 3e-04
Identities = 27/188 (14%), Positives = 61/188 (32%), Gaps = 9/188 (4%)
Query: 250 PIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPL-FPSKVQKV 308
L++ L +T V + L + + ++ + + + + ++
Sbjct: 13 TDTALAEKMKT---VLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSIDGVEYLNNLTQI 67
Query: 309 SLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGR 368
+ +N + + D+ A L++ + + +
Sbjct: 68 NFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNL 127
Query: 369 IITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428
L + A + LTSL+ L N +T P L L +L+ LD+S+N +S
Sbjct: 128 TNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKVS 185
Query: 429 GKVPDFGS 436
+
Sbjct: 186 D-ISVLAK 192
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 782 | |||
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.97 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.97 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.97 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.95 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.95 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.94 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.94 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.91 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.85 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.82 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.78 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.77 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.77 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.76 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.76 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.75 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.73 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.69 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.66 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.52 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.51 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.51 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.5 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.5 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.45 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.44 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.39 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.29 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.29 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.29 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.29 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.27 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.64 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.39 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.36 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.01 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.66 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.64 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.5 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.11 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.91 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.78 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.43 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.82 |
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=3e-41 Score=356.27 Aligned_cols=293 Identities=25% Similarity=0.389 Sum_probs=208.4
Q ss_pred ccchhHHHHHHHHHhcCCCCCCCCCCCCCCCc--cccceEeCCC---CCEEEEEeCCCCCCc--ccCccccCCccCceee
Q 003982 24 SLGDDGSVMLKLAQSLQNLPSDWSSTSSTGYC--EWTGINCDNS---NRVTTISLAKSGLSG--TLSPEISSLTQLETLS 96 (782)
Q Consensus 24 ~~~~~~~~l~~~~~~~~~~~~~w~~~~~~~~c--~w~gv~c~~~---~~v~~L~l~~~~l~~--~~~~~l~~l~~L~~L~ 96 (782)
|.++|++||++||+++.++....+|+.++||| .|+||+|+.. .||+.|+|++++++| .+|++|++|++|++|+
T Consensus 3 c~~~e~~aLl~~k~~~~~~~~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~ 82 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLY 82 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEE
T ss_pred CCHHHHHHHHHHHHHCCCCCcCCCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccccccc
Confidence 67899999999999998765322234567888 5999999874 379999999999998 5889999999999999
Q ss_pred ccc-CccCccCC-CCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccc
Q 003982 97 FQM-NNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNAN 174 (782)
Q Consensus 97 L~~-N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~ 174 (782)
|++ |+++|.+| .|.++++|++|+|++|+|+++++..+..+.+|+++++++|++.
T Consensus 83 Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~------------------------ 138 (313)
T d1ogqa_ 83 IGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALS------------------------ 138 (313)
T ss_dssp EEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEE------------------------
T ss_pred cccccccccccccccccccccchhhhccccccccccccccchhhhccccccccccc------------------------
Confidence 997 89998777 7999999999999999998877766666666666666665544
Q ss_pred cCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCCC-CcEEEeecccccCCCCC
Q 003982 175 IFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQ-LRQVWLHKNQFTGPIPD 253 (782)
Q Consensus 175 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~ 253 (782)
+.+|..+.+++.|+++++++|.+++.+|..+.. +.+ ++.+++++|++++..+.
T Consensus 139 --~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~------------------------l~~l~~~l~~~~n~l~~~~~~ 192 (313)
T d1ogqa_ 139 --GTLPPSISSLPNLVGITFDGNRISGAIPDSYGS------------------------FSKLFTSMTISRNRLTGKIPP 192 (313)
T ss_dssp --SCCCGGGGGCTTCCEEECCSSCCEEECCGGGGC------------------------CCTTCCEEECCSSEEEEECCG
T ss_pred --ccCchhhccCcccceeecccccccccccccccc------------------------ccccccccccccccccccccc
Confidence 444555555555555555555555555544321 222 24555555555554443
Q ss_pred -CCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCCCCCCccEEEccCCcCCCCCCCCCCCCChhhhh
Q 003982 254 -LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTT 332 (782)
Q Consensus 254 -~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~ 332 (782)
+..+ .+..++++.|.+.+.+|..+..+++|+.+++++|.+.+.+|.
T Consensus 193 ~~~~l-~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~-------------------------------- 239 (313)
T d1ogqa_ 193 TFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-------------------------------- 239 (313)
T ss_dssp GGGGC-CCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG--------------------------------
T ss_pred ccccc-cccccccccccccccccccccccccccccccccccccccccc--------------------------------
Confidence 3333 334677777777777777777777788887777777654331
Q ss_pred HHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccccCccccccccCCeEecccccccccCCccCC
Q 003982 333 LLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLT 412 (782)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~ 412 (782)
+...++|+.|+|++|+|+|.+|..|+++++|++|+|++|+|+|.+|+ ++
T Consensus 240 ------------------------------~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~ 288 (313)
T d1ogqa_ 240 ------------------------------VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GG 288 (313)
T ss_dssp ------------------------------CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-ST
T ss_pred ------------------------------cccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cc
Confidence 22334666777777777777777777777888888888888777774 56
Q ss_pred CCCCCCeEecCCCc-CCCC
Q 003982 413 KLASLQNLDVSNNN-LSGK 430 (782)
Q Consensus 413 ~l~~L~~L~ls~N~-l~g~ 430 (782)
++++|+.+++++|+ ++|.
T Consensus 289 ~L~~L~~l~l~~N~~l~g~ 307 (313)
T d1ogqa_ 289 NLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp TGGGSCGGGTCSSSEEEST
T ss_pred cCCCCCHHHhCCCccccCC
Confidence 77777777777776 4554
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-40 Score=340.20 Aligned_cols=190 Identities=24% Similarity=0.373 Sum_probs=161.6
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
.++|++.+.||+|+||+||+|.. .+|+.||||++..... ....+++++|++++++++||||+++++++.+++..|+||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 46899999999999999999965 5789999999976542 234467899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++|+|.+++.. ...+++.++..++.|+++||+|||+ +||+||||||+|||+++++.+||+|||+|+...
T Consensus 83 Ey~~gg~L~~~l~~-----~~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~ 154 (271)
T d1nvra_ 83 EYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFR 154 (271)
T ss_dssp ECCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECE
T ss_pred eccCCCcHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeec
Confidence 99999999998854 3469999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCc-eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKY-SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.... ......+||+.|||||++.+.. ..+.++||||+||+
T Consensus 155 ~~~~~~~~~~~~GT~~Y~APE~~~~~~--~~~~~~DiwSlGvi 195 (271)
T d1nvra_ 155 YNNRERLLNKMCGTLPYVAPELLKRRE--FHAEPVDVWSCGIV 195 (271)
T ss_dssp ETTEECCBCCCCSCGGGSCTHHHHCSS--BCHHHHHHHHHHHH
T ss_pred cCCccccccceeeCcCccCHhHhcCCC--CCCCceeeeHhHHH
Confidence 4332 2234568999999999987651 23678999999996
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-40 Score=338.46 Aligned_cols=185 Identities=26% Similarity=0.440 Sum_probs=164.0
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
++|++.+.||+|+||+||+|.. .+|+.||||+++... ....+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc--ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 4799999999999999999954 579999999997654 2345789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++|+|.+++.+ ..+++.++..++.|++.||+|||+ +||+||||||+|||++.++++||+|||+|+....
T Consensus 98 y~~gg~L~~~~~~------~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 98 YLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (293)
T ss_dssp CCTTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecCCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence 9999999988754 358999999999999999999999 8999999999999999999999999999998765
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... .....+||+.|||||++.+. .++.++||||+||+
T Consensus 169 ~~~-~~~~~~gt~~Y~aPE~~~~~---~~~~~~DiwSlGvi 205 (293)
T d1yhwa1 169 EQS-KRSTMVGTPYWMAPEVVTRK---AYGPKVDIWSLGIM 205 (293)
T ss_dssp TTC-CBCCCCSCGGGCCHHHHSSS---CBCTHHHHHHHHHH
T ss_pred ccc-cccccccCCCccChhhhcCC---CCCchhceehHhHH
Confidence 432 22445799999999998875 45778999999986
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-40 Score=334.75 Aligned_cols=186 Identities=29% Similarity=0.519 Sum_probs=164.1
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCC-hhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
++|++.+.||+|+||+||+|.. .+++.||+|++.+.... ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 5799999999999999999965 57899999999764322 234677899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++|+|.+++... ..+++.++..++.|+++||+|||+ +||+||||||+|||+++++.+||+|||+|+...
T Consensus 86 Ey~~~g~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~ 157 (263)
T d2j4za1 86 EYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 157 (263)
T ss_dssp ECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred eecCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecC
Confidence 999999999999763 458999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.... ....||+.|||||++.+. .++.++||||+||+
T Consensus 158 ~~~~---~~~~Gt~~Y~APE~~~~~---~~~~~~DiwSlGvi 193 (263)
T d2j4za1 158 SSRR---TTLCGTLDYLPPEMIEGR---MHDEKVDLWSLGVL 193 (263)
T ss_dssp CCCC---EETTEEGGGCCHHHHTTC---CCCTTHHHHHHHHH
T ss_pred CCcc---cccCCCCcccCHHHHcCC---CCCchhhhhhHhHH
Confidence 5332 345799999999999875 45778999999986
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-40 Score=337.32 Aligned_cols=196 Identities=20% Similarity=0.361 Sum_probs=155.7
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEe--CCeEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN--GSERLL 656 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~--~~~~~l 656 (782)
.++|++.+.||+|+||+||+|+. .+|+.||||++......+...+.+.+|++++++++||||+++++++.+ .+..|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 36799999999999999999954 578999999998876666677889999999999999999999999865 456899
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeEEcCCCCCCEEECCCCcEEEEeeccc
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA--QQSFIHRDLKPSNILIGDDMRAKVADFGLV 734 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--~~~ivHrDikp~NIll~~~~~~kL~DfG~a 734 (782)
|||||++|+|.+++.+..+. ...+++.+++.++.|++.||+|||+.. ..+|+||||||+|||++.++.+||+|||+|
T Consensus 83 vmEy~~~g~L~~~i~~~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEecCCCCcHHHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 99999999999998765433 346899999999999999999999821 124999999999999999999999999999
Q ss_pred eecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 735 KNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 735 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+....... .....+||+.|||||++.+. .++.++||||+||+
T Consensus 162 ~~~~~~~~-~~~~~~gt~~Y~APE~l~~~---~~~~~~DIwSlGvi 203 (269)
T d2java1 162 RILNHDTS-FAKAFVGTPYYMSPEQMNRM---SYNEKSDIWSLGCL 203 (269)
T ss_dssp HHC------------CCCSCCCHHHHTTC---CCCHHHHHHHHHHH
T ss_pred eecccCCC-ccccCCCCcccCCHHHHcCC---CCChHHHHHhhCHH
Confidence 88754332 22346799999999998765 45789999999986
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-39 Score=335.67 Aligned_cols=189 Identities=24% Similarity=0.403 Sum_probs=162.4
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
++|++.+.||+|+||+||+|.. .+++.||||++.+... .....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5799999999999999999965 5789999999976432 2335678999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++|+|.+++... +.+++.++..++.|++.||+|||+ .||+||||||+|||+++++.+||+|||+|+...
T Consensus 88 Ey~~gg~L~~~~~~~-----~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 159 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 159 (288)
T ss_dssp CCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EccCCCCHHHhhhcc-----CCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecc
Confidence 999999999988763 458999999999999999999999 899999999999999999999999999999875
Q ss_pred CCCc-eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKY-SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.... ......+||+.|||||++.+. .++.++||||+||+
T Consensus 160 ~~~~~~~~~~~~GT~~Y~APE~~~~~---~~~~~~DiwSlGvi 199 (288)
T d1uu3a_ 160 PESKQARANSFVGTAQYVSPELLTEK---SACKSSDLWALGCI 199 (288)
T ss_dssp ----------CCCCGGGCCHHHHHTC---CCCHHHHHHHHHHH
T ss_pred cCCcccccccccCCccccCceeeccC---CCCcccceehhhHH
Confidence 4332 223346799999999998775 45789999999986
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-39 Score=331.76 Aligned_cols=187 Identities=28% Similarity=0.465 Sum_probs=154.7
Q ss_pred cCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEc
Q 003982 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 660 (782)
++|++.+.||+|+||+||+|++.+++.||||+++... ...++|.+|++++++++||||+++++++.+++..++||||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc---CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 4688899999999999999998888999999997644 3347899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~ 740 (782)
+++|+|.+++... ...+++..+..++.|+++||+|||+ ++|+||||||+||++++++.+||+|||+|+.....
T Consensus 82 ~~~g~L~~~l~~~----~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 154 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 154 (263)
T ss_dssp CTTCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred cCCCcHHHHhhcc----ccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCC
Confidence 9999999998652 3458999999999999999999999 89999999999999999999999999999877654
Q ss_pred CceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 741 KYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.........||+.|+|||++.+. .++.++|||||||+
T Consensus 155 ~~~~~~~~~gt~~y~aPE~l~~~---~~~~k~DVwS~Gvi 191 (263)
T d1sm2a_ 155 QYTSSTGTKFPVKWASPEVFSFS---RYSSKSDVWSFGVL 191 (263)
T ss_dssp ----------CTTSCCHHHHTTC---CCCHHHHHHHHHHH
T ss_pred CceeecceecCcccCChHHhcCC---CCCchhhhcchHHH
Confidence 44344445789999999998875 46889999999986
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-39 Score=331.39 Aligned_cols=191 Identities=28% Similarity=0.472 Sum_probs=158.8
Q ss_pred hcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
.++|++.+.||+|+||+||+|+.. ..||||+++.........+.|++|++++++++||||+++++++. .+..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEe
Confidence 467999999999999999999864 36999999876656667889999999999999999999999875 456899999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++|+|.+++... ...+++.++..++.|+++||+|||+ +|||||||||+|||++.++.+||+|||+|+....
T Consensus 84 y~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 84 WCEGSSLYHHLHII----ETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp CCCEEEHHHHHHTS----CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred cCCCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 99999999999652 2458999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCc-eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKY-SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... .......||+.|||||++.+.-.-.++.++|||||||+
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~ 198 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIV 198 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHH
T ss_pred cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHH
Confidence 322 22344679999999999865322245789999999986
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-39 Score=333.59 Aligned_cols=190 Identities=26% Similarity=0.387 Sum_probs=163.1
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
+.|++.+.||+|+||+||+|+. .+++.||||+++... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 5689999999999999999965 578999999997654 3456789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
||++|+|.+++.+. ..++++.++..++.|++.||+|||+ +||+||||||+|||++.++++||+|||+|+....
T Consensus 90 y~~~g~L~~~~~~~----~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 90 FCAGGAVDAVMLEL----ERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp CCTTEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred cCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCC
Confidence 99999999988653 2458999999999999999999999 8999999999999999999999999999976543
Q ss_pred CCceeeecccccccccCccccccch--hhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHW--MILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~dvws~Gvv 780 (782)
.. .......||+.|||||++.... ..+++.++||||+||+
T Consensus 163 ~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvi 204 (288)
T d2jfla1 163 TI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGIT 204 (288)
T ss_dssp HH-HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHH
T ss_pred Cc-ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHH
Confidence 21 1223457999999999875331 2246788999999986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-39 Score=329.87 Aligned_cols=188 Identities=28% Similarity=0.489 Sum_probs=164.0
Q ss_pred hcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
.++|++.+.||+|+||+||+|...+++.||||+++... ...+.|.+|++++++++||||+++++++.+ +..++|||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E 87 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc---CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence 35788999999999999999998888999999997644 345789999999999999999999998754 56799999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++|+|.+++..... ..+++.++..++.|+++||.|||+ ++|+||||||+|||+++++.+||+|||+|+....
T Consensus 88 y~~~g~L~~~~~~~~~---~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 88 YMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp CCTTCBHHHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred eCCCCcHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccC
Confidence 9999999998755332 348999999999999999999999 8999999999999999999999999999998876
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..........||+.|||||++.+. .++.++|||||||+
T Consensus 162 ~~~~~~~~~~gt~~y~APE~~~~~---~~~~~sDvwS~Gvv 199 (272)
T d1qpca_ 162 NEYTAREGAKFPIKWTAPEAINYG---TFTIKSDVWSFGIL 199 (272)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHC---EECHHHHHHHHHHH
T ss_pred CccccccccCCcccccChHHHhCC---CCCchhhhhhhHHH
Confidence 554444556789999999998764 45789999999986
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.6e-39 Score=333.84 Aligned_cols=189 Identities=29% Similarity=0.495 Sum_probs=166.1
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
.++|++.+.||+|+||+||+|.+ .+++.||||+++... ...++|.+|++++++++||||+++++++.+++..++||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc---chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 35788899999999999999965 468899999997654 34578999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++|+|.+++.+.. ...+++..+..++.|+++||+|||+ +||+||||||+|||+++++++||+|||+|+...
T Consensus 93 E~~~~g~l~~~l~~~~---~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 93 EFMTYGNLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp ECCTTCBHHHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred ecccCcchHHHhhhcc---ccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecC
Confidence 9999999999987632 3468999999999999999999999 899999999999999999999999999998876
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
...........||+.|+|||++.+. .++.++||||+||+
T Consensus 167 ~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~k~DiwS~Gv~ 205 (287)
T d1opja_ 167 GDTYTAHAGAKFPIKWTAPESLAYN---KFSIKSDVWAFGVL 205 (287)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHC---CCSHHHHHHHHHHH
T ss_pred CCCceeeccccccccccChHHHcCC---CCCchhhhhhHHHH
Confidence 6554444555689999999988765 46789999999986
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.1e-39 Score=333.70 Aligned_cols=187 Identities=26% Similarity=0.371 Sum_probs=161.4
Q ss_pred cCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCC-hhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
+.|+..+.||+|+||+||+|. ..+++.||||++...... ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 358999999999999999995 467899999999866533 335577999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
|||++|++..++.. ..++++.++..++.|++.||.|||+ +||+||||||+|||+++++.+||+|||+|+...
T Consensus 95 E~~~~g~l~~~~~~-----~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH-----KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (309)
T ss_dssp ECCSEEHHHHHHHH-----TSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EecCCCchHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccC
Confidence 99999988766544 2468999999999999999999999 899999999999999999999999999998654
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.. ....||+.|||||++.+...-.++.++||||+||+
T Consensus 167 ~~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvi 203 (309)
T d1u5ra_ 167 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 203 (309)
T ss_dssp SB-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHH
T ss_pred CC-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHH
Confidence 32 23579999999999865422245778999999986
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-38 Score=324.37 Aligned_cols=182 Identities=24% Similarity=0.358 Sum_probs=157.4
Q ss_pred CccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEe----CCeEEEEE
Q 003982 584 SEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN----GSERLLVY 658 (782)
Q Consensus 584 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~----~~~~~lv~ 658 (782)
+..+.||+|+||+||+|.. .+++.||+|++..........+.+.+|++++++++||||+++++++.+ ....|+||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 5667899999999999955 578899999998776666677889999999999999999999999875 34579999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEEcCCCCCCEEEC-CCCcEEEEeeccce
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS--FIHRDLKPSNILIG-DDMRAKVADFGLVK 735 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~--ivHrDikp~NIll~-~~~~~kL~DfG~a~ 735 (782)
||+++|+|.+++.+. ..+++.++..++.|+++||+|||+ ++ |+||||||+|||++ +++.+||+|||+|+
T Consensus 92 E~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp ECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred eCCCCCcHHHHHhcc-----ccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 999999999999763 458999999999999999999998 67 99999999999997 57899999999998
Q ss_pred ecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 736 NAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 736 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
...... ....+||+.|||||++.+. ++.++||||+||+
T Consensus 164 ~~~~~~---~~~~~GT~~Y~aPE~~~~~----~~~~~DIwSlGvi 201 (270)
T d1t4ha_ 164 LKRASF---AKAVIGTPEFMAPEMYEEK----YDESVDVYAFGMC 201 (270)
T ss_dssp GCCTTS---BEESCSSCCCCCGGGGGTC----CCTHHHHHHHHHH
T ss_pred eccCCc---cCCcccCccccCHHHhCCC----CCCcCchhhHHHH
Confidence 654432 2345799999999998774 4678999999986
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-39 Score=343.00 Aligned_cols=187 Identities=27% Similarity=0.398 Sum_probs=162.4
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
.++|++.+.||+|+||+||+|.. .+|+.||+|+++... .....+++.+|++++++++||||+++++++.+++..|+||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56899999999999999999964 578999999997643 2345678999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+++|+|.+++.+. +.+++.++..++.|++.||.|||+ ++||+||||||+|||+++++++||+|||+|+...
T Consensus 84 Ey~~gg~L~~~l~~~-----~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp ECCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EcCCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 999999999999763 358999999999999999999996 1489999999999999999999999999998664
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+.. ....+||+.|||||++.+. .++.++||||+||+
T Consensus 157 ~~~---~~~~~GT~~Y~APEvl~~~---~y~~~~DiWSlGvi 192 (322)
T d1s9ja_ 157 DSM---ANSFVGTRSYMSPERLQGT---HYSVQSDIWSMGLS 192 (322)
T ss_dssp HHT---C---CCSSCCCCHHHHHCS---CCCTTHHHHHHHHH
T ss_pred CCc---cccccCCccccCchHHcCC---CCCcHHHHHHHHHH
Confidence 322 2345899999999998875 45778999999986
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-38 Score=335.37 Aligned_cols=188 Identities=28% Similarity=0.363 Sum_probs=165.6
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
++|++.+.||+|+||.||+|+. .+|+.||||++++... .....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5799999999999999999954 6799999999976532 2335678899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
|||++|+|.+++... ..+++.++..++.|++.||+|||+ +||+||||||+|||+++++.+||+|||+|+...
T Consensus 85 ey~~gg~L~~~~~~~-----~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 85 EYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp ECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eccCCCchhhhhhcc-----cCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccc
Confidence 999999999998763 458999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.... .....+||+.|||||++.+. +++.++|+||+||+
T Consensus 157 ~~~~-~~~~~~GT~~Y~aPE~~~~~---~y~~~~DiwSlGvi 194 (337)
T d1o6la_ 157 SDGA-TMKTFCGTPEYLAPEVLEDN---DYGRAVDWWGLGVV 194 (337)
T ss_dssp CTTC-CBCCCEECGGGCCGGGGSSS---CBCTTHHHHHHHHH
T ss_pred cCCc-ccccceeCHHHhhhhhccCC---CCChhhcccchhhH
Confidence 4332 23446899999999999875 56778999999986
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-38 Score=319.67 Aligned_cols=187 Identities=30% Similarity=0.470 Sum_probs=166.3
Q ss_pred cCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEc
Q 003982 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 660 (782)
++|++.+.||+|+||+||+|+.++++.||||+++.... ..++|.+|++++++++||||+++++++.+++..++||||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~---~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS---CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC---CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 57899999999999999999988888999999986543 346899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~ 740 (782)
+++|++.+++.... ..+++..+..++.|+++||+|||+ .||+||||||+||++++++.+||+|||+|+.....
T Consensus 81 ~~~g~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 153 (258)
T d1k2pa_ 81 MANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153 (258)
T ss_dssp CTTEEHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred cCCCcHHHhhhccc----cCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence 99999999876532 358899999999999999999999 89999999999999999999999999999877665
Q ss_pred CceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 741 KYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.........||+.|+|||++.+. .++.++|||||||+
T Consensus 154 ~~~~~~~~~~t~~y~aPE~~~~~---~~~~ksDiwS~G~~ 190 (258)
T d1k2pa_ 154 EYTSSVGSKFPVRWSPPEVLMYS---KFSSKSDIWAFGVL 190 (258)
T ss_dssp SCCCCCCSCCCGGGCCHHHHHHC---CCCHHHHHHHHHHH
T ss_pred CceeecccCCCCCcCCcHHhcCC---CCCcceeecccchh
Confidence 54444456789999999998765 46789999999986
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-38 Score=331.73 Aligned_cols=188 Identities=29% Similarity=0.447 Sum_probs=147.2
Q ss_pred HhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
+.+.|++.+.||+|+||+||+|.. .+++.||||++.+.... ...+.+.+|++++++++||||+++++++.+++..|+|
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 356799999999999999999965 57899999999765432 2346688999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEC---CCCcEEEEeeccc
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIG---DDMRAKVADFGLV 734 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~---~~~~~kL~DfG~a 734 (782)
||||+||+|.+++.+ ...+++.++..++.|++.||+|||+ +||+||||||+||++. +++.+||+|||+|
T Consensus 86 mE~~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a 157 (307)
T d1a06a_ 86 MQLVSGGELFDRIVE-----KGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLS 157 (307)
T ss_dssp ECCCCSCBHHHHHHT-----CSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred EeccCCCcHHHhhhc-----ccCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEecccee
Confidence 999999999999965 3469999999999999999999999 8999999999999995 5789999999999
Q ss_pred eecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 735 KNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 735 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+....... ....+||+.|||||++.+. .++.++||||+||+
T Consensus 158 ~~~~~~~~--~~~~~GT~~y~APE~~~~~---~~~~~~DiwSlGvi 198 (307)
T d1a06a_ 158 KMEDPGSV--LSTACGTPGYVAPEVLAQK---PYSKAVDCWSIGVI 198 (307)
T ss_dssp -----------------CTTSCHHHHTTC---CCCTHHHHHHHHHH
T ss_pred EEccCCCe--eeeeeeCccccCcHHHcCC---CCCcHHHhhhhhHH
Confidence 87654332 2345799999999998875 45789999999986
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3e-38 Score=331.17 Aligned_cols=185 Identities=28% Similarity=0.420 Sum_probs=163.7
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
++|++.+.||+|+||+||+|+. .+|+.||||++++... .....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5799999999999999999965 5799999999976432 2235678999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||++||++..++.. ...+++.++..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+|+...
T Consensus 84 E~~~gg~l~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~ 155 (316)
T d1fota_ 84 DYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 155 (316)
T ss_dssp CCCCSCBHHHHHHH-----TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred eecCCccccccccc-----cccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEec
Confidence 99999999998876 3457899999999999999999998 899999999999999999999999999999876
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... ...+||+.|||||++.+. +++.++||||+||+
T Consensus 156 ~~~----~~~~Gt~~Y~APE~l~~~---~y~~~~DiwSlGvi 190 (316)
T d1fota_ 156 DVT----YTLCGTPDYIAPEVVSTK---PYNKSIDWWSFGIL 190 (316)
T ss_dssp SCB----CCCCSCTTTCCHHHHTTC---CBCTTHHHHHHHHH
T ss_pred ccc----ccccCcccccCHHHHcCC---CCCchhhccccchh
Confidence 533 245799999999998875 45678999999986
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.9e-38 Score=332.67 Aligned_cols=187 Identities=26% Similarity=0.401 Sum_probs=164.0
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
.++|++.+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 46899999999999999999964 578999999997654 345678999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECC--CCcEEEEeecccee
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD--DMRAKVADFGLVKN 736 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~--~~~~kL~DfG~a~~ 736 (782)
|||++|+|.+++.+. ...+++.++..++.||+.||+|||+ +|||||||||+|||++. ++.+||+|||+|+.
T Consensus 103 E~~~gg~L~~~l~~~----~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~ 175 (350)
T d1koaa2 103 EFMSGGELFEKVADE----HNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175 (350)
T ss_dssp CCCCSCBHHHHHTCT----TSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EcCCCCCHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchhee
Confidence 999999999998542 3459999999999999999999999 89999999999999964 57899999999998
Q ss_pred cCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 737 APDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
....... ....||+.|||||++.+. +++.++||||+||+
T Consensus 176 ~~~~~~~--~~~~gT~~Y~aPEv~~~~---~~~~~~DiwSlGvi 214 (350)
T d1koaa2 176 LDPKQSV--KVTTGTAEFAAPEVAEGK---PVGYYTDMWSVGVL 214 (350)
T ss_dssp CCTTSCE--EEECSCTTTCCHHHHHTC---CBCHHHHHHHHHHH
T ss_pred ccccccc--ceecCcccccCHHHHcCC---CCChhHhhhhhhHH
Confidence 7654432 345799999999998775 45788999999996
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.4e-37 Score=330.62 Aligned_cols=187 Identities=21% Similarity=0.341 Sum_probs=163.8
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
.++|++.+.||+|+||+||+|.. .+|+.||||+++... ....+.+++|++++++++||||+++++++.+++..|+||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 46799999999999999999954 679999999997654 344567899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEEC--CCCcEEEEeecccee
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIG--DDMRAKVADFGLVKN 736 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~--~~~~~kL~DfG~a~~ 736 (782)
|||++|+|.+.+... ..++++.++..++.||+.||+|||+ +||+||||||+|||++ .++.+||+|||+|+.
T Consensus 106 E~~~gg~L~~~~~~~----~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~ 178 (352)
T d1koba_ 106 EFLSGGELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATK 178 (352)
T ss_dssp ECCCCCBHHHHTTCT----TCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EcCCCChHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeeccccee
Confidence 999999998877542 3459999999999999999999998 8999999999999998 578999999999998
Q ss_pred cCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 737 APDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
...... .....||+.|||||++.+. .++.++||||+||+
T Consensus 179 ~~~~~~--~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlGvi 217 (352)
T d1koba_ 179 LNPDEI--VKVTTATAEFAAPEIVDRE---PVGFYTDMWAIGVL 217 (352)
T ss_dssp CCTTSC--EEEECSSGGGCCHHHHTTC---CBCHHHHHHHHHHH
T ss_pred cCCCCc--eeeccCcccccCHHHHcCC---CCCCccchHHHHHH
Confidence 866443 2335789999999998875 45789999999986
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-37 Score=323.58 Aligned_cols=189 Identities=28% Similarity=0.424 Sum_probs=164.6
Q ss_pred HhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCCh----hhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCe
Q 003982 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGN----KGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE 653 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~ 653 (782)
+.++|++.+.||+|+||+||+|.. .+|+.||||++++..... ...+.+.+|++++++++||||+++++++.+++.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 346899999999999999999965 578999999997654322 246789999999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCC----cEEEE
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM----RAKVA 729 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~----~~kL~ 729 (782)
.|+|||||++|+|.+++.+. ..+++.++..++.|++.||+|||+ .||+||||||+||+++.++ .+|++
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~-----~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~ 159 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKII 159 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEEC
T ss_pred EEEEEEcCCCccccchhccc-----cccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEec
Confidence 99999999999999999763 358999999999999999999999 8999999999999998776 59999
Q ss_pred eeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 730 DFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 730 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|||+|+....... .....||+.|+|||++.+. .++.++||||+||+
T Consensus 160 DfG~a~~~~~~~~--~~~~~~t~~y~APE~~~~~---~~~~~~DiwSlGvi 205 (293)
T d1jksa_ 160 DFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYE---PLGLEADMWSIGVI 205 (293)
T ss_dssp CCTTCEECTTSCB--CSCCCCCGGGCCHHHHTTC---CBCTHHHHHHHHHH
T ss_pred chhhhhhcCCCcc--ccccCCCCcccCHHHHcCC---CCCCcccchhhhHH
Confidence 9999988765432 2345789999999998875 35778999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-37 Score=318.55 Aligned_cols=182 Identities=26% Similarity=0.389 Sum_probs=152.1
Q ss_pred ceeecccceEEEEEEeC---CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEccCC
Q 003982 587 NILGRGGFGVVYGGELP---DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPR 663 (782)
Q Consensus 587 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~ 663 (782)
++||+|+||+||+|.+. .++.||||+++....+....++|.+|++++++++||||+++++++.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999653 34689999997655445566789999999999999999999999865 467899999999
Q ss_pred CCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCCCce
Q 003982 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743 (782)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~~~~ 743 (782)
|+|.+++.+ ...+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+|+........
T Consensus 92 g~L~~~l~~-----~~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 92 GPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp EEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence 999999876 3468999999999999999999999 89999999999999999999999999999987654332
Q ss_pred e--eecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 744 V--ETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 744 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
. .....||+.|||||++.+. .++.++|||||||+
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~---~~~~~sDiwS~Gv~ 199 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYY---KFSSKSDVWSFGVL 199 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHC---EEEHHHHHHHHHHH
T ss_pred cccccccCCCceecCchhhcCC---CCCchhhhccchhh
Confidence 2 2335689999999988765 46789999999986
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-37 Score=324.65 Aligned_cols=189 Identities=26% Similarity=0.419 Sum_probs=149.7
Q ss_pred cCCCccceeecccceEEEEEEeC-CC---cEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGELP-DG---TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 656 (782)
++|++.+.||+|+||+||+|... ++ ..||||++.... .....++|.+|++++++++||||+++++++.+++..++
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56888899999999999999654 33 258899886543 34566789999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecccee
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~ 736 (782)
|||||++|+|.+++... ...+++.++..++.|+++||+|||+ +||+||||||+|||++.++++||+|||+|+.
T Consensus 105 v~Ey~~~g~L~~~~~~~----~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 177 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQN----DGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177 (299)
T ss_dssp EEECCTTEEHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEecCCCcceeeeccc----cCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceE
Confidence 99999999999988652 3458999999999999999999999 8999999999999999999999999999987
Q ss_pred cCCCCce----eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 737 APDGKYS----VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 737 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
....... ......||+.|||||++.+. .++.++|||||||+
T Consensus 178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~sDvwS~Gvv 222 (299)
T d1jpaa_ 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYR---KFTSASDVWSYGIV 222 (299)
T ss_dssp ------------------CGGGSCHHHHHSC---CCCHHHHHHHHHHH
T ss_pred ccCCCCcceeeecccccCCccccCHHHHhcC---CCCcccccccchHH
Confidence 6543321 11224579999999998765 45778999999986
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-37 Score=330.07 Aligned_cols=185 Identities=29% Similarity=0.362 Sum_probs=164.1
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 658 (782)
++|++++.||+|+||.||+|+. .+|+.||||++.+... .....+.+.+|++++++++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5799999999999999999965 5799999999975432 2345678999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecC
Q 003982 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (782)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~ 738 (782)
||+.+|++.+++.+. +.+++.++..++.||+.||.|||+ +|||||||||+|||++.++.+||+|||+|+...
T Consensus 121 e~~~~g~l~~~l~~~-----~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~ 192 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp ECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred ccccccchhhhHhhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeecc
Confidence 999999999998763 358999999999999999999999 899999999999999999999999999999876
Q ss_pred CCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 739 DGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... ....||+.|||||++.+. +++.++||||+||+
T Consensus 193 ~~~----~~~~Gt~~Y~APE~~~~~---~~~~~~DiwSlGvi 227 (350)
T d1rdqe_ 193 GRT----WTLCGTPEALAPEIILSK---GYNKAVDWWALGVL 227 (350)
T ss_dssp SCB----CCCEECGGGCCHHHHTTC---CBCTHHHHHHHHHH
T ss_pred ccc----ccccCccccCCHHHHcCC---CCCccccccchhHH
Confidence 533 235799999999998875 45778999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-37 Score=320.90 Aligned_cols=187 Identities=30% Similarity=0.495 Sum_probs=155.7
Q ss_pred cCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEc
Q 003982 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 660 (782)
++|++.+.||+|+||+||+|...+++.||||+++... ...+.|.+|+.++++++||||+++++++. .+..++||||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey 92 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 92 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc---CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEe
Confidence 5799999999999999999998888899999997654 23478999999999999999999999985 4568999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~ 740 (782)
+++|++..++..... ..+++.++..++.|++.||+|||+ .||+||||||+|||+++++++||+|||+|+.....
T Consensus 93 ~~~g~l~~~~~~~~~---~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 93 MSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp CTTCBHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred cCCCchhhhhhhccc---ccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 999999998866432 358999999999999999999999 89999999999999999999999999999877654
Q ss_pred CceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 741 KYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.........||+.|+|||++.+. .++.++||||+||+
T Consensus 167 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDI~S~Gii 203 (285)
T d1fmka3 167 EYTARQGAKFPIKWTAPEAALYG---RFTIKSDVWSFGIL 203 (285)
T ss_dssp ---------CCGGGSCHHHHHHC---CCCHHHHHHHHHHH
T ss_pred CceeeccccccccccChHHHhCC---CCCcHHhhhcchHH
Confidence 44444445789999999998765 45789999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-37 Score=317.69 Aligned_cols=188 Identities=26% Similarity=0.406 Sum_probs=158.5
Q ss_pred cCCCccce-eecccceEEEEEEeC---CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEE
Q 003982 581 DNFSEANI-LGRGGFGVVYGGELP---DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656 (782)
Q Consensus 581 ~~y~~~~~-lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 656 (782)
++|.+.+. ||+|+||+||+|... ++..||||+++... .....++|.+|++++++++||||+++++++.+ +..|+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 45666774 999999999999553 35579999997643 34567889999999999999999999999865 56899
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecccee
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~ 736 (782)
||||+++|+|.+++... ...+++.++..++.|+++||+|||+ +||+||||||+||+++.++.+||+|||+|+.
T Consensus 86 vmE~~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp EEECCTTEEHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEeCCCCcHHHHhhcc----ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhc
Confidence 99999999999987542 2468999999999999999999999 8999999999999999999999999999998
Q ss_pred cCCCCcee--eecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 737 APDGKYSV--ETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 737 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
........ .....||+.|||||++.+. .++.++|||||||+
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDVwS~Gv~ 201 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECINFR---KFSSRSDVWSYGVT 201 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHC---EECHHHHHHHHHHH
T ss_pred ccccccccccccccccCccccChHHHhCC---CCCccchhhcchHH
Confidence 76543322 2334689999999998765 46789999999986
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-37 Score=318.00 Aligned_cols=189 Identities=26% Similarity=0.436 Sum_probs=153.9
Q ss_pred cCCCccceeecccceEEEEEEeCCC-----cEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEE
Q 003982 581 DNFSEANILGRGGFGVVYGGELPDG-----TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL 655 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~ 655 (782)
+.|++.++||+|+||.||+|.+... ..||||++.... ......+|.+|++++++++||||+++++++.+.+..+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 4578899999999999999965432 369999997543 3445667999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccce
Q 003982 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (782)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~ 735 (782)
+||||+.++++.+.+... ...+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+|+
T Consensus 86 ~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 86 IITEYMENGALDKFLREK----DGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp EEEECCTTEEHHHHHHHT----TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEEecccCcchhhhhcc----cccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhh
Confidence 999999999999887653 3458999999999999999999999 899999999999999999999999999998
Q ss_pred ecCCCCce--eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 736 NAPDGKYS--VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 736 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
........ ......||+.|||||++.+. .++.++|||||||+
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~---~~~~~sDI~S~Gvi 202 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAISYR---KFTSASDVWSFGIV 202 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSC---CCCHHHHHHHHHHH
T ss_pred cccCCCccceEeccCCCCccccCHHHHccC---CCCCcccccccHHH
Confidence 76543321 22334689999999988775 46789999999986
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.1e-36 Score=313.01 Aligned_cols=191 Identities=30% Similarity=0.385 Sum_probs=163.6
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCCh-------hhHHHHHHHHHHHHhcC-CCCcceEEeEEEe
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGN-------KGLSEFQAEIAVLTKVR-HRHLVALLGYCIN 650 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~ 650 (782)
.++|++.+.||+|+||+||+|+. .+|+.||||++++..... ...+.+.+|++++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 47899999999999999999965 578999999997754332 12346889999999997 9999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEe
Q 003982 651 GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVAD 730 (782)
Q Consensus 651 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~D 730 (782)
++..|+||||+++|+|.+++... .++++.++..++.||+.||+|||+ +||+||||||+||+++.++.+||+|
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~D 153 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTD 153 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEcc
Confidence 99999999999999999999762 458999999999999999999998 8999999999999999999999999
Q ss_pred eccceecCCCCceeeecccccccccCccccccc---hhhhHHHHHHHHHhccc
Q 003982 731 FGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKH---WMILCQMTGLIWLHGSV 780 (782)
Q Consensus 731 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~~dvws~Gvv 780 (782)
||+|+...... ......||+.|+|||++.+. -...++.++||||+||+
T Consensus 154 FG~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvi 204 (277)
T d1phka_ 154 FGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 204 (277)
T ss_dssp CTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHH
T ss_pred chheeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchh
Confidence 99999876543 22345799999999987642 11234668999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-37 Score=323.67 Aligned_cols=193 Identities=26% Similarity=0.459 Sum_probs=158.6
Q ss_pred cCCCccceeecccceEEEEEEeCC-C-----cEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCCe
Q 003982 581 DNFSEANILGRGGFGVVYGGELPD-G-----TKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSE 653 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~ 653 (782)
++|++.++||+|+||+||+|.... + ..||||++.... .......+.+|+++++++ +||||+++++++.+.+.
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 578999999999999999996532 2 369999986543 234456789999999998 89999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhhccC------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCC
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHDH------------------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKP 715 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp 715 (782)
.++|||||++|+|.++++..... ....+++.+++.++.|+++||+|||+ ++||||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCch
Confidence 99999999999999999764321 12358999999999999999999999 8999999999
Q ss_pred CCEEECCCCcEEEEeeccceecCCCCc-eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 716 SNILIGDDMRAKVADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 716 ~NIll~~~~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+||+++.++.+||+|||+|+....... .......||+.|||||++.+. .++.++||||+||+
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~~~DiwS~Gvi 255 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG---IYTIKSDVWSYGIL 255 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC---CCCHHHHHHHHHHH
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC---CCCcceeccchhHH
Confidence 999999999999999999987654432 233345689999999988765 45789999999986
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9.8e-37 Score=325.81 Aligned_cols=187 Identities=25% Similarity=0.398 Sum_probs=158.1
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCCh-hhHHHH---HHHHHHHHhcCCCCcceEEeEEEeCCeEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGN-KGLSEF---QAEIAVLTKVRHRHLVALLGYCINGSERL 655 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~---~~E~~~l~~l~h~nI~~~~~~~~~~~~~~ 655 (782)
++|++.+.||+|+||.||+|+. .+|+.||||++.+..... .....+ .+|+++++.++||||+++++++.+++..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 6799999999999999999965 579999999997543211 122233 44577777788999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccce
Q 003982 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (782)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~ 735 (782)
+||||+++|+|.+++.+. ..+++.++..++.||+.||+|||+ +|||||||||+|||++.++.+||+|||+|+
T Consensus 84 ivmE~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEECCCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEecCCCcHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceee
Confidence 999999999999999763 457899999999999999999999 899999999999999999999999999999
Q ss_pred ecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 736 NAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 736 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
....... ...+||+.|||||++.+. .+++.++||||+||+
T Consensus 156 ~~~~~~~---~~~~GT~~y~APE~~~~~--~~~~~~~DiwSlGvi 195 (364)
T d1omwa3 156 DFSKKKP---HASVGTHGYMAPEVLQKG--VAYDSSADWFSLGCM 195 (364)
T ss_dssp ECSSSCC---CSCCSCGGGCCHHHHSTT--CCCCTHHHHHHHHHH
T ss_pred ecCCCcc---cccccccccchhHHhhcC--CCCCcccchhHHHHH
Confidence 7765332 345799999999998653 245778999999986
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-36 Score=317.12 Aligned_cols=187 Identities=21% Similarity=0.335 Sum_probs=162.5
Q ss_pred HhcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEE
Q 003982 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 579 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
+.++|++.+.||+|+||+||+|.. .+++.||||+++... .....+.+|++++++++||||+++++++.+++..|+|
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 357899999999999999999955 578899999997643 3446688999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCC--CcEEEEeeccce
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD--MRAKVADFGLVK 735 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~--~~~kL~DfG~a~ 735 (782)
||||+||+|.+++... ...+++.++..++.||+.||+|||+ .||+||||||+|||++.+ ..+||+|||+++
T Consensus 80 mE~~~gg~L~~~i~~~----~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~ 152 (321)
T d1tkia_ 80 FEFISGLDIFERINTS----AFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152 (321)
T ss_dssp ECCCCCCBHHHHHTSS----SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred EecCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhh
Confidence 9999999999998642 2358999999999999999999998 899999999999999854 589999999998
Q ss_pred ecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 736 NAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 736 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
....... .....||+.|+|||...+. .++.++||||+||+
T Consensus 153 ~~~~~~~--~~~~~~t~~y~ape~~~~~---~~~~~~DiWSlGvi 192 (321)
T d1tkia_ 153 QLKPGDN--FRLLFTAPEYYAPEVHQHD---VVSTATDMWSLGTL 192 (321)
T ss_dssp ECCTTCE--EEEEESCGGGSCHHHHTTC---EECHHHHHHHHHHH
T ss_pred ccccCCc--ccccccccccccchhccCC---CCCchhhcccHHHH
Confidence 8765432 2335689999999998775 46789999999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-36 Score=319.85 Aligned_cols=188 Identities=26% Similarity=0.419 Sum_probs=162.0
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHH-hcCCCCcceEEeEEEeCCeEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLT-KVRHRHLVALLGYCINGSERLLV 657 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~-~l~h~nI~~~~~~~~~~~~~~lv 657 (782)
++|++.+.||+|+||+||+|.. .+++.||||++++... .....+.+.+|+.++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5799999999999999999954 5789999999976432 1234566777777765 68999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~ 737 (782)
|||+++|+|.+++... ..+++.++..++.||+.||+|||+ +||+||||||+|||+++++.+||+|||+|+..
T Consensus 82 mEy~~~g~L~~~i~~~-----~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~ 153 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 153 (320)
T ss_dssp EECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EeecCCCcHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhc
Confidence 9999999999999763 358999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 738 PDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..... ......||+.|+|||++.+. +++.++||||+||+
T Consensus 154 ~~~~~-~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlGvi 192 (320)
T d1xjda_ 154 MLGDA-KTNTFCGTPDYIAPEILLGQ---KYNHSVDWWSFGVL 192 (320)
T ss_dssp CCTTC-CBCCCCSCGGGCCHHHHTTC---CBCTHHHHHHHHHH
T ss_pred ccccc-cccccCCCCCcCCHHHHcCC---CCCchhhhhhhhHH
Confidence 54332 23445799999999999875 56789999999987
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.6e-36 Score=313.33 Aligned_cols=190 Identities=26% Similarity=0.382 Sum_probs=156.3
Q ss_pred hcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCC-hhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCC----e
Q 003982 580 TDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS----E 653 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~----~ 653 (782)
.++|++.+.||+|+||+||+|. ..+|+.||||+++..... ....+++.+|++++++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 4679999999999999999995 467999999999876543 345678999999999999999999999988654 3
Q ss_pred EEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecc
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~ 733 (782)
.|+||||++|++|.+++... +++++.++..++.|++.||+|||+ .||+||||||+||+++.++..+++|||.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~-----~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~ 157 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGI 157 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTT
T ss_pred EEEEEECCCCCEehhhhccc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhh
Confidence 78999999999999988663 458999999999999999999998 8999999999999999999999999999
Q ss_pred ceecCCCCc--eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 734 VKNAPDGKY--SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 734 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+........ ......+||+.|||||++.+. .++.++||||+||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~---~~~~~~DiwSlGvi 203 (277)
T d1o6ya_ 158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGD---SVDARSDVYSLGCV 203 (277)
T ss_dssp CEECC----------------TTCCHHHHTTC---CCCHHHHHHHHHHH
T ss_pred hhhhccccccccccccccCcccccCHHHHcCC---CCCcceecccchHH
Confidence 876644321 223445799999999998875 45789999999997
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-36 Score=315.53 Aligned_cols=183 Identities=25% Similarity=0.364 Sum_probs=155.7
Q ss_pred hcCCCccc-eeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEe----CC
Q 003982 580 TDNFSEAN-ILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCIN----GS 652 (782)
Q Consensus 580 ~~~y~~~~-~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~----~~ 652 (782)
.++|.+.+ .||+|+||+||+|.. .+++.||||+++.. +.+++|++++.++ +||||+++++++.+ ..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 46898875 699999999999954 67899999998642 4678899987655 79999999999876 35
Q ss_pred eEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECC---CCcEEEE
Q 003982 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD---DMRAKVA 729 (782)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~---~~~~kL~ 729 (782)
..|+|||||+||+|.+++.+. +...+++.++..++.|++.||+|||+ .||+||||||+|||+++ ++.+||+
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~---~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~ 156 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLT 156 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSC---SCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred EEEEEEECCCCCcHHHHHHhc---CCCCcCHHHHHHHHHHHHHHHHHHHH---cCCcccccccccccccccccccccccc
Confidence 689999999999999999652 23469999999999999999999999 89999999999999985 4679999
Q ss_pred eeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 730 DFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 730 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|||+|+....... ....+||+.|||||++.+. .++.++||||+||+
T Consensus 157 DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~---~y~~~~DiwSlGvi 202 (335)
T d2ozaa1 157 DFGFAKETTSHNS--LTTPCYTPYYVAPEVLGPE---KYDKSCDMWSLGVI 202 (335)
T ss_dssp CCTTCEECCCCCC--CCCCSCCCSSCCCCCCCGG---GGSHHHHHHHHHHH
T ss_pred ccceeeeccCCCc--cccccCCcccCCcHHHcCC---CCCHHHHHHhhchh
Confidence 9999988765432 2345799999999999875 56889999999997
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-36 Score=314.56 Aligned_cols=190 Identities=27% Similarity=0.400 Sum_probs=156.9
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
++|++.+.||+|+||+||+|.. .+|+.||||+++.........+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5899999999999999999954 679999999997665444456789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+.+ ++.+++... ....+++.++..++.|++.||+|||+ .|||||||||+|||++.++.+||+|||.|+....
T Consensus 82 ~~~~-~~~~~~~~~---~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~ 154 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDAS---ALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 154 (298)
T ss_dssp CCSE-EHHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred ecCC-chhhhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccC
Confidence 9965 555555432 23468999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... ......||+.|+|||...... .++.++|+||+||+
T Consensus 155 ~~~-~~~~~~gt~~y~apE~~~~~~--~~~~~~DiwSlGvi 192 (298)
T d1gz8a_ 155 PVR-TYTHEVVTLWYRAPEILLGCK--YYSTAVDIWSLGCI 192 (298)
T ss_dssp CSB-CTTCCBCCCTTCCHHHHTTCS--SCCTHHHHHHHHHH
T ss_pred Ccc-cceeecccceeeehhhhcccc--CCCccccccccchh
Confidence 332 223457999999999866542 24678999999986
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-36 Score=316.02 Aligned_cols=185 Identities=26% Similarity=0.338 Sum_probs=151.1
Q ss_pred ccceeecccceEEEEEEe-CCCcEEEEEEeccccCChh---hHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEc
Q 003982 585 EANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNK---GLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (782)
Q Consensus 585 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~---~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 660 (782)
.+++||+|+||+||+|.. .+|+.||||+++....... ..+.+.+|++++++++||||+++++++.+++..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 367899999999999965 5789999999976543211 235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~ 740 (782)
++++++...... ...+++.++..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~~~~~~~~~-----~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~ 153 (299)
T d1ua2a_ 82 METDLEVIIKDN-----SLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 153 (299)
T ss_dssp CSEEHHHHHTTC-----CSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred hcchHHhhhhhc-----ccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCC
Confidence 988766544422 3568899999999999999999999 89999999999999999999999999999876553
Q ss_pred CceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 741 KYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.. .....+||+.|+|||++.+. ..++.++||||+||+
T Consensus 154 ~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlGvi 190 (299)
T d1ua2a_ 154 NR-AYTHQVVTRWYRAPELLFGA--RMYGVGVDMWAVGCI 190 (299)
T ss_dssp CC-CCCCSCCCCTTCCHHHHTTC--SCCCHHHHHHHHHHH
T ss_pred cc-cccceecChhhccHHHHccC--CCCChhhhhhhcchH
Confidence 32 22345799999999987654 235778999999997
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-36 Score=309.07 Aligned_cols=189 Identities=23% Similarity=0.384 Sum_probs=148.8
Q ss_pred hcCCCccceeecccceEEEEEEeCC----CcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGELPD----GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL 655 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~ 655 (782)
.++|++.+.||+|+||+||+|.... +..||||+++... .....+.|.+|++++++++||||+++++++. ++..+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 3579999999999999999996532 3468899886543 3445678999999999999999999999985 56789
Q ss_pred EEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccce
Q 003982 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (782)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~ 735 (782)
+||||+++|++.+++... ...+++.++..++.|+++||+|||+ +||+||||||+||++++++.+||+|||+|+
T Consensus 84 iv~E~~~~g~l~~~~~~~----~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVR----KYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp EEEECCTTEEHHHHHHHT----TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEEeccCCcHHhhhhcc----CCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhhe
Confidence 999999999999987652 3458999999999999999999999 899999999999999999999999999998
Q ss_pred ecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 736 NAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 736 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
..............||+.|+|||++.+. .++.++||||+||+
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~---~~~~~~DiwSlGvi 198 (273)
T d1mp8a_ 157 YMEDSTYYKASKGKLPIKWMAPESINFR---RFTSASDVWMFGVC 198 (273)
T ss_dssp --------------CCGGGCCHHHHHHC---CCSHHHHHHHHHHH
T ss_pred eccCCcceeccceecCcccchhhHhccC---CCCCccccccchHH
Confidence 7765444444456789999999998765 46789999999986
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-35 Score=308.91 Aligned_cols=191 Identities=26% Similarity=0.356 Sum_probs=154.8
Q ss_pred hcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCC----eEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS----ERL 655 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~----~~~ 655 (782)
.++|.+.+.||+|+||+||+|+. +|+.||||+++... .....++.|+..+.+++||||+++++++.+.+ ..|
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 35688899999999999999987 78999999996532 21222334555556789999999999998654 579
Q ss_pred EEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCCeEEcCCCCCCEEECCCCcEEEEe
Q 003982 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSL-----AQQSFIHRDLKPSNILIGDDMRAKVAD 730 (782)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-----~~~~ivHrDikp~NIll~~~~~~kL~D 730 (782)
+||||+++|+|.+++++ ..+++.++..++.|++.||+|+|+. ..+||+||||||+|||+++++.+||+|
T Consensus 78 lv~Ey~~~g~L~~~l~~------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~D 151 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp EEEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred EEEecccCCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEe
Confidence 99999999999999975 3589999999999999999999962 136999999999999999999999999
Q ss_pred eccceecCCCCce---eeecccccccccCccccccchh---hhHHHHHHHHHhccc
Q 003982 731 FGLVKNAPDGKYS---VETRLAGTFGYLAPEYAGKHWM---ILCQMTGLIWLHGSV 780 (782)
Q Consensus 731 fG~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~---~~~~~~~dvws~Gvv 780 (782)
||+++........ .....+||+.|||||++.+.+. ..++.++|||||||+
T Consensus 152 FGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvv 207 (303)
T d1vjya_ 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV 207 (303)
T ss_dssp CTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHH
T ss_pred cCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHH
Confidence 9999877543322 1234679999999999877532 347889999999986
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-36 Score=309.06 Aligned_cols=188 Identities=26% Similarity=0.368 Sum_probs=158.0
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChh----hHHHHHHHHHHHHhcC--CCCcceEEeEEEeCC
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNK----GLSEFQAEIAVLTKVR--HRHLVALLGYCINGS 652 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~--h~nI~~~~~~~~~~~ 652 (782)
.++|++.+.||+|+||+||+|.. .+|+.||||++++...... ...++.+|+.++++++ ||||+++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 46899999999999999999954 6789999999976543221 2345778999999997 899999999999999
Q ss_pred eEEEEEEccCC-CCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECC-CCcEEEEe
Q 003982 653 ERLLVYEYMPR-GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD-DMRAKVAD 730 (782)
Q Consensus 653 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~-~~~~kL~D 730 (782)
..++||||+.+ +++.+++... ..+++.++..++.|++.||+|||+ +||+||||||+|||++. ++.+||+|
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~-----~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~D 154 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLID 154 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECC
T ss_pred eEEEEEEeccCcchHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECc
Confidence 99999999976 5777777652 458999999999999999999999 89999999999999985 47999999
Q ss_pred eccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 731 FGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 731 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
||+|+...... .....||+.|+|||++.+. ..++.++||||+||+
T Consensus 155 FG~a~~~~~~~---~~~~~GT~~y~aPE~~~~~--~~~~~~~DiwSlGvi 199 (273)
T d1xwsa_ 155 FGSGALLKDTV---YTDFDGTRVYSPPEWIRYH--RYHGRSAAVWSLGIL 199 (273)
T ss_dssp CTTCEECCSSC---BCCCCSCGGGSCHHHHHHS--CBCHHHHHHHHHHHH
T ss_pred cccceeccccc---ccccccCCCcCCHHHHcCC--CCCCcccccccceee
Confidence 99998765433 2345799999999998754 123677999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4e-36 Score=313.89 Aligned_cols=198 Identities=31% Similarity=0.525 Sum_probs=165.1
Q ss_pred HHHHhcCCCccceeecccceEEEEEEeC------CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEE
Q 003982 576 LRQVTDNFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCI 649 (782)
Q Consensus 576 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~ 649 (782)
++...++|++.+.||+|+||+||+|+.. +++.||||+++... .....++|.+|++++++++||||+++++++.
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 3334578999999999999999999653 45789999997543 3445678999999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHHhhcc-------------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEE
Q 003982 650 NGSERLLVYEYMPRGTLAQHLFEWHD-------------------HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIH 710 (782)
Q Consensus 650 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH 710 (782)
+.+..+++|||+++|+|.+++..... .....+++.++..++.|++.||+|||+ .+|||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEe
Confidence 99999999999999999999975321 112348999999999999999999999 89999
Q ss_pred cCCCCCCEEECCCCcEEEEeeccceecCCCC-ceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 711 RDLKPSNILIGDDMRAKVADFGLVKNAPDGK-YSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 711 rDikp~NIll~~~~~~kL~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|||||+|||++.++++||+|||+|+...... ....+...||+.|+|||++.+. .++.++||||||||
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~t~ksDVwS~Gvv 231 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN---RYTTESDVWAYGVV 231 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC---CCCHHHHHHHHHHH
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC---CCChhhhhccchhh
Confidence 9999999999999999999999998664432 2223345789999999998875 46789999999997
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.6e-36 Score=309.91 Aligned_cols=189 Identities=25% Similarity=0.339 Sum_probs=160.1
Q ss_pred cCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEEc
Q 003982 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 660 (782)
++|++.+.||+|+||+||+|+..+|+.||||+++.........+.+.+|+.++++++||||+++++++.+++..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 58999999999999999999888999999999977654445568899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~ 740 (782)
+.++.+..+... ...+++.++..++.|++.||+|||+ .|||||||||+|||++.++.+|++|||.|......
T Consensus 82 ~~~~~~~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 82 LDQDLKKLLDVC-----EGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CSEEHHHHHHTS-----TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ehhhhHHHHHhh-----cCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 977665555432 3569999999999999999999999 89999999999999999999999999999876543
Q ss_pred CceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 741 KYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.. ......|++.|+|||.+.+. ..++.++|+||+||+
T Consensus 154 ~~-~~~~~~~~~~y~~pE~~~~~--~~~~~~~DiwslGv~ 190 (286)
T d1ob3a_ 154 VR-KYTHEIVTLWYRAPDVLMGS--KKYSTTIDIWSVGCI 190 (286)
T ss_dssp ---------CCCTTCCHHHHTTC--CSCCTHHHHHHHHHH
T ss_pred cc-ccceecccchhhhHHHHhCC--CCCCcceeehhcCcH
Confidence 32 22334689999999998764 245788999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-35 Score=311.36 Aligned_cols=188 Identities=26% Similarity=0.444 Sum_probs=153.5
Q ss_pred cCCCccceeecccceEEEEEEeC-CCc----EEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEE
Q 003982 581 DNFSEANILGRGGFGVVYGGELP-DGT----KIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL 655 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~ 655 (782)
.+|++.++||+|+||+||+|.+. +|+ +||+|+++... .....++|.+|++++++++||||+++++++.++ ..+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence 46999999999999999999653 444 58899886543 234578899999999999999999999999865 567
Q ss_pred EEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccce
Q 003982 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (782)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~ 735 (782)
++|||+.+|+|.+++... ...+++.++..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||+|+
T Consensus 87 ~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~ 159 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAK 159 (317)
T ss_dssp EEEECCTTCBHHHHHHHT----SSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred EEEEeccCCccccccccc----ccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccce
Confidence 889999999999988663 3468999999999999999999999 899999999999999999999999999998
Q ss_pred ecCCCCce-eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 736 NAPDGKYS-VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 736 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
........ ......||+.|||||++.+. .++.++|||||||+
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~---~~~~~sDvwS~Gvi 202 (317)
T d1xkka_ 160 LLGAEEKEYHAEGGKVPIKWMALESILHR---IYTHQSDVWSYGVT 202 (317)
T ss_dssp HTTTTCC--------CCTTTSCHHHHHHC---CCCHHHHHHHHHHH
T ss_pred ecccccccccccccccCccccChHHHhcC---CCChhhhhhhHHHH
Confidence 77554322 22334689999999988765 45789999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-36 Score=303.45 Aligned_cols=182 Identities=32% Similarity=0.521 Sum_probs=149.8
Q ss_pred cCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEe-CCeEEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN-GSERLLVYE 659 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~-~~~~~lv~e 659 (782)
++|++.+.||+|+||.||+|+. .|+.||||+++.. ...+.+++|++++++++||||+++++++.+ .+..++|||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 4678899999999999999988 5789999999753 345789999999999999999999999865 456899999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
|+++|+|.+++..... ..+++.+++.++.|++.||.|||+ .+|+||||||+||+++.++.+|++|||+++....
T Consensus 82 y~~~g~L~~~l~~~~~---~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp CCTTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred ccCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCC
Confidence 9999999999976322 248999999999999999999999 8999999999999999999999999999987644
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.. ....+|+.|+|||++.+. .++.++|||||||+
T Consensus 156 ~~----~~~~~~~~y~aPE~l~~~---~~t~~sDIwSfG~i 189 (262)
T d1byga_ 156 TQ----DTGKLPVKWTAPEALREK---KFSTKSDVWSFGIL 189 (262)
T ss_dssp ----------CCTTTSCHHHHHHC---CCCHHHHHHHHHHH
T ss_pred CC----ccccccccCCChHHHhCC---CCChHHHHHhHHHH
Confidence 22 223578999999998764 45889999999985
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-35 Score=302.00 Aligned_cols=189 Identities=29% Similarity=0.512 Sum_probs=149.2
Q ss_pred cCCCccceeecccceEEEEEEe--CCC--cEEEEEEeccccCC-hhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL--PDG--TKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL 655 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~--~~~--~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~ 655 (782)
++|++.+.||+|+||+||+|+. .++ ..||||++++.... ....++|.+|++++++++||||+++++++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 5689999999999999999964 223 36899998765432 3356789999999999999999999999965 4678
Q ss_pred EEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccce
Q 003982 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (782)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~ 735 (782)
+||||+++|++.+++.... ..+++..+..++.|+++||.|||+ +||+||||||+||+++.++++||+|||+++
T Consensus 87 lv~e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeeeecCcchhhhhhccc----CCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhh
Confidence 9999999999999887643 358999999999999999999999 899999999999999999999999999999
Q ss_pred ecCCCCcee--eecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 736 NAPDGKYSV--ETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 736 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
......... .....|+..|+|||++.+. .++.++|||||||+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~Di~S~Gvi 203 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTR---TFSHASDTWMFGVT 203 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHC---EEEHHHHHHHHHHH
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCC---CCCcchhhhhhHHH
Confidence 876543222 2334578899999998876 45788999999985
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-35 Score=306.88 Aligned_cols=194 Identities=25% Similarity=0.422 Sum_probs=152.0
Q ss_pred hcCCCccceeecccceEEEEEEeC------CCcEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeC-
Q 003982 580 TDNFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCING- 651 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~- 651 (782)
.++|++.+.||+|+||.||+|... +++.||||+++... .....+.+.+|++++.++ +|+||+.+++++.++
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 467999999999999999999642 34689999997543 244567788888888877 589999999988765
Q ss_pred CeEEEEEEccCCCCHHHHHHhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE
Q 003982 652 SERLLVYEYMPRGTLAQHLFEWHDH-----------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI 720 (782)
Q Consensus 652 ~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll 720 (782)
...++|||||++|+|.++++..... ....+++.++..++.|+++||+|||+ +||+||||||+|||+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl 167 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILL 167 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEE
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeE
Confidence 4679999999999999999764321 12358999999999999999999999 899999999999999
Q ss_pred CCCCcEEEEeeccceecCCCCc-eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 721 GDDMRAKVADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 721 ~~~~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
++++++||+|||+|+....... .......||+.|||||++.+. .++.++||||+||+
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~---~~~~~sDiwS~Gvi 225 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR---VYTIQSDVWSFGVL 225 (299)
T ss_dssp CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC---CCCHHHHHHHHHHH
T ss_pred CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcC---CCCcccceeehHHH
Confidence 9999999999999987654332 223345799999999998775 46889999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-35 Score=304.76 Aligned_cols=191 Identities=31% Similarity=0.524 Sum_probs=156.3
Q ss_pred cCCCccceeecccceEEEEEEeC-CCc--EEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCCeEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGELP-DGT--KIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLL 656 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~l 656 (782)
++|++.++||+|+||+||+|.+. ++. .||||+++... .....++|.+|+++++++ +||||+++++++.+.+..++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 57888999999999999999654 444 47788775433 233566899999999998 79999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhc-----------cCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCc
Q 003982 657 VYEYMPRGTLAQHLFEWH-----------DHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR 725 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~-----------~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~ 725 (782)
||||+++|+|.++++... ......+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCc
Confidence 999999999999997531 1223568999999999999999999999 89999999999999999999
Q ss_pred EEEEeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 726 AKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 726 ~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+||+|||+|+....... .....||..|+|||.+.+. .++.++|||||||+
T Consensus 166 ~kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~---~~~~~sDvwSfGvi 215 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYS---VYTTNSDVWSYGVL 215 (309)
T ss_dssp EEECCTTCEESSCEECC--C----CCTTTCCHHHHHHC---EECHHHHHHHHHHH
T ss_pred eEEcccccccccccccc--ccceecCCcccchHHhccC---CCCccceeehhHHH
Confidence 99999999986543221 1234689999999998765 56789999999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-34 Score=304.05 Aligned_cols=193 Identities=27% Similarity=0.448 Sum_probs=165.0
Q ss_pred cCCCccceeecccceEEEEEEe------CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeCCe
Q 003982 581 DNFSEANILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSE 653 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~ 653 (782)
++|++.++||+|+||.||+|.+ .+++.||||+++... ......+|.+|+.+++++ +||||+++++++.+++.
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 5788899999999999999964 346789999997654 244567899999999999 69999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhhcc-------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHD-------------HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI 720 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll 720 (782)
.++|||||++|+|.++++.... .....+++.++..++.||++||+|||+ +||+||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccccccccc
Confidence 9999999999999999976432 123358999999999999999999999 899999999999999
Q ss_pred CCCCcEEEEeeccceecCCCC-ceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 721 GDDMRAKVADFGLVKNAPDGK-YSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 721 ~~~~~~kL~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+.++.+|++|||.++...... ........||+.|+|||++.+. .++.++|||||||+
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DIwS~G~~ 236 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC---VYTFESDVWSYGIF 236 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC---CCCHHHHHHHHHHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCC---CCCCcccccchHHH
Confidence 999999999999999876543 2334456789999999998764 46889999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-34 Score=298.25 Aligned_cols=184 Identities=30% Similarity=0.518 Sum_probs=154.6
Q ss_pred cceeecccceEEEEEEeCCC----cEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEe-CCeEEEEEEc
Q 003982 586 ANILGRGGFGVVYGGELPDG----TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN-GSERLLVYEY 660 (782)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~-~~~~~lv~e~ 660 (782)
.++||+|+||+||+|.+.++ ..||||+++... .....++|.+|++++++++||||+++++++.+ ++..++||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 46899999999999976432 258999997532 35567889999999999999999999999876 4688999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCCC
Q 003982 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (782)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~~ 740 (782)
|++|+|.+++... ....++.++..++.|+++||.|||+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 111 ~~~g~l~~~~~~~----~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 111 MKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp CTTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred eecCchhhhhccc----cccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 9999999988652 3457888999999999999999999 89999999999999999999999999999876543
Q ss_pred Cce---eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 741 KYS---VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 741 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... ......||+.|+|||.+.+. .++.++||||||++
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDI~SfGiv 223 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQTQ---KFTTKSDVWSFGVL 223 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHHC---CCCHHHHHHHHHHH
T ss_pred ccccceecccccccccccChHHHhcC---CCCChhHhhhhHHH
Confidence 321 12234689999999988765 46889999999986
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-34 Score=300.88 Aligned_cols=193 Identities=32% Similarity=0.494 Sum_probs=158.5
Q ss_pred cCCCccceeecccceEEEEEEeCC--------CcEEEEEEeccccCChhhHHHHHHHHHHHHhc-CCCCcceEEeEEEeC
Q 003982 581 DNFSEANILGRGGFGVVYGGELPD--------GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCING 651 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~ 651 (782)
++|++.+.||+|+||.||+|+... +..||||++++.. ......++.+|...+.++ +||||+++++++.++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 578899999999999999996422 3479999997644 345667889999999888 799999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHHhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEE
Q 003982 652 SERLLVYEYMPRGTLAQHLFEWHDH-----------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI 720 (782)
Q Consensus 652 ~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll 720 (782)
+..++||||+++|+|.+++...... ....+++.+++.++.|++.||+|||+ .+||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceee
Confidence 9999999999999999999764321 12458999999999999999999999 899999999999999
Q ss_pred CCCCcEEEEeeccceecCCCCce-eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 721 GDDMRAKVADFGLVKNAPDGKYS-VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 721 ~~~~~~kL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+.++.+||+|||+++........ ......||+.|+|||++.+. .++.++||||||||
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~---~y~~k~DiwS~Gvv 226 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR---IYTHQSDVWSFGVL 226 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC---CCCHHHHHHHHHHH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCC---CCCchhhhHHhHHH
Confidence 99999999999999876543322 23345789999999998775 46889999999996
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-34 Score=300.87 Aligned_cols=193 Identities=26% Similarity=0.494 Sum_probs=163.4
Q ss_pred cCCCccceeecccceEEEEEEeC------CCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeE
Q 003982 581 DNFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSER 654 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~ 654 (782)
++|.+.+.||+|+||.||+|.+. +++.||||+++... .......|.+|++++++++||||+++++++..++..
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 67888999999999999999652 35789999997543 345567799999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhhcc-----CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEE
Q 003982 655 LLVYEYMPRGTLAQHLFEWHD-----HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVA 729 (782)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~ 729 (782)
++||||+++|+|.+++..... .....+++..+..++.|+++||.|||+ ++|+||||||+|||++.++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEe
Confidence 999999999999999875431 122457899999999999999999999 899999999999999999999999
Q ss_pred eeccceecCCCCcee-eecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 730 DFGLVKNAPDGKYSV-ETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 730 DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|||+|+......... .....||+.|+|||.+.+. .++.++||||||++
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~---~~~~~~Dv~S~G~i 224 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG---VFTTYSDVWSFGVV 224 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC---CCCHHHHHHHHHHH
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccC---CCCcccccccHHHH
Confidence 999998765433222 2334689999999998765 45778999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-34 Score=307.22 Aligned_cols=185 Identities=25% Similarity=0.402 Sum_probs=153.8
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCC------
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS------ 652 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~------ 652 (782)
.++|++++.||+|+||+||+|.. .+|+.||||+++.........+.+.+|+++|++++||||+++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46899999999999999999954 57999999999876555566788999999999999999999999998654
Q ss_pred eEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeec
Q 003982 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (782)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG 732 (782)
..|+||||+ +.++..+.+. ..+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+|++|||
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg 166 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFG 166 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEecc-cccHHHHHHh------ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhccccccccccccc
Confidence 469999999 6677776643 359999999999999999999999 899999999999999999999999999
Q ss_pred cceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 733 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+|+...... +...||+.|+|||++.+. ..++.++||||+||+
T Consensus 167 ~a~~~~~~~----~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlGvi 208 (346)
T d1cm8a_ 167 LARQADSEM----TGYVVTRWYRAPEVILNW--MRYTQTVDIWSVGCI 208 (346)
T ss_dssp TCEECCSSC----CSSCSCGGGCCTHHHHTT--TCCCTTHHHHHHHHH
T ss_pred ceeccCCcc----ccccccccccCHHHHcCC--CCCCccchhhcchHH
Confidence 998775432 345789999999987653 234678999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-34 Score=302.46 Aligned_cols=189 Identities=25% Similarity=0.360 Sum_probs=153.1
Q ss_pred hcCCCccceeecccceEEEEEEe-CC-CcEEEEEEeccccCChhhHHHHHHHHHHHHhc---CCCCcceEEeEEEe----
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PD-GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV---RHRHLVALLGYCIN---- 650 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~nI~~~~~~~~~---- 650 (782)
.++|++++.||+|+||+||+|.. .+ ++.||||+++...........+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 47899999999999999999965 34 56799999976554333444566777777665 79999999999863
Q ss_pred -CCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEE
Q 003982 651 -GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVA 729 (782)
Q Consensus 651 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~ 729 (782)
....+++|||++++.+...... ....+++..+..++.|++.||+|||+ +||+||||||+|||+++++.+||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~----~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~ 158 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV----PEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLA 158 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS----CTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCceEEEEEEeccCCchhhhhhc----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeec
Confidence 2467999999987765443322 23568999999999999999999999 899999999999999999999999
Q ss_pred eeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 730 DFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 730 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|||+++...... ......||+.|||||++.+. .++.++||||+||+
T Consensus 159 dfg~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~---~y~~~~DiwSlG~i 204 (305)
T d1blxa_ 159 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQS---SYATPVDLWSVGCI 204 (305)
T ss_dssp SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTC---CCCTHHHHHHHHHH
T ss_pred chhhhhhhcccc--cCCCcccChhhcCcchhcCC---CCChhehhhchHHH
Confidence 999987654332 22345799999999998765 46789999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-34 Score=301.73 Aligned_cols=191 Identities=24% Similarity=0.329 Sum_probs=154.5
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEe--------
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN-------- 650 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~-------- 650 (782)
.++|++++.||+|+||+||+|.. .+|+.||||++......+...+++.+|++++++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 37899999999999999999964 689999999997766555567889999999999999999999998865
Q ss_pred CCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEe
Q 003982 651 GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVAD 730 (782)
Q Consensus 651 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~D 730 (782)
....++||||++++.+..... ....+++.+++.++.|++.||+|||+ .||+||||||+|||++.++.+||+|
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~-----~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~d 160 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN-----VLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLAD 160 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC-----TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECC
T ss_pred CceEEEEEeccCCCccchhhh-----cccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeee
Confidence 345799999997765544332 23468999999999999999999999 8999999999999999999999999
Q ss_pred eccceecCCCCce---eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 731 FGLVKNAPDGKYS---VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 731 fG~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
||+|+........ .....+||+.|+|||++.+. ..++.++||||+||+
T Consensus 161 fg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~--~~~~~k~DiwSlGvi 211 (318)
T d3blha1 161 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE--RDYGPPIDLWGAGCI 211 (318)
T ss_dssp CTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTC--SSCCTHHHHHHHHHH
T ss_pred cceeeecccccccccccccceecCHHHhhHHHHcCC--CCCCcHHHcccCCce
Confidence 9999876543321 12235799999999987654 235678999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-34 Score=303.75 Aligned_cols=189 Identities=23% Similarity=0.356 Sum_probs=154.6
Q ss_pred hcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCC----eE
Q 003982 580 TDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS----ER 654 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~----~~ 654 (782)
.++|++++.||+|+||+||+|. ..+|+.||||++.+.. .....+++.+|+++|++++||||+++++++.... ..
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 4679999999999999999995 5689999999997543 2445678999999999999999999999987653 23
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccc
Q 003982 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734 (782)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a 734 (782)
+++++|+.+|+|.+++.. ..+++.++..++.|++.||+|||+ +|||||||||+|||++.++.+||+|||+|
T Consensus 86 ~~l~~~~~~g~L~~~l~~------~~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a 156 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT------QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLA 156 (345)
T ss_dssp EEEEEECCCEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeecCCchhhhhhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCce
Confidence 455566679999999864 358999999999999999999999 89999999999999999999999999999
Q ss_pred eecCCCCce--eeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 735 KNAPDGKYS--VETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 735 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+........ .....+||+.|+|||++... ..+..++||||+||+
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~~DiwSlG~i 202 (345)
T d1pmea_ 157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNS--KGYTKSIDIWSVGCI 202 (345)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCGGGTTTB--CSCSTHHHHHHHHHH
T ss_pred eeccCCCccceeeccccccceechHHHhhcC--CCCCchhhhhccCce
Confidence 876543221 12345799999999998654 234678999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-33 Score=294.61 Aligned_cols=189 Identities=22% Similarity=0.315 Sum_probs=164.2
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeCCeEEEEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 659 (782)
++|++++.||+|+||+||+|+. .+++.||||+++.........+++.+|+.+++.++||||+++++++.+....++++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5899999999999999999954 678999999998766555667889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeeccceecCC
Q 003982 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (782)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~~~~ 739 (782)
++.++++..++.. .+.+++.++..++.|++.||+|||+ +||+||||||+|||++.++++||+|||.|+....
T Consensus 82 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~ 153 (292)
T d1unla_ 82 FCDQDLKKYFDSC-----NGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSEEHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecccccccccccc-----ccccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccC
Confidence 9999888777654 3468999999999999999999999 8999999999999999999999999999988765
Q ss_pred CCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 740 GKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
... ......+++.|+|||++.+.. ..+.++||||+||+
T Consensus 154 ~~~-~~~~~~~~~~~~~pe~~~~~~--~~~~~~DiwSlG~i 191 (292)
T d1unla_ 154 PVR-CYSAEVVTLWYRPPDVLFGAK--LYSTSIDMWSAGCI 191 (292)
T ss_dssp CCS-CCCSCCSCGGGCCHHHHTTCS--CCCTHHHHHHHHHH
T ss_pred CCc-cceeeccccchhhhhHhccCC--CCCchhhccccchH
Confidence 432 223345788999999887652 24678999999987
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-34 Score=303.64 Aligned_cols=184 Identities=25% Similarity=0.397 Sum_probs=150.2
Q ss_pred CCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC------CeE
Q 003982 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING------SER 654 (782)
Q Consensus 582 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~------~~~ 654 (782)
+|+..++||+|+||+||+|+. .+|+.||||++..... .+.+|++++++++||||+++++++... .+.
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 588899999999999999965 5789999999976542 234799999999999999999998653 347
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCC-cEEEEeecc
Q 003982 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM-RAKVADFGL 733 (782)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~-~~kL~DfG~ 733 (782)
++||||++++ +.+.+...... ...+++.+++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 95 ~lv~Ey~~~~-~~~~l~~~~~~-~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~ 169 (350)
T d1q5ka_ 95 NLVLDYVPET-VYRVARHYSRA-KQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGS 169 (350)
T ss_dssp EEEEECCSEE-HHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred EEEEeccCCc-cHHHHHhhhhc-cCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccc
Confidence 8999999765 44444432222 3568999999999999999999998 8999999999999999775 899999999
Q ss_pred ceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 734 VKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 734 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|+........ ...+||+.|+|||.+.+. ..++.++||||+||+
T Consensus 170 a~~~~~~~~~--~~~~gt~~y~aPE~~~~~--~~~~~~~DIwSlG~i 212 (350)
T d1q5ka_ 170 AKQLVRGEPN--VSYICSRYYRAPELIFGA--TDYTSSIDVWSAGCV 212 (350)
T ss_dssp CEECCTTSCC--CSCCSCTTSCCHHHHTTC--SSCCTHHHHHHHHHH
T ss_pred hhhccCCccc--ccccccccccChHHhhcc--cCCCcceeecccceE
Confidence 9887654422 335799999999987654 245778999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-34 Score=300.74 Aligned_cols=191 Identities=25% Similarity=0.338 Sum_probs=161.7
Q ss_pred cCCCccceeecccceEEEEEEe----CCCcEEEEEEeccccC--ChhhHHHHHHHHHHHHhcCC-CCcceEEeEEEeCCe
Q 003982 581 DNFSEANILGRGGFGVVYGGEL----PDGTKIAVKRMESNTM--GNKGLSEFQAEIAVLTKVRH-RHLVALLGYCINGSE 653 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h-~nI~~~~~~~~~~~~ 653 (782)
++|++.+.||+|+||+||+|.. .+|+.||||++++... .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6799999999999999999954 2578999999976432 12345678899999999976 899999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecc
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~ 733 (782)
.+++|||+.+|+|.+++... ..+++..+..++.|++.||+|+|+ .+|+||||||+||+++.++.+||+|||+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~-----~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eeeeeecccccHHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccc
Confidence 99999999999999999763 347889999999999999999999 8999999999999999999999999999
Q ss_pred ceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 734 VKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 734 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|+..............|++.|+|||.+.+. ...++.++||||+||+
T Consensus 176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~-~~~~~~ksDIWSlG~i 221 (322)
T d1vzoa_ 176 SKEFVADETERAYDFCGTIEYMAPDIVRGG-DSGHDKAVDWWSLGVL 221 (322)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTC-C---CTHHHHHHHHHH
T ss_pred hhhhcccccccccccccccccchhHHhhcC-CcCCCchhhhHHHHHH
Confidence 988765444444456799999999988653 1245678999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.9e-33 Score=297.68 Aligned_cols=180 Identities=21% Similarity=0.360 Sum_probs=153.0
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC-CCCcceEEeEEEeC--CeEEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCING--SERLL 656 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~--~~~~l 656 (782)
++|++.+.||+|+||+||+|+. .+++.||||+++... .+++.+|+++|+.++ ||||+++++++... ...++
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 5799999999999999999955 678999999997532 467899999999996 99999999998754 56899
Q ss_pred EEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCC-cEEEEeeccce
Q 003982 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM-RAKVADFGLVK 735 (782)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~-~~kL~DfG~a~ 735 (782)
||||+++++|.... +.+++.++..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+
T Consensus 110 v~e~~~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~ 178 (328)
T d3bqca1 110 VFEHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178 (328)
T ss_dssp EEECCCSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred EEeecCCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccce
Confidence 99999999987653 348999999999999999999999 8999999999999998655 69999999998
Q ss_pred ecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 736 NAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 736 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
....... ....+||+.|+|||.+.+. ..++.++||||+|++
T Consensus 179 ~~~~~~~--~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~~ 219 (328)
T d3bqca1 179 FYHPGQE--YNVRVASRYFKGPELLVDY--QMYDYSLDMWSLGCM 219 (328)
T ss_dssp ECCTTCC--CCSCCSCGGGCCHHHHTTC--CCCCTHHHHHHHHHH
T ss_pred eccCCCc--ccccccCccccCcccccCC--CCCCcccchhhhhhh
Confidence 8765432 2345789999999987654 124668899999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.8e-33 Score=289.75 Aligned_cols=186 Identities=22% Similarity=0.280 Sum_probs=157.0
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCC-CCcceEEeEEEeCCeEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH-RHLVALLGYCINGSERLLV 657 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~nI~~~~~~~~~~~~~~lv 657 (782)
.++|++.+.||+|+||+||+|+. .+|+.||||++.... ....+++|++.++.++| +||+.+++++.+....++|
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc----CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 46899999999999999999964 578999999886543 22457788999999975 8999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECC-----CCcEEEEeec
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD-----DMRAKVADFG 732 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~-----~~~~kL~DfG 732 (782)
|||+ +++|.+++... ...+++.++..++.|++.||+|||+ .||+||||||+||+++. ++.+||+|||
T Consensus 80 me~~-~~~l~~~~~~~----~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG 151 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLC----GRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 151 (293)
T ss_dssp EECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred EEec-CCCHHHHHHhh----ccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccc
Confidence 9999 78999988653 2358999999999999999999998 89999999999999974 5789999999
Q ss_pred cceecCCCCc------eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 733 LVKNAPDGKY------SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 733 ~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+|+....... ......+||+.|||||++.+. .++.++||||+||+
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~---~~~~~~DiwSlG~~ 202 (293)
T d1csna_ 152 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR---EQSRRDDLEALGHV 202 (293)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC---CCCHHHHHHHHHHH
T ss_pred eeEEcccCccccceeecccCceEEchhhcCHHHhcCC---CCChHHHHHHhhHH
Confidence 9987654321 122345799999999998875 46889999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=1.7e-32 Score=286.42 Aligned_cols=186 Identities=23% Similarity=0.312 Sum_probs=152.2
Q ss_pred hcCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCC-cceEEeEEEeCCeEEEE
Q 003982 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH-LVALLGYCINGSERLLV 657 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-I~~~~~~~~~~~~~~lv 657 (782)
.++|++.+.||+|+||+||+|.. .+|+.||||++..... .+++.+|++++++++|++ |+.+.+++.+.+..++|
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 46799999999999999999954 5789999999876432 245788999999998665 55566667788899999
Q ss_pred EEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECC---CCcEEEEeeccc
Q 003982 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD---DMRAKVADFGLV 734 (782)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~---~~~~kL~DfG~a 734 (782)
|||+ ++++...+... ...+++.++..++.|++.||+|||+ +||+||||||+|||++. +..+||+|||+|
T Consensus 82 me~~-~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a 153 (299)
T d1ckia_ 82 MELL-GPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 153 (299)
T ss_dssp EECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSC
T ss_pred EEEc-CCchhhhhhhc----cCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcc
Confidence 9999 66777766542 3458999999999999999999999 89999999999999864 457999999999
Q ss_pred eecCCCCc------eeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 735 KNAPDGKY------SVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 735 ~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
+....... .......||+.|||||++.+. +++.++||||+||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~~ 202 (299)
T d1ckia_ 154 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGI---EQSRRDDLESLGYV 202 (299)
T ss_dssp EECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTB---CCCHHHHHHHHHHH
T ss_pred eeccccccccceeccccCCcCCCccccCHHHHhCC---CCCChhhEEecCHH
Confidence 98754331 122345799999999998875 46889999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.5e-33 Score=297.66 Aligned_cols=186 Identities=25% Similarity=0.398 Sum_probs=154.2
Q ss_pred hcCCCccceeecccceEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC-----Ce
Q 003982 580 TDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING-----SE 653 (782)
Q Consensus 580 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~-----~~ 653 (782)
.++|++.+.||+|+||+||+|+ ..+|+.||||++++...+....+++.+|++++++++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 4689999999999999999995 46799999999987665556677899999999999999999999998643 34
Q ss_pred EEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecc
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~ 733 (782)
.+++|+|+.+|+|.+++.. +.+++.++..++.|++.||+|||+ +||+||||||+|||++.++.+|++|||.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~------~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~ 167 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL 167 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC--
T ss_pred eEEEEEeecCCchhhhccc------ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccch
Confidence 4667778889999998843 359999999999999999999999 8999999999999999999999999999
Q ss_pred ceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 734 VKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 734 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
|....... ....||+.|+|||+..+. ...+.++||||+||+
T Consensus 168 a~~~~~~~----~~~~g~~~y~apE~~~~~--~~~~~~~DiwSlGv~ 208 (348)
T d2gfsa1 168 ARHTDDEM----TGYVATRWYRAPEIMLNW--MHYNQTVDIWSVGCI 208 (348)
T ss_dssp --CCTGGG----SSSCHHHHTSCHHHHTTC--SCCCTTHHHHHHHHH
T ss_pred hcccCccc----ccccccccccCchhhcCC--ccCCcccchhhhhHH
Confidence 97654322 335689999999986654 123567899999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8.7e-33 Score=295.45 Aligned_cols=184 Identities=26% Similarity=0.361 Sum_probs=147.1
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcceEEeEEEeC------Ce
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING------SE 653 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~------~~ 653 (782)
++|++.++||+|+||+||+|.. .+|+.||||+++.........+++.+|++++++++||||+++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 6899999999999999999965 5799999999987665556677899999999999999999999998643 67
Q ss_pred EEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcEEEEeecc
Q 003982 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (782)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~kL~DfG~ 733 (782)
.|+||||+.+ ++.+.+. ..+++.++..++.|++.||+|||+ .||+||||||+|||++.++.+|++|||+
T Consensus 97 ~~iv~Ey~~~-~l~~~~~-------~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 97 VYLVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp EEEEEECCSE-EHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred eEEEEeccch-HHHHhhh-------cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhh
Confidence 8999999965 4545442 348999999999999999999999 8999999999999999999999999999
Q ss_pred ceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 734 VKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 734 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
++...... .....+||+.|+|||++.+. .++.++||||+||+
T Consensus 166 ~~~~~~~~--~~~~~~~t~~y~aPE~l~~~---~~~~~~DiwSlG~~ 207 (355)
T d2b1pa1 166 ARTAGTSF--MMTPYVVTRYYRAPEVILGM---GYKENVDIWSVGCI 207 (355)
T ss_dssp -----------------CCTTCCHHHHTTC---CCCTTHHHHHHHHH
T ss_pred hhcccccc--ccccccccccccChhhhcCC---CCCCCcccccccch
Confidence 88665433 22345789999999998775 45678999999986
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=7e-31 Score=276.29 Aligned_cols=252 Identities=26% Similarity=0.413 Sum_probs=182.2
Q ss_pred CCCEEeccCCCCCCCCCCCcccCCCcccCeeeccc-cccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhh
Q 003982 138 NLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN-ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLW 216 (782)
Q Consensus 138 ~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~ 216 (782)
+++.|||++|.+.....+|..+.++++|++|+|++ |+++|.+|..|+++++|++|+|++|++.+..|..+.
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~-------- 122 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS-------- 122 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGG--------
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhcccccccccccccc--------
Confidence 35555555555554334566666667777777764 566666676777777777777777776654444332
Q ss_pred cccccCCCccccccccCCCCCcEEEeecccccCCCC-CCCCCCCCCEEEcCCCcCccCcchhhcCCCCC-CEEEccCCcc
Q 003982 217 MNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIP-DLSKCESLFDLSLRDNQLTGVVPASVISLPAL-LNISLQNNKL 294 (782)
Q Consensus 217 l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L-~~L~l~~N~l 294 (782)
.+++|+.+++++|++.+.+| .+..++.|+.+++++|.+++.+|..+..+..+ +.+++++|++
T Consensus 123 ----------------~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l 186 (313)
T d1ogqa_ 123 ----------------QIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRL 186 (313)
T ss_dssp ----------------GCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEE
T ss_pred ----------------chhhhcccccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccc
Confidence 36667777777776666554 46667777777777777777777777666664 6677777777
Q ss_pred cCCCCCCCCC--ccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEE
Q 003982 295 QGPYPLFPSK--VQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITI 372 (782)
Q Consensus 295 ~~~~~~~~~~--l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L 372 (782)
++..|..+.. ...+++++|.+.+ .+|..+...++++.|
T Consensus 187 ~~~~~~~~~~l~~~~l~l~~~~~~~----------------------------------------~~~~~~~~~~~l~~l 226 (313)
T d1ogqa_ 187 TGKIPPTFANLNLAFVDLSRNMLEG----------------------------------------DASVLFGSDKNTQKI 226 (313)
T ss_dssp EEECCGGGGGCCCSEEECCSSEEEE----------------------------------------CCGGGCCTTSCCSEE
T ss_pred ccccccccccccccccccccccccc----------------------------------------ccccccccccccccc
Confidence 7666654432 2345555554433 335556667899999
Q ss_pred EccCcccccccCccccccccCCeEecccccccccCCccCCCCCCCCeEecCCCcCCCCCCCCC--CCcceecCCCCCCCC
Q 003982 373 NLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFG--SNVKFTVSPGNPFIG 450 (782)
Q Consensus 373 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~--~~~~~~~~~~n~~~~ 450 (782)
++++|.+.+.+| .++.+++|++|+|++|+|+|.+|+.|+++++|+.|||++|+|+|.+|+++ +.++...+.+|+.+|
T Consensus 227 ~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~ 305 (313)
T d1ogqa_ 227 HLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLC 305 (313)
T ss_dssp ECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEE
T ss_pred cccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCcccc
Confidence 999999998765 68999999999999999999999999999999999999999999999876 477778899999999
Q ss_pred CCCC
Q 003982 451 TNVD 454 (782)
Q Consensus 451 ~~~~ 454 (782)
+.|.
T Consensus 306 g~pl 309 (313)
T d1ogqa_ 306 GSPL 309 (313)
T ss_dssp STTS
T ss_pred CCCC
Confidence 8765
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.95 E-value=4.8e-27 Score=254.08 Aligned_cols=234 Identities=26% Similarity=0.374 Sum_probs=135.3
Q ss_pred CCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEecc
Q 003982 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145 (782)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls 145 (782)
.++++|++++++|+. + +.+..+++|++|+|++|+|+++++ +.++++|++|+|++|+++++++ +.++++|+.|+++
T Consensus 44 ~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l~~-l~~L~~L~~L~L~~n~i~~i~~--l~~l~~L~~L~~~ 118 (384)
T d2omza2 44 DQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLF 118 (384)
T ss_dssp TTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECC
T ss_pred CCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCCcc-ccCCcccccccccccccccccc--ccccccccccccc
Confidence 468999999999984 4 458899999999999999998764 9999999999999999998875 8899999999999
Q ss_pred CCCCCCCCCCCcccCCCcccCeeeccccccCCC-----------------------------------------Cccccc
Q 003982 146 DNPNLAPWPFPNELTKSTSLTTLYMDNANIFGL-----------------------------------------IPDFFD 184 (782)
Q Consensus 146 ~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~-----------------------------------------~~~~~~ 184 (782)
+|.+... ........+..+....|.+... ....+.
T Consensus 119 ~~~~~~~----~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (384)
T d2omza2 119 NNQITDI----DPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA 194 (384)
T ss_dssp SSCCCCC----GGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGG
T ss_pred ccccccc----ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccccccccccc
Confidence 9988772 1222333444444444433221 123344
Q ss_pred CCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeecccccCCCCCCCCCCCCCEEE
Q 003982 185 SFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLS 264 (782)
Q Consensus 185 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~ 264 (782)
.+++++.|++++|.+++..|. -....++.+++++|.+... +.+..+++|+.|++++|++++.+ .+..+++|++|+
T Consensus 195 ~l~~~~~l~l~~n~i~~~~~~-~~~~~L~~L~l~~n~l~~~---~~l~~l~~L~~L~l~~n~l~~~~-~~~~~~~L~~L~ 269 (384)
T d2omza2 195 KLTNLESLIATNNQISDITPL-GILTNLDELSLNGNQLKDI---GTLASLTNLTDLDLANNQISNLA-PLSGLTKLTELK 269 (384)
T ss_dssp GCTTCSEEECCSSCCCCCGGG-GGCTTCCEEECCSSCCCCC---GGGGGCTTCSEEECCSSCCCCCG-GGTTCTTCSEEE
T ss_pred cccccceeeccCCccCCCCcc-cccCCCCEEECCCCCCCCc---chhhcccccchhccccCccCCCC-cccccccCCEee
Confidence 556666666666666633222 1122344444444433221 12333444444444444444322 234444444444
Q ss_pred cCCCcCccCcchhhcCCCCCCEEEccCCcccCCCC-CCCCCccEEEccCCcC
Q 003982 265 LRDNQLTGVVPASVISLPALLNISLQNNKLQGPYP-LFPSKVQKVSLDHNNF 315 (782)
Q Consensus 265 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~l~~N~~ 315 (782)
+++|++++.. .+..++.++.+++++|++++... ..+.+++.|++++|++
T Consensus 270 l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~~~~~~~~~l~~L~ls~n~l 319 (384)
T d2omza2 270 LGANQISNIS--PLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNI 319 (384)
T ss_dssp CCSSCCCCCG--GGTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCC
T ss_pred ccCcccCCCC--ccccccccccccccccccccccccchhcccCeEECCCCCC
Confidence 4444444322 13344444444444444443211 1223444444444444
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.95 E-value=1.2e-26 Score=242.76 Aligned_cols=275 Identities=22% Similarity=0.315 Sum_probs=221.9
Q ss_pred CCCCCCccccceEeCCCCCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCcccC
Q 003982 49 TSSTGYCEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTS 127 (782)
Q Consensus 49 ~~~~~~c~w~gv~c~~~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~ 127 (782)
++..|-|.|++|.|++ ++|+ ++|..+. ++|++|+|++|+|+.+++ .|.++++|++|++++|.++.
T Consensus 4 ~p~~c~c~~~~~~C~~-----------~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~ 69 (305)
T d1xkua_ 4 CPFRCQCHLRVVQCSD-----------LGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69 (305)
T ss_dssp CCTTCEEETTEEECTT-----------SCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCC
T ss_pred CCCCCEecCCEEEecC-----------CCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccc
Confidence 5666779999999975 3455 6677664 689999999999999888 79999999999999999999
Q ss_pred CCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccc
Q 003982 128 VPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASF 207 (782)
Q Consensus 128 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 207 (782)
+++..|.++++|++|++++|+++. +|..+ ...+..|++.+|.+.++.+..+.....+..++...|..... ..
T Consensus 70 i~~~~f~~l~~L~~L~l~~n~l~~---l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~-~~-- 141 (305)
T d1xkua_ 70 ISPGAFAPLVKLERLYLSKNQLKE---LPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSS-GI-- 141 (305)
T ss_dssp BCTTTTTTCTTCCEEECCSSCCSB---CCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGG-GB--
T ss_pred cchhhhhCCCccCEecccCCccCc---Cccch--hhhhhhhhccccchhhhhhhhhhcccccccccccccccccc-CC--
Confidence 999999999999999999999988 55443 35789999999999998888888888999999988876411 11
Q ss_pred cccccchhhcccccCCCccccccccCCCCCcEEEeecccccCCCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEE
Q 003982 208 AKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNI 287 (782)
Q Consensus 208 ~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 287 (782)
....+..+++|+.+++++|+++..+..+ +++|+.|++++|.+++..+.+|.+++.++.|
T Consensus 142 -------------------~~~~~~~l~~L~~l~l~~n~l~~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L 200 (305)
T d1xkua_ 142 -------------------ENGAFQGMKKLSYIRIADTNITTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKL 200 (305)
T ss_dssp -------------------CTTGGGGCTTCCEEECCSSCCCSCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEE
T ss_pred -------------------CccccccccccCccccccCCccccCccc--CCccCEEECCCCcCCCCChhHhhcccccccc
Confidence 1123556899999999999998765443 6899999999999999999999999999999
Q ss_pred EccCCcccCCCCCCCCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCC
Q 003982 288 SLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQG 367 (782)
Q Consensus 288 ~l~~N~l~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 367 (782)
++++|.+++..+. .+..++
T Consensus 201 ~~s~n~l~~~~~~-------------------------------------------------------------~~~~l~ 219 (305)
T d1xkua_ 201 GLSFNSISAVDNG-------------------------------------------------------------SLANTP 219 (305)
T ss_dssp ECCSSCCCEECTT-------------------------------------------------------------TGGGST
T ss_pred ccccccccccccc-------------------------------------------------------------cccccc
Confidence 9999998854332 233456
Q ss_pred ceeEEEccCcccccccCccccccccCCeEecccccccccCCcc------CCCCCCCCeEecCCCcCC
Q 003982 368 RIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDG------LTKLASLQNLDVSNNNLS 428 (782)
Q Consensus 368 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~------~~~l~~L~~L~ls~N~l~ 428 (782)
+|++|+|++|+|+ .+|.+|.++++|++|+|++|+|+..-... +..+.+|+.|+|++|+++
T Consensus 220 ~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 220 HLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp TCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred cceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence 7888888888887 46778888999999999999988433333 345778888999888875
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.94 E-value=9.3e-28 Score=257.67 Aligned_cols=186 Identities=22% Similarity=0.245 Sum_probs=147.2
Q ss_pred cCCCccceeecccceEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC-----------CCCcceEEeEE
Q 003982 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-----------HRHLVALLGYC 648 (782)
Q Consensus 581 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~nI~~~~~~~ 648 (782)
++|+++++||+|+||+||+|+. .+|+.||||++++.. ...+.+.+|++++++++ |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 4599999999999999999964 679999999997643 34567888999988875 47899999887
Q ss_pred Ee--CCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCC--
Q 003982 649 IN--GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM-- 724 (782)
Q Consensus 649 ~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~-- 724 (782)
.. ....+++|+++..+.......... ....+++..++.++.|++.||+|||+ ..||+||||||+|||++.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~ 165 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSP 165 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETT
T ss_pred eeccccceeeeeeecccccccccccccc--cccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcc
Confidence 64 456677777776554433333322 24568999999999999999999997 37999999999999998654
Q ss_pred ----cEEEEeeccceecCCCCceeeecccccccccCccccccchhhhHHHHHHHHHhccc
Q 003982 725 ----RAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAGKHWMILCQMTGLIWLHGSV 780 (782)
Q Consensus 725 ----~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~dvws~Gvv 780 (782)
.+|++|||.|....... ...+||+.|+|||++.+. +++.++|+||+||+
T Consensus 166 ~~~~~~kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~i 218 (362)
T d1q8ya_ 166 ENLIQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGA---PWGCGADIWSTACL 218 (362)
T ss_dssp TTEEEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTC---CCCTHHHHHHHHHH
T ss_pred cccceeeEeeccccccccccc----ccccccccccChhhcccc---CCCccccccchHHH
Confidence 49999999998765432 345799999999987764 45678999999986
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.94 E-value=9.9e-26 Score=243.63 Aligned_cols=335 Identities=24% Similarity=0.308 Sum_probs=242.3
Q ss_pred eCCCCCCcccCccccCCccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCC
Q 003982 73 LAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAP 152 (782)
Q Consensus 73 l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 152 (782)
+...++++.++ ...+.+|++|+++++.|+.+ +.+..+++|++|+|++|+|+++++ ++++++|++|++++|++..
T Consensus 29 l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~l-~gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i~~- 102 (384)
T d2omza2 29 LGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD- 102 (384)
T ss_dssp TTCSSTTSEEC--HHHHTTCCEEECCSSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-
T ss_pred hCCCCCCCccC--HHHhCCCCEEECCCCCCCCc-cccccCCCCCEEeCcCCcCCCCcc--ccCCccccccccccccccc-
Confidence 44445555443 34677899999999999864 578899999999999999999875 8999999999999999987
Q ss_pred CCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccc-----------cccchhhc----
Q 003982 153 WPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-----------SDIQNLWM---- 217 (782)
Q Consensus 153 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----------~~l~~l~l---- 217 (782)
++ .+..+++|+.|++++|.+++..+ ......+..+....|.+....+..... ..+..+..
T Consensus 103 --i~-~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (384)
T d2omza2 103 --IT-PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTL 177 (384)
T ss_dssp --CG-GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTC
T ss_pred --cc-ccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccchhhhhcccccc
Confidence 33 48899999999999999988643 445677888888888765322211110 00111100
Q ss_pred --ccccCCCccccccccCCCCCcEEEeecccccCCCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCccc
Q 003982 218 --NDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQ 295 (782)
Q Consensus 218 --~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 295 (782)
.............+..+++++.+++++|++++..+ +..+++|+.|++++|+++. + ..+..+++|+.|++++|+++
T Consensus 178 ~~~~~~~~~~~~~~~~~~l~~~~~l~l~~n~i~~~~~-~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~ 254 (384)
T d2omza2 178 ERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP-LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQIS 254 (384)
T ss_dssp CEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCC
T ss_pred ccccccccccccccccccccccceeeccCCccCCCCc-ccccCCCCEEECCCCCCCC-c-chhhcccccchhccccCccC
Confidence 00000112223456778999999999999997654 5667899999999999984 3 46888999999999999999
Q ss_pred CCCCC-CCCCccEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEc
Q 003982 296 GPYPL-FPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINL 374 (782)
Q Consensus 296 ~~~~~-~~~~l~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~L 374 (782)
+..+. ...+|+.|++++|.++++..... .+ .+.......+.+..+ ..+...++++.|++
T Consensus 255 ~~~~~~~~~~L~~L~l~~~~l~~~~~~~~------------------~~-~l~~l~~~~n~l~~~-~~~~~~~~l~~L~l 314 (384)
T d2omza2 255 NLAPLSGLTKLTELKLGANQISNISPLAG------------------LT-ALTNLELNENQLEDI-SPISNLKNLTYLTL 314 (384)
T ss_dssp CCGGGTTCTTCSEEECCSSCCCCCGGGTT------------------CT-TCSEEECCSSCCSCC-GGGGGCTTCSEEEC
T ss_pred CCCcccccccCCEeeccCcccCCCCcccc------------------cc-ccccccccccccccc-cccchhcccCeEEC
Confidence 87653 45789999999999876542110 00 011111122233333 34677789999999
Q ss_pred cCcccccccCccccccccCCeEecccccccccCCccCCCCCCCCeEecCCCcCCCCCCCCC--CCcceecCCCC
Q 003982 375 ANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFG--SNVKFTVSPGN 446 (782)
Q Consensus 375 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~--~~~~~~~~~~n 446 (782)
++|++++.. .+..+++|++|+|++|+|++ +| .|..+++|+.|++++|+|++.+| +. ..++...+++|
T Consensus 315 s~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~-l~~l~~L~~L~L~~N 383 (384)
T d2omza2 315 YFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQ 383 (384)
T ss_dssp CSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG-GTTCTTCSEEECCCE
T ss_pred CCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh-hccCCCCCEeeCCCC
Confidence 999999754 38899999999999999984 44 68999999999999999998876 32 45666666655
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=6.5e-25 Score=229.35 Aligned_cols=265 Identities=21% Similarity=0.250 Sum_probs=174.1
Q ss_pred cCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeec
Q 003982 91 QLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYM 170 (782)
Q Consensus 91 ~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L 170 (782)
.++.+|.++++++.+|+.+. +++++|+|++|+|+.+++..|.++++|++|++++|++.. ..|..|.++++|++|++
T Consensus 11 ~~~~~~C~~~~L~~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~--i~~~~f~~l~~L~~L~l 86 (305)
T d1xkua_ 11 HLRVVQCSDLGLEKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK--ISPGAFAPLVKLERLYL 86 (305)
T ss_dssp ETTEEECTTSCCCSCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCC--BCTTTTTTCTTCCEEEC
T ss_pred cCCEEEecCCCCCccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccc--cchhhhhCCCccCEecc
Confidence 45667777777776655553 567777777777777776667777777777776666665 23444555555555555
Q ss_pred cccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeecccccCC
Q 003982 171 DNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGP 250 (782)
Q Consensus 171 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~ 250 (782)
++|+++.+... ....++.|+++.|.+ .+.
T Consensus 87 ~~n~l~~l~~~---~~~~l~~L~~~~n~l------------------------------------------------~~l 115 (305)
T d1xkua_ 87 SKNQLKELPEK---MPKTLQELRVHENEI------------------------------------------------TKV 115 (305)
T ss_dssp CSSCCSBCCSS---CCTTCCEEECCSSCC------------------------------------------------CBB
T ss_pred cCCccCcCccc---hhhhhhhhhccccch------------------------------------------------hhh
Confidence 55555443221 123444445544444 433
Q ss_pred CCC-CCCCCCCCEEEcCCCcCc--cCcchhhcCCCCCCEEEccCCcccCCCCCCCCCccEEEccCCcCCCCCCCCCCCCC
Q 003982 251 IPD-LSKCESLFDLSLRDNQLT--GVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCD 327 (782)
Q Consensus 251 ~~~-~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~ 327 (782)
.+. +.....+..++...|... ...+..+..+++|+.+++++|+++......+.+|+.|++++|.++...
T Consensus 116 ~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~~~~~~L~~L~l~~n~~~~~~-------- 187 (305)
T d1xkua_ 116 RKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVD-------- 187 (305)
T ss_dssp CHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSCCTTCSEEECTTSCCCEEC--------
T ss_pred hhhhhhccccccccccccccccccCCCccccccccccCccccccCCccccCcccCCccCEEECCCCcCCCCC--------
Confidence 321 334444455555554332 233445566666666666666666544445566777777766654322
Q ss_pred hhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccccCccccccccCCeEecccccccccC
Q 003982 328 PQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPI 407 (782)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~ 407 (782)
+..+..++.++.|++++|.+++..+..+.++++|++|+|++|+|+ .+
T Consensus 188 --------------------------------~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~l 234 (305)
T d1xkua_ 188 --------------------------------AASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KV 234 (305)
T ss_dssp --------------------------------TGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SC
T ss_pred --------------------------------hhHhhccccccccccccccccccccccccccccceeeeccccccc-cc
Confidence 344566678999999999999999999999999999999999998 77
Q ss_pred CccCCCCCCCCeEecCCCcCCCCCCC-C--------CCCcceecCCCCCCCCC
Q 003982 408 PDGLTKLASLQNLDVSNNNLSGKVPD-F--------GSNVKFTVSPGNPFIGT 451 (782)
Q Consensus 408 p~~~~~l~~L~~L~ls~N~l~g~~p~-~--------~~~~~~~~~~~n~~~~~ 451 (782)
|..|..+++|+.|+|++|+|+...+. + ...+....+.+||+.+.
T Consensus 235 p~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~ 287 (305)
T d1xkua_ 235 PGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW 287 (305)
T ss_dssp CTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGG
T ss_pred ccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccC
Confidence 99999999999999999999965432 1 14566678899998754
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=2.4e-25 Score=230.08 Aligned_cols=201 Identities=23% Similarity=0.310 Sum_probs=161.7
Q ss_pred EEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEecc-CC
Q 003982 70 TISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS-DN 147 (782)
Q Consensus 70 ~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls-~N 147 (782)
.++.++++++ .+|..+. +.+++|+|++|+|+++++ .|.++++|++|++++|+++.++...+.+++.++.++.. .|
T Consensus 15 ~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~ 91 (284)
T d1ozna_ 15 TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91 (284)
T ss_dssp EEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred EEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence 3455666777 6776654 578999999999998887 69999999999999999999999999999999998875 45
Q ss_pred CCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccc
Q 003982 148 PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGT 227 (782)
Q Consensus 148 ~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~ 227 (782)
.+.. ..+..|.++++|++|++++|.+....+..+...++|+.+++++|+|++..+..
T Consensus 92 ~~~~--l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~--------------------- 148 (284)
T d1ozna_ 92 QLRS--VDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDT--------------------- 148 (284)
T ss_dssp TCCC--CCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTT---------------------
T ss_pred cccc--ccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhH---------------------
Confidence 5555 45677888899999999999988887888888888999999999988433333
Q ss_pred cccccCCCCCcEEEeecccccCCCC-CCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCC
Q 003982 228 LDVLSGMTQLRQVWLHKNQFTGPIP-DLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYP 299 (782)
Q Consensus 228 ~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~ 299 (782)
|..+++|++|++++|++++.++ .|..+++|+.+++++|++++..|..|.++++|++|++++|++.+..+
T Consensus 149 ---f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~ 218 (284)
T d1ozna_ 149 ---FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPT 218 (284)
T ss_dssp ---TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCH
T ss_pred ---hccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccc
Confidence 3457888888888888887666 47888888888888888888888888888888888888888875433
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.9e-24 Score=223.28 Aligned_cols=221 Identities=22% Similarity=0.294 Sum_probs=193.5
Q ss_pred CCCCCcc---ccceEeCCC----------CCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCC
Q 003982 50 SSTGYCE---WTGINCDNS----------NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSL 115 (782)
Q Consensus 50 ~~~~~c~---w~gv~c~~~----------~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L 115 (782)
+..+.|. |.-|.|++. ..+++|+|++|+|++..+..|..+++|++|++++|++..+.+ .+.++..+
T Consensus 3 p~~C~C~~~~~~~v~c~~~~L~~iP~~ip~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~ 82 (284)
T d1ozna_ 3 PGACVCYNEPKVTTSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82 (284)
T ss_dssp CTTCEEECSSSCEEECCSSCCSSCCTTCCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTC
T ss_pred CCCCEEcCCCCeEEEcCCCCCCccCCCCCCCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccc
Confidence 4445563 446888752 257899999999996666679999999999999999999887 68889999
Q ss_pred CEEeC-CCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEc
Q 003982 116 QDIYL-DNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRL 194 (782)
Q Consensus 116 ~~L~L-s~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 194 (782)
..++. ..|.++.+++..|.++++|++|++++|.+.. ..+..+..+++|+.+++++|+|+++.+..|..+++|++|++
T Consensus 83 ~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~--~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l 160 (284)
T d1ozna_ 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE--LGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFL 160 (284)
T ss_dssp CEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCC--CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cccccccccccccccchhhcccccCCEEecCCccccc--ccccccchhcccchhhhccccccccChhHhccccchhhccc
Confidence 99976 5788999999999999999999999999877 45667888999999999999999998999999999999999
Q ss_pred ccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeecccccCCCC-CCCCCCCCCEEEcCCCcCccC
Q 003982 195 SYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIP-DLSKCESLFDLSLRDNQLTGV 273 (782)
Q Consensus 195 s~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~ 273 (782)
++|++++..+.. |.++++|+.+++++|++++..+ .|..+++|++|++++|++++.
T Consensus 161 ~~N~l~~l~~~~------------------------f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~ 216 (284)
T d1ozna_ 161 HGNRISSVPERA------------------------FRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSAL 216 (284)
T ss_dssp CSSCCCEECTTT------------------------TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCC
T ss_pred ccCcccccchhh------------------------hccccccchhhhhhccccccChhHhhhhhhcccccccccccccc
Confidence 999998444443 4569999999999999999776 589999999999999999999
Q ss_pred cchhhcCCCCCCEEEccCCcccC
Q 003982 274 VPASVISLPALLNISLQNNKLQG 296 (782)
Q Consensus 274 ~p~~~~~l~~L~~L~l~~N~l~~ 296 (782)
.|..|..+++|++|++++|++.+
T Consensus 217 ~~~~~~~~~~L~~L~l~~N~l~C 239 (284)
T d1ozna_ 217 PTEALAPLRALQYLRLNDNPWVC 239 (284)
T ss_dssp CHHHHTTCTTCCEEECCSSCEEC
T ss_pred cccccccccccCEEEecCCCCCC
Confidence 99999999999999999999985
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=1.1e-23 Score=215.13 Aligned_cols=202 Identities=23% Similarity=0.245 Sum_probs=174.5
Q ss_pred eCCCCCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCC
Q 003982 62 CDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQ 140 (782)
Q Consensus 62 c~~~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 140 (782)
|.......+++.++++|+ .+|+.+. ++|++|+|++|+|+++++ .|.++++|++|+|++|+|+.++. +..+++|+
T Consensus 6 ~~~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~~--~~~l~~L~ 80 (266)
T d1p9ag_ 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVLG 80 (266)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTCC
T ss_pred EcccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccccc--cccccccc
Confidence 333344566788889998 5787765 579999999999998887 79999999999999999998875 57899999
Q ss_pred EEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccc
Q 003982 141 VLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQ 220 (782)
Q Consensus 141 ~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~ 220 (782)
+|+|++|++.. .+..+..+++|+.|++++|.+....+..+..+.++++|++++|.++ .+|..+
T Consensus 81 ~L~Ls~N~l~~---~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~-~l~~~~------------- 143 (266)
T d1p9ag_ 81 TLDLSHNQLQS---LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGL------------- 143 (266)
T ss_dssp EEECCSSCCSS---CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCC-CCCTTT-------------
T ss_pred ccccccccccc---cccccccccccccccccccccceeeccccccccccccccccccccc-eecccc-------------
Confidence 99999999987 5778899999999999999999998999999999999999999998 555432
Q ss_pred cCCCccccccccCCCCCcEEEeecccccCCCCC-CCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccC
Q 003982 221 QLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG 296 (782)
Q Consensus 221 ~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 296 (782)
+..+++|+.|++++|++++.++. |..+++|++|+|++|+|+ .+|+.+..+++|+.|+|++|++..
T Consensus 144 ----------~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 144 ----------LTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp ----------TTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred ----------ccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCC
Confidence 34689999999999999988775 888999999999999999 788888899999999999998863
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=2.6e-23 Score=212.27 Aligned_cols=177 Identities=21% Similarity=0.203 Sum_probs=123.4
Q ss_pred ccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEee
Q 003982 164 SLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLH 243 (782)
Q Consensus 164 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~ 243 (782)
+|++|+|++|+|+++.+..|.++++|++|+|++|+|+ .+|. ++.+++|++|+|+
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~-------------------------~~~l~~L~~L~Ls 85 (266)
T d1p9ag_ 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-------------------------DGTLPVLGTLDLS 85 (266)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC-------------------------CSCCTTCCEEECC
T ss_pred CCCEEECcCCcCCCcCHHHhhcccccccccccccccc-cccc-------------------------ccccccccccccc
Confidence 4555555566665555566777777777777777776 3331 2346677777777
Q ss_pred cccccCCCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCCCCCCccEEEccCCcCCCCCCCCC
Q 003982 244 KNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAG 323 (782)
Q Consensus 244 ~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~l~~N~~~~~~~~~~ 323 (782)
+|+++..++.+..+++|+.|++++|.+....+..+..+.+++.|++++|.++...+.
T Consensus 86 ~N~l~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~----------------------- 142 (266)
T d1p9ag_ 86 HNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPG----------------------- 142 (266)
T ss_dssp SSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTT-----------------------
T ss_pred cccccccccccccccccccccccccccceeeccccccccccccccccccccceeccc-----------------------
Confidence 777776666677777777777777777766667777777777777777776643322
Q ss_pred CCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccccCccccccccCCeEecccccc
Q 003982 324 KPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNL 403 (782)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 403 (782)
.+..+++|+.|++++|+|++..+..|..+++|++|+|++|+|
T Consensus 143 --------------------------------------~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L 184 (266)
T d1p9ag_ 143 --------------------------------------LLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 184 (266)
T ss_dssp --------------------------------------TTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCC
T ss_pred --------------------------------------cccccccchhcccccccccccCccccccccccceeecccCCC
Confidence 122344667777777777766667788888888999999888
Q ss_pred cccCCccCCCCCCCCeEecCCCcCC
Q 003982 404 TGPIPDGLTKLASLQNLDVSNNNLS 428 (782)
Q Consensus 404 ~g~~p~~~~~l~~L~~L~ls~N~l~ 428 (782)
+ .+|+.+..+++|+.|+|++|++.
T Consensus 185 ~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 185 Y-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp C-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred c-ccChhHCCCCCCCEEEecCCCCC
Confidence 8 78888888888888888876654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=2.2e-23 Score=201.28 Aligned_cols=138 Identities=13% Similarity=0.156 Sum_probs=108.1
Q ss_pred CCccceeecccceEEEEEEeCCCcEEEEEEeccccCC----------------hhhHHHHHHHHHHHHhcCCCCcceEEe
Q 003982 583 FSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMG----------------NKGLSEFQAEIAVLTKVRHRHLVALLG 646 (782)
Q Consensus 583 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------~~~~~~~~~E~~~l~~l~h~nI~~~~~ 646 (782)
+.+.++||+|+||+||+|...+|+.||||+++..... ........+|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 3467899999999999998888999999987642211 011234567899999999999999886
Q ss_pred EEEeCCeEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEcCCCCCCEEECCCCcE
Q 003982 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRA 726 (782)
Q Consensus 647 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDikp~NIll~~~~~~ 726 (782)
+. ..+++|||+++..+.+ ++...+..++.|++.|++|||+ .||+||||||+|||++++ .+
T Consensus 82 ~~----~~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~ 141 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GI 141 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EE
T ss_pred ec----CCEEEEEeeccccccc------------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CE
Confidence 53 2379999998755432 3334567899999999999998 899999999999999865 58
Q ss_pred EEEeeccceecCCC
Q 003982 727 KVADFGLVKNAPDG 740 (782)
Q Consensus 727 kL~DfG~a~~~~~~ 740 (782)
+|+|||.|......
T Consensus 142 ~liDFG~a~~~~~~ 155 (191)
T d1zara2 142 WIIDFPQSVEVGEE 155 (191)
T ss_dssp EECCCTTCEETTST
T ss_pred EEEECCCcccCCCC
Confidence 99999999876543
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.85 E-value=1.8e-19 Score=191.18 Aligned_cols=309 Identities=20% Similarity=0.264 Sum_probs=168.4
Q ss_pred CEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccC
Q 003982 67 RVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSD 146 (782)
Q Consensus 67 ~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~ 146 (782)
++++|||++++|+ .+|+. +++|++|+|++|+|+.++.. +.+|+.|++++|+++.++.- .+.|++|++++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~~lp~~---~~~L~~L~l~~n~l~~l~~l----p~~L~~L~L~~ 107 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLTELPEL---PQSLKSLLVDNNNLKALSDL----PPLLEYLGVSN 107 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCSSCCCC---CTTCCEEECCSSCCSCCCSC----CTTCCEEECCS
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCcccccc---hhhhhhhhhhhcccchhhhh----ccccccccccc
Confidence 4678888888887 57753 46788888888888855433 35788888888888876531 24688888888
Q ss_pred CCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccc-cccchhhcccccCCCc
Q 003982 147 NPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLS 225 (782)
Q Consensus 147 N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~l~l~~~~~~~~ 225 (782)
|.+.. +|. +..+++|+.|++++|.+..... ....+..+.+..+.... +..+.. ..++.+.+..+.....
T Consensus 108 n~l~~---lp~-~~~l~~L~~L~l~~~~~~~~~~----~~~~l~~l~~~~~~~~~--~~~l~~l~~l~~L~l~~n~~~~~ 177 (353)
T d1jl5a_ 108 NQLEK---LPE-LQNSSFLKIIDVDNNSLKKLPD----LPPSLEFIAAGNNQLEE--LPELQNLPFLTAIYADNNSLKKL 177 (353)
T ss_dssp SCCSS---CCC-CTTCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSS--CCCCTTCTTCCEEECCSSCCSSC
T ss_pred ccccc---ccc-hhhhccceeecccccccccccc----ccccccchhhccccccc--cccccccccceeccccccccccc
Confidence 88776 443 5677888888888887765422 23556666666555441 111111 1222222222222110
Q ss_pred cccccccCCCCCcEEEeecccccCCCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCCCCCCc
Q 003982 226 GTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKV 305 (782)
Q Consensus 226 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l 305 (782)
. ......+.+...++.+. ..+.+..++.|+.+++++|... .++. ...++..+.+.+|.+.. .+..+..+
T Consensus 178 ~-----~~~~~~~~l~~~~~~~~-~~~~~~~l~~L~~l~l~~n~~~-~~~~---~~~~l~~~~~~~~~~~~-~~~~~~~l 246 (353)
T d1jl5a_ 178 P-----DLPLSLESIVAGNNILE-ELPELQNLPFLTTIYADNNLLK-TLPD---LPPSLEALNVRDNYLTD-LPELPQSL 246 (353)
T ss_dssp C-----CCCTTCCEEECCSSCCS-SCCCCTTCTTCCEEECCSSCCS-SCCS---CCTTCCEEECCSSCCSC-CCCCCTTC
T ss_pred c-----ccccccccccccccccc-cccccccccccccccccccccc-cccc---ccccccccccccccccc-cccccccc
Confidence 0 00112223333322222 2223344455555555555444 1221 12334445555554442 22233344
Q ss_pred cEEEccCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccccCc
Q 003982 306 QKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISP 385 (782)
Q Consensus 306 ~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~ 385 (782)
..+++..|.+.++..... .....+.....++......++|++|+|++|+|+ .+|.
T Consensus 247 ~~~~~~~~~~~~l~~l~~------------------------~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~ 301 (353)
T d1jl5a_ 247 TFLDVSENIFSGLSELPP------------------------NLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPA 301 (353)
T ss_dssp CEEECCSSCCSEESCCCT------------------------TCCEEECCSSCCSEECCCCTTCCEEECCSSCCS-CCCC
T ss_pred cccccccccccccccccc------------------------hhcccccccCccccccccCCCCCEEECCCCccC-cccc
Confidence 444444444433221000 000000011122222333468889999999888 4665
Q ss_pred cccccccCCeEecccccccccCCccCCCCCCCCeEecCCCcCCCCCCCCCCCcce
Q 003982 386 AYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKF 440 (782)
Q Consensus 386 ~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~~~~ 440 (782)
. +++|+.|+|++|+|+ .+|+. +++|+.|+|++|+|+ .+|++...++.
T Consensus 302 ~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~~~~L~~ 348 (353)
T d1jl5a_ 302 L---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDIPESVED 348 (353)
T ss_dssp C---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCCCTTCCE
T ss_pred c---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCccccccCe
Confidence 4 467888899999988 66753 457888999999987 45655444443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.82 E-value=3.8e-18 Score=180.81 Aligned_cols=301 Identities=21% Similarity=0.225 Sum_probs=213.5
Q ss_pred ccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeee
Q 003982 90 TQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLY 169 (782)
Q Consensus 90 ~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~ 169 (782)
.+|++|||++|.++.+++ .+++|++|+|++|+|+.+|.. +.+|+.|++++|++.....+| +.|++|+
T Consensus 38 ~~l~~LdLs~~~L~~lp~---~~~~L~~L~Ls~N~l~~lp~~----~~~L~~L~l~~n~l~~l~~lp------~~L~~L~ 104 (353)
T d1jl5a_ 38 RQAHELELNNLGLSSLPE---LPPHLESLVASCNSLTELPEL----PQSLKSLLVDNNNLKALSDLP------PLLEYLG 104 (353)
T ss_dssp HTCSEEECTTSCCSCCCS---CCTTCSEEECCSSCCSSCCCC----CTTCCEEECCSSCCSCCCSCC------TTCCEEE
T ss_pred cCCCEEEeCCCCCCCCCC---CCCCCCEEECCCCCCcccccc----hhhhhhhhhhhcccchhhhhc------ccccccc
Confidence 468999999999997654 257899999999999999854 568999999999988732222 4699999
Q ss_pred ccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeecccccC
Q 003982 170 MDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTG 249 (782)
Q Consensus 170 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~ 249 (782)
+++|.+..+ |. +..+++|++|++++|.+. ..|.... .+..+.+..+... ....+..++.++.|++++|.+..
T Consensus 105 L~~n~l~~l-p~-~~~l~~L~~L~l~~~~~~-~~~~~~~--~l~~l~~~~~~~~---~~~~l~~l~~l~~L~l~~n~~~~ 176 (353)
T d1jl5a_ 105 VSNNQLEKL-PE-LQNSSFLKIIDVDNNSLK-KLPDLPP--SLEFIAAGNNQLE---ELPELQNLPFLTAIYADNNSLKK 176 (353)
T ss_dssp CCSSCCSSC-CC-CTTCTTCCEEECCSSCCS-CCCCCCT--TCCEEECCSSCCS---SCCCCTTCTTCCEEECCSSCCSS
T ss_pred ccccccccc-cc-hhhhccceeecccccccc-ccccccc--cccchhhcccccc---ccccccccccceecccccccccc
Confidence 999999876 43 678999999999999998 4444332 2333444333322 12346678899999999999886
Q ss_pred CCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCCCCCCccEEEccCCcCCCCCCCCCCCCChh
Q 003982 250 PIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQ 329 (782)
Q Consensus 250 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~~~ 329 (782)
.+... ...+.+.+.++.+. .++ .+..++.|+.+++++|.... .+....++..+.+.+|.+..........
T Consensus 177 ~~~~~---~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~l---- 246 (353)
T d1jl5a_ 177 LPDLP---LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDLPPSLEALNVRDNYLTDLPELPQSL---- 246 (353)
T ss_dssp CCCCC---TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSCCTTCCEEECCSSCCSCCCCCCTTC----
T ss_pred ccccc---cccccccccccccc-ccc-cccccccccccccccccccc-cccccccccccccccccccccccccccc----
Confidence 54322 34466777777766 444 46788999999999998774 5667788999999999886544211000
Q ss_pred hhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccccCccccccccCCeEecccccccccCCc
Q 003982 330 VTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPD 409 (782)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~ 409 (782)
..........+.+..+ .......++..|.+.+. ...+++|++|+|++|+|+ .+|.
T Consensus 247 --------------~~~~~~~~~~~~l~~l------~~~~~~~~~~~~~~~~~----~~~~~~L~~L~Ls~N~l~-~lp~ 301 (353)
T d1jl5a_ 247 --------------TFLDVSENIFSGLSEL------PPNLYYLNASSNEIRSL----CDLPPSLEELNVSNNKLI-ELPA 301 (353)
T ss_dssp --------------CEEECCSSCCSEESCC------CTTCCEEECCSSCCSEE----CCCCTTCCEEECCSSCCS-CCCC
T ss_pred --------------cccccccccccccccc------cchhcccccccCccccc----cccCCCCCEEECCCCccC-cccc
Confidence 0000000000111111 13456778888887743 234678999999999999 6775
Q ss_pred cCCCCCCCCeEecCCCcCCCCCCCCCCCcceecCCCCCCCC
Q 003982 410 GLTKLASLQNLDVSNNNLSGKVPDFGSNVKFTVSPGNPFIG 450 (782)
Q Consensus 410 ~~~~l~~L~~L~ls~N~l~g~~p~~~~~~~~~~~~~n~~~~ 450 (782)
. +++|+.|+|++|+|+ .+|.....++...+.+|++..
T Consensus 302 ~---~~~L~~L~L~~N~L~-~l~~~~~~L~~L~L~~N~L~~ 338 (353)
T d1jl5a_ 302 L---PPRLERLIASFNHLA-EVPELPQNLKQLHVEYNPLRE 338 (353)
T ss_dssp C---CTTCCEEECCSSCCS-CCCCCCTTCCEEECCSSCCSS
T ss_pred c---cCCCCEEECCCCcCC-ccccccCCCCEEECcCCcCCC
Confidence 4 678999999999998 577777788889999999753
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.78 E-value=2.4e-19 Score=172.73 Aligned_cols=180 Identities=21% Similarity=0.290 Sum_probs=139.7
Q ss_pred CCCCCccccceEeCCCCCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCC--CCCCCCCCCEEeCCCCcccC
Q 003982 50 SSTGYCEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP--SLANATSLQDIYLDNNNFTS 127 (782)
Q Consensus 50 ~~~~~c~w~gv~c~~~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~--~l~~l~~L~~L~Ls~n~l~~ 127 (782)
+..+-|+|..|.|+ +++|+ .+|+.+. +++++|+|++|+|++.++ .|.++++|++|+|++|+++.
T Consensus 3 P~~C~C~~~~v~Cs-----------~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~ 68 (192)
T d1w8aa_ 3 PAMCHCEGTTVDCT-----------GRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG 68 (192)
T ss_dssp CTTSEEETTEEECT-----------TSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCC
T ss_pred CCCCEEcCCEEEEe-----------CCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeecccccccc
Confidence 44455677655554 56777 6787664 689999999999987554 68999999999999999999
Q ss_pred CCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccc
Q 003982 128 VPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASF 207 (782)
Q Consensus 128 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 207 (782)
++++.|..+++|++|+|++|++.. ..+..|.++++|++|+|++|+|+++.+++|..+++|++|+|++|.+....+..+
T Consensus 69 ~~~~~~~~~~~L~~L~Ls~N~l~~--l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~ 146 (192)
T d1w8aa_ 69 IEPNAFEGASHIQELQLGENKIKE--ISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW 146 (192)
T ss_dssp BCTTTTTTCTTCCEEECCSCCCCE--ECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHH
T ss_pred ccccccccccccceeeeccccccc--cCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHH
Confidence 999999999999999999999998 556789999999999999999999999999999999999999999985443322
Q ss_pred cccccchhhcccccCCCccccccccCCCCCcEEEeecccccCCCCCCCCCCCCCEEEcCCCcCcc
Q 003982 208 AKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTG 272 (782)
Q Consensus 208 ~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~ 272 (782)
.... ++.+.+..|.++...| ..+..++.++|+.|.+..
T Consensus 147 ~~~~-------------------------l~~~~l~~~~~~c~~p--~~l~~~~l~~L~~n~l~C 184 (192)
T d1w8aa_ 147 FAEW-------------------------LRKKSLNGGAARCGAP--SKVRDVQIKDLPHSEFKC 184 (192)
T ss_dssp HHHH-------------------------HHHHCCSGGGCBBCSS--TTTTTSBGGGSCTTTCCC
T ss_pred Hhhh-------------------------hhhhcccCCCeEeCCC--hhhcCCEeeecCHhhCcC
Confidence 2111 2233344455553322 234456667777777764
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=1.3e-18 Score=174.42 Aligned_cols=86 Identities=19% Similarity=0.346 Sum_probs=45.7
Q ss_pred CCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeecc-ccccCCCCcccccCCCCCcEE
Q 003982 114 SLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMD-NANIFGLIPDFFDSFSNLQNL 192 (782)
Q Consensus 114 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~-~N~l~~~~~~~~~~l~~L~~L 192 (782)
++++|+|++|+|+.++...|.++++|++|+|++|.+... ..+..|.+++.++++.+. .|++....+..|.++++|++|
T Consensus 30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~-i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l 108 (242)
T d1xwdc1 30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEV-IEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 108 (242)
T ss_dssp CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCE-ECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEE
T ss_pred CCCEEECcCCcCCccChhHhhccchhhhhhhccccccce-eecccccccccccccccccccccccccccccccccccccc
Confidence 344444444444444444455555555555555544331 112234444455554443 244555556667777777777
Q ss_pred EcccCcCC
Q 003982 193 RLSYNNFT 200 (782)
Q Consensus 193 ~Ls~N~l~ 200 (782)
++++|++.
T Consensus 109 ~l~~~~l~ 116 (242)
T d1xwdc1 109 LISNTGIK 116 (242)
T ss_dssp EEESCCCC
T ss_pred ccchhhhc
Confidence 77777776
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.77 E-value=1.4e-18 Score=172.28 Aligned_cols=187 Identities=26% Similarity=0.372 Sum_probs=89.2
Q ss_pred cCCccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccC
Q 003982 87 SSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLT 166 (782)
Q Consensus 87 ~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~ 166 (782)
..+.+|+.|++.+|.|+.. +.+..+++|++|+|++|+++.+++ +.++++|+++++++|.++. + ..+..+++|+
T Consensus 38 ~~l~~L~~L~l~~~~i~~l-~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~---i-~~l~~l~~L~ 110 (227)
T d1h6ua2 38 ADLDGITTLSAFGTGVTTI-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN---V-SAIAGLQSIK 110 (227)
T ss_dssp HHHHTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC---C-GGGTTCTTCC
T ss_pred HHcCCcCEEECCCCCCCcc-hhHhcCCCCcEeecCCceeecccc--ccccccccccccccccccc---c-cccccccccc
Confidence 3444455555555555433 334455555555555555554432 4445555555555554443 1 2344455555
Q ss_pred eeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeeccc
Q 003982 167 TLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQ 246 (782)
Q Consensus 167 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~ 246 (782)
.++++++...+. ..+...+.++.+.++++.+....+ +.++++|++|++++|.
T Consensus 111 ~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~~--------------------------~~~~~~L~~L~l~~n~ 162 (227)
T d1h6ua2 111 TLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNISP--------------------------LAGLTNLQYLSIGNAQ 162 (227)
T ss_dssp EEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCGG--------------------------GGGCTTCCEEECCSSC
T ss_pred cccccccccccc--chhccccchhhhhchhhhhchhhh--------------------------hccccccccccccccc
Confidence 555555544433 223444555555555554442111 2234555555555555
Q ss_pred ccCCCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCC-CCCCCccEEEcc
Q 003982 247 FTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYP-LFPSKVQKVSLD 311 (782)
Q Consensus 247 l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~l~ 311 (782)
++... .+..+++|+.|+|++|++++. + .+.++++|++|+|++|++++..| ..+.+|+.|+++
T Consensus 163 ~~~~~-~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 163 VSDLT-PLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLT 225 (227)
T ss_dssp CCCCG-GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCGGGTTCTTCCEEEEE
T ss_pred cccch-hhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCCcccccCCCCCEEEee
Confidence 54322 245555555555555555532 2 25555555555555555554433 134455555554
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.76 E-value=1.5e-18 Score=169.66 Aligned_cols=179 Identities=21% Similarity=0.328 Sum_probs=127.0
Q ss_pred eCCCCCCcccCccccCCccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCC
Q 003982 73 LAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAP 152 (782)
Q Consensus 73 l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 152 (782)
+..+.+++.++. ..+.+|++|++++|.++... .+..+++|++|+|++|+|+++++ +.++++|++|++++|+++.
T Consensus 31 l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~-~l~~l~~L~~L~L~~n~i~~l~~--~~~l~~L~~L~l~~n~i~~- 104 (210)
T d1h6ta2 31 LKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD- 104 (210)
T ss_dssp TTCSCTTSEECH--HHHHTCCEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-
T ss_pred hCcCccCCccCH--HHhcCccEEECcCCCCCCch-hHhhCCCCCEEeCCCccccCccc--cccCccccccccccccccc-
Confidence 334444443332 34667778888888777543 46777888888888888877664 5677888888888887766
Q ss_pred CCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCcccccccc
Q 003982 153 WPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLS 232 (782)
Q Consensus 153 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~ 232 (782)
+| .+..+++|+.|++++|.+... ..+..+++|+++++++|.+++ .+ . +.
T Consensus 105 --l~-~l~~l~~L~~L~l~~~~~~~~--~~l~~l~~l~~l~~~~n~l~~-~~-~------------------------~~ 153 (210)
T d1h6ta2 105 --LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITD-IT-V------------------------LS 153 (210)
T ss_dssp --GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCC-CG-G------------------------GG
T ss_pred --cc-ccccccccccccccccccccc--ccccccccccccccccccccc-cc-c------------------------cc
Confidence 33 477777888888888877553 357777888888888888762 22 1 23
Q ss_pred CCCCCcEEEeecccccCCCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccC
Q 003982 233 GMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQN 291 (782)
Q Consensus 233 ~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 291 (782)
.+++|+++++++|++++. +.+.++++|+.|+|++|+|+. +| .+.++++|++|+|++
T Consensus 154 ~l~~L~~l~l~~n~l~~i-~~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 154 RLTKLDTLSLEDNQISDI-VPLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp GCTTCSEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred cccccccccccccccccc-ccccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence 478888888888888764 347788888888888888874 44 588888888888764
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.76 E-value=4.3e-18 Score=168.69 Aligned_cols=185 Identities=23% Similarity=0.390 Sum_probs=158.9
Q ss_pred CEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccC
Q 003982 67 RVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSD 146 (782)
Q Consensus 67 ~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~ 146 (782)
.++.|++.+++++. ++ .+..+++|++|++++|++++..| +..+++|++|++++|.++.++ .+.++++|+++++++
T Consensus 42 ~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~~-l~~l~~l~~l~~~~n~~~~i~--~l~~l~~L~~l~l~~ 116 (227)
T d1h6ua2 42 GITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLKNVS--AIAGLQSIKTLDLTS 116 (227)
T ss_dssp TCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCSCCG--GGTTCTTCCEEECTT
T ss_pred CcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeecccc-ccccccccccccccccccccc--ccccccccccccccc
Confidence 68999999999984 54 58999999999999999997665 889999999999999999876 378999999999999
Q ss_pred CCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCcc
Q 003982 147 NPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSG 226 (782)
Q Consensus 147 N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~ 226 (782)
|.... ...+...+.++.+.++++.+.... .+..+++|++|++++|.++. .+
T Consensus 117 ~~~~~----~~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~-~~---------------------- 167 (227)
T d1h6ua2 117 TQITD----VTPLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSD-LT---------------------- 167 (227)
T ss_dssp SCCCC----CGGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCC-CG----------------------
T ss_pred ccccc----cchhccccchhhhhchhhhhchhh--hhcccccccccccccccccc-ch----------------------
Confidence 98776 345777889999999999987653 47788999999999999873 22
Q ss_pred ccccccCCCCCcEEEeecccccCCCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEEEccC
Q 003982 227 TLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQN 291 (782)
Q Consensus 227 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 291 (782)
.++++++|++|+|++|++++. +.+..+++|++|+|++|+|++.. .+.++++|+.|++++
T Consensus 168 ---~l~~l~~L~~L~Ls~n~l~~l-~~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 168 ---PLANLSKLTTLKADDNKISDI-SPLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTN 226 (227)
T ss_dssp ---GGTTCTTCCEEECCSSCCCCC-GGGGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEE
T ss_pred ---hhcccccceecccCCCccCCC-hhhcCCCCCCEEECcCCcCCCCc--ccccCCCCCEEEeeC
Confidence 145689999999999999974 45889999999999999999654 388999999999974
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=5e-18 Score=164.37 Aligned_cols=163 Identities=27% Similarity=0.377 Sum_probs=101.5
Q ss_pred cCCccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccC
Q 003982 87 SSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLT 166 (782)
Q Consensus 87 ~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~ 166 (782)
..+.+|++|++++|.++.. +.++.+++|++|+|++|+++++++ +.++++|++|++++|.+.. ++ .+.++++|+
T Consensus 37 ~~l~~l~~L~l~~~~i~~l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~---~~-~l~~l~~L~ 109 (199)
T d2omxa2 37 TDLDQVTTLQADRLGIKSI-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD---IT-PLANLTNLT 109 (199)
T ss_dssp HHHTTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC---CG-GGTTCTTCS
T ss_pred HHhcCCCEEECCCCCCCCc-cccccCCCcCcCccccccccCccc--ccCCccccccccccccccc---cc-ccccccccc
Confidence 3455666666666666643 345666667777777777666554 6666677777777666655 22 356666677
Q ss_pred eeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeeccc
Q 003982 167 TLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQ 246 (782)
Q Consensus 167 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~ 246 (782)
.|++++|.+... +.+..+++|+.|++++|++. .++. +..+++|++|++++|+
T Consensus 110 ~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~-~~~~-------------------------l~~~~~L~~L~l~~n~ 161 (199)
T d2omxa2 110 GLTLFNNQITDI--DPLKNLTNLNRLELSSNTIS-DISA-------------------------LSGLTSLQQLNFSSNQ 161 (199)
T ss_dssp EEECCSSCCCCC--GGGTTCTTCSEEECCSSCCC-CCGG-------------------------GTTCTTCSEEECCSSC
T ss_pred cccccccccccc--cccchhhhhHHhhhhhhhhc-cccc-------------------------cccccccccccccccc
Confidence 777766666553 23566677777777777665 2321 2346677777777777
Q ss_pred ccCCCCCCCCCCCCCEEEcCCCcCccCcchhhcCCCCCCEE
Q 003982 247 FTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNI 287 (782)
Q Consensus 247 l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 287 (782)
+++. +.+..+++|++|++++|+|++ ++ .+.++++|+.|
T Consensus 162 l~~l-~~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 162 VTDL-KPLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp CCCC-GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred ccCC-ccccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 7654 236667777777777777764 22 46666666654
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=9.4e-18 Score=168.00 Aligned_cols=219 Identities=15% Similarity=0.165 Sum_probs=161.8
Q ss_pred EeCCCCCCcccCccccCCccCceeecccCccCccCC-CCCCCCCCCEEeCCCCcccC-CCCCCCCCCCCCCEEeccC-CC
Q 003982 72 SLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTS-VPTGCFDGLTNLQVLSLSD-NP 148 (782)
Q Consensus 72 ~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~-N~ 148 (782)
+.++.+++ .+|+.+. +++++|+|++|+|+.+++ .|.++++|++|+|++|.+.. +++..|.+++++++|++.. |+
T Consensus 14 ~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~ 90 (242)
T d1xwdc1 14 LCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 90 (242)
T ss_dssp EEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTT
T ss_pred EEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccccc
Confidence 33345666 6776654 578999999999998877 68999999999999998875 6788899999999998865 56
Q ss_pred CCCCCCCCcccCCCcccCeeeccccccCCCCc-ccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccc
Q 003982 149 NLAPWPFPNELTKSTSLTTLYMDNANIFGLIP-DFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGT 227 (782)
Q Consensus 149 l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~ 227 (782)
+.. ..+..|.++++|++|++++|++....+ ..+..+..+..+..+++.+...-+..|
T Consensus 91 l~~--~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~-------------------- 148 (242)
T d1xwdc1 91 LLY--INPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSF-------------------- 148 (242)
T ss_dssp CCE--ECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSS--------------------
T ss_pred ccc--cccccccccccccccccchhhhccccccccccccccccccccccccccccccccc--------------------
Confidence 655 456778999999999999999876543 334556677777777777763222222
Q ss_pred cccccCC-CCCcEEEeecccccCCCCCCCCCCCCCEE-EcCCCcCccCcchhhcCCCCCCEEEccCCcccCCCCCCCCCc
Q 003982 228 LDVLSGM-TQLRQVWLHKNQFTGPIPDLSKCESLFDL-SLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKV 305 (782)
Q Consensus 228 ~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~l~~L~~L-~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l 305 (782)
.++ ..++.|++++|+++.........++++.+ ++++|+|+...+..|.++++|++|++++|+|+...+..+.++
T Consensus 149 ----~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l 224 (242)
T d1xwdc1 149 ----VGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENL 224 (242)
T ss_dssp ----TTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTC
T ss_pred ----ccccccceeeecccccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCC
Confidence 233 47888999999998877765556665555 578888886666678899999999999999987666667777
Q ss_pred cEEE-ccCCcCCCCC
Q 003982 306 QKVS-LDHNNFCKNS 319 (782)
Q Consensus 306 ~~L~-l~~N~~~~~~ 319 (782)
..|. ++.+++..++
T Consensus 225 ~~L~~l~~~~l~~lp 239 (242)
T d1xwdc1 225 KKLRARSTYNLKKLP 239 (242)
T ss_dssp CEEESSSEESSSCSC
T ss_pred cccccCcCCCCCcCC
Confidence 7765 3444454443
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.73 E-value=2.5e-18 Score=165.46 Aligned_cols=171 Identities=21% Similarity=0.222 Sum_probs=92.8
Q ss_pred EEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEccc
Q 003982 117 DIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSY 196 (782)
Q Consensus 117 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 196 (782)
+++.++++++.+|.+.+ +++++|+|++|+|+.. ..+..|.++++|+.|+|++|++....+..|..+++|++|+|++
T Consensus 12 ~v~Cs~~~L~~iP~~lp---~~l~~L~Ls~N~i~~~-~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 12 TVDCTGRGLKEIPRDIP---LHTTELLLNDNELGRI-SSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EEECTTSCCSSCCSCCC---TTCSEEECCSCCCCSB-CCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred EEEEeCCCcCccCCCCC---CCCCEEEeCCCCCccc-ccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 44444444444444321 3444444444444321 1233445555555555555555555555666666666666666
Q ss_pred CcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeecccccCCCCC-CCCCCCCCEEEcCCCcCccCcc
Q 003982 197 NNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVP 275 (782)
Q Consensus 197 N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~p 275 (782)
|+|+...|.. |.++++|++|+|++|+|+++++. |..+++|++|+|++|.+.....
T Consensus 88 N~l~~l~~~~------------------------F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~ 143 (192)
T d1w8aa_ 88 NKIKEISNKM------------------------FLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCEECSSS------------------------STTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred ccccccCHHH------------------------HhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc
Confidence 6665222222 33466666666666666665553 6666777777777777664322
Q ss_pred hhhcCCCCCCEEEccCCcccCCCCCCCCCccEEEccCCcCC
Q 003982 276 ASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFC 316 (782)
Q Consensus 276 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~l~~N~~~ 316 (782)
..+ -...++.+.+..|.++...|..+..++.++|+.|.|+
T Consensus 144 ~~~-~~~~l~~~~l~~~~~~c~~p~~l~~~~l~~L~~n~l~ 183 (192)
T d1w8aa_ 144 LAW-FAEWLRKKSLNGGAARCGAPSKVRDVQIKDLPHSEFK 183 (192)
T ss_dssp GHH-HHHHHHHHCCSGGGCBBCSSTTTTTSBGGGSCTTTCC
T ss_pred hHH-HhhhhhhhcccCCCeEeCCChhhcCCEeeecCHhhCc
Confidence 111 1123455566677777666666666777777777663
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=4e-17 Score=159.28 Aligned_cols=163 Identities=25% Similarity=0.380 Sum_probs=141.1
Q ss_pred CEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccC
Q 003982 67 RVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSD 146 (782)
Q Consensus 67 ~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~ 146 (782)
.++.|++++++++. ++ .+..+++|++|+|++|+|++.+ .+.++++|++|++++|+|+.++ .+.++++|+.|++++
T Consensus 47 ~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~l~-~~~~l~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~l~~ 121 (210)
T d1h6ta2 47 SIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIK-PLANLKNLGWLFLDENKVKDLS--SLKDLKKLKSLSLEH 121 (210)
T ss_dssp TCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCCGG--GGTTCTTCCEEECTT
T ss_pred CccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccCcc-ccccCccccccccccccccccc--ccccccccccccccc
Confidence 58899999999985 33 4889999999999999999765 4788999999999999999987 388999999999999
Q ss_pred CCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCcc
Q 003982 147 NPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSG 226 (782)
Q Consensus 147 N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~ 226 (782)
|.+.. ...+..+++|+.+++++|.++.. ..+..+++|+++++++|++++ ++.
T Consensus 122 ~~~~~----~~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~-i~~--------------------- 173 (210)
T d1h6ta2 122 NGISD----INGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD-IVP--------------------- 173 (210)
T ss_dssp SCCCC----CGGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCC-CGG---------------------
T ss_pred ccccc----ccccccccccccccccccccccc--ccccccccccccccccccccc-ccc---------------------
Confidence 99876 34688999999999999999864 467789999999999999983 432
Q ss_pred ccccccCCCCCcEEEeecccccCCCCCCCCCCCCCEEEcCC
Q 003982 227 TLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRD 267 (782)
Q Consensus 227 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~ 267 (782)
+.++++|++|+|++|+++.. +.+..+++|++|+|++
T Consensus 174 ----l~~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 174 ----LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFS 209 (210)
T ss_dssp ----GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEEEEE
T ss_pred ----ccCCCCCCEEECCCCCCCCC-hhhcCCCCCCEEEccC
Confidence 44689999999999999864 5699999999999863
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.69 E-value=1e-16 Score=155.02 Aligned_cols=160 Identities=28% Similarity=0.417 Sum_probs=138.0
Q ss_pred CCEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEecc
Q 003982 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145 (782)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls 145 (782)
.+++.|++++++++. ++ .+..+++|++|++++|+|++..+ +.++++|++|++++|.+..++. +.++++|++|+++
T Consensus 40 ~~l~~L~l~~~~i~~-l~-~l~~l~nL~~L~Ls~N~l~~~~~-l~~l~~L~~L~l~~n~~~~~~~--l~~l~~L~~L~l~ 114 (199)
T d2omxa2 40 DQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLF 114 (199)
T ss_dssp TTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEECC
T ss_pred cCCCEEECCCCCCCC-cc-ccccCCCcCcCccccccccCccc-ccCCcccccccccccccccccc--ccccccccccccc
Confidence 368899999999984 43 58899999999999999998765 8999999999999999998874 8899999999999
Q ss_pred CCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCc
Q 003982 146 DNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLS 225 (782)
Q Consensus 146 ~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~ 225 (782)
+|.+.. ...+..+++|+.|++++|++... +.+..+++|++|++++|++++ ++.
T Consensus 115 ~~~~~~----~~~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~~-l~~-------------------- 167 (199)
T d2omxa2 115 NNQITD----IDPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTD-LKP-------------------- 167 (199)
T ss_dssp SSCCCC----CGGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-CGG--------------------
T ss_pred cccccc----ccccchhhhhHHhhhhhhhhccc--ccccccccccccccccccccC-Ccc--------------------
Confidence 998877 24588899999999999999764 368899999999999999983 332
Q ss_pred cccccccCCCCCcEEEeecccccCCCCCCCCCCCCCEE
Q 003982 226 GTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDL 263 (782)
Q Consensus 226 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L 263 (782)
++++++|++|++++|++++. +.+..+++|+.|
T Consensus 168 -----l~~l~~L~~L~ls~N~i~~i-~~l~~L~~L~~L 199 (199)
T d2omxa2 168 -----LANLTTLERLDISSNKVSDI-SVLAKLTNLESL 199 (199)
T ss_dssp -----GTTCTTCCEEECCSSCCCCC-GGGGGCTTCSEE
T ss_pred -----ccCCCCCCEEECCCCCCCCC-ccccCCCCCCcC
Confidence 45699999999999999874 467888888876
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.66 E-value=4.2e-19 Score=195.43 Aligned_cols=327 Identities=16% Similarity=0.199 Sum_probs=209.6
Q ss_pred CEEEEEeCCCCCCcc-cCccccCCccCceeecccCccCccC----C-CCCCCCCCCEEeCCCCcccCC-----CCCCCCC
Q 003982 67 RVTTISLAKSGLSGT-LSPEISSLTQLETLSFQMNNIAGAI----P-SLANATSLQDIYLDNNNFTSV-----PTGCFDG 135 (782)
Q Consensus 67 ~v~~L~l~~~~l~~~-~~~~l~~l~~L~~L~L~~N~l~~~~----~-~l~~l~~L~~L~Ls~n~l~~~-----~~~~~~~ 135 (782)
++++||++++++++. +..-+..++++++|+|++|.|+... . .+..+++|++|||++|+|+.. .......
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 588999999999853 2344677899999999999987421 2 467889999999999998742 2222223
Q ss_pred CCCCCEEeccCCCCCCCC--CCCcccCCCcccCeeeccccccCCCCccc-------------------------------
Q 003982 136 LTNLQVLSLSDNPNLAPW--PFPNELTKSTSLTTLYMDNANIFGLIPDF------------------------------- 182 (782)
Q Consensus 136 l~~L~~L~Ls~N~l~~~~--~~p~~~~~l~~L~~L~L~~N~l~~~~~~~------------------------------- 182 (782)
..+|++|+|++|+++... .++..+..+++|++|+|++|.++......
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 162 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccc
Confidence 458999999999986521 13456788899999999999875321111
Q ss_pred --ccCCCCCcEEEcccCcCCCCCC----ccccc--cccchhhcccccCCCcccc---ccccCCCCCcEEEeecccccCCC
Q 003982 183 --FDSFSNLQNLRLSYNNFTGSLP----ASFAK--SDIQNLWMNDQQLGLSGTL---DVLSGMTQLRQVWLHKNQFTGPI 251 (782)
Q Consensus 183 --~~~l~~L~~L~Ls~N~l~~~~p----~~~~~--~~l~~l~l~~~~~~~~~~~---~~~~~l~~L~~L~L~~N~l~~~~ 251 (782)
+.....++.++++++......- ..+.. .....+.+..+.....+.. ..+...+.++.++++.|++....
T Consensus 163 ~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~ 242 (460)
T d1z7xw1 163 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 242 (460)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccc
Confidence 1123455555555554431100 00000 1222333333333322211 23445678889999888765321
Q ss_pred -----C-CCCCCCCCCEEEcCCCcCccC----cchhhcCCCCCCEEEccCCcccCC--------CCCCCCCccEEEccCC
Q 003982 252 -----P-DLSKCESLFDLSLRDNQLTGV----VPASVISLPALLNISLQNNKLQGP--------YPLFPSKVQKVSLDHN 313 (782)
Q Consensus 252 -----~-~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~--------~~~~~~~l~~L~l~~N 313 (782)
. .......++.|++++|.+... ....+...+.++.+++++|.+++. .......|+.+++++|
T Consensus 243 ~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~ 322 (460)
T d1z7xw1 243 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSC 322 (460)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred cchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccccccccccccccccc
Confidence 1 245567899999999988743 334456678899999999988642 1223357888888888
Q ss_pred cCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccccCCceeEEEccCcccccc----cCcccc-
Q 003982 314 NFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGN----ISPAYA- 388 (782)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~L~~L~Ls~N~l~~~----~p~~~~- 388 (782)
.++... ... +...+....+|++|+|++|.|++. ++..+.
T Consensus 323 ~l~~~~----------~~~--------------------------l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~ 366 (460)
T d1z7xw1 323 SFTAAC----------CSH--------------------------FSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQ 366 (460)
T ss_dssp CCBGGG----------HHH--------------------------HHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTS
T ss_pred chhhhh----------hhh--------------------------cccccccccchhhhheeeecccCcccchhhhhhhc
Confidence 774322 011 111223345789999999998753 333343
Q ss_pred ccccCCeEecccccccc----cCCccCCCCCCCCeEecCCCcCCC
Q 003982 389 NLTSLKNLYLQQNNLTG----PIPDGLTKLASLQNLDVSNNNLSG 429 (782)
Q Consensus 389 ~l~~L~~L~Ls~N~l~g----~~p~~~~~l~~L~~L~ls~N~l~g 429 (782)
..+.|++|+|++|+|+. .+++.+..+++|+.|||++|+|+.
T Consensus 367 ~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~ 411 (460)
T d1z7xw1 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 411 (460)
T ss_dssp TTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred ccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCH
Confidence 45679999999999874 255566677889999999999874
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=6.2e-15 Score=136.58 Aligned_cols=124 Identities=18% Similarity=0.195 Sum_probs=87.2
Q ss_pred CEEEEEeCCCCCCcccCccccCCccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccC
Q 003982 67 RVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSD 146 (782)
Q Consensus 67 ~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~ 146 (782)
++.+|+|++|+|+ .++..+..+++|+.|+|++|+|+.. +.|..+++|++|+|++|+++.+++..+..+++|++|+|++
T Consensus 19 ~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~ 96 (162)
T d1a9na_ 19 RDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTN 96 (162)
T ss_dssp SCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCS
T ss_pred cCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc-CCcccCcchhhhhcccccccCCCccccccccccccceecc
Confidence 5677888888877 4455556777788888888877755 4577777888888888888877777777777888888888
Q ss_pred CCCCCCCCCCcccCCCcccCeeeccccccCCCC---cccccCCCCCcEEE
Q 003982 147 NPNLAPWPFPNELTKSTSLTTLYMDNANIFGLI---PDFFDSFSNLQNLR 193 (782)
Q Consensus 147 N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~l~~L~~L~ 193 (782)
|++..... ...+..+++|++|++++|.++... +..+..+++|++||
T Consensus 97 N~i~~~~~-l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 97 NSLVELGD-LDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CCCCCGGG-GGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred cccccccc-ccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 87766111 134667777777777777776542 23466677777776
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=2.6e-17 Score=180.75 Aligned_cols=328 Identities=19% Similarity=0.181 Sum_probs=213.6
Q ss_pred CEEEEEeCCCCCCc----ccCccccCCccCceeecccCccCccC----C-CCC-CCCCCCEEeCCCCcccCCC----CCC
Q 003982 67 RVTTISLAKSGLSG----TLSPEISSLTQLETLSFQMNNIAGAI----P-SLA-NATSLQDIYLDNNNFTSVP----TGC 132 (782)
Q Consensus 67 ~v~~L~l~~~~l~~----~~~~~l~~l~~L~~L~L~~N~l~~~~----~-~l~-~l~~L~~L~Ls~n~l~~~~----~~~ 132 (782)
+.++|+|++|+++. .+...+...++|++|||++|.|+... . .+. ...+|++|+|++|+++... ...
T Consensus 28 ~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~ 107 (460)
T d1z7xw1 28 QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSST 107 (460)
T ss_dssp TCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred CCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccccccch
Confidence 46789999999873 45566788999999999999986321 1 233 3357999999999998643 234
Q ss_pred CCCCCCCCEEeccCCCCCCCC-----------------------CC--------CcccCCCcccCeeeccccccCCCC--
Q 003982 133 FDGLTNLQVLSLSDNPNLAPW-----------------------PF--------PNELTKSTSLTTLYMDNANIFGLI-- 179 (782)
Q Consensus 133 ~~~l~~L~~L~Ls~N~l~~~~-----------------------~~--------p~~~~~l~~L~~L~L~~N~l~~~~-- 179 (782)
+..+++|++|+|++|.+.... .. ...+.....++.++++++.+....
T Consensus 108 l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ls~~~~~~~~~~ 187 (460)
T d1z7xw1 108 LRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVR 187 (460)
T ss_dssp TTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHH
T ss_pred hhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhccccccccccccccccccccccccccccc
Confidence 678899999999999864310 00 001222356777777766653211
Q ss_pred --cccc-cCCCCCcEEEcccCcCCCCCCccc-----cccccchhhcccccCCCccc----cccccCCCCCcEEEeecccc
Q 003982 180 --PDFF-DSFSNLQNLRLSYNNFTGSLPASF-----AKSDIQNLWMNDQQLGLSGT----LDVLSGMTQLRQVWLHKNQF 247 (782)
Q Consensus 180 --~~~~-~~l~~L~~L~Ls~N~l~~~~p~~~-----~~~~l~~l~l~~~~~~~~~~----~~~~~~l~~L~~L~L~~N~l 247 (782)
...+ ........+++..+.+....-..+ ....++.+.+..|.....+. .........++.|++++|.+
T Consensus 188 ~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i 267 (460)
T d1z7xw1 188 VLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGI 267 (460)
T ss_dssp HHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred ccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccccchhhcccccccccccccccccccc
Confidence 1111 233456778888877652211111 11345566666665432211 12344567899999999988
Q ss_pred cCCCC-----CCCCCCCCCEEEcCCCcCccCcchhh----c-CCCCCCEEEccCCcccCCCCC-------CCCCccEEEc
Q 003982 248 TGPIP-----DLSKCESLFDLSLRDNQLTGVVPASV----I-SLPALLNISLQNNKLQGPYPL-------FPSKVQKVSL 310 (782)
Q Consensus 248 ~~~~~-----~~~~l~~L~~L~L~~N~l~~~~p~~~----~-~l~~L~~L~l~~N~l~~~~~~-------~~~~l~~L~l 310 (782)
..... .+...+.++.+++++|.++......+ . ..+.|+.+++++|.++..... ...+|++|+|
T Consensus 268 ~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~L 347 (460)
T d1z7xw1 268 TAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQI 347 (460)
T ss_dssp CHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEEC
T ss_pred cccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhhe
Confidence 75322 24567899999999999975433333 2 346899999999998854322 1247999999
Q ss_pred cCCcCCCCCCCCCCCCChhhhhHHHhhcCCCCCcccccCcCCCCCCCCCCcccc-cCCceeEEEccCcccccc----cCc
Q 003982 311 DHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTC-SQGRIITINLANKLLAGN----ISP 385 (782)
Q Consensus 311 ~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~-~~~~L~~L~Ls~N~l~~~----~p~ 385 (782)
++|+++... ...+ +..+. ..+.|++|+|++|.|+.. ++.
T Consensus 348 s~N~i~~~g-------------~~~l-----------------------~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~ 391 (460)
T d1z7xw1 348 SNNRLEDAG-------------VREL-----------------------CQGLGQPGSVLRVLWLADCDVSDSSCSSLAA 391 (460)
T ss_dssp CSSBCHHHH-------------HHHH-----------------------HHHHTSTTCCCCEEECTTSCCCHHHHHHHHH
T ss_pred eeecccCcc-------------cchh-----------------------hhhhhcccCCCCEEECCCCCCChHHHHHHHH
Confidence 999874311 1111 11111 235799999999999853 556
Q ss_pred cccccccCCeEecccccccccCCc----cCC-CCCCCCeEecCCCcCCCC
Q 003982 386 AYANLTSLKNLYLQQNNLTGPIPD----GLT-KLASLQNLDVSNNNLSGK 430 (782)
Q Consensus 386 ~~~~l~~L~~L~Ls~N~l~g~~p~----~~~-~l~~L~~L~ls~N~l~g~ 430 (782)
.+..+++|++|+|++|+|+..... .+. +...|+.|++++|.+...
T Consensus 392 ~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~ 441 (460)
T d1z7xw1 392 TLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE 441 (460)
T ss_dssp HHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHH
T ss_pred HHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHH
Confidence 677789999999999999864333 232 345799999999998753
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.51 E-value=2.6e-14 Score=125.81 Aligned_cols=100 Identities=20% Similarity=0.211 Sum_probs=42.5
Q ss_pred eeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeecccc
Q 003982 94 TLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNA 173 (782)
Q Consensus 94 ~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N 173 (782)
+|+|++|+|+.. +.+.++++|++|++++|+|+.+|+. |..+++|++|++++|+++. +| .+..+++|++|++++|
T Consensus 2 ~L~Ls~n~l~~l-~~l~~l~~L~~L~ls~N~l~~lp~~-~~~l~~L~~L~l~~N~i~~---l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 2 VLHLAHKDLTVL-CHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALEN---VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp EEECTTSCCSSC-CCGGGGTTCCEEECCSSCCCCCCGG-GGGCTTCCEEECCSSCCCC---CG-GGTTCSSCCEEECCSS
T ss_pred EEEcCCCCCCCC-cccccCCCCCEEECCCCccCcchhh-hhhhhcccccccccccccc---cC-ccccccccCeEECCCC
Confidence 445555555422 2344445555555555555444432 4444444444444444443 11 2334444444444444
Q ss_pred ccCCCC-cccccCCCCCcEEEcccCcC
Q 003982 174 NIFGLI-PDFFDSFSNLQNLRLSYNNF 199 (782)
Q Consensus 174 ~l~~~~-~~~~~~l~~L~~L~Ls~N~l 199 (782)
+|+... ...+..+++|++|++++|++
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i 102 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSL 102 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcC
Confidence 443321 12333344444444444443
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.50 E-value=2e-14 Score=126.46 Aligned_cols=118 Identities=19% Similarity=0.251 Sum_probs=101.2
Q ss_pred EEEeCCCCCCcccCccccCCccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCC
Q 003982 70 TISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPN 149 (782)
Q Consensus 70 ~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 149 (782)
.|+|++|+++ .++ .+..+++|++|++++|.|+..++.+..+++|++|++++|+|++++. +.++++|++|++++|++
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~~l~~--~~~l~~L~~L~l~~N~i 77 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG--VANLPRLQELLLCNNRL 77 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccCcchhhhhhhhcccccccccccccccCc--cccccccCeEECCCCcc
Confidence 6899999998 555 5899999999999999999877789999999999999999999863 89999999999999999
Q ss_pred CCCCCCCcccCCCcccCeeeccccccCCC---CcccccCCCCCcEE
Q 003982 150 LAPWPFPNELTKSTSLTTLYMDNANIFGL---IPDFFDSFSNLQNL 192 (782)
Q Consensus 150 ~~~~~~p~~~~~l~~L~~L~L~~N~l~~~---~~~~~~~l~~L~~L 192 (782)
.... ....+..+++|+.|++++|.++.. ....+..+|+|+.|
T Consensus 78 ~~~~-~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 78 QQSA-AIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp CSSS-TTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred CCCC-CchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence 8731 235688999999999999999754 34455667888776
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=1.1e-14 Score=134.98 Aligned_cols=115 Identities=18% Similarity=0.122 Sum_probs=98.8
Q ss_pred cccCCccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcc
Q 003982 85 EISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTS 164 (782)
Q Consensus 85 ~l~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~ 164 (782)
.+.+..+|++|+|++|+|+.++..+..+++|++|+|++|+|+.++ .|..+++|++|++++|+++. ..+..+..+++
T Consensus 13 ~~~n~~~lr~L~L~~n~I~~i~~~~~~l~~L~~L~Ls~N~i~~l~--~~~~l~~L~~L~ls~N~i~~--l~~~~~~~l~~ 88 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLD--GFPLLRRLKTLLVNNNRICR--IGEGLDQALPD 88 (162)
T ss_dssp EEECTTSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCCEEC--CCCCCSSCCEEECCSSCCCE--ECSCHHHHCTT
T ss_pred hccCcCcCcEEECCCCCCCccCccccccccCCEEECCCCCCCccC--CcccCcchhhhhcccccccC--CCccccccccc
Confidence 467888999999999999987655678999999999999999985 38899999999999999988 23344678999
Q ss_pred cCeeeccccccCCCCc-ccccCCCCCcEEEcccCcCCCCCC
Q 003982 165 LTTLYMDNANIFGLIP-DFFDSFSNLQNLRLSYNNFTGSLP 204 (782)
Q Consensus 165 L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p 204 (782)
|+.|+|++|+|+.... ..+..+++|++|++++|.++ ..|
T Consensus 89 L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~ 128 (162)
T d1a9na_ 89 LTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKK 128 (162)
T ss_dssp CCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GST
T ss_pred cccceeccccccccccccccccccccchhhcCCCccc-ccc
Confidence 9999999999987633 57889999999999999997 555
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.45 E-value=2.2e-15 Score=158.88 Aligned_cols=45 Identities=9% Similarity=0.042 Sum_probs=29.2
Q ss_pred cCccccCCccCceeecccCccCccC-----CCCCCCCCCCEEeCCCCccc
Q 003982 82 LSPEISSLTQLETLSFQMNNIAGAI-----PSLANATSLQDIYLDNNNFT 126 (782)
Q Consensus 82 ~~~~l~~l~~L~~L~L~~N~l~~~~-----~~l~~l~~L~~L~Ls~n~l~ 126 (782)
+..++.+.+.|+.|+|++|.|+... ..+...++|+.|+++++.+.
T Consensus 23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~ 72 (344)
T d2ca6a1 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTG 72 (344)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTT
T ss_pred HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCccc
Confidence 3445666777888888887775421 24566677777777766554
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.44 E-value=1.2e-15 Score=156.16 Aligned_cols=245 Identities=17% Similarity=0.227 Sum_probs=150.6
Q ss_pred EEEeCCCCCCcccCccccCCccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCC-CCCCCCCCCCCCEEeccCCC
Q 003982 70 TISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSV-PTGCFDGLTNLQVLSLSDNP 148 (782)
Q Consensus 70 ~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~-~~~~~~~l~~L~~L~Ls~N~ 148 (782)
.|||+++.+.......+.. ..+..+.++...+...........+|++|||+++.++.. ....+.++++|++|+|++++
T Consensus 4 ~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~ 82 (284)
T d2astb2 4 TLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLR 82 (284)
T ss_dssp EEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCB
T ss_pred EEECCCCCCCchHHHHHHh-ccceEeeccccccccchhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccC
Confidence 6788877775333222221 234455565555554333444556788888888877642 23346777888888888887
Q ss_pred CCCCCCCCcccCCCcccCeeecccc-ccCCC-CcccccCCCCCcEEEcccC-cCCCC-CCccccc--cccchhhccccc-
Q 003982 149 NLAPWPFPNELTKSTSLTTLYMDNA-NIFGL-IPDFFDSFSNLQNLRLSYN-NFTGS-LPASFAK--SDIQNLWMNDQQ- 221 (782)
Q Consensus 149 l~~~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~--~~l~~l~l~~~~- 221 (782)
+.. ..+..+..+++|++|+++++ .++.. +...+.++++|++|+++++ +++.. +...+.. ..++.|+++++.
T Consensus 83 l~~--~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~ 160 (284)
T d2astb2 83 LSD--PIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRK 160 (284)
T ss_dssp CCH--HHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGG
T ss_pred CCc--HHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccccc
Confidence 665 34556777788888888874 44421 1223456788888888875 34311 1111211 356666666532
Q ss_pred -CCCccccccccCCCCCcEEEeecc-cccCCC-CCCCCCCCCCEEEcCCC-cCccCcchhhcCCCCCCEEEccCCcccC-
Q 003982 222 -LGLSGTLDVLSGMTQLRQVWLHKN-QFTGPI-PDLSKCESLFDLSLRDN-QLTGVVPASVISLPALLNISLQNNKLQG- 296 (782)
Q Consensus 222 -~~~~~~~~~~~~l~~L~~L~L~~N-~l~~~~-~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~~- 296 (782)
+...+....+.++++|++|++++| .+++.. ..+..+++|++|+|++| .+++.....++++++|+.|+++++ ++.
T Consensus 161 ~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d~ 239 (284)
T d2astb2 161 NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDG 239 (284)
T ss_dssp GSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTT
T ss_pred ccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CCHH
Confidence 222222233456889999999886 466533 35778899999999984 688777778888999999999887 332
Q ss_pred CCCCCCCCccEEEccCCcCCCC
Q 003982 297 PYPLFPSKVQKVSLDHNNFCKN 318 (782)
Q Consensus 297 ~~~~~~~~l~~L~l~~N~~~~~ 318 (782)
.++.....+..|.++.+.++.+
T Consensus 240 ~l~~l~~~lp~L~i~~~~ls~~ 261 (284)
T d2astb2 240 TLQLLKEALPHLQINCSHFTTI 261 (284)
T ss_dssp CHHHHHHHSTTSEESCCCSCCT
T ss_pred HHHHHHHhCccccccCccCCCC
Confidence 2222223455566666666554
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.39 E-value=1.2e-14 Score=148.45 Aligned_cols=102 Identities=17% Similarity=0.140 Sum_probs=60.8
Q ss_pred ceeecccCccCccCC-CCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeecc
Q 003982 93 ETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMD 171 (782)
Q Consensus 93 ~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~ 171 (782)
+.|||+++.+..... .+.. ..+..+.++...+...... .....+|++|||+++.+... .+...+.++++|++|+|+
T Consensus 3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~~-~~~~~~L~~LdLs~~~i~~~-~l~~l~~~c~~L~~L~L~ 79 (284)
T d2astb2 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVS-TLHGILSQCSKLQNLSLE 79 (284)
T ss_dssp SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHH-HHHHHHTTBCCCSEEECT
T ss_pred CEEECCCCCCCchHHHHHHh-ccceEeeccccccccchhh-hccCCCCCEEECCCCccCHH-HHHHHHHhCCCccccccc
Confidence 468888887753222 1111 2356677776666543333 33445777777777765441 123345666777777777
Q ss_pred ccccCCCCcccccCCCCCcEEEcccC
Q 003982 172 NANIFGLIPDFFDSFSNLQNLRLSYN 197 (782)
Q Consensus 172 ~N~l~~~~~~~~~~l~~L~~L~Ls~N 197 (782)
+|.++...+..+..+++|++|+++++
T Consensus 80 ~~~l~~~~~~~l~~~~~L~~L~Ls~c 105 (284)
T d2astb2 80 GLRLSDPIVNTLAKNSNLVRLNLSGC 105 (284)
T ss_dssp TCBCCHHHHHHHTTCTTCSEEECTTC
T ss_pred ccCCCcHHHHHHhcCCCCcCcccccc
Confidence 77766655666666777777777764
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.29 E-value=5.3e-12 Score=115.62 Aligned_cols=75 Identities=16% Similarity=0.139 Sum_probs=48.2
Q ss_pred CCCCcccCccccCCccCceeecccC-ccCccCC-CCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCC
Q 003982 76 SGLSGTLSPEISSLTQLETLSFQMN-NIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLA 151 (782)
Q Consensus 76 ~~l~~~~~~~l~~l~~L~~L~L~~N-~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 151 (782)
+++. .+|..+..+++|++|++++| .|+.+.+ .|.++++|+.|+|++|+|+.+++.+|.++++|++|+|++|+++.
T Consensus 18 ~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~ 94 (156)
T d2ifga3 18 DGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALES 94 (156)
T ss_dssp SCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSC
T ss_pred CCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCcc
Confidence 3443 44556666777777777654 4666555 56677777777777777777766666666666666666666555
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.29 E-value=6e-15 Score=141.67 Aligned_cols=116 Identities=23% Similarity=0.281 Sum_probs=99.8
Q ss_pred ccCccccCCccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccC
Q 003982 81 TLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELT 160 (782)
Q Consensus 81 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~ 160 (782)
.++..+..|++|++|+|++|+|+.+ +.|.++++|++|+|++|+|+.++. .+..+++|++|++++|+++. + ..+.
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~~i-~~l~~l~~L~~L~Ls~N~i~~i~~-~~~~~~~L~~L~l~~N~i~~---l-~~~~ 112 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIEKI-SSLSGMENLRILSLGRNLIKKIEN-LDAVADTLEELWISYNQIAS---L-SGIE 112 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEESCC-CCHHHHTTCCEEECCEEEECSCSS-HHHHHHHCCEEECSEEECCC---H-HHHH
T ss_pred hhhhHHhcccccceeECcccCCCCc-ccccCCccccChhhcccccccccc-cccccccccccccccccccc---c-cccc
Confidence 4567799999999999999999965 568899999999999999999864 34556789999999999987 3 4588
Q ss_pred CCcccCeeeccccccCCCCc-ccccCCCCCcEEEcccCcCCCC
Q 003982 161 KSTSLTTLYMDNANIFGLIP-DFFDSFSNLQNLRLSYNNFTGS 202 (782)
Q Consensus 161 ~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~ 202 (782)
.+++|+.|+|++|+|+.... ..+..+++|++|+|++|++...
T Consensus 113 ~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~ 155 (198)
T d1m9la_ 113 KLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYND 155 (198)
T ss_dssp HHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHH
T ss_pred ccccccccccccchhccccccccccCCCccceeecCCCccccC
Confidence 89999999999999987633 5789999999999999998743
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.29 E-value=1.2e-14 Score=139.59 Aligned_cols=86 Identities=26% Similarity=0.374 Sum_probs=51.5
Q ss_pred CCCCCCCCCEEeCCCCcccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCC
Q 003982 108 SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFS 187 (782)
Q Consensus 108 ~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 187 (782)
.+..+++|++|+|++|+|+.++ .+.++++|++|+|++|++.. +|..+..+++|+.|++++|+|+.+ +.+..++
T Consensus 43 sl~~L~~L~~L~Ls~n~I~~i~--~l~~l~~L~~L~Ls~N~i~~---i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~ 115 (198)
T d1m9la_ 43 TLSTLKACKHLALSTNNIEKIS--SLSGMENLRILSLGRNLIKK---IENLDAVADTLEELWISYNQIASL--SGIEKLV 115 (198)
T ss_dssp HHHHTTTCCEEECSEEEESCCC--CHHHHTTCCEEECCEEEECS---CSSHHHHHHHCCEEECSEEECCCH--HHHHHHH
T ss_pred HHhcccccceeECcccCCCCcc--cccCCccccChhhccccccc---cccccccccccccccccccccccc--ccccccc
Confidence 4666777777777777777764 26666677777777666655 344344444566666666655543 2344555
Q ss_pred CCcEEEcccCcCC
Q 003982 188 NLQNLRLSYNNFT 200 (782)
Q Consensus 188 ~L~~L~Ls~N~l~ 200 (782)
+|++|++++|+++
T Consensus 116 ~L~~L~L~~N~i~ 128 (198)
T d1m9la_ 116 NLRVLYMSNNKIT 128 (198)
T ss_dssp HSSEEEESEEECC
T ss_pred cccccccccchhc
Confidence 5555555555554
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.29 E-value=5.4e-12 Score=115.61 Aligned_cols=107 Identities=19% Similarity=0.245 Sum_probs=93.8
Q ss_pred cCceeecccCccCccCCCCCCCCCCCEEeCCCC-cccCCCCCCCCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeee
Q 003982 91 QLETLSFQMNNIAGAIPSLANATSLQDIYLDNN-NFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLY 169 (782)
Q Consensus 91 ~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~ 169 (782)
..+.++++++.+...+..+..+++|++|+|++| .|+.++...|.++++|+.|+|++|+|+. ..+.+|..+++|++|+
T Consensus 9 ~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~--i~~~~f~~l~~L~~L~ 86 (156)
T d2ifga3 9 GSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRF--VAPDAFHFTPRLSRLN 86 (156)
T ss_dssp SSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCE--ECTTGGGSCSCCCEEE
T ss_pred CCCeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCC--ccccccccccccccee
Confidence 345688888888877778889999999999765 5999999999999999999999999998 5577899999999999
Q ss_pred ccccccCCCCcccccCCCCCcEEEcccCcCC
Q 003982 170 MDNANIFGLIPDFFDSFSNLQNLRLSYNNFT 200 (782)
Q Consensus 170 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 200 (782)
|++|+|+.+.+..|..+ +|++|+|++|.+.
T Consensus 87 Ls~N~l~~l~~~~~~~~-~l~~L~L~~Np~~ 116 (156)
T d2ifga3 87 LSFNALESLSWKTVQGL-SLQELVLSGNPLH 116 (156)
T ss_dssp CCSSCCSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred ccCCCCcccChhhhccc-cccccccCCCccc
Confidence 99999998877777655 7999999999996
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.27 E-value=4.8e-14 Score=148.46 Aligned_cols=233 Identities=20% Similarity=0.178 Sum_probs=159.3
Q ss_pred CCEEEEEeCCCCCCc----ccCccccCCccCceeecccCccCccCC-----------CCCCCCCCCEEeCCCCcccCCCC
Q 003982 66 NRVTTISLAKSGLSG----TLSPEISSLTQLETLSFQMNNIAGAIP-----------SLANATSLQDIYLDNNNFTSVPT 130 (782)
Q Consensus 66 ~~v~~L~l~~~~l~~----~~~~~l~~l~~L~~L~L~~N~l~~~~~-----------~l~~l~~L~~L~Ls~n~l~~~~~ 130 (782)
..++.|+|++|.+.. .+...+...++|+.|+++++.+....+ .+...++|++|+|++|.++....
T Consensus 31 ~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~ 110 (344)
T d2ca6a1 31 DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQ 110 (344)
T ss_dssp SCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTH
T ss_pred CCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccccccc
Confidence 458899999998864 344567888999999999876543211 25678899999999999886432
Q ss_pred C----CCCCCCCCCEEeccCCCCCCCCC--C---------CcccCCCcccCeeeccccccCCC----CcccccCCCCCcE
Q 003982 131 G----CFDGLTNLQVLSLSDNPNLAPWP--F---------PNELTKSTSLTTLYMDNANIFGL----IPDFFDSFSNLQN 191 (782)
Q Consensus 131 ~----~~~~l~~L~~L~Ls~N~l~~~~~--~---------p~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~ 191 (782)
. .+...++|+.|++++|.+..... + .......+.|+.+++++|+++.. +...+...+.|++
T Consensus 111 ~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~ 190 (344)
T d2ca6a1 111 EPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHT 190 (344)
T ss_dssp HHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCE
T ss_pred cchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhcc
Confidence 2 23457899999999997643100 0 00113456788889988887633 2344566788999
Q ss_pred EEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeecccccCCC-----CCCCCCCCCCEEEcC
Q 003982 192 LRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPI-----PDLSKCESLFDLSLR 266 (782)
Q Consensus 192 L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~-----~~~~~l~~L~~L~L~ 266 (782)
|+|++|.++..-...+ ....+..+++|+.|+|++|.++... ..+..+++|++|+|+
T Consensus 191 L~L~~n~i~~~g~~~~-------------------l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls 251 (344)
T d2ca6a1 191 VKMVQNGIRPEGIEHL-------------------LLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLN 251 (344)
T ss_dssp EECCSSCCCHHHHHHH-------------------HHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECT
T ss_pred cccccccccccccccc-------------------hhhhhcchhhhcccccccccccccccccccccccccccchhhhhh
Confidence 9999888762100000 0123456788999999999886521 236778999999999
Q ss_pred CCcCccCcchhh----cC--CCCCCEEEccCCcccCCCC--------CCCCCccEEEccCCcCCC
Q 003982 267 DNQLTGVVPASV----IS--LPALLNISLQNNKLQGPYP--------LFPSKVQKVSLDHNNFCK 317 (782)
Q Consensus 267 ~N~l~~~~p~~~----~~--l~~L~~L~l~~N~l~~~~~--------~~~~~l~~L~l~~N~~~~ 317 (782)
+|.|++.....+ .. .+.|++|++++|+++.... .-.++|+.|+|++|.|..
T Consensus 252 ~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 252 DCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp TCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred cCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 999986533333 33 3679999999999874211 123578999999998854
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.64 E-value=6.4e-08 Score=96.30 Aligned_cols=150 Identities=15% Similarity=0.114 Sum_probs=105.8
Q ss_pred HHHHHHhcCCCccceeecccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcC-CCCcceEEeEEEeCC
Q 003982 574 EVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGS 652 (782)
Q Consensus 574 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~ 652 (782)
.++....+.|+..+..+-++.+.||+... +++.+++|+..... ......+.+|...++.+. +--+++++++..+++
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~--~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~ 83 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRY--KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDG 83 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGG--TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCc--ccchhhHHHHHHHHHHHhccCCCCcEEEEEecCC
Confidence 45666667888777655555679999875 66778889886543 222345778888888774 444788888888899
Q ss_pred eEEEEEEccCCCCHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------
Q 003982 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA---------------------------- 704 (782)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---------------------------- 704 (782)
..++||++++|.++.+.... .. ....++.++++.++.||+..
T Consensus 84 ~~~lv~~~l~G~~~~~~~~~-------~~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (263)
T d1j7la_ 84 WSNLLMSEADGVLCSEEYED-------EQ---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADV 153 (263)
T ss_dssp EEEEEEECCSSEEHHHHTTT-------CS---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCC
T ss_pred ceEEEEEecccccccccccc-------cc---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhh
Confidence 99999999999877654321 01 12334556666666666410
Q ss_pred ----------------------------CCCeEEcCCCCCCEEECCCCcEEEEeecccee
Q 003982 705 ----------------------------QQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (782)
Q Consensus 705 ----------------------------~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~ 736 (782)
...++|+|+.|.||++++++.+-|+||+.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 154 DCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12489999999999999877678999998764
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.39 E-value=5.5e-09 Score=95.81 Aligned_cols=71 Identities=17% Similarity=0.096 Sum_probs=42.6
Q ss_pred CCCCCCCCEEeccCCCCCCCCCCCcccCCCcccCeeeccccccCCCCcccccCCCCCcEEEcccCcCCCCC
Q 003982 133 FDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSL 203 (782)
Q Consensus 133 ~~~l~~L~~L~Ls~N~l~~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 203 (782)
+.++++|++|+|++|+|+....++..+..+++|+.|+|++|+|+...+-.+....+|+.|++++|.+....
T Consensus 61 ~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~ 131 (162)
T d1koha1 61 EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTF 131 (162)
T ss_dssp HHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSS
T ss_pred HHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCc
Confidence 34456666666666666553223344556667777777777776654433444456777777777776443
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.36 E-value=5.7e-09 Score=95.68 Aligned_cols=105 Identities=19% Similarity=0.188 Sum_probs=69.6
Q ss_pred ccCCccCceeecccCccCccCCCCCCCCCCCEEeCCCCcccCCCC--CCCCCCCCCCEEeccCCCCCCCCCCCc-ccCCC
Q 003982 86 ISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPT--GCFDGLTNLQVLSLSDNPNLAPWPFPN-ELTKS 162 (782)
Q Consensus 86 l~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~p~-~~~~l 162 (782)
+..+..+..++..++.+......+.++++|++|+|++|+|+.+.+ ..+..+++|+.|||++|+++. ++. .+...
T Consensus 38 l~~~~~~~~l~~~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~---l~~l~~l~~ 114 (162)
T d1koha1 38 LVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS---ERELDKIKG 114 (162)
T ss_dssp TTTTTCCCCTTSHHHHHHHHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCC---GGGHHHHTT
T ss_pred hhhccchhhcchhhhHhhhhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCcccc---chhhhhhhc
Confidence 444444555555554443322234567888888888888887753 446678888888888888887 222 22334
Q ss_pred cccCeeeccccccCCCCc-------ccccCCCCCcEEE
Q 003982 163 TSLTTLYMDNANIFGLIP-------DFFDSFSNLQNLR 193 (782)
Q Consensus 163 ~~L~~L~L~~N~l~~~~~-------~~~~~l~~L~~L~ 193 (782)
.+|+.|++++|.+..... ..+..+|+|+.||
T Consensus 115 ~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 115 LKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred cccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 568888899888876544 2366789999886
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.01 E-value=5.5e-06 Score=81.32 Aligned_cols=131 Identities=21% Similarity=0.159 Sum_probs=87.2
Q ss_pred eeecccc-eEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCC--CCcceEEeEEEeCCeEEEEEEccCCC
Q 003982 588 ILGRGGF-GVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH--RHLVALLGYCINGSERLLVYEYMPRG 664 (782)
Q Consensus 588 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~nI~~~~~~~~~~~~~~lv~e~~~~g 664 (782)
.+..|.. +.||+....++..+++|...... ...+.+|++.++.+.. -.+++++++..+++..++||++++|.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~-----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC-----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 3445553 68999988788889999876543 2346778888877642 34678888888888999999999886
Q ss_pred CHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc-----------------------------------------
Q 003982 665 TLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSL----------------------------------------- 703 (782)
Q Consensus 665 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----------------------------------------- 703 (782)
++.+. ..+.. .++.++.+.+.-||+.
T Consensus 92 ~~~~~----------~~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (255)
T d1nd4a_ 92 DLLSS----------HLAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP 158 (255)
T ss_dssp ETTTS----------CCCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred ccccc----------cccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHH
Confidence 54221 01111 1122333333333320
Q ss_pred --------------CCCCeEEcCCCCCCEEECCCCcEEEEeecccee
Q 003982 704 --------------AQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (782)
Q Consensus 704 --------------~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~ 736 (782)
....++|+|+.|.||+++++..+-|+||+.+..
T Consensus 159 ~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 159 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 113489999999999999877778999998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.66 E-value=6.1e-05 Score=78.69 Aligned_cols=78 Identities=13% Similarity=0.152 Sum_probs=50.9
Q ss_pred cceeecccceEEEEEEeCC-CcEEEEEEeccccC--C---hhhHHHHHHHHHHHHhcC-C--CCcceEEeEEEeCCeEEE
Q 003982 586 ANILGRGGFGVVYGGELPD-GTKIAVKRMESNTM--G---NKGLSEFQAEIAVLTKVR-H--RHLVALLGYCINGSERLL 656 (782)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~---~~~~~~~~~E~~~l~~l~-h--~nI~~~~~~~~~~~~~~l 656 (782)
.+.||.|....||++...+ ++.|+||.-..... . .....+...|.+.++.+. + ..+++++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4568999999999996544 67899997643210 0 112345667888887663 2 346666654 5666789
Q ss_pred EEEccCCCC
Q 003982 657 VYEYMPRGT 665 (782)
Q Consensus 657 v~e~~~~gs 665 (782)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.64 E-value=4.2e-06 Score=76.34 Aligned_cols=93 Identities=10% Similarity=0.156 Sum_probs=53.5
Q ss_pred cccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeecccccCCCC-----CCCC
Q 003982 182 FFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIP-----DLSK 256 (782)
Q Consensus 182 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-----~~~~ 256 (782)
.+...++|++|+|++|.+.......++ ..+...+.|++|+|++|.++.... .+..
T Consensus 39 ~L~~n~~L~~L~Ls~n~l~~~~~~~la--------------------~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~ 98 (167)
T d1pgva_ 39 AACNSKHIEKFSLANTAISDSEARGLI--------------------ELIETSPSLRVLNVESNFLTPELLARLLRSTLV 98 (167)
T ss_dssp HHTTCSCCCEEECTTSCCBHHHHTTHH--------------------HHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTT
T ss_pred HHhhCCccceeeccccccchhHHHHHh--------------------hhhhhcccccceeeehhhcchHHHHHHHHHHHh
Confidence 445556677777777766522111121 123335667777777777664221 2566
Q ss_pred CCCCCEEEcCCCcCccC-------cchhhcCCCCCCEEEccCCcc
Q 003982 257 CESLFDLSLRDNQLTGV-------VPASVISLPALLNISLQNNKL 294 (782)
Q Consensus 257 l~~L~~L~L~~N~l~~~-------~p~~~~~l~~L~~L~l~~N~l 294 (782)
.++|++|+|++|.+... +...+...+.|+.|+++.+..
T Consensus 99 n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 99 TQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp TCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred CCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 67788888877765422 344455567777777766543
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.50 E-value=1e-05 Score=73.65 Aligned_cols=40 Identities=10% Similarity=0.027 Sum_probs=20.6
Q ss_pred ccccccCCeEecccccccc-------cCCccCCCCCCCCeEecCCCc
Q 003982 387 YANLTSLKNLYLQQNNLTG-------PIPDGLTKLASLQNLDVSNNN 426 (782)
Q Consensus 387 ~~~l~~L~~L~Ls~N~l~g-------~~p~~~~~l~~L~~L~ls~N~ 426 (782)
+...+.|++|+|++|++.. .+.+.+...+.|+.|+++++.
T Consensus 96 L~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 96 TLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp TTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 3444556666666655431 123334445666666665543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.11 E-value=0.00067 Score=68.57 Aligned_cols=138 Identities=14% Similarity=0.054 Sum_probs=79.4
Q ss_pred ceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCcc--eEE-----eEEEeCCeEEEEEEccCCCCH
Q 003982 594 FGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV--ALL-----GYCINGSERLLVYEYMPRGTL 666 (782)
Q Consensus 594 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~--~~~-----~~~~~~~~~~lv~e~~~~gsL 666 (782)
--.||++...+|+.|++|+..... ...+.+..|.+.+..+....|. ..+ ......+..+.++++++|..+
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~---~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPER---WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTT---SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred cceeEEEEcCCCCEEEEEEeCCCC---CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence 358999998899999999987643 2346677888888887533322 111 123446678899999976332
Q ss_pred H-----------HHHHhhcc-------CCCCCCCH-------------------H---HHHHHHHHHHHHHHHHh-hcCC
Q 003982 667 A-----------QHLFEWHD-------HGYTPLTW-------------------K---QRVTIALDVARGVEYLH-SLAQ 705 (782)
Q Consensus 667 ~-----------~~l~~~~~-------~~~~~l~~-------------------~---~~~~i~~qi~~aL~~LH-~~~~ 705 (782)
. +.+.+.+. ......+. . .....+.++...+.-.- ....
T Consensus 112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p 191 (325)
T d1zyla1 112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT 191 (325)
T ss_dssp CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred CCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCC
Confidence 1 11111110 00111111 1 11122222222222221 1123
Q ss_pred CCeEEcCCCCCCEEECCCCcEEEEeecccee
Q 003982 706 QSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (782)
Q Consensus 706 ~~ivHrDikp~NIll~~~~~~kL~DfG~a~~ 736 (782)
.++||+|+.+.|||++++ ..++||+-+..
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 589999999999999754 45899998764
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.91 E-value=0.0016 Score=65.27 Aligned_cols=161 Identities=12% Similarity=0.046 Sum_probs=85.9
Q ss_pred ccHHHHHHHhcCCCccceee-----cccceEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHHhcCCCCc--ce
Q 003982 571 ISIEVLRQVTDNFSEANILG-----RGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHL--VA 643 (782)
Q Consensus 571 ~~~~~l~~~~~~y~~~~~lg-----~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI--~~ 643 (782)
.+.+++..+..+|.+.+... .|---+.|+....+| .|++|+++... ..+++..|++++..+...++ +.
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~----~~~~l~~~~~~l~~L~~~g~pvp~ 77 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPL 77 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC----CHHHHHHHHHHHHhhhhccccccc
Confidence 45678888889998855543 455567899987555 58999986532 12345566777776643222 22
Q ss_pred EEe------EEEeCCeEEEEEEccCCCCHHH-----------H---HHhhccCC----CCCCC-----------------
Q 003982 644 LLG------YCINGSERLLVYEYMPRGTLAQ-----------H---LFEWHDHG----YTPLT----------------- 682 (782)
Q Consensus 644 ~~~------~~~~~~~~~lv~e~~~~gsL~~-----------~---l~~~~~~~----~~~l~----------------- 682 (782)
.+. +.........++.++.+..... . ++...... .....
T Consensus 78 pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (316)
T d2ppqa1 78 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 157 (316)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred cceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhh
Confidence 111 1223455677777776643211 0 11000000 00000
Q ss_pred -HHHHHHHHHHHHHHHHHHhh-cCCCCeEEcCCCCCCEEECCCCcEEEEeecccee
Q 003982 683 -WKQRVTIALDVARGVEYLHS-LAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (782)
Q Consensus 683 -~~~~~~i~~qi~~aL~~LH~-~~~~~ivHrDikp~NIll~~~~~~kL~DfG~a~~ 736 (782)
.......+......+.-.+. .-..|+||+|+.+.||+++.+...-++||+.+..
T Consensus 158 ~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 158 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 00111111122222222221 1246899999999999999888778999998753
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.78 E-value=4e-05 Score=69.58 Aligned_cols=94 Identities=13% Similarity=0.199 Sum_probs=52.6
Q ss_pred ccccCCCCCcEEEcccCcCCCCCCccccccccchhhcccccCCCccccccccCCCCCcEEEeecccccCCC-----CCCC
Q 003982 181 DFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPI-----PDLS 255 (782)
Q Consensus 181 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~-----~~~~ 255 (782)
..+...++|++|+|++|.++...-..++ ..+...++++.|++++|.++... ..+.
T Consensus 40 ~al~~n~~L~~L~Ls~n~l~~~~~~~L~--------------------~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~ 99 (166)
T d1io0a_ 40 EALKTNTYVKKFSIVGTRSNDPVAFALA--------------------EMLKVNNTLKSLNVESNFISGSGILALVEALQ 99 (166)
T ss_dssp HHHTTCCSCCEEECTTSCCCHHHHHHHH--------------------HHHHHCSSCCEEECCSSCCCHHHHHHHHHGGG
T ss_pred HHHhcCCccCeeeccCCcccHHHHHHHH--------------------HHHhhcccchhhhhccccccchhHHHHHHHHH
Confidence 3445666777777777766522211121 12333566777777777665421 1245
Q ss_pred CCCCCCEEEc--CCCcCcc----CcchhhcCCCCCCEEEccCCcc
Q 003982 256 KCESLFDLSL--RDNQLTG----VVPASVISLPALLNISLQNNKL 294 (782)
Q Consensus 256 ~l~~L~~L~L--~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l 294 (782)
..++|+.++| +.|.+.. .+.+.+...++|+.|+++.+..
T Consensus 100 ~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 100 SNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp GCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred hCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 5667776444 4566654 2445555677788887776654
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.43 E-value=0.00086 Score=60.31 Aligned_cols=63 Identities=13% Similarity=0.133 Sum_probs=28.8
Q ss_pred CCCCCcEEEeec-ccccCCCC-----CCCCCCCCCEEEcCCCcCccC----cchhhcCCCCCCEEEccCCccc
Q 003982 233 GMTQLRQVWLHK-NQFTGPIP-----DLSKCESLFDLSLRDNQLTGV----VPASVISLPALLNISLQNNKLQ 295 (782)
Q Consensus 233 ~l~~L~~L~L~~-N~l~~~~~-----~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~ 295 (782)
+.++|++|+|++ +.++...- .+...+.|+.|+|++|.++.. +...+...+.++.+++++|.++
T Consensus 15 ~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 15 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 87 (166)
T ss_dssp TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred cCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence 345666666655 33432110 134455555555555555432 1222233444555555444443
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.82 E-value=0.012 Score=60.71 Aligned_cols=73 Identities=18% Similarity=0.190 Sum_probs=48.8
Q ss_pred cceeecccceEEEEEEeCC--------CcEEEEEEeccccCChhhHHHHHHHHHHHHhcC-CCCcceEEeEEEeCCeEEE
Q 003982 586 ANILGRGGFGVVYGGELPD--------GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSERLL 656 (782)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~~~l 656 (782)
++.|+.|-.-.+|++...+ .+.|.+++.-. . ....+..+|.++++.+. +.-.+++++++.. .+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~---~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~ 118 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P---ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 118 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C---CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c---chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence 4678778888999997643 34577776642 2 22345668999998885 4444577776532 68
Q ss_pred EEEccCCCCH
Q 003982 657 VYEYMPRGTL 666 (782)
Q Consensus 657 v~e~~~~gsL 666 (782)
|+||++|..+
T Consensus 119 I~efi~g~~l 128 (395)
T d1nw1a_ 119 LEEYIPSRPL 128 (395)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeccccC
Confidence 9999987443
|